PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hoffman, MR				Hoffman, Melissa Red			Trauma Comes Home	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a surgeon tells of her experience as a caretaker for her partner disabled by chronic sequelae of head trauma, and the challenges it poses as she tries to maintain the professional distance required to do her job as a trauma attending.	[Hoffman, Melissa Red] Mission Hosp, 509 Biltmore Ave, Asheville, NC 28801 USA		Hoffman, MR (corresponding author), Mission Hosp, 509 Biltmore Ave, Asheville, NC 28801 USA.	redhoffman@gmail.com						Hoffman MR, 2019, JAMA-J AM MED ASSOC, V322, P117, DOI 10.1001/jama.2019.8385	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					937	938		10.1001/jama.2021.0594	http://dx.doi.org/10.1001/jama.2021.0594			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687466				2022-12-28	WOS:000627899400014
J	Kuehn, BM				Kuehn, Bridget M.			Dramatic Cervical Cancer Screening Decline During Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					925	925		10.1001/jama.2021.1977	http://dx.doi.org/10.1001/jama.2021.1977			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687473	Bronze			2022-12-28	WOS:000627899400007
J	Rimmer, A				Rimmer, Abi			Covid-19: Female doctors felt compelled to step up during the pandemic, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2021	372								n658	10.1136/bmj.n658	http://dx.doi.org/10.1136/bmj.n658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YR5OK	33685934				2022-12-28	WOS:000750041400001
J	Miller-Jones, JCA; Bahramian, A; Orosz, JA; Mandel, I; Gou, LJ; Maccarone, TJ; Neijssel, CJ; Zhao, XS; Ziolkowski, J; Reid, MJ; Uttley, P; Zheng, XY; Byun, DY; Dodson, R; Grinberg, V; Jung, T; Kim, JS; Marcote, B; Markoff, S; Rioja, MJ; Rushton, AP; Russell, DM; Sivakoff, GR; Tetarenko, AJ; Tudose, V; Wilms, J				Miller-Jones, James C. A.; Bahramian, Arash; Orosz, Jerome A.; Mandel, Ilya; Gou, Lijun; Maccarone, Thomas J.; Neijssel, Coenraad J.; Zhao, Xueshan; Ziolkowski, Janusz; Reid, Mark J.; Uttley, Phil; Zheng, Xueying; Byun, Do-Young; Dodson, Richard; Grinberg, Victoria; Jung, Taehyun; Kim, Jeong-Sook; Marcote, Benito; Markoff, Sera; Rioja, Maria J.; Rushton, Anthony P.; Russell, David M.; Sivakoff, Gregory R.; Tetarenko, Alexandra J.; Tudose, Valeriu; Wilms, Joern			Cygnus X-1 contains a 21-solar mass black hole-Implications for massive star winds	SCIENCE			English	Article								The evolution of massive stars is influenced by the mass lost to stellar winds over their lifetimes. These winds limit the masses of the stellar remnants (such as black holes) that the stars ultimately produce. We used radio astrometry to refine the distance to the black hole x-ray binary Cygnus X-1, which we found to be 2.22(-0.17)(+0.18) kiloparsecs. When combined with archival optical data, this implies a black hole mass of 21.2 +/- +/- 2.2 solar masses, which is higher than previous measurements. The formation of such a high-mass black hole in a high-metallicity system (within the Milky Way) constrains wind mass loss from massive stars.	[Miller-Jones, James C. A.; Bahramian, Arash] Curtin Univ, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Orosz, Jerome A.] San Diego State Univ, Dept Astron, San Diego, CA 92182 USA; [Mandel, Ilya; Neijssel, Coenraad J.] Monash Univ, Sch Phys & Astron, Clayton, Vic 3800, Australia; [Mandel, Ilya; Neijssel, Coenraad J.] OzGrav Australian Res Council Ctr Excellence Grav, Hawthorn, Vic 3122, Australia; [Mandel, Ilya; Neijssel, Coenraad J.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Gou, Lijun; Zhao, Xueshan; Zheng, Xueying] Chinese Acad Sci, Key Lab Computat Astrophys, Natl Astron Observ, Beijing 100012, Peoples R China; [Gou, Lijun; Zhao, Xueshan; Zheng, Xueying] Univ Chinese Acad Sci, Beijing 100012, Peoples R China; [Maccarone, Thomas J.] Texas Tech Univ, Dept Phys & Astron, Lubbock, TX 79409 USA; [Ziolkowski, Janusz] Nicolaus Copernicus Astron Ctr, PL-00716 Warsaw, Poland; [Reid, Mark J.] Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA 02138 USA; [Uttley, Phil; Markoff, Sera] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Byun, Do-Young; Jung, Taehyun; Kim, Jeong-Sook] Korea Astron & Space Sci Inst, Daejeon 34055, South Korea; [Byun, Do-Young; Jung, Taehyun] Univ Sci & Technol, Daejeon 34113, South Korea; [Dodson, Richard; Rioja, Maria J.] Univ Western Australia, Int Ctr Radio Astron Res, Crawley, WA 6009, Australia; [Grinberg, Victoria] Univ Tubingen, Inst Astron & Astrophys, D-72076 Tubingen, Germany; [Marcote, Benito] European Res Infrastruct Consortium, Joint Inst Very Long Baseline Interferometry, NL-7991 PD Dwingeloo, Netherlands; [Markoff, Sera] Univ Amsterdam, Gravitat & Astroparticle Phys Amsterdam Inst, NL-1098 XH Amsterdam, Netherlands; [Rioja, Maria J.] CSIRO, Astron & Space Sci, Perth, WA 6102, Australia; [Rioja, Maria J.] Inst Geog Nacl Expanol, Observ Astronom Nacl, Madrid 28014, Spain; [Rushton, Anthony P.] Univ Oxford, Dept Phys, Astrophys, Oxford OX1 3RH, England; [Rushton, Anthony P.] Univ Southampton, Sch Phys & Astron, Southampton SO17 1BJ, Hants, England; [Russell, David M.] New York Univ Abu Dhabi, Ctr Astro Particle & Planetary Phys, Abu Dhabi, U Arab Emirates; [Sivakoff, Gregory R.] Univ Alberta, Centennial Ctr Interdisciplinary Sci, Dept Phys, Edmonton, AB T6G 2E1, Canada; [Tetarenko, Alexandra J.] East Asian Observ, Hilo, HI 96720 USA; [Tudose, Valeriu] Inst Space Sci, Bucharest 077125, Romania; [Wilms, Joern] Friedrich Alexander Univ Erlangen Nurnberg, Dr Karl Remeis Sternwarte & Erlangen Ctr Astropar, D-96049 Bamberg, Germany; [Zheng, Xueying] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany	Curtin University; California State University System; San Diego State University; Monash University; University of Birmingham; Chinese Academy of Sciences; National Astronomical Observatory, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Texas Tech University System; Texas Tech University; Polish Academy of Sciences; Nicolaus Copernicus Astronomical Center of the Polish Academy of Sciences; Smithsonian Institution; University of Amsterdam; Korea Astronomy & Space Science Institute (KASI); University of Science & Technology (UST); University of Western Australia; Eberhard Karls University of Tubingen; University of Amsterdam; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Oxford; University of Southampton; University of Alberta; Institute of Space Science; University of Erlangen Nuremberg; Max Planck Society	Miller-Jones, JCA (corresponding author), Curtin Univ, Int Ctr Radio Astron Res, Perth, WA 6845, Australia.	james.miller-jones@curtin.edu.au	Wilms, Joern/C-8116-2013; Dodson, Richard/H-9100-2014; Miller-Jones, James/B-2411-2013	Wilms, Joern/0000-0003-2065-5410; Tetarenko, Alexandra/0000-0003-3906-4354; Marcote, Benito/0000-0001-9814-2354; Dodson, Richard/0000-0003-0392-3604; Russell, David/0000-0002-3500-631X; Miller-Jones, James/0000-0003-3124-2814; Mandel, Ilya/0000-0002-6134-8946; Tudose, Valeriu/0000-0001-5317-220X; Zhao, Xue-Shan/0000-0002-3281-5306; Reid, Mark/0000-0001-7223-754X; Grinberg, Victoria/0000-0003-2538-0188; Rioja, Maria J./0000-0003-4871-9535	Australian Research Council Future Fellowships - Australian government [FT140101082, FT190100574]; National Program on Key Research and Development Project [2016YFA0400804]; National NSFC [U1838114]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB23040100]; Margarete von Wrangell fellowship by the ESF; Ministry of Science, Research and the Arts Baden-Wurttemberg; Spanish Ministerio de Economia y Competitividad (MINECO) [AYA2016-76012-C3-1-P]; Spanish Ministerio de Ciencia e Innovacion under ICCUB (Unidad de Excelencia "Maria de Maeztu" 2020-2023) [PID2019-105510GB-C31, CEX2019-000918-M]; Netherlands Organization for Scientific Research (NWO) VICI grant [639.043.513]; NSERC [RGPIN-2016-06569]; program Laplas VI of the Romanian National Authority for Scientific Research; Bundesministerium fur Wirtschaft und Technologie under Deutsches Zentrum fur Luft-und Raumfahrt grant [50 OR 1606]; Polish National Science Centre [2015/18/A/ST9/00746]	Australian Research Council Future Fellowships - Australian government(Australian Research Council); National Program on Key Research and Development Project; National NSFC(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Margarete von Wrangell fellowship by the ESF; Ministry of Science, Research and the Arts Baden-Wurttemberg; Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Spanish Ministerio de Ciencia e Innovacion under ICCUB (Unidad de Excelencia "Maria de Maeztu" 2020-2023); Netherlands Organization for Scientific Research (NWO) VICI grant(Netherlands Organization for Scientific Research (NWO)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); program Laplas VI of the Romanian National Authority for Scientific Research; Bundesministerium fur Wirtschaft und Technologie under Deutsches Zentrum fur Luft-und Raumfahrt grant; Polish National Science Centre	J.C.A.M.-J. and I.M. are recipients of Australian Research Council Future Fellowships (FT140101082 and FT190100574, respectively) funded by the Australian government. L.G. acknowledges support from the National Program on Key Research and Development Project through grant 2016YFA0400804, and from the National NSFC with grant U1838114, and by the Strategic Priority Research Program of the Chinese Academy of Sciences through grant XDB23040100. V.G. is supported through the Margarete von Wrangell fellowship by the ESF and the Ministry of Science, Research and the Arts Baden-Wurttemberg. B.M. acknowledges support from the Spanish Ministerio de Economia y Competitividad (MINECO) under grant AYA2016-76012-C3-1-P and from the Spanish Ministerio de Ciencia e Innovacion under grants PID2019-105510GB-C31 and CEX2019-000918-M of ICCUB (Unidad de Excelencia "Maria de Maeztu" 2020-2023). S.M. was supported by the Netherlands Organization for Scientific Research (NWO) VICI grant (639.043.513). G.R.S. acknowledges support from an NSERC Discovery Grant (RGPIN-2016-06569). V.T. is supported by program Laplas VI of the Romanian National Authority for Scientific Research. J.W. acknowledges funding from the Bundesministerium fur Wirtschaft und Technologie under Deutsches Zentrum fur Luft-und Raumfahrt grant 50 OR 1606. J.Z. acknowledges the support from the Polish National Science Centre grant 2015/18/A/ST9/00746.	Abbott BP, 2019, ASTROPHYS J LETT, V882, DOI 10.3847/2041-8213/ab3800; Abdul-Masih M, 2020, NATURE, V580, pE11, DOI 10.1038/s41586-020-2216-x; Arcavi I, 2017, NATURE, V551, P210, DOI 10.1038/nature24030; Arcavi I, 2017, NATURE, V551, P64, DOI 10.1038/nature24291; Astraatmadja TL, 2016, ASTROPHYS J, V832, DOI 10.3847/0004-637X/832/2/137; Axelsson M, 2011, MON NOT R ASTRON SOC, V412, P2260, DOI 10.1111/j.1365-2966.2010.18050.x; BARDEEN JM, 1972, ASTROPHYS J, V178, P347, DOI 10.1086/151796; Barrett JW, 2018, MON NOT R ASTRON SOC, V477, P4685, DOI 10.1093/mnras/sty908; Bavera SS, 2020, ASTRON ASTROPHYS, V635, DOI 10.1051/0004-6361/201936204; Belczynski K, 2020, ASTRON ASTROPHYS, V636, DOI 10.1051/0004-6361/201936528; Belczynski K, 2010, ASTROPHYS J, V714, P1217, DOI 10.1088/0004-637X/714/2/1217; Betancourt M., 2017, ARXIV170601520 STATM; Bianco G., 2009, ITN, V35, P1; Binder B, 2015, MON NOT R ASTRON SOC, V451, P4471, DOI 10.1093/mnras/stv1305; Binder B, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/128; Blaauw A., 1961, BAN, V15, P265; Bressan A, 2012, MON NOT R ASTRON SOC, V427, P127, DOI 10.1111/j.1365-2966.2012.21948.x; Brocksopp C, 1999, MON NOT R ASTRON SOC, V309, P1063, DOI 10.1046/j.1365-8711.1999.02919.x; Brocksopp C, 2002, MON NOT R ASTRON SOC, V336, P699, DOI 10.1046/j.1365-8711.2002.05813.x; Brocksopp C, 1999, ASTRON ASTROPHYS, V343, P861; Brown AGA, 2021, ASTRON ASTROPHYS, V649, DOI 10.1051/0004-6361/202039657; Brown AGA, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201833051; Caballero-Nieves SM, 2009, ASTROPHYS J, V701, P1895, DOI 10.1088/0004-637X/701/2/1895; Carpano S, 2007, ASTRON ASTROPHYS, V466, pL17, DOI 10.1051/0004-6361:20077363; Casares J, 2014, SPACE SCI REV, V183, P223, DOI 10.1007/s11214-013-0030-6; Chan VC, 2020, MON NOT R ASTRON SOC, V493, P4367, DOI 10.1093/mnras/staa571; Charlot P, 2020, ASTRON ASTROPHYS, V644, DOI 10.1051/0004-6361/202038368; Chruslinska M, 2019, MON NOT R ASTRON SOC, V488, P5300, DOI 10.1093/mnras/stz2057; Condon JJ, 1998, ASTRON J, V115, P1693, DOI 10.1086/300337; Crowther PA, 2010, MON NOT R ASTRON SOC, V403, pL41, DOI 10.1111/j.1745-3933.2010.00811.x; Deller AT, 2011, PUBL ASTRON SOC PAC, V123, P275, DOI 10.1086/658907; Duro R, 2016, ASTRON ASTROPHYS, V589, DOI 10.1051/0004-6361/201424740; El-Badry K, 2020, MON NOT R ASTRON SOC, V493, pL22, DOI 10.1093/mnrasl/slaa004; Farr WM, 2017, NATURE, V548, P426, DOI 10.1038/nature23453; Fryer CL, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/91; Fuller J, 2019, ASTROPHYS J LETT, V881, DOI 10.3847/2041-8213/ab339b; Gies DR, 2003, ASTROPHYS J, V583, P424, DOI 10.1086/345345; Gou LJ, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/29; Gou LJ, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/85; Grinberg V, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201322969; Haiman Z, 1997, ASTROPHYS J, V483, P21, DOI 10.1086/304238; Heck A., 2003, INFORM HANDLING ASTR, V285; HERRERO A, 1995, ASTRON ASTROPHYS, V297, P556; Higgins ER, 2019, ASTRON ASTROPHYS, V622, DOI 10.1051/0004-6361/201834123; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Hotokezaka K, 2017, ASTROPHYS J, V842, DOI 10.3847/1538-4357/aa6f61; HUMPHREYS RM, 1994, PUBL ASTRON SOC PAC, V106, P1025, DOI 10.1086/133478; Hurley JR, 2000, MON NOT R ASTRON SOC, V315, P543, DOI 10.1046/j.1365-8711.2000.03426.x; Israelian G, 1999, NATURE, V401, P142, DOI 10.1038/43625; KIPPENHAHN R, 1967, Z ASTROPHYS, V65, P251; KIPPENHAHN R, 1980, ASTRON ASTROPHYS, V91, P175; Kushnir D, 2016, MON NOT R ASTRON SOC, V462, P844, DOI 10.1093/mnras/stw1684; Laycock SGT, 2015, MON NOT R ASTRON SOC, V452, pL31, DOI 10.1093/mnrasl/slv082; Lindegren L., 2020, ARXIV201201742ASTROP; Liu JF, 2019, NATURE, V575, P618, DOI 10.1038/s41586-019-1766-2; Luri X, 2018, ASTRON ASTROPHYS, V616, DOI 10.1051/0004-6361/201832964; MAEDER A, 1983, ASTRON ASTROPHYS, V120, P113; Mandel I, 2016, MON NOT R ASTRON SOC, V458, P2634, DOI 10.1093/mnras/stw379; Marchant P, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201628133; McClintock JE, 2006, ASTROPHYS J, V652, P518, DOI 10.1086/508457; McClintock JE, 2014, SPACE SCI REV, V183, P295, DOI 10.1007/s11214-013-0003-9; Mennekens N, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322198; Miller MC, 2015, PHYS REP, V548, P1, DOI 10.1016/j.physrep.2014.09.003; Miller-Jones J. C. A, 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4548614, DOI 10.5281/ZENODO.4548614]; Mirabel IF, 2003, SCIENCE, V300, P1119, DOI 10.1126/science.1083451; Neal RM, 2011, CH CRC HANDB MOD STA, P113; Neijssel CJ, 2021, ASTROPHYS J, V908, DOI 10.3847/1538-4357/abde4a; Neijssel CJ, 2019, MON NOT R ASTRON SOC, V490, P3740, DOI 10.1093/mnras/stz2840; Novikov I., 1973, LES ASTRES OCCLUS, V343; Orosz JA, 2000, ASTRON ASTROPHYS, V364, P265; Orosz JA, 2007, NATURE, V449, P872, DOI 10.1038/nature06218; Orosz JA, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/84; Parker ML, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/9; Paxton B, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/3; Podsiadlowski P, 2003, MON NOT R ASTRON SOC, V341, P385, DOI 10.1046/j.1365-8711.2003.06464.x; Podsiadlowski P, 2002, ASTROPHYS J, V567, P491, DOI 10.1086/338418; Pradel N, 2006, ASTRON ASTROPHYS, V452, P1099, DOI 10.1051/0004-6361:20053021; Prestwich AH, 2007, ASTROPHYS J, V669, P21; Puls J, 2006, ASTRON ASTROPHYS, V454, P625, DOI 10.1051/0004-6361:20065073; Puls J, 2008, ASTRON ASTROPHYS REV, V16, P209, DOI 10.1007/s00159-008-0015-8; Qin Y, 2019, ASTROPHYS J LETT, V870, DOI 10.3847/2041-8213/aaf97b; Rao A, 2020, MON NOT R ASTRON SOC, V495, P1491, DOI 10.1093/mnras/staa1217; Reid MJ, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa7850; Reid MJ, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/83; Renzo M, 2017, ASTRON ASTROPHYS, V603, DOI 10.1051/0004-6361/201730698; Russell DM, 2007, MON NOT R ASTRON SOC, V376, P1341, DOI 10.1111/j.1365-2966.2007.11539.x; Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55; Schroder SL, 2018, ASTROPHYS J LETT, V862, DOI 10.3847/2041-8213/aacf8d; Shafee R, 2006, ASTROPHYS J, V636, pL113, DOI 10.1086/498938; Shenar T, 2020, ASTRON ASTROPHYS, V639, DOI 10.1051/0004-6361/202038275; Shimanskii VV, 2012, ASTRON REP+, V56, P741, DOI 10.1134/S106377291210006X; Silverman JM, 2008, ASTROPHYS J LETT, V678, pL17, DOI 10.1086/588096; Steiner JF, 2009, ASTROPHYS J LETT, V701, pL83, DOI 10.1088/0004-637X/701/2/L83; Stevenson S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14906; Stirling AM, 2001, MON NOT R ASTRON SOC, V327, P1273, DOI 10.1046/j.1365-8711.2001.04821.x; Szostek A, 2007, MON NOT R ASTRON SOC, V375, P793, DOI 10.1111/j.1365-2966.2006.11346.x; Tetarenko AJ, 2019, MON NOT R ASTRON SOC, V484, P2987, DOI 10.1093/mnras/stz165; Tetarenko BE, 2016, ASTROPHYS J SUPPL S, V222, DOI 10.3847/0067-0049/222/2/15; THORNE KS, 1974, ASTROPHYS J, V191, P507, DOI 10.1086/152991; Tomsick JA, 2018, ASTROPHYS J, V855, DOI 10.3847/1538-4357/aaaab1; Tomsick JA, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/78; Valsecchi F, 2010, NATURE, V468, P77, DOI 10.1038/nature09463; Vigna-Gomez A, 2018, MON NOT R ASTRON SOC, V481, P4009, DOI 10.1093/mnras/sty2463; Vink JS, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0269; Vink JS, 2001, ASTRON ASTROPHYS, V369, P574, DOI 10.1051/0004-6361:20010127; Vink JS, 2005, ASTRON ASTROPHYS, V442, P587, DOI 10.1051/0004-6361:20052862; Walton DJ, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/1/87; Wong TW, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/111; Yoon D, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/1/55; Zaldarriaga M, 2018, MON NOT R ASTRON SOC, V473, P4174, DOI 10.1093/mnras/stx2577; Zanin R, 2016, ASTRON ASTROPHYS, V596, DOI 10.1051/0004-6361/201628917; Zhao XS, 2021, ASTROPHYS J, V908, DOI 10.3847/1538-4357/abbcd6; Ziolkowski J, 2005, MON NOT R ASTRON SOC, V358, P851, DOI 10.1111/j.1365-2966.2005.08796.x; Ziolkowski J, 2014, MON NOT R ASTRON SOC, V440, pL61, DOI 10.1093/mnrasl/slu002	118	67	68	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1046	+		10.1126/science.abb3363	http://dx.doi.org/10.1126/science.abb3363			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33602863	Green Submitted			2022-12-28	WOS:000625876100054
J	Song, YB; Shan, L; Gbyli, R; Liu, W; Strowig, T; Patel, A; Fu, XY; Wang, XM; Xu, ML; Gao, YM; Qin, A; Bruscia, EM; Tebaldi, T; Biancon, G; Mamillapalli, P; Urbonas, D; Eynon, E; Gonzalez, DG; Chen, J; Krause, DS; Alderman, J; Halene, S; Flavell, RA				Song, Yuanbin; Shan, Liang; Gbyli, Rana; Liu, Wei; Strowig, Till; Patel, Amisha; Fu, Xiaoying; Wang, Xiaman; Xu, Mina L.; Gao, Yimeng; Qin, Ashley; Bruscia, Emanuela M.; Tebaldi, Toma; Biancon, Giulia; Mamillapalli, Padmavathi; Urbonas, David; Eynon, Elizabeth; Gonzalez, David G.; Chen, Jie; Krause, Diane S.; Alderman, Jonathan; Halene, Stephanie; Flavell, Richard A.			Combined liver-cytokine humanization comes to the rescue of circulating human red blood cells	SCIENCE			English	Article								In vivo models that recapitulate human erythropoiesis with persistence of circulating red blood cells (RBCs) have remained elusive. We report an immunodeficient murine model in which combined human liver and cytokine humanization confer enhanced human erythropoiesis and RBC survival in the circulation. We deleted the fumarylacetoacetate hydrolase (Fah) gene in MISTRG mice expressing several human cytokines in place of their murine counterparts. Liver humanization by intrasplenic injection of human hepatocytes (huHep) eliminated murine complement C3 and reduced murine Kupffer cell density. Engraftment of human sickle cell disease (SCD)-derived hematopoietic stem cells in huHepMISTRGFah(-/-) mice resulted in vaso-occlusion that replicated acute SCD pathology. Combined liver-cytokine-humanized mice will facilitate the study of diseases afflicting RBCs, including bone marrow failure, hemoglobinopathies, and malaria, and also preclinical testing of therapies.	[Song, Yuanbin; Gbyli, Rana; Liu, Wei; Patel, Amisha; Fu, Xiaoying; Wang, Xiaman; Gao, Yimeng; Qin, Ashley; Tebaldi, Toma; Biancon, Giulia; Mamillapalli, Padmavathi; Halene, Stephanie] Yale Univ, Sch Med, Dept Internal Med, Sect Hematol,Yale Canc Ctr, New Haven, CT 06510 USA; [Song, Yuanbin; Gbyli, Rana; Liu, Wei; Patel, Amisha; Fu, Xiaoying; Wang, Xiaman; Gao, Yimeng; Qin, Ashley; Tebaldi, Toma; Biancon, Giulia; Mamillapalli, Padmavathi; Halene, Stephanie] Yale Univ, Sch Med, Yale Ctr RNA Sci & Med, 333 Cedar St, New Haven, CT 06520 USA; [Song, Yuanbin; Gbyli, Rana; Liu, Wei; Patel, Amisha; Fu, Xiaoying; Wang, Xiaman; Gao, Yimeng; Qin, Ashley; Tebaldi, Toma; Biancon, Giulia; Mamillapalli, Padmavathi; Krause, Diane S.; Halene, Stephanie] Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA; [Song, Yuanbin] Sun Yat Sen Univ, Dept Hematol Oncol, Ctr Canc, State Key Lab Oncol South China,Collaborat Innova, Guangzhou, Peoples R China; [Shan, Liang; Strowig, Till; Urbonas, David; Eynon, Elizabeth; Chen, Jie; Alderman, Jonathan; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Shan, Liang] Washington Univ, Sch Med, Dept Med Pathol & Immunol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63130 USA; [Strowig, Till] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Fu, Xiaoying] Shenzhen Childrens Hosp, Dept Lab Med, Shenzhen, Peoples R China; [Wang, Xiaman] Xi An Jiao Tong Univ, Dept Hematol, Affiliated Hosp 2, Xian, Peoples R China; [Xu, Mina L.; Krause, Diane S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Bruscia, Emanuela M.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Tebaldi, Toma] Univ Trento, Dept Cellular Computat & Integrat Biol CIBIO, Trento, Italy; [Gonzalez, David G.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Krause, Diane S.] Yale Sch Med, Dept Lab Med, New Haven, CT USA; [Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA	Yale University; Yale University; Yale University; State Key Lab Oncology South China; Sun Yat Sen University; Yale University; Washington University (WUSTL); Helmholtz Association; Helmholtz-Center for Infection Research; Xi'an Jiaotong University; Yale University; Yale University; University of Trento; Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Halene, S (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Hematol,Yale Canc Ctr, New Haven, CT 06510 USA.; Halene, S (corresponding author), Yale Univ, Sch Med, Yale Ctr RNA Sci & Med, 333 Cedar St, New Haven, CT 06520 USA.; Halene, S (corresponding author), Yale Univ, Sch Med, Yale Stem Cell Ctr, 333 Cedar St, New Haven, CT 06520 USA.; Shan, L; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Shan, L (corresponding author), Washington Univ, Sch Med, Dept Med Pathol & Immunol, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63130 USA.; Flavell, RA (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA.	liang.shan@wustl.edu; stephanie.halene@yale.edu; richard.flavell@yale.edu	Shan, Liang/ABB-9210-2021; Tebaldi, Toma/AAZ-5955-2020	Tebaldi, Toma/0000-0002-0625-1631; Song, Yuanbin/0000-0001-5580-5998; Strowig, Till/0000-0003-0185-1459; Shan, Liang/0000-0002-8833-2514	Animal Modeling Core of the YCCEH, a YCCEH Pilot grant [NIDDK U54DK106857]; Bill and Melinda Gates Foundation; NIH/NIDDK [R01DK102792]; Frederick A. Deluca Foundation; Howard Hughes Medical Institute; National Science Foundation for Young Scientists of China [81800122, 81801588]; NIH/NIAID [K99AI125065]; James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship	Animal Modeling Core of the YCCEH, a YCCEH Pilot grant; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Frederick A. Deluca Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation for Young Scientists of China; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship	This study was supported by the Animal Modeling Core of the YCCEH (NIDDK U54DK106857), a YCCEH Pilot grant (to Y.S.), in part by the Bill and Melinda Gates Foundation (to R.A.F.), in part by NIH/NIDDK R01DK102792 (to S.H.), The Frederick A. Deluca Foundation (to S.H.), and the Howard Hughes Medical Institute (to R.A.F.). Y.S. and X.F. were supported by the National Science Foundation for Young Scientists of China (Grant Nos. 81800122, 81801588). L.S. was supported by NIH/NIAID K99AI125065. Y.G. was supported by a James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellowship.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Bissig KD, 2007, P NATL ACAD SCI USA, V104, P20507, DOI 10.1073/pnas.0710528105; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Chang JC, 1998, P NATL ACAD SCI USA, V95, P14886, DOI 10.1073/pnas.95.25.14886; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Chen B, 2017, STEM CELL REP, V9, P1034, DOI 10.1016/j.stemcr.2017.08.018; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; Edwards Mina, 2013, Methods Mol Biol, V987, P283, DOI 10.1007/978-1-62703-321-3_24; Frenette PS, 2002, CURR OPIN HEMATOL, V9, P101, DOI 10.1097/00062752-200203000-00003; Guillot A, 2019, HEPATOL COMMUN, V3, P730, DOI 10.1002/hep4.1356; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hu Z, 2011, BLOOD, V118, P5938, DOI 10.1182/blood-2010-11-321414; Kaul DK, 2004, MICROCIRCULATION, V11, P153, DOI 10.1080/10739680490278457; Liu YF, 2019, BLOOD, V134, P579, DOI 10.1182/blood.2019000172; Malowany JI, 2012, SEMIN DIAGN PATHOL, V29, P49, DOI 10.1053/j.semdp.2011.07.005; Muncie HL, 2009, AM FAM PHYSICIAN, V80, P339; Nagel RL, 2001, BRIT J HAEMATOL, V112, P19, DOI 10.1046/j.1365-2141.2001.02286.x; Naik RP, 2017, EXPERT REV HEMATOL, V10, P1087, DOI 10.1080/17474086.2017.1395279; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; Rahmig S, 2016, STEM CELL REP, V7, P591, DOI 10.1016/j.stemcr.2016.08.005; Rathinam C, 2011, BLOOD, V118, P3119, DOI 10.1182/blood-2010-12-326926; Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; SADAHIRA Y, 1995, J EXP MED, V181, P411, DOI 10.1084/jem.181.1.411; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seu KG, 2017, FRONT IMMUNOL, V8, DOI [10.3389/fimmu.2017.01140, 10.3389/fimmu.2017.00300]; Song YB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08166-x; Thogmartin JR, 2009, AM J FOREN MED PATH, V30, P36, DOI 10.1097/PAF.0b013e3181873835; Ulyanova T, 2016, BLOOD, V128, P1756, DOI 10.1182/blood-2016-05-714527; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Williams Adam, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top087536; Yurino A, 2016, STEM CELL REP, V7, P425, DOI 10.1016/j.stemcr.2016.07.002	39	7	7	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1019	+		10.1126/science.abe2485	http://dx.doi.org/10.1126/science.abe2485			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674488	Green Accepted			2022-12-28	WOS:000625876100049
J	Zindel, J; Peiseler, M; Hossain, M; Deppermann, C; Lee, WY; Haenni, B; Zuber, B; Deniset, JF; Surewaard, BGJ; Candinas, D; Kubes, P				Zindel, J.; Peiseler, M.; Hossain, M.; Deppermann, C.; Lee, W. Y.; Haenni, B.; Zuber, B.; Deniset, J. F.; Surewaard, B. G. J.; Candinas, D.; Kubes, P.			Primordial GATA6 macrophages function as extravascular platelets in sterile injury	SCIENCE			English	Article							PERITONEAL-MACROPHAGES; IMMUNE-RESPONSE; INNATE IMMUNITY; KUPFFER CELLS; BINDING-SITE; RECEPTOR; CELOMOCYTES; EVOLUTION; ADHESION; GENES	Most multicellular organisms have a major body cavity that harbors immune cells. In primordial species such as purple sea urchins, these cells perform phagocytic functions but are also crucial in repairing injuries. In mammals, the peritoneal cavity contains large numbers of resident GATA6(+) macrophages, which may function similarly. However, it is unclear how cavity macrophages suspended in the fluid phase (peritoneal fluid) identify and migrate toward injuries. In this study, we used intravital microscopy to show that cavity macrophages in fluid rapidly form thrombus-like structures in response to injury by means of primordial scavenger receptor cysteine-rich domains. Aggregates of cavity macrophages physically sealed injuries and promoted rapid repair of focal lesions. In iatrogenic surgical situations, these cavity macrophages formed extensive aggregates that promoted the growth of intra-abdominal scar tissue known as peritoneal adhesions.	[Zindel, J.; Peiseler, M.; Hossain, M.; Deppermann, C.; Lee, W. Y.; Deniset, J. F.; Surewaard, B. G. J.; Kubes, P.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Zindel, J.; Peiseler, M.; Hossain, M.; Deppermann, C.; Lee, W. Y.; Deniset, J. F.; Surewaard, B. G. J.; Kubes, P.] Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada; [Zindel, J.; Peiseler, M.; Hossain, M.; Deppermann, C.; Deniset, J. F.; Surewaard, B. G. J.; Kubes, P.] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Zindel, J.; Candinas, D.] Univ Bern, Dept Visceral Surg & Med, Dept BioMed Res DBMR, Bern, Switzerland; [Deppermann, C.] Univ Med Ctr Hamburg Eppendorf, Inst Clin Chem & Lab Med, Hamburg, Germany; [Haenni, B.; Zuber, B.] Univ Bern, Inst Anat, Bern, Switzerland; [Deniset, J. F.] Univ Calgary, Cumming Sch Med, Dept Cardiac Sci, Calgary, AB, Canada; [Deniset, J. F.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bern; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Kubes, P (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Calgary, AB, Canada.; Kubes, P (corresponding author), Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada.	pkubes@ucalgary.ca		Deppermann, Carsten/0000-0003-3740-8635; Candinas, Daniel/0000-0002-9924-1749; Zindel, Joel/0000-0003-3685-9338; HOSSAIN, MOKARRAM/0000-0003-0411-944X; Peiseler, Moritz/0000-0001-6195-3866; Zuber, Benoit/0000-0001-7725-5579	Swiss National Science Foundation [SNSF P1BEP3_181164]; Deutsche Forschungsgemeinschaft (DFG) Research Fellowships [DE 2654/1-1, PE 2737/1-1]; Banting Fellowship; Canadian Institutes of Health Research; NSERC [RGPIN/07191-2019]; Heart and Stroke Foundation of Canada; Canada Research Chairs Program	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft (DFG) Research Fellowships(German Research Foundation (DFG)); Banting Fellowship; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chairs Program(Canada Research Chairs)	J.Z is supported by a fellowship from the Swiss National Science Foundation (SNSF P1BEP3_181164). C.D. and M.P. are supported by Deutsche Forschungsgemeinschaft (DFG) Research Fellowships (DE 2654/1-1 and PE 2737/1-1, respectively). M.H. is supported by a Banting Fellowship. J.F.D. and B.G.J.S. are supported by a fellowship from Canadian Institutes of Health Research. P.K. is supported by the NSERC Discover grant (RGPIN/07191-2019), the Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research, and the Canada Research Chairs Program.	Bianchi E, 2016, J SURG RES, V201, P226, DOI 10.1016/j.jss.2015.10.044; Blumbach B, 1998, J CELL SCI, V111, P2635; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; Brykczynska U, 2020, CELL REP, V30, P1627, DOI 10.1016/j.celrep.2020.01.005; Buchmann K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00459; Cassado AD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00225; CATES W, 1985, LANCET, V2, P596; Chia FS, 1996, ZOOL STUD, V35, P231; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; COFFARO KA, 1977, SCIENCE, V197, P1389, DOI 10.1126/science.331476; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Deniset JF, 2019, IMMUNITY, V51, P131, DOI 10.1016/j.immuni.2019.06.010; Deppermann C, 2013, J CLIN INVEST, V123, P3331, DOI 10.1172/JCI69210; Faust N, 2000, BLOOD, V96, P719; Freyer L, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0086-5; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/nmeth.3322, 10.1038/NMETH.3322]; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hillier BJ, 2003, J CELL BIOL, V160, P597, DOI 10.1083/jcb.200210053; Hooper, 1911, ENCYCL BRITANNICA, V6, P642; JOHNSON PT, 1969, J INVERTEBR PATHOL, V13, P25, DOI 10.1016/0022-2011(69)90236-5; Klingberg A, 2017, J AM SOC NEPHROL, V28, P452, DOI 10.1681/ASN.2016020232; Kraemer B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435056; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nagasawa T, 2015, FRONT IMMUNOL, V6, DOI [10.3389/fimmu.2015.00301, 10.3389/fimmu.2014.00445]; NELSON DS, 1963, LANCET, V2, P175; Nieuwenhuijzen M, 1998, BRIT J SURG, V85, P1242; NOLPH KD, 1979, J LAB CLIN MED, V93, P246; Pancer Z, 2000, P NATL ACAD SCI USA, V97, P13156, DOI 10.1073/pnas.230096397; Pancer Z, 1999, IMMUNOGENETICS, V49, P773, DOI 10.1007/s002510050551; Ritsma L, 2013, NAT PROTOC, V8, P583, DOI 10.1038/nprot.2013.026; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schreiber HA, 2013, J EXP MED, V210, P2025, DOI 10.1084/jem.20130903; Sikirica V, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-13; Smith LC, 1996, J IMMUNOL, V156, P593; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Stosik M, 2002, VET MED-CZECH, V47, P21, DOI 10.17221/5798-VETMED; Surewaard BGJ, 2017, METHODS, V128, P12, DOI 10.1016/j.ymeth.2017.05.004; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tsai JM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan6735; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; WEILER JM, 1992, J IMMUNOL, V148, P3210; Wong CHY, 2013, NAT IMMUNOL, V14, P785, DOI 10.1038/ni.2631; Yap NVL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00342; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024; Zindel J., 2021, DRYAD, DOI [10.5061/dryad.05qfttf1w, DOI 10.5061/DRYAD.05QFTTF1W]; Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847; ZUHLKE HV, 1990, LANGENBECK ARCH CHIR, P1009	56	33	33	18	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1013	+		10.1126/science.abe0595	http://dx.doi.org/10.1126/science.abe0595			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674464				2022-12-28	WOS:000625876100047
J	Wise, J				Wise, Jacqui			Covid-19: Highest death rates seen in countries with most overweight populations	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	20	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n623	10.1136/bmj.n623	http://dx.doi.org/10.1136/bmj.n623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664055	Bronze			2022-12-28	WOS:000632920100001
J	Camilleri, M				Camilleri, Michael			Diagnosis and Treatment of Irritable Bowel Syndrome A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FUNCTIONAL GASTROINTESTINAL DISORDERS; INTESTINAL BACTERIAL OVERGROWTH; COLONIC TRANSIT; CLINICAL-TRIAL; PHYSICAL-ACTIVITY; PEPPERMINT OIL; CONSTIPATION; EFFICACY; SAFETY; BIOFEEDBACK	This narrative review summarizes the epidemiology, pathophysiology, diagnosis, management, and prognosis of irritable bowel syndrome. Importance The prevalence of irritable bowel syndrome (IBS) in the United States is between 7% and 16%, most common in women and young people, with annual direct costs estimated at more than $1 billion dollars in the United States. Traditionally, the diagnosis of IBS has been based on the positive identification of symptoms that correlate with several different syndromes associated with disorders such as IBS diarrhea, IBS constipation, functional diarrhea, functional constipation, chronic functional abdominal pain, or bloating. Several peripheral and central mechanisms initiate gastrointestinal motor and sensory dysfunctions leading to IBS symptoms. Those dysfunctions may require evaluation in patients whose symptoms do not respond to first-line treatments. Observations Validation studies of consensus symptom-based criteria have identified deficiencies that favor a simpler identification of the predominant symptoms of abdominal pain, bowel dysfunction, and bloating and exclusion of alarm symptoms such as unintentional weight loss, rectal bleeding, or recent change in bowel function. Symptom-based diagnosis of IBS is enhanced with additional history for symptoms of somatoform and psychological disorders and alarm symptoms, physical examination including digital rectal examination, and screening tests to exclude organic disease (by measuring hemoglobin and C-reactive protein concentrations). The initial treatment plan should include patient education, reassurance, and first-line treatments such as fiber and osmotic laxatives for constipation, opioids for diarrhea, antispasmodics for pain and for management of associated psychological disorders. For patients who do not respond to those IBS treatments, testing for specific functional disorders may be required in a minority of patients with IBS. These disorders include rectal evacuation disorder, abnormal colonic transit, and bile acid diarrhea. Their identification is followed by individualized treatment, such as pelvic floor retraining for rectal evacuation disorders, sequestrants for bile acid diarrhea, and secretory agents for constipation, although there is only limited evidence that this individualized management approach is effective. Conclusions and Relevance Advances in the identification of specific dysfunctions as causes of individual symptoms in the "IBS spectrum" leads to the potential to enhance the diagnosis and management of symptoms for the majority of patients for whom first-line therapies of IBS and management of comorbid psychological disorders are insufficient.	[Camilleri, Michael] Mayo Clin, Div Gastroenterol & Hepatol, Clin Enter Neurosci Translat & Epidemiol Res CENT, Rochester, MN USA	Mayo Clinic	Camilleri, M (corresponding author), Mayo Clin, 200 First St SW,Charlton Bldg,Room 8-110, Rochester, MN 55905 USA.	camilleri.michael@mayo.edu						Andresen V, 2008, CLIN GASTROENTEROL H, V6, P545, DOI 10.1016/j.cgh.2007.12.015; Andriulli A, 2008, J CLIN GASTROENTEROL, V42, pS218, DOI 10.1097/MCG.0b013e31817fadd6; [Anonymous], FECAL MICROBIOTA TRA; Atieh J, 2021, J CLIN GASTROENTEROL, V55, P694, DOI 10.1097/MCG.0000000000001414; Aziz I, 2017, CURR OPIN GASTROEN, V33, P196, DOI 10.1097/MOG.0000000000000348; Bajor A, 2015, GUT, V64, P84, DOI 10.1136/gutjnl-2013-305965; Barish CF, 2018, CURR MED RES OPIN, V34, P751, DOI 10.1080/03007995.2018.1430024; Bijkerk CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3154; Black CJ, 2020, GUT, V69, P1441, DOI 10.1136/gutjnl-2020-321191; Black CJ, 2020, LANCET GASTROENTEROL, V5, P117, DOI 10.1016/S2468-1253(19)30324-3; Black CJ, 2020, CLIN GASTROENTEROL H, V18, P1238, DOI 10.1016/j.cgh.2019.07.007; Black CJ, 2020, GUT, V69, P74, DOI 10.1136/gutjnl-2018-318160; Blaser MJ, 2019, NEW ENGL J MED, V381, P2064, DOI 10.1056/NEJMe1913807; Brandler J, 2020, CLIN GASTROENTEROL H, V18, P2479, DOI 10.1016/j.cgh.2019.11.049; Brenner DM, 2018, AM J GASTROENTEROL, V113, P735, DOI 10.1038/s41395-018-0026-7; Camilleri M, 2015, ALIMENT PHARM THER, V41, P438, DOI 10.1111/apt.13065; Camilleri M, 2010, NEUROGASTROENT MOTIL, V22, P874, DOI 10.1111/j.1365-2982.2010.01517.x; Camilleri M, 2008, CLIN GASTROENTEROL H, V6, P772, DOI 10.1016/j.cgh.2008.02.060; Camilleri M, 2020, GUT, V69, P1730, DOI 10.1136/gutjnl-2019-320325; Camilleri M, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13957; Camilleri M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6110101; Camilleri M, 2012, NEW ENGL J MED, V367, P1626, DOI 10.1056/NEJMra1207068; Cangemi DJ, 2019, AM J GASTROENTEROL, V114, P519, DOI 10.14309/ajg.0000000000000149; Carrington EV, 2018, NAT REV GASTRO HEPAT, V15, P309, DOI 10.1038/nrgastro.2018.27; Chapman RW, 2013, AM J GASTROENTEROL, V108, P1508, DOI 10.1038/ajg.2013.197; Chedid V, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13510; Chey WD, 2012, ALIMENT PHARM THER, V35, P587, DOI 10.1111/j.1365-2036.2011.04983.x; Chey WD, 2020, AM J GASTROENTEROL, V115, P281, DOI 10.14309/ajg.0000000000000516; Chey WD, 2010, AM J GASTROENTEROL, V105, P859, DOI 10.1038/ajg.2010.55; Chiarioni G, 2010, GASTROENTEROLOGY, V138, P1321, DOI 10.1053/j.gastro.2009.12.040; Drossman DA, 2009, ALIMENT PHARM THER, V29, P329, DOI 10.1111/j.1365-2036.2008.03881.x; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Drossman DA, 2020, CLIN GASTROENTEROL H, V18, P1417, DOI 10.1016/j.cgh.2019.12.007; Drossman DA, 2018, GASTROENTEROLOGY, V154, P1140, DOI 10.1053/j.gastro.2017.11.279; El-Salhy M, 2020, GUT, V69, P859, DOI 10.1136/gutjnl-2019-319630; Evans BW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003960.pub3; Everitt HA, 2019, LANCET GASTROENTEROL, V4, P863, DOI 10.1016/S2468-1253(19)30243-2; Farid M, 2009, INT J COLORECTAL DIS, V24, P115, DOI 10.1007/s00384-008-0567-0; Ford AC, 2018, AM J GASTROENTEROL, V113, P1, DOI 10.1038/s41395-018-0084-x; Ford AC, 2018, ALIMENT PHARM THER, V48, P1044, DOI 10.1111/apt.15001; Ford AC, 2019, AM J GASTROENTEROL, V114, P21, DOI 10.1038/s41395-018-0222-5; Ford AC, 2014, AM J GASTROENTEROL, V109, P1350, DOI 10.1038/ajg.2014.148; Ford AC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2313; Garcia-Etxebarria K, 2018, CLIN GASTROENTEROL H, V16, P1673, DOI 10.1016/j.cgh.2018.01.047; Halder SLS, 2007, GASTROENTEROLOGY, V133, P799, DOI 10.1053/j.gastro.2007.06.010; Hanlon I, 2018, ALIMENT PHARM THER, V48, P244, DOI 10.1111/apt.14840; Heymen S, 2007, DIS COLON RECTUM, V50, P428, DOI 10.1007/s10350-006-0814-9; Ianiro G, 2019, ALIMENT PHARM THER, V50, P240, DOI 10.1111/apt.15330; Irvine AJ, 2017, AM J GASTROENTEROL, V112, P65, DOI 10.1038/ajg.2016.466; Johannesson E, 2015, WORLD J GASTROENTERO, V21, P600, DOI 10.3748/wjg.v21.i2.600; Johannesson E, 2011, AM J GASTROENTEROL, V106, P915, DOI 10.1038/ajg.2010.480; Keefer L, 2016, GASTROENTEROLOGY, V150, P1408, DOI 10.1053/j.gastro.2016.02.034; Khanna R, 2014, J CLIN GASTROENTEROL, V48, P505, DOI 10.1097/MCG.0b013e3182a88357; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Krogsgaard LR, 2017, ALIMENT PHARM THER, V45, P1506, DOI 10.1111/apt.14065; Lackner JM, 2019, AM J GASTROENTEROL, V114, P330, DOI 10.1038/s41395-018-0396-x; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Lembo A, 2003, NEW ENGL J MED, V349, P1360, DOI 10.1056/NEJMra020995; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lin L, 2020, CLIN GASTROENTEROL H, V18, P297, DOI 10.1016/j.cgh.2019.10.004; Liu A, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13845; Locke GR, 2005, NEUROGASTROENT MOTIL, V17, P29, DOI 10.1111/j.1365-2982.2004.00581.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Luthra P, 2019, LANCET GASTROENTEROL, V4, P831, DOI 10.1016/S2468-1253(19)30246-8; Manabe N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01442.x; Manheimer E, 2012, AM J GASTROENTEROL, V107, P835, DOI 10.1038/ajg.2012.66; Massey BT, 2021, DIGEST DIS SCI, V66, P338, DOI 10.1007/s10620-020-06623-6; medlineplus, LACTOSE INTOLERANCE; Menees SB, 2012, AM J GASTROENTEROL, V107, P28, DOI 10.1038/ajg.2011.355; Metcalf AM, 1987, GASTROENTEROLOGY, V92, P40, DOI 10.1016/0016-5085(87)90837-7; Micic D, 2019, JAMA-J AM MED ASSOC, V322, P1600, DOI 10.1001/jama.2019.14740; Murphy CC, 2019, GASTROENTEROLOGY, V156, P958, DOI [10.1053/j.gastro.2018.08.063, 10.1053/j.gastro.2018.11.060]; Nakajima A, 2018, LANCET GASTROENTEROL, V3, P537, DOI 10.1016/S2468-1253(18)30123-7; National Institute for Health and Care Excellence, 2015, ADDENDUM NICE GUIDEL; Nullens S, 2012, GUT, V61, P1132, DOI 10.1136/gutjnl-2011-301181; Oka P, 2020, LANCET GASTROENTEROL, V5, P908, DOI 10.1016/S2468-1253(20)30217-X; Palsson OS, 2020, GASTROENTEROLOGY, V158, P1262, DOI 10.1053/j.gastro.2019.12.021; Park SY, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13044; Park SY, 2017, CLIN GASTROENTEROL H, V15, P543, DOI 10.1016/j.cgh.2016.11.013; Pimentel M, 2020, AM J GASTROENTEROL, V115, P165, DOI 10.14309/ajg.0000000000000501; Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409; Pinto-Sanchez MI, 2017, GASTROENTEROLOGY, V153, P448, DOI 10.1053/j.gastro.2017.05.003; Pittayanon R, 2019, GASTROENTEROLOGY, V157, P97, DOI 10.1053/j.gastro.2019.03.049; Posserud I, 2007, GUT, V56, P802, DOI 10.1136/gut.2006.108712; Quartero AO, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003460.pub2; Rao SSC, 2007, CLIN GASTROENTEROL H, V5, P331, DOI 10.1016/j.cgh.2006.12.023; Rao SSC, 2010, AM J GASTROENTEROL, V105, P890, DOI 10.1038/ajg.2010.53; Shahabi L, 2016, PSYCHOL HEALTH MED, V21, P176, DOI 10.1080/13548506.2015.1051557; Shim L, 2010, AM J GASTROENTEROL, V105, P883, DOI 10.1038/ajg.2010.54; Simren M, 2019, GASTROENTEROLOGY, V157, P391, DOI 10.1053/j.gastro.2019.04.019; Singh P, 2020, CLIN GASTROENTEROL H, V18, P399, DOI 10.1016/j.cgh.2019.08.020; Sood R, 2016, AM J GASTROENTEROL, V111, P1446, DOI 10.1038/ajg.2016.308; Sperber AD, 2021, GASTROENTEROLOGY, V160, P99, DOI 10.1053/j.gastro.2020.04.014; Storhaug CL, 2017, LANCET GASTROENTEROL, V2, P738, DOI 10.1016/S2468-1253(17)30154-1; SUAREZ FL, 1995, NEW ENGL J MED, V333, P1, DOI 10.1056/NEJM199507063330101; Tack J, 2018, GUT, V67, P1425, DOI 10.1136/gutjnl-2016-312230; Tanitiphlachiva K, 2010, CLIN GASTROENTEROL H, V8, P955, DOI 10.1016/j.cgh.2010.06.031; Thompson WG, 1999, GUT, V45, P43; Thompson WG., 1989, GASTROENTEROL INT, V2, P92; Tornblom H, 2012, AM J GASTROENTEROL, V107, P754, DOI 10.1038/ajg.2012.5; Trifan A, 2019, UNITED EUR GASTROENT, V7, P1093, DOI 10.1177/2050640619862721; Valentin N, 2016, GUT, V65, P1951, DOI 10.1136/gutjnl-2015-309889; Videlock EJ, 2013, CLIN GASTROENTEROL H, V11, P1084, DOI 10.1016/j.cgh.2013.04.032; Vijayvargiya P, 2020, AM J GASTROENTEROL, V115, P1094, DOI 10.14309/ajg.0000000000000637; Vijayvargiya P, 2020, CLIN GASTROENTEROL H, V18, P2962, DOI 10.1016/j.cgh.2020.02.027; Vijayvargiya P, 2019, GASTROENTEROLOGY, V156, P1233, DOI 10.1053/j.gastro.2018.11.069; Wang XJ, 2019, ALIMENT PHARM THER, V50, P517, DOI 10.1111/apt.15419; Williams RE, 2006, ALIMENT PHARM THERAP, V23, P1667, DOI 10.1111/j.1365-2036.2006.02928.x; Williams R, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.36; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457; Yan J, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/7680963; Yu D, 2011, GUT, V60, P334, DOI 10.1136/gut.2009.205476	112	46	50	28	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					865	877		10.1001/jama.2020.22532	http://dx.doi.org/10.1001/jama.2020.22532			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651094				2022-12-28	WOS:000625843100015
J	Shortliffe, EH; Lyman, GH; Amankwah, FK				Shortliffe, Edward H.; Lyman, Gary H.; Amankwah, Francis K.			Medications in Single-Dose Vials and Implications of Discarded Injectable Drugs A National Academies Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Shortliffe, Edward H.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Biomed Informat, 272 W107th St,5B, New York, NY 10025 USA; [Lyman, Gary H.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci & Clin Res Div, 1124 Columbia St, Seattle, WA 98104 USA; [Lyman, Gary H.] Hutchinson Inst Canc Outcomes Res, Healthcare Qual & Policy, Seattle, WA USA; [Amankwah, Francis K.] Natl Acad Sci Engn & Med, Hlth & Med Div, Washington, DC USA	Columbia University; Fred Hutchinson Cancer Center; National Academies of Sciences, Engineering & Medicine	Shortliffe, EH (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Biomed Informat, 272 W107th St,5B, New York, NY 10025 USA.	ted@shortliffe.net	Lyman, Gary H/K-5227-2019	Lyman, Gary H/0000-0002-0823-8086				Bach PB, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i788; Centers for Medicaid and Medicare Services, MED B; Emanuel EJ, 2020, JAMA INTERN MED, V180, P1510, DOI 10.1001/jamainternmed.2020.4793; Mulcahy AW., INT PRESCRIPTION DRU; National Academies of Sciences, 2017, MAK MED AFF NAT IMP; National Academies of Sciences Engineering and Medicine, 2021, MED SINGL DOS VIALS	6	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1507	1508		10.1001/jama.2021.2414	http://dx.doi.org/10.1001/jama.2021.2414		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33630017				2022-12-28	WOS:000621911900002
J	Liu, JM; Zhang, L; Yan, YQ; Zhou, YC; Yin, P; Qi, JL; Wang, LJ; Pan, JJ; You, JL; Yang, J; Zhao, ZP; Wang, W; Liu, YN; Lin, L; Wu, J; Li, XH; Chen, ZM; Zhou, MG				Liu, Jiangmei; Zhang, Lan; Yan, Yaqiong; Zhou, Yuchang; Yin, Peng; Qi, Jinlei; Wang, Lijun; Pan, Jingju; You, Jinling; Yang, Jing; Zhao, Zhenping; Wang, Wei; Liu, Yunning; Lin, Lin; Wu, Jing; Li, Xinhua; Chen, Zhengming; Zhou, Maigeng			Excess mortality in Wuhan city and other parts of China during the three months of the covid-19 outbreak: findings from nationwide mortality registries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURVEILLANCE; KEY	OBJECTIVE To assess excess all cause and cause specific mortality during the three months (1 January to 31 March 2020) of the coronavirus disease 2019 (covid-19) outbreak in Wuhan city and other parts of China. DESIGN Nationwide mortality registries. SETTING 605 urban districts and rural counties in China's nationally representative Disease Surveillance Point (DSP) system. PARTICIPANTS More than 300 million people of all ages. MAIN OUTCOME MEASURES Observed overall and weekly mortality rates from all cause and cause specific diseases for three months (1 January to 31 March 2020) of the covid-19 outbreak compared with the predicted (or mean rates for 201519) in different areas to yield rate ratio. RESULTS The DSP system recorded 580819 deaths from January to March 2020. In Wuhan DSP districts (n=3), the observed total mortality rate was 56% (rate ratio 1.56, 95% confidence interval 1.33 to 1.87) higher than the predicted rate (1147 v 735 per 100000), chiefly as a result of an eightfold increase in deaths from pneumonia (n=1682; 275 v33 per 100000; 8.32, 5.19 to 17.02), mainly covid-19 related, but a more modest increase in deaths from certain other diseases, including cardiovascular disease (n=2347; 408 v316 per 100000; 1.29, 1.05 to 1.65) and diabetes (n=262; 46 v25 per 100000; 1.83, 1.08 to 4.37). In Wuhan city (n=13 districts), 5954 additional (4573 pneumonia) deaths occurred in 2020 compared with 2019, with excess risks greater in central than in suburban districts (50% v 15%). In other parts of Hubei province (n=19 DSP areas), the observed mortality rates from pneumonia and chronic respiratory diseases were non-significantly 28% and 23% lower than the predicted rates, despite excess deaths from covid-19 related pneumonia. Outside Hubei (n=583 DSP areas), the observed total mortality rate was non-significantly lower than the predicted rate (675 v 715 per 100000), with significantly lower death rates from pneumonia (0.53, 0.46 to 0.63), chronic respiratory diseases (0.82, 0.71 to 0.96), and road traffic incidents (0.77, 0.68 to 0.88). CONCLUSIONS Except in Wuhan, no increase in overall mortality was found during the three months of the covid-19 outbreak in other parts of China. The lower death rates from certain non-covid-19 related diseases might be attributable to the associated behaviour changes during lockdown.	[Liu, Jiangmei; Zhou, Yuchang; Yin, Peng; Qi, Jinlei; Wang, Lijun; You, Jinling; Yang, Jing; Zhao, Zhenping; Wang, Wei; Liu, Yunning; Lin, Lin; Wu, Jing; Zhou, Maigeng] Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing 100050, Peoples R China; [Zhang, Lan; Pan, Jingju] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Yan, Yaqiong] Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Li, Xinhua] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Chen, Zhengming] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; University of Oxford	Zhou, MG (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing 100050, Peoples R China.	zhoumaigeng@ncncd.chinacdc.cn	Yin, Peng/AFP-5157-2022; Zhao, Zhenping/R-6323-2016; Zhou, Maigeng/HCH-7703-2022	Zhao, Zhenping/0000-0003-4227-3034; 	National Natural Science Foundation of China [82073675]; MRC [MC_UU_00017/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Natural Science Foundation of China (grant No 82073675). The funder of the study had no role in the study design, data collection, data analysis, data interpretation, or the writing of the report. One of the corresponding authors (MZ) had full access to all the data in the study, and both corresponding authors (MZ and ZC) had final responsibility for the decision to submit for publication.	Akhmerov A, 2020, CIRC RES, V126, P1443, DOI 10.1161/CIRCRESAHA.120.317055; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chan KH, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1628; Chen SM, 2020, LANCET, V395, P1305, DOI 10.1016/S0140-6736(20)30744-3; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hanlon Peter, 2020, Wellcome Open Res, V5, P75, DOI 10.12688/wellcomeopenres.15849.1; Jan Hasnain, 2020, Discoveries (Craiova), V8, pe108, DOI 10.15190/d.2020.5; Kaur I, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13677; Khamis RY, 2016, HEART, V102, P1142, DOI 10.1136/heartjnl-2014-306463; Li L, 2019, LANCET PUBLIC HEALTH, V4, pE473, DOI 10.1016/S2468-2667(19)30163-X; Li Q., 2020, NEW ENGL J MED, V382, P1199; Li ZJ, 2020, LANCET, V396, P63, DOI 10.1016/S0140-6736(20)31278-2; Liu SW, 2016, B WORLD HEALTH ORGAN, V94, P46, DOI 10.2471/BLT.15.153148; Meyer S, 2017, J STAT SOFTW, V77, DOI 10.18637/jss.v077.i11; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Noufaily A, 2013, STAT MED, V32, P1206, DOI 10.1002/sim.5595; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; WHO, 2020, WHO COR COVID 19 DAS; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yan YX, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072323; Yang G, 1992, Zhonghua Liu Xing Bing Xue Za Zhi, V13, P197; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	35	47	49	9	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n415	10.1136/bmj.n415	http://dx.doi.org/10.1136/bmj.n415			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627311	Green Published, hybrid			2022-12-28	WOS:000623404800016
J	Mahase, E				Mahase, Elisabeth			Home testing HPV kits will be offered to women in England as part of screening trial	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		WHO, 2020, HUM PAP HPV SELF SAM	1	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n315	10.1136/bmj.n537	http://dx.doi.org/10.1136/bmj.n537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33622707				2022-12-28	WOS:000623404800020
J	Sugimoto, S; Kobayashi, E; Fujii, M; Ohta, Y; Arai, K; Matano, M; Ishikawa, K; Miyamoto, K; Toshimitsu, K; Takahashi, S; Nanki, K; Hakamata, Y; Kanai, T; Sato, T				Sugimoto, Shinya; Kobayashi, Eiji; Fujii, Masayuki; Ohta, Yuki; Arai, Kazuya; Matano, Mami; Ishikawa, Keiko; Miyamoto, Kentaro; Toshimitsu, Kohta; Takahashi, Sirirat; Nanki, Kosaku; Hakamata, Yoji; Kanai, Takanori; Sato, Toshiro			An organoid-based organ-repurposing approach to treat short bowel syndrome	NATURE			English	Article							PARENTERAL-NUTRITION; SMALL-INTESTINE; STEM-CELLS; IN-VITRO; EPITHELIUM; ENGRAFTMENT; SURVIVAL; MOUSE; MODEL	The small intestine is the main organ for nutrient absorption, and its extensive resection leads to malabsorption and wasting conditions referred to as short bowel syndrome (SBS). Organoid technology enables an efficient expansion of intestinal epithelium tissue in vitro(1), but reconstruction of the whole small intestine, including the complex lymphovascular system, has remained challenging(2). Here we generate a functional small intestinalized colon (SIC) by replacing the native colonic epithelium with ileum-derived organoids. We first find that xenotransplanted human ileum organoids maintain their regional identity and form nascent villus structures in the mouse colon. In vitro culture of an organoid monolayer further reveals an essential role for luminal mechanistic flow in the formation of villi. We then develop a rat SIC model by repositioning the SIC at the ileocaecal junction, where the epithelium is exposed to a constant luminal stream of intestinal juice. This anatomical relocation provides the SIC with organ structures of the small intestine, including intact vasculature and innervation, villous structures, and the lacteal (a fat-absorbing lymphatic structure specific to the small intestine). The SIC has absorptive functions and markedly ameliorates intestinal failure in a rat model of SBS, whereas transplantation of colon organoids instead of ileum organoids invariably leads to mortality. These data provide a proof of principle for the use of intestinal organoids for regenerative purposes, and offer a feasible strategy for SBS treatment.	[Sugimoto, Shinya; Fujii, Masayuki; Ohta, Yuki; Arai, Kazuya; Matano, Mami; Ishikawa, Keiko; Toshimitsu, Kohta; Takahashi, Sirirat; Nanki, Kosaku; Sato, Toshiro] Keio Univ, Dept Organoid Med, Sch Med, Tokyo, Japan; [Sugimoto, Shinya; Ishikawa, Keiko; Miyamoto, Kentaro; Toshimitsu, Kohta; Nanki, Kosaku; Kanai, Takanori; Sato, Toshiro] Keio Univ, Dept Gastroenterol, Sch Med, Tokyo, Japan; [Kobayashi, Eiji] Keio Univ, Dept Organ Fabricat, Sch Med, Tokyo, Japan; [Fujii, Masayuki] Univ Tokyo, Dept Surg Oncol, Tokyo, Japan; [Arai, Kazuya] JSR Corp, JSR Keio Univ Med & Chem Innovat Ctr JKiC, Tokyo, Japan; [Miyamoto, Kentaro] Miyarisan Pharmaceut Co Ltd, Tokyo, Japan; [Hakamata, Yoji] Nippon Vet & Life Sci Univ, Sch Vet Nursing & Technol, Tokyo, Japan; [Hakamata, Yoji] Nippon Vet & Life Sci Univ, Res Ctr Anim Life Sci, Tokyo, Japan	Keio University; Keio University; Keio University; University of Tokyo; JSR Corporation; Nippon Veterinary & Life Science University; Nippon Veterinary & Life Science University	Sato, T (corresponding author), Keio Univ, Dept Organoid Med, Sch Med, Tokyo, Japan.; Sato, T (corresponding author), Keio Univ, Dept Gastroenterol, Sch Med, Tokyo, Japan.; Kobayashi, E (corresponding author), Keio Univ, Dept Organ Fabricat, Sch Med, Tokyo, Japan.	organfabri@keio.jp; t.sato@keio.jp	Miyamoto, Kentaro/GLV-0439-2022; Sugimoto, Shinya/X-6548-2018; Sato, Toshiro/J-3522-2014	Miyamoto, Kentaro/0000-0001-5302-2607; Sato, Toshiro/0000-0001-8353-8137; Hakamata, Yoji/0000-0002-0138-6692; Nanki, Kosaku/0000-0003-4232-0523	Japan Agency for Medical Research and Development (AMED)-CREST [JP20gm1210001]; AMED [JP20bm0304001]; JSPS KAKENHI [20H03746, JP17H06176]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Keio University Academic Development Funds; Japan Society for the Promotion of Science Research Fellowships for Young Scientists	Japan Agency for Medical Research and Development (AMED)-CREST(Japan Agency for Medical Research and Development (AMED)); AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Keio University Academic Development Funds; Japan Society for the Promotion of Science Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part supported by the Japan Agency for Medical Research and Development (AMED)-CREST (grant number JP20gm1210001), AMED (grant number JP20bm0304001), JSPS KAKENHI (grant numbers 20H03746 and JP17H06176), The Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Keio University Academic Development Funds. K.T. was supported by the Japan Society for the Promotion of Science Research Fellowships for Young Scientists. We thank the Collaborative Research Resources and JSR-Keio University Medical and Chemical Innovation Center (JKiC), Keio University School of Medicine for technical support (T. Tajima from Olympus).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Amiot A, 2013, CLIN NUTR, V32, P368, DOI 10.1016/j.clnu.2012.08.007; Bein A, 2018, CELL MOL GASTROENTER, V5, P659, DOI 10.1016/j.jcmgh.2017.12.010; Bernier-Latmani J, 2016, NAT PROTOC, V11, P1617, DOI 10.1038/nprot.2016.092; BUCHMAN AL, 1995, JPEN-PARENTER ENTER, V19, P453, DOI 10.1177/0148607195019006453; Buchman AL, 2003, GASTROENTEROLOGY, V124, P1111, DOI 10.1053/gast.2003.50139; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clevers H, 2019, CELL STEM CELL, V24, P855, DOI 10.1016/j.stem.2019.04.018; Demehri FR, 2015, J PEDIATR SURG, V50, P131, DOI 10.1016/j.jpedsurg.2014.10.011; DORNEY SFA, 1985, J PEDIATR-US, V107, P521, DOI 10.1016/S0022-3476(85)80008-1; Drucker DJ, 2014, ANNU REV PHYSIOL, V76, P561, DOI 10.1146/annurev-physiol-021113-170317; Duggan CP, 2017, NEW ENGL J MED, V377, P666, DOI 10.1056/NEJMra1602650; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Fujii M, 2020, NAT MED, V26, P1517, DOI 10.1038/s41591-020-1096-9; Fujii M, 2018, CELL STEM CELL, V23, P787, DOI 10.1016/j.stem.2018.11.016; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Fukuda M, 2014, GENE DEV, V28, P1752, DOI 10.1101/gad.245233.114; GAMBEE LP, 1956, AM J SURG, V92, P222, DOI 10.1016/S0002-9610(56)80063-9; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Kasendra M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21201-7; Kesseli S, 2019, SURG CLIN N AM, V99, P103, DOI 10.1016/j.suc.2018.09.008; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kitano K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00779-y; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; LEEPER LL, 1990, AM J PHYSIOL, V258, pG52, DOI 10.1152/ajpgi.1990.258.1.G52; Massironi S, 2020, DIGEST LIVER DIS, V52, P253, DOI 10.1016/j.dld.2019.11.013; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Meran L, 2020, NAT MED, V26, P1593, DOI 10.1038/s41591-020-1024-z; Middendorp S, 2014, STEM CELLS, V32, P1083, DOI 10.1002/stem.1655; Mihara E, 2016, ELIFE, V5, DOI 10.7554/eLife.11621; Moor AE, 2018, CELL, V175, P1156, DOI 10.1016/j.cell.2018.08.063; Nightingale J, 2006, GUT, V55; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHEAHAN DG, 1976, AM J ANAT, V146, P103, DOI 10.1002/aja.1001460202; Spurrier RG, 2013, CLIN GASTROENTEROL H, V11, P354, DOI 10.1016/j.cgh.2013.01.028; Sugimoto S, 2020, METHODS MOL BIOL, V2171, P303, DOI 10.1007/978-1-0716-0747-3_21; Sugimoto S, 2018, CELL STEM CELL, V22, P171, DOI 10.1016/j.stem.2017.11.012; Thompson JS, 2011, SURG CLIN N AM, V91, P493, DOI 10.1016/j.suc.2011.02.006; Warner BW, 2016, CELL MOL GASTROENTER, V2, P429, DOI 10.1016/j.jcmgh.2016.05.001; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695	47	48	53	16	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2021	592	7852					99	+		10.1038/s41586-021-03247-2	http://dx.doi.org/10.1038/s41586-021-03247-2		FEB 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT0ZX	33627870				2022-12-28	WOS:000621335600001
J	Rubin, R				Rubin, Rita			Detecting Heart Transplant Rejection Earlier, More Easily	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					712	712		10.1001/jama.2021.1228	http://dx.doi.org/10.1001/jama.2021.1228			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620388				2022-12-28	WOS:000621957400004
J	Burki, T				Burki, Talha			Research Focus: The Cleveland Clinic at 100	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					658	658						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33610200				2022-12-28	WOS:000620991800012
J	Zampieri, M				Zampieri, Mattia			The genetic underground of antibiotic resistance	SCIENCE			English	Editorial Material									[Zampieri, Mattia] Swiss Fed Inst Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Zampieri, M (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	zampieri@imsb.biol.ethz.ch						Belenky P, 2015, CELL REP, V13, P968, DOI 10.1016/j.celrep.2015.09.059; Campos AI, 2019, MOL CELL, V74, P1291, DOI 10.1016/j.molcel.2019.04.001; Fridman O, 2014, NATURE, V513, P418, DOI 10.1038/nature13469; Hart Y, 2015, NAT METHODS, V12, P233, DOI [10.1038/NMETH.3254, 10.1038/nmeth.3254]; Kavvas ES, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16310-9; Lopatkin AJ, 2021, SCIENCE, V371, P799, DOI 10.1126/science.aba0862; Meylan S, 2017, CELL CHEM BIOL, V24, P195, DOI 10.1016/j.chembiol.2016.12.015; Shan Y, 2017, MBIO, V8, DOI 10.1128/mBio.02267-16; Vestergaard M, 2017, MBIO, V8, DOI 10.1128/mBio.01114-17; Yelin I, 2018, CELL, V172, P1136, DOI 10.1016/j.cell.2018.02.018; Zampieri M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167028	11	3	4	4	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					783	+		10.1126/science.abf7922	http://dx.doi.org/10.1126/science.abf7922			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602844				2022-12-28	WOS:000619664700031
J	Scheltens, P; De Strooper, B; Kivipelto, M; Holstege, H; Chetelat, G; Teunissen, CE; Cummings, J; van der Flier, WM				Scheltens, Philip; De Strooper, Bart; Kivipelto, Miia; Holstege, Henne; Chetelat, Gael; Teunissen, Charlotte E.; Cummings, Jeffrey; van der Flier, Wiesje M.			Alzheimer's disease	LANCET			English	Review							POSITRON-EMISSION-TOMOGRAPHY; AMYLOID-BETA; CEREBROSPINAL-FLUID; VASCULAR DYSFUNCTION; DEMENTIA; DIAGNOSIS; TAU; INTERVENTION; MICROGLIA; VARIANTS	In this Seminar, we highlight the main developments in the field of Alzheimer's disease. The most recent data indicate that, by 2050, the prevalence of dementia will double in Europe and triple worldwide, and that estimate is 3 times higher when based on a biological (rather than clinical) definition of Alzheimer's disease. The earliest phase of Alzheimer's disease (cellular phase) happens in parallel with accumulating amyloid beta, inducing the spread of tau pathology. The risk of Alzheimer's disease is 60-80% dependent on heritable factors, with more than 40 Alzheimer's disease-associated genetic risk loci already identified, of which the APOE alleles have the strongest association with the disease. Novel biomarkers include PET scans and plasma assays for amyloid beta and phosphorylated tau, which show great promise for clinical and research use. Multidomain lifestyle-based prevention trials suggest cognitive benefits in participants with increased risk of dementia. Lifestyle factors do not directly affect Alzheimer's disease pathology, but can still contribute to a positive outcome in individuals with Alzheimer's disease. Promising pharmacological treatments are poised at advanced stages of clinical trials and include anti-amyloid beta, anti-tau, and anti-inflammatory strategies.	[Scheltens, Philip; Holstege, Henne; van der Flier, Wiesje M.] Amsterdam Univ Med Ctr, Alzheimer Ctr Amsterdam, Amsterdam, Netherlands; [Scheltens, Philip] Amsterdam Univ Med Ctr, Dept Neurol, NL-1081 HX Amsterdam, Netherlands; [Holstege, Henne] Amsterdam Univ Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Teunissen, Charlotte E.] Amsterdam Univ Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [van der Flier, Wiesje M.] Amsterdam Univ Med Ctr, Dept Epidemiol & Datasci, Amsterdam, Netherlands; [Scheltens, Philip] Life Sci Partners, Amsterdam, Netherlands; [De Strooper, Bart] VIB Ctr Brain & Dis Res, Leuven, Belgium; [De Strooper, Bart] Katholieke Univ Leuven, Dept Neurol, Leuven, Belgium; [De Strooper, Bart] UCL, Dementia Res Inst, London, England; [Kivipelto, Miia] Karolinska Univ Hosp, Div Clin Geriatr, Stockholm, Sweden; [Kivipelto, Miia] Karolinska Univ Hosp, Ctr Alzheimer Res, Stockholm, Sweden; [Kivipelto, Miia] Karolinska Univ Hosp, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Kivipelto, Miia] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; Imperial Coll London, Sch Publ Hlth, Ageing & Epidemiol Res Unit, London, England; [Chetelat, Gael] Univ Caen, Normandie Univ, INSERM, Gtp Interet Publ Cyceron, Caen, France; [Cummings, Jeffrey] Univ Nevada, Dept Brain Hlth, Chambers Grundy Ctr Transformat Neurosci, Las Vegas, NV 89154 USA; [Cummings, Jeffrey] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA	Flanders Institute for Biotechnology (VIB); KU Leuven; University of London; University College London; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Eastern Finland; Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Cleveland Clinic Foundation	Scheltens, P (corresponding author), Amsterdam Univ Med Ctr, Dept Neurol, NL-1081 HX Amsterdam, Netherlands.	p.scheltens@amsterdamumc.nl	; Hardy, John/C-2451-2009	Scheltens, Philip/0000-0002-1046-6408; De Strooper, Bart/0000-0001-5455-5819; Hardy, John/0000-0002-3122-0423; Gael, Chetelat/0000-0002-4889-7932	Stichting Alzheimer Nederland; Stichting VUmc Fonds; Pasman Stichting; JPND [ZonMW 733051102]; MRC [UKDRI-1009] Funding Source: UKRI	Stichting Alzheimer Nederland; Stichting VUmc Fonds; Pasman Stichting; JPND; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research at the Alzheimer Center Amsterdam is part of the neurodegeneration research programme of Amsterdam Neuroscience. The Alzheimer Centre Amsterdam is supported by Stichting Alzheimer Nederland and Stichting VUmc Fonds. The chair of Wiesje van der Flier is supported by the Pasman Stichting. MK and PS are recipients of the JPND-funded Euro-FINGERS project (#ZonMW 733051102).	Al Shweiki MHDR, 2019, J PSYCHIATR RES, V113, P137, DOI 10.1016/j.jpsychires.2019.03.019; Altomare D, 2019, NEUROLOGY, V93, pE1635, DOI 10.1212/WNL.0000000000008361; Alzforum, 2020, DIAN TU GANT BRINGS; Alzheimer Europe, 2020, DEM EUR YB 2019 EST; Alzheimer's Disease International, 2018, WORLD ALZH REP 2018; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Andrieu S, 2017, LANCET NEUROL, V16, P377, DOI 10.1016/S1474-4422(17)30040-6; Arboleda-Velasquez JF, 2019, NAT MED, V25, P1680, DOI 10.1038/s41591-019-0611-3; Aschenbrenner AJ, 2018, NEUROLOGY, V91, pE859, DOI 10.1212/WNL.0000000000006075; Atri A, 2018, JAMA-J AM MED ASSOC, V319, P130, DOI 10.1001/jama.2017.20373; Barro C, 2018, BRAIN, V141, P2382, DOI 10.1093/brain/awy154; Bateman RJ, 2017, ALZHEIMERS DEMENT, V13, P8, DOI 10.1016/j.jalz.2016.07.005; Beker N, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0094; Bellenguez C, 2017, NEUROBIOL AGING, V59, DOI 10.1016/j.neurobiolaging.2017.07.001; Belloy ME, 2020, JAMA NEUROL, V77, P849, DOI 10.1001/jamaneurol.2020.0414; Bennett RE, 2018, P NATL ACAD SCI USA, V115, pE1289, DOI 10.1073/pnas.1710329115; Blennow K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54204-z; Bridel C, 2019, JAMA NEUROL, V76, P1035, DOI 10.1001/jamaneurol.2019.1534; Brier MR, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2362; Buckley RF, 2019, JAMA NEUROL, V76, P542, DOI 10.1001/jamaneurol.2018.4693; Cai ZX, 2019, NEUROSCI LETT, V691, P44, DOI 10.1016/j.neulet.2018.07.038; Chen MK, 2018, JAMA NEUROL, V75, P1215, DOI 10.1001/jamaneurol.2018.1836; Cho H, 2016, ANN NEUROL, V80, P247, DOI 10.1002/ana.24711; Cummings J, 2018, JPAD-J PREV ALZHEIM, V5, P253, DOI 10.14283/jpad.2018.29; Cuyvers E, 2015, LANCET NEUROL, V14, P814, DOI 10.1016/S1474-4422(15)00133-7; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; de Leeuw Francisca A, 2017, Alzheimers Dement (Amst), V8, P196, DOI 10.1016/j.dadm.2017.07.006; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; de Wilde A, 2018, JAMA NEUROL, V75, P1062, DOI 10.1001/jamaneurol.2018.1346; Delrieu J, 2019, ALZHEIMERS DEMENT, V15, P1392, DOI 10.1016/j.jalz.2019.07.008; Deming Y, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau2291; Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014; Dodiya HB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64797-5; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Duits FH, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-017-0335-x; Ebenau JL, 2020, NEUROLOGY, V95, pE46, DOI 10.1212/WNL.0000000000009724; Egan MF, 2019, NEW ENGL J MED, V380, P1408, DOI 10.1056/NEJMoa1812840; Engelborghs Sebastiaan, 2017, Alzheimers Dement (Amst), V8, P111, DOI 10.1016/j.dadm.2017.04.007; Escott-Price V, 2015, BRAIN, V138, P3673, DOI 10.1093/brain/awv268; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Franzmeier N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14159-1; Frigerio CS, 2019, CELL REP, V27, P1293, DOI 10.1016/j.celrep.2019.03.099; Frisoni GB, 2017, LANCET NEUROL, V16, P661, DOI 10.1016/S1474-4422(17)30159-X; Fruijtier AD, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0531-y; Galasko D, 2019, ALZH DEMENT-TRCI, V5, P871, DOI 10.1016/j.trci.2019.11.002; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Gottesman RF, 2020, JAMA NEUROL, V77, P350, DOI 10.1001/jamaneurol.2019.4339; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Griciuc A, 2019, NEURON, V103, P820, DOI 10.1016/j.neuron.2019.06.010; Grothe MJ, 2017, NEUROLOGY, V89, P2031, DOI 10.1212/WNL.0000000000004643; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gustavsson AM, 2020, ANN NEUROL, V87, P52, DOI 10.1002/ana.25645; Halpern R, 2019, INT J GERIATR PSYCH, V34, P420, DOI 10.1002/gps.5030; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; Hardy J, 2014, J INTERN MED, V275, P296, DOI 10.1111/joim.12192; Harrison TM, 2019, ANN NEUROL, V85, P229, DOI 10.1002/ana.25406; Hasselmann J, 2019, NEURON, V103, P1016, DOI 10.1016/j.neuron.2019.07.002; Hoglund K, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104645; Hok-A-Hin YS, 2019, METHODS MOL BIOL, V2044, P27, DOI 10.1007/978-1-4939-9706-0_2; Holstege H, 2017, EUR J HUM GENET, V25, P973, DOI 10.1038/ejhg.2017.87; Jack CR, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav0511; Jack CR, 2019, JAMA NEUROL, V76, P1174, DOI 10.1001/jamaneurol.2019.1971; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2018, BRAIN, V141, P1517, DOI 10.1093/brain/awy059; Janelidze S, 2020, NAT MED, V26, P379, DOI 10.1038/s41591-020-0755-1; Janelidze S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26801; Janelidze S, 2016, ANN CLIN TRANSL NEUR, V3, P12, DOI 10.1002/acn3.266; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Janto K, 2018, J CLIN SLEEP MED, V14, P1399, DOI 10.5664/jcsm.7282; Jessen F, 2020, LANCET NEUROL, V19, P271, DOI 10.1016/S1474-4422(19)30368-0; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kaplow J, 2020, ALZHEIMERS DEMENT, V16, P144, DOI 10.1002/alz.12000; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kivipelto M, 2020, ALZHEIMERS DEMENT, V16, P1078, DOI 10.1002/alz.12123; Kivipelto M, 2018, NAT REV NEUROL, V14, P653, DOI 10.1038/s41582-018-0070-3; Knopman DS, 2019, NEUROLOGY, V92, P1053, DOI 10.1212/WNL.0000000000007583; Koper MJ, 2020, ACTA NEUROPATHOL, V139, P463, DOI 10.1007/s00401-019-02103-y; Kuhlmann J, 2017, CLIN CHIM ACTA, V467, P27, DOI 10.1016/j.cca.2016.05.014; La Joie R, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aau5732; Leuzy A, 2019, MOL PSYCHIATR, V24, P1112, DOI 10.1038/s41380-018-0342-8; Leyns CEG, 2019, NAT NEUROSCI, V22, P1217, DOI 10.1038/s41593-019-0433-0; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Liu CS, 2016, CURR ALZHEIMER RES, V13, P1134, DOI 10.2174/1567205013666160502122933; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Mancuso R, 2019, NAT NEUROSCI, V22, P2111, DOI 10.1038/s41593-019-0525-x; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Mattke S, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12081; Mattsson N, 2013, ALZHEIMERS DEMENT, V9, P251, DOI 10.1016/j.jalz.2013.01.010; Mayeda ER, 2017, ALZHEIMERS DEMENT, V13, P761, DOI 10.1016/j.jalz.2016.12.008; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mofrad RB, 2020, NEUROLOGY, V95, pE2378, DOI 10.1212/WNL.0000000000010629; Montagne A, 2020, NATURE, V581, P70, DOI 10.1038/s41586-020-2247-3; Nabers A, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708763; Naj AC, 2017, AM J MED GENET B, V174, P5, DOI 10.1002/ajmg.b.32499; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Olsson B, 2019, J NEUROL, V266, P2129, DOI 10.1007/s00415-019-09389-8; Ossenkoppele R, 2018, JAMA-J AM MED ASSOC, V320, P1151, DOI 10.1001/jama.2018.12917; Ossenkoppele R, 2015, ANN NEUROL, V77, P338, DOI 10.1002/ana.24321; Ovod V, 2017, ALZHEIMERS DEMENT, V13, P841, DOI 10.1016/j.jalz.2017.06.2266; Palmqvist S, 2020, JAMA-J AM MED ASSOC, V324, P772, DOI 10.1001/jama.2020.12134; Palmqvist S, 2019, JAMA NEUROL, V76, P1060, DOI 10.1001/jamaneurol.2019.1632; Pannee J, 2016, ALZHEIMERS DEMENT, V12, P55, DOI 10.1016/j.jalz.2015.06.1890; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Rabinovici GD, 2019, JAMA-J AM MED ASSOC, V321, P1286, DOI 10.1001/jama.2019.2000; Reiman EM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14279-8; Rhodius-Meester HFM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226784; Rhodius-Meester HFM, 2019, J NEUROL NEUROSUR PS, V90, P726, DOI 10.1136/jnnp-2018-318820; Ridge PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079771; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schindler SE, 2019, NEUROLOGY, V93, pE1647, DOI 10.1212/WNL.0000000000008081; Schindler SE, 2019, ALZHEIMERS DEMENT, V15, P655, DOI 10.1016/j.jalz.2018.12.019; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Sierksma A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910606; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Soininen H, 2021, ALZHEIMERS DEMENT, V17, P29, DOI 10.1002/alz.12172; Soininen H, 2017, LANCET NEUROL, V16, P965, DOI 10.1016/S1474-4422(17)30332-0; Solomon A, 2018, JAMA NEUROL, V75, P462, DOI 10.1001/jamaneurol.2017.4365; Sormani MP, 2019, ANN CLIN TRANSL NEUR, V6, P1081, DOI 10.1002/acn3.795; Stamate D, 2019, ALZH DEMENT-TRCI, V5, P933, DOI 10.1016/j.trci.2019.11.001; Suarez-Calvet M, 2018, EMBO MOL MED, V10, DOI [10.15252/emmm.201809712, 10.15252/emmm.2018097121]; Sweeney MD, 2019, ALZHEIMERS DEMENT, V15, P158, DOI 10.1016/j.jalz.2018.07.222; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Szaruga M, 2017, CELL, V170, P443, DOI 10.1016/j.cell.2017.07.004; Teunissen CE, 2018, J ALZHEIMERS DIS, V62, P1857, DOI 10.3233/JAD-170784; Teunissen Charlotte E, 2016, Alzheimers Dement (Amst), V2, P86, DOI 10.1016/j.dadm.2015.12.004; Thijssen EH, 2020, NAT MED, V26, P387, DOI 10.1038/s41591-020-0762-2; Valentina EP, 2017, ANN NEUROL, V82, P311, DOI 10.1002/ana.24999; Van Cauwenberghe C, 2016, GENET MED, V18, P421, DOI 10.1038/gim.2015.117; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; van der Lee SJ, 2019, ACTA NEUROPATHOL, V138, P237, DOI 10.1007/s00401-019-02026-8; van der Lee SJ, 2018, ALZHEIMERS DEMENT, V14, P707, DOI 10.1016/j.jalz.2017.11.012; van der Lee SJ, 2018, LANCET NEUROL, V17, P434, DOI [10.1016/s1474-4422(18)30053-X, 10.1016/S1474-4422(18)30053-X]; van Dyck CH, 2018, BIOL PSYCHIAT, V83, P311, DOI 10.1016/j.biopsych.2017.08.010; van Maurik IS, 2019, LANCET NEUROL, V18, P1034, DOI 10.1016/S1474-4422(19)30283-2; van Maurik Ingrid S, 2019, JMIR Form Res, V3, pe13417, DOI 10.2196/13417; van Maurik IS, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0487-y; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Verberk IMW, 2018, ANN NEUROL, V84, P648, DOI 10.1002/ana.25334; Verheijen J, 2018, TRENDS GENET, V34, P434, DOI 10.1016/j.tig.2018.02.007; Vermunt L, 2019, ALZHEIMERS DEMENT, V15, P888, DOI 10.1016/j.jalz.2019.04.001; Villemagne VL, 2018, NAT REV NEUROL, V14, P225, DOI 10.1038/nrneurol.2018.9; Visser LNC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227282; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Wang XY, 2019, CELL RES, V29, P787, DOI 10.1038/s41422-019-0216-x; Williamson JD, 2019, JAMA-J AM MED ASSOC, V321, P553, DOI 10.1001/jama.2018.21442; World Health Organization, 2019, RISK RED COGN DECL D; Wu YT, 2017, NAT REV NEUROL, V13, P327, DOI 10.1038/nrneurol.2017.63; Yang GH, 2019, NATURE, V565, P192, DOI 10.1038/s41586-018-0813-8; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Zhou R, 2019, SCIENCE, V363, P708, DOI 10.1126/science.aaw0930	163	395	407	317	1004	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1577	1590		10.1016/S0140-6736(20)32205-4	http://dx.doi.org/10.1016/S0140-6736(20)32205-4		APR 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR7QA	33667416	Green Accepted			2022-12-28	WOS:000643286900024
J	Sun, L; Li, P; Ju, XH; Rao, J; Huang, WZ; Ren, LL; Zhang, SJ; Xiong, TL; Xu, K; Zhou, XL; Gong, ML; Miska, E; Ding, Q; Wang, JW; Zhang, QFC				Sun, Lei; Li, Pan; Ju, Xiaohui; Rao, Jian; Huang, Wenze; Ren, Lili; Zhang, Shaojun; Xiong, Tuanlin; Xu, Kui; Zhou, Xiaolin; Gong, Mingli; Miska, Eric; Ding, Qiang; Wang, Jianwei; Zhang, Qiangfeng Cliff			In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs	CELL			English	Article							SECONDARY STRUCTURE; MECHANISTIC INSIGHTS; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; CORONAVIRUS; REGION; CELLS; REPLICATION; RECOGNITION; COMPONENTS	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Understanding of the RNA virus and its interactions with host proteins could improve therapeutic interventions for COVID-19. By using icSHAPE, we determined the structural landscape of SARS-CoV-2 RNA in infected human cells and from refolded RNAs, as well as the regulatory untranslated regions of SARS-CoV-2 and six other coronaviruses. We validated several structural elements predicted in silico and discovered structural features that affect the translation and abundance of subgenomic viral RNAs in cells. The structural data informed a deep-learning tool to predict 42 host proteins that bind to SARS-CoV-2 RNA. Strikingly, antisense oligonucleotides targeting the structural elements and FDA-approved drugs inhibiting the SARS-CoV-2 RNA binding proteins dramatically reduced SARS-CoV-2 infection in cells derived from human liver and lung tumors. Our findings thus shed light on coronavirus and reveal multiple candidate therapeutics for COVID-19 treatment.	[Sun, Lei; Li, Pan; Huang, Wenze; Zhang, Shaojun; Xiong, Tuanlin; Xu, Kui; Zhou, Xiaolin; Zhang, Qiangfeng Cliff] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, MOE Key Lab Bioinformat, Ctr Synthet & Syst Biol,Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Lei; Li, Pan; Huang, Wenze; Zhang, Shaojun; Xiong, Tuanlin; Xu, Kui; Zhou, Xiaolin; Zhang, Qiangfeng Cliff] Tsinghua Univ, Ctr Synthet & Syst Biol, Sch Life Sci, Frontier Res Ctr Biol Struct, Beijing 100084, Peoples R China; [Sun, Lei; Li, Pan; Huang, Wenze; Zhang, Shaojun; Xiong, Tuanlin; Xu, Kui; Zhou, Xiaolin; Zhang, Qiangfeng Cliff] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Ju, Xiaohui; Gong, Mingli; Ding, Qiang] Tsinghua Univ, Ctr Infect Dis Res, Sch Med, Beijing 100084, Peoples R China; [Rao, Jian; Ren, Lili; Wang, Jianwei] Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Rao, Jian; Ren, Lili; Wang, Jianwei] Chinese Acad Med Sci & Peking Union Med Coll, Christophe Merieux Lab, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Ren, Lili; Wang, Jianwei] Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Resp Dis Pathogen, Beijing 100730, Peoples R China; [Miska, Eric] Univ Cambridge, Canc Res UK Gurdon Inst, Dept Genet, Wellcome Trust, Cambridge CB2 1QN, England; [Miska, Eric] Wellcome Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute	Zhang, QFC (corresponding author), Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, MOE Key Lab Bioinformat, Ctr Synthet & Syst Biol,Sch Life Sci, Beijing 100084, Peoples R China.; Zhang, QFC (corresponding author), Tsinghua Univ, Ctr Synthet & Syst Biol, Sch Life Sci, Frontier Res Ctr Biol Struct, Beijing 100084, Peoples R China.; Zhang, QFC (corresponding author), Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Ding, Q (corresponding author), Tsinghua Univ, Ctr Infect Dis Res, Sch Med, Beijing 100084, Peoples R China.; Wang, JW (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, NHC Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; Wang, JW (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Christophe Merieux Lab, Inst Pathogen Biol, Beijing 100730, Peoples R China.; Wang, JW (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Key Lab Resp Dis Pathogen, Beijing 100730, Peoples R China.	qding@tsinghua.edu.cn; wangjw28@163.com; qczhang@tsinghua.edu.cn	Wang, Jianwei/W-5916-2019; Sun, Lei/ABF-1422-2021	Sun, Lei/0000-0003-1400-2157; Ju, Xiaohui/0000-0002-9552-0222; Wang, Jianwei/0000-0002-1116-4559; rao, jian/0000-0002-6929-070X; Li, Pan/0000-0002-6902-5762	National Natural Science Foundation of China [91740204, 91940306, 31761163007, 32070153, 81930063]; National Key R&D Program of China [2018YFA0107603, 2019YFA0110002]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences [2016-I2M-1014]; Tsinghua University Spring Breeze Fund [2020Z99CFY029]; Tsinghua University Initiative Scientific Research Program [2019Z06QCX10]; Tsinghua-Cambridge Joint Research Initiative Fund [2019Z02CAU]; TsinghuaPeking Center for Life Sciences Postdoctoral Fellowship	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences; Tsinghua University Spring Breeze Fund; Tsinghua University Initiative Scientific Research Program; Tsinghua-Cambridge Joint Research Initiative Fund; TsinghuaPeking Center for Life Sciences Postdoctoral Fellowship	We thank Profs. Jianbin Wang and Yonghui Zhang for the help with the project, Juanrong Zhang and Yao Li for the help of docking analysis, and the Life Science Editors for editing assistance. This work is supported by the National Natural Science Foundation of China (grants no. 91740204, 91940306, 31761163007, 32070153, and 81930063), the National Key R&D Program of China (2018YFA0107603 and 2019YFA0110002), Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (2016-I2M-1014), Tsinghua University Spring Breeze Fund (2020Z99CFY029), Tsinghua University Initiative Scientific Research Program (2019Z06QCX10), and Tsinghua-Cambridge Joint Research Initiative Fund (2019Z02CAU). We thank the Tsinghua University Branch of China National Center for Protein Sciences (Beijing) for computational facility support. L.S. was supported by the TsinghuaPeking Center for Life Sciences Postdoctoral Fellowship.	Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963; Andrews Ryan J, 2020, bioRxiv, DOI 10.1101/2020.04.17.045161; Andronescu M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-340; Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Aw JGA, 2016, MOL CELL, V62, P603, DOI 10.1016/j.molcel.2016.04.028; Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015; Bennett CF, 2017, ANNU REV PHARMACOL, V57, P81, DOI 10.1146/annurev-pharmtox-010716-104846; Bernier CR, 2014, FARADAY DISCUSS, V169, P195, DOI 10.1039/c3fd00126a; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brion P, 1997, ANNU REV BIOPH BIOM, V26, P113, DOI 10.1146/annurev.biophys.26.1.113; Burkhardt DH, 2017, ELIFE, V6, DOI [10.7554/elife.22037, 10.7554/eLife.22037]; Cai ZK, 2020, NATURE, V582, P432, DOI 10.1038/s41586-020-2249-1; Chen FF, 2016, NAT CHEM BIOL, V12, P174, DOI [10.1038/nchembio.2003, 10.1038/NCHEMBIO.2003]; Chen JH, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100594; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Dethoff EA, 2018, P NATL ACAD SCI USA, V115, P11513, DOI 10.1073/pnas.1716689115; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Egli M, 2005, BIOCHEMISTRY-US, V44, P9045, DOI 10.1021/bi050574m; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157; Ennifar E, 2000, J MOL BIOL, V304, P35, DOI 10.1006/jmbi.2000.4204; Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265; Finkel Yaara, 2021, Nature, V589, P125, DOI 10.1038/s41586-020-2739-1; Fraser CS, 2007, NAT REV MICROBIOL, V5, P29, DOI 10.1038/nrmicro1558; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Goebel SJ, 2004, J VIROL, V78, P669, DOI 10.1128/JVI.78.2.669-682.2004; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Hofacker Ivo L., 2007, V395, P527; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hu BQ, 2017, NUCLEIC ACIDS RES, V45, pD104, DOI 10.1093/nar/gkw888; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kalvari Ioanna, 2018, Curr Protoc Bioinformatics, V62, pe51, DOI 10.1002/cpbi.51; Kalvari I, 2018, NUCLEIC ACIDS RES, V46, pD335, DOI 10.1093/nar/gkx1038; Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Klein S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19619-7; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee S., 2020, SARS COV 2 RNA INTER, DOI [10.1101/2020.11.02.364497, DOI 10.1101/2020.11.02.364497]; Leman JK, 2020, NAT METHODS, V17, P665, DOI 10.1038/s41592-020-0848-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LC, 2008, J MOL BIOL, V377, P790, DOI 10.1016/j.jmb.2008.01.068; Li P, 2020, METHODS, V178, P96, DOI 10.1016/j.ymeth.2019.09.020; Li PTX, 2008, ANNU REV BIOCHEM, V77, P77, DOI 10.1146/annurev.biochem.77.061206.174353; Li S., 2020, NOVEL CELL CULTURE S, DOI [10.1101/2020.1112.1113.422469, DOI 10.1101/2020.1112.1113.422469]; Li ZH, 2011, RNA BIOL, V8, P305, DOI 10.4161/rna.8.2.15391; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu Yiwei, 2020, Biosaf Health, V2, P232, DOI 10.1016/j.bsheal.2020.07.009; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu ZP, 2016, CELL, V165, P1267, DOI 10.1016/j.cell.2016.04.028; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nakagawa K, 2018, J VIROL, V92, DOI 10.1128/JVI.00902-18; Nakamura T, 2018, BIOINFORMATICS, V34, P2490, DOI 10.1093/bioinformatics/bty121; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Nawrocki EP, 2013, RNA BIOL, V10, P1170, DOI 10.4161/rna.25038; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288; Ooi YS, 2019, NAT MICROBIOL, V4, P2369, DOI 10.1038/s41564-019-0518-2; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Piao ML, 2017, GENOM PROTEOM BIOINF, V15, P267, DOI 10.1016/j.gpb.2017.05.002; Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024; Ramanathan M, 2018, NAT METHODS, V15, P207, DOI [10.1038/NMETH.4601, 10.1038/nmeth.4601]; Rangan R, 2020, RNA, V26, P937, DOI 10.1261/rna.076141.120; Ren AM, 2017, CURR OPIN CHEM BIOL, V41, P71, DOI 10.1016/j.cbpa.2017.09.017; Ren AM, 2014, NAT CHEM BIOL, V10, P780, DOI [10.1038/NCHEMBIO.1606, 10.1038/nchembio.1606]; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rix U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077155; Roberts TC, 2020, NAT REV DRUG DISCOV, V19, P673, DOI 10.1038/s41573-020-0075-7; Robertson MP, 2005, PLOS BIOL, V3, P86, DOI 10.1371/journal.pbio.0030005; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Schmidt N, 2021, NAT MICROBIOL, V6, P339, DOI 10.1038/s41564-020-00846-z; Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839; Shi ST, 2000, EMBO J, V19, P4701, DOI 10.1093/emboj/19.17.4701; Simon LM, 2019, NUCLEIC ACIDS RES, V47, P7003, DOI 10.1093/nar/gkz318; Sola I, 2011, J VIROL, V85, P5136, DOI 10.1128/JVI.00195-11; Spitale RC, 2015, NATURE, V519, P486, DOI 10.1038/nature14263; Spurgers KB, 2008, ANTIVIR RES, V78, P26, DOI 10.1016/j.antiviral.2007.12.008; Sun L, 2019, NAT STRUCT MOL BIOL, V26, P322, DOI 10.1038/s41594-019-0200-7; Thapar R, 2014, WIRES RNA, V5, P49, DOI 10.1002/wrna.1196; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van den Born E, 2005, J VIROL, V79, P6312, DOI 10.1128/JVI.79.10.6312-6324.2005; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Warner KD, 2018, NAT REV DRUG DISCOV, V17, P547, DOI 10.1038/nrd.2018.93; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Weinlich S, 2009, RNA, V15, P1528, DOI 10.1261/rna.1578409; Wu F, 2020, NATURE, V580, pE7, DOI 10.1038/s41586-020-2202-3; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang D, 2015, VIROLOGY, V475, P15, DOI 10.1016/j.virol.2014.11.001; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yang XF, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00671; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Kaiming, 2020, bioRxiv, DOI 10.1101/2020.07.18.209270; Ziv O, 2018, NAT METHODS, V15, P785, DOI 10.1038/s41592-018-0121-0; Zubradt M, 2017, NAT METHODS, V14, P75, DOI [10.1038/nmeth.4057, 10.1038/NMETH.4057]	110	66	66	18	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2021	184	7					1865	+		10.1016/j.cell.2021.02.008	http://dx.doi.org/10.1016/j.cell.2021.02.008		APR 2021	39	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RI2IU	33636127	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000636734000019
J	Hodder, SL; Feinberg, J; Strathdee, SA; Shoptaw, S; Altice, FL; Ortenzio, L; Beyrer, C				Hodder, Sally L.; Feinberg, Judith; Strathdee, Steffanie A.; Shoptaw, Steven; Altice, Frederick L.; Ortenzio, Louis; Beyrer, Chris			The opioid crisis and HIV in the USA: deadly synergies	LANCET			English	Review							MEDICATION-ASSISTED TREATMENT; INJECT DRUGS; UNITED-STATES; PREEXPOSURE PROPHYLAXIS; SUBSTITUTION TREATMENT; METHADONE TREATMENT; VIRUS-INFECTION; RISK BEHAVIORS; RURAL-AREAS; PREVENTION	The opioid epidemic is one of the greatest public health problems that the USA faces. Opioid overdose death rates have increased steadily for more than a decade and doubled in 2013-17, as the highly potent synthetic opioid fentanyl entered the drug supply. Demographics of new HIV diagnoses among people who inject drugs are also changing, with more new HIV diagnoses occurring among White people, young people (aged 13-34 years), and people who reside outside large central metropolitan areas. Racial differences also exist in syringe sharing, which decreased among Black people and Hispanic people but remained unchanged among White people in 2005-15. Recent HIV outbreaks have occurred in rural areas of the USA, as well as among marginalised people in urban areas with robust HIV prevention and treatment services (eg, Seattle, WA). Multiple evidence-based interventions can effectively treat opioid use disorder and prevent HIV acquisition. However, considerable barriers exist precluding delivery of these solutions to many people who inject drugs. If the USA is serious about HIV prevention among this group, stigma must be eliminated, discriminatory policies must change, and comprehensive health care must be accessible to all. Finally, root causes of the opioid epidemic such as hopelessness need to be identified and addressed.	[Hodder, Sally L.; Feinberg, Judith] West Virginia Univ, Univ Hlth Sci Ctr, West Virginia Clin & Translat Sci Inst, Morgantown, WV 26506 USA; [Strathdee, Steffanie A.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Shoptaw, Steven] Univ Calif Los Angeles, Los Angeles, CA USA; [Altice, Frederick L.] Yale Univ, New Haven, CT USA; [Ortenzio, Louis] Clarksburg Mission, Clarksburg, WV USA; [Beyrer, Chris] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD USA	West Virginia University; University of California System; University of California San Diego; University of California System; University of California Los Angeles; Yale University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hodder, SL (corresponding author), West Virginia Univ, Univ Hlth Sci Ctr, West Virginia Clin & Translat Sci Inst, Morgantown, WV 26506 USA.	slhodder@hsc.wvu.edu		Shoptaw, Steven/0000-0002-3583-0026; feinberg, judith/0000-0003-4206-7214	Foundation for AIDS Research (amfAR); National Institute on Drug Abuse (NIDA) [R01-DA030768, U01 DA045384, R01 DA033679, R01 DA043125, R01 DA029910]; West Virginia Clinical and Translational Science Institute [NIGMS U54GM104942]; NIDA Merit Award [R37-DA019829]	Foundation for AIDS Research (amfAR); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); West Virginia Clinical and Translational Science Institute; NIDA Merit Award	This Series paper was supported by unrestricted grants from the Foundation for AIDS Research (amfAR), the National Institute on Drug Abuse (NIDA; R01-DA030768, U01 DA045384, R01 DA033679, R01 DA043125, R01 DA029910), and the West Virginia Clinical and Translational Science Institute NIGMS U54GM104942), and by a NIDA Merit Award (R37-DA019829).	Akbarzadeh V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3887-y; Allen ST, 2020, AIDS BEHAV, V24, P1942, DOI 10.1007/s10461-019-02767-3; Alpren C, 2020, AM J PUBLIC HEALTH, V110, P37, DOI 10.2105/AJPH.2019.305366; Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Andrilla CHA, 2019, J RURAL HEALTH, V35, P108, DOI 10.1111/jrh.12307; Arias Elizabeth, 2019, Natl Vital Stat Rep, V68, P1; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Auty SG, 2020, J SUBST ABUSE TREAT, V115, DOI 10.1016/j.jsat.2020.108032; Baker DW, 2017, JAMA-J AM MED ASSOC, V317, P1117, DOI 10.1001/jama.2017.0935; Barnett ML, 2019, HEALTH AFFAIR, V38, P2048, DOI 10.1377/hlthaff.2019.00859; Bazzi AR, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6314-8; Bennett AS, 2011, J URBAN HEALTH, V88, P1020, DOI 10.1007/s11524-011-9600-7; Bernard CL, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002312; Bromberg DJ, 2020, CURR OPIN HIV AIDS, V15, P232, DOI 10.1097/COH.0000000000000631; Carroll Kathleen M, 2019, Focus (Am Psychiatr Publ), V17, P183, DOI 10.1176/appi.focus.17206; Case A, 2017, BROOKINGS PAP ECO AC, P397; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cicero TJ, 2015, JAMA PSYCHIAT, V72, P424, DOI 10.1001/jamapsychiatry.2014.3043; Cole ES, 2019, J GEN INTERN MED, V34, P936, DOI 10.1007/s11606-019-04943-6; Davies MC, ASSOCIATIONS NONMEDI; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Dennis BB, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-105; Des Jarlais DC, 2015, MMWR-MORBID MORTAL W, V64, P1337, DOI 10.15585/mmwr.mm6448a3; Des Jarlais DC, 2012, DRUG ALCOHOL DEPEN, V124, P95, DOI 10.1016/j.drugalcdep.2011.12.020; Deweerdt S, 2019, NATURE, V573, pS10, DOI 10.1038/d41586-019-02686-2; Dowell D, 2016, HEALTH AFFAIR, V35, P1876, DOI 10.1377/hlthaff.2016.0448; Esmaeili A, 2017, J VIRAL HEPATITIS, V24, P117, DOI 10.1111/jvh.12628; Eyre E., 2016, DRUG FIRMS POURED 78; Feinberg J, 2019, NATURE, V573, P165, DOI 10.1038/d41586-019-02671-9; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Fleischauer AT, 2017, MMWR-MORBID MORTAL W, V66, P569, DOI 10.15585/mmwr.mm6622a1; Gibson A, 2008, ADDICTION, V103, P462, DOI 10.1111/j.1360-0443.2007.02090.x; Gibson BA, 2017, J HEALTH CARE POOR U, V28, P643, DOI 10.1353/hpu.2017.0065; Golden MR, 2019, MMWR-MORBID MORTAL W, V68, P344, DOI 10.15585/mmwr.mm6815a2; Gonsalves GS, 2018, LANCET HIV, V5, pE569, DOI 10.1016/S2352-3018(18)30176-0; Green TC, 2020, SUBST ABUS, V41, P147, DOI 10.1080/08897077.2020.1752351; Guise A, 2017, ADDICTION, V112, P572, DOI 10.1111/add.13437; Guy GP, 2017, MMWR-MORBID MORTAL W, V66, P697, DOI 10.15585/mmwr.mm6626a4; Hagan H, 2000, J SUBST ABUSE TREAT, V19, P247, DOI 10.1016/S0740-5472(00)00104-5; Hansen H, 2016, DRUG ALCOHOL DEPEN, V164, P14, DOI 10.1016/j.drugalcdep.2016.03.028; Hedegaard Holly, 2018, NCHS Data Brief, P1; Institute of Medicine, 2007, PREV HIV INF DRUG US; International Network of People who Use Drugs, 2015, POSITION PAPER PREEX; Irwin A, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0153-2; Jalal H, 2018, SCIENCE, V361, P1218, DOI 10.1126/science.aau1184; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Jones CM, 2019, ADDICTION, V114, P471, DOI 10.1111/add.14436; Jones CM, 2013, DRUG ALCOHOL DEPEN, V132, P95, DOI 10.1016/j.drugalcdep.2013.01.007; Joudrey PJ, 2019, JAMA-J AM MED ASSOC, V322, P1310, DOI 10.1001/jama.2019.12562; Kelly JF, 2019, TREATING OPIOID ADDI; Kennedy-Hendricks A, 2016, AM J PUBLIC HEALTH, V106, P291, DOI 10.2105/AJPH.2015.302953; Kerr Thomas, 2007, Curr HIV/AIDS Rep, V4, P158, DOI 10.1007/s11904-007-0023-8; Kishore S, 2019, NEW ENGL J MED, V380, P1988, DOI 10.1056/NEJMp1901276; Knudsen HK, 2019, INT J DRUG POLICY, V70, P8, DOI 10.1016/j.drugpo.2019.04.008; Lambdin BH, 2019, INT J DRUG POLICY, V74, P299, DOI 10.1016/j.drugpo.2019.10.004; Lee JD, 2018, LANCET, V391, P309, DOI 10.1016/S0140-6736(17)32812-X; Low AJ, 2016, CLIN INFECT DIS, V63, P1094, DOI 10.1093/cid/ciw416; MacArthur GJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5945; MacDonald M., 2003, International Journal of Drug Policy, V14, P353, DOI 10.1016/S0955-3959(03)00133-6; Madden LM, 2018, ADDICTION, V113, P1450, DOI 10.1111/add.14198; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Mancher M., 2019, MEDICATIONS OPIOID U; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; McFarland W, 2020, AIDS BEHAV, V24, P1290, DOI 10.1007/s10461-019-02682-7; Melvin SC, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200256; Miller WC, 2018, LANCET, V392, P747, DOI 10.1016/S0140-6736(18)31487-9; MMWR, 2017, MMWR-MORBID MORTAL W, V66, P697; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; National Institute on Drug Abuse, 2021, OV DEATH RAT; Oster AM, 2018, C RETR OPP INF BOST; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2203, DOI 10.1001/jama.2019.6390; Page K, 2015, JAIDS-J ACQ IMM DEF, V69, pS169, DOI 10.1097/QAI.0000000000000641; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Pitt AL, 2018, AM J PUBLIC HEALTH, V108, P1394, DOI 10.2105/AJPH.2018.304590; Ruiz MS, 2019, JAIDS-J ACQ IMM DEF, V82, pS148, DOI 10.1097/QAI.0000000000002176; Salmon AM, 2009, DRUG ALCOHOL DEPEN, V101, P132, DOI 10.1016/j.drugalcdep.2008.12.002; Schranz AJ, 2018, CURR HIV-AIDS REP, V15, P245, DOI 10.1007/s11904-018-0393-0; Sherman SG, 2019, DRUG ALCOHOL DEPEN, V195, P148, DOI 10.1016/j.drugalcdep.2018.08.014; Shrestha R, 2020, PATIENT PREFER ADHER, V14, P107, DOI 10.2147/PPA.S236794; Shrestha R, 2018, AIDS BEHAV, V22, P2640, DOI 10.1007/s10461-018-2099-0; Shrestha R, 2018, AIDS BEHAV, V22, P1228, DOI 10.1007/s10461-017-1851-1; Shrestha R, 2017, DRUG ALCOHOL DEPEN, V173, P107, DOI 10.1016/j.drugalcdep.2016.12.023; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; Strathdee SA, 2020, AIDS, V34, P1997, DOI 10.1097/QAD.0000000000002673; Strathdee SA, 2015, NEW ENGL J MED, V373, P1380, DOI 10.1056/NEJMc1510396; Substance Abuse and Mental Health Services Administration, 2017, KEY SUBSTANCE USE ME; Substance Abuse and Mental Health Services Agency, 2020, MED ASS TREATM 2020; Suryaprasad AG, 2014, CLIN INFECT DIS, V59, P1411, DOI 10.1093/cid/ciu643; Swiss Health Service for Small Ruminants, 2020, TECHN INSTR FOOTR CO; Sypsa V, 2017, J INFECT DIS, V215, P1496, DOI 10.1093/infdis/jix100; Timko C, 2016, J ADDICT DIS, V35, P22, DOI 10.1080/10550887.2016.1100960; Twillman RK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.18514; US Centers for Disease Control and Prevention, 2018, HIV SURVEILLANCE SPE; US Centers for Disease Control and Prevention, 2018, HIV SURV WOM; US Centers for Disease Control and Prevention, 2019, SYNTH OP OV DAT; US Centers for Disease Control and Prevention, 2018, HIV SURV PERS WHO IN; US Centers for Disease Control and Prevention, HIV SURVEILLANCE REP; US Department of Health and Human Services, 2019, WHAT IS END HIV EP P; US National Academies of Sciences Engineering and Medicine, 2020, OPPORTUNITIES IMPROV; US Public Health Service, 2018, PREXP PROPH PREV HIV; US Veterans Health Administration, 2000, PAIN 5 VITAL SIGN TO; Wegman MP, 2017, LANCET GLOB HEALTH, V5, pE198, DOI 10.1016/S2214-109X(16)30303-5; Wejnert C, 2016, MMWR-MORBID MORTAL W, V65, P1336, DOI 10.15585/mmwr.mm6547e1; Wood E, 2005, INT J DRUG POLICY, V16, P281, DOI 10.1016/j.drugpo.2005.07.004; Wood E, 2007, ADDICTION, V102, P916, DOI 10.1111/j.1360-0443.2007.01818.x; Zee AV, 2009, AM J PUBLIC HEALTH, V99, P221, DOI 10.2105/AJPH.2007.131714; Zhang C, 2019, AIDS PATIENT CARE ST, V33, P507, DOI 10.1089/apc.2019.0119; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	109	27	27	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1139	1150		10.1016/S0140-6736(21)00391-3	http://dx.doi.org/10.1016/S0140-6736(21)00391-3		MAR 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617769				2022-12-28	WOS:000630397800031
J	Meza, R; Jeon, J; Toumazis, I; ten Haaf, K; Cao, PP; Bastani, M; Han, SS; Blom, EF; Jonas, DE; Feuer, EJ; Plevritis, SK; de Koning, HJ; Kong, CY				Meza, Rafael; Jeon, Jihyoun; Toumazis, Iakovos; ten Haaf, Kevin; Cao, Pianpian; Bastani, Mehrad; Han, Summer S.; Blom, Erik F.; Jonas, Daniel E.; Feuer, Eric J.; Plevritis, Sylvia K.; de Koning, Harry J.; Kong, Chung Yin			Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography Modeling Study for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CESSATION INTERVENTIONS; SMOKING-CESSATION; UNITED-STATES; MORTALITY; IMPLEMENTATION; SELECTION; AMERICAN; CRITERIA; HISTORY; IMPACT	This simluation study models the benefits and harms associated with low-dose computed tomography (LDCT) screening for lung cancer based on a range of starting and stopping ages, screening frequencies, cumulative pack-years, and years since quitting smoking. Importance The US Preventive Services Task Force (USPSTF) is updating its 2013 lung cancer screening guidelines, which recommend annual screening for adults aged 55 through 80 years who have a smoking history of at least 30 pack-years and currently smoke or have quit within the past 15 years. Objective To inform the USPSTF guidelines by estimating the benefits and harms associated with various low-dose computed tomography (LDCT) screening strategies. Design, Setting, and Participants Comparative simulation modeling with 4 lung cancer natural history models for individuals from the 1950 and 1960 US birth cohorts who were followed up from aged 45 through 90 years. Exposures Screening with varying starting ages, stopping ages, and screening frequency. Eligibility criteria based on age, cumulative pack-years, and years since quitting smoking (risk factor-based) or on age and individual lung cancer risk estimation using risk prediction models with varying eligibility thresholds (risk model-based). A total of 1092 LDCT screening strategies were modeled. Full uptake and adherence were assumed for all scenarios. Main Outcomes and Measures Estimated lung cancer deaths averted and life-years gained (benefits) compared with no screening. Estimated lifetime number of LDCT screenings, false-positive results, biopsies, overdiagnosed cases, and radiation-related lung cancer deaths (harms). Results Efficient screening programs estimated to yield the most benefits for a given number of screenings were identified. Most of the efficient risk factor-based strategies started screening at aged 50 or 55 years and stopped at aged 80 years. The 2013 USPSTF-recommended criteria were not among the efficient strategies for the 1960 US birth cohort. Annual strategies with a minimum criterion of 20 pack-years of smoking were efficient and, compared with the 2013 USPSTF-recommended criteria, were estimated to increase screening eligibility (20.6%-23.6% vs 14.1% of the population ever eligible), lung cancer deaths averted (469-558 per 100 000 vs 381 per 100 000), and life-years gained (6018-7596 per 100 000 vs 4882 per 100 000). However, these strategies were estimated to result in more false-positive test results (1.9-2.5 per person screened vs 1.9 per person screened with the USPSTF strategy), overdiagnosed lung cancer cases (83-94 per 100 000 vs 69 per 100 000), and radiation-related lung cancer deaths (29.0-42.5 per 100 000 vs 20.6 per 100 000). Risk model-based vs risk factor-based strategies were estimated to be associated with more benefits and fewer radiation-related deaths but more overdiagnosed cases. Conclusions and Relevance Microsimulation modeling studies suggested that LDCT screening for lung cancer compared with no screening may increase lung cancer deaths averted and life-years gained when optimally targeted and implemented. Screening individuals at aged 50 or 55 years through aged 80 years with 20 pack-years or more of smoking exposure was estimated to result in more benefits than the 2013 USPSTF-recommended criteria and less disparity in screening eligibility by sex and race/ethnicity.	[Meza, Rafael; Jeon, Jihyoun; Cao, Pianpian] Univ Michigan, Dept Epidemiol, 1415Washington Hts, Ann Arbor, MI 48109 USA; [Toumazis, Iakovos; Bastani, Mehrad; Plevritis, Sylvia K.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Toumazis, Iakovos; Bastani, Mehrad] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [ten Haaf, Kevin; Blom, Erik F.; de Koning, Harry J.] Erasmus MC, Rotterdam, Netherlands; [Han, Summer S.] Stanford Univ, Dept Med, Quantitat Sci Unit, Stanford, CA 94305 USA; [Jonas, Daniel E.] Univ N Carolina, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC 27515 USA; [Jonas, Daniel E.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Feuer, Eric J.] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Kong, Chung Yin] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Kong, Chung Yin] Mt Sinai Hosp, Dept Med, Div Gen Internal Med, New York, NY 10029 USA	University of Michigan System; University of Michigan; Stanford University; Stanford University; Erasmus University Rotterdam; Erasmus MC; Stanford University; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai	Meza, R (corresponding author), Univ Michigan, Dept Epidemiol, 1415Washington Hts, Ann Arbor, MI 48109 USA.	rmeza@umich.edu	Haaf, Kevin ten/AAI-3998-2020	Haaf, Kevin ten/0000-0001-5006-6938				Aberle DR, 2019, J THORAC ONCOL, V14, P1732, DOI 10.1016/j.jtho.2019.05.044; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aldrich MC, 2019, JAMA ONCOL, V5, P1318, DOI 10.1001/jamaoncol.2019.1402; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; Becker N, 2020, INT J CANCER, V146, P1503, DOI 10.1002/ijc.32486; Cao PP, 2020, J THORAC ONCOL, V15, P1160, DOI 10.1016/j.jtho.2020.02.008; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Crosbie PA, 2019, THORAX, V74, P405, DOI 10.1136/thoraxjnl-2017-211377; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Field JK, 2016, THORAX, V71, P161, DOI 10.1136/thoraxjnl-2015-207140; Han SS, 2020, JNCI-J NATL CANCER I, V112, P1136, DOI 10.1093/jnci/djaa013; Holford TR, 2016, NICOTINE TOB RES, V18, pS16, DOI 10.1093/ntr/ntv274; Howlader N, 2020, NEW ENGL J MED, V383, P640, DOI 10.1056/NEJMoa1916623; Huo JH, 2017, JAMA INTERN MED, V177, P439, DOI 10.1001/jamainternmed.2016.9016; Jeon J, 2018, ANN INTERN MED, V169, P684, DOI [10.7326/M18-1250, 10.7326/m18-1250]; Joseph AM, 2018, AM J RESP CRIT CARE, V197, P172, DOI 10.1164/rccm.201705-0909CI; Kathuria H, 2017, AM J RESP CRIT CARE, V196, P1202, DOI 10.1164/rccm.201709-1858ST; Katki HA, 2018, ANN INTERN MED, V169, P10, DOI [10.7326/M17-2701, 10.7326/m17-2701]; Kazerooni Ella A, 2016, J Am Coll Radiol, V13, pR30, DOI 10.1016/j.jacr.2015.12.010; Kinsinger LS, 2017, JAMA INTERN MED, V177, P399, DOI 10.1001/jamainternmed.2016.9022; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Kumar V, 2018, ANN INTERN MED, V168, P161, DOI 10.7326/M17-1401; MELBLATT J, 2016, ANN INTERN MED, V164, P215, DOI DOI 10.7326/M15-1536; Meza R., 2021, AHRQ PUBLICATION; Meza R, 2014, CANCER-AM CANCER SOC, V120, P1713, DOI 10.1002/cncr.28623; Moolgavkar SH, 2012, JNCI-J NATL CANCER I, V104, P541, DOI 10.1093/jnci/djs136; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; National Comprehensive Cancer Network, CLIN PRACTICE GUIDEL; Pinsky PF, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv226; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Richards TB, 2019, AM J PREV MED, V56, P66, DOI 10.1016/j.amepre.2018.07.030; Tammemagi MC, 2018, TRANSL LUNG CANCER R, V7, P243, DOI 10.21037/tlcr.2018.06.03; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tammemagi MC, 2017, LANCET ONCOL, V18, P1523, DOI [10.1016/S1470-2045(17)30597-1, 10.1016/s1470-2045(17)30597-1]; ten Haaf K, 2020, JNCI-J NATL CANCER I, V112, P466, DOI 10.1093/jnci/djz164; ten Haaf K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002277; Vu C, 2019, CHEST, V156, p407A, DOI 10.1016/j.chest.2019.08.444; Wang Y, 2015, JAMA-J AM MED ASSOC, V313, P853, DOI 10.1001/jama.2015.413	39	69	72	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					988	997		10.1001/jama.2021.1077	http://dx.doi.org/10.1001/jama.2021.1077			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687469	Green Accepted, Bronze			2022-12-28	WOS:000627899400020
J	Shi, S; Li, Y; Ngo-Dinh, BN; Markmann, J; Weissmuller, J				Shi, Shan; Li, Yong; Ngo-Dinh, Bao-Nam; Markmann, Juergen; Weissmueller, Joerg			Scaling behavior of stiffness and strength of hierarchical network nanomaterials	SCIENCE			English	Article							NANOPOROUS-GOLD; MECHANICAL RESPONSE; YIELD STRENGTH; SIZE; METALS; BONE; DEFORMATION; FABRICATION; GENERATION; ULTRALIGHT	Structural hierarchy can enhance the mechanical behavior of materials and systems. This is exemplified by the fracture toughness of nacre or enamel in nature and by human-made architected microscale network structures. Nanoscale structuring promises further strengthening, yet macroscopic bodies built this way contain an immense number of struts, calling for scalable preparation schemes. In this work, we demonstrated macroscopic hierarchical network nanomaterials made by the self-organization processes of dealloying. Their hierarchical architecture affords enhanced strength and stiffness at a given solid fraction, and it enables reduced solid fractions by dealloying. Scaling laws for the mechanics and atomistic simulation support the observations. Because they expose the systematic benefits of hierarchical structuring in nanoscale network structures, our materials may serve as prototypes for future lightweight structural materials.	[Shi, Shan; Li, Yong; Ngo-Dinh, Bao-Nam; Markmann, Juergen; Weissmueller, Joerg] Helmholtz Zentrum Geesthacht, Inst Mat Res, Mat Mech, D-21502 Geesthacht, Germany; [Shi, Shan; Li, Yong; Markmann, Juergen; Weissmueller, Joerg] Hamburg Univ Technol, Inst Mat Phys & Technol, D-21073 Hamburg, Germany; [Ngo-Dinh, Bao-Nam] Tech Univ Carolo Wilhelmina Braunschweig, Inst Mat, D-38106 Braunschweig, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; Hamburg University of Technology; Braunschweig University of Technology	Shi, S; Weissmuller, J (corresponding author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Mat Mech, D-21502 Geesthacht, Germany.; Shi, S; Weissmuller, J (corresponding author), Hamburg Univ Technol, Inst Mat Phys & Technol, D-21073 Hamburg, Germany.	shan.shi@hzg.de; weissmueller@tuhh.de	Ngo-Dinh, Bao-Nam/T-4807-2017; Weissmüller, Jörg/C-3967-2009; Markmann, Jürgen/G-4057-2010	Ngo-Dinh, Bao-Nam/0000-0002-8451-6658; Weissmüller, Jörg/0000-0002-8958-4414; Markmann, Jürgen/0000-0002-1384-0581; Li, Yong/0000-0003-1472-9567; Shi, Shan/0000-0001-8510-4586	Deutsche Forschungsgemeinschaft [192346071 -SFB 986]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Projektnummer 192346071 -SFB 986). The authors gratefully acknowledge U. Dette for her assistance with sample preparation.	ALONSO C, 1990, ELECTROCHIM ACTA, V35, P1331, DOI 10.1016/0013-4686(90)85003-6; Artymowicz DM, 2009, PHILOS MAG, V89, P1663, DOI 10.1080/14786430903025708; Badwe N, 2017, ACTA MATER, V129, P251, DOI 10.1016/j.actamat.2017.02.040; Balk TJ, 2009, JOM-US, V61, P26, DOI 10.1007/s11837-009-0176-6; Bauer J, 2017, ADV MATER, V29, DOI 10.1002/adma.201701850; Biener J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1832742; Biener J, 2006, NANO LETT, V6, P2379, DOI 10.1021/nl061978i; Briot NJ, 2015, PHILOS MAG, V95, P2955, DOI 10.1080/14786435.2015.1078512; Briot NJ, 2014, PHILOS MAG, V94, P847, DOI 10.1080/14786435.2013.868944; Burckert M, 2017, PHILOS MAG, V97, P1157, DOI 10.1080/14786435.2017.1292060; Chandross M. E., 2009, 20096226 SAND US DEP; Corsi JS, 2019, ACS SUSTAIN CHEM ENG, V7, P11194, DOI 10.1021/acssuschemeng.9b00481; Ding Y, 2003, J AM CHEM SOC, V125, P7772, DOI 10.1021/ja035318g; do Rosario JJ, 2015, ADV ENG MATER, V17, P1420, DOI 10.1002/adem.201500118; Emerson DR, 2006, LAB CHIP, V6, P447, DOI 10.1039/b516975e; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Erlebacher J, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.225504; Espinosa HD, 2009, PROG MATER SCI, V54, P1059, DOI 10.1016/j.pmatsci.2009.05.001; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4; Garcia AE, 2019, NANOSCALE ADV, V1, P3870, DOI 10.1039/c9na00358d; Gibson L.J., 1988, CELLULAR SOLIDS STRU, DOI [10.1017/CBO9781139878326, DOI 10.1017/CBO9781139878326]; Greer JR, 2019, MRS BULL, V44, P750, DOI 10.1557/mrs.2019.232; Greer JR, 2011, PROG MATER SCI, V56, P654, DOI 10.1016/j.pmatsci.2011.01.005; Gu XW, 2015, EXTREME MECH LETT, V2, P7, DOI 10.1016/j.eml.2015.01.006; Han SC, 2015, ADV MATER, V27, P5506, DOI 10.1002/adma.201501546; Hodge AM, 2007, ACTA MATER, V55, P1343, DOI 10.1016/j.actamat.2006.09.038; Hodge AM, 2009, J MATER RES, V24, P1600, DOI 10.1557/JMR.2009.0184; Hsieh MT, 2019, J MECH PHYS SOLIDS, V125, P401, DOI 10.1016/j.jmps.2019.01.002; Huber N, 2014, ACTA MATER, V67, P252, DOI 10.1016/j.actamat.2013.12.003; Jang DC, 2013, NAT MATER, V12, P893, DOI [10.1038/NMAT3738, 10.1038/nmat3738]; Jin HJ, 2018, MRS BULL, V43, P35, DOI 10.1557/mrs.2017.302; Jin HJ, 2010, NANO LETT, V10, P187, DOI 10.1021/nl903262b; Jin HJ, 2009, ACTA MATER, V57, P2665, DOI 10.1016/j.actamat.2009.02.017; Joo SH, 2020, ADV MATER, V32, DOI 10.1002/adma.201906160; Juarez T, 2017, ADV ENG MATER, V19, DOI 10.1002/adem.201700389; LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0; LI R, 1992, PHYS REV LETT, V68, P1168, DOI 10.1103/PhysRevLett.68.1168; Li Y, 2019, PHYS REV MATER, V3, DOI 10.1103/PhysRevMaterials.3.076001; Liu F, 2017, PHYS CHEM CHEM PHYS, V19, P19217, DOI 10.1039/c7cp03033a; Liu LZ, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4984108; Liu LZ, 2016, ACTA MATER, V118, P77, DOI 10.1016/j.actamat.2016.07.033; Mameka N, 2016, MATER RES LETT, V4, P27, DOI 10.1080/21663831.2015.1094679; Meza LR, 2015, P NATL ACAD SCI USA, V112, P11502, DOI 10.1073/pnas.1509120112; Meza LR, 2014, SCIENCE, V345, P1322, DOI 10.1126/science.1255908; Montemayor LC, 2015, J APPL MECH-T ASME, V82, DOI 10.1115/1.4030361; Mousanezhad D, 2015, SCI REP-UK, V5, DOI 10.1038/srep18306; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Muth JT, 2017, P NATL ACAD SCI USA, V114, P1832, DOI 10.1073/pnas.1616769114; Ngo BND, 2015, ACTA MATER, V93, P144, DOI 10.1016/j.actamat.2015.04.021; Okulov IV, 2018, NANO RES, V11, P6428, DOI 10.1007/s12274-018-2167-9; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Portela CM, 2020, P NATL ACAD SCI USA, V117, P5686, DOI 10.1073/pnas.1916817117; Qi Z, 2013, ACS NANO, V7, P5948, DOI 10.1021/nn4021345; Schaedler TA, 2011, SCIENCE, V334, P962, DOI 10.1126/science.1211649; Sieradzki K, 2002, J ELECTROCHEM SOC, V149, pB370, DOI 10.1149/1.1492288; Soyarslan C, 2018, ACTA MATER, V149, P326, DOI 10.1016/j.actamat.2018.01.005; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Suen JY, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0041; Sun SF, 2015, NAT MATER, V14, P894, DOI [10.1038/NMAT4335, 10.1038/nmat4335]; Torrents A, 2012, ACTA MATER, V60, P3511, DOI 10.1016/j.actamat.2012.03.007; Trogadas P, 2016, ANGEW CHEM INT EDIT, V55, P122, DOI 10.1002/anie.201506394; Tsuda M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4821066; Volkert CA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240109; Volkert CA, 2006, PHILOS MAG, V86, P5567, DOI 10.1080/14786430600567739; Wang CC, 2018, CHEM MATER, V30, P3894, DOI 10.1021/acs.chemmater.8b01431; Wang K, 2015, NPG ASIA MATER, V7, DOI 10.1038/am.2015.58; Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271; Xiang YH, 2020, ACTA MATER, V186, P105, DOI 10.1016/j.actamat.2019.12.046; Yang XY, 2017, CHEM SOC REV, V46, P481, DOI 10.1039/c6cs00829a; Yilmaz ED, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0130; Zheng XY, 2016, NAT MATER, V15, P1100, DOI [10.1038/NMAT4694, 10.1038/nmat4694]; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291	73	46	46	34	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1026	+		10.1126/science.abd9391	http://dx.doi.org/10.1126/science.abd9391			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674489				2022-12-28	WOS:000625876100050
J	Hodcroft, EB; De Maio, N; Lanfear, R; MacCannell, DR; Minh, BQ; Schmidt, HA; Stamatakis, A; Goldman, N; Dessimoz, C				Hodcroft, Emma B.; De Maio, Nicola; Lanfear, Rob; MacCannell, Duncan R.; Minh, Bui Quang; Schmidt, Heiko A.; Stamatakis, Alexandros; Goldman, Nick; Dessimoz, Christophe			Want to track pandemic variants faster? Fix the bioinformatics bottleneck Comment	NATURE			English	Editorial Material							SARS-COV-2	Tools, rules and incentives are buckling under the flood of coronavirus genome sequences - to help control the pandemic, researchers need new approaches.	[Hodcroft, Emma B.] Nextstrain, Bern, Switzerland; [Hodcroft, Emma B.] Univ Bern, Bern, Switzerland; [Goldman, Nick] EMBL European Bioinformat Inst, Cambridge, England; [Goldman, Nick] EMBL European Bioinformat Inst, Res, Cambridge, England; [Dessimoz, Christophe] Univ Lausanne, Bioinformat, Lausanne, Switzerland; [Dessimoz, Christophe] UCL, London, England; [Dessimoz, Christophe] Swiss Inst Bioinformat, Lausanne, Switzerland	University of Bern; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Lausanne; University of London; University College London; Swiss Institute of Bioinformatics	Hodcroft, EB (corresponding author), Nextstrain, Bern, Switzerland.; Hodcroft, EB (corresponding author), Univ Bern, Bern, Switzerland.	emma.hodcroft@ispm.unibe.ch; goldman@ebi.ac.uk; christophe.dessimoz@unil.ch	Stamatakis, Alexandros/B-8740-2009; Schmidt, Heiko A/AAC-4650-2022; Minh, Bui Quang/E-8899-2016; Lanfear, Robert/A-2022-2010; Dessimoz, Christophe/D-3678-2011	Stamatakis, Alexandros/0000-0003-0353-0691; Schmidt, Heiko A/0000-0002-2311-8592; Minh, Bui Quang/0000-0002-5535-6560; Goldman, Nick/0000-0001-8486-2211; Lanfear, Robert/0000-0002-1140-2596; Dessimoz, Christophe/0000-0002-2170-853X				[Anonymous], 2021, NATURE, V590, P195, DOI [10.1038/d41586-021-00305-7 1:CAS:528:DC%2BB3MXjsF2nsrw%3D, DOI 10.1038/D41586-021-00305-7]; Dorp L., 2020, NATURE COMMUN, V11, P5986, DOI [10.1038/s41467-020-19818-2, DOI 10.1038/S41467-020-19818-2]; GEOGHEGAN JL, 2020, NAT COMMUN, V11, pNIL_0156, DOI DOI 10.1038/s41467-020-20235-8; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Haussler D., NATURE; Lemieux J. E., 2021, SCIENCE, V371, peabe3261, DOI 10.1126/science.abe3261; Plessis L., 2021, SCIENCE, V371, P708, DOI [10.1126/science.abf2946, DOI 10.1126/SCIENCE.ABF2946]; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Swadi T, 2021, EMERG INFECT DIS, V27, P687, DOI 10.3201/eid2703.204714; Turakhia Y, 2020, PREPRINT BIORXIV, DOI [10.1101/2020.09.26.314971, DOI 10.1101/2020.09.26.314971]; Turakhia Y, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1009175; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a	12	34	34	0	20	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					30	33		10.1038/d41586-021-00525-x	http://dx.doi.org/10.1038/d41586-021-00525-x			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QP8JF	33649511	Green Submitted			2022-12-28	WOS:000624076300001
J	[Anonymous]				[Anonymous]			Seven days in medicine: 24 February to 2 March 2021	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Jones NK, 2021, ELIFE, V10, DOI 10.7554/eLife.68808	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n588	10.1136/bmj.n588	http://dx.doi.org/10.1136/bmj.n588			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664051	Bronze			2022-12-28	WOS:000632920100003
J	Shahsavar, A; Stohler, P; Bourenkov, G; Zimmermann, I; Siegrist, M; Guba, W; Pinard, E; Sinning, S; Seeger, MA; Schneider, TR; Dawson, RJP; Nissen, P				Shahsavar, Azadeh; Stohler, Peter; Bourenkov, Gleb; Zimmermann, Iwan; Siegrist, Martin; Guba, Wolfgang; Pinard, Emmanuel; Sinning, Steffen; Seeger, Markus A.; Schneider, Thomas R.; Dawson, Roger J. P.; Nissen, Poul			Structural insights into the inhibition of glycine reuptake	NATURE			English	Article							X-RAY-STRUCTURE; NMDA RECEPTOR; TRANSPORTER; GLYT1; MECHANISM; DISCOVERY; SCHIZOPHRENIA; RG1678; MODEL; SITE	The human glycine transporter 1 (GlyT1) regulates glycine-mediated neuronal excitation and inhibition through the sodium- and chloride-dependent reuptake of glycine(1-3). Inhibition of GlyT1 prolongs neurotransmitter signalling, and has long been a key strategy in the development of therapies for a broad range of disorders of the central nervous system, including schizophrenia and cognitive impairments(4). Here, using a synthetic single-domain antibody (sybody) and serial synchrotron crystallography, we have determined the structure of GlyT1 in complex with a benzoylpiperazine chemotype inhibitor at 3.4 angstrom resolution. We find that the inhibitor locks GlyT1 in an inward-open conformation and binds at the intracellular gate of the release pathway, overlapping with the glycine-release site. The inhibitor is likely to reach GlyT1 from the cytoplasmic leaflet of the plasma membrane. Our results define the mechanism of inhibition and enable the rational design of new, clinically efficacious GlyT1 inhibitors.	[Shahsavar, Azadeh; Nissen, Poul] Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE, Dept Mol Biol & Genet, Nord EMBL Partnership Mol Med, Aarhus, Denmark; [Shahsavar, Azadeh; Bourenkov, Gleb; Schneider, Thomas R.] European Mol Biol Lab, Hamburg Unit DESY, Hamburg, Germany; [Stohler, Peter; Siegrist, Martin; Guba, Wolfgang; Pinard, Emmanuel; Dawson, Roger J. P.] Roche Innovat Ctr, Roche Pharma Res & Early Dev, Therapeut Modal, Basel, Switzerland; [Zimmermann, Iwan; Seeger, Markus A.] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Zimmermann, Iwan; Dawson, Roger J. P.] Linkster Therapeut AG, Zurich, Switzerland; [Sinning, Steffen] Aarhus Univ, Dept Forens Med, Aarhus, Denmark	Aarhus University; European Molecular Biology Laboratory (EMBL); Roche Holding; University of Zurich; Aarhus University	Nissen, P (corresponding author), Aarhus Univ, Danish Res Inst Translat Neurosci DANDRITE, Dept Mol Biol & Genet, Nord EMBL Partnership Mol Med, Aarhus, Denmark.; Schneider, TR (corresponding author), European Mol Biol Lab, Hamburg Unit DESY, Hamburg, Germany.; Dawson, RJP (corresponding author), Roche Innovat Ctr, Roche Pharma Res & Early Dev, Therapeut Modal, Basel, Switzerland.; Dawson, RJP (corresponding author), Linkster Therapeut AG, Zurich, Switzerland.	thomas.schneider@embl-hamburg.de; roger.dawson@linkstertherapeutics.com; pn@mbg.au.dk	Schneider, Thomas/B-7442-2011; Bourenkov, Gleb/C-7794-2017	Schneider, Thomas/0000-0001-6955-7374; Sinning, Steffen/0000-0001-6971-6929; Shahsavar, Azadeh/0000-0001-5405-597X; Nissen, Poul/0000-0003-0948-6628; Zimmermann, Iwan/0000-0003-3476-4749; Bourenkov, Gleb/0000-0002-2617-5920; Seeger, Markus/0000-0003-1761-8571	Novo Nordisk Foundation; Lundbeck Foundation via the DANDRITE Neuroscience Center; F. Hoffmann-La Roche; EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie Sklodowska-Curie Actions COFUND [664726]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation via the DANDRITE Neuroscience Center; F. Hoffmann-La Roche(Hoffmann-La Roche); EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie Sklodowska-Curie Actions COFUND	We thank R. Thoma (F. Hoffmann-La Roche) for long-term project support and discussions; L. Hetemann and J. Gera for early contributions to producing the mutants; J. Thornton for advice and discussions on the project; F. Dall'Antonia for writing the Ctrl-d script; J. Pieprzyk for assistance with mammalian cell expression; H. Poulsen for assistance with electrophysiology studies; M. M. Garcia Alai for access to sample preparation and crystallization facilities at EMBL Hamburg; and I. M. Nemtanu and C. Guenther for technical assistance. We acknowledge the support offered at the P14 beamline operated by EMBL Hamburg at the PETRA III storage ring (DESY, Hamburg). We thank J. A. Lyons, B. Pedersen, C. Low and the PROMEMO Center of Excellence of the Danish Research Foundation for discussions. This project has received funding from Novo Nordisk Foundation (to P.N.), the Lundbeck Foundation via the DANDRITE Neuroscience Center, and F. Hoffmann-La Roche. A.S. was supported by a fellowship from the EMBL Interdisciplinary Postdoc (EIPOD) programme under Marie Sklodowska-Curie Actions COFUND (grant agreement number 664726).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Alberati D, 2012, NEUROPHARMACOLOGY, V62, P1152, DOI 10.1016/j.neuropharm.2011.11.008; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; [Anonymous], 2019, MOL OPERATING ENV MO; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bricogne G., 2019, BUSTER V2103; Brown A, 2001, BIOORG MED CHEM LETT, V11, P2007, DOI 10.1016/S0960-894X(01)00355-9; Bugarski-Kirola D, 2017, BIOL PSYCHIAT, V82, P8, DOI 10.1016/j.biopsych.2016.11.014; Carland JE, 2018, ACS CHEM NEUROSCI, V9, P603, DOI 10.1021/acschemneuro.7b00407; CAULFIELD WL, 2001, NUCLEIC ACIDS RES, V44, P2679, DOI DOI 10.1021/jm0011272; Cioffi CL, 2018, EXPERT OPIN THER PAT, V28, P197, DOI 10.1080/13543776.2018.1429408; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Cubelos B, 2005, J NEUROCHEM, V95, P1047, DOI 10.1111/j.1471-4159.2005.03438.x; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; D'Souza DC, 2018, BIOL PSYCHIAT, V84, P413, DOI 10.1016/j.biopsych.2017.12.019; DIEDERICHS K, 2012, NAT STRUCT BIOL, V336, P1030, DOI DOI 10.1126/science.1218231; DIEDERICHS K, 1997, SCIENCE, V4, P269; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Focht D, 2021, EMBO J, V40, DOI 10.15252/embj.2020105164; GATI C, 2014, J BIOL CHEM, V1, P87, DOI DOI 10.1107/S2052252513033939; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gotfryd K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14735-w; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Harvey RJ, 2013, NAT REV DRUG DISCOV, V12, P866, DOI 10.1038/nrd3893; HATTORI M, 2012, ACTA CRYSTALLOGR D, V20, P1293, DOI DOI 10.1016/j.str.2012.06.009; HAWKINS PCD, 2007, STRUCTURE, V50, P74, DOI DOI 10.1021/jm0603365; JACOBS MT, 2007, ANESTHESIOLOGY, V282, P29441, DOI DOI 10.1074/jbc.M704456200; JAEGER K, 2019, EMBO J, V178, P1222, DOI DOI 10.1016/j.cell.2019.07.028; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jolidon S., 2006, WIPO patent, Patent No. [WO/2006/082001, 2006082001]; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KANTCHEVA AK, 2013, ACTA CRYSTALLOGR D, V110, P8489, DOI DOI 10.1073/pnas.1221279110; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI 10.1016/j.brainresbull.2010.04.006; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Krystal JH, 2009, DRUG DISCOV TODAY, V14, P690, DOI 10.1016/j.drudis.2009.05.002; LeVine MV, 2019, P NATL ACAD SCI USA, V116, P15947, DOI 10.1073/pnas.1903020116; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Malinauskaite L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11673; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; MARTINFACKLAM M, 2013, BIOL PSYCHIAT, V38, P504, DOI DOI 10.1038/npp.2012.212; MOSCA R, 2008, J MOL BIOL, V36, pW42, DOI DOI 10.1093/nar/gkn197; OLIVARES L, 1995, CELL REP, V270, P9437; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Pinard E, 2018, CHIMIA, V72, P477, DOI 10.2533/chimia.2018.477; Pinard E, 2010, BIOORG MED CHEM LETT, V20, P6960, DOI 10.1016/j.bmcl.2010.09.124; Pinard E, 2010, J MED CHEM, V53, P4603, DOI 10.1021/jm100210p; Popov A. N., 2016, DOZOR; Shim SS, 2007, EUR ARCH PSY CLIN N, V258, P16, DOI 10.1007/s00406-007-0757-8; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; SINGH SK, 2008, P NATL ACAD SCI USA, V322, P1655, DOI DOI 10.1126/science.1166777; Tange O, 2011, USENIX MAG, V36, P42; VANDENBERG RJ, 2007, CELL, V282, P14447, DOI DOI 10.1074/jbc.M609158200; Weber F, 2018, CELL REP, V22, P149, DOI 10.1016/j.celrep.2017.12.019; Werdehausen R, 2012, ANESTHESIOLOGY, V116, P147, DOI 10.1097/ALN.0b013e31823cf233; WINN MD, 2011, NUCLEIC ACIDS RES, V67, P235, DOI DOI 10.1107/S0907444910045749; ZANDER U, 2015, IUCRJ, V71, P2328, DOI DOI 10.1107/S1399004715017927; Zhang Y.-W., 2021, P NATL ACAD SCI US; Zimmermann I, 2018, ELIFE, V7, DOI 10.7554/eLife.34317	64	29	29	3	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					677	+		10.1038/s41586-021-03274-z	http://dx.doi.org/10.1038/s41586-021-03274-z		MAR 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33658720				2022-12-28	WOS:000625125200009
J	Hsiang, MS; Mumbengegwi, D; Chimumbwa, J				Hsiang, Michelle S.; Mumbengegwi, Davis; Chimumbwa, John			Mini-outbreak response for malaria using indoor residual spraying	LANCET			English	Editorial Material							VECTOR CONTROL; TRANSMISSION		[Hsiang, Michelle S.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Hsiang, Michelle S.] Univ Calif San Francisco, Malaria Eliminat Initiat, San Francisco, CA 94143 USA; [Hsiang, Michelle S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Mumbengegwi, Davis] Univ Namibia, Multidisciplinary Res Ctr, Windhoek, Namibia; [Chimumbwa, John] Southern African Dev Community Malaria Eliminat E, Windhoek, Namibia	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Namibia	Hsiang, MS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.; Hsiang, MS (corresponding author), Univ Calif San Francisco, Malaria Eliminat Initiat, San Francisco, CA 94143 USA.; Hsiang, MS (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	michelle.hsiang@utsouthwestern.edu						[Anonymous], 2019, SADC MALARIA ELIMINA; Bath D, 2021, LANCET, V397, P816, DOI 10.1016/S0140-6736(21)00251-8; Gosling R, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03185-w; Greenhouse Bryan, 2019, Gates Open Res, V3, P131, DOI 10.12688/gatesopenres.12897.1; Hsiang MS, 2020, LANCET, V395, P1361, DOI 10.1016/S0140-6736(20)30470-0; Hsiang MS, 2020, CLIN INFECT DIS, V70, P1316, DOI 10.1093/cid/ciz403; Nankabirwa JI, 2020, AM J TROP MED HYG, V103, P1525, DOI 10.4269/ajtmh.20-0250; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Stresman G, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003370; Tangena JAA, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03216-6; WHO, 2020, WORLD MAL REP 2020; Williams YA, 2018, ADV PARASIT, V99, P345, DOI 10.1016/bs.apar.2018.01.003	12	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					771	773						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640045				2022-12-28	WOS:000623925500005
J	Eisenstein, M				Eisenstein, Michael			CLOSING IN ON A COMPLETE HUMAN GENOME	NATURE			English	Editorial Material						Genomics; Computational biology and bioinformatics; Genetics; Molecular biology												Jain M, 2018, NAT BIOTECHNOL, V36, P338, DOI 10.1038/nbt.4060; Jain M, 2018, NAT BIOTECHNOL, V36, P321, DOI 10.1038/nbt.4109; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Logsdon G. A, 2020, PREPRINT BIORXIV, DOI [10.1101/2020.09.08.285395, DOI 10.1101/2020.09.08.285395]; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Suzuki Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd9230; Wenger AM, 2019, NAT BIOTECHNOL, V37, P1155, DOI 10.1038/s41587-019-0217-9	7	1	1	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847					679	681		10.1038/d41586-021-00462-9	http://dx.doi.org/10.1038/d41586-021-00462-9			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK7TR	33619406				2022-12-28	WOS:000620584900001
J	Mahdessian, D; Cesnik, AJ; Gnann, C; Danielsson, F; Stenstrom, L; Arif, M; Zhang, C; Le, T; Johansson, F; Shutten, R; Backstrom, A; Axelsson, U; Thul, P; Cho, NH; Carja, O; Uhlen, M; Mardinoglu, A; Stadler, C; Lindskog, C; Ayoglu, B; Leonetti, MD; Ponten, F; Sullivan, DP; Lundberg, E				Mahdessian, Diana; Cesnik, Anthony J.; Gnann, Christian; Danielsson, Frida; Stenstrom, Lovisa; Arif, Muhammad; Zhang, Cheng; Le, Trang; Johansson, Fredric; Shutten, Rutger; Backstrom, Anna; Axelsson, Ulrika; Thul, Peter; Cho, Nathan H.; Carja, Oana; Uhlen, Mathias; Mardinoglu, Adil; Stadler, Charlotte; Lindskog, Cecilia; Ayoglu, Burcu; Leonetti, Manuel D.; Ponten, Fredrik; Sullivan, Devin P.; Lundberg, Emma			Spatiotemporal dissection of the cell cycle with single-cell proteogenomics	NATURE			English	Article							GENE ONTOLOGY; PROTEIN; CANCER; IDENTIFICATION; MAINTENANCE; RESOURCE; REVEALS; ATLAS; TOOL	Spatial and temporal variations among individual human cell proteomes are comprehensively mapped across the cell cycle using proteomic imaging and transcriptomics. The cell cycle, over which cells grow and divide, is a fundamental process of life. Its dysregulation has devastating consequences, including cancer(1-3). The cell cycle is driven by precise regulation of proteins in time and space, which creates variability between individual proliferating cells. To our knowledge, no systematic investigations of such cell-to-cell proteomic variability exist. Here we present a comprehensive, spatiotemporal map of human proteomic heterogeneity by integrating proteomics at subcellular resolution with single-cell transcriptomics and precise temporal measurements of individual cells in the cell cycle. We show that around one-fifth of the human proteome displays cell-to-cell variability, identify hundreds of proteins with previously unknown associations with mitosis and the cell cycle, and provide evidence that several of these proteins have oncogenic functions. Our results show that cell cycle progression explains less than half of all cell-to-cell variability, and that most cycling proteins are regulated post-translationally, rather than by transcriptomic cycling. These proteins are disproportionately phosphorylated by kinases that regulate cell fate, whereas non-cycling proteins that vary between cells are more likely to be modified by kinases that regulate metabolism. This spatially resolved proteomic map of the cell cycle is integrated into the Human Protein Atlas and will serve as a resource for accelerating molecular studies of the human cell cycle and cell proliferation.	[Mahdessian, Diana; Cesnik, Anthony J.; Gnann, Christian; Danielsson, Frida; Stenstrom, Lovisa; Arif, Muhammad; Zhang, Cheng; Le, Trang; Johansson, Fredric; Shutten, Rutger; Backstrom, Anna; Axelsson, Ulrika; Thul, Peter; Uhlen, Mathias; Mardinoglu, Adil; Stadler, Charlotte; Ayoglu, Burcu; Sullivan, Devin P.; Lundberg, Emma] KTH Royal Inst Technol, Sch Engn Sci Chem, Sci Life Lab Biotechnol & Hearth, Stockholm, Sweden; [Cesnik, Anthony J.; Carja, Oana; Lundberg, Emma] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Cesnik, Anthony J.; Gnann, Christian; Cho, Nathan H.; Carja, Oana; Leonetti, Manuel D.; Lundberg, Emma] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Carja, Oana] Carnegie Mellon Univ, Computat Biol Dept, Pittsburgh, PA USA; [Mardinoglu, Adil] Kings Coll London, Fac Dent Oral & Craniofaciar Sci, Ctr Host Microbiome Interact, London, England; [Lindskog, Cecilia; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Royal Institute of Technology; Stanford University; Carnegie Mellon University; University of London; King's College London; Uppsala University	Lundberg, E (corresponding author), KTH Royal Inst Technol, Sch Engn Sci Chem, Sci Life Lab Biotechnol & Hearth, Stockholm, Sweden.; Lundberg, E (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Lundberg, E (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	emma.rundberg@scilifelab.se	Arif, Muhammad/AFQ-6409-2022; Zhang, Cheng/L-7906-2016; Lindskog, Cecilia/AAO-2441-2021; Arif, Muhammad/GSO-0267-2022; huang, dezhi/ABC-6566-2021; Mardinoglu, Adil/AAS-6360-2021; Cesnik, Anthony/J-9238-2014	Arif, Muhammad/0000-0003-2261-0881; Zhang, Cheng/0000-0002-3721-8586; Arif, Muhammad/0000-0003-2261-0881; Kaller Lundberg, Emma/0000-0001-7034-0850; Cesnik, Anthony/0000-0002-5326-7134; Sullivan, Devin/0000-0001-6176-108X				[Anonymous], 2018, UMAP UNIFORM MANIFOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Bar-Joseph Z, 2008, P NATL ACAD SCI USA, V105, P955, DOI 10.1073/pnas.0704723105; Barnum KJ, 2014, METHODS MOL BIOL, V1170, P29, DOI 10.1007/978-1-4939-0888-2_2; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Bostrom J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188772; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Collins E.J., GENOME RES; Cooper S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-28; Cowley, 2014, SCI DATA, V1; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez D, 2016, CELL RES, V26, P946, DOI 10.1038/cr.2016.84; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edfors F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06642-y; Eid S, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1433-7; Feng SY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00494-8; Fischer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063187; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Hsiao CJ, 2020, GENOME RES, V30, P611, DOI 10.1101/gr.247759.118; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ietswaart, 2019, PREPRINT BIORXIV, DOI [10.1101/755579, DOI 10.1101/755579]; Izumi M, 2017, J BIOL CHEM, V292, P13008, DOI 10.1074/jbc.M117.779371; Jarzab A, 2020, NAT METHODS, V17, P495, DOI 10.1038/s41592-020-0801-4; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Karlsson J, 2017, J MOL BIOL, V429, P3909, DOI 10.1016/j.jmb.2017.10.011; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Koster J, 2018, BIOINFORMATICS, V34, P3600, DOI 10.1093/bioinformatics/bty350; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lane KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058456; Leonetti MD, 2016, P NATL ACAD SCI USA, V113, pE3501, DOI 10.1073/pnas.1606731113; Li, 2016, CELL DEATH DIS, V7; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Ly T, 2015, ELIFE, V4, DOI 10.7554/eLife.04534; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nilsson P, 2005, PROTEOMICS, V5, P4327, DOI 10.1002/pmic.200500072; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Oyinlade O, 2018, ONCOGENE, V37, P2615, DOI 10.1038/s41388-018-0138-y; Pagliuca FW, 2011, MOL CELL, V43, P406, DOI 10.1016/j.molcel.2011.05.031; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pena-Diaz J, 2013, NUCLEIC ACIDS RES, V41, P2846, DOI 10.1093/nar/gks1336; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Robles MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004047; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Santos A, 2015, NUCLEIC ACIDS RES, V43, pD1140, DOI 10.1093/nar/gku1092; Scialdone A, 2015, METHODS, V85, P54, DOI 10.1016/j.ymeth.2015.06.021; Sellers K, 2015, J CLIN INVEST, V125, P687, DOI 10.1172/JCI72873; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; St-Denis N, 2016, CELL REP, V17, P2488, DOI 10.1016/j.celrep.2016.10.078; Stadler C, 2010, J PROTEOMICS, V73, P1067, DOI 10.1016/j.jprot.2009.10.012; Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Talevich E., 2018, CNVKIT RNA COPY NUMB, DOI 10.1101/408534; Talevich E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004873; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Tran PV, 2014, J AM SOC NEPHROL, V25, P2385, DOI 10.1681/ASN.2014050453; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varjosalo M, 2013, CELL REP, V3, P1306, DOI 10.1016/j.celrep.2013.03.027; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Williams E, 2017, NAT METHODS, V14, P775, DOI [10.1038/NMETH.4326, 10.1038/nmeth.4326]; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xu YL, 2012, CANCER SCI, V103, P1000, DOI 10.1111/j.1349-7006.2012.02258.x; Zielke N, 2015, WIRES DEV BIOL, V4, P469, DOI 10.1002/wdev.189	92	44	44	32	114	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03232-9	http://dx.doi.org/10.1038/s41586-021-03232-9			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627808				2022-12-28	WOS:000621583600020
J	Wadden, TA; Bailey, TS; Billings, LK; Davies, M; Frias, JP; Koroleva, A; Lingvay, I; O'Neil, PM; Rubino, DM; Skovgaard, D; Wallenstein, SOR; Garvey, WT				Wadden, Thomas A.; Bailey, Timothy S.; Billings, Liana K.; Davies, Melanie; Frias, Juan P.; Koroleva, Anna; Lingvay, Ildiko; O'Neil, Patrick M.; Rubino, Domenica M.; Skovgaard, Dorthe; Wallenstein, Signe O. R.; Garvey, W. Timothy		STEP 3 Investigators	Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity The STEP 3 Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-STYLE INTERVENTION; ONCE-WEEKLY SEMAGLUTIDE; LIRAGLUTIDE 3.0 MG; PRACTICE GUIDELINES; AMERICAN-COLLEGE; ASSOCIATION; MANAGEMENT; EFFICACY; 56-WEEK; SAFETY	IMPORTANCE Weight loss improves cardiometabolic risk factors in people with overweight or obesity. Intensive lifestyle intervention and pharmacotherapy are the most effective noninvasive weight loss approaches. OBJECTIVE To compare the effects of once-weekly subcutaneous semaglutide, 2.4 mg vs placebo for weight management as an adjunct to intensive behavioral therapy with initial low-calorie diet in adults with overweight or obesity. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, parallel-group, 68-week, phase 3a study (STEP 3) conducted at 41 sites in the US from August 2018 to April 2020 in adults without diabetes (N = 611) and with either overweight (body mass index >= 27) plus at least 1 comorbidity or obesity (body mass index >= 30). INTERVENTIONS Participants were randomized (2:1) to semaglutide, 2.4 mg (n = 407) or placebo (n = 204), both combined with a low-calorie diet for the first 8 weeks and intensive behavioral therapy (ie, 30 counseling visits) during 68 weeks. MAIN OUTCOMES AND MEASURES The co-primary end points were percentage change in body weight and the loss of 5% or more of baseline weight by week 68. Confirmatory secondary end points included losses of at least 10% or 15% of baseline weight. RESULTS Of 611 randomized participants (495 women [81.0%], mean age 46 years [SD, 13], body weight 105.8 kg [SD, 22.9], and body mass index 38.0 [SD, 6.7]), 567 (92.8%) completed the trial, and 505 (82.7%) were receiving treatment at trial end. At week 68, the estimated mean body weight change from baseline was -16.0% for semaglutide vs -5.7% for placebo (difference, -10.3 percentage points [95% CI, -12.0 to -8.6]; P < .001). More participants treated with semaglutide vs placebo lost at least 5% of baseline body weight (86.6% vs 47.6%, respectively; P < .001). A higher proportion of participants in the semaglutide vs placebo group achieved weight losses of at least 10% or 15% (75.3% vs 27.0% and 55.8% vs 13.2%, respectively; P < .001). Gastrointestinal adverse events were more frequent with semaglutide (82.8%) vs placebo (63.2%). Treatment was discontinued owing to these events in 3.4% of semaglutide participants vs 0% of placebo participants. CONCLUSIONS AND RELEVANCE Among adults with overweight or obesity, once-weekly subcutaneous semaglutide compared with placebo, used as an adjunct to intensive behavioral therapy and initial low-calorie diet, resulted in significantly greater weight loss during 68 weeks. Further research is needed to assess the durability of these findings.	[Wadden, Thomas A.] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bailey, Timothy S.] AMCR Inst, Escondido, CA USA; [Billings, Liana K.] Univ Chicago, NorthShore Univ HealthSyst, Pritzker Sch Med, Dept Med, Skokie, IL USA; [Davies, Melanie] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Davies, Melanie] Leicester Gen Hosp, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Frias, Juan P.] Natl Res Inst, Los Angeles, CA USA; [Koroleva, Anna; Skovgaard, Dorthe; Wallenstein, Signe O. R.] Novo Nordisk AS, Soborg, Denmark; [Lingvay, Ildiko] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Lingvay, Ildiko] Univ Texas Southwestern Med Ctr Dallas, Dept Endocrinol, Dallas, TX 75390 USA; [Lingvay, Ildiko] Univ Texas Southwestern Med Ctr Dallas, Dept Populat & Data Sci, Dallas, TX 75390 USA; [O'Neil, Patrick M.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Weight Management Ctr, Charleston, SC 29425 USA; [Rubino, Domenica M.] Washington Ctr Weight Management & Res, Arlington, VA USA; [Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA	University of Pennsylvania; Pennsylvania Medicine; NorthShore University Health System; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; Novo Nordisk; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham	Wadden, TA (corresponding author), Univ Penn, Perelman Sch Med, 3535 Market St,Ste 3027, Philadelphia, PA 19104 USA.	wadden@pennmedicine.upenn.edu		Davies, Melanie/0000-0002-9987-9371	Novo Nordisk A/S	Novo Nordisk A/S(Novo Nordisk)	This trial was funded by Novo Nordisk A/S.	Ahmann AJ, 2018, DIABETES CARE, V41, P258, DOI 10.2337/dc17-0417; Ahren B, 2017, LANCET DIABETES ENDO, V5, P341, DOI 10.1016/S2213-8587(17)30092-X; Bettge K, 2017, DIABETES OBES METAB, V19, P336, DOI 10.1111/dom.12824; Food and Drug Administration, GUIDANCE IND DEVELOP; Food and Drug Administration, E9 R1 STAT PRINCIPLE; Food and Drug Administration, OZEMPIC SEMAGLUTIDE; Friedrichsen M, 2021, DIABETES OBES METAB, V23, P754, DOI 10.1111/dom.14280; Gabery S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133429; Garvey WT, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161365.GL; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Hall KD, 2018, MED CLIN N AM, V102, P183, DOI 10.1016/j.mcna.2017.08.012; Heckman BW, 2015, CURR OPIN PSYCHOL, V5, P31, DOI 10.1016/j.copsyc.2015.03.004; Heymsfield SB, 2003, INT J OBESITY, V27, P537, DOI 10.1038/sj.ijo.0802258; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Kuna ST, 2021, AM J RESP CRIT CARE, V203, P221, DOI 10.1164/rccm.201912-2511OC; Kushner RF, 2020, OBESITY, V28, P1050, DOI 10.1002/oby.22794; Leibel RL, 2015, DIABETES, V64, P2299, DOI 10.2337/db15-0004; McEvoy BW, 2016, J BIOPHARM STAT, V26, P30, DOI 10.1080/10543406.2015.1094814; Nauck MA, 2019, EUR J ENDOCRINOL, V181, pR211, DOI 10.1530/EJE-19-0566; O'Neil PM, 2018, LANCET, V392, P637, DOI 10.1016/S0140-6736(18)31773-2; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Ryan DH, 2017, CURR OBES REP, V6, P187, DOI 10.1007/s13679-017-0262-y; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Wadden TA, 2004, AM J CLIN NUTR, V80, P560; Wadden TA, 2020, OBESITY, V28, P529, DOI 10.1002/oby.22726; Wadden TA, 2019, OBESITY, V27, P75, DOI 10.1002/oby.22359; Webb VL, 2017, GASTROENTEROLOGY, V152, P1752, DOI 10.1053/j.gastro.2017.01.045; WEINSIER RL, 1995, AM J MED, V98, P115, DOI 10.1016/S0002-9343(99)80394-5; Wharton S, 2021, INT J OBESITY, V45, P923, DOI 10.1038/s41366-020-00733-x; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415	31	155	157	11	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2021	325	14					1403	1413		10.1001/jama.2021.1831	http://dx.doi.org/10.1001/jama.2021.1831		FEB 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9GZ	33625476	Green Published, Bronze			2022-12-28	WOS:000621915300003
J	Mahase, E				Mahase, Elisabeth			Flexible working and teamwork are needed to protect doctors' wellbeing, say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Goddard AF, 2021, CHANGING FACE MED PR	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2021	372								n535	10.1136/bmj.n535	http://dx.doi.org/10.1136/bmj.n535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8SP	33622701				2022-12-28	WOS:000623407800016
J	[Anonymous]				[Anonymous]			The Worth of a Miracle (Reprinted from JAMA, vol 215, pg 1320, 1971)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					793	793		10.1001/jama.2020.17810	http://dx.doi.org/10.1001/jama.2020.17810			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620392				2022-12-28	WOS:000621957400036
J	Iacobucci, G				Iacobucci, Gareth			Subsidiary of US healthcare firm will run more than 50 GP practices after takeover deal	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Central London Clinical Commissioning Group, 2021, AT MED LTD CHANG CON	1	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2021	372								n519	10.1136/bmj.n519	http://dx.doi.org/10.1136/bmj.n519			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7AW	33619035				2022-12-28	WOS:000621236700006
J	Wacholder, A; Carvunis, AR				Wacholder, Aaron; Carvunis, Anne-Ruxandra			New genes from borrowed parts	SCIENCE			English	Editorial Material														Carvunis, Anne-Ruxandra/0000-0002-6474-6413					0	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					779	779						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602841				2022-12-28	WOS:000619664700027
J	Colaianni, CA				Colaianni, C. Alessandra			Breathe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Colaianni, C. Alessandra] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Colaianni, CA (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7					595	597		10.1056/NEJMp2035380	http://dx.doi.org/10.1056/NEJMp2035380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2HH	33605569				2022-12-28	WOS:000620900000006
J	Hotez, PJ; Usa, LCVRAD; Cooney, RE; Benjamin, RM; Brewer, NT; Buttenheim, AM; Callaghan, T; Caplan, A; Carpiano, RM; Clinton, C; DiResta, R; Elharake, JA; Flowers, LC; Galvani, AP; Lakshmanan, R; Maldonado, YA; McFadden, SM; Mello, MM; Opel, DJ; Reiss, DR; Salmon, DA; Schwartz, JL; Sharfstein, JM; Omer, SB				Hotez, Peter J.; USA, Lancet Commission Vaccine Refusal Acceptance Demand; Cooney, Rebecca E.; Benjamin, Regina M.; Brewer, Noel T.; Buttenheim, Alison M.; Callaghan, Timothy; Caplan, Arthur; Carpiano, Richard M.; Clinton, Chelsea; DiResta, Renee; Elharake, Jad A.; Flowers, Lisa C.; Galvani, Alison P.; Lakshmanan, Rekha; Maldonado, Yvonne A.; McFadden, SarahAnn M.; Mello, Michelle M.; Opel, Douglas J.; Reiss, Dorit R.; Salmon, Daniel A.; Schwartz, Jason L.; Sharfstein, Joshua M.; Omer, Saad B.			Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA	LANCET			English	Editorial Material							UNITED-STATES; MEASLES		[Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Dept Pediat, Texas Childrens Ctr Vaccine Dev, Houston, TX 77030 USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Dept Mol Virol & Microbiol, Texas Childrens Ctr Vaccine Dev, Houston, TX 77030 USA; [Hotez, Peter J.] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Hotez, Peter J.] Texas A&M Univ, Hagler Inst Adv Study, College Stn, TX USA; [Hotez, Peter J.] Rice Univ, James A Baker III Inst Publ Policy, Houston, TX USA; [Hotez, Peter J.] Texas A&M Univ, Bush Sch Govt & Publ Serv, Scowcroft Inst Int Affairs, College Stn, TX USA; [Cooney, Rebecca E.] Lancet, New York, NY USA; [Benjamin, Regina M.] Gulf States Hlth Policy Ctr, Bayou La Batre, AL USA; [Brewer, Noel T.] Univ N Carolina, Dept Hlth Behav, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Brewer, Noel T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Buttenheim, Alison M.] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA; Univ Penn, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Callaghan, Timothy] Texas A&M Univ, Sch Publ Hlth, Dept Hlth Policy & Management, College Stn, TX USA; [Caplan, Arthur] NYU, Langone Sch Med, New York, NY USA; [Carpiano, Richard M.] Univ Calif Riverside, Sch Publ Policy, Riverside, CA 92521 USA; [Carpiano, Richard M.] Univ Calif Riverside, Dept Sociol, Riverside, CA 92521 USA; [Clinton, Chelsea] Clinton Fdn, New York, NY USA; [Clinton, Chelsea] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [DiResta, Renee] Stanford Univ, Stanford Internet Observ, Stanford, CA 94305 USA; [Elharake, Jad A.; McFadden, SarahAnn M.; Omer, Saad B.] Yale Inst Global Hlth, New Haven, CT 06510 USA; [Elharake, Jad A.] Yale Sch Publ Hlth, New Haven, CT USA; [Flowers, Lisa C.] Emory Univ, Dept Obstet & Gynecol, Atlanta, GA 30322 USA; [Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, New Haven, CT USA; [Lakshmanan, Rekha] Immunizat Partnership, Houston, TX USA; [Maldonado, Yvonne A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [McFadden, SarahAnn M.; Omer, Saad B.] Yale Sch Med, Dept Internal Med Infect Dis, New Haven, CT 06510 USA; [Mello, Michelle M.] Stanford Law Sch, Stanford, CA USA; [Mello, Michelle M.] Stanford Univ, Ctr Hlth Policy, Primary Care & Outcomes Res, Dept Med,Sch Med, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA 94305 USA; [Opel, Douglas J.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Opel, Douglas J.] Childrens Res Inst, Seattle, WA USA; [Reiss, Dorit R.] UC Hastings Coll Law, San Francisco, CA USA; [Salmon, Daniel A.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD USA; [Schwartz, Jason L.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA; [Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Omer, Saad B.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor University; Texas A&M University System; Texas A&M University College Station; Rice University; Texas A&M University System; Texas A&M University College Station; Bush School of Government & Public Service; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Pennsylvania; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; New York University; NYU Langone Medical Center; University of California System; University of California Riverside; University of California System; University of California Riverside; Columbia University; Stanford University; Yale University; Emory University; Yale University; Stanford University; Yale University; Stanford University; Stanford University; Stanford University; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University	Omer, SB (corresponding author), Yale Inst Global Hlth, New Haven, CT 06510 USA.; Omer, SB (corresponding author), Yale Sch Med, Dept Internal Med Infect Dis, New Haven, CT 06510 USA.; Omer, SB (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.	saad.omer@yale.edu		Callaghan, Timothy/0000-0002-9056-9123; Mello, Michelle/0000-0003-2877-4270				[Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567; Doustmohammadi S, 2020, EMERG TOP LIFE SCI, V4, P241, DOI 10.1042/ETLS20190198; Fine PEM, 2018, PLOTKINS VACCINES, P1512, DOI 10.1016/B978-0-323-35761-6.00077-8; Frass M, 2012, OCHSNER J, V12, P45; Hamel L., 2021, KFF COVID 19 VACCINE; Hardt K, 2016, VACCINE, V34, P6691, DOI 10.1016/j.vaccine.2016.10.078; Hotez P, 2019, PEDIATR RES, V85, P912, DOI 10.1038/s41390-019-0354-3; Hotez PJ, 2020, MICROBES INFECT, V22, P505, DOI 10.1016/j.micinf.2020.09.005; Jamison AM, 2020, VACCINE, V38, P512, DOI 10.1016/j.vaccine.2019.10.066; Johns Hopkins University, 2021, COR RES CTR COVID 19; Olive JK, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002578; Patel M, 2019, MMWR-MORBID MORTAL W, V68, P893, DOI 10.15585/mmwr.mm6840e2; Paules CI, 2019, NEW ENGL J MED, V380, P2185, DOI 10.1056/NEJMp1905099; Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353; Quinn SC, 2019, VACCINE, V37, P1168, DOI 10.1016/j.vaccine.2019.01.033; Scharff DP, 2010, J HEALTH CARE POOR U, V21, P879, DOI 10.1353/hpu.0.0323; Senkomago V, 2019, MMWR-MORBID MORTAL W, V68, P724, DOI 10.15585/mmwr.mm6833a3; Shang M, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2918; Vedam S, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0729-2; Warren RC, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2030033	21	12	12	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 27	2021	397	10280					1165	1167		10.1016/S0140-6736(21)00372-X	http://dx.doi.org/10.1016/S0140-6736(21)00372-X		MAR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RC7YE	33639088	Bronze			2022-12-28	WOS:000633010800006
J	Dance, A; Leach, D				Dance, Amber; Leach, Desiree			Where I work Amber Dance	NATURE			English	Editorial Material						Careers; Medical research; Cardiovascular biology		Molecular biologist Desiree Leach studies the mechanisms of heart disease, the leading cause of death among Black people in the United States. Molecular biologist Desiree Leach studies the mechanisms of heart disease, the leading cause of death among Black people in the United States.	[Leach, Desiree] Feinberg Cardiovasc & Renal Res Inst, Chicago, IL USA										0	0	0	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					338	338		10.1038/d41586-021-00595-x	http://dx.doi.org/10.1038/d41586-021-00595-x			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT5WO	33686267				2022-12-28	WOS:000626658100002
J	Michot, JM; Ribrag, V				Michot, Jean-Marie; Ribrag, Vincent			Pirtobrutinib shows evidence to inaugurate a third generation of BTK inhibitors	LANCET			English	Editorial Material							IBRUTINIB		[Michot, Jean-Marie] Univ Paris Saclay, Gustave Roussy, Dept Innovat Therapeut & Essais Precoces, F-94500 Villejuif, France; [Ribrag, Vincent] Univ Paris Saclay, Gustave Roussy, Dept Hematol, F-94500 Villejuif, France	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Michot, JM (corresponding author), Univ Paris Saclay, Gustave Roussy, Dept Innovat Therapeut & Essais Precoces, F-94500 Villejuif, France.	jean-marie.michot@gustaveroussy.fr	Michot, Jean-Marie/AAC-3028-2022	Michot, Jean-Marie/0000-0003-3482-3331				Burger JA, 2020, LEUKEMIA, V34, P787, DOI 10.1038/s41375-019-0602-x; Burger JA, 2018, NAT REV CANCER, V18, P148, DOI 10.1038/nrc.2017.121; Ghez D, 2018, BLOOD, V131, P1955, DOI 10.1182/blood-2017-11-818286; Italiano A, 2018, LANCET ONCOL, V19, P649, DOI 10.1016/S1470-2045(18)30145-1; Johnson AR, 2016, ACS CHEM BIOL, V11, P2897, DOI 10.1021/acschembio.6b00480; Mato AR, 2021, LANCET, V397, P892, DOI 10.1016/S0140-6736(21)00224-5; Sharman JP, 2020, LANCET, V395, P1278, DOI 10.1016/S0140-6736(20)30262-2; Tam CS, 2020, BLOOD, V136, P2038, DOI 10.1182/blood.2020006844; Wang ML, 2015, BLOOD, V126, P739, DOI 10.1182/blood-2015-03-635326; Wen TY, 2021, LEUKEMIA, V35, P312, DOI 10.1038/s41375-020-01072-6; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029	11	5	5	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					855	857						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676615				2022-12-28	WOS:000626603400003
J	Moore, AS; Coscia, SM; Simpson, CL; Ortega, FE; Wait, EC; Heddleston, JM; Nirschl, JJ; Obara, CJ; Guedes-Dias, P; Boecker, CA; Chew, TL; Theriot, JA; Lippincott-Schwartz, J; Holzbaur, ELF				Moore, Andrew S.; Coscia, Stephen M.; Simpson, Cory L.; Ortega, Fabian E.; Wait, Eric C.; Heddleston, John M.; Nirschl, Jeffrey J.; Obara, Christopher J.; Guedes-Dias, Pedro; Boecker, C. Alexander; Chew, Teng-Leong; Theriot, Julie A.; Lippincott-Schwartz, Jennifer; Holzbaur, Erika L. F.			Actin cables and comet tails organize mitochondrial networks in mitosis	NATURE			English	Article							FILAMENTS; MOTILITY; FISSION; FORMIN; PHOSPHORYLATION; POLYMERIZATION; INHERITANCE; MICROSCOPY; MOVEMENT; PLATFORM	Symmetric cell division requires the even partitioning of genetic information and cytoplasmic contents between daughter cells. Whereas the mechanisms coordinating the segregation of the genome are well known, the processes that ensure organelle segregation between daughter cells remain less well understood(1). Here we identify multiple actin assemblies with distinct but complementary roles in mitochondrial organization and inheritance in mitosis. First, we find a dense meshwork of subcortical actin cables assembled throughout the mitotic cytoplasm. This network scaffolds the endoplasmic reticulum and organizes three-dimensional mitochondrial positioning to ensure the equal segregation of mitochondrial mass at cytokinesis. Second, we identify a dynamic wave of actin filaments reversibly assembling on the surface of mitochondria during mitosis. Mitochondria sampled by this wave are enveloped within actin clouds that can spontaneously break symmetry to form elongated comet tails. Mitochondrial comet tails promote randomly directed bursts of movement that shuffle mitochondrial position within the mother cell to randomize inheritance of healthy and damaged mitochondria between daughter cells. Thus, parallel mechanisms mediated by the actin cytoskeleton ensure both equal and random inheritance of mitochondria in symmetrically dividing cells.	[Moore, Andrew S.; Coscia, Stephen M.; Simpson, Cory L.; Nirschl, Jeffrey J.; Guedes-Dias, Pedro; Boecker, C. Alexander; Holzbaur, Erika L. F.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Moore, Andrew S.; Coscia, Stephen M.; Simpson, Cory L.; Nirschl, Jeffrey J.; Guedes-Dias, Pedro; Holzbaur, Erika L. F.] Univ Penn, Penn Muscle Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Moore, Andrew S.; Wait, Eric C.; Heddleston, John M.; Obara, Christopher J.; Chew, Teng-Leong; Lippincott-Schwartz, Jennifer] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Coscia, Stephen M.; Holzbaur, Erika L. F.] Univ Penn, Cell & Mol Biol Grad Grp, Perelman Sch Med, Philadelphia, PA USA; [Simpson, Cory L.] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ortega, Fabian E.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Guedes-Dias, Pedro] Tech Univ Munich, Inst Neuronal Cell Biol, Munich, Germany; [Theriot, Julie A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Theriot, Julie A.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Technical University of Munich; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Holzbaur, ELF (corresponding author), Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Holzbaur, ELF (corresponding author), Univ Penn, Penn Muscle Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Holzbaur, ELF (corresponding author), Univ Penn, Cell & Mol Biol Grad Grp, Perelman Sch Med, Philadelphia, PA USA.	holzbaur@pennmedicine.upenn.edu	Wait, Eric/P-3167-2019; Boecker, C. Alexander/ABD-2147-2021; Nirschl, Jeffrey/GYQ-5009-2022; Theriot, Julie/HHN-2034-2022	Wait, Eric/0000-0002-1614-9219; Nirschl, Jeffrey/0000-0001-6857-341X; Simpson, Cory/0000-0002-3933-6404; Theriot, Julie/0000-0002-2334-2535; Boecker, C. Alexander/0000-0001-9701-5273; Guedes-Dias, Pedro/0000-0003-0992-5141	NIH [R35 GM126950, RM1 GM136511, F31 GM123644, R37 AI036929]; CHOP MitoRAG Pilot Grant; HHMI investigator support; HHMI Gilliam Fellowship; NIAMS/NIH [K08 AR075846, P30 AR069589]; Dermatology Foundation; National Psoriasis Foundation; UPenn NGG Hearst Fellowship; German Research Foundation (DFG) [BO 5434/1-1]; HHMI;  [F30NS092227]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHOP MitoRAG Pilot Grant; HHMI investigator support; HHMI Gilliam Fellowship; NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Dermatology Foundation; National Psoriasis Foundation; UPenn NGG Hearst Fellowship; German Research Foundation (DFG)(German Research Foundation (DFG)); HHMI(Howard Hughes Medical Institute); 	We thank M. Tokito, A. Stout and the UPenn Cell and Developmental Biology microscopy core, and F. Tuluc and the CHOP Flow Cytometry core for technical contributions; S. Weber for MATLAB code; O. Quintero and D. Matus for cell lines; H. Choi and B. Rossetti for advice on analyses; and M. Ostap, F. Cross, M. Moore, C. Evans, S. Cason, Y. Wong and O. Harding for critical feedback. This work was funded by support from NIH R35 GM126950 and RM1 GM136511 to E.L.F.H., NIH F31 GM123644 and CHOP MitoRAG Pilot Grant to A.S.M., NIH R37 AI036929 and HHMI investigator support to J.A.T., and a HHMI Gilliam Fellowship to F.E.O. C.L.S. was supported by grants from NIAMS/NIH (K08 AR075846), the Dermatology Foundation, and the National Psoriasis Foundation. NHEKs were supplied by Penn SBDRC Core B supported by NIAMS/NIH (P30 AR069589). J.J.N. was supported by F30NS092227 and the UPenn NGG Hearst Fellowship. C.A.B. was supported by the German Research Foundation (DFG; BO 5434/1-1). J.L.-S. was supported by HHMI. The Advanced Imaging Center at the Janelia Research Campus is a jointly funded venture of the Gordon and Betty Moore Foundation and the Howard Hughes Medical Institute.	Altmann K, 2008, J CELL BIOL, V181, P119, DOI 10.1083/jcb.200709099; Aryaman J, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700001; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Berg S., 2019, Nat Methods, V16, P1226, DOI 10.1038/s41592-019-0582-9; Carlton JG, 2020, NAT REV MOL CELL BIO, V21, P151, DOI 10.1038/s41580-019-0208-1; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Chozinski TJ, 2016, NAT METHODS, V13, P485, DOI [10.1038/NMETH.3833, 10.1038/nmeth.3833]; Chung JYM, 2016, CELL REP, V16, P2142, DOI 10.1016/j.celrep.2016.07.055; Fernandopulle Michael S, 2018, Curr Protoc Cell Biol, V79, pe51, DOI 10.1002/cpcb.51; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Guo YT, 2018, CELL, V175, P1430, DOI 10.1016/j.cell.2018.09.057; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kast DJ, 2015, CURR BIOL, V25, P1791, DOI 10.1016/j.cub.2015.05.042; Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384; KITA A, 2019, MOL BIOL CELL, V30, P1645, DOI DOI 10.1091/MBC.E19-02-0126; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; McFaline-Figueroa JR, 2011, AGING CELL, V10, P885, DOI 10.1111/j.1474-9726.2011.00731.x; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Monnier N, 2012, BIOPHYS J, V103, P616, DOI 10.1016/j.bpj.2012.06.029; Moore AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12886; Nishimura, 2020, BIORXIV, DOI [10.1101/2020.08.30.274613., DOI 10.1101/2020.08.30.274613, 10.1101/2020.08.30.274613]; Ortega FE, 2019, ELIFE, V8, DOI 10.7554/eLife.40032; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Rohn JL, 2014, CURR BIOL, V24, P2598, DOI 10.1016/j.cub.2014.09.045; Rue P, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145549; Salvador-Gallego R, 2017, CELL, V171, P1224, DOI 10.1016/j.cell.2017.11.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SIMON VR, 1995, J CELL BIOL, V130, P345, DOI 10.1083/jcb.130.2.345; Simpson CL, 2010, METHODS MOL BIOL, V585, P127, DOI 10.1007/978-1-60761-380-0_10; Steger C, 1998, IEEE T PATTERN ANAL, V20, P113, DOI 10.1109/34.659930; Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; THERIOT JA, 1992, NATURE, V357, P257, DOI 10.1038/357257a0; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; UPTON GJG, 1973, J ROY STAT SOC A STA, V136, P262, DOI 10.2307/2345118; Vincent AE, 2018, ANN NEUROL, V84, P289, DOI 10.1002/ana.25288; Wait E, 2019, BIOINFORMATICS, V35, P5393, DOI 10.1093/bioinformatics/btz523; Weber SC, 2012, BIOPHYS J, V102, P2443, DOI 10.1016/j.bpj.2012.03.062; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251	49	32	32	3	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					659	+		10.1038/s41586-021-03309-5	http://dx.doi.org/10.1038/s41586-021-03309-5		MAR 2021	31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33658713	Green Accepted			2022-12-28	WOS:000625125200011
J	Wu, NB; Sun, HX; Zhao, XY; Zhang, Y; Tan, JM; Qi, YY; Wang, Q; Ng, M; Liu, ZY; He, LJ; Niu, XY; Chen, L; Liu, ZD; Li, HB; Zeng, YA; Roulis, M; Liu, D; Cheng, JK; Zhou, B; Ng, LG; Zou, DW; Ye, YQ; Flavell, RA; Ginhoux, F; Su, B				Wu, Ningbo; Sun, Hongxiang; Zhao, Xiaoyun; Zhang, Yao; Tan, Jianmei; Qi, Yuanyuan; Wang, Qun; Ng, Melissa; Liu, Zhaoyuan; He, Lingjuan; Niu, Xiaoyin; Chen, Lei; Liu, Zhiduo; Li, Hua-Bing; Zeng, Yi Arial; Roulis, Manolis; Liu, Dou; Cheng, Jinke; Zhou, Bin; Ng, Lai Guan; Zou, Duowu; Ye, Youqiong; Flavell, Richard A.; Ginhoux, Florent; Su, Bing			MAP3K2-regulated intestinal stromal cells define a distinct stem cell niche	NATURE			English	Article								Intestinal stromal cells are known to modulate the propagation and differentiation of intestinal stem cells(1,2). However, the precise cellular and molecular mechanisms by which this diverse stromal cell population maintains tissue homeostasis and repair are poorly understood. Here we describe a subset of intestinal stromal cells, named MAP3K2-regulated intestinal stromal cells (MRISCs), and show that they are the primary cellular source of the WNT agonist R-spondin 1 following intestinal injury in mice. MRISCs, which are epigenetically and transcriptomically distinct from subsets of intestinal stromal cells that have previously been reported(3-6), are strategically localized at the bases of colon crypts, and function to maintain LGR5(+) intestinal stem cells and protect against acute intestinal damage through enhanced R-spondin 1 production. Mechanistically, this MAP3K2 specific function is mediated by a previously unknown reactive oxygen species (ROS)-MAP3K2-ERK5-KLF2 axis to enhance production of R-spondin 1. Our results identify MRISCs as a key component of an intestinal stem cell niche that specifically depends on MAP3K2 to augment WNT signalling for the regeneration of damaged intestine.	[Wu, Ningbo; Sun, Hongxiang; Zhao, Xiaoyun; Zhang, Yao; Tan, Jianmei; Qi, Yuanyuan; Wang, Qun; Liu, Zhaoyuan; Niu, Xiaoyin; Chen, Lei; Liu, Zhiduo; Li, Hua-Bing; Ginhoux, Florent; Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai Inst Immunol, Shanghai, Peoples R China; [Wu, Ningbo; Sun, Hongxiang; Zhao, Xiaoyun; Tan, Jianmei; Liu, Zhaoyuan; Chen, Lei; Liu, Zhiduo; Li, Hua-Bing; Ye, Youqiong; Su, Bing] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China; [Zhang, Yao; Zou, Duowu] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Ng, Melissa; Ng, Lai Guan] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [He, Lingjuan; Zeng, Yi Arial; Zhou, Bin] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai, Peoples R China; [Chen, Lei; Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Ctr Microbiota & Immunol Dis,Inst Translat Med, Shanghai, Peoples R China; [Li, Hua-Bing; Flavell, Richard A.; Su, Bing] Shanghai Jiao Tong Univ, Sch Med, Yale Inst Immune Metab, Shanghai, Peoples R China; [Roulis, Manolis; Liu, Dou; Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA; [Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflamm, Dept Biochem & Mol Cell Biol, Shanghai, Peoples R China; [Ginhoux, Florent] SingHlth DukeNUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore; [Su, Bing] Cent South Univ, Xiangya Hosp, Key Lab Mol Radiat Oncol Hunan Prov, Changsha, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Howard Hughes Medical Institute; Yale University; Shanghai Jiao Tong University; Central South University	Su, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai Inst Immunol, Shanghai, Peoples R China.; Su, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai, Peoples R China.; Su, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Ctr Microbiota & Immunol Dis,Inst Translat Med, Shanghai, Peoples R China.; Su, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Yale Inst Immune Metab, Shanghai, Peoples R China.; Su, B (corresponding author), Cent South Univ, Xiangya Hosp, Key Lab Mol Radiat Oncol Hunan Prov, Changsha, Peoples R China.	bingsu@sjtu.edu.cn	Ng, Lai Guan/E-5673-2011	Ng, Lai Guan/0000-0003-1905-3586; Zou, Duowu/0000-0002-2461-5304; ROULIS, MANOLIS/0000-0002-6898-3547; Ng, Melissa/0000-0003-3826-2746	National Natural Science Foundation of China [3201101152, 91942311, 31930035]; Shanghai Science and Technology Commission [20410714000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	We thank Y. Zhuang, G. Su, Z. Yang, and Q. Wang for reading the manuscript and making suggestions; C. Gao, X. Liu, and Y. Han for their initial help and suggestions in scRNA-seq, organoid culture, and the generation of Map3k2 flox mice, respectively; all the members of the Su laboratory for discussion and suggestions; and the sequencing and flow cytometry core facilities at Shanghai Institute of Immunology for their support. This work was supported in part by grants from the National Natural Science Foundation of China (3201101152, 91942311 and 31930035), Shanghai Science and Technology Commission (20410714000).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Degirmenci B, 2018, NATURE, V558, P449, DOI 10.1038/s41586-018-0190-3; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Guo ZJ, 2002, MOL CELL BIOL, V22, P5761, DOI 10.1128/MCB.22.16.5761-5768.2002; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Karpus ON, 2019, CELL REP, V26, P3698, DOI 10.1016/j.celrep.2019.02.101; Khan A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1708-7; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McCarthy N, 2020, NAT CELL BIOL, V22, P1033, DOI 10.1038/s41556-020-0567-z; McCarthy N, 2020, CELL STEM CELL, V26, P391, DOI 10.1016/j.stem.2020.01.008; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Roulis M, 2020, NATURE, V580, P524, DOI 10.1038/s41586-020-2166-3; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schuijers J, 2015, CELL STEM CELL, V16, P158, DOI 10.1016/j.stem.2014.12.006; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Stzepourginski I, 2017, P NATL ACAD SCI USA, V114, pE506, DOI 10.1073/pnas.1620059114; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tian XY, 2020, EMBO J, V39, DOI 10.15252/embj.2019102675; van de Sande B, 2020, NAT PROTOC, V15, P2247, DOI 10.1038/s41596-020-0336-2; Wei Z, 2018, BIOINFORMATICS, V34, P2664, DOI 10.1093/bioinformatics/bty141; Wu NB, 2021, SCI CHINA LIFE SCI, V64, P389, DOI 10.1007/s11427-020-1720-9; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913	42	22	25	16	96	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					606	+		10.1038/s41586-021-03283-y	http://dx.doi.org/10.1038/s41586-021-03283-y		MAR 2021	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SA5CU	33658717				2022-12-28	WOS:000625125200010
J	Bolland, MJ; Avenell, A; Smith, K; Witham, MD; Grey, A				Bolland, Mark J.; Avenell, Alison; Smith, Karen; Witham, Miles D.; Grey, Andrew			Vitamin D supplementation and testing in the UK: costly but ineffective?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							D DEFICIENCY; CHILDREN		[Bolland, Mark J.; Grey, Andrew] Univ Auckland, Dept Med, Auckland 1142, New Zealand; [Bolland, Mark J.] Greenlane Clin Ctr, Dept Endocrinol, Auckland, New Zealand; [Avenell, Alison] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Smith, Karen] Glasgow Royal Infirm, Dept Clin Biochem, Glasgow, Lanark, Scotland; [Witham, Miles D.] Newcastle Univ, NIHR Newcastle Biomed Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Witham, Miles D.] Newcastle Upon Tyne Hosp Trust, Newcastle Upon Tyne, Tyne & Wear, England	University of Auckland; University of Aberdeen; University of Glasgow; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Northumbria University	Bolland, MJ (corresponding author), Univ Auckland, Dept Med, Auckland 1142, New Zealand.; Bolland, MJ (corresponding author), Greenlane Clin Ctr, Dept Endocrinol, Auckland, New Zealand.	m.bolland@auckland.ac.nz		Witham, Miles/0000-0002-1967-0990				Aguiar M, 2020, EUR J CLIN NUTR, V74, P825, DOI 10.1038/s41430-019-0486-x; Ahmed SF, 2011, ARCH DIS CHILD, V96, P694, DOI 10.1136/adc.2009.173195; Aul AJ, 2019, J PEDIATR-US, V211, P98, DOI 10.1016/j.jpeds.2019.02.018; Autier P, 2017, LANCET DIABETES ENDO, V5, P986, DOI [10.1016/s2213-8587(17)30357-1, 10.1016/S2213-8587(17)30357-1]; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Avenell Alison, 2021, Drug Ther Bull, V59, P7, DOI 10.1136/dtb.2020.000060; Basatemur E, 2017, EUR J PEDIATR, V176, P1405, DOI 10.1007/s00431-017-2986-9; Basatemur E, 2015, J CLIN ENDOCR METAB, V100, pE91, DOI 10.1210/jc.2014-2773; Bilinski K, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4743; Bolland MJ, 2018, LANCET DIABETES ENDO, V6, P847, DOI [10.1016/S2213-8587(18)30265-1, 10.1016/s2213-8587(18)30265-1]; Bolland MJ, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6201; Bolland MJ, 2014, LANCET DIABETES ENDO, V2, P573, DOI 10.1016/S2213-8587(14)70068-3; Brown M., 2019, GUARDIAN; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Caulfield T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006395; Crowe FL, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028355; Department for Environment Food and Rural Affairs, 2014, SPREAD FATS MILK MIL; Julies P, 2020, ARCH DIS CHILD, V105, P587, DOI 10.1136/archdischild-2019-317934; Martineau AR, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6583; National Institute for Health and Clinical Excellence (NICE), 2016, CLIN KNOWL SUMM VIT; Pilz S, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00373; SAMUEL H S, 1964, Br Med J, V1, P1659; Sattar N, 2012, LANCET, V379, P95, DOI 10.1016/S0140-6736(11)61816-3; Scientific Advisory Committee on Nutrition, 2016, VIT D HLTH; STEWART WK, 1964, LANCET, V1, P679; Theodoratou E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2035; TORJESEN I, 2020, BMJ-BRIT MED J, V369, P6036, DOI DOI 10.1136/BMJ.M2629; Uday S, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1159-y; Uday S, 2018, ARCH DIS CHILD, V103, P901, DOI 10.1136/archdischild-2018-314826; WISE AK, 2012, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD007146.PUB3	30	3	3	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n484	10.1136/bmj.n484	http://dx.doi.org/10.1136/bmj.n484			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653683	Green Submitted			2022-12-28	WOS:000625340300014
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lopez Bernal J, EARLY EFFECTIVENESS	1	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n612	10.1136/bmj.n612	http://dx.doi.org/10.1136/bmj.n612			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653737	Bronze			2022-12-28	WOS:000625340300010
J	Barneche, DR; Hulatt, CJ; Dossena, M; Padfield, D; Woodward, G; Trimmer, M; Yvon-Durocher, G				Barneche, Diego R.; Hulatt, Chris J.; Dossena, Matteo; Padfield, Daniel; Woodward, Guy; Trimmer, Mark; Yvon-Durocher, Gabriel			Warming impairs trophic transfer efficiency in a long-term field experiment	NATURE			English	Article							CARBON-USE EFFICIENCY; METABOLIC THEORY; FOOD WEBS; TEMPERATURE; ALTERS; GROWTH; SIZE; BIOMASS; SHIFTS; CYCLE	In ecosystems, the efficiency of energy transfer from resources to consumers determines the biomass structure of food webs. As a general rule, about 10% of the energy produced in one trophic level makes it up to the next(1-3). Recent theory suggests that this energy transfer could be further constrained if rising temperatures increase metabolic growth costs(4), although experimental confirmation in whole ecosystems is lacking. Here we quantify nitrogen transfer efficiency-a proxy for overall energy transfer-in freshwater plankton in artificial ponds that have been exposed to seven years of experimental warming. We provide direct experimental evidence that, relative to ambient conditions, 4 degrees C of warming can decrease trophic transfer efficiency by up to 56%. In addition, the biomass of both phytoplankton and zooplankton was lower in the warmed ponds, which indicates major shifts in energy uptake, transformation and transfer(5,6). These findings reconcile observed warming-driven changes in individual-level growth costs and in carbon-use efficiency across diverse taxa(4,7-10) with increases in the ratio of total respiration to gross primary production at the ecosystem level(11-13). Our results imply that an increasing proportion of the carbon fixed by photosynthesis will be lost to the atmosphere as the planet warms, impairing energy flux through food chains, which will have negative implications for larger consumers and for the functioning of entire ecosystems.	[Barneche, Diego R.] Australian Inst Marine Sci, Indian Ocean Marine Res Ctr, Crawley, WA, Australia; [Barneche, Diego R.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Barneche, Diego R.; Padfield, Daniel; Yvon-Durocher, Gabriel] Univ Exeter, Environm & Sustainabil Inst, Penryn, England; [Hulatt, Chris J.; Dossena, Matteo; Trimmer, Mark] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Hulatt, Chris J.] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway; [Woodward, Guy] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England	Australian Institute of Marine Science; University of Western Australia; University of Exeter; University of London; Queen Mary University London; Nord University; Imperial College London	Yvon-Durocher, G (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, England.; Trimmer, M (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	m.trimmer@qmul.ac.uk; g.yvon-durocher@exeter.ac.uk	Trimmer, Mark/HGT-8823-2022; Trimmer, Mark/ABB-2336-2021	Trimmer, Mark/0000-0002-9859-5537; Padfield, Daniel/0000-0001-6799-9670; Woodward, Guy/0000-0001-6158-2559; Hulatt, Chris/0000-0002-2741-8402; Barneche, Diego/0000-0002-4568-2362	AXA Research Fund; Natural Environment Research Council [NE/H022511/1]; European Research Council [ERC StG 677278 TEMPDEP]	AXA Research Fund(AXA Research Fund); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission)	We thank J. H. Brown for suggestions on the manuscript. We thank T. J. McKinley for providing feedback on the statistical analysis, and P. Goncalves for assistance with illustrations. This work was supported by an AXA Research Fund (to M.D.), by the Natural Environment Research Council (NE/H022511/1, to M.T., G.Y.-D. and G.W.), and by a European Research Council grant (ERC StG 677278 TEMPDEP, to G.Y.-D.).	Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Allen AP, 2005, FUNCT ECOL, V19, P202, DOI 10.1111/j.1365-2435.2005.00952.x; Barneche DR, 2019, FUNCT ECOL, V33, P1256, DOI 10.1111/1365-2435.13348; Barneche DR, 2018, ECOL LETT, V21, P836, DOI 10.1111/ele.12947; Bradford MA, 2013, NEW PHYTOL, V199, P7, DOI 10.1111/nph.12334; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Brown JH, 2003, P NATL ACAD SCI USA, V100, P1467, DOI 10.1073/pnas.0630310100; Burkner PC, 2018, R J, V10, P395; CROSSLEY DA, 1969, BIOSCIENCE, V19, P341, DOI 10.2307/1294518; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dossena M, 2012, P ROY SOC B-BIOL SCI, V279, P3011, DOI 10.1098/rspb.2012.0394; Elton C., 1927, ANIMAL ECOLOGY; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lansdown K, 2016, NAT GEOSCI, V9, P357, DOI [10.1038/ngeo2684, 10.1038/NGEO2684]; Laws EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1231, DOI 10.1029/1999GB001229; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Lopez-Sepulcre A, 2020, AM NAT, V195, P964, DOI [10.5061/dryad.8sf7m0chx, 10.1086/708546]; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Mulholland PJ, 2004, LIMNOL OCEANOGR, V49, P809, DOI 10.4319/lo.2004.49.3.0809; Mulholland PJ, 2000, J N AM BENTHOL SOC, V19, P145, DOI 10.2307/1468287; Padfield D, 2018, ECOL LETT, V21, P1152, DOI 10.1111/ele.13082; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Rosenberg A. A., 2014, FAO Fisheries and Aquaculture Report; Schaum CE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0094; Schaum CE., 2018, NAT COMMUN, V9, DOI [DOI 10.1038/S41467-018-03906-5, 10.1038/s41467-018-03906-5]; Semper K, 1881, ANIMAL LIFE AFFECTED; SHELDON RW, 1977, J FISH RES BOARD CAN, V34, P2344, DOI 10.1139/f77-314; Solic M, 2017, J MARINE SYST, V173, P81, DOI [10.1016/j.jmarsys.2017.01.001, 10.1016/jjmarsys.2017.01.001]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stan Development Team, 2016, RSTAN R INT STAN; Stock CA, 2017, P NATL ACAD SCI USA, V114, pE1441, DOI 10.1073/pnas.1610238114; Ullah H, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2003446; Wang H, 2009, ECOL MODEL, V220, P1376, DOI 10.1016/j.ecolmodel.2009.03.005; Yvon-Durocher G, 2017, NAT CLIM CHANGE, V7, P209, DOI [10.1038/nclimate3229, 10.1038/NCLIMATE3229]; Yvon-Durocher G, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002324; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205; Yvon-Durocher G, 2011, GLOBAL CHANGE BIOL, V17, P1681, DOI 10.1111/j.1365-2486.2010.02321.x; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	44	22	23	46	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2021	592	7852					76	+		10.1038/s41586-021-03352-2	http://dx.doi.org/10.1038/s41586-021-03352-2		MAR 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT0ZX	33647927	Green Submitted, Green Accepted			2022-12-28	WOS:000629906000001
J	MacDougall, P				MacDougall, Peter			In fibromyalgia, some therapies may provide small improvements in pain and quality of life	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[MacDougall, Peter] Dalhousie Univ, Halifax, NS, Canada	Dalhousie University	MacDougall, P (corresponding author), Dalhousie Univ, Halifax, NS, Canada.							Marques AP, 2017, REV BRAS REUMATOL, V57, P356, DOI [10.1016/j.rbre.2017.01.005, 10.1016/j.rbr.2016.10.004]; Schaefer C, 2016, PAIN PRACT, V16, P565, DOI 10.1111/papr.12302	2	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC32	JC32		10.7326/ACPJ202103160-032	http://dx.doi.org/10.7326/ACPJ202103160-032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646839				2022-12-28	WOS:000669667000007
J	Dalchand, N				Dalchand, Naomi			A perfect illusion	SCIENCE			English	Editorial Material									[Dalchand, Naomi] Northwestern Univ, Evanston, IL 60208 USA	Northwestern University	Dalchand, N (corresponding author), Northwestern Univ, Evanston, IL 60208 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					958	958		10.1126/science.371.6532.958	http://dx.doi.org/10.1126/science.371.6532.958			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632848				2022-12-28	WOS:000621813400045
J	Rakitzis, TP				Rakitzis, T. Peter			Transition states and spin-orbit structure	SCIENCE			English	Editorial Material									[Rakitzis, T. Peter] Univ Crete, Dept Phys, Iraklion, Greece; [Rakitzis, T. Peter] Fdn Res & Technol Hellas, IESL FORTH Inst Elect Struct & Laser, Iraklion, Greece	University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Rakitzis, TP (corresponding author), Univ Crete, Dept Phys, Iraklion, Greece.; Rakitzis, TP (corresponding author), Fdn Res & Technol Hellas, IESL FORTH Inst Elect Struct & Laser, Iraklion, Greece.	ptr@iesl.forth.gr	Rakitzis, Peter/ABA-1640-2021; Rakitzis, T. Peter/C-5564-2011	Rakitzis, T. Peter/0000-0002-0385-3936				Bartlett NCM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2973628; Broderick BM, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4871995; Chen WT, 2021, SCIENCE, V371, P936, DOI 10.1126/science.abf4205; Clark AP, 2006, PHYS CHEM CHEM PHYS, V8, P5591, DOI 10.1039/b612590e; Kvaran A, 2006, J MOL STRUCT, V790, P27, DOI 10.1016/j.molstruc.2005.10.032; Papp D, 2020, J PHYS CHEM LETT, V11, P4762, DOI 10.1021/acs.jpclett.0c01263; Sun ZG, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3290946; Wang T, 2018, CHEM SOC REV, V47, P6744, DOI 10.1039/c8cs00041g	8	3	3	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					886	887		10.1126/science.abg3184	http://dx.doi.org/10.1126/science.abg3184			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632833				2022-12-28	WOS:000621813400023
J	Rimmer, A				Rimmer, Abi			Staff wellbeing: NHS England expands support with 40 hubs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England, 2020, NHS STRENGTH MENT HL	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n559	10.1136/bmj.n559	http://dx.doi.org/10.1136/bmj.n559			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632721				2022-12-28	WOS:000624298000003
J	Yoo, JJ; Seo, G; Chua, MR; Park, TG; Lu, YL; Rotermund, F; Kim, YK; Moon, CS; Jeon, NJ; Correa-Baena, JP; Bulovic, V; Shin, SS; Bawendi, MG; Seo, J				Yoo, Jason J.; Seo, Gabkyung; Chua, Matthew R.; Park, Tae Gwan; Lu, Yongli; Rotermund, Fabian; Kim, Young-Ki; Moon, Chan Su; Jeon, Nam Joong; Correa-Baena, Juan-Pablo; Bulovic, Vladimir; Shin, Seong Sik; Bawendi, Moungi G.; Seo, Jangwon			Efficient perovskite solar cells via improved carrier management	NATURE			English	Article							LIGHT-EMITTING-DIODES; SNO2 NANOPARTICLES; PERFORMANCE; SN6O4(OH)(4); VOLTAGE; BANDGAP; LAYERS; FILM	Metal halide perovskite solar cells (PSCs) are an emerging photovoltaic technology with the potential to disrupt the mature silicon solar cell market. Great improvements in device performance over the past few years, thanks to the development of fabrication protocols(1-3), chemical compositions(4,5) and phase stabilization methods(6-10), have made PSCs one of the most efficient and low-cost solution-processable photovoltaic technologies. However, the light-harvesting performance of these devices is still limited by excessive charge carrier recombination. Despite much effort, the performance of the best-performing PSCs is capped by relatively low fill factors and high open-circuit voltage deficits (the radiative open-circuit voltage limit minus the high open-circuit voltage)(11). Improvements in charge carrier management, which is closely tied to the fill factor and the open-circuit voltage, thus provide a path towards increasing the device performance of PSCs, and reaching their theoretical efficiency limit(12). Here we report a holistic approach to improving the performance of PSCs through enhanced charge carrier management. First, we develop an electron transport layer with an ideal film coverage, thickness and composition by tuning the chemical bath deposition of tin dioxide (SnO2). Second, we decouple the passivation strategy between the bulk and the interface, leading to improved properties, while minimizing the bandgap penalty. In forward bias, our devices exhibit an electroluminescence external quantum efficiency of up to 17.2 per cent and an electroluminescence energy conversion efficiency of up to 21.6 per cent. As solar cells, they achieve a certified power conversion efficiency of 25.2 per cent, corresponding to 80.5 per cent of the thermodynamic limit of its bandgap. An improved device design for perovskite-based photovoltaic cells enables a certified power conversion efficiency of 25.2 per cent, translating to 80.5 per cent of the thermodynamic limit for its bandgap, which approaches those achieved by silicon solar cells.	[Yoo, Jason J.; Lu, Yongli; Bawendi, Moungi G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Yoo, Jason J.; Seo, Gabkyung; Moon, Chan Su; Jeon, Nam Joong; Shin, Seong Sik; Seo, Jangwon] Korea Res Inst Chem Technol, Div Adv Mat, Daejeon, South Korea; [Chua, Matthew R.; Bulovic, Vladimir] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Park, Tae Gwan; Rotermund, Fabian] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Kim, Young-Ki] Ulsan Natl Inst Sci & Technol UNIST, Cent Res Facil, Ulsan, South Korea; [Correa-Baena, Juan-Pablo] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA USA; [Seo, Gabkyung] Sungkyunkwan Univ, Dept Energy Sci, Suwon, South Korea	Massachusetts Institute of Technology (MIT); Korea Research Institute of Chemical Technology (KRICT); Massachusetts Institute of Technology (MIT); Korea Advanced Institute of Science & Technology (KAIST); Ulsan National Institute of Science & Technology (UNIST); University System of Georgia; Georgia Institute of Technology; Sungkyunkwan University (SKKU)	Bawendi, MG (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Shin, SS; Seo, J (corresponding author), Korea Res Inst Chem Technol, Div Adv Mat, Daejeon, South Korea.	sss85@krict.re.kr; mgb@mit.edu; jwseo@krict.re.kr	Chua, Matthew/GZK-2488-2022; Correa-Baena, Juan-Pablo/N-3143-2016	Correa-Baena, Juan-Pablo/0000-0002-3860-1149; Rotermund, Fabian/0000-0001-9053-3916; Lu, Yongli/0000-0002-7113-4124; Park, Tae Gwan/0000-0002-6158-0091; /0000-0002-5773-1360				Abdi-Jalebi M, 2018, NATURE, V555, P497, DOI 10.1038/nature25989; Anaraki EH, 2018, ACS ENERGY LETT, V3, P773, DOI 10.1021/acsenergylett.8b00055; Baena JPC, 2015, ENERG ENVIRON SCI, V8, P2928, DOI 10.1039/c5ee02608c; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Cao Y, 2018, NATURE, V562, P249, DOI 10.1038/s41586-018-0576-2; Chiba T, 2018, NAT PHOTONICS, V12, P681, DOI 10.1038/s41566-018-0260-y; COHEN RL, 1972, J ELECTROCHEM SOC, V119, P433, DOI 10.1149/1.2404224; Correa-Baena JP, 2019, SCIENCE, V363, P627, DOI 10.1126/science.aah5065; Fan CM, 2013, J PHYS CHEM C, V117, P24157, DOI 10.1021/jp407296f; Ghosh S, 2017, J SOL-GEL SCI TECHN, V81, P769, DOI 10.1007/s10971-016-4251-5; Guillemoles JF, 2019, NAT PHOTONICS, V13, P501, DOI 10.1038/s41566-019-0479-2; Han D, 2017, ANGEW CHEM INT EDIT, V56, P7792, DOI 10.1002/anie.201702563; Ibarguen CA, 2007, MATER CHEM PHYS, V101, P433, DOI 10.1016/j.matchemphys.2006.08.003; Jeon J, 2017, J PHYS CHEM C, V121, P9508, DOI 10.1021/acs.jpcc.7b03176; Jeon Nam Joong, 2014, Nat Mater, V13, P897, DOI 10.1038/nmat4014; Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133; Jeong S, 2019, CHEM COMMUN, V55, P2433, DOI 10.1039/c8cc09557d; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Jung EH, 2019, NATURE, V567, P511, DOI 10.1038/s41586-019-1036-3; Jung KH, 2017, J MATER CHEM A, V5, P24790, DOI 10.1039/c7ta08040a; Kam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42962-9; Kiermasch D, 2019, JOULE, V3, P16, DOI 10.1016/j.joule.2018.10.016; Kim DH, 2017, ADV MATER, V29, DOI 10.1002/adma.201606831; Kim S, 2020, CHEM MATER, V32, P4265, DOI 10.1021/acs.chemmater.0c00893; Kruckemeier L, 2020, ADV ENERGY MATER, V10, DOI 10.1002/aenm.201902573; Li J, 2018, CHEMSUSCHEM, V11, P2898, DOI 10.1002/cssc.201801433; Li N, 2013, J MATER CHEM A, V1, P1536, DOI 10.1039/c2ta01012g; Lin KB, 2018, NATURE, V562, P245, DOI 10.1038/s41586-018-0575-3; Liu YH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2543; Matsuno H, 2012, B CHEM SOC JPN, V85, P746, DOI 10.1246/bcsj.20120074; Min H, 2019, SCIENCE, V366, P749, DOI 10.1126/science.aay7044; Ning JJ, 2009, LANGMUIR, V25, P1818, DOI 10.1021/la8037473; NREL, 2019, NATL RENEWABLE ENERG; Rau U, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085303; Rehman W, 2015, ADV MATER, V27, P7938, DOI 10.1002/adma.201502969; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Shi SW, 2019, RSC ADV, V9, P9946, DOI 10.1039/c8ra10603g; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Stolterfoht M, 2019, ACS ENERGY LETT, V4, P2887, DOI 10.1021/acsenergylett.9b02262; Sun ML, 2014, RSC ADV, V4, P30820, DOI 10.1039/c4ra04356a; Uchiyama H, 2006, CRYST GROWTH DES, V6, P2186, DOI 10.1021/cg060328p; Wang HK, 2013, ADV FUNCT MATER, V23, P4847, DOI 10.1002/adfm.201300303; Wang J, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4916345; Wang JH, 2017, RSC ADV, V7, P27024, DOI 10.1039/c7ra04041e; Wang YB, 2019, SCIENCE, V365, P687, DOI 10.1126/science.aax8018; Yang WS, 2017, SCIENCE, V356, P1376, DOI 10.1126/science.aan2301; Yang YJ, 2017, APPL SURF SCI, V420, P399, DOI 10.1016/j.apsusc.2017.05.176; Yoo JJ, 2019, ENERG ENVIRON SCI, V12, P2192, DOI 10.1039/c9ee00751b; Yun AJ, 2019, ACS APPL ENERG MATER, V2, P3554, DOI 10.1021/acsaem.9b00293; Zhou YY, 2016, ACS APPL MATER INTER, V8, P2232, DOI 10.1021/acsami.5b10987	50	1034	1038	329	1609	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03285-w	http://dx.doi.org/10.1038/s41586-021-03285-w			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627807				2022-12-28	WOS:000621583600010
J	Shepherd, A				Shepherd, Alison			Sambadrome marks Brazil's covid deaths	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n518	10.1136/bmj.n518	http://dx.doi.org/10.1136/bmj.n518			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627318	Bronze			2022-12-28	WOS:000623404800007
J	Hyde, R				Hyde, Rob			von der Leyen admits to COVID-19 vaccine failures	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					655	656						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33610198	Bronze, Green Published			2022-12-28	WOS:000620991800010
J	Liu, RB				Liu, Ren-Bao			A masing ladder	SCIENCE			English	Editorial Material							RADIATION		[Liu, Ren-Bao] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China; [Liu, Ren-Bao] Chinese Univ Hong Kong, Hong Kong Inst Quantum Informat Sci & Technol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Liu, RB (corresponding author), Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China.; Liu, RB (corresponding author), Chinese Univ Hong Kong, Hong Kong Inst Quantum Informat Sci & Technol, Shatin, Hong Kong, Peoples R China.	rbliu@phy.cuhk.edu.hk	Liu, Ren-Bao/B-3729-2011; Liu, Ren-Bao/AAZ-8261-2021	Liu, Ren-Bao/0000-0002-0620-2370; 	Hong Kong Research Grants Council	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	R.-B.L.is supported by the Hong Kong Research Grants Council.	Banks HB, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041042; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; Jiang M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe0719; Lindner NH, 2011, NAT PHYS, V7, P490, DOI 10.1038/NPHYS1926; SHIRLEY JH, 1965, PHYS REV, V138, pB979, DOI 10.1103/PhysRev.138.B979; Svidzinsky AA, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041001; Wang DW, 2015, OPTICA, V2, P712, DOI 10.1364/OPTICA.2.000712; Zaks B, 2012, NATURE, V483, P580, DOI 10.1038/nature10864	12	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					780	+		10.1126/science.abg1081	http://dx.doi.org/10.1126/science.abg1081			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602842				2022-12-28	WOS:000619664700029
J	Stenmark, P				Stenmark, Pal			Re-engineering Botox	SCIENCE			English	Editorial Material							BOTULINUM NEUROTOXIN; TOXIN; SNARE		[Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Stenmark, Pal] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Stockholm University; Lund University	Stenmark, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	stenmark@dbb.su.se			Swedish Research Council [2018-03406]; Swedish Cancer Society [20 1287]; Novo Nordisk Foundation [NNF20OC0064789]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	I thank the Swedish Research Council (2018-03406),the Swedish Cancer Society (20 1287), and the Novo Nordisk Foundation (NNF20OC0064789) for financial support.I thank J. Davies for discussions.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Blum TR, 2021, SCIENCE, V371, P803, DOI 10.1126/science.abf5972; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Dong M, 2019, ANNU REV BIOCHEM, V88, P811, DOI 10.1146/annurev-biochem-013118-111654; Elliott M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7196; Jankovic J., 2009, BOTULINUM TOXIN E BO; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Montal M, 2010, ANNU REV BIOCHEM, V79, P591, DOI 10.1146/annurev.biochem.051908.125345; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Truong D., 2014, MANUAL BOTULINUM TOX; Zhang SC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14130	15	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					782	+		10.1126/science.abg3535	http://dx.doi.org/10.1126/science.abg3535			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602843				2022-12-28	WOS:000619664700030
J	Su, GH; Logez, M; Xu, J; Tao, SL; Villeger, S; Brosse, S				Su, Guohuan; Logez, Maxime; Xu, Jun; Tao, Shengli; Villeger, Sebastien; Brosse, Sebastien			Human impacts on global freshwater fish biodiversity	SCIENCE			English	Article							FUNCTIONAL DIVERSITY; HOMOGENIZATION; CONSEQUENCES; ASSEMBLAGES; ECOSYSTEMS; HYDROPOWER; GEOGRAPHY; PATTERNS; ECOLOGY; THREATS	Freshwater fish represent one-fourth of the world's vertebrates and provide irreplaceable goods and services but are increasingly affected by human activities. A new index, Cumulative Change in Biodiversity Facets, revealed marked changes in biodiversity in >50% of the world's rivers covering >40% of the world's continental surface and >37% of the world's river length, whereas <14% of the world's surface and river length remain least impacted. Present-day rivers are more similar to each other and have more fish species with more diverse morphologies and longer evolutionary legacies. In temperate rivers, where the impact has been greatest, biodiversity changes were primarily due to river fragmentation and introduction of non-native species.	[Su, Guohuan; Tao, Shengli; Brosse, Sebastien] Univ Toulouse 3 Paul Sabatier, Lab Evolut & Diversite Biol EDB, UMR5174, CNRS,IRD, Toulouse, France; [Logez, Maxime] Aix Marseille Univ, RECOVER, INRAE, Aix En Provence, France; [Logez, Maxime] Pole R&D ECLA, Aix En Provence, France; [Xu, Jun] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol China, Donghu Expt Stn Lake Ecosyst, Wuhan, Peoples R China; [Xu, Jun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Villeger, Sebastien] Univ Montpellier, IFREMER, CNRS, MARBEC,IRD, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); INRAE; UDICE-French Research Universities; Aix-Marseille Universite; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Qingdao National Laboratory for Marine Science & Technology; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Su, GH (corresponding author), Univ Toulouse 3 Paul Sabatier, Lab Evolut & Diversite Biol EDB, UMR5174, CNRS,IRD, Toulouse, France.	guohuan.su@gmail.com	Villéger, Sébastien/AAW-9949-2021; Su, Guohuan/ABD-4122-2022; Su, Guohuan/AAA-4850-2020; Villéger, Sébastien/C-6272-2011	Villéger, Sébastien/0000-0002-2362-7178; Su, Guohuan/0000-0003-0091-9773; Villéger, Sébastien/0000-0002-2362-7178; Brosse, Sebastien/0000-0002-3659-8177; Tao, Shengli/0000-0002-2145-4736; Logez, Maxime/0000-0001-9843-0495	CEBA project [ANR-10-LABX-0025]; TULIP project [ANR-10-LABX-41]; China Scholarship Council; CNES; National Key R&D Program of China [2018YFD0900904]; International Cooperation Project of the Chinese Academy of Sciences [152342KYSB20190025]	CEBA project; TULIP project; China Scholarship Council(China Scholarship Council); CNES(Centre National D'etudes Spatiales); National Key R&D Program of China; International Cooperation Project of the Chinese Academy of Sciences	Supported by CEBA, ANR-10-LABX-0025 and TULIP, ANR-10-LABX-41 projects; the China Scholarship Council (G.S.); a CNES postdoctoral fellowship (S.T.); and National Key R&D Program of China grant 2018YFD0900904 and International Cooperation Project of the Chinese Academy of Sciences grant 152342KYSB20190025 (J.X.).	Albert JS, 2021, AMBIO, V50, P85, DOI 10.1007/s13280-020-01318-8; Allen GH, 2018, SCIENCE, V361, P585, DOI 10.1126/science.aat0636; Anderson EP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1642; Arlinghaus R, 2019, P NATL ACAD SCI USA, V116, P5209, DOI 10.1073/pnas.1902796116; Baselga A., 2017, PACKAGE BETAPART; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bellwood DR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3046; Bivand R, 2015, J STAT SOFTW, V63, P1; Bivand RS, 2018, TEST-SPAIN, V27, P716, DOI 10.1007/s11749-018-0599-x; Blanchet S, 2010, ECOL LETT, V13, P421, DOI 10.1111/j.1461-0248.2009.01432.x; Blowes SA, 2019, SCIENCE, V366, P339, DOI 10.1126/science.aaw1620; Boyle KS, 2006, MAR ECOL PROG SER, V319, P65, DOI 10.3354/meps319065; Brosse S, 2013, HYDROBIOLOGIA, V700, P343, DOI 10.1007/s10750-012-1242-6; Bruggeman J, 2009, NUCLEIC ACIDS RES, V37, pW179, DOI 10.1093/nar/gkp370; Brun P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13678-1; Burgin S, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020280; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Cliff A. D., 1981, SPATIAL PROCESSES MO; Craven D, 2018, NAT ECOL EVOL, V2, P1579, DOI 10.1038/s41559-018-0647-7; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dias MS, 2017, ECOL INDIC, V79, P37, DOI 10.1016/j.ecolind.2017.03.053; Dinerstein E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2869; Doll P, 2009, HYDROL EARTH SYST SC, V13, P2413; Doll P, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000355; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duffy JE, 2016, P NATL ACAD SCI USA, V113, P6230, DOI 10.1073/pnas.1524465113; Dumay O, 2004, J FISH BIOL, V64, P970, DOI 10.1111/j.1095-8649.2004.00365.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Froese R., 2020, FISHBASE; Fulton CJ, 2001, MAR BIOL, V139, P25; Grill G, 2019, NATURE, V569, P215, DOI 10.1038/s41586-019-1111-9; Guegan JF, 1998, NATURE, V391, P382, DOI 10.1038/34899; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hoffmann RC, 1996, AM HIST REV, V101, P631, DOI 10.2307/2169418; International Union for Conservation of Nature and Natural Resources (IUCN), 2015, IUCN RED LIST THREAT; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Lefcheck JS, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00284.1; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Leprieur Fabien, 2008, PLoS Biol, V6, pe28, DOI 10.1371/journal.pbio.0060028; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Leveque C, 2008, HYDROBIOLOGIA, V595, P545, DOI 10.1007/s10750-007-9034-0; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nordhaus W., 2016, GLOBAL GRIDDED GEOGR; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pimiento C, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay7650; Pimm SL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat2616; Rabosky DL, 2020, J BIOGEOGR, V47, P1207, DOI 10.1111/jbi.13839; Rabosky DL, 2018, NATURE, V559, P392, DOI 10.1038/s41586-018-0273-1; Reecht Y, 2013, J FISH BIOL, V83, P355, DOI 10.1111/jfb.12177; Reid AJ, 2019, BIOL REV, V94, P849, DOI 10.1111/brv.12480; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Su GH, 2019, GLOBAL ECOL BIOGEOGR, V28, P211, DOI 10.1111/geb.12843; Tedesco PA, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.141; Tickner D, 2020, BIOSCIENCE, V70, P330, DOI 10.1093/biosci/biaa002; Toussaint A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22125; Toussaint A, 2018, ECOL LETT, V21, P1649, DOI 10.1111/ele.13141; Van der Laan R., 2020, FRESHWATER FISH LIST, V30th; Venter O, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.67; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2017, AQUAT SCI, V79, P783, DOI 10.1007/s00027-017-0546-z; Villeger S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1450, DOI 10.1111/geb.12226; Villeger S, 2011, P NATL ACAD SCI USA, V108, P18003, DOI 10.1073/pnas.1107614108; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; WEBB PW, 1984, AM ZOOL, V24, P107; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; WINEMILLER KO, 1991, ECOL MONOGR, V61, P343, DOI 10.2307/2937046; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0	80	86	91	102	325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					835	+		10.1126/science.abd3369	http://dx.doi.org/10.1126/science.abd3369			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602854	Green Submitted			2022-12-28	WOS:000619664700054
J	Silvester, E; Vollmer, B; Prazak, V; Vasishtan, D; Machala, EA; Whittle, C; Black, S; Bath, J; Turberfield, AJ; Grunewald, K; Baker, LA				Silvester, Emma; Vollmer, Benjamin; Prazak, Vojtech; Vasishtan, Daven; Machala, Emily A.; Whittle, Catheryne; Black, Susan; Bath, Jonathan; Turberfield, Andrew J.; Gruenewald, Kay; Baker, Lindsay A.			DNA origami signposts for identifying proteins on cell membranes by electron cryotomography	CELL			English	Article								Electron cryotomography (cryoET), an electron cryomicroscopy (cryoEM) modality, has changed our understanding of biological function by revealing the native molecular details of membranes, viruses, and cells. However, identification of individual molecules within tomograms from cryoET is challenging because of sample crowding and low signal-to-noise ratios. Here, we present a tagging strategy for cryoET that precisely identifies individual protein complexes in tomograms without relying on metal clusters. Our method makes use of DNA origami to produce "molecular signposts" that target molecules of interest, here via fluorescent fusion proteins, providing a platform generally applicable to biological surfaces. We demonstrate the specificity of signpost origami tags (SPOTs) in vitro as well as their suitability for cryoET of membrane vesicles, enveloped viruses, and the exterior of intact mammalian cells.	[Silvester, Emma; Vollmer, Benjamin; Prazak, Vojtech; Vasishtan, Daven; Machala, Emily A.; Whittle, Catheryne; Black, Susan; Gruenewald, Kay; Baker, Lindsay A.] Univ Oxford, Oxford Particle Imaging Ctr, Wellcome Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England; [Silvester, Emma; Bath, Jonathan; Turberfield, Andrew J.] Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England; [Silvester, Emma; Vollmer, Benjamin; Prazak, Vojtech; Vasishtan, Daven; Black, Susan; Gruenewald, Kay; Baker, Lindsay A.] Leibniz Inst Expt Virol, Heinrich Pette Inst, Ctr Struct Syst Biol, Notkestr 85, D-22607 Hamburg, Germany; [Gruenewald, Kay] Univ Hamburg, Dept Chem, Martin Luther King Pl 6, D-20146 Hamburg, Germany	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Heinrich Pette Institute; University of Hamburg	Grunewald, K; Baker, LA (corresponding author), Univ Oxford, Oxford Particle Imaging Ctr, Wellcome Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.; Turberfield, AJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.; Grunewald, K; Baker, LA (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Ctr Struct Syst Biol, Notkestr 85, D-22607 Hamburg, Germany.; Grunewald, K (corresponding author), Univ Hamburg, Dept Chem, Martin Luther King Pl 6, D-20146 Hamburg, Germany.	andrew.turberfield@physics.ox.ac.uk; kay.gruenewald@cssb-hamburg.de; lindsay@strubi.ox.ac.uk	Vollmer, Benjamin/AAJ-7327-2021	Vollmer, Benjamin/0000-0002-7526-0582; Machala, Emily Ann/0000-0001-8560-5954; Prazak, Vojtech/0000-0001-8149-218X; Grunewald, Kay/0000-0002-4788-2691; Silvester, Emma/0000-0001-5175-7087	Wellcome Trust; MRC; BBSRC; MRC UK [MR/R017875/1]; Human Frontier Science Program Long Term Fellowship; Canadian Institutes for Health Research Postdoctoral Fellowship; Wellcome Trust [107806/Z/15/Z, 209250/Z/17/Z]; Royal Society Wolfson Research Merit Award; Wellcome Trust core award [090532/Z/09/Z]; EPSRC studentship [1734437]; Nuffield Dept of Medicine Prize Studentship; Marie-Curie Individual Fellowship (KGBVIFEF); DFG (a Cluster of Excellence RESIST) [EXC 2155]; DFG [INST 152/772-1, INST 152/774-1, INST 152/775-1, INST 152/776-1 FUGG]; BBSRC [BB/H000321/1] Funding Source: UKRI; MRC [MR/R017875/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program Long Term Fellowship(Human Frontier Science Program); Canadian Institutes for Health Research Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome Trust); Royal Society Wolfson Research Merit Award(Royal Society of London); Wellcome Trust core award(Wellcome Trust); EPSRC studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Nuffield Dept of Medicine Prize Studentship; Marie-Curie Individual Fellowship (KGBVIFEF); DFG (a Cluster of Excellence RESIST)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank David Staunton for his help with ITC and supporting the Oxford Molecular Biophysics Suite. We acknowledge Diamond Light Source for access and support of the cryo-EM facilities at the UK's National Electron Bio-imaging Centre (eBIC) (proposal EM-AP22), funded by the Wellcome Trust, MRC, and BBSRC. This research was funded by a grant (MR/R017875/1) from the MRC UK to L.A.B., B.V., A.J.T. and K.G. L.A.B. was supported by a Human Frontier Science Program Long Term Fellowship and a Canadian Institutes for Health Research Postdoctoral Fellowship. K.G. was supported by Wellcome Trust grants 107806/Z/15/Z and 209250/Z/17/Z. A.J.T. was supported by a Royal Society Wolfson Research Merit Award. This research was funded in part by a Wellcome Trust core award to The Wellcome Trust Centre for Human Genetics (090532/Z/09/Z). E.S. was supported by an EPSRC studentship (1734437). V.P. was supported by a Nuffield Dept of Medicine Prize Studentship. B.V. was supported by a Marie-Curie Individual Fellowship (KGBVIFEF). We gratefully acknowledge funding from the DFG (a Cluster of Excellence RESIST [EXC 2155] project to K.G., and INST 152/772-1, 774-1, 775-1, 776-1 FUGG to the CSSB cryoEM facility).	Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Azubel M, 2019, ELIFE, V8, DOI 10.7554/eLife.43146; Azubel M, 2016, NANO LETT, V16, P3348, DOI 10.1021/acs.nanolett.6b00981; Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; Bairoch Amos, 2018, J Biomol Tech, V29, P25, DOI 10.7171/jbt.18-2902-002; BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405; Bos E, 2014, J STRUCT BIOL, V186, P273, DOI 10.1016/j.jsb.2014.03.021; Bykov YS, 2017, ELIFE, V6, DOI 10.7554/eLife.32493; Castro CE, 2011, NAT METHODS, V8, P221, DOI 10.1038/NMETH.1570; Clarke NI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04993-0; Dahan I, 2018, STRUCTURE, V26, P1408, DOI 10.1016/j.str.2018.06.009; de Jong Rob N., 2006, Journal of Structural and Functional Genomics, V7, P109, DOI 10.1007/s10969-006-9014-z; Doh JK, 2018, P NATL ACAD SCI USA, V115, P12961, DOI 10.1073/pnas.1808626115; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Engel BD, 2015, P NATL ACAD SCI USA, V112, P11264, DOI 10.1073/pnas.1515337112; ERENPREISA J, 1981, ACTA HISTOCHEM, V68, P22; Fernandez JJ, 2016, BIOPHYS J, V110, P850, DOI 10.1016/j.bpj.2015.10.043; Geary C, 2014, SCIENCE, V345, P799, DOI 10.1126/science.1253920; Goossens J, 2017, ANAL METHODS-UK, V9, P3430, DOI 10.1039/c7ay00854f; Grange M, 2017, J STRUCT BIOL, V197, P181, DOI 10.1016/j.jsb.2016.06.024; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; HAINFELD JF, 1992, J HISTOCHEM CYTOCHEM, V40, P177, DOI 10.1177/40.2.1552162; Han DR, 2017, SCIENCE, V358, DOI 10.1126/science.aao2648; Heumann JM, 2011, J STRUCT BIOL, V175, P288, DOI 10.1016/j.jsb.2011.05.011; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Jiang Q, 2012, J AM CHEM SOC, V134, P13396, DOI 10.1021/ja304263n; Kato T, 2009, NANO LETT, V9, P2747, DOI 10.1021/nl901265n; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ke YG, 2009, J AM CHEM SOC, V131, P15903, DOI 10.1021/ja906381y; Kijanka M, 2017, J STRUCT BIOL, V199, P1, DOI 10.1016/j.jsb.2017.05.008; Kovtun O, 2018, NATURE, V561, P561, DOI 10.1038/s41586-018-0526-z; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Malo J, 2005, ANGEW CHEM INT EDIT, V44, P3057, DOI 10.1002/anie.200463027; Martin TG, 2016, P NATL ACAD SCI USA, V113, pE7456, DOI 10.1073/pnas.1612720113; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Maurer UE, 2008, P NATL ACAD SCI USA, V105, P10559, DOI 10.1073/pnas.0801674105; Maurer UE, 2013, STRUCTURE, V21, P1396, DOI 10.1016/j.str.2013.05.018; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Modi S, 2009, NAT NANOTECHNOL, V4, P325, DOI [10.1038/nnano.2009.83, 10.1038/NNANO.2009.83]; Morphew MK, 2015, J MICROSC-OXFORD, V260, P20, DOI 10.1111/jmi.12262; Ni TW, 2015, NANOSCALE, V7, P17320, DOI 10.1039/c5nr04097c; Niazy N, 2017, FASEB J, V31, P1650, DOI 10.1096/fj.201600521R; Niemeyer CM, 2010, ANGEW CHEM INT EDIT, V49, P1200, DOI 10.1002/anie.200904930; Oliver C, 2010, METHODS MOL BIOL, V588, P369, DOI 10.1007/978-1-59745-324-0_39; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; PARK K, 1989, SCANNING MICROSCOPY, P15; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14516; PINTER A, 1977, VIROLOGY, V83, P417, DOI 10.1016/0042-6822(77)90187-8; Riedel C, 2017, J STRUCT BIOL, V197, P172, DOI 10.1016/j.jsb.2016.06.017; Risco C, 2012, STRUCTURE, V20, P759, DOI 10.1016/j.str.2012.04.001; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Schellenberger P, 2014, ULTRAMICROSCOPY, V143, P41, DOI 10.1016/j.ultramic.2013.10.011; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schuller VJ, 2011, ACS NANO, V5, P9696, DOI 10.1021/nn203161y; Schur FKM, 2019, CURR OPIN STRUC BIOL, V58, P1, DOI 10.1016/j.sbi.2019.03.018; Schur FKM, 2016, SCIENCE, V353, P506, DOI 10.1126/science.aaf9620; Schur FKM, 2015, NATURE, V517, P505, DOI 10.1038/nature13838; Selmi DN, 2011, NANO LETT, V11, P657, DOI 10.1021/nl1037769; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Shui B, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1264; Sjoberg M, 2014, P NATL ACAD SCI USA, V111, P6034, DOI 10.1073/pnas.1317972111; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Stahl E, 2014, ANGEW CHEM INT EDIT, V53, P12735, DOI 10.1002/anie.201405991; Stoeber M, 2016, P NATL ACAD SCI USA, V113, pE8069, DOI 10.1073/pnas.1616838113; Strauss JD, 2016, J VIROL, V90, P1507, DOI 10.1128/JVI.01880-15; Tan XH, 2012, ANAL CHEM, V84, P8272, DOI 10.1021/ac301764q; Tsuji S, 2009, BIOCHEM BIOPH RES CO, V386, P227, DOI 10.1016/j.bbrc.2009.06.014; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vollmer B, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc1726; von Appen A, 2015, NATURE, V526, P140, DOI 10.1038/nature15381; Walsh AS, 2011, ACS NANO, V5, P5427, DOI 10.1021/nn2005574; Wang Q, 2011, STRUCTURE, V19, P147, DOI 10.1016/j.str.2010.12.002; Weber MS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010057; Wolff G, 2016, BIOL CELL, V108, P245, DOI 10.1111/boc.201600008; Yadavalli T, 2017, MOL THER-NUCL ACIDS, V9, P365, DOI 10.1016/j.omtn.2017.10.009; Yi H, 2015, J HISTOCHEM CYTOCHEM, V63, P780, DOI 10.1369/0022155415593323; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeev-Ben-Mordehai T, 2016, P NATL ACAD SCI USA, V113, P4176, DOI 10.1073/pnas.1523234113; Zeev-Ben-Mordehai T, 2014, STRUCTURE, V22, P1687, DOI 10.1016/j.str.2014.09.005; Zeev-Ben-Mordehai T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4912; Zhang F, 2015, NAT NANOTECHNOL, V10, P779, DOI [10.1038/NNANO.2015.162, 10.1038/nnano.2015.162]	89	16	16	10	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					1110	+		10.1016/j.cell.2021.01.033	http://dx.doi.org/10.1016/j.cell.2021.01.033		FEB 2021	28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606980	Green Published, hybrid			2022-12-28	WOS:000629633400022
J	Tulenko, FJ; Currie, PD				Tulenko, Frank J.; Currie, Peter D.			Bones of contention: skeletal patterning across the fin-to-limb transition	CELL			English	Editorial Material								The fin-to-limb transition has long fascinated evolutionary biologists, but a unifying theory as to its developmental origins has remained elusive. New work by Hawkins and colleagues demonstrates the surprising potential of teleost fins to exhibit a Hox-regulated limb-like skeletal pattern, shedding new light on the evolution of proximo-distal patterning processes.	[Tulenko, Frank J.; Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Level 1,15 Innovat Walk,Wellington Rd, Clayton, Vic 3800, Australia; [Tulenko, Frank J.; Currie, Peter D.] Monash Univ, EMBL Australia, Victorian Node, Level 1,15 Innovat Walk,Wellington Rd, Clayton, Vic 3800, Australia	Australian Regenerative Medicine Institute; Monash University; European Molecular Biology Laboratory (EMBL); Monash University	Tulenko, FJ; Currie, PD (corresponding author), Monash Univ, Australian Regenerat Med Inst, Level 1,15 Innovat Walk,Wellington Rd, Clayton, Vic 3800, Australia.; Tulenko, FJ; Currie, PD (corresponding author), Monash Univ, EMBL Australia, Victorian Node, Level 1,15 Innovat Walk,Wellington Rd, Clayton, Vic 3800, Australia.	frank.tulenko@monash.edu; peter.currie@monash.edu		Currie, Peter/0000-0001-8874-8862				Hawkins MB, 2021, CELL, V184, P899, DOI 10.1016/j.cell.2021.01.003; Kherdjemil Y, 2016, NATURE, V539, P89, DOI 10.1038/nature19813; Molnar JL, 2018, BIOL REV, V93, P1077, DOI 10.1111/brv.12386; Nakamura T, 2016, NATURE, V537, P225, DOI 10.1038/nature19322; Onimaru K, 2015, ELIFE, V4, DOI 10.7554/eLife.07048; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Tulenko FJ, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2780; Woltering JM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc3510; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784	10	0	0	4	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					854	856		10.1016/j.cell.2021.01.039	http://dx.doi.org/10.1016/j.cell.2021.01.039		FEB 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606983	Bronze			2022-12-28	WOS:000629633400003
J	Butler, CC; Dorward, J; Yu, LM; Gbinigie, O; Hayward, G; Saville, BR; Van Hecke, O; Berry, N; Detry, M; Saunders, C; Fitzgerald, M; Harris, V; Patel, MG; de Lusignan, S; Ogburn, E; Evans, PH; Thomas, NPB; Hobbs, FDR; Allen, J; Andersson, M; Bongard, E; Borek, A; Butler, CC; Ferreira, F; Gbinigie, O; Grabey, J; Hobbs, FDR; Hopkins, S; Judge, D; Koshkouei, M; Llewelyn, MJ; Richards-Doran, D; Rutter, H; Swayze, H; Tripathy, M; Tonkin-Crine, S; Tonner, S				Butler, Christopher C.; Dorward, Jienchi; Yu, Ly-Mee; Gbinigie, Oghenekome; Hayward, Gail; Saville, Benjamin R.; Van Hecke, Oliver; Berry, Nick; Detry, Michelle; Saunders, Christina; Fitzgerald, Mark; Harris, Victoria; Patel, Mahendra G.; de Lusignan, Simon; Ogburn, Emma; Evans, Philip H.; Thomas, Nicholas P. B.; Hobbs, F. D. Richard; Allen, Julie; Andersson, Monique; Bongard, Emily; Borek, Aleksandra; Butler, Christopher C.; Ferreira, Filipa; Gbinigie, Oghenekome; Grabey, Jenna; Hobbs, F. D. Richard; Hopkins, Susan; Judge, David; Koshkouei, Mona; Llewelyn, Martin J.; Richards-Doran, Dan; Rutter, Heather; Swayze, Hannah; Tripathy, Manasa; Tonkin-Crine, Sarah; Tonner, Sharon		PRINCIPLE Trial Collaborative Grp	Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial	LANCET			English	Article								Background Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties, has been used to treat COVID-19, but evidence from community randomised trials is lacking. We aimed to assess the effectiveness of azithromycin to treat suspected COVID-19 among people in the community who had an increased risk of complications. Methods In this UK-based, primary care, open-label, multi-arm, adaptive platform randomised trial of interventions against COVID-19 in people at increased risk of an adverse clinical course (PRINCIPLE), we randomly assigned people aged 65 years and older, or 50 years and older with at least one comorbidity, who had been unwell for 14 days or less with suspected COVID-19, to usual care plus azithromycin 500 mg daily for three days, usual care plus other interventions, or usual care alone. The trial had two coprimary endpoints measured within 28 days from randomisation: time to first self-reported recovery, analysed using a Bayesian piecewise exponential, and hospital admission or death related to COVID-19, analysed using a Bayesian logistic regression model. Eligible participants with outcome data were included in the primary analysis, and those who received the allocated treatment were included in the safety analysis. The trial is registered with ISRCTN, ISRCTN86534580. Findings The first participant was recruited to PRINCIPLE on April 2, 2020. The azithromycin group enrolled participants between May 22 and Nov 30, 2020, by which time 2265 participants had been randomly assigned, 540 to azithromycin plus usual care, 875 to usual care alone, and 850 to other interventions. 2120 (94%) of 2265 participants provided follow-up data and were included in the Bayesian primary analysis, 500 participants in the azithromycin plus usual care group, 823 in the usual care alone group, and 797 in other intervention groups. 402 (80%) of 500 participants in the azithromycin plus usual care group and 631 (77%) of 823 participants in the usual care alone group reported feeling recovered within 28 days. We found little evidence of a meaningful benefit in the azithromycin plus usual care group in time to first reported recovery versus usual care alone (hazard ratio 1.08, 95% Bayesian credibility interval [BCI] 0.95 to 1.23), equating to an estimated benefit in median time to first recovery of 0.94 days (95% BCI -0.56 to 2.43). The probability that there was a clinically meaningful benefit of at least 1.5 days in time to recovery was 0.23. 16 (3%) of 500 participants in the azithromycin plus usual care group and 28 (3%) of 823 participants in the usual care alone group were hospitalised (absolute benefit in percentage 0.3%, 95% BCI -1.7 to 2.2). There were no deaths in either study group. Safety outcomes were similar in both groups. Two (1%) of 455 participants in the azothromycin plus usual care group and four (1%) of 668 participants in the usual care alone group reported admission to hospital during the trial, not related to COVID-19. Interpretation Our findings do not justify the routine use of azithromycin for reducing time to recovery or risk of hospitalisation for people with suspected COVID-19 in the community. These findings have important antibiotic stewardship implications during this pandemic, as inappropriate use of antibiotics leads to increased antimicrobial resistance, and there is evidence that azithromycin use increased during the pandemic in the UK. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Butler, Christopher C.; Dorward, Jienchi; Yu, Ly-Mee; Gbinigie, Oghenekome; Hayward, Gail; Van Hecke, Oliver; de Lusignan, Simon; Hobbs, F. D. Richard; Andersson, Monique; Butler, Christopher C.; Ferreira, Filipa; Grabey, Jenna; Hobbs, F. D. Richard; Judge, David; Koshkouei, Mona; Rutter, Heather; Swayze, Hannah; Tripathy, Manasa; Tonkin-Crine, Sarah; Tonner, Sharon; PRINCIPLE Trial Collaborative Grp] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Dorward, Jienchi; Andersson, Monique] Oxford Univ Hosp NHS Trust, Dept Microbiol, Headley Way Headington, Oxford OX3 9DU, England; [Berry, Nick] Berry Consultants, 3345 Bee Cave Rd Suite 201, Austin, TX 78746 USA; [Dorward, Jienchi] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, ZA-3630 Durban, South Africa; [Evans, Philip H.] Univ Exeter, Coll Med & Hlth, B3183, Exeter EX1 2HZ, England; [Patel, Mahendra G.] Univ Bradford, Sch Pharm & Med Sci, Richmond Rd, Bradford BD7 1DP, England; [Llewelyn, Martin J.] Univ Sussex, Brighton & Sussex Med Sch, 94 N S Rd Falmer, Brighton BN1 9PX, England; [Hopkins, Susan] Publ Hlth England, London, England; [Saville, Benjamin R.] Vanderbilt Univ Sch Med, Dept Biostat, 2525 West End Ave Suite 1100, Nashville, TN 37203 USA	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Kwazulu Natal; University of Exeter; University of Bradford; University of Brighton; University of Sussex; Public Health England; Vanderbilt University	Butler, CC; Hobbs, FDR (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	principle@phc.ox.ac.uk	Llewelyn, Martin/A-7194-2011; Dorward, Jienchi/P-7100-2019	Llewelyn, Martin/0000-0002-6811-1124; Dorward, Jienchi/0000-0001-6072-1430; Gbinigie, Oghenekome/0000-0002-2963-4491; Evans, Philip/0000-0002-5277-3545; Yu, Ly-Mee/0000-0003-0331-7364; Hayward, Gail/0000-0003-0852-627X; Tonner, Sharon/0000-0002-7775-9926; de Lusignan, Simon/0000-0002-8553-2641	UK Research and Innovation; UK Department of Health and Social Care; MRC [MC_PC_19079] Funding Source: UKRI	UK Research and Innovation(UK Research & Innovation (UKRI)); UK Department of Health and Social Care; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Research and Innovation and UK Department of Health and Social Care.	[Anonymous], 2020, NAT MICROBIOL, V5, P779, DOI 10.1038/s41564-020-0739-4; Beigel JH, 2020, NEW ENGL J MED, V383, P994, DOI 10.1056/NEJMc2022236; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; de Lusignan S, PRINCIPLE TRIAL DEMO, V2021, DOI [10.1101/2021.02.02.21250902, DOI 10.1101/2021.02.02.21250902]; de Lusignan S, 2020, JMIR PUBLIC HLTH SUR, V6, P130, DOI 10.2196/19773; de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Joy M, 2020, BRIT J GEN PRACT, V70, pE890, DOI 10.3399/bjgp20X713393; Kim PS, 2020, JAMA-J AM MED ASSOC, V324, P2149, DOI 10.1001/jama.2020.22813; Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Million M, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101738; Min JY, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649570; Moustgaard H, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6802; National Institute for Health and Care Excellence (NICE), 2021, COVID 19 RAP GUID MA; NHS Digital, 2020, SEC US SERV SUS; Oliver ME, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2163; Poschet Jens F, 2020, bioRxiv, DOI 10.1101/2020.03.29.008631; Public Health England, 2020, COVID 19 INV IN CLIN; Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207; Sudre CH, 2020, ATTRIBUTES PREDICTOR, DOI [10.1101/2020.10.19.20214494, DOI 10.1101/2020.10.19.20214494, 10.19.20214494]; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Touret F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70143-6; UK National Health Service, 2021, SYMPT COR; UK Office for National Statistics, 2020, PREV LONG COVID SYMP; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062	31	124	124	4	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1063	1074		10.1016/S0140-6736(21)00461-X	http://dx.doi.org/10.1016/S0140-6736(21)00461-X		MAR 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ0AN	33676597	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000630397800024
J	Rodriguez-Diaz, CE; Martinez, O; Bland, S; Crowley, JS				Rodriguez-Diaz, Carlos E.; Martinez, Omar; Bland, Sean; Crowley, Jeffrey S.			Ending the HIV epidemic in US Latinx sexual and gender minorities	LANCET			English	Editorial Material									[Rodriguez-Diaz, Carlos E.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA; [Martinez, Omar] Temple Univ, Coll Publ Hlth, Sch Social Work, Philadelphia, PA 19122 USA; [Bland, Sean; Crowley, Jeffrey S.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA	George Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Georgetown University	Rodriguez-Diaz, CE (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC 20052 USA.	carlosrd@gwu.edu			District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Cancer Institute [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute on Drug Abuse [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Mental Health [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute on Aging [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute on Minority Health and Health Disparities [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Dental and Craniofacial Research [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Nursing Research [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - Fogarty International Center [AI117970]; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - Office ofAIDS Research [AI117970]	District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Cancer Institute; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - Eunice Kennedy Shriver National Institute of Child Health and Human Development; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute on Drug Abuse; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Mental Health; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute on Aging; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute on Minority Health and Health Disparities; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Dental and Craniofacial Research; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - National Institute of Nursing Research; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - Fogarty International Center; District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) - Office ofAIDS Research	We declare no competing interests. This Comment resulted in part from work supported by the District of Columbia Center for AIDS Research, a US National Institutes of Health (NIH) funded programme (AI117970), which is supported by the following US NIH co-funding and participating institutes and centres: the National Institute of Allergy and Infectious Diseases, the National Cancer Institute, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Heart, Lung, and Blood Institute, the National Institute on Drug Abuse, the National Institute of Mental Health, the National Institute on Aging, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Minority Health and Health Disparities,the National Institute of Dental and Craniofacial Research, the National Institute of Nursing Research, the Fogarty International Center, and the Office ofAIDS Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adimora AA, 2021, LANCET, V397, P1107, DOI 10.1016/S0140-6736(21)00396-2; Bauer Mark S, 2015, BMC Psychol, V3, P32, DOI 10.1186/s40359-015-0089-9; Beyrer C, 2021, LANCET, V397, P1151, DOI 10.1016/S0140-6736(21)00390-1; Cashman SB, 2008, AM J PUBLIC HEALTH, V98, P1407, DOI 10.2105/AJPH.2007.113571; Gant Z., 2019, HIV SURVEILLANCE REP, V24, P1; Garcia M, 2019, J HIV-AIDS SOC SERV, V18, P206, DOI 10.1080/15381501.2019.1607795; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Guilamo-Ramos V, 2020, AM J PUBLIC HEALTH, V110, P27, DOI 10.2105/AJPH.2019.305309; Hodder SL, 2021, LANCET, V397, P1139, DOI 10.1016/S0140-6736(21)00391-3; Hoppe TA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw7238; Kates J, 2021, LANCET, V397, P1127, DOI 10.1016/S0140-6736(21)00397-4; Kates J, 2020, AM J PUBLIC HEALTH, V110, P58, DOI 10.2105/AJPH.2019.305429; Martinez O, 2019, HEALTH SOC WORK, V44, P103, DOI 10.1093/hsw/hlz008; Martinez O, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2582-y; Martinez-Velez JJ, 2019, TRANSGENDER HEALTH, V4, P9, DOI 10.1089/trgh.2018.0045; Mayer KH, 2021, LANCET, V397, P1116, DOI 10.1016/S0140-6736(21)00321-4; McCree DH, 2018, PREV MED, V114, P64, DOI 10.1016/j.ypmed.2018.06.007; Poteat T, 2020, CLIN INFECT DIS, V70, P1131, DOI 10.1093/cid/ciz322; Reisner SL, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25391; Rhodes SD, 2017, AIDS EDUC PREV, V29, P491, DOI 10.1521/aeap.2017.29.6.491; Rodriguez-Diaz CE, 2016, INT AIDS C DURB S AF; Sullivan PS, 2021, LANCET, V397, P1095, DOI 10.1016/S0140-6736(21)00395-0; Sutton MY, 2021, J RACIAL ETHN HEALTH, V8, P1456, DOI 10.1007/s40615-020-00908-2; US Centers for Disease Control and Prevention, 2020, HIV GAY BIS MEN; US Department of Health and Human Services, 2020, WHAT IS END HIV EP P; Wood S, 2019, AIDS BEHAV, V23, P2719, DOI 10.1007/s10461-019-02502-y	26	8	8	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1043	1045		10.1016/S0140-6736(20)32521-6	http://dx.doi.org/10.1016/S0140-6736(20)32521-6		MAR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617767	Green Accepted			2022-12-28	WOS:000630397800007
J	Castillo, JC; Ahuja, A; Athey, S; Baker, A; Budish, E; Chipty, T; Glennerster, R; Kominers, SD; Kremer, M; Larson, G; Lee, J; Prendergast, C; Snyder, CM; Tabarrok, A; Tan, BJ; Wiecek, W				Castillo, Juan Camilo; Ahuja, Amrita; Athey, Susan; Baker, Arthur; Budish, Eric; Chipty, Tasneem; Glennerster, Rachel; Kominers, Scott Duke; Kremer, Michael; Larson, Greg; Lee, Jean; Prendergast, Canice; Snyder, Christopher M.; Tabarrok, Alex; Tan, Brandon Joel; Wiecek, Witold			Market design to accelerate COVID-19 vaccine supply	SCIENCE			English	Editorial Material									[Castillo, Juan Camilo] Univ Penn, Philadelphia, PA 19104 USA; [Ahuja, Amrita] Douglas B Marshall Jr Family Fdn, Houston, TX USA; [Athey, Susan] Stanford Grad Sch Business, Stanford, CA USA; [Athey, Susan; Budish, Eric; Kominers, Scott Duke; Kremer, Michael; Snyder, Christopher M.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Baker, Arthur] Univ Chicago, Chicago, IL 60637 USA; [Budish, Eric; Prendergast, Canice] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Chipty, Tasneem] AlixPartners, Boston, MA USA; [Glennerster, Rachel] Foreign Commonwealth & Dev Off FCDO, London, England; [Kominers, Scott Duke] Harvard Sch Business, Boston, MA USA; [Kominers, Scott Duke; Tan, Brandon Joel] Harvard Univ, Cambridge, MA 02138 USA; [Lee, Jean] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Snyder, Christopher M.] Dartmouth Coll, Hanover, NH 03755 USA; [Tabarrok, Alex] George Mason Univ, Fairfax, VA 22030 USA	University of Pennsylvania; Stanford University; National Bureau of Economic Research; University of Chicago; University of Chicago; Harvard University; Harvard University; The World Bank; Dartmouth College; George Mason University	Kremer, M (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.	kremermr@uchicago.edu		Athey, Susan/0000-0001-6934-562X	Emergent Ventures; Golub Capital Social Impact Lab; Inter-American Development Bank; Schmidt Futures; Washington Center for Equitable Growth; Wellspring Philanthropic Fund	Emergent Ventures; Golub Capital Social Impact Lab; Inter-American Development Bank; Schmidt Futures; Washington Center for Equitable Growth; Wellspring Philanthropic Fund	We thank H. Kettler and N.Lurie for helpful discussions on vaccine exchange; J. Pickett for review and comments; and E.Chaudhuri, J.Chen, A. Simoes Gomes Junior, and Z. Xia for research assistance. We thank Emergent Ventures,the Golub Capital Social Impact Lab, the Inter-American Development Bank, Schmidt Futures,the Washington Center for Equitable Growth, and the Wellspring Philanthropic Fund for funding. M.K.is a senior advisor to theWorld Bank on vaccines. J.L. is a senior economist at theWorld Bank and has some involvement in vaccine financing. S.A., M.K., and C.M.S.served on a pro-bono advisory group on the design of COVAX. E.B., S.D.K., and C.P. serve on a pro-bono expert group advising on the design of the COVAX exchange mechanism. W.W. provides consultancy for Certara, a drug development company, and 1 Day Sooner, a human challenge trial advocacy group. This article does not necessarily reflect FCDO policy.	Ahuja A., 2021, W28492 NBER; [Anonymous], 2018, GLOB AIDS UPD; [Anonymous], 2021, NY TIMES; [Anonymous], 2020, WASHINGTON POST; [Anonymous], 2021, GUARDIAN; [Anonymous], 2021, WORLD BANK OPEN DATA; [Anonymous], 2021, S AFR UN RAT HITS NE; Boone L., 2020, ECOSCOPE; Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810; Bubar KM, 2021, SCIENCE, V371, P916, DOI 10.1126/science.abe6959; Budish E., 2007, J ECON PERSPECT, V21, P37; Budish E, 2017, OPER RES, V65, P314, DOI 10.1287/opre.2016.1544; Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Demombynes G., 2020, Policy Research Working Paper - World Bank; Duke Global Health Innovation Center, 2020, MAPP COVID 19 VACC P; Fiercepharma, 2021, NOV TAPS BAXT COMM P; Gopinath G., 2020, IMF BLOG; Hanushek E.A., 2020, 225 OECD; Hogan A.B., 2020, 33 IMP COLL; IMF, 2021, FISC MON JAN 2021 DA; IMF, 2021, DAT FISC POL RESP CO; International Monetary Fund, 2020, WORLD EC OUTLOOK UPD; Kremer M., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Mulligan C.B., 2020, NBER WORKING PAPER N, DOI DOI 10.3386/W27060; Prendergast C, 2017, J ECON PERSPECT, V31, P145, DOI 10.1257/jep.31.4.145; Roth AE, 2007, J ECON PERSPECT, V21, P37, DOI 10.1257/jep.21.3.37; Snyder CM, 2020, HEALTH AFFAIR, V39, P1633, DOI 10.1377/hlthaff.2020.00646; WHO, 2020, LIST STRING REG AUTH	29	38	39	6	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2021	371	6534					1107	+		10.1126/science.abg0889	http://dx.doi.org/10.1126/science.abg0889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QY5RG	33632897				2022-12-28	WOS:000630096400016
J	Ubel, PA				Ubel, Peter A.			Vaccinating Health Care Employees - Do They All Deserve Early Access?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								In vaccinating low-risk employees early, leaders of some U.S. health care organizations violated their duty to promote public health and contributed to the narrative that powerful people in health care are willing to serve their own interests ahead of society's.	[Ubel, Peter A.] Duke Univ, Durham, NC 27706 USA	Duke University	Ubel, PA (corresponding author), Duke Univ, Durham, NC 27706 USA.			Ubel, Peter/0000-0001-8218-519X				[Anonymous], 2020, FRAM EQ ALL COVID 19; Ferguson K, 2021, HASTINGS BIOETHICS F; Huang ECH, 2018, INQUIRY-J HEALTH CAR, V55, DOI 10.1177/0046958018759174; Mandavilli A, 2021, DELTA VARIANT IS SYM; North Carolina Department of Health and Human Services, COVID 19 VACC INF	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2021	384	10							e39	10.1056/NEJMpv2101203	http://dx.doi.org/10.1056/NEJMpv2101203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UD5XO	33606365	Bronze			2022-12-28	WOS:000687279800005
J	Lexchin, J; Bero, LA; Davis, C; Gagnon, MA				Lexchin, Joel; Bero, Lisa A.; Davis, Courtney; Gagnon, Marc-Andre			Achieving greater independence from commercial influence in research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFLICTS-OF-INTEREST; CLINICAL-TRIAL; INDUSTRY PAYMENTS; UNITED-STATES; DISCLOSURE; POLICIES; PRESCRIPTION; REQUIREMENT; DEPRESSION; AUTHORSHIP		[Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada; [Lexchin, Joel] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Lexchin, Joel] Univ Hlth Network, Toronto, ON, Canada; [Bero, Lisa A.] Univ Colorado, Ctr Bioeth & Humanities, Anschutz Med Campus, Aurora, CO USA; [Davis, Courtney] Kings Coll London, Dept Global Hlth & Social Med, London, England; [Gagnon, Marc-Andre] Carleton Univ, Sch Publ Policy & Adm, Ottawa, ON, Canada	York University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of London; King's College London; Carleton University	Lexchin, J (corresponding author), York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada.; Lexchin, J (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.; Lexchin, J (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	jlexchin@yorku.ca		Gagnon, Marc-Andre/0000-0001-6113-4772				Ahn R, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6770; Anderson TS, 2014, JAMA-J AM MED ASSOC, V311, P1353, DOI 10.1001/jama.2013.284925; Attaran A, 2014, LANCET, V384, P477, DOI 10.1016/S0140-6736(13)60845-4; Bassand JP, 2002, LANCET, V360, P1866, DOI 10.1016/S0140-6736(02)11776-4; Bero LA, 2005, TOB CONTROL, V14, P118; Bero LA, 1998, JAMA-J AM MED ASSOC, V279, P1031, DOI 10.1001/jama.279.13.1031; Boyd EA, 2003, ACAD MED, V78, P769, DOI 10.1097/00001888-200308000-00002; Campbell EG, 2007, JAMA-J AM MED ASSOC, V298, P1779, DOI 10.1001/jama.298.15.1779; Campbell EG, 2015, JAMA INTERN MED, V175, P1500, DOI 10.1001/jamainternmed.2015.3167; CenterWatch, 2021, FDA FINALIZES ENFORC; Chan AW, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2510-1; Chang L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2613; Chatani N, 2002, RELATIVE EFFICIENCY; Consultative Expert Working Group on Research and Development Financing and Coordination, 2012, RES DEV MEET HLTH NE; Darrow JJ, 2020, JAMA-J AM MED ASSOC, V323, P164, DOI 10.1001/jama.2019.20288; DeVito NJ, 2020, LANCET, V395, P361, DOI 10.1016/S0140-6736(19)33220-9; Drugs for Neglected Diseases initiative, 2021, TREATMENTS DELIVERED; Dyer O, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3868; Ehringhaus SH, 2008, JAMA-J AM MED ASSOC, V299, P665, DOI 10.1001/jama.299.6.665; Fabbri A, 2018, AM J PUBLIC HEALTH, V108, pE9, DOI 10.2105/AJPH.2018.304677; Fabbri A, 2018, INT J HEALTH POLICY, V7, P504, DOI 10.15171/ijhpm.2018.20; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; Gaffney A, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1039; Godlee F, 2013, BMJ OPEN BLOG; Godlee F, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4930; Goldacre B, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3218; Grundy Q, 2018, HEALTH POLICY, V122, P509, DOI 10.1016/j.healthpol.2018.03.015; Handel AE, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4212; Harris G, 2008, NEW YORK TIMES; Health Canada, 2017, FEE PROP DRUGS MED D; International Committee of Medical Journal Editors (ICMJE), 2019, RECOMMENDATIONS COND; Jefferson AA, 2017, JAMA INTERN MED, V177, P352, DOI 10.1001/jamainternmed.2016.8439; Jones CW, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0520-3; Kasenda B, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002046; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V316, P858, DOI 10.1001/jama.2016.11237; Khan R, 2018, JAMA INTERN MED, V178, P1712, DOI 10.1001/jamainternmed.2018.5106; Le Noury J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4320; Lexchin J, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1825; Liu JJ, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4619; Love J., 2015, KNOWLEDGE ECOLOGY IN; Lundh A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000033.pub3; Lundh A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000354; Matheson A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001072; Matheson A, 2008, BIOSOCIETIES, V3, P355, DOI 10.1017/S1745855208006297; Maturo AF, 2015, GOOD PHARMA, DOI [10.1057/9781137374332, DOI 10.1057/9781137374332]; Mello MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203179; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Moynihan R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2456; Moynihan R, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1706; Pedrique B, 2013, LANCET GLOB HEALTH, V1, pE371, DOI 10.1016/S2214-109X(13)70078-0; Policy Cures Research, 2020, GFINDER 2019 NEGLECT, DOI [11150341/G-Finder2019.pdf, DOI 11150341/G-FINDER2019.PDF]; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; Ropars AL, 2005, NEW LANDSCAPE NEGLEC; Rosenthal MB, 2013, NEW ENGL J MED, V368, P2052, DOI 10.1056/NEJMp1305090; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Schafer A, 2004, J MED ETHICS, V30, P8, DOI 10.1136/jme.2003.005702; Sismondo S., 2018, GHOST MANAGED MED BI; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Vivli, 2021, GLOBAL CLIN RES DATA; Wei S, 2019, DOLLARS PROFS; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526; Wilson Mark, 2014, Open Med, V8, pe10; Wright JM, 2001, JAMA-J AM MED ASSOC, V286, P2398; Zinner DE, 2009, HEALTH AFFAIR, V28, P1814, DOI 10.1377/hlthaff.28.6.1814	65	3	3	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2021	372								n370	10.1136/bmj.n370	http://dx.doi.org/10.1136/bmj.n370			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RC6QO	33687982				2022-12-28	WOS:000632923400004
J	Dyer, C				Dyer, Clare			Judge overturns decision to strike consultant surgeon off medical register	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n629	10.1136/bmj.n629	http://dx.doi.org/10.1136/bmj.n629			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS9AK	33664056				2022-12-28	WOS:000626184500001
J	Iqbal, J; Zaidi, M				Iqbal, Jameel; Zaidi, Mone			Bone resorption goes green	CELL			English	Editorial Material							CELLS	In this issue of Cell, McDonald et al. show that giant multinucleated, bone-resorbing osteoclasts dissolve into smaller cells, termed "osteopmorhs,'' which re-form into osteoclasts at distal bone sites (McDonald et al., 2021). These findings overturn the long-standing premise that osteoclasts differentiate solely from hematopoietic precursors and undergo apoptosis after completing resorption.	[Iqbal, Jameel; Zaidi, Mone] Icahn Sch Med Mt Sinai, Mt Sinai Bone Program, Ctr Translat Med & Pharmacol, Dept Med & Pharmacol Sci, New York, NY 10029 USA; [Iqbal, Jameel] James J Peters VA Med Ctr, Dept Pathol, Bronx, NY 10463 USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Zaidi, M (corresponding author), Icahn Sch Med Mt Sinai, Mt Sinai Bone Program, Ctr Translat Med & Pharmacol, Dept Med & Pharmacol Sci, New York, NY 10029 USA.	mone.zaidi@mssm.edu		Zaidi, Mone/0000-0001-5911-9522				Anastasilakis AD, 2020, BONE REP, V12, DOI 10.1016/j.bonr.2020.100267; BARON R, 1981, METAB BONE DIS RELAT, V2, P339, DOI 10.1016/0221-8747(81)90020-5; BURING K, 1975, CLIN ORTHOP RELAT R, P293; Hunter W., 1743, SURGEON, V42, P514, DOI [10.1098/rstl.1742.0079, DOI 10.1098/RSTL.1742.0079)]; Jacome-Galarza CE, 2019, NATURE, V568, P541, DOI 10.1038/s41586-019-1105-7; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; McDonald M.M., 2021, CELL, V184; Qiao JH, 2015, EXP MOL PATHOL, V99, P654, DOI 10.1016/j.yexmp.2015.11.010; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zaidi M, 2018, ENDOCR REV, V39, P701, DOI 10.1210/er.2018-00050	10	1	2	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1137	1139		10.1016/j.cell.2021.02.023	http://dx.doi.org/10.1016/j.cell.2021.02.023		MAR 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33636131	Bronze			2022-12-28	WOS:000629635700005
J	Meghji, J; Mortimer, K; Agusti, A; Allwood, BW; Asher, I; Bateman, ED; Bissell, K; Bolton, CE; Bush, A; Celli, B; Chiang, CY; Cruz, AA; Dinh-Xuan, AT; El Sony, A; Fong, KM; Fujiwara, PI; Gaga, M; Garcia-Marcos, L; Halpin, DMG; Hurst, JR; Jayasooriya, S; Kumar, A; Lopez-Varela, MV; Masekela, R; Ngahane, BHM; de Oca, MM; Pearce, N; Reddel, HK; Salvi, S; Singh, SJ; Varghese, C; Vogelmeier, CF; Walker, P; Zar, HJ; Marks, GB				Meghji, Jamilah; Mortimer, Kevin; Agusti, Alvar; Allwood, Brian W.; Asher, Innes; Bateman, Eric D.; Bissell, Karen; Bolton, Charlotte E.; Bush, Andrew; Celli, Bartolome; Chiang, Chen-Yuan; Cruz, Alvaro A.; Anh-Tuan Dinh-Xuan; El Sony, Asma; Fong, Kwun M.; Fujiwara, Paula I.; Gaga, Mina; Garcia-Marcos, Luis; Halpin, David M. G.; Hurst, John R.; Jayasooriya, Shamanthi; Kumar, Ajay; Lopez-Varela, Maria V.; Masekela, Refiloe; Ngahane, Bertrand H. Mbatchou; Montes de Oca, Maria; Pearce, Neil; Reddel, Helen K.; Salvi, Sundeep; Singh, Sally J.; Varghese, Cherian; Vogelmeier, Claus F.; Walker, Paul; Zar, Heather J.; Marks, Guy B.			Improving lung health in low-income and middle-income countries: from challenges to solutions	LANCET			English	Review							OBSTRUCTIVE PULMONARY-DISEASE; STRUCTURED OPERATIONAL-RESEARCH; LATIN-AMERICAN CITIES; AIR-FLOW OBSTRUCTION; CHRONIC RESPIRATORY-DISEASE; INHALED CORTICOSTEROIDS; BUDESONIDE-FORMOTEROL; RESEARCH CAPACITY; DIESEL EXHAUST; TRAINING SORT	Low-income and middle-income countries (LMICs) bear a disproportionately high burden of the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including asthma, chronic obstructive pulmonary disease, bronchiectasis, and post-tuberculosis lung disease. CRDs are strongly associated with poverty, infectious diseases, and other non-communicable diseases (NCDs), and contribute to complex multi-morbidity, with major consequences for the lives and livelihoods of those affected. The relevance of CRDs to health and socioeconomic wellbeing is expected to increase in the decades ahead, as life expectancies rise and the competing risks of early childhood mortality and infectious diseases plateau. As such, the World Health Organization has identified the prevention and control of NCDs as an urgent development issue and essential to the achievement of the Sustainable Development Goals by 2030. In this Review, we focus on CRDs in LMICs. We discuss the early life origins of CRDs; challenges in their prevention, diagnosis, and management in LMICs; and pathways to solutions to achieve true universal health coverage.	[Meghji, Jamilah; Mortimer, Kevin] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England; [Mortimer, Kevin; Bateman, Eric D.; Cruz, Alvaro A.; Reddel, Helen K.] Global Initiat Asthma GINA, Fontana, WI USA; [Mortimer, Kevin; Agusti, Alvar; Celli, Bartolome; Halpin, David M. G.; Lopez-Varela, Maria V.; Montes de Oca, Maria; Salvi, Sundeep; Vogelmeier, Claus F.] Global Initiat COPD GOLD, Fontana, WI USA; [Mortimer, Kevin; Agusti, Alvar; Bolton, Charlotte E.; Bush, Andrew; Hurst, John R.; Jayasooriya, Shamanthi; Singh, Sally J.; Walker, Paul] British Thorac Soc Global Hlth Grp, London, England; [Mortimer, Kevin; Asher, Innes; Bissell, Karen; El Sony, Asma; Garcia-Marcos, Luis; Pearce, Neil; Marks, Guy B.] Global Asthma Network GAN, Auckland, New Zealand; [Mortimer, Kevin; Masekela, Refiloe; Ngahane, Bertrand H. Mbatchou; Zar, Heather J.] Pan African Thorac Soc, Durban, South Africa; [Mortimer, Kevin; Chiang, Chen-Yuan; El Sony, Asma; Fujiwara, Paula I.; Kumar, Ajay; Ngahane, Bertrand H. Mbatchou; Marks, Guy B.] Int Union TB & Lung Dis, Paris, France; [Agusti, Alvar] Univ Barcelona, CIBERES, IDIBAPS, Resp Inst,Hosp Clin, Barcelona, Spain; [Allwood, Brian W.] Stellenbosch Univ, Div Pulmonol, Dept Med, Stellenbosch, South Africa; [Asher, Innes] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Bissell, Karen] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Bateman, Eric D.] Univ Cape Town, Div Pulmonol, Dept Med, Cape Town, South Africa; [Bolton, Charlotte E.] Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Bush, Andrew] Imperial Coll, London, England; [Bush, Andrew] Royal Brompton Hosp, London, England; [Celli, Bartolome] Harvard Med Sch, Boston, MA 02115 USA; [Chiang, Chen-Yuan] Taipei Med Univ, Wan Fang Hosp, Div Pulm Med, Dept Internal Med, Taipei, Taiwan; [Chiang, Chen-Yuan] Taipei Med Univ, Sch Med, Div Pulm Med, Dept Internal Med,Coll Med, Taipei, Taiwan; [Cruz, Alvaro A.] Univ Fed Bahia, Dept Internal Med, Salvador, BA, Brazil; [Anh-Tuan Dinh-Xuan] Univ Paris, Cochin Hosp, Paris, France; [Anh-Tuan Dinh-Xuan] European Resp Soc, Lausanne, Switzerland; [El Sony, Asma] Epidemiol Lab EPI Lab Publ Hlth & Res, Khartoum, Sudan; [Fong, Kwun M.] Univ Queensland, Thorac Res Ctr, Brisbane, Qld, Australia; [Fong, Kwun M.] Prince Charles Hosp, Chermside, Qld, Australia; [Fong, Kwun M.] Asian Pacific Soc Respirol, Tokyo, Japan; [Gaga, Mina] Athens Chest Hosp Sotiria, Athens, Greece; [Gaga, Mina] WHO, Geneva, Switzerland; [Garcia-Marcos, Luis] Univ Murcia, Arrixaca Childrens Univ Hosp, Paediat Pulmonol Unit, Murcia, Spain; [Garcia-Marcos, Luis] Univ Murcia, Arrixaca Childrens Univ Hosp, Allergy Unit, Murcia, Spain; [Garcia-Marcos, Luis] BioHlth Res Inst Murcia, Murcia, Spain; [Garcia-Marcos, Luis] ARADyAL Network, Madrid, Spain; [Halpin, David M. G.] Univ Exeter, Sch Med, Coll Med & Hlth, Exeter, Devon, England; [Hurst, John R.] UCL, UCL Resp, London, England; [Jayasooriya, Shamanthi] Univ Sheffield, Acad Unit Primary Care, Sheffield, S Yorkshire, England; [Lopez-Varela, Maria V.] Univ Republica, Dept Pulm, Montevideo, Uruguay; [Masekela, Refiloe] Univ KwaZulu Natal, Nelson R Mandela Sch Clin Med, Coll Hlth Sci, Durban, South Africa; [Ngahane, Bertrand H. Mbatchou] Douala Gen Hosp, Douala, Cameroon; [Montes de Oca, Maria] Univ Cent Venezuela, Dept Pulm, Caracas, Venezuela; [Pearce, Neil] London Sch Hyg & Trop Med, London, England; [Reddel, Helen K.; Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW, Australia; [Salvi, Sundeep] Pulmocare Res & Educ Fdn, Pune, Maharashtra, India; [Singh, Sally J.] Univ Leicester, Dept Resp Sci, Leicester, Leics, England; [Varghese, Cherian] WHO, Dept Noncommunicable Dis Disabil Violence & Injur, Geneva, Switzerland; [Vogelmeier, Claus F.] Philipps Univ Marburg, Univ Med Ctr Giessen & Marburg, Dept Med Pulm & Crit Care Med, Marburg, Germany; [Vogelmeier, Claus F.] German Ctr Lung Res DZL, Giessen, Germany; [Walker, Paul] Liverpool Teaching Hosp, Dept Resp Med, Liverpool, Merseyside, England; [Zar, Heather J.] Red Cross Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Zar, Heather J.] Univ CapeTown, SA MRC Unit Child & Adolescent Hlth, Cape Town, South Africa; [Marks, Guy B.] UNSW Med, Sydney, NSW, Australia	Liverpool School of Tropical Medicine; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Stellenbosch University; University of Auckland; University of Auckland; University of Cape Town; University of Nottingham; Imperial College London; Royal Brompton Hospital; Harvard University; Harvard Medical School; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Universidade Federal da Bahia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Queensland; Prince Charles Hospital; World Health Organization; University of Murcia; University of Murcia; University of Exeter; University of London; University College London; University of Sheffield; Universidad de la Republica, Uruguay; University of Kwazulu Natal; University of Central Venezuela; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; Woolcock Institute of Medical Research; University of Leicester; World Health Organization; Philipps University Marburg; University Hospital of Giessen & Marburg; University of Cape Town	Mortimer, K (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool L3 5QA, Merseyside, England.	kevin.mortimer@lstmed.ac.uk	DINH-XUAN, Anh Tuan/A-9691-2008; Marks, Guy B./F-5058-2013; Reddel, Helen/ABD-6338-2021; Zar, Heather/GZL-5350-2022; Masekela, Refiloe/ABB-4774-2021; de, Maria Montes/AAP-7687-2021; Bolton, Charlotte/S-9589-2017	DINH-XUAN, Anh Tuan/0000-0001-8651-5176; Marks, Guy B./0000-0002-8976-8053; Zar, Heather/0000-0002-9046-759X; Masekela, Refiloe/0000-0001-9665-2035; Bolton, Charlotte/0000-0002-9578-2249; Hurst, John/0000-0002-7246-6040; Jayasooriya, Shamanthi/0000-0002-1147-5744; Mortimer, Kevin/0000-0002-8118-8871; Meghji, Jamilah/0000-0002-4693-8884; Pearce, Neil/0000-0002-9938-7852	Global Initiative for Asthma; Global Initiative for COPD; Global Asthma Network; Pan African Thoracic Society; British Thoracic Society Global Health Group; European Respiratory Society; Asian Pacific Society of Respirology; Asociacion Latinoamericana de Torax; World Health Organization; National Institute for Health Research (NIHR) Global Health Research Unit on Lung Health and TB in Africa at the Liverpool School of Tropical Medicine (IMPALA) [16/136/35]; NIHR using UK aid from the UK Government; MRC [MR/S002359/1, MR/S02042X/1, MR/P008984/1] Funding Source: UKRI	Global Initiative for Asthma; Global Initiative for COPD; Global Asthma Network; Pan African Thoracic Society; British Thoracic Society Global Health Group; European Respiratory Society; Asian Pacific Society of Respirology; Asociacion Latinoamericana de Torax; World Health Organization(World Health Organization); National Institute for Health Research (NIHR) Global Health Research Unit on Lung Health and TB in Africa at the Liverpool School of Tropical Medicine (IMPALA)(National Institute for Health Research (NIHR)); NIHR using UK aid from the UK Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the support of the following organisations and their members who have contributed to this Review: the Global Initiative for Asthma, the Global Initiative for COPD, the Global Asthma Network, The Union, the Pan African Thoracic Society, the British Thoracic Society Global Health Group, the European Respiratory Society, the Asian Pacific Society of Respirology, the Asociacion Latinoamericana de Torax, and the World Health Organization. We thank the National Institute for Health Research (NIHR) Global Health Research Unit on Lung Health and TB in Africa at the Liverpool School of Tropical Medicine (IMPALA) (16/136/35) for facilitating this collaboration. IMPALA was funded by the NIHR using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, the UK Department of Health and Social Care, or other affiliated organisations.	Ade G, 2013, PUBLIC HEALTH ACTION, V3, P76, DOI 10.5588/pha.12.0080; Agodokpessi Gildas, 2015, J Pharm Policy Pract, V8, P12, DOI 10.1186/s40545-015-0033-7; Agrawal A, 2019, LANCET RESP MED, V7, P743, DOI 10.1016/S2213-2600(19)30204-8; Agusti A, 2018, LANCET RESP MED, V6, P324, DOI 10.1016/S2213-2600(18)30060-2; Agusti A, 2017, LANCET RESP MED, V5, P935, DOI 10.1016/S2213-2600(17)30434-4; Allwood BW, 2020, INT J TUBERC LUNG D, V24, P820, DOI 10.5588/ijtld.20.0067; Allwood BW, 2013, RESPIRATION, V86, P76, DOI 10.1159/000350917; Amaral AFS, 2015, EUR RESPIR J, V46, P1104, DOI 10.1183/13993003.02325-2014; Andrejak C, 2013, THORAX, V68, P256, DOI 10.1136/thoraxjnl-2012-201772; Asher I, 2019, LANCET RESP MED, V7, P13, DOI 10.1016/S2213-2600(18)30513-7; Awotiwon A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001079; Balmes JR, 2011, THORAX, V66, P4, DOI 10.1136/thx.2010.145391; Barnes BR, 2014, INT J ENV RES PUB HE, V11, P4607, DOI 10.3390/ijerph110504607; Bateman ED, 2018, NEW ENGL J MED, V378, P1877, DOI 10.1056/NEJMoa1715275; Beasley R, 2019, NEW ENGL J MED, V380, P2020, DOI 10.1056/NEJMoa1901963; Beckhaus AA, 2015, ALLERGY, V70, P1588, DOI 10.1111/all.12729; Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Bissell K, 2012, PUBLIC HEALTH ACTION, V2, P92, DOI 10.5588/pha.12.0022; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Boaventura R, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01269-2018; Bolton CE, 2015, THORAX, V70, P574, DOI 10.1136/thoraxjnl-2014-206590; British Thoracic Society, 2019, BRIT GUID MAN ASTHM; Brunekreef B, 2009, ENVIRON HEALTH PERSP, V117, P1791, DOI 10.1289/ehp.0800467; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Buist A Sonia, 2013, Ann Am Thorac Soc, V10, P281, DOI 10.1513/AnnalsATS.201304-081OT; Bukhman G, 2020, LANCET, V396, P991, DOI 10.1016/S0140-6736(20)31907-3; Burney PGJ, 2011, THORAX, V66, P49, DOI 10.1136/thx.2010.147041; Burney P, 2014, THORAX, V69, DOI 10.1136/thoraxjnl-2013-204460; Bush A, 2016, ANN AM THORAC SOC, V13, pS438, DOI 10.1513/AnnalsATS.201602-112AW; Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Herrera AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152266; Castro-Rodriguez JA, 2006, PEDIATR PULM, V41, P947, DOI 10.1002/ppul.20472; Chandrasekaran R, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0638-0; Chang AB, 2014, PAEDIATR RESPIR REV, V15, P325, DOI 10.1016/j.prrv.2014.04.016; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cornick R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001088; Cornick R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000962; de Oca MM, 2008, PULM PHARMACOL THER, V21, P788, DOI 10.1016/j.pupt.2008.06.003; Dhar R, 2019, LANCET GLOB HEALTH, V7, pE1269, DOI 10.1016/S2214-109X(19)30327-4; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Dong YH, 2014, CHEST, V145, P1286, DOI 10.1378/chest.13-2137; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Duong M, 2019, LANCET GLOB HEALTH, V7, pE613, DOI 10.1016/S2214-109X(19)30070-1; Echazarreta AL, 2018, ARCH BRONCONEUMOL, V54, P260, DOI [10.1016/j.arbres.2017.09.018, 10.1016/j.arbr.2017.09.017]; El Sony AI, 2013, PUBLIC HEALTH ACTION, V3, P247, DOI 10.5588/pha.13.0019; Ezzati M, 2018, NATURE, V559, P507, DOI 10.1038/s41586-018-0306-9; Faber T, 2017, LANCET PUBLIC HEALTH, V2, pE420, DOI 10.1016/S2468-2667(17)30144-5; Fairall L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4451; Fairall L, 2010, TROP MED INT HEALTH, V15, P277, DOI 10.1111/j.1365-3156.2009.02455.x; Fairall LR, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002178; Famoroti T, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1222-8; Fatima R, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2018.1555215; Ferrand RA, 2012, CLIN INFECT DIS, V55, P145, DOI 10.1093/cid/cis271; Fonjungo PN, 2012, J PUBLIC HEALTH POL, V33, P34, DOI 10.1057/jphp.2011.57; Forno E, 2017, AM J RESP CRIT CARE, V195, P314, DOI 10.1164/rccm.201605-1039OC; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; Garcia-Marcos L, 2014, INT J EPIDEMIOL, V43, P1846, DOI 10.1093/ije/dyu145; Gauderman WJ, 2015, NEW ENGL J MED, V372, P905, DOI 10.1056/NEJMoa1414123; GBD, 2020, GLOBAL BURDEN DIS CO; Githinji LN, 2017, ANN AM THORAC SOC, V14, P722, DOI [10.1513/annalsats.201612-1018oc, 10.1513/AnnalsATS.201612-1018OC]; Global Asthma Network, 2018, GLOBAL ASTHMA REPORT; Global Initiative for Asthma, 2020, REV FR DALLERGOL DIM; Gray D, 2017, THORAX, V72, P445, DOI 10.1136/thoraxjnl-2015-207401; Gray DM, 2020, AIDS, V34, P549, DOI 10.1097/QAD.0000000000002444; Gray DM, 2017, AM J RESP CRIT CARE, V195, P212, DOI [10.1164/rccm.201601-0188OC, 10.1164/rccm.201601-01880C]; Guillerm N, 2016, PUBLIC HEALTH ACTION, V6, P207, DOI 10.5588/pha.16.0057; Guillerm N, 2015, PUBLIC HEALTH ACTION, V5, P266, DOI 10.5588/pha.15.0045; Guillerm N, 2014, PUBLIC HEALTH ACTION, V4, P89, DOI [10.5588/pha.14.0014, 10.5588/pha.13.0014]; Halpin DMG, 2019, INT J TUBERC LUNG D, V23, P1131, DOI 10.5588/ijtld.19.0397; Halpin DMG, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00914-2019; Hannon B, 2016, J CLIN ONCOL, V34, P62, DOI 10.1200/JCO.2015.62.1615; Hardy J, 2019, LANCET, V394, P919, DOI 10.1016/S0140-6736(19)31948-8; Harries AD, 2019, INT J TUBERC LUNG D, V23, P1253, DOI 10.5588/ijtld.19.0471; Heinzerling AP, 2016, THORAX, V71, P421, DOI 10.1136/thoraxjnl-2015-207783; Houben RMGJ, 2019, CLIN INFECT DIS, V68, P150, DOI 10.1093/cid/ciy544; Hurst JR, 2020, AM J RESP CRIT CARE, V202, P422, DOI 10.1164/rccm.202001-0016OC; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Jardim JR, 2017, INT J TUBERC LUNG D, V21, P458, DOI 10.5588/ijtld.16.0633; Jones R, 2017, INT J CHRONIC OBSTR, V12, P3533, DOI 10.2147/COPD.S146659; Kan XH, 2012, PUBLIC HEALTH ACTION, V2, P87, DOI 10.5588/pha.12.0025; Kendall EA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002472; Khosa C, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1167-1; KINYOKI DK, 2020, NATURE, V577, P231, DOI DOI 10.1038/S41586-019-1878-8; Knowledge Translation Unit University of Cape Town, PRACT APPR CAR KIT P; Kumar Ajay M V, 2014, BMC Res Notes, V7, P819, DOI 10.1186/1756-0500-7-819; Lamprecht B, 2015, CHEST, V148, P971, DOI 10.1378/chest.14-2535; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Landeo-Gutierrez J, 2020, AM J RESP CRIT CARE, V201, P917, DOI 10.1164/rccm.201905-1073PP; Lange P, 2015, NEW ENGL J MED, V373, P1575, DOI 10.1056/NEJMc1510089; Lee AG, 2019, AM J RESP CRIT CARE, V199, P738, DOI 10.1164/rccm.201804-0694OC; Lee CH, 2013, THORAX, V68, P1105, DOI 10.1136/thoraxjnl-2012-203175; Lenney W, 2018, THORAX, V73, P662, DOI 10.1136/thoraxjnl-2018-211626; MacGinty RP, 2020, COMPR PSYCHIAT, V96, DOI 10.1016/j.comppsych.2019.152128; Marx FM, 2016, EUR RESPIR J, V48, P1227, DOI 10.1183/13993003.00716-2016; Masekela R, 2019, INT J TUBERC LUNG D, V23, P952, DOI 10.5588/ijtld.18.0442; Masekela R, 2012, INT J TUBERC LUNG D, V16, P114, DOI 10.5588/ijtld.11.0244; Mash B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032358; Meghji J, 2020, THORAX, V75, P269, DOI [10.1136/thoraxjnl-2019-213808, 10.1136/thoraxjnl-2020-214580]; Meghji J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161176; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Metcalfe JZ, 2014, LANCET INFECT DIS, V14, P794, DOI 10.1016/S1473-3099(14)70879-5; Morrow BM, 2019, SOUTH AFR J PHYSIOTH, V75, DOI 10.4102/sajp.v75i1.1295; O'Byrne PM, 2018, NEW ENGL J MED, V378, P1865, DOI 10.1056/NEJMoa1715274; Obaseki D, 2015, ANN AM THORAC SOC, V12, P591, DOI 10.1513/AnnalsATS.201410-443AR; Obaseki DO, 2016, COPD, V13, P42, DOI 10.3109/15412555.2015.1041102; Pandya RJ, 2002, ENVIRON HEALTH PERSP, V110, P103, DOI 10.1289/ehp.02110s1103; Peck M, 2019, MMWR-MORBID MORTAL W, V68, P937, DOI 10.15585/mmwr.mm6842a1; Perez-Padilla R, 2012, ARCH MED RES, V43, P159, DOI 10.1016/j.arcmed.2012.03.007; Picken S, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000957; Quint JK, 2016, EUR RESPIR J, V47, P186, DOI 10.1183/13993003.01033-2015; Ramsay A, 2014, PUBLIC HEALTH ACTION, V4, P79, DOI 10.5588/pha.14.0011; Ranabhat CL, 2020, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00414; Ranzani OT, 2020, LANCET INFECT DIS, V20, P123, DOI [10.1016/S1473-3099(19), 10.1016/S1473-3099(19)30518-3]; Reddel HK, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01046-2019; Romanowski K, 2019, LANCET INFECT DIS, V19, P1129, DOI 10.1016/S1473-3099(19)30309-3; Rylance S, 2019, THORAX, V74, P1070, DOI 10.1136/thoraxjnl-2018-212945; Sagili KD, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1445467; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Shoemark A, 2007, RESP MED, V101, P1163, DOI 10.1016/j.rmed.2006.11.008; Singh SJ, 2019, LANCET RESP MED, V7, P1002, DOI 10.1016/S2213-2600(19)30364-9; Sobieraj DM, 2018, JAMA-J AM MED ASSOC, V319, P1485, DOI 10.1001/jama.2018.2769; Talamo C, 2007, CHEST, V131, P60, DOI 10.1378/chest.06-1149; The Union, 2019, MAN TUB GUID ESS PRA; Tran DN, 2016, EPIDEMIOL INFECT, V144, P527, DOI 10.1017/S095026881500134X; Tripathy JP, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1500762; Troeger CE, 2020, LANCET INFECT DIS, V20, P60, DOI 10.1016/S1473-3099(19)30410-4; United Nations, 2015, TRANSF OUR WORLD 203; van de Loo KFE, 2016, EUR RESPIR J, V47, P133, DOI 10.1183/13993003.00299-2015; van Kampen SC, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000745; Vanjare N, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2016.36; Varela MVL, 2008, ARCH BRONCONEUMOL, V44, P58; Vazquez-Garcia JC, 2014, ARCH BRONCONEUMOL, V50, P34, DOI 10.1016/j.arbres.2013.07.011; Wattrus C, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001016; WHO, 2011, IMAI DISTR CLIN MAN; WHO, 2018, GLOBAL TUBERCULOSIS; WHO, 2010, MONITORING BUILDING; Wilmshurst JM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2741; Woldeamanuel GG, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0946-z; WOODRUFF AW, 1984, LANCET, V2, P506; World Health Organization, 2013, PACK ESS NONC PEN DI; World Health Organization, 2019, WHO MOD LIST ESS MED; YOUNG S, 1995, ARCH DIS CHILD, V72, P16, DOI 10.1136/adc.72.1.16; Zachariah R, 2014, TROP MED INT HEALTH, V19, P1068, DOI 10.1111/tmi.12343; Zachariah R, 2009, LANCET INFECT DIS, V9, P711, DOI 10.1016/S1473-3099(09)70229-4; Zar HJ, 2017, ANN AM THORAC SOC, V14, P500, DOI 10.1513/AnnalsATS.201612-953PS; Zar HJ, 2016, LANCET RESP MED, V4, P463, DOI 10.1016/S2213-2600(16)00096-5; Zwarenstein M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2022	149	63	63	17	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					928	940		10.1016/S0140-6736(21)00458-X	http://dx.doi.org/10.1016/S0140-6736(21)00458-X		MAR 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33631128	Green Submitted, Green Accepted			2022-12-28	WOS:000626603400031
J	Kesselheim, AS; Hwang, TJ; Avorn, J				Kesselheim, Aaron S.; Hwang, Thomas J.; Avorn, Jerry			Paying for Prescription Drugs in the New Administration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses policies the Biden administration can enact to reduce costs, including benchmarking Medicare Part B drug payments to the lowest price paid in similar countries, preventing Part D plans from negotiating confidential rebates with manufacturers, and patent reform to promote generic drug use.	[Kesselheim, Aaron S.; Hwang, Thomas J.; Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Hwang, Thomas J.; Avorn, Jerry] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@bwh.harvard.edu			Arnold Ventures	Arnold Ventures	This work was supported by Arnold Ventures.	Congressional Budget Office, 2019, INC EFF PROP RUL SAF; Hwang TJ, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3434; Hwang TJ, 2020, REDUCING PRESCRIPTIO	3	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					819	820		10.1001/jama.2021.0009	http://dx.doi.org/10.1001/jama.2021.0009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651097				2022-12-28	WOS:000625843100005
J	Morgan, M				Morgan, Matt			Matt Morgan: Head, shoulders, knees, and toes-what's next on the NHS waiting list?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, Wales.	mmorgan@bmj.com		Morgan, Matt/0000-0002-2357-7190				BBC, 2021, BBC; Reform, 2021, WHATS NEXT NHS; Siemieniuk RAC, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1982; Zhang ZH, 2018, INTENS CARE MED, V44, P1189, DOI 10.1007/s00134-018-5142-8	4	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n554	10.1136/bmj.n554	http://dx.doi.org/10.1136/bmj.n554			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653684	Bronze			2022-12-28	WOS:000625340300008
J	Eskin, B				Eskin, Barnet			The AbC-19 Rapid Test had 85% sensitivity and 99% specificity for detecting previous SARS-CoV-2 infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Eskin, Barnet] Morristown Med Ctr, Morristown, NJ 07960 USA	Atlantic Health System	Eskin, B (corresponding author), Morristown Med Ctr, Morristown, NJ 07960 USA.							FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; WHO-Worl Health Organization, 2020, CRIT REL COVID 19 PA; Wu SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17972-1	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC35	JC35		10.7326/ACPJ202103160-035	http://dx.doi.org/10.7326/ACPJ202103160-035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646844				2022-12-28	WOS:000669667000010
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Outcomes worsened in second wave for Pakistanis and Bangladeshis in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HM Government, RAC DISP UN 2 Q REP; IACOBUCCI G, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4099; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n467	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2021	372								n572	10.1136/bmj.n572	http://dx.doi.org/10.1136/bmj.n572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1OX	33637553	Bronze			2022-12-28	WOS:000624297200005
J	Gordon, AC; Al-Beidh, F; Rowan, KM; Nichol, AD; Arabi, YM; Annane, D; Beane, A; Van Bentum-Puijk, W; Berry, LR; Bhimani, Z; Bonten, MJM; Bradbury, CA; Brunkhorst, FM; Buzgau, A; Cheng, AC; Detry, MA; Duffy, EJ; Estcourt, LJ; Fitzgerald, M; Goossens, H; Haniffa, R; Higgins, AM; Hills, TE; Horvat, CM; Lamontagne, F; Lawler, PR; Leavis, HL; Linstrum, KM; Litton, E; Lorenzi, E; Marshall, JC; Mayr, FB; McAuley, DF; McGlothlin, A; McGuinness, SP; McVerry, BJ; Montgomery, SK; Morpeth, SC; Murthy, S; Orr, K; Parke, RL; Parker, JC; Patanwala, AE; Pettill, V; Rademaker, E; Santos, MS; Saunders, CT; Seymour, CW; Shankar-Hari, M; Sligl, WL; Turgeon, AF; Turner, AM; van de Veerdonk, FL; Zarychanski, R; Green, C; Lewis, RJ; Angus, DC; McArthur, CJ; Berry, S; Webb, SA; Derde, LPG				Gordon, Anthony C.; Al-Beidh, Farah; Rowan, Kathryn M.; Nichol, Alistair D.; Arabi, Yaseen M.; Annane, Djillali; Beane, Ahi; Van Bentum-Puijk, Wilma; Berry, Lindsay R.; Bhimani, Zahra; Bonten, Marc J. M.; Bradbury, Charlotte A.; Brunkhorst, Frank M.; Buzgau, Adrian; Cheng, Allen C.; Detry, Michelle A.; Duffy, Eamon J.; Estcourt, Lise J.; Fitzgerald, Mark; Goossens, Herman; Haniffa, Rashan; Higgins, Alisa M.; Hills, Thomas E.; Horvat, Christopher M.; Lamontagne, Francois; Lawler, Patrick R.; Leavis, Helen L.; Linstrum, Kelsey M.; Litton, Edward; Lorenzi, Elizabeth; Marshall, John C.; Mayr, Florian B.; McAuley, Daniel F.; McGlothlin, Anna; McGuinness, Shay P.; McVerry, Bryan J.; Montgomery, Stephanie K.; Morpeth, Susan C.; Murthy, Srinivas; Orr, Katrina; Parke, Rachael L.; Parker, Jane C.; Patanwala, Asad E.; Pettill, Ville; Rademaker, Emma; Santos, Marlene S.; Saunders, Christina T.; Seymour, Christopher W.; Shankar-Hari, Manu; Sligl, Wendy L.; Turgeon, Alexis F.; Turner, Anne M.; van de Veerdonk, Frank L.; Zarychanski, Ryan; Green, Cameron; Lewis, Roger J.; Angus, Derek C.; McArthur, Colin J.; Berry, Scott; Webb, Steve A.; Derde, Lennie P. G.		REMAP-CAP Investigators	Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear. METHODS We evaluated tocilizumab and sarilumab in an ongoing international, multifactorial, adaptive platform trial. Adult patients with Covid-19, within 24 hours after starting organ support in the intensive care unit (ICU), were randomly assigned to receive tocilizumab (8 mg per kilogram of body weight), sarilumab (400 mg), or standard care (control). The primary outcome was respiratory and cardiovascular organ support-free days, on an ordinal scale combining in-hospital death (assigned a value of -1) and days free of organ support to day 21. The trial uses a Bayesian statistical model with predefined criteria for superiority, efficacy, equivalence, or futility. An odds ratio greater than 1 represented improved survival, more organ support-free days, or both. RESULTS Both tocilizumab and sarilumab met the predefined criteria for efficacy. At that time, 353 patients had been assigned to tocilizumab, 48 to sarilumab, and 402 to control. The median number of organ support-free days was 10 (interquartile range, -1 to 16) in the tocilizumab group, 11 (interquartile range, 0 to 16) in the sarilumab group, and 0 (interquartile range, -1 to 15) in the control group. The median adjusted cumulative odds ratios were 1.64 (95% credible interval, 1.25 to 2.14) for tocilizumab and 1.76 (95% credible interval, 1.17 to 2.91) for sarilumab as compared with control, yielding posterior probabilities of superiority to control of more than 99.9% and of 99.5%, respectively. An analysis of 90-day survival showed improved survival in the pooled interleukin-6 receptor antagonist groups, yielding a hazard ratio for the comparison with the control group of 1.61 (95% credible interval, 1.25 to 2.08) and a posterior probability of superiority of more than 99.9%. All secondary analyses supported efficacy of these interleukin-6 receptor antagonists. CONCLUSIONS In critically ill patients with Covid-19 receiving organ support in ICUs, treatment with the interleukin-6 receptor antagonists tocilizumab and sarilumab improved outcomes, including survival.(REMAP-CAP ClinicalTrials.gov number, NCT02735707.)	[Gordon, Anthony C.; Al-Beidh, Farah] Imperial Coll London, London, England; [Cheng, Allen C.] St Marys Hosp, Imperial Coll Healthcare NHS Trust, London, England; [Rowan, Kathryn M.; Lawler, Patrick R.] Intens Care Natl Audit & Res Ctr, London, England; [Haniffa, Rashan] Coll London Hosp, London, England; [Shankar-Hari, Manu] Kings Coll London, London, England; [Shankar-Hari, Manu] Guys & St ThomasNHS Fdn Trust, London, England; [Beane, Ahi; Fitzgerald, Mark] Univ Oxford, Oxford, England; [Estcourt, Lise J.; Goossens, Herman] NHS Blood & Transplant, Oxford, England; [Bradbury, Charlotte A.] Univ Bristol, Bristol, Avon, England; [Nichol, Alistair D.; Buzgau, Adrian; Cheng, Allen C.; Higgins, Alisa M.; McGuinness, Shay P.; Parker, Jane C.; Green, Cameron; Webb, Steve A.] Monash Univ, Melbourne, Vic, Australia; [Nichol, Alistair D.; Cheng, Allen C.] Alfred Hlth, Melbourne, Vic, Australia; [Litton, Edward; Orr, Katrina] Fiona Stanley Hosp, Perth, WA, Australia; [Litton, Edward] Univ Western Australia, Perth, WA, Australia; [Patanwala, Asad E.] Univ Sydney, Sydney, NSW, Australia; [Patanwala, Asad E.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Webb, Steve A.] St John God Hosp, Subiaco, WA, Australia; [Nichol, Alistair D.] Univ Coll Dublin, Dublin, Ireland; [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Arabi, Yaseen M.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Annane, Djillali] Hop Raymond Poincare, AP HP, Garches, France; [Annane, Djillali] Univ Paris Saclay, Univ Versailles St Quentin Yvelines, INSEAM, Garches, France; [Annane, Djillali] Univ Paris Saclay, Univ Versailles St Quentin Yvelines, Montigny Le Bretonneux, France; [Van Bentum-Puijk, Wilma; Bonten, Marc J. M.; Leavis, Helen L.; Rademaker, Emma; Derde, Lennie P. G.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [van de Veerdonk, Frank L.] Radboudumc, Nijmegen, Netherlands; [Berry, Lindsay R.; Detry, Michelle A.; Lorenzi, Elizabeth; McGlothlin, Anna; Saunders, Christina T.; Lewis, Roger J.; Berry, Scott] Berry Consultants, Austin, TX USA; [Bhimani, Zahra; Marshall, John C.; Santos, Marlene S.] St Michaels Hosp Unity Hlth, Toronto, ON, Canada; [Lawler, Patrick R.] Univ Hlth Network, Toronto, ON, Canada; [Lawler, Patrick R.] Univ Toronto, Toronto, ON, Canada; [Lamontagne, Francois] Univ Sherbrooke, Sherbrooke, PQ, Canada; [Murthy, Srinivas] Univ British Columbia, Vancouver, BC, Canada; [Sligl, Wendy L.; Turner, Anne M.] Univ Alberta, Edmonton, AB, Canada; [Turgeon, Alexis F.] Univ Laval, Quebec City, PQ, Canada; [Zarychanski, Ryan] Univ Manitoba, Winnipeg, MB, Canada; [Brunkhorst, Frank M.] Jena Univ Hosp, Jena, Germany; [Duffy, Eamon J.; Hills, Thomas E.; McGuinness, Shay P.; Parke, Rachael L.; McArthur, Colin J.] Auckland City Hosp, Auckland, New Zealand; [Morpeth, Susan C.] Middlemore Hosp, Auckland, New Zealand; [Parke, Rachael L.] Univ Auckland, Auckland, New Zealand; [Horvat, Christopher M.] Med Res Inst New Zealand, Wellington, New Zealand; [Linstrum, Kelsey M.; Mayr, Florian B.; McVerry, Bryan J.; Montgomery, Stephanie K.; Seymour, Christopher W.; Angus, Derek C.] Univ Pittsburgh, Pittsburgh, PA USA; [McAuley, Daniel F.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [McAuley, Daniel F.] Royal Victoria Hosp, Belfast, Antrim, North Ireland; [Pettill, Ville] Univ Helsinki, Helsinki, Finland; [Pettill, Ville] Helsinki Univ Hosp, Helsinki, Finland; [Lewis, Roger J.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA	Imperial College London; Imperial College London; Intensive Care National Audit & Research Centre; University College London Hospitals NHS Foundation Trust; University of London; King's College London; University of Oxford; University of Bristol; Monash University; University of Western Australia; University of Sydney; University of Sydney; St John of God Health Care; University College Dublin; King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Sherbrooke; University of British Columbia; University of Alberta; Laval University; University of Manitoba; Friedrich Schiller University of Jena; Auckland City Hospital; University of Auckland; Medical Research Institute Of New Zealand; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Queens University Belfast; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Gordon, AC (corresponding author), Imperial Coll London, St Marys Hosp, Div Anaesthet Pain Med & Inten Sive Care, Praed St, London W2 1NY, England.	anthony.gordon@imperial.ac.uk	Zarychanski, Ryan/AAB-6369-2022; Leaf, David/AAO-8977-2021; Bégin, Philippe/AAU-9126-2021; Gordon, Anthony/A-3472-2012; Tong, Steven/N-2353-2013; Dushianthan, Ahilanandan/T-8390-2019; Veenith, Tonny/A-9948-2010; McVerry, Bryan/AAS-7790-2021; Shankar-Hari, Manu/I-6948-2012; Neal, Matthew/GMW-5601-2022; Parke, Rachael/AAX-4004-2021; van de Veerdonk, Frank L/C-7256-2008; Derde, Lennie/AAF-2725-2021; Veenith, Tonny/AAI-3067-2020; Philips, Barbara/H-1670-2011; Fysh, Edward/E-2855-2018; Presneill, Jeffrey/B-4894-2012; Summers, Charlotte/A-6973-2012; litton, edward/C-5384-2017	Leaf, David/0000-0001-7875-090X; Gordon, Anthony/0000-0002-0419-547X; Tong, Steven/0000-0002-1368-8356; Dushianthan, Ahilanandan/0000-0002-0165-3359; Veenith, Tonny/0000-0002-4125-8804; McVerry, Bryan/0000-0002-1175-4874; Shankar-Hari, Manu/0000-0002-5338-2538; Neal, Matthew/0000-0001-8931-6236; Parke, Rachael/0000-0003-4209-0334; van de Veerdonk, Frank L/0000-0002-1121-4894; Derde, Lennie/0000-0002-3577-5629; Veenith, Tonny/0000-0002-4125-8804; Nichol, Alistair/0000-0002-4689-1238; Kiiski, Heikki/0000-0002-5235-1772; Venkatesh, Bala/0000-0002-3234-5244; Philips, Barbara/0000-0002-1124-0988; Dempster, David/0000-0002-2262-4039; brightling, chris/0000-0002-9345-4903; McAuley, Daniel/0000-0002-3283-1947; Hays, Leanne/0000-0002-6936-1459; Fysh, Edward/0000-0003-1126-3773; Jayakumar, Devachandran/0000-0001-7134-3746; Haniffa, Rashan/0000-0002-8288-449X; Mouncey, Paul/0000-0002-8510-8517; Murthy, Srinivas/0000-0002-9476-839X; Rowan, Kathryn/0000-0001-8217-5602; Frakking, Thuy/0000-0003-2724-6919; Jhanji, Shaman/0000-0002-1116-628X; Bannard-Smith, Jonathan/0000-0001-7120-480X; Presneill, Jeffrey/0000-0001-7177-7667; Girard, Timothy/0000-0002-9833-4871; Binnie, Alexandra/0000-0003-2969-8177; Turner, Anne/0000-0002-4092-1424; Parekh, Dhruv/0000-0002-1508-8362; Summers, Charlotte/0000-0002-7269-2873; McGuinness, Shay/0000-0003-0620-4787; Marin-Corral, Judith/0000-0003-1320-4427; King, Andrew/0000-0002-9809-0563; Young, Paul/0000-0002-3428-3083; Zammit, Claire/0000-0002-3199-6715; Dark, Paul/0000-0003-3309-0164; Hills, Thomas/0000-0003-0322-5822; Hormis, Anil/0000-0001-5510-7639; Puxty, Kathryn/0000-0002-5742-6171; Vodovar, Dominique/0000-0002-8196-5511; McGlothlin, Anna/0000-0002-9079-6166; litton, edward/0000-0002-5125-6829; Lamontagne, Francois/0000-0002-0360-3427; Beane, Abigail/0000-0001-7046-1580; Duffy, Eamon/0000-0002-4515-5116; Waite, Alicia/0000-0001-8734-994X; Nigel, Brunskill/0000-0002-7109-7108; Tolppa, Timo/0000-0002-4119-7335; Koirala, Sabin/0000-0001-8741-8079	European Union -through FP7-HEALTH2013-INNOVATION: the Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) consortium [602525]; European Union -through Horizon 2020 research and innovation program: the Rapid European Covid-19 Emergency Research response (RECOVER) consortium [101003589]; Australian National Health and Medical Research Council [APP1101719]; Health Research Council of New Zealand [16/631]; Canadian Institutes of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program Grant [158584]; U.K. NIHR; NIHR Imperial Biomedical Research Centre; Health Research Board of Ireland [CTN 2014-012]; UPMC Learning While Doing Program; Breast Cancer Research Foundation; French Ministry of Health [PHRC-20-0147]; Minderoo Foundation; Amgen; Eisai; Global Coalition for Adaptive Research; Wellcome Trust Innovations Project [215522]; NIHR Research Professorship [RP-2015-06-18]; NIHR Clinician Scientist Fellowship [CS2016-16-011]	European Union -through FP7-HEALTH2013-INNOVATION: the Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) consortium; European Union -through Horizon 2020 research and innovation program: the Rapid European Covid-19 Emergency Research response (RECOVER) consortium; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Health Research Council of New Zealand(Health Research Council of New Zealand); Canadian Institutes of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program Grant(Canadian Institutes of Health Research (CIHR)); U.K. NIHR(National Institute for Health Research (NIHR)); NIHR Imperial Biomedical Research Centre; Health Research Board of Ireland; UPMC Learning While Doing Program; Breast Cancer Research Foundation; French Ministry of Health; Minderoo Foundation; Amgen(Amgen); Eisai(Eisai Co Ltd); Global Coalition for Adaptive Research; Wellcome Trust Innovations Project(Wellcome Trust); NIHR Research Professorship; NIHR Clinician Scientist Fellowship	Supported by the European Union -through FP7-HEALTH2013-INNOVATION: the Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) consortium (602525); and the Horizon 2020 research and innovation program: the Rapid European Covid-19 Emergency Research response (RECOVER) consortium (101003589) -and by the Australian National Health and Medical Research Council (APP1101719), the Health Research Council of New Zealand (16/631), a Canadian Institutes of Health Research Strategy for Patient-Oriented Research Innovative Clinical Trials Program Grant (158584), the U.K. NIHR and the NIHR Imperial Biomedical Research Centre, the Health Research Board of Ireland (CTN 2014-012), the UPMC Learning While Doing Program, the Breast Cancer Research Foundation, the French Ministry of Health (PHRC-20-0147), the Minderoo Foundation, Amgen, Eisai, the Global Coalition for Adaptive Research, and the Wellcome Trust Innovations Project (215522). Dr. Gordon is funded by an NIHR Research Professorship (RP-2015-06-18), and Dr. Shankar-Hari by an NIHR Clinician Scientist Fellowship (CS2016-16-011).	Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; Angus DC, 2020, ANN AM THORAC SOC, V17, P879, DOI 10.1513/AnnalsATS.202003-192SD; [Anonymous], 2020, PRESS RELEASE; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Gremese E, 2020, ECLINICALMEDICINE, V27, DOI 10.1016/j.eclinm.2020.100553; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Kotch C, 2019, EXPERT REV CLIN IMMU, V15, P813, DOI 10.1080/1744666X.2019.1629904; Laterre PF, 2019, JAMA-J AM MED ASSOC, V322, P1476, DOI 10.1001/jama.2019.14607; Lee K, 2009, GLOB INST, P1; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Pairo-Castineira E, 2021, NATURE, V591, P92, DOI 10.1038/s41586-020-03065-y; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615; Sinha P, 2020, LANCET RESP MED, V8, P1209, DOI 10.1016/S2213-2600(20)30366-0; Somers EC, 2021, CLIN INFECT DIS, V73, pE445, DOI [10.1093/cid/ciaa954, 10.1101/2020.05.29.20117358]; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; Veiga VC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n84; Viele K, 2014, PHARM STAT, V13, P41, DOI 10.1002/pst.1589; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou YG, 2020, NATL SCI REV, V7, P998, DOI 10.1093/nsr/nwaa041; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]	24	401	411	4	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1491	1502		10.1056/NEJMoa2100433	http://dx.doi.org/10.1056/NEJMoa2100433		FEB 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ6OT	33631065	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000640379800001
J	Menon, BS; Teh, KH				Menon, Bina S.; Teh, Kok-Hoi			Gum Hypertrophy from Cyclosporine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Menon, Bina S.; Teh, Kok-Hoi] Hosp Kuala Lumpur, Kuala Lumpur, Malaysia		Menon, BS (corresponding author), Hosp Kuala Lumpur, Kuala Lumpur, Malaysia.	drmenon2013@yahoo.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					744	744		10.1056/NEJMicm2026082	http://dx.doi.org/10.1056/NEJMicm2026082			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP4LK	33626603				2022-12-28	WOS:000623807600013
J	O'Dowd, A				O'Dowd, Adrian			NHS and social care workforce planning is a "joke," says former health secretary	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n335	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n564	10.1136/bmj.n564	http://dx.doi.org/10.1136/bmj.n564			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632726				2022-12-28	WOS:000624298000005
J	Rosas, IO; Brau, N; Waters, M; Go, RC; Hunter, BD; Bhagani, S; Skiest, D; Aziz, MS; Cooper, N; Douglas, IS; Savic, S; Youngstein, T; Del Sorbo, L; Gracian, AC; De la Zerda, DJ; Ustianowski, A; Bao, M; Dimonaco, S; Graham, E; Matharu, B; Spotswood, H; Tsai, L; Malhotra, A				Rosas, I. O.; Brau, N.; Waters, M.; Go, R. C.; Hunter, B. D.; Bhagani, S.; Skiest, D.; Aziz, M. S.; Cooper, N.; Douglas, I. S.; Savic, S.; Youngstein, T.; Del Sorbo, L.; Gracian, A. Cubillo; De la Zerda, D. J.; Ustianowski, A.; Bao, M.; Dimonaco, S.; Graham, E.; Matharu, B.; Spotswood, H.; Tsai, L.; Malhotra, A.			Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in better outcomes in patients with severe Covid-19 pneumonia in case reports and retrospective observational cohort studies. Data are needed from randomized, placebo-controlled trials. METHODS In this phase 3 trial, we randomly assigned patients who were hospitalized with severe Covid-19 pneumonia in a 2:1 ratio receive a single intravenous infusion of tocilizumab (at a dose of 8 mg per kilogram of body weight) or placebo. Approximately one quarter of the participants received a second dose of tocilizumab or placebo 8 to 24 hours after the first dose. The primary outcome was clinical status at day 28 on an ordinal scale ranging from 1 (discharged or ready for discharge) to 7 (death) in the modified intention-to-treat population, which included all the patients who had received at least one dose of tocilizumab or placebo. RESULTS Of the 452 patients who underwent randomization, 438 (294 in the tocilizumab group and 144 in the placebo group) were included in the primary and secondary analyses. The median value for clinical status on the ordinal scale at day 28 was 1.0 (95% confidence interval [CI], 1.0 to 1.0) in the tocilizumab group and 2.0 (non-ICU hospitalization without supplemental oxygen) (95% CI, 1.0 to 4.0) in the placebo group (between-group difference, -1.0; 95% CI, -2.5 to 0; P=0.31 by the van Elteren test). In the safety population, serious adverse events occurred in 103 of 295 patients (34.9%) in the tocilizumab group and in 55 of 143 patients (38.5%) in the placebo group. Mortality at day 28 was 19.7% in the tocilizumab group and 19.4% in the placebo group (weighted difference, 0.3 percentage points; 95% CI, -7.6 to 8.2; nominal P=0.94). CONCLUSIONS In this randomized trial involving hospitalized patients with severe Covid-19 pneumonia, the use of tocilizumab did not result in significantly better clinical status or lower mortality than placebo at 28 days.	[Rosas, I. O.] Baylor Coll Med, Houston, TX 77030 USA; [Brau, N.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA; [Brau, N.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Waters, M.] eStudy Site, Chula Vista, CA USA; [Bao, M.; Tsai, L.] Genentech Inc, San Francisco, CA USA; [Malhotra, A.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Go, R. C.] Hackensack Meridian Sch Med, Hackensack, NJ USA; [Go, R. C.] Hacksensack Univ, Med Ctr, Hackensack, NJ USA; [Hunter, B. D.] Intermt Healthcare, Salt Lake City, UT USA; [Bhagani, S.] Royal Free Hosp, London, England; [Cooper, N.; Youngstein, T.] Imperial Coll London, London, England; [Savic, S.] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Savic, S.] Natl Inst Hlth Res, Leeds Biomed Res Ctr, Leeds, W Yorkshire, England; [Ustianowski, A.] North Manchester Gen Hosp, Manchester, Lancs, England; [Dimonaco, S.; Graham, E.; Matharu, B.; Spotswood, H.] Roche Prod, Welwyn Garden City, Herts, England; [Skiest, D.] Univ Massachusetts, Med Sch Baystate, Springfield, MA USA; [Aziz, M. S.] Rush Univ, Med Ctr, Chicago, IL 60612 USA; [Douglas, I. S.] Denver Hlth Med Ctr, Denver, CO USA; [Douglas, I. S.] Univ Colorado, Anschutz Sch Med, Aurora, CO USA; [Del Sorbo, L.] Univ Hlth Network, Toronto, ON, Canada; [Gracian, A. Cubillo] Univ CEU San Pablo, Hosp Univ HM Sanchinarro, Ctr Integral, Oncol Clara Campal, Madrid, Spain; [Gracian, A. Cubillo] Univ CEU San Pablo, Fac Med, Dept Ciencias Med Clin, Madrid, Spain; [De la Zerda, D. J.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Roche Holding; Genentech; University of California System; University of California San Diego; Intermountain Healthcare; Intermountain Medical Center; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Imperial College London; University of Leeds; Leeds Biomedical Research Centre; Roche Holding; University of Massachusetts System; Rush University; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto; San Pablo CEU University; San Pablo CEU University; University of Miami	Rosas, IO (corresponding author), Baylor Coll Med, Sect Pulm Crit Care & Sleep Med, 7200 Cambridge St, Houston, TX 77030 USA.	ivan.rosas@bcm.edu	, Felipe/F-4242-2014	, Felipe/0000-0001-7658-5832; Bhagani, Sanjay/0000-0003-2557-4337; Ustianowski, Andrew/0000-0002-6134-7855; Savic, Sinisa/0000-0001-7910-0554; Douglas, Ivor/0000-0002-4541-1431	Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services [HHSO100201800036C]; Biomedical Research Centre of the United Kingdom National Institute for Health Research; National Institutes of Health; F. Hoffmann-La Roche	Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services; Biomedical Research Centre of the United Kingdom National Institute for Health Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F. Hoffmann-La Roche(Hoffmann-La Roche)	Supported F. Hoffmann-La Roche and by a grant -(HHSO100201800036C) from the Biomedical Advanced Research and Development Authority of the Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services. Drs. Cooper and Youngstein were supported in part by the Biomedical Research Centre of the United Kingdom National Institute for Health Research. Dr. Malhotra is supported by the National Institutes of Health.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Antwi-Amoabeng D, 2020, J MED VIROL, V92, P2516, DOI 10.1002/jmv.26038; Aziz M, 2020, J MED VIROL, V92, P2283, DOI 10.1002/jmv.25948; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cellina M, 2020, DIAGN INTERV IMAG, V101, P323, DOI 10.1016/j.diii.2020.03.010; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guaraldi G, 2020, LANCET RHEUMATOL, V2, pE474, DOI 10.1016/S2665-9913(20)30173-9; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Kaye AG, 2020, PEERJ, V8, DOI 10.7717/peerj.10322; Kotch C, 2019, EXPERT REV CLIN IMMU, V15, P813, DOI 10.1080/1744666X.2019.1629904; Lee K, 2009, GLOB INST, P1; Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801; Mastroianni A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100410; Michot JM, 2020, ANN ONCOL, V31, P961, DOI 10.1016/j.annonc.2020.03.300; Pons S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03062-7; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Rubbert-Roth A, 2018, RHEUMATOL THER, V5, P21, DOI 10.1007/s40744-018-0102-x; Somers EC, 2021, CLIN INFECT DIS, V73, pE445, DOI [10.1093/cid/ciaa954, 10.1101/2020.05.29.20117358]; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yehya N, 2019, AM J RESP CRIT CARE, V200, P828, DOI 10.1164/rccm.201810-2050CP; Zhang XH, 2020, BLOOD ADV, V4, P1307, DOI 10.1182/bloodadvances.2020001907; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]	29	451	461	5	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1503	1516		10.1056/NEJMoa2028700	http://dx.doi.org/10.1056/NEJMoa2028700		FEB 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ6OT	33631066	Green Published, Bronze			2022-12-28	WOS:000640379900001
J	Mittra, I; Mishra, GA; Dikshit, RP; Gupta, S; Kulkarni, VY; Shaikh, HKA; Shastri, SS; Hawaldar, R; Gupta, S; Pramesh, CS; Badwe, RA				Mittra, Indraneel; Mishra, Gauravi A.; Dikshit, Rajesh P.; Gupta, Subhadra; Kulkarni, Vasundhara Y.; Shaikh, Heena Kauser A.; Shastri, Surendra S.; Hawaldar, Rohini; Gupta, Sudeep; Pramesh, C. S.; Badwe, Rajendra A.			Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To test the efficacy of screening by clinical breast examination in downstaging breast cancer at diagnosis and in reducing mortality from the disease, when compared with no screening. DESIGN Prospective, cluster randomised controlled trial. SETTING 20 geographically distinct clusters located in Mumbai, India, randomly allocated to 10 screening and 10 control clusters; total trial duration was 20 years (recruitment began in May 1998; database locked in March 2019 for analysis). PARTICIPANTS 151 538 women aged 35-64 with no history of breast cancer. INTERVENTIONS Women in the screening arm (n=75 360) received four screening rounds of clinical breast examination (conducted by trained female primary health workers) and cancer awareness every two years, followed by five rounds of active surveillance every two years. Women in the control arm (n=76 178) received one round of cancer awareness followed by eight rounds of active surveillance every two years. MAIN OUTCOME MEASURES Downstaging of breast cancer at diagnosis and reduction in mortality from breast cancer. RESULTS Breast cancer was detected at an earlier age in the screening group than in the control group (age 55.18 (standard deviation 9.10) v 56.50 (9.10); P=0.01), with a significant reduction in the proportion of women with stage III or IV disease (37% (n=220) v 47% (n=271), P=0.001). A non-significant 15% reduction in breast cancer mortality was observed in the screening arm versus control arm in the overall study population (age 35-64; 20.82 deaths per 100 000 person years (95% confidence interval 18.25 to 23.97) v 24.62 (21.71 to 28.04); rate ratio 0.85 (95% confidence interval 0.71 to 1.01); P=0.07). However, a post hoc subset analysis showed nearly 30% relative reduction in breast cancer mortality in women aged 50 and older (24.62 (20.62 to 29.76) v 34.68 (27.54 to 44.37); 0.71 (0.54 to 0.94); P=0.02), but no significant reduction in women younger than 50 (19.53 (17.24 to 22.29) v 21.03 (18.97 to 23.44); 0.93 (0.79 to 1.09); P=0.37). A 5% reduction in all cause mortality was seen in the screening arm versus the control arm, but it was not statistically significant (rate ratio 0.95 (95% confidence interval 0.81 to 1.10); P=0.49). CONCLUSIONS These results indicate that clinical breast examination conducted every two years by primary health workers significantly downstaged breast cancer at diagnosis and led to a non-significant 15% reduction in breast cancer mortality overall (but a significant reduction of nearly 30%in mortality in women aged >= 50). No significant reduction in mortality was seen in women younger than 50 years. Clinical breast examination should be considered for breast cancer screening in low and middle income countries.	[Mittra, Indraneel; Pramesh, C. S.; Badwe, Rajendra A.] Homi Bhabha Natl Inst, Dept Surg Oncol, Tata Mem Ctr, Dr Ernest Borges Rd, Mumbai 400012, Maharashtra, India; [Mishra, Gauravi A.; Gupta, Subhadra; Kulkarni, Vasundhara Y.; Shaikh, Heena Kauser A.; Shastri, Surendra S.] Homi Bhabha Natl Inst, Dept Prevent Oncol, Ctr Canc Epidemiol, Tata Mem Ctr, Mumbai, Maharashtra, India; [Dikshit, Rajesh P.] Homi Bhabha Natl Inst, Ctr Canc Epidemiol, Tata Mem Ctr, Adv Ctr Treatment Res & Educ Canc, Mumbai, Maharashtra, India; [Hawaldar, Rohini] Homi Bhabha Natl Inst, Res Adm Council, Tata Mem Ctr, Mumbai, Maharashtra, India; [Gupta, Sudeep] Homi Bhabha Natl Inst, Dept Med Oncol, Tata Mem Ctr, Mumbai, Maharashtra, India	Homi Bhabha National Institute; Tata Memorial Centre (TMC); Homi Bhabha National Institute; Tata Memorial Centre (TMC); Centre for Cancer Epidemiology Mumbai; Homi Bhabha National Institute; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Centre for Cancer Epidemiology Mumbai; Homi Bhabha National Institute; Tata Memorial Centre (TMC); Homi Bhabha National Institute; Tata Memorial Centre (TMC)	Mittra, I (corresponding author), Homi Bhabha Natl Inst, Dept Surg Oncol, Tata Mem Ctr, Dr Ernest Borges Rd, Mumbai 400012, Maharashtra, India.	indraneel.mittra@gmail.com		Gupta, Subhadra/0000-0001-9620-0282; Hawaldar, Rohini/0000-0002-3114-5689; Shaikh, Heena Kauser/0000-0003-4945-3919; Gupta, Sudeep/0000-0002-6742-6378; Mishra, Gauravi/0000-0002-0154-7302; Pramesh, C S/0000-0002-3635-0083	US National Institutes of Health RO1 grant [RO1CA074801]; Tata Memorial Centre; Sir Dorabji Tata Trusts; M K Tata Trusts; Department of Atomic Energy, Government of India; Women's Cancer Initiative, India	US National Institutes of Health RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tata Memorial Centre; Sir Dorabji Tata Trusts; M K Tata Trusts; Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Women's Cancer Initiative, India	The trial was funded by a US National Institutes of Health RO1 grant (RO1CA074801) for 1997-2000, 2000-03, 2005-10, and 2010-15. The trial was also supported in 2003-04 and 2016-19 by Intramural funding from the Tata Memorial Centre. The study was also supported by Sir Dorabji Tata Trusts, M K Tata Trusts, and the Department of Atomic Energy, Government of India. Treatment costs were supported by the Women's Cancer Initiative, India. Funders had no role in study design, in collection, analysis, and interpretation of data, in writing the report, and in decision to submit the paper for publication. The principal investigator had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Black E, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-018-0446-6; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; BRESLOW L, 1977, J NATL CANCER I, V59, P467, DOI 10.1093/jnci/59.2.479; Dhillon PK, 2018, LANCET ONCOL, V19, P1289, DOI 10.1016/S1470-2045(18)30447-9; Dinshaw K, 2007, ONCOLOGY-BASEL, V73, P145, DOI 10.1159/000126497; Dinshaw K, 2007, ONCOLOGY-BASEL, V73, P154, DOI 10.1159/000126498; Elwood JM, 1993, ONLINE J CURR CLIN T, P195; Hackshaw AK, 2003, BRIT J CANCER, V88, P1047, DOI 10.1038/sj.bjc.6600847; Harford JB, 2011, LANCET ONCOL, V12, P306, DOI 10.1016/S1470-2045(10)70273-4; Harvey BJ, 1997, CAN MED ASSOC J, V157, P1205; Horeweg N, 2012, LUNG CANCER, V77, P522, DOI 10.1016/j.lungcan.2012.04.018; Indian Cancer Society, REGISTRY RES ED; International Agency for Research on Cancer, 2018, CI5 PLUS CANC INCIDE; Kohler U, 2012, STATA DATA ANAL STAT, V3rd; Marcus PM, 2011, CONTEMP CLIN TRIALS, V32, P834, DOI 10.1016/j.cct.2011.07.003; MILLER AB, 1992, CAN MED ASSOC J, V147, P1477; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Mittra I, 2000, BMJ-BRIT MED J, V321, P1071, DOI 10.1136/bmj.321.7268.1071; MITTRA I, 1994, LANCET, V343, P342, DOI 10.1016/S0140-6736(94)91170-3; Mittra I, 2011, PREV MED, V53, P121, DOI 10.1016/j.ypmed.2011.06.010; Mittra I, 2010, INT J CANCER, V126, P976, DOI 10.1002/ijc.24840; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Moss SM, 2015, LANCET ONCOL, V16, P1123, DOI 10.1016/S1470-2045(15)00128-X; Mumbai Cancer Registry, 2016, ANN REPORTS 1992 201; Municipal Corporation of Greater Mumbai, DEATH REGISTRATION D; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Retsky M, 2003, CURR OPIN OBSTET GYN, V15, P1, DOI 10.1097/00001703-200302000-00001; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Shapiro S, 1997, J Natl Cancer Inst Monogr, P27; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858	33	38	39	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n256	10.1136/bmj.n256	http://dx.doi.org/10.1136/bmj.n256			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627312	Green Published, hybrid			2022-12-28	WOS:000623404800001
J	Li, Z; Wang, ZX; Lee, MC; Zenkel, M; Peh, E; Ozaki, M; Topouzis, F; Nakano, S; Chan, A; Chen, SW; Williams, SEI; Orr, A; Nakano, M; Kobakhidze, N; Zarnowski, T; Popa-Cherecheanu, A; Mizoguchi, T; Manabe, S; Hayashi, K; Kazama, S; Inoue, K; Mori, Y; Miyata, K; Sugiyama, K; Higashide, T; Chihara, E; Ideta, R; Ishiko, S; Yoshida, A; Tokumo, K; Kiuchi, Y; Ohashi, T; Sakurai, T; Sugimoto, T; Chuman, H; Aihara, M; Inatani, M; Mori, K; Ikeda, Y; Ueno, M; Gaston, D; Rafuse, P; Shuba, L; Saunders, J; Nicolela, M; Chichua, G; Tabagari, S; Founti, P; Sim, KS; Meah, WY; Soo, HM; Chen, XY; Chatzikyriakidou, A; Keskini, C; Pappas, T; Anastasopoulos, E; Lambropoulos, A; Panagiotou, ES; Mikropoulos, DG; Kosior-Jarecka, E; Cheong, A; Li, YH; Lukasik, U; Nongpiur, ME; Husain, R; Perera, SA; Alvarez, L; Garcia, M; Gonzalez-Iglesias, H; Cueto, AFV; Cueto, LFV; Martinon-Torres, F; Salas, A; Oguz, C; Tamcelik, N; Atalay, E; Batu, B; Irkec, M; Aktas, D; Kasim, B; Astakhov, YS; Astakhov, SY; Akopov, EL; Giessl, A; Mardin, C; Hellerbrand, C; Bailey, JNC; Igo, RP; Haines, JL; Edward, DP; Heegaard, S; Davila, S; Tan, P; Kang, JH; Pasquale, LR; Kruse, FE; Reis, A; Carmichael, TR; Hauser, M; Ramsay, M; Mossbock, G; Yildirim, N; Tashiro, K; Konstas, AGP; Coca-Prados, M; Foo, JN; Kinoshita, S; Sotozono, C; Kubota, T; Dubina, M; Ritch, R; Wiggs, JL; Pasutto, F; Schlotzer-Schrehardt, U; Ho, YS; Aung, T; Tam, WL; Khor, CC				Li, Zheng; Wang, Zhenxun; Lee, Mei Chin; Zenkel, Matthias; Peh, Esther; Ozaki, Mineo; Topouzis, Fotis; Nakano, Satoko; Chan, Anita; Chen, Shuwen; Williams, Susan E. I.; Orr, Andrew; Nakano, Masakazu; Kobakhidze, Nino; Zarnowski, Tomasz; Popa-Cherecheanu, Alina; Mizoguchi, Takanori; Manabe, Shin-ichi; Hayashi, Ken; Kazama, Shigeyasu; Inoue, Kenji; Mori, Yosai; Miyata, Kazunori; Sugiyama, Kazuhisa; Higashide, Tomomi; Chihara, Etsuo; Ideta, Ryuichi; Ishiko, Satoshi; Yoshida, Akitoshi; Tokumo, Kana; Kiuchi, Yoshiaki; Ohashi, Tsutomu; Sakurai, Toshiya; Sugimoto, Takako; Chuman, Hideki; Aihara, Makoto; Inatani, Masaru; Mori, Kazuhiko; Ikeda, Yoko; Ueno, Morio; Gaston, Daniel; Rafuse, Paul; Shuba, Lesya; Saunders, Joseph; Nicolela, Marcelo; Chichua, George; Tabagari, Sergo; Founti, Panayiota; Sim, Kar Seng; Meah, Wee Yang; Soo, Hui Meng; Chen, Xiao Yin; Chatzikyriakidou, Anthi; Keskini, Christina; Pappas, Theofanis; Anastasopoulos, Eleftherios; Lambropoulos, Alexandros; Panagiotou, Evangelia S.; Mikropoulos, Dimitrios G.; Kosior-Jarecka, Ewa; Cheong, Augustine; Li, Yuanhan; Lukasik, Urszula; Nongpiur, Monisha E.; Husain, Rahat; Perera, Shamira A.; Alvarez, Lydia; Garcia, Montserrat; Gonzalez-Iglesias, Hector; Cueto, Andres F. V.; Cueto, Luis F. V.; Martinon-Torres, Federico; Salas, Antonio; Oguz, Cilingir; Tamcelik, Nevbahar; Atalay, Eray; Batu, Bilge; Irkec, Murat; Aktas, Dilek; Kasim, Burcu; Astakhov, Yury S.; Astakhov, Sergei Y.; Akopov, Eugeny L.; Giessl, Andreas; Mardin, Christian; Hellerbrand, Claus; Bailey, Jessica N. Cooke; Igo, Robert P., Jr.; Haines, Jonathan L.; Edward, Deepak P.; Heegaard, Steffen; Davila, Sonia; Tan, Patrick; Kang, Jae H.; Pasquale, Louis R.; Kruse, Friedrich E.; Reis, Andre; Carmichael, Trevor R.; Hauser, Michael; Ramsay, Michele; Mossbock, Georg; Yildirim, Nilgun; Tashiro, Kei; Konstas, Anastasios G. P.; Coca-Prados, Miguel; Foo, Jia Nee; Kinoshita, Shigeru; Sotozono, Chie; Kubota, Toshiaki; Dubina, Michael; Ritch, Robert; Wiggs, Janey L.; Pasutto, Francesca; Schloetzer-Schrehardt, Ursula; Ho, Ying Swan; Aung, Tin; Tam, Wai Leong; Khor, Chiea Chuen		Genetics Exfoliation Syndrome	Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PSEUDOEXFOLIATION SYNDROME; LOW-FREQUENCY; SUSCEPTIBILITY; RISK; DISEASE; PROTEIN; LOXL1; GENE	IMPORTANCE Exfoliation syndrome is a systemic disorder characterized by progressive accumulation of abnormal fibrillar protein aggregates manifesting clinically in the anterior chamber of the eye. This disorder is the most commonly known cause of glaucoma and a major cause of irreversible blindness. OBJECTIVE To determine if exfoliation syndrome is associated with rare, protein-changing variants predicted to impair protein function. DESIGN, SETTING, AND PARTICIPANTS A 2-stage, case-control, whole-exome sequencing association study with a discovery cohort and 2 independently ascertained validation cohorts. Study participants from 14 countries were enrolled between February 1999 and December 2019. The date of last clinical follow-up was December 2019. Affected individuals had exfoliation material on anterior segment structures of at least 1 eye as visualized by slit lamp examination. Unaffected individuals had no signs of exfoliation syndrome. EXPOSURES Rare, coding-sequence genetic variants predicted to be damaging by bioinformatic algorithms trained to recognize alterations that impair protein function. MAIN OUTCOMES AND MEASURES The primary outcome was the presence of exfoliation syndrome. Exome-wide significance for detected variants was defined as P < 2.5 x 10(-6). The secondary outcomes included biochemical enzymatic assays and gene expression analyses. RESULTS The discovery cohort included 4028 participants with exfoliation syndrome (median age, 78 years [interquartile range, 73-83 years]; 2377 [59.0%] women) and 5638 participants without exfoliation syndrome (median age, 72 years [interquartile range, 65-78 years]; 3159 [56.0%] women). In the discovery cohort, persons with exfoliation syndrome, compared with those without exfoliation syndrome, were significantly more likely to carry damaging CYP39A1 variants (1.3% vs 0.30%, respectively; odds ratio, 3.55 [95% CI, 2.07-6.10]; P = 6.1 x 10(-7). This outcome was validated in 2 independent cohorts. The first validation cohort included 2337 individuals with exfoliation syndrome (median age, 74 years; 1132 women; n = 1934 with demographic data) and 2813 individuals without exfoliation syndrome (median age, 72 years; 1287 women; n = 2421 with demographic data). The second validation cohort included 1663 individuals with exfoliation syndrome (median age, 75 years; 587 women; n = 1064 with demographic data) and 3962 individuals without exfoliation syndrome (median age, 74 years; 951 women; n = 1555 with demographic data). Of the individuals from both validation cohorts, 5.2% with exfoliation syndrome carried CYP39A1 damaging alleles vs 3.1% without exfoliation syndrome (odds ratio, 1.82 [95% CI, 1.47-2.26]; P < .001). Biochemical assays classified 34 of 42 damaging CYP39A1 alleles as functionally deficient (median reduction in enzymatic activity compared with wild-type CYP39A1, 94.4%[interquartile range, 78.7%-98.2%] for the 34 deficient variants). CYP39A1 transcript expression was 47% lower (95% CI, 30%-64% lower; P < .001) in ciliary body tissues from individuals with exfoliation syndrome compared with individuals without exfoliation syndrome. CONCLUSIONS AND RELEVANCE In this whole-exome sequencing case-control study, presence of exfoliation syndrome was significantly associated with carriage of functionally deficient CYP39A1 sequence variants. Further research is needed to understand the clinical implications of these findings.	[Li, Zheng; Wang, Zhenxun; Sim, Kar Seng; Meah, Wee Yang; Soo, Hui Meng; Chen, Xiao Yin; Cheong, Augustine; Tan, Patrick; Foo, Jia Nee; Tam, Wai Leong; Khor, Chiea Chuen] Agcy Sci Technol &, Genome Inst Singapore, Singapore, Singapore; [Wang, Zhenxun; Lee, Mei Chin; Chan, Anita; Li, Yuanhan; Nongpiur, Monisha E.; Husain, Rahat; Perera, Shamira A.; Aung, Tin; Khor, Chiea Chuen] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Zenkel, Matthias; Giessl, Andreas; Mardin, Christian; Kruse, Friedrich E.; Schloetzer-Schrehardt, Ursula] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Dept Ophthalmol, Erlangen, Germany; [Peh, Esther; Chen, Shuwen; Ho, Ying Swan] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore; [Ozaki, Mineo] Ozaki Eye Hosp, Miyazaki, Japan; [Topouzis, Fotis; Founti, Panayiota; Keskini, Christina; Pappas, Theofanis; Anastasopoulos, Eleftherios; Panagiotou, Evangelia S.; Mikropoulos, Dimitrios G.] Aristotle Univ Thessaloniki, Sch Med, Fac Hlth Sci, Dept Ophthalmol 1, Thessaloniki, Greece; [Topouzis, Fotis] Aristotle Univ Thessaloniki, Ctr Interdisciplinary Res & Innovat, IScreen Res Team, Thessaloniki, Greece; [Nakano, Satoko; Kubota, Toshiaki] Oita Univ, Fac Med, Dept Ophthalmol, Oita, Japan; [Chan, Anita; Nongpiur, Monisha E.; Aung, Tin; Khor, Chiea Chuen] Duke NUS Med Sch, Singapore, Singapore; [Williams, Susan E. I.; Carmichael, Trevor R.] Univ Witwatersrand, Dept Neurosci, Div Ophthalmol, Johannesburg, South Africa; [Orr, Andrew; Rafuse, Paul; Shuba, Lesya; Saunders, Joseph; Nicolela, Marcelo] Dalhousie Univ, Dept Ophthalmol & Visual Sci, Halifax, NS, Canada; [Orr, Andrew; Gaston, Daniel] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Nakano, Masakazu; Tashiro, Kei] Kyoto Prefectural Univ Med, Dept Genom Med Sci, Kyoto, Japan; [Kobakhidze, Nino; Chichua, George] Chichua Med Ctr Mzera, Tbilisi, Georgia; [Zarnowski, Tomasz; Kosior-Jarecka, Ewa; Lukasik, Urszula] Med Univ, Dept Diagnost & Microsurg Glaucoma, Lublin, Poland; [Popa-Cherecheanu, Alina] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Popa-Cherecheanu, Alina] Univ Emergency Hosp, Dept Ophthalmol, Bucharest, Romania; [Mizoguchi, Takanori] Mizoguchi Eye Hosp, Nagasaki, Japan; [Manabe, Shin-ichi; Hayashi, Ken] Hayashi Eye Hosp, Fukuoka, Japan; [Kazama, Shigeyasu] Shinjo Eye Clin, Miyazaki, Japan; [Inoue, Kenji] Inouye Eye Hosp, Tokyo, Japan; [Mori, Yosai; Miyata, Kazunori] Miyata Eye Hosp, Miyazaki, Japan; [Sugiyama, Kazuhisa; Higashide, Tomomi] Kanazawa Univ, Grad Sch Med Sci, Dept Ophthalmol, Kanazawa, Ishikawa, Japan; [Chihara, Etsuo] Sensho Kai Eye Inst, Kyoto, Japan; [Ideta, Ryuichi] Ideta Heisei Retina Consultants, Kumamoto, Japan; [Ishiko, Satoshi] Asahikawa Med Univ, Dept Med, Asahikawa, Hokkaido, Japan; [Ishiko, Satoshi] Asahikawa Med Univ, Engn Combined Res Inst, Asahikawa, Hokkaido, Japan; [Yoshida, Akitoshi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan; [Tokumo, Kana; Kiuchi, Yoshiaki] Hiroshima Univ, Dept Ophthalmol & Visual Sci, Hiroshima, Japan; [Ohashi, Tsutomu] Ohashi Eye Ctr, Sapporo, Hokkaido, Japan; [Sakurai, Toshiya] Tane Mem Eye Hosp, Osaka, Japan; [Sugimoto, Takako; Chuman, Hideki] Miyazaki Med Coll Hosp, Dept Ophthalmol, Miyazaki, Japan; [Aihara, Makoto] Univ Tokyo, Dept Ophthalmol, Tokyo, Japan; [Inatani, Masaru] Univ Fukui, Dept Ophthalmol, Fac Med Sci, Fukui, Japan; [Mori, Kazuhiko; Ikeda, Yoko; Ueno, Morio; Sotozono, Chie] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Tabagari, Sergo] David Tvildiani Med Univ, Tbilisi, Georgia; [Founti, Panayiota] Moorfields Eye Hosp NHS Fdn Trust, Glaucoma Unit, London, England; [Chatzikyriakidou, Anthi; Lambropoulos, Alexandros] Aristotle Univ Thessaloniki, Sch Med, Lab Med Biol Genet, Thessaloniki, Greece; [Alvarez, Lydia; Garcia, Montserrat; Gonzalez-Iglesias, Hector; Cueto, Andres F. V.; Cueto, Luis F. V.; Coca-Prados, Miguel] Univ Oviedo, Fernandez Vega Univ Inst, Oviedo, Spain; [Alvarez, Lydia; Garcia, Montserrat; Gonzalez-Iglesias, Hector; Cueto, Andres F. V.; Cueto, Luis F. V.; Coca-Prados, Miguel] Univ Oviedo, Fdn Ophthalmol Res, Oviedo, Spain; [Alvarez, Lydia; Garcia, Montserrat; Gonzalez-Iglesias, Hector; Cueto, Andres F. V.; Cueto, Luis F. V.; Coca-Prados, Miguel] Fernandez Vega Ophthalmol Inst, Oviedo, Spain; [Martinon-Torres, Federico] Univ Santiago de Compostela, Hosp Clin Univ Santiago, Translat Pediat & Infect Dis, Santiago De Compostela, Spain; [Martinon-Torres, Federico] Univ Santiago de Compostela, GENVIP Res Grp, Inst Invest Sanitaria, Santiago De Compostela, Spain; [Salas, Antonio] Univ Santiago de Compostela, Unidade Xenet, Inst Ciencias Forenses, Fac Med, Galicia, Spain; [Salas, Antonio] Univ Santiago, Hosp Clin, Inst Invest Sanitaria, GenPoB Res Grp, Galicia, Spain; [Oguz, Cilingir] Eskisehir Osmangazi Univ, Dept Genet, Eskisehir, Turkey; [Tamcelik, Nevbahar; Batu, Bilge] Istanbul Univ Cerrahpasa, Fac Med, Istanbul, Turkey; [Atalay, Eray; Yildirim, Nilgun] Eskisehir Osmangazi Univ, Dept Ophthalmol, Eskisehir, Turkey; [Irkec, Murat; Kasim, Burcu] Hacettepe Univ, Fac Med, Dept Ophthalmol, Ankara, Turkey; [Aktas, Dilek] DAMAGEN Genet Diagnost Ctr, Ankara, Turkey; [Astakhov, Yury S.; Astakhov, Sergei Y.; Akopov, Eugeny L.] Pavlov First St Petersburg State Med Univ, Dept Ophthalmol, St Petersburg, Russia; [Hellerbrand, Claus] Friedrich Alexander Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Erlangen, Germany; [Bailey, Jessica N. Cooke; Igo, Robert P., Jr.; Haines, Jonathan L.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Inst Computat Biol, Cleveland, OH 44106 USA; [Edward, Deepak P.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Edward, Deepak P.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL USA; [Heegaard, Steffen] Univ Copenhagen, Dept Ophthalmol, Rigshosp, Copenhagen, Denmark; [Heegaard, Steffen] Univ Copenhagen, Eye Pathol Sect, Dept Pathol, Rigshosp, Copenhagen, Denmark; [Davila, Sonia; Tan, Patrick] SingHlth Duke NUS Inst Precis Med, Singapore, Singapore; [Davila, Sonia] Duke NUS Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore; [Tan, Patrick] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore; [Tan, Patrick; Tam, Wai Leong] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Kang, Jae H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Pasquale, Louis R.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA; [Reis, Andre; Pasutto, Francesca] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Inst Human Genet, Erlangen, Germany; [Hauser, Michael] Duke Univ, Dept Med, Durham, NC USA; [Hauser, Michael] Duke Univ, Dept Ophthalmol, Durham, NC USA; [Ramsay, Michele] Univ Witwatersrand, Fac Hlth Sci, Sydney Brenner Inst Mol Biosci, Johannesburg, South Africa; [Mossbock, Georg] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Konstas, Anastasios G. P.] Aristotle Univ Thessaloniki, Sch Med, Dept Ophthalmol 1, Thessaloniki, Greece; [Konstas, Anastasios G. P.] Aristotle Univ Thessaloniki, Sch Med, Dept Ophthalmol 3, Thessaloniki, Greece; [Coca-Prados, Miguel] Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, New Haven, CT 06510 USA; [Foo, Jia Nee] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan; [Dubina, Michael] State Res Inst Highly Pure Biopreparat FMBA Russi, St Petersburg, Russia; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY USA; [Wiggs, Janey L.] Harvard Med Sch, Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02115 USA; [Aung, Tin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore, Singapore; [Tam, Wai Leong] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Tam, Wai Leong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Singapore National Eye Center; University of Erlangen Nuremberg; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Oita University; National University of Singapore; University of Witwatersrand; Dalhousie University; Dalhousie University; Kyoto Prefectural University of Medicine; Medical University of Lublin; Carol Davila University of Medicine & Pharmacy; Kanazawa University; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Hiroshima University; University of Miyazaki; University of Tokyo; University of Fukui; Kyoto Prefectural University of Medicine; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Aristotle University of Thessaloniki; University of Oviedo; University of Oviedo; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Eskisehir Osmangazi University; Istanbul University; Istanbul University - Cerrahpasa; Eskisehir Osmangazi University; Hacettepe University; Pavlov First Saint Petersburg State Medical University; University of Erlangen Nuremberg; Case Western Reserve University; King Khaled Eye Specialist Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; National University of Singapore; National University of Singapore; National University of Singapore; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icahn School of Medicine at Mount Sinai; University of Erlangen Nuremberg; Duke University; Duke University; University of Witwatersrand; Medical University of Graz; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Yale University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Kyoto Prefectural University of Medicine; New York Eye & Ear Infirmary of Mount Sinai; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Khor, CC (corresponding author), Genome Inst Singapore, 60 Biopolis St,02-01 Genome Bldg, Singapore 138672, Singapore.	khorcc@gis.a-star.edu.sg	chen, xia/GYR-3948-2022; Gonzalez-Iglesias, Hector/AAB-5993-2019; Yildirim, Nilgun/ABA-6534-2021; Salas, Antonio/E-3977-2012; Garcia, Montserrat/AAA-7781-2019; Salas, Antonio/U-2029-2019; Akopov, Evgeny/AAM-4563-2021; Reis, André/D-2309-2009; García Diaz, Montserrat/GXV-7857-2022; Foo, Jia Nee/D-6069-2014; Kubota, Toshiaki/AAN-4334-2021; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Atalay, Eray/O-5377-2018; Gonzalez-Iglesias, Hector/K-2447-2014; Dubina, Michael/E-1888-2014; Martinon-Torres, Federico/E-4982-2016	Salas, Antonio/0000-0002-2336-702X; Garcia, Montserrat/0000-0001-9983-546X; Salas, Antonio/0000-0002-2336-702X; Akopov, Evgeny/0000-0002-7827-1180; Reis, André/0000-0002-6301-6363; Foo, Jia Nee/0000-0001-9899-2308; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Atalay, Eray/0000-0002-2536-4279; Gonzalez-Iglesias, Hector/0000-0001-5251-0967; Dubina, Michael/0000-0002-6606-3309; Nakano, Satoko/0000-0003-4016-7676; Zarnowski, Tomasz/0000-0002-6978-7417; Zenkel, Matthias/0000-0003-0141-120X; Giessl, Andreas/0000-0002-9768-2049; Orr, Andrew/0000-0002-9388-9034; Popa-Cherecheanu, Alina/0000-0003-4189-6571; Wang, Zhenxun/0000-0002-7862-4636; Chen, Shuwen/0000-0003-1245-1469; Fernandez-Vega Cueto Felgueroso, Luis/0000-0001-9197-5847; Tam, Wai Leong/0000-0003-2365-5264; Martinon-Torres, Federico/0000-0002-9023-581X; Li, Zheng/0000-0002-7060-2213	National Research Foundation of Singapore [NRF-NRFI2018-01]; US National Eye Institute of the National Institutes of Health [R01 EY020928, P30 EY014104, UM1 CA186107, U01 CA167552, EY015473]; Glaucoma Research Foundation of Canada [X052, CIRG17may053]; National Medical Research Council of Singapore	National Research Foundation of Singapore(National Research Foundation, Singapore); US National Eye Institute of the National Institutes of Health; Glaucoma Research Foundation of Canada; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	The study was funded by grant NRF-NRFI2018-01 from the National Research Foundation of Singapore. Additional support was provided by grants R01 EY020928, P30 EY014104, UM1 CA186107, U01 CA167552, and EY015473 from the US National Eye Institute of the National Institutes of Health, funding from the Glaucoma Research Foundation of Canada, and grants X052 and CIRG17may053 from the National Medical Research Council of Singapore.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrikopoulos GK, 2014, WORLD J CARDIOL, V6, P847, DOI 10.4330/wjc.v6.i8.847; Aung T, 2017, NAT GENET, V49, P993, DOI 10.1038/ng.3875; Choi SH, 2018, JAMA-J AM MED ASSOC, V320, P2354, DOI 10.1001/jama.2018.18179; Chung HL, 2018, CAN J OPHTHALMOL, V53, P365, DOI 10.1016/j.jcjo.2017.10.039; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Curcio CA, 2009, METHODS MOL BIOL, V580, P267, DOI 10.1007/978-1-60761-325-1_15; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Estrada K, 2014, JAMA-J AM MED ASSOC, V311, P2305, DOI 10.1001/jama.2014.6511; Farhan SMK, 2019, NAT NEUROSCI, V22, P1966, DOI 10.1038/s41593-019-0530-0; Flannick J, 2019, NATURE, V570, P71, DOI 10.1038/s41586-019-1231-2; Flannick J, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1142-5; Germain M, 2013, NAT GENET, V45, P518, DOI 10.1038/ng.2581; Kathiresan S, 2015, J AM COLL CARDIOL, V65, P1562, DOI 10.1016/j.jacc.2015.02.049; Khera AV, 2017, JAMA-J AM MED ASSOC, V317, P937, DOI 10.1001/jama.2017.0972; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Nazarali S, 2018, BRIT J OPHTHALMOL, V102, P1342, DOI 10.1136/bjophthalmol-2017-311321; Okada Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03274-0; Orr A C, 2001, Ophthalmic Genet, V22, P171, DOI 10.1076/opge.22.3.171.2223; Povysil G, 2019, NAT REV GENET, V20, P747, DOI 10.1038/s41576-019-0177-4; Sharma S, 2009, EXP EYE RES, V89, P479, DOI 10.1016/j.exer.2009.05.001; Stiles AR, 2014, P NATL ACAD SCI USA, V111, pE4006, DOI 10.1073/pnas.1413561111; Sun MY, 2016, NEUROSCIENTIST, V22, P132, DOI 10.1177/1073858414568122; Teekhasaenee C, 2016, OPHTHALMOLOGY, V123, P2328, DOI 10.1016/j.ophtha.2016.07.030; Zenkel Matthias, 2014, J Glaucoma, V23, pS12, DOI 10.1097/IJG.0000000000000123	31	8	8	3	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					753	764		10.1001/jama.2021.0507	http://dx.doi.org/10.1001/jama.2021.0507			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620406	Green Published, Bronze			2022-12-28	WOS:000621957400024
J	Rubin, R				Rubin, Rita			Collecting Data About COVID-19-Related Brain Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					712	712		10.1001/jama.2021.0791	http://dx.doi.org/10.1001/jama.2021.0791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620387	Bronze			2022-12-28	WOS:000621957400003
J	Peters, A; Nawrot, TS; Baccarelli, AA				Peters, Annette; Nawrot, Tim S.; Baccarelli, Andrea A.			Hallmarks of environmental insults	CELL			English	Review							PARTICULATE AIR-POLLUTION; MITOCHONDRIAL-DNA CONTENT; OXIDATIVE STRESS; RELATIVE-HUMIDITY; SKIN MICROBIOTA; METHYLATION AGE; EXPOSURE; TEMPERATURE; IMMUNITY; HEALTH	Environmental insults impair human health around the world. Contaminated air, water, soil, food, and occupational and household settings expose humans of all ages to a plethora of chemicals and environmental stressors. We propose eight hallmarks of environmental insults that jointly underpin the damaging impact of environmental exposures during the lifespan. Specifically, they include oxidative stress and inflammation, genomic alterations and mutations, epigenetic alterations, mitochondrial dysfunction, endocrine disruption, altered intercellular communication, altered microbiome communities, and impaired nervous system function. They provide a framework to understand why complex mixtures of environmental exposures induce severe health effects even at relatively modest concentrations.	[Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Peters, Annette] Ludwig Maximilians Univ Munchen, Med Fac, Inst Med Informat Proc Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany; [Peters, Annette] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Nawrot, Tim S.] Hasselt Univ, Ctr Environm Sci, Hasselt, Belgium; [Nawrot, Tim S.] Leuven Univ, Environm & Hlth Unit, Leuven, Belgium; [Baccarelli, Andrea A.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Harvard University; Harvard T.H. Chan School of Public Health; Hasselt University; KU Leuven; Columbia University	Peters, A (corresponding author), Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany.; Peters, A (corresponding author), Ludwig Maximilians Univ Munchen, Med Fac, Inst Med Informat Proc Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany.; Peters, A (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	peters@helmholtz-muenchen.de	Peters, Annette/A-6117-2011	Peters, Annette/0000-0001-6645-0985; Nawrot, Tim/0000-0002-3583-3593	European Union's Horizon 2020 research and innovation program [874627]; Flemish Research Fund, Belgium [G048420N]; National Institute of Environmental Health Sciences, National Institutes of Health, USA [P30009089, R01ES025225, R01ES032638]	European Union's Horizon 2020 research and innovation program; Flemish Research Fund, Belgium; National Institute of Environmental Health Sciences, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Regina Pickford, Helmholtz Zentrum Munchen, for her comments to the initial and revised manuscript. A.P. has received funding for this work from the European Union's Horizon 2020 research and innovation program under grant agreement no. 874627, T.S.N. is currently funded by the Flemish Research Fund, Belgium (G048420N), and A.A.B.'s work on this review was supported by funding from the National Institute of Environmental Health Sciences, National Institutes of Health, USA (P30009089, R01ES025225, R01ES032638).	Abraham E, 2018, ENVIRON INT, V118, P334, DOI 10.1016/j.envint.2018.05.007; Alkoussa S, 2020, CRIT REV TOXICOL, V50, P402, DOI 10.1080/10408444.2020.1763252; [Anonymous], 2005, PREV CHRON DIS VIT I; Babisch W, 2011, NOISE HEALTH, V13, P201, DOI 10.4103/1463-1741.80148; Baccarelli A, 2000, J ENDOCRINOL INVEST, V23, P771, DOI 10.1007/BF03345069; Balmain A, 2020, NAT GENET, V52, P1139, DOI 10.1038/s41588-020-00727-5; Barouki R, 2021, ENVIRON INT, V146, DOI 10.1016/j.envint.2020.106272; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Bijnens EM, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2105-y; Bind MA, 2014, EPIDEMIOLOGY, V25, P561, DOI 10.1097/EDE.0000000000000120; Bollati V, 2015, J APPL TOXICOL, V35, P59, DOI 10.1002/jat.2987; Bratman GN, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0903; Breton CV, 2019, MITOCHONDRION, V46, P22, DOI 10.1016/j.mito.2019.04.001; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Byun HM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-18; Calderon-Garciduenas L, 2019, J ALZHEIMERS DIS, V70, P341, DOI 10.3233/JAD-190331; Chen YE, 2018, NATURE, V553, P427, DOI 10.1038/nature25177; Chi L, 2018, MAMM GENOME, V29, P63, DOI 10.1007/s00335-018-9736-9; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/S0140-6736(17)30505-6, 10.1016/s0140-6736(17)30505-6]; Conrad M, 2019, NAT CHEM BIOL, V15, P1137, DOI 10.1038/s41589-019-0408-1; Corvalan, 2016, PREVENTING DIS HLTH; Cox B, 2016, J EPIDEMIOL COMMUN H, V70, P1191, DOI 10.1136/jech-2015-206384; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; De Weerdt A, 2020, INTENS CARE MED, V46, P1204, DOI 10.1007/s00134-020-05999-3; Dhingra R, 2018, CURR ENV HLTH REP, V5, P317, DOI 10.1007/s40572-018-0203-2; Dorrington MG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00705; Fafian-Labora JA, 2020, TRENDS CELL BIOL, V30, P628, DOI 10.1016/j.tcb.2020.05.003; Feng FF, 2016, ENVIRON TOXICOL, V31, P2016, DOI 10.1002/tox.22202; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gao X, 2019, ENVIRON INT, V126, P395, DOI 10.1016/j.envint.2019.02.053; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Ghio AJ, 2012, J TOXICOL ENV HEAL B, V15, P1, DOI 10.1080/10937404.2012.632359; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Ijomone OM, 2020, NEUROTOXICOLOGY, V81, P51, DOI 10.1016/j.neuro.2020.08.005; Jaiswal S, 2020, NAT REV CARDIOL, V17, P137, DOI 10.1038/s41569-019-0247-5; Janssen BG, 2017, ENVIRON HEALTH PERSP, V125, P699, DOI 10.1289/EHP508; Janssen BG, 2012, ENVIRON HEALTH PERSP, V120, P1346, DOI 10.1289/ehp.1104458; Jiang C, 2018, CELL, V175, P277, DOI 10.1016/j.cell.2018.08.060; Kim Minhoo, 2020, Transl Med Aging, V4, P103; Kleinstreuer NC, 2014, NAT BIOTECHNOL, V32, P583, DOI 10.1038/nbt.2914; Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0; Lappalainen T, 2017, NAT REV GENET, V18, P441, DOI 10.1038/nrg.2017.32; Lind PM, 2018, ENVIRON INT, V113, P109, DOI 10.1016/j.envint.2018.01.019; Liu CQ, 2015, AM J PHYSIOL-HEART C, V309, pH1793, DOI 10.1152/ajpheart.00199.2015; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lunn RM, 2017, SCI TOTAL ENVIRON, V607, P1073, DOI 10.1016/j.scitotenv.2017.07.056; Madden CJ, 2019, NEUROSCI LETT, V696, P225, DOI 10.1016/j.neulet.2018.11.027; Marioni RE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0584-6; Martens DS, 2019, ENVIRON HEALTH PERSP, V127, DOI 10.1289/EHP5153; Martens DS, 2017, JAMA PEDIATR, V171, P1160, DOI 10.1001/jamapediatrics.2017.3024; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Messerlian C, 2017, NAT REV ENDOCRINOL, V13, P740, DOI 10.1038/nrendo.2017.81; Mudway IS, 2020, FREE RADICAL BIO MED, V151, P2, DOI 10.1016/j.freeradbiomed.2020.04.031; Munzel T, 2017, EUR HEART J, V38, P557, DOI 10.1093/eurheartj/ehw294; Mutlu EA, 2018, ENVIRON POLLUT, V240, P817, DOI 10.1016/j.envpol.2018.04.130; Neven KY, 2018, LANCET PLANET HEALTH, V2, pE174, DOI 10.1016/s2542-5196(18)30049-4; Nieuwenhuijsen MJ, 2020, ENVIRON INT, V140, DOI 10.1016/j.envint.2020.105661; Nieuwenhuijsen MJ, 2018, NAT REV CARDIOL, V15, P432, DOI 10.1038/s41569-018-0003-2; Nowarski R, 2017, CELL, V168, P362, DOI 10.1016/j.cell.2016.11.040; Nwanaji-Enwerem JC, 2018, AGEING RES REV, V45, P15, DOI 10.1016/j.arr.2018.04.005; Nwanaji-Enwerem JC, 2016, ENVIRON EPIGENETICS, V2, DOI 10.1093/eep/dvw006; Panagiotou N, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7080110; Peters A, 2006, PART FIBRE TOXICOL, V3, DOI 10.1186/1743-8977-3-13; Pieters N, 2016, ENVIRON HEALTH PERSP, V124, P943, DOI 10.1289/ehp.1509728; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Ryu HW, 2015, TOX RESEARCH, V31, P1, DOI 10.5487/TR.2015.31.1.001; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Sattler C, 2017, PART FIBRE TOXICOL, V14, DOI 10.1186/s12989-016-0181-1; Schneider Alexandra, 2017, Curr Environ Health Rep, V4, P21, DOI 10.1007/s40572-017-0129-0; Shaughnessy DT, 2014, ENVIRON HEALTH PERSP, V122, P1271, DOI 10.1289/ehp.1408418; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Smits HH, 2016, CURR OPIN IMMUNOL, V42, P41, DOI 10.1016/j.coi.2016.05.009; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Stefanovic N, 2020, ALLERGY, V75, P63, DOI 10.1111/all.13946; Stone V, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP424; Sun LY, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040211; Suwanpradid J, 2017, J INVEST DERMATOL, V137, P288, DOI 10.1016/j.jid.2016.08.013; Thurston GD, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00419-2016; Tost H, 2019, NAT NEUROSCI, V22, P1389, DOI 10.1038/s41593-019-0451-y; Touitou Y, 2020, ENVIRON RES, V190, DOI 10.1016/j.envres.2020.109942; Tumolo MR, 2022, INT J ENVIRON HEAL R, V32, P332, DOI 10.1080/09603123.2020.1757043; United Nations Department of Economic and Social Affairs Population Division, 2019, WORLD POP AG, DOI DOI 10.18356/9DF3CAED-EN; van den Bosch M, 2019, ANNU REV PUBL HEALTH, V40, P239, DOI 10.1146/annurev-publhealth-040218-044106; Vermeulen R, 2020, SCIENCE, V367, P392, DOI 10.1126/science.aay3164; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Ward-Caviness CK, 2016, ONCOTARGET, V7, P74510, DOI 10.18632/oncotarget.12903; Watts N, 2019, LANCET, V394, P1836, DOI 10.1016/S0140-6736(19)32596-6; World Health Organization, 2013, STATE SCI ENDOCRINE; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Yin RC, 2017, ACS CHEM BIOL, V12, P1494, DOI 10.1021/acschembio.7b00261; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	101	67	67	20	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2021	184	6					1455	1468		10.1016/j.cell.2021.01.043	http://dx.doi.org/10.1016/j.cell.2021.01.043		MAR 2021	14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QY9LN	33657411	Bronze, Green Accepted			2022-12-28	WOS:000630357400012
J	Mahase, E				Mahase, Elisabeth			NHS England agrees deal for gene therapy for spinal muscular atrophy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2021	372								n653	10.1136/bmj.n653	http://dx.doi.org/10.1136/bmj.n653			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6RV	33685863				2022-12-28	WOS:000632926700005
J	Normile, D				Normile, Dennis			NUCLEAR MEDICINE	SCIENCE			English	Editorial Material																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					978	982						5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674477				2022-12-28	WOS:000625876100020
J	Epp, R; Malcolm, J; Jolin-Dahel, K; Clermont, M; Keely, E				Epp, Riley; Malcolm, Janine; Jolin-Dahel, Khiera; Clermont, Michaela; Keely, Erin			Postpartum thyroiditis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Epp, Riley; Malcolm, Janine; Keely, Erin] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Epp, Riley; Malcolm, Janine; Keely, Erin] Ottawa Hosp, Div Endocrinol & Metab, Ottawa, ON, Canada; [Jolin-Dahel, Khiera] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Keely, E (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON, Canada.; Keely, E (corresponding author), Ottawa Hosp, Div Endocrinol & Metab, Ottawa, ON, Canada.	Ekeely@toh.ca						Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; AMINO N, 1982, NEW ENGL J MED, V306, P849, DOI 10.1056/NEJM198204083061405; Andersen SL, 2015, J CLIN ENDOCR METAB, V100, P1164, DOI 10.1210/jc.2014-3588; Azizi F, 2005, EUR J ENDOCRINOL, V153, P367, DOI 10.1530/eje.1.01976; Bartalena L, 2013, NAT REV ENDOCRINOL, V9, P724, DOI 10.1038/nrendo.2013.193; Benveng S, 2019, J CLIN TRANSL ENDOCR, V15, P12, DOI 10.1016/j.jcte.2018.11.004; Benvenga S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00220; Bergink V, 2018, PSYCHOL MED, V48, P1291, DOI 10.1017/S0033291717002732; Caixas A, 1999, J CLIN ENDOCR METAB, V84, P4000, DOI 10.1210/jc.84.11.4000; Davanzo R, 2008, ARCH DIS CHILD-FETAL, V93, pF249, DOI 10.1136/adc.2007.135764; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Elefsiniotis IS, 2008, J CLIN VIROL, V41, P318, DOI 10.1016/j.jcv.2007.12.010; Galofre JC, 2010, THYROID, V20, P901, DOI 10.1089/thy.2009.0391; GERSTEIN HC, 1993, ANN INTERN MED, V118, P419, DOI 10.7326/0003-4819-118-6-199303150-00004; Groer M, 2014, J THROID RES, V2014, DOI 10.1155/2014/531969; Groer MW, 2013, JOGNN-J OBST GYN NEO, V42, pE26, DOI 10.1111/j.1552-6909.2012.01425.x; HAYSLIP CC, 1988, AM J OBSTET GYNECOL, V159, P203, DOI 10.1016/0002-9378(88)90522-4; HIDAKA Y, 1994, CLIN ENDOCRINOL, V41, P15, DOI 10.1111/j.1365-2265.1994.tb03778.x; Ide A, 2014, THYROID, V24, P1027, DOI 10.1089/thy.2013.0585; Joshi J V, 1993, J Postgrad Med, V39, P137; Keely EJ, 2011, OBSTET MED, V4, P7, DOI 10.1258/om.2010.100041; Kita M, 2002, J ENDOCRINOL INVEST, V25, P513, DOI 10.1007/BF03345493; Kuijpens JL, 1998, EUR J ENDOCRINOL, V139, P36, DOI 10.1530/eje.0.1390036; Kuijpens JL, 2001, EUR J ENDOCRINOL, V145, P579, DOI 10.1530/eje.0.1450579; Lazarus JH, 1999, THYROID, V9, P685, DOI 10.1089/thy.1999.9.685; Le Donne M, 2012, PSYCHONEUROENDOCRINO, V37, P519, DOI 10.1016/j.psyneuen.2011.08.001; Li CY, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/8871951; Lucas A, 2005, THYROID, V15, P1177, DOI 10.1089/thy.2005.15.1177; Maleki N, 2015, DIABETIC MED, V32, P206, DOI 10.1111/dme.12580; Marqusee E, 1997, J CLIN ENDOCR METAB, V82, P2455, DOI 10.1210/jc.82.8.2455; Moleti M, 2020, J CLIN ENDOCR METAB, V105, pE2421, DOI 10.1210/clinem/dgaa197; National Guideline Centre (UK), 2019, THYR DIS ASS MAN NIC; National Institute for Health and Care Excellence, 2020, HYP SCEN POSTP; Nguyen CT, 2019, CLIN OBSTET GYNECOL, V62, P359, DOI 10.1097/GRF.0000000000000430; Premawardhana LDKE, 2000, J CLIN ENDOCR METAB, V85, P71, DOI 10.1210/jc.85.1.71; Rotondi M, 2008, EUR J ENDOCRINOL, V159, P161, DOI 10.1530/EJE-08-0236; Sergi M, 2015, CLIN ENDOCRINOL, V83, P389, DOI 10.1111/cen.12604; Speller Elisabeth, 2012, Breastfeed Rev, V20, P41; Stagnaro-Green A, 2011, LUPUS, V20, P690, DOI 10.1177/0961203310394894; Stagnaro-Green A, 2002, J CLIN ENDOCR METAB, V87, P4042, DOI 10.1210/jc.2002-020524; Stagnaro-Green A, 2000, ENDOCRIN METAB CLIN, V29, P417, DOI 10.1016/S0889-8529(05)70140-7; Stagnaro-Green A, 2012, J CLIN ENDOCR METAB, V97, P334, DOI 10.1210/jc.2011-2576; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; WALFISH PG, 1992, J ENDOCRINOL INVEST, V15, P265, DOI 10.1007/BF03348726; Weetman AP, 2010, NAT REV ENDOCRINOL, V6, P311, DOI 10.1038/nrendo.2010.46	45	2	3	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2021	372								n495	10.1136/bmj.n495	http://dx.doi.org/10.1136/bmj.n495			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6OT	33658175				2022-12-28	WOS:000632918700001
J	Voelker, R				Voelker, Rebecca			Import Alert on Hand Sanitizers From South of the Border	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					816	816		10.1001/jama.2021.1934	http://dx.doi.org/10.1001/jama.2021.1934			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651078				2022-12-28	WOS:000625843100024
J	[Anonymous]				[Anonymous]			Monthly Injection Is Approved for Patients With HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					816	816		10.1001/jama.2021.1932	http://dx.doi.org/10.1001/jama.2021.1932			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651077				2022-12-28	WOS:000625843100022
J	Karagiannis, T; Tsapas, A; Bekiari, E				Karagiannis, Thomas; Tsapas, Apostolos; Bekiari, Eleni			KDIGO made 12 recommendations for managing diabetes with CKD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Karagiannis, Thomas; Tsapas, Apostolos; Bekiari, Eleni] Aristotle Univ Thessaloniki, Thessaloniki, Greece	Aristotle University of Thessaloniki	Karagiannis, T (corresponding author), Aristotle Univ Thessaloniki, Thessaloniki, Greece.		Karagiannis, Thomas/H-9476-2019	Karagiannis, Thomas/0000-0001-5242-0574; Bekiari, Eleni/0000-0001-9975-3835				Heerspink HJL, 2020, NEW ENGL J MED, V383, P1436, DOI 10.1056/NEJMoa2024816; Kristensen SL, 2019, LANCET DIABETES ENDO, V7, P776, DOI 10.1016/S2213-8587(19)30249-9; Laine C, 2020, ANN INTERN MED, V173, P153, DOI 10.7326/M20-2627; Neuen BL, 2019, LANCET DIABETES ENDO, V7, P845, DOI 10.1016/S2213-8587(19)30256-6; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X	6	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC26	JC26		10.7326/ACPJ202103160-026	http://dx.doi.org/10.7326/ACPJ202103160-026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646846				2022-12-28	WOS:000669667000001
J	Topol, EJ				Topol, Eric J.			What's lurking in your electrocardiogram?	LANCET			English	Editorial Material									[Topol, Eric J.] Scripps Res Translat Inst, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Topol, EJ (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.; Topol, EJ (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	etopol@scripps.edu		Topol, Eric/0000-0002-1478-4729	US National Institutes of Health/National Center for Advancing Translational Sciences [UL1TR001114]	US National Institutes of Health/National Center for Advancing Translational Sciences	EJT is supported by the US National Institutes of Health/National Center for Advancing Translational Sciences grant UL1TR001114		0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					785	785						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640054	Green Published			2022-12-28	WOS:000623925500015
J	Brannan, SK; Sawchak, S; Miller, AC; Lieberman, JA; Paul, SM; Breier, A				Brannan, Stephen K.; Sawchak, Sharon; Miller, Andrew C.; Lieberman, Jeffrey A.; Paul, Steven M.; Breier, Alan			Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							XANOMELINE; HYPOTHESIS	BACKGROUND The muscarinic receptor agonist xanomeline has antipsychotic properties and is devoid of dopamine receptor-blocking activity but causes cholinergic adverse events. Trospium is a peripherally restricted muscarinic receptor antagonist that reduces peripheral cholinergic effects of xanomeline. The efficacy and safety of combined xanomeline and trospium in patients with schizophrenia are unknown. METHODS In this double-blind, phase 2 trial, we randomly assigned patients with schizophrenia in a 1:1 ratio to receive twice-daily xanomeline-trospium (increased to a maximum of 125 mg of xanomeline and 30 mg of trospium per dose) or placebo for 5 weeks. The primary end point was the change from baseline to week 5 in the total score on the Positive and Negative Syndrome Scale (PANSS; range, 30 to 210, with higher scores indicating more severe symptoms of schizophrenia). Secondary end points were the change in the PANSS positive symptom subscore, the score on the Clinical Global Impression-Severity (CGI-S) scale (range, 1 to 7, with higher scores indicating greater severity of illness), the change in the PANSS negative symptom subscore, the change in the PANSS Marder negative symptom subscore, and the percentage of patients with a response according to a CGI-S score of 1 or 2. RESULTS A total of 182 patients were enrolled, with 90 assigned to receive xanomeline-trospium and 92 to receive placebo. The PANSS total score at baseline was 97.7 in the xanomeline-trospium group and 96.6 in the placebo group. The change from baseline to week 5 was -17.4 points with xanomeline-trospium and -5.9 points with placebo (least-squares mean difference, -11.6 points; 95% confidence interval, -16.1 to -7.1; P<0.001). The results for the secondary end points were significantly better in the xanomeline-trospium group than in the placebo group, with the exception of the percentage of patients with a CGI-S response. The most common adverse events in the xanomeline-trospium group were constipation, nausea, dry mouth, dyspepsia, and vomiting. The incidences of somnolence, weight gain, restlessness, and extrapyramidal symptoms were similar in the two groups. CONCLUSIONS In a 5-week trial, xanomeline-trospium resulted in a greater decrease in the PANSS total score than placebo but was associated with cholinergic and anticholinergic adverse events. Larger and longer trials are required to determine the efficacy and safety of xanomeline-trospium in patients with schizophrenia.	[Brannan, Stephen K.; Sawchak, Sharon; Miller, Andrew C.; Paul, Steven M.] Karuna Therapeut, 33 Arch St,Suite 3110, Boston, MA 02110 USA; [Lieberman, Jeffrey A.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA; [Breier, Alan] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Columbia University; Indiana University System; Indiana University Bloomington	Brannan, SK (corresponding author), Karuna Therapeut, 33 Arch St,Suite 3110, Boston, MA 02110 USA.	steve@karunatx.com			Karuna Therapeutics; Wellcome Trust [208970/Z/17/Z]	Karuna Therapeutics; Wellcome Trust(Wellcome Trust)	Supported by Karuna Therapeutics and the Wellcome Trust (award 208970/Z/17/Z).	Agid O, 2013, AM J PSYCHIAT, V170, P1335, DOI 10.1176/appi.ajp.2013.12030315; [Anonymous], 2013, DIAGNOSTIC STAT MANU, V5; [Anonymous], 2012, SANCTURA TROSPIUM CH; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Brannan SK, 2017, AM SOC CLIN PSYCH AN; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Crook JM, 1999, LIFE SCI, V64, P1761, DOI 10.1016/S0024-3205(99)00114-9; Erskine D, 2019, DRUG DISCOV TODAY, V24, P2307, DOI 10.1016/j.drudis.2019.08.009; Felder CC, 2000, J MED CHEM, V43, P4333, DOI 10.1021/jm990607u; Ghoshal A, 2016, NEUROPSYCHOPHARMACOL, V41, P598, DOI 10.1038/npp.2015.189; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; Huhn M, 2019, LANCET, V394, P939, DOI [10.1016/S0140-6736(19)31135-3, 10.1176/appi.focus.18306]; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lieberman JA, 2018, NEW ENGL J MED, V379, P270, DOI 10.1056/NEJMra1801490; Marder SR, 1997, J CLIN PSYCHIAT, V58, P538, DOI 10.4088/JCP.v58n1205; Marder SR, 2019, NEW ENGL J MED, V381, P1753, DOI 10.1056/NEJMra1808803; Paul SM, 2018, SESS 1 AM COLL NEUR; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Raedler TJ, 2007, MOL PSYCHIATR, V12, P232, DOI 10.1038/sj.mp.4001924; Raedler TJ, 2003, AM J PSYCHIAT, V160, P118, DOI 10.1176/appi.ajp.160.1.118; Rutherford BR, 2014, JAMA PSYCHIAT, V71, P1409, DOI 10.1001/jamapsychiatry.2014.1319; SHANNON HE, 1994, J PHARMACOL EXP THER, V269, P271; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; SIMPSON GM, 1970, ACTA PSYCHIAT SCAND, P11; Staskin D, 2010, INT J CLIN PRACT, V64, P1294, DOI 10.1111/j.1742-1241.2010.02433.x; Thorn CA, 2019, ACS CHEM NEUROSCI, V10, P3910, DOI 10.1021/acschemneuro.9b00335	31	52	52	7	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					717	726		10.1056/NEJMoa2017015	http://dx.doi.org/10.1056/NEJMoa2017015			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP4LK	33626254	Green Accepted, Bronze			2022-12-28	WOS:000623807600011
J	Dyer, C				Dyer, Clare			Covid-19: Judge caps costs that campaigners will have to pay for PPE court action	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n511; IACOBUCCI G, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4474	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n566	10.1136/bmj.n566	http://dx.doi.org/10.1136/bmj.n566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632788	Bronze			2022-12-28	WOS:000624298000006
J	Vaughan, J; Levi, M				Vaughan, Jenny; Levi, Marcel			Should NHS managers be regulated like doctors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Vaughan, Jenny] Doctors Assoc, London, England; [Levi, Marcel] Univ Coll London Hosp, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Vaughan, J (corresponding author), Doctors Assoc, London, England.; Levi, M (corresponding author), Univ Coll London Hosp, London, England.	jenny.vaughan@nhs.net; marcel.levi@nhs.net						Committee on Standards in Public Life, 1995, GUID 7 PRINC PUBL LI; Department of Health and Social Care, 2019, KARK REV FIT PROP PE; Francis R., 2013, REP MIDST NHS FDN TR; IACOBUCCI G, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F856; Kirby R., 2017, TRENDS UROL MEN HLTH; NHS, 2019, NHS OV FRAM 2019 20; RIMMER A, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J2055; Smith R, 1998, BRIT MED J, V317, P1539, DOI 10.1136/bmj.317.7172.1539; Vincent C, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m760	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2021	372								m4909	10.1136/bmj.m4909	http://dx.doi.org/10.1136/bmj.m4909			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8SP	33622694				2022-12-28	WOS:000623407800008
J	Tanzi, L; Maloberti, JG; Biagioni, G; Fioretti, A; Gabbanini, C; Modugno, G				Tanzi, L.; Maloberti, J. G.; Biagioni, G.; Fioretti, A.; Gabbanini, C.; Modugno, G.			Evidence of superfluidity in a dipolar supersolid from nonclassical rotational inertia	SCIENCE			English	Article								A key manifestation of superfluidity in liquids and gases is a reduction of the moment of inertia under slow rotations. Nonclassical rotational effects have also been considered in the context of the elusive supersolid phase of matter, in which superfluidity coexists with a lattice structure. Here, we show that the recently discovered supersolid phase in dipolar quantum gases features a reduced moment of inertia. Using a dipolar gas of dysprosium atoms, we studied a peculiar rotational oscillation mode in a harmonic potential, the scissors mode, previously investigated in ordinary superfluids. From the measured moment of inertia, we deduced a superfluid fraction that is different from zero and of order of unity, providing direct evidence of the superfluid nature of the dipolar supersolid.	[Tanzi, L.; Maloberti, J. G.; Biagioni, G.; Fioretti, A.; Gabbanini, C.; Modugno, G.] CNR INO, Sede Secondaria Pisa, I-56124 Pisa, Italy; [Tanzi, L.; Maloberti, J. G.; Biagioni, G.; Modugno, G.] Univ Firenze, LENS, I-50019 Sesto Fiorentino, Italy; [Tanzi, L.; Maloberti, J. G.; Biagioni, G.; Modugno, G.] Univ Firenze, Dipartimento Fis & Astron, I-50019 Sesto Fiorentino, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Florence; University of Florence	Modugno, G (corresponding author), CNR INO, Sede Secondaria Pisa, I-56124 Pisa, Italy.; Modugno, G (corresponding author), Univ Firenze, LENS, I-50019 Sesto Fiorentino, Italy.; Modugno, G (corresponding author), Univ Firenze, Dipartimento Fis & Astron, I-50019 Sesto Fiorentino, Italy.	modugno@lens.unifi.it	Modugno, Giovanni/AAT-9718-2021; Modugno, Giovanni/C-3179-2009; Tanzi, Luca/M-1809-2014	Modugno, Giovanni/0000-0002-4394-8593; Modugno, Giovanni/0000-0002-4394-8593; Tanzi, Luca/0000-0002-1933-5092; Biagioni, Giulio/0000-0001-7668-6027; Gabbanini, Carlo/0000-0002-8348-4041; Fioretti, Andrea/0000-0002-3503-5743	EC-H2020 research and innovation program [641122 - QUIC]	EC-H2020 research and innovation program	This work was supported by the EC-H2020 research and innovation program (grant no. 641122 - QUIC).	Aftalion A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.135301; ANDREEV AF, 1969, SOV PHYS JETP-USSR, V29, P1107; Bottcher F, 2019, PHYS REV RES, V1, DOI 10.1103/PhysRevResearch.1.033088; Bottcher F, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.011051; Chan MHW, 2013, J LOW TEMP PHYS, V172, P317, DOI 10.1007/s10909-013-0882-x; CHESTER GV, 1970, PHYS REV A, V2, P256, DOI 10.1103/PhysRevA.2.256; Chevy F, 2000, PHYS REV LETT, V85, P2223, DOI 10.1103/PhysRevLett.85.2223; Chomaz L, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.021012; Day J, 2007, NATURE, V450, P853, DOI 10.1038/nature06383; Edwards M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.070405; Eyal A, 2016, P NATL ACAD SCI USA, V113, pE3203, DOI 10.1073/pnas.1605738113; Ferrier-Barbut I, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.160402; FETTER AL, 1974, J LOW TEMP PHYS, V16, P533, DOI 10.1007/BF00654901; Giorgini S, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063615; Guery-Odelin D, 1999, PHYS REV LETT, V83, P4452, DOI 10.1103/PhysRevLett.83.4452; Guo M, 2019, NATURE, V574, P386, DOI 10.1038/s41586-019-1569-5; HAKONEN PJ, 1982, PHYS REV LETT, V48, P1838, DOI 10.1103/PhysRevLett.48.1838; Hechenblaikner G, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.070406; HESS GB, 1967, PHYS REV LETT, V19, P216, DOI 10.1103/PhysRevLett.19.216; Josserand C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195301; Kim DY, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.155301; Kim E, 2004, SCIENCE, V305, P1941, DOI 10.1126/science.1101501; Kim E, 2004, NATURE, V427, P225, DOI 10.1038/nature02220; Lagoudakis KG, 2008, NAT PHYS, V4, P706, DOI 10.1038/nphys1051; Leggett A. J, 2006, **DROPPED REF**, P20; LEGGETT AJ, 1970, PHYS REV LETT, V25, P1543, DOI 10.1103/PhysRevLett.25.1543; Leggett AJ, 1998, J STAT PHYS, V93, P927, DOI 10.1023/B:JOSS.0000033170.38619.6c; LOIUDICE N, 1978, PHYS REV LETT, V41, P1532, DOI 10.1103/PhysRevLett.41.1532; Lucioni E, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.060701; Marago O, 2001, PHYS REV LETT, V86, P3938, DOI 10.1103/PhysRevLett.86.3938; Marago OM, 2000, PHYS REV LETT, V84, P2056, DOI 10.1103/PhysRevLett.84.2056; MIGDAL AB, 1960, SOV PHYS JETP-USSR, V10, P176; Modugno M, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.023608; Natale G, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.050402; Nyeki J, 2017, NAT PHYS, V13, P455, DOI [10.1038/nphys4023, 10.1038/NPHYS4023]; POMEAU Y, 1994, PHYS REV LETT, V72, P2426, DOI 10.1103/PhysRevLett.72.2426; Rittner ASC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.165301; Roccuzzo SM, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.045702; Stringari S, 1996, PHYS REV LETT, V77, P2360, DOI 10.1103/PhysRevLett.77.2360; Tanzi L, 2019, NATURE, V574, P382, DOI 10.1038/s41586-019-1568-6; Tanzi L, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.130405; Tanzi L., 2020, **DATA OBJECT**, DOI [10.5281/zenodo.4288848, DOI 10.5281/ZENODO.4288848]; Tanzi L., 2020, **DATA OBJECT**, DOI [10.5281/zenodo.4288848, DOI 10.5281/ZENODO.4288848]; van Bijnen RMW, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.033612; Wright MJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150403; Zambelli F, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033602; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	47	24	24	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2021	371	6534					1162	+		10.1126/science.aba4309	http://dx.doi.org/10.1126/science.aba4309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY5RG	33602866	Bronze, Green Submitted			2022-12-28	WOS:000630096400036
J	Ghogawala, Z; Terrin, N; Dunbar, MR; Breeze, JL; Freund, KM; Kanter, AS; Mummaneni, PV; Bisson, EF; Barker, FG; Schwartz, JS; Harrop, JS; Magge, SN; Heary, RF; Fehlings, MG; Albert, TJ; Arnold, PM; Riew, KD; Steinmetz, MP; Wang, MC; Whitmore, RG; Heller, JG; Benzel, EC				Ghogawala, Zoher; Terrin, Norma; Dunbar, Melissa R.; Breeze, Janis L.; Freund, Karen M.; Kanter, Adam S.; Mummaneni, Praveen V.; Bisson, Erica F.; Barker, Fred G., II; Schwartz, J. Sanford; Harrop, James S.; Magge, Subu N.; Heary, Robert F.; Fehlings, Michael G.; Albert, Todd J.; Arnold, Paul M.; Riew, K. Daniel; Steinmetz, Michael P.; Wang, Marjorie C.; Whitmore, Robert G.; Heller, John G.; Benzel, Edward C.			Effect of Ventral vs Dorsal Spinal Surgery on Patient-Reported Physical Functioning in Patients With Cervical Spondylotic Myelopathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Question In patients with cervical spondylotic myelopathy, does a ventral surgical approach, compared with a dorsal surgical approach, improve patient-reported physical functioning at 1 year? Findings In this randomized clinical trial that included 163 patients, mean improvement in the Short Form 36 physical component summary score (range, 0-100) was 5.9 points in the ventral surgery group and 6.2 points in the dorsal surgery group at 1 year, a difference that was not statistically significant. Meaning Among patients with cervical spondylotic myelopathy undergoing cervical spinal surgery, a ventral approach did not significantly improve patient-reported physical functioning at 1 year compared with outcomes after a dorsal approach. This randomized trial compares the effects of ventral surgery (disk removal and fusion) vs dorsal surgery (laminectomy or laminoplasty) on patient-reported physical functioning 1 year after surgery among patients with multilevel cervical spondylotic myelopathy. Importance Cervical spondylotic myelopathy is the most common cause of spinal cord dysfunction worldwide. It remains unknown whether a ventral or dorsal surgical approach provides the best results. Objective To determine whether a ventral surgical approach compared with a dorsal surgical approach for treatment of cervical spondylotic myelopathy improves patient-reported physical functioning at 1 year. Design, Setting, and Participants Randomized clinical trial of patients aged 45 to 80 years with multilevel cervical spondylotic myelopathy enrolled at 15 large North American hospitals from April 1, 2014, to March 30, 2018; final follow-up was April 15, 2020. Interventions Patients were randomized to undergo ventral surgery (n = 63) or dorsal surgery (n = 100). Ventral surgery involved anterior cervical disk removal and instrumented fusion. Dorsal surgery involved laminectomy with instrumented fusion or open-door laminoplasty. Type of dorsal surgery (fusion or laminoplasty) was at surgeon's discretion. Main Outcomes and Measures The primary outcome was 1-year change in the Short Form 36 physical component summary (SF-36 PCS) score (range, 0 [worst] to 100 [best]; minimum clinically important difference = 5). Secondary outcomes included 1-year change in modified Japanese Orthopaedic Association scale score, complications, work status, sagittal vertical axis, health resource utilization, and 1- and 2-year changes in the Neck Disability Index and the EuroQol 5 Dimensions score. Results Among 163 patients who were randomized (mean age, 62 years; 80 [49%] women), 155 (95%) completed the trial at 1 year (80% at 2 years). All patients had surgery, but 5 patients did not receive their allocated surgery (ventral: n = 1; dorsal: n = 4). One-year SF-36 PCS mean improvement was not significantly different between ventral surgery (5.9 points) and dorsal surgery (6.2 points) (estimated mean difference, 0.3; 95% CI, -2.6 to 3.1; P = .86). Of 7 prespecified secondary outcomes, 6 showed no significant difference. Rates of complications in the ventral and dorsal surgery groups, respectively, were 48% vs 24% (difference, 24%; 95% CI, 8.7%-38.5%; P = .002) and included dysphagia (41% vs 0%), new neurological deficit (2% vs 9%), reoperations (6% vs 4%), and readmissions within 30 days (0% vs 7%). Conclusions and Relevance Among patients with cervical spondylotic myelopathy undergoing cervical spinal surgery, a ventral surgical approach did not significantly improve patient-reported physical functioning at 1 year compared with outcomes after a dorsal surgical approach.	[Ghogawala, Zoher; Dunbar, Melissa R.; Magge, Subu N.; Whitmore, Robert G.] Lahey Hosp & Med Ctr, Dept Neurosurg, Burlington, MA USA; [Terrin, Norma; Breeze, Janis L.; Freund, Karen M.] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Terrin, Norma; Breeze, Janis L.; Freund, Karen M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Kanter, Adam S.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburg, KS USA; [Mummaneni, Praveen V.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Bisson, Erica F.] Univ Utah, Sch Med, Dept Neurosurg, Clin Neurosci Ctr, Salt Lake City, UT USA; [Barker, Fred G., II] Massachusetts Gen Hosp, Brain Tumor Ctr, Boston, MA 02114 USA; [Schwartz, J. Sanford] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Harrop, James S.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Heary, Robert F.] Hackensack Meridian Sch Med, Dept Neurol Surg, Nutley, NJ USA; [Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Dept Surg, Toronto, ON, Canada; [Fehlings, Michael G.] Univ Hlth Network, Div Neurosurg, Krembil Neurosci Ctr, Toronto, ON, Canada; [Albert, Todd J.] Hosp Special Surg, Dept Orthoped Surg, 535 E 70th St, New York, NY 10021 USA; [Albert, Todd J.] Weill Cornell Med, Dept Neurosurg, New York, NY USA; [Arnold, Paul M.] Carle Fdn Hosp, Carle Neurosci Inst, Urbana, IL USA; [Riew, K. Daniel] Columbia Univ Irving Med Ctr, New York, NY USA; [Steinmetz, Michael P.; Benzel, Edward C.] Cleveland Clin Fdn, Neurosurg, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Wang, Marjorie C.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Heller, John G.] Emory Univ, Sch Med, Emory Orthopaed & Spine Ctr, Atlanta, GA USA	Lahey Hospital & Medical Center; Tufts University; Tufts Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco; Utah System of Higher Education; University of Utah; Harvard University; Massachusetts General Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Jefferson University; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cornell University; NewYork-Presbyterian Hospital; Cleveland Clinic Foundation; Medical College of Wisconsin; Emory University	Ghogawala, Z (corresponding author), Lahey Hosp Med Ctr, Dept Neurosurg, 41 Mall Rd, Burlington, MA 01805 USA.	zoher.ghogawala@lahey.org						Akter F, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00138; Badhiwala JH, 2020, NAT REV NEUROL, V16, P108, DOI 10.1038/s41582-019-0303-0; Badhiwala JH, 2018, SPINE J, V18, P2220, DOI 10.1016/j.spinee.2018.05.009; Bakhsheshian J, 2017, GLOB SPINE J, V7, P572, DOI 10.1177/2192568217699208; Birkmeyer NJO, 2002, SPINE, V27, P1361, DOI 10.1097/00007632-200206150-00020; Centers for Medicare & Medicaid Services, RES STAT DATA SYSTEM; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Coric D, 2006, J NEUROSURG-SPINE, V4, P31, DOI 10.3171/spi.2006.4.1.31; Fehlings MG, 2013, SPINE, V38, P2247, DOI 10.1097/BRS.0000000000000047; Ghogawala Z, 2007, SPINE, V32, P429, DOI 10.1097/01.brs.0000255068.94058.8a; Ghogawala Z, 2016, ANN SURG, V264, P81, DOI 10.1097/SLA.0000000000001483; Ghogawala Z, 2016, NEW ENGL J MED, V374, P1424, DOI 10.1056/NEJMoa1508788; Ghogawala Z, 2011, NEUROSURGERY, V68, P622, DOI 10.1227/NEU.0b013e31820777cf; Glassman Steven, 2006, Spine J, V6, P21, DOI 10.1016/j.spinee.2005.09.004; Heller JG, 2001, SPINE, V26, P1330, DOI 10.1097/00007632-200106150-00013; Henderson FC, 2005, NEUROSURGERY, V56, P1101, DOI 10.1227/01.NEU.0000157929.85251.7C; Highsmith JM, 2011, J NEUROSURG-SPINE, V14, P619, DOI 10.3171/2011.1.SPINE10206; Hillard Virany H, 2006, Spine J, V6, p242S, DOI 10.1016/j.spinee.2006.05.005; Huang RC, 2003, J SPINAL DISORD TECH, V16, P123, DOI 10.1097/00024720-200304000-00002; Hurwitz EE, 2017, ANESTHESIOLOGY, V126, P614, DOI 10.1097/ALN.0000000000001541; Institute of Medicine , APPENDIX C TABLE 5 1; Kato S, 2019, EUR SPINE J, V28, P1234, DOI 10.1007/s00586-019-05945-y; King JT, 2009, NEUROSURGERY, V65, P1011, DOI 10.1227/01.NEU.0000360347.10596.BD; Kurokawa R, 2015, NEUROL MED-CHIR, V55, P529, DOI 10.2176/nmc.ra.2014-0387; Kwon BK, 2007, NEUROSURGERY, V60, P118, DOI 10.1227/01.NEU.0000249222.57709.59; Lad SP, 2009, SURG NEUROL, V71, P66, DOI 10.1016/j.surneu.2008.02.045; Lau D, 2017, J NEUROSURG-SPINE, V27, P508, DOI 10.3171/2017.4.SPINE16831; Patil PG, 2005, NEUROSURGERY, V57, P753, DOI 10.1227/01.NEU.0000175729.79119.1d; Schriger DL, 2018, ANN EMERG MED, V71, P239, DOI 10.1016/j.annemergmed.2017.05.033; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009; Stewart TJ, 2007, NEUROSURGERY, V60, P143, DOI 10.1227/01.NEU.0000217015.96212.1B; Suda K, 2003, SPINE, V28, P1258, DOI 10.1097/00007632-200306150-00008; Suhonen R, 2008, QUAL LIFE RES, V17, P169, DOI 10.1007/s11136-007-9292-3; Tang JA, 2012, NEUROSURGERY, V71, P662, DOI 10.1227/NEU.0b013e31826100c9; Tetreault L, 2015, SPINE, V40, P1653, DOI 10.1097/BRS.0000000000001127; Wang MC, 2007, SPINE, V32, P342, DOI 10.1097/01.brs.0000254120.25411.ae; Ware JE, 2001, SF 36 PHYS MENTAL HL; Warren DT, 2013, INT J SPINE SURG, V7, DOI 10.1016/j.ijsp.2013.04.001; Witiw CD, 2017, SPINE J, V17, P15, DOI 10.1016/j.spinee.2016.10.015; Zaveri GR, 2019, INDIAN J ORTHOP, V53, P493, DOI 10.4103/ortho.IJOrtho_8_16	40	33	33	4	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					942	951		10.1001/jama.2021.1233	http://dx.doi.org/10.1001/jama.2021.1233			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687463	Green Published, Bronze			2022-12-28	WOS:000627899400016
J	Reijman, M; Eggerding, V; van Es, E; van Arkel, E; van den Brand, I; van Linge, J; Zijl, J; Waarsing, E; Bierma-Zeinstra, S; Meuffels, D				Reijman, Max; Eggerding, Vincent; van Es, Eline; van Arkel, Ewoud; van den Brand, Igor; van Linge, Joost; Zijl, Jacco; Waarsing, Erwin; Bierma-Zeinstra, Sita; Meuffels, Duncan			Early surgical reconstruction versus rehabilitation with elective delayed reconstruction for patients with anterior cruciate ligament rupture: COMPARE randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To assess whether a clinically relevant difference exists in patients' perceptions of symptoms, knee function, and ability to participate in sports over a period of two years after rupture of the anterior cruciate ligament (ACL) between two commonly used treatment regimens. DESIGN Open labelled, multicentre, parallel randomised controlled trial (COMPARE). SETTING Six hospitals in the Netherlands, between May 2011 and April 2016. PARTICIPANTS Patients aged 18 to 65 with an acute rupture of the ACL, recruited from six hospitals. Patients were evaluated at three, six, nine, 12, and 24 months. INTERVENTIONS 85 patients were randomised to early ACL reconstruction and 82 to rehabilitation followed by optional delayed ACL reconstruction after a three month period (primary non-operative treatment). MAIN OUTCOMES Patients' perceptions of symptoms, knee function, and ability to participate in sporting activities were assessed with the International Knee Documentation Committee score (optimum score 100) at each time point over 24 months. RESULTS Between May 2011 and April 2016, 167 patients were enrolled in the study and randomised to one of two treatments (mean age 31.3; 67 (40.%) women), and 163 (98%) completed the trial. In the rehabilitation and optional delayed ACL reconstruction group, 41 (50%) patients underwent reconstruction during follow-up. After 24 months, the early ACL reconstruction group had a significantly better (P=0.026) but not clinically relevant International Knee Documentation Committee score (84.7 v 79.4 (difference between groups 5.3, 95% confidence interval 0.6 to 9.9). After three months of follow-up, the International Knee Documentation Committee score was significantly better (P=0.002) for the rehabilitation and optional delayed ACL reconstruction group (difference between groups -9.3, -14.6 to -4.0). After nine months of follow-up, the difference in the International Knee Documentation Committee score changed in favour of the early ACL reconstruction group. After 12 months, differences between the groups were smaller. In the early ACL reconstruction group, four re-ruptures and three ruptures of the contralateral ACL occurred during follow-up versus two re-ruptures and one rupture of the contralateral ACL in the rehabilitation and optional delayed ACL reconstruction group. CONCLUSIONS In patients with acute rupture of the ACL, those who underwent early surgical reconstruction, compared with rehabilitation followed by elective surgical reconstruction, had improved perceptions of symptoms, knee function, and ability to participate in sports at the two year follow-up. This finding was significant (P=0.026) but the clinical importance is unclear. Interpretation of the results of the study should consider that 50% of the patients randomised to the rehabilitation group did not need surgical reconstruction.	[Reijman, Max; Eggerding, Vincent; van Es, Eline; Waarsing, Erwin; Bierma-Zeinstra, Sita; Meuffels, Duncan] Erasmus MC, Univ Med Ctr, Dept Orthopaed & Sports Med, Room NC-424,POB 2040, NL-3000 CA Rotterdam, Netherlands; [van Arkel, Ewoud] Haaglanden Med Ctr, Dept Orthopaed, The Hague, Netherlands; [van den Brand, Igor] Elisabeth Tweesteden Hosp, Dept Orthopaed, Tilburg, Netherlands; [van Linge, Joost] Reinier Graaf Gasthuis, Dept Orthopaed, Delft, Netherlands; [Zijl, Jacco] St Antonius Hosp, Dept Orthopaed, Nieuwegein, Netherlands; [Bierma-Zeinstra, Sita] Erasmus MC, Univ Med Ctr, Dept Gen Practice, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Haaglanden Medical Center; Elisabeth-TweeSteden Ziekenhuis (ETZ); Reinier de Graaf Hospital; St. Antonius Hospital Utrecht; Erasmus University Rotterdam; Erasmus MC	Reijman, M (corresponding author), Erasmus MC, Univ Med Ctr, Dept Orthopaed & Sports Med, Room NC-424,POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.reijman@erasmusmc.nl	Reijman, Max/AFO-6451-2022	Reijman, Max/0000-0001-6316-9629; van Es, Eline/0000-0001-5346-4237	ZonMw, a Dutch organisation for health research and care innovation	ZonMw, a Dutch organisation for health research and care innovation	A grant for the study was received from ZonMw, a Dutch organisation for health research and care innovation. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. EW and MR conducted and are responsible for the data analysis.	Abram SGF, 2019, AM J SPORT MED, V47, P2533, DOI 10.1177/0363546519861393; [Anonymous], 2018, VOORSTE KRUISBAND LE; Ardern CL, 2014, BRIT J SPORT MED, V48, P1543, DOI 10.1136/bjsports-2013-093398; Collins NJ, 2011, ARTHRIT CARE RES, V63, pS208, DOI 10.1002/acr.20632; Filbay SR, 2015, BRIT J SPORT MED, V49, P1033, DOI 10.1136/bjsports-2015-094864; Frobell RB, 2007, CONTEMP CLIN TRIALS, V28, P295, DOI 10.1016/j.cct.2006.10.002; Frobell RB, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f232; Frobell RB, 2010, NEW ENGL J MED, V363, P331, DOI 10.1056/NEJMoa0907797; Haverkamp D, 2006, AM J SPORT MED, V34, P1680, DOI 10.1177/0363546506288854; Herzog MM, 2018, SPORTS HEALTH, V10, P523, DOI 10.1177/1941738118803616; Irrgang JJ, 2001, AM J SPORT MED, V29, P600, DOI 10.1177/03635465010290051301; Lie MM, 2019, BRIT J SPORT MED, V53, P1162, DOI 10.1136/bjsports-2018-099751; Meuffels DE, 2012, ACTA ORTHOP, V83, P379, DOI 10.3109/17453674.2012.704563; Poulsen E, 2019, BRIT J SPORT MED, V53, P1454, DOI 10.1136/bjsports-2018-100022; Roos EM, 2011, CARTILAGE, V2, P122, DOI 10.1177/1947603510391084; Siebold R, 2008, ARTHROSCOPY, V24, P137, DOI 10.1016/j.arthro.2007.11.013; Sutherland K, 2019, ANZ J SURG, V89, P1151, DOI 10.1111/ans.15404; van Meer BL, 2015, BRIT J SPORT MED, V49, P975, DOI 10.1136/bjsports-2013-093258; van Meer BL, 2013, ARTHROSCOPY, V29, P701, DOI 10.1016/j.arthro.2012.12.015; van Yperen DT, 2018, AM J SPORT MED, V46, P1129, DOI 10.1177/0363546517751683; Weiler Richard, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208012; Zhang YY, 2020, CLIN J SPORT MED, V30, pE207, DOI 10.1097/JSM.0000000000000676	22	28	28	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2021	372								n375	10.1136/bmj.n375	http://dx.doi.org/10.1136/bmj.n375			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6QO	33687926	Green Published, hybrid			2022-12-28	WOS:000632923400001
J	Pinney, MM; Mokhtari, DA; Akiva, E; Yabukarski, F; Sanchez, DM; Liang, RB; Doukov, T; Martinez, TJ; Babbitt, PC; Herschlag, D				Pinney, Margaux M.; Mokhtari, Daniel A.; Akiva, Eyal; Yabukarski, Filip; Sanchez, David M.; Liang, Ruibin; Doukov, Tzanko; Martinez, Todd J.; Babbitt, Patricia C.; Herschlag, Daniel			Parallel molecular mechanisms for enzyme temperature adaptation	SCIENCE			English	Article							PSYCHROPHILE COLWELLIA-PSYCHRERYTHRAEA; EXTREMELY THERMOPHILIC EUBACTERIUM; ACTIVITY-STABILITY RELATIONSHIPS; THERMOSTABLE GLUCOSE-ISOMERASE; ESCHERICHIA-COLI THIOREDOXIN; PULLULANASE TYPE-I; HYPERTHERMOPHILIC ARCHAEON; BIOCHEMICAL-CHARACTERIZATION; GLUTAMATE-DEHYDROGENASE; PYROCOCCUS-FURIOSUS	The mechanisms that underly the adaptation of enzyme activities and stabilities to temperature are fundamental to our understanding of molecular evolution and how enzymes work. Here, we investigate the molecular and evolutionary mechanisms of enzyme temperature adaption, combining deep mechanistic studies with comprehensive sequence analyses of thousands of enzymes. We show that temperature adaptation in ketosteroid isomerase (KSI) arises primarily from one residue change with limited, local epistasis, and we establish the underlying physical mechanisms. This residue change occurs in diverse KSI backgrounds, suggesting parallel adaptation to temperature. We identify residues associated with organismal growth temperature across 1005 diverse bacterial enzyme families, suggesting widespread parallel adaptation to temperature. We assess the residue properties, molecular interactions, and interaction networks that appear to underly temperature adaptation.	[Pinney, Margaux M.; Mokhtari, Daniel A.; Yabukarski, Filip; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Akiva, Eyal; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94158 USA; [Akiva, Eyal; Babbitt, Patricia C.] Univ Calif San Francisco, Therapeut Sci & Quantitat Biosci Inst, San Francisco, CA 94158 USA; [Yabukarski, Filip] Chan Zuckerberg Biohub, San Francisco, CA 94110 USA; [Sanchez, David M.; Liang, Ruibin; Martinez, Todd J.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Sanchez, David M.; Liang, Ruibin; Martinez, Todd J.] SLAC Natl Accelerator Lab, Dept Photon Sci, Menlo Pk, CA 94025 USA; [Doukov, Tzanko] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Stanford University	Pinney, MM; Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Stanford ChEM H, Stanford, CA 94305 USA.	margauxp@stanford.edu; herschla@stanford.edu	Martinez, Todd/HDN-6985-2022; Martinez, Todd/F-4306-2010	Martinez, Todd/0000-0002-4798-8947; Mokhtari, Daniel/0000-0003-4206-9471; Pinney, Margaux/0000-0002-7735-5032; Doukov, Tzanko/0000-0001-8625-2572	National Science Foundation (NSF) [MCB-1714723]; National Institutes of Health (NIH) [R01 GM60595]; National Energy Research Scientific Computing Center (NERSC), a U.S. Department of Energy (DOE) Office of Science User Facility [DE-AC02-05CH11231]; FICUS program [503369]; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIH, National Institute of General Medical Sciences (NIGMS) [P41GM103393]; NSF; Stanford Medical Scientist Training Program; Stanford Interdisciplinary Graduate Fellowship; NSF Graduate Research Fellowship; Human Frontiers Postdoctoral Fellowship	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Energy Research Scientific Computing Center (NERSC), a U.S. Department of Energy (DOE) Office of Science User Facility; FICUS program; U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); NSF(National Science Foundation (NSF)); Stanford Medical Scientist Training Program; Stanford Interdisciplinary Graduate Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Human Frontiers Postdoctoral Fellowship	This work was funded by a National Science Foundation (NSF) grant (MCB-1714723) and a National Institutes of Health (NIH) grant (R01 GM60595). This research used resources of the National Energy Research Scientific Computing Center (NERSC), a U.S. Department of Energy (DOE) Office of Science User Facility operated under contract no. DE-AC02-05CH11231, as well as resources obtained from the FICUS program (https://jgi.doe.gov/user-programs/program-info/ficus-overview/), proposal 503369. Use of the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, is supported by the U.S. DOE, Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the NIH, National Institute of General Medical Sciences (NIGMS) (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. M.M.P. was supported by NSF Graduate Research and Gerald J. Lieberman Fellowships. D.A.M. was supported by the Stanford Medical Scientist Training Program and a Stanford Interdisciplinary Graduate Fellowship (anonymous donor) affiliated with Stanford ChEM-H. D.M.S. was supported by an NSF Graduate Research Fellowship. F.Y. was supported by a Human Frontiers Postdoctoral Fellowship.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alam SI, 2005, ENZYME MICROB TECH, V36, P824, DOI 10.1016/j.enzmictec.2005.01.011; Alberts IL, 1998, PROTEIN SCI, V7, P1700, DOI 10.1002/pro.5560070805; Altermark B, 2007, FEBS J, V274, P252, DOI 10.1111/j.1742-4658.2006.05580.x; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Aqvist J, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0051; Arcus VL, 2016, BIOCHEMISTRY-US, V55, P1681, DOI 10.1021/acs.biochem.5b01094; Arndt W., 2018, IEEE INT PAR DISTR P; Arnott MA, 2000, J MOL BIOL, V304, P657, DOI 10.1006/jmbi.2000.4240; Aurilia V, 2007, GENE, V397, P51, DOI 10.1016/j.gene.2007.04.004; Bae E, 2008, P NATL ACAD SCI USA, V105, P9594, DOI 10.1073/pnas.0800938105; Bauer MW, 1998, CURR OPIN BIOTECH, V9, P141, DOI 10.1016/S0958-1669(98)80106-7; Beaucamp N, 1997, PROTEIN SCI, V6, P2159; Bertoldo C, 1999, APPL ENVIRON MICROB, V65, P2084; Birolo L, 2000, EUR J BIOCHEM, V267, P2790, DOI 10.1046/j.1432-1327.2000.01299.x; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; BREITUNG J, 1992, EUR J BIOCHEM, V210, P971, DOI 10.1111/j.1432-1033.1992.tb17502.x; BRITTON KL, 1995, EUR J BIOCHEM, V229, P688, DOI 10.1111/j.1432-1033.1995.tb20515.x; BROWN SH, 1993, APPL ENVIRON MICROB, V59, P2614, DOI 10.1128/AEM.59.8.2614-2621.1993; BROWN SH, 1993, BIOTECHNOL BIOENG, V41, P878, DOI 10.1002/bit.260410907; Buchmann JP, 2019, BIOINFORMATICS, V35, P4511, DOI 10.1093/bioinformatics/btz385; BULLOCK TH, 1955, BIOL REV, V30, P311, DOI 10.1111/j.1469-185X.1955.tb01211.x; Burlacu-Miron S, 1998, J BIOL CHEM, V273, P19102, DOI 10.1074/jbc.273.30.19102; Cambi A, 2001, PROTEIN ENG, V14, P807, DOI 10.1093/protein/14.10.807; Can B, 2010, PROTEIN J, V29, P250, DOI 10.1007/s10930-010-9246-4; CANGANELLA F, 1994, APPL MICROBIOL BIOT, V42, P239, DOI 10.1007/s002530050244; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Charton, 2007, PROGR PHYS ORGANIC C, V13; Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901; Chen JM, 2000, J MOL BIOL, V303, P125, DOI 10.1006/jmbi.2000.4140; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng TC, 1999, PROTEIN SCI, V8, P2474; Chessa JP, 1999, CAN J MICROBIOL, V45, P452, DOI 10.1139/cjm-45-6-452; Chiuri R, 2009, BIOPHYS J, V96, P1586, DOI 10.1016/j.bpj.2008.11.017; CHUNG YC, 1995, APPL ENVIRON MICROB, V61, P1502, DOI 10.1128/AEM.61.4.1502-1506.1995; Ciardiello MA, 2000, BBA-PROTEIN STRUCT M, V1543, P11, DOI 10.1016/S0167-4838(00)00186-2; Collins T, 2003, J MOL BIOL, V328, P419, DOI 10.1016/S0022-2836(03)00287-0; Collins T, 2002, J BIOL CHEM, V277, P35133, DOI 10.1074/jbc.M204517200; Coquelle N, 2007, J MOL BIOL, V374, P547, DOI 10.1016/j.jmb.2007.09.049; Corazza A, 2006, PROTEINS, V62, P64, DOI 10.1002/prot.20703; COSTANTINO HR, 1990, J BACTERIOL, V172, P3654, DOI 10.1128/jb.172.7.3654-3660.1990; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; DAVAIL S, 1994, J BIOL CHEM, V269, P17448; Dhaked RK, 2005, ENZYME MICROB TECH, V36, P855, DOI 10.1016/j.enzmictec.2004.11.017; DOIG AJ, 1995, PROTEIN SCI, V4, P2247, DOI 10.1002/pro.5560041101; Dominy BN, 2004, PROTEINS, V57, P128, DOI 10.1002/prot.20190; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Dong GQ, 1997, APPL ENVIRON MICROB, V63, P3577, DOI 10.1128/AEM.63.9.3577-3584.1997; Doud MB, 2015, MOL BIOL EVOL, V32, P2944, DOI 10.1093/molbev/msv167; Dwyer Donard S, 2005, BMC Chem Biol, V5, P2, DOI 10.1186/1472-6769-5-2; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; EIJSINK VGH, 1993, STUD ORG CHEM, V47, P91; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engqvist MKM, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1320-7; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fardeau ML, 2004, INT J SYST EVOL MICR, V54, P467, DOI 10.1099/ijs.0.02711-0; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Folch B, 2008, J CHEM INF MODEL, V48, P119, DOI 10.1021/ci700237g; Folch B, 2010, BIOPHYS J, V98, P667, DOI 10.1016/j.bpj.2009.10.050; Fritz S.A., 2012, CAPER PACKAGE COMP A; Fritz SA, 2010, CONSERV BIOL, V24, P1042, DOI 10.1111/j.1523-1739.2010.01455.x; Fujiwara S, 1996, FEBS LETT, V394, P66, DOI 10.1016/0014-5793(96)00904-0; FUKUSUMI S, 1988, EUR J BIOCHEM, V174, P15, DOI 10.1111/j.1432-1033.1988.tb14056.x; Ganghofner D, 1998, BIOSCI BIOTECH BIOCH, V62, P302, DOI 10.1271/bbb.62.302; Gantelet H, 1999, BIOTECHNOL LETT, V21, P71, DOI 10.1023/A:1005453303688; Garsoux G, 2004, BIOCHEM J, V384, P247, DOI 10.1042/BJ20040325; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Georlette D, 2003, J BIOL CHEM, V278, P37015, DOI 10.1074/jbc.M305142200; GLEASON FK, 1992, PROTEIN SCI, V1, P609, DOI 10.1002/pro.5560010507; Goldstein RA, 2007, PROTEIN SCI, V16, P1887, DOI 10.1110/ps.072947007; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Gross KC, 2001, INT J QUANTUM CHEM, V85, P569, DOI 10.1002/qua.1525; Gross KC, 2001, J ORG CHEM, V66, P6919, DOI 10.1021/jo010234g; Gross KC, 2000, INT J QUANTUM CHEM, V80, P1107, DOI 10.1002/1097-461X(2000)80:4/5<1107::AID-QUA60>3.0.CO;2-T; Guagliardi A, 1996, INT J BIOCHEM CELL B, V28, P239, DOI 10.1016/1357-2725(95)00138-7; Guo JN, 2014, BIOCHEMISTRY-US, V53, P2855, DOI 10.1021/bi500238q; Ha JS, 2003, J MOL CATAL B-ENZYM, V26, P231, DOI 10.1016/j.molcatb.2003.06.008; Hait S, 2020, PROTEINS, V88, P788, DOI 10.1002/prot.25866; Hamelryck T, 2003, BIOINFORMATICS, V19, P2308, DOI 10.1093/bioinformatics/btg299; Han JS, 2002, EUR J BIOCHEM, V269, P969, DOI 10.1046/j.0014-2956.2001.02731.x; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Herschlag D, 2018, BIOCHEMISTRY-US, V57, P3338, DOI 10.1021/acs.biochem.8b00217; Horinouchi M, 2010, J STEROID BIOCHEM, V122, P253, DOI 10.1016/j.jsbmb.2010.06.002; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huston AL, 2008, BBA-PROTEINS PROTEOM, V1784, P1865, DOI 10.1016/j.bbapap.2008.06.002; Huston AL, 2004, APPL ENVIRON MICROB, V70, P3321, DOI 10.1128/AEM.70.6.3321-3328.2004; HYUN HH, 1985, APPL ENVIRON MICROB, V49, P1162, DOI 10.1128/AEM.49.5.1162-1167.1985; Ishida Y, 1998, BIOSCI BIOTECH BIOCH, V62, P2246, DOI 10.1271/bbb.62.2246; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jeon SJ, 2002, EUR J BIOCHEM, V269, P5423, DOI 10.1046/j.1432-1033.2002.03231.x; Jeske L, 2019, NUCLEIC ACIDS RES, V47, pD542, DOI 10.1093/nar/gky1048; JR RLD, 2002, CURR OPIN STRUC BIOL, V12, P431; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karasova-Lipovova P, 2003, ENZYME MICROB TECH, V33, P836, DOI 10.1016/S0141-0229(03)00211-4; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; Kashiwabara S, 1999, BIOSCI BIOTECH BIOCH, V63, P1736, DOI 10.1271/bbb.63.1736; Katoh K, 2012, BIOINFORMATICS, V28, P3144, DOI 10.1093/bioinformatics/bts578; Kim CH, 1996, FEMS MICROBIOL LETT, V138, P147, DOI 10.1111/j.1574-6968.1996.tb08148.x; Kim SB, 2008, J MICROBIOL, V46, P100, DOI 10.1007/s12275-007-0185-5; KIRINO H, 1994, EUR J BIOCHEM, V220, P275, DOI 10.1111/j.1432-1033.1994.tb18623.x; Koch R, 1997, APPL ENVIRON MICROB, V63, P1088, DOI 10.1128/AEM.63.3.1088-1094.1997; KOCH R, 1991, ARCH MICROBIOL, V155, P572, DOI 10.1007/BF00245352; Kotzler M. P., 2014, GLYCOSIDASES FUNCTIO; Kovacic F, 2016, PROTEIN ENG DES SEL, V29, P65, DOI 10.1093/protein/gzv061; Kraut DA, 2006, PLOS BIOL, V4, P501, DOI 10.1371/journal.pbio.0040099; Kraut DA, 2010, P NATL ACAD SCI USA, V107, P1960, DOI 10.1073/pnas.0911168107; Kumar S, 2000, J BIOMOL STRUCT DYN, P79, DOI 10.1080/07391102.2000.10506606; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; KUO MJ, 1966, J BACTERIOL, V92, P723, DOI 10.1128/JB.92.3.723-726.1966; Kursula I, 2001, EUR J BIOCHEM, V268, P5189, DOI 10.1046/j.0014-2956.2001.02452.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamba V, 2016, J AM CHEM SOC, V138, P9902, DOI 10.1021/jacs.6b04796; Lebbink JHG, 1998, J MOL BIOL, V280, P287, DOI 10.1006/jmbi.1998.1870; LEE C, 1991, BIOCHEM J, V273, P565, DOI 10.1042/bj2730565; Lee HS, 2006, BIOSCI BIOTECH BIOCH, V70, P1140, DOI 10.1271/bbb.70.1140; Lee JT, 1996, J FERMENT BIOENG, V82, P432, DOI 10.1016/S0922-338X(97)86978-4; LEE SH, 1992, BIOSCI BIOTECH BIOCH, V56, P1839, DOI 10.1271/bbb.56.1839; Lee YM, 2008, J MOL BIOL, V379, P545, DOI 10.1016/j.jmb.2008.04.004; LEHMACHER A, 1990, BIOL CHEM H-S, V371, P527, DOI 10.1515/bchm3.1990.371.1.527; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li XH, 2008, EXTREMOPHILES, V12, P325, DOI 10.1007/s00792-007-0131-9; Li YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-62; Lin JS, 2017, BIOCHEMISTRY-US, V56, P391, DOI 10.1021/acs.biochem.6b00906; Lins L, 2003, PROTEIN SCI, V12, P1406, DOI 10.1110/ps.0304803; Liu SY, 1996, J BACTERIOL, V178, P5938, DOI 10.1128/jb.178.20.5938-5945.1996; Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w; Loppes R, 1996, J PHYCOL, V32, P276, DOI 10.1111/j.0022-3646.1996.00276.x; LOW PS, 1973, P NATL ACAD SCI USA, V70, P430, DOI 10.1073/pnas.70.2.430; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Maki S, 2006, EXTREMOPHILES, V10, P237, DOI 10.1007/s00792-005-0493-9; Makwana KM, 2015, PROTEIN SCI, V24, P1920, DOI 10.1002/pro.2814; MATHUPALA SP, 1993, J BIOL CHEM, V268, P16332; MATHUPALA SP, 1993, APPL MICROBIOL BIOT, V39, P487, DOI 10.1007/BF00205038; Matsumoto K, 2010, APPL MICROBIOL BIOT, V86, P1431, DOI 10.1007/s00253-009-2351-7; MATTHEWS BW, 1987, P NATL ACAD SCI USA, V84, P6663, DOI 10.1073/pnas.84.19.6663; Mayordomo I, 2000, J AGR FOOD CHEM, V48, P105, DOI 10.1021/jf9903354; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCracken KG, 2009, MOL ECOL, V18, P3992, DOI 10.1111/j.1365-294X.2009.04352.x; MCELHANEY RN, 1976, BIOCHIM BIOPHYS ACTA, V443, P348, DOI 10.1016/0005-2787(76)90499-8; Menendez-Arias L, 2010, ANTIVIR RES, V85, P210, DOI 10.1016/j.antiviral.2009.07.006; Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709; Mingardon F, 2011, APPL ENVIRON MICROB, V77, P1436, DOI 10.1128/AEM.01802-10; Miralles F, 2011, J MOL EVOL, V72, P450, DOI 10.1007/s00239-011-9443-6; Mizuguchi K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S15; Momany C, 2004, BIOCHEMISTRY-US, V43, P1193, DOI 10.1021/bi035744e; Moon S, 2019, STRUCT DYNAM-US, V6, DOI 10.1063/1.5089707; Moon S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16266-9; Moon S, 2014, PROTEINS, V82, P1947, DOI 10.1002/prot.24549; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mou ZL, 2014, PROTEIN PEPTIDE LETT, V21, P578, DOI 10.2174/0929866521666140108110050; Moura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077319; Mykytczuk NCS, 2013, ISME J, V7, P1211, DOI 10.1038/ismej.2013.8; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; Natarajan A, 2014, J AM CHEM SOC, V136, P7643, DOI 10.1021/ja413174b; Nemeth A, 2000, FEBS LETT, V468, P48, DOI 10.1016/S0014-5793(00)01190-X; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Obexer R, 2017, NAT CHEM, V9, P50, DOI [10.1038/NCHEM.2596, 10.1038/nchem.2596]; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Pack SP, 2004, J BIOTECHNOL, V111, P269, DOI 10.1016/j.jbiotec.2004.01.018; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Patten PA, 1996, SCIENCE, V271, P1086, DOI 10.1126/science.271.5252.1086; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Perrier V, 1998, J BIOL CHEM, V273, P19097, DOI 10.1074/jbc.273.30.19097; Petrounia IP, 1998, BIOCHEMISTRY-US, V37, P700, DOI 10.1021/bi972262s; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinney M. M., 2020, PARALLEL MOL MECH EN, DOI [10.5061/dryad.3ffbg79h2, DOI 10.5061/DRYAD.3FFBG79H2]; Pinney MM, 2018, J AM CHEM SOC, V140, P9827, DOI 10.1021/jacs.8b01596; Pollack RM, 2004, BIOORG CHEM, V32, P341, DOI 10.1016/j.bioorg.2004.06.005; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Prajapati RS, 2006, BIOCHEMISTRY-US, V45, P15000, DOI 10.1021/bi061275f; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Reimer LC, 2019, NUCLEIC ACIDS RES, V47, pD631, DOI 10.1093/nar/gky879; Rhee SK, 2002, EXTREMOPHILES, V6, P57, DOI 10.1007/s007920100233; Ribeiro AJM, 2018, NUCLEIC ACIDS RES, V46, pD618, DOI 10.1093/nar/gkx1012; Rice DW, 1996, FEMS MICROBIOL REV, V18, P105; Robinson-Rechavi M, 2006, J MOL BIOL, V356, P547, DOI 10.1016/j.jmb.2005.11.065; Rokas A, 2008, MOL BIOL EVOL, V25, P1943, DOI 10.1093/molbev/msn143; Roulling F, 2016, EXTREMOPHILES, V20, P621, DOI 10.1007/s00792-016-0851-9; RUDIGER A, 1995, APPL ENVIRON MICROB, V61, P567; SAHA BC, 1991, APPL MICROBIOL BIOT, V35, P568, DOI 10.1007/BF00169617; Sako Y, 1997, FEBS LETT, V415, P329, DOI 10.1016/S0014-5793(97)01153-8; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Sammond DW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145848; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Saunders NFW, 2003, GENOME RES, V13, P1580, DOI 10.1101/gr.1180903; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schroder KH, 1997, INT J SYST BACTERIOL, V47, P86, DOI 10.1099/00207713-47-1-86; Schrodinger L., 2020, MAESTR; Schuliger J. W., 1993, Molecular Marine Biology and Biotechnology, V2, P76; SCHUMANN J, 1991, FEBS LETT, V282, P122, DOI 10.1016/0014-5793(91)80459-G; Secades P, 2001, APPL ENVIRON MICROB, V67, P2436, DOI 10.1128/AEM.67.6.2436-2444.2001; Shan SO, 1996, P NATL ACAD SCI USA, V93, P14474, DOI 10.1073/pnas.93.25.14474; Shan SO, 1996, SCIENCE, V272, P97, DOI 10.1126/science.272.5258.97; Shan SO, 1999, METHOD ENZYMOL, V308, P246; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SHEN GJ, 1988, BIOCHEM J, V254, P835, DOI 10.1042/bj2540835; Shenhav L, 2020, SCIENCE, V370, P683, DOI 10.1126/science.aaz9642; SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Sigala PA, 2009, BIOCHEMISTRY-US, V48, P6932, DOI 10.1021/bi900713j; Somero GN, 2004, COMP BIOCHEM PHYS B, V139, P321, DOI 10.1016/j.cbpc.2004.05.003; SOMERO GN, 1968, COMP BIOCHEM PHYSIOL, V26, P223, DOI 10.1016/0010-406X(68)90327-7; SPECKA U, 1991, APPL ENVIRON MICROB, V57, P2317, DOI 10.1128/AEM.57.8.2317-2323.1991; Sriprapundh D, 2000, PROTEIN ENG, V13, P259, DOI 10.1093/protein/13.4.259; Starr TN, 2016, PROTEIN SCI, V25, P1204, DOI 10.1002/pro.2897; Sterpone F, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/28/284113; Sterpone F, 2009, J PHYS CHEM B, V113, P131, DOI 10.1021/jp805199c; Sun K, 1998, FEMS MICROBIOL LETT, V164, P375, DOI 10.1111/j.1574-6968.1998.tb13112.x; SUZUKI Y, 1991, APPL MICROBIOL BIOT, V34, P707; SUZUKI Y, 1976, BIOCHIM BIOPHYS ACTA, V445, P386, DOI 10.1016/0005-2744(76)90092-9; Talevich E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-209; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; Thomas TM, 1998, BIOCHEM J, V330, P1087; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tiago I, 2012, J BACTERIOL, V194, P7010, DOI 10.1128/JB.01880-12; Toth K, 2009, BIOCHEMISTRY-US, V48, P8006, DOI 10.1021/bi901064k; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; VIEILLE C, 1995, APPL ENVIRON MICROB, V61, P1867, DOI 10.1128/AEM.61.5.1867-1875.1995; Nguyen V, 2017, SCIENCE, V355, P289, DOI 10.1126/science.aah3717; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang SY, 2003, ARCH BIOCHEM BIOPHYS, V411, P56, DOI 10.1016/S0003-9861(02)00713-0; Watanabe S, 2001, BIOSCI BIOTECH BIOCH, V65, P1095, DOI 10.1271/bbb.65.1095; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilquet V, 1998, EUR J BIOCHEM, V255, P628, DOI 10.1046/j.1432-1327.1998.2550628.x; Wintrode PL, 2001, ADV PROTEIN CHEM, V55, P161, DOI 10.1016/S0065-3233(01)55004-4; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Xu Y, 2003, J BACTERIOL, V185, P2161, DOI 10.1128/JB.185.7.2161-2168.2003; Yang HQ, 2010, ELECTROPHORESIS, V31, P1764, DOI 10.1002/elps.201000027; YEH MF, 1976, J BIOL CHEM, V251, P3134; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47; Zhou XX, 2008, AMINO ACIDS, V34, P25, DOI 10.1007/s00726-007-0589-x; ZWICKL P, 1990, J BACTERIOL, V172, P4329, DOI 10.1128/jb.172.8.4329-4338.1990	258	20	20	21	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1010	+	eaay2784	10.1126/science.aay2784	http://dx.doi.org/10.1126/science.aay2784			112	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674467	Green Submitted			2022-12-28	WOS:000625876100044
J	Choueiri, TK; Powles, T; Burotto, M; Escudier, B; Bourlon, MT; Zurawski, B; Juarez, VMO; Hsieh, JJ; Basso, U; Shah, AY; Suarez, C; Hamzaj, A; Goh, JC; Barrios, C; Richardet, M; Porta, C; Kowalyszyn, R; Feregrino, JP; Zolnierek, J; Pook, D; Kessler, ER; Tomita, Y; Mizuno, R; Bedke, J; Zhang, J; Maurer, MA; Simsek, B; Ejzykowicz, F; Schwab, GM; Apolo, AB; Motzer, RJ				Choueiri, T. K.; Powles, T.; Burotto, M.; Escudier, B.; Bourlon, M. T.; Zurawski, B.; Juarez, V. M. Oyervides; Hsieh, J. J.; Basso, U.; Shah, A. Y.; Suarez, C.; Hamzaj, A.; Goh, J. C.; Barrios, C.; Richardet, M.; Porta, C.; Kowalyszyn, R.; Feregrino, J. P.; Zolnierek, J.; Pook, D.; Kessler, E. R.; Tomita, Y.; Mizuno, R.; Bedke, J.; Zhang, J.; Maurer, M. A.; Simsek, B.; Ejzykowicz, F.; Schwab, G. M.; Apolo, A. B.; Motzer, R. J.		CheckMate 9ER Investigators	Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC UROTHELIAL CARCINOMA; FUNCTIONAL ASSESSMENT; OPEN-LABEL; THERAPY; CANCER; IMMUNOTHERAPY; COMBINATION; EVEROLIMUS	BACKGROUND The efficacy and safety of nivolumab plus cabozantinib as compared with those of sunitinib in the treatment of previously untreated advanced renal-cell carcinoma are not known. METHODS In this phase 3, randomized, open-label trial, we randomly assigned adults with previously untreated clear-cell, advanced renal-cell carcinoma to receive either nivolumab (240 mg every 2 weeks) plus cabozantinib (40 mg once daily) or sunitinib (50 mg once daily for 4 weeks of each 6-week cycle). The primary end point was progression-free survival, as determined by blinded independent central review. Secondary end points included overall survival, objective response as determined by independent review, and safety. Health-related quality of life was an exploratory end point. RESULTS Overall, 651 patients were assigned to receive nivolumab plus cabozantinib (323 patients) or sunitinib (328 patients). At a median follow-up of 18.1 months for overall survival, the median progression-free survival was 16.6 months (95% confidence interval [CI], 12.5 to 24.9) with nivolumab plus cabozantinib and 8.3 months (95% CI, 7.0 to 9.7) with sunitinib (hazard ratio for disease progression or death, 0.51; 95% CI, 0.41 to 0.64; P<0.001). The probability of overall survival at 12 months was 85.7% (95% CI, 81.3 to 89.1) with nivolumab plus cabozantinib and 75.6% (95% CI, 70.5 to 80.0) with sunitinib (hazard ratio for death, 0.60; 98.89% CI, 0.40 to 0.89; P = 0.001). An objective response occurred in 55.7% of the patients receiving nivolumab plus cabozantinib and in 27.1% of those receiving sunitinib (P<0.001). Efficacy benefits with nivolumab plus cabozantinib were consistent across subgroups. Adverse events of any cause of grade 3 or higher occurred in 75.3% of the 320 patients receiving nivolumab plus cabozantinib and in 70.6% of the 320 patients receiving sunitinib. Overall, 19.7% of the patients in the combination group discontinued at least one of the trial drugs owing to adverse events, and 5.6% discontinued both. Patients reported better health-related quality of life with nivolumab plus cabozantinib than with sunitinib. CONCLUSIONS Nivolumab plus cabozantinib had significant benefits over sunitinib with respect to progression-free survival, overall survival, and likelihood of response in patients with previously untreated advanced renal-cell carcinoma. (Funded by Bristol Myers Squibb and others; CheckMate 9ER ClinicalTrials.gov number, NCT03141177.)	[Choueiri, T. K.] Brigham & Womens Hosp, Dept Med Oncol, Lank Ctr Genitourinary Oncol, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA; [Choueiri, T. K.] Harvard Med Sch, 450 Brookline Ave, Boston, MA 02215 USA; [Powles, T.] Queen Mary Univ London, Royal Free Natl Hlth Serv Trust, Canc Res UK Expt Canc Med Ctr, Dept Genitourinary Oncol,Barts Canc Inst, London, England; [Burotto, M.] Bradford Hill Clin Res Ctr, Santiago, Chile; [Escudier, B.] Gustave Roussy, Dept Med Oncol, Villejuif, France; [Bourlon, M. T.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Urol Oncol Clin, Dept Hematooncol, Mexico City, DF, Mexico; [Juarez, V. M. Oyervides] Univ Autonoma Nuevo Leon, Dept Med Oncol, Ctr Univ Canc, Hosp Univ Dr Jose Eleuterio Gonzalez, San Nicolas De Los Garza, Nuevo Leon, Mexico; [Feregrino, J. P.] Hosp H Queretaro, Dept Med Oncol, Queretaro, Mexico; [Zurawski, B.] Franciszek Lukaszczyk Oncol Ctr, Dept Outpatient Chemotherapy, Bydgoszcz, Poland; [Zolnierek, J.] Reg Specialist Hosp, Dept Clin Oncol & Hematol, Biala Podlaska, Poland; [Hsieh, J. J.] Washington Univ, Sch Med, Dept Med, Siteman Canc Ctr,Div Oncol, St Louis, MO 63110 USA; [Basso, U.] IRCCS, Ist Oncol Veneto, Dept Oncol, Oncol Unit 1, Padua, Italy; [Shah, A. Y.; Hamzaj, A.] Osped San Donato, Ist Toscano & Arezzo, Dept Med Oncol, Arezzo, Italy; [Porta, C.] Univ Pavia, Dept Internal Med, Pavia, Italy; [Porta, C.] Univ Bari A Moro, Bari, Italy; [Shah, A. Y.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Suarez, C.] Hosp Univ Vall Hebron, Vall Hebron Inst Oncol, Dept Med Oncol, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain; [Goh, J. C.] Royal Brisbane & Womens Hosp, Dept Med Oncol, Herston, Qld, Australia; [Pook, D.] Cabrini Monash Univ, Dept Med Oncol, Cabrini Hlth, Malvern, Vic, Australia; [Barrios, C.] Hosp Sao Lucas, Oncol Res Ctr, Porto Alegre, RS, Brazil; [Richardet, M.] Inst Oncol Cordoba, Fdn Richardet Longo, Cordoba, Argentina; [Kowalyszyn, R.] Clin Viedma, Inst Multidisciplinario Oncol, Viedma, Argentina; [Kessler, E. R.] Univ Colorado, Dept Internal Med, Div Med Oncol, Sch Med, Aurora, CO USA; [Tomita, Y.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Urol, Niigata, Japan; [Tomita, Y.] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Niigata, Japan; [Mizuno, R.] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan; [Bedke, J.] Eberhard Karls Univ Tubingen, Dept Urol, Tubingen, Germany; [Zhang, J.] Bristol Myers Squibb, Dept Clin Res, Princeton, NJ USA; [Maurer, M. A.] Bristol Myers Squibb, Dept Clin Oncol, Princeton, NJ USA; [Simsek, B.] Bristol Myers Squibb, Dept Biostat, Princeton, NJ USA; [Ejzykowicz, F.] Bristol Myers Squibb, Dept Hlth Econ & Outcomes Res, Princeton, NJ USA; [Schwab, G. M.] Exelixis, Dept Clin Oncol, Alameda, CA USA; [Apolo, A. B.] NCI, Genitourinary Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Motzer, R. J.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Cancer Research UK; University of London; Queen Mary University London; UNICANCER; Gustave Roussy; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Siteman Cancer Center; Washington University (WUSTL); IRCCS Istituto Oncologico Veneto (IOV); IRCCS Policlinico San Donato; University of Pavia; Universita degli Studi di Bari Aldo Moro; University of Texas System; UTMD Anderson Cancer Center; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Royal Brisbane & Women's Hospital; Cabrini Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Niigata University; Niigata University; Keio University; Eberhard Karls University of Tubingen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Exelixis, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center	Choueiri, TK (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, 450 Brookline Ave, Boston, MA 02215 USA.; Motzer, RJ (corresponding author), Mem Hosp, Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; Choueiri, TK (corresponding author), Harvard Med Sch, 450 Brookline Ave, Boston, MA 02215 USA.	toni_choueiri@dfci.harvard.edu; motzerr@mskcc.org	Simsek, Burcin/M-2067-2019; Bedke, Jens/AAS-2837-2020; Choueiri, Toni/K-5238-2019; riccardi, ferdinando/K-7370-2016	Simsek, Burcin/0000-0003-2857-6629; Bedke, Jens/0000-0003-2778-3108; Choueiri, Toni/0000-0002-9201-3217; Powles, Thomas/0000-0001-7760-4724; Apolo, Andrea/0000-0001-9409-1836; Suarez, Cristina/0000-0002-0502-5528; riccardi, ferdinando/0000-0002-2852-2770	Bristol Myers Squibb; Ono Pharmaceutical; Exelixis; Ipsen Pharma; Takeda Pharmaceutical; Dana-Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence; Kohlberg Chair at Harvard Medical School; Loker Pinard Funds for Kidney Cancer Research at Dana-Farber Cancer Institute; National Cancer Institute, Department of Defense; Cancer Center Support Grant-Core Grant [P30 CA008748]; National Institutes of Health Core Grant [P30 CA016672]; Trust Family	Bristol Myers Squibb(Bristol-Myers Squibb); Ono Pharmaceutical; Exelixis; Ipsen Pharma(Ipsen); Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Dana-Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence; Kohlberg Chair at Harvard Medical School; Loker Pinard Funds for Kidney Cancer Research at Dana-Farber Cancer Institute; National Cancer Institute, Department of Defense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Department of Defense); Cancer Center Support Grant-Core Grant; National Institutes of Health Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Trust Family	Supported by Bristol Myers Squibb in collaboration with Ono Pharmaceutical and with Exelixis, Ipsen Pharma, and Takeda Pharmaceutical. The authors received no financial support or compensation for publication of this manuscript. Dr. Choueiri is supported in part by the Dana-Farber/Harvard Cancer Center Kidney Specialized Program of Research Excellence, the Kohlberg Chair at Harvard Medical School, the Trust Family, Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at Dana-Farber Cancer Institute and by various grants from the National Cancer Institute, Department of Defense, and foundations. Patients treated at the Memorial Sloan Kettering Cancer Center were supported in part by a Cancer Center Support Grant-Core Grant (P30 CA008748). The University of Texas M.D. Anderson Cancer Center is supported by a National Institutes of Health Core Grant (P30 CA016672).	Agarwal N, 2020, J CLIN ONCOL, V29; Amin A, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0420-0; Apolo AB, 2020, J CLIN ONCOL, V38, P3672, DOI 10.1200/JCO.20.01652; Apolo AB, 2020, LANCET ONCOL, V21, P1099, DOI 10.1016/S1470-2045(20)30202-3; Bedke J, 2020, VIRT ANN EUR ASS UR; Bergerot P, 2019, MOL CANCER THER, V18, P2185, DOI 10.1158/1535-7163.MCT-18-1399; Cella D, 2019, LANCET ONCOL, V20, P297, DOI 10.1016/S1470-2045(18)30778-2; Cella D, 2018, VALUE HEALTH, V21, P1413, DOI 10.1016/j.jval.2018.04.1371; Choueiri TK, 2017, J CLIN ONCOL, V35, P591, DOI 10.1200/JCO.2016.70.7398; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Choueiri TK, 2016, LANCET ONCOL, V17, P917, DOI 10.1016/S1470-2045(16)30107-3; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Glimm E, 2010, STAT MED, V29, P219, DOI 10.1002/sim.3748; Grimm MO, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020565; Heidegger I, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00490; Heng DYC, 2013, LANCET ONCOL, V14, P141, DOI 10.1016/S1470-2045(12)70559-4; Heng DYC, 2009, J CLIN ONCOL, V27, P5794, DOI 10.1200/JCO.2008.21.4809; Krigsfeld GS, 2020, J CLIN PATHOL, V73, P656, DOI 10.1136/jclinpath-2020-206466; Lu X, 2017, NATURE, V543, P728, DOI 10.1038/nature21676; McKay RR, 2018, J CLIN ONCOL, V36, P3615, DOI 10.1200/JCO.2018.79.0253; Mennitto A, 2016, THER ADV UROL, V8, P319, DOI 10.1177/1756287216656811; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; MOTZER RJ, 2020, J IMMUNOTHER CANCER, P8, DOI [DOI 10.1136/jitc-2020-000891, 10.1136/jitc-2020-000891]; Motzer R, 2019, LANCET ONCOL, V20, P1370, DOI 10.1016/S1470-2045(19)30413-9; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; National Cancer Institute, COMMON TERMINOLOGY C; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pal S, 2020, ANN ONCOL, V31, pS554, DOI 10.1016/j.annonc.2020.08.774; Rao D, 2009, J PAIN SYMPTOM MANAG, V38, P291, DOI 10.1016/j.jpainsymman.2008.08.013; Rini BI, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0813-8; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; Saeed A, 2020, J CLIN ONCOL, V38; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Schmidt E, 2018, TARGET ONCOL, V13, P205, DOI 10.1007/s11523-018-0559-0	35	438	440	12	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					829	841		10.1056/NEJMoa2026982	http://dx.doi.org/10.1056/NEJMoa2026982			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS8DS	33657295	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000626124800018
J	Lopez-Medina, E; Lopez, P; Hurtado, IC; Davalos, DM; Ramirez, O; Martinez, E; Diazgranados, JA; Onate, JM; Chavarriaga, H; Herrera, S; Parra, B; Libreros, G; Jaramillo, R; Avendano, AC; Toro, DF; Torres, M; Lesmes, MC; Rios, CA; Caicedo, I				Lopez-Medina, Eduardo; Lopez, Pio; Hurtado, Isabel C.; Davalos, Diana M.; Ramirez, Oscar; Martinez, Ernesto; Diazgranados, Jesus A.; Onate, Jose M.; Chavarriaga, Hector; Herrera, Socrates; Parra, Beatriz; Libreros, Gerardo; Jaramillo, Roberto; Avendano, Ana C.; Toro, Dilian F.; Torres, Miyerlandi; Lesmes, Maria C.; Rios, Carlos A.; Caicedo, Isabella			Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INHIBITOR; REPLICATION	Importance: Ivermectin is widely prescribed as a potential treatment for COVID-19 despite uncertainty about its clinical benefit. Objective: To determine whether ivermectin is an efficacious treatment for mild COVID-19. Design, Setting, and ParticipantsL Double-blind, randomized trial conducted at a single site in Cali, Colombia. Potential study participants were identified by simple random sampling from the state's health department electronic database of patients with symptomatic, laboratory-confirmed COVID-19 during the study period. A total of 476 adult patients with mild disease and symptoms for 7 days or fewer (at home or hospitalized) were enrolled between July 15 and November 30, 2020, and followed up through December 21, 2020. Intervention: Patients were randomized to receive ivermectin, 300 mu g/kg of body weight per day for 5 days (n = 200) or placebo (n = 200). Main Outcomes and Measures: Primary outcome was time to resolution of symptoms within a 21-day follow-up period. Solicited adverse events and serious adverse events were also collected. Results: Among 400 patients who were randomized in the primary analysis population (median age, 37 years [interquartile range {IQR}, 29-48]; 231 women [58%]), 398 (99.5%) completed the trial. The median time to resolution of symptoms was 10 days (IQR, 9-13) in the ivermectin group compared with 12 days (IQR, 9-13) in the placebo group (hazard ratio for resolution of symptoms, 1.07 [95% CI, 0.87 to 1.32]; P = .53 by log-rank test). By day 21, 82% in the ivermectin group and 79% in the placebo group had resolved symptoms. The most common solicited adverse event was headache, reported by 104 patients (52%) given ivermectin and 111 (56%) who received placebo. The most common serious adverse event was multiorgan failure, occurring in 4 patients (2 in each group). Conclusion and Relevance: Among adults with mild COVID-19, a 5-day course of ivermectin, compared with placebo, did not significantly improve the time to resolution of symptoms. The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes.	[Lopez-Medina, Eduardo; Lopez, Pio] Ctr Estudios Infectol Pediat, Calle 5 B 5 37 BIS-28, Cali, Colombia; [Lopez-Medina, Eduardo; Lopez, Pio; Hurtado, Isabel C.] Univ Valle, Dept Pediat, Cali, Colombia; [Lopez-Medina, Eduardo; Ramirez, Oscar; Onate, Jose M.; Caicedo, Isabella] Clin Imbanaco, Cali, Colombia; [Hurtado, Isabel C.; Lesmes, Maria C.] State Hlth Dept, Valle Del Cauca, Colombia; [Davalos, Diana M.] Univ ICESI, Dept Publ Hlth, Cali, Colombia; [Ramirez, Oscar] POHEMA Pediat Oncol & Hematol Fdn, Cali, Colombia; [Ramirez, Oscar] Calis Canc Populat Based Registry, Cali, Colombia; [Martinez, Ernesto; Onate, Jose M.] Univ Valle, Dept Internal Med, Cali, Colombia; [Martinez, Ernesto] Christus Sinergia Salud, Cali, Colombia; [Diazgranados, Jesus A.] Neurol Occidente, Cali, Colombia; [Onate, Jose M.] Clin Occidente, Cali, Colombia; [Chavarriaga, Hector; Torres, Miyerlandi] Municipal Hlth Dept, Cali, Colombia; [Herrera, Socrates] Malaria Vaccine & Drug Dev Ctr, Caucaseco Sci Res Ctr, Cali, Colombia; [Parra, Beatriz; Libreros, Gerardo] Univ Valle, Dept Microbiol, Cali, Colombia; [Jaramillo, Roberto; Avendano, Ana C.] Hemato Oncologos, Cali, Colombia; [Toro, Dilian F.] Hlth Experts Comm, Valle Del Cauca, Colombia; [Rios, Carlos A.] Ctr Medico Santuario, Cali, Colombia	Universidad del Valle; Universidad ICESI; Universidad del Valle; Universidad del Valle	Lopez-Medina, E (corresponding author), Ctr Estudios Infectol Pediat, Calle 5 B 5 37 BIS-28, Cali, Colombia.	eduardo.lopez@ceiponline.org		Libreros-Zuniga, Gerardo Andres/0000-0003-0196-1957; Lopez Lopez, Pio/0000-0001-5230-6595; Hurtado Palacios, Isabel Cristina/0000-0002-3625-4892	Centro de Estudios en Infectologia Pediatrica [ScDi823]	Centro de Estudios en Infectologia Pediatrica	This study received an unrestricted grant from Centro de Estudios en Infectologia Pediatrica (grant ScDi823).	[Anonymous], CLIN TRIAL IVERMECTI; [Anonymous], FRONTLINE COVID 19 C; Arevalo A., 2020, LVERMECTIN REDUCE CO, DOI [10.1101/2020.11.02.363242, DOI 10.1101/2020.11.02.363242]; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Diazgranados-Sanchez JA, 2017, REV NEUROLOGIA, V65, P303, DOI 10.33588/rn.6507.2016574; Elgazzar A, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-100956/v1, DOI 10.21203/RS.3.RS-100956/V1]; Hashim HA., 2020, INFEC DIS EXCEPT HIV, DOI [10.1101/2020.10.26.20219345, DOI 10.1101/2020.10.26.20219345, 10.26.20219345]; Karaca-Mandic P, 2021, JAMA INTERN MED, V181, P131, DOI 10.1001/jamainternmed.2020.3857; Larrous, 2021, BIORXIV, DOI 10.1101/2020.11.21.392639; Mahajan UV, 2020, J PUBLIC HEALTH-UK, V42, P445, DOI 10.1093/pubmed/fdaa070; Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147; Ministerio de Salud Gobierno del Estado de Bolivia, RES MIN NO 0259, DOI 10.1101/2020.10.26.20219345; Ministerio de Salud Republica del Peru, RES MIN NO 270 2020, DOI DOI 10.1093/cid/ciaa1009; Mitja O, 2021, CLIN INFECT DIS, V73, pE4073, DOI 10.1093/cid/ciaa1009; Molento MB, 2020, ONE HEALTH-AMSTERDAM, V10, DOI 10.1016/j.onehlt.2020.100148; Momekov G, 2020, BIOTECHNOL BIOTEC EQ, V34, P469, DOI 10.1080/13102818.2020.1775118; Omura S, 2008, INT J ANTIMICROB AG, V31, P91, DOI 10.1016/j.ijantimicag.2007.08.023; Rajter JC, 2021, CHEST, V159, P85, DOI 10.1016/j.chest.2020.10.009; Rayner CR, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104805; Rodriguez Mega E., NATURE, DOI [10.21203/rs.3.rs-100956/v1, DOI 10.21203/RS.3.RS-100956/V3]; Schmith VD, 2020, CLIN PHARMACOL THER, V108, P762, DOI 10.1002/cpt.1889; Shakhsi Niaee M, 2020, RES SQUARE, DOI [10.21203/rs.3.rs-109670/v1, DOI 10.21203/RS.3.RS-109670/V1]; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Smit MR, 2018, LANCET INFECT DIS, V18, P615, DOI 10.1016/S1473-3099(18)30163-4; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002; US Department of Health and Human Services, COMMON TERMINOLOGY C; US Senate Committee on Homeland Security & Governmental Affairs, EARL OUTP TREATM ESS; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; World Health Organization, WHO R D BLU NOV COR; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang SNY, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104760	34	173	174	4	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2021	325	14					1426	1435		10.1001/jama.2021.3071	http://dx.doi.org/10.1001/jama.2021.3071		MAR 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9GZ	33662102	Bronze, Green Published			2022-12-28	WOS:000625440200001
J	Oliver, D				Oliver, David			David Oliver: Has covid-19 shown society ? s disregard for old and sick people?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2020, GREAT BARRINGTON DEC; Comas-Herrera A., 2020, MORTALITY ASS COVID; Hanlon Peter, 2020, Wellcome Open Res, V5, P75, DOI 10.12688/wellcomeopenres.15849.1; Kelly J, 2020, FINANC TIMES; National Institute for Health Research, LIV COVID19, DOI [10.3310/themedreview_41169, DOI 10.3310/THEMEDREVIEW_41169]; Office for National Statistics, 2021, COVID 19 DEATHS PREE; Office for National Statistics, 2021, DEATHS INVOLVING COV; Oliver D., 2020, BYLINE TIMES    1126; Roxby Philippa, 2021, BBC NEWS; Science Media Centre, 2020, EXP REACT BARR DECL; Shone E., 2021, SCOTSMAN	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n531	10.1136/bmj.n531	http://dx.doi.org/10.1136/bmj.n531			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664049	Bronze			2022-12-28	WOS:000632920100014
J	Mahase, E				Mahase, Elisabeth			Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2021	372								n617	10.1136/bmj.n617	http://dx.doi.org/10.1136/bmj.n617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6OT	33658188	Bronze			2022-12-28	WOS:000632918700005
J	Schumm, MA; Hadaya, JE; Mody, N; Myers, BA; Maggard-Gibbons, M				Schumm, Max A.; Hadaya, Joseph E.; Mody, Nisha; Myers, Bethany A.; Maggard-Gibbons, Melinda			Filtering Facepiece Respirator (N95 Respirator) Reprocessing A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VAPORIZED HYDROGEN-PEROXIDE; DECONTAMINATION METHODS; FIT; PERFORMANCE; VALIDATION; PARTICLES; IMPACT; REUSE	Question What methods of filtering facepiece respirator decontamination are effective and feasible? Findings Five decontamination processes and 42 studies were reviewed. Ultraviolet germicidal irradiation, moist heat, and microwave-generated steam processing were effective for pathogen removal, preserved respirator filtration, and had short treatment times and readily available equipment. Vaporized hydrogen peroxide is a suitable alternative with longer decontamination durations and is more expensive. Ethylene oxide may leave toxic residues and is less easily implemented. Meaning Ultraviolet germicidal irradiation, moist heat, and microwave-generated steam processing of filtering facepiece respirators are effective means for decontamination and are simple to implement. In the context of widespread reuse and reprocessing of N95 respirators due to shortages caused by the COVID-19 pandemic, this systematic review summarizes evidence on effectiveness and feasibility of 5 decontaminating processes: UV irradiation, vaporized hydrogen peroxide, moist-heat incubation, microwave-generated steam, and ethylene oxide. Importance The COVID-19 pandemic has resulted in a persistent shortage of personal protective equipment; therefore, a need exists for hospitals to reprocess filtering facepiece respirators (FFRs), such as N95 respirators. Objective To perform a systematic review to evaluate the evidence on effectiveness and feasibility of different processes used for decontaminating N95 respirators. Evidence Review A search of PubMed and EMBASE (through January 31, 2021) was completed for 5 types of respirator-decontaminating processes including UV irradiation, vaporized hydrogen peroxide, moist-heat incubation, microwave-generated steam, and ethylene oxide. Data were abstracted on process method, pathogen removal, mask filtration efficiency, facial fit, user safety, and processing capability. Findings Forty-two studies were included that examined 65 total types of masks. All were laboratory studies (no clinical trials), and 2 evaluated respirator performance and fit with actual clinical use of N95 respirators. Twenty-seven evaluated UV germicidal irradiation, 19 vaporized hydrogen peroxide, 9 moist-heat incubation, 10 microwave-generated steam, and 7 ethylene oxide. Forty-three types of N95 respirators were treated with UV irradiation. Doses of 1 to 2 J/cm(2) effectively sterilized most pathogens on N95 respirators (>10(3) reduction in influenza virus [4 studies], MS2 bacteriophage [3 studies], Bacillus spores [2 studies], Escherichia virus MS2 [1 study], vesicular stomatitis virus [1 study], and Middle East respiratory syndrome virus/SARS-CoV-1 [1 study]) without degrading respirator components. Doses higher than 1.5 to 2 J/cm(2) may be needed based on 2 studies demonstrating greater than 10(3) reduction in SARS-CoV-2. Vaporized hydrogen peroxide eradicated the pathogen in all 7 efficacy studies (>10(4) reduction in SARS-CoV-2 [3 studies] and >10(6) reduction of Bacillus and Geobacillus stearothermophilus spores [4 studies]). Pressurized chamber systems with higher concentrations of hydrogen peroxide caused FFR damage (6 studies), while open-room systems did not degrade respirator components. Moist heat effectively reduced SARS-CoV-2 (2 studies), influenza virus by greater than 10(4) (2 studies), vesicular stomatitis virus (1 study), and Escherichia coli (1 study) and preserved filtration efficiency and facial fit for 11 N95 respirators using preheated containers/chambers at 60 degrees C to 85 degrees C (5 studies); however, diminished filtration performance was seen for the Caron incubator. Microwave-generated steam (1100-W to 1800-W devices; 40 seconds to 3 minutes) effectively reduced pathogens by greater than 10(3) (influenza virus [2 studies], MS2 bacteriophage [3 studies], and Staphylococcus aureus [1 study]) and maintained filtration performance in 10 N95 respirators; however, damage was noted in least 1 respirator type in 4 studies. In 6 studies, ethylene oxide preserved respirator components in 16 N95 respirator types but left residual carcinogenic by-product (1 study). Conclusions and Relevance Ultraviolet germicidal irradiation, vaporized hydrogen peroxide, moist heat, and microwave-generated steam processing effectively sterilized N95 respirators and retained filtration performance. Ultraviolet irradiation and vaporized hydrogen peroxide damaged respirators the least. More research is needed on decontamination effectiveness for SARS-CoV-2 because few studies specifically examined this pathogen.	[Schumm, Max A.; Hadaya, Joseph E.; Maggard-Gibbons, Melinda] Univ Calif Los Angeles, Dept Surg, David Geffen Sch Med, 10833 Le Conte Ave,72-227 CHS, Los Angeles, CA 90025 USA; [Mody, Nisha; Myers, Bethany A.] Univ Calif Los Angeles, Louise M Darling Biomed Lib, UCLA Lib, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Schumm, MA (corresponding author), Univ Calif Los Angeles, Dept Surg, David Geffen Sch Med, 10833 Le Conte Ave,72-227 CHS, Los Angeles, CA 90025 USA.	mschumm@mednet.ucla.edu	Max A, Schumm/AAL-8180-2021	Max A, Schumm/0000-0001-9694-4185; Myers, Bethany/0000-0002-4137-6245				[Anonymous], MICROWAVE RES APPL I; [Anonymous], CARON 6010 ENV CHAMB; [Anonymous], UV C REPLACEMENT BUL; [Anonymous], CARON ENV TEST CHAMB; [Anonymous], BEST SELLERS COMMERC; Baluja A, 2020, J OCCUP ENVIRON HYG, V17, P390, DOI 10.1080/15459624.2020.1786576; Bar-On YM, 2020, ELIFE, V9, DOI 10.7554/eLife.57309; Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P1911, DOI 10.1001/jama.2020.4770; Bergman MS, 2010, J ENG FIBER FABR, V5, P33; Bergman MS., 2011, J INT SOC RESP PROT, V28, P12, DOI DOI 10.1080/15459624.2011.585927; Bourouiba L, 2020, JAMA-J AM MED ASSOC, V323, P1837, DOI 10.1001/jama.2020.4756; Boyce JM, 2019, INFECT CONT HOSP EP, V40, P1030, DOI 10.1017/ice.2019.161; Cadnum J.L., 2020, PATHOG IMMUN, V5, P52, DOI 10.20411/pai.v5i1.372; Centers for Disease Control and Prevention, RESP FACT SHEET; Centers for Disease Control and Prevention, 2020, DEC REUS FILT FAC RE; Daeschler SC, 2020, CAN MED ASSOC J, V192, pE1189, DOI 10.1503/cmaj.201203; Department of Health and Human Services, 2020, REC SPONS REQ EUAS D; Fischer RJ, 2020, EMERG INFECT DIS, V26, P2253, DOI 10.3201/eid2609.201524; Fisher E., 2010, J INT SOC RESP PROT, V27, P16; Fisher EM, 2011, J APPL MICROBIOL, V110, P287, DOI 10.1111/j.1365-2672.2010.04881.x; Fisher E, 2009, APPL ENVIRON MICROB, V75, P1500, DOI 10.1128/AEM.01653-08; Fisher EM, 2014, RISK ANAL, V34, P1423, DOI 10.1111/risa.12185; Fisher EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018585; Gilbert RM, 2020, GLOB HEALTH-SCI PRAC, V8, P582, DOI 10.9745/GHSP-D-20-00218; Goyal SM, 2014, J HOSP INFECT, V86, P255, DOI 10.1016/j.jhin.2014.02.003; Grillet AM, 2021, EXP BIOL MED, V246, P740, DOI 10.1177/1535370220976386; Heimbuch B., 2021, HHSF223201400158C FD; Heimbuch BK, 2011, AM J INFECT CONTROL, V39, pE1, DOI 10.1016/j.ajic.2010.07.004; Jatta M, 2021, AM J INFECT CONTROL, V49, P8, DOI 10.1016/j.ajic.2020.06.194; Jinot J, 2018, TOXICOL MECH METHOD, V28, P386, DOI 10.1080/15376516.2017.1414343; Jung S, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13010045; Kayani BJ, 2021, AM J INFECT CONTROL, V49, P424, DOI 10.1016/j.ajic.2020.11.010; Kumar A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243965; Levine C, 2021, J HOSP INFECT, V107, P50, DOI 10.1016/j.jhin.2020.10.007; Liao L, 2020, ACS NANO, V14, P6348, DOI 10.1021/acsnano.0c03597; Lieu A, 2020, AM J INFECT CONTROL, V48, P1457, DOI 10.1016/j.ajic.2020.08.010; Lin TH, 2018, INDOOR AIR, V28, P754, DOI 10.1111/ina.12475; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P509, DOI 10.1080/15459624.2015.1018518; Livingston E, 2020, JAMA-J AM MED ASSOC, V323, P1912, DOI 10.1001/jama.2020.5317; Lore MB, 2012, ANN OCCUP HYG, V56, P92, DOI 10.1093/annhyg/mer054; McCreanor V, 2017, AM J INFECT CONTROL, V45, P756, DOI 10.1016/j.ajic.2017.02.026; Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014; Mills D, 2018, AM J INFECT CONTROL, V46, pE49, DOI 10.1016/j.ajic.2018.02.018; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Occupational Safety and Health Administration, 2009, ASS PROT FACT REV RE; Ou QS, 2020, J AEROSOL SCI, V150, DOI 10.1016/j.jaerosci.2020.105609; Ozog D, 2020, J AM ACAD DERMATOL, V83, P672, DOI 10.1016/j.jaad.2020.05.008; Ozog DM, 2020, INT J INFECT DIS, V100, P224, DOI 10.1016/j.ijid.2020.08.077; Pascoe MJ, 2020, J HOSP INFECT, V106, P10, DOI 10.1016/j.jhin.2020.07.008; Peltier RE, 2020, INFECT CONT HOSP EP, V41, P1446, DOI 10.1017/ice.2020.332; Perkins DJ, 2020, EXP BIOL MED, V245, P933, DOI 10.1177/1535370220925768; Purschke M, 2020, APPL OPTICS, V59, P7585, DOI 10.1364/AO.401602; Reponen T, 2011, ANN OCCUP HYG, V55, P264, DOI 10.1093/annhyg/meq085; Richardson AW, 2020, MRS ADV, V5, P2881, DOI 10.1557/adv.2020.378; Rohit A, 2021, INT J INFECT DIS, V104, P41, DOI 10.1016/j.ijid.2020.12.070; Russo R, 2021, J HOSP INFECT, V109, P52, DOI 10.1016/j.jhin.2020.12.006; Saini V, 2020, GUT PATHOG, V12, DOI 10.1186/s13099-020-00367-4; Salter WB, 2010, J OCCUP ENVIRON HYG, V7, P437, DOI [10.1080/15459624.2010.484794, 10.1080/15459624.2010484794]; Sickbert-Bennett EE, 2020, JAMA INTERN MED, V180, P1607, DOI 10.1001/jamainternmed.2020.4221; Smith JS, 2021, J CLIN TRANSL SCI, V5, DOI 10.1017/cts.2020.494; US Food and Drug Administration, 2016, FIN REP BIOQ HYDR PE; Viscusi DJ, 2011, J OCCUP ENVIRON HYG, V8, P426, DOI 10.1080/15459624.2011.585927; Viscusi DJ, 2009, ANN OCCUP HYG, V53, P815, DOI 10.1093/annhyg/mep070; Viscusi DJ, 2007, J INT SOC RESP PROT, V24, P93; Vo E, 2009, APPL ENVIRON MICROB, V75, P7303, DOI 10.1128/AEM.00799-09; Woo MH, 2012, APPL ENVIRON MICROB, V78, P5781, DOI 10.1128/AEM.00465-12; Zulauf KE, 2020, MBIO, V11, DOI 10.1128/mBio.00997-20	68	15	15	3	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2021	325	13					1296	1317		10.1001/jama.2021.2531	http://dx.doi.org/10.1001/jama.2021.2531		MAR 2021	22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK4TM	33656543	Bronze			2022-12-28	WOS:000625441500003
J	Dyer, O				Dyer, Owen			Researcher broke embargo to leak BMJ paper to Trump administration	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer O, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3589; Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n590	10.1136/bmj.n590	http://dx.doi.org/10.1136/bmj.n590			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33649042	Bronze			2022-12-28	WOS:000625342000007
J	Nanna, MG; Newby, LK				Nanna, Michael G.; Newby, L. Kristin			In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Nanna, Michael G.; Newby, L. Kristin] Duke Clin Res Inst, Durham, NC 27701 USA	Duke University	Nanna, MG (corresponding author), Duke Clin Res Inst, Durham, NC 27701 USA.							Fihn SD, 2012, CIRCULATION, V126, P3097, DOI 10.1161/CIR.0b013e3182776f83; Stone GW, 2019, NEW ENGL J MED, V381, P1820, DOI 10.1056/NEJMoa1909406	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC27	JC27		10.7326/ACPJ202103160-027	http://dx.doi.org/10.7326/ACPJ202103160-027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646845				2022-12-28	WOS:000669667000002
J	Andersson, ER				Andersson, Emma R.			In the zone for liver proliferation	SCIENCE			English	Editorial Material							HOMEOSTASIS		[Andersson, Emma R.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Andersson, ER (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	emma.andersson@ki.se	Andersson, Emma/AAB-8532-2019; Andersson, Emma R/J-4236-2012	Andersson, Emma/0000-0002-8608-625X; Andersson, Emma R/0000-0002-8608-625X				Baron CS, 2019, NAT REV MOL CELL BIO, V20, P753, DOI 10.1038/s41580-019-0186-3; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; CADY B, 1979, AM J SURG, V137, P514, DOI 10.1016/0002-9610(79)90123-5; Chen F, 2020, CELL STEM CELL, V26, P27, DOI 10.1016/j.stem.2019.11.001; Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; He LJ, 2021, SCIENCE, V371, P905, DOI 10.1126/science.abc4346; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4; MONACO AP, 1964, ANN SURG, V159, P513, DOI 10.1097/00000658-196415940-00006; Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015; Russell JO, 2019, HEPATOLOGY, V69, P742, DOI 10.1002/hep.30270; Schaub JR, 2018, NATURE, V557, P247, DOI 10.1038/s41586-018-0075-5; Wei YL, 2021, SCIENCE, V371, P906, DOI 10.1126/science.abb1625	15	4	4	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					887	888		10.1126/science.abg4864	http://dx.doi.org/10.1126/science.abg4864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632834				2022-12-28	WOS:000621813400024
J	Rosen, J				Rosen, Julia			SHIFTING GROUND	SCIENCE			English	Editorial Material																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					876	880		10.1126/science.371.6532.876	http://dx.doi.org/10.1126/science.371.6532.876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632830				2022-12-28	WOS:000621813400020
J	Dyer, C				Dyer, Clare			GP academic can practise again after suspension for dishonesty is cut short	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, BMJ BRIT MED J; Dyer C, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m90; Dyer C, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4733	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n563	10.1136/bmj.n563	http://dx.doi.org/10.1136/bmj.n563			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632705				2022-12-28	WOS:000624298000007
J	Yang, WB; Cortijo, S; Korsbo, N; Roszak, P; Schiessl, K; Gurzadyan, A; Wightman, R; Jonsson, H; Meyerowitz, E				Yang, Weibing; Cortijo, Sandra; Korsbo, Niklas; Roszak, Pawel; Schiessl, Katharina; Gurzadyan, Aram; Wightman, Raymond; Jonsson, Henrik; Meyerowitz, Elliot			Molecular mechanism of cytokinin-activated cell division in Arabidopsis	SCIENCE			English	Article							R1R2R3-MYB PROTEINS; CYCLE; EXPRESSION; MULTIPLE; RECEPTOR; SHOOT; QUANTIFICATION; MORPHOGENESIS; TRANSCRIPTION; MERISTEMS	Mitogens trigger cell division in animals. In plants, cytokinins, a group of phytohormones derived from adenine, stimulate cell proliferation. Cytokinin signaling is initiated by membrane-associated histidine kinase receptors and transduced through a phosphorelay system. We show that in the Arabidopsis shoot apical meristem (SAM), cytokinin regulates cell division by promoting nuclear shuttling of Myb-domain protein 3R4 (MYB3R4), a transcription factor that activates mitotic gene expression. Newly synthesized MYB3R4 protein resides predominantly in the cytoplasm. At the G2-to-M transition, rapid nuclear accumulation of MYB3R4-consistent with an associated transient peak in cytokinin concentration-feeds a positive feedback loop involving importins and initiates a transcriptional cascade that drives mitosis and cytokinesis. An engineered nuclear-restricted MYB3R4 mimics the cytokinin effects of enhanced cell proliferation and meristem growth.	[Yang, Weibing; Cortijo, Sandra; Korsbo, Niklas; Roszak, Pawel; Schiessl, Katharina; Gurzadyan, Aram; Wightman, Raymond; Jonsson, Henrik; Meyerowitz, Elliot] Univ Cambridge, Sainsbury Lab, Bateman St, Cambridge CB2 1LR, England; [Korsbo, Niklas; Gurzadyan, Aram; Jonsson, Henrik] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; [Jonsson, Henrik] Lund Univ, Dept Astron & Theoret Phys, SE-22362 Lund, Sweden; [Meyerowitz, Elliot] CALTECH, Howard Hughes Med Inst, 1200 East Calif Blvd, Pasadena, CA 91125 USA; [Meyerowitz, Elliot] CALTECH, Div Biol & Biol Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA; [Yang, Weibing] Chinese Acad Sci, CAS Ctr Excellence Mol Plant Sci, Natl Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China; [Yang, Weibing] CAS JIC Ctr Excellence Plant & Microbial Sci CEPA, Shanghai 200032, Peoples R China; [Cortijo, Sandra] Univ Montpellier, BPMP, CNRS, INRAE,Inst Agro, Montpellier, France	University of Cambridge; University of Cambridge; Lund University; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Chinese Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); INRAE; Institut Agro; Universite de Montpellier	Jonsson, H; Meyerowitz, E (corresponding author), Univ Cambridge, Sainsbury Lab, Bateman St, Cambridge CB2 1LR, England.; Jonsson, H (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England.; Jonsson, H (corresponding author), Lund Univ, Dept Astron & Theoret Phys, SE-22362 Lund, Sweden.; Meyerowitz, E (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	henrik.jonssoe@slcu.cam.ac.uk; meyerow@caltech.edu	; Wightman, Raymond/G-1054-2017	Gurzadyan, Aram/0000-0003-0618-9361; Roszak, Pawel/0000-0002-7822-494X; Wightman, Raymond/0000-0003-1295-4875; Meyerowitz, Elliot/0000-0003-4798-5153; Cortijo, Sandra/0000-0003-3291-6729; Korsbo, Niklas/0000-0001-9811-3190; Schiessl, Katharina/0000-0002-7694-0619	Gatsby Charitable Foundation; Howard Hughes Medical Institute; Leverhulme Trust [RPG-2015-285]	Gatsby Charitable Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leverhulme Trust(Leverhulme Trust)	This work was supported by the Gatsby Charitable Foundation (GAT3395/DAA and GAT3395/PR4B to E.M.and H.J.).The laboratory of E.M. is supported by the Howard Hughes Medical Institute. R.W. received funding from Leverhulme Trust grant RPG-2015-285. The microscopy facility at the Sainsbury Laboratory is supported by the Gatsby Charitable Foundation.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Blecher-Gonen R, 2013, NAT PROTOC, V8, P539, DOI 10.1038/nprot.2013.023; Bourbousse C, 2018, P NATL ACAD SCI USA, V115, pE12453, DOI 10.1073/pnas.1810582115; Caesar K, 2011, J EXP BOT, V62, P5571, DOI 10.1093/jxb/err238; Chen PY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00676-4; de Reuille PB, 2015, ELIFE, V4, DOI 10.7554/eLife.05864; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Dobrev P, 2002, PLANT PHYSIOL BIOCH, V40, P333, DOI 10.1016/S0981-9428(02)01383-9; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Greb T, 2016, CURR BIOL, V26, pR816, DOI 10.1016/j.cub.2016.07.070; Haga N, 2007, DEVELOPMENT, V134, P1101, DOI 10.1242/dev.02801; Haga N, 2011, PLANT PHYSIOL, V157, P706, DOI 10.1104/pp.111.180836; Hellens RP, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-13; Heyman J, 2012, MOL PLANT, V5, P1182, DOI 10.1093/mp/sss094; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Huang WC, 2013, BIOINFORMATICS, V29, P3097, DOI 10.1093/bioinformatics/btt520; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Ito M, 2005, J PLANT RES, V118, P61, DOI 10.1007/s10265-005-0192-8; Jones AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15060; Kieber JJ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.149344; Kobayashi K, 2015, EMBO J, V34, P1992, DOI 10.15252/embj.201490899; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau OS, 2014, SCIENCE, V345, P1605, DOI 10.1126/science.1256888; Laureys F, 1998, FEBS LETT, V426, P29, DOI 10.1016/S0014-5793(98)00297-X; Lindsay DL, 2006, PLANT SCI, V170, P1111, DOI 10.1016/j.plantsci.2006.01.015; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Meier I, 2017, ANNU REV PLANT BIOL, V68, P139, DOI 10.1146/annurev-arplant-042916-041115; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; MILLER CO, 1955, J AM CHEM SOC, V77, P1392, DOI 10.1021/ja01610a105; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Moubayidin L, 2009, TRENDS PLANT SCI, V14, P557, DOI 10.1016/j.tplants.2009.06.010; NISHINARI N, 1986, PLANT CELL PHYSIOL, V27, P147; Palma K, 2005, CURR BIOL, V15, P1129, DOI 10.1016/j.cub.2005.05.022; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Redig P, 1996, FEBS LETT, V391, P175, DOI 10.1016/0014-5793(96)00728-4; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schaller GE, 2015, PLANT CELL, V27, P44, DOI 10.1105/tpc.114.133595; Schaller GE, 2014, CURR OPIN PLANT BIOL, V21, P7, DOI 10.1016/j.pbi.2014.05.015; Takahashi N, 2019, ELIFE, V8, DOI 10.7554/eLife.43944; Umeda M, 2019, CURR OPIN PLANT BIOL, V51, P1, DOI 10.1016/j.pbi.2019.03.001; Wang WP, 2018, P NATL ACAD SCI USA, V115, pE3045, DOI 10.1073/pnas.1715903115; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Wulfetange K, 2011, PLANT PHYSIOL, V156, P1808, DOI 10.1104/pp.111.180539; Wybouw B, 2019, TRENDS PLANT SCI, V24, P177, DOI 10.1016/j.tplants.2018.10.012; Yang WB, 2020, PLANT PHYSIOL, V182, P147, DOI 10.1104/pp.19.00980; Yang WB, 2017, MOL CELL, V68, P1108, DOI 10.1016/j.molcel.2017.11.008; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	56	32	33	32	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2021	371	6536					1350	+		10.1126/science.abe2305	http://dx.doi.org/10.1126/science.abe2305			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2GI	33632892	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000636043400047
J	Rimmer, A				Rimmer, Abi			NHS pensions: what do changes to the lifetime allowance mean?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HM Treasury, 2021, BUDG 2021 PROT JOBS; NHS Employers, 2020, APR 2020 BRIEF LIF A	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2021	372								n660	10.1136/bmj.n660	http://dx.doi.org/10.1136/bmj.n660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6QO	33687980				2022-12-28	WOS:000632923400009
J	Hsiue, EHC; Wright, KM; Douglass, J; Hwang, MS; Mog, BJ; Pearlman, AH; Paul, S; DiNapoli, SR; Konig, MF; Wang, Q; Schaefer, A; Miller, MS; Skora, AD; Azurmendi, PA; Murphy, MB; Liu, Q; Watson, E; Li, YN; Pardoll, DM; Bettegowda, C; Papadopoulos, N; Kinzler, KW; Vogelstein, B; Gabelli, SB; Zhou, SB				Hsiue, Emily Han-Chung; Wright, Katharine M.; Douglass, Jacqueline; Hwang, Michael S.; Mog, Brian J.; Pearlman, Alexander H.; Paul, Suman; DiNapoli, Sarah R.; Konig, Maximilian F.; Wang, Qing; Schaefer, Annika; Miller, Michelle S.; Skora, Andrew D.; Azurmendi, P. Aitana; Murphy, Michael B.; Liu, Qiang; Watson, Evangeline; Li, Yana; Pardoll, Drew M.; Bettegowda, Chetan; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Gabelli, Sandra B.; Zhou, Shibin			Targeting a neoantigen derived from a common TP53 mutation	SCIENCE			English	Article							RECEPTOR MIMIC ANTIBODY; TERM-FOLLOW-UP; T-CELLS; POTENT; PREDICTION; TOXICITY; EPITOPES; THERAPY; LESSONS; LYSIS	TP53 (tumor protein p53) is the most commonly mutated cancer driver gene, but drugs that target mutant tumor suppressor genes, such as TP53, are not yet available. Here, we describe the identification of an antibody highly specific to the most common TP53 mutation (R175H, in which arginine at position 175 is replaced with histidine) in complex with a common human leukocyte antigen-A (HLA-A) allele on the cell surface. We describe the structural basis of this specificity and its conversion into an immunotherapeutic agent: a bispecific single-chain diabody. Despite the extremely low p53 peptide-HLA complex density on the cancer cell surface, the bispecific antibody effectively activated T cells to lyse cancer cells that presented the neoantigen in vitro and in mice. This approach could in theory be used to target cancers containing mutations that are difficult to target in conventional ways.Y	[Hsiue, Emily Han-Chung; Douglass, Jacqueline; Hwang, Michael S.; Mog, Brian J.; Pearlman, Alexander H.; Paul, Suman; DiNapoli, Sarah R.; Konig, Maximilian F.; Wang, Qing; Schaefer, Annika; Skora, Andrew D.; Liu, Qiang; Watson, Evangeline; Bettegowda, Chetan; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Zhou, Shibin] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Ludwig Ctr, Baltimore, MD 21287 USA; [Hsiue, Emily Han-Chung; Wright, Katharine M.; Douglass, Jacqueline; Hwang, Michael S.; Mog, Brian J.; Pearlman, Alexander H.; Paul, Suman; DiNapoli, Sarah R.; Konig, Maximilian F.; Wang, Qing; Schaefer, Annika; Miller, Michelle S.; Skora, Andrew D.; Azurmendi, P. Aitana; Liu, Qiang; Watson, Evangeline; Vogelstein, Bert] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Hsiue, Emily Han-Chung; Douglass, Jacqueline; Hwang, Michael S.; Mog, Brian J.; Pearlman, Alexander H.; Paul, Suman; DiNapoli, Sarah R.; Konig, Maximilian F.; Schaefer, Annika; Liu, Qiang; Watson, Evangeline; Bettegowda, Chetan; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Zhou, Shibin] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Lustgarten Pancreat Canc Res Lab, Baltimore, MD 21287 USA; [Wright, Katharine M.; DiNapoli, Sarah R.; Azurmendi, P. Aitana; Li, Yana; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21287 USA; [Wright, Katharine M.; Miller, Michelle S.; Azurmendi, P. Aitana; Pardoll, Drew M.; Papadopoulos, Nickolas; Kinzler, Kenneth W.; Vogelstein, Bert; Zhou, Shibin] Sidney Kimmel Comprehens Canc Ctr, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21287 USA; [Mog, Brian J.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Paul, Suman; Pardoll, Drew M.; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Konig, Maximilian F.] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21224 USA; [Wang, Qing] Complete Omics, Baltimore, MD 21227 USA; [Murphy, Michael B.] Cytiva, Marlborough, MA 01752 USA; [Bettegowda, Chetan] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Papadopoulos, Nickolas; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Miller, Michelle S.] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Miller, Michelle S.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Skora, Andrew D.] Eli Lilly & Co, Lilly Biotechnol Ctr, San Diego, CA 92121 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Eli Lilly	Vogelstein, B; Zhou, SB (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Ludwig Ctr, Baltimore, MD 21287 USA.; Vogelstein, B (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Vogelstein, B; Zhou, SB (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Lustgarten Pancreat Canc Res Lab, Baltimore, MD 21287 USA.; Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21287 USA.; Vogelstein, B; Zhou, SB (corresponding author), Sidney Kimmel Comprehens Canc Ctr, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD 21287 USA.; Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA.; Vogelstein, B (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.; Gabelli, SB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	vogelbe@jhmi.edu; gabelli@jhmi.edu; sbzhou@jhmi.edu	Konig, Maximilian F/I-9356-2019; Gabelli, Sandra/A-3705-2008	Konig, Maximilian F/0000-0001-5045-5255; Wright, Katharine/0000-0001-9060-3849; Douglass, Jacqueline/0000-0002-9113-7090; Gabelli, Sandra/0000-0003-1205-5204; Mog, Brian/0000-0001-9988-7147; Hsiue, Emily Han-Chung/0000-0001-5882-5142; Wang, Qing/0000-0002-7979-766X; DiNapoli, Sarah/0000-0002-3675-9030; Paul, Suman/0000-0001-9357-3702; Pearlman, Alexander/0000-0002-3504-7517	Virginia and D. K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Commonwealth Fund; Bloomberg-Kimmel Institute for Cancer Immunotherapy; Bloomberg Philanthropies; Mark Foundation for Cancer Research; NIH Cancer Center support grant [P30 CA006973]; NIH [T32 GM73009, 5T32 CA009071-38, T32 AR048522]; SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship; NCI [R37 CA230400]; NIH, the National Institute of General Medical Sciences [P41GM111244]; U.S. Department of Energy (DOE) Office of Biological and Environmental Research [KP1605010]; National Synchrotron Light Source II at Brookhaven National Laboratory; DOE Office of Basic Energy Sciences [DE-SC0012704 (KC0401040)]	Virginia and D. K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Commonwealth Fund; Bloomberg-Kimmel Institute for Cancer Immunotherapy; Bloomberg Philanthropies; Mark Foundation for Cancer Research; NIH Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, the National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Synchrotron Light Source II at Brookhaven National Laboratory; DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the Virginia and D. K. Ludwig Fund for Cancer Research, the Lustgarten Foundation for Pancreatic Cancer Research, the Commonwealth Fund, the Bloomberg-Kimmel Institute for Cancer Immunotherapy, Bloomberg Philanthropies, the Mark Foundation for Cancer Research, and NIH Cancer Center support grant P30 CA006973. J.D., B.J.M., A.H. P., and S.R.D. were supported by NIH grant T32 GM73009. S.P. was supported by NIH grant 5T32 CA009071-38 and SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship. M.F.K. was supported by NIH grant T32 AR048522. C.B. was supported by NCI grant R37 CA230400. Work at the AMX (17-ID-1) and FMX (17-ID-2) beamlines was supported by the NIH, the National Institute of General Medical Sciences (P41GM111244), the U.S. Department of Energy (DOE) Office of Biological and Environmental Research (KP1605010), and the National Synchrotron Light Source II at Brookhaven National Laboratory, which is supported by the DOE Office of Basic Energy Sciences under contract DE-SC0012704 (KC0401040).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altman John D, 2016, Curr Protoc Immunol, V115, DOI 10.1002/cpim.14; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Ataie N, 2016, J MOL BIOL, V428, P194, DOI 10.1016/j.jmb.2015.12.002; BEVERLEY PCL, 1981, EUR J IMMUNOL, V11, P329, DOI 10.1002/eji.1830110412; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Chang AY, 2017, J CLIN INVEST, V127, P2705, DOI 10.1172/JCI92335; Chapuis AG, 2019, NAT MED, V25, P1064, DOI 10.1038/s41591-019-0472-9; Cheng M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1168557; Coles CH, 2020, J IMMUNOL, V204, P1943, DOI 10.4049/jimmunol.1900915; Dao T, 2015, NAT BIOTECHNOL, V33, P1079, DOI 10.1038/nbt.3349; Dao T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005661; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Douglass J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd5515; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gejman RS, 2020, CANCER IMMUNOL RES, V8, P672, DOI 10.1158/2326-6066.CIR-19-0745; Gerstung M, 2020, NATURE, V578, P122, DOI 10.1038/s41586-019-1907-7; Goebeler ME, 2020, NAT REV CLIN ONCOL, V17, P418, DOI 10.1038/s41571-020-0347-5; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gowthaman R, 2019, BIOINFORMATICS, V35, P5323, DOI 10.1093/bioinformatics/btz517; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Harper J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205491; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; JEFFERIES WA, 1987, EUR J IMMUNOL, V17, P1257, DOI 10.1002/eji.1830170907; Johnson, 2014, MACROGENICS; Junttila TT, 2014, CANCER RES, V74, P5561, DOI 10.1158/0008-5472.CAN-13-3622-T; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kula T, 2019, CELL, V178, P1016, DOI 10.1016/j.cell.2019.07.009; Labrijn AF, 2019, NAT REV DRUG DISCOV, V18, P585, DOI 10.1038/s41573-019-0028-1; Li DM, 2017, CANCER RES, V77, P2699, DOI 10.1158/0008-5472.CAN-16-3247; Li Q, 2008, ANGEW CHEM INT EDIT, V47, P10179, DOI 10.1002/anie.200803507; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Liu LQ, 2017, CLIN CANCER RES, V23, P1506, DOI 10.1158/1078-0432.CCR-16-0666; Lo W, 2019, CANCER IMMUNOL RES, V7, P534, DOI 10.1158/2326-6066.CIR-18-0686; Low L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13305-z; Malekzadeh P, 2019, J CLIN INVEST, V129, P1109, DOI 10.1172/JCI123791; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller MS, 2019, J BIOL CHEM, V294, P19322, DOI 10.1074/jbc.RA119.010251; Miller PJ, 2007, J MOL BIOL, V373, P315, DOI 10.1016/j.jmb.2007.07.028; Mishto M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02572; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NIJMAN HW, 1993, EUR J IMMUNOL, V23, P1215, DOI 10.1002/eji.1830230603; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Parkhurst MR, 2019, CANCER DISCOV, V9, P1022, DOI 10.1158/2159-8290.CD-18-1494; Paul S, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd3595; Pierce BG, 2013, PROTEIN SCI, V22, P35, DOI 10.1002/pro.2181; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rafiq S, 2017, LEUKEMIA, V31, P1788, DOI 10.1038/leu.2016.373; Rafiq S, 2020, NAT REV CLIN ONCOL, V17, P147, DOI 10.1038/s41571-019-0297-y; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Reusch U, 2015, MABS-AUSTIN, V7, P584, DOI 10.1080/19420862.2015.1029216; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Sarkizova S, 2020, NAT BIOTECHNOL, V38, P199, DOI 10.1038/s41587-019-0322-9; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Skora AD, 2015, P NATL ACAD SCI USA, V112, P9967, DOI 10.1073/pnas.1511996112; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Stone JD, 2012, ONCOIMMUNOLOGY, V1, P863, DOI 10.4161/onci.20592; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang Q, 2019, CANCER IMMUNOL RES, V7, P1748, DOI 10.1158/2326-6066.CIR-19-0107; Webb AI, 2004, J BIOL CHEM, V279, P23438, DOI 10.1074/jbc.M314066200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2011, METHODS, V55, P81, DOI 10.1016/j.ymeth.2011.06.010; Wu H, 1996, P NATL ACAD SCI USA, V93, P15030, DOI 10.1073/pnas.93.26.15030; Yoshiya N, 1989, Nihon Sanka Fujinka Gakkai Zasshi, V41, P7; ZHU ZP, 1995, INT J CANCER, V62, P319, DOI 10.1002/ijc.2910620315	84	98	100	35	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1009	+	eabc8697	10.1126/science.abc8697	http://dx.doi.org/10.1126/science.abc8697			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33649166	Green Accepted			2022-12-28	WOS:000625876100043
J	Chen, ZY; Arai, E; Khan, O; Zhang, Z; Ngiow, SF; He, Y; Huang, H; Manne, S; Cao, ZD; Baxter, AE; Cai, ZY; Freilich, E; Ali, MA; Giles, JR; Wu, JE; Greenplate, AR; Hakeem, MA; Chen, QZ; Kurachi, M; Nzingha, K; Ekshyyan, V; Mathew, D; Wen, ZY; Speck, NA; Battle, A; Berger, SL; Wherry, EJ; Shi, JW				Chen, Zeyu; Arai, Eri; Khan, Omar; Zhang, Zhen; Ngiow, Shin Foong; He, Yuan; Huang, Hua; Manne, Sasikanth; Cao, Zhendong; Baxter, Amy E.; Cai, Zhangying; Freilich, Elizabeth; Ali, Mohammed A.; Giles, Josephine R.; Wu, Jennifer E.; Greenplate, Allison R.; Hakeem, Mohamed A.; Chen, Qingzhou; Kurachi, Makoto; Nzingha, Kito; Ekshyyan, Viktoriya; Mathew, Divij; Wen, Zhuoyu; Speck, Nancy A.; Battle, Alexis; Berger, Shelley L.; Wherry, E. John; Shi, Junwei			In vivo CD8(+) T cell CRISPR screening reveals control by Fli1 in infection and cancer	CELL			English	Article							TRANSCRIPTION FACTOR IRF4; READ ALIGNMENT; EXHAUSTION; EFFECTOR; PD-1; CHROMATIN; GENE; EXPRESSION; CHECKPOINT; REGULATOR	Improving effector activity of antigen-specific T cells is a major goal in cancer immunotherapy. Despite the identification of several effector T cell (T-EFF)-driving transcription factors (TFs), the transcriptional coordination of T-EFF biology remains poorly understood. We developed an in vivo T cell CRISPR screening platform and identified a key mechanism restraining T-EFF biology through the ETS family TF, Fli1. Genetic deletion of Fli1 enhanced T-EFF responses without compromising memory or exhaustion precursors. Fli1 restrained T-EFF lineage differentiation by binding to cis-regulatory elements of effector-associated genes. Loss of Fli1 increased chromatin accessibility at ETS:RUNX motifs, allowing more efficient Runx3-driven T-EFF biology. CD8(+) T cells lacking Fli1 provided substantially better protection against multiple infections and tumors. These data indicate that Fli1 safeguards the developing CD8(+) T cell transcriptional landscape from excessive ETS:RUNX-driven T-EFF cell differentiation. Moreover, genetic deletion of Fli1 improves T-EFF differentiation and protective immunity in infections and cancer.	[Chen, Zeyu; Khan, Omar; Ngiow, Shin Foong; Huang, Hua; Manne, Sasikanth; Baxter, Amy E.; Cai, Zhangying; Ali, Mohammed A.; Giles, Josephine R.; Wu, Jennifer E.; Greenplate, Allison R.; Hakeem, Mohamed A.; Kurachi, Makoto; Nzingha, Kito; Ekshyyan, Viktoriya; Mathew, Divij; Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Chen, Zeyu; Khan, Omar; Ngiow, Shin Foong; Huang, Hua; Manne, Sasikanth; Baxter, Amy E.; Cai, Zhangying; Ali, Mohammed A.; Giles, Josephine R.; Wu, Jennifer E.; Greenplate, Allison R.; Hakeem, Mohamed A.; Kurachi, Makoto; Nzingha, Kito; Ekshyyan, Viktoriya; Mathew, Divij; Wherry, E. John; Shi, Junwei] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Chen, Zeyu; Arai, Eri; Cao, Zhendong; Freilich, Elizabeth; Chen, Qingzhou; Wen, Zhuoyu; Shi, Junwei] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Arai, Eri; Zhang, Zhen; Huang, Hua; Cao, Zhendong; Chen, Qingzhou; Berger, Shelley L.; Shi, Junwei] Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA; [Zhang, Zhen; Huang, Hua; Speck, Nancy A.; Berger, Shelley L.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Chen, Zeyu; Ngiow, Shin Foong; Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [He, Yuan; Battle, Alexis] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Khan, Omar] Arsenal Biosci, San Francisco, CA USA; [Kurachi, Makoto] Kanazawa Univ, Dept Biochem 1, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University; Kanazawa University	Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Wherry, EJ; Shi, JW (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Shi, JW (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.; Shi, JW (corresponding author), Univ Penn, Perelman Sch Med, Epigenet Inst, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	wherry@pennmedicine.upenn.edu; jushi@upenn.edu	Chen, Zeyu/HGE-0239-2022; Chen, Zeyu/HGF-2358-2022; Wu, Jennifer/GRX-1831-2022	Abdel Hakeem, Mohamed/0000-0003-0226-3464; Baxter, Amy/0000-0002-1555-0713; Khan, Omar/0000-0002-7641-6163	NIH [AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, AI149680, CA210944, CA234842, CA009140, MH109905, HG010480]; Stand Up 2 Cancer; Mark Foundation; Searle Scholars Program; Parker Institute for Cancer Immunotherapy; Australia NH&MRC CJ Martin Fellowship [1111469]; Mark Foundation Momentum Fellowship; Cancer Research InstituteMark Foundation Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up 2 Cancer; Mark Foundation; Searle Scholars Program; Parker Institute for Cancer Immunotherapy; Australia NH&MRC CJ Martin Fellowship; Mark Foundation Momentum Fellowship; Cancer Research InstituteMark Foundation Fellowship	We thank the Wherry and Shi Labs for discussions. This work was supported by grants from NIH (AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, AI149680, CA210944), Stand Up 2 Cancer (to E.J.W.), the Mark Foundation (to E.J.W.), NIH (CA234842 to Z. Chen, CA009140 to J.R.G., MH109905 and HG010480 to A.B.), and Searle Scholars Program (to A.B.). E.J.W. is supported by the Parker Institute for Cancer Immunotherapy that supports the cancer immunology program at UPenn. S.F.N. is supported by an Australia NH&MRC CJ Martin Fellowship (1111469) and the Mark Foundation Momentum Fellowship. J.R.G. is supported by Cancer Research InstituteMark Foundation Fellowship.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Brown CE, 2019, NAT REV IMMUNOL, V19, P73, DOI 10.1038/s41577-018-0119-y; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Chen ZY, 2017, CELL REP, V20, P2584, DOI 10.1016/j.celrep.2017.08.060; Cheng CK, 2008, BLOOD, V112, P3391, DOI 10.1182/blood-2008-02-137083; Choo A, 2006, CURR GENE THER, V6, P543, DOI 10.2174/156652306778520683; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dong MB, 2019, CELL, V178, P1189, DOI 10.1016/j.cell.2019.07.044; Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0; Pham D, 2019, CELL REP, V29, P1203, DOI 10.1016/j.celrep.2019.09.064; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Grevet JD, 2018, SCIENCE, V361, P285, DOI 10.1126/science.aao0932; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kaelin WG, 2017, NAT REV CANCER, V17, P441, DOI 10.1038/nrc.2017.32; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Koyama S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10501; Kruse EA, 2009, P NATL ACAD SCI USA, V106, P13814, DOI 10.1073/pnas.0906556106; Kurachi M, 2019, IMMUNITY, V51, P591, DOI 10.1016/j.immuni.2019.09.010; Kurachi M, 2017, NAT PROTOC, V12, P1980, DOI 10.1038/nprot.2017.083; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; LaFleur MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09656-2; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDSTEN T, 1988, EMBO J, V7, P2787, DOI 10.1002/j.1460-2075.1988.tb03133.x; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Martinez G.J., 2015, TRANSCRIPTION FACTOR, P265; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Shang WJ, 2018, P NATL ACAD SCI USA, V115, pE4051, DOI 10.1073/pnas.1801340115; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Skene PJ, 2018, NAT PROTOC, V13, P1006, DOI 10.1038/nprot.2018.015; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Tiemessen MM, 2014, J IMMUNOL, V193, P5480, DOI 10.4049/jimmunol.1303417; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wang DP, 2018, IMMUNITY, V48, P659, DOI 10.1016/j.immuni.2018.03.028; Wang G., 2019, NAT IMMUNOL, V168, P707; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2005, J VIROL, V79, P8960, DOI 10.1128/JVI.79.14.8960-8968.2005; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xing SJ, 2016, NAT IMMUNOL, V17, P695, DOI 10.1038/ni.3456; Xu L, 2019, NEW ENGL J MED, V381, P1240, DOI 10.1056/NEJMoa1817426; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	107	32	33	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1262	+		10.1016/j.cell.2021.02.019	http://dx.doi.org/10.1016/j.cell.2021.02.019		MAR 2021	41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33636129	Bronze, Green Accepted			2022-12-28	WOS:000629635700015
J	Heyde, A; Rohde, D; McAlpine, CS; Zhang, S; Hoyer, FF; Gerold, JM; Cheek, D; Iwamoto, Y; Schloss, MJ; Vandoorne, K; Iborra-Egea, O; Munoz-Guijosa, C; Bayes-Genis, A; Reiter, JG; Craig, M; Swirski, FK; Nahrendorf, M; Nowak, MA; Naxerova, K				Heyde, Alexander; Rohde, David; McAlpine, Cameron S.; Zhang, Shuang; Hoyer, Friedrich F.; Gerold, Jeffrey M.; Cheek, David; Iwamoto, Yoshiko; Schloss, Maximilian J.; Vandoorne, Katrien; Iborra-Egea, Oriol; Munoz-Guijosa, Christian; Bayes-Genis, Antoni; Reiter, Johannes G.; Craig, Morgan; Swirski, Filip K.; Nahrendorf, Matthias; Nowak, Martin A.; Naxerova, Kamila			Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis	CELL			English	Article							BONE-MARROW; MUTATIONS; ACCUMULATION; DRIVER; BLOOD; RISK	Clonal hematopoiesis, a condition in which individual hematopoietic stem cell clones generate a disproportionate fraction of blood leukocytes, correlates with higher risk for cardiovascular disease. The mechanisms behind this association are incompletely understood. Here, we show that hematopoietic stem cell division rates are increased in mice and humans with atherosclerosis. Mathematical analysis demonstrates that increased stem cell proliferation expedites somatic evolution and expansion of clones with driver mutations. The experimentally determined division rate elevation in atherosclerosis patients is sufficient to produce a 3.5-fold increased risk of clonal hematopoiesis by age 70. We confirm the accuracy of our theoretical framework in mouse models of atherosclerosis and sleep fragmentation by showing that expansion of competitively transplanted Tet2(-/-) cells is accelerated under conditions of chronically elevated hematopoietic activity. Hence, increased hematopoietic stem cell proliferation is an important factor contributing to the association between cardiovascular disease and clonal hematopoiesis.	[Heyde, Alexander; Gerold, Jeffrey M.; Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Rohde, David; McAlpine, Cameron S.; Zhang, Shuang; Hoyer, Friedrich F.; Cheek, David; Iwamoto, Yoshiko; Schloss, Maximilian J.; Vandoorne, Katrien; Swirski, Filip K.; Nahrendorf, Matthias; Naxerova, Kamila] Massachusetts Gen Hosp Res Inst, Ctr Syst Biol, Dept Radiol, Boston, MA 02114 USA; [Rohde, David; McAlpine, Cameron S.; Zhang, Shuang; Hoyer, Friedrich F.; Cheek, David; Iwamoto, Yoshiko; Schloss, Maximilian J.; Vandoorne, Katrien; Swirski, Filip K.; Nahrendorf, Matthias; Naxerova, Kamila] Harvard Med Sch, Boston, MA 02114 USA; [Iborra-Egea, Oriol; Munoz-Guijosa, Christian; Bayes-Genis, Antoni] Hosp Badalona Germans Trias & Pujol, CIBERCV, Inst Cor, Barcelona 08916, Spain; [Reiter, Johannes G.] Stanford Univ, Canary Ctr Canc Early Detect, Dept Radiol, Palo Alto, CA 94305 USA; [Craig, Morgan] Univ Montreal, Dept Math & Stat, Montreal, PQ H3T 1C5, Canada; [Craig, Morgan] Univ Montreal, St Justine Univ Hosp Res Ctr, Montreal, PQ H3T 1C5, Canada; [Nahrendorf, Matthias] Univ Hosp Wurzburg, Dept Internal Med 1, D-97080 Wurzburg, Germany; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Hospital Germans Trias i Pujol; Stanford University; Universite de Montreal; Universite de Montreal; University of Wurzburg; Harvard University	Naxerova, K (corresponding author), Massachusetts Gen Hosp Res Inst, Ctr Syst Biol, Dept Radiol, Boston, MA 02114 USA.	naxerova.kamila@mgh.harvard.edu	Egea, Oriol Iborra/AAL-3294-2020; Reiter, Johannes G./Y-4083-2019; Hoyer, Friedrich/AAC-8097-2022; Bayes-Genis, Antonio/AAV-9422-2021	Egea, Oriol Iborra/0000-0002-7280-859X; Reiter, Johannes G./0000-0002-0170-7353; Bayes-Genis, Antonio/0000-0002-3044-197X; Vandoorne, Katrien/0000-0002-8132-8280; Naxerova, Kamila/0000-0001-7744-5110; McAlpine, Cameron/0000-0002-9832-6345; Craig, Morgan/0000-0003-4852-4770	NIH [R37CA225655, R35HL139598, P01HL142494, T32HL076136, K99HL151750]; NSF [DGE-1144152]; German Research Foundation [RO5071/1-1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG))	This work was supported by NIH grants R37CA225655 (to K.N.), R35HL139598 (to M.N.), P01HL142494 (to K.N., M.N., and F.K.S.), and T32HL076136 (to M.J.S.); NSF grant DGE-1144152 (to A.H.); NIH grant K99HL151750 (to C.S.M.); and German Research Foundation grant RO5071/1-1 (to D.R.). We thank Drs. Razavi and Reis-Filho for sharing data and Kaley Joyes for her help editing the manuscript.	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Abkowitz JL, 2000, BLOOD, V96, P3399, DOI 10.1182/blood.V96.10.3399.h8003399_3399_3405; Abkowitz JL, 2002, BLOOD, V100, P2665, DOI 10.1182/blood-2002-03-0822; Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Ashcroft P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005803; AVERILL LE, 1989, AM J PATHOL, V135, P369; Bae T, 2018, SCIENCE, V359, P550, DOI 10.1126/science.aan8690; Basu S, 2002, BLOOD, V100, P854, DOI 10.1182/blood.V100.3.854; Bick Alexander G, 2020, medRxiv, DOI 10.1101/2020.11.06.20225607; Bick AG, 2020, CIRCULATION, V141, P124, DOI 10.1161/CIRCULATIONAHA.119.044362; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Buscarlet M, 2017, BLOOD, V130, P753, DOI 10.1182/blood-2017-04-777029; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Coombs CC, 2017, CELL STEM CELL, V21, P374, DOI 10.1016/j.stem.2017.07.010; Dorsheimer L, 2019, JAMA CARDIOL, V4, P25, DOI 10.1001/jamacardio.2018.3965; Dutta P, 2015, CELL STEM CELL, V16, P477, DOI 10.1016/j.stem.2015.04.008; FELDMAN DL, 1991, ARTERIOSCLER THROMB, V11, P985, DOI 10.1161/01.ATV.11.4.985; Fulcher DA, 1997, IMMUNOL CELL BIOL, V75, P446, DOI 10.1038/icb.1997.69; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gossel G, 2017, ELIFE, V6, DOI 10.7554/eLife.23013; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hidalgo A, 2019, CIRC RES, V124, P481, DOI 10.1161/CIRCRESAHA.119.314677; Hwang SM, 2018, LEUKEMIA RES, V71, P92, DOI 10.1016/j.leukres.2018.07.007; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; KARLIN S, 1962, B AM MATH SOC, V68, P204, DOI 10.1090/S0002-9904-1962-10749-6; Kaskie RE, 2020, CURR OPIN PSYCHOL, V34, P68, DOI 10.1016/j.copsyc.2019.09.011; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; Loh PR, 2018, NATURE, V559, P350, DOI 10.1038/s41586-018-0321-x; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; Moran P., 1962, STAT PROCESSES EVOLU; Murphy AJ, 2016, EUR HEART J, V37, P1113, DOI 10.1093/eurheartj/ehv718; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Osorio FG, 2018, CELL REP, V25, P2308, DOI 10.1016/j.celrep.2018.11.014; Otto SP, 2007, BIOL GUIDE MATH MODE; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pedersen KM, 2019, ARTERIOSCL THROM VAS, V39, P965, DOI 10.1161/ATVBAHA.118.312338; Razavi P, 2019, NAT MED, V25, P1928, DOI 10.1038/s41591-019-0652-7; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Sano S, 2018, CIRC RES, V123, P335, DOI 10.1161/CIRCRESAHA.118.313225; Sano S, 2018, J AM COLL CARDIOL, V71, P875, DOI 10.1016/j.jacc.2017.12.037; Silver AJ, 2019, ADV CANCER RES, V141, P85, DOI 10.1016/bs.acr.2018.12.003; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tefferi A, 2015, JAMA ONCOL, V1, P97, DOI 10.1001/jamaoncol.2015.89; Traulsen A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0810; van der Valk FM, 2017, EUR HEART J, V38, P425, DOI 10.1093/eurheartj/ehw246; Wakeley J., 2008, COALESCENT THEORY IN; Watson CJ, 2020, SCIENCE, V367, P1449, DOI 10.1126/science.aay9333; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	62	66	66	14	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1348	+		10.1016/j.cell.2021.01.049	http://dx.doi.org/10.1016/j.cell.2021.01.049		MAR 2021	36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33636128	Bronze, Green Accepted			2022-12-28	WOS:000629635700020
J	Jilg, N; Lau, ES; Baker, MA; Levy, BD; Loscalzo, J				Jilg, Nikolaus; Lau, Emily S.; Baker, Meghan A.; Levy, Bruce D.; Loscalzo, Joseph			A Treacherous Course	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEVERE LEPTOSPIROSIS		[Jilg, Nikolaus; Lau, Emily S.; Baker, Meghan A.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Jilg, Nikolaus] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Baker, Meghan A.] Harvard Med Sch, Dept Populat Med, Boston, MA 02115 USA; [Baker, Meghan A.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	blevy@bwh.harvard.edu	Loscalzo, Joseph/ABD-8980-2021; Jilg, Nikolaus/GON-5240-2022	Levy, Bruce David/0000-0001-9515-5731				Centers for Disease Control and Preven- tion, LEPTOSPIROSIS LEPTOS; Centers for Disease Control and Prevention, 2012, DOMESTIC EXAMINATION; Costa F, 2012, REV PANAM SALUD PUBL, V32, P169, DOI 10.1590/S1020-49892012000900001; Fonseka CL, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/4520185; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Guerrier G, 2017, AM J TROP MED HYG, V96, P791, DOI 10.4269/ajtmh.16-0457; Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5; Hartskeerl RA, 2011, CLIN MICROBIOL INFEC, V17, P494, DOI 10.1111/j.1469-0691.2011.03474.x; Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lo YC, 2011, EMERG INFECT DIS, V17, P1145, DOI [10.3201/eid1706.100980, 10.3201/eid/1706.100980]; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Rodrigo C, 2014, T ROY SOC TROP MED H, V108, P743, DOI 10.1093/trstmh/tru148; Sejvar J, 2003, EMERG INFECT DIS, V9, P702; Togami E, 2018, AM J TROP MED HYG, V99, P849, DOI 10.4269/ajtmh.18-0335	15	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					860	865		10.1056/NEJMcps2020668	http://dx.doi.org/10.1056/NEJMcps2020668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33657298				2022-12-28	WOS:000626124800021
J	Zhang, L; Wu, FC; Hou, SC; Zhang, Z; Chou, YH; Watanabe, K; Taniguchi, T; Forrest, SR; Deng, H				Zhang, Long; Wu, Fengcheng; Hou, Shaocong; Zhang, Zhe; Chou, Yu-Hsun; Watanabe, Kenji; Taniguchi, Takashi; Forrest, Stephen R.; Deng, Hui			Van der Waals heterostructure polaritons with moire-induced nonlinearity	NATURE			English	Article								Controlling matter-light interactions with cavities is of fundamental importance in modern science and technology(1). This is exemplified in the strong-coupling regime, where matter-light hybrid modes form, with properties that are controllable by optical-wavelength photons(2,3). By contrast, matter excitations on the nanometre scale are harder to access. In two-dimensional van der Waals heterostructures, a tunable moire lattice potential for electronic excitations may form(4), enabling the generation of correlated electron gases in the lattice potentials(5-9). Excitons confined in moire lattices have also been reported(10,11), but no cooperative effects have been observed and interactions with light have remained perturbative(12-15). Here, by integrating MoSe2-WS2 heterobilayers in a microcavity, we establish cooperative coupling between moire-lattice excitons and microcavity photons up to the temperature of liquid nitrogen, thereby integrating versatile control of both matter and light into one platform. The density dependence of the moire polaritons reveals strong nonlinearity due to exciton blockade, suppressed exciton energy shift and suppressed excitation-induced dephasing, all of which are consistent with the quantum confined nature of the moire excitons. Such a moire polariton system combines strong nonlinearity and microscopic-scale tuning of matter excitations using cavity engineering and long-range light coherence, providing a platform with which to study collective phenomena from tunable arrays of quantum emitters.	[Zhang, Long; Zhang, Zhe; Forrest, Stephen R.; Deng, Hui] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Zhang, Long] Xiamen Univ, Dept Phys, Xiamen, Fujian, Peoples R China; [Wu, Fengcheng] Univ Maryland, Dept Phys, Condensed Matter Theory Ctr, College Pk, MD 20742 USA; [Wu, Fengcheng] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Hou, Shaocong; Forrest, Stephen R.] Univ Michigan, Dept Elect Engn & Comp Sci, Ann Arbor, MI 48109 USA; [Chou, Yu-Hsun] Natl Cheng Kung Univ, Dept Photon, Tainan, Taiwan; [Watanabe, Kenji] Natl Inst Mat Sci, Funct Mat Res Ctr, Tsukuba, Ibaraki, Japan; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan	University of Michigan System; University of Michigan; Xiamen University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of Michigan System; University of Michigan; National Cheng Kung University; National Institute for Materials Science; National Institute for Materials Science	Deng, H (corresponding author), Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA.	dengh@umich.edu	Watanabe, Kenji/ABB-2135-2021; Deng, Hui/AAD-6979-2020; Deng, Hui/E-8950-2010; Hou, Shaocong/ABD-5281-2021; Wu, Fengcheng/AAD-8588-2020; Zhang, Long/AAM-3265-2021	Watanabe, Kenji/0000-0003-3701-8119; Deng, Hui/0000-0003-0629-3230; Deng, Hui/0000-0003-0629-3230; Hou, Shaocong/0000-0001-6162-4448; Wu, Fengcheng/0000-0002-1185-0073; Forrest, Stephen/0000-0003-0131-1903	Army Research Office [W911NF-17-1-0312]; Air Force Office of Scientific Research [FA2386-18-1-4086]; National Science Foundation [DMR 1838412]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0017971]; Laboratory for Physical Sciences; Young Scholar Fellowship Program of the Ministry of Science and Technology (MOST) in Taiwan [MOST 108-2636-M006-010]; Elemental Strategy Initiative by MEXT, Japan [JPMXP0112101001]; JSPS KAKENHI [JP20H00354]; CREST, JST [JPMJCR15F3]	Army Research Office; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Laboratory for Physical Sciences; Young Scholar Fellowship Program of the Ministry of Science and Technology (MOST) in Taiwan; Elemental Strategy Initiative by MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We are grateful to D. Steel and M. Kira for discussions. L.Z., S.H., S.R.F. and H.D. acknowledge support by the Army Research Office under award W911NF-17-1-0312. L.Z. and H.D. also acknowledge support by the Air Force Office of Scientific Research under award FA2386-18-1-4086 and by the National Science Foundation under award DMR 1838412. S.R.F. also acknowledges support from the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under award DE-SC0017971. F.W. is supported by the Laboratory for Physical Sciences. Y.-H.C. acknowledges support by the Young Scholar Fellowship Program of the Ministry of Science and Technology (MOST) in Taiwan, under grant MOST 108-2636-M006-010. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by MEXT, Japan, grant number JPMXP0112101001, JSPS KAKENHI grant number JP20H00354 and CREST (JPMJCR15F3), JST.	Alexeev EM, 2019, NATURE, V567, P81, DOI 10.1038/s41586-019-0986-9; Ballarini D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2734; Barachati F, 2018, NAT NANOTECHNOL, V13, P906, DOI 10.1038/s41565-018-0219-7; Berloff NG, 2017, NAT MATER, V16, P1120, DOI [10.1038/NMAT4971, 10.1038/nmat4971]; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chernikov A, 2015, NAT PHOTONICS, V9, P466, DOI 10.1038/NPHOTON.2015.104; Daskalakis KS, 2014, NAT MATER, V13, P272, DOI [10.1038/NMAT3874, 10.1038/nmat3874]; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Deiteil A, 2019, NAT MATER, V18, P219, DOI 10.1038/s41563-019-0282-y; Deng H, 2010, REV MOD PHYS, V82, P1489, DOI 10.1103/RevModPhys.82.1489; Emmanuele RPA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17340-z; Gonzalez-Tudela A, 2015, NAT PHOTONICS, V9, P320, DOI 10.1038/NPHOTON.2015.54; Gu J., 2019, PREPRINT; HUANG D, 1990, PHYS REV B, V42, P5147, DOI 10.1103/PhysRevB.42.5147; Jin CH, 2019, NATURE, V567, P76, DOI 10.1038/s41586-019-0976-y; Tran K, 2019, NATURE, V567, P71, DOI 10.1038/s41586-019-0975-z; Kim S, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.085302; Kravtsov V, 2020, LIGHT-SCI APPL, V9, DOI 10.1038/s41377-020-0286-z; Leonard J, 2017, NATURE, V543, P87, DOI 10.1038/nature21067; Moody G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9315; Munoz-Matutano G, 2019, NAT MATER, V18, P213, DOI 10.1038/s41563-019-0281-z; Regan EC, 2020, NATURE, V579, P359, DOI 10.1038/s41586-020-2092-4; Ritsch H, 2013, REV MOD PHYS, V85, P553, DOI 10.1103/RevModPhys.85.553; Schneider C, 2017, REP PROG PHYS, V80, DOI 10.1088/0034-4885/80/1/016503; Scuri G, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.037402; Seyler KL, 2019, NATURE, V567, P66, DOI 10.1038/s41586-019-0957-1; Shimazaki Y, 2020, NATURE, V580, P472, DOI 10.1038/s41586-020-2191-2; Tan L, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021011; Tang YH, 2020, NATURE, V579, P353, DOI 10.1038/s41586-020-2085-3; Walker PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9317; Walther H, 2006, REP PROG PHYS, V69, P1325, DOI 10.1088/0034-4885/69/5/R02; Wu FC, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.147401; Yu HY, 2020, SCI BULL, V65, P1555, DOI 10.1016/j.scib.2020.05.030; Yu HY, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701696; Zhang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17233-1; Zhang T, 2020, OPTOELECTRON LETT, V16, P52, DOI 10.1007/s11801-020-9032-2	37	46	46	39	163	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					61	+		10.1038/s41586-021-03228-5	http://dx.doi.org/10.1038/s41586-021-03228-5			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33658695	Green Submitted			2022-12-28	WOS:000626921700011
J	Horio, N; Liberles, SD				Horio, Nao; Liberles, Stephen D.			Hunger enhances food-odour attraction through a neuropeptide Y spotlight	NATURE			English	Article								Internal state controls olfaction through poorly understood mechanisms. Odours that represent food, mates, competitors and predators activate parallel neural circuits that may be flexibly shaped by physiological need to alter behavioural outcome(1). Here we identify a neuronal mechanism by which hunger selectively promotes attraction to food odours over other olfactory cues. Optogenetic activation of hypothalamic agouti-related peptide (AGRP) neurons enhances attraction to food odours but not to pheromones, and branch-specific activation and inhibition reveal a key role for projections to the paraventricularthalamus. Mice that lack neuropeptide Y (NPY) or NPY receptor type 5 (NPY5R) fail toprefer food odours over pheromones after fasting, and hunger-dependent food-odour attraction is restored by cell-specific NPY rescue in AGRP neurons. Furthermore, acute NPY injection immediately rescues food-odour preference without additional training, indicating that NPY is required for reading olfactory circuits during behavioural expression rather than writing olfactory circuits during odour learning. Together, these findings show that food-odour-responsive neurons comprise an olfactory subcircuit that listens to hunger state through thalamic NPY release, and more generally, provide mechanisticinsights into how internal state regulates behaviour.	[Horio, Nao; Liberles, Stephen D.] Harvard Med Sch, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Liberles, SD (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	Stephen_Liberles@hms.harvard.edu		Liberles, Stephen/0000-0002-2177-9741	National Institutes of Health [R01 DC013289]; Uehara Memorial Foundation; Mishima Kaiun Memorial Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation)	We thank B. Lowell, M. Andermann, S. Datta, M. Albers, J. Flanagan, C. Ran and K. Tao for comments on the manuscript; Q. Li and K. Tao for experimental assistance; and the Nikon Imaging Center at Harvard Medical School for microscopy assistance. The work was supported by a National Institutes of Health grant to S.D.L. (R01 DC013289) and a Uehara Memorial Foundation postdoctoral fellowship and Mishima Kaiun Memorial Foundation funding to N.H. S.D.L. is an investigator of the Howard Hughes Medical Institute.	Alhadeff AL, 2018, CELL, V173, P140, DOI 10.1016/j.cell.2018.02.057; Andermann ML, 2017, NEURON, V95, P757, DOI 10.1016/j.neuron.2017.06.014; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Ben-Shaul Y, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0377-3; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002; Burnett CJ, 2019, ELIFE, V8, DOI 10.7554/eLife.44527; Chen YM, 2019, ELIFE, V8, DOI 10.7554/eLife.46348; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; Essner RA, 2017, J NEUROSCI, V37, P8678, DOI 10.1523/JNEUROSCI.0798-17.2017; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Kirouac GJ, 2015, NEUROSCI BIOBEHAV R, V56, P315, DOI 10.1016/j.neubiorev.2015.08.005; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Li Q, 2015, CURR BIOL, V25, pR120, DOI 10.1016/j.cub.2014.11.044; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Livneh Y, 2017, NATURE, V546, P611, DOI 10.1038/nature22375; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Negroni J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045266; Otis JM, 2019, NEURON, V103, P423, DOI 10.1016/j.neuron.2019.05.018; Padilla SL, 2016, NAT NEUROSCI, V19, P734, DOI 10.1038/nn.4274; Rolls ET, 2015, PROG NEUROBIOL, V127, P64, DOI 10.1016/j.pneurobio.2015.03.002; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Rousseaux M, 1996, STROKE, V27, P2328, DOI 10.1161/01.STR.27.12.2328; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Tham WWP, 2009, BRAIN RES REV, V62, P109, DOI 10.1016/j.brainresrev.2009.09.007; Tong J, 2011, J NEUROSCI, V31, P5841, DOI 10.1523/JNEUROSCI.5680-10.2011; Zhu YJ, 2018, SCIENCE, V362, P423, DOI 10.1126/science.aat0481	32	16	17	11	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2021	592	7853					262	+		10.1038/s41586-021-03299-4	http://dx.doi.org/10.1038/s41586-021-03299-4		MAR 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8ZE	33658716	Green Accepted			2022-12-28	WOS:000625125200005
J	Stewart, RAH; Jones, P; Dicker, B; Jiang, YN; Smith, T; Swain, A; Kerr, A; Scott, T; Smyth, D; Ranchord, A; Edmond, J; Than, M; Webster, M; White, HD; Devlin, G				Stewart, Ralph A. H.; Jones, Peter; Dicker, Bridget; Jiang, Yannan; Smith, Tony; Swain, Andrew; Kerr, Andrew; Scott, Tony; Smyth, David; Ranchord, Anil; Edmond, John; Than, Martin; Webster, Mark; White, Harvey D.; Devlin, Gerard			High flow oxygen and risk of mortality in patients with a -suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; TASK-FORCE; THERAPY; MANAGEMENT	OBJECTIVE To determine the association between high flow supplementary oxygen and 30 day mortality in patients presenting with a suspected acute coronary syndrome (ACS). DESIGN Pragmatic, cluster randomised, crossover trial. SETTING Four geographical regions in New Zealand. PARTICIPANTS 40 872 patients with suspected or confirmed ACS included in the All New Zealand Acute Coronary Syndrome Quality Improvement registry or ambulance ACS pathway during the study periods. 20 304 patients were managed using the high oxygen protocol and 20 568 were managed using the low oxygen protocol. Final diagnosis of ST elevation myocardial infarction (STEMI) and non-STEMI were determined from the registry and ICD-10 discharge codes. INTERVENTIONS The four geographical regions were randomly allocated to each of two oxygen protocols in six month blocks over two years. The high oxygen protocol recommended oxygen at 6-8 L/min by face mask for ischaemic symptoms or electrocardiographic changes, irrespective of the transcapillary oxygen saturation (SpO(2)). The low oxygen protocol recommended oxygen only if SpO(2) was less than 90%, with a target SpO(2) of less than 95%. MAIN OUTCOME MEASURE 30 day all cause mortality determined from linkage to administrative data. RESULTS Personal and clinical characteristics of patients managed under both oxygen protocols were well matched. For patients with suspected ACS, 30 day mortality for the high and low oxygen groups was 613 (3.0%) and 642 (3.1%), respectively (odds ratio 0.97, 95% confidence interval 0.86 to 1.08). For 4159 (10%) patients with STEMI, 30 day mortality for the high and low oxygen groups was 8.8% (n=178) and 10.6% (n=225), respectively (0.81, 0.66 to 1.00) and for 10 218 (25%) patients with non-STEMI was 3.6% (n=187) and 3.5% (n=176), respectively (1.05, 0.85 to 1.29). CONCLUSION In a large patient cohort presenting with suspected ACS, high flow oxygen was not associated with an increase or decrease in 30 day mortality.	[Stewart, Ralph A. H.; Webster, Mark; White, Harvey D.] Auckland City Hosp, Green Lane Cardiovasc Serv, Private Bag 92024, Auckland 1030, New Zealand; [Stewart, Ralph A. H.; Webster, Mark; White, Harvey D.] Univ Auckland, Dept Med, Auckland, New Zealand; [Jones, Peter] Auckland City Hosp, Emergency Med Res, Auckland, New Zealand; [Jones, Peter] Univ Auckland, Dept Surg, Auckland, New Zealand; [Dicker, Bridget] St John Auckland, Auckland, New Zealand; [Dicker, Bridget] Auckland Univ Technol, Paramed Dept, Auckland, New Zealand; [Jiang, Yannan] Univ Auckland, Natl Inst Hlth Innovat, Auckland, New Zealand; [Smith, Tony] St John Ambulance, Auckland, New Zealand; [Swain, Andrew] Wellington Free Ambulance, Wellington, New Zealand; [Kerr, Andrew] Middlemore Hosp, Dept Cardiol, Otahuhu, Aukland, New Zealand; [Kerr, Andrew] Univ Auckland, Sect Epidemiol & Biostat, Auckland, New Zealand; [Scott, Tony] Northshore Hosp, Cardiol Dept, Auckland, New Zealand; [Smyth, David] Canterbury Dist Hlth Board, Christchurch, New Zealand; [Ranchord, Anil] Wellington Hosp, Cardiol Dept, Capital & Coast Dist Hlth Board, Wellington, New Zealand; [Edmond, John] Southern Dist Hlth Board, Dunedin, New Zealand; [Edmond, John] Univ Otago, Dunedin Sch Med, Dunedin, New Zealand; [Than, Martin] Christchurch Hosp, Dept Emergency Med, Christchurch, New Zealand; [Devlin, Gerard] Hauroa Tairawhiti Gisborne & Heart Fdn New Zealan, Gisborn, New Zealand	Auckland City Hospital; University of Auckland; Auckland City Hospital; University of Auckland; Auckland University of Technology; University of Auckland; University of Auckland; Dunedin Public Hospital; University of Otago; Christchurch Hospital New Zealand	Stewart, RAH (corresponding author), Auckland City Hosp, Green Lane Cardiovasc Serv, Private Bag 92024, Auckland 1030, New Zealand.; Stewart, RAH (corresponding author), Univ Auckland, Dept Med, Auckland, New Zealand.	rstewart@adhb.govt.nz	Dicker, Bridget/F-8770-2019	Dicker, Bridget/0000-0002-8151-7356	National Heart Foundation of New Zealand [1649]; Health Research Council of New Zealand (HRC); Ministry of Health [ANZACS-QI 41]; HRC	National Heart Foundation of New Zealand; Health Research Council of New Zealand (HRC)(Health Research Council of New Zealand); Ministry of Health; HRC	This work was supported by the National Heart Foundation of New Zealand (grant No 1649) and by the Health Research Council of New Zealand (HRC) clinical practitioner fellowships to RAHS and MT. The trial was undertaken as part of the All New Zealand Acute Coronary Syndrome Quality Improvement (ANZACS-QI), which is funded by the Ministry of Health (ANZACS-QI 41). Data linkage for mortality was obtained through the VIEW programme funded by the HRC. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; Atkinson J., 2014, NZDEP2013 INDEX DEPR; Beasley R, 2007, J ROY SOC MED, V100, P130, DOI 10.1258/jrsm.100.3.130; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Hofmann R, 2017, NEW ENGL J MED, V377, P1240, DOI 10.1056/NEJMoa1706222; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; James SK, 2020, JACC-CARDIOVASC INTE, V13, P502, DOI 10.1016/j.jcin.2019.09.016; Kerr AJ, 2016, NEW ZEAL MED J, V129, P23; Kerr AJ, 2019, NEW ZEAL MED J, V132, P19; Kohn MA, 2005, J EMERG MED, V29, P383, DOI 10.1016/j.jemermed.2005.04.010; McNulty PH, 2005, AM J PHYSIOL-HEART C, V288, pH1057, DOI 10.1152/ajpheart.00625.2004; O'Driscoll BR, 2017, THORAX, V72, DOI 10.1136/thoraxjnl-2016-209729; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Sepehrvand N, 2018, HEART, V104, P1691, DOI 10.1136/heartjnl-2018-313089; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012	17	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n355	10.1136/bmj.n355	http://dx.doi.org/10.1136/bmj.n355			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653685	hybrid, Green Published			2022-12-28	WOS:000625340300013
J	Wilcock, W				Wilcock, William			Illuminating tremors in the deep	SCIENCE			English	Editorial Material									[Wilcock, William] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wilcock, W (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	wilcock@uw.edu		Wilcock, William/0000-0001-7224-7246				Aoi S, 2020, EARTH PLANETS SPACE, V72, DOI 10.1186/s40623-020-01250-x; Howe BM, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00424; Kawakatsu H., 2016, EGU GEN ASSEMBLY 201, V18; Kohler MD, 2020, SEISMOL RES LETT, V91, P1343, DOI 10.1785/0220190123; Lindsey NJ, 2019, SCIENCE, V366, P1103, DOI 10.1126/science.aay5881; Marra G, 2018, SCIENCE, V361, P486, DOI 10.1126/science.aat4458; Parker T., 2014, 1 BREAK, V32; Simons FJ, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006088; Sladen A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13793-z; Williams EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13262-7; You YZ, 2010, NATURE, V466, P690, DOI 10.1038/466690a; Zhan ZW, 2021, SCIENCE, V371, P931, DOI 10.1126/science.abe6648	12	0	0	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					882	884		10.1126/science.abg4479	http://dx.doi.org/10.1126/science.abg4479			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632831				2022-12-28	WOS:000621813400021
J	Zhan, ZW; Cantono, M; Kamalov, V; Mecozzi, A; Muller, R; Yin, S; Castellanos, JC				Zhan, Zhongwen; Cantono, Mattia; Kamalov, Valey; Mecozzi, Antonio; Mueller, Rafael; Yin, Shuang; Castellanos, Jorge C.			Optical polarization-based seismic and water wave sensing on transoceanic cables	SCIENCE			English	Article							MODE DISPERSION; MAGNITUDE; PMD	Seafloor geophysical instrumentation is challenging to deploy and maintain but critical for studying submarine earthquakes and Earth's interior. Emerging fiber-optic sensing technologies that can leverage submarine telecommunication cables present an opportunity to fill the data gap. We successfully sensed seismic and water waves over a 10,000-kilometer-long submarine cable connecting Los Angeles, California, and Valparaiso, Chile, by monitoring the polarization of regular optical telecommunication channels. We detected multiple moderate-to-large earthquakes along the cable in the 10-millihertz to 5-hertz band. We also recorded pressure signals from ocean swells in the primary microseism band, implying the potential for tsunami sensing. Our method, because it does not require specialized equipment, laser sources, or dedicated fibers, is highly scalable for converting global submarine cables into continuous real-time earthquake and tsunami observatories.	[Zhan, Zhongwen; Castellanos, Jorge C.] CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA; [Cantono, Mattia; Kamalov, Valey; Mueller, Rafael; Yin, Shuang] Google LLC, Mountain View, CA USA; [Mecozzi, Antonio] Univ Aquila, Dept Phys & Chem Sci, Coppito, Italy	California Institute of Technology; University of L'Aquila	Zhan, ZW (corresponding author), CALTECH, Div Geol & Planetary Sci, Seismol Lab, Pasadena, CA 91125 USA.	zwzhan@caltech.edu	Mecozzi, Antonio/D-8464-2011; Yin, Shuang/B-7416-2014	Mecozzi, Antonio/0000-0001-8730-5699; Yin, Shuang/0000-0002-5384-4018; Cantono, Mattia/0000-0001-8619-4480; Zhan, Zhongwen/0000-0002-5586-2607; Kamalov, Valey/0000-0002-5020-5499	Gordon and Betty Moore Foundation - Italian Government through the INCIPICT project	Gordon and Betty Moore Foundation - Italian Government through the INCIPICT project	Z.Z. and J.C.C. are funded by the Gordon and Betty Moore Foundation. A.M. is partially funded by the Italian Government through the INCIPICT project.	Bernard E, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0371; Boaz R. I, 2006, 20051438 USGS; Born G, 2000, PHYS TODAY, V53, P74, DOI 10.1063/1.1292494; Born M., 2013, PRINCIPLES OPTICS EL; BUDIANSKY B, 1979, APPL OPTICS, V18, P4085, DOI 10.1364/AO.18.004085; Burgmann R, 2014, ANNU REV EARTH PL SC, V42, P509, DOI 10.1146/annurev-earth-060313-054953; Charlet G, 2009, J LIGHTWAVE TECHNOL, V27, P153, DOI 10.1109/JLT.2008.2005506; Charlton D, 2017, OPT EXPRESS, V25, P9689, DOI 10.1364/OE.25.009689; CHUA TH, 1989, APPL OPTICS, V28, P3158, DOI 10.1364/AO.28.003158; Clivati C, 2020, OPT EXPRESS, V28, P8494, DOI 10.1364/OE.378602; Clivati C, 2018, OPTICA, V5, P893, DOI 10.1364/OPTICA.5.000893; EISSLER H, 1986, GEOPHYS RES LETT, V13, P569, DOI 10.1029/GL013i006p00569; EVANGELIDES SG, 1992, J LIGHTWAVE TECHNOL, V10, P28, DOI 10.1109/50.108732; Fludger CRS, 2008, J LIGHTWAVE TECHNOL, V26, P64, DOI 10.1109/JLT.2007.912128; Galtarossa A, 2000, OPT LETT, V25, P384, DOI 10.1364/OL.25.000384; Geyer JC, 2008, IEEE PHOTONIC TECH L, V20, P776, DOI 10.1109/LPT.2008.921104; Gordon JP, 2000, P NATL ACAD SCI USA, V97, P4541, DOI 10.1073/pnas.97.9.4541; Hansryd J, 2000, IEEE PHOTONIC TECH L, V12, P1261, DOI 10.1109/68.874255; Haubrich R., 1963, B SEISMOL SOC AM, V53, P27, DOI [10.1785/bssa0530010027, DOI 10.1785/BSSA0530010027]; Howe BM, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00424; Jing Liu, 2013, Arxiv, DOI arXiv:1306.4383; Kanamori H, 2019, GEOPHYS J INT, V218, P1, DOI 10.1093/gji/ggz113; Kanamori H, 2008, GEOPHYS J INT, V175, P222, DOI 10.1111/j.1365-246X.2008.03887.x; Karlsson M, 1999, OPT LETT, V24, P939, DOI 10.1364/OL.24.000939; Karlsson M, 2000, J LIGHTWAVE TECHNOL, V18, P941, DOI 10.1109/50.850739; Krummrich P. M., 2005, FIELD TRIAL RESULTS; Lindsey NJ, 2019, SCIENCE, V366, P1103, DOI 10.1126/science.aay5881; Marra G, 2018, SCIENCE, V361, P486, DOI 10.1126/science.aat4458; Menyuk C. R., 2004, OPTICAL FIBER COMMUN, V1; National Research Council,, 2011, TSUNAMI WARNING PREP; Nolet G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36835-w; Okal EA, 2008, ADV GEOPHYS, V49, P1, DOI 10.1016/S0065-2687(07)49001-X; Savory SJ, 2010, IEEE J SEL TOP QUANT, V16, P1164, DOI 10.1109/JSTQE.2010.2044751; Shtaif M, 2000, IEEE PHOTONIC TECH L, V12, P53, DOI 10.1109/68.817491; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Sladen A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13793-z; Suetsugu D, 2014, ANNU REV EARTH PL SC, V42, P27, DOI 10.1146/annurev-earth-060313-054818; Titov V, 2005, SCIENCE, V309, P2045, DOI 10.1126/science.1114576; ULRICH R, 1979, APPL OPTICS, V18, P2241, DOI 10.1364/AO.18.002241; ULRICH R, 1980, OPT LETT, V5, P273, DOI 10.1364/OL.5.000273; Vallee M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3606; Williams EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13262-7; Wuttke J, 2003, IEEE PHOTONIC TECH L, V15, P882, DOI 10.1109/LPT.2003.811143; Zhan Z., 2021, **DATA OBJECT**, DOI [10.22002/D1.1668, DOI 10.22002/D1.1668]; Zhan Z., 2021, **DATA OBJECT**, DOI [10.22002/D1.1668, DOI 10.22002/D1.1668]; Zhan ZW, 2020, SEISMOL RES LETT, V91, P1, DOI 10.1785/0220190112; Zheng Y., 2013, ARXIV13064383PHYSICS	49	44	44	25	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					931	+		10.1126/science.abe6648	http://dx.doi.org/10.1126/science.abe6648			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632843				2022-12-28	WOS:000621813400040
J	Lewis, D				Lewis, Dyani			THE SUPERSPREADING PROBLEM	NATURE			English	News Item							EVENTS	Uneven transmission of the SARS-CoV-2 coronavirus has had tragic consequences - but also offers clues for how best to target control measures.										Asadi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38808-z; Barrett JC., 2021, POLISH ARCH INTERNAL, V1, P2012, DOI [10.1101/2020.12.30.20249034, DOI 10.1101/2020.12.30.20249034]; Berggren K. K., 2020, PREPRINT MEDRXIV, DOI [10.1101/2020.10.21.20216895, DOI 10.1101/2020.10.21.20216895]; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Edwards, 2021, P NATL ACAD SCI US, V118; Endo Akira, 2020, Wellcome Open Res, V5, P239, DOI 10.12688/wellcomeopenres.16344.1; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.3, 10.12688/wellcomeopenres.15842.1]; Lau MSY, 2020, P NATL ACAD SCI USA, V117, P22430, DOI 10.1073/pnas.2011802117; Lemieux Jacob E, 2020, medRxiv, DOI 10.1101/2020.08.23.20178236; Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1; Murbe, 2020, PREPRINT, DOI [10.14279/depositonce-10375.3, DOI 10.14279/DEPOSITONCE-10375.3]; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573	12	57	60	2	9	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847					544	546		10.1038/d41586-021-00460-x	http://dx.doi.org/10.1038/d41586-021-00460-x			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QL3BA	33623168	Bronze			2022-12-28	WOS:000620954000014
J	Das, P				Das, Pamela			Sharrelle Barber: at the intersection of place, race, and health	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					659	659						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33610201				2022-12-28	WOS:000620991800013
J	Latini, R; Staszewsky, L				Latini, Roberto; Staszewsky, Lidia			Semaglutide and effective weight control	LANCET			English	Editorial Material							CARDIOVASCULAR OUTCOMES; INSULIN-RESISTANCE; OBESITY; LIRAGLUTIDE		[Latini, Roberto; Staszewsky, Lidia] Mario Negri Inst Pharmacol Res IRCCS, Dept Cardiovasc Med, I-20156 Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Latini, R (corresponding author), Mario Negri Inst Pharmacol Res IRCCS, Dept Cardiovasc Med, I-20156 Milan, Italy.	roberto.latini@marionegri.it		Latini, Roberto/0000-0002-3729-4650				Cefalu WT, 2015, DIABETES CARE, V38, P1567, DOI 10.2337/dc15-1081; Cosmi F, 2017, NEW ENGL J MED, V376, P890, DOI 10.1056/NEJMc1615712; Davies M, 2021, LANCET, V397, P971, DOI 10.1016/S0140-6736(21)00213-0; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim JA, 2006, CIRCULATION, V113, P1888, DOI 10.1161/CIRCULATIONAHA.105.563213; Kushner RF, 2020, OBESITY, V28, P1050, DOI 10.1002/oby.22794; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827	8	1	1	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2021	397	10278					942	943		10.1016/S0140-6736(21)00377-9	http://dx.doi.org/10.1016/S0140-6736(21)00377-9		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV2NT	33667415				2022-12-28	WOS:000627814200003
J	Blumenthal, KG; Robinson, LB; Camargo, CA; Shenoy, ES; Banerji, A; Landman, AB; Wickner, P				Blumenthal, Kimberly G.; Robinson, Lacey B.; Camargo, Carlos A., Jr.; Shenoy, Erica S.; Banerji, Aleena; Landman, Adam B.; Wickner, Paige			Acute Allergic Reactions to mRNA COVID-19 Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study examines the incidence of acute allergic reactions to mRNA COVID-19 vaccine administrations in health care employees in Massachusetts.	[Blumenthal, Kimberly G.; Robinson, Lacey B.; Banerji, Aleena] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Shenoy, Erica S.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Landman, Adam B.] Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA; [Wickner, Paige] Brigham & Womens Hosp, Div Allergy & Clin Immunol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Blumenthal, KG (corresponding author), Massachusetts Gen Hosp, Mongan Inst, 100 Cambridge St,16th Floor, Boston, MA 02114 USA.	kblumenthal@mgh.harvard.edu	Banerji, Aleena/ABG-1245-2021; Blumenthal, Kimberly/AAG-8290-2019; Shenoy, Erica/AAD-7521-2021; Camargo, Carlos A./C-2145-2008	Blumenthal, Kimberly/0000-0003-4773-9817; Camargo, Carlos A./0000-0002-5071-7654	NIH [K01 AI125631]; Massachusetts General Hospital Department of Medicine Transformative Scholar Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Department of Medicine Transformative Scholar Program	This work was supported by NIH K01 AI125631 and the Massachusetts General Hospital Department of Medicine Transformative Scholar Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH nor Massachusetts General Hospital.	Dhopeshwarkar N, 2019, J ALLER CL IMM-PRACT, V7, P103, DOI 10.1016/j.jaip.2018.06.010; Kim MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100154; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Shimabukuro TT, 2021, JAMA-J AM MED ASSOC, V325, P1101, DOI 10.1001/jama.2021.1967	6	132	132	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1562	1565		10.1001/jama.2021.3976	http://dx.doi.org/10.1001/jama.2021.3976		MAR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33683290	Bronze, Green Published			2022-12-28	WOS:000627901400001
J	Rimmer, A				Rimmer, Abi			What should I do if I'm asked to work outside of my practice?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		GMC, 2020, SUPP COV 19 RESP GUI; GMC, 2021, JOINT STAT CHIEF EX; GMC, 2020, COV 19 SPEC GUID PUB	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2021	372								n586	10.1136/bmj.n586	http://dx.doi.org/10.1136/bmj.n586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6RV	33685926	Bronze			2022-12-28	WOS:000632926700003
J	Pena-Llopis, S				Pena-Llopis, Samuel			Leadership challenges defused	SCIENCE			English	Editorial Material								Boom! The bomb exploded. But don't worry-it was a virtual bomb, part of a game I started to play with my research group through teleconferencing in the early days of the pandemic. Called Keep Talking and Nobody Explodes (KTANE), the game consists of a "defuser"-me-who has the bomb but no idea how to defuse it, and a group of "experts"-the members of my team-who have an instruction manual but cannot see the bomb. I have to describe the components of the bomb to them. They have to identify each component in their manual, figure out how to defuse it, and explain the solution to me. Then I have to execute based on their instructions. If we make too many mistakes or run out of time-boom!-the bomb explodes and the game is over. For our group, playing offered excitement and camaraderie-and for me, a lesson in how games can hone leadership skills.	[Pena-Llopis, Samuel] Univ Hosp Essen, Sch Oncol, German Canc Consortium DKTK, Essen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Pena-Llopis, S (corresponding author), Univ Hosp Essen, Sch Oncol, German Canc Consortium DKTK, Essen, Germany.	SciCareerEditor@aaas.org		Pena-Llopis, Samuel/0000-0003-3847-1353					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1070	1070		10.1126/science.371.6533.1070	http://dx.doi.org/10.1126/science.371.6533.1070			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674495				2022-12-28	WOS:000625876100058
J	Weidanz, J				Weidanz, Jon			Targeting cancer with bispecific antibodies Bispecific antibodies might provide off-the-shelf immunotherapeutics for treating cancer	SCIENCE			English	Editorial Material									[Weidanz, Jon] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Weidanz, J (corresponding author), Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76019 USA.	weidanz@uta.edu						Ahmed M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97805; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Douglass J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abd5515; Groeneveldt C., 2020, J IMMUNOTHER CANC, V8, P1; Han X, 2019, INT REV CEL MOL BIO, V342, P1, DOI 10.1016/bs.ircmb.2018.07.003; Hsiue E. H.-C., 2021, SCIENCE, V371; Kobold S, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00285; Kurosawa N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46198-5; Levine AJ, 2020, NAT REV CANCER, V20, P471, DOI 10.1038/s41568-020-0262-1; Lo W, 2019, CANCER IMMUNOL RES, V7, P534, DOI 10.1158/2326-6066.CIR-18-0686; Middelburg J, 2021, CANCERS, V13, DOI 10.3390/cancers13020287; Paul S, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd3595; Weidanz JA, 2006, J IMMUNOL, V177, P5088, DOI 10.4049/jimmunol.177.8.5088	13	6	6	9	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					996	997		10.1126/science.abg5568	http://dx.doi.org/10.1126/science.abg5568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33649167				2022-12-28	WOS:000625876100036
J	Armstrong, S				Armstrong, Stephen			Covid-19: Government pursued in the courts over controversial antibody test	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Armstrong S, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4427; Dyer C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n511; Mulchandani R, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4262; Rose D., 2021, DAILY MAIL	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n626	10.1136/bmj.n626	http://dx.doi.org/10.1136/bmj.n626			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664019	Bronze			2022-12-28	WOS:000632920100010
J	Hassan, Y; Park, JH; Crawford, ML; Sadhanala, A; Lee, J; Sadighian, JC; Mosconi, E; Shivanna, R; Radicchi, E; Jeong, M; Yang, C; Choi, H; Park, SH; Song, MH; De Angelis, F; Wong, CY; Friend, RH; Lee, BR; Snaith, HJ				Hassan, Yasser; Park, Jong Hyun; Crawford, Michael L.; Sadhanala, Aditya; Lee, Jeongjae; Sadighian, James C.; Mosconi, Edoardo; Shivanna, Ravichandran; Radicchi, Eros; Jeong, Mingyu; Yang, Changduk; Choi, Hyosung; Park, Sung Heum; Song, Myoung Hoon; De Angelis, Filippo; Wong, Cathy Y.; Friend, Richard H.; Lee, Bo Ram; Snaith, Henry J.			Ligand-engineered bandgap stability in mixed-halide perovskite LEDs	NATURE			English	Article							LIGHT-EMITTING-DIODES; ION MIGRATION; SOLAR-CELLS; EFFICIENT; SEGREGATION; GLUTATHIONE; PASSIVATION; PERFORMANCE; BRIGHT	Lead halide perovskites are promising semiconductors for light-emitting applications because they exhibit bright, bandgap-tunable luminescence with high colour purity(1,2). Photoluminescence quantum yields close to unity have been achieved for perovskite nanocrystals across a broad range of emission colours, and light-emitting diodes with external quantum efficiencies exceeding 20 per cent-approaching those of commercial organic light-emitting diodes-have been demonstrated in both the infrared and the green emission channels(1,3,4). However, owing to the formation of lower-bandgap iodide-rich domains, efficient and colour-stable red electroluminescence from mixed-halide perovskites has not yet been realized(5,6). Here we report the treatment of mixed-halide perovskite nanocrystals with multidentate ligands to suppress halide segregation under electroluminescent operation. We demonstrate colour-stable, red emission centred at 620 nanometres, with an electroluminescence external quantum efficiency of 20.3 per cent. We show that a key function of the ligand treatment is to 'clean' the nanocrystal surface through the removal of lead atoms. Density functional theory calculations reveal that the binding between the ligands and the nanocrystal surface suppresses the formation of iodine Frenkel defects, which in turn inhibits halide segregation. Our work exemplifies how the functionality of metal halide perovskites is extremely sensitive to the nature of the (nano)crystalline surface and presents a route through which to control the formation and migration of surface defects. This is critical to achieve bandgap stability for light emission and could also have a broader impact on other optoelectronic applications-such as photovoltaics-for which bandgap stability is required.	[Hassan, Yasser; Sadhanala, Aditya; Snaith, Henry J.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England; [Park, Jong Hyun; Song, Myoung Hoon] Ulsan Natl Inst Sci & Technol UNIST, Dept Mat Sci & Engn, Ulsan, South Korea; [Crawford, Michael L.; Sadighian, James C.; Wong, Cathy Y.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Sadhanala, Aditya] Indian Inst Sci, Ctr Nano Sci & Engn, Bangalore, Karnataka, India; [Sadhanala, Aditya; Shivanna, Ravichandran; Friend, Richard H.] Univ Cambridge, Cavendish Lab, Cambridge, England; [Lee, Jeongjae] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Mosconi, Edoardo; Radicchi, Eros; De Angelis, Filippo] Ist CNR Sci & Tecnol Chim Giulio Natta CNR SCITEC, Computat Lab Hybrid Organ Photovolta CLHYO, Perugia, Italy; [Radicchi, Eros] Univ Perugia, Dept Chem Biol & Biotechnol, Perugia, Italy; [Jeong, Mingyu; Yang, Changduk] Ulsan Natl Inst Sci & Technol UNIST, Sch Energy & Chem Engn, Perovtron Res Ctr, Low Dimens Carbon Mat Ctr,Dept Energy Engn, Ulsan, South Korea; [Choi, Hyosung] Hanyang Univ, Res Inst Convergence Basic Sci, Res Inst Nat Sci, Dept Chem, Seoul, South Korea; [Park, Sung Heum; Lee, Bo Ram] Pukyong Natl Univ, Dept Phys, Busan, South Korea; [De Angelis, Filippo] Ist Italiano Tecnol, CompuNet, Genoa, Italy; [Wong, Cathy Y.] Univ Oregon, Inst Mat Sci, Eugene, OR 97403 USA; [Wong, Cathy Y.] Oregon Res Inst, Oregon Ctr Opt Mol & Quantum Sci, Eugene, OR 97403 USA	University of Oxford; Ulsan National Institute of Science & Technology (UNIST); University of Oregon; Indian Institute of Science (IISC) - Bangalore; University of Cambridge; Seoul National University (SNU); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Tecnologie Chimiche "Giulio Natta" (SCITEC-CNR); University of Perugia; Ulsan National Institute of Science & Technology (UNIST); Hanyang University; Pukyong National University; Istituto Italiano di Tecnologia - IIT; University of Oregon; Oregon Research Institute	Hassan, Y; Snaith, HJ (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England.; Wong, CY (corresponding author), Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA.; Lee, BR (corresponding author), Pukyong Natl Univ, Dept Phys, Busan, South Korea.; Wong, CY (corresponding author), Univ Oregon, Inst Mat Sci, Eugene, OR 97403 USA.; Wong, CY (corresponding author), Oregon Res Inst, Oregon Ctr Opt Mol & Quantum Sci, Eugene, OR 97403 USA.	yasserhassan8085@gmail.com; cwong3@uoregon.edu; brlee@pknu.ac.kr; henry.snaith@physics.ox.ac.uk	Mosconi, Edoardo/F-5469-2016; Lee, Bo Ram/AAQ-9275-2021; Song, Myoung Hoon/F-3766-2010; Hassan, Yasser/AAH-8469-2021; Snaith, Henry J/A-7367-2016; Sadhanala, Aditya/J-1212-2017; Shivanna, Ravichandran/A-7053-2019	Mosconi, Edoardo/0000-0001-5075-6664; Lee, Bo Ram/0000-0002-4670-6717; Hassan, Yasser/0000-0003-3887-1752; Snaith, Henry J/0000-0001-8511-790X; Sadhanala, Aditya/0000-0003-2832-4894; Sadighian, James/0000-0001-9509-2355; Crawford, Michael/0000-0001-6023-7614; Shivanna, Ravichandran/0000-0002-0915-6066; Wong, Cathy/0000-0001-6867-1968	Engineering and Physical Sciences Research Council (EPSRC) UK [EP/M005143/1, EP/M015254/2]; European Union's Horizon 2020 research and innovation program [861985]; SUNRISE project - EPSRC [EP/P032591/1]; UKIERI project; DST; Pratiksha Trust; Newton International Fellowship from The Royal Society; Achievement Rewards for College Scientists (ARCS) Foundation, Oregon Chapter; National Research Foundation of the Republic of Korea [NRF-2018R1C1B6005778, 2018R1A2B2006198, 2020R1A4A1018163, 2019R1A6A1A10073437]; Materials Innovation Project - National Research Foundation of Korea [NRF2020M3H4A3081793]; UNIST Central Research Facilities (UCRF); IISc; MHRD; Linguistix Tank Inc. (LXT AI), Canada; EPSRC [EP/P032591/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC) UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union's Horizon 2020 research and innovation program; SUNRISE project - EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UKIERI project; DST(Department of Science & Technology (India)); Pratiksha Trust; Newton International Fellowship from The Royal Society; Achievement Rewards for College Scientists (ARCS) Foundation, Oregon Chapter; National Research Foundation of the Republic of Korea(National Research Foundation of Korea); Materials Innovation Project - National Research Foundation of Korea(National Research Foundation of Korea); UNIST Central Research Facilities (UCRF); IISc; MHRD; Linguistix Tank Inc. (LXT AI), Canada; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially funded by the Engineering and Physical Sciences Research Council (EPSRC) UK through grants EP/M005143/1 and EP/M015254/2. This work is part of the PEROCUBE project, which has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 861985. Y.H., A.S., R.S., H.J.S. and R.H.F. acknowledge funding and support from the SUNRISE project (EP/P032591/1), funded by the EPSRC. A.S. and R.H.F. acknowledge support from the UKIERI project. A.S. acknowledges funding and support from DST, Pratiksha Trust, IISc and MHRD. R.S. acknowledges a Newton International Fellowship from The Royal Society. M.L.C. acknowledges financial support from the Achievement Rewards for College Scientists (ARCS) Foundation, Oregon Chapter. This study was partially supported by the National Research Foundation of the Republic of Korea (NRF-2018R1C1B6005778, 2018R1A2B2006198, 2020R1A4A1018163 and 2019R1A6A1A10073437) and the Materials Innovation Project (NRF2020M3H4A3081793) funded by the National Research Foundation of Korea. NMR data were acquired on a 400-MHz solid-state NMR spectrometer (AVANCE III HD, Bruker) at KBSI Western Seoul Center. The HR-TEM, XPS, NMR, confocal photoluminescence and SEM experiments were supported by UNIST Central Research Facilities (UCRF). J.H.P. thanks A. Lee for assistance with TEM. Y.H. thanks M. Danie for assistance with TEM; S. M. Rabea, T. S. Ibrahim, A. M. Ali and T. Janes for assistance with NMR analysis; and M. N. Ahmed for advice on Fig. 1. We thank B. Wenger for discussions concerning the use of EDTA as a ligand in perovskite nanocrystals. Y.H. thanks A. Marshall and J. Sahmsi for discussions concerning the FTIR and N. Sakai for discussing XRD results. We thank V. Burlakov and S. Mahesh for discussions concerning the halide-segregation mechanism. Y.H. acknowledges funding and support from Linguistix Tank Inc. (LXT AI), Canada.	Abdi-Jalebi M, 2018, NATURE, V555, P497, DOI 10.1038/nature25989; Auer-Berger M, 2016, ORG ELECTRON, V35, P164, DOI 10.1016/j.orgel.2016.04.044; Barker AJ, 2017, ACS ENERGY LETT, V2, P1416, DOI 10.1021/acsenergylett.7b00282; Belisle RA, 2018, ACS ENERGY LETT, V3, P2694, DOI 10.1021/acsenergylett.8b01562; Bischak CG, 2017, NANO LETT, V17, P1028, DOI 10.1021/acs.nanolett.6b04453; Bodnarchuk MI, 2019, ACS ENERGY LETT, V4, P63, DOI 10.1021/acsenergylett.8b01669; Burlakov VM, 2020, J PHYS CHEM LETT, V11, P6535, DOI 10.1021/acs.jpclett.0c01794; Bush KA, 2018, ACS ENERGY LETT, V3, P428, DOI 10.1021/acsenergylett.7b01255; Chang J, 2018, J PHYS CHEM LETT, V9, P881, DOI 10.1021/acs.jpclett.7b03417; Chiba T, 2018, NAT PHOTONICS, V12, P681, DOI 10.1038/s41566-018-0260-y; Cho C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14124-y; Delalande O, 2010, FEBS J, V277, P5086, DOI 10.1111/j.1742-4658.2010.07913.x; Draguta S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00284-2; Ferrero ME, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8274504; Flora SJS, 2010, INT J ENV RES PUB HE, V7, P2745, DOI 10.3390/ijerph7072745; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Gualdron-Reyes AF, 2019, ACS ENERGY LETT, V4, P54, DOI 10.1021/acsenergylett.8b02207; Hassan Y, 2019, J AM CHEM SOC, V141, P1269, DOI 10.1021/jacs.8b09706; Hassan Y, 2016, ADV MATER, V28, P566, DOI 10.1002/adma.201503461; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hu M, 2016, ADV SCI, V3, DOI 10.1002/advs.201500301; Lee D, 2018, ACS ENERGY LETT, V3, P647, DOI 10.1021/acsenergylett.8b00121; Li W, 2017, ACS ENERGY LETT, V2, P1270, DOI 10.1021/acsenergylett.7b00183; Lin KB, 2018, NATURE, V562, P245, DOI 10.1038/s41586-018-0575-3; Mah V, 2012, INORG CHEM, V51, P6285, DOI 10.1021/ic300496t; Meggiolaro D, 2019, ACS ENERGY LETT, V4, P779, DOI 10.1021/acsenergylett.9b00247; Meggiolaro D, 2018, ENERG ENVIRON SCI, V11, P702, DOI 10.1039/c8ee00124c; Motti SG, 2019, NAT PHOTONICS, V13, P532, DOI 10.1038/s41566-019-0435-1; Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; POGLITSCH A, 1987, J CHEM PHYS, V87, P6373, DOI 10.1063/1.453467; Richter JM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00546-z; Richter JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13941; Salehi A, 2018, ACS APPL MATER INTER, V10, P9595, DOI 10.1021/acsami.7b18514; Shao YC, 2016, ENERG ENVIRON SCI, V9, P1752, DOI 10.1039/c6ee00413j; Sisombath NS, 2015, CHEM RES TOXICOL, V28, P2313, DOI 10.1021/acs.chemrestox.5b00323; Sun Q, 2007, NAT PHOTONICS, V1, P717, DOI 10.1038/nphoton.2007.226; Tian Y, 2018, ADV MATER, V30, DOI 10.1002/adma.201707093; Vashishtha P, 2017, CHEM MATER, V29, P5965, DOI 10.1021/acs.chemmater.7b01609; Wang ZP, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.135; Wu T, 2020, ANGEW CHEM INT EDIT, V59, P4099, DOI 10.1002/anie.201914000; Xiao ZG, 2017, NANO LETT, V17, P6863, DOI 10.1021/acs.nanolett.7b03179; Xiao ZG, 2017, NAT PHOTONICS, V11, P108, DOI [10.1038/NPHOTON.2016.269, 10.1038/nphoton.2016.269]; Yan F, 2018, NANO LETT, V18, P3157, DOI 10.1021/acs.nanolett.8b00789; Yan JL, 2018, J MATER CHEM A, V6, P11063, DOI 10.1039/c8ta02288g; Yang ZB, 2016, NANO LETT, V16, P7739, DOI 10.1021/acs.nanolett.6b03857; Yi CY, 2016, ENERG ENVIRON SCI, V9, P656, DOI 10.1039/c5ee03255e; Zhang HC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09047-7; Zhang LH, 2019, J MATER CHEM A, V7, P2135, DOI 10.1039/c8ta09512d; Zhang XY, 2016, J PHYS CHEM LETT, V7, P4602, DOI 10.1021/acs.jpclett.6b02073; Zhao BD, 2018, NAT PHOTONICS, V12, P783, DOI 10.1038/s41566-018-0283-4; Zhao Q, 2020, ACS ENERGY LETT, V5, P238, DOI 10.1021/acsenergylett.9b02395; Zhao XF, 2020, NAT PHOTONICS, V14, P215, DOI 10.1038/s41566-019-0559-3; Zhou Y, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201803130; Zhou Y, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201701048	55	209	208	142	657	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					72	+		10.1038/s41586-021-03217-8	http://dx.doi.org/10.1038/s41586-021-03217-8			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33658694	Green Submitted			2022-12-28	WOS:000626921700012
J	Mallapaty, S				Mallapaty, Smriti			THE HUNT FOR CORONAVIRUS CARRIERS	NATURE			English	Editorial Material																		Banerjee A, 2021, CELL HOST MICROBE, V29, P160, DOI 10.1016/j.chom.2021.01.004; Bosco-Lauth A. M., 2021, PREPRINT BIORXIV, DOI [10.1101/2020.12.24.424203, DOI 10.1101/2020.12.24.424203]; Bosco-Lauth AM, 2020, P NATL ACAD SCI USA, V117, P26382, DOI 10.1073/pnas.2013102117; Gu HJ, 2020, SCIENCE, V369, P1603, DOI 10.1126/science.abc4730; Michelitsch A, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040772; Munnink Bas B. Oude, 2021, Science (Washington D C), V371, P172, DOI 10.1126/science.abe5901; Palmer M. V., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.01.13.426628, DOI 10.1101/2021.01.13.426628]; Patterson E I, 2020, Nat Commun, V11, P6231, DOI [10.1101/2020.07.21.214346, 10.1038/s41467-020-20097-0]; Sawatzki K., 2020, PREPRINT BIORXIV, DOI [10.1101/2020.08.21.254995, DOI 10.1101/2020.08.21.254995]; Schlottau K, 2020, LANCET MICROBE, V1, pE218, DOI 10.1016/S2666-5247(20)30089-6; Shi JZ, 2020, SCIENCE, V368, P1016, DOI 10.1126/science.abb7015; Ulrich L., 2020, PREPRINT BIORXIV, DOI [10.1101/2020.12.24.424203, DOI 10.1101/2020.12.24.424203]; Ulrich L, 2020, EMERG INFECT DIS, V26, P2979, DOI 10.3201/eid2612.203799; Wang LF, 2007, CURR TOP MICROBIOL, V315, P325; Yan H, 2021, NAT ECOL EVOL, V5, P600, DOI 10.1038/s41559-021-01407-1; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9	17	19	19	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					26	28						3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QQ5WB	33654304	Bronze			2022-12-28	WOS:000624594200015
J	Rimmer, A				Rimmer, Abi			Covid-19: 237m vaccine doses to be distributed worldwide over next three months	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2021, GAVI	1	1	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								631	10.1136/bmj.n631	http://dx.doi.org/10.1136/bmj.n631			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664018	Bronze			2022-12-28	WOS:000632920100008
J	Baeyens, A; Bracero, S; Chaluvadi, VS; Khodadadi-Jamayran, A; Cammer, M; Schwab, SR				Baeyens, Audrey; Bracero, Sabrina; Chaluvadi, Venkata S.; Khodadadi-Jamayran, Alireza; Cammer, Michael; Schwab, Susan R.			Monocyte-derived S1P in the lymph node regulates immune responses	NATURE			English	Article								The lipid chemoattractant sphingosine 1-phosphate (S1P) guides cells out of tissues, where the concentration of S1P is relatively low, into circulatory fluids, where the concentration of S1P is high(1). For example, S1P directs the exit of T cells from lymph nodes, where T cells are initially activated, into lymph, from which T cells reach the blood and ultimately inflamed tissues(1). T cells follow S1P gradients primarily using S1P receptor 1 (ref.(1)). Recent studies have described how S1P gradients are established at steady state, but little is known about the distribution of S1P in disease or about how changing levels of S1P may affect immune responses. Here we show that the concentration of S1P increases in lymph nodes during an immune response. We found that haematopoietic cells, including inflammatory monocytes, were an important source of this S1P, which was an unexpected finding as endothelial cells provide S1P to lymph(1). Inflammatory monocytes required the early activation marker CD69 to supply this S1P, in part because the expression of CD69 was associated with reduced levels of S1pr5 (which encodes S1P receptor 5). CD69 acted as a 'stand-your-ground' signal, keeping immune cells at a site of inflammation by regulating both the receptors and the gradients of S1P. Finally, increased levels of S1P prolonged the residence time of T cells in the lymph nodes and exacerbated the severity of experimental autoimmune encephalomyelitis in mice. This finding suggests that residence time in the lymph nodes might regulate the differentiation of T cells, and points to new uses of drugs that target S1P signalling.	[Baeyens, Audrey; Bracero, Sabrina; Chaluvadi, Venkata S.; Schwab, Susan R.] NYU, Skirball Inst Biomol Med, Langone Med Ctr, New York, NY 10012 USA; [Khodadadi-Jamayran, Alireza; Cammer, Michael] NYU, Off Collaborat Sci, Langone Med Ctr, New York, NY USA; [Bracero, Sabrina] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Chaluvadi, Venkata S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Harvard University; University of Pennsylvania; Pennsylvania Medicine	Schwab, SR (corresponding author), NYU, Skirball Inst Biomol Med, Langone Med Ctr, New York, NY 10012 USA.	Susan.Schwab@med.nyu.edu		Chaluvadi, Venkata/0000-0002-0055-149X; Schwab, Susan/0000-0002-0834-0822; Cammer, Michael/0000-0003-4930-1739; Khodadadi-Jamayran, Alireza/0000-0003-2495-7504	NIH [R01AI085166, R01AI123308, P30CA016087]; Blood Cancer Discoveries Grant Program - Leukemia & Lymphoma Society; Mark Foundation for Cancer Research; Paul G. Allen Frontiers Group; NCRR [S10RR023704-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blood Cancer Discoveries Grant Program - Leukemia & Lymphoma Society; Mark Foundation for Cancer Research; Paul G. Allen Frontiers Group; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank members of the Schwab laboratory, J. Cyster, D. Littman and K. Narasimhan for discussions; E. Pamer for the CCR2-DTR mice; and the NIH Tetramer Core Facility for the MOG/Ab and hCLIP/Ab tetramers. This work was supported by NIH grants R01AI085166 and R01AI123308, and the Blood Cancer Discoveries Grant Program sponsored by the Leukemia & Lymphoma Society, the Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group (to S.R.S.). NYU's core facilities were supported in part by NIH grants P30CA016087 to the Laura and Isaac Perlmutter Cancer Center and NCRR S10RR023704-01A1. This work is dedicated to Nilabh Shastri.	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andorko JI, 2014, JOVE-J VIS EXP, DOI 10.3791/50984; Baeyens AAL, 2020, ANNU REV IMMUNOL, V38, P759, DOI 10.1146/annurev-immunol-081519-083952; Bankovich AJ, 2010, J BIOL CHEM, V285, P22328, DOI 10.1074/jbc.M110.123299; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Chi HB, 2011, TRENDS PHARMACOL SCI, V32, P16, DOI 10.1016/j.tips.2010.11.002; Cibrian D, 2017, EUR J IMMUNOL, V47, P946, DOI 10.1002/eji.201646837; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fang V, 2017, NAT IMMUNOL, V18, P15, DOI 10.1038/ni.3619; Garris CS, 2014, IMMUNOLOGY, V142, P347, DOI 10.1111/imm.12272; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hatcher SE, 2016, JAMA NEUROL, V73, P790, DOI 10.1001/jamaneurol.2016.0826; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Johansen P, 2014, JOVE-J VIS EXP, DOI 10.3791/51031; Kimura MY, 2017, IMMUNOL REV, V278, P87, DOI 10.1111/imr.12559; Kono M, 2014, J CLIN INVEST, V124, P2076, DOI 10.1172/JCI71194; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee JY, 2015, IMMUNITY, V42, P252, DOI 10.1016/j.immuni.2015.01.013; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; Olivera A, 2013, BBA-MOL CELL BIOL L, V1831, P193, DOI 10.1016/j.bbalip.2012.06.007; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramos-Perez WD, 2015, NAT IMMUNOL, V16, P1245, DOI 10.1038/ni.3296; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Xiong HZ, 2015, IMMUNOBIOLOGY, V220, P210, DOI 10.1016/j.imbio.2014.08.007; Yanagida K, 2017, ANNU REV PHYSIOL, V79, P67, DOI 10.1146/annurev-physiol-021014-071635	37	11	11	9	24	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2021	592	7853					290	+		10.1038/s41586-021-03227-6	http://dx.doi.org/10.1038/s41586-021-03227-6		MAR 2021	31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8ZE	33658712	Green Accepted			2022-12-28	WOS:000625125200001
J	Kramer, DB; Opel, DJ; Parasidis, E; Mello, MM				Kramer, Daniel B.; Opel, Douglas J.; Parasidis, Efthimios; Mello, Michelle M.			Choices in a Crisis - Individual Preferences among SARS-CoV-2 Vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Choices in a Crisis As experience with SARS-CoV-2 vaccination accumulates, meaningful differences among vaccines may emerge, making the question of whether individual vaccinees should be able to choose which vaccine they receive increasingly salient.	[Kramer, Daniel B.] Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02215 USA; [Kramer, Daniel B.] Harvard Med Sch, Boston, MA 02115 USA; [Opel, Douglas J.] Univ Washington, Sch Med, Seattle, WA USA; [Opel, Douglas J.] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA USA; [Parasidis, Efthimios] Ohio State Univ, Moritz Coll Law, Columbus, OH 43210 USA; [Parasidis, Efthimios] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Stanford Hlth Policy, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Sch Med, Dept Med, Stanford Law Sch, Stanford, CA 94305 USA; [Mello, Michelle M.] Freeman Spogli Inst Int Studies, Stanford, CA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Stanford University; Stanford University	Kramer, DB (corresponding author), Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Boston, MA 02215 USA.; Kramer, DB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.			Mello, Michelle/0000-0003-2877-4270				Branswell H., 2021, COMPARING COVID 19 V, DOI 10.1007/s11894-012-0300-6; Goodnough Abby, 2021, NEW YORK TIMES; Kreps S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25594; Peek ME, 2021, AM J PUBLIC HEALTH, V111, P286, DOI 10.2105/AJPH.2020.305990; Tidman Z., 2021, INDEPENDENT	5	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					e62	e62		10.1056/NEJMp2102146	http://dx.doi.org/10.1056/NEJMp2102146		MAR 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV1ND	33657289	Bronze			2022-12-28	WOS:000640362900001
J	Horton, R				Horton, Richard			Offline: Thinking the pandemic	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					780	780						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640049	Bronze			2022-12-28	WOS:000623925500010
J	Nassiri, N; Maas, M; Asanad, K; Cacciamani, G; Nabhani, J				Nassiri, Nima; Maas, Marissa; Asanad, Kian; Cacciamani, Giovanni; Nabhani, Jamal			Testicular cancer with neurological symptoms indicates brain metastases	LANCET			English	Editorial Material									[Nassiri, Nima; Maas, Marissa; Asanad, Kian; Cacciamani, Giovanni; Nabhani, Jamal] Los Angeles County Univ Southern Calif Med Ctr, Dept Urol, Los Angeles, CA 90033 USA; [Nassiri, Nima; Maas, Marissa; Asanad, Kian; Cacciamani, Giovanni; Nabhani, Jamal] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA	University of Southern California	Nassiri, N (corresponding author), Los Angeles County Univ Southern Calif Med Ctr, Dept Urol, Los Angeles, CA 90033 USA.	nima.nassiri@med.usc.edu		Cacciamani, Giovanni/0000-0002-8892-5539					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					E7	E7						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640071				2022-12-28	WOS:000623925500001
J	Slomski, A				Slomski, Anita			Oral Rimegepant Safe, Effective for Migraine Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					713	713		10.1001/jama.2021.0651	http://dx.doi.org/10.1001/jama.2021.0651			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620400				2022-12-28	WOS:000621957400006
J	Rimmer, A				Rimmer, Abi			Sixty seconds on . . . human challenge trials	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department for Business Energy and Industrial Strategy, 2021, WORLDS 1 COR HUM CHA; McPartlin SO, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4258	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2021	372								n515	10.1136/bmj.n515	http://dx.doi.org/10.1136/bmj.n515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7AW	33619015	Bronze			2022-12-28	WOS:000621236700009
J	Ho, J				Ho, Jin			Atopic dermatitis in children: when topical steroid treatment "does not work"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EUROPEAN GUIDELINES; MANAGEMENT; ECZEMA; TINEA; CORTICOSTEROIDS; ADULTS; CARE; SKIN		[Ho, Jin] Raffles Hosp, Raffles Childrens Ctr, Singapore, Singapore	Raffles Hospital	Ho, J (corresponding author), Raffles Hosp, Raffles Childrens Ctr, Singapore, Singapore.	chong_jinho@rafflesmedical.com						Admani S, 2015, CLIN DERMATOL, V33, P657, DOI 10.1016/j.clindermatol.2015.09.008; Alkeswani A, 2019, PEDIATR DERMATOL, V36, pE20, DOI 10.1111/pde.13724; Bergmann MM, 2013, J ALLER CL IMM-PRACT, V1, P22, DOI 10.1016/j.jaip.2012.11.005; Chin XY, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k8; Chong JH, 2017, ARCH DIS CHILD, V102, P681, DOI 10.1136/archdischild-2016-312106; Chong JH, 2015, EUR J PEDIATR, V174, P1405, DOI 10.1007/s00431-015-2563-z; Davari DR, 2020, J ASTHMA ALLERGY, V13, P563, DOI 10.2147/JAA.S246175; Eichenfield LF, 2017, J ALLERGY CLIN IMMUN, V139, pS49, DOI 10.1016/j.jaci.2017.01.009; Eichenfield LF, 2015, PEDIATRICS, V136, P554, DOI 10.1542/peds.2014-3678; Eichenfield LF, 2014, J AM ACAD DERMATOL, V71, P116, DOI 10.1016/j.jaad.2014.03.023; Ersser SJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004054.pub3; Ference JD, 2009, AM FAM PHYSICIAN, V79, P135; Ferguson L, 2017, J INFECTION, V74, pS54, DOI 10.1016/S0163-4453(17)30192-5; Galli E, 2016, ITAL J PEDIATR, V42, DOI 10.1186/s13052-016-0229-8; George SMC, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003871.pub3; Glutsch V, 2019, J DTSCH DERMATOL GES, V17, P589, DOI 10.1111/ddg.13811; Green C, 2004, HEALTH TECHNOL ASSES, V8, P1; Leung AKC, 2020, CURR PEDIATR REV, V16, P33, DOI 10.2174/1573396315666190717114131; Leung AKC, 2019, WORLD J PEDIATR, V15, P536, DOI 10.1007/s12519-019-00304-9; Li AW, 2017, JAMA DERMATOL, V153, P1036, DOI 10.1001/jamadermatol.2017.2437; Liew HM, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3606; Mortz CG, 2019, CLIN EXP ALLERGY, V49, P744, DOI 10.1111/cea.13381; National Institute for Health and Care Excellence, 2020, CRIS TREAT MILD MOD; National Institute for Health and Care Excellence, 2004, FREQ APPL TOP CORT A; National Institute for Health and Care Excellence, AT ECZ UND 12S DIAGN; Ng SY, 2016, PEDIATR DERMATOL, V33, P160, DOI 10.1111/pde.12758; Pinson R, 2016, PSORIASIS-TARGETS TH, V6, DOI 10.2147/PTT.S87650; Rathi Sanjay K, 2012, Indian J Dermatol, V57, P251, DOI 10.4103/0019-5154.97655; Ridd MJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5882; Sidbury R, 2014, J AM ACAD DERMATOL, V71, P1218, DOI 10.1016/j.jaad.2014.08.038; Siegfried EC, 2015, J CLIN MED, V4, P884, DOI 10.3390/jcm4050884; Stringer T, 2018, CUTIS, V102, P370; Tay YK, 2016, ANN ACAD MED SINGAP, V45, P439; Teasdale EJ, 2017, BRIT J DERMATOL, V176, P1500, DOI 10.1111/bjd.15130; Tham EH, 2020, PEDIAT ALLERG IMM-UK, V31, P7, DOI 10.1111/pai.13127; Tollefson MM, 2018, JAMA DERMATOL, V154, P286, DOI 10.1001/jamadermatol.2017.5417; Tollefson MM, 2014, PEDIATRICS, V134, pE1735, DOI 10.1542/peds.2014-2812; Wang V, 2021, ANN ALLERG ASTHMA IM, V126, P3, DOI 10.1016/j.anai.2020.08.002; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P850, DOI 10.1111/jdv.14888; Wollenberg A, 2018, J EUR ACAD DERMATOL, V32, P657, DOI 10.1111/jdv.14891; Wu JLH, 2020, PEDIATR DERMATOL, V37, P18, DOI 10.1111/pde.14026; Yang EJ, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1102; Zampella JG, 2017, J PEDIATR-US, V183, P12, DOI 10.1016/j.jpeds.2016.12.042	43	2	2	3	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2021	372								n297	10.1136/bmj.n297	http://dx.doi.org/10.1136/bmj.n297			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC1WK	33602868				2022-12-28	WOS:000686324400001
J	Paltiel, AD; Zheng, A; Sax, PE				Paltiel, A. David; Zheng, Amy; Sax, Paul E.			Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission	ANNALS OF INTERNAL MEDICINE			English	Article								Background:The value of frequent, rapid testing to reduce community transmission of SARS-CoV-2 is poorly understood. Objective: To define performance standards and predict the clinical, epidemiologic, and economic outcomes of nationwide, home-based antigen testing. Design: A simple compartmental epidemic model that estimated viral transmission, portrayed disease progression, and forecast resource use, with and without testing. Data Sources: Parameter values and ranges as informed by Centers for Disease Control and Prevention guidance and published literature. Target Population: U.S. population. Time Horizon: 60 days Perspective: Societal; costs included testing, inpatient care, and lost workdays. Intervention: Home-based SARS-CoV-2 antigen testing. Outcome Measures: Cumulative infections and deaths, number of persons isolated and hospitalized, and total costs. Results of Base-Case Analysis: Without a testing intervention, the model anticipates 11.6 million infections, 119 000 deaths, and $10.1 billion in costs ($6.5 billion in inpatient care and $3.5 billion in lost productivity) over a 60-day horizon. Weekly availability of testing would avert 2.8 million infections and 15 700 deaths, increasing costs by $22.3 billion. Lower inpatient outlays ($5.9 billion) would partially offset additional testing expenditures ($12.5 billion) and workdays lost ($14.0 billion), yielding incremental cost-effectiveness ratios of $7890 per infection averted and $1 430 000 per death averted. Results of Sensitivity Analysis: Outcome estimates vary widely under different behavioral assumptions and testing frequencies. However, key findings persist across all scenarios, with large reductions in infections, mortality, and hospitalizations. Costs per death averted are roughly an order of magnitude lower than commonly accepted willingness-topay values per statistical life saved ($5 to $17 million). Limitations: Analysis was restricted to at-home testing. There are uncertainties concerning test performance. Conclusion: High-frequency home testing for SARS-CoV-2 with an inexpensive, imperfect test could contribute to pandemic control at justifiable cost and warrants consideration as part of a national containment strategy.	[Paltiel, A. David] Yale Sch Publ Hlth, Publ Hlth Modeling Unit, New Haven, CT USA; [Zheng, Amy; Sax, Paul E.] Harvard Med Sch, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Paltiel, A. David; Zheng, Amy] Yale Sch Publ Hlth, 60 Coll St, New Haven, CT 06510 USA; [Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St,PBB-A-4, Boston, MA 02115 USA	Yale University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Harvard University; Brigham & Women's Hospital	Paltiel, AD (corresponding author), Yale Sch Publ Hlth, 60 Coll St, New Haven, CT 06510 USA.				National Institute on Drug Abuse [R37DA015612]; National Institutes of Health	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	By grant R37DA015612 from the National Institute on Drug Abuse (Dr. Paltiel), National Institutes of Health.	Abbott Laboratories, 2020, BINAXNOW COVID 19 AG; Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Alemany A, 2021, J INFECTION, V82, P188, DOI 10.1016/j.jinf.2020.12.033; Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; Anesi GL, 2021, ANN INTERN MED, V174, P613, DOI 10.7326/M20-5327; Angulo FJ, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.33706; [Anonymous], 2021, NEW YORK TIMES; Baggett TP, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.28195; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bajema KL, 2021, JAMA INTERN MED, V181, P450, DOI 10.1001/jamainternmed.2020.7976; Bartsch SM, 2020, HEALTH AFFAIR, V39, P927, DOI 10.1377/hlthaff.2020.00426; Castillo E, 2017, J OBSTET GYNAECOL CA, V39, P181, DOI 10.1016/j.jogc.2016.11.001; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Centers for Disease Control and Prevention; Office of the Assistant Secretary for Preparedness and Response, COVID 19 PAND PLANN; Courage KH, 2020, VOX             0827; Du ZW, 2021, LANCET PUBLIC HEALTH, V6, pE184, DOI 10.1016/S2468-2667(21)00002-5; FAIR Health, 2020, KEY CHAR COVID 19 PA; Feuer W., 2020, FDA AUTHORIZES ABBOT; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Ganyani T, 2020, ESTIMATING GENERATIO, DOI DOI 10.1101/2020.03.05.20031815; Hammitt JK, 2000, ENVIRON SCI TECHNOL, V34, P1396, DOI 10.1021/es990733n; Hammitt JK, 2002, RISK ANAL, V22, P985, DOI 10.1111/1539-6924.00265; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Horwitz LI, 2021, J HOSP MED, V16, P90, DOI 10.12788/jhm.3552; International Monetary Fund, 2020, IMF DAT MAPP; Jefferson T, 2021, CLIN INFECT DIS, V73, pe3884, DOI [10.1093/cid/ciaa1764, DOI 10.1093/CID/CIAA1764]; Komarov A, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11010102; Levin AT, 2020, EUR J EPIDEMIOL, V35, P1123, DOI 10.1007/s10654-020-00698-1; Lieberman JA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00821-20; McCarthy MW, 2021, EXPERT REV MOL DIAGN, V21, P1, DOI 10.1080/14737159.2021.1873133; Mina M, 2020, NEW YORK TIMES; Mina MJ, 2021, SCIENCE, V371, P126, DOI 10.1126/science.abe9187; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; National Center for Health Statistics, 2022, PROV COVID 18 DEATH; Noh J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246772; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; Office of the Assistant Secretary for Planning and Evaluation, 2016, GUID REG IMP AN; Oran DP, 2021, ANN INTERN MED, V174, P286, DOI 10.7326/L20-1285; Pavelka M, 2020, EFFECTIVENESS POPULA, DOI [10.1101/2020.12.02.20240648, DOI 10.1101/2020.12.02.20240648]; Pettengill MA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02225-20; Pilarowski G, 2021, J INFECT DIS, V223, P1139, DOI 10.1093/infdis/jiaa802; Pilarowski G, 2021, CLIN INFECT DIS, V73, pE3098, DOI 10.1093/cid/ciaa1890; Pray IW, 2021, MMWR-MORBID MORTAL W, V69, P1642, DOI 10.15585/mmwr.mm695152a3; Roser M., 2021, CORONAVIRUS PANDEMIC; Sax PE, 2020, APPEAL RAPID ANTIGEN; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Silcox C., 2020, NATL DECISION POINT; Stein R., 2021, WBUR NEWS       0210; Stock J, 2020, EC BENEFITS COVID 19, DOI [10.1101/2020.10.22.20217984, DOI 10.1101/2020.10.22.20217984]; The Global Fund, 2020, PRIC QUAL REP PRIC R; The World Bank, GDP PERC CURR US US; Toptan T, 2021, J CLIN VIROL, V135, DOI 10.1016/j.jcv.2020.104713; U.S. Census Bureau, NAT POP CHAR 2010 20; van Beek, 2020, CLIN EVALUATION ROCH, DOI [10.1101/2020.11.18.20234104, DOI 10.1101/2020.11.18.20234104]; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Walensky RP, 2020, SCREENING PREVENT SA, DOI [10.1377/hblog20200909.430047/full, DOI 10.1377/HBLOG20200909.430047/FULL]; Wang F, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02423-8; Wise J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4690; Wortham JM, 2020, MMWR-MORBID MORTAL W, V69, P923, DOI 10.15585/mmwr.mm6928e1; Wu K., 2021, MRNA 1273 VACCINE IN, V73, P1946, DOI [10.1101/2021.01.25.427948, DOI 10.1101/2021.01.25.427948]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	61	12	13	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2021	174	6					803	+		10.7326/M21-0510	http://dx.doi.org/10.7326/M21-0510			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS5IR	33683930	Green Accepted, Green Published			2022-12-28	WOS:000661788700020
J	Fields, EL; Copeland, R; Hopkins, E				Fields, Errol L.; Copeland, Raniyah; Hopkins, Ernest			Same script, different viruses: HIV and COVID-19 in US Black communities	LANCET			English	Editorial Material							DISPARITIES; INFECTION; SEX		[Fields, Errol L.] Johns Hopkins Univ, Dept Pediat, Sch Med, Div Adolescent Young Adult Med, Baltimore, MD 21287 USA; [Copeland, Raniyah] Black AIDS Inst, Los Angeles, CA USA; [Hopkins, Ernest] San Francisco AIDS Fdn, San Francisco, CA USA	Johns Hopkins University	Fields, EL (corresponding author), Johns Hopkins Univ, Dept Pediat, Sch Med, Div Adolescent Young Adult Med, Baltimore, MD 21287 USA.	errol.fields@jhmi.edu			amfAR, The Foundation for AIDS Research; The US National Institute on Drug Abuse; The Desmond M Tutu Professorship in Public Health and Human Rights at Johns Hopkins	amfAR, The Foundation for AIDS Research; The US National Institute on Drug Abuse; The Desmond M Tutu Professorship in Public Health and Human Rights at Johns Hopkins	ELF has served on HIV Prevention and Treatment Advisory Boards for Gilead Sciences. RC has served on community advisory boards for ViiV Healthcare and Merck and has received grant funding from Gilead Sciences. EH declares no competing interests. Support for this Comment and the Lancet HIV In the USA Series was provided, in part, by amfAR, The Foundation for AIDS Research, The US National Institute on Drug Abuse, and The Desmond M Tutu Professorship in Public Health and Human Rights at Johns Hopkins.	Adimora AA, 2021, LANCET, V397, P1107, DOI 10.1016/S0140-6736(21)00396-2; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Beyrer C, 2021, LANCET, V397, P1151, DOI 10.1016/S0140-6736(21)00390-1; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [10.2307/1229039, DOI 10.2307/1229039]; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Hodder SL, 2021, LANCET, V397, P1139, DOI 10.1016/S0140-6736(21)00391-3; Kates J, 2021, LANCET, V397, P1127, DOI 10.1016/S0140-6736(21)00397-4; Maqbool A., 2020, BBC NEWS; Mayer KH, 2021, LANCET, V397, P1116, DOI 10.1016/S0140-6736(21)00321-4; MAYS VM, 1987, PUBLIC HEALTH REP, V102, P224; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Oster AM, 2011, AIDS, V25, P1103, DOI 10.1097/QAD.0b013e3283471efa; Recht H., 2021, BLACK AM ARE GETTING; Satcher D, 2005, HEALTH AFFAIR, V24, P459, DOI 10.1377/hlthaff.24.2.459; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Sullivan PS, 2021, LANCET, V397, P1095, DOI 10.1016/S0140-6736(21)00395-0; Thomas SB, 2001, AM J PUBLIC HEALTH, V91, P1046, DOI 10.2105/AJPH.91.7.1046; US Census Bureau, 2020, POP EST AG SEX RAC H; US Centers for Disease Control and Prevention, 2021, CAS COR DIS COVID 19; US Centers for Disease Control and Prevention, 2020, HIV SURV REP, V31	22	15	15	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1040	1042		10.1016/S0140-6736(20)32522-8	http://dx.doi.org/10.1016/S0140-6736(20)32522-8		MAR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617773	Bronze			2022-12-28	WOS:000630397800006
J	Kates, J; Dawson, L; Horn, TH; Killelea, A; McCann, NC; Crowley, JS; Walensky, RP				Kates, Jennifer; Dawson, Lindsey; Horn, Tim H.; Killelea, Amy; McCann, Nicole C.; Crowley, Jeffrey S.; Walensky, Rochelle P.			Insurance coverage and financing landscape for HIV treatment and prevention in the USA	LANCET			English	Review							CARE	In 2010, the US health insurance system underwent one of its most substantial transformations with the passage of the Affordable Care Act, which increased coverage for millions of people in the USA, including those with and at risk of HIV. Even so, the system of HIV care and prevention services in the USA is a complex patchwork of payers, providers, and financing mechanisms. People with HIV are primarily covered by Medicaid, Medicare, private insurance, or a combination of these; many get care through other programmes, particularly the Ryan White HIV/AIDS Program, which serves as the nation's safety net for people with HIV who remain uninsured or underinsured but offers modest to no support for prevention services. While uninsurance has drastically declined over the past decade, the USA trails other high-income countries in key HIV-specific metrics, including rates of viral suppression. In this paper in the Series, we provide an overview of the coverage and financing landscape for HIV treatment and prevention in the USA, discuss how the Affordable Care Act has changed the domestic health-care system, examine the major programmes that provide coverage and services, and identify remaining challenges.	[Kates, Jennifer; Dawson, Lindsey] Henry J Kaiser Family Fdn, Washington, DC 20005 USA; [Horn, Tim H.; Killelea, Amy] Natl Alliance State & Terr AIDS Directors NASTAD, Washington, DC USA; [McCann, Nicole C.] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Crowley, Jeffrey S.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Georgetown University; Harvard University; Massachusetts General Hospital	Kates, J (corresponding author), Henry J Kaiser Family Fdn, Washington, DC 20005 USA.	jkates@kff.org		McCann, Nicole/0000-0002-4916-4319				[Anonymous], PATIENT PROTECTION A; CDC,, 2022, MEN DIS FLOR 2022 SE; Center on Budget and Policy Priorities, 2019, SABOTAGE WATCH TRACK; Claxton G, 2018, EMPLOYER HLTH BENEFI; Cornachione E, 2016, SUMMARY HHSS FINAL R; Dawson L, 2018, SHORT TERM LTD DURAT; Dawson L., 2020, INSURANCE COVERAGE V; Dawson L, 2020, US ENDING HIV EPIDEM; Dawson L, 2017, INSURANCE COVERAGE C; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Gilead, 2019, GILEAD SCI PROVIDE F; Health Resources and Services Administration, 2016, RYAN WHITE HIV AIDS; Health Resources and Services Administration, 2019, 340B DRUG PRICING PR; Health Resources and Services Administration, 2019, RYAN WHITE HIVAIDS P; HIV.gov, 2012, FDA APPROVES 1 DRUG; HIV Prevention Trials Network, 2020, **NON-TRADITIONAL**; Isbell M, 2012, RESPONDING AIDS HOME; Kaiser Family Foundation, 2019, HIV VIRAL SUPPRESSIO; Kaiser Family Foundation, 2020, HLTH COVERAGE IMMIGR; Kaiser Family Foundation, 2019, PREVENTIVE SERVICES; Kaiser Family Foundation, 2019, STATUS PARTICIPATION; Kaiser Family Foundation, 2016, MEDICARE HIV; Kaiser Family Foundation, 2019, MED HIV; Kaiser Family Foundation, 2019, US FEDERAL FUNDING H; Kaiser Family Foundation, 2019, STAT STAT ACT MED EX; Kaiser Family Foundation, 2004, FINANCING HIVAIDS CA; Kaiser Family Foundation, 2015, PREVENTIVE SERVICES; Kates J., 2018, HLTH ACCESS CARE COV; Kates J, 2014, ACA PEOPLE HIV ACAS, DOI [10.1377/hblog20140303.037472/full/, DOI 10.1377/HBLOG20140303.037472/FULL]; Micromedex IBM, WEB APPL ACCESS; National Alliance of State and Territorial AIDS Directors, NATL HIV PREVENTION; National Alliance of State and Territorial AIDS Directors, 2019, 2019 NATL RWHAP PART; National Research Council Institute of Medicine., 2013, US HLTH INT PERSPECT; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; ObamaCareFacts.com, 2014, OBAMACARE ESSENTIAL; Padamsee TJ, 2020, SOC HIST MED, V33, P1001, DOI 10.1093/shm/hky108; Reif S, 2016, DEEP S INFRASTRUCTUR; Reif SS, 2017, HIV STIGMA STUDY DEE; Reif SS, 2019, SO HIVAIDS STRATEGY; Rosenbaum S, 2015, MEDICAID BENEFIT DES; Saloner B, 2019, HEALTH AFFAIR, V38, P633, DOI 10.1377/hlthaff.2018.05049; Schackman BR, 2015, MED CARE, V53, P293, DOI 10.1097/MLR.0000000000000308; Schneider EC, 2017, INT COMP REFLECTS FL; Selberg Jeffery, 2018, GENERATION HEALTHCAR; Stringer KL, 2016, AIDS BEHAV, V20, P115, DOI 10.1007/s10461-015-1256-y; United States Code, 2006, TITLE 42 THE PUBLIC; US Centers for Disease Control and Prevention, HIV OLDER AM; US Centers for Disease Control and Prevention, 2020, BEHAV CLIN CHARACTER; US Centers for Disease Control and Prevention, 2018, MONITORING SELECTED; US Department of Health and Human Services, 2019, GUIDELINES USE ANTIR; US Department of Homeland Security, 2019, INADMISSIBILITY PUBL; US Health Resources and Services Administration, HRSA RYAN WHITE GLOB; US House Rules Committee, 2020, RULES COMMITTEE PRIN; US Preventive Services Task Force, 2019, FINAL RECOMMENDATION; Walensky RP, 2019, PREP SCH FIELD MANUA, DOI [10.1377/hblog20190826.11005/full/, DOI 10.1377/HBLOG20190826.11005/FULL]; Weiser J, 2015, JAMA INTERN MED, V175, P1650, DOI 10.1001/jamainternmed.2015.4095; WHO European Centre for Disease Prevention and Control., 2018, HIVAIDS SURVEILLANCE; Xiao D, 2018, J AM COLL SURGEONS, V226, P22, DOI 10.1016/j.jamcollsurg.2017.09.012	59	16	16	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1127	1138		10.1016/S0140-6736(21)00397-4	http://dx.doi.org/10.1016/S0140-6736(21)00397-4		MAR 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617778				2022-12-28	WOS:000630397800030
J	Hernandez-Lopez, RA; Yu, W; Cabral, KA; Creasey, OA; Pazmino, MDL; Tonai, Y; De Guzman, A; Makela, A; Saksela, K; Gartner, ZJ; Lim, WA				Hernandez-Lopez, Rogelio A.; Yu, Wei; Cabral, Katelyn A.; Creasey, Olivia A.; Lopez Pazmino, Maria Del Pilar; Tonai, Yurie; De Guzman, Arsenia; Makela, Anna; Saksela, Kalle; Gartner, Zev J.; Lim, Wendell A.			T cell circuits that sense antigen density with an ultrasensitive threshold	SCIENCE			English	Article							RECEPTOR; EXPRESSION; ROAD	Overexpressed tumor-associated antigens [for example, epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2)] are attractive targets for therapeutic T cells, but toxic "off-tumor" cross-reaction with normal tissues that express low levels of target antigen can occur with chimeric antigen receptor (CAR)-T cells. Inspired by natural ultrasensitive response circuits, we engineered a two-step positive-feedback circuit that allows human cytotoxic T cells to discriminate targets on the basis of a sigmoidal antigen-density threshold. In this circuit, a low-affinity synthetic Notch receptor for HER2 controls the expression of a high-affinity CAR for HER2. Increasing HER2 density thus has cooperative effects on T cells-it increases both CAR expression and activation-leading to a sigmoidal response. T cells with this circuit show sharp discrimination between target cells expressing normal amounts of HER2 and cancer cells expressing 100 times as much HER2, both in vitro and in vivo.	[Hernandez-Lopez, Rogelio A.; Yu, Wei; Lopez Pazmino, Maria Del Pilar; Tonai, Yurie; De Guzman, Arsenia; Lim, Wendell A.] Univ Calif San Francisco, Cell Design Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Hernandez-Lopez, Rogelio A.; Cabral, Katelyn A.; Creasey, Olivia A.; Lopez Pazmino, Maria Del Pilar; Gartner, Zev J.; Lim, Wendell A.] Univ Calif San Francisco, Ctr Cellular Construct, San Francisco, CA 94143 USA; [Cabral, Katelyn A.; Creasey, Olivia A.; Gartner, Zev J.] Univ Calif San Francisco, Dept Pharmaceut Chem, Chan Zuckerberg BioHub, San Francisco, CA USA; [Cabral, Katelyn A.; Creasey, Olivia A.] Univ Calif Berkeley, Grad Program Bioengn, Berkeley, CA 94720 USA; [Cabral, Katelyn A.; Creasey, Olivia A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Makela, Anna; Saksela, Kalle] Univ Helsinki, Haartman Inst, Dept Virol, Helsinki, Finland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Helsinki	Lim, WA (corresponding author), Univ Calif San Francisco, Cell Design Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Lim, WA (corresponding author), Univ Calif San Francisco, Ctr Cellular Construct, San Francisco, CA 94143 USA.	wendell.lim@ucsf.edu		Saksela, Kalle/0000-0003-0827-122X; gartner, zev/0000-0001-7803-1219; Hernandez-Lopez, Rogelio/0000-0003-3968-4908; Lopez Pazmino, Maria del Pilar/0000-0003-3219-6944; Cabral, Katelyn/0000-0002-5161-1018; Tonai, Yurie/0000-0001-9610-6667	NIH [P50GM081879, U54CA244438, R01 CA196277]; Howard Hughes Medical Institute; UCSF Center for Cellular Construction [DBI-1548297]; NSF Science and Technology Center; Cancer Research Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); UCSF Center for Cellular Construction; NSF Science and Technology Center(National Science Foundation (NSF)); Cancer Research Institute	This work was supported by NIH grants (P50GM081879, U54CA244438, and R01 CA196277 to W.A.L.), Howard Hughes Medical Institute (W.A.L.), and the UCSF Center for Cellular Construction (DBI-1548297), an NSF Science and Technology Center. R.A.H.-L. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. R.A.H.-L. was a postdoctoral fellow of UC-MEXUS.	Brudno JN, 2018, NAT REV CLIN ONCOL, V15, P31, DOI 10.1038/nrclinonc.2017.128; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; Cerchiari AE, 2015, P NATL ACAD SCI USA, V112, P2287, DOI 10.1073/pnas.1410776112; D'Aloia MM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0278-6; Dangles-Marie V, 2003, CANCER RES, V63, P3682; Enot DP, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1462431; Ferrell JE, 2014, TRENDS BIOCHEM SCI, V39, P612, DOI 10.1016/j.tibs.2014.10.002; Frank SA, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-31; Guo YL, 2018, CLIN CANCER RES, V24, P1277, DOI 10.1158/1078-0432.CCR-17-0432; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Klichinsky M, 2020, NAT BIOTECHNOL, V38, P947, DOI 10.1038/s41587-020-0462-y; Lamers CHJ, 2013, MOL THER, V21, P904, DOI 10.1038/mt.2013.17; Lehmann A, 2015, MABS-AUSTIN, V7, P1058, DOI 10.1080/19420862.2015.1088618; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Roovers RC, 2011, INT J CANCER, V129, P2013, DOI 10.1002/ijc.26145; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Roybal KT, 2016, CELL, V164, P770, DOI 10.1016/j.cell.2016.01.011; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Thistlethwaite FC, 2017, CANCER IMMUNOL IMMUN, V66, P1425, DOI 10.1007/s00262-017-2034-7; Wan XY, 2019, NAT CHEM BIOL, V15, P540, DOI 10.1038/s41589-019-0244-3; Whilding LM, 2015, MOL ONCOL, V9, P1994, DOI 10.1016/j.molonc.2015.10.012; Wu CY, 2015, CURR OPIN IMMUNOL, V35, P123, DOI 10.1016/j.coi.2015.06.015; YASUI W, 1988, CANCER RES, V48, P137; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	32	42	42	15	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2021	371	6534					1166	+		10.1126/science.abc1855	http://dx.doi.org/10.1126/science.abc1855			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY5RG	33632893	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000630096400037
J	Taylor, L				Taylor, Luke			Covid-19: Why Peru suffers from one of the highest excess death rates in the world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lukestephentaylor@gmail.com						[Anonymous], 2021, AL JAZEERA; Barreto C, 2021, ASS PRESS       0111; Bel PP, 2020, BBC NEWS; Collyns D., 2020, GUARDIAN; Yacila RC, 2020, NY TIMES	5	16	19	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2021	372								n611	10.1136/bmj.n611	http://dx.doi.org/10.1136/bmj.n611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6QO	33687923	Bronze			2022-12-28	WOS:000632923400012
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... Dolly Parton	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2021	372								n647	10.1136/bmj.n647	http://dx.doi.org/10.1136/bmj.n647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QX3QJ	33685855	Bronze			2022-12-28	WOS:000629260700001
J	Bent, S; O'Malley, MJ				Bent, Stephen; O'Malley, Martin J.			Diagnosis of Achilles' Tendon Rupture during a Virtual Examination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bent, Stephen] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [O'Malley, Martin J.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA	University of California System; University of California San Francisco	Bent, S (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	stephen.bent@ucsf.edu		Bent, Stephen/0000-0002-4767-9714					0	0	0	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					859	859		10.1056/NEJMicm2029689	http://dx.doi.org/10.1056/NEJMicm2029689			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33657684				2022-12-28	WOS:000626124800020
J	Kschonsak, M; Rouge, L; Arthur, CP; Hoangdung, H; Patel, N; Kim, I; Johnson, MC; Kraft, E; Rohou, AL; Gill, A; Martinez-Martin, N; Payandeh, J; Ciferri, C				Kschonsak, Marc; Rouge, Lionel; Arthur, Christopher P.; Hoangdung, Ho; Patel, Nidhi; Kim, Ingrid; Johnson, Matthew C.; Kraft, Edward; Rohou, Alexis L.; Gill, Avinash; Martinez-Martin, Nadia; Payandeh, Jian; Ciferri, Claudio			Structures of HCMV Trimer reveal the basis for receptor recognition and cell entry	CELL			English	Article							CRYO-EM; CRYSTAL-STRUCTURE; CYTOMEGALOVIRUS; RESOLUTION; COMPLEX; REGULATOR; GH/GL/GO; INSIGHTS; FEATURES	Human cytomegalovirus (HCMV) infects the majority of the human population and represents the leading viral cause of congenital birth defects. HCMV utilizes the glycoproteins gHgLgO (Trimer) to bind to platelet-derived growth factor receptor alpha (PDGFR alpha) and transforming growth factor beta receptor 3 (TGF beta R3) to gain entry into multiple cell types. This complex is targeted by potent neutralizing antibodies and represents an important candidate for therapeutics against HCMV. Here, we determine three cryogenic electron microscopy (cryo-EM) structures of the trimer and the details of its interactions with four binding partners: the receptor proteins PDGFR alpha and TGF beta R3 as well as two broadly neutralizing antibodies. Trimer binding to PDGFR alpha and TGF beta R3 is mutually exclusive, suggesting that they function as independent entry receptors. In addition, Trimer-PDGFR alpha interaction has an inhibitory effect on PDGFR alpha signaling. Our results provide a framework for understanding HCMV receptor engagement, neutralization, and the development of anti-viral strategies against HCMV.	[Kschonsak, Marc; Rouge, Lionel; Arthur, Christopher P.; Hoangdung, Ho; Patel, Nidhi; Johnson, Matthew C.; Rohou, Alexis L.; Payandeh, Jian; Ciferri, Claudio] Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA; [Kim, Ingrid; Gill, Avinash; Payandeh, Jian] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Kraft, Edward] Genentech Inc, Dept BioMol Resources, San Francisco, CA 94080 USA; [Martinez-Martin, Nadia] Genentech Inc, Dept Microchem, Prote & Lipid Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kschonsak, M; Payandeh, J; Ciferri, C (corresponding author), Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA.; Payandeh, J (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.; Martinez-Martin, N (corresponding author), Genentech Inc, Dept Microchem, Prote & Lipid Dept, San Francisco, CA 94080 USA.	kschonsak.marc@gene.com; martinez-martin.nadia@gene.com; payandeh.jian@gene.com; ciferri.claudio@gene.com		Johnson, Matthew/0000-0002-1477-7801				Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Anderholm KM, 2016, DRUGS, V76, P1625, DOI 10.1007/s40265-016-0653-5; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chandramouli S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan1457; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837; Chu WF, 2011, J CELL PHYSIOL, V226, P2586, DOI 10.1002/jcp.22604; Ciferri C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005230; Ciferri C, 2015, P NATL ACAD SCI USA, V112, P1767, DOI 10.1073/pnas.1424818112; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falk JJ, 2018, J INFECT DIS, V218, P876, DOI 10.1093/infdis/jiy229; Foglierini M, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01005; Fouts AE, 2014, P NATL ACAD SCI USA, V111, P8209, DOI 10.1073/pnas.1404653111; GALLANT JE, 1992, J INFECT DIS, V166, P1223, DOI 10.1093/infdis/166.6.1223; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; HO M, 1990, REV INFECT DIS, V12, pS701; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Hyde TB, 2010, REV MED VIROL, V20, P311, DOI 10.1002/rmv.659; Jovanovic B, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3684; Kabanova A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.82, 10.1038/nmicrobiol.2016.82]; Kim SK, 2019, STRUCTURE, V27, P1427, DOI 10.1016/j.str.2019.06.010; Kotton CN, 2010, NAT REV NEPHROL, V6, P711, DOI 10.1038/nrneph.2010.141; KUPPERMANN BD, 1993, AM J OPHTHALMOL, V115, P575, DOI 10.1016/S0002-9394(14)71453-9; Lin SJ, 2011, P NATL ACAD SCI USA, V108, P5232, DOI 10.1073/pnas.1010689108; Liu J, 2018, J VIROL, V92, DOI 10.1128/JVI.01336-18; Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09; Mamer SB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16610-z; Martinez-Martin N, 2018, CELL, V174, P1158, DOI 10.1016/j.cell.2018.06.028; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matsuura H, 2010, P NATL ACAD SCI USA, V107, P22641, DOI 10.1073/pnas.1011806108; Nguyen CC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120704; Nishida J, 2018, ONCOGENE, V37, P2197, DOI 10.1038/s41388-017-0084-0; NOKTA M, 1994, ANTIVIR RES, V24, P17, DOI 10.1016/0166-3542(94)90048-5; Park J, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008647; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ryckman BJ, 2008, J VIROL, V82, P60, DOI 10.1128/JVI.01910-07; Saito T, 2017, CELL REP, V19, P1917, DOI 10.1016/j.celrep.2017.05.011; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schleiss MR, 2011, J INFECT DIS, V203, P1513, DOI 10.1093/infdis/jir144; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shim AHR, 2010, P NATL ACAD SCI USA, V107, P11307, DOI 10.1073/pnas.1000806107; Si Z, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007452; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinzger C, 2008, J CLIN VIROL, V41, P174, DOI 10.1016/j.jcv.2007.12.002; Stegmann C, 2019, J VIROL, V93, DOI 10.1128/JVI.00138-19; Stegmann C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006273; Stegmann C, 2017, J VIROL, V91, DOI 10.1128/JVI.01339-16; Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wille PT, 2013, MBIO, V4, DOI 10.1128/mBio.00332-13; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu K, 2018, P NATL ACAD SCI USA, V115, pE9889, DOI 10.1073/pnas.1806305115; Wu YQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006281; Zhang Y, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a022145; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou MM, 2015, J VIROL, V89, P8999, DOI 10.1128/JVI.01325-15	60	17	17	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1232	+		10.1016/j.cell.2021.01.036	http://dx.doi.org/10.1016/j.cell.2021.01.036		MAR 2021	29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33626330	Bronze			2022-12-28	WOS:000629635700013
J	Zhu, XG; Zhu, JK				Zhu, Xin-Guang; Zhu, Jian-Kang			Precision genome editing heralds rapid de novo domestication for new crops	CELL			English	Editorial Material							RICE; GENE	The de novo domestication has the potential to rapidly capitalize on desirable traits of wild plants. In this issue of Cell, Yu et al. report a route of de novo domestication of an allotetraploid rice, heralding the creation of a novel staple food crop to support global food security.	[Zhu, Xin-Guang] Chinese Acad Sci, Ctr Excellence Mol Plant Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Zhu, Jian-Kang] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhu, XG (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Plant Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	zhuxg@cemps.ac.cn						Chen EW, 2019, ANNU REV PLANT BIOL, V70, P639, DOI 10.1146/annurev-arplant-050718-100320; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Lemmon ZH, 2018, NAT PLANTS, V4, P766, DOI 10.1038/s41477-018-0259-x; Li TD, 2018, NAT BIOTECHNOL, V36, P1160, DOI 10.1038/nbt.4273; Lu YM, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0581-5; Maher MF, 2020, NAT BIOTECHNOL, V38, P84, DOI 10.1038/s41587-019-0337-2; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Watson A, 2018, NAT PLANTS, V4, P23, DOI 10.1038/s41477-017-0083-8; Yu H, 2021, CELL, V184, P1156, DOI 10.1016/j.cell.2021.01.013; Zsogon A, 2018, NAT BIOTECHNOL, V36, P1211, DOI 10.1038/nbt.4272	10	5	6	10	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1133	1134		10.1016/j.cell.2021.02.004	http://dx.doi.org/10.1016/j.cell.2021.02.004		MAR 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33667365	Bronze			2022-12-28	WOS:000629635700003
J	Mc Cord, KA; Ewald, H; Agarwal, A; Glinz, D; Aghlmandi, S; Ioannidis, JPA; Hemkens, LG				Cord, Kimberly A. Mc; Ewald, Hannah; Agarwal, Arnav; Glinz, Dominik; Aghlmandi, Soheila; Ioannidis, John P. A.; Hemkens, Lars G.			Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							REAL-WORLD EVIDENCE; DATA QUALITY; PROMISES; ERROR	OBJECTIVE To compare effect estimates of randomised clinical trials that use routinely collected data (RCD-RCT) for outcome ascertainment with traditional trials not using routinely collected data. DESIGN Meta-research study. DATA SOURCE Studies included in the same meta-analysis in a Cochrane review. ELIGIBILITY CRITERIA FOR STUDY SELECTION Randomised clinical trials using any type of routinely collected data for outcome ascertainment, including from registries, electronic health records, and administrative databases, that were included in a meta-analysis of a Cochrane review on any clinical question and any health outcome together with traditional trials not using routinely collected data for outcome measurement. REVIEW METHODS Effect estimates from trials using or not using routinely collected data were summarised in random effects meta-analyses. Agreement of (summary) treatment effect estimates from trials using routinely collected data and those not using such data was expressed as the ratio of odds ratios. Subgroup analyses explored effects in trials based on different types of routinely collected data. Two investigators independently assessed the quality of each data source. RESULTS 84 RCD-RCTs and 463 traditional trials on 22 clinical questions were included. Trials using routinely collected data for outcome ascertainment showed 20% less favourable treatment effect estimates than traditional trials (ratio of odds ratios 0.80, 95% confidence interval 0.70 to 0.91, I-2=14%). Results were similar across various types of outcomes (mortality outcomes: 0.92, 0.74 to 1.15, I-2=12%; non-mortality outcomes: 0.71, 0.60 to 0.84, I-2=8%), data sources (electronic health records: 0.81, 0.59 to 1.11, I-2=28%; registries: 0.86, 0.75 to 0.99, I-2=20%; administrative data: 0.84, 0.72 to 0.99, I-2=0%), and data quality (high data quality: 0.82, 0.72 to 0.93, I-2=0%). CONCLUSIONS Randomised clinical trials using routinely collected data for outcome ascertainment show smaller treatment benefits than traditional trials not using routinely collected data. These differences could have implications for healthcare decision making and the application of real world evidence.	[Cord, Kimberly A. Mc; Ewald, Hannah; Glinz, Dominik; Aghlmandi, Soheila; Hemkens, Lars G.] Univ Basel, Univ Hosp Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, CH-4031 Basel, Switzerland; [Ewald, Hannah] Univ Basel, Univ Med Lib, Basel, Switzerland; [Agarwal, Arnav] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Hemkens, Lars G.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.; Hemkens, Lars G.] Berlin Inst Hlth, Meta Res Innovat Ctr Berlin METRIC B, Berlin, Germany	University of Basel; University of Basel; University of Toronto; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Berlin Institute of Health	Hemkens, LG (corresponding author), Univ Basel, Univ Hosp Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, CH-4031 Basel, Switzerland.	lars.hemkens@usb.ch	Ioannidis, John P. A./G-9836-2011; Agarwal, Arnav/J-1553-2014; Cord, Kimberly Mc/ABG-4905-2021; Hemkens, Lars G./AAB-2653-2020	Agarwal, Arnav/0000-0002-0931-7851; Cord, Kimberly Mc/0000-0002-2147-3160; Hemkens, Lars G./0000-0002-3444-1432; Ewald, Hannah/0000-0002-5081-1093	Stiftung Institut fur klinische Epidemiologie; Laura and John Arnold Foundation; Stiftung Charite; Einstein Stiftung	Stiftung Institut fur klinische Epidemiologie; Laura and John Arnold Foundation; Stiftung Charite; Einstein Stiftung	The Basel Institute for Clinical Epidemiology and Biostatistics is supported by the Stiftung Institut fur klinische Epidemiologie (KAM, LGH, EH, SA, and DG). METRICS has been supported by grants from the Laura and John Arnold Foundation (JPAI and LGH). METRIC-B has been supported by an Einstein fellowship award to JPAI from the Stiftung Charite and the Einstein Stiftung (JPAI and LGH). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript or its submission for publication.	Adler AJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009217.pub3; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Balduzzi S, 2019, EVID-BASED MENT HEAL, V22, P153, DOI 10.1136/ebmental-2019-300117; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Cameron ID, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub3; Capurro Daniel, 2014, EGEMS (Wash DC), V2, P1079, DOI 10.13063/2327-9214.1079; Christensen M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008986.pub3; Dal-Re R, 2020, EUR J CLIN PHARMACOL, V76, P1093, DOI 10.1007/s00228-020-02901-4; Dal-Re R, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1038-2; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; Diakou LAN, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000043.pub2; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Everett T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002834.pub2; Fanning Jonathon P, 2016, Cochrane Database Syst Rev, pCD004815, DOI 10.1002/14651858.CD004815.pub4; Feder SL, 2018, WESTERN J NURS RES, V40, P753, DOI 10.1177/0193945916689084; Goncalves-Bradley DC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub5; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gunaratne AW, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010085.pub2; Harron K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-36; Hemkens L, PRAGMETA GEN APPLICA; Hemkens LG, 2020, CLIN TRIALS, V17, P247, DOI 10.1177/1740774520913845; Hemkens LG, 2016, CAN MED ASSOC J, V188, pE158, DOI 10.1503/cmaj.150653; Henry DA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub4; Inglis SC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub3; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kwakkenbos L, 2018, RES INTEGR PEER REV, V3, DOI 10.1186/s41073-018-0053-3; Ladanie A, 2019, J CLIN EPIDEMIOL, V114, P49, DOI 10.1016/j.jclinepi.2019.05.033; Long L, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003331.pub5; Marjoribanks J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003855.pub3; Mathes T, 2019, J CLIN EPIDEMIOL, V105, P80, DOI 10.1016/j.jclinepi.2018.09.011; Mc Cord Kimberly A, 2019, CMAJ Open, V7, pE23, DOI 10.9778/cmajo.20180096; Mc Cord KA, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2394-5; Moller CH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007224.pub2; Nicholls SG, 2017, CAN MED ASSOC J, V189, pE1054, DOI 10.1503/cmaj.170807; Palmer SC, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007784.pub2, 10.1590/1516-3180.20141325T1]; Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217; Ramsberg J., 2015, NORDIC J HLTH EC, V5, P62, DOI [10.5617/njhe.1386, DOI 10.5617/NJHE.1386]; Reilly S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008345.pub2; Renfrew MJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub4; RStudio, OP SOURC PROF SOFTW; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Strom JB, 2020, CIRCULATION, V142, P203, DOI 10.1161/CIRCULATIONAHA.120.046159; US FDA, 2018, FRAMEWORK FDAS REAL; van Smeden M, 2020, INT J EPIDEMIOL, V49, P338, DOI 10.1093/ije/dyz251; Vann JCJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub3; Wagner M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007746.pub2; Weisberg HI, 2009, CLIN TRIALS, V6, P109, DOI 10.1177/1740774509102563; Weiskopf NG, 2013, J AM MED INFORM ASSN, V20, P144, DOI 10.1136/amiajnl-2011-000681; Wong WT, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003587.pub3; Zuidgeest MGP, 2017, J CLIN EPIDEMIOL, V88, P7, DOI 10.1016/j.jclinepi.2016.12.023; Zwarenstein M, 2009, CAN MED ASSOC J, V180, P998, DOI 10.1503/cmaj.082007; Zwerink M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub3	54	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2021	372								n450	10.1136/bmj.n450	http://dx.doi.org/10.1136/bmj.n450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6OT	33658187	Green Published			2022-12-28	WOS:000632918700004
J	Fustinana, MS; Eichlisberger, T; Bouwmeester, T; Bitterman, Y; Luthi, A				Fustinana, Maria Sol; Eichlisberger, Tobias; Bouwmeester, Tewis; Bitterman, Yael; Luthi, Andreas			State-dependent encoding of exploratory behaviour in the amygdala	NATURE			English	Article								The behaviour of an animal is determined by metabolic, emotional and social factors(1,2). Depending on its state, an animal will focus on avoiding threats, foraging for food or on social interactions, and will display the appropriate behavioural repertoire(3). Moreover, survival and reproduction depend on the ability of an animal to adapt to changes in the environment by prioritizing the appropriate state(4). Although these states are thought to be associated with particular functional configurations of large-brain systems(5,6), the underlying principles are poorly understood. Here we use deep-brain calcium imaging of mice engaged in spatial or social exploration to investigate how these processes are represented at the neuronal population level in the basolateral amygdala, which is a region of the brain that integrates emotional, social and metabolic information. We demonstrate that the basolateral amygdala encodes engagement in exploratory behaviour by means of two large, functionally anticorrelated ensembles that exhibit slow dynamics. We found that spatial and social exploration were encoded by orthogonal pairs of ensembles with stable and hierarchical allocation of neurons according to the saliency of the stimulus. These findings reveal that the basolateral amygdala acts as a low-dimensional, but context-dependent, hierarchical classifier that encodes state-dependent behavioural repertoires. This computational function may have a fundamental role in the regulation of internal states in health and disease.	[Fustinana, Maria Sol; Eichlisberger, Tobias; Bitterman, Yael; Luthi, Andreas] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Bouwmeester, Tewis] Novartis Pharma AG, Novartis Inst Biomed Res, Basel, Switzerland; [Luthi, Andreas] Univ Basel, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Basel	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.; Luthi, A (corresponding author), Univ Basel, Basel, Switzerland.	andreas.luthi@fmi.ch	bitterman, yael/GRS-6144-2022; Luthi, Andreas/D-7940-2016	Fustinana, Maria Sol/0000-0001-9701-4393; Eichlisberger, Tobias/0000-0003-3293-5962; Luthi, Andreas/0000-0002-1859-4252; bitterman, yael/0000-0002-4153-3888	European Research Council under the European Union [669582]; Swiss National Science Foundation [310030B_170268]; Novartis Presidential Postdoc fellowship; Novartis Research Foundation	European Research Council under the European Union(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Presidential Postdoc fellowship; Novartis Research Foundation	We thank J. J. Letzkus, A. Ramos-Prats, J. Grundemann, S. Krabbe, P. Tovote, M. S. Esposito, M. B. Pardi, A. Depino and all members of the laboratory of A.L. for comments and discussions; P. Argast, P. Buchmann and C. Muller and all staff of the Friedrich Miescher Institute for Biomedical Research (FMI) Animal Facility for technical assistance; the IT department of the FMI, in particular D. Flanders, S. Grzybek, R. Milani, E. Tagliavini, E. Brondolo, S. van Eden and A. Naylor, for their support with data acquisition and analyses; the Facility for Imaging and Microscopy at the FMI, in particular S. Bourke and J. Eglinger; and M. Stadler for statistical advice. This work was supported by the following grants: the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 669582) and a Swiss National Science Foundation core grant (310030B_170268) to A.L.; a Novartis Presidential Postdoc fellowship to M.S.F.; as well as by the Novartis Research Foundation.	Adolphs R., 2018, NEUROSCIENCE EMOTION; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Chen P, 2018, NEURON, V98, P16, DOI 10.1016/j.neuron.2018.02.026; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Darwin C., 1872, P374; Davis M., 2000, AMYGDALA, P213; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Fanselow MS, 2018, CURR OPIN BEHAV SCI, V24, P44, DOI 10.1016/j.cobeha.2018.03.003; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; Froemke RC, 2015, ANNU REV NEUROSCI, V38, P195, DOI 10.1146/annurev-neuro-071714-034002; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Grundemann J, 2019, SCIENCE, V364, P254, DOI 10.1126/science.aav8736; Hadjikhani N, 2017, SOC COGN AFFECT NEUR, V12, P1197, DOI 10.1093/scan/nsx046; Headley DB, 2019, NEURON, V103, P189, DOI 10.1016/j.neuron.2019.05.024; Hung LW, 2017, SCIENCE, V357, P1406, DOI 10.1126/science.aan4994; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kingsbury L, 2019, CELL, V178, P429, DOI 10.1016/j.cell.2019.05.022; Kodama NX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18097-0; Krabbe S, 2019, NAT NEUROSCI, V22, P1834, DOI 10.1038/s41593-019-0508-y; Kyriazi P, 2018, NEURON, V99, P1315, DOI 10.1016/j.neuron.2018.07.036; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Levy DR, 2019, NAT NEUROSCI, V22, P2013, DOI 10.1038/s41593-019-0531-z; Li Y, 2017, CELL, V171, P1176, DOI 10.1016/j.cell.2017.10.015; Liang B, 2018, NEURON, V100, P700, DOI 10.1016/j.neuron.2018.08.043; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; O'Neill PK, 2018, CURR OPIN NEUROBIOL, V49, P175, DOI 10.1016/j.conb.2018.02.012; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Remedios R, 2017, NATURE, V550, P388, DOI 10.1038/nature23885; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tinbergen N, 1951, STUDY INSTINCT; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; von Heimendahl M, 2012, J NEUROSCI, V32, P2129, DOI 10.1523/JNEUROSCI.3812-11.2012	37	7	7	3	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2021	592	7853					267	+		10.1038/s41586-021-03301-z	http://dx.doi.org/10.1038/s41586-021-03301-z		MAR 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RJ8ZE	33658711				2022-12-28	WOS:000625125200003
J	Wilson, JN; Thisse, D; Lebois, M; Jovancevic, N; Gjestvang, D; Canavan, R; Rudigier, M; Etasse, D; Gerst, RB; Gaudefroy, L; Adamska, E; Adsley, P; Algora, A; Babo, M; Belvedere, K; Benito, J; Benzoni, G; Blazhev, A; Boso, A; Bottoni, S; Bunce, M; Chakma, R; Cieplicka-Orynczak, N; Courtin, S; Cortes, ML; Davies, P; Delafosse, C; Fallot, M; Fornal, B; Fraile, L; Gottardo, A; Guadilla, V; Hafner, G; Hauschild, K; Heine, M; Henrich, C; Homm, I; Ibrahim, F; Iskra, LW; Ivanov, P; Jazrawi, S; Korgul, A; Koseoglou, P; Kroll, T; Kurtukian-Nieto, T; Le Meur, L; Leoni, S; Ljungvall, J; Lopez-Martens, A; Lozeva, R; Matea, I; Miernik, K; Nemer, J; Oberstedt, S; Paulsen, W; Piersa, M; Popovitch, Y; Porzio, C; Qi, L; Ralet, D; Regan, PH; Rezynkina, K; Sanchez-Tembleque, V; Siem, S; Schmitt, C; Soderstrom, PA; Surder, C; Tocabens, G; Vedia, V; Verney, D; Warr, N; Wasilewska, B; Wiederhold, J; Yavahchova, M; Zeiser, F; Ziliani, S				Wilson, J. N.; Thisse, D.; Lebois, M.; Jovancevic, N.; Gjestvang, D.; Canavan, R.; Rudigier, M.; Etasse, D.; Gerst, R-B; Gaudefroy, L.; Adamska, E.; Adsley, P.; Algora, A.; Babo, M.; Belvedere, K.; Benito, J.; Benzoni, G.; Blazhev, A.; Boso, A.; Bottoni, S.; Bunce, M.; Chakma, R.; Cieplicka-Orynczak, N.; Courtin, S.; Cortes, M. L.; Davies, P.; Delafosse, C.; Fallot, M.; Fornal, B.; Fraile, L.; Gottardo, A.; Guadilla, V; Haefner, G.; Hauschild, K.; Heine, M.; Henrich, C.; Homm, I; Ibrahim, F.; Iskra, L. W.; Ivanov, P.; Jazrawi, S.; Korgul, A.; Koseoglou, P.; Kroell, T.; Kurtukian-Nieto, T.; Le Meur, L.; Leoni, S.; Ljungvall, J.; Lopez-Martens, A.; Lozeva, R.; Matea, I; Miernik, K.; Nemer, J.; Oberstedt, S.; Paulsen, W.; Piersa, M.; Popovitch, Y.; Porzio, C.; Qi, L.; Ralet, D.; Regan, P. H.; Rezynkina, K.; Sanchez-Tembleque, V; Siem, S.; Schmitt, C.; Soderstrom, P-A; Surder, C.; Tocabens, G.; Vedia, V.; Verney, D.; Warr, N.; Wasilewska, B.; Wiederhold, J.; Yavahchova, M.; Zeiser, F.; Ziliani, S.			Angular momentum generation in nuclear fission	NATURE			English	Article							PROMPT; FRAGMENTS; HEAVY; MULTIPLICITY; FUSION; SPINS; MASS	When a heavy atomic nucleus splits (fission), the resulting fragments are observed to emerge spinning(1); this phenomenon has been a mystery in nuclear physics for over 40 years(2,3). The internal generation of typically six or seven units of angular momentum in each fragment is particularly puzzling for systems that start with zero, or almost zero, spin. There are currently no experimental observations that enable decisive discrimination between the many competing theories for the mechanism that generates the angular momentum(4-12). Nevertheless, the consensus is that excitation of collective vibrational modes generates the intrinsic spin before the nucleus splits (pre-scission). Here we show that there is no significant correlation between the spins of the fragment partners, which leads us to conclude that angular momentum in fission is actually generated after the nucleus splits (post-scission). We present comprehensive data showing that the average spin is strongly mass-dependent, varying in saw-tooth distributions. We observe no notable dependence of fragment spin on the mass or charge of the partner nucleus, confirming the uncorrelated post-scission nature of the spin mechanism. To explain these observations, we propose that the collective motion of nucleons in the ruptured neck of the fissioning system generates two independent torques, analogous to the snapping of an elastic band. A parameterization based on occupation of angular momentum states according to statistical theory describes the full range of experimental data well. This insight into the role of spin in nuclear fission is not only important for the fundamental understanding and theoretical description of fission, but also has consequences for the gamma-ray heating problem in nuclear reactors(13,14), for the study of the structure of neutron-rich isotopes(15,16), and for the synthesis and stability of super-heavy elements(17,18). gamma-ray spectroscopy experiments on the origin of spin in the products of nuclear fission of spin-zero nuclei suggest that the fission fragments acquire their spin after scission, rather than before.	[Wilson, J. N.; Thisse, D.; Lebois, M.; Jovancevic, N.; Adsley, P.; Babo, M.; Chakma, R.; Delafosse, C.; Haefner, G.; Hauschild, K.; Ibrahim, F.; Ljungvall, J.; Lopez-Martens, A.; Lozeva, R.; Matea, I; Nemer, J.; Popovitch, Y.; Qi, L.; Tocabens, G.; Verney, D.] Univ Paris Saclay, IJC Lab, CNRS, IN2P3, Orsay, France; [Gjestvang, D.; Paulsen, W.; Siem, S.; Zeiser, F.] Univ Oslo, Dept Phys, Blindern, Oslo, Norway; [Canavan, R.; Rudigier, M.; Belvedere, K.; Jazrawi, S.; Regan, P. H.] Univ Surrey, Dept Phys, Guildford, Surrey, England; [Canavan, R.; Boso, A.; Bunce, M.; Ivanov, P.; Jazrawi, S.; Regan, P. H.] Natl Phys Lab, Teddington, Middx, England; [Rudigier, M.; Henrich, C.; Homm, I; Koseoglou, P.; Kroell, T.; Soderstrom, P-A; Surder, C.; Wiederhold, J.] Tech Univ Darmstadt, Inst Kernphys, Fachbereich Phys, Darmstadt, Germany; [Etasse, D.] LPC Caen, Caen, France; [Gerst, R-B; Blazhev, A.; Haefner, G.; Warr, N.] Univ Cologne, Inst Kernphys, Cologne, Germany; [Gaudefroy, L.] CEA, DAM Bruyeres Chatel, Arpajon, France; [Adamska, E.; Korgul, A.; Miernik, K.; Piersa, M.] Univ Warsaw, Fac Phys, Warsaw, Poland; [Algora, A.] Univ Valencia, IFIC, CSIC, Valencia, Spain; [Algora, A.] Inst Nucl Res Atomki, Debrecen, Hungary; [Benito, J.; Fraile, L.; Sanchez-Tembleque, V; Vedia, V.] Univ Complutense Madrid, CEI Moncloa, Grp Fis Nucl, Madrid, Spain; [Benito, J.; Fraile, L.; Sanchez-Tembleque, V; Vedia, V.] Univ Complutense Madrid, CEI Moncloa, IPARCOS, Madrid, Spain; [Benzoni, G.; Bottoni, S.; Iskra, L. W.; Leoni, S.; Porzio, C.; Ziliani, S.] Ist Nazl Fis Nucl, Milan, Italy; [Bottoni, S.; Leoni, S.; Porzio, C.; Ziliani, S.] Univ Milan, Dipartimento Fis, Milan, Italy; [Cieplicka-Orynczak, N.; Fornal, B.; Iskra, L. W.; Wasilewska, B.] Polish Acad Sci, Inst Nucl Phys, Krakow, Poland; [Courtin, S.; Heine, M.; Schmitt, C.] Univ Strasbourg, CNRS, IPHC UMR 7178, Strasbourg, France; [Cortes, M. L.] RIKEN, Nishina Ctr, Hirosawa, Japan; [Davies, P.] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Fallot, M.; Guadilla, V; Le Meur, L.] Univ Nantes, IMT Atlantique, Subatech, Nantes, France; [Gottardo, A.] Ist Nazl Fis Nucl, Lab Nazl Legnaro, Legnaro, Italy; [Koseoglou, P.] GSI Helmoltzzentrum Schwerionenforsch GmbH, Darmstadt, Germany; [Kurtukian-Nieto, T.] Univ Bordeaux, CNRS, CENBG UMR 5797, Gradignan, France; [Oberstedt, S.] European Commiss, Joint Res Ctr, Geel, Belgium; [Porzio, C.] TRIUMF, Vancouver, BC, Canada; [Ralet, D.] Grand Accelerateur Natl Ions Lourds, Caen, France; [Rezynkina, K.] Katholieke Univ Leuven, Inst Nucl & Radiat Phys, Leuven, Belgium; [Soderstrom, P-A] Horia Hulubei Natl Inst Phys & Nucl Engn, Extreme Light Infrastruct Nucl Phys, Bucharest, Romania; [Yavahchova, M.] Bulgarian Acad Sci, Inst Nucl Res & Nucl Energy, Sofia, Bulgaria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Saclay; University of Oslo; University of Surrey; National Physical Laboratory - UK; Technical University of Darmstadt; Universite de Caen Normandie; University of Cologne; CEA; University of Warsaw; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; Complutense University of Madrid; Complutense University of Madrid; Istituto Nazionale di Fisica Nucleare (INFN); University of Milan; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; RIKEN; University of Manchester; IMT - Institut Mines-Telecom; IMT Atlantique; Nantes Universite; Istituto Nazionale di Fisica Nucleare (INFN); Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of British Columbia; CEA; KU Leuven; Horia Hulubei National Institute of Physics & Nuclear Engineering; Bulgarian Academy of Sciences	Wilson, JN (corresponding author), Univ Paris Saclay, IJC Lab, CNRS, IN2P3, Orsay, France.	jonathan.wilson@ijclab.in2p3.fr	Wiederhold, Johannes/C-7628-2017; Guadilla, Victor/AAP-5242-2020; Kurtukian-Nieto, Teresa/J-1707-2014; Adsley, Philip/AAE-5503-2019; Iskra, Lukasz/AAM-4356-2021; Lozeva, Radomira/J-1806-2015; Wasilewska, Barbara A./N-5405-2018; Soderstrom, Par-Anders/E-2983-2017; Hauschild, Karl/A-6726-2009; Fornal, Bogdan/Q-3139-2017	Wiederhold, Johannes/0000-0001-6229-0945; Kurtukian-Nieto, Teresa/0000-0002-0028-0220; Adsley, Philip/0000-0003-1373-679X; Iskra, Lukasz/0000-0003-1495-4174; Lozeva, Radomira/0000-0002-0024-7068; Wasilewska, Barbara A./0000-0001-9321-7759; Yavahchova, Mariya/0000-0002-4672-4667; Soderstrom, Par-Anders/0000-0002-9504-2814; Zeiser, Fabio/0000-0001-6327-9107; Wilson, Jonathan/0000-0002-8988-8178; Miernik, Krzysztof/0000-0002-4373-5600; Bottoni, Simone/0000-0003-2249-4825; Guadilla, Victor/0000-0002-9736-2491; Porzio, Carlotta/0000-0002-4855-784X; Hauschild, Karl/0000-0003-2862-2445; Gjestvang, Dorthea/0000-0002-3215-7585; Courtin, Sandrine/0000-0001-6972-2798; Ziliani, Sara/0000-0001-9202-8788; Lebois, Matthieu/0000-0001-6340-8722; Heine, Marcel/0000-0001-6219-3635; Fornal, Bogdan/0000-0002-1142-8067; Gerst, Rosa-Belle/0000-0002-9716-8752; Piersa-Silkowska, Monika/0000-0002-5877-2818; Sanchez-Tembleque, Victor/0000-0002-4153-4055; Korgul, Agnieszka/0000-0003-0316-170X; Ljungvall, Joa/0000-0003-1938-1889; Benito, Jaime/0000-0002-0351-7027				ABDELRAHMAN Y, 1987, PHYS LETT B, V199, P504, DOI 10.1016/0370-2693(87)91617-0; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Andreyev AN, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aa82eb; Andreyev AN, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.252502; ARMBRUSTER P, 1971, Z NATURFORSCH PT A, VA 26, P512; Bertsch GF, 2019, PHYS REV C, V99, DOI 10.1103/PhysRevC.99.034603; Bethe HA, 1936, PHYS REV, V50, P332, DOI 10.1103/PhysRev.50.332; Bonneau L, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.064313; Boutoux G, 2012, PHYS LETT B, V712, P319, DOI 10.1016/j.physletb.2012.05.012; BROSA U, 1990, PHYS REP, V197, P167, DOI 10.1016/0370-1573(90)90114-H; Chyzh A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.034620; Dudouet J, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.162501; England T.R, 1993, ALAMOS REPORT LA UR; Etasse D, 2013, FAST ACQUISITION SYS; FLYNN KF, 1972, PHYS REV C, V5, P1725, DOI 10.1103/PhysRevC.5.1725; Franke-Arnold S, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/103; Gaudefroy L, 2018, PHYS REV C, V97, DOI 10.1103/PhysRevC.97.064317; GLASSEL P, 1989, NUCL PHYS A, V502, pC315, DOI 10.1016/0375-9474(89)90672-6; Gonnenwein F, 2007, INT J MOD PHYS E, V16, P410, DOI 10.1142/S0218301307005843; Gook A, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.064611; Ha J, 2020, PHYS REV C, V101, DOI 10.1103/PhysRevC.101.044311; Hamilton JH, 1995, PROG PART NUCL PHYS, V35, P635, DOI 10.1016/0146-6410(95)00048-N; HOFFMAN MM, 1964, PHYS REV B, V133, pB714, DOI 10.1103/PhysRev.133.B714; Itkis MG, 2015, NUCL PHYS A, V944, P204, DOI 10.1016/j.nuclphysa.2015.09.007; Kirsch LE, 2018, NUCL INSTRUM METH A, V892, P30, DOI 10.1016/j.nima.2018.02.096; Lebois M, 2020, NUCL INSTRUM METH A, V960, DOI 10.1016/j.nima.2020.163580; Lebois M, 2014, NUCL INSTRUM METH A, V735, P145, DOI 10.1016/j.nima.2013.07.061; Lemaire M, 2015, J NUCL SCI TECHNOL, V52, P1093, DOI 10.1080/00223131.2015.1009957; Mikhailov IN, 1999, PHYS LETT B, V462, P7, DOI 10.1016/S0370-2693(99)00891-6; Misicu S., 1999, PHYS REV C, V60; MORETTO LG, 1989, NUCL PHYS A, V502, pC453, DOI 10.1016/0375-9474(89)90682-9; Naik H, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.014304; Oberstedt A, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.051602; PLEASONTON F, 1973, NUCL PHYS A, VA213, P413, DOI 10.1016/0375-9474(73)90161-9; PUHLHOFER F, 1977, NUCL PHYS A, V280, P267, DOI 10.1016/0375-9474(77)90308-6; Qi L, 2018, PHYS REV C, V98, DOI 10.1103/PhysRevC.98.014612; RADFORD DC, 1995, NUCL INSTRUM METH A, V361, P297, DOI 10.1016/0168-9002(95)00183-2; RASMUSSEN JO, 1969, NUCL PHYS A, VA136, P465, DOI 10.1016/0375-9474(69)90066-9; Rimpault G, 2012, PHYSCS PROC, V31, P3, DOI 10.1016/j.phpro.2012.04.002; Schmidt KH, 2018, REP PROG PHYS, V81, DOI 10.1088/1361-6633/aacfa7; Shneidman TM, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.064302; Smith AG, 1999, AIP CONF PROC, V481, P283, DOI 10.1063/1.59541; Talou P, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.064613; Terrell J., 1962, PHYS REV, V128, P2925; Tuli JK, 1996, NUCL INSTRUM METH A, V369, P506, DOI 10.1016/S0168-9002(96)80040-4; von Weizsacker CF, 1935, Z PHYS, V96, P431; Valentine T.E., 2001, OAK RIDGE NATL LAB R; WILHELMY JB, 1972, PHYS REV C, V5, P2041, DOI 10.1103/PhysRevC.5.2041; Wilson JN, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.222501; Wilson JN, 2015, PHYSCS PROC, V64, P107, DOI 10.1016/j.phpro.2015.04.014; Zagrebaev V. I., 2002, Physical Review C (Nuclear Physics), V65, p014607/1, DOI 10.1103/PhysRevC.65.014607	51	23	23	2	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03304-w	http://dx.doi.org/10.1038/s41586-021-03304-w			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627809	Green Published, Green Submitted			2022-12-28	WOS:000621583600006
J	Brittin, CA; Cook, SJ; Hall, DH; Emmons, SW; Cohen, N				Brittin, Christopher A.; Cook, Steven J.; Hall, David H.; Emmons, Scott W.; Cohen, Netta			A multi-scale brain map derived from whole-brain volumetric reconstructions	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MECHANOSENSORY NEURONS; NERVOUS-SYSTEM; CIRCUIT; CONNECTIVITY; DISTORTION; NETWORKS; DYNAMICS; PATTERNS; PATHWAY	Animal nervous system organization is crucial for all body functions and its disruption can lead to severe cognitive and behavioural impairment(1). This organization relies on features across scales-from the localization of synapses at the nanoscale, through neurons, which possess intricate neuronal morphologies that underpin circuit organization, to stereotyped connections between different regions of the brain(2). The sheer complexity of this organ means that the feat of reconstructing and modelling the structure of a complete nervous system that is integrated across all of these scales has yet to be achieved. Here we present a complete structure-function model of the main neuropil in the nematode Caenorhabditis elegans-the nerve ring-which we derive by integrating the volumetric reconstructions from two animals with corresponding(3) synaptic and gap-junctional connectomes. Whereas previously the nerve ring was considered to be a densely packed tract of neural processes, we uncover internal organization and show how local neighbourhoods spatially constrain and support the synaptic connectome. We find that the C. elegans connectome is not invariant, but that a precisely wired core circuit is embedded in a background of variable connectivity, and identify a candidate reference connectome for the core circuit. Using this reference, we propose a modular network architecture of the C. elegans brain that supports sensory computation and integration, sensorimotor convergence and brain-wide coordination. These findings reveal scalable and robust features of brain organization that may be universal across phyla.	[Brittin, Christopher A.; Cohen, Netta] Univ Leeds, Sch Comp, Leeds, W Yorkshire, England; [Brittin, Christopher A.; Emmons, Scott W.] Albert Einstein Coll Med, Dept Genet, New York, NY USA; [Cook, Steven J.; Hall, David H.; Emmons, Scott W.] Albert Einstein Coll Med, Dept Neurosci, New York, NY USA; [Brittin, Christopher A.] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Cook, Steven J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of Leeds; Yeshiva University; Yeshiva University; Memorial Sloan Kettering Cancer Center; Columbia University	Cohen, N (corresponding author), Univ Leeds, Sch Comp, Leeds, W Yorkshire, England.	N.Cohen@leeds.ac.uk		Hall, David/0000-0001-8459-9820; Cohen, Netta/0000-0002-1633-3315	NIH [NIMH F32MH115438, OD 010943]; NIHD [P30HD071593]; NIMH [R01MH112689]; G. Harold and Leila Y. Mathers Charitable Foundation; EPSRC [EP/J004057/1]; Leeds International Research Scholarship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHD; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); G. Harold and Leila Y. Mathers Charitable Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leeds International Research Scholarship	We thank J. Hodgkin and J. White for their help in donating archival transmission electron microscopy material from the MRC Laboratory of Molecular Biology to the Hall laboratory for curation. T. Ilett, F. Salfelder and S. L. Braunstein provided useful discussion. We thank M. Zhen for making their synaptic and gap junction data available (https://nemanode.org/).This work was supported by NIH grant NIMH F32MH115438 (S.J.C.), NIHD grant P30HD071593 (S.W.E.), NIMH grant R01MH112689 (S.W.E.), the G. Harold and Leila Y. Mathers Charitable Foundation (S.W.E.), NIH OD 010943 (D.H.H.) and EPSRC EP/J004057/1 (N.C.). C.A.B. was supported by the Leeds International Research Scholarship.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Barabasi DL, 2020, NEURON, V105, P435, DOI 10.1016/j.neuron.2019.10.031; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bumbarger DJ, 2013, CELL, V152, P109, DOI 10.1016/j.cell.2012.12.013; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Chen XY, 2018, NEURON, V100, P876, DOI 10.1016/j.neuron.2018.09.042; Cohen Netta, 2019, Current Opinion in Systems Biology, V13, P150, DOI 10.1016/j.coisb.2018.12.002; Cook SJ, 2020, J COMP NEUROL, V528, P2767, DOI 10.1002/cne.24932; Cook SJ, 2019, NATURE, V571, P63, DOI 10.1038/s41586-019-1352-7; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Durbin R., 1987, THESIS; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hahamy A, 2015, NAT NEUROSCI, V18, P302, DOI 10.1038/nn.3919; HALL DH, 1991, J NEUROSCI, V11, P1; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Kang LJ, 2010, NEURON, V67, P381, DOI 10.1016/j.neuron.2010.06.032; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Li C, 2013, LEARN MEMORY, V20, P103, DOI 10.1101/lm.028993.112; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Morgan JL, 2020, NEURON, V106, P468, DOI 10.1016/j.neuron.2020.02.001; Motta A, 2019, SCIENCE, V366, P1093, DOI 10.1126/science.aay3134; Moyle MW, 2021, NATURE, V591, P99, DOI 10.1038/s41586-020-03169-5; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; PEACHEY LD, 1958, J BIOPHYS BIOCHEM CY, V4, P233, DOI 10.1083/jcb.4.3.233; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rapti G, 2017, NAT NEUROSCI, V20, P1350, DOI 10.1038/nn.4630; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Ryan K, 2016, ELIFE, V5, DOI 10.7554/eLife.16962; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Stern S, 2017, CELL, V171, P1649, DOI 10.1016/j.cell.2017.10.041; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Swanson LW, 2016, ANNU REV NEUROSCI, V39, P197, DOI 10.1146/annurev-neuro-071714-033954; Thomson AM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00013; Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wang L, 2013, CURR OPIN NEUROBIOL, V23, P974, DOI 10.1016/j.conb.2013.08.004; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; Witvliet D, 2020, BIORXIV; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054050; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	54	20	20	2	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					105	+		10.1038/s41586-021-03284-x	http://dx.doi.org/10.1038/s41586-021-03284-x		FEB 2021	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33627874	Green Accepted			2022-12-28	WOS:000621335600004
J	Park, AJ; Harris, AZ; Martyniuk, KM; Chang, CY; Abbas, AI; Lowes, DC; Kellendonk, C; Gogos, JA; Gordon, JA				Park, Alan J.; Harris, Alexander Z.; Martyniuk, Kelly M.; Chang, Chia-Yuan; Abbas, Atheir I.; Lowes, Daniel C.; Kellendonk, Christoph; Gogos, Joseph A.; Gordon, Joshua A.			Reset of hippocampal-prefrontal circuitry facilitates learning	NATURE			English	Article								The ability to rapidly adapt to novel situations is essential for survival, and this flexibility is impaired in many neuropsychiatric disorders(1). Thus, understanding whether and how novelty prepares, or primes, brain circuitry to facilitate cognitive flexibility has important translational relevance. Exposure to novelty recruits the hippocampus and medial prefrontal cortex (mPFC)(2) and may prime hippocampal-prefrontal circuitry for subsequent learning-associated plasticity. Here we show that novelty resets the neural circuits that link the ventral hippocampus (vHPC) and the mPFC, facilitating the ability to overcome an established strategy. Exposing mice to novelty disrupted a previously encoded strategy by reorganizing vHPC activity to local theta (4-12 Hz) oscillations and weakening existing vHPC-mPFC connectivity. As mice subsequently adapted to a new task, vHPC neurons developed new task-associated activity, vHPC-mPFC connectivity was strengthened, and mPFC neurons updated to encode the new rules. Without novelty, however, mice adhered to their established strategy. Blocking dopamine D1 receptors (D1Rs) or inhibiting novelty-tagged cells that express D1Rs in the vHPC prevented these behavioural and physiological effects of novelty. Furthermore, activation of D1Rs mimicked the effects of novelty. These results suggest that novelty promotes adaptive learning by D1R-mediated resetting of vHPC-mPFC circuitry, thereby enabling subsequent learning-associated circuit plasticity.	[Park, Alan J.; Harris, Alexander Z.; Chang, Chia-Yuan; Abbas, Atheir I.; Lowes, Daniel C.; Kellendonk, Christoph] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Park, Alan J.; Harris, Alexander Z.; Chang, Chia-Yuan; Abbas, Atheir I.] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Park, Alan J.; Chang, Chia-Yuan; Gogos, Joseph A.] Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA; [Martyniuk, Kelly M.; Lowes, Daniel C.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Abbas, Atheir I.] Oregon Hlth & Sci Univ, VA Portland Hlth Care Syst, Dept Behav Neurosci, Portland, OR 97201 USA; [Abbas, Atheir I.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Kellendonk, Christoph] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Kellendonk, Christoph] Columbia Univ, Dept Mol Pharmacol & Therapeut, New York, NY USA; [Gordon, Joshua A.] NIMH, Bethesda, MD 20892 USA	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; New York State Psychiatry Institute; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Park, AJ (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.; Park, AJ (corresponding author), New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA.; Park, AJ (corresponding author), Columbia Univ, Mortimer B Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA.; Gordon, JA (corresponding author), NIMH, Bethesda, MD 20892 USA.	alanjpark2014@gmail.com; joshua.gordon@nih.gov	Harris, Alexander/GPT-0688-2022; Kellendonk, Christoph/O-7229-2018	Harris, Alexander/0000-0001-9089-0366; Kellendonk, Christoph/0000-0003-3302-2188; Lowes, Daniel/0000-0002-2857-7990	NIMH [R01 MH096274, T32 MH018870-29, R21 MH117454, K08 MH109735]; Leon Levy Foundation; Hope for Depression Research Foundation; BBRF Young Investigator Award; National Institutes of Health Intramural Research Program	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Leon Levy Foundation; Hope for Depression Research Foundation; BBRF Young Investigator Award; National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIMH (R01 MH096274 to J. A. Gogos, T32 MH018870-29 to A.I.A., R21 MH117454 to C.K., and K08 MH109735 to A.Z.H.). A.I.A. was also supported by the Leon Levy Foundation. A.Z.H. was also supported by the Hope for Depression Research Foundation and BBRF Young Investigator Award. J. A. Gordon is supported by the National Institutes of Health Intramural Research Program. We thank N. Padilla-Coreano for providing sample multiunit and LFP recordings; R. Hen, A. Losonczy, and S. Siegelbaum for suggestions; and A. Ciarleglio for advice on logistic regression models of learning curves.	Abbas AI, 2018, NEURON, V100, P926, DOI 10.1016/j.neuron.2018.09.029; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Adhikari A, 2010, NEURON, V65, P257, DOI 10.1016/j.neuron.2009.12.002; Alam MJ, 2018, J NEUROSCI, V38, P6854, DOI 10.1523/JNEUROSCI.2976-17.2018; Ballarini F, 2009, P NATL ACAD SCI USA, V106, P14599, DOI 10.1073/pnas.0907078106; Belluscio MA, 2012, J NEUROSCI, V32, P423, DOI 10.1523/JNEUROSCI.4122-11.2012; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Binder S, 2019, J NEUROSCI, V39, P6978, DOI 10.1523/JNEUROSCI.2158-18.2019; Blot K, 2015, CEREB CORTEX, V25, P1348, DOI 10.1093/cercor/bht329; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chen ZX, 1996, RECEPTOR CHANNEL, V4, P1; Cohen JD, 2017, ELIFE, V6, DOI 10.7554/eLife.23040; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; DEBRUIN JPC, 1994, BRAIN RES, V652, P323, DOI 10.1016/0006-8993(94)90243-7; Dietz B, 2017, NEUROPHARMACOLOGY, V115, P30, DOI 10.1016/j.neuropharm.2016.02.026; Epp JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10838; Fredes F, 2021, CURR BIOL, V31, P25, DOI 10.1016/j.cub.2020.09.074; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Hansen N, 2014, CEREB CORTEX, V24, P845, DOI 10.1093/cercor/bhs362; Hyman JM, 2003, J NEUROSCI, V23, P11725; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Keller CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153154; Kim JI, 2011, NAT NEUROSCI, V14, P1447, DOI 10.1038/nn.2937; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Krause MR, 2017, CURR BIOL, V27, P3086, DOI 10.1016/j.cub.2017.09.020; Latif-Hernandez A, 2016, SCI REP-UK, V6, DOI 10.1038/srep36489; Laubach M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0315-18.2018; Lee D, 2017, NAT BIOTECHNOL, V35, P858, DOI 10.1038/nbt.3902; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810548; Lowet E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146443; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; Mukai J, 2015, NEURON, V86, P680, DOI 10.1016/j.neuron.2015.04.003; O'Dell T J, 1994, Learn Mem, V1, P129; Oishi N, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-018-0424-1; Oswal A, 2016, BRAIN, V139, P1482, DOI 10.1093/brain/aww048; Otmakhova N., 2013, INTRINSICALLY MOTIVA, P235, DOI DOI 10.1007/978-3-642-32375-1; Scheffer-Teixeira R, 2013, J NEUROSCI, V33, P1535, DOI 10.1523/JNEUROSCI.4217-12.2013; Schmidt B, 2013, J NEUROSCI, V33, P6212, DOI 10.1523/JNEUROSCI.2915-12.2013; Shah D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24657-9; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Stebbins MJ, 2001, P NATL ACAD SCI USA, V98, P10775, DOI 10.1073/pnas.121186498; Takeuchi T, 2016, NATURE, V537, P357, DOI 10.1038/nature19325; Tran AH, 2008, J NEUROSCI, V28, P13390, DOI 10.1523/JNEUROSCI.2680-08.2008; Vecsey CG, 2013, SLEEP, V36, P601, DOI 10.5665/sleep.2556; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Waltz JA, 2017, NEUROSCIENCE, V345, P203, DOI 10.1016/j.neuroscience.2016.06.005; Yamada M, 2018, CELL REP, V25, P487, DOI 10.1016/j.celrep.2018.09.026; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004	51	26	26	1	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					615	+		10.1038/s41586-021-03272-1	http://dx.doi.org/10.1038/s41586-021-03272-1		FEB 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33627872	Green Accepted			2022-12-28	WOS:000621335600006
J	Kolte, D; Libby, P; Jang, IK				Kolte, Dhaval; Libby, Peter; Jang, Ik-Kyung			New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIAGNOSIS		[Kolte, Dhaval; Jang, Ik-Kyung] Harvard Med Sch, Massachusetts Gen Hosp, Cardiol Div, Boston, MA 02115 USA; [Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Jang, Ik-Kyung] Kyung Hee Univ, Seoul, South Korea	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Kyung Hee University	Jang, IK (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,GRB 800, Boston, MA 02114 USA.; Jang, IK (corresponding author), Harvard Med Sch, 55 Fruit St,GRB 800, Boston, MA 02114 USA.	ijang@mgh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X				Jia HB, 2017, EUR HEART J, V38, P792, DOI 10.1093/eurheartj/ehw381; Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071; Kim HO, 2019, INT J CARDIOL, V288, P12, DOI 10.1016/j.ijcard.2019.03.039; Leistner DM, 2020, EUR HEART J, V41, P3549, DOI 10.1093/eurheartj/ehaa703; Libby Peter, 2019, Circ Res, V124, P150, DOI 10.1161/CIRCRESAHA.118.311098; Partida RA, 2018, EUR HEART J, V39, P2070, DOI 10.1093/eurheartj/ehx786; Prati F, 2013, JACC-CARDIOVASC IMAG, V6, P283, DOI 10.1016/j.jcmg.2012.12.007; Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950; Yamamoto E, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012322	9	13	13	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1043	1044		10.1001/jama.2021.0069	http://dx.doi.org/10.1001/jama.2021.0069		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33616637				2022-12-28	WOS:000621912400002
J	Wongvibulsin, S; Garibaldi, BT; Antar, AAR; Wen, JY; Wang, MC; Gupta, A; Bollinger, R; Xu, YX; Wang, KB; Betz, JF; Muschelli, J; Bandeen-Roche, K; Zeger, SL; Robinson, ML				Wongvibulsin, Shannon; Garibaldi, Brian T.; Antar, Annukka A. R.; Wen, Jiyang; Wang, Mei-Cheng; Gupta, Amita; Bollinger, Robert; Xu, Yanxun; Wang, Kunbo; Betz, Joshua F.; Muschelli, John; Bandeen-Roche, Karen; Zeger, Scott L.; Robinson, Matthew L.			Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19	ANNALS OF INTERNAL MEDICINE			English	Article							SURVIVAL	Background: Predicting the clinical trajectory of individual patients hospitalized with coronavirus disease 2019 (COVID-19) is challenging but necessary to inform clinical care. The majority of COVID-19 prognostic tools use only data present upon admission and do not incorporate changes occurring after admission. Objective: To develop the Severe COVID-19 Adaptive Risk Predictor (SCARP) (https://rsconnect.biostat.jhsph.edu/covid _trajectory/), a novel tool that can provide dynamic risk predictions for progression from moderate disease to severe illness or death in patients with COVID-19 at any time within the first 14 days of their hospitalization. Design: Retrospective observational cohort study. Settings: Five hospitals in Maryland and Washington, D.C. Patients: Patients who were hospitalized between 5 March and 4 December 2020 with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed by nucleic acid test and symptomatic disease. Measurements: A clinical registry for patients hospitalized with COVID-19 was the primary data source; data included demographic characteristics, admission source, comorbid conditions, time-varying vital signs, laboratory measurements, and clinical severity. Random forest for survival, longitudinal, and multivariate (RF-SLAM) data analysis was applied to predict the 1-day and 7-day risks for progression to severe disease or death for any given day during the first 14 days of hospitalization. Results: Among 3163 patients admitted with moderate COVID-19, 228 (7%) became severely ill or died in the next 24 hours; an additional 355 (11%) became severely ill or died in the next 7 days. The area under the receiver-operating characteristic curve (AUC) for 1-day risk predictions for progression to severe disease or death was 0.89 (95% CI, 0.88 to 0.90) and 0.89 (CI, 0.87 to 0.91) during the first and second weeks of hospitalization, respectively. The AUC for 7-day risk predictions for progression to severe disease or death was 0.83 (CI, 0.83 to 0.84) and 0.87 (CI, 0.86 to 0.89) during the first and second weeks of hospitalization, respectively. Limitation: The SCARP tool was developed by using data from a single health system. Conclusion: Using the predictive power of RF-SLAM and longitudinal data from more than 3000 patients hospitalized with COVID-19, an interactive tool was developed that rapidly and accurately provides the probability of an individual patient's progression to severe illness or death on the basis of readily available clinical information. Primary Funding Source: Hopkins inHealth and COVID-19 Administrative Supplement for the HHS Region 3 Treatment Center from the Office of the Assistant Secretary for Preparedness and Response.	[Wongvibulsin, Shannon; Garibaldi, Brian T.; Antar, Annukka A. R.; Gupta, Amita; Bollinger, Robert; Robinson, Matthew L.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Wen, Jiyang; Wang, Mei-Cheng; Betz, Joshua F.; Muschelli, John; Bandeen-Roche, Karen; Zeger, Scott L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Xu, Yanxun; Wang, Kunbo] Johns Hopkins Univ, Baltimore, MD USA; [Gupta, Amita; Bollinger, Robert; Robinson, Matthew L.] Johns Hopkins Sch Med, Ctr Clin Global Hlth Educ, 600 North Wolfe St,Phipps 521, Baltimore, MD 21287 USA; [Wongvibulsin, Shannon] Johns Hopkins Univ, Sch Med, Med Scientist Training Program, 1830 East Monument St,Suite 2-300, Baltimore, MD 21205 USA; [Garibaldi, Brian T.] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care, 1830 East Monument St,Fifth Floor, Baltimore, MD 21205 USA; [Antar, Annukka A. R.] Div Infect Dis, Miller Res Bldg,Room 869,733 North Broadway, Baltimore, MD 21205 USA; [Wen, Jiyang; Wang, Kunbo; Betz, Joshua F.; Muschelli, John; Bandeen-Roche, Karen; Zeger, Scott L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Biostat, 615 North Wolfe St, Baltimore, MD 21205 USA; [Xu, Yanxun; Wang, Kunbo] Johns Hopkins Univ, Dept Appl Math & Stat, 3300 North Charles St, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Robinson, ML (corresponding author), Johns Hopkins Sch Med, Ctr Clin Global Hlth Educ, 600 North Wolfe St,Phipps 521, Baltimore, MD 21287 USA.	mrobin85@jhmi.edu		Robinson, Matthew L/0000-0003-0376-8560; Garibaldi, Brian/0000-0001-8632-5567; Wen, Jiyang/0000-0003-1976-8127; Antar, Annukka/0000-0002-6775-1103; Gupta, Amita/0000-0001-7036-2718	Hopkins inHealth; Johns Hopkins Precision Medicine Program; Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases, Division of Infectious Diseases of the Johns Hopkins University School of Medicine; National Institutes of Health [F30HL142131, 5T32GM007309]; COVID-19 Administrative Supplement for the HHS Region 3 Treatment Center from the Office of the Assistant Secretary for Preparedness and Response	Hopkins inHealth; Johns Hopkins Precision Medicine Program; Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases, Division of Infectious Diseases of the Johns Hopkins University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COVID-19 Administrative Supplement for the HHS Region 3 Treatment Center from the Office of the Assistant Secretary for Preparedness and Response	JH-CROWN received funding from Hopkins inHealth, the Johns Hopkins Precision Medicine Program, the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases, Division of Infectious Diseases of the Johns Hopkins University School of Medicine. Dr. Wongvibulsin is funded by National Institutes of Health grants F30HL142131 and 5T32GM007309. Drs. Garibaldi, Gupta, and Robinson received funding from the COVID-19 Administrative Supplement for the HHS Region 3 Treatment Center from the Office of the Assistant Secretary for Preparedness and Response.	Adhikari S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16938; Ah YM, 2019, BASIC CLIN PHARMACOL, V124, P741, DOI 10.1111/bcpt.13184; Andersen KM, 2021, CLIN INFECT DIS, V73, pE4124, DOI 10.1093/cid/ciaa1488; [Anonymous], 2020, JAMA INTERNAL MED, DOI DOI 10.1001/JAMAINTERNMED.2020.3596; Bansal Aasthaa, 2019, Diagn Progn Res, V3, P14, DOI 10.1186/s41512-019-0057-6; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Garibaldi BT, 2021, ANN INTERN MED, V174, P33, DOI 10.7326/M20-3905; Ignatius EH, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofaa598; Ishwaran H, 2019, FAST UNIFIED RANDOM; Ishwaran H., 2007, R NEWS, V7, P25; Ishwaran H, 2008, ANN APPL STAT, V2, P841, DOI 10.1214/08-AOAS169; Johns Hopkins Institute for Clinical and Translational Research, 2021, COVID 19 PRECISION M; Joyner Michael J, 2020, medRxiv, DOI 10.1101/2020.08.12.20169359; Knight SR, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3339; Levy Todd J, 2020, medRxiv, DOI 10.1101/2020.04.22.20075416; Liang WH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17280-8; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; The COVID Tracking Project, ATLANTIC; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wongvibulsin S, 2020, JMIR MED INF, V8, DOI 10.2196/15791; Wongvibulsin S, 2019, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-019-0863-0; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Xiao LS, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102880; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	28	24	23	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2021	174	6					777	+		10.7326/M20-6754	http://dx.doi.org/10.7326/M20-6754			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS5IR	33646849	Green Published			2022-12-28	WOS:000661788700017
J	Sullivan, PS; Johnson, AS; Pembleton, ES; Stephenson, R; Justice, AC; Althoff, KN; Bradley, H; Castel, AD; Oster, AM; Rosenberg, ES; Mayer, KH; Beyrer, C				Sullivan, Patrick S.; Johnson, Anna Satcher; Pembleton, Elizabeth S.; Stephenson, Rob; Justice, Amy C.; Althoff, Keri N.; Bradley, Heather; Castel, Amanda D.; Oster, Alexandra M.; Rosenberg, Eli S.; Mayer, Kenneth H.; Beyrer, Chris			Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses	LANCET			English	Review							UNITED-STATES; CARE CONTINUUM; INJECT DRUGS; WHITE MEN; INFECTION; SEX; PREVENTION; SURVEILLANCE; DISPARITIES; POPULATION	The HIV epidemic in the USA began as a bicoastal epidemic focused in large cities but, over nearly four decades, the epidemiology of HIV has changed. Public health surveillance data can inform an understanding of the evolution of the HIV epidemic in terms of the populations and geographical areas most affected. We analysed publicly available HIV surveillance data and census data to describe: current HIV prevalence and new HIV diagnoses by region, race or ethnicity, and age; trends in HIV diagnoses over time by HIV acquisition risk and age; and the distribution of HIV prevalence by geographical area. We reviewed published literature to explore the reasons for the current distribution of HIV cases and important disparities in HIV prevalence. We identified opportunities to improve public health surveillance systems and uses of data for planning and monitoring public health responses. The current US HIV epidemic is marked by geographical concentration in the US South and profound disparities between regions and by race or ethnicity. Rural areas vary in HIV prevalence; rural areas in the South are more likely to have a high HIV prevalence than rural areas in other US Census regions. Ongoing disparities in HIV in the South are probably driven by the restricted expansion of Medicaid, health-care provider shortages, low health literacy, and HIV stigma. HIV diagnoses overall declined in 2009-18, but HIV diagnoses among individuals aged 25-34 years increased during the same period. HIV diagnoses decreased for all risk groups in 2009-18; among men who have sex with men (MSM), new diagnoses decreased overall and for White MSM, remained stable for Black MSM, and increased for Hispanic or Latino MSM. Surveillance data indicate profound and ongoing disparities in HIV cases, with disproportionate impact among people in the South, racial or ethnic minorities, and MSM.	[Sullivan, Patrick S.; Pembleton, Elizabeth S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30329 USA; [Johnson, Anna Satcher; Oster, Alexandra M.] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Stephenson, Rob] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Justice, Amy C.] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Althoff, Keri N.; Beyrer, Chris] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Bradley, Heather] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Castel, Amanda D.] George Washington Univ, Milken Inst Sch Publ Hlth, Washington, DC USA; [Rosenberg, Eli S.] SUNY Albany, Sch Publ Hlth, Albany, NY 12222 USA; [Mayer, Kenneth H.] Harvard Med Sch, Boston, MA 02115 USA; [Mayer, Kenneth H.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; Yale University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Georgia; Georgia State University; George Washington University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sullivan, PS (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30329 USA.	pssulli@emory.edu	Althoff, Keri N/HGC-5595-2022	Sullivan, Patrick Sean/0000-0002-7728-0587; Satcher Johnson, Anna/0000-0002-8915-6903; Althoff, Keri/0000-0002-5068-6595	Center for AIDS Research at Emory University [P30AI050409]	Center for AIDS Research at Emory University	This work was supported by the Center for AIDS Research at Emory University (P30AI050409). The funder had no role in the review process or the formulation of conclusions.	Althoff KN, 2012, ANN INTERN MED, V157, P325, DOI 10.7326/0003-4819-157-5-201209040-00005; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Bradley H, 2019, ANN EPIDEMIOL, V31, P3, DOI 10.1016/j.annepidem.2018.11.005; Clark H, 2017, AIDS BEHAV, V21, P2774, DOI 10.1007/s10461-016-1656-7; Conrad C, 2015, MMWR-MORBID MORTAL W, V64, P443; Cranston K, 2019, MMWR-MORBID MORTAL W, V68, P253, DOI 10.15585/mmwr.mm6810a6; CURRAN JW, 1988, SCIENCE, V239, P610, DOI 10.1126/science.3340847; Dailey AF, 2017, MMWR-MORBID MORTAL W, V66, P97, DOI 10.15585/mmwr.mm6604a2; Dasgupta S, 2015, AIDS RES HUM RETROV, V31, P473, DOI 10.1089/aid.2014.0365; Edelman EJ, 2013, DRUG AGING, V30, P613, DOI 10.1007/s40266-013-0093-9; Eshel A, 2008, ETHNIC HEALTH, V13, P39, DOI 10.1080/13557850701803155; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Feinstein MJ, 2016, AM J CARDIOL, V117, P214, DOI 10.1016/j.amjcard.2015.10.030; Fitzmaurice AG, 2019, EMERG INFECT DIS, V25, P988, DOI 10.3201/eid2505.180776; Flores A, 2016, MANY ADULTS IDENTIFY; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Golden MR, 2019, MMWR-MORBID MORTAL W, V68, P344, DOI 10.15585/mmwr.mm6815a2; Golub SA, 2018, CURR HIV-AIDS REP, V15, P190, DOI 10.1007/s11904-018-0385-0; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hall H Irene, 2017, JMIR Public Health Surveill, V3, pe8, DOI 10.2196/publichealth.7051; Harris N, 2013, MMWR-MORBID MORTAL W, V62, P757; Hood JE, 2017, AIDS CARE, V29, P1543, DOI 10.1080/09540121.2017.1308466; Horberg M, 2011, AIDS PATIENT CARE ST, V25, P21, DOI 10.1089/apc.2010.0315; Hou J, 2018, CURR OPIN NEPHROL HY, V27, P144, DOI 10.1097/MNH.0000000000000400; Johnson C, 2010, ESTIMATING NUMBER IN; Jones J, 2019, SEX TRANSM DIS, V46, P357, DOI 10.1097/OLQ.0000000000000980; Kaiser Family Foundation, 2019, STATUS STATE MEDICAI; Kaiser Family Foundation, 2019, PRIMARY CARE HLTH PR; Kaiser Family Foundation, 2015, WHO IS LIV TOG SAM S; Keith Katie, 2020, HHS STRIPS GENDER ID, DOI [10.1377/hblog20200613.671888/full/, DOI 10.1377/HBLOG20200613.671888/FULL]; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Lansky A, 2007, PUBLIC HEALTH REP, V122, P16, DOI 10.1177/00333549071220S104; Lansky A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133543; Lansky A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097596; Lerner AM, 2019, JAMA-J AM MED ASSOC, V322, P1041, DOI 10.1001/jama.2019.10657; Lo Re V, 2014, ANN INTERN MED, V160, P369, DOI 10.7326/M13-1829; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Meerwijk EL, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303578; Ocampo Joanne Michelle F, 2016, JMIR Public Health Surveill, V2, pe3, DOI 10.2196/publichealth.5317; Ojikutu BO, 2019, JMIR PUBLIC HLTH SUR, V5, P72, DOI 10.2196/12405; Oster AM, 2018, JAMA-J AM MED ASSOC, V319, P1657, DOI 10.1001/jama.2018.1513; Owens DK, 2019, JAMA-J AM MED ASSOC, V321, P2203, DOI 10.1001/jama.2019.6390; Park LS, 2018, ANN INTERN MED, V169, P87, DOI [10.7326/m16-2094, 10.7326/M16-2094]; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Poon AFY, 2016, LANCET HIV, V3, pE231, DOI 10.1016/S2352-3018(16)00046-1; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rosenberg ES, 2014, LANCET HIV, V1, pE112, DOI 10.1016/S2352-3018(14)00011-3; Rosenberg Eli Samuel, 2016, JMIR Public Health Surveill, V2, pe22, DOI 10.2196/publichealth.5684; Rueda S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011453; Sanchez Travis Howard, 2015, JMIR Public Health Surveill, V1, pe3, DOI 10.2196/publichealth.4314; Schweiz TA, 2019, J INFECT DIS, V220, P346, DOI 10.1093/infdis/jiz133; Siegler AJ, 2019, AM J PUBLIC HEALTH, V109, P1216, DOI [10.2105/AJPH.2019.305172, 10.2105/ajph.2019.305172]; Siegler AJ, 2019, JMIR RES PROTOC, V8, DOI 10.2196/13982; Siegler AJ, 2018, ANN EPIDEMIOL, V28, P841, DOI 10.1016/j.annepidem.2018.06.005; Song RG, 2017, JAIDS-J ACQ IMM DEF, V74, P3, DOI 10.1097/QAI.0000000000001151; Sullivan PS, 2019, CURR HIV-AIDS REP, V16, P259, DOI 10.1007/s11904-019-00447-4; Sullivan PS, 2018, ANN EPIDEMIOL, V28, P833, DOI 10.1016/j.annepidem.2018.06.009; Sullivan PS, 2018, AM J PUBLIC HEALTH, V108, pS266, DOI [10.2105/AJPH.2018.304762, 10.2105/ajph.2018.304762]; Sullivan PS, 2015, ANN EPIDEMIOL, V25, P445, DOI 10.1016/j.annepidem.2015.03.006; Sullivan PS, 2020, J MED INTERNET RES, V22, DOI 10.2196/23173; Sweeney P, 2018, PUBLIC HEALTH REP, V133, p60S, DOI 10.1177/0033354918805987; Terzian AS, 2018, AIDS BEHAV, V22, P3009, DOI 10.1007/s10461-018-2103-8; Thompson JH, 2017, DIRECTORS BLOG PLANN; U.S. Census Bureau, 2020, INCOME POVERTY US 20; US Census Bureau, 2019, POV THRESH; US Census Bureau, 2019, QUICK FACTS US; US Centers for Disease Control and Prevention, 2020, HIV SURV REP, V31; US Centers for Disease Control and Prevention, 2018, DATA CARE; US Centers for Disease Control and Prevention, 2019, NCHHSTP ATLASPLUS; US Centers for Disease Control and Prevention, 2016, TOD HIV AIDS EP; US Centers for Disease Control and Prevention, 2019, CDC HIV PREVENTION P; US Centers for Disease Control and Prevention, 2019, DRUG OV MORT STAT; US Centers for Disease Control and Prevention, 2018, VIR HEP SURV US; VALDISERRI RO, 1995, J COMMUN HEALTH, V20, P87, DOI 10.1007/BF02260331; Young SD, 2015, PREV MED, V70, P17, DOI 10.1016/j.ypmed.2014.11.002; Young SD, 2014, PREV MED, V63, P112, DOI 10.1016/j.ypmed.2014.01.024	76	51	52	18	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1095	1106		10.1016/S0140-6736(21)00395-0	http://dx.doi.org/10.1016/S0140-6736(21)00395-0		MAR 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617774				2022-12-28	WOS:000630397800027
J	Goddard, AF; Patel, M				Goddard, Andrew F.; Patel, Mumtaz			The changing face of medical professionalism and the impact of COVID-19	LANCET			English	Editorial Material							CARE		[Goddard, Andrew F.; Patel, Mumtaz] Royal Coll Physicians, London NW1 4LE, England	Royal College of Physicians	Goddard, AF (corresponding author), Royal Coll Physicians, London NW1 4LE, England.	andrew.goddard@rcplondon.ac.uk						[Anonymous], 2019, LANCET, V394, P93, DOI 10.1016/S0140-6736(19)31573-9; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; British Medical Association, 2017, CHANG FAC MED ROL DO; Dean W, 2019, FED PRACT, V36, P447; Dzau VJ, 2020, NEW ENGL J MED, V383, P513, DOI 10.1056/NEJMp2011027; Feiler T, 2017, NEW BIOETH, V23, P1, DOI 10.1080/20502877.2017.1314895; Garros D, 2021, CHEST, V159, P1484, DOI 10.1016/j.chest.2020.11.012; Harkin DW, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1606; Lemaire JB, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3360; Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7; Rosenbaum L, 2020, NEW ENGL J MED, V382, P1873, DOI 10.1056/NEJMp2005492; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Royal College of Physicians, 2018, ADV MED PROF; Royal College of Physicians, 2019, FOC PHYS 2018 19 CEN; Shale S, 2020, BMJ LEAD, V4, P224, DOI 10.1136/leader-2020-000295; Shaukat N, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00299-5; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Ultimate software, 2019, STAT MED ED PRACT UK; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williamson V, 2020, OCCUP MED-OXFORD, V70, P317, DOI 10.1093/occmed/kqaa052	21	15	15	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2021	397	10278					950	952		10.1016/S0140-6736(21)00436-0	http://dx.doi.org/10.1016/S0140-6736(21)00436-0		MAR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV2NT	33636125	Bronze, Green Published			2022-12-28	WOS:000627814200007
J	Hoffman, RM; Reuland, DS; Volk, RJ				Hoffman, Richard M.; Reuland, Daniel S.; Volk, Robert J.			The Centers for Medicare & Medicaid Services Requirement for Shared Decision-making for Lung Cancer Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses implications of the USPSTF 2021 lung cancer screening recommendation update, which broadens the number of patients eligible for screening, for CMS' shared decision-making requirement, arguing that to make shared decision-making a reality, CMS should reimburse these visits delivered by nonphysician staff and/or telehealth.	[Hoffman, Richard M.] Univ Iowa, Dept Med, Div Gen Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Hoffman, Richard M.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Reuland, Daniel S.] Univ N Carolina, Div Gen Med & Clin Epidemiol, Dept Med, Chapel Hill, NC 27515 USA; [Reuland, Daniel S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Volk, Robert J.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Houston, TX 77030 USA	University of Iowa; University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center	Hoffman, RM (corresponding author), Univ Iowa, Carver Coll Med, 200 Hawkins Dr,SE 618 GH, Iowa City, IA 52242 USA.	richard-m-hoffman@uiowa.edu		Hoffman, Richard/0000-0002-4714-7726	Cancer Prevention and Research Institute of Texas (CPRIT) [RP190210]; MD Anderson Cancer Center - NCI [P30CA016672]; Holden Comprehensive Cancer Center - NCI [P30CA086862]	Cancer Prevention and Research Institute of Texas (CPRIT); MD Anderson Cancer Center - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Holden Comprehensive Cancer Center - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Volk is supported in part by grants from the Cancer Prevention and Research Institute of Texas (CPRIT; RP190210) and the MD Anderson Cancer Center support grant P30CA016672, funded by NCI (using the Shared Decision Making Core). Dr Hoffman is supported in part by the Holden Comprehensive Cancer Center support grant P30CA086862, funded by NCI.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Brenner AT, 2018, JAMA INTERN MED, V178, P1311, DOI 10.1001/jamainternmed.2018.3054; Centers for Medicare & Medicaid Services, 2015, CAG00439N CTR MED ME; Fukunaga MI, 2020, CHEST, V158, P2646, DOI 10.1016/j.chest.2020.05.610; Krist AH, 2021, JAMA-J AM MED ASSOC, V325, P962, DOI 10.1001/jama.2021.1117; Lopez-Olivo MA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25102; Rivera MP, 2020, AM J RESP CRIT CARE, V202, pE95, DOI 10.1164/rccm.202008-3053ST; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Stacey D, 2012, MED DECIS MAKING, V32, pE22, DOI 10.1177/0272989X12443311	9	6	6	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					933	934		10.1001/jama.2021.1817	http://dx.doi.org/10.1001/jama.2021.1817			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687471				2022-12-28	WOS:000627899400012
J	Tregoning, J				Tregoning, John			LAUGHTER IS THE BEST MEDICINE	NATURE			English	Editorial Material									[Tregoning, John] Imperial Coll London, Resp Infect, Dept Infect Dis, London, England	Imperial College London	Tregoning, J (corresponding author), Imperial Coll London, Resp Infect, Dept Infect Dis, London, England.			Tregoning, John/0000-0001-8093-8741					0	0	0	2	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					165	165		10.1038/d41586-021-00474-5	http://dx.doi.org/10.1038/d41586-021-00474-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QN3BH	33608685				2022-12-28	WOS:000622339000001
J	Woolston, C				Woolston, Chris			WE'LL MEET AGAIN: SCIENTISTS' POST-PANDEMIC WISH LIST	NATURE			English	Editorial Material								Trapped in a holding pattern, and nostalgic for lab lunches and field trips, researchers share their hopes for a lockdown-free future.											0	0	0	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					163	164		10.1038/d41586-021-00532-y	http://dx.doi.org/10.1038/d41586-021-00532-y			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QP8JF	33649509				2022-12-28	WOS:000624076300002
J	Christie, B				Christie, Bryan			Record drug deaths need radical response, says Scottish college	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Christie B, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m822; Christie B, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4731; Transform Drug Policy Foundation, 2018, DRUG DECR PORT SETT	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n593	10.1136/bmj.n593	http://dx.doi.org/10.1136/bmj.n593			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653696				2022-12-28	WOS:000625340300002
J	Fischer, I; Gauthier, DJ				Fischer, Ingo; Gauthier, Daniel J.			High-speed harvesting of random numbers	SCIENCE			English	Editorial Material									[Fischer, Ingo] Univ Illes Balears, Consejo Super Invest Cient, Inst Fis Interdisciplinar & Sistemas Complejos IF, Campus Univ Illes Balears, E-07122 Palma De Mallorca, Spain; [Gauthier, Daniel J.] Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University System of Ohio; Ohio State University	Fischer, I (corresponding author), Univ Illes Balears, Consejo Super Invest Cient, Inst Fis Interdisciplinar & Sistemas Complejos IF, Campus Univ Illes Balears, E-07122 Palma De Mallorca, Spain.	ingo@ifisc.uib-csic.es; gauthier.51@osu.edu	Fischer, Ingo/C-2843-2011	Fischer, Ingo/0000-0003-1881-9842				Bittner S, 2018, SCIENCE, V361, P1225, DOI 10.1126/science.aas9437; Brunner D, 2019, PHOTONIC RESERVOIR C; Cao H, 2015, REV MOD PHYS, V87, P61, DOI 10.1103/RevModPhys.87.61; Fischer I, 1996, EUROPHYS LETT, V35, P579, DOI 10.1209/epl/i1996-00154-7; Hart JD, 2017, APL PHOTONICS, V2, DOI 10.1063/1.5000056; Kim K, 2021, SCIENCE, V371, P948, DOI 10.1126/science.abc2666; Marangon DG, 2018, J LIGHTWAVE TECHNOL, V36, P3778, DOI 10.1109/JLT.2018.2841773; Prucnal PR, 2017, NEUROMORPHIC PHOTONICS, P1	8	2	2	5	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					889	890		10.1126/science.abg5445	http://dx.doi.org/10.1126/science.abg5445			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632835	Green Submitted			2022-12-28	WOS:000621813400025
J	Kim, K; Bittner, S; Zeng, YQ; Guazzotti, S; Hess, O; Wang, QJ; Cao, H				Kim, Kyungduk; Bittner, Stefan; Zeng, Yongquan; Guazzotti, Stefano; Hess, Ortwin; Wang, Qi Jie; Cao, Hui			Massively parallel ultrafast random bit generation with a chip-scale laser	SCIENCE			English	Article								Random numbers are widely used for information security, cryptography, stochastic modeling, and quantum simulations. Key technical challenges for physical random number generation are speed and scalability. We demonstrate a method for ultrafast generation of hundreds of random bit streams in parallel with a single laser diode. Spatiotemporal interference of many lasing modes in a specially designed cavity is introduced as a scheme for greatly accelerated random bit generation. Spontaneous emission, caused by quantum fluctuations, produces stochastic noise that makes the bit streams unpredictable. We achieve a total bit rate of 250 terabits per second with off-line postprocessing, which is more than two orders of magnitude higher than the current postprocessing record. Our approach is robust, compact, and energy-efficient, with potential applications in secure communication and high-performance computation.	[Kim, Kyungduk; Bittner, Stefan; Cao, Hui] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Bittner, Stefan] Cent Supelec, LMOPS EA 4423 Lab, Chair Photon, F-57070 Metz, France; [Bittner, Stefan] Univ Lorraine, F-57070 Metz, France; [Zeng, Yongquan; Wang, Qi Jie] Nanyang Technol Univ, Ctr OptoElect & Biophoton, Sch Elect & Elect Engn, Sch Phys & Math Sci, Singapore 639798, Singapore; [Zeng, Yongquan; Wang, Qi Jie] Nanyang Technol Univ, Photon Inst, Singapore 639798, Singapore; [Guazzotti, Stefano; Hess, Ortwin] Imperial Coll London, Blackett Lab, London SW7 2AZ, England; [Guazzotti, Stefano; Hess, Ortwin] Trinity Coll Dublin, Sch Phys, Dublin 2, Ireland; [Guazzotti, Stefano; Hess, Ortwin] Trinity Coll Dublin, CRANN Inst, Dublin 2, Ireland	Yale University; UDICE-French Research Universities; Universite Paris Saclay; Universite de Lorraine; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Trinity College Dublin; Trinity College Dublin	Cao, H (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	hui.cao@yale.edu	wang, qi/HGV-1859-2022; Wang, Qi Jie/E-6987-2010; Hess, Ortwin/O-1345-2019	Wang, Qi Jie/0000-0002-9910-1455; Hess, Ortwin/0000-0002-6024-0677; Kim, Kyungduk/0000-0001-6961-6186; Cao, Hui/0000-0002-5339-6892; Guazzotti, Stefano/0000-0001-8502-7437; Bittner, Stefan/0000-0003-3651-5762				Arahata M, 2015, IEEE J SEL TOP QUANT, V21, DOI 10.1109/JSTQE.2015.2422473; Argyris A, 2010, OPT EXPRESS, V18, P18763, DOI 10.1364/OE.18.018763; Bassham III L. E, 2010, STAT TEST SUITE RAND; Bittner S, 2018, SCIENCE, V361, P1225, DOI 10.1126/science.aas9437; Butler T, 2016, OPT LETT, V41, P388, DOI 10.1364/OL.41.000388; Cerjan A, 2016, OPT EXPRESS, V24, P26006, DOI 10.1364/OE.24.026006; COHEN A, 1985, PHYS REV A, V31, P1872, DOI 10.1103/PhysRevA.31.1872; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; ELSASSER W, 1985, IEEE J QUANTUM ELECT, V21, P687, DOI 10.1109/JQE.1985.1072697; Fang XL, 2014, IEEE T CIRCUITS-I, V61, P888, DOI 10.1109/TCSI.2013.2284001; Fischer I, 1996, EUROPHYS LETT, V35, P579, DOI 10.1209/epl/i1996-00154-7; Franz AL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.053905; GALLION PB, 1984, IEEE J QUANTUM ELECT, V20, P343, DOI 10.1109/JQE.1984.1072399; GASPARD P, 1993, PHYS REP, V235, P291, DOI 10.1016/0370-1573(93)90012-3; Ge L, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.063824; Hart JD, 2017, APL PHOTONICS, V2, DOI 10.1063/1.5000056; HENRY CH, 1986, J LIGHTWAVE TECHNOL, V4, P298, DOI 10.1109/JLT.1986.1074721; Herrero-Collantes M, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.015004; HESS O, 1994, CHAOS SOLITON FRACT, V4, P1597, DOI 10.1016/0960-0779(94)90099-X; Hess O, 1996, PROG QUANT ELECTRON, V20, P85, DOI 10.1016/0079-6727(96)89779-5; Hirano K, 2010, OPT EXPRESS, V18, P5512, DOI 10.1364/OE.18.005512; Kanter I, 2010, NAT PHOTONICS, V4, P58, DOI 10.1038/NPHOTON.2009.235; Kim K, 2019, APPL PHYS LETT, V115, DOI 10.1063/1.5109234; LALANNE P, 1990, OPT COMMUN, V76, P387, DOI 10.1016/0030-4018(90)90272-U; Li P, 2019, OPT LETT, V44, P2446, DOI 10.1364/OL.44.002446; Li XZ, 2013, IEEE J QUANTUM ELECT, V49, P829, DOI 10.1109/JQE.2013.2279261; Li XW, 2011, OPT LETT, V36, P1020, DOI 10.1364/OL.36.001020; Liew SF, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043828; Lihua D., 2014, 2014 10 INT C COMP I, P402; Marciante JR, 1997, IEEE J QUANTUM ELECT, V33, P1174, DOI 10.1109/3.594881; MARRON J, 1986, APPL OPTICS, V25, P26, DOI 10.1364/AO.25.000026; Ohtsubo J, 2017, SPRINGER SER OPT SCI, V111, P1, DOI 10.1007/978-3-319-56138-7; Oliver N, 2013, IEEE J QUANTUM ELECT, V49, P910, DOI 10.1109/JQE.2013.2280917; Reidler I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.024102; Sakuraba R, 2015, OPT EXPRESS, V23, P1470, DOI 10.1364/OE.23.001470; Shinohara S, 2017, OPT EXPRESS, V25, P6461, DOI 10.1364/OE.25.006461; Siegman A. E., 1986, LASER; Tang X, 2015, OPT EXPRESS, V23, P33130, DOI 10.1364/OE.23.033130; Tsoi KH, 2007, IET COMPUT DIGIT TEC, V1, P349, DOI 10.1049/iet-cdt:20050173; Uchida A, 2008, NAT PHOTONICS, V2, P728, DOI 10.1038/nphoton.2008.227; Ugajin K, 2017, OPT EXPRESS, V25, P6511, DOI 10.1364/OE.25.006511; Virte M, 2014, OPT EXPRESS, V22, P17271, DOI 10.1364/OE.22.017271; Xiang SY, 2019, J LIGHTWAVE TECHNOL, V37, P3987, DOI 10.1109/JLT.2019.2920476; Yamaguchi Akihiro, 2010, JSIAM Letters, V2, P123; Zhang JZ, 2012, OPT EXPRESS, V20, P7496, DOI 10.1364/OE.20.007496	45	25	26	14	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					948	+		10.1126/science.abc2666	http://dx.doi.org/10.1126/science.abc2666			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632847	Green Accepted, Green Submitted			2022-12-28	WOS:000621813400044
J	Wei, YL; Wang, YG; Jia, YM; Li, L; Yoon, J; Zhang, SY; Wang, ZX; Zhang, Y; Zhu, M; Sharma, T; Lin, YH; Hsieh, MH; Albrecht, JH; Le, PT; Rosen, CJ; Wang, T; Zhu, H				Wei, Yonglong; Wang, Yunguan G.; Jia, Yuemeng; Li, Lin; Yoon, Jung; Zhang, Shuyuan; Wang, Zixi; Zhang, Yu; Zhu, Min; Sharma, Tripti; Lin, Yu-Hsuan; Hsieh, Meng-Hsiung; Albrecht, Jeffrey H.; Le, Phuong T.; Rosen, Clifford J.; Wang, Tao; Zhu, Hao			Liver homeostasis is maintained by midlobular zone 2 hepatocytes	SCIENCE			English	Article							APOPTOTIC BODIES; EPITHELIAL-CELLS; MOUSE; PROLIFERATION; PROGENITORS; SIZE	The liver is organized into zones in which hepatocytes express different metabolic enzymes. The cells most responsible for liver repopulation and regeneration remain undefined, because fate mapping has only been performed on a few hepatocyte subsets. Here, 14 murine fate-mapping strains were used to systematically compare distinct subsets of hepatocytes. During homeostasis, cells from both periportal zone 1 and pericentral zone 3 contracted in number, whereas cells from midlobular zone 2 expanded in number. Cells within zone 2, which are sheltered from common injuries, also contributed to regeneration after pericentral and periportal injuries. Repopulation from zone 2 was driven by the insulin-like growth factor binding protein 2-mechanistic target of rapamycin-cyclin D1 (IGFBP2-mTOR-CCND1) axis. Therefore, different regions of the lobule exhibit differences in their contribution to hepatocyte turnover, and zone 2 is an important source of new hepatocytes during homeostasis and regeneration.	[Wei, Yonglong; Wang, Yunguan G.; Jia, Yuemeng; Li, Lin; Yoon, Jung; Zhang, Shuyuan; Zhang, Yu; Sharma, Tripti; Lin, Yu-Hsuan; Hsieh, Meng-Hsiung; Zhu, Hao] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dept Pediat, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Wei, Yonglong; Wang, Yunguan G.; Jia, Yuemeng; Li, Lin; Yoon, Jung; Zhang, Shuyuan; Zhang, Yu; Sharma, Tripti; Lin, Yu-Hsuan; Hsieh, Meng-Hsiung; Zhu, Hao] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dept Internal Med, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Wang, Yunguan G.; Wang, Tao] Univ Texas Southwestern Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Populat & Data Sci, Dallas, TX 75390 USA; [Wang, Zixi; Zhu, Min; Zhu, Hao] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst Mouse Genome Engn Core, Dallas, TX 75390 USA; [Albrecht, Jeffrey H.] Minneapolis VA Hlth Care Syst, Gastroenterol Div, Minneapolis, MN 55417 USA; [Albrecht, Jeffrey H.] Univ Minnesota, Div Gastroenterol Hepatol & Nutr, Minneapolis, MN 55455 USA; [Le, Phuong T.; Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Maine Medical Center	Zhu, H (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dept Pediat, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.; Zhu, H (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dept Internal Med, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.; Zhu, H (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst Mouse Genome Engn Core, Dallas, TX 75390 USA.	hao.zhu@utsouthwestern.edu	Jia, Yuemeng/AAQ-9853-2021; Sharma, Tripti/AAI-6278-2021; Zhu, Hao/L-5114-2013	Sharma, Tripti/0000-0003-1799-1157; ZHANG, SHUYUAN/0000-0002-6220-5998; Zhu, Hao/0000-0002-8417-9698; Wei, Yonglong/0000-0001-6152-7963; Wang, Zixi/0000-0002-9354-1206	NIH/NIDDK [R01DK54921, R01DK111588]; NIH [R03ES026397]; CPRIT [RP150596, RP190208, RP170267, RP180268]; Pollack Foundation; NIH/NCI [R01CA251928]; Burroughs Wellcome Career Award for Medical Scientists; Stand Up To Cancer Innovative Research Grant [SU2C-AACR-IRG 10-16]; American Association for Cancer Research, the scientific partner of SU2C	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Pollack Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); Stand Up To Cancer Innovative Research Grant; American Association for Cancer Research, the scientific partner of SU2C	J.H.A. was supported by NIH/NIDDK R01DK54921. T.W. was supported by NIH R03ES026397 and CPRIT (RP150596, RP190208). H.Z. was supported by the Pollack Foundation, NIH/NIDDK R01DK111588, NIH/NCI R01CA251928, CPRIT (RP170267, RP180268), a Burroughs Wellcome Career Award for Medical Scientists, and a Stand Up To Cancer Innovative Research Grant (SU2C-AACR-IRG 10-16). Stand Up To Cancer (SU2C) is a program of the Entertainment Industry Foundation, and its research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C.	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Ang CH, 2019, P NATL ACAD SCI USA, V116, P19530, DOI 10.1073/pnas.1908099116; Ben-Moshe S, 2019, NAT METAB, V1, P899, DOI 10.1038/s42255-019-0109-9; Ben-Moshe S, 2019, NAT REV GASTRO HEPAT, V16, P395, DOI 10.1038/s41575-019-0134-x; BENEDETTI A, 1988, J HEPATOL, V7, P319, DOI 10.1016/S0168-8278(88)80004-7; BENEDETTI A, 1988, LIVER, V8, P172; BERGMANN P, 1995, LAB ANIM, V29, P102, DOI 10.1258/002367795780740447; Birchmeier W, 2016, NAT CELL BIOL, V18, P463, DOI 10.1038/ncb3349; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bowman AN, 2013, P NATL ACAD SCI USA, V110, P7324, DOI 10.1073/pnas.1305411110; Canver MC, 2018, NAT PROTOC, V13, P946, DOI 10.1038/nprot.2018.005; Chen F, 2020, CELL STEM CELL, V26, P27, DOI 10.1016/j.stem.2019.11.001; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022; Espeillac C, 2011, J CLIN INVEST, V121, P2821, DOI 10.1172/JCI44203; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Ghafoory S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078262; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kulik L, 2019, GASTROENTEROLOGY, V156, P477, DOI 10.1053/j.gastro.2018.08.065; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Pu WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13369; Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015; Sun TL, 2020, CELL STEM CELL, V26, P97, DOI 10.1016/j.stem.2019.10.011; Sun XX, 2016, CELL STEM CELL, V18, P456, DOI 10.1016/j.stem.2016.03.001; Tanami S, 2017, CELL TISSUE RES, V368, P405, DOI 10.1007/s00441-016-2427-5; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593; Zhu M, 2019, CELL, V177, P608, DOI 10.1016/j.cell.2019.03.026	42	55	58	15	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					906	+	eabb1625	10.1126/science.abb1625	http://dx.doi.org/10.1126/science.abb1625			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632817	Green Accepted			2022-12-28	WOS:000621813400048
J	Kuehn, BM				Kuehn, Bridget M.			Drug-Resistant Yeast Infections Spread in COVID-19 Unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					714	714		10.1001/jama.2021.1031	http://dx.doi.org/10.1001/jama.2021.1031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620416	Bronze			2022-12-28	WOS:000621957400012
J	McGinley, MP; Goldschmidt, CH; Rae-Grant, AD				McGinley, Marisa P.; Goldschmidt, Carolyn H.; Rae-Grant, Alexander D.			Diagnosis and Treatment of Multiple Sclerosis A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DISEASE-MODIFYING THERAPY; PLACEBO-CONTROLLED TRIAL; STEM-CELL TRANSPLANTATION; DOUBLE-BLIND; INTERFERON BETA-1A; CONTROLLED PHASE-3; 25-HYDROXYVITAMIN-D LEVELS; INTRAMUSCULAR INTERFERON; DISABILITY PROGRESSION; COGNITIVE DYSFUNCTION	IMPORTANCE Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease of the central nervous system characterized by inflammatory demyelination with axonal transection. MS affects an estimated 900 000 people in the US. MS typically presents in young adults (mean age of onset, 20-30 years) and can lead to physical disability, cognitive impairment, and decreased quality of life. This review summarizes current evidence regarding diagnosis and treatment of MS. OBSERVATIONS MS typically presents in young adults aged 20 to 30 years with unilateral optic neuritis, partial myelitis, sensory disturbances, or brainstem syndromes such as internuclear ophthalmoplegia developing over several days. The prevalence of MS worldwide ranges from 5 to 300 per 100 000 people and increases at higher latitudes. Overall life expectancy is less than in the general population (75.9 vs 83.4 years), and MS more commonly affects women (female to male sex distribution of nearly 3:1). Diagnosis is made based on a combination of signs and symptoms, radiographic findings (eg, magnetic resonance imaging [MRI] T2 lesions), and laboratory findings (eg, cerebrospinal fluid-specific oligoclonal bands), which are components of the 2017 McDonald Criteria. Nine classes of disease-modifying therapies (DMTs), with varying mechanisms of action and routes of administration, are available for relapsing-remitting MS, defined as relapses at onset with stable neurologic disability between episodes, and secondary progressive MS with activity, defined as steadily increasing neurologic disability following a relapsing course with evidence of ongoing inflammatory activity. These drugs include interferons, glatiramer acetate, teriflunomide, sphingosine 1-phosphate receptor modulators, fumarates, cladribine, and 3 types of monoclonal antibodies. One additional DMT, ocrelizumab, is approved for primary progressive MS. These DMTs reduce clinical relapses and MRI lesions (new T2 lesions, gadolinium-enhancing lesions). Efficacy rates of current DMTs, defined by reduction in annualized relapse rates compared with placebo or active comparators, range from 29%-68%. Adverse effects include infections, bradycardia, heart blocks, macular edema, infusion reactions, injection-site reactions, and secondary autoimmune adverse effects, such as autoimmune thyroid disease. CONCLUSIONS AND RELEVANCE MS is characterized by physical disability, cognitive impairment, and other symptoms that affect quality of life. Treatment with DMT can reduce the annual relapse rate by 29% to 68% compared with placebo or active comparator.	[McGinley, Marisa P.; Goldschmidt, Carolyn H.; Rae-Grant, Alexander D.] Cleveland Clin, Mellen Ctr, Cleveland, OH 44106 USA; [Rae-Grant, Alexander D.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Rae-Grant, AD (corresponding author), 10 Estes St, Ipswich, MA 01938 USA.	raegranta@gmail.com						Aboud T, 2019, CURR TREAT OPTION NE, V21, DOI 10.1007/s11940-019-0601-2; Alali D, 2018, MULT SCLER RELAT DIS, V25, P227, DOI 10.1016/j.msard.2018.08.003; Almas S, 2016, MULT SCLER INT, V2016, DOI 10.1155/2016/6527458; Alusi SH, 2001, BRAIN, V124, P720, DOI 10.1093/brain/124.4.720; Amato MP, 2012, EXPERT OPIN PHARMACO, V13, P207, DOI 10.1517/14656566.2012.647767; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Azevedo CJ, 2019, LANCET NEUROL, V18, P329, DOI 10.1016/S1474-4422(19)30076-6; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; Bamer AM, 2008, MULT SCLER J, V14, P1127, DOI 10.1177/1352458508092807; Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Boneschi FM, 2008, MULT SCLER, V14, P514, DOI 10.1177/1352458507085551; Brass SD, 2014, J CLIN SLEEP MED, V10, P1025, DOI 10.5664/jcsm.4044; Briken S, 2014, MULT SCLER J, V20, P382, DOI 10.1177/1352458513507358; Brown JWL, 2019, JAMA-J AM MED ASSOC, V321, P175, DOI 10.1001/jama.2018.20588; Browne P, 2014, NEUROLOGY, V83, P1022, DOI 10.1212/WNL.0000000000000768; Burt RK, 2019, JAMA-J AM MED ASSOC, V321, P165, DOI 10.1001/jama.2018.18743; Cadavid D, 2019, LANCET NEUROL, V18, P845, DOI 10.1016/S1474-4422(19)30137-1; Calabresi PA, 2014, LANCET NEUROL, V13, P657, DOI 10.1016/S1474-4422(14)70068-7; Caminero A, 2011, J NEUROL SCI, V309, P86, DOI 10.1016/j.jns.2011.07.015; CHIA YW, 1995, J NEUROL, V242, P105, DOI 10.1007/BF00887825; Cohen JA, 2019, LANCET NEUROL, V18, P1021, DOI 10.1016/S1474-4422(19)30238-8; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2017, NEUROLOGY, V89, P1117, DOI 10.1212/WNL.0000000000004354; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Comi G, 2019, LANCET NEUROL, V18, P1009, DOI 10.1016/S1474-4422(19)30239-X; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Confavreux C, 2014, LANCET NEUROL, V13, P247, DOI 10.1016/S1474-4422(13)70308-9; Coyle Patricia K, 2016, Continuum (Minneap Minn), V22, P815, DOI 10.1212/CON.0000000000000325; Cree BAC, 2020, LANCET NEUROL, V19, P988, DOI 10.1016/S1474-4422(20)30347-1; Cree BAC, 2016, ANN NEUROL, V80, P499, DOI 10.1002/ana.24747; de Vries RMV, 2018, JAMA NEUROL, V75, P1392, DOI 10.1001/jamaneurol.2018.2160; Dobson R, 2020, MULT SCLER RELAT DIS, V44, DOI 10.1016/j.msard.2020.102241; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Fitzgerald KC, 2015, JAMA NEUROL, V72, P1458, DOI 10.1001/jamaneurol.2015.2742; Fox Robert J, 2015, Neurodegener Dis Manag, V5, P3, DOI 10.2217/nmt.15.55; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Fragoso Yara Dadalti, 2014, Pract Neurol, V14, P206, DOI 10.1136/practneurol-2013-000735; Frischer JM, 2015, ANN NEUROL, V78, P710, DOI 10.1002/ana.24497; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Geraldes R, 2017, BRAIN PATHOL, V27, P707, DOI 10.1111/bpa.12460; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Green AJ, 2017, LANCET, V390, P2481, DOI 10.1016/S0140-6736(17)32346-2; Handel AE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016149, 10.1371/journal.pone.0014606]; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012496; Harris VK, 2018, EBIOMEDICINE, V29, P23, DOI 10.1016/j.ebiom.2018.02.002; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2020, NEW ENGL J MED, V383, P546, DOI 10.1056/NEJMoa1917246; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; Howell OW, 2011, BRAIN, V134, P2755, DOI 10.1093/brain/awr182; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Kappos L, 2018, LANCET, V391, P1263, DOI 10.1016/S0140-6736(18)30475-6; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kister I, 2018, J NEUROL SCI, V391, P72, DOI 10.1016/j.jns.2018.06.001; Kister I, 2016, J NEUROL NEUROSUR PS, V87, P1133, DOI 10.1136/jnnp-2016-313760; Korostil M, 2007, MULT SCLER, V13, P67, DOI 10.1177/1352458506071161; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Le Page E, 2015, LANCET, V386, P974, DOI 10.1016/S0140-6736(15)61137-0; Lerdal A, 2007, EUR J NEUROL, V14, P1338, DOI 10.1111/j.1468-1331.2007.01974.x; Litwiller SE, 1999, J UROLOGY, V161, P743, DOI 10.1016/S0022-5347(01)61760-9; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Luna G, 2020, JAMA NEUROL, V77, P184, DOI 10.1001/jamaneurol.2019.3365; Mancardi GL, 2015, NEUROLOGY, V84, P981, DOI 10.1212/WNL.0000000000001329; Marrie RA, 2010, NEUROLOGY, V74, P1041, DOI 10.1212/WNL.0b013e3181d6b125; Marrie RA, 2009, MULT SCLER, V15, P385, DOI 10.1177/1352458508099477; Marrie RA, 2009, NEUROLOGY, V72, P117, DOI 10.1212/01.wnl.0000333252.78173.5f; Marrie RA, 2015, NEUROLOGY, V85, P240, DOI 10.1212/WNL.0000000000001718; Martin SI, 2006, CLIN INFECT DIS, V43, P16, DOI 10.1086/504811; McKay KA, 2018, NEUROLOGY, V90, pE1316, DOI 10.1212/WNL.0000000000005302; Michel L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00636; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2013, MULT SCLER J, V19, P1323, DOI 10.1177/1352458513483889; Naismith RT, 2020, CNS DRUGS, V34, P185, DOI 10.1007/s40263-020-00700-0; Nash RA, 2015, JAMA NEUROL, V72, P159, DOI 10.1001/jamaneurol.2014.3780; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; Okwuokenye M, 2017, NEUROL THER, V6, P1, DOI 10.1007/s40120-017-0063-y; Pakpoor J, 2012, J NEUROL, V259, P2246, DOI 10.1007/s00415-012-6553-z; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pittock SJ, 2004, MOVEMENT DISORD, V19, P1482, DOI 10.1002/mds.20227; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rizzo MA, 2004, MULT SCLER, V10, P589, DOI 10.1191/1352458504ms1085oa; Rolfes L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101623; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Sedel F, 2016, NEUROPHARMACOLOGY, V110, P644, DOI 10.1016/j.neuropharm.2015.08.028; Simon KC, 2015, MULT SCLER J, V21, P703, DOI 10.1177/1352458514551780; Skuladottir H, 2014, BIRTH DEFECTS RES A, V100, P499, DOI 10.1002/bdra.23248; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Sormani MP, 2013, LANCET NEUROL, V12, P669, DOI 10.1016/S1474-4422(13)70103-0; Sumowski JF, 2014, NEUROLOGY, V82, P1776, DOI 10.1212/WNL.0000000000000433; Sundstrom P, 2008, MULT SCLER J, V14, P1031, DOI 10.1177/1352458508093615; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vukusic S, 2015, NAT REV NEUROL, V11, P280, DOI 10.1038/nrneurol.2015.53; Wallin MT, 2019, NEUROLOGY, V92, pE1029, DOI 10.1212/WNL.0000000000007035; WEINSHENKER BG, 1989, BRAIN, V112, P133, DOI 10.1093/brain/112.1.133; Zhu N, 2015, NEUROLOGY, V84, P2347, DOI 10.1212/WNL.0000000000001658; Zorzon M, 2001, J NEUROL SCI, V187, P1, DOI 10.1016/S0022-510X(01)00493-2	106	152	155	38	89	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					765	779		10.1001/jama.2020.26858	http://dx.doi.org/10.1001/jama.2020.26858			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620411				2022-12-28	WOS:000621957400025
J	Sacks, CA				Sacks, Chana A.			Omental Endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7					E21	E21		10.1056/NEJMicm2027936	http://dx.doi.org/10.1056/NEJMicm2027936			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2HH	33605570				2022-12-28	WOS:000620900000002
J	Ren, XW; Wen, W; Fan, XY; Hou, WH; Su, B; Cai, PF; Li, JS; Liu, Y; Tang, F; Zhang, F; Yang, Y; He, JP; Ma, WJ; He, JJ; Wang, PP; Cao, QQ; Chen, FJ; Chen, YQ; Cheng, XL; Deng, GH; Deng, XL; Ding, WY; Feng, YM; Gan, R; Guo, C; Guo, WQ; He, S; Jiang, C; Liang, JR; Li, YM; Lin, J; Ling, Y; Liu, HF; Liu, JW; Liu, NP; Liu, SQ; Luo, M; Ma, Q; Song, QB; Sun, WJN; Wang, GX; Wang, F; Wang, Y; Wen, XF; Wu, Q; Xu, G; Xie, XW; Xiong, XX; Xing, XD; Xu, H; Yin, CH; Yu, DD; Yu, KZ; Yuan, J; Zhang, B; Zhang, PP; Zhang, T; Zhao, JC; Zhao, PD; Zhou, JF; Zhou, W; Zhong, SJ; Zhong, XS; Zhang, SY; Zhu, L; Zhu, P; Zou, B; Zou, JH; Zuo, ZT; Bai, F; Huang, X; Zhou, PH; Jiang, QH; Huang, ZW; Bei, JX; Wei, L; Bian, XW; Liu, XD; Cheng, T; Li, XP; Zhao, PS; Wang, FS; Wang, HY; Su, B; Zhang, Z; Qu, K; Wang, XQ; Chen, JK; Jin, RH; Zhang, ZM				Ren, Xianwen; Wen, Wen; Fan, Xiaoying; Hou, Wenhong; Su, Bin; Cai, Pengfei; Li, Jiesheng; Liu, Yang; Tang, Fei; Zhang, Fan; Yang, Yu; He, Jiangping; Ma, Wenji; He, Jingjing; Wang, Pingping; Cao, Qiqi; Chen, Fangjin; Chen, Yuqing; Cheng, Xuelian; Deng, Guohong; Deng, Xilong; Ding, Wenyu; Feng, Yingmei; Gan, Rui; Guo, Chuang; Guo, Weiqiang; He, Shuai; Jiang, Chen; Liang, Juanran; Li, Yi-min; Lin, Jun; Ling, Yun; Liu, Haofei; Liu, Jianwei; Liu, Nianping; Liu, Shu-Qiang; Luo, Meng; Ma, Qiang; Song, Qibing; Sun, Wujianan; Wang, GaoXiang; Wang, Feng; Wang, Ying; Wen, Xiaofeng; Wu, Qian; Xu, Gang; Xie, Xiaowei; Xiong, Xinxin; Xing, Xudong; Xu, Hao; Yin, Chonghai; Yu, Dongdong; Yu, Kezhuo; Yuan, Jin; Zhang, Biao; Zhang, Peipei; Zhang, Tong; Zhao, Jincun; Zhao, Peidong; Zhou, Jianfeng; Zhou, Wei; Zhong, Sujuan; Zhong, Xiaosong; Zhang, Shuye; Zhu, Lin; Zhu, Ping; Zou, Bin; Zou, Jiahua; Zuo, Zengtao; Bai, Fan; Huang, Xi; Zhou, Penghui; Jiang, Qinghua; Huang, Zhiwei; Bei, Jin-Xin; Wei, Lai; Bian, Xiu-Wu; Liu, Xindong; Cheng, Tao; Li, Xiangpan; Zhao, Pingsen; Wang, Fu-Sheng; Wang, Hongyang; Su, Bing; Zhang, Zheng; Qu, Kun; Wang, Xiaoqun; Chen, Jiekai; Jin, Ronghua; Zhang, Zemin			COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas	CELL			English	Article							MILD; INFECTION; OUTBREAK	A dysfunctional immune response in coronavirus disease 2019 (COVID-19) patients is a recurrent theme impacting symptoms and mortality, yet a detailed understanding of pertinent immune cells is not complete. We applied single-cell RNA sequencing to 284 samples from 196 COVID-19 patients and controls and created a comprehensive immune landscape with 1.46 million cells. The large dataset enabled us to identify that different peripheral immune subtype changes are associated with distinct clinical features, including age, sex, severity, and disease stages of COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) RNA was found in diverse epithelial and immune cell types, accompanied by dramatic transcriptomic changes within virus-positive cells. Systemic upregulation of S100A8/A9, mainly by megakaryocytes and monocytes in the peripheral blood, may contribute to the cytokine storms frequently observed in severe patients. Our data provide a rich resource for understanding the pathogenesis of and developing effective therapeutic strategies for COVID-19.	[Ren, Xianwen; Li, Jiesheng; Tang, Fei; Yang, Yu; Chen, Yuqing; Yu, Kezhuo; Bai, Fan; Zhang, Zemin] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing Adv Innovat Ctr Genom ICG,Peking Tsinghua, Biomed Pioneering Innovat Ctr BIOPIC,Sch Life Sci, Beijing 100871, Peoples R China; [Wen, Wen; Cao, Qiqi; Wang, Hongyang] Second Mil Med Univ, Natl Ctr Liver Canc, Shanghai 200003, Peoples R China; [Wen, Wen; Cao, Qiqi; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200003, Peoples R China; [Wen, Wen; Cao, Qiqi; Wang, Hongyang] Second Mil Med Univ, Minist Educ MOE, Key Lab Signaling Regulat & Targeting Therapy Liv, Shanghai 200003, Peoples R China; [Fan, Xiaoying; He, Jiangping; Liu, Jianwei; Zhou, Wei; Wang, Xiaoqun; Chen, Jiekai] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou 510005, Peoples R China; [Hou, Wenhong; Zhang, Zemin] Inst Canc Res, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China; [Su, Bin; Feng, Yingmei; Zhang, Tong; Jin, Ronghua] Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China; [Cai, Pengfei; Guo, Chuang; Jiang, Chen; Lin, Jun; Liu, Nianping; Sun, Wujianan; Xu, Hao; Zhu, Lin; Qu, Kun] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Oncol,Div Mol Med, Hefei Natl Lab Phys Sci Microscale,Div Life Sci &, Hefei 230021, Anhui, Peoples R China; [Liu, Yang; Xu, Gang; Yuan, Jin; Zhang, Zheng] Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Natl Clin Res Ctr Infect Dis,Inst Hepatol, Shenzhen 518112, Peoples R China; [Zhang, Fan; Gan, Rui; Huang, Zhiwei] Harbin Inst Technol, Sch Life Sci & Technol, Ctr Life Sci, Harbin 150080, Peoples R China; [Fan, Xiaoying; Ma, Wenji; Ding, Wenyu; Ma, Qiang; Yin, Chonghai; Zuo, Zengtao; Wang, Xiaoqun] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Brain Intelligence Technol Shanghai,Inst Bio, CAS Ctr Excellence Brain Sci & Intelligence Techn, Beijing 100101, Peoples R China; [He, Jingjing; He, Shuai; Liu, Shu-Qiang; Xiong, Xinxin; Zhou, Penghui; Bei, Jin-Xin] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China; [Wang, Pingping; Luo, Meng; Jiang, Qinghua] Harbin Inst Technol, Sch Life Sci & Technol, Ctr Bioinformat, Harbin, Peoples R China; [Cheng, Xuelian; Xie, Xiaowei; Zhang, Biao; Zhu, Ping; Cheng, Tao] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China; [Cheng, Xuelian; Xie, Xiaowei; Zhang, Biao; Zhu, Ping; Cheng, Tao] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, Inst Hematol, Tianjin 300020, Peoples R China; [Cheng, Xuelian; Xie, Xiaowei; Zhang, Biao; Zhu, Ping; Cheng, Tao] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Stem Cell Med, Tianjin 300020, Peoples R China; [Cheng, Xuelian; Xie, Xiaowei; Zhang, Biao; Zhu, Ping; Cheng, Tao] Chinese Acad Med Sci & Peking Union Med Coll, Dept Stem Cell & Regenerat Med, Tianjin 300020, Peoples R China; [Deng, Guohong] Army Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing 400038, Peoples R China; [Ding, Wenyu; Wu, Qian; Zhong, Sujuan] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhao, Peidong] Analyt Biosci Beijing Ltd, Beijing 100084, Peoples R China; [Liang, Juanran; Wen, Xiaofeng; Zou, Bin; Wei, Lai] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Peoples R China; [Deng, Xilong] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Peoples R China; [Li, Yi-min; Zhao, Jincun] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis,Guangzhou Inst Resp Hl, Guangzhou 510120, Guangdong, Peoples R China; [Chen, Jiekai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Peoples R China; [Ling, Yun] Shanghai Publ Hlth Clin Ctr, Dept Infect Dis, Shanghai 201052, Peoples R China; [Liu, Haofei; Zhang, Peipei; Bian, Xiu-Wu; Liu, Xindong] Army Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China; [Liu, Haofei; Zhang, Peipei; Bian, Xiu-Wu; Liu, Xindong] Army Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China; [Song, Qibing; Yu, Dongdong; Li, Xiangpan] Wuhan Univ, Canc Ctr, Renmin Hosp, Wuhan 430060, Peoples R China; [Wang, GaoXiang; Zhou, Jianfeng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan 430030, Hubei, Peoples R China; [Wang, Feng; Wang, Ying; Su, Bing] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Microbiol & Immunol, Sch Med, Shanghai 200025, Peoples R China; [Xing, Xudong; Wang, Fu-Sheng] Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Dept Infect Dis, Med Ctr 5, Beijing 100039, Peoples R China; [Zhang, Peipei; Zou, Jiahua] Huanggang Hosp Tradit Chinese Med, Canc Ctr, Huanggang 438000, Peoples R China; [Huang, Xi] Sun Yat Sen Univ, Affiliated Hosp 5, Ctr Infect & Immun, Zhuhai 519000, Guangdong, Peoples R China; [Zhao, Pingsen] Shantou Univ, Yuebei Peoples Hosp, Dept Lab Med, Med Coll, Shaoguan 512025, Peoples R China; [Zhao, Pingsen] Shantou Univ, Med Res Ctr, Lab Diag Clin Microbiol & Infect, Med Coll, Shaoguan 512025, Peoples R China; [Chen, Fangjin] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Zhong, Xiaosong] Capital Med Univ, Beijing Shijitan Hosp, Beijing 100038, Peoples R China; [Zhang, Shuye] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China; [Zhang, Shuye] Fudan Univ, Inst Biomed Sci, Shanghai 201508, Peoples R China; [Guo, Weiqiang] Shantou Univ, Yuebei Peoples Hosp, Med Coll, Shaoguan 512025, Peoples R China; [Bian, Xiu-Wu; Liu, Xindong] Univ Sci & Technol China USTC, Div Life Sci & Med, Intelligent Pathol Inst, Hefei 230036, Anhui, Peoples R China; [Bian, Xiu-Wu; Liu, Xindong] USTC, Hosp 1, Dept Pathol, Hefei 230036, Anhui, Peoples R China; [Zhang, Peipei] Shanghai Jiao Tong Univ, Dept Pathol, Sch Med, Shanghai 200025, Peoples R China	Peking University; Naval Medical University; Naval Medical University; Naval Medical University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Shenzhen Bay Laboratory; Capital Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southern University of Science & Technology; Harbin Institute of Technology; Chinese Academy of Sciences; State Key Lab Oncology South China; Sun Yat Sen University; Harbin Institute of Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Army Medical University; Beijing Normal University; Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Army Medical University; Army Medical University; Wuhan University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese People's Liberation Army General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Sun Yat Sen University; Shantou University; Shantou University; Peking University; Capital Medical University; Fudan University; Fudan University; Shantou University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Shanghai Jiao Tong University	Zhang, ZM (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Beijing Adv Innovat Ctr Genom ICG,Peking Tsinghua, Biomed Pioneering Innovat Ctr BIOPIC,Sch Life Sci, Beijing 100871, Peoples R China.; Wang, HY (corresponding author), Second Mil Med Univ, Natl Ctr Liver Canc, Shanghai 200003, Peoples R China.; Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200003, Peoples R China.; Wang, HY (corresponding author), Second Mil Med Univ, Minist Educ MOE, Key Lab Signaling Regulat & Targeting Therapy Liv, Shanghai 200003, Peoples R China.; Wang, XQ; Chen, JK (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou 510005, Peoples R China.; Zhang, ZM (corresponding author), Inst Canc Res, Shenzhen Bay Lab, Shenzhen 518132, Peoples R China.; Jin, RH (corresponding author), Capital Med Univ, Beijing Youan Hosp, Beijing 100069, Peoples R China.; Qu, K (corresponding author), Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Oncol,Div Mol Med, Hefei Natl Lab Phys Sci Microscale,Div Life Sci &, Hefei 230021, Anhui, Peoples R China.; Zhang, Z (corresponding author), Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Natl Clin Res Ctr Infect Dis,Inst Hepatol, Shenzhen 518112, Peoples R China.; Huang, ZW (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Ctr Life Sci, Harbin 150080, Peoples R China.; Wang, XQ (corresponding author), Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Inst Brain Intelligence Technol Shanghai,Inst Bio, CAS Ctr Excellence Brain Sci & Intelligence Techn, Beijing 100101, Peoples R China.; Zhou, PH; Bei, JX (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Peoples R China.; Jiang, QH (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Ctr Bioinformat, Harbin, Peoples R China.; Cheng, T (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China.; Cheng, T (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Blood Dis, Inst Hematol, Tianjin 300020, Peoples R China.; Cheng, T (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Ctr Stem Cell Med, Tianjin 300020, Peoples R China.; Cheng, T (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Dept Stem Cell & Regenerat Med, Tianjin 300020, Peoples R China.; Wei, L (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Peoples R China.; Chen, JK (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Peoples R China.; Bian, XW; Liu, XD (corresponding author), Army Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China.; Bian, XW; Liu, XD (corresponding author), Army Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China.; Li, XP (corresponding author), Wuhan Univ, Canc Ctr, Renmin Hosp, Wuhan 430060, Peoples R China.; Su, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Dept Microbiol & Immunol, Sch Med, Shanghai 200025, Peoples R China.; Wang, FS (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Natl Clin Res Ctr Infect Dis, Dept Infect Dis, Med Ctr 5, Beijing 100039, Peoples R China.; Zhao, PS (corresponding author), Shantou Univ, Yuebei Peoples Hosp, Dept Lab Med, Med Coll, Shaoguan 512025, Peoples R China.; Zhao, PS (corresponding author), Shantou Univ, Med Res Ctr, Lab Diag Clin Microbiol & Infect, Med Coll, Shaoguan 512025, Peoples R China.; Bian, XW; Liu, XD (corresponding author), Univ Sci & Technol China USTC, Div Life Sci & Med, Intelligent Pathol Inst, Hefei 230036, Anhui, Peoples R China.; Bian, XW; Liu, XD (corresponding author), USTC, Hosp 1, Dept Pathol, Hefei 230036, Anhui, Peoples R China.	zhouph@sysucc.org.cn; qhjiang@hit.edu.cn; huangzhiwei2009@gmail.com; beijx@sysucc.org.cn; weilai@gzzoc.com; bianxiuwu@263.net; xindongliu@hotmail.com; chengtao@ihcams.ac.cn; rm001227@whu.edu.cn; zhaopingsen01@163.com; fswang302@163.com; hywangk@vip.sina.com; bingsu@sjtu.edu.cn; zhangzheng1975@aliyun.com; qukun@ustc.edu.cn; xiaoqunwang@ibp.ac.cn; chen_jiekai@gibh.ac.cn; ronghuajin_youan@126.com; zemin@pku.edu.cn	Bian, Xiu-Wu/D-4736-2017; Zhao, Jincun/ABD-8679-2021; Guo, Chuang/GPS-8725-2022; Ma, Wenji/AFN-8974-2022; ma, qiang/HCI-1013-2022; Zhang, Shuye/ABG-7815-2021; Zhao, Pingsen/GON-6370-2022	Bian, Xiu-Wu/0000-0003-4383-0197; Zhao, Jincun/0000-0003-2515-5589; Guo, Chuang/0000-0002-3912-0793; Ma, Wenji/0000-0003-2840-3015; Zhang, Shuye/0000-0002-4749-6790; Xing, Xudong/0000-0003-0681-9378; Yun, Ling/0000-0002-4289-3594; Yu, Kezhuo/0000-0003-1576-8293; He, Jiangping/0000-0002-1425-3530; zhou, penghui/0000-0003-0519-461X; Li, Jiesheng/0000-0002-8720-1344; Su, Bin/0000-0001-5140-0440; Liu, Yang/0000-0002-5221-7725; Cheng, Tao/0000-0002-5925-2769	Beijing Advanced Innovation Centre for Genomics at Peking University; Ministry of Science and Technology of the People's Republic of China [2020YFC0848700, 2016YFA0100600, CSTC2020jscx-fyzxX0037]; National Key R&D Program of China [2017YFA0102900]; National Natural Science Foundation of China [91940306, 81788101, 31970858, 32022016, 31771428, 91640113, 31700796, 81871479, 81772165, 81974303, 31991171, 31530036, 91742203, 31825008, 31422014, 61872117, 61822108, 62032007]; China Primary Health Care Foundation-Youan Medical Development Fund [BJYAYY-2020PY-01]; Beijing Municipal of Science and Technology Major Project [Z201100005420018, Z201100005420022]; CAMS Initiative for Innovative Medicine [2017-I2M-1-015]; Fundamental Research Funds for the Central Universities [YD2070002019]; Research Project for Outstanding Scholar of Yuebei People's Hospital, Shantou University Medical College [RS202001]; Chang Jiang Scholars Program	Beijing Advanced Innovation Centre for Genomics at Peking University; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Primary Health Care Foundation-Youan Medical Development Fund; Beijing Municipal of Science and Technology Major Project; CAMS Initiative for Innovative Medicine; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Project for Outstanding Scholar of Yuebei People's Hospital, Shantou University Medical College; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	Y We thank the COVID-19 patients from Wuhan Jinyintan Hospital and their families for their dedication and Professor Dingyu Zhang and his colleagues at Wuhan Jinyintan Hospital for their contribution to the study. We thank the Computing Platform of the Center for Life Science for their contributions. We also thank the 10x Genomics China team for their strong support in the coordination and discussion of this study. We thank Analytical BioSciences for their help in building the visualization website of this dataset. We thank Zhuo Zhou of BIOPIC, Peking University for helpful discussion regarding the interferon responses of SARS-CoV-2 infection. We thank the USTC supercomputing center and the School of Life Science Bioinformatics Center for providing supercomputing resources for this project. We thank the CAS interdisciplinary innovation team for helpful discussion. We also thank W. Chen, C. Xiao, Y. Zheng, W. Su, Y. Zhang, C. Zhang, X. Wang, H. Ma, T. Jin, X. Wang, H. Wei, B. Fu, L. Liu, J. Weng, and X. Ma for their support of this project. This work was supported by the Beijing Advanced Innovation Centre for Genomics at Peking University, the Ministry of Science and Technology of the People's Republic of China (grants 2020YFC0848700, 2016YFA0100600, and CSTC2020jscx-fyzxX0037), the National Key R&D Program of China (grant 2017YFA0102900), the National Natural Science Foundation of China (grants 91940306, 81788101, 31970858, 32022016, 31771428, 91640113, 31700796, 81871479, 81772165, 81974303, 31991171, 31530036, 91742203, 31825008, 31422014, 61872117, 61822108, and 62032007), the China Primary Health Care Foundation-Youan Medical Development Fund (BJYAYY-2020PY-01), the Beijing Municipal of Science and Technology Major Project (Z201100005420018 and Z201100005420022), the CAMS Initiative for Innovative Medicine (2017-I2M-1-015), the Fundamental Research Funds for the Central Universities (YD2070002019), the Research Project for Outstanding Scholar of Yuebei People's Hospital, Shantou University Medical College (RS202001), and the Chang Jiang Scholars Program (J.-X.B.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bost P, 2020, CELL, V181, P1475, DOI 10.1016/j.cell.2020.05.006; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; Chen Z, 2017, MABS-AUSTIN, V9, P342, DOI 10.1080/19420862.2016.1267086; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Fan X., 2020, 20101238 MEDRXIV; Gavins FNE, 2012, FASEB J, V26, P4977, DOI 10.1096/fj.12-205971; Guo C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17834-w; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Jouan Y, 2020, J EXP MED, V217, DOI 10.1084/jem.20200872; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Laouedj M, 2017, BLOOD, V129, P1980, DOI 10.1182/blood-2016-09-738005; Lee JS, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd1554; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Manne BK, 2020, BLOOD, V136, P1317, DOI 10.1182/blood.2020007214; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Osei-Owusu P, 2019, NATURE, V574, P57, DOI 10.1038/s41586-019-1570-z; Raybould Matthew I J, 2021, Bioinformatics, V37, P734, DOI 10.1093/bioinformatics/btaa739; Ren XW, 2020, CELL RES, V30, P763, DOI 10.1038/s41422-020-0353-2; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002; Singh M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108175; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su YP, 2020, CELL, V183, P1479, DOI 10.1016/j.cell.2020.10.037; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; Tang X, 2020, BIORXIV; Thachil J, 2020, SEMIN THROMB HEMOST, V46, P831, DOI 10.1055/s-0040-1714274; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang Y., 2019, BIORXIV, P507871, DOI [DOI 10.1101/507871, 10.1101/507871]; Wen W, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0168-9; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Xie XW, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwaa180; Younes M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5674; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang CY, 1997, J BIOL CHEM, V272, P26236, DOI 10.1074/jbc.272.42.26236; Zhang F, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00263-y; Zhang JY, 2020, NAT IMMUNOL, V21, P1107, DOI 10.1038/s41590-020-0762-x; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zheng YF, 2020, PROTEIN CELL, V11, P740, DOI 10.1007/s13238-020-00762-2; Zhou J., 2020, 20187435 MEDRXIV; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	58	259	269	62	230	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2021	184	7					1895	+		10.1016/j.cell.2021.01.053	http://dx.doi.org/10.1016/j.cell.2021.01.053		APR 2021	38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RI2IU	33657410	Bronze, Green Published			2022-12-28	WOS:000636734000021
J	Hahn, WC; Bader, JS; Braun, TP; Califano, A; Clemons, PA; Druker, BJ; Ewald, AJ; Fu, HA; Jagu, S; Kemp, CJ; Kim, W; Kuo, CJ; McManus, M; Mills, GB; Mo, XL; Sahni, N; Schreiber, SL; Talamas, JA; Tamayo, P; Tyner, JW; Wagner, BK; Weiss, WA; Gerhard, DS				Hahn, William C.; Bader, Joel S.; Braun, Theodore P.; Califano, Andrea; Clemons, Paul A.; Druker, Brian J.; Ewald, Andrew J.; Fu, Haian; Jagu, Subhashini; Kemp, Christopher J.; Kim, William; Kuo, Calvin J.; McManus, Michael; Mills, Gordon B.; Mo, Xiulei; Sahni, Nidhi; Schreiber, Stuart L.; Talamas, Jessica A.; Tamayo, Pablo; Tyner, Jeffrey W.; Wagner, Bridget K.; Weiss, William A.; Gerhard, Daniela S.		Canc Target Discovery Dev Network	An expanded universe of cancer targets	CELL			English	Review							PROTEIN-PROTEIN INTERACTIONS; GENOME-WIDE; IMMUNE CELLS; TUMOR-CELLS; IMMUNOTHERAPY; DEPENDENCY; DISCOVERY; BLOCKADE; THERAPY; SCREENS	The characterization of cancer genomes has provided insight into somatically altered genes across tumors, transformed our understanding of cancer biology, and enabled tailoring of therapeutic strategies. However, the function of most cancer alleles remains mysterious, and many cancer features transcend their genomes. Consequently, tumor genomic characterization does not influence therapy for most patients. Approaches to understand the function and circuitry of cancer genes provide complementary approaches to elucidate both oncogene and non-oncogene dependencies. Emerging work indicates that the diversity of therapeutic targets engendered by non-oncogene dependencies is much larger than the list of recurrently mutated genes. Here we describe a framework for this expanded list of cancer targets, providing novel opportunities for clinical translation.	[Hahn, William C.; Talamas, Jessica A.] Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA; [Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Bader, Joel S.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Dept Syst Biol Biomed Informat Biochem & Mol Biop, New York, NY USA; [Braun, Theodore P.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Braun, Theodore P.; Druker, Brian J.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA; [Fu, Haian; Mo, Xiulei] Emory Univ, Emory Chem Biol Discovery Ctr, Dept Pharmacol & Chem Biol, Atlanta, GA 30322 USA; [Fu, Haian; Mo, Xiulei] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Kemp, Christopher J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Kuo, Calvin J.] Stanford Univ, Hematol Div, Sch Med, Stanford, CA USA; [McManus, Michael] Univ Calif San Francisco, Dept Microbiol & Immunol, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [McManus, Michael; Weiss, William A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Mills, Gordon B.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Knight Canc Inst, Portland, OR 97201 USA; [Clemons, Paul A.; Schreiber, Stuart L.; Wagner, Bridget K.] Broad Inst, 415 Main St, Cambridge, MA USA; [Kim, William; Tamayo, Pablo] Univ Calif San Diego, Ctr Novel Therapeut, Moores Canc Ctr, La Jolla, CA USA; [Kim, William; Tamayo, Pablo] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Jagu, Subhashini; Gerhard, Daniela S.] NCI, Off Canc Genom, Ctr Canc Genom, NIH, Bethesda, MD 20892 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Sahni, Nidhi] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX USA; [Ewald, Andrew J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Dept Cell Biol, Baltimore, MD USA	Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Columbia University; Oregon Health & Science University; Oregon Health & Science University; Emory University; Emory University; Fred Hutchinson Cancer Center; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Oregon Health & Science University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center; Johns Hopkins University; Johns Hopkins Medicine	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Moreno, Carlos S/B-3863-2009; Bhattacharya, Asmita/GQR-2455-2022; Chen, Ken/AAU-1432-2021; Stockwell, Brent R/AAE-7200-2019	Moreno, Carlos S/0000-0002-5582-0028; Bhattacharya, Asmita/0000-0002-5669-8036; Chen, Ken/0000-0003-4013-5279; Stockwell, Brent R/0000-0002-3532-3868; Nakano, Michitaka/0000-0003-1049-5791; Grasset, Eloise/0000-0001-9857-582X; Tay, Neil/0000-0001-5643-050X; Kaufman, Dan/0000-0002-2003-2494; Dunworth, Matthew/0000-0002-8852-169X; Kuo, Calvin/0000-0002-7427-5985; Bader, Joel/0000-0002-6020-4625; Padmanaban, Veena/0000-0002-4810-2597; Perrone, Matthew/0000-0002-3720-212X; Bollam, Saumya/0000-0002-6903-4618; Lind, Evan/0000-0001-7026-2012; Serwas, Nina/0000-0003-2243-5446	NCI [U01 CA217846, U01 CA217858, U01 CA217862, U01 CA217875, U01 CA176058, U01 CA217883, U01 CA217851, U01 CA217882, U01 CA217842, U01 CA217848, U01 CA21788, U01 CA217864]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Data generated by the CTD<SUP>2</SUP> Network can be found in the Data Portal and Dashboard. More information about the centers can be found on the Network web site. CTD2 Centers are funded in part by NCI grants U01 CA217846, U01 CA217858, U01 CA217862, U01 CA217875, U01 CA176058, U01 CA217883, U01 CA217851, U01 CA217882, U01 CA217842, U01 CA217848, U01 CA21788, and U01 CA217864.	Alvarez MJ, 2018, NAT GENET, V50, P979, DOI 10.1038/s41588-018-0138-4; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Arbour KC, 2019, JAMA-J AM MED ASSOC, V322, P764, DOI 10.1001/jama.2019.11058; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Ashiru O, 2010, CANCER RES, V70, P481, DOI 10.1158/0008-5472.CAN-09-1688; Bannon AE, 2017, EXPERT REV MOL DIAGN, V17, P445, DOI 10.1080/14737159.2017.1308826; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Biffi G, 2021, PHYSIOL REV, V101, P147, DOI 10.1152/physrev.00048.2019; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Braun TP, 2020, CANCER CELL, V37, P530, DOI 10.1016/j.ccell.2020.03.006; Brown JS, 2017, CANCER DISCOV, V7, P20, DOI 10.1158/2159-8290.CD-16-0860; Califano A, 2017, NAT REV CANCER, V17, P116, DOI 10.1038/nrc.2016.124; Cancer Target Discovery and Development Network, 2016, Mol Cancer Res, V14, P675, DOI 10.1158/1541-7786.MCR-16-0090; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Chan EM, 2019, NATURE, V568, P551, DOI 10.1038/s41586-019-1102-x; Chan IS, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202001134; Chari A, 2019, NEW ENGL J MED, V381, P727, DOI 10.1056/NEJMoa1903455; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; de Andrade LF, 2018, SCIENCE, V359, P1537, DOI 10.1126/science.aao0505; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Dijkstra KK, 2018, CELL, V174, P1586, DOI 10.1016/j.cell.2018.07.009; Dong MB, 2019, CELL, V178, P1189, DOI 10.1016/j.cell.2019.07.044; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Grosse-Wilde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126522; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hammerl D, 2018, SEMIN CANCER BIOL, V52, P178, DOI 10.1016/j.semcancer.2017.11.003; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Hedlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016899; Hekman RM, 2020, MOL CELL, V80, P1104, DOI 10.1016/j.molcel.2020.11.028; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Hosein AN, 2020, NAT REV GASTRO HEPAT, V17, P487, DOI 10.1038/s41575-020-0300-1; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Ilic N, 2017, P NATL ACAD SCI USA, V114, pE3434, DOI 10.1073/pnas.1617922114; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Janes KA, 2016, CURR OPIN BIOTECH, V39, P120, DOI 10.1016/j.copbio.2016.03.015; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jenkins RW, 2018, CANCER DISCOV, V8, P196, DOI 10.1158/2159-8290.CD-17-0833; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Kim JW, 2017, CELL SYST, V5, P105, DOI 10.1016/j.cels.2017.08.002; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Kupiec J, 1997, MOL GEN GENET, V255, P201, DOI 10.1007/s004380050490; Lane-Reticker SK, 2018, IMMUNOTHERAPY-UK, V10, P167, DOI 10.2217/imt-2017-0164; Lanier LL, 2019, J EXP MED, V216, P1726, DOI 10.1084/jem.20191183; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; LeBleu VS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.029447; Levine AJ, 2019, J MOL CELL BIOL, V11, P524, DOI 10.1093/jmcb/mjz026; Li HX, 2019, NAT MED, V25, P850, DOI 10.1038/s41591-019-0404-8; Li JJ, 2017, CELL STEM CELL, V20, P303, DOI 10.1016/j.stem.2016.11.004; Li ZG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14356; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Lord CJ, 2017, SCIENCE, V355, P1152, DOI 10.1126/science.aam7344; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Lui GYL, 2020, EBIOMEDICINE, V60, DOI 10.1016/j.ebiom.2020.102988; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MacLean Adam L, 2018, Curr Opin Syst Biol, V9, P32, DOI 10.1016/j.coisb.2018.02.009; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; Menendez JA, 2006, CURR OPIN CLIN NUTR, V9, P346, DOI 10.1097/01.mco.0000232893.21050.15; Miller JS, 2019, ANNU REV CANC BIOL, V3, P77, DOI 10.1146/annurev-cancerbio-030518-055653; Mo XL, 2019, CELL CHEM BIOL, V26, P331, DOI 10.1016/j.chembiol.2018.11.011; Monje M, 2020, CANCER RES, V80, P2979, DOI 10.1158/0008-5472.CAN-20-0646; Moore AR, 2020, NAT REV DRUG DISCOV, V19, P533, DOI 10.1038/s41573-020-0068-6; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Neal JT, 2018, CELL, V175, P1972, DOI 10.1016/j.cell.2018.11.021; Neal JT, 2016, ANNU REV PATHOL-MECH, V11, P199, DOI 10.1146/annurev-pathol-012615-044249; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Niedermaier B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54757-z; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Paul P, 2019, MUTAT RES-REV MUTAT, V781, P88, DOI 10.1016/j.mrrev.2019.04.004; Pettitt SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03917-2; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Prior IA, 2020, CANCER RES, V80, P2969, DOI 10.1158/0008-5472.CAN-19-3682; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Samanta D, 2016, CANCER RES, V76, P4430, DOI 10.1158/0008-5472.CAN-16-0530; Schaub FX, 2018, CELL SYST, V6, P282, DOI 10.1016/j.cels.2018.03.003; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Socinski MA, 2018, NEW ENGL J MED, V378, P2288, DOI 10.1056/NEJMoa1716948; Stadhouders R, 2019, NATURE, V569, P345, DOI 10.1038/s41586-019-1182-7; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Talos F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14662; Thompson TW, 2017, ELIFE, V6, DOI 10.7554/eLife.30881; Tommasini-Ghelfi S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4543; Tran HC, 2017, CLIN CANCER RES, V23, P804, DOI 10.1158/1078-0432.CCR-16-1743; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Venkatesh HS, 2019, NATURE, V573, P539, DOI 10.1038/s41586-019-1563-y; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Wagner AD, 2007, ANN ONCOL, V18, P82, DOI 10.1093/annonc/mdl340; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wong KM, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0608-3; Ye LP, 2019, NAT BIOTECHNOL, V37, P1302, DOI 10.1038/s41587-019-0246-4; Yuki K, 2020, TRENDS IMMUNOL, V41, P652, DOI 10.1016/j.it.2020.06.010; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503; Zhu GW, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-119	123	51	51	6	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1142	1155		10.1016/j.cell.2021.02.020	http://dx.doi.org/10.1016/j.cell.2021.02.020		MAR 2021	14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33667368	Bronze, Green Accepted			2022-12-28	WOS:000629635700007
J	Topoll, A; Arnold, R				Topoll, Alicia; Arnold, Robert			In chronic noncancer illness, palliative care reduces symptoms and health care use but does not improve QoL	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Topoll, Alicia; Arnold, Robert] UPMC Hlth Syst, Pittsburgh, PA 15206 USA		Topoll, A (corresponding author), UPMC Hlth Syst, Pittsburgh, PA 15206 USA.							Kavalieratos D, 2016, JAMA-J AM MED ASSOC, V316, P2104, DOI 10.1001/jama.2016.16840; Traue DC, 2005, J ROY SOC MED, V98, P503, DOI 10.1258/jrsm.98.11.503; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC31	JC31		10.7326/ACPJ202103160-031	http://dx.doi.org/10.7326/ACPJ202103160-031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646840				2022-12-28	WOS:000669667000006
J	Tanne, JH				Tanne, Janice Hopkins			US abortions: Nine in 10 laws on access since 2017 increased restrictions, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Center for Reproductive Rights, WHAT ROE FELL AB MAP; Collins J, 2021, AP NEWS 0219; Gaj EB, 2021, JAMA INTERN MED, V181, P711, DOI 10.1001/jamainternmed.2020.8781; Guttmacher Institute, 2019, IND AB US; Jatlaoui TC, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6625a1	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n542	10.1136/bmj.n542	http://dx.doi.org/10.1136/bmj.n542			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627338				2022-12-28	WOS:000623404800015
J	McNally, A				McNally, Alan			What makes new variants of SARS-CoV-2 concerning is not where they come from, but the mutations they contain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McNally, Alan] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham	McNally, A (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	A.McNally.1@bham.ac.uk		McNally, Alan/0000-0002-3099-630X					0	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2021	372								n504	10.1136/bmj.n504	http://dx.doi.org/10.1136/bmj.n504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7AW	33619064	Bronze			2022-12-28	WOS:000621236700005
J	Cohen, J				Cohen, Jon			THE LONG ROAD	SCIENCE			English	Editorial Material																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					768	+		10.1126/science.371.6531.768	http://dx.doi.org/10.1126/science.371.6531.768			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602838				2022-12-28	WOS:000619664700018
J	Mayer, KH; Nelson, L; Hightow-Weidman, L; Mimiaga, MJ; Mena, L; Reisner, S; Daskalakis, D; Safren, SA; Beyrer, C; Sullivan, PS				Mayer, Kenneth H.; Nelson, LaRon; Hightow-Weidman, Lisa; Mimiaga, Matthew J.; Mena, Leandro; Reisner, Sari; Daskalakis, Demetre; Safren, Steven A.; Beyrer, Chris; Sullivan, Patrick S.			The persistent and evolving HIV epidemic in American men who have sex with men	LANCET			English	Review							PSYCHOSOCIAL HEALTH-PROBLEMS; PREEXPOSURE PROPHYLAXIS; TRANSGENDER MEN; METHAMPHETAMINE USE; UNITED-STATES; SUBSTANCE USE; BLACK-MEN; CONTINGENCY MANAGEMENT; AFRICAN-AMERICAN; ANAL INTERCOURSE	Men who have sex with men (MSM) in the USA were the first population to be identified with AIDS and continue to be at very high risk of HIV acquisition. We did a systematic literature search to identify the factors that explain the reasons for the ongoing epidemic in this population, using a social-ecological perspective. Common features of the HIV epidemic in American MSM include role versatility and biological, individual, and social and structural factors. The high-prevalence networks of some racial and ethnic minority men are further concentrated because of assortative mixing, adverse life experiences (including high rates of incarceration), and avoidant behaviour because of negative interactions with the health-care system. Young MSM have additional risks for HIV because their impulse control is less developed and they are less familiar with serostatus and other risk mitigation discussions. They might benefit from prevention efforts that use digital technologies, which they often use to meet partners and obtain health-related information. Older MSM remain at risk of HIV and are the largest population of US residents with chronic HIV, requiring culturally responsive programmes that address longer-term comorbidities. Transgender MSM are an understudied population, but emerging data suggest that some are at great risk of HIV and require specifically tailored information on HIV prevention. In the current era of pre-exposure prophylaxis and the undetectable equals untransmittable campaign, training of health-care providers to create culturally competent programmes for all MSM is crucial, since the use of antiretrovirals is foundational to optimising HIV care and prevention. Effective control of the HIV epidemic among all American MSM will require scaling up programmes that address their common vulnerabilities, but are sufficiently nuanced to address the specific sociocultural, structural, and behavioural issues of diverse subgroups.	[Mayer, Kenneth H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Reisner, Sari] Boston Childrens Hosp, Boston, MA USA; Fenway Hlth, Boston, MA USA; [Nelson, LaRon] Yale Univ, Sch Nursing, New Haven, CT 06536 USA; [Hightow-Weidman, Lisa] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA; [Mimiaga, Matthew J.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Mimiaga, Matthew J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Mena, Leandro] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Daskalakis, Demetre] New York City Dept Hlth, New York, NY USA; [Safren, Steven A.] Univ Miami, Coral Gables, FL 33124 USA; [Beyrer, Chris] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Fenway Health; Yale University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Mississippi; University of Mississippi Medical Center; New York City Department of Health & Mental Hygiene; University of Miami; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Emory University; Rollins School Public Health	Mayer, KH (corresponding author), Fenway Hlth, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	kmayer@fenwayhealth.org		Sullivan, Patrick Sean/0000-0002-7728-0587	Foundation for AIDS Research (amfAR); National Institute on Drug Abuse; Harvard Center for AIDS Research [NIAID P30AI060354]	Foundation for AIDS Research (amfAR); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Harvard Center for AIDS Research	This Series paper was supported by unrestricted grants from The Foundation for AIDS Research (amfAR), the National Institute on Drug Abuse, and the Harvard Center for AIDS Research (NIAID P30AI060354). The helpful insights of Brian Mustanski and Alex Keuroghlian are gratefully acknowledged, as is the assistance of Whitney Crebase in the preparation of the manuscript. This work occurred before Demetre Daskalakis joined the Centers for Disease Control and Prevention (CDC) and the Division for HIV/AIDS Prevention (DHAP). The findings and conclusions in this report are those of the authors and do not necessarily represent the official positions of the CDC or DHAP.	Amirkhanian YA, 2014, CURR HIV-AIDS REP, V11, P81, DOI 10.1007/s11904-013-0194-4; [Anonymous], 2018, HIV SURVEILLANCE S; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Balik CHA, 2020, INT J HEALTH SERV, V50, P44, DOI 10.1177/0020731419885093; Barskey AE, 2016, AM J PUBLIC HEALTH, V106, P103, DOI 10.2105/AJPH.2015.302868; Batchelder AW, 2017, SEX HEALTH, V14, P59, DOI 10.1071/SH16083; Bauer GR, 2013, INT J TRANSGENDERISM, V14, P66, DOI 10.1080/15532739.2013.791650; Bavinton BR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-917; Becasen JS, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2018.304727; Bernstein KT, 2010, JAIDS-J ACQ IMM DEF, V53, P537, DOI 10.1097/QAI.0b013e3181c3ef29; Bourne A, 2017, SEX TRANSM INFECT, V93, P342, DOI 10.1136/sextrans-2016-052674; Brennan-Ing M, 2014, BEHAV MED, V40, P108, DOI 10.1080/08964289.2014.889069; Brewer RA, 2014, AM J PUBLIC HEALTH, V104, P448, DOI 10.2105/AJPH.2013.301786; Brooks JT, 2012, AM J PUBLIC HEALTH, V102, P1516, DOI 10.2105/AJPH.2012.300844; Cahill S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107104; Calabrese SK, 2014, AIDS BEHAV, V18, P226, DOI 10.1007/s10461-013-0675-x; Centers for Disease Control and Prevention, 2018, HIV SURVEILLANCE REP; Chapin-Bardales J, 2018, ANN EPIDEMIOL, V28, P874, DOI 10.1016/j.annepidem.2018.09.006; Coffin PO, 2020, JAMA PSYCHIAT, V77, P246, DOI 10.1001/jamapsychiatry.2019.3655; Crepaz N, 2018, MMWR-MORBID MORTAL W, V67, P113, DOI 10.15585/mmwr.mm6704a2; Dailey AF, 2017, MMWR-MORBID MORTAL W, V66, P1300, DOI 10.15585/mmwr.mm6647e1; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Denford S, 2017, HEALTH PSYCHOL REV, V11, P33, DOI 10.1080/17437199.2016.1240625; Feldman MB, 2015, DRUG ALCOHOL DEPEN, V147, P266, DOI 10.1016/j.drugalcdep.2014.09.780; Fields EL, 2021, LANCET, V397, P1040, DOI 10.1016/S0140-6736(20)32522-8; GARFIELD R, 2020, COVERAGE GAP UNINSUR; Golub SA, 2010, SEX TRANSM DIS, V37, P615, DOI 10.1097/OLQ.0b013e3181e15f20; GOTTLIEB MS, 1983, ANN INTERN MED, V99, P208, DOI 10.7326/0003-4819-99-2-208; Halkitis PN, 2015, J HOMOSEXUAL, V62, P571, DOI 10.1080/00918369.2014.987567; Han CS, 2015, ARCH SEX BEHAV, V44, P411, DOI 10.1007/s10508-014-0331-1; Harkness A, 2019, ARCH SEX BEHAV, V48, P1159, DOI 10.1007/s10508-018-1329-x; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Hickson DA, 2017, AM J EPIDEMIOL, V185, P786, DOI 10.1093/aje/kww144; Hightow-Weidman LB, 2018, JMIR RES PROTOC, V7, DOI 10.2196/10365; Hightow-Weidman LB, 2017, SEX TRANSM INFECT, V93, P309, DOI 10.1136/sextrans-2016-052673; Hightow-Weidman LB, 2015, CURR HIV-AIDS REP, V12, P500, DOI 10.1007/s11904-015-0280-x; Hoenigl M, 2020, CLIN INFECT DIS, V71, pE135, DOI 10.1093/cid/ciz1093; Hoenigl M, 2016, JAIDS-J ACQ IMM DEF, V71, P551, DOI 10.1097/QAI.0000000000000888; Hollenbach AD., 2014, IMPLEMENTING CURRICU; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179; Huang YLA, 2018, MMWR-MORBID MORTAL W, V67, P1147, DOI 10.15585/mmwr.mm6741a3; Jarama SL, 2005, AIDS BEHAV, V9, P513, DOI 10.1007/s10461-005-9022-1; Jenness SM, 2019, AM J EPIDEMIOL, V188, P743, DOI 10.1093/aje/kwy230; Jones J, 2019, SEX TRANSM DIS, V46, P357, DOI 10.1097/OLQ.0000000000000980; Kahler CW, 2015, AIDS BEHAV, V19, P422, DOI 10.1007/s10461-014-0896-7; Kelley CF, 2017, MUCOSAL IMMUNOL, V10, P996, DOI 10.1038/mi.2016.97; Kelley CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053284; Lally MA, 2018, JAIDS-J ACQ IMM DEF, V77, P110, DOI 10.1097/QAI.0000000000001563; Ling W, 2014, ADDICTION, V109, P1489, DOI 10.1111/add.12608; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; Lyons A, 2011, J SEX MED, V8, P2164, DOI 10.1111/j.1743-6109.2010.02197.x; Mayer KH, 2018, PUBLIC HEALTH REP, V133, P109, DOI 10.1177/0033354917748670; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; McCree DH, 2018, PREV MED, V114, P64, DOI 10.1016/j.ypmed.2018.06.007; McFarland W, 2017, AIDS BEHAV, V21, P3346, DOI 10.1007/s10461-017-1735-4; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Mimiaga MJ, 2019, AIDS CARE, V31, P1083, DOI 10.1080/09540121.2019.1595518; Mimiaga MJ, 2015, JAIDS-J ACQ IMM DEF, V68, P329, DOI 10.1097/QAI.0000000000000475; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V51, P340, DOI 10.1097/QAI.0b013e3181a24b38; Minozzi S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003352.pub4; Muessig KE, 2015, CURR HIV-AIDS REP, V12, P173, DOI 10.1007/s11904-014-0239-3; Munoz-Laboy M, 2017, J IMMIGR MINOR HEALT, V19, P1073, DOI 10.1007/s10903-017-0554-z; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Mustanski B, 2019, JAIDS-J ACQ IMM DEF, V80, P24, DOI 10.1097/QAI.0000000000001886; Mustanski B, 2018, AM J PREV MED, V55, P151, DOI 10.1016/j.amepre.2018.04.026; Mustanski B, 2016, AM J PUBLIC HEALTH, V106, P527, DOI 10.2105/AJPH.2015.302976; Myers JE, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy097; Nelson LE, 2016, J URBAN HEALTH, V93, P170, DOI 10.1007/s11524-015-0020-y; Vu NTT, 2017, AIDS BEHAV, V21, P1105, DOI 10.1007/s10461-016-1467-x; Ojikutu BO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198258; Onen NF, 2010, AIDS CARE, V22, P711, DOI 10.1080/09540120903373573; Parsons JT, 2012, AM J PUBLIC HEALTH, V102, P156, DOI 10.2105/AJPH.2011.300284; Pathela P, 2017, AIDS BEHAV, V21, P1444, DOI 10.1007/s10461-016-1499-2; Poteat T, 2017, CURR HIV-AIDS REP, V14, P141, DOI 10.1007/s11904-017-0360-1; Poteat T, 2016, JAIDS-J ACQ IMM DEF, V72, pS210, DOI 10.1097/QAI.0000000000001087; Quesada J, 2011, MED ANTHROPOL, V30, P339, DOI 10.1080/01459740.2011.576725; Rawson RA, 2006, ADDICTION, V101, P267, DOI 10.1111/j.1360-0443.2006.01312.x; Reisner SL, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25391; Reisner SL, 2016, INT J STD AIDS, V27, P955, DOI 10.1177/0956462415602418; Reisner SL, 2016, GLOB PUBLIC HEALTH, V11, P866, DOI 10.1080/17441692.2015.1134613; Reisner SL, 2016, J URBAN HEALTH, V93, P189, DOI 10.1007/s11524-015-0011-z; Reisner SL, 2010, AIDS PATIENT CARE ST, V24, P501, DOI 10.1089/apc.2010.0059; Rios-Spicer R, 2019, AIDS BEHAV, V23, P259, DOI 10.1007/s10461-018-2212-4; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Rodriguez-Diaz CE, 2021, LANCET, V397, P1043, DOI 10.1016/S0140-6736(20)32521-6; Rowniak S, 2017, AIDS EDUC PREV, V29, P302, DOI 10.1521/aeap.2017.29.4.302; Safren SA, 2018, HEALTH PSYCHOL, V37, P820, DOI 10.1037/hea0000617; Safren SA, 2010, JAIDS-J ACQ IMM DEF, V55, pS74, DOI 10.1097/QAI.0b013e3181fbc939; Sanchez TH, 2020, AIDS BEHAV, V24, P2024, DOI 10.1007/s10461-020-02894-2; Santos GM, 2021, AIDS BEHAV, V25, P311, DOI 10.1007/s10461-020-02969-0; Santos GM, 2016, JAIDS-J ACQ IMM DEF, V72, P21, DOI 10.1097/QAI.0000000000000922; Santos GM, 2014, SEX TRANSM INFECT, V90, P250, DOI 10.1136/sextrans-2013-051318; Scheim AI, 2017, JAIDS-J ACQ IMM DEF, V74, pE89, DOI [10.1097/QAI.0000000000001222, 10.1097/qai.0000000000001222]; Sevelius J, 2009, J ASSOC NURSE AIDS C, V20, P398, DOI 10.1016/j.jana.2009.06.001; Sheehan DM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8442-1; Shoptaw S, 2006, DRUG ALCOHOL DEPEN, V85, P12, DOI 10.1016/j.drugalcdep.2006.03.005; Stephenson R, 2017, J SEX RES, V54, P424, DOI 10.1080/00224499.2016.1271863; Sullivan PS, 2021, LANCET, V397, P1095, DOI 10.1016/S0140-6736(21)00395-0; Uthman OA, 2014, CURR HIV-AIDS REP, V11, P291, DOI 10.1007/s11904-014-0220-1; Wohl AR, 2013, AIDS BEHAV, V17, P1454, DOI 10.1007/s10461-012-0385-9; Woods WJ, 2010, JAIDS-J ACQ IMM DEF, V55, pS88, DOI 10.1097/QAI.0b013e3181fbca1b; Woody GE, 2001, J ACQ IMMUN DEF SYND, V27, P86, DOI 10.1097/00126334-200105010-00015; Ybarra ML, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2999	105	24	24	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1116	1126		10.1016/S0140-6736(21)00321-4	http://dx.doi.org/10.1016/S0140-6736(21)00321-4		MAR 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617771	Green Accepted			2022-12-28	WOS:000630397800029
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Dealing with covid trauma and grief	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2021	372								n649	10.1136/bmj.n649	http://dx.doi.org/10.1136/bmj.n649			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6QO	33687946	Bronze			2022-12-28	WOS:000632923400008
J	Neal, LA; Vosshall, LB				Neal, Lauren A.; Vosshall, Leslie B.			Eyeless worms detect color Roundworms discriminate color of toxic food despite a lack of eyes and opsin photoreceptor genes	SCIENCE			English	Editorial Material							LIGHT; BACTERIA		[Neal, Lauren A.; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA; [Vosshall, Leslie B.] Howard Hughes Med Inst, New York, NY USA; [Vosshall, Leslie B.] Kavli Neural Syst Inst, New York, NY USA	Rockefeller University; Howard Hughes Medical Institute	Neal, LA (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave, New York, NY 10021 USA.	lneal@rockefeller.edu; leslie@rockefeller.edu						Bhatla N, 2015, NEURON, V85, P804, DOI 10.1016/j.neuron.2014.12.061; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Ghosh DD, 2021, SCIENCE, V371, P1059, DOI 10.1126/science.abd3010; Gong JK, 2016, CELL, V167, P1252, DOI 10.1016/j.cell.2016.10.053; Harris G, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007706; Lee K, 2017, CELL REP, V20, P2501, DOI 10.1016/j.celrep.2017.08.053; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; Samuel BS, 2016, P NATL ACAD SCI USA, V113, pE3941, DOI 10.1073/pnas.1607183113; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	10	0	0	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					995	995		10.1126/science.abg5201	http://dx.doi.org/10.1126/science.abg5201			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674482				2022-12-28	WOS:000625876100035
J	Cooley, SW; Ryan, JC; Smith, LC				Cooley, Sarah W.; Ryan, Jonathan C.; Smith, Laurence C.			Human alteration of global surface water storage variability	NATURE			English	Article							RESERVOIRS; LAND; IMPACT; LAKES; ELEVATION; SEDIMENT; DAMS; AREA	Knowing the extent of human influence on the global hydrological cycle is essential for the sustainability of freshwater resources on Earth(1,2). However, a lack of water level observations for the world's ponds, lakes and reservoirs has limited the quantification of human-managed (reservoir) changes in surface water storage compared to its natural variability(3). The global storage variability in surface water bodies and the extent to which it is altered by humans therefore remain unknown. Here we show that 57 per cent of the Earth's seasonal surface water storage variability occurs in human-managed reservoirs. Using measurements from NASA's ICESat-2 satellite laser altimeter, which was launched in late 2018, we assemble an extensive global water level dataset that quantifies water level variability for 227,386 water bodies from October 2018 to July 2020. We find that seasonal variability in human-managed reservoirs averages 0.86 metres, whereas natural water bodies vary by only 0.22 metres. Natural variability in surface water storage is greatest in tropical basins, whereas human-managed variability is greatest in the Middle East, southern Africa and the western USA. Strong regional patterns are also found, with human influence driving 67 per cent of surface water storage variability south of 45 degrees north and nearly 100 per cent in certain arid and semi-arid regions. As economic development, population growth and climate change continue to pressure global water resources(4), our approach provides a useful baseline from which ICESat-2 and future satellite missions will be able to track human modifications to the global hydrologic cycle.	[Cooley, Sarah W.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Cooley, Sarah W.; Ryan, Jonathan C.] Univ Oregon, Dept Geog, Eugene, OR 97403 USA; [Ryan, Jonathan C.; Smith, Laurence C.] Brown Univ, Inst Brown Environm & Soc, Providence, RI 02912 USA; [Smith, Laurence C.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA	Stanford University; University of Oregon; Brown University; Brown University	Cooley, SW (corresponding author), Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA.; Cooley, SW (corresponding author), Univ Oregon, Dept Geog, Eugene, OR 97403 USA.	scooley@stanford.edu		Cooley, Sarah/0000-0001-8953-6730	NASA Studies with ICESat-2 programme [80NSSC20K0963]; NASA Surface Water and Ocean Topography mission [80NSSC20K1144S]; NSF Graduate Research Fellowship; Stanford Science Fellows programme; Voss Postdoctoral Fellowship through the Institute at Brown for Environment and Society	NASA Studies with ICESat-2 programme; NASA Surface Water and Ocean Topography mission; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Science Fellows programme; Voss Postdoctoral Fellowship through the Institute at Brown for Environment and Society	This research was funded by the NASA Studies with ICESat-2 programme (grant #80NSSC20K0963) managed by T. Markus, and the NASA Surface Water and Ocean Topography mission (grant #80NSSC20K1144S) managed by N. Vinogradova-Shiffer. S.W.C. gratefully acknowledges support from an NSF Graduate Research Fellowship and the Stanford Science Fellows programme. J.C.R. is grateful for support from a Voss Postdoctoral Fellowship through the Institute at Brown for Environment and Society. We thank M. Mulligan at King's College London for making the GOODD dataset publicly available at Global Dam Watch.	Alsdorf DE, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000197; Biancamaria S, 2016, SURV GEOPHYS, V37, P307, DOI 10.1007/s10712-015-9346-y; Birkett C. M., 2018, AM GEOPH UN FALL M; Chao BF, 2008, SCIENCE, V320, P212, DOI 10.1126/science.1154580; CUSHMAN R M, 1985, North American Journal of Fisheries Management, V5, P330, DOI 10.1577/1548-8659(1985)5<330:ROEEOR>2.0.CO;2; Deemer BR, 2016, BIOSCIENCE, V66, P949, DOI 10.1093/biosci/biw117; Famiglietti JS, 2014, NAT CLIM CHANGE, V4, P945, DOI 10.1038/nclimate2425; Gao HL, 2015, WIRES WATER, V2, P147, DOI 10.1002/wat2.1065; Gao H, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012063; Getirana A, 2017, GEOPHYS RES LETT, V44, P10359, DOI 10.1002/2017GL074684; Gillespie BR, 2015, FRESHWATER BIOL, V60, P410, DOI 10.1111/fwb.12506; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Global Runoff Data Center, MAJ RIV BAS WORLD; Grill G, 2019, NATURE, V572, pE9, DOI 10.1038/s41586-019-1379-9; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Kondolf GM, 2014, WATER RESOUR RES, V50, P5158, DOI 10.1002/2013WR014651; Lammers R., 2002, EOS T AM GEOPHYS UNI, V83, P13, DOI [10.1029/2002EO000007, DOI 10.1029/2002EO000007]; Lawford R, 2013, CURR OPIN ENV SUST, V5, P633, DOI 10.1016/j.cosust.2013.11.009; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Lehner B, 2013, HYDROL PROCESS, V27, P2171, DOI 10.1002/hyp.9740; Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125; Markus T, 2017, REMOTE SENS ENVIRON, V190, P260, DOI 10.1016/j.rse.2016.12.029; Marzeion B, 2014, SCIENCE, V345, P919, DOI 10.1126/science.1254702; Mekonnen MM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500323; Mulligan M, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0362-5; Neuenschwander A. L., ATLAS ICESAT 2 L3A L; Neuenschwander A. L., 2019, ALGORITHM THEORETICA; Neuenschwander A, 2019, REMOTE SENS ENVIRON, V221, P247, DOI 10.1016/j.rse.2018.11.005; Neumann TA, 2019, REMOTE SENS ENVIRON, V233, DOI 10.1016/j.rse.2019.111325; Nienhuis JH, 2020, NATURE, V577, P514, DOI 10.1038/s41586-019-1905-9; Parrish CE, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11141634; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Pelicice FM, 2015, FISH FISH, V16, P697, DOI 10.1111/faf.12089; Rodell M, 2019, NATURE, V565, pE7, DOI 10.1038/s41586-018-0831-6; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Ryan JC, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL088543; Smith L.C., 2020, RIVERS POWER NATURAL; Smith LC, 2007, PERMAFROST PERIGLAC, V18, P201, DOI 10.1002/ppp.581; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Taubert F, 2018, NATURE, V554, P519, DOI 10.1038/nature25508; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Wang J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044012; Yamazaki D, 2019, WATER RESOUR RES, V55, P5053, DOI [10.1029/2019wr024873, 10.1029/2019WR024873]; Zemp M, 2020, NATURE, V577, pE9, DOI 10.1038/s41586-019-1889-5; Zhao G, 2019, REMOTE SENS ENVIRON, V226, P109, DOI 10.1016/j.rse.2019.03.015; Zhou T, 2016, J HYDROMETEOROL, V17, P309, DOI 10.1175/JHM-D-15-0002.1	46	75	78	70	241	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					78	+		10.1038/s41586-021-03262-3	http://dx.doi.org/10.1038/s41586-021-03262-3			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33658697				2022-12-28	WOS:000626921700013
J	Ma, SH; Wu, ZM; Yang, F; Zhang, JM; Johnson, RL; Rosenfeld, MG; Guan, KL				Ma, Shenghong; Wu, Zhengming; Yang, Feng; Zhang, Jianmin; Johnson, Randy L.; Rosenfeld, Michael G.; Guan, Kun-Liang			Hippo signalling maintains ER expression and ER+ breast cancer growth	NATURE			English	Letter							SIZE-CONTROL; PATHWAY; WNT		[Ma, Shenghong; Wu, Zhengming; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Ma, Shenghong; Wu, Zhengming; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Yang, Feng; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Zhang, Jianmin] Roswell Pk Canc Inst, Dept Canc Genet & Genom, Buffalo, NY USA; [Johnson, Randy L.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022	Rosenfeld, Michael/0000-0002-1572-156X; Zhang, Jianmin/0000-0001-7844-6254	National Cancer Institute [CA207504]; National Institutes of Health [R01CA217642, GM51586]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the laboratory of K.-L.G. for discussions. This work was supported by National Cancer Institute grant CA207504 (to J.Z.) and National Institutes of Health grants R01CA217642 and GM51586 (to K.-L.G.).	Britschgi A, 2017, NATURE, V541, P541, DOI 10.1038/nature20829; Cheung P, 2020, CELL STEM CELL, V27, P590, DOI 10.1016/j.stem.2020.07.003; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Jarde T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13207; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; Li Q, 2020, CELL STEM CELL, V26, P675, DOI 10.1016/j.stem.2020.03.002; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Turco MY, 2017, NAT CELL BIOL, V19, P568, DOI 10.1038/ncb3516; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003	14	15	15	11	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					E1	E10		10.1038/s41586-020-03131-5	http://dx.doi.org/10.1038/s41586-020-03131-5			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33658690	Green Accepted			2022-12-28	WOS:000626921700001
J	Creech, CB; Walker, SC; Samuels, RJ				Creech, C. Buddy; Walker, Shannon C.; Samuels, Robert J.			SARS-CoV-2 Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Creech, C. Buddy; Walker, Shannon C.; Samuels, Robert J.] Vanderbilt Univ, Sch Med, Dept Pediat, Vanderbilt Vaccine Res Program, Nashville, TN 37212 USA	Vanderbilt University	Creech, CB (corresponding author), Vanderbilt Univ, Sch Med, Div Infect Dis, D-7235 MCN, Nashville, TN 37232 USA.	buddy.creech@vanderbilt.edu		Walker, Shannon/0000-0003-4390-3931				Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	6	184	188	9	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2021	325	13					1318	1320		10.1001/jama.2021.3199	http://dx.doi.org/10.1001/jama.2021.3199		FEB 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK4TM	33635317	Bronze			2022-12-28	WOS:000621913000002
J	Hua, MT; Wu, SW; Ma, YF; Zhao, YS; Chen, ZL; Frenkel, I; Strzalka, J; Zhou, H; Zhu, XY; He, XM				Hua, Mutian; Wu, Shuwang; Ma, Yanfei; Zhao, Yusen; Chen, Zilin; Frenkel, Imri; Strzalka, Joseph; Zhou, Hua; Zhu, Xinyuan; He, Ximin			Strong tough hydrogels via the synergy of freeze-casting and salting out	NATURE			English	Article							STRENGTH; DESIGN	Natural load-bearing materials such as tendons have a high water content of about 70 per cent but are still strong and tough, even when used for over one million cycles per year, owing to the hierarchical assembly of anisotropic structures across multiple length scales(1). Synthetic hydrogels have been created using methods such as electro-spinning(2), extrusion(3), compositing(4,5), freeze-casting(6,7), self-assembly(8) and mechanical stretching(9,10) for improved mechanical performance. However, in contrast to tendons, many hydrogels with the same high water content do not show high strength, toughness or fatigue resistance. Here we present a strategy to produce a multi-length-scale hierarchical hydrogel architecture using a freezing-assisted salting-out treatment. The produced poly(vinyl alcohol) hydrogels are highly anisotropic, comprising micrometre-scale honeycomb-like pore walls, which in turn comprise interconnected nanofibril meshes. These hydrogels have a water content of 70-95 per cent and properties that compare favourably to those of other tough hydrogels and even natural tendons; for example, an ultimate stress of 23.5 +/- 2.7 megapascals, strain levels of 2,900 +/- 450 per cent, toughness of 210 +/- 13 megajoules per cubic metre, fracture energy of 170 +/- 8 kilojoules per square metre and a fatigue threshold of 10.5 +/- 1.3 kilojoules per square metre. The presented strategy is generalizable to other polymers, and could expand the applicability of structural hydrogels to conditions involving more demanding mechanical loading. A strategy that combines freeze-casting and salting-out treatments produces strong, tough, stretchable and fatigue-resistant poly(vinyl alcohol) hydrogels.	[Hua, Mutian; Wu, Shuwang; Ma, Yanfei; Zhao, Yusen; Chen, Zilin; Frenkel, Imri; He, Ximin] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA; [Wu, Shuwang; Zhu, Xinyuan] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, State Key Lab Met Matrix Composites, Shanghai, Peoples R China; [Strzalka, Joseph; Zhou, Hua] Argonne Natl Lab, Xray Sci Div, Lemont, IL USA	University of California System; University of California Los Angeles; Shanghai Jiao Tong University; United States Department of Energy (DOE); Argonne National Laboratory	He, XM (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA.	ximinhe@ucla.edu	Ma, Yanfei/F-4583-2019; Zhou, Hua/V-1827-2017; Hua, Mutian/AAE-9309-2022; He, Ximin/D-3533-2017	Ma, Yanfei/0000-0001-5896-9461; Zhou, Hua/0000-0001-9642-8674; Strzalka, Joseph/0000-0003-4619-8932; Hua, Mutian/0000-0002-4079-316X; He, Ximin/0000-0001-8845-4637				Bai R, 2019, MACROMOL RAPID COMM, V40, DOI 10.1002/marc.201800883; Ebrahimi D, 2015, ACS BIOMATER SCI ENG, V1, P864, DOI 10.1021/acsbiomaterials.5b00152; Fan HL, 2020, MACROMOLECULES, V53, P2769, DOI 10.1021/acs.macromol.0c00238; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Gu L, 2019, ADV MATER, V31, DOI 10.1002/adma.201904311; He QY, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201705069; Hong SM, 2015, ADV MATER, V27, P4035, DOI [10.1002/adma.201501099, 10.1002/adma.201570182]; Hu XB, 2015, ADV MATER, V27, P6899, DOI 10.1002/adma.201503724; Huang YW, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201605350; Illeperuma WRK, 2014, EXTREME MECH LETT, V1, P90, DOI 10.1016/j.eml.2014.11.001; Iwaseya M, 2005, J MATER SCI, V40, P5695, DOI 10.1007/s10853-005-1429-6; Jiang Z, 2015, J APPL CRYSTALLOGR, V48, P917, DOI 10.1107/S1600576715004434; Johnston ID, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/3/035017; King DR, 2019, ACS APPL MATER INTER, V11, P35343, DOI 10.1021/acsami.9b12935; Kinloch A. J., 1984, FRACTURE BEHAV POLYM; LAKE GJ, 1967, PROC R SOC LON SER-A, V300, P108, DOI 10.1098/rspa.1967.0160; Lin P, 2015, ADV MATER, V27, P2054, DOI 10.1002/adma.201405022; Lin ST, 2019, P NATL ACAD SCI USA, V116, P10244, DOI 10.1073/pnas.1903019116; Lin ST, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8528; Lin ST, 2014, SOFT MATTER, V10, P7519, DOI 10.1039/c4sm01039f; Long R, 2016, SOFT MATTER, V12, P8069, DOI 10.1039/c6sm01694d; Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x; Mredha MTI, 2019, MATER HORIZ, V6, P1504, DOI 10.1039/c9mh00320g; Mredha MTI, 2018, ADV MATER, V30, DOI 10.1002/adma.201704937; PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604; Qin HL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10243-8; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; vandeWitte P, 1996, J MEMBRANE SCI, V117, P1, DOI 10.1016/0376-7388(96)00088-9; Wang ZJ, 2019, P NATL ACAD SCI USA, V116, P5967, DOI 10.1073/pnas.1821420116; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; WOOD LA, 1978, RUBBER CHEM TECHNOL, V51, P840, DOI 10.5254/1.3535767; Xiang CP, 2020, MATER TODAY, V34, P7, DOI 10.1016/j.mattod.2019.08.009; Zhang H, 2018, ICE TEMPLATING AND FREEZE-DRYING FOR POROUS MATERIALS AND THEIR APPLICATIONS, P1; Zhang HF, 2005, NAT MATER, V4, P787, DOI 10.1038/nmat1487; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhao XH, 2014, SOFT MATTER, V10, P672, DOI 10.1039/c3sm52272e	36	245	247	306	1219	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03212-z	http://dx.doi.org/10.1038/s41586-021-03212-z			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627812	Green Submitted			2022-12-28	WOS:000621583600011
J	Weimer, MB; Wakeman, SE; Saitz, R				Weimer, Melissa B.; Wakeman, Sarah E.; Saitz, Richard			Removing One Barrier to Opioid Use Disorder Treatment Is It Enough?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weimer, Melissa B.] Yale Sch Med, Dept Med, Program Addict Med, New Haven, CT USA; [Wakeman, Sarah E.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Saitz, Richard] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA USA; [Saitz, Richard] Boston Univ, Sect Gen Internal Med, Clin Addict Res & Educ Unit, Grayken Ctr Addict,Boston Med Ctr,Sch Med, Boston, MA 02118 USA	Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Boston Medical Center; Boston University	Weimer, MB (corresponding author), Yale Sch Med, 367 Cedar St,Harkness Hall A,Ste 417A, New Haven, CT 06510 USA.	Melissa.weimer@yale.edu		Weimer, Melissa/0000-0002-5624-2434				Ahmad FB., 2021, NATL HLTH STAT REPOR; Department of Health and Human Services, ANN PRACT GUID ADM B; Fatseas M, 2007, Curr Psychiatry Rep, V9, P358, DOI 10.1007/s11920-007-0046-2; Haffajee RL, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6373; Lin LK, 2019, J GEN INTERN MED, V34, P2313, DOI 10.1007/s11606-019-05165-6; Sigmon SC, 2016, NEW ENGL J MED, V375, P2504, DOI 10.1056/NEJMc1610047; Substance Abuse and Mental Health Services Administration, 2019, 2019 NAT SURV DRUG U	7	11	11	2	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2021	325	12					1147	1148		10.1001/jama.2021.0958	http://dx.doi.org/10.1001/jama.2021.0958		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7PB	33630020				2022-12-28	WOS:000621911900003
J	Shen, B; Tasdogan, A; Ubellacker, JM; Zhang, JZ; Nosyreva, ED; Du, LM; Murphy, MM; Hu, SQ; Yi, YT; Kara, N; Liu, X; Guela, S; Jia, YM; Ramesh, V; Embree, C; Mitchell, EC; Zhao, YDC; Ju, LAN; Hu, Z; Crane, GM; Zhao, ZY; Syeda, R; Morrison, SJ				Shen, Bo; Tasdogan, Alpaslan; Ubellacker, Jessalyn M.; Zhang, Jingzhu; Nosyreva, Elena D.; Du, Liming; Murphy, Malea M.; Hu, Shuiqing; Yi, Yating; Kara, Nergis; Liu, Xin; Guela, Shay; Jia, Yuemeng; Ramesh, Vijayashree; Embree, Claire; Mitchell, Evann C.; Zhao, Yunduo C.; Ju, Lining A.; Hu, Zhao; Crane, Genevieve M.; Zhao, Zhiyu; Syeda, Ruhma; Morrison, Sean J.			A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis	NATURE			English	Article								Stromal cells in adult bone marrow that express leptin receptor (LEPR) are a critical source of growth factors, including stem cell factor (SCF), for the maintenance of haematopoietic stem cells and early restricted progenitors(1-6). LEPR+ cells are heterogeneous, including skeletal stem cells and osteogenic and adipogenic progenitors(7-12), although few markers have been available to distinguish these subsets or to compare their functions. Here we show that expression of an osteogenic growth factor, osteolectin(13,14), distinguishes peri-arteriolar LEPR+ cells poised to undergo osteogenesis from peri-sinusoidal LEPR+ cells poised to undergo adipogenesis (but retaining osteogenic potential). Peri-arteriolar LEPR(+)osteolectin(+) cells are rapidly dividing, short-lived osteogenic progenitors that increase in number after fracture and are depleted during ageing. Deletion of Scf from adult osteolectin(+) cells did not affect the maintenance of haematopoietic stem cells or most restricted progenitors but depleted common lymphoid progenitors, impairing lymphopoiesis, bacterial clearance, and survival after acute bacterial infection. Peri-arteriolar osteolectin(+) cell maintenance required mechanical stimulation. Voluntary running increased, whereas hindlimb unloading decreased, the frequencies of peri-arteriolar osteolectin(+) cells and common lymphoid progenitors. Deletion of the mechanosensitive ion channel PIEZO1 from osteolectin(+) cells depleted osteolectin(+) cells and common lymphoid progenitors. These results show that a peri-arteriolar niche for osteogenesis and lymphopoiesis in bone marrow is maintained by mechanical stimulation and depleted during ageing.	[Shen, Bo; Tasdogan, Alpaslan; Ubellacker, Jessalyn M.; Zhang, Jingzhu; Du, Liming; Murphy, Malea M.; Kara, Nergis; Liu, Xin; Guela, Shay; Jia, Yuemeng; Ramesh, Vijayashree; Embree, Claire; Mitchell, Evann C.; Zhao, Zhiyu; Morrison, Sean J.] Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA; [Shen, Bo; Tasdogan, Alpaslan; Ubellacker, Jessalyn M.; Zhang, Jingzhu; Du, Liming; Murphy, Malea M.; Kara, Nergis; Liu, Xin; Guela, Shay; Jia, Yuemeng; Ramesh, Vijayashree; Embree, Claire; Mitchell, Evann C.; Zhao, Zhiyu; Morrison, Sean J.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Nosyreva, Elena D.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hu, Shuiqing; Syeda, Ruhma] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yi, Yating] Texas A&M Univ, Sch Dent, Dept Restorat Sci, Dallas, TX USA; [Zhao, Yunduo C.; Ju, Lining A.; Hu, Zhao] Univ Sydney, Heart Res Inst, Sch Biomed Engn, Darlington, NSW, Australia; [Zhao, Yunduo C.; Ju, Lining A.; Hu, Zhao] Univ Sydney, Charles Perkins Ctr, Darlington, NSW, Australia; [Crane, Genevieve M.] Cleveland Clin, Robert J Tomsich Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Morrison, Sean J.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas A&M University System; University of Sydney; Heart Research Institute; University of Sydney; Cleveland Clinic Foundation; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Morrison, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Childrens Res Inst, Dallas, TX 75390 USA.; Morrison, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.; Morrison, SJ (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	Sean.Morrison@UTSouthwestern.edu	Morrison, Sean/ABD-5326-2021; Jia, Yuemeng/AAQ-9853-2021; Zhang, Jingzhu/ABA-9690-2020; Shen, Bo/G-2012-2014	Hu, Zhao/0000-0002-2961-0086; Shen, Bo/0000-0002-5237-6144; Ju, Lining Arnold/0000-0002-7591-0864; Zhao, Yunduo/0000-0002-1802-2318; Murphy, Malea/0000-0001-7071-6862	National Institutes of Health [DK118745]; Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship from the National Heart, Lung, and Blood Institute [F32 HL139016-01]; Leopoldina Fellowship Program of the German National Academy of Sciences [LPDS 2016-16]; Fritz Thyssen Foundation; ARC [DP200101970, DE190100609]; UT Southwestern Medical Center Endowed Scholar Program; Welch Foundation [I-1965-20180324]; American Heart Association [17SDG33410184]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship from the National Heart, Lung, and Blood Institute; Leopoldina Fellowship Program of the German National Academy of Sciences; Fritz Thyssen Foundation; ARC(Australian Research Council); UT Southwestern Medical Center Endowed Scholar Program; Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association)	S.J.M. is a Howard Hughes Medical Institute (HHMI) Investigator, the Mary McDermott Cook Chair in Pediatric Genetics, the Kathryn and Gene Bishop Distinguished Chair in Pediatric Research, the director of the Hamon Laboratory for Stem Cells and Cancer, and a Cancer Prevention and Research Institute of Texas Scholar. This work was supported partly by the National Institutes of Health (DK118745 to S.J.M.). B.S. was supported by a Ruth L. Kirschstein National Research Service Award Postdoctoral Fellowship from the National Heart, Lung, and Blood Institute (F32 HL139016-01). A.T. was supported by the Leopoldina Fellowship Program (LPDS 2016-16) of the German National Academy of Sciences and the Fritz Thyssen Foundation. L.A.J. was supported by ARC Discovery grants (DP200101970, DE190100609). R.S. was supported by the UT Southwestern Medical Center Endowed Scholar Program, Welch Foundation Award (I-1965-20180324) and an American Heart Association scientist development grant (17SDG33410184). We thank H. Zeng and H. Taniguchi for providing the Ai47 mice; N. Loof, T. Shih and the Moody Foundation Flow Cytometry Facility; and the BioHPC high-performance computing cloud at University of Texas Southwestern Medical Center for providing computational resources.	Acar M, 2015, NATURE, V526, P126, DOI 10.1038/nature15250; Baccin C, 2020, NAT CELL BIOL, V22, P38, DOI 10.1038/s41556-019-0439-6; Baryawno N, 2019, CELL, V177, P1915, DOI 10.1016/j.cell.2019.04.040; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; Boron W, 2009, MED PHYSL; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Christodoulou C, 2020, NATURE, V578, P278, DOI 10.1038/s41586-020-1971-z; Comazzetto S, 2019, CELL STEM CELL, V24, P477, DOI 10.1016/j.stem.2018.11.022; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Gruneboom A, 2019, NAT METAB, V1, P236, DOI 10.1038/s42255-018-0016-5; Himburg HA, 2018, CELL STEM CELL, V23, P370, DOI 10.1016/j.stem.2018.07.003; Iwaniec UT, 2016, J ENDOCRINOL, V230, pR115, DOI 10.1530/JOE-16-0089; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kayraklioglu N, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00742-19; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; LADEL CH, 1994, J IMMUNOL, V153, P3116; Li XH, 2019, ELIFE, V8, DOI 10.7554/eLife.49631; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matsushita Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14029-w; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sacma M, 2019, NAT CELL BIOL, V21, P1309, DOI 10.1038/s41556-019-0418-y; Shen B, 2019, ELIFE, V8, DOI 10.7554/eLife.42274; Sivaraj KK, 2016, DEVELOPMENT, V143, P2706, DOI 10.1242/dev.136861; Sun WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47454; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang LJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14146-6; Young K, 2016, J EXP MED, V213, P2259, DOI 10.1084/jem.20160168; Yue R, 2016, ELIFE, V5, DOI 10.7554/eLife.18782; Zhou BO, 2017, NAT CELL BIOL, V19, P891, DOI 10.1038/ncb3570; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	50	76	81	15	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					438	+		10.1038/s41586-021-03298-5	http://dx.doi.org/10.1038/s41586-021-03298-5		FEB 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33627868	Green Accepted			2022-12-28	WOS:000621335600003
J	Thacker, PD				Thacker, Paul D.			Tracking down John Bell: how the case of the Oxford professor exposes a transparency crisis in government	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												thackerpd@gmail.com						Amin L., 2020, OPENDEMOCRACY; [Anonymous], 2011, ANN REPORT; Ennals E., 2020, DAILY MAIL; Geoghegan P, 2020, OPENDEMOCRACY; Godlee F, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7305; THACKER PD, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4716; Thompson MJ, 2012, BMJ; Vallance P, 2005, LANCET, V366, P1062, DOI 10.1016/S0140-6736(05)66835-3	8	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n490	10.1136/bmj.n490	http://dx.doi.org/10.1136/bmj.n490			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33622805	Bronze			2022-12-28	WOS:000623404800002
J	Looi, MK				Looi, Mun-Keat			Jeremy Farrar: Make vaccine available to other countries as soon as our most vulnerable people have received it	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												mlooi@bmj.com							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n459	10.1136/bmj.n459	http://dx.doi.org/10.1136/bmj.n459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608412	Bronze			2022-12-28	WOS:000621237300005
J	Wengert, E				Wengert, Eric			Mentor as you'd want to be mentored	SCIENCE			English	Editorial Material									[Wengert, Eric] Univ Virginia, Charlottesville, VA 22903 USA	University of Virginia	Wengert, E (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.			Wengert, Eric/0000-0001-7679-4183					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					858	+		10.1126/science.371.6531.858	http://dx.doi.org/10.1126/science.371.6531.858			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602857				2022-12-28	WOS:000619664700058
J	Starbird, C				Starbird, Chrystal			Transforming myself and academia for good	CELL			English	Editorial Material								Dr. Chrystal Starbird is the winner of the first Rising Black Scientist Award for a postgraduate scholar. For this award, we asked emerging Black scientists to tell us about the experiences that sparked their journey in the life sciences. This is her story.	[Starbird, Chrystal] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Starbird, C (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.	chrystal.starbird@yale.edu							0	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					851	853		10.1016/j.cell.2021.01.032	http://dx.doi.org/10.1016/j.cell.2021.01.032		FEB 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606982	Bronze			2022-12-28	WOS:000629633400002
J	Saad-Roy, CM; Morris, SE; Metcalf, CJE; Mina, MJ; Baker, RE; Farrar, J; Holmes, EC; Pybus, OG; Graham, AL; Levin, SA; Grenfell, BT; Wagner, CE				Saad-Roy, Chadi M.; Morris, Sinead E.; Metcalf, C. Jessica E.; Mina, Michael J.; Baker, Rachel E.; Farrar, Jeremy; Holmes, Edward C.; Pybus, Oliver G.; Graham, Andrea L.; Levin, Simon A.; Grenfell, Bryan T.; Wagner, Caroline E.			Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes	SCIENCE			English	Article							DYNAMICS; HETEROGENEITY; MODELS	Given vaccine dose shortages and logistical challenges, various deployment strategies are being proposed to increase population immunity levels to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Two critical issues arise: How timing of delivery of the second dose will affect infection dynamics and how it will affect prospects for the evolution of viral immune escape via a buildup of partially immune individuals. Both hinge on the robustness of the immune response elicited by a single dose as compared with natural and two-dose immunity. Building on an existing immuno-epidemiological model, we find that in the short term, focusing on one dose generally decreases infections, but that longer-term outcomes depend on this relative immune robustness. We then explore three scenarios of selection and find that a one-dose policy may increase the potential for antigenic evolution under certain conditions of partial population immunity. We highlight the critical need to test viral loads and quantify immune responses after one vaccine dose and to ramp up vaccination efforts globally.	[Saad-Roy, Chadi M.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA; [Morris, Sinead E.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA; [Metcalf, C. Jessica E.; Baker, Rachel E.; Graham, Andrea L.; Levin, Simon A.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Metcalf, C. Jessica E.; Grenfell, Bryan T.] Princeton Univ, Princeton Sch Publ & Int Affairs, Princeton, NJ 08540 USA; [Mina, Michael J.] Harvard Sch Publ Hlth, Dept Epidemiol & Immunol, Boston, MA 02115 USA; [Baker, Rachel E.] Princeton Univ, High Meadows Environm Inst, Princeton, NJ 08544 USA; [Farrar, Jeremy] Wellcome Trust Res Labs, London NW1 2BE, England; [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England; [Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Wagner, Caroline E.] McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada	Princeton University; Columbia University; Princeton University; Princeton University; Harvard University; Harvard T.H. Chan School of Public Health; Princeton University; University of Sydney; University of Sydney; University of Oxford; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); McGill University	Saad-Roy, CM (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA.; Grenfell, BT (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA.; Grenfell, BT (corresponding author), Princeton Univ, Princeton Sch Publ & Int Affairs, Princeton, NJ 08540 USA.; Grenfell, BT (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.; Wagner, CE (corresponding author), McGill Univ, Dept Bioengn, Montreal, PQ H3A 0C3, Canada.	csaadroy@princeton.edu; grenfell@princeton.edu; carollne.wagner@mcgill.ca	Holmes, Edward/GVR-9499-2022; Pybus, Oliver G/B-2640-2012; Graham, Andrea/GON-8450-2022	Pybus, Oliver G/0000-0002-8797-2667; 	Open Philanthropy; Natural Sciences and Engineering Research Council of Canada; Cooperative Institute for Modeling the Earth System (CIMES); James S. McDonnell Foundation 21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multiscale Systems; C3.ai Digital Transformation Institute and Microsoft Corporation; Google, LLC; National Science Foundation [CNS-2027908, CCF1917819]; U.S. CDC; Flu Lab	Open Philanthropy; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cooperative Institute for Modeling the Earth System (CIMES); James S. McDonnell Foundation 21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multiscale Systems; C3.ai Digital Transformation Institute and Microsoft Corporation(Microsoft); Google, LLC(Google Incorporated); National Science Foundation(National Science Foundation (NSF)); U.S. CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Flu Lab	This work was funded in part by Open Philanthropy; the Natural Sciences and Engineering Research Council of Canada through a post-graduate doctoral scholarship (C.M.S.-R.); the Cooperative Institute for Modeling the Earth System (CIMES) (R.E.B.); the James S. McDonnell Foundation 21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multiscale Systems (C.M.S.-R., S.A.L.); the C3.ai Digital Transformation Institute and Microsoft Corporation (S.A.L.); a gift from Google, LLC (S.A.L.); the National Science Foundation (CNS-2027908, CCF1917819) (S.A.L.); the U.S. CDC (B.T.G.); and Flu Lab (B.T.G.).	Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; [Anonymous], 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMclde2101987; [Anonymous], 2021, CBC NEWS; [Anonymous], 2020, COMMUN DIS INTELL, V44, DOI [10.33321/ cdi.2020.44.92, DOI 10.33321/CDI.2020.44.92]; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203; Baker RE, 2020, SCIENCE, V369, P315, DOI 10.1126/science.abc2535; Baker RE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13562-y; Baraniuk C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n421; Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009; Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810; Burki T, 2021, LANCET INFECT DIS, V21, P33, DOI 10.1016/S1473-3099(20)30949-X; Buss LF, 2021, SCIENCE, V371, P288, DOI 10.1126/science.abe9728; Chodick G., 2021, EFFECTIVENESS 1 DOSE, DOI [10.1101/2021.01.27.21250612, DOI 10.1101/2021.01.27.21250612, 10.1101/2021.01.27.21250612v1]; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Eguia R., 2020, HUMAN CORONAVIRUS EV, DOI 10.1101/2020.12.17.423313; Emanuel EJ, 2020, SCIENCE, V369, P1309, DOI 10.1126/science.abe2803; Faria N., 2021, GENOMIC CHARACTERISA, DOI 10.1093/cid/ciaa1864; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Gog JR, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.210530; Gravagnuolo AM, 2021, MEDRXIV2021011421249, DOI [10.1101/2021.01.14.21249386, DOI 10.1101/2021.01.14.21249386, 10.1101/2021.02.05.430003, DOI 10.1101/2021.02.05.430003]; Grenfell B.T., 2021, J R SOC INTERFACE, V18, DOI [10.1098/ rsif.2020.0683; pmid: 33530857, DOI 10.1098/RSIF.2020.0683, 10.1098/rsif.2020.0683]; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; HADLER SC, 1989, VACCINE, V7, P106, DOI 10.1016/0264-410X(89)90046-7; Iacobucci Gareth, 2021, BMJ, V372, pn18, DOI 10.1136/bmj.n18; Jarvis, 2020, MEDRXIV, DOI [10.1126/science.abg3055, 10.1101/2020.12.24.20248822]; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lavine JS, 2021, SCIENCE, V371, P741, DOI 10.1126/science.abe6522; Laxminarayan R, 2020, SCIENCE, V370, P691, DOI 10.1126/science.abd7672; Letizia AG, 2020, NEW ENGL J MED, V383, P2407, DOI 10.1056/NEJMoa2029717; Lumley SF, 2021, NEW ENGL J MED, V384, P533, DOI 10.1056/NEJMoa2034545; Madhi S.A., 2021, JACC-BASIC TRANSL SC, DOI [10.1101/2021.02.10.21251247, DOI 10.1016/J.JACBTS.2020.10.003]; MAY RM, 1984, MATH BIOSCI, V72, P83, DOI 10.1016/0025-5564(84)90063-4; McGill COVID19 Vaccine Tracker Team, COVID19 VACC TRACK; Metcalf C.J.E., 2020, MEDRXIV2020120120241, DOI [10.1101/2020.12.01.20241836, DOI 10.1101/2020.12.01.20241836]; Morris DH, 2020, ELIFE, V9, DOI 10.7554/eLife.62105; Morris SE, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1245; Pepin KM, 2010, J THEOR BIOL, V265, P501, DOI 10.1016/j.jtbi.2010.05.036; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rabson M, 2021, CTV NEWS; Saad-Roy CM, 2020, SCIENCE, V370, P811, DOI 10.1126/science.abd7343; Saad-Roy CM, 2019, J INFECT DIS, V219, pS46, DOI 10.1093/infdis/jiz044; Saad-Roy CM, 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4556111, DOI 10.5281/ZENODO.4556111]; Su Y., 2020, CLIN INFECT DIS, V71, P2027, DOI [DOI 10.1093/cid/ciaa344, 10.1093/cid/ciaa344]; Summers J, 2020, LANCET REG HEALTH-W, V4, DOI 10.1016/j.lanwpc.2020.100044; Sun KY, 2021, SCIENCE, V371, P254, DOI 10.1126/science.abe2424; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; TULJAPURKAR S, 1991, SCIENCE, V254, P591, DOI 10.1126/science.254.5031.591; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Volz EM, 2009, GENETICS, V183, P1421, DOI 10.1534/genetics.109.106021; Voysey M, 2021, 3777268 SSRN; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wagner CE, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.614113; Zahradnik J., 2021, BIORXIV, DOI [10.1101/2021.01.06.425392, DOI 10.1101/2021.01.06.425392]; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9	61	73	74	5	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					363	370		10.1126/science.abg8663	http://dx.doi.org/10.1126/science.abg8663			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33688062	Green Published, Green Submitted			2022-12-28	WOS:000645009800035
J	Baranello, G; Darras, BT; Day, JW; Deconinck, N; Klein, A; Masson, R; Mercuri, E; Rose, K; El-Khairi, M; Gerber, M; Gorni, K; Khwaja, O; Kletzl, H; Scalco, RS; Seabrook, T; Fontoura, P; Servais, L				Baranello, Giovanni; Darras, Basil T.; Day, John W.; Deconinck, Nicolas; Klein, Andrea; Masson, Riccardo; Mercuri, Eugenio; Rose, Kristy; El-Khairi, Muna; Gerber, Marianne; Gorni, Ksenija; Khwaja, Omar; Kletzl, Heidemarie; Scalco, Renata S.; Seabrook, Timothy; Fontoura, Paulo; Servais, Laurent			Risdiplam in Type 1 Spinal Muscular Atrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SHAM CONTROL; NUSINERSEN; SURVIVAL	BackgroundType 1 spinal muscular atrophy is a rare, progressive neuromuscular disease that is caused by low levels of functional survival of motor neuron (SMN) protein. Risdiplam is an orally administered, small molecule that modifies SMN2 pre-messenger RNA splicing and increases levels of functional SMN protein. MethodsWe report the results of part 1 of a two-part, phase 2-3, open-label study of risdiplam in infants 1 to 7 months of age who had type 1 spinal muscular atrophy, which is characterized by the infant not attaining the ability to sit without support. Primary outcomes were safety, pharmacokinetics, pharmacodynamics (including the blood SMN protein concentration), and the selection of the risdiplam dose for part 2 of the study. Exploratory outcomes included the ability to sit without support for at least 5 seconds. ResultsA total of 21 infants were enrolled. Four infants were in a low-dose cohort and were treated with a final dose at month 12 of 0.08 mg of risdiplam per kilogram of body weight per day, and 17 were in a high-dose cohort and were treated with a final dose at month 12 of 0.2 mg per kilogram per day. The baseline median SMN protein concentrations in blood were 1.31 ng per milliliter in the low-dose cohort and 2.54 ng per milliliter in the high-dose cohort; at 12 months, the median values increased to 3.05 ng per milliliter and 5.66 ng per milliliter, respectively, which represented a median of 3.0 times and 1.9 times the baseline values in the low-dose and high-dose cohorts, respectively. Serious adverse events included pneumonia, respiratory tract infection, and acute respiratory failure. At the time of this publication, 4 infants had died of respiratory complications. Seven infants in the high-dose cohort and no infants in the low-dose cohort were able to sit without support for at least 5 seconds. The higher dose of risdiplam (0.2 mg per kilogram per day) was selected for part 2 of the study. ConclusionsIn infants with type 1 spinal muscular atrophy, treatment with oral risdiplam led to an increased expression of functional SMN protein in the blood. (Funded by F. Hoffmann-La Roche; ClinicalTrials.gov number, NCT02913482.) The small molecule risdiplam increased the expression of SMN protein in blood in 21 infants with type 1 spinal muscular atrophy. Post hoc clinical features of sitting ability and respiratory status were reported.	[Baranello, Giovanni] UCL, Great Ormond St Inst Child Hlth, Great Ormond St Hosp Biomed Res Ctr, Dubowitz Neuromuscular Ctr,Natl Inst Hlth Res, London, England; [Baranello, Giovanni] Great Ormond St Hosp Trust, London, England; [El-Khairi, Muna] Roche Prod, Welwyn Garden City, Herts, England; [Servais, Laurent] Univ Oxford, Dept Paediat, Muscular Dystrophy UK Oxford Neuromuscular Ctr, Oxford, England; [Baranello, Giovanni; Masson, Riccardo] Fdn IRCCS Ist Neurol Carlo Besta, Dev Neurol Unit, Milan, Italy; [Mercuri, Eugenio] Catholic Univ, Pediat Neurol Inst, Rome, Italy; [Mercuri, Eugenio] Fdn Policlin Gemelli IRCCS, Nemo Pediat, Rome, Italy; [Darras, Basil T.] Harvard Med Sch, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Day, John W.] Stanford Univ, Dept Neurol, Palo Alto, CA 94304 USA; [Deconinck, Nicolas] Univ Libre Bruxelles, Queen Fabiola Childrens Univ Hosp, Ctr Reference Malad Neuromusculaires, Brussels, Belgium; [Deconinck, Nicolas] Univ Ziekenhuis Gent, Neuromuscular Reference Ctr, Ghent, Belgium; [Servais, Laurent] Univ Hosp Liege, Div Child Neurol, Dept Pediat, Ctr References Malad Neuromusculaires, Liege, Belgium; [Servais, Laurent] Univ Liege, Liege, Belgium; [Klein, Andrea] Univ Childrens Hosp Basel, Div Pediat Neurol, Basel, Switzerland; [Gerber, Marianne] Pharma Dev Safety, Basel, Switzerland; [Gorni, Ksenija; Fontoura, Paulo] Prod Dev Med Affairs Neurosci & Rare Dis, Basel, Switzerland; [Scalco, Renata S.] Pharma Dev Neurol, Basel, Switzerland; [Khwaja, Omar; Kletzl, Heidemarie; Seabrook, Timothy] F Hoffmann La Roche, Basel, Switzerland; [Khwaja, Omar; Kletzl, Heidemarie; Seabrook, Timothy] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Basel, Switzerland; [Klein, Andrea] Univ Bern, Pediat Neurol, Inselspital, Bern, Switzerland; [Rose, Kristy] Univ Sydney, Fac Med & Hlth, Discipline Physiotherapy, Sydney, NSW, Australia; [Servais, Laurent] Hop Armand Trousseau, Paris, France	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Roche Holding; University of Oxford; IRCCS Istituto Neurologico Besta; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Harvard University; Boston Children's Hospital; Harvard Medical School; Stanford University; Universite Libre de Bruxelles; Ghent University; Ghent University Hospital; University of Liege; University of Liege; University of Basel; Roche Holding; Roche Holding; University of Bern; University of Sydney; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Baranello, G (corresponding author), UCL, Great Ormond St Inst Child Hlth, Great Ormond St Hosp Biomed Res Ctr, Dubowitz Neuromuscular Ctr,Natl Inst Hlth Res, London, England.; Baranello, G (corresponding author), Great Ormond St Hosp Trust, London, England.; Baranello, G (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dev Neurol Unit, Milan, Italy.	g.baranello@ucl.ac.uk	Masson, Riccardo/AAB-8896-2019; Sposetti, Lorenza/ABA-4660-2021; Zanin, Riccardo/AAM-6341-2021; Gorni, Ksenija/HCH-8475-2022; de Oliveira A, Juliana Caires/AAC-9229-2019; Pera, Maria Carmela/J-6068-2018	Masson, Riccardo/0000-0002-9311-452X; Sposetti, Lorenza/0000-0001-9521-6426; Zanin, Riccardo/0000-0002-6200-3632; de Oliveira A, Juliana Caires/0000-0002-9249-2318; Coratti, Giorgia/0000-0001-6666-5628; Duong, Tina/0000-0003-3177-4722; Gugleta, Konstantin/0000-0002-3520-2791; Baranello, Giovanni/0000-0003-4871-6692; Pera, Maria Carmela/0000-0001-6777-1721; D'AMICO, GUGLIELMO/0000-0003-3758-7397; Day, John/0000-0002-0086-9529	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	Supported by F. Hoffmann-La Roche.	Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; [Anonymous], 2020, EVR RISD PRESCR INF; Chiriboga CA, 2016, NEUROLOGY, V86, P890, DOI 10.1212/WNL.0000000000002445; Czech C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139950; De Sanctis R, 2016, NEUROMUSCULAR DISORD, V26, P754, DOI 10.1016/j.nmd.2016.10.002; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Finkel RS, 2014, NEUROLOGY, V83, P810, DOI 10.1212/WNL.0000000000000741; Food and Drug Administration, 2016, SPINR NUS PRESCR INF; Food and Drug Administration, 2019, ZOLG ON AB XIOI PRE; Glanzman AM, 2010, NEUROMUSCULAR DISORD, V20, P155, DOI 10.1016/j.nmd.2009.11.014; Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8; Kolb SJ, 2017, ANN NEUROL, V82, P883, DOI 10.1002/ana.25101; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504; Mercuri E, 2012, LANCET NEUROL, V11, P443, DOI 10.1016/S1474-4422(12)70061-3; Poirier A, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.447; Ratni H, 2018, J MED CHEM, V61, P6501, DOI 10.1021/acs.jmedchem.8b00741; Schroth MK, 2009, PEDIATRICS, V123, pS245, DOI 10.1542/peds.2008-2952K; Singh RN, 2017, BBA-GENE REGUL MECH, V1860, P299, DOI 10.1016/j.bbagrm.2016.12.008; Sivaramakrishnan M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01559-4; Sturm S, 2019, BRIT J CLIN PHARMACO, V85, P181, DOI 10.1111/bcp.13786; Wijngaarde CA, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01367-y; Yeo CJJ, 2020, PEDIATR NEUROL, V109, P12, DOI 10.1016/j.pediatrneurol.2020.01.003	25	107	114	6	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2021	384	10					915	923		10.1056/NEJMoa2009965	http://dx.doi.org/10.1056/NEJMoa2009965			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD5XO	33626251	Bronze, Green Published			2022-12-28	WOS:000687279800011
J	Davies, M; Faerch, L; Jeppesen, OK; Pakseresht, A; Pedersen, SD; Perreault, L; Rosenstock, J; Shimomura, I; Viljoen, A; Wadden, TA; Lingvay, I				Davies, Melanie; Faerch, Louise; Jeppesen, Ole K.; Pakseresht, Arash; Pedersen, Sue D.; Perreault, Leigh; Rosenstock, Julio; Shimomura, Iichiro; Viljoen, Adie; Wadden, Thomas A.; Lingvay, Ildiko		STEP 2 Study Grp	Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, doubleblind, double-dummy, placebo-controlled, phase 3 trial	LANCET			English	Article							WEIGHT-LOSS; CARDIOVASCULAR OUTCOMES; LIRAGLUTIDE; MANAGEMENT; COMBINATION; EFFICACY; RISK	Background This trial assessed the efficacy and safety of the GLP-1 analogue once a week subcutaneous semaglutide 2.4 mg versus semaglutide 1.0 mg (the dose approved for diabetes treatment) and placebo for weight management in adults with overweight or obesity, and type 2 diabetes. Methods This double-blind, double-dummy, phase 3, superiority study enrolled adults with a body-mass index of at least 27 kg/m(2) and glycated haemoglobin 7-10% (53-86 mmol/mol) who had been diagnosed with type 2 diabetes at least 180 days before screening. Patients were recruited from 149 outpatient clinics in 12 countries across Europe, North America, South America, the Middle East, South Africa, and Asia. Patients were randomly allocated (1:1:1) via an interactive web-response system and stratified by background glucose-lowering medication and glycated haemoglobin, to subcutaneous injection of semaglutide 2.4 mg, or semaglutide 1.0 mg, or visually matching placebo, once a week for 68 weeks, plus a lifestyle intervention. Patients, investigators, and those assessing outcomes were masked to group assignment. Coprimary endpoints were percentage change in bodyweight and achievement of weight reduction of at least 5% at 68 weeks for semaglutide 2.4 mg versus placebo, assessed by intention to treat. Safety was assessed in all patients who received at least one dose of study drug. This study is registered with ClinicalTrials.gov, NCT03552757 and is closed to new participants. Findings From June 4 to Nov 14, 2018, 1595 patients were screened, of whom 1210 were randomly assigned to semaglutide 2.4 mg (n=404), semaglutide 1.0 mg (n=403), or placebo (n=403) and included in the intention-to-treat analysis. Estimated change in mean bodyweight from baseline to week 68 was -9.6% (SE 0.4) with semaglutide 2.4 mg vs -3.4% (0.4) with placebo. Estimated treatment difference for semaglutide 2.4 mg versus placebo was -6.2 percentage points (95% CI -7.3 to -5.2; p<0.0001). At week 68, more patients on semaglutide 2.4 mg than on placebo achieved weight reductions of at least 5% (267 [68.8%] of 388 vs 107 [28.5%] of 376; odds ratio 4.88, 95% CI 3.58 to 6.64; p<0.0001). Adverse events were more frequent with semaglutide 2.4 mg (in 353 [87.6%] of 403 patients) and 1.0 mg (329 [81.8%] of 402) than with placebo (309 [76.9%] of 402). Gastrointestinal adverse events, which were mostly mild to moderate, were reported in 256 (63.5%) of 403 patients with semaglutide 2.4 mg, 231 (57.5%) of 402 with semaglutide 1.0 mg, and 138 (34.3%) of 402 with placebo. Interpretation In adults with overweight or obesity, and type 2 diabetes, semaglutide 2.4 mg once a week achieved a superior and clinically meaningful decrease in bodyweight compared with placebo. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Davies, Melanie] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Davies, Melanie] NIHR Leicester Biomed Res Ctr, Leicester, Leics, England; [Faerch, Louise; Jeppesen, Ole K.; Pakseresht, Arash] Novo Nordisk, Soborg, Denmark; [Pedersen, Sue D.] C ENDO Diabet & Endocrinol Clin Calgary, Calgary, AB, Canada; [Perreault, Leigh] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Rosenstock, Julio] Dallas Diabet Res Ctr Med City, Dallas, TX USA; [Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Viljoen, Adie] Lister Hosp, Borthwick Diabet Res Unit, Stevenage, Herts, England; [Wadden, Thomas A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lingvay, Ildiko] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	University of Leicester; University of Colorado System; University of Colorado Anschutz Medical Campus; Diabetes & Endocrine Center; Osaka University; Lister Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lingvay, I (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	ildiko.lingvay@utsouthwestern.edu		Davies, Melanie/0000-0002-9987-9371; Avramidis, Iakovos/0000-0002-9114-5541	Novo Nordisk	Novo Nordisk(Novo Nordisk)	The study was funded by Novo Nordisk. The authors thank the study participants, and the investigators and study site staff who did the study.; The authors also thank Lisa von Huth Smith of Novo Nordisk for support with patient-reported outcomes data presentation and critical review of the manuscript draft, and Paul Barlass of Axis, a division of Spirit Medical Communications Group, for medical writing and editorial assistance (funded by Novo Nordisk).	Ahren B, 2017, LANCET DIABETES ENDO, V5, P341, DOI 10.1016/S2213-8587(17)30092-X; Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS89, DOI 10.2337/dc20-S008; Aroda VR, 2019, DIABETES METAB, V45, P409, DOI 10.1016/j.diabet.2018.12.001; Aroda VR, 2017, LANCET DIABETES ENDO, V5, P355, DOI 10.1016/S2213-8587(17)30085-2; Berne C, 2005, DIABETIC MED, V22, P612, DOI 10.1111/j.1464-5491.2004.01474.x; Bettge K, 2017, DIABETES OBES METAB, V19, P336, DOI 10.1111/dom.12824; Bramante Carolyn T, 2017, Diabetes Spectr, V30, P237, DOI 10.2337/ds17-0030; Buse JB, 2020, DIABETES CARE, V43, P487, DOI 10.2337/dci19-0066; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Davies MJ, 2015, JAMA-J AM MED ASSOC, V314, P687, DOI 10.1001/jama.2015.9676; Food and Agriculture Organization of the UN WHO and UN University, 2004, HUMAN ENERGY REQUIRE; Foster GD, 2009, ARCH INTERN MED, V169, P1619, DOI 10.1001/archinternmed.2009.266; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Gough SCL, 2009, DIABETES METAB SYNDR, V2, P179, DOI 10.2147/DMSO.S7088; Hall KD, 2018, MED CLIN N AM, V102, P183, DOI 10.1016/j.mcna.2017.08.012; Heckman BW, 2015, CURR OPIN PSYCHOL, V5, P31, DOI 10.1016/j.copsyc.2015.03.004; Hollander P, 2013, DIABETES CARE, V36, P4022, DOI 10.2337/dc13-0234; Holst JJ, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.11.10; Houston DK, 2018, J GERONTOL A-BIOL, V73, P1552, DOI 10.1093/gerona/glx204; International Conference on Harmonisation, 2016, **NON-TRADITIONAL**; Kushner RF, 2020, OBESITY, V28, P1050, DOI 10.1002/oby.22794; Little R. J. A., 1987, STAT ANAL MISSING DA; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Nauck MA, 2019, EUR J ENDOCRINOL, V181, pR211, DOI 10.1530/EJE-19-0566; Novo Nordisk, 2020, SAXENDA LIRAGLUTIDE; Novo Nordisk, 2020, HIGHLIGHTS PRESCRIBI; O'Neil PM, 2018, LANCET, V392, P637, DOI 10.1016/S0140-6736(18)31773-2; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Provilus A., 2011, THERAPY, V8, P113; Rigato M, 2014, DIABETES METAB SYNDR, V7, P107, DOI 10.2147/DMSO.S37644; Rodbard HW, 2018, J CLIN ENDOCR METAB, V103, P2291, DOI 10.1210/jc.2018-00070; Ryan DH, 2020, AM HEART J, V229, P61, DOI 10.1016/j.ahj.2020.07.008; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Su W, 2015, J MED ECON, V18, P886, DOI 10.3111/13696998.2015.1058805; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Wharton S, 2021, INT J OBESITY, V45, P923, DOI 10.1038/s41366-020-00733-x; Wilding JPH, 2014, INT J CLIN PRACT, V68, P682, DOI 10.1111/ijcp.12384; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415	39	150	153	12	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2021	397	10278					971	984		10.1016/S0140-6736(21)00213-0	http://dx.doi.org/10.1016/S0140-6736(21)00213-0		MAR 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV2NT	33667417				2022-12-28	WOS:000627814200026
J	Christie, A; Mbaeyi, SA; Walensky, RP				Christie, Athalia; Mbaeyi, Sarah A.; Walensky, Rochelle P.			CDC Interim Recommendations for Fully Vaccinated People An Important First Step	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint summarizes CDC activity recommendations for individuals fully vaccinated against SARS-CoV-2 infection, including resumption of low-risk gatherings among vaccinated people and maintenance of public health measures in activities involving unvaccinated people.	[Christie, Athalia; Mbaeyi, Sarah A.; Walensky, Rochelle P.] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Christie, A (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30333 USA.	akc9@cdc.gov						Centers for Disease Control and Prevention, 2021, SCI BRIEF BACKGR RAT; Centers for Disease Control and Prevention, 2021, INT GUID RET QUAR AD; Centers for Disease Control and Prevention, 2021, PUBL HLTH REC FULL V; Centers for Disease Control and Prevention, INT CLIN CONS US COV; Centers for Disease Control and Prevention, CDC COVID DAT TRACK; Centers for Disease Control and Prevention, US COVID 19 CAS CAUS; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063	7	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1501	1502		10.1001/jama.2021.4367	http://dx.doi.org/10.1001/jama.2021.4367		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33688914	Bronze			2022-12-28	WOS:000627900900001
J	Herrick, SE; Allen, JE				Herrick, Sarah E.; Allen, Judith E.			Surgical adhesions: A sticky macrophage problem Body-cavity macrophages superaggregate in a platelet-like response to wounding	SCIENCE			English	Editorial Material							PERITONEAL ADHESIONS		[Herrick, Sarah E.; Allen, Judith E.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Manchester, Lancs, England	University of Manchester	Herrick, SE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Manchester, Lancs, England.	sarah.herrick@manchester.ac.uk			MRC [MR/S02560X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bain CC, 2018, CELL IMMUNOL, V330, P126, DOI 10.1016/j.cellimm.2018.01.003; Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Foster DS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17883-1; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Namvar S, 2018, J PATHOL, V245, P491, DOI 10.1002/path.5101; Okabayashi K, 2014, SURG TODAY, V44, P405, DOI 10.1007/s00595-013-0591-8; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; RYAN GB, 1971, AM J PATHOL, V65, P117; Sandoval P, 2016, J PATHOL, V239, P48, DOI 10.1002/path.4695; Tang JY, 2020, ACTA BIOMATER, V116, P84, DOI 10.1016/j.actbio.2020.08.036; Tsai JM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan6735; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024; Zindel J., 2021, SCIENCE, V371	15	3	3	4	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					993	994		10.1126/science.abg5416	http://dx.doi.org/10.1126/science.abg5416			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674481				2022-12-28	WOS:000625876100034
J	Desai, P; Janova, H; White, JP; Reynoso, GV; Hickman, HD; Baldridge, MT; Jr, JFU; Stappenbeck, TS; Thackray, LB; Diamond, MS				Desai, Pritesh; Janova, Hana; White, James P.; Reynoso, Glennys, V; Hickman, Heather D.; Baldridge, Megan T.; Jr, Joseph F. Urban; Stappenbeck, Thaddeus S.; Thackray, Larissa B.; Diamond, Michael S.			Enteric helminth coinfection enhances host susceptibility to neurotropic flaviviruses via a tuft cell-IL-4 receptor signaling axis	CELL			English	Article							WEST-NILE-VIRUS; INNATE LYMPHOID-CELLS; TYPE-2 IMMUNITY; DISEASE SEVERITY; MOUSE MODEL; T-CELLS; INFECTION; MICE; STAT6; DIFFERENTIATION	Although enteric helminth infections modulate immunity to mucosal pathogens, their effects on systemic microbes remain less established. Here, we observe increased mortality in mice coinfected with the enteric helminth Heligmosomoides polygyrus bakeri (Hpb) and West Nile virus (WNV). This enhanced susceptibility is associated with altered gut morphology and transit, translocation of commensal bacteria, impaired WNV-specific T cell responses, and increased virus infection in the gastrointestinal tract and central nervous system. These outcomes were due to type 2 immune skewing, because coinfection in Stat6(-/-) mice rescues mortality, treatment of helminth-free WNV-infected mice with interleukin (IL)-4 mirrors coinfection, and IL-4 receptor signaling in intestinal epithelial cells mediates the susceptibility phenotypes. Moreover, tuft cell-deficient mice show improved outcomes with coinfection, whereas treatment of helminth-free mice with tuft cell-derived cytokine IL-25 or ligand succinate worsens WNV disease. Thus, helminth activation of tuft cell-IL-4-receptor circuits in the gut exacerbates infection and disease of a neurotropic flavivirus.	[Desai, Pritesh; White, James P.; Baldridge, Megan T.; Thackray, Larissa B.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Janova, Hana; Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Reynoso, Glennys, V; Hickman, Heather D.] NIID, Viral Immun & Pathogenesis Unit, Lab Clin Microbiol & Immunol, NIH, Bethesda, MD 20892 USA; [Baldridge, Megan T.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Jr, Joseph F. Urban] ARS, USDA, Beltsville Human Nutr Res Ctr, Diet Genom & Immunol Lab, Beltsville, MD 20705 USA; [Jr, Joseph F. Urban] USDA ARS, Anim Parasit Dis Lab, Beltsville, MD 20705 USA; [Stappenbeck, Thaddeus S.] Cleveland Clin, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; Washington University (WUSTL); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Cleveland Clinic Foundation; Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	diamond@wusm.wustl.edu	Baldridge, Megan/T-7274-2019	Baldridge, Megan/0000-0002-7030-6131; Urban, Joseph/0000-0002-1590-8869; Desai, Pritesh/0000-0002-4697-9475	NIH [R01 AI101400, R01 HD091218, R01AI145296, R01 DK122790]; ARS-CRIS [8042-31000-107-00D]; NIAID Division of Intramural Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARS-CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NIAID Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH (R01 AI101400, R01 HD091218, R01AI145296, and R01 DK122790) and ARS-CRIS (8042-31000-107-00D). H.D.H. is supported by the NIAID Division of Intramural Research. We would like to thank Jakob von Moltke for providing the Sucnr1<SUP>-/-</SUP> mice and Craig Wilen for development of the Pou2f3<SUP>-/-</SUP> mice. The model in Figure S8 was created with https://BioRender.com.	Aguilar-Valenzuela R, 2018, J VIROL, V92, DOI [10.1128/JVI.00014-18, 10.1128/jvi.00014-18]; Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Beura LK, 2015, J LEUKOCYTE BIOL, V97, P217, DOI 10.1189/jlb.1HI0314-154R; Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745; Bouchery T, 2017, Curr Protoc Mouse Biol, V7, P236, DOI 10.1002/cpmo.34; Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31; Camberis M., 2003, CURR PROTOC IMMUNOL; Cheng LE, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016352; da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480; Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z; Danahy DB, 2016, CRIT REV IMMUNOL, V36, P57, DOI 10.1615/CritRevImmunol.2016017098; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Ebel GD, 2001, EMERG INFECT DIS, V7, P650; Edwards MJ, 2005, J IMMUNOL, V175, P6275, DOI 10.4049/jimmunol.175.10.6275; Finkelman FD, 2000, J IMMUNOL, V164, P2303, DOI 10.4049/jimmunol.164.5.2303; Furze RC, 2006, INFECT IMMUN, V74, P1924, DOI 10.1128/IAI.74.3.1924-1932.2006; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jensen IJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007405; Johnston CJC, 2015, JOVE-J VIS EXP, DOI 10.3791/52412; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; King IL, 2017, MUCOSAL IMMUNOL, V10, P1160, DOI 10.1038/mi.2016.127; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Li SY, 2018, IMMUNITY, V49, P915, DOI 10.1016/j.immuni.2018.09.015; Lindsey NP, 2012, AM J TROP MED HYG, V87, P179, DOI 10.4269/ajtmh.2012.12-0113; Liu QK, 2019, NAT IMMUNOL, V20, P1023, DOI 10.1038/s41590-019-0421-2; Loke P, 2015, PARASITE IMMUNOL, V37, P314, DOI 10.1111/pim.12193; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; McFarlane AJ, 2017, J ALLERGY CLIN IMMUN, V140, P1068, DOI 10.1016/j.jaci.2017.01.016; Monin L, 2015, J CLIN INVEST, V125, P4699, DOI 10.1172/JCI77378; Moriyama S, 2019, ADV IMMUNOL, V143, P1, DOI 10.1016/bs.ai.2019.08.001; Muller PA, 2020, CURR OPIN IMMUNOL, V62, P54, DOI 10.1016/j.coi.2019.11.011; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; NAYAK DP, 1965, J PARASITOL, V51, P297, DOI 10.2307/3276103; Ogilvy S, 1998, BLOOD, V91, P419, DOI 10.1182/blood.V91.2.419.419_419_430; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Perez OA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5520; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reynolds LA, 2012, SEMIN IMMUNOPATHOL, V34, P829, DOI 10.1007/s00281-012-0347-3; Rolot M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06978-5; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Scheer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112469; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Straub T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06609-z; Sule WF, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2998-y; Szabo R, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.183392; Thackray LB, 2018, CELL REP, V22, P3440, DOI 10.1016/j.celrep.2018.03.001; Ting HA, 2019, J IMMUNOL, V202, P1321, DOI 10.4049/jimmunol.1801069; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Urban JF, 2000, J IMMUNOL, V164, P2046, DOI 10.4049/jimmunol.164.4.2046; VanBlargan LA, 2018, CELL REP, V25, P3382, DOI 10.1016/j.celrep.2018.11.082; Vergnolle N, 2018, PHYSIOLOGY, V33, P269, DOI 10.1152/physiol.00009.2018; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; WESCOTT RB, 1966, J PARASITOL, V52, P242, DOI 10.2307/3276478; White JP, 2018, CELL, V175, P1198, DOI 10.1016/j.cell.2018.08.069; Wilen CB, 2018, SCIENCE, V360, P204, DOI 10.1126/science.aar3799; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	73	25	25	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1214	+		10.1016/j.cell.2021.01.051	http://dx.doi.org/10.1016/j.cell.2021.01.051		MAR 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33636133	Bronze, Green Accepted			2022-12-28	WOS:000629635700012
J	Li, GR; Chen, XP; Zhou, FH; Liang, YM; Xiao, YH; Cao, X; Zhang, Z; Zhang, MQ; Wu, BS; Yin, SY; Xu, Y; Fan, HB; Chen, Z; Song, W; Yang, WJ; Pan, BB; Hou, JY; Zou, WF; He, SP; Yang, XX; Mao, GY; Jia, Z; Zhou, HF; Li, TF; Qu, SX; Xu, ZB; Huang, ZL; Luo, YW; Xie, T; Gu, J; Zhu, SQ; Yang, W				Li, Guorui; Chen, Xiangping; Zhou, Fanghao; Liang, Yiming; Xiao, Youhua; Cao, Xunuo; Zhang, Zhen; Zhang, Mingqi; Wu, Baosheng; Yin, Shunyu; Xu, Yi; Fan, Hongbo; Chen, Zheng; Song, Wei; Yang, Wenjing; Pan, Binbin; Hou, Jiaoyi; Zou, Weifeng; He, Shunping; Yang, Xuxu; Mao, Guoyong; Jia, Zheng; Zhou, Haofei; Li, Tiefeng; Qu, Shaoxing; Xu, Zhongbin; Huang, Zhilong; Luo, Yingwu; Xie, Tao; Gu, Jason; Zhu, Shiqiang; Yang, Wei			Self-powered soft robot in the Mariana Trench	NATURE			English	Article								The deep sea remains the largest unknown territory on Earth because it is so difficult to explore(1-4). Owing to the extremely high pressure in the deep sea, rigid vessels(5-7) and pressure-compensation systems(8-10) are typically required to protect mechatronic systems. However, deep-sea creatures that lack bulky or heavy pressure-tolerant systems can thrive at extreme depths(11-17). Here, inspired by the structure of a deep-sea snailfish(15), we develop an untethered soft robot for deep-sea exploration, with onboard power, control and actuation protected from pressure by integrating electronics in a silicone matrix. This self-powered robot eliminates the requirement for any rigid vessel. To reduce shear stress at the interfaces between electronic components, we decentralize the electronics by increasing the distance between components or separating them from the printed circuit board. Careful design of the dielectric elastomer material used for the robot's flapping fins allowed the robot to be actuated successfully in a field test in the Mariana Trench down to a depth of 10,900 metres and to swim freely in the South China Sea at a depth of 3,224 metres. We validate the pressure resilience of the electronic components and soft actuators through systematic experiments and theoretical analyses. Our work highlights the potential of designing soft, lightweight devices for use in extreme conditions. A free-swimming soft robot inspired by deep-sea creatures, with artificial muscle, power and control electronics spread across a polymer matrix, successfully adapts to high pressure and operates in the deep ocean.	[Li, Guorui; Zhang, Mingqi; Chen, Zheng; Song, Wei; Li, Tiefeng; Qu, Shaoxing; Huang, Zhilong] Zhejiang Univ, State Key Lab Fluid Power & Mechatron Syst, Hangzhou, Peoples R China; [Li, Guorui; Liang, Yiming; Song, Wei; Li, Tiefeng; Gu, Jason; Zhu, Shiqiang] Zhejiang Lab, Hangzhou, Peoples R China; [Li, Guorui; Chen, Xiangping; Zhou, Fanghao; Yin, Shunyu; Xu, Yi; Yang, Xuxu; Mao, Guoyong; Jia, Zheng; Zhou, Haofei; Li, Tiefeng; Qu, Shaoxing; Huang, Zhilong; Yang, Wei] Zhejiang Univ, Dept Engn Mech, Ctr Xmech, Hangzhou, Peoples R China; [Chen, Xiangping; Cao, Xunuo; Zhang, Zhen; Zhang, Mingqi; Yin, Shunyu; Xu, Yi; Yang, Xuxu; Mao, Guoyong; Jia, Zheng; Zhou, Haofei; Qu, Shaoxing; Huang, Zhilong; Yang, Wei] Zhejiang Univ, Key Lab Soft Machines & Smart Devices Zhejiang Pr, Hangzhou, Peoples R China; [Zhou, Fanghao; Xiao, Youhua; Luo, Yingwu; Xie, Tao] Zhejiang Univ, State Key Lab Chem Engn, Hangzhou, Peoples R China; [Zhou, Fanghao; Xu, Zhongbin] Zhejiang Univ, Inst Proc Equipment, Coll Energy Engn, Hangzhou, Peoples R China; [Cao, Xunuo; Fan, Hongbo; Chen, Zheng; Song, Wei; Zhu, Shiqiang] Zhejiang Univ, Ocean Coll, Zhoushan, Peoples R China; [Wu, Baosheng; He, Shunping] Chinese Acad Sci, Inst Deep Sea Sci & Engn, Sanya, Peoples R China; [Yang, Wenjing] Natl Univ Def Technol, Coll Mechatron Engn & Automat, Changsha, Peoples R China; [Pan, Binbin] Shanghai Ocean Univ, Shanghai Engn Res Ctr Hadal Sci & Technol, Shanghai, Peoples R China; [Hou, Jiaoyi; Zou, Weifeng] Dalian Maritime Univ, Natl Ctr Int Res Subsea Engn Technol & Equipment, Dalian, Peoples R China	Zhejiang University; Zhejiang Laboratory; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS; National University of Defense Technology - China; Shanghai Ocean University; Dalian Maritime University	Li, TF (corresponding author), Zhejiang Univ, State Key Lab Fluid Power & Mechatron Syst, Hangzhou, Peoples R China.; Li, TF (corresponding author), Zhejiang Lab, Hangzhou, Peoples R China.; Li, TF (corresponding author), Zhejiang Univ, Dept Engn Mech, Ctr Xmech, Hangzhou, Peoples R China.	litiefeng@zju.edu.cn	Liang, Yiming/HII-3493-2022; Jia, Zheng/ADH-7787-2022; Mao, Guoyong/F-1095-2015; Xie, Tao/H-8633-2013	Mao, Guoyong/0000-0002-7570-6206; Xie, Tao/0000-0003-0222-9717; Li, Guorui/0000-0002-7872-4135; Jia, Zheng/0000-0001-8459-515X; Gu, Jason/0000-0002-7626-1077				Acome E, 2018, SCIENCE, V359, P61, DOI 10.1126/science.aao6139; Aubin CA, 2019, NATURE, V571, P51, DOI 10.1038/s41586-019-1313-1; Bingham N, DESIGNING PRESSURE T; Blachut J, 2008, OCEAN ENG, V35, P247, DOI 10.1016/j.oceaneng.2007.08.003; Chen YF, 2019, NATURE, V575, P324, DOI 10.1038/s41586-019-1737-7; Chiba S, 2011, IEEE SENS J, V11, P3, DOI 10.1109/JSEN.2010.2053702; Christianson C, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat1893; Clarke T, 2003, NATURE, V421, P468, DOI 10.1038/421468a; Danovaro R, 2017, CURR BIOL, V27, pR461, DOI 10.1016/j.cub.2017.02.046; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Galloway KC, 2016, SOFT ROBOT, V3, P23, DOI 10.1089/soro.2015.0019; Giorgio-Serchi F, 2018, IEEE-ASME T MECH, V23, P2968, DOI 10.1109/TMECH.2018.2873253; Giorgio-Serchi F, 2016, INT J ROBOT RES, V35, P1395, DOI 10.1177/0278364915622569; Hernes M., 2009, 13 EUR C POW EL APPL; Hoving HJT, 2017, SCI REP-UK, V7, DOI 10.1038/srep44952; Ji XB, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aaz6451; JONESPARRY E, 1973, J MATER SCI, V8, P1510, DOI 10.1007/BF00551675; Joung Tae-Hwan, 2008, SHIPS SHORE STRUCTUR, V3, P205; Kampmann P., 2012, IEEE OC C, DOI [10.1109/OCEANS.2012.6404828, DOI 10.1109/OCEANS.2012.6404828]; Kawabata T, 2013, FISHERIES SCI, V79, P487, DOI 10.1007/s12562-013-0612-y; Koh SJA, 2011, J POLYM SCI POL PHYS, V49, P504, DOI 10.1002/polb.22223; Kunzig R, 2003, SCIENCE, V302, P991, DOI 10.1126/science.1090808; Laschi C, 2012, ADV ROBOTICS, V26, P709, DOI 10.1163/156855312X626343; Li SG, 2017, P NATL ACAD SCI USA, V114, P13132, DOI 10.1073/pnas.1713450114; Li TF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602045; Liang CC, 1998, INT J PRES VES PIP, V75, P447, DOI 10.1016/S0308-0161(98)00041-6; Linley TD, 2016, DEEP-SEA RES PT I, V114, P99, DOI 10.1016/j.dsr.2016.05.003; Lum GZ, 2016, P NATL ACAD SCI USA, V113, pE6007, DOI 10.1073/pnas.1608193113; Ma ZP, 2017, MACROMOL RAPID COMM, V38, DOI 10.1002/marc.201700268; Marchese AD, 2014, SOFT ROBOT, V1, P75, DOI 10.1089/soro.2013.0009; McPhail S, 2009, J BIONIC ENG, V6, P55, DOI 10.1016/S1672-6529(08)60095-5; Morin SA, 2012, SCIENCE, V337, P828, DOI 10.1126/science.1222149; PASSAGLIA E, 1964, J RES NBS A PHYS CH, VA 68, P273, DOI 10.6028/jres.068A.024; Petersen S, 2016, MAR POLICY, V70, P175, DOI 10.1016/j.marpol.2016.03.012; Phillips BT., 2018, SCI REP-UK, V8; Picardi G, 2020, SCI ROBOT, V5, DOI 10.1126/scirobotics.aaz1012; Renda F, 2014, IEEE T ROBOT, V30, P1109, DOI 10.1109/TRO.2014.2325992; Sandoval JA, 2019, BIOINSPIR BIOMIM, V14, DOI 10.1088/1748-3190/ab47d1; Stachiw J.D., 2006, IEEE OC C, DOI [10.1109/OCEANS.2006.306971, DOI 10.1109/OCEANS.2006.306971]; Stuart H, 2017, INT J ROBOT RES, V36, P150, DOI 10.1177/0278364917694723; Stuart HS, 2019, IEEE T ROBOT, V35, P295, DOI 10.1109/TRO.2018.2880094; Thiede C, 2009, IEEE OC C, DOI [10.1038/s41586-020-03153-z, DOI 10.1038/S41586-020-03153-Z]; Umapathy A, 2019, MAR TECHNOL SOC J, V53, P67, DOI 10.4031/MTSJ.53.1.7; Vogt DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200386; Wang K, 2019, NAT ECOL EVOL, V3, P823, DOI 10.1038/s41559-019-0864-8; Wang YP, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aan8072; Wehner M, 2016, NATURE, V536, P451, DOI 10.1038/nature19100; Weymouth GD, 2013, J FLUID MECH, V721, P367, DOI 10.1017/jfm.2013.65; Yancey PH, 2014, P NATL ACAD SCI USA, V111, P4461, DOI 10.1073/pnas.1322003111; Yang CX, 2020, CHEM ENG J, V382, DOI 10.1016/j.cej.2019.123037; Yoerger DR, 2007, INT J ROBOT RES, V26, P41, DOI 10.1177/0278364907073773; Yuk H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14230; Zhao XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3054159	53	193	201	249	919	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					66	+		10.1038/s41586-020-03153-z	http://dx.doi.org/10.1038/s41586-020-03153-z			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QZ7VS	33658693				2022-12-28	WOS:000630931100001
J	Liu, JD; Gao, MW; He, JP; Wu, KX; Lin, SY; Jin, LM; Chen, YP; Liu, H; Shi, JJ; Wang, XW; Chang, L; Lin, YY; Zhao, YL; Zhang, XF; Zhang, M; Luo, GZ; Wu, GM; Pei, DQ; Wang, J; Bao, XC; Chen, JK				Liu, Jiadong; Gao, Mingwei; He, Jiangping; Wu, Kaixin; Lin, Siyuan; Jin, Lingmei; Chen, Yaping; Liu, He; Shi, Junjie; Wang, Xiwei; Chang, Lei; Lin, Yingying; Zhao, Yu-Li; Zhang, Xiaofei; Zhang, Man; Luo, Guan-Zheng; Wu, Guangming; Pei, Duanqing; Wang, Jie; Bao, Xichen; Chen, Jiekai			The RNA m(6)A reader YTHDC1 silences retrotransposons and guards ES cell identity	NATURE			English	Article							FATE TRANSITION; STEM-CELLS; ALIGNMENT; BINDING; N-6-METHYLADENOSINE; RECOGNITION; METHYLATION; ELEMENTS; REVEALS	The RNA modification N-6-methyladenosine (m(6)A) has critical roles in many biological processes(1,2). However, the function of m(6)A in the early phase of mammalian development remains poorly understood. Here we show that the m(6)A reader YT521-B homology-domain-containing protein 1 (YTHDC1) is required for the maintenance of mouse embryonic stem (ES) cells in an m(6)A-dependent manner, and that its deletion initiates cellular reprogramming to a 2C-like state. Mechanistically, YTHDC1 binds to the transcripts of retrotransposons (such as intracisternal A particles, ERVK and LINE1) in mouse ES cells and its depletion results in the reactivation of these silenced retrotransposons, accompanied by a global decrease in SETDB1-mediated trimethylation at lysine 9 of histone H3 (H3K9me3). We further demonstrate that YTHDC1 and its target m(6)A RNAs act upstream of SETDB1 to repress retrotransposons and Dux, the master inducer of the two-cell stage (2C)-like program. This study reveals an essential role for m(6)A RNA and YTHDC1 in chromatin modification and retrotransposon repression.	[Liu, Jiadong; Gao, Mingwei; Wu, Kaixin; Lin, Siyuan; Jin, Lingmei; Chen, Yaping; Shi, Junjie; Zhang, Xiaofei; Pei, Duanqing; Wang, Jie; Bao, Xichen; Chen, Jiekai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou, Peoples R China; [Liu, Jiadong; Gao, Mingwei; Lin, Siyuan; Jin, Lingmei; Chen, Yaping; Shi, Junjie; Zhang, Xiaofei; Wang, Jie; Bao, Xichen; Chen, Jiekai] Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Liu, Jiadong; Gao, Mingwei; Jin, Lingmei; Chen, Yaping; Shi, Junjie; Chen, Jiekai] Univ Chinese Acad Sci, Beijing, Peoples R China; [He, Jiangping; Liu, He; Wang, Xiwei; Chang, Lei; Zhang, Xiaofei; Zhang, Man; Wu, Guangming; Pei, Duanqing; Bao, Xichen; Chen, Jiekai] Guangzhou Regenerat Med & Hlth GuangDong Lab, Ctr Cell Lineage & Atlas CCLA, Bioland Lab, Guangzhou, Peoples R China; [Wu, Kaixin] Guangzhou Med Univ, Qingyuan Peoples Hosp, Cent Lab, Affiliated Hosp 6, Qingyuan, Peoples R China; [Wu, Kaixin] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, Guangzhou, Peoples R China; [Liu, He; Chen, Jiekai] Chinese Acad Sci, Guangzhou Med Univ, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, Guangzhou, Peoples R China; [Lin, Yingying] Sun Yat Sen Univ, Sch Med, Shenzhen, Peoples R China; [Zhao, Yu-Li; Luo, Guan-Zheng] Sun Yat Sen Univ, Sch Life Sci, MOE Key Lab Gene Funct & Regulat, Guangzhou, Peoples R China; [Pei, Duanqing] Westlake Univ, Sch Life Sci, Hangzhou, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Guangzhou Medical University; Southern Medical University - China; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Westlake University	Chen, JK (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, CAS Key Lab Regenerat Biol, Guangzhou, Peoples R China.; Chen, JK (corresponding author), Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China.; Chen, JK (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Chen, JK (corresponding author), Guangzhou Regenerat Med & Hlth GuangDong Lab, Ctr Cell Lineage & Atlas CCLA, Bioland Lab, Guangzhou, Peoples R China.; Chen, JK (corresponding author), Chinese Acad Sci, Guangzhou Med Univ, Guangzhou Inst Biomed & Hlth, Joint Sch Life Sci, Guangzhou, Peoples R China.	chen_jiekai@gibh.ac.cn	Wang, Jie/GPT-0245-2022; MQ, Li/HGU-6545-2022	Chang, Lei/0000-0002-2606-3347	Guangzhou Branch of the Supercomputing Center of Chinese Academy of Sciences; Cloud Computing Center of Chinese Academy of Sciences; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110104003]; Frontier Science Research Program of the CAS [ZDBS-LY-SM007]; Science and Technology Program of Guangzhou [201804020052]; National Natural Science Foundation of China [31771424, 32070794, 32000501, 32000503]; Science and Technology Planning Project of Guangdong Province [2020B1212060052]; National Key R&D Program of China [2019YFA0110200, 2017YFA0504100, 2016YFA0100400]	Guangzhou Branch of the Supercomputing Center of Chinese Academy of Sciences; Cloud Computing Center of Chinese Academy of Sciences; Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory; Frontier Science Research Program of the CAS; Science and Technology Program of Guangzhou; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; National Key R&D Program of China	We thank X. Quan, Z. Zhang, J.-Y. Ji, Y. Liu, S. Shu, W. Pang and S. Xu for experimental assistance; Y. Shi and H. Shen for valuable suggestions and for sharing unpublished results; H. Chen, C.-H. Hsu, M. Min, L. Shen, J. Wang and Y. Yu for discussion and constructive suggestions; and the Guangzhou Branch of the Supercomputing Center of Chinese Academy of Sciences, and the Cloud Computing Center of Chinese Academy of Sciences for their support. This work was supported by the National Key R&D Program of China (2019YFA0110200, 2017YFA0504100 and 2016YFA0100400), Key Research & Development Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory (2018GZR110104003), Frontier Science Research Program of the CAS (ZDBS-LY-SM007), the Science and Technology Program of Guangzhou (201804020052), National Natural Science Foundation of China (31771424, 32070794, 32000501, 32000503), and Science and Technology Planning Project of Guangdong Province (2020B1212060052).	Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Chelmicki T, 2021, NATURE, V591, P312, DOI 10.1038/s41586-020-03135-1; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen ZY, 2019, NAT GENET, V51, P947, DOI 10.1038/s41588-019-0418-7; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fuchs G, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r69; Genet M, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.189688; Geula S., 2015, Science, V347, P1002, DOI 10.1126/science.1261417; Gu JQ, 2018, GENOM PROTEOM BIOINF, V16, P136, DOI 10.1016/j.gpb.2018.04.003; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; He JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08006-y; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Iturbide A, 2020, CURR OPIN GENET DEV, V64, P26, DOI 10.1016/j.gde.2020.05.038; Ivanova I, 2017, MOL CELL, V67, P1059, DOI 10.1016/j.molcel.2017.08.003; Jachowicz JW, 2017, NAT GENET, V49, P1502, DOI 10.1038/ng.3945; Jin Y, 2015, BIOINFORMATICS, V31, P3593, DOI 10.1093/bioinformatics/btv422; Kasowitz SD, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007412; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latos PA, 2016, DEVELOPMENT, V143, P3650, DOI 10.1242/dev.133462; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li X, 2017, NAT BIOTECHNOL, V35, P940, DOI 10.1038/nbt.3968; Liu JD, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108120; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Percharde M, 2018, CELL, V174, P391, DOI 10.1016/j.cell.2018.05.043; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Summers MC, 2000, HUM REPROD, V15, P1791, DOI 10.1093/humrep/15.8.1791; Wang CY, 2016, NUCLEIC ACIDS RES, V44, P969, DOI 10.1093/nar/gkv1382; Wu G., 2013, NatCell Biol, V15, P1089, DOI 10.1038/ncb2816; Wu KX, 2020, CELL REP, V30, P25, DOI 10.1016/j.celrep.2019.12.010; Wu Y, 2019, CELL REP, V29, P2461, DOI 10.1016/j.celrep.2019.10.055; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhang Y, 2019, P NATL ACAD SCI USA, V116, P976, DOI 10.1073/pnas.1812536116; Zofall M, 2012, SCIENCE, V335, P96, DOI 10.1126/science.1211651	53	72	75	13	86	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					322	+		10.1038/s41586-021-03313-9	http://dx.doi.org/10.1038/s41586-021-03313-9		MAR 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8UA	33658714				2022-12-28	WOS:000625125200004
J	Baicker, K				Baicker, Katherine			Trade-offs in Public Health Insurance Design	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Baicker, Katherine] Univ Chicago, Harris Sch Publ Policy, 1307 E 60th St, Chicago, IL 60637 USA	University of Chicago	Baicker, K (corresponding author), Univ Chicago, Harris Sch Publ Policy, 1307 E 60th St, Chicago, IL 60637 USA.	kbaicker@uchicago.edu							0	1	1	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					814	815		10.1001/jama.2021.0647	http://dx.doi.org/10.1001/jama.2021.0647			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651081	Bronze			2022-12-28	WOS:000625843100003
J	Nabavi, N				Nabavi, Nikki			Cautious optimism: Light at the end of the tunnel	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nnabavi@bmj.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n589	10.1136/bmj.n589	http://dx.doi.org/10.1136/bmj.n589			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33648953	Bronze			2022-12-28	WOS:000625342000006
J	Hilgartner, S; Hurlbut, JB; Jasanoff, S				Hilgartner, Stephen; Hurlbut, J. Benjamin; Jasanoff, Sheila			Was "science" on the ballot?	SCIENCE			English	Editorial Material									[Hilgartner, Stephen] Cornell Univ, Dept Sci & Technol Studies, Ithaca, NY 14853 USA; [Hurlbut, J. Benjamin] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Jasanoff, Sheila] Harvard Kennedy Sch, Cambridge, MA USA	Cornell University; Arizona State University; Arizona State University-Tempe; Harvard University	Hilgartner, S (corresponding author), Cornell Univ, Dept Sci & Technol Studies, Ithaca, NY 14853 USA.	shh6@cornell.edu			Schmidt Futures; National Science Foundation [2028567, 2028585]	Schmidt Futures; National Science Foundation(National Science Foundation (NSF))	We acknowledge funding from Schmidt Futures and the National Science Foundation (award nos. 2028567 and 2028585). The views expressed here are the authors' alone.	[Anonymous], 2017, EXPT DEMOCRACY HUMAN; BAYER R, 1993, AM J PUBLIC HEALTH, V83, P1471, DOI 10.2105/AJPH.83.10.1471; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Florko N., 2020, STAT; Hilgartner S., 2000, SCI STAGE EXPERT ADV; Jasanoff S., 2020, DROIT SCI TECHNOLOGI, V11, P125; Jasanoff S., 2021, COMP COVID RESPONSE; Jasanoff S., 2005, DESIGNS NATURE SCI D; Stern P. C., 1996, UNDERSTANDING RISK I	9	5	5	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					893	894		10.1126/science.abf8762	http://dx.doi.org/10.1126/science.abf8762			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632837				2022-12-28	WOS:000621813400028
J	Neo, SH; Lee, LS				Neo, Shu Hui; Lee, Lui Shiong			A Large Abdominal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Neo, Shu Hui; Lee, Lui Shiong] Sengkang Gen Hosp, Singapore, Singapore		Neo, SH (corresponding author), Sengkang Gen Hosp, Singapore, Singapore.	shuhui.neo@mohh.com.sg							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					E24	E24		10.1056/NEJMicm2026560	http://dx.doi.org/10.1056/NEJMicm2026560			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP4LK	33626256				2022-12-28	WOS:000623807600005
J	Wagner, G; Anthoff, D; Cropper, M; Dietz, S; Gillingham, KT; Groom, B; Kelleher, JP; Moore, FC; Stock, JH				Wagner, Gernot; Anthoff, David; Cropper, Maureen; Dietz, Simon; Gillingham, Kenneth T.; Groom, Ben; Kelleher, J. Paul; Moore, Frances C.; Stock, James H.			Eight priorities for calculating the social cost of carbon	NATURE			English	Editorial Material						Climate change; Economics; Government			[Wagner, Gernot] NYU, Environm Studies & Publ Serv, New York, NY 10003 USA	New York University	Wagner, G (corresponding author), NYU, Environm Studies & Publ Serv, New York, NY 10003 USA.	gwagner@nyu.edu	Groom, Ben/AAP-9305-2021	Groom, Ben/0000-0003-0729-143X				Arrow K, 2013, SCIENCE, V341, P349, DOI 10.1126/science.1235665; BROECKER WS, 1987, NATURE, V328, P123, DOI 10.1038/328123a0; Carleton T., 2021, BECKER FRIEDMAN I EC; Christensen P, 2018, P NATL ACAD SCI USA, V115, P5409, DOI 10.1073/pnas.1713628115; Drupp MA, 2018, AM ECON J-ECON POLIC, V10, P109, DOI 10.1257/pol.20160240; Kotchen MJ, 2018, J ASSOC ENVIRON RESO, V5, P673, DOI 10.1086/697241; Natl Acad Sci Engn Med, 2017, VALUING CLIMATE DAMAGES: UPDATING ESTIMATION OF THE SOCIAL COST OF CARBON DIOXIDE, P1, DOI 10.17226/24651; Negro M., 2017, BROOKINGS PAPERS EC, V2017, P235, DOI [10.1353/eca.2017.0003, DOI 10.1353/ECA.2017.0003]; Park RJ, 2020, AM ECON J-ECON POLIC, V12, P306, DOI 10.1257/pol.20180612; Stern N., 2006, EC CLIMATE CHANGE ST; US Government Accountability Office, 2020, GAO20254	11	17	17	8	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847					548	550		10.1038/d41586-021-00441-0	http://dx.doi.org/10.1038/d41586-021-00441-0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ6RH	33608674				2022-12-28	WOS:000619815200001
J	Wise, J				Wise, Jacqui			Covid-19: Pfizer BioNTech vaccine reduced cases by 94% in Israel, shows peer reviewed study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765	1	9	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n567	10.1136/bmj.n567	http://dx.doi.org/10.1136/bmj.n567			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632676	Bronze			2022-12-28	WOS:000624298000012
J	Lim, SA; Wei, J; Nguyen, TLM; Shi, H; Su, W; Palacios, G; Dhungana, Y; Chapman, NM; Long, LY; Saravia, J; Vogel, P; Chi, HB				Lim, Seon Ah; Wei, Jun; Nguyen, Thanh-Long M.; Shi, Hao; Su, Wei; Palacios, Gustavo; Dhungana, Yogesh; Chapman, Nicole M.; Long, Lingyun; Saravia, Jordy; Vogel, Peter; Chi, Hongbo			Lipid signalling enforces functional specialization of T-reg cells in tumours	NATURE			English	Article							REGULATORY T; DIFFERENTIATION; INFLAMMATION; MAINTENANCE; PROGRAMS; MICE	Regulatory T cells (T-reg cells) are essential for immune tolerance(1), but also drive immunosuppression in the tumour microenvironment(2). Therapeutic targeting of T-reg cells in cancer will therefore require the identification of context-specific mechanisms that affect their function. Here we show that inhibiting lipid synthesis and metabolic signalling that are dependent on sterol-regulatory-element-binding proteins (SREBPs) in T-reg cells unleashes effective antitumour immune responses without autoimmune toxicity. We find that the activity of SREBPs is upregulated in intratumoral T-reg cells. Moreover, deletion of SREBP-cleavage-activating protein (SCAP)-a factor required for SREBP activity-in these cells inhibits tumour growth and boosts immunotherapy that is triggered by targeting the immune-checkpoint protein PD-1. These effects of SCAP deletion are associated with uncontrolled production of interferon-gamma and impaired function of intratumoral T-reg cells. Mechanistically, signalling through SCAP and SREBPs coordinates cellular programs for lipid synthesis and inhibitory receptor signalling in these cells. First, de novo fatty-acid synthesis mediated by fatty-acid synthase (FASN) contributes to functional maturation of T-reg cells, and loss of FASN from T-reg cells inhibits tumour growth. Second, T-reg cells in tumours show enhanced expression of the PD-1 gene, through a process that depends on SREBP activity and signalsvia mevalonate metabolism to protein geranylgeranylation. Blocking PD-1 or SREBP signalling results in dysregulated activation of phosphatidylinositol-3-kinase in intratumoral T-reg cells. Our findings show that metabolic reprogramming enforces the functional specialization of T-reg cells in tumours, pointing to new ways of targeting these cells for cancer therapy.	[Lim, Seon Ah; Wei, Jun; Nguyen, Thanh-Long M.; Shi, Hao; Su, Wei; Palacios, Gustavo; Dhungana, Yogesh; Chapman, Nicole M.; Long, Lingyun; Saravia, Jordy; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018; SHI, HAO/ABE-4662-2020; Lim, Seon Ah/AAQ-6274-2021; SU, WEI/GPC-6511-2022	Chi, Hongbo/0000-0002-9997-2496; SHI, HAO/0000-0002-2796-629X; SU, WEI/0000-0003-4165-8776; Wei, Jun/0000-0002-6769-847X; Saravia, Jordy/0000-0002-2691-501X; Dhungana, Yogesh/0000-0002-4021-0075	National Institutes of Health (NIH) [CA221290, CA250533, AI105887, AI131703, AI140761, AI150241, AI150514]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Hendren, A. KC and S. Rankin for management of animal colonies; Y. Wang and S. Brown for help with immunological experiments; J. Easton and St Jude Genomics Lab of Computational Biology for scRNAseq; and the St Jude Immunology fluorescence-activated cell sorting (FACS) core facility for cell sorting. This work was supported by National Institutes of Health (NIH) grants CA221290, CA250533, AI105887, AI131703, AI140761, AI150241 and AI150514. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Brovkovych V, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0076-0; Buescher JM, 2015, CURR OPIN BIOTECH, V34, P189, DOI 10.1016/j.copbio.2015.02.003; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Di Pilato M, 2019, NATURE, V570, P112, DOI 10.1038/s41586-019-1215-2; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kumagai S, 2020, NAT IMMUNOL, V21, P1346, DOI 10.1038/s41590-020-0769-3; Lacher SM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.221; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Liu C, 2019, IMMUNITY, V51, P381, DOI 10.1016/j.immuni.2019.06.017; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu M, 2010, P NATL ACAD SCI USA, V107, P6471, DOI 10.1073/pnas.0908396107; Lucca LE, 2020, NAT REV IMMUNOL, V20, P680, DOI 10.1038/s41577-020-0296-3; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nagashima S, 2012, ARTERIOSCL THROM VAS, V32, P1824, DOI 10.1161/ATVBAHA.111.240754; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Pacella I, 2018, P NATL ACAD SCI USA, V115, pE6546, DOI 10.1073/pnas.1720113115; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Savage PA, 2020, ANNU REV IMMUNOL, V38, P421, DOI 10.1146/annurev-immunol-100219-020937; Sawant DV, 2019, NAT IMMUNOL, V20, P724, DOI 10.1038/s41590-019-0346-9; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shi H, 2019, IMMUNITY, V51, P1012, DOI 10.1016/j.immuni.2019.10.001; Shi H, 2018, IMMUNITY, V49, P899, DOI 10.1016/j.immuni.2018.10.010; Su W, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vahl JC, 2014, IMMUNITY, V41, P722, DOI 10.1016/j.immuni.2014.10.012; van der Veeken J, 2016, CELL, V166, P977, DOI 10.1016/j.cell.2016.07.006; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Xiao G, 2012, P NATL ACAD SCI USA, V109, P15419, DOI 10.1073/pnas.1206370109; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	51	80	85	20	101	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					306	+		10.1038/s41586-021-03235-6	http://dx.doi.org/10.1038/s41586-021-03235-6		FEB 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU6WY	33627871	Green Accepted			2022-12-28	WOS:000621335600008
J	Moyle, MW; Barnes, KM; Kuchroo, M; Gonopolskiy, A; Duncan, LH; Sengupta, T; Shao, L; Guo, M; Santella, A; Christensen, R; Kumar, A; Wu, Y; Moon, KR; Wolf, G; Krishnaswamy, S; Bao, ZR; Shroff, H; Mohler, WA; Colon-Ramos, DA				Moyle, Mark W.; Barnes, Kristopher M.; Kuchroo, Manik; Gonopolskiy, Alex; Duncan, Leighton H.; Sengupta, Titas; Shao, Lin; Guo, Min; Santella, Anthony; Christensen, Ryan; Kumar, Abhishek; Wu, Yicong; Moon, Kevin R.; Wolf, Guy; Krishnaswamy, Smita; Bao, Zhirong; Shroff, Hari; Mohler, William A.; Colon-Ramos, Daniel A.			Structural and developmental principles of neuropil assembly in C. elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; AXON GUIDANCE; CELL LINEAGE; CIRCUIT; MODULARITY; INSECT; BRAIN; RING; HUB	Neuropil is a fundamental form of tissue organization within the brain(1), in which densely packed neurons synaptically interconnect into precise circuit architecture(2,3). However, the structural and developmental principles that govern this nanoscale precision remain largely unknown(4,5). Here we use an iterative data coarse-graining algorithm termed 'diffusion condensation'(6) to identify nested circuit structures within the Caenorhabditis elegans neuropil, which is known as the nerve ring. We show that the nerve ring neuropil is largely organized into four strata that are composed of related behavioural circuits. The stratified architecture of the neuropil is a geometrical representation of the functional segregation of sensory information and motor outputs, with specific sensory organs and muscle quadrants mapping onto particular neuropil strata. We identify groups of neurons with unique morphologies that integrate information across strata and that create neural structures that cage the strata within the nerve ring. We use high resolution light-sheet microscopy(7,8) coupled with lineage-tracing and cell-tracking algorithms(9,10) to resolve the developmental sequence and reveal principles of cell position, migration and outgrowth that guide stratified neuropil organization. Our results uncover conserved structural design principles that underlie the architecture and function of the nerve ring neuropil, and reveal a temporal progression of outgrowth-based on pioneer neurons-that guides the hierarchical development of the layered neuropil. Our findings provide a systematic blueprint for using structural and developmental approaches to understand neuropil organization within the brain.	[Moyle, Mark W.; Duncan, Leighton H.; Sengupta, Titas; Shao, Lin; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Dept Neurosci, New Haven, CT 06520 USA; [Moyle, Mark W.; Duncan, Leighton H.; Sengupta, Titas; Shao, Lin; Colon-Ramos, Daniel A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Barnes, Kristopher M.; Santella, Anthony; Bao, Zhirong] Sloan Kettering Inst, Dev Biol Program, New York, NY USA; [Kuchroo, Manik; Gonopolskiy, Alex; Krishnaswamy, Smita] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Guo, Min; Christensen, Ryan; Wu, Yicong; Shroff, Hari] Natl Inst Biomed Imaging & Bioengneering, Lab High Resolut Opt Imaging, NIH, Bethesda, MD USA; [Kumar, Abhishek; Shroff, Hari] Marine Biol Lab, Woods Hole, MA 02543 USA; [Moon, Kevin R.] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA; [Wolf, Guy] Univ Montreal, Dept Math & Stat, Montreal, PQ, Canada; [Mohler, William A.] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT USA; [Mohler, William A.] Univ Connecticut, Ctr Hlth, Ctr Cell Anal & Modeling, Farmington, CT USA; [Colon-Ramos, Daniel A.] Univ Puerto Rico, Inst Neurobiol, Recinto Ciencias Med, San Juan, PR 00936 USA	Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Yale University; National Institutes of Health (NIH) - USA; Marine Biological Laboratory - Woods Hole; Utah System of Higher Education; Utah State University; Universite de Montreal; University of Connecticut; University of Connecticut; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Colon-Ramos, DA (corresponding author), Yale Univ, Sch Med, Dept Neurosci, New Haven, CT 06520 USA.; Colon-Ramos, DA (corresponding author), Univ Puerto Rico, Inst Neurobiol, Recinto Ciencias Med, San Juan, PR 00936 USA.	daniel.colon-ramos@yale.edu		Kuchroo, Manik/0000-0001-7512-9739; Shao, Lin/0000-0002-1905-4442; Duncan, Leighton H./0000-0003-0136-5530; Kumar, Abhishek/0000-0002-4961-6469	NIH [OD010943, R24-OD016474, F32-NS098616, P30CA008748, R01NS076558, DP1NS111778]; National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; MBL; HHMI Scholar Award; intramural research program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH) Office of Research Infrastructure Programs; MBL; HHMI Scholar Award; intramural research program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH	We thank S. Emmons, S. Cook and C. Brittin for sharing the segmented electron microscopy datasets and adjacency analysis code, and for comments on this work; O. Hobert for sharing the ceh-48p promoter and for advice; Z. Zhou for sharing a 2xFYVE-containing plasmid; J. White for transferring the electron microscopy data archive from MCR/LMB to the laboratory of D. Hall for long-term curation and display on the WormImage website (website supported by NIH grant no. OD010943 to D.H.); D. Hall for use of the young adult scanning electron microscopy images, for advice, and for help with electron microscopy images; R. Sommer for use of an electron microscopy image; H. Eden for comments on the manuscript; and members of the D.A.C-R. laboratory for comments during manuscript preparation. We thank the Caenorhabditis Genetic Center (funded by National Institutes of Health (NIH) Office of Research Infrastructure Programs P40 OD010440) for C. elegans strains; the Research Center for Minority Institutions program; the Marine Biological Laboratories (MBL); and the Instituto de Neurobiologia de la Universidad de Puerto Rico for providing meeting and brainstorming platforms. H.S. and D.A.C-R. acknowledge the Whitman and Fellows program at MBL for providing funding and space for discussions valuable to this work. H.S. and D.A.C-R. are MBL Fellows. Research in the D.A.C.-R., W.A.M. and Z.B. laboratories was supported by NIH grant no. R24-OD016474. M.W.M. was supported by NIH grant no. F32-NS098616. Research in the H.S. laboratory was further supported by the intramural research program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. Research in the Z.B. laboratory was further supported by an NIH center grant to MSKCC (P30CA008748). Research in the D.A.C.-R. laboratory was further supported by NIH grant nos R01NS076558 and DP1NS111778 and by an HHMI Scholar Award.	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Azulay A, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005021; Baier H, 2013, ANNU REV CELL DEV BI, V29, P385, DOI 10.1146/annurev-cellbio-101011-155748; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bargmann C. I., 2006, WORMBOOK; BLASHFIELD RK, 1991, J CLASSIF, V8, P277; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyle TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-275; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Brittin, 2018, VOLUMETRIC RECONSTRU, DOI 10.1101/485771; Brittin CA, 2021, NATURE, V591, P105, DOI 10.1038/s41586-021-03284-x; Brugnone N, 2019, IEEE INT CONF BIG DA, P2624, DOI 10.1109/BigData47090.2019.9006013; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Cook SJ, 2019, NATURE, V571, P63, DOI 10.1038/s41586-019-1352-7; Dasgupta A, 2006, LECT NOTES COMPUT SC, V4168, P256; Duncan LH, 2019, JOVE-J VIS EXP, DOI 10.3791/59533; Goodman M. B., 2006, WORMBOOK; Goodman MB, 2019, GENETICS, V212, P25, DOI 10.1534/genetics.118.300241; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Groh J.M., 2014, MAKING SPACE BRAIN K; Guo M, 2020, NAT BIOTECHNOL, V38, P1337, DOI 10.1038/s41587-020-0560-x; Insley P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194861; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Kindt KS, 2007, NAT NEUROSCI, V10, P568, DOI 10.1038/nn1886; Kumar A, 2014, NAT PROTOC, V9, P2555, DOI 10.1038/nprot.2014.172; Lockery SR, 2009, NATURE, V458, P1124, DOI 10.1038/4581124a; Lu N, 2009, METHODS MOL BIOL, V559, P357, DOI 10.1007/978-1-60327-017-5_25; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; MAYNARD DM, 1962, AM ZOOL, V2, P79; Millard SS, 2018, NEURAL DEV, V13, DOI 10.1186/s13064-018-0106-9; Moon KR, 2019, NAT BIOTECHNOL, V37, P1482, DOI 10.1038/s41587-019-0336-3; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Priess J. R., 1997, C ELEGANS 2; Rapti G, 2017, NAT NEUROSCI, V20, P1350, DOI 10.1038/nn.4630; Sabrin KM, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007526; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Santella A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0627-8; Sasakura H, 2013, CURR OPIN NEUROBIOL, V23, P92, DOI 10.1016/j.conb.2012.09.005; Schurmann FW, 2016, ARTHROPOD STRUCT DEV, V45, P399, DOI 10.1016/j.asd.2016.08.005; Shah PK, 2017, DEV CELL, V43, P530, DOI 10.1016/j.devcel.2017.10.021; Soiza-Reilly M, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00105; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Towlson EK, 2013, J NEUROSCI, V33, P6380, DOI 10.1523/JNEUROSCI.3784-12.2013; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WALTHALL WW, 1988, SCIENCE, V239, P643, DOI 10.1126/science.3340848; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1983, COLD SPRING HARB SYM, V48, P633, DOI 10.1101/SQB.1983.048.01.067; White J, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0367; WICKS SR, 1995, J NEUROSCI, V15, P2434, DOI 10.1523/JNEUROSCI.15-03-02434.1995; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713; Yan G, 2017, NATURE, V550, P519, DOI 10.1038/nature24056; Yoshimura S, 2008, DEVELOPMENT, V135, P2263, DOI 10.1242/dev.019547; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019	60	23	23	7	44	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					99	+		10.1038/s41586-020-03169-5	http://dx.doi.org/10.1038/s41586-020-03169-5		FEB 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33627875	Green Accepted, Green Submitted			2022-12-28	WOS:000621284800001
J	Torjesen, I				Torjesen, Ingrid			Covid-19: First doses of vaccines in Scotland led to a substantial fall in hospital admissions	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Vasileiou E, 2021, SSRN ELECT J	1	17	17	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2021	372								n523	10.1136/bmj.n523	http://dx.doi.org/10.1136/bmj.n523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7AW	33619037	Bronze			2022-12-28	WOS:000621236700007
J	Wang, CC; Yeh, HY; Popov, AN; Zhang, HQ; Matsumura, H; Sirak, K; Cheronet, O; Kovalev, A; Rohland, N; Kim, AM; Mallick, S; Bernardos, R; Tumen, D; Zhao, J; Liu, YC; Liu, JY; Mah, M; Wang, K; Zhang, Z; Adamski, N; Broomandkhoshbacht, N; Callan, K; Candilio, F; Carlson, KSD; Culleton, BJ; Eccles, L; Freilich, S; Keating, D; Lawson, AM; Mandl, K; Michel, M; Oppenheimer, J; Ozdogan, KT; Stewardson, K; Wen, SQ; Yan, S; Zalzala, F; Chuang, R; Huang, CJ; Looh, H; Shiung, CC; Nikitin, YG; Tabarev, AV; Tishkin, AA; Lin, S; Sun, ZY; Wu, XM; Yang, TL; Hu, X; Chen, L; Du, H; Bayarsaikhan, J; Mijiddorj, E; Erdenebaatar, D; Iderkhangai, TO; Myagmar, E; Kanzawa-Kiriyama, H; Nishino, M; Shinoda, K; Shubina, OA; Guo, JX; Cai, WW; Deng, QY; Kang, LL; Li, DW; Li, DN; Lin, R; Nini; Shrestha, R; Wang, LX; Wei, LH; Xie, GM; Yao, HB; Zhang, MF; He, GL; Yang, XM; Hu, R; Robbeets, M; Schiffels, S; Kennett, DJ; Jin, L; Li, H; Krause, J; Pinhasi, R; Reich, D				Wang, Chuan-Chao; Yeh, Hui-Yuan; Popov, Alexander N.; Zhang, Hu-Qin; Matsumura, Hirofumi; Sirak, Kendra; Cheronet, Olivia; Kovalev, Alexey; Rohland, Nadin; Kim, Alexander M.; Mallick, Swapan; Bernardos, Rebecca; Tumen, Dashtseveg; Zhao, Jing; Liu, Yi-Chang; Liu, Jiun-Yu; Mah, Matthew; Wang, Ke; Zhang, Zhao; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Callan, Kimberly; Candilio, Francesca; Carlson, Kellie Sara Duffett; Culleton, Brendan J.; Eccles, Laurie; Freilich, Suzanne; Keating, Denise; Lawson, Ann Marie; Mandl, Kirsten; Michel, Megan; Oppenheimer, Jonas; Ozdogan, Kadir Toykan; Stewardson, Kristin; Wen, Shaoqing; Yan, Shi; Zalzala, Fatma; Chuang, Richard; Huang, Ching-Jung; Looh, Hana; Shiung, Chung-Ching; Nikitin, Yuri G.; Tabarev, Andrei V.; Tishkin, Alexey A.; Lin, Song; Sun, Zhou-Yong; Wu, Xiao-Ming; Yang, Tie-Lin; Hu, Xi; Chen, Liang; Du, Hua; Bayarsaikhan, Jamsranjav; Mijiddorj, Enkhbayar; Erdenebaatar, Diimaajav; Iderkhangai, Tumur-Ochir; Myagmar, Erdene; Kanzawa-Kiriyama, Hideaki; Nishino, Masato; Shinoda, Ken-ichi; Shubina, Olga A.; Guo, Jianxin; Cai, Wangwei; Deng, Qiongying; Kang, Longli; Li, Dawei; Li, Dongna; Lin, Rong; Nini; Shrestha, Rukesh; Wang, Ling-Xiang; Wei, Lanhai; Xie, Guangmao; Yao, Hongbing; Zhang, Manfei; He, Guanglin; Yang, Xiaomin; Hu, Rong; Robbeets, Martine; Schiffels, Stephan; Kennett, Douglas J.; Jin, Li; Li, Hui; Krause, Johannes; Pinhasi, Ron; Reich, David			Genomic insights into the formation of human populations in East Asia	NATURE			English	Article							HUMAN OCCUPATION; TIBETAN PLATEAU; ADMIXTURE; NORTHERN; BONES; EVOLUTION; ANCESTRY; SEQUENCE; HISTORY; ORIGIN	The deep population history of East Asia remains poorly understood owing to a lack of ancient DNA data and sparse sampling of present-day people(1,2). Here we report genome-wide data from 166 East Asian individuals dating to between 6000 BC and AD 1000 and 46 present-day groups. Hunter-gatherers from Japan, the Amur River Basin, and people of Neolithic and Iron Age Taiwan and the Tibetan Plateau are linked by a deeply splitting lineage that probably reflects a coastal migration during the Late Pleistocene epoch. We also follow expansions during the subsequent Holocene epoch from four regions. First, hunter-gatherers from Mongolia and the Amur River Basin have ancestry shared by individuals who speak Mongolic and Tungusic languages, but do not carry ancestry characteristic of farmers from the West Liao River region (around 3000 BC), which contradicts theories that the expansion of these farmers spread the Mongolic and Tungusic proto-languages. Second, farmers from the Yellow River Basin (around 3000 BC) probably spread Sino-Tibetan languages, as their ancestry dispersed both to Tibet-where it forms approximately 84% of the gene pool in some groups-and to the Central Plain, where it has contributed around 59-84% to modern Han Chinese groups. Third, people from Taiwan from around 1300 BC to AD 800 derived approximately 75% of their ancestry from a lineage that is widespread in modern individuals who speak Austronesian, Tai-Kadai and Austroasiatic languages, and that we hypothesize derives from farmers of the Yangtze River Valley. Ancient people from Taiwan also derived about 25% of their ancestry from a northern lineage that is related to, but different from, farmers of the Yellow River Basin, which suggests an additional north-to-south expansion. Fourth, ancestry from Yamnaya Steppe pastoralists arrived in western Mongolia after around 3000 BC but was displaced by previously established lineages even while it persisted in western China, as would be expected if this ancestry was associated with the spread of proto-Tocharian Indo-European languages. Two later gene flows affected western Mongolia: migrants after around 2000 BC with Yamnaya and European farmer ancestry, and episodic influences of later groups with ancestry from Turan.	[Wang, Chuan-Chao; Guo, Jianxin; Wei, Lanhai; He, Guanglin; Yang, Xiaomin; Hu, Rong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Dept Anthropol & Ethnol,Inst Anthropol, Xiamen, Fujian, Peoples R China; [Wang, Chuan-Chao; Sirak, Kendra; Rohland, Nadin; Kim, Alexander M.; Mallick, Swapan; Bernardos, Rebecca; Zhang, Zhao; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Callan, Kimberly; Lawson, Ann Marie; Michel, Megan; Oppenheimer, Jonas; Stewardson, Kristin; Zalzala, Fatma; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Wang, Chuan-Chao; Mallick, Swapan; Wang, Ke; Schiffels, Stephan; Krause, Johannes] Max Planck Inst Sci Human Hist, Dept Archaeogenet, Jena, Germany; [Wang, Chuan-Chao; Shrestha, Rukesh; Wang, Ling-Xiang; Zhang, Manfei; Jin, Li; Li, Hui] Fudan Univ, Sch Life Sci, Dept Anthropol & Human Genet, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China; [Yeh, Hui-Yuan] Nanyang Technol Univ, Sch Humanities, Nanyang, Singapore; [Popov, Alexander N.] Far Eastern Fed Univ, Sci Museum, Vladivostok, Russia; [Zhang, Hu-Qin; Zhao, Jing; Lin, Song; Wu, Xiao-Ming; Yang, Tie-Lin; Hu, Xi] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian, Shaanxi, Peoples R China; [Matsumura, Hirofumi] Sapporo Med Univ, Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Sirak, Kendra; Reich, David] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Cheronet, Olivia; Candilio, Francesca; Carlson, Kellie Sara Duffett; Freilich, Suzanne; Keating, Denise; Mandl, Kirsten; Ozdogan, Kadir Toykan; Pinhasi, Ron] Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria; [Kovalev, Alexey] Russian Acad Sci, Inst Archaeol, Moscow, Russia; [Kim, Alexander M.] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Mallick, Swapan; Mah, Matthew; Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Mallick, Swapan; Mah, Matthew; Adamski, Nicole; Broomandkhoshbacht, Nasreen; Callan, Kimberly; Lawson, Ann Marie; Michel, Megan; Stewardson, Kristin; Zalzala, Fatma; Reich, David] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Tumen, Dashtseveg; Myagmar, Erdene] Natl Univ Mongolia, Dept Anthropol & Archaeol, Ulaanbaatar, Mongolia; [Liu, Yi-Chang; Chuang, Richard; Huang, Ching-Jung; Shiung, Chung-Ching] Natl Cheng Kung Univ, Inst Archaeol, Tainan, Taiwan; [Liu, Jiun-Yu] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Culleton, Brendan J.] Penn State Univ, Inst Energy, University Pk, PA 16802 USA; [Culleton, Brendan J.] Penn State Univ, Inst Environm, University Pk, PA 16802 USA; [Eccles, Laurie] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Wen, Shaoqing] Fudan Univ, Inst Archaeol Sci, Shanghai, Peoples R China; [Yan, Shi] Minzu Univ China, Sch Ethnol & Sociol, Beijing, Peoples R China; [Looh, Hana] Acad Sinica, Inst Hist & Philol, Taipei, Taiwan; [Nikitin, Yuri G.] Russian Acad Sci, Far Eastern Branch, Inst Hist Archaeol & Ethnol, Museum Archaeol & Ethnol, Vladivostok, Russia; [Tabarev, Andrei V.] Russian Acad Sci, Siberian Branch, Inst Archaeol & Ethnog, Novosibirsk, Russia; [Tishkin, Alexey A.] Altai State Univ, Dept Archeol Ethnog & Museol, Barnaul, Russia; [Sun, Zhou-Yong] Shaanxi Prov Inst Archaeol, Xian, Shaanxi, Peoples R China; [Chen, Liang] Northwest Univ, Sch Cultural Heritage, Xian, Shaanxi, Peoples R China; [Du, Hua] Chinese Acad Sci, Inst Earth Environm, Xian AMS Ctr, Xian, Shaanxi, Peoples R China; [Bayarsaikhan, Jamsranjav] Natl Museum Mongolia, Res Ctr, Ulaanbaatar, Mongolia; [Mijiddorj, Enkhbayar; Erdenebaatar, Diimaajav; Iderkhangai, Tumur-Ochir] Ulaanbaatar State Univ, Dept Archaeol, Ulaanbaatar, Mongolia; [Kanzawa-Kiriyama, Hideaki] Natl Museum Nat & Sci, Dept Anthropol, Tsukuba, Ibaraki, Japan; [Nishino, Masato; Shinoda, Ken-ichi] Archaeol Ctr Chiba City, Chiba, Japan; [Shubina, Olga A.] Sakhalin Reg Museum, Dept Archeol, Yuzhno Sakhalinsk, Russia; [Cai, Wangwei] Hainan Med Univ, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China; [Deng, Qiongying] Guangxi Med Univ, Dept Human Anat, Nanning, Peoples R China; [Deng, Qiongying] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China; [Kang, Longli; Lin, Rong; Nini] Xizang Minzu Univ Tibet Univ Nationalities, Sch Med, Minist Educ, Key Lab Mol Genet Mech & Intervent Res High Altit, Xianyang, Peoples R China; [Li, Dawei] Guangxi Univ Nationalities, Inst Hist & Culture Sci & Technol, Nanning, Peoples R China; [Li, Dongna] Hainan Med Univ, Dept Biol, Haikou, Hainan, Peoples R China; [Xie, Guangmao] Guangxi Normal Univ, Coll Hist Culture & Tourism, Guilin, Peoples R China; [Xie, Guangmao] Guangxi Inst Cultural Relics Protect & Archaeol, Nanning, Peoples R China; [Yao, Hongbing] Gansu Inst Polit Sci & Law, Key Lab Evidence Sci Gansu Prov, Belt & Rd Res Ctr Forens Mol Anthropol, Lanzhou, Gansu, Peoples R China; [Robbeets, Martine] Max Planck Inst Sci Human Hist, Eurasia3angle Res Grp, Jena, Germany; [Kennett, Douglas J.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Xiamen University; Harvard University; Harvard Medical School; Fudan University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Far Eastern Federal University; Xi'an Jiaotong University; Sapporo Medical University; Harvard University; University of Vienna; Institute of Archaeology, Russian Academy of Sciences; Russian Academy of Sciences; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; National University of Mongolia; National Cheng Kung University; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Fudan University; Minzu University of China; Academia Sinica - Taiwan; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; Altai State University; Northwest University Xi'an; Chinese Academy of Sciences; Institute of Earth Environment, CAS; Ulaanbaatar State University; National Museum of Nature and Science; Hainan Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Minzu University; Hainan Medical University; Guangxi Normal University; Gansu University of Political Science & Law; University of California System; University of California Santa Barbara	Wang, CC (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Dept Anthropol & Ethnol,Inst Anthropol, Xiamen, Fujian, Peoples R China.; Wang, CC; Reich, D (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Wang, CC; Krause, J (corresponding author), Max Planck Inst Sci Human Hist, Dept Archaeogenet, Jena, Germany.; Wang, CC (corresponding author), Fudan Univ, Sch Life Sci, Dept Anthropol & Human Genet, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China.; Reich, D (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.; Pinhasi, R (corresponding author), Univ Vienna, Dept Evolutionary Anthropol, Vienna, Austria.; Reich, D (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Reich, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.	wang@xmu.edu.cn; krause@shh.mpg.de; ron.pinhasi@univie.ac.at; reich@genetics.med.harvard.edu	Aleksandr, Popov/ABI-1123-2020; Tishkin, Alexey A./A-7059-2016; Kovalev, Alexey/GRF-1494-2022; Candilio, Francesca/C-8634-2019; Krause, Johannes/AFP-2642-2022; Wang, Chuan-Chao/AGY-2940-2022; Tabarev, Andrey V/E-3947-2016; Liu, Jiun-Yu/B-2319-2016; Wen, Shaoqing/CAH-8955-2022; wu, xiaoming/E-6837-2015	Candilio, Francesca/0000-0002-4668-1361; Krause, Johannes/0000-0001-9144-3920; Wang, Chuan-Chao/0000-0003-4630-5232; Liu, Jiun-Yu/0000-0002-1095-6933; Kovalev, Alexey/0000-0003-2637-3131; Cheronet, Olivia/0000-0001-6760-1204; Duffett Carlson, KS/0000-0002-7194-6608; Freilich, Suzanne/0000-0003-0472-6311; Popov, Alexander/0000-0002-1423-8410; Callan, Kimberly/0000-0003-3170-8514; Oppenheimer, Jonas/0000-0001-7973-6173; wu, xiaoming/0000-0003-0908-0986	Far Eastern Federal University; Institute of History, Archaeology and Ethnology Far Eastern Branch of the Russian Academy of Sciences; RFBR [18-09-40101]; Max Planck Society; National Natural Science Foundation of China [NSFC 31801040]; Nanqiang Outstanding Young Talents Program of Xiamen University [X2123302]; National Social Science Foundation of China, a European Research Council (ERC) [20ZD248, ERC-2019-ADG-883700-TRAM]; Fundamental Research Funds for the Central Universities [ZK1144]; JSPS [16H02527]; ERC under the European Union [646612]; DFG [KR 4015/1-1]; Baden Wurttemberg Foundation; Max Planck Institute; National Science Foundation (NSF) [BCS-1460369]; NSF [BCS-1032255]; NIH (NIGMS) [GM100233]; Paul M. Allen Frontiers Group; John Templeton Foundation [61220];  [91731303];  [31671297];  [18490750300]	Far Eastern Federal University; Institute of History, Archaeology and Ethnology Far Eastern Branch of the Russian Academy of Sciences; RFBR(Russian Foundation for Basic Research (RFBR)); Max Planck Society(Max Planck SocietyFoundation CELLEX); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanqiang Outstanding Young Talents Program of Xiamen University(Xiamen University); National Social Science Foundation of China, a European Research Council (ERC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ERC under the European Union; DFG(German Research Foundation (DFG)); Baden Wurttemberg Foundation; Max Planck Institute(Foundation CELLEX); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF(National Science Foundation (NSF)); NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Paul M. Allen Frontiers Group; John Templeton Foundation; ; ; 	We thank D. Anthony, O. Bar-Yosef, K. Brunson, R. Flad, P. Flegontov, Q. Fu, W. Haak, I. Lazaridis, M. Lipson, I. Mathieson, R. Meadow, I. Olalde, N. Patterson, P. Skoglund, D. Xu, P. Bellwood and C. Chiang for comments; N. Saitou and the Asian DNA Repository Consortium for sharing genotype data from present-day Japanese groups; T. Nishimoto and T. Fujisawa from the Rebun Town Board of Education for sharing the Funadomari Jomon samples, and H. Tanaka and W. Nagahara from the Archeological Center of Chiba City, who are excavators of the Rokutsu Jomon site. The excavations at Boisman-2 site (Boisman culture), the Pospelovo-1 site (Yankovsky culture) and the Roshino-4 site (Heishui Mohe culture) were funded by the Far Eastern Federal University and the Institute of History, Archaeology and Ethnology Far Eastern Branch of the Russian Academy of Sciences; research on Pospelovo-1 is funded by RFBR project number 18-09-40101. C.-C.W. was funded by the Max Planck Society, the National Natural Science Foundation of China (NSFC 31801040), the Nanqiang Outstanding Young Talents Program of Xiamen University (X2123302), the Major project of National Social Science Foundation of China (20&ZD248), a European Research Council (ERC) grant to D. Xu (ERC-2019-ADG-883700-TRAM) and Fundamental Research Funds for the Central Universities (ZK1144). H.M. was supported by grant JSPS 16H02527. M.R. and C.-C.W. received funding from the ERC under the European Union's Horizon 2020 research and innovation program (grant no. 646612) to M.R. H. Li was funded NSFC (91731303, 31671297), B&R International Joint Laboratory of Eurasian Anthropology (18490750300). J.K. was funded by DFG grant KR 4015/1-1, the Baden Wurttemberg Foundation and the Max Planck Institute. Accelerator Mass Spectrometry radiocarbon dating work was supported by the National Science Foundation (NSF) (BCS-1460369) to D.J.K. and B.J.C. D.R. was funded by NSF grant BCS-1032255, NIH (NIGMS) grant GM100233, the Paul M. Allen Frontiers Group, John Templeton Foundation grant 61220, a gift from J.-F. Clin and the Howard Hughes Medical Institute.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bellwood P., 2013, ENCY GLOBAL HUMAN MI; Bellwood P., 2002, EXAMINING FARMINGLAN; Bellwood P, 2011, RICE, V4, P93, DOI 10.1007/s12284-011-9068-9; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Cavalli-Sforza LL, 1998, P NATL ACAD SCI USA, V95, P11501, DOI 10.1073/pnas.95.20.11501; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Chiang CWK, 2018, MOL BIOL EVOL, V35, P2736, DOI 10.1093/molbev/msy170; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gansauge MT, 2014, GENOME RES, V24, P1543, DOI 10.1101/gr.174201.114; Ge J, 1997, MIGRATION HIST CHINA; Gunther T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008302; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Jeong C, 2020, CELL, V183, P890, DOI 10.1016/j.cell.2020.10.015; Jeong C, 2016, P NATL ACAD SCI USA, V113, P7485, DOI 10.1073/pnas.1520844113; John J., 2011, SEQPREP; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kennett DJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14115; Ko AMS, 2014, AM J HUM GENET, V94, P426, DOI 10.1016/j.ajhg.2014.02.003; Korlevic P, 2015, BIOTECHNIQUES, V59, P87, DOI 10.2144/000114320; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kovalev A., 2011, INT J EURASIAN STUD, V1, P1; Kuhn JMM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195491; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipson M, 2018, SCIENCE, V361, P92, DOI 10.1126/science.aat3188; Lipson M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5689; Liu SY, 2018, CELL, V175, P347, DOI 10.1016/j.cell.2018.08.016; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; Lohse JC, 2014, QUATERNARY SCI REV, V102, P14, DOI 10.1016/j.quascirev.2014.07.021; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Mallory J. P, 1991, SEARCH INDO EUROPEAN; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Massilani D, 2020, SCIENCE, V370, P579, DOI 10.1126/science.abc1166; McColl H, 2018, SCIENCE, V361, P88, DOI 10.1126/science.aat3628; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nakashima A, 2010, AM J HUM BIOL, V22, P782, DOI 10.1002/ajhb.21083; Narasimhan VM, 2019, SCIENCE, V365, P999, DOI 10.1126/science.aat7487; Ning C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16557-2; Ning C, 2019, CURR BIOL, V29, P2526, DOI 10.1016/j.cub.2019.06.044; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pinhasi R, 2019, NAT PROTOC, V14, P1194, DOI 10.1038/s41596-019-0137-7; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Ringbauer H., 2020, PREPRINT BIORXIV, DOI [10.1038/s41586-021-03336-2, DOI 10.1038/S41586-021-03336-2]; Robbeets M., 2020, OXFORD GUIDE TRANSEU; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Rohland N, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0050-5; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sirak KA, 2017, BIOTECHNIQUES, V62, P283, DOI 10.2144/000114558; Siska V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601877; Skoglund P, 2016, NATURE, V538, P510, DOI 10.1038/nature19844; Van Driem G., 2005, PEOPLING E ASIA PUTT, P81; Wang Chuan-Chao, 2013, Investig Genet, V4, P11, DOI 10.1186/2041-2223-4-11; Wang K, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008552; Wang LX, 2018, MOL GENET GENOMICS, V293, P1293, DOI 10.1007/s00438-018-1461-2; Wei LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175080; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Wilkin S, 2020, NAT ECOL EVOL, V4, P346, DOI 10.1038/s41559-020-1120-y; Yang MA, 2020, SCIENCE, V369, P282, DOI 10.1126/science.aba0909; Yang MA, 2017, CURR BIOL, V27, P3202, DOI 10.1016/j.cub.2017.09.030; Yang XY, 2012, P NATL ACAD SCI USA, V109, P3726, DOI 10.1073/pnas.1115430109; Zhang MH, 2019, NATURE, V569, P112, DOI 10.1038/s41586-019-1153-z; Zhang XL, 2018, SCIENCE, V362, P1049, DOI 10.1126/science.aat8824	75	102	110	49	180	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					413	+		10.1038/s41586-021-03336-2	http://dx.doi.org/10.1038/s41586-021-03336-2		FEB 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33618348	Green Accepted			2022-12-28	WOS:000627286100001
J	Lu, J; Xue, Y; Bernardino, K; Zhang, NN; Gomes, WR; Ramesar, NS; Liu, SH; Hu, Z; Sun, TM; de Moura, AF; Kotov, NA; Liu, K				Lu, Jun; Xue, Yao; Bernardino, Kalil; Zhang, Ning-Ning; Gomes, Weverson R.; Ramesar, Naomi S.; Liu, Shuhan; Hu, Zheng; Sun, Tianmeng; de Moura, Andre Farias; Kotov, Nicholas A.; Liu, Kun			Enhanced optical asymmetry in supramolecular chiroplasmonic assemblies with long-range order	SCIENCE			English	Article								Chiral assemblies of plasmonic nanoparticles are known for strong circular dichroism but not for high optical asymmetry, which is limited by the unfavorable combination of electrical and magnetic field components compounded by strong scattering. Here, we show that these limitations can be overcome by the long-range organization of nanoparticles in a manner similar to the liquid crystals and found in helical assemblies of gold nanorods with human islet amyloid polypeptides. A strong, polarization-dependent spectral shift and the reduced scattering of energy states with antiparallel orientation of dipoles activated in assembled helices increased optical asymmetry g-factors by a factor of more than 4600. The liquid crystal-like color variations and the nanorod-accelerated fibrillation enable drug screening in complex biological media. Improvement of long-range order can also provide structural guidance for the design of materials with high optical asymmetry.	[Lu, Jun; Xue, Yao; Zhang, Ning-Ning; Liu, Kun] Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, Changchun, Jilin, Peoples R China; [Lu, Jun; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Lu, Jun; Ramesar, Naomi S.; Kotov, Nicholas A.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Bernardino, Kalil] Univ Sao Paulo, Inst Chem, BR-05508000 Sao Paulo, SP, Brazil; [Gomes, Weverson R.; de Moura, Andre Farias] Univ Fed Sao Carlos, Dept Chem, BR-13565905 Sao Carlos, SP, Brazil; [Ramesar, Naomi S.; Kotov, Nicholas A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Liu, Shuhan; Hu, Zheng; Sun, Tianmeng] Jilin Univ, Hosp 1, Inst Immunol, Key Lab Organ Regenerat & Transplantat,Minist Edu, Changchun, Peoples R China; [Liu, Kun] Jilin Univ, Hosp 1, Opt Funct Theranost Joint Lab Med & Chem, Changchun, Peoples R China; [Liu, Kun] Jilin Univ, Chiral Nanomat Res Ctr, Int Ctr Future Sci, Changchun, Peoples R China	Jilin University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidade de Sao Paulo; Universidade Federal de Sao Carlos; University of Michigan System; University of Michigan; Jilin University; Jilin University; Jilin University	Liu, K (corresponding author), Jilin Univ, Coll Chem, State Key Lab Supramol Struct & Mat, Changchun, Jilin, Peoples R China.; Kotov, NA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; de Moura, AF (corresponding author), Univ Fed Sao Carlos, Dept Chem, BR-13565905 Sao Carlos, SP, Brazil.; Kotov, NA (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.; Liu, K (corresponding author), Jilin Univ, Hosp 1, Opt Funct Theranost Joint Lab Med & Chem, Changchun, Peoples R China.; Liu, K (corresponding author), Jilin Univ, Chiral Nanomat Res Ctr, Int Ctr Future Sci, Changchun, Peoples R China.	moura@ufscar.br; kotov@umich.edu; kliu@jlu.edu.cn	Bernardino, Kalil/M-3227-2013; Kotov, Nicholas/AAZ-4204-2021	Bernardino, Kalil/0000-0002-6469-0245; Kotov, Nicholas/0000-0002-6864-5804; Farias de Moura, Andre/0000-0003-1974-4803; gomes, weverson/0000-0002-9456-9534; Xue, Yao/0000-0002-2514-9595; Lu, Jun/0000-0001-7029-855X; Liu, Kun/0000-0003-2940-9814; Ramesar, Naomi/0000-0002-8848-8308	National Natural Science Foundation of China [21534004, 21674042, 21911530179]; JLU Science and Technology Innovative Research Team [2017TD-06]; Open Project of State Key Laboratory of Supramolecular Structure and Materials [sklssm201736]; Jilin Province International Collaboration Base of Science and Technology [YDZJ202102CXJD004]; Interdisciplinary Innovation Project of the First Hospital of JLU [JDYYJCHX001, JDYYJCHX2020002]; CAPES [001]; CNPq; FAPESP [2012/15147-4, 2013/07296-2, 17/12063-8]; NSF project "Energy-and Cost-Efficient Manufacturing Employing Nanoparticles" [NSF 1463474]; Vannevar Bush DoD Fellowship [ONR N000141812876]; Office of Naval Research Multidisciplinary University Research Initiative Award [ONR N00014-18-1-2497]; NSF [1566460]; Defense Advanced Research Projects Agency (DARPA) [HR00111720067]; Newton Award [ONRHQ00342010033]; University of Michigan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); JLU Science and Technology Innovative Research Team; Open Project of State Key Laboratory of Supramolecular Structure and Materials; Jilin Province International Collaboration Base of Science and Technology; Interdisciplinary Innovation Project of the First Hospital of JLU; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NSF project "Energy-and Cost-Efficient Manufacturing Employing Nanoparticles"; Vannevar Bush DoD Fellowship; Office of Naval Research Multidisciplinary University Research Initiative Award(MURI); NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Newton Award; University of Michigan(University of Michigan System)	K.L. gratefully acknowledges the financial support from the National Natural Science Foundation of China (21534004, 21674042, and 21911530179), the JLU Science and Technology Innovative Research Team (2017TD-06), and the Open Project of State Key Laboratory of Supramolecular Structure and Materials (sklssm201736). K.L. also thanks the Jilin Province International Collaboration Base of Science and Technology (YDZJ202102CXJD004). K.L., T.S., and Z.H. acknowledge financial support from the Interdisciplinary Innovation Project of the First Hospital of JLU (JDYYJCHX001 and JDYYJCHX2020002). The authors thank the Brazilian funding agencies CAPES (process 001), CNPq, and FAPESP (processes 2012/15147-4, 2013/07296-2, and 17/12063-8) for financial support. This work was supported by the NSF project "Energy-and Cost-Efficient Manufacturing Employing Nanoparticles" (NSF 1463474) and a Vannevar Bush DoD Fellowship to N.A.K. entitled "Engineered Chiral Ceramics" (ONR N000141812876); partially supported by Office of Naval Research Multidisciplinary University Research Initiative Award ONR N00014-18-1-2497 (N.A.K. and J.L.); and NSF 1566460 "Nanospiked Particles for Photocatalysis" is also acknowledged (N.A.K. and N.S.R.). N.A.K. is also grateful to the Defense Advanced Research Projects Agency (DARPA) for the HR00111720067 project entitled "Electromagnetic Processes and Normal Modes in Bacterial Biofilms," the Newton Award ONRHQ00342010033 entitled "Pathways to Complexity with `Imperfect' Nanoparticles," and for discretionary funds from the University of Michigan for the supplementary funding for this work.	Aguiar J, 2003, J COLLOID INTERF SCI, V258, P116, DOI 10.1016/S0021-9797(02)00082-6; [Anonymous], MEDLINE, DOI [10.1126/science.1089171, DOI 10.1126/SCIENCE.1089171]; [Anonymous], MEDLINE, DOI [10.1021/jacs.8b06526, DOI 10.1021/JACS.8B06526]; [Anonymous], J MOL BIOL, DOI [10.1016/j.jmb.2005.02.029, DOI 10.1016/J.JMB.2005.02.029]; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bergueiro J, 2020, NANOSCALE HORIZ, V5, P495, DOI 10.1039/c9nh00659a; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Caillon L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5639875; CASSIM JY, 1969, BIOCHEMISTRY-US, V8, P1947, DOI 10.1021/bi00833a026; Chen W, 2009, NANO LETT, V9, P2153, DOI 10.1021/nl900726s; Cheng GQ, 2019, ACS NANO, V13, P1479, DOI 10.1021/acsnano.8b07151; Cheng JJ, 2017, ACS NANO, V11, P3806, DOI 10.1021/acsnano.6b08723; CHIELLINI E, 1985, MACROMOLECULES, V18, P1652, DOI 10.1021/ma00151a003; Collins JT, 2017, ADV OPT MATER, V5, DOI 10.1002/adom.201700182; Craig MR, 2003, ADV MATER, V15, P1435, DOI 10.1002/adma.200305243; De Simone A, 2020, J PHARMACEUT BIOMED, V178, DOI 10.1016/j.jpba.2019.112899; DETAR DF, 1969, ANAL CHEM, V41, P1406, DOI 10.1021/ac60280a009; Engel MFM, 2012, J AM CHEM SOC, V134, P14781, DOI 10.1021/ja3031664; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feng WC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601159; Gomez-Grana S, 2012, LANGMUIR, V28, P1453, DOI 10.1021/la203451p; Gonzalez-Rubio G, 2020, SCIENCE, V368, P1472, DOI 10.1126/science.aba0980; Goto H, 2007, MACROMOLECULES, V40, P1377, DOI 10.1021/ma062296k; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Heinz H, 2008, J PHYS CHEM C, V112, P17281, DOI 10.1021/jp801931d; Hentschel M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602735; Ho CS, 2017, ACS PHOTONICS, V4, P197, DOI 10.1021/acsphotonics.6b00701; Hore MJA, 2015, NANO LETT, V15, P5730, DOI 10.1021/acs.nanolett.5b03088; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jana NR, 2001, LANGMUIR, V17, P6782, DOI 10.1021/1a0104323; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kang MK, 2015, BIOSENS BIOELECTRON, V72, P197, DOI 10.1016/j.bios.2015.05.017; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kim Y, 2016, NAT MATER, V15, P461, DOI [10.1038/NMAT4525, 10.1038/nmat4525]; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kumar J, 2018, P NATL ACAD SCI USA, V115, P3225, DOI 10.1073/pnas.1721690115; Kuzyk A, 2018, ACS PHOTONICS, V5, P1151, DOI 10.1021/acsphotonics.7b01580; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Lan X, 2018, J AM CHEM SOC, V140, P11763, DOI 10.1021/jacs.8b06526; Lee A, 2011, J AM CHEM SOC, V133, P7563, DOI 10.1021/ja2015179; Lee HE, 2018, NATURE, V556, P360, DOI 10.1038/s41586-018-0034-1; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Liu G, 2010, J AM CHEM SOC, V132, P18223, DOI 10.1021/ja1069882; Liu H, 2014, NANOSCALE, V6, P9331, DOI 10.1039/c3nr06913c; Liu K, 2010, SCIENCE, V329, P197, DOI 10.1126/science.1189457; Lu J, 2019, CHEM SCI, V10, P2067, DOI 10.1039/c8sc02847h; Lu J, 2017, ACS NANO, V11, P3463, DOI 10.1021/acsnano.6b07697; Ma W, 2017, CHEM REV, V117, P8041, DOI 10.1021/acs.chemrev.6b00755; Mark AG, 2013, NAT MATER, V12, P802, DOI [10.1038/NMAT3685, 10.1038/nmat3685]; MARSHALL AG, 1978, ANAL CHEM, V50, P756, DOI 10.1021/ac50027a023; Merg AD, 2016, J AM CHEM SOC, V138, P13655, DOI 10.1021/jacs.6b07322; Milton FP, 2016, NANOSCALE HORIZ, V1, P14, DOI 10.1039/c5nh00072f; Morrow SM, 2017, NAT NANOTECHNOL, V12, P410, DOI [10.1038/nnano.2017.62, 10.1038/NNANO.2017.62]; Mudedla SK, 2018, J PHYS CHEM B, V122, P9654, DOI 10.1021/acs.jpcb.8b07917; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Nordlander P, 2004, NANO LETT, V4, P899, DOI 10.1021/nl049681c; Orendorff CJ, 2006, J PHYS CHEM B, V110, P3990, DOI 10.1021/jp0570972; Polavarapu PL, 2005, J PHYS CHEM A, V109, P7013, DOI 10.1021/jp0524328; Prodan E, 2003, SCIENCE, V302, P419, DOI 10.1126/science.1089171; Schulz M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04811-7; Seo J, 2017, NAT CHEM, V9, P39, DOI [10.1038/NCHEM.2615, 10.1038/nchem.2615]; Shafiqa A.R., 2018, J PHYS C SER, V1083, P12040; Shiota M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03899-1; Srivastava A, 2010, CHEM-EUR J, V16, P9257, DOI 10.1002/chem.200902968; Srivastava AK, 2019, PROTEIN SCI, V28, P1567, DOI 10.1002/pro.3674; Stsiapura VI, 2007, J PHYS CHEM A, V111, P4829, DOI 10.1021/jp070590o; Tang YQ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.163901; TOYOZAWA Y, 1958, PROG THEOR PHYS, V20, P53, DOI 10.1143/PTP.20.53; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Der Spoel David, 2005, J COMPUT CHEM, V26, P1701, DOI [10.1002/jcc.20291, DOI 10.1002/JCC.20291, 10.1002/JCC.20291]; Varnholt B, 2014, J PHYS CHEM C, V118, P9604, DOI 10.1021/jp502453q; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Wu L, 2012, BIOSENS BIOELECTRON, V38, P94, DOI 10.1016/j.bios.2012.05.005; Xiang YJ, 2008, J PHYS CHEM C, V112, P3203, DOI 10.1021/jp710505t; Xue QB, 2004, LIQ CRYST, V31, P137, DOI 10.1080/02678290410001637185; Yan J, 2020, CHEM MATER, V32, P476, DOI 10.1021/acs.chemmater.9b04143; Yao K, 2018, NANOSCALE, V10, P8779, DOI 10.1039/c8nr00902c; Yeom J, 2018, SCIENCE, V359, P309, DOI 10.1126/science.aao7172; Zhang QF, 2019, SCIENCE, V365, P1475, DOI 10.1126/science.aax5415; Zhao J, 2006, NANOMEDICINE-UK, V1, P219, DOI 10.2217/17435889.1.2.219	89	89	88	78	425	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2021	371	6536					1368	+		10.1126/science.abd8576	http://dx.doi.org/10.1126/science.abd8576			76	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2GI	33632891				2022-12-28	WOS:000636043400051
J	Qiao, JX; Li, YS; Zeng, R; Liu, FL; Luo, RH; Huang, C; Wang, YF; Zhang, J; Quan, BX; Shen, CJ; Mao, X; Liu, XL; Sun, WN; Yang, W; Ni, XC; Wang, K; Xu, L; Duan, ZL; Zou, QC; Zhang, HL; Qu, W; Long, YHP; Li, MH; Yang, RC; Liu, XL; You, J; Zhou, YL; Yao, R; Li, WP; Liu, JM; Chen, P; Liu, Y; Lin, GF; Yang, X; Zou, J; Li, LL; Hu, YG; Lu, GW; Li, WM; Wei, YQ; Zheng, YT; Lei, J; Yang, SY				Qiao, Jingxin; Li, Yue-Shan; Zeng, Rui; Liu, Feng-Liang; Luo, Rong-Hua; Huang, Chong; Wang, Yi-Fei; Zhang, Jie; Quan, Baoxue; Shen, Chenjian; Mao, Xin; Liu, Xinlei; Sun, Weining; Yang, Wei; Ni, Xincheng; Wang, Kai; Xu, Ling; Duan, Zi-Lei; Zou, Qing-Cui; Zhang, Hai-Lin; Qu, Wang; Long, Yang-Hao-Peng; Li, Ming-Hua; Yang, Rui-Cheng; Liu, Xiaolong; You, Jing; Zhou, Yangli; Yao, Rui; Li, Wen-Pei; Liu, Jing-Ming; Chen, Pei; Liu, Yang; Lin, Gui-Feng; Yang, Xin; Zou, Jun; Li, Linli; Hu, Yiguo; Lu, Guang-Wen; Li, Wei-Min; Wei, Yu-Quan; Zheng, Yong-Tang; Lei, Jian; Yang, Shengyong			SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model	SCIENCE			English	Article							3CL PROTEASE INHIBITORS; SARS; DISCOVERY; DESIGN	The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continually poses serious threats to global public health. The main protease (M-pro) of SARS-CoV-2 plays a central role in viral replication. We designed and synthesized 32 new bicycloproline-containing M-pro inhibitors derived from either boceprevir or telaprevir, both of which are approved antivirals. All compounds inhibited SARS-CoV-2 M-pro activity in vitro, with 50% inhibitory concentration values ranging from 7.6 to 748.5 nM. The cocrystal structure of M-pro in complex with MI-23, one of themost potent compounds, revealed its interactionmode. Two compounds (MI-09 and MI-30) showed excellent antiviral activity in cell-based assays. In a transgenic mouse model of SARS-CoV-2 infection, oral or intraperitoneal treatment withMI-09 or MI-30 significantly reduced lung viral loads and lung lesions. Both also displayed good pharmacokinetic properties and safety in rats.	[Qiao, Jingxin; Li, Yue-Shan; Zeng, Rui; Huang, Chong; Zhang, Jie; Quan, Baoxue; Shen, Chenjian; Mao, Xin; Liu, Xinlei; Sun, Weining; Yang, Wei; Ni, Xincheng; Wang, Kai; Yang, Rui-Cheng; Liu, Xiaolong; You, Jing; Zhou, Yangli; Yao, Rui; Li, Wen-Pei; Liu, Jing-Ming; Liu, Yang; Lin, Gui-Feng; Yang, Xin; Zou, Jun; Hu, Yiguo; Lu, Guang-Wen; Li, Wei-Min; Wei, Yu-Quan; Lei, Jian; Yang, Shengyong] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China; [Liu, Feng-Liang; Luo, Rong-Hua; Xu, Ling; Duan, Zi-Lei; Zheng, Yong-Tang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China; [Liu, Feng-Liang; Luo, Rong-Hua; Xu, Ling; Duan, Zi-Lei; Zou, Qing-Cui; Zhang, Hai-Lin; Qu, Wang; Long, Yang-Hao-Peng; Li, Ming-Hua; Zheng, Yong-Tang] Chinese Acad Sci, Ctr Biosafety Megasci, Kunming Inst Zool, Kunming Natl High Level Biosafety Res Ctr Nonhuma, Kunming 650107, Yunnan, Peoples R China; [Wang, Yi-Fei; Chen, Pei; Li, Linli] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Hai-Lin] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Lei, Jian] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Zoology; Sichuan University; Chinese Academy of Sciences; Kunming Institute of Zoology; Sichuan University	Lei, J; Yang, SY (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Sichuan, Peoples R China.; Zheng, YT (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming Inst Zool, Kunming 650223, Yunnan, Peoples R China.; Zheng, YT (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Kunming Inst Zool, Kunming Natl High Level Biosafety Res Ctr Nonhuma, Kunming 650107, Yunnan, Peoples R China.; Lei, J (corresponding author), Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, Chengdu 610041, Sichuan, Peoples R China.	zhengyt@mail.kiz.ac.cn; leijian@scu.edu.cn; yangsy@scu.edu.cn	ronghua, luo/AHE-19098-2022; Zeng, Rui/GRY-0646-2022; Liu, Jingming/GPG-2366-2022; Zhang, Jiujun/M-5668-2017; Lu, Guangwen/HCH-9193-2022; Liu, Yang/AHH-3577-2022	Zeng, Rui/0000-0003-1188-3198; Liu, Yang/0000-0002-5071-3928; Chong, Huang/0000-0003-0951-3411; Wei, Yu-quan/0000-0002-6211-3217; Liu, Feng-Liang/0000-0002-5038-5012; Zhang, Jie/0000-0002-0249-6674; qiao, jingxin/0000-0002-8617-5148; Wang, Yifei/0000-0002-8873-613X; Lei, Jian/0000-0001-9326-0554; Zou, Jun/0000-0002-5395-6052; Li, Yueshan/0000-0003-2343-1252	fast-track research fund on COVID-19 of Sichuan Province [2020YFS0006, 2020YFS0010]; fast-track grants of SARS-CoV-2 research from West China Hospital, Sichuan University [HX-2019-nCoV-053, HX-2019-nCoV039]; National Natural Science Foundation of China [81930125, 00402354A1028]; 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University; Fundamental Research Funds for the Central Universities [20822041D4060]; National Key R&D Program of China [2020YFC0842000]	fast-track research fund on COVID-19 of Sichuan Province; fast-track grants of SARS-CoV-2 research from West China Hospital, Sichuan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key R&D Program of China	Supported by the fast-track research fund on COVID-19 of Sichuan Province (2020YFS0006, 2020YFS0010), the fast-track grants of SARS-CoV-2 research from West China Hospital, Sichuan University (HX-2019-nCoV-053, HX-2019-nCoV039), the National Natural Science Foundation of China (81930125 and 00402354A1028), 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University, the Fundamental Research Funds for the Central Universities (20822041D4060), and the National Key R&D Program of China (2020YFC0842000 to Y.-T.Z.).	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; [Anonymous], 2020, TRANSL PEDIATR, DOI DOI 10.21037/TP.2020.02.06; Boras B., 2020, 293498 BIORXIV; Boras Britton, 2021, bioRxiv, DOI 10.1101/2020.09.12.293498; Bricogne G, 2017, BUSTER VERSION 2 10; Cannalire R., 2020, **DROPPED REF**; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; Dragovich PS, 1999, J MED CHEM, V42, P1213, DOI 10.1021/jm9805384; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gampe C, 2020, J MED CHEM, V63, P14357, DOI 10.1021/acs.jmedchem.0c01177; Ganguly Himal Kanti, 2020, Biophys Rev, V12, P25, DOI 10.1007/s12551-020-00621-8; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Hoffman RL, 2020, J MED CHEM, V63, P12725, DOI 10.1021/acs.jmedchem.0c01063; Jain RP, 2004, J MED CHEM, V47, P6113, DOI 10.1021/jm0494873; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Looi MK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4113; Ma CL, 2020, CELL RES, V30, P678, DOI 10.1038/s41422-020-0356-z; Martin YC, 2005, J MED CHEM, V48, P3164, DOI 10.1021/jm0492002; Pillaiyar T, 2016, J MED CHEM, V59, P6595, DOI 10.1021/acs.jmedchem.5b01461; Rathnayake AD, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc5332; Rognan D, 2015, **DROPPED REF**, V4, P319; Sacco MD, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abe0751; Smith P, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3350; Sun SH, 2020, CELL HOST MICROBE, V28, P124, DOI 10.1016/j.chom.2020.05.020; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Westberg M., 2020, 275891 BIORXIV; Wu F, 2020, NATURE, V580, pE7; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang K. S, 2020, CHEMMEDCHEM, V15, P1; Yang KS, 2021, CHEMMEDCHEM, V16, P942, DOI 10.1002/cmdc.202000924; Yip Y, 2004, BIOORG MED CHEM LETT, V14, P251, DOI 10.1016/j.bmcl.2003.09.074; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhang LL, 2020, J MED CHEM, V63, P4562, DOI 10.1021/acs.jmedchem.9b01828; Zhou P., 2020, NATURE, V579, P270; Zhu LL, 2011, ANTIVIR RES, V92, P204, DOI 10.1016/j.antiviral.2011.08.001; Zhu W, 2020, ACS PHARMACOL TRANSL, V3, P1008, DOI 10.1021/acsptsci.0c00108	45	166	170	41	233	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2021	371	6536					1374	+		10.1126/science.abf1611	http://dx.doi.org/10.1126/science.abf1611			89	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2GI	33602867	Green Published			2022-12-28	WOS:000636043400052
J	Bate, J				Bate, Jonathan			John Keats in the season of mists	LANCET			English	Editorial Material									[Bate, Jonathan] Arizona State Univ, Global Inst Sustainabil & Innovat, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe	Bate, J (corresponding author), Arizona State Univ, Global Inst Sustainabil & Innovat, Tempe, AZ 85281 USA.	jonathan.bate@asu.edu	Bate, Jonathan/E-5181-2019	Bate, Jonathan/0000-0002-3894-8580					0	0	0	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 27	2021	397	10280					1174	1175		10.1016/S0140-6736(21)00449-9	http://dx.doi.org/10.1016/S0140-6736(21)00449-9		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RC7YE	33631130				2022-12-28	WOS:000633010800011
J	Hutson, M				Hutson, Matthew			THE LANGUAGE MACHINES	NATURE			English	Editorial Material																		Bender Emily M., 2021, FAccT '21: Proceedings of the 2021 ACM Conference on Fairness, Accountability, and Transparency, P610, DOI 10.1145/3442188.3445922; Brown Tom B., 2020, PREPRINT; Carlini N., 2020, PREPRINT; Gehman S., 2020, PREPRINT; Guan J, 2020, T ASSOC COMPUT LING, V8, P93, DOI 10.1162/tacl_a_00302; Hendrycks D., 2020, PREPRINT; McGuffie K., 2020, PREPRINT; Raffel C, 2020, J MACH LEARN RES, V21; Stiennon N., 2020, P ADV NEUR INF PROC, V33; Tamkin A., 2021, PREPRINT	10	9	9	5	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					22	25		10.1038/d41586-021-00530-0	http://dx.doi.org/10.1038/d41586-021-00530-0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QT9QO	33658699				2022-12-28	WOS:000626921700006
J	Lusis, AJ				Lusis, Aldons J.			A vicious cycle in atherosclerosis	CELL			English	Editorial Material							CLONAL HEMATOPOIESIS; TET2	Clonal hematopoiesis, defined as the presence of expanded somatic blood cell clones, is associated with about a doubling in the risk of coronary heart disease in humans. Heyde and colleagues now provide evidence that clonal hematopoiesis results largely from increased stem cell proliferation, which is, in turn, stimulated by atherosclerosis.	[Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.; Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Microbiol, Los Angeles, CA 90095 USA.; Lusis, AJ (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	jlusis@mednet.ucla.edu						Abplanalp WT, 2021, CIRC RES, V128, P216, DOI 10.1161/CIRCRESAHA.120.317104; Bick AG, 2020, CIRCULATION, V141, P124, DOI 10.1161/CIRCULATIONAHA.119.044362; Dorsheimer L, 2019, JAMA CARDIOL, V4, P25, DOI 10.1001/jamacardio.2018.3965; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Heyde A., 2021, CELL, V184; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; McAlpine CS, 2019, NATURE, V566, P383, DOI 10.1038/s41586-019-0948-2; Murphy AJ, 2016, EUR HEART J, V37, P1113, DOI 10.1093/eurheartj/ehv718; Sano S, 2018, CIRC RES, V123, P335, DOI 10.1161/CIRCRESAHA.118.313225; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719	10	6	6	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1139	1141		10.1016/j.cell.2021.02.005	http://dx.doi.org/10.1016/j.cell.2021.02.005		MAR 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33667367	Bronze			2022-12-28	WOS:000629635700006
J	Mercer, SW; Patterson, J; Robson, JP; Smith, SM; Walton, E; Watt, G				Mercer, Stewart W.; Patterson, John; Robson, John P.; Smith, Susan M.; Walton, Elizabeth; Watt, Graham			The inverse care law and the potential of primary care in deprived areas	LANCET			English	Editorial Material							GENERAL-PRACTITIONERS; MULTIMORBIDITY		[Mercer, Stewart W.] Univ Edinburgh, Usher Inst, Old Med Sch, Edinburgh, Midlothian, Scotland; [Patterson, John] NHS Oldham Clin Commissioning Grp, Oldham, England; [Robson, John P.] Queen Mary Univ London, Inst Populat Hlth Sci, London, England; [Smith, Susan M.] RCSI Univ Med & Hlth Sci, Dept Gen Practice, Dublin, Ireland; [Walton, Elizabeth] Univ Sheffield, Northern Gen Hosp, Acad Unit Primary Med Care, Sheffield, S Yorkshire, England; [Watt, Graham] Univ Glasgow, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland	University of Edinburgh; University of London; Queen Mary University London; Northern General Hospital; University of Sheffield; University of Glasgow	Watt, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland.	graham.watt@glasgow.ac.uk		Smith, Susan/0000-0001-6027-2727				[Anonymous], 2020, GPS DEEP END DEEP EN; Bambra C, 2020, J EPIDEMIOL COMMUN H, V74, P964, DOI 10.1136/jech-2020-214401; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Boomla K, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7648; Cookson R, 2021, LANCET, V397, P828, DOI 10.1016/S0140-6736(21)00243-9; Egan J, 2019, INTEGRATING MONEY AD; Fisher R., 2020, BRIEFING LEVEL NOT C; Gopfert A, 2021, BRIT J GEN PRACT, V71, pE185, DOI 10.3399/bjgp20X714029; HART JT, 1991, BMJ-BRIT MED J, V302, P1509, DOI 10.1136/bmj.302.6791.1509; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hart JT, 1988, NEW KIND DOCTOR GEN; Marmot M, 2020, BUILD BACK FAIRER CO; Marmot M., 2020, HLTH EQUITY ENGLAND; McGarry V., 2020, GOVAN SHIP PROJECT R; McKeown T., 1976, ROLE MED DREAM MIRAG; McLean G, 2015, BRIT J GEN PRACT, V65, pE799, DOI 10.3399/bjgp15X687829; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Mercer SW, 2019, ANN FAM MED, V17, P518, DOI 10.1370/afm.2429; Mercer SW, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0634-2; Mercer SW, 2016, ANN FAM MED, V14, P117, DOI 10.1370/afm.1910; O'Brien R, 2011, CHRONIC ILLN, V7, P45, DOI 10.1177/1742395310382461; Roberts L, 2019, QUALITATIVE EVALUATI; Robson J, 2020, BRIT J GEN PRACT, V70, pE215, DOI 10.3399/bjgp20X708281; University of Glasgow, 2021, SCOTT DEEP END PROJ; Walton E, 2018, BRIT J GEN PRACT, V68, pE826, DOI 10.3399/bjgp18X699785; Watt G, 2020, GEN PRACTITIONERS DE	26	15	14	3	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					775	776						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640047	Green Submitted			2022-12-28	WOS:000623925500007
J	Chang, CW; Shao, E; Mucke, L				Chang, Che-Wei; Shao, Eric; Mucke, Lennart			Tau: Enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies	SCIENCE			English	Review							MICROTUBULE-STABILIZING AGENT; AMYLOID-BETA TOXICITY; MOUSE MODEL; APOLIPOPROTEIN E4; A-BETA; COGNITIVE DEFICITS; AXONAL-TRANSPORT; TRANSGENIC MICE; MEDIATED NEURODEGENERATION; NEUROFIBRILLARY TANGLES	Several lines of evidence implicate the protein tau in the pathogenesis of multiple brain disorders, including Alzheimer's disease, other neurodegenerative conditions, autism, and epilepsy. Tau is abundant in neurons and interacts with microtubules, but its main functions in the brain remain to be defined. These functions may involve the regulation of signaling pathways relevant to diverse biological processes. Informative disease models have revealed a plethora of abnormal tau species and mechanisms that might contribute to neuronal dysfunction and loss, but the relative importance of their respective contributions is uncertain. This knowledge gap poses major obstacles to the development of truly impactful therapeutic strategies. The current expansion and intensification of efforts to translate mechanistic insights into tau-related therapeutics should address this issue and could deliver better treatments for a host of devastating conditions.	[Chang, Che-Wei; Shao, Eric; Mucke, Lennart] Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Mucke, Lennart] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mucke, L (corresponding author), Gladstone Inst, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.; Mucke, L (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.; Mucke, L (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94158 USA.	lennart.mucke@gladstone.ucsf.edu	Shao, Eric Qiang/I-1359-2019	Shao, Eric Qiang/0000-0001-5307-8264; Mucke, Lennart/0000-0001-6256-9559	National Institutes of Health [R01 MH115679, R56 AG060631, UH3 AG054304]; Tau Consortium; Alzheimer's Association; Cure Network Dolby Acceleration Partners	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium; Alzheimer's Association(Alzheimer's Association); Cure Network Dolby Acceleration Partners	Tau-related research in the Mucke laboratory is supported by the National Institutes of Health (grants R01 MH115679, R56 AG060631, and UH3 AG054304), the Tau Consortium, and Cure Network Dolby Acceleration Partners. C.-W.C. is supported by a Research Fellowship from the Alzheimer's Association.	Abbondante S, 2014, AM J PATHOL, V184, P819, DOI 10.1016/j.ajpath.2013.11.021; Ahmed T, 2014, NEUROBIOL AGING, V35, P2474, DOI 10.1016/j.neurobiolaging.2014.05.005; Ahmed Z, 2014, ACTA NEUROPATHOL, V127, P667, DOI 10.1007/s00401-014-1254-6; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Apicco DJ, 2018, NAT NEUROSCI, V21, P72, DOI 10.1038/s41593-017-0022-z; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Ashton NJ, 2020, NAT REV NEUROL, V16, P265, DOI 10.1038/s41582-020-0348-0; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Barthelemy NR, 2020, NAT MED, V26, P398, DOI 10.1038/s41591-020-0781-z; Beevers JE, 2017, STEM CELL REP, V9, P587, DOI 10.1016/j.stemcr.2017.06.005; Bi M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00618-0; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brelstaff J, 2018, CELL REP, V24, P1939, DOI 10.1016/j.celrep.2018.07.072; Bright J, 2015, NEUROBIOL AGING, V36, P693, DOI 10.1016/j.neurobiolaging.2014.09.007; Burslem GM, 2020, CELL, V181, P102, DOI 10.1016/j.cell.2019.11.031; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692; Caillet-Boudin ML, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0025-8; Cantero JL, 2011, HIPPOCAMPUS, V21, P827, DOI 10.1002/hipo.20798; Cantero JL, 2010, J ALZHEIMERS DIS, V21, P411, DOI 10.3233/JAD-2010-100285; Chen JL, 2020, J AM CHEM SOC, V142, P8706, DOI 10.1021/jacs.0c00768; Chen X, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-019-0354-0; Chen XQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00659; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Coppola G, 2012, HUM MOL GENET, V21, P3500, DOI 10.1093/hmg/dds161; Cowan CM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00114; Das M, 2018, NEUROBIOL DIS, V117, P181, DOI 10.1016/j.nbd.2018.05.020; Dehdashti SJ, 2013, CURR ALZHEIMER RES, V10, P679, DOI 10.2174/15672050113109990143; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; DeVos SL, 2018, BRAIN, V141, P2194, DOI 10.1093/brain/awy117; DeVos SL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0481; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dujardin S, 2020, NAT MED, V26, P1256, DOI 10.1038/s41591-020-0938-9; Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393; Faraco G, 2019, NATURE, V574, P686, DOI 10.1038/s41586-019-1688-z; Fu HJ, 2019, NAT NEUROSCI, V22, P47, DOI 10.1038/s41593-018-0298-7; Fuster-Matanzo A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00104; Gamache J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10428-1; Garcia-Cabrero AM, 2013, NEUROBIOL DIS, V58, P200, DOI 10.1016/j.nbd.2013.06.005; Gheyara AL, 2014, ANN NEUROL, V76, P443, DOI 10.1002/ana.24230; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Gibbons GS, 2019, JAMA NEUROL, V76, P101, DOI 10.1001/jamaneurol.2018.2505; Goedert M, 2019, ADV EXP MED BIOL, V1184, P3, DOI 10.1007/978-981-32-9358-8_1; Goodwin LO, 2019, GENOME RES, V29, P494, DOI 10.1101/gr.233866.117; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz JJ, 2019, ADV EXP MED BIOL, V1184, P381, DOI 10.1007/978-981-32-9358-8_28; Gouw AA, 2017, NEUROBIOL AGING, V57, P133, DOI 10.1016/j.neurobiolaging.2017.05.017; Guo CW, 2018, CELL REP, V23, P2874, DOI 10.1016/j.celrep.2018.05.004; Gupta RK, 2020, LANCET HIV, V7, pE340, DOI 10.1016/S2352-3018(20)30069-2; Hall AM, 2015, J NEUROSCI, V35, P6221, DOI 10.1523/JNEUROSCI.2552-14.2015; Hallinan GI, 2019, J NEUROSCI, V39, P9623, DOI 10.1523/JNEUROSCI.1590-19.2019; Hamano T, 2012, NEUROBIOL AGING, V33, P2306, DOI 10.1016/j.neurobiolaging.2011.10.020; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hatch RJ, 2017, ACTA NEUROPATHOL, V133, P717, DOI 10.1007/s00401-017-1674-1; Hernandez I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat3005; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Holth JK, 2019, SCIENCE, V363, P880, DOI 10.1126/science.aav2546; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Iovino M, 2015, BRAIN, V138, DOI 10.1093/brain/awv222; Ising C, 2019, NATURE, V575, P669, DOI 10.1038/s41586-019-1769-z; Ittner A, 2018, NEURON, V99, P13, DOI 10.1016/j.neuron.2018.06.003; Ittner A, 2016, SCIENCE, V354, P904, DOI 10.1126/science.aah6205; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jadhav S, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0664-z; Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7; Janning D, 2014, MOL BIOL CELL, V25, P3541, DOI 10.1091/mbc.E14-06-1099; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Johnson DK, 2006, ARCH NEUROL-CHICAGO, V63, P1312, DOI 10.1001/archneur.63.9.1312; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Ke Yazi D, 2012, Int J Alzheimers Dis, V2012, P873270, DOI 10.1155/2012/873270; Kimura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0144; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; La Joie R, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aau5732; Leboucher A, 2019, NEUROBIOL DIS, V125, P14, DOI 10.1016/j.nbd.2019.01.008; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Leuzy A, 2020, JAMA NEUROL, V77, P955, DOI 10.1001/jamaneurol.2020.0989; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Li ZY, 2014, NEUROBIOL AGING, V35, P2617, DOI 10.1016/j.neurobiolaging.2014.05.001; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Liu C, 2016, J BIOL CHEM, V291, P8173, DOI 10.1074/jbc.M115.641902; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; Lopez A, 2017, BRAIN, V140, P1128, DOI 10.1093/brain/awx005; Ma QL, 2014, J NEUROSCI, V34, P7124, DOI 10.1523/JNEUROSCI.3439-13.2014; Maeda S, 2016, EMBO REP, V17, P530, DOI 10.15252/embr.201541438; Mair W, 2016, ANAL CHEM, V88, P3704, DOI 10.1021/acs.analchem.5b04509; Marciniak E, 2017, J EXP MED, V214, P2257, DOI 10.1084/jem.20161731; McInnes J, 2018, NEURON, V97, P823, DOI 10.1016/j.neuron.2018.01.022; Mercuri E, 2018, NEW ENGL J MED, V378, P625, DOI 10.1056/NEJMoa1710504; Min SW, 2018, J NEUROSCI, V38, P3680, DOI 10.1523/JNEUROSCI.2369-17.2018; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Morris M, 2013, NEUROBIOL AGING, V34, P1523, DOI 10.1016/j.neurobiolaging.2012.12.003; Moussaud S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-43; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Outeiro TF, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0306-8; Palmqvist S, 2020, JAMA-J AM MED ASSOC, V324, P772, DOI 10.1001/jama.2020.12134; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Peter-Derex L, 2015, SLEEP MED REV, V19, P29, DOI 10.1016/j.smrv.2014.03.007; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Puzzo D, 2020, J CLIN INVEST, V130, P4831, DOI 10.1172/JCI137040; Qiang L, 2018, CURR BIOL, V28, P2181, DOI 10.1016/j.cub.2018.05.045; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sapir T, 2012, HUM MOL GENET, V21, P1681, DOI 10.1093/hmg/ddr603; Sato C, 2018, NEURON, V97, P1284, DOI 10.1016/j.neuron.2018.02.015; Scheres SHW, 2020, CURR OPIN STRUC BIOL, V64, P17, DOI 10.1016/j.sbi.2020.05.011; Schoch KM, 2017, NEURON, V94, P1056, DOI 10.1016/j.neuron.2017.04.010; Shanbhag NM, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0723-5; Shi Y, 2019, J EXP MED, V216, P2546, DOI 10.1084/jem.20190980; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Silva MC, 2019, ELIFE, V8, DOI 10.7554/eLife.45457; Sohn PD, 2019, NEURON, V104, P458, DOI 10.1016/j.neuron.2019.08.008; Sotiropoulos I, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0489-6; Sun WY, 2018, NAT NEUROSCI, V21, P1038, DOI 10.1038/s41593-018-0194-1; Tabrizi SJ, 2019, NEW ENGL J MED, V380, P2307, DOI 10.1056/NEJMoa1900907; Tai C, 2020, NEURON, V106, P421, DOI 10.1016/j.neuron.2020.01.038; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tam OH, 2019, MOBILE DNA-UK, V10, DOI 10.1186/s13100-019-0176-1; Tesseur I, 2000, AM J PATHOL, V156, P951, DOI 10.1016/S0002-9440(10)64963-2; Tracy TE, 2018, CURR OPIN NEUROBIOL, V51, P134, DOI 10.1016/j.conb.2018.04.027; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; van der Kant R, 2019, CELL STEM CELL, V24, P363, DOI 10.1016/j.stem.2018.12.013; VandeVrede L, 2020, NEUROSCI LETT, V731, DOI 10.1016/j.neulet.2020.134919; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Vogels T, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0754-y; Vossel KA, 2015, J CELL BIOL, V209, P419, DOI 10.1083/jcb.201407065; Vossel KA, 2010, SCIENCE, V330, P198, DOI 10.1126/science.1194653; Wang CZ, 2018, NAT MED, V24, P647, DOI 10.1038/s41591-018-0004-z; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wheeler JM, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0210-6; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yu A, 2019, J BIOL CHEM, V294, P7917, DOI 10.1074/jbc.RA119.007527; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008; Zempel H, 2017, J BIOL CHEM, V292, P12192, DOI 10.1074/jbc.M117.784702; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012; Zhao XH, 2016, NAT MED, V22, P1268, DOI 10.1038/nm.4199; Zollino M, 2012, NAT GENET, V44, P636, DOI 10.1038/ng.2257	150	63	63	23	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					904	+	eabb8255	10.1126/science.abb8255	http://dx.doi.org/10.1126/science.abb8255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632820	Green Accepted			2022-12-28	WOS:000621813400046
J	Cote, B; Eichler, M; Lopez, AY; Vassh, N; Mumpower, MR; Vilagos, B; Soos, B; Arcones, A; Sprouse, TM; Surman, R; Pignatari, M; Peto, MK; Wehmeyer, B; Rauscher, T; Lugaro, M				Cote, Benoit; Eichler, Marius; Lopez, Andres Yague; Vassh, Nicole; Mumpower, Matthew R.; Vilagos, Blanka; Soos, Benjamin; Arcones, Almudena; Sprouse, Trevor M.; Surman, Rebecca; Pignatari, Marco; Peto, Maria K.; Wehmeyer, Benjamin; Rauscher, Thomas; Lugaro, Maria			I-129 and Cm-247 in meteorites constrain the last astrophysical source of solar r-process elements	SCIENCE			English	Article								The composition of the early Solar System can be inferred from meteorites. Many elements heavier than iron were formed by the rapid neutron capture process (r-process), but the astrophysical sources where this occurred remain poorly understood. We demonstrate that the near-identical half-lives (similar or equal to 15:6 million years) of the radioactive r-process nuclei iodine-129 and curium-247 preserve their ratio, irrespective of the time between production and incorporation into the Solar System. We constrain the last r-process source by comparing the measured meteoritic ratio I-129/Cm-247 = 438 +/- 184 with nucleosynthesis calculations based on neutron star merger and magneto-rotational supernova simulations. Moderately neutron-rich conditions, often found in merger disk ejecta simulations, are most consistent with the meteoritic value. Uncertain nuclear physics data limit our confidence in this conclusion.	[Cote, Benoit; Lopez, Andres Yague; Vilagos, Blanka; Soos, Benjamin; Pignatari, Marco; Peto, Maria K.; Wehmeyer, Benjamin; Lugaro, Maria] Eotvos Lorand Res Network, Res Ctr Astron & Earth Sci, Konkoly Observ, H-1121 Budapest, Hungary; [Cote, Benoit; Vilagos, Blanka; Soos, Benjamin; Lugaro, Maria] Eotvos Lorand Univ, Inst Phys, H-1117 Budapest, Hungary; [Cote, Benoit] Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA; [Eichler, Marius; Arcones, Almudena] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Vassh, Nicole; Sprouse, Trevor M.; Surman, Rebecca] Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA; [Mumpower, Matthew R.; Sprouse, Trevor M.] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87545 USA; [Mumpower, Matthew R.] Los Alamos Natl Lab, Ctr Theoret Astrophys, Los Alamos, NM 87545 USA; [Arcones, Almudena] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Pignatari, Marco] Univ Hull, EA Milne Ctr Astrophys, Kingston Upon Hull HU6 7RX, N Humberside, England; [Wehmeyer, Benjamin; Rauscher, Thomas] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Rauscher, Thomas] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Lugaro, Maria] Monash Univ, Monash Ctr Astrophys, Sch Phys & Astron, Clayton, Vic 3800, Australia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; Eotvos Lorand University; Michigan State University; Technical University of Darmstadt; University of Notre Dame; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; University of Hull; University of Hertfordshire; University of Basel; Monash University	Cote, B (corresponding author), Eotvos Lorand Res Network, Res Ctr Astron & Earth Sci, Konkoly Observ, H-1121 Budapest, Hungary.; Cote, B (corresponding author), Eotvos Lorand Univ, Inst Phys, H-1117 Budapest, Hungary.; Cote, B (corresponding author), Michigan State Univ, Natl Superconducting Cyclotron Lab, E Lansing, MI 48824 USA.	benoit.cote@csfk.org	Wehmeyer, Benjamin/AAQ-9671-2021; Rauscher, Thomas/D-2086-2009; Pignatari, Marco/AAO-6015-2021; Arcones, Almudena/HCH-2975-2022	Rauscher, Thomas/0000-0002-1266-0642; Pignatari, Marco/0000-0002-9048-6010; Arcones, Almudena/0000-0002-6995-3032; Vilagos, Blanka/0000-0001-9688-2332; Yague Lopez, Andres/0000-0002-7294-9288; Cote, Benoit/0000-0002-9986-8816; Vassh, Nicole/0000-0002-3305-4326; Eichler, Marius/0000-0002-4445-8908; Soos, Benjamin/0000-0002-2503-4181	ERC Consolidator Grant (Hungary) funding scheme (project RADIOSTAR) [724560]; Hungarian Academy of Sciences through the Lendulet project [LP2014-17]; National Science Foundation (NSF, United States) [PHY-1430152]; U.S. Department of Energy through the Los Alamos National Laboratory; Laboratory Directed Research and Development program of Los Alamos National Laboratory [20190021DR]; National Nuclear Security Administration of the U.S. Department of Energy [89233218CNA000001]; European Research Council [677912 EUROPIUM]; Deutsche Forschungsgemeinschaft [SFB 1245]; Fission In R-process Elements (FIRE) topical collaboration in nuclear theory - U.S. Department of Energy; Helmholtz Forschungsakademie Hessen fur FAIR; U.S. Department of Energy SciDAC collaboration TEAMS [DE-SC0018232]; Los Alamos National Laboratory Center for Space and Earth Science - Laboratory Directed Research and Development program [20180475DR]; NuGrid from STFC through the University of Hull [ST/R000840/1]; STFC [ST/R000840/1] Funding Source: UKRI	ERC Consolidator Grant (Hungary) funding scheme (project RADIOSTAR); Hungarian Academy of Sciences through the Lendulet project; National Science Foundation (NSF, United States)(National Science Foundation (NSF)); U.S. Department of Energy through the Los Alamos National Laboratory; Laboratory Directed Research and Development program of Los Alamos National Laboratory; National Nuclear Security Administration of the U.S. Department of Energy(National Nuclear Security Administration); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fission In R-process Elements (FIRE) topical collaboration in nuclear theory - U.S. Department of Energy; Helmholtz Forschungsakademie Hessen fur FAIR; U.S. Department of Energy SciDAC collaboration TEAMS(United States Department of Energy (DOE)); Los Alamos National Laboratory Center for Space and Earth Science - Laboratory Directed Research and Development program(United States Department of Energy (DOE)Los Alamos National Laboratory); NuGrid from STFC through the University of Hull; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	B.C., A.Y.L., B.W., M.K.P., and M.L. were supported by the ERC Consolidator Grant (Hungary) funding scheme (project RADIOSTAR, G.A. no. 724560). B.C. and M.L. were supported by the Hungarian Academy of Sciences through the Lendulet project LP2014-17. B.C., M.R.M., and M.P. acknowledge support from the National Science Foundation (NSF, United States) under grant no. PHY-1430152 (JINA Center for the Evolution of the Elements). M.R.M. was supported by the U.S. Department of Energy through the Los Alamos National Laboratory and by the Laboratory Directed Research and Development program of Los Alamos National Laboratory under project no. 20190021DR. Los Alamos National Laboratory is operated by Triad National Security, LLC., for the National Nuclear Security Administration of the U.S. Department of Energy (contract no. 89233218CNA000001). M.E. and A.A. acknowledge support from the European Research Council through ERC starting grant no. 677912 EUROPIUM and Deutsche Forschungsgemeinschaft through SFB 1245. N.V. and R.S. were supported by the Fission In R-process Elements (FIRE) topical collaboration in nuclear theory, funded by the U.S. Department of Energy. A.A. was supported by the Helmholtz Forschungsakademie Hessen fur FAIR. T.M.S. and R.S. were supported by the U.S. Department of Energy SciDAC collaboration TEAMS (DE-SC0018232). T.M.S. was supported by the Los Alamos National Laboratory Center for Space and Earth Science, which is funded by its Laboratory Directed Research and Development program under project no. 20180475DR. M.P. acknowledges support to NuGrid from STFC through the University of Hull's consolidated grant ST/R000840/1.	Abadie J, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/17/173001; Abbott BP, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.161101; ABOUSSIR Y, 1995, ATOM DATA NUCL DATA, V61, P127, DOI 10.1016/S0092-640X(95)90014-4; Arcones A., 2021, DETAILED ABUNDANCES, DOI [10.5281/zenodo.4446099, DOI 10.5281/ZENODO.4446099]; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Audi G, 2017, CHINESE PHYS C, V41, DOI 10.1088/1674-1137/41/3/030001; Bartos I, 2019, NATURE, V569, P85, DOI 10.1038/s41586-019-1113-7; Beniamini P, 2020, MON NOT R ASTRON SOC, V496, P1891, DOI 10.1093/mnras/staa1690; Beun J, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.035804; Botelho RB, 2019, MON NOT R ASTRON SOC, V482, P1690, DOI 10.1093/mnras/sty2791; Bovard L, 2017, PHYS REV D, V96, DOI 10.1103/PhysRevD.96.124005; Browne E, 2013, NUCL DATA SHEETS, V114, P751, DOI 10.1016/j.nds.2013.05.002; Chabanat E, 1998, NUCL PHYS A, V635, P231, DOI 10.1016/S0375-9474(98)00180-8; Clay PL, 2017, NATURE, V551, P614, DOI 10.1038/nature24625; CLAYTON DD, 1984, ASTROPHYS J, V285, P411, DOI 10.1086/162518; Cote B, 2020, ANDRESYAGUE STOCHAST, DOI [10.5281/zenodo.4321747, DOI 10.5281/ZENODO.4321747]; Cote B, 2019, ASTROPHYS J, V887, DOI 10.3847/1538-4357/ab5a88; Cote B, 2019, ASTROPHYS J, V878, DOI 10.3847/1538-4357/ab21d1; Cote B, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/aa5c8d; Cowperthwaite PS, 2017, ASTROPHYS J LETT, V848, DOI 10.3847/2041-8213/aa8fc7; Cyburt RH, 2010, ASTROPHYS J SUPPL S, V189, P240, DOI 10.1088/0067-0049/189/1/240; Dauphas N, 2015, GEOCHIM COSMOCHIM AC, V163, P234, DOI 10.1016/j.gca.2015.03.037; DUFLO J, 1995, PHYS REV C, V52, pR23, DOI 10.1103/PhysRevC.52.R23; Eichler M, 2019, ASTROPHYS J, V879, DOI 10.3847/1538-4357/ab24cf; Eichler M, 2015, ASTROPHYS J, V808, DOI 10.1088/0004-637X/808/1/30; Elmegreen BG, 2004, ANNU REV ASTRON ASTR, V42, P211, DOI 10.1146/annurev.astro.41.011802.094859; Emerick A, 2018, ASTROPHYS J, V869, DOI 10.3847/1538-4357/aaec7d; Esteban C, 2015, MON NOT R ASTRON SOC, V452, P1553, DOI 10.1093/mnras/stv1367; Freiburghaus C, 1999, ASTROPHYS J, V525, pL121, DOI 10.1086/312343; Gilmour JD, 2006, METEORIT PLANET SCI, V41, P19, DOI 10.1111/j.1945-5100.2006.tb00190.x; Goriely S, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.035804; Goriely S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.152503; Goriely S, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.024612; HALL DNB, 1972, ASTROPHYS J, V175, pL95, DOI 10.1086/180993; Hansen, ASTROPHYS J, V859, pL24; Holmbeck EM, 2019, ASTROPHYS J, V881, DOI 10.3847/1538-4357/ab2a01; Horowitz CJ, 2019, J PHYS G NUCL PARTIC, V46, DOI 10.1088/1361-6471/ab0849; Hotokezaka K, 2015, NAT PHYS, V11, P1042, DOI [10.1038/NPHYS3574, 10.1038/nphys3574]; Kawano T, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.014612; Kawano T, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.054601; Kellogg JB, 2002, EARTH PLANET SC LETT, V204, P183, DOI 10.1016/S0012-821X(02)00981-0; Kim C, 2015, MON NOT R ASTRON SOC, V448, P928, DOI 10.1093/mnras/stu2729; Kobayashi C, 2020, ASTROPHYS J, V900, DOI 10.3847/1538-4357/abae65; KODAMA T, 1975, NUCL PHYS A, VA239, P489, DOI 10.1016/0375-9474(75)90381-4; Korobkin O, 2012, MON NOT R ASTRON SOC, V426, P1940, DOI 10.1111/j.1365-2966.2012.21859.x; Kortelainen M, 2010, PHYS REV C, V82, DOI 10.1103/PhysRevC.82.024313; Krause MGH, 2018, ASTRON ASTROPHYS, V619, DOI 10.1051/0004-6361/201732416; Lodders K, 2010, ASTROPHYSICS SPACE, P379, DOI 10.1007/978-3-642-10352-0_8; Lopez, 2020, ANDRESYAGUE IODINECU, DOI [10.5281/zenodo.3969830, DOI 10.5281/ZENODO.3969830]; Lopez A. Yague, 2020, ANDRESYAGUE IODINECU, DOI [10.5281/zenodo.3969829, DOI 10.5281/ZENODO.3969829]; Lopez A. Yague, 2020, ANDRESYAGUE STOCHAST, DOI [10.5281/zenodo.4321747, DOI 10.5281/ZENODO.4321747]; Lopez A. Yague, 2020, ZENODO, DOI [10.5281/zenodo.4300334, DOI 10.5281/ZENODO.4300334]; LuEpez A. Yaguae, 2020, ZENODO, DOI [10.5281/zenodo.3969830, DOI 10.5281/ZENODO.3969830]; Lugaro M, 2014, SCIENCE, V345, P650, DOI 10.1126/science.1253338; Maas ZG, 2016, ASTRON J, V152, DOI 10.3847/0004-6256/152/6/196; Mamdouh A, 2001, NUCL PHYS A, V679, P337, DOI 10.1016/S0375-9474(00)00358-4; Marketin T, 2016, PHYS REV C, V93, DOI 10.1103/PhysRevC.93.025805; Metzger BD, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/1/48; Miller JM, 2019, PHYS REV D, V100, DOI 10.1103/PhysRevD.100.023008; Moller P, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.024310; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; Moller P, 2019, ATOM DATA NUCL DATA, V125, P1, DOI 10.1016/j.adt.2018.03.003; Moller P, 2016, ATOM DATA NUCL DATA, V109, P1, DOI 10.1016/j.adt.2015.10.002; Moller P, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.055802; Mosta P, 2018, ASTROPHYS J, V864, DOI 10.3847/1538-4357/aad6ec; Mumpower MR, 2018, ASTROPHYS J, V869, DOI 10.3847/1538-4357/aaeaca; Mumpower MR, 2016, PHYS REV C, V94, DOI 10.1103/PhysRevC.94.064317; Mumpower MR, 2016, PROG PART NUCL PHYS, V86, P86, DOI 10.1016/j.ppnp.2015.09.001; Mumpower MR, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.035807; Myers WD, 1996, NUCL PHYS A, V601, P141, DOI 10.1016/0375-9474(95)00509-9; MYERS WD, 1999, PHYS REV C, V60; Nesaraja CD, 2014, NUCL DATA SHEETS, V121, P695, DOI 10.1016/j.nds.2014.09.005; Panov I. V., 2001, NUCL PHYS A, V688, P587, DOI [10.1016/S0375-9474(01)00797-7, DOI 10.1016/S0375-9474(01)00797-7]; Pearson JM, 1996, PHYS LETT B, V387, P455, DOI 10.1016/0370-2693(96)01071-4; Piran T, 2013, MON NOT R ASTRON SOC, V430, P2121, DOI 10.1093/mnras/stt037; Prantzos N, 2020, MON NOT R ASTRON SOC, V491, P1832, DOI 10.1093/mnras/stz3154; Prantzos N, 2018, MON NOT R ASTRON SOC, V476, P3432, DOI 10.1093/mnras/sty316; Radice D, 2018, ASTROPHYS J, V869, DOI 10.3847/1538-4357/aaf054; Rennehan D, 2019, MON NOT R ASTRON SOC, V483, P3810, DOI 10.1093/mnras/sty3376; Roederer IU, 2009, ASTROPHYS J, V698, P1963, DOI 10.1088/0004-637X/698/2/1963; Rosswog S, 2013, MON NOT R ASTRON SOC, V430, P2585, DOI 10.1093/mnras/sts708; Schmidt, 2009, ARXIV09064193NUCLTH; Schmidt KH, 2016, NUCL DATA SHEETS, V131, P107, DOI 10.1016/j.nds.2015.12.009; Siegel DM, 2019, NATURE, V569, P241, DOI 10.1038/s41586-019-1136-0; Sylwester B, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/49; Tang HL, 2017, GEOCHIM COSMOCHIM AC, V207, P1, DOI 10.1016/j.gca.2017.03.001; Thielemann, 2019, ARXIV190101410ASTROP; Timar J, 2014, NUCL DATA SHEETS, V121, P143, DOI 10.1016/j.nds.2014.09.002; Tissot FLH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501400; TOMEOKA K, 1988, GEOCHIM COSMOCHIM AC, V52, P1627, DOI 10.1016/0016-7037(88)90231-1; Tsujimoto T, 2017, ASTROPHYS J LETT, V835, DOI 10.3847/2041-8213/835/1/L3; Unterborn CT, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/139; Vassh N, 2019, J PHYS G NUCL PARTIC, V46, DOI 10.1088/1361-6471/ab0bea; Vassh N., 2021, R PROCESS ABUNDANCES, DOI [10.5281/zenodo.4456126, DOI 10.5281/ZENODO.4456126]; Wallner A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6956; Watson D, 2019, NATURE, V574, P497, DOI 10.1038/s41586-019-1676-3; Winteler C, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L22; Wu MR, 2016, MON NOT R ASTRON SOC, V463, P2323, DOI 10.1093/mnras/stw2156; YagileLopez A, 2020, ANDRESYAGUE IODINECU, DOI [10.5281/zenodo.3969829, DOI 10.5281/ZENODO.3969829]; YagtieLopez A, 2020, BENSOOS ANDRESYAGUED, DOI [10.5281/zenodo.4300334, DOI 10.5281/ZENODO.4300334]; Zhao G, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/2/225	107	18	18	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					945	+		10.1126/science.aba1111	http://dx.doi.org/10.1126/science.aba1111			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632846	Green Submitted, Green Accepted			2022-12-28	WOS:000621813400043
J	Deng, XJ; Chao, A; Feikes, J; Hoehl, A; Huang, WH; Klein, R; Kruschinski, A; Li, J; Matveenko, A; Petenev, Y; Ries, M; Tang, CX; Yan, LX				Deng, Xiujie; Chao, Alexander; Feikes, Joerg; Hoehl, Arne; Huang, Wenhui; Klein, Roman; Kruschinski, Arnold; Li, Ji; Matveenko, Aleksandr; Petenev, Yuriy; Ries, Markus; Tang, Chuanxiang; Yan, Lixin			Experimental demonstration of the mechanism of steady-state microbunching	NATURE			English	Article							AMPLIFIED SPONTANEOUS-EMISSION; FREE-ELECTRON LASER; STORAGE-RING FEL; SYNCHROTRON-RADIATION; 1ST OPERATION; GAIN; MANIPULATION; GENERATION; BEAM	The mechanism of steady-state electron microbunching is demonstrated, providing a basis that will enable its full implementation in electron storage rings to generate high-repetition, high-power coherent radiation. The use of particle accelerators as photon sources has enabled advances in science and technology(1). Currently the workhorses of such sources are storage-ring-based synchrotron radiation facilities(2-4) and linear-accelerator-based free-electron lasers(5-14). Synchrotron radiation facilities deliver photons with high repetition rates but relatively low power, owing to their temporally incoherent nature. Free-electron lasers produce radiation with high peak brightness, but their repetition rate is limited by the driving sources. The steady-state microbunching(15-22) (SSMB) mechanism has been proposed to generate high-repetition, high-power radiation at wavelengths ranging from the terahertz scale to the extreme ultraviolet. This is accomplished by using microbunching-enabled multiparticle coherent enhancement of the radiation in an electron storage ring on a steady-state turn-by-turn basis. A crucial step in unveiling the potential of SSMB as a future photon source is the demonstration of its mechanism in a real machine. Here we report an experimental demonstration of the SSMB mechanism. We show that electron bunches stored in a quasi-isochronous ring can yield sub-micrometre microbunching and coherent radiation, one complete revolution after energy modulation induced by a 1,064-nanometre-wavelength laser. Our results verify that the optical phases of electrons can be correlated turn by turn at a precision of sub-laser wavelengths. On the basis of this phase correlation, we expect that SSMB will be realized by applying a phase-locked laser that interacts with the electrons turn by turn. This demonstration represents a milestone towards the implementation of an SSMB-based high-repetition, high-power photon source.	[Deng, Xiujie; Huang, Wenhui; Tang, Chuanxiang; Yan, Lixin] Tsinghua Univ, Dept Engn Phys, Beijing, Peoples R China; [Chao, Alexander] Tsinghua Univ, Inst Adv Study, Beijing, Peoples R China; [Chao, Alexander] Stanford Univ, Stanford, CA 94305 USA; [Feikes, Joerg; Kruschinski, Arnold; Li, Ji; Matveenko, Aleksandr; Petenev, Yuriy; Ries, Markus] Helmholtz Zentrum Berlin HZB, Berlin, Germany; [Hoehl, Arne; Klein, Roman] Phys Tech Bundesanstalt PTB, Berlin, Germany	Tsinghua University; Tsinghua University; Stanford University; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Physikalisch-Technische Bundesanstalt (PTB)	Tang, CX (corresponding author), Tsinghua Univ, Dept Engn Phys, Beijing, Peoples R China.; Feikes, J (corresponding author), Helmholtz Zentrum Berlin HZB, Berlin, Germany.	joerg.feikes@helmholtz-berlin.de; tang.xuh@tsinghua.edu.cn		Li, Ji/0000-0003-2454-6019; Feikes, Joerg/0000-0003-0810-3963; Deng, Xiujie/0000-0001-7532-9917				Andruszkow J, 2000, PHYS REV LETT, V85, P3825, DOI 10.1103/PhysRevLett.85.3825; Bakshi V., 2018, EUV LITHOGRAPHY, V2nd; BILLARDON M, 1983, PHYS REV LETT, V51, P1652, DOI 10.1103/PhysRevLett.51.1652; Bjorken J. D., 1983, Particle Accelerators, V13, P115; BONIFACIO R, 1984, OPT COMMUN, V50, P373, DOI 10.1016/0030-4018(84)90105-6; Byrd JM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.224801; Carr GL, 2002, NATURE, V420, P153, DOI 10.1038/nature01175; Chao A, P 7 INT PART ACCEL C; Chao A., 2018, TECHNICAL REPORT NO; Chao A, P 33 INT FREE ELECT; Chou W., 2011, ACCELERATORS PHOTON, V3; Cole BE, 2001, NATURE, V410, P60, DOI 10.1038/35065032; COURANT ED, 1958, ANN PHYS-NEW YORK, V3, P1, DOI 10.1016/0003-4916(58)90012-5; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; DEACON DAG, 1977, PHYS REV LETT, V38, P892, DOI 10.1103/PhysRevLett.38.892; Deng X., P 9 INT PART ACCEL C; Deng XJ, 2020, PHYS REV ACCEL BEAMS, V23, DOI 10.1103/PhysRevAccelBeams.23.044001; Deng XJ, 2020, PHYS REV ACCEL BEAMS, V23, DOI 10.1103/PhysRevAccelBeams.23.044002; ELDER FR, 1947, PHYS REV, V71, P829, DOI 10.1103/PhysRev.71.829.5; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Falkenstern F., 2009, P DIPAC09, P128; Feikes J, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.030705; GIRARD B, 1984, PHYS REV LETT, V53, P2405, DOI 10.1103/PhysRevLett.53.2405; Gover A, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.035003; Hemsing E, 2014, REV MOD PHYS, V86, P897, DOI 10.1103/RevModPhys.86.897; Hogan MJ, 1998, PHYS REV LETT, V81, P4867, DOI 10.1103/PhysRevLett.81.4867; Jiao Y, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.110702; Klein R, 2008, PHYS REV SPEC TOP-AC, V11, DOI 10.1103/PhysRevSTAB.11.110701; Kondratenko A. M., 1980, PART ACCEL, V10, P207; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Lv BQ, 2019, NAT REV PHYS, V1, P609, DOI 10.1038/s42254-019-0088-5; Machida S., PROG THEOR EXP PHYS, V2016; MADEY JMJ, 1971, J APPL PHYS, V42, P1906, DOI 10.1063/1.1660466; NODVICK JS, 1954, PHYS REV, V96, P180, DOI 10.1103/PhysRev.96.180; PELLEGRINI C, 1991, NUCL INSTRUM METH A, V301, P27, DOI 10.1016/0168-9002(91)90734-8; Piwinski A., 1974, TECHNICAL REPORT NO; Ratner DF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.154801; Ries M., 2014, THESIS HUMBOLDT U; Sands M., 1970, TECHNICAL REPORT NO; SCHWINGER J, 1949, PHYS REV, V75, P1912, DOI 10.1103/PhysRev.75.1912; Seddon EA, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa7cca; Shimada M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.144802; Shoji Y, 1996, PHYS REV E, V54, pR4556, DOI 10.1103/PhysRevE.54.R4556; Shoji Y, 2005, PHYS REV SPEC TOP-AC, V8, DOI 10.1103/PhysRevSTAB.8.094001; Shoji Y, 2004, PHYS REV SPEC TOP-AC, V7, DOI 10.1103/PhysRevSTAB.7.090703; Tanaka T, 2001, J SYNCHROTRON RADIAT, V8, P1221, DOI 10.1107/S090904950101425X; Tang C., P 60 ICFA ADV BEAM D; Trovo M, 2002, NUCL INSTRUM METH A, V483, P157, DOI 10.1016/S0168-9002(02)00303-0; Veksler VI, 1944, CR ACAD SCI URSS, V43, P329; Venturini M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.224802; Walker RP, 2001, NUCL INSTRUM METH A, V475, P20, DOI 10.1016/S0168-9002(01)01529-7; WILLIAMS GP, 1989, PHYS REV LETT, V62, P261, DOI 10.1103/PhysRevLett.62.261; YU LH, 1991, PHYS REV A, V44, P5178, DOI 10.1103/PhysRevA.44.5178; Yu LH, 2000, SCIENCE, V289, P932, DOI 10.1126/science.289.5481.932; Zhao ZT, 2010, REV ACCEL SCI TECH, V3, P57, DOI 10.1142/S1793626810000361	59	21	22	9	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03203-0	http://dx.doi.org/10.1038/s41586-021-03203-0			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627811				2022-12-28	WOS:000621583600008
J	Yamey, G				Yamey, Gavin			Rich countries should tithe their vaccines	NATURE			English	Editorial Material						SARS-CoV-2; Vaccines; Health care; Developing world			[Yamey, Gavin] Duke Univ, Ctr Policy Impact Global Hlth, Durham, NC 27710 USA	Duke University	Yamey, G (corresponding author), Duke Univ, Ctr Policy Impact Global Hlth, Durham, NC 27710 USA.	gavin.yamey@duke.edu							0	15	15	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847					529	529		10.1038/d41586-021-00470-9	http://dx.doi.org/10.1038/d41586-021-00470-9			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM2BL	33627806				2022-12-28	WOS:000621583600002
J	Limb, M				Limb, Matthew			Covid-19: Plans to share vaccines aren't enough, says charity	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, JOINT STATEMENT G7 L; European Commission, 2021, EU DOUBL CONTR COVAX	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2021	372								n516	10.1136/bmj.n516	http://dx.doi.org/10.1136/bmj.n516			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7AW	33619121	Bronze			2022-12-28	WOS:000621236700003
J	Bugge, C; Dembinsky, M; Kearney, R; Hagen, S				Bugge, Carol; Dembinsky, Melanie; Kearney, Rohna; Hagen, Suzanne			Does self-management of vaginal pessaries improve care for women with pelvic organ prolapse?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bugge, Carol; Dembinsky, Melanie] Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland; [Kearney, Rohna] Manchester Univ NHS Trust, Manchester Acad Hlth Sci, St Marys Hosp, Warrell Unit, Manchester, Lancs, England; [Kearney, Rohna] Univ Manchester, Sch Med Sci, Div Dev Biol & Med, Manchester, Lancs, England; [Hagen, Suzanne] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow, Lanark, Scotland	University of Stirling; University of Manchester; University of Manchester; Glasgow Caledonian University	Bugge, C (corresponding author), Univ Stirling, Fac Hlth Sci & Sport, Stirling, Scotland.	carol.bugge@stir.ac.uk		Kearney, Rohna/0000-0002-1489-4397; HAGEN, SUZANNE/0000-0002-9741-9160; Bugge, Carol/0000-0002-4071-0803	National Institute for Health Research (NIHR) (Health Technology Assessment Programme) [16/82/01]	National Institute for Health Research (NIHR) (Health Technology Assessment Programme)(National Institute for Health Research (NIHR))	The TOPSY Trial is funded by the National Institute for Health Research (NIHR) (Health Technology Assessment Programme (project reference 16/82/01)). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.	American College of Obstetricians and Gynecologists, 2019, OBSTET GYNECOL; Bugge C, 2013, INT UROGYNECOL J, V24, P1017, DOI 10.1007/s00192-012-1985-7; Chien CW, 2020, FEMALE PELVIC MED RE, V26, pE47, DOI 10.1097/SPV.0000000000000770; Dumoulin C., 2017, INCONTINENCE, P1443, DOI DOI 10.1002/14651858.CD005654.PUB4; Hagen S, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04738-9; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Kapoor DS, 2009, INT UROGYNECOL J, V20, P1157, DOI 10.1007/s00192-009-0930-x; Kearney R, 2014, BMJ QUAL IMPROV REP, V3; Lough K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021276; Manonai J, 2019, MENOPAUSE, V26, P665, DOI 10.1097/GME.0000000000001277; National Institute for Health and Care Excellence, 2019, UR INC PELV ORG PROL; Nemeth Z, 2013, INT UROGYNECOL J, V24, P1695, DOI 10.1007/s00192-013-2093-z; Propst K, 2020, OBSTET GYNECOL, V135, P100, DOI 10.1097/AOG.0000000000003580; Royal College of Obstetricians and Gynaecologists, BSUG GUID MAN UR CON; Tam MS, 2019, MATURITAS, V128, P29, DOI 10.1016/j.maturitas.2019.07.002; Thys SD, 2020, INT UROGYNECOL J, V31, P1567, DOI 10.1007/s00192-019-04200-8	16	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n310	10.1136/bmj.n310	http://dx.doi.org/10.1136/bmj.n310			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608314	Green Accepted, Green Published			2022-12-28	WOS:000621237300001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: GPs opt to prioritise all patients with learning disabilities for vaccination	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Kent and Medway CCG, 2021, COV 19 VACC UPD; Office for National Statistics, UPD EST COR COVID 19; Public Health England, 2021, GREEN BOOK COVID 19; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n467	4	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n510	10.1136/bmj.n510	http://dx.doi.org/10.1136/bmj.n510			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608253	Bronze			2022-12-28	WOS:000621237300004
J	Kurial, SNT; Willenbring, H				Kurial, Simone N. T.; Willenbring, Holger			Emerging cell therapy for biliary diseases	SCIENCE			English	Editorial Material							HEPATOCYTES		[Kurial, Simone N. T.; Willenbring, Holger] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Willenbring, Holger] Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA; [Willenbring, Holger] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Willenbring, H (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Willenbring, H (corresponding author), Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA.; Willenbring, H (corresponding author), Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA.	holger.willenbring@ucsf.edu		Kurial, Simone/0000-0003-1175-6076	National Institutes of Health [F31 DK126419, R01 DK107553, R01 AA026578, UH3 DK120004, P30 DK026743]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are funded by the National Institutes of Health (F31 DK126419, R01 DK107553, R01 AA026578, UH3 DK120004, and P30 DK026743). H.W. is a cofounder and advisory board member of Ambys Medicines.	Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; De Assuncao TM, 2015, LAB INVEST, V95, P684, DOI 10.1038/labinvest.2015.51; Deuse T, 2019, NAT BIOTECHNOL, V37, P252, DOI 10.1038/s41587-019-0016-3; Inada H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19041-z; Katsuda T, 2017, CELL STEM CELL, V20, P41, DOI 10.1016/j.stem.2016.10.007; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Nguyen MP, 2020, EXPERT REV GASTROENT, V14, P185, DOI 10.1080/17474124.2020.1733975; Sampaziotis F, 2021, SCIENCE, V371, P839, DOI 10.1126/science.aaz6964; Schaub JR, 2018, NATURE, V557, P247, DOI 10.1038/s41586-018-0075-5; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Wang ZG, 2021, TISSUE ENG PART C-ME, V27, P59, DOI [10.1089/ten.tec.2020.0283, 10.1089/ten.TEC.2020.0283]; Yovchev MI, 2019, HEPATOL COMMUN, V3, P1137, DOI 10.1002/hep4.1367; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017	15	2	2	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					786	+		10.1126/science.abg3179	http://dx.doi.org/10.1126/science.abg3179			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602846	Green Accepted			2022-12-28	WOS:000619664700033
J	Glassman, CR; Mathiharan, YK; Jude, KM; Su, L; Panova, O; Lupardus, PJ; Spangler, JB; Ely, LK; Thomas, C; Skiniotis, G; Garcia, KC				Glassman, Caleb R.; Mathiharan, Yamuna Kalyani; Jude, Kevin M.; Su, Leon; Panova, Ouliana; Lupardus, Patrick J.; Spangler, Jamie B.; Ely, Lauren K.; Thomas, Christoph; Skiniotis, Georgios; Garcia, K. Christopher			Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells	CELL			English	Article								Interleukin-12 (IL-12) and IL-23 are heterodimeric cytokines that are produced by antigen-presenting cells to regulate the activation and differentiation of lymphocytes, and they share IL-12R beta 1 as a receptor signaling subunit. We present a crystal structure of the quaternary IL-23 (IL-23p19/p40)/IL-23R/IL-12R beta 1 complex, together with cryoelectron microscopy (cryo-EM) maps of the complete IL-12 (IL-12p35/p40)/IL-12R beta 2/IL-12R beta 1 and IL-23 receptor (IL-23R) complexes, which reveal "non-canonical'' topologies where IL-12R beta 1 directly engages the common p40 subunit. We targeted the shared IL-12R beta 1/p40 interface to design a panel of IL-12 partial agonists that preserved interferon gamma (IFN gamma) induction by CD8(+) T cells but impaired cytokine production from natural killer (NK) cells in vitro. These cell-biased properties were recapitulated in vivo, where IL-12 partial agonists elicited anti-tumor immunity to MC-38 murine adenocarcinoma absent the NK-cell-mediated toxicity seen with wild-type IL-12. Thus, the structural mechanism of receptor sharing used by IL-12 family cytokines provides a protein interface blueprint for tuning this cytokine axis for therapeutics.	[Glassman, Caleb R.; Garcia, K. Christopher] Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Glassman, Caleb R.; Mathiharan, Yamuna Kalyani; Jude, Kevin M.; Su, Leon; Panova, Ouliana; Lupardus, Patrick J.; Spangler, Jamie B.; Ely, Lauren K.; Thomas, Christoph; Skiniotis, Georgios; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Glassman, Caleb R.; Mathiharan, Yamuna Kalyani; Jude, Kevin M.; Su, Leon; Panova, Ouliana; Lupardus, Patrick J.; Spangler, Jamie B.; Ely, Lauren K.; Thomas, Christoph; Skiniotis, Georgios; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA; [Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Lupardus, Patrick J.] Synthekine, Menlo Pk, CA 94025 USA; [Spangler, Jamie B.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Spangler, Jamie B.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Ely, Lauren K.] Pfizer, San Francisco, CA 94080 USA; [Thomas, Christoph] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Johns Hopkins University; Johns Hopkins University; Pfizer; Goethe University Frankfurt	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Struct Biol, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Spangler, Jamie/0000-0001-8187-3732; Jude, Kevin/0000-0002-3675-5136; Mathiharan, Yamuna Kalyani/0000-0003-4042-6199; Glassman, Caleb/0000-0002-3342-7989; Skiniotis, Georgios/0000-0003-0238-7846; Thomas, Christoph/0000-0001-7441-1089; Su, Leon/0000-0001-7654-9997	National Institutes of Health [R01-AI51321]; Mathers Foundation; Ludwig Foundation; National Science Foundation Graduate Research Fellowship Program [DGE-1656518]; Department of Energy Office of Science User Facility [DE-AC02-05CH11231]; US Department of Energy Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Ludwig Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); US Department of Energy Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Amy Fan, Robert Saxton, and members of the Garcia lab for helpful feedback and discussion. Technical support for cryo-EM was provided by Elizabeth Montabana. The pCDH-EF1-cOVA-T2A-copGFP plasmid was a kind gift of Irving L. Weissman. K.C.G. is an investigator with the Howard Hughes Medical Institute. K.C.G. is supported by National Institutes of Health grant R01-AI51321, the Mathers Foundation, and the Ludwig Foundation. C.R.G. is supported by the National Science Foundation Graduate Research Fellowship Program under grant DGE-1656518. We thank the staff at Stanford Synchrotron Radiation Lightsource (SSRL) and Advanced Light Source (ALS) for their assistance. ALS is a Department of Energy Office of Science User Facility under contract DE-AC02-05CH11231. Use of SSRL at Stanford Linear Accelerator Center (SLAC) National Accelerator Laboratory is supported by the US Department of Energy Office of Science, Office of Basic Energy Sciences under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research and the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393). The graphical abstract was created with BioRender.com.	Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; ASTEAMEZAGA M, 1994, CELL IMMUNOL, V156, P480, DOI 10.1006/cimm.1994.1192; Au-Yeung BB, 2017, J IMMUNOL, V198, P2445, DOI 10.4049/jimmunol.1601453; Benson JM, 2011, NAT BIOTECHNOL, V29, P615, DOI 10.1038/nbt.1903; Berraondo P, 2018, CLIN CANCER RES, V24, P2716, DOI 10.1158/1078-0432.CCR-18-0381; Biber JL, 2002, CELL IMMUNOL, V216, P31, DOI 10.1016/S0008-8749(02)00501-4; Bloch Y, 2018, IMMUNITY, V48, P45, DOI 10.1016/j.immuni.2017.12.008; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRUNDA MJ, 1995, J IMMUNOTHER, V17, P71, DOI 10.1097/00002371-199502000-00001; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Carson WE, 2000, BLOOD, V96, P1465, DOI 10.1182/blood.V96.4.1465.h8001465_1465_1473; Carson WE, 1999, J IMMUNOL, V162, P4943; Chan TC, 2018, THER ADV CHRONIC DIS, V9, P111, DOI 10.1177/2040622318759282; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; CHUA AO, 1994, J IMMUNOL, V153, P128; COHEN J, 1995, SCIENCE, V270, P908; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2012, NAT IMMUNOL, V13, P290, DOI 10.1038/ni.2227; CORBETT TH, 1975, CANCER RES, V35, P2434; Dambuza IM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00838-4; Desmyter A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00884; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Fewell JG, 2009, J GENE MED, V11, P718, DOI 10.1002/jgm.1356; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huyton T, 2007, P NATL ACAD SCI USA, V104, P12737, DOI 10.1073/pnas.0705577104; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kopp T, 2015, NATURE, V521, P222, DOI 10.1038/nature14175; Koutruba N, 2010, THER CLIN RISK MANAG, V6, P123; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Lehmann C, 2001, BRIT J HAEMATOL, V114, P660, DOI 10.1046/j.1365-2141.2001.02995.x; Leonard JP, 1997, BLOOD, V90, P2541; Leong JW, 2014, BIOL BLOOD MARROW TR, V20, P463, DOI 10.1016/j.bbmt.2014.01.006; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Luo JQ, 2010, J MOL BIOL, V402, P797, DOI 10.1016/j.jmb.2010.07.046; Lupardus PJ, 2008, J MOL BIOL, V382, P931, DOI 10.1016/j.jmb.2008.07.051; MATTNER F, 1993, EUR J IMMUNOL, V23, P2202, DOI 10.1002/eji.1830230923; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Momin N, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw2614; Mondal S, 2020, P NATL ACAD SCI USA, V117, P21557, DOI 10.1073/pnas.2000653117; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Oka N, 2020, CANCER IMMUNOL IMMUN, V69, P1699, DOI 10.1007/s00262-020-02553-4; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pasche N, 2012, CLIN CANCER RES, V18, P4092, DOI 10.1158/1078-0432.CCR-12-0282; Pegram HJ, 2012, BLOOD, V119, P4133, DOI 10.1182/blood-2011-12-400044; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Rubinstein MP, 2015, CANCER IMMUNOL IMMUN, V64, P539, DOI 10.1007/s00262-015-1655-y; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroder J, 2015, J BIOL CHEM, V290, P359, DOI 10.1074/jbc.M114.617597; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tamura T, 2001, HUM GENE THER, V12, P1265, DOI 10.1089/104303401750270922; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tseng D, 2013, P NATL ACAD SCI USA, V110, P11103, DOI 10.1073/pnas.1305569110; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wallington JC, 2018, J ALLERGY CLIN IMMUN, V141, P2182, DOI 10.1016/j.jaci.2017.08.009; Wang XQ, 2016, EUR J IMMUNOL, V46, P1343, DOI 10.1002/eji.201546095; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wojtowicz WM, 2020, CELL, V182, P1027, DOI 10.1016/j.cell.2020.07.025; Yao BB, 1999, ARCH BIOCHEM BIOPHYS, V368, P147, DOI 10.1006/abbi.1999.1302; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yeste A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4753; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; ZITVOGEL L, 1995, J IMMUNOL, V155, P1393; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	88	30	31	10	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					983	+		10.1016/j.cell.2021.01.018	http://dx.doi.org/10.1016/j.cell.2021.01.018		FEB 2021	41	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606986	Green Accepted, Bronze			2022-12-28	WOS:000629633400014
J	Myers, CA; Martin, CK; Apolzan, JW; Arnold, CL; Davis, TC; Johnson, WD; Katzmarzyk, PT				Myers, Candice A.; Martin, Corby K.; Apolzan, John W.; Arnold, Connie L.; Davis, Terry C.; Johnson, William D.; Katzmarzyk, Peter T.			Food Insecurity and Weight Loss in an Underserved Primary Care Population: A Post Hoc Analysis of a Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Letter									[Myers, Candice A.; Martin, Corby K.; Apolzan, John W.; Johnson, William D.; Katzmarzyk, Peter T.] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Arnold, Connie L.; Davis, Terry C.] Louisiana State Univ, Hlth Sci Ctr, Shreveport, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Myers, CA (corresponding author), Pennington Biomed Res Ctr, Baton Rouge, LA USA.	candice.myers@pbrc.edu	Myers, Candice/N-1979-2017; Apolzan, John William/N-1949-2017; Katzmarzyk, Peter/N-1974-2017	Myers, Candice/0000-0003-1923-3448; Apolzan, John William/0000-0001-8492-7820; Arnold, Connie/0000-0001-8961-2342; Katzmarzyk, Peter/0000-0002-9280-6022	Patient-Centered Outcomes Research Institute award [OB-1402-10977]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940]; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK072476]	Patient-Centered Outcomes Research Institute award(Patient-Centered Outcomes Research Institute - PCORI); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By a Patient-Centered Outcomes Research Institute award (OB-1402-10977). Additional support was provided by grant 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center, and by grant P30DK072476 entitled "Nutrition and Metabolic Health Through the Lifespan" sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases.	Katzmarzy PT, 2018, CONTEMP CLIN TRIALS, V67, P1, DOI 10.1016/j.cct.2018.02.002; Katzmarzyk PT, 2020, NEW ENGL J MED, V383, P909, DOI 10.1056/NEJMoa2007448; Myers CA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12767; Myers CA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061376; Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301	5	4	4	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					1032	+		10.7326/M20-6326	http://dx.doi.org/10.7326/M20-6326			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33683931	Green Accepted			2022-12-28	WOS:000675809000040
J	Gaber, CE; Kinlaw, AC; Edwards, JK; Lund, JL; Sturmer, T; Hinton, SP; Pate, V; Bartelt, LA; Sandler, RS; Peery, AF				Gaber, Charles E.; Kinlaw, Alan C.; Edwards, Jessie K.; Lund, Jennifer L.; Sturmer, Til; Hinton, Sharon Peacock; Pate, Virginia; Bartelt, Luther A.; Sandler, Robert S.; Peery, Anne F.			Comparative Effectiveness and Harms of Antibiotics for Outpatient Diverticulitis Two Nationwide Cohort Studies	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION; GUIDELINES; SELECTION; SOCIETY; RISK	Background: Outpatient diverticulitis is commonly treated with either a combination of metronidazole and a fluoroquinolone (metronidazole-with-fluoroquinolone) or amoxicillin-clavulanate alone. The U.S. Food and Drug Administration advised that fluoroquinolones be reserved for conditions with no alternative treatment options. The comparative effectiveness of metronidazole-with-fluoroquinolone versus amoxicillin-clavulanate for diverticulitis is uncertain. Objective: To determine the effectiveness and harms of metronidazole-with-fluoroquinolone versus amoxicillin-clavulanate for outpatient diverticulitis. Design: Active-comparator, new-user, retrospective cohort studies. Setting: Nationwide population-based claims data on U.S. residents aged 18 to 64 years with private employer-sponsored insurance (2000 to 2018) or those aged 65 years or older with Medicare (2006 to 2015). Participants: Immunocompetent adults with diverticulitis in the outpatient setting. Intervention: Metronidazole-with-fluoroquinolone or amoxicillin-clavulanate. Measurements: 1-year risks for inpatient admission, urgent surgery, and Clostridioides difficile infection (CDI) and 3-year risk for elective surgery. Results: In MarketScan (IBM Watson Health), new users of metronidazole-with-fluoroquinolone (n = 106 361) and amoxicillin-clavulanate (n = 13 160) were identified. There were no differences in 1-year admission risk (risk difference, 0.1 percentage points [95% CI, -0.3 to 0.6]), 1-year urgent surgery risk (risk difference, 0.0 percentage points [CI, -0.1 to 0.11), 3-year elective surgery risk (risk difference, 0.2 percentage points [CI, -0.3 to 0.7]), or 1-year CDI risk (risk difference, 0.0 percentage points [CI, -0.1 to 0.1]) between groups. In Medicare, new users of metronidazole-with-fluoroquinolone (n = 17639) and amoxicillin-clavulanate (n = 2709) were identified. There were no differences in 1-year admission risk (risk difference, 0.1 percentage points [CI, -0.7 to 0.9]), 1-year urgent surgery risk (risk difference, -0.2 percentage points [CI, -0.6 to 0.11), or 3-year elective surgery risk (risk difference, -0.3 percentage points [CI, -1.1 to 0.4]) between groups. The 1-year CDI risk was higher for metronidazole-with-fluoroquinolone than for amoxicillin-clavulanate (risk difference, 0.6 percentage points [CI, 0.2 to 1.0]). Limitation: Residual confounding is possible, and not all harms associated with these antibiotics, most notably drug-induced liver injury, could be assessed. Conclusion: Treating diverticulitis in the outpatient setting with amoxicillin-clavulanate may reduce the risk for fluoroquinolone-related harms without adversely affecting diverticulitis-specific outcomes.	[Gaber, Charles E.; Bartelt, Luther A.; Sandler, Robert S.; Peery, Anne F.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Sch Med, Chapel Hill, NC 27599 USA; [Gaber, Charles E.; Edwards, Jessie K.; Lund, Jennifer L.; Sturmer, Til; Hinton, Sharon Peacock; Pate, Virginia] Univ N Carolina, Sch Publ Hlth, 135 Dauer Dr, Chapel Hill, NC 27599 USA; [Kinlaw, Alan C.] Univ N Carolina, Sch Pharm, 301 Pharm Lane, Chapel Hill, NC 27599 USA; [Kinlaw, Alan C.; Sturmer, Til] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; [Bartelt, Luther A.; Sandler, Robert S.; Peery, Anne F.] Univ N Carolina, Sch Med, Bioinformat Bldg CB 7080,130 Mason Farm Rd, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Peery, AF (corresponding author), Univ N Carolina, Sch Med, Bioinformat Bldg CB 7080,130 Mason Farm Rd, Chapel Hill, NC 27599 USA.	cgaber@unc.edu; Anne_Peery@med.unc.edu	Stürmer, Til/AAB-5459-2022	Gaber, Charles/0000-0002-6752-2968; Edwards, Jessie/0000-0002-1741-335X; Kinlaw, Alan/0000-0002-4279-8685	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health.	Alves C, 2019, EUR J CLIN PHARMACOL, V75, P1431, DOI 10.1007/s00228-019-02713-1; Au S, 2019, DIS COLON RECTUM, V62, P1533, DOI 10.1097/DCR.0000000000001330; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Bharucha AE, 2015, AM J GASTROENTEROL, V110, P1588, DOI 10.1038/ajg.2015.302; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brunelli SM, 2013, PHARMACOEPIDEM DR S, V22, P542, DOI 10.1002/pds.3434; Chabok A, 2012, BRIT J SURG, V99, P532, DOI 10.1002/bjs.8688; Chalasani N, 2015, GASTROENTEROLOGY, V148, P1340, DOI 10.1053/j.gastro.2015.03.006; Chubak J, 2012, J CLIN EPIDEMIOL, V65, P343, DOI 10.1016/j.jclinepi.2011.09.002; D'Arcy M, 2018, CURR EPIDEMIOL REP, V5, P272, DOI 10.1007/s40471-018-0155-y; Daniels L, 2017, BRIT J SURG, V104, P52, DOI 10.1002/bjs.10309; Danielson Group, 2014, DAN GROUP; Dong HR, 2015, AM J EPIDEMIOL, V181, P532, DOI 10.1093/aje/kwu289; Edwards Jessie K, 2016, Curr Epidemiol Rep, V3, P285, DOI 10.1007/s40471-016-0089-1; Etzioni DA, 2010, DIS COLON RECTUM, V53, P861, DOI 10.1007/DCR.0b013e3181cdb243; Feuerstadt P, 2020, J MED ECON, V23, P603, DOI 10.1080/13696998.2020.1724117; Francis NK, 2019, SURG ENDOSC, V33, P2726, DOI 10.1007/s00464-019-06882-z; Hall J, 2020, DIS COLON RECTUM, V63, P728, DOI 10.1097/DCR.0000000000001679; IBM Watson Health, IBM MARKETSCAN RES D; Kawatkar A, 2015, PHARMACOEPIDEM DR S, V24, P27, DOI 10.1002/pds.3708; KELLUM JM, 1992, CLIN THER, V14, P376; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lee CC, 2015, JAMA INTERN MED, V175, P1839, DOI 10.1001/jamainternmed.2015.5389; Lo Re V, 2013, PHARMACOEPIDEM DR S, V22, P861, DOI 10.1002/pds.3470; Lund Jennifer L, 2015, Curr Epidemiol Rep, V2, P221; McCusker ME, 2003, EMERG INFECT DIS, V9, P730; Morales D, 2019, JAMA NEUROL, V76, P827, DOI 10.1001/jamaneurol.2019.0887; Murphy CC, 2019, GASTROENTEROLOGY, V156, P958, DOI [10.1053/j.gastro.2018.08.063, 10.1053/j.gastro.2018.11.060]; Orman ES, 2011, CLIN GASTROENTEROL H, V9, P517, DOI 10.1016/j.cgh.2011.02.019; Pant C, 2012, TRANSPL INFECT DIS, V14, P540, DOI 10.1111/j.1399-3062.2012.00761.x; Parekh TM, 2014, JAMA INTERN MED, V174, P1605, DOI 10.1001/jamainternmed.2014.3293; Peery AF, 2021, GASTROENTEROLOGY, V160, P906, DOI 10.1053/j.gastro.2020.09.059; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sartelli M, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00313-4; Sellick J, 2018, PSYCHOSOMATICS, V59, P259, DOI 10.1016/j.psym.2017.11.001; Simianu VV, 2016, ANN SURG, V263, P123, DOI 10.1097/SLA.0000000000001053; Stollman N, 2015, GASTROENTEROLOGY, V149, P1944, DOI 10.1053/j.gastro.2015.10.003; Strate LL, 2012, AM J GASTROENTEROL, V107, P1486, DOI 10.1038/ajg.2012.194; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Swanson SM, 2018, ANN INTERN MED, V168, pITC65, DOI 10.7326/AITC201805010; U.S. Food and Drug Administration, FDA REINF SAF INF SE; U.S. Food and Drug Administration, DRUG IND LIV INJ RAN; Westreich D, 2017, EPIDEMIOLOGY, V28, P525, DOI 10.1097/EDE.0000000000000648; Westreich D, 2014, AM J EPIDEMIOL, V179, P797, DOI 10.1093/aje/kwt328; Yang D., SAS GLOBAL FORUM 201; Young-Fadok TM, 2018, NEW ENGL J MED, V379, P1635, DOI 10.1056/NEJMcp1800468	47	5	5	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2021	174	6					737	+		10.7326/M20-6315	http://dx.doi.org/10.7326/M20-6315			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SS5IR	33617725	Green Accepted			2022-12-28	WOS:000661788700013
J	Anderson, EM; Goodwin, EC; Verma, A; Arevalo, CP; Bolton, MJ; Weirick, ME; Gouma, S; McAllister, CM; Christensen, SR; Weaver, J; Hicks, P; Manzoni, TB; Oniyide, O; Ramage, H; Mathew, D; Baxter, AE; Oldridge, DA; Greenplate, AR; Wu, JE; Alanio, C; D'Andrea, K; Kuthuru, O; Dougherty, J; Pattekar, A; Kim, J; Han, N; Apostolidis, SA; Huang, AC; Vella, LA; Kuri-Cervantes, L; Pampena, MB; Betts, MR; Wherry, EJ; Meyer, NJ; Cherry, S; Bates, P; Rader, DJ; Hensley, SE				Anderson, Elizabeth M.; Goodwin, Eileen C.; Verma, Anurag; Arevalo, Claudia P.; Bolton, Marcus J.; Weirick, Madison E.; Gouma, Sigrid; McAllister, Christopher M.; Christensen, Shannon R.; Weaver, JoEllen; Hicks, Philip; Manzoni, Tomaz B.; Oniyide, Oluwatosin; Ramage, Holly; Mathew, Divij; Baxter, Amy E.; Oldridge, Derek A.; Greenplate, Allison R.; Wu, Jennifer E.; Alanio, Cecile; D'Andrea, Kurt; Kuthuru, Oliva; Dougherty, Jeanette; Pattekar, Ajinkya; Kim, Justin; Han, Nicholas; Apostolidis, Sokratis A.; Huang, Alex C.; Vella, Laura A.; Kuri-Cervantes, Leticia; Pampena, M. Betina; Betts, Michael R.; Wherry, E. John; Meyer, Nuala J.; Cherry, Sara; Bates, Paul; Rader, Daniel J.; Hensley, Scott E.		UPenn COVID Proc Unit	Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection	CELL			English	Article							VIRUS; NL63; OC43; HKU1	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had been previously exposed to other antigenically distinct common seasonal human coronaviruses (hCoVs) before the coronavirus disease 2019 (COVID-19) pandemic. Here, we quantified levels of SARS-CoV-2-reactive antibodies and hCoV-reactive antibodies in serum samples collected from 431 humans before the COVID-19 pandemic. We then quantified pre-pandemic antibody levels in serum from a separate cohort of 251 individuals who became PCR-confirmed infected with SARS-CoV-2. Finally, we longitudinally measured hCoV and SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients. Our studies indicate that most individuals possessed hCoV-reactive antibodies before the COVID-19 pandemic. We determined that similar to 20% of these individuals possessed non-neutralizing antibodies that cross-reacted with SARS-CoV-2 spike and nucleocapsid proteins. These antibodies were not associated with protection against SARS-CoV-2 infections or hospitalizations, but they were boosted upon SARS-CoV-2 infection.	[Anderson, Elizabeth M.; Goodwin, Eileen C.; Arevalo, Claudia P.; Bolton, Marcus J.; Weirick, Madison E.; Gouma, Sigrid; McAllister, Christopher M.; Christensen, Shannon R.; Manzoni, Tomaz B.; Kuri-Cervantes, Leticia; Pampena, M. Betina; Betts, Michael R.; Bates, Paul; Hensley, Scott E.] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Verma, Anurag; Weaver, JoEllen; Rader, Daniel J.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Hicks, Philip] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Oniyide, Oluwatosin; Meyer, Nuala J.] Univ Penn, Div Pulm Allergy & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Oniyide, Oluwatosin; Meyer, Nuala J.] Univ Penn, Ctr Translat Lung Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ramage, Holly; Cherry, Sara] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mathew, Divij; Baxter, Amy E.; Oldridge, Derek A.; Greenplate, Allison R.; Wu, Jennifer E.; Alanio, Cecile; D'Andrea, Kurt; Kuthuru, Oliva; Dougherty, Jeanette; Pattekar, Ajinkya; Kim, Justin; Han, Nicholas; Apostolidis, Sokratis A.; Huang, Alex C.; Vella, Laura A.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Mathew, Divij; Baxter, Amy E.; Oldridge, Derek A.; Greenplate, Allison R.; Wu, Jennifer E.; Alanio, Cecile; D'Andrea, Kurt; Kuthuru, Oliva; Dougherty, Jeanette; Pattekar, Ajinkya; Kim, Justin; Han, Nicholas; Apostolidis, Sokratis A.; Huang, Alex C.; Vella, Laura A.; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Wu, Jennifer E.; Alanio, Cecile; Wherry, E. John] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Vella, Laura A.] Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA; [Bates, Paul] Univ Penn, Penn Ctr Res Coronavirus & Other Emerging Pathoge, Philadelphia, PA 19104 USA; [Ramage, Holly] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Jefferson University	Hensley, SE (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	hensley@pennmedicine.upenn.edu	Pattekar, Ajinkya/AHC-7838-2022; Pattekar, Dr. Ajinkya/AHC-7868-2022; Wu, Jennifer/GRX-1831-2022	Pattekar, Ajinkya/0000-0002-1416-1230; Pattekar, Dr. Ajinkya/0000-0002-1416-1230; Weaver, JoEllen/0000-0002-0596-0188; Kim, Justin/0000-0003-0774-8137; cherry, sara/0000-0003-3956-6610; Ramage, Holly/0000-0002-0390-6786; Han, Nicholas/0000-0003-1410-9931; Hamilton, Jacob/0000-0003-1277-6925; Verma, Anurag/0000-0002-5063-9107; McAllister, Christopher/0000-0002-0011-4089; Descamps, Helene/0000-0001-5591-5839	NIH [U19AI082630, HL137006, HL137915, R21AI129531, R21AI142638]; Peer Reviewed Medical Research Program [PR182551]; NIH Training in Virology T32 Program [T32AI007324]; NIH Emerging Infectious Diseases T32 Program [T32AI055400]; University of Pennsylvania	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peer Reviewed Medical Research Program; NIH Training in Virology T32 Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Emerging Infectious Diseases T32 Program; University of Pennsylvania	This work was supported by institutional funds from the University of Pennsylvania, NIH grants U19AI082630 (E.J. W. and S.E.H.), HL137006 (N.J.M.), HL137915 (N.J.M.), R21AI129531 (P.B.), and R21AI142638 (P.B.); and Peer Reviewed Medical Research Program award PR182551 (P.B.). E.M.A. and T.B.M. were supported by the NIH Training in Virology T32 Program (T32AI007324). P.H. and C.P.A. were supported by the NIH Emerging Infectious Diseases T32 Program (T32AI055400). We thank J. Lurie, J. Embiid, J. Harris, and D. Blitzer for philanthropic support. We thank all members of the Wherry Lab and the Penn COVID-19 Sample Processing Unit (Zahidul Alam, Mary M. Addison, Katelyn T. Byrne, Aditi Chandra, Helene C. Descamps, Yaroslav Kaminskiy, Jacob T. Hamilton, Julia Han Noll, Dalia K. Omran, Eric Perkey, Elizabeth M. Prager, Dana Pueschl, Jennifer B. Shah, Jake S. Shilan, and Ashley N. Vanderbeck) for sample procurement, processing, and logistics. We thank the staff of the PMBB. We thank F. Krammer (Mt. Sinai) for sending us the SARS-CoV-2 spike RBD expression plasmids. We thank David Anderson for assistance with the graphical abstract.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; [Anonymous], 2021, LANG ENV STAT COMP; Arevalo CP, 2020, P NATL ACAD SCI USA, V117, P17221, DOI 10.1073/pnas.1920321117; Bolton M.J., 2020, J PEDIAT INFECT DIS; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; Davis BH, 2013, CYTOM PART B-CLIN CY, V84, P286, DOI 10.1002/cyto.b.21105; Dijkman R, 2012, J CLIN VIROL, V53, P135, DOI 10.1016/j.jcv.2011.11.011; Flannery DD, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd5709; Friedman N, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100515; Gaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10; Gouma S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18465-x; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Killerby ME, 2018, J CLIN VIROL, V101, P52, DOI 10.1016/j.jcv.2018.01.019; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Phillips N, 2021, NATURE, V590, P382, DOI 10.1038/d41586-021-00396-2; Nguyen-Contant P, 2020, MBIO, V11, DOI 10.1128/mBio.01991-20; Poston D, 2021, CLIN INFECT DIS, V73, pE1208, DOI [10.1093/cid/ciaa1803, 10.1101/2020.10.08.20209650]; Pyrc K, 2006, J MOL BIOL, V364, P964, DOI 10.1016/j.jmb.2006.09.074; Sagar M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143380; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Sette A, 2020, NAT REV IMMUNOL, V20, P457, DOI 10.1038/s41577-020-0389-z; Shrock E, 2020, SCIENCE, V370, P1058, DOI 10.1126/science.abd4250; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Wu AC, 2020, LANCET MICROBE, V1, pE254, DOI [10.1016/s2666-5247(20)30114-2, 10.1016/S2666-5247(20)30114-2]	32	177	175	4	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2021	184	7					1858	+		10.1016/j.cell.2021.02.010	http://dx.doi.org/10.1016/j.cell.2021.02.010		APR 2021	17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RI2IU	33631096	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000636734000018
J	Mato, AR; Shah, NN; Jurczak, W; Cheah, CY; Pagel, JM; Woyach, JA; Fakhri, B; Eyre, TA; Lamanna, N; Patel, MR; Alencar, A; Lech-Maranda, E; Wierda, WG; Coombs, CC; Gerson, JN; Ghia, P; Le Gouill, S; Lewis, DJ; Sundaram, S; Cohen, JB; Flinn, IW; Tam, CS; Barve, MA; Kuss, B; Taylor, J; Abdel-Wahab, O; Schuster, SJ; Palomba, ML; Lewis, KL; Roeker, LE; Davids, MS; Tan, XN; Fenske, TS; Wallin, J; Tsai, DE; Ku, NC; Zhu, E; Chen, J; Yin, M; Nair, B; Ebata, K; Marella, N; Brown, JR; Wang, M				Mato, Anthony R.; Shah, Nirav N.; Jurczak, Wojciech; Cheah, Chan Y.; Pagel, John M.; Woyach, Jennifer A.; Fakhri, Bita; Eyre, Toby A.; Lamanna, Nicole; Patel, Manish R.; Alencar, Alvaro; Lech-Maranda, Ewa; Wierda, William G.; Coombs, Catherine C.; Gerson, James N.; Ghia, Paolo; Le Gouill, Steven; Lewis, David John; Sundaram, Suchitra; Cohen, Jonathon B.; Flinn, Ian W.; Tam, Constantine S.; Barve, Minal A.; Kuss, Bryone; Taylor, Justin; Abdel-Wahab, Omar; Schuster, Stephen J.; Palomba, M. Lia; Lewis, Katharine L.; Roeker, Lindsey E.; Davids, Matthew S.; Tan, Xuan Ni; Fenske, Timothy S.; Wallin, Johan; Tsai, Donald E.; Ku, Nora C.; Zhu, Edward; Chen, Jessica; Yin, Ming; Nair, Binoj; Ebata, Kevin; Marella, Narasimha; Brown, Jennifer R.; Wang, Michael			Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study	LANCET			English	Article							IBRUTINIB THERAPY; TARGETING BTK; OUTCOMES; RESISTANCE; DISCONTINUATION; INHIBITOR; KINASE	Background Covalent Bruton's tyrosine kinase (BTK) inhibitors are efficacious in multiple B-cell malignancies, but patients discontinue these agents due to resistance and intolerance. We evaluated the safety and efficacy of pirtobrutinib (working name; formerly known as LOXO-305), a highly selective, reversible BTK inhibitor, in these patients. Methods Patients with previously treated B-cell malignancies were enrolled in a first-in-human, multicentre, open-label, phase 1/ 2 trial of the BTK inhibitor pirtobrutinib. The primary endpoint was the maximum tolerated dose (phase 1) and overall response rate (ORR; phase 2). This trial is registered with ClinicalTrials.gov, NCT03740529. Findings 323 patients were treated with pirtobrutinib across seven dose levels (25 mg, 50 mg, 100 mg, 150 mg, 200 mg, 250 mg, and 300 mg once per day) with linear dose-proportional exposures. No dose-limiting toxicities were observed and the maximum tolerated dose was not reached. The recommended phase 2 dose was 200 mg daily. Adverse events in at least 10% of 323 patients were fatigue (65 [20%]), diarrhoea (55 [17%]), and contusion (42 [13%]). The most common adverse event of grade 3 or higher was neutropenia (32 [10%]). There was no correlation between pirtobrutinib exposure and the frequency of grade 3 treatment-related adverse events. Grade 3 atrial fibrillation or flutter was not observed, and grade 3 haemorrhage was observed in one patient in the setting of mechanical trauma. Five (1%) patients discontinued treatment due to a treatment-related adverse event. In 121 efficacy evaluable patients with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) treated with a previous covalent BTK inhibitor (median previous lines of treatment 4), the ORR with pirtobrutinib was 62% (95% CI 53-71). The ORR was similar in CLL patients with previous covalent BTK inhibitor resistance (53 [67%] of 79), covalent BTK inhibitor intolerance (22 [52%] of 42), BTK C481-mutant (17 [71%] of 24) and BTK wild-type (43 [66%] of 65) disease. In 52 efficacy evaluable patients with mantle cell lymphoma (MCL) previously treated with covalent BTK inhibitors, the ORR was 52% (95% CI 38-66). Of 117 patients with CLL, SLL, or MCL who responded, all but eight remain progression-free to date. Interpretation Pirtobrutinib was safe and active in multiple B-cell malignancies, including patients previously treated with covalent BTK inhibitors. Pirtobrutinib might address a growing unmet need for alternative therapies for these patients. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Mato, Anthony R.; Abdel-Wahab, Omar; Palomba, M. Lia; Roeker, Lindsey E.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Shah, Nirav N.] Med Coll Wisconsin, Brookfield, WI USA; [Jurczak, Wojciech] Maria Sklodowska Curie Natl Res Inst Oncol, Krakow, Poland; [Cheah, Chan Y.; Lewis, Katharine L.; Tan, Xuan Ni] Linear Clin Res, Perth, WA, Australia; [Cheah, Chan Y.; Lewis, Katharine L.; Tan, Xuan Ni] Sir Charles Gairdner Hosp, Perth, WA, Australia; [Cheah, Chan Y.; Lewis, Katharine L.; Tan, Xuan Ni] Univ Western Australia, Perth, WA, Australia; [Pagel, John M.] Swedish Canc Inst, Ctr Blood Disorders & Stem Cell Transplantat, Seattle, WA USA; [Woyach, Jennifer A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Fakhri, Bita] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94143 USA; [Eyre, Toby A.] Oxford Univ Hosp NHS Fdn Trust, Churchill Canc Ctr, Oxford, England; [Lamanna, Nicole] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Patel, Manish R.] Florida Canc Specialists, Sarasota, FL USA; [Patel, Manish R.] Sarah Cannon Res Inst, Sarasota, FL USA; [Alencar, Alvaro; Taylor, Justin] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Lech-Maranda, Ewa] Inst Hematol & Transfus Med, Dept Hematol, Warsaw, Poland; [Wierda, William G.; Wang, Michael] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Coombs, Catherine C.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Gerson, James N.; Schuster, Stephen J.] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA; [Ghia, Paolo] Univ Vita Salute San Raffaele, Milan, Italy; [Ghia, Paolo] IRCCS Osped San Raffaele, Milan, Italy; [Le Gouill, Steven] NeXT Univ Nantes, Serv Hematol Clin, CHU Nantes, INSERM,CRCINA Nantes Angers, Nantes, France; [Lewis, David John] Univ Hosp Plymouth NHS Trust, Plymouth, Devon, England; [Sundaram, Suchitra] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA; [Cohen, Jonathon B.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Flinn, Ian W.] Sarah Cannon Res Inst, Nashville, TN USA; [Flinn, Ian W.] Tennessee Oncol, Nashville, TN USA; [Tam, Constantine S.] Royal Melbourne Hosp, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Tam, Constantine S.] Univ Melbourne, Melbourne, Vic, Australia; [Barve, Minal A.] Mary Crowley Canc Res Ctr, Dallas, TX USA; [Kuss, Bryone] Flinders Univ S Australia, Med Ctr, Bedford Pk, SA, Australia; [Davids, Matthew S.; Brown, Jennifer R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Davids, Matthew S.; Brown, Jennifer R.] Harvard Med Sch, Boston, MA 02115 USA; [Fenske, Timothy S.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Wallin, Johan; Tsai, Donald E.; Ku, Nora C.; Zhu, Edward; Chen, Jessica; Yin, Ming; Nair, Binoj; Ebata, Kevin; Marella, Narasimha] Loxo Oncol Lilly, Stamford, CT USA	Memorial Sloan Kettering Cancer Center; Medical College of Wisconsin; University of Western Australia; University of Western Australia; Swedish Cancer Institute; Swedish Medical Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of California System; University of California San Francisco; Oxford University Hospitals NHS Foundation Trust; Columbia University; Florida Cancer Specialists; Sarah Cannon Research Institute; University of Miami; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Pennsylvania Medicine; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Emory University; Sarah Cannon Research Institute; Tennessee Oncology; Peter Maccallum Cancer Center; Royal Melbourne Hospital; University of Melbourne; Mary Crowley Cancer Research; Flinders University South Australia; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Medical College of Wisconsin	Mato, AR (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; Wang, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	matoa@mskcc.org; miwang@mdanderson.org	Lech-Maranda, Ewa/AAH-5474-2020; Jurczak, Wojciech/ABB-2136-2020	Lech-Maranda, Ewa/0000-0001-9592-0851; Jurczak, Wojciech/0000-0003-1879-8084; Ebata, Kevin/0000-0001-7166-7513; Cheah, Chan Yoon/0000-0001-7988-1565; Fakhri, Bita/0000-0002-2124-7243	Loxo Oncology	Loxo Oncology	Loxo Oncology.	[Anonymous], 2019, PHARMACEUTICALS-BASE; [Anonymous], 2019, BLOOD ADV, V3, P1799; Brandhuber B, 2018, CL LYMPH MYELOM LEUK, V18, pS216, DOI 10.1016/j.clml.2018.07.081; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Cheah CY, 2015, ANN ONCOL, V26, P1175, DOI 10.1093/annonc/mdv111; Cheson BD, 2012, J CLIN ONCOL, V30, P2820, DOI 10.1200/JCO.2012.43.3748; Chiron D, 2014, CANCER DISCOV, V4, P1022, DOI 10.1158/2159-8290.CD-14-0098; Coutre SE, LONG TERM SAFETY SIN; Di L, 2017, EXPERT OPIN DRUG DIS, V12, P1105, DOI 10.1080/17460441.2017.1367280; Epperla N, 2017, HEMATOL ONCOL, V35, P528, DOI 10.1002/hon.2380; Eyre TA, 2019, BRIT J HAEMATOL, V185, P656, DOI 10.1111/bjh.15802; Innocenti I, 2019, BRIT J HAEMATOL, V187, pE8, DOI 10.1111/bjh.16123; Jain P, 2019, AM J HEMATOL, V94, P710, DOI 10.1002/ajh.25487; Jain P, 2018, BRIT J HAEMATOL, V183, P578, DOI 10.1111/bjh.15567; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Martin P, 2016, BLOOD, V127, P1559, DOI 10.1182/blood-2015-10-673145; Mato AR, 2019, BLOOD, V134, DOI 10.1182/blood-2019-123747; Mato AR, 2020, CLIN CANCER RES, V26, P3589, DOI 10.1158/1078-0432.CCR-19-3815; Mato AR, 2018, HAEMATOLOGICA, V103, P1511, DOI 10.3324/haematol.2018.193615; Mato AR, 2018, CANCER BIOL THER, V19, P636, DOI 10.1080/15384047.2018.1449616; Mato AR, 2016, BLOOD, V128, P2199, DOI 10.1182/blood-2016-05-716977; Noy A, 2017, BLOOD, V129, P2224, DOI 10.1182/blood-2016-10-747345; Rule S, 2019, HAEMATOLOGICA, V104, pE211, DOI 10.3324/haematol.2018.205229; Song YQ, 2020, CLIN CANCER RES, V26, P4216, DOI 10.1158/1078-0432.CCR-19-3703; Treon SP, 2015, NEW ENGL J MED, V372, P1430, DOI 10.1056/NEJMoa1501548; van Leersum NJ, 2013, INT J CANCER, V132, P2157, DOI 10.1002/ijc.27871; Wang MH, 2020, NEW ENGL J MED, V382, P1331, DOI 10.1056/NEJMoa1914347; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Woyach JA, 2017, J CLIN ONCOL, V35, P1437, DOI 10.1200/JCO.2016.70.2282; Zhang L, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau1167; Zhao XH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14920	31	112	113	8	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					892	901						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676628				2022-12-28	WOS:000626603400027
J	McCurry, J				McCurry, Justin			The 2011 Tohoku disaster: 10 years on	LANCET			English	Editorial Material																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					866	867						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676620				2022-12-28	WOS:000626603400010
J	Hyun, I; Bredenoord, AL; Briscoe, J; Klipstein, S; Tan, T				Hyun, Insoo; Bredenoord, Annelien L.; Briscoe, James; Klipstein, Sigal; Tan, Tao			Human embryo research beyond the primitive streak It is time to revisit the "14-day limit"	SCIENCE			English	Editorial Material							SELF-ORGANIZATION		[Hyun, Insoo] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Hyun, Insoo] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA; [Bredenoord, Annelien L.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Humanities, Utrecht, Netherlands; [Briscoe, James] Francis Crick Inst, London, England; [Briscoe, James] Co Biologists, Dev, Cambridge, England; [Klipstein, Sigal] InVia Fertil Specialists, Hoffman Estates, IL USA; [Klipstein, Sigal] Univ Chicago, Pritzker Sch Med, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Tan, Tao] Kunming Univ Sci & Technol, Inst Primate Translat Med, Yunnan Key Lab Primate Biomed Res, Kunming, Yunnan, Peoples R China	Case Western Reserve University; Harvard University; Harvard Medical School; Utrecht University; Utrecht University Medical Center; Francis Crick Institute; University of Chicago; Kunming University of Science & Technology	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.; Hyun, I (corresponding author), Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA.	insoo.hyun@case.edu						Ad Hoc Group of Consultants to the Advisory Committee to the Director,NIH, 1994, REP HUM EMBR RES PAN; Appleby JB, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809437; Cohain JS, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1620-1; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; DHEW ETHICS ADVISORY BOARD, 1979, HEW SUPP RES INV HUM; Hurlbut JB, 2017, NAT BIOTECHNOL, V35, P1029, DOI 10.1038/nbt.4015; Hyun I, 2016, NATURE, V533, P169, DOI 10.1038/533169a; Ma HX, 2019, SCIENCE, V366, P836, DOI 10.1126/science.aax7890; Moris N, 2020, NATURE, V582, P410, DOI 10.1038/s41586-020-2383-9; Niu YY, 2019, SCIENCE, V366, P837, DOI 10.1126/science.aaw5754; Reincke CM, 2020, EMBO REP, V21, DOI 10.15252/embr.202051278; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; UK Department of Health and Social Security, 1984, REP COMM INQ HUM FER	13	16	16	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					998	1000		10.1126/science.abf3751	http://dx.doi.org/10.1126/science.abf3751			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674483				2022-12-28	WOS:000625876100037
J	Trifonov, T; Caballero, JA; Morales, JC; Seifahrt, A; Ribas, I; Reiners, A; Bean, JL; Luque, R; Parviainen, H; Palle, E; Stock, S; Zechmeister, M; Amado, PJ; Anglada-Escude, G; Azzaro, M; Barclay, T; Bejar, VJS; Bluhm, P; Casasayas-Barris, N; Cifuentes, C; Collins, KA; Collins, KI; Cortes-Contreras, M; de Leon, J; Dreizler, S; Dressing, CD; Esparza-Borges, E; Espinoza, N; Fausnaugh, M; Fukui, A; Hatzes, AP; Hellier, C; Henning, T; Henze, CE; Herrero, E; Jeffers, SV; Jenkins, JM; Jensen, ELN; Kaminski, A; Kasper, D; Kossakowski, D; Kurster, M; Lafarga, M; Latham, DW; Mann, AW; Molaverdikhani, K; Montes, D; Montet, BT; Murgas, F; Narita, N; Oshagh, M; Passegger, VM; Pollacco, D; Quinn, SN; Quirrenbach, A; Ricker, GR; Lopez, CR; Sanz-Forcada, J; Schwarz, RP; Schweitzer, A; Seager, S; Shporer, A; Stangret, M; Sturmer, J; Tan, TG; Tenenbaum, P; Twicken, JD; Vanderspek, R; Winn, JN				Trifonov, T.; Caballero, J. A.; Morales, J. C.; Seifahrt, A.; Ribas, I.; Reiners, A.; Bean, J. L.; Luque, R.; Parviainen, H.; Palle, E.; Stock, S.; Zechmeister, M.; Amado, P. J.; Anglada-Escude, G.; Azzaro, M.; Barclay, T.; Bejar, V. J. S.; Bluhm, P.; Casasayas-Barris, N.; Cifuentes, C.; Collins, K. A.; Collins, K. I.; Cortes-Contreras, M.; de Leon, J.; Dreizler, S.; Dressing, C. D.; Esparza-Borges, E.; Espinoza, N.; Fausnaugh, M.; Fukui, A.; Hatzes, A. P.; Hellier, C.; Henning, Th.; Henze, C. E.; Herrero, E.; Jeffers, S. V.; Jenkins, J. M.; Jensen, E. L. N.; Kaminski, A.; Kasper, D.; Kossakowski, D.; Kuerster, M.; Lafarga, M.; Latham, D. W.; Mann, A. W.; Molaverdikhani, K.; Montes, D.; Montet, B. T.; Murgas, F.; Narita, N.; Oshagh, M.; Passegger, V. M.; Pollacco, D.; Quinn, S. N.; Quirrenbach, A.; Ricker, G. R.; Rodriguez Lopez, C.; Sanz-Forcada, J.; Schwarz, R. P.; Schweitzer, A.; Seager, S.; Shporer, A.; Stangret, M.; Sturmer, J.; Tan, T. G.; Tenenbaum, P.; Twicken, J. D.; Vanderspek, R.; Winn, J. N.			A nearby transiting rocky exoplanet that is suitable for atmospheric investigation	SCIENCE			English	Article							LOW-MASS STARS; M-DWARFS; RADIAL-VELOCITIES; SUPER-EARTHS; INPUT CATALOG; PLANET; SEARCH; MULTIPLICITY; PERIODOGRAM; VARIABILITY	Spectroscopy of transiting exoplanets can be used to investigate their atmospheric properties and habitability. Combining radial velocity (RV) and transit data provides additional information on exoplanet physical properties. We detect a transiting rocky planet with an orbital period of 1.467 days around the nearby red dwarf star Gliese 486. The planet Gliese 486 b is 2.81 Earth masses and 1.31 Earth radii, with uncertainties of 5%, as determined from RV data and photometric light curves. The host star is at a distance of similar to 8.1 parsecs, has a J-band magnitude of similar to 7.2, and is observable from both hemispheres of Earth. On the basis of these properties and the planet's short orbital period and high equilibrium temperature, we show that this terrestrial planet is suitable for emission and transit spectroscopy.	[Trifonov, T.; Henning, Th.; Kossakowski, D.; Kuerster, M.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Caballero, J. A.; Cifuentes, C.; Cortes-Contreras, M.; Sanz-Forcada, J.] CSIC, Inst Nacl Tecn Aeroesp, Ctr Astrobiol, E-28692 Madrid, Spain; [Morales, J. C.; Ribas, I.; Anglada-Escude, G.; Herrero, E.; Lafarga, M.] CSIC, Inst Ciencies Espai, E-08193 Barcelona, Spain; [Morales, J. C.; Ribas, I.; Anglada-Escude, G.; Herrero, E.; Lafarga, M.] Inst Estudis Espacials Catalunya, E-08034 Barcelona, Spain; [Seifahrt, A.; Bean, J. L.; Kasper, D.] Univ Chicago, Dept Astron & Astrophys, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Reiners, A.; Zechmeister, M.; Dreizler, S.; Jeffers, S. V.] Georg August Univ, Inst Astrophys, D-37077 Gottingen, Germany; [Luque, R.; Parviainen, H.; Palle, E.; Bejar, V. J. S.; Casasayas-Barris, N.; Esparza-Borges, E.; Fukui, A.; Murgas, F.; Narita, N.; Oshagh, M.; Stangret, M.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Luque, R.; Parviainen, H.; Palle, E.; Bejar, V. J. S.; Casasayas-Barris, N.; Esparza-Borges, E.; Murgas, F.; Oshagh, M.; Stangret, M.] Univ La Laguna, Dept Astrofis, E-38205 Tenerife, Spain; [Stock, S.; Bluhm, P.; Kaminski, A.; Molaverdikhani, K.; Quirrenbach, A.; Sturmer, J.] Heidelberg Univ, Zentrum Astron, Landessternwarte, D-69117 Heidelberg, Germany; [Amado, P. J.; Rodriguez Lopez, C.] CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Azzaro, M.] Observ Calar Alto, Ctr Astron Hispano Aleman, E-04550 Almeria, Spain; [Barclay, T.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Barclay, T.] Univ Maryland, Baltimore, MD 21250 USA; [Collins, K. A.; Latham, D. W.; Quinn, S. N.] Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA 02138 USA; [Collins, K. I.] George Mason Univ, Dept Phys & Astron, Fairfax, VA 22030 USA; [de Leon, J.] Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo 1130033, Japan; [Dressing, C. D.] Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA; [Espinoza, N.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Fausnaugh, M.; Ricker, G. R.; Seager, S.; Shporer, A.; Tenenbaum, P.; Vanderspek, R.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Fausnaugh, M.; Ricker, G. R.; Seager, S.; Shporer, A.; Tenenbaum, P.; Vanderspek, R.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Fukui, A.] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Hatzes, A. P.] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Hellier, C.] Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Henze, C. E.; Jenkins, J. M.; Twicken, J. D.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Jeffers, S. V.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Fukui, A.; Jensen, E. L. N.] Swarthmore Coll, Dept Phys & Astron, Swarthmore, PA 19081 USA; [Mann, A. W.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Montes, D.] Univ Complutense Madrid, Dept Fis Tierra & Astrofis, E-28040 Madrid, Spain; [Montes, D.] Univ Complutense Madrid, Fac Ciencias Fis, Inst Fis Particulas & Cosmos, E-28040 Madrid, Spain; [Montet, B. T.] Univ New South Wales, Sch Phys, Sydney, NSW 2052, Australia; [Narita, N.] Univ Tokyo, Komaba Inst Sci, Tokyo 1538902, Japan; [Narita, N.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Tokyo 1538902, Japan; [Narita, N.] Astrobiol Ctr, Mitaka, Tokyo 1818588, Japan; [Passegger, V. M.; Schweitzer, A.] Univ Hamburg, Hamburger Sternwarte, D-21029 Hamburg, Germany; [Passegger, V. M.] Univ Oklahoma, Homer L Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Pollacco, D.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Schwarz, R. P.] Patashnick Voorheesville Observ, Voorheesville, NY 12186 USA; [Seager, S.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Seager, S.] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Tan, T. G.] Perth Exoplanet Survey Telescope, Perth, WA 6010, Australia; [Twicken, J. D.] Search Extraterr Intelligence Inst, Mountain View, CA 94043 USA; [Winn, J. N.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Max Planck Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Chicago; University of Gottingen; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore; Smithsonian Institution; George Mason University; University of Tokyo; University of California System; University of California Berkeley; Space Telescope Science Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Tokyo; Keele University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Max Planck Society; Swarthmore College; University of North Carolina; University of North Carolina Chapel Hill; Complutense University of Madrid; Complutense University of Madrid; University of New South Wales Sydney; University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Astrobiology Center (ABC); University of Hamburg; University of Oklahoma System; University of Oklahoma - Norman; University of Warwick; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Princeton University	Trifonov, T (corresponding author), Max Planck Inst Astron, D-69117 Heidelberg, Germany.	trifonov@mpia.de	Trifonov, Trifon/GLN-5773-2022; Montes, David/N-2760-2019; Luque, Rafael/AAU-1245-2021; Morales, Juan Carlos/H-5548-2015; Lafarga, Marina/B-6280-2019; Caballero, Jose A./C-2819-2017; Cortes Contreras, Miriam/L-4106-2017; Ribas, Ignasi/M-2134-2014; Herrero, Enrique/G-2450-2016	Trifonov, Trifon/0000-0002-0236-775X; Montes, David/0000-0002-7779-238X; Luque, Rafael/0000-0002-4671-2957; Morales, Juan Carlos/0000-0003-0061-518X; Murgas, Felipe/0000-0001-9087-1245; Lafarga, Marina/0000-0002-8815-9416; Passegger, Vera Maria/0000-0002-8569-7243; Palle, Enric/0000-0003-0987-1593; Quirrenbach, Andreas/0000-0002-3302-1962; Bean, Jacob/0000-0003-4733-6532; Collins, Kevin/0000-0003-2781-3207; Caballero, Jose A./0000-0002-7349-1387; Montet, Benjamin/0000-0001-7516-8308; Jensen, Eric/0000-0002-4625-7333; Latham, David/0000-0001-9911-7388; Tan, Thiam-Guan/0000-0001-5603-6895; Mann, Andrew/0000-0003-3654-1602; Seifahrt, Andreas/0000-0003-4526-3747; Reiners, Ansgar/0000-0003-1242-5922; Cortes Contreras, Miriam/0000-0003-3734-9866; Ribas, Ignasi/0000-0002-6689-0312; Molaverdikhani, Karan/0000-0002-0502-0428; Rodriguez-Lopez, Cristina/0000-0001-5559-7850; Shporer, Avi/0000-0002-1836-3120; Herrero, Enrique/0000-0001-8602-6639; Bluhm, Paz/0000-0002-0374-8466	Deutsche Forschungsgemeinschaft [FOR2544, SPP1992]; Agencia Estatal de Investigacion of the Ministerio de Ciencia e Innovacion [PID2019-109522GB-C51/2/3/4, PGC2018-098153-B-C33, SEV-2017-0709, MDM-2017-0737, AYA2016-79425-C3-1/2/3-P, ESP2016-80435-C2-1-R, SEV-2015-0548]; European Regional Development Fund [PID2019-109522GB-C51/2/3/4, PGC2018-098153-B-C33, SEV-2017-0709, MDM-2017-0737, AYA2016-79425-C3-1/2/3-P, ESP2016-80435-C2-1-R, SEV-2015-0548]; Klaus Tschira Stiftung; European Union's Horizon 2020 through Marie Sklodowska Curie grant [713673]; "la Caixa" through INPhINT grant [LCF/BQ/IN17/1162033]; NASA [NNX17AG24G, 80NSSC19K0533, 80NSSC19K1721, 80NSSC18K158]; NASA Science Mission Directorate; Japan Society for the Promotion of Science KAKENHI [JP17H04574, JP18H01265, JP18H05439]; Japan Science and Technology Agency PRESTO [JPMJPR1775]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agencia Estatal de Investigacion of the Ministerio de Ciencia e Innovacion; European Regional Development Fund(European Commission); Klaus Tschira Stiftung; European Union's Horizon 2020 through Marie Sklodowska Curie grant; "la Caixa" through INPhINT grant; NASA(National Aeronautics & Space Administration (NASA)); NASA Science Mission Directorate(National Aeronautics & Space Administration (NASA)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST))	Funding was provided by Deutsche Forschungsgemeinschaft through research unit FOR2544 "Blue Planets around Red Stars" and priority program SPP1992 "Exploring the Diversity of Extrasolar Planets"; Agencia Estatal de Investigacion of the Ministerio de Ciencia e Innovacion and the European Regional Development Fund through projects PID2019-109522GB-C51/2/3/4, PGC2018-098153-B-C33, SEV-2017-0709, MDM-2017-0737, AYA2016-79425-C3-1/2/3-P, ESP2016-80435-C2-1-R, and SEV-2015-0548; Klaus Tschira Stiftung; European Union's Horizon 2020 through Marie Sklodowska Curie grant 713673; "la Caixa" through INPhINT grant LCF/BQ/IN17/1162033; NASA through grants NNX17AG24G, 80NSSC19K0533, 80NSSC19K1721, and 80NSSC18K158 and the NASA Science Mission Directorate; Japan Society for the Promotion of Science KAKENHI through grants JP17H04574, JP18H01265, and JP18H05439; and Japan Science and Technology Agency PRESTO through grant JPMJPR1775.	Ahn CP, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/2/21; Aller A, 2020, ASTRON ASTROPHYS, V635, DOI 10.1051/0004-6361/201937118; Alonso-Floriano FJ, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201525803; Anglada-Escude G, 2016, NATURE, V536, P437, DOI 10.1038/nature19106; [Anonymous], MAT METHODS ARE AVAI; Astudillo-Defru N, 2017, ASTRON ASTROPHYS, V600, DOI 10.1051/0004-6361/201527078; Baluev RV, 2008, MON NOT R ASTRON SOC, V385, P1279, DOI 10.1111/j.1365-2966.2008.12689.x; Barnes R, 2017, CELEST MECH DYN ASTR, V129, P509, DOI 10.1007/s10569-017-9783-7; Bauer FF, 2020, ASTRON ASTROPHYS, V640, DOI 10.1051/0004-6361/202038031; Bean JL, 2010, ASTROPHYS J, V713, P410, DOI 10.1088/0004-637X/713/1/410; BIDELMAN WP, 1985, ASTROPHYS J SUPPL S, V59, P197, DOI 10.1086/191069; Bonnarel F, 2000, ASTRON ASTROPHYS SUP, V143, P33, DOI 10.1051/aas:2000331; Brown TM, 2013, PUBL ASTRON SOC PAC, V125, P1031, DOI 10.1086/673168; Butler RP, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa66ca; Caballero J.A., 2016, 19 CAMBR WORKSH COOL; Cheng WH, 2014, ICARUS, V233, P242, DOI 10.1016/j.icarus.2014.01.046; Cifuentes C, 2020, ASTRON ASTROPHYS, V642, DOI 10.1051/0004-6361/202038295; Collins KA, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/153/2/77; Costa E, 2006, ASTRON J, V132, P2360, DOI 10.1086/508233; Damasso M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax7467; Delfosse X, 1998, ASTRON ASTROPHYS, V338, pL67; Demory BO, 2016, MON NOT R ASTRON SOC, V455, P2018, DOI 10.1093/mnras/stv2239; Dieterich SB, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/2/64; Alonso ED, 2019, ASTRON ASTROPHYS, V621, DOI 10.1051/0004-6361/201833316; Espinoza N, 2019, MON NOT R ASTRON SOC, V490, P2262, DOI 10.1093/mnras/stz2688; Ferraz-Mello S, 2008, CELEST MECH DYN ASTR, V101, P171, DOI 10.1007/s10569-008-9133-x; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Fulton BJ, 2017, ASTRON J, V154, DOI 10.3847/1538-3881/aa80eb; GOLDREICH P, 1966, ASTRON J, V71, P425, DOI 10.1086/109947; Henden Arne A., 2012, Electronic Journal of the AAVSO, V40; Hippke M, 2019, ASTRON J, V158, DOI 10.3847/1538-3881/ab3984; Hippke M, 2019, ASTRON ASTROPHYS, V623, DOI 10.1051/0004-6361/201834672; Hojjatpanah S, 2019, ASTRON ASTROPHYS, V629, DOI 10.1051/0004-6361/201834729; Huang CX, 2018, ASTROPHYS J LETT, V868, DOI 10.3847/2041-8213/aaef91; Jeffers SV, 2018, ASTRON ASTROPHYS, V614, DOI 10.1051/0004-6361/201629599; Jenkins JS, 2009, ASTROPHYS J, V704, P975, DOI 10.1088/0004-637X/704/2/975; Jenkins JM, 2016, PROC SPIE, V9913, DOI 10.1117/12.2233418; Kaufl HU, 2004, P SOC PHOTO-OPT INS, V5492, P1218, DOI 10.1117/12.551480; Kochanek CS, 2017, PUBL ASTRON SOC PAC, V129, DOI 10.1088/1538-3873/aa80d9; Kreidberg L, 2019, NATURE, V573, P87, DOI 10.1038/s41586-019-1497-4; Kreidberg L, 2015, PUBL ASTRON SOC PAC, V127, P1161, DOI 10.1086/683602; Lafarga M, 2020, ASTRON ASTROPHYS, V636, DOI 10.1051/0004-6361/201937222; Luque R, 2019, ASTRON ASTROPHYS, V628, DOI 10.1051/0004-6361/201935801; Kempton EMR, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aadf6f; Mansfield M, 2019, ASTROPHYS J, V886, DOI 10.3847/1538-4357/ab4c90; Mayor M., 2003, MESSENGER, V114, P20; McArthur BE, 2004, ASTROPHYS J, V614, pL81, DOI 10.1086/425561; McCully C, 2018, PROC SPIE, V10707, DOI 10.1117/12.2314340; Motalebi F, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201526822; Moutou C, 2017, MON NOT R ASTRON SOC, V472, P4563, DOI 10.1093/mnras/stx2306; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Narita N, 2019, J ASTRON TELESC INST, V5, DOI 10.1117/1.JATIS.5.1.015001; Newton ER, 2014, ASTRON J, V147, DOI 10.1088/0004-6256/147/1/20; Parviainen H, 2020, ASTRON ASTROPHYS, V633, DOI 10.1051/0004-6361/201935958; Parviainen H, 2015, MON NOT R ASTRON SOC, V450, P3233, DOI 10.1093/mnras/stv894; Passegger VM, 2019, ASTRON ASTROPHYS, V627, DOI 10.1051/0004-6361/201935679; Pollacco DL, 2006, PUBL ASTRON SOC PAC, V118, P1407, DOI 10.1086/508556; Queloz D, 2001, ASTRON ASTROPHYS, V379, P279, DOI 10.1051/0004-6361:20011308; Quirrenbach A, 2016, PROC SPIE, V9908, DOI 10.1117/12.2231880; Reid IN, 2002, ASTRON J, V124, P2721, DOI 10.1086/343777; Reiners A, 2018, ASTRON ASTROPHYS, V612, DOI 10.1051/0004-6361/201732054; Reiners A, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201732165; Ribas I, 2018, NATURE, V563, P365, DOI 10.1038/s41586-018-0677-y; Rice K, 2019, MON NOT R ASTRON SOC, V484, P3731, DOI 10.1093/mnras/stz130; Ricker GR, 2015, J ASTRON TELESC INST, V1, DOI 10.1117/1.JATIS.1.1.014003; Sanz-Forcada J, 2011, ASTRON ASTROPHYS, V532, DOI 10.1051/0004-6361/201116594; Schofer P, 2019, ASTRON ASTROPHYS, V623, DOI 10.1051/0004-6361/201834114; Schweitzer A, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201834965; Seifahrt A., 2018, P SPIE; Seifahrt A, 2018, PROC SPIE, V10702, DOI 10.1117/12.2312936; Seifahrt A, 2016, PROC SPIE, V9908, DOI 10.1117/12.2232069; Skilling J, 2004, AIP CONF PROC, V735, P395, DOI 10.1063/1.1835238; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Speagle JS, 2020, MON NOT R ASTRON SOC, V493, P3132, DOI 10.1093/mnras/staa278; STAUFFER JR, 1986, ASTROPHYS J SUPPL S, V61, P531, DOI 10.1086/191123; Stelzer B, 2013, MON NOT R ASTRON SOC, V431, P2063, DOI 10.1093/mnras/stt225; Stumpe MC, 2012, PUBL ASTRON SOC PAC, V124, P985, DOI 10.1086/667698; Tal-Or L, 2019, MON NOT R ASTRON SOC, V484, pL8, DOI 10.1093/mnrasl/sly227; Tarter JC, 2007, ASTROBIOLOGY, V7, P30, DOI 10.1089/ast.2006.0124; Trifonov T, 2020, ASTRON ASTROPHYS, V638, DOI 10.1051/0004-6361/201936987; Trifonov T, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201731442; Trifonov T., 2019, EXO STRIKER TRANSIT; Trifonov T, 2020, ASTRON ASTROPHYS, V636, DOI 10.1051/0004-6361/201936686; Van Eylen V, 2018, MON NOT R ASTRON SOC, V479, P4786, DOI 10.1093/mnras/sty1783; van Heck HJ, 2011, EARTH PLANET SC LETT, V310, P252, DOI 10.1016/j.epsl.2011.07.029; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Ward-Duong K, 2015, MON NOT R ASTRON SOC, V449, P2618, DOI 10.1093/mnras/stv384; Wolf M., 1919, VEROEFFENTLICHUNGEN, V10, P195; Wozniak PR, 2004, ASTRON J, V127, P2436, DOI 10.1086/382719; Zacharias N, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/2/44; Zechmeister M, 2019, ASTRON ASTROPHYS, V627, DOI 10.1051/0004-6361/201935460; Zechmeister M, 2018, ASTRON ASTROPHYS, V609, DOI 10.1051/0004-6361/201731483; Zechmeister M, 2009, ASTRON ASTROPHYS, V496, P577, DOI 10.1051/0004-6361:200811296; Zeng L, 2019, P NATL ACAD SCI USA, V116, P9723, DOI 10.1073/pnas.1812905116	99	25	25	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1038	+		10.1126/science.abd7645	http://dx.doi.org/10.1126/science.abd7645			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674491	Green Submitted, Green Accepted			2022-12-28	WOS:000625876100052
J	Zani, D; Crowther, TW; Mo, LD; Renner, SS; Zohner, CM				Zani, Deborah; Crowther, Thomas W.; Mo, Lidong; Renner, Susanne S.; Zohner, Constantin M.			Response to Comment on "Increased growing-season productivity drives earlier autumn leaf senescence in temperate trees"	SCIENCE			English	Editorial Material							ATMOSPHERIC CO2; PHENOLOGY; GROWTH	Our study showed that increases in seasonal productivity drive earlier autumn senescence of temperate trees. Norby argues that this finding is contradicted by observations from free-air CO2 enrichment (FACE) experiments, where elevated CO2 has been found to delay senescence in some cases. We provide a detailed answer showing that the results from FACE studies are in agreement with our conclusions.	[Zani, Deborah; Crowther, Thomas W.; Mo, Lidong; Zohner, Constantin M.] Swiss Fed Inst Technol, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Zani, Deborah] Swiss Fed Inst Forest Snow & Landscape Res WSL, Dynam Macroecol Land Change Sci, Birmensdorf, Switzerland; [Zani, Deborah] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Renner, Susanne S.] Ludwig Maximilians Univ Munchen, Systemat Bot & Mycol, D-80638 Munich, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Lund University; University of Munich	Zohner, CM (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol, CH-8092 Zurich, Switzerland.	constantin.zohner@gmail.com		Zani, Deborah/0000-0002-3302-2893; Crowther, Thomas/0000-0001-5674-8913				Asshoff R, 2006, GLOBAL CHANGE BIOL, V12, P848, DOI 10.1111/j.1365-2486.2006.01133.x; Doty SL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155979; Fatichi S, 2014, NEW PHYTOL, V201, P1086, DOI 10.1111/nph.12614; Godbold D, 2014, ANN FOREST SCI, V71, P831, DOI 10.1007/s13595-014-0382-4; Norby R. J., 2021, SCIENCE, V371; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Richardson AD, 2018, NATURE, V560, P368, DOI 10.1038/s41586-018-0399-1; Sigurdsson BD, 2001, TREES-STRUCT FUNCT, V15, P403, DOI 10.1007/s004680100121; Taylor G, 2008, GLOBAL CHANGE BIOL, V14, P264, DOI 10.1111/j.1365-2486.2007.01473.x; Zani D, 2020, SCIENCE, V370, P1066, DOI 10.1126/science.abd8911	11	1	1	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533								10.1126/science.abg2679	http://dx.doi.org/10.1126/science.abg2679			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674466				2022-12-28	WOS:000625876100002
J	Mahase, E				Mahase, Elisabeth			Government's new scientific research agency will be exempt from public contract rules and Freedom of Information Act	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Abbasi K, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4425; Armstrong S., 2021, BMJ, V372; Iacobucci G, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4474; Sabbagh Dan, 2021, GUARDIAN	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n634	10.1136/bmj.n634	http://dx.doi.org/10.1136/bmj.n634			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664016				2022-12-28	WOS:000632920100009
J	Brown, PA; Ji, LY; Xu, XX; Devidas, M; Hogan, LE; Borowitz, MJ; Raetz, EA; Zugmaier, G; Sharon, E; Bernhardt, MB; Terezakis, SA; Gore, L; Whitlock, JA; Pulsipher, MA; Hunger, SP; Loh, ML				Brown, Patrick A.; Ji, Lingyun; Xu, Xinxin; Devidas, Meenakshi; Hogan, Laura E.; Borowitz, Michael J.; Raetz, Elizabeth A.; Zugmaier, Gerhard; Sharon, Elad; Bernhardt, Melanie B.; Terezakis, Stephanie A.; Gore, Lia; Whitlock, James A.; Pulsipher, Michael A.; Hunger, Stephen P.; Loh, Mignon L.			Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; HIGH-RISK	Question Does immunotherapy with blinatumomab result in longer disease-free survival compared with chemotherapy as postreinduction consolidation therapy prior to hematopoietic stem cell transplant in children, adolescents, and young adults with high- and intermediate-risk first relapse of B-cell acute lymphoblastic leukemia? Findings In this randomized clinical trial that included 208 patients with high- and intermediate-risk first relapse of B-cell acute lymphoblastic leukemia and was terminated early, treatment with blinatumomab vs chemotherapy resulted in 2-year disease-free survival of 54% vs 39% of participants, but the difference was not statistically significant. Meaning Postreinduction treatment with blinatumomab compared with chemotherapy, followed by hematopoietic stem cell transplant, did not result in a statistically significant difference in disease-free survival, but study interpretation is limited by early termination with possible underpowering for the primary end point. This randomized trial compares the effects of postreinduction therapy consolidation using blinatumomab, an antibody construct that links CD3+ T cells to CD19+ leukemia cells, vs chemotherapy on disease-free survival among children, adolescents, and young adults with first relapse of B-cell acute lymphoblastic leukemia (ALL). Importance Standard chemotherapy for first relapse of B-cell acute lymphoblastic leukemia (B-ALL) in children, adolescents, and young adults is associated with high rates of severe toxicities, subsequent relapse, and death, especially for patients with early relapse (high risk) or late relapse with residual disease after reinduction chemotherapy (intermediate risk). Blinatumomab, a bispecific CD3 to CD19 T cell-engaging antibody construct, is efficacious in relapsed/refractory B-ALL and has a favorable toxicity profile. Objective To determine whether substituting blinatumomab for intensive chemotherapy in consolidation therapy would improve survival in children, adolescents, and young adults with high- and intermediate-risk first relapse of B-ALL. Design, Setting, and Participants This trial was a randomized phase 3 clinical trial conducted by the Children's Oncology Group at 155 hospitals in the US, Canada, Australia, and New Zealand with enrollment from December 2014 to September 2019 and follow-up until September 30, 2020. Eligible patients included those aged 1 to 30 years with B-ALL first relapse, excluding those with Down syndrome, Philadelphia chromosome-positive ALL, prior hematopoietic stem cell transplant, or prior blinatumomab treatment (n = 669). Interventions All patients received a 4-week reinduction chemotherapy course, followed by randomized assignment to receive 2 cycles of blinatumomab (n = 105) or 2 cycles of multiagent chemotherapy (n = 103), each followed by transplant. Main Outcome and Measures The primary end point was disease-free survival and the secondary end point was overall survival, both from the time of randomization. The threshold for statistical significance was set at a 1-sided P Results Among 208 randomized patients (median age, 9 years; 97 [47%] females), 118 (57%) completed the randomized therapy. Randomization was terminated at the recommendation of the data and safety monitoring committee without meeting stopping rules for efficacy or futility; at that point, 80 of 131 planned events occurred. With 2.9 years of median follow-up, 2-year disease-free survival was 54.4% for the blinatumomab group vs 39.0% for the chemotherapy group (hazard ratio for disease progression or mortality, 0.70 [95% CI, 0.47-1.03]); 1-sided P = .03). Two-year overall survival was 71.3% for the blinatumomab group vs 58.4% for the chemotherapy group (hazard ratio for mortality, 0.62 [95% CI, 0.39-0.98]; 1-sided P = .02). Rates of notable serious adverse events included infection (15%), febrile neutropenia (5%), sepsis (2%), and mucositis (1%) for the blinatumomab group and infection (65%), febrile neutropenia (58%), sepsis (27%), and mucositis (28%) for the chemotherapy group. Conclusions and Relevance Among children, adolescents, and young adults with high- and intermediate-risk first relapse of B-ALL, postreinduction treatment with blinatumomab compared with chemotherapy, followed by transplant, did not result in a statistically significant difference in disease-free survival. However, study interpretation is limited by early termination with possible underpowering for the primary end point.	[Brown, Patrick A.] Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,CRB1 Room 2M51, Baltimore, MD 21205 USA; [Brown, Patrick A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Ji, Lingyun] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Xu, Xinxin] Childrens Oncol Grp, Monrovia, CA USA; [Devidas, Meenakshi] St Jude Childrens Res Hosp, Dept Global Pediat Med, 332 N Lauderdale St, Memphis, TN 38105 USA; [Hogan, Laura E.] Stony Brook Childrens, Dept Pediat, Stony Brook, NY USA; [Borowitz, Michael J.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Borowitz, Michael J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Raetz, Elizabeth A.] NYU Langone Hlth, Dept Pediat, New York, NY USA; [Zugmaier, Gerhard] Amgen Res Munich GmbH, Munich, Germany; [Sharon, Elad] NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, Bethesda, MD 20892 USA; [Bernhardt, Melanie B.] Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX 77030 USA; [Terezakis, Stephanie A.] Univ Minnesota, Dept Radiat Oncol, Minneapolis, MN USA; [Gore, Lia] Univ Colorado, Sch Med, Aurora, CO USA; [Gore, Lia] Childrens Hosp Colorado, Ctr Canc & Blood Disorders, Aurora, CO USA; [Whitlock, James A.] Hosp Sick Children, Toronto, ON, Canada; [Whitlock, James A.] Univ Toronto, Toronto, ON, Canada; [Pulsipher, Michael A.] Childrens Hosp Los Angeles, Transplantat & Cellular Therapy, Canc & Blood Dis Inst, Los Angeles, CA 90027 USA; [Hunger, Stephen P.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Univ Penn, Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Hunger, Stephen P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Loh, Mignon L.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins University; University of Southern California; Children's Oncology Group (COG); St Jude Children's Research Hospital; Johns Hopkins University; Johns Hopkins University; NYU Langone Medical Center; Amgen; Amgen Research Munich GmbH; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Children's Hospital Los Angeles; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Brown, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, 1650 Orleans St,CRB1 Room 2M51, Baltimore, MD 21205 USA.	pbrown2@jhmi.edu		Whitlock, James/0000-0002-7887-0634; Loh, Mignon/0000-0003-4099-4700				Bader P, 2019, BLOOD ADV, V3, P3393, DOI 10.1182/bloodadvances.2019000449; Borowitz MJ, 2008, BLOOD, V111, P5477, DOI 10.1182/blood-2008-01-132837; Cherian S, 2018, CYTOM PART B-CLIN CY, V94, P112, DOI 10.1002/cyto.b.21482; Dunsmore KP, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.00256; Eckert C, 2019, J CLIN ONCOL, V37, P3493, DOI 10.1200/JCO.19.01694; Freidlin B, 2002, CONTROL CLIN TRIALS, V23, P355, DOI 10.1016/S0197-2456(02)00218-0; Gokbuget N, 2018, BLOOD, V131, P1522, DOI 10.1182/blood-2017-08-798322; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Horton TM, 2019, BRIT J HAEMATOL, V186, P274, DOI 10.1111/bjh.15919; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Kantarjian HM, 2016, NEW ENGL J MED, V375, P740, DOI 10.1056/NEJMoa1509277; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Larsen EC, 2016, J CLIN ONCOL, V34, P2380, DOI 10.1200/JCO.2015.62.4544; Lew G, 2021, HAEMATOLOGICA, V106, P46, DOI 10.3324/haematol.2019.237230; Locatelli F, 2012, BLOOD, V120, P2807, DOI 10.1182/blood-2012-02-265884; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Oskarsson T, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26909; Parker C, 2019, LANCET HAEMATOL, V6, pE204, DOI 10.1016/S2352-3026(19)30003-1; Parker C, 2010, LANCET, V376, P2009, DOI 10.1016/S0140-6736(10)62002-8; Pulsipher MA, 2015, BLOOD, V125, P3501, DOI 10.1182/blood-2014-12-615757; Raetz EA, 2015, PEDIATR BLOOD CANCER, V62, P1171, DOI 10.1002/pbc.25454; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; von Stackelberg A, 2016, J CLIN ONCOL, V34, P4381, DOI 10.1200/JCO.2016.67.3301	26	75	77	3	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					833	842		10.1001/jama.2021.0669	http://dx.doi.org/10.1001/jama.2021.0669			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651090	Bronze, Green Published			2022-12-28	WOS:000625843100012
J	Locatelli, F; Zugmaier, G; Rizzari, C; Morris, JD; Gruhn, B; Klingebiel, T; Parasole, R; Linderkamp, C; Flotho, C; Petit, A; Micalizzi, C; Mergen, N; Mohammad, A; Kormany, WN; Eckert, C; Moricke, A; Sartor, M; Hrusak, O; Peters, C; Saha, V; Vinti, L; von Stackelberg, A				Locatelli, Franco; Zugmaier, Gerhard; Rizzari, Carmelo; Morris, Joan D.; Gruhn, Bernd; Klingebiel, Thomas; Parasole, Rosanna; Linderkamp, Christin; Flotho, Christian; Petit, Arnaud; Micalizzi, Concetta; Mergen, Noemi; Mohammad, Abeera; Kormany, William N.; Eckert, Cornelia; Moricke, Anja; Sartor, Mary; Hrusak, Ondrej; Peters, Christina; Saha, Vaskar; Vinti, Luciana; von Stackelberg, Arend			Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMAL RESIDUAL DISEASE; PEDIATRIC-PATIENTS; RELAPSE; TRANSPLANTATION; PERFORMANCE	This randomized trial compares the effects of blinatumomab, an antibody construct that links CD3+ T cells to CD19+ leukemia cells, vs consolidation chemotherapy as a third consolidation block before allogeneic hematopoietic stem cell transplant (HST) on event-free survival in children with high-risk first-relapse B-cell acute lymphoblastic leukemia (B-ALL). Importance Blinatumomab is a CD3/CD19-directed bispecific T-cell engager molecule with efficacy in children with relapsed or refractory B-cell acute lymphoblastic leukemia (B-ALL). Objective To evaluate event-free survival in children with high-risk first-relapse B-ALL after a third consolidation course with blinatumomab vs consolidation chemotherapy before allogeneic hematopoietic stem cell transplant. Design, Setting, and Participants In this randomized phase 3 clinical trial, patients were enrolled November 2015 to July 2019 (data cutoff, July 17, 2019). Investigators at 47 centers in 13 countries enrolled children older than 28 days and younger than 18 years with high-risk first-relapse B-ALL in morphologic complete remission (M1 marrow, <5% blasts) or with M2 marrow (blasts >= 5% and <25%) at randomization. Intervention Patients were randomized to receive 1 cycle of blinatumomab (n = 54; 15 mu g/m(2)/d for 4 weeks, continuous intravenous infusion) or chemotherapy (n = 54) for the third consolidation. Main Outcomes and Measures The primary end point was event-free survival (events: relapse, death, second malignancy, or failure to achieve complete remission). The key secondary efficacy end point was overall survival. Other secondary end points included minimal residual disease remission and incidence of adverse events. Results A total of 108 patients were randomized (median age, 5.0 years [interquartile range {IQR}, 4.0-10.5]; 51.9% girls; 97.2% M1 marrow) and all patients were included in the analysis. Enrollment was terminated early for benefit of blinatumomab in accordance with a prespecified stopping rule. After a median of 22.4 months of follow-up (IQR, 8.1-34.2), the incidence of events in the blinatumomab vs consolidation chemotherapy groups was 31% vs 57% (log-rank P < .001; hazard ratio [HR], 0.33 [95% CI, 0.18-0.61]). Deaths occurred in 8 patients (14.8%) in the blinatumomab group and 16 (29.6%) in the consolidation chemotherapy group. The overall survival HR was 0.43 (95% CI, 0.18-1.01). Minimal residual disease remission was observed in more patients in the blinatumomab vs consolidation chemotherapy group (90% [44/49] vs 54% [26/48]; difference, 35.6% [95% CI, 15.6%-52.5%]). No fatal adverse events were reported. In the blinatumomab vs consolidation chemotherapy group, the incidence of serious adverse events was 24.1% vs 43.1%, respectively, and the incidence of adverse events greater than or equal to grade 3 was 57.4% vs 82.4%. Adverse events leading to treatment discontinuation were reported in 2 patients in the blinatumomab group. Conclusions and Relevance Among children with high-risk first-relapse B-ALL, treatment with 1 cycle of blinatumomab compared with standard intensive multidrug chemotherapy before allogeneic hematopoietic stem cell transplant resulted in an improved event-free survival at a median of 22.4 months of follow-up. Question After induction therapy and 2 blocks of consolidation chemotherapy, does 1 cycle of blinatumomab compared with a third course of consolidation chemotherapy before allogeneic hematopoietic stem cell transplant improve event-free survival in high-risk first-relapse B-cell acute lymphoblastic leukemia (B-ALL) in children? Findings In this randomized clinical trial that included 108 children with high-risk first-relapse B-ALL, treatment with blinatumomab compared with chemotherapy for consolidation treatment resulted in a statistically significant hazard ratio for event-free survival of 0.33 after a median of 22.4 months of follow-up. Meaning Blinatumomab compared with chemotherapy for consolidation treatment improved event-free survival in children with relapsed B-ALL.	[Locatelli, Franco; Vinti, Luciana] IRCCS Osped Pediat Bambino Gesu, Rome, Italy; [Locatelli, Franco; Vinti, Luciana] Sapienza Univ Rome, Rome, Italy; [Zugmaier, Gerhard; Mergen, Noemi] Amgen Res Munich GmbH, Munich, Germany; [Rizzari, Carmelo] Univ Milano Bicocca, MBBM Fdn, Monza, Italy; [Morris, Joan D.; Kormany, William N.] Amgen Inc, Thousand Oaks, CA 91320 USA; [Gruhn, Bernd] Jena Univ Hosp, Jena, Germany; [Klingebiel, Thomas] Univ Klinikum Frankfurt Main, Frankfurt, Germany; [Parasole, Rosanna] Azienda Osped Rilievo Nazl Santobono Pausilipon, Naples, Italy; [Linderkamp, Christin] Hannover Med Sch, Hannover, Germany; [Flotho, Christian] Univ Klinikum Freiburg, Freiburg, Germany; [Petit, Arnaud] Sorbonne Univ, Hop Armand Trousseau, AP HP, Paris, France; [Micalizzi, Concetta] IRCCS Ist Giannina Gaslini, Genoa, Italy; [Mohammad, Abeera] Amgen Ltd, Uxbridge, Middx, England; [Eckert, Cornelia; von Stackelberg, Arend] Charite Univ Med Berlin, Berlin, Germany; [Moricke, Anja] Univ Klinikum Schleswig Holstein, Kiel, Germany; [Sartor, Mary] Westmead Hosp, Sydney, NSW, Australia; [Hrusak, Ondrej] Charles Univ Prague, Motol Univ Hosp, Prague, Czech Republic; [Peters, Christina] St Anna Childrens Hosp, Vienna, Austria; [Saha, Vaskar] Univ Manchester, Manchester, Lancs, England; [Saha, Vaskar] Tata Med Ctr, Tata Translat Canc Res Ctr, Kolkata, W Bengal, India	IRCCS Bambino Gesu; Sapienza University Rome; Amgen; Amgen Research Munich GmbH; University of Milano-Bicocca; Amgen; Friedrich Schiller University of Jena; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hannover Medical School; University of Freiburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Genoa; IRCCS Istituto Giannina Gaslini; Amgen; Amgen Limited; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; University of Sydney; Charles University Prague; Motol University Hospital; Saint Anna Children's Hospital; University of Manchester	Locatelli, F (corresponding author), Sapienza Univ Rome, IRCCS Osped Pediat Bambino Gesu, Dept Pediat Hematol & Oncol, Piazza St Onofrio 4, I-00165 Rome, Italy.	franco.locatelli@opbg.net	Parasole, Rosanna/AAC-3759-2022	Parasole, Rosanna/0000-0003-3350-5286; RIZZARI, Carmelo/0000-0002-4828-3893; Saha, Vaskar/0000-0002-2916-9649; Peters, Christina/0000-0003-0369-8515				Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Branson M, 2002, STAT MED, V21, P2449, DOI 10.1002/sim.1219; Brown PA, 2019, BLOOD, V134, DOI 10.1182/blood-2019-132435; Bruggemann M, 2010, LEUKEMIA, V24, P521, DOI 10.1038/leu.2009.268; Bruggemann M, 2012, SEMIN ONCOL, V39, P47, DOI 10.1053/j.seminoncol.2011.11.009; CharitU-University Hospital of Berlin, INT STUD TREATM STAN; Cooper SL, 2015, PEDIATR CLIN N AM, V62, P61, DOI 10.1016/j.pcl.2014.09.006; Curran KJ, 2019, BLOOD, V134, P2361, DOI 10.1182/blood.2019001641; Domenech C, 2008, EUR J CANCER, V44, P2461, DOI 10.1016/j.ejca.2008.08.007; Eckert C, 2013, J CLIN ONCOL, V31, P2736, DOI 10.1200/JCO.2012.48.5680; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Forero-Castro M, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10070455; Gokbuget N, 2018, BLOOD, V131, P1522, DOI 10.1182/blood-2017-08-798322; HGRETINGER R, 2011, LEUKEMIA, V25, P181, DOI DOI 10.1038/LEU.2010.239; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Irving JAE, 2016, BLOOD, V128, P911, DOI 10.1182/blood-2016-03-704973; Kantarjian H, 2017, NEW ENGL J MED, V376, P836, DOI 10.1056/NEJMoa1609783; Krentz S, 2013, LEUKEMIA, V27, P295, DOI 10.1038/leu.2012.155; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LANSKY SB, 1987, CANCER, V60, P1651, DOI 10.1002/1097-0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO;2-J; Locatelli F, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-00342-x; Locatelli F, 2012, BLOOD, V120, P2807, DOI 10.1182/blood-2012-02-265884; Malempati S, 2007, J CLIN ONCOL, V25, P5800, DOI 10.1200/JCO.2007.10.7508; Martinelli G, 2017, J CLIN ONCOL, V35, P1795, DOI 10.1200/JCO.2016.69.3531; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Mejstrikova E, 2017, BLOOD CANCER J, V7, DOI 10.1038/s41408-017-0023-x; Moricke A, 2016, BLOOD, V127, P2101, DOI 10.1182/blood-2015-09-670729; Mouttet B, 2019, HAEMATOLOGICA, V104, pE244, DOI 10.3324/haematol.2018.210104; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Paganin M, 2008, LEUKEMIA, V22, P2193, DOI 10.1038/leu.2008.227; Parker C, 2010, LANCET, V376, P2009, DOI 10.1016/S0140-6736(10)62002-8; Peters C, 2015, J CLIN ONCOL, V33, P1265, DOI 10.1200/JCO.2014.58.9747; Ruggeri A, 2012, LEUKEMIA, V26, P2455, DOI 10.1038/leu.2012.123; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Schmiegelow K, 2016, LANCET ONCOL, V17, pE231, DOI 10.1016/S1470-2045(16)30035-3; Stein AS, 2019, ANN HEMATOL, V98, P159, DOI 10.1007/s00277-018-3497-0; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; van der Velden VHJ, 2007, LEUKEMIA, V21, P604, DOI 10.1038/sj.leu.2404586; von Stackelberg A, 2016, J CLIN ONCOL, V34, P4381, DOI 10.1200/JCO.2016.67.3301	41	89	92	4	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					843	854		10.1001/jama.2021.0987	http://dx.doi.org/10.1001/jama.2021.0987			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651091	Bronze, Green Published			2022-12-28	WOS:000625843100013
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... flu	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, THE ECONOMIST; CDC, WEEKL US INFL SURV R	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n584	10.1136/bmj.n584	http://dx.doi.org/10.1136/bmj.n584			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33648931				2022-12-28	WOS:000625342000003
J	Rubens, JH; Akindele, NP; Tschudy, MM; Sick-Samuels, AC				Rubens, Jessica H.; Akindele, Nadine Peart; Tschudy, Megan M.; Sick-Samuels, Anna C.			Acute covid-19 and multisystem inflammatory syndrome in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFANTS; STATES; INFECTION		[Rubens, Jessica H.; Akindele, Nadine Peart; Sick-Samuels, Anna C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Infect Dis, Baltimore, MD 21205 USA; [Tschudy, Megan M.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Gen Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Sick-Samuels, AC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Infect Dis, Baltimore, MD 21205 USA.	asick1@jhmi.edu		Sick-Samuels, Anna/0000-0002-9247-9340	Eunice Kennedy Shriver National Institute of Child Health and Human Development Award [K12-HD000850]; National Institutes of Health [T32-AI052071, KL2TR003099]	Eunice Kennedy Shriver National Institute of Child Health and Human Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JHR is a fellow in the Paediatric Scientist Development Program; this work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development Award K12-HD000850 (JHR), and by the National Institutes of Health T32-AI052071 (JHR, NPA) and KL2TR003099 (ACS).	Assaker R, 2020, BRIT J ANAESTH, V125, pE330, DOI 10.1016/j.bja.2020.05.026; Bixler D, 2020, MMWR-MORBID MORTAL W, V69, P1324, DOI 10.15585/mmwr.mm6937e4; Centers for Disease Control and Prevention, 2021, COVID 19 TEST INF; Centers for Disease Control and Prevention (CDC), HLTH DEP REP CAS MUL; Centers for Disease Control and Prevention (CDC), 2020, COVID DAT TRACK VACC; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Cui XJ, 2021, J MED VIROL, V93, P1057, DOI 10.1002/jmv.26398; Daneshgaran G, 2020, AM J CLIN DERMATOL, V21, P627, DOI 10.1007/s40257-020-00558-4; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Diorio C, 2020, J CLIN INVEST, V130, P5967, DOI 10.1172/JCI140970; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; European Center for Disease Prevention and Control, 2020, OBJ COVID 19 TEST SC; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Giovanni JE, 2021, PEDIATR INFECT DIS J, V40, pE35, DOI 10.1097/INF.0000000000002946; Gisondi P, 2020, J EUR ACAD DERMATOL, V34, P2499, DOI 10.1111/jdv.16774; Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2; Hall A, 2021, ARCH DIS CHILD, V106, DOI 10.1136/archdischild-2020-319971; Hatcher SM, 2020, MMWR-MORBID MORTAL W, V69, P1166, DOI 10.15585/mmwr.mm6934e1; Heald-Sargent T, 2020, JAMA PEDIATR, V174, P902, DOI 10.1001/jamapediatrics.2020.3651; Hoang A, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100433; Hobbs CV, 2020, MMWR-MORBID MORTAL W, V69, P1925, DOI 10.15585/mmwr.mm6950e3; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Jiang L, 2020, LANCET INFECT DIS, V20, pE276, DOI 10.1016/S1473-3099(20)30651-4; Kim L, 2020, MMWR-MORBID MORTAL W, V69, P1081, DOI 10.15585/mmwr.mm6932e3; King JA, 2021, CAN MED ASSOC J, V193, pE1, DOI 10.1503/cmaj.202065; Leeb RT, 2020, MMWR-MORBID MORTAL W, V69, P1410, DOI 10.15585/mmwr.mm6939e2; Mark EG, 2021, J PEDIATR-US, V228, P94, DOI 10.1016/j.jpeds.2020.09.008; Maryland Department of Health, 2021, COVID 19 GUID CHILD; Mithal LB, 2020, J PEDIATR-US, V224, P150, DOI 10.1016/j.jpeds.2020.06.047; Ouldali N, 2021, JAMA-J AM MED ASSOC, V325, P855, DOI 10.1001/jama.2021.0694; Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315; Poline J, 2020, CLIN INFECT DIS, Vciaa1044, DOI 10.1093/cid/ciaa1044; Schwartz NG, 2020, MMWR-MORBID MORTAL W, V69, P1457, DOI 10.15585/mmwr.mm6940e2; Song XY, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20495; Stein-Zamir C, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.29.2001352; Suwanwongse K, 2020, ARCH PEDIATRIE, V27, P400, DOI 10.1016/j.arcped.2020.07.009; Swann OV, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3249; Szablewski CM, 2020, MMWR-MORBID MORTAL W, V69, P1023, DOI 10.15585/mmwr.mm6931e1; UK Department for Education, 2021, WHAT DO CHILD AD DIS; Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131; Zhang Lu, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0273-8; Zimmerman KO, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-048090	43	42	41	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n385	10.1136/bmj.n385	http://dx.doi.org/10.1136/bmj.n385			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33648933	Bronze			2022-12-28	WOS:000625342000005
J	Bath, D; Cook, J; Govere, J; Mathebula, P; Morris, N; Hlongwana, K; Raman, J; Seocharan, I; Zitha, A; Zitha, M; Mabuza, A; Mbokazi, F; Machaba, E; Mabunda, E; Jamesboy, E; Biggs, J; Drakeley, C; Moonasar, D; Maharaj, R; Coetzee, M; Pitt, C; Kleinschmidt, I				Bath, David; Cook, Jackie; Govere, John; Mathebula, Phillemon; Morris, Natashia; Hlongwana, Khumbulani; Raman, Jaishree; Seocharan, Ishen; Zitha, Alpheus; Zitha, Matimba; Mabuza, Aaron; Mbokazi, Frans; Machaba, Elliot; Mabunda, Erik; Jamesboy, Eunice; Biggs, Joseph; Drakeley, Chris; Moonasar, Devanand; Maharaj, Rajendra; Coetzee, Maureen; Pitt, Catherine; Kleinschmidt, Immo			Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa	LANCET			English	Article							PLASMODIUM-FALCIPARUM; VECTOR CONTROL; OPEN-LABEL; ELIMINATION; PROVINCE; INTERVENTIONS; ALLOCATION; RESISTANCE; MORTALITY; EFFICACY	Background Increasing insecticide costs and constrained malaria budgets could make universal vector control strategies, such as indoor residual spraying (IRS), unsustainable in low-transmission settings. We investigated the effectiveness and cost-effectiveness of a reactive, targeted IRS strategy. Methods This cluster-randomised, open-label, non-inferiority trial compared reactive, targeted IRS with standard IRS practice in northeastern South Africa over two malaria seasons (2015-17). In standard IRS clusters, programme managers conducted annual mass spray campaigns prioritising areas using historical data, expert opinion, and other factors. In targeted IRS clusters, only houses of index cases (identified through passive surveillance) and their immediate neighbours were sprayed. The non-inferiority margin was 1 case per 1000 person-years. Health service costs of real-world implementation were modelled from primary and secondary data. Incremental costs per disability-adjusted life-year (DALY) were estimated and deterministic and probabilistic sensitivity analyses conducted. This study is registered with ClinicalTrials.gov, NCT02556242. Findings Malaria incidence was 0.95 per 1000 person-years (95% CI 0.58 to 1.32) in the standard IRS group and 1.05 per 1000 person-years (0.72 to 1.38) in the targeted IRS group, corresponding to a rate difference of 0.10 per 1000 person-years (-0.38 to 0.59), demonstrating non-inferiority for targeted IRS (p<0.0001). Per additional DALY incurred, targeted IRS saved US$7845 (2902 to 64907), giving a 94-98% probability that switching to targeted IRS would be cost-effective relative to plausible cost-effectiveness thresholds for South Africa ($2637 to $3557 per DALY averted). Depending on the threshold used, targeted IRS would remain cost-effective at incidences of less than 2.0-2.7 per 1000 person-years. Findings were robust to plausible variation in other parameters. Interpretation Targeted IRS was non-inferior, safe, less costly, and cost-effective compared with standard IRS in this very-low-transmission setting. Saved resources could be reallocated to other malaria control and elimination activities. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Bath, David; Pitt, Catherine] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England; [Bath, David] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Cook, Jackie; Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Biggs, Joseph; Drakeley, Chris] London Sch Hyg & Trop Med, Dept Infect Biol, London, England; [Govere, John; Mathebula, Phillemon; Raman, Jaishree; Zitha, Matimba; Jamesboy, Eunice; Coetzee, Maureen; Kleinschmidt, Immo] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Morris, Natashia] South African Med Res Council, Hlth GIS Ctr, Durban, South Africa; [Seocharan, Ishen] South African Med Res Council, Biostat Unit, Durban, South Africa; [Maharaj, Rajendra] South African Med Res Council, Off Malaria Res, Durban, South Africa; [Hlongwana, Khumbulani] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Raman, Jaishree; Jamesboy, Eunice; Coetzee, Maureen] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Emerging Zoonot & Parasit Dis, Johannesburg, South Africa; [Raman, Jaishree; Maharaj, Rajendra] Univ Pretoria, Inst Sustainable Malaria Control, Pretoria, South Africa; [Moonasar, Devanand] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Zitha, Alpheus; Mabuza, Aaron; Mbokazi, Frans] Mpumalanga Prov Malaria Control Programme, Nelspruit, South Africa; [Machaba, Elliot; Mabunda, Erik] Limpopo Prov Malaria Control Programme, Polokwane, South Africa; [Moonasar, Devanand] Natl Dept Hlth, South Africa Natl Malaria Programme, Pretoria, South Africa; [Kleinschmidt, Immo] Southern African Dev Community Malaria Eliminat E, Windhoek, Namibia	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; South African Medical Research Council; South African Medical Research Council; South African Medical Research Council; University of Kwazulu Natal; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; University of Pretoria	Bath, D (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1E 7HT, England.	david.bath@lshtm.ac.uk	Hlongwana, Khumbulani/AHB-0309-2022; Raman, Jaishree/AAB-8960-2020	Raman, Jaishree/0000-0003-0728-3093; Hlongwana, Khumbulani/0000-0002-1777-0402; Biggs, Joe/0000-0001-7273-874X	Joint Global Health Trials; MRC [MR/R010161/1, MR/L00433X/1] Funding Source: UKRI	Joint Global Health Trials; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Joint Global Health Trials.	Africa Science News, 2018, AFRICA SCI NEWS; Baltzell KA, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2877-9; Bekolo CE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026678; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Biggs J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1701-7; Bousema T, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001993; Briggs A, 2006, DECISION MODELLING H; Brooke B, 2013, SAMJ S AFR MED J, V103, P784, DOI [10.7196/SAMJ.7447, 10.7196/samj.7447]; Brooke B, 2016, COMMUNICABLE DIS SUR, V14; Chitnis N, 2018, J THEOR BIOL, V455, P118, DOI 10.1016/j.jtbi.2018.07.007; Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090; Coetzee M, 2013, SAMJ S AFR MED J, V103, P770, DOI [10.7196/samj.7446, 10.7196/SAMJ.7446]; Cunnama L, 2016, HEALTH ECON, V25, P53, DOI 10.1002/hec.3295; Davies C, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2683-4; Dowie Jack, 2015, F1000Res, V4, P1078; Drake TL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0886-x; Eisele TP, 2016, J INFECT DIS, V214, P1831, DOI 10.1093/infdis/jiw416; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Fullman N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-62; Gerritsen AAM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-162; Gueye CS, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1054-z; Hast MA, 2019, AM J EPIDEMIOL, V188, P2120, DOI 10.1093/aje/kwz107; Hayes RJ, 2017, CLUSTER RANDOMISED T, V2nd; Hsiang MS, 2020, LANCET, V395, P1361, DOI 10.1016/S0140-6736(20)30470-0; Hsiang MS, 2020, CLIN INFECT DIS, V70, P1316, DOI 10.1093/cid/ciz403; Kafy HT, 2017, P NATL ACAD SCI USA, V114, pE11267, DOI 10.1073/pnas.1713814114; Keating J, 2011, ACTA TROP, V119, P107, DOI 10.1016/j.actatropica.2011.04.015; Kleinschmidt I, 2018, LANCET INFECT DIS, V18, P640, DOI 10.1016/S1473-3099(18)30172-5; Lourenco C, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2960-2; Maharaj R, 2012, MALARIA J, V11, DOI [10.1186/1475-2875-11-320, 10.1186/1475-2875-11-423]; Martin C, 2002, HEALTH PLACE, V8, P227, DOI 10.1016/S1353-8292(02)00008-4; Mnzava AP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0693-4; Nardini L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-229; Ochalek J, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000964; Okumu F, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1859-z; Quan V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-151; Raman J, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2841-8; Raman J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1497-x; Sculpher M J, 2004, Health Technol Assess, V8, piii; Sherrard-Smith E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07357-w; Silal SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076640; South Africa National Department of Health, 2012, SURV GUID MAL EL PRE; Southern African Development Community, 2017, SADC MAL REP 2017; Sy O, 2019, PARASITE EPIDEM CONT, V6, DOI 10.1016/j.parepi.2019.e00109; The Global Fund, 2019, POOL PROC MECH REF P; Turner HC, 2019, VALUE HEALTH, V22, P1026, DOI 10.1016/j.jval.2019.03.021; Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0; WHO, 2021, WORLD MALARIA REPORT; WHO, 2006, GUID TEST MOSW AD IN; WHO, 2011, HLTH SERVICE DELIVER; Wilkinson T, 2016, VALUE HEALTH, V19, P921, DOI 10.1016/j.jval.2016.04.015; World Health Organization, 2016, GLOB HLTH OBS DAT RE; World Health Organization, 2012, WHO GLOB MAL PROGR G; World Health Organization, 2015, IND RES SPRAYING OP; World Health Organization, 2017, FRAM MAL EL; Yeomans F., 2020, IVCC INDO PACIFIC DE	56	9	10	4	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					816	827						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP6DN	33640068	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000623925500032
J	Dyer, C				Dyer, Clare			Covid-19: Young mother should be allowed to die in "almost unbearable" tragedy, says judge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2021	372								n577	10.1136/bmj.n577	http://dx.doi.org/10.1136/bmj.n577			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1OX	33637555	Bronze			2022-12-28	WOS:000624297200007
J	Taher, AT; Musallam, KM; Cappellini, MD				Taher, Ali T.; Musallam, Khaled M.; Cappellini, M. Domenica			beta-Thalassemias	NEW ENGLAND JOURNAL OF MEDICINE			English	Review									[Taher, Ali T.] Amer Univ Beirut, Dept Internal Med, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon; [Musallam, Khaled M.] Int Network Hematol, London, England; [Cappellini, M. Domenica] Univ Milan, Dept Clin Sci & Community, Ca Granda Fdn IRCCS Maggiore Policlin Hosp, Milan, Italy	American University of Beirut; University of Milan	Taher, AT (corresponding author), Amer Univ Beirut, Dept Internal Med, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon.	ataher@aub.edu.lb						Angastiniotis M, 2013, SCI WORLD J, DOI 10.1155/2013/727905; Angelucci E, 2000, NEW ENGL J MED, V343, P327, DOI 10.1056/NEJM200008033430503; Angelucci E, 2014, HAEMATOLOGICA, V99, P811, DOI 10.3324/haematol.2013.099747; Antoniani C, 2018, BLOOD, V131, P1960, DOI 10.1182/blood-2017-10-811505; Barry RM, 2020, J PEDIAT HEMATOL ONC, V42, pE107, DOI 10.1097/MPH.0000000000001524; Basak A, 2020, NAT GENET, V52, P138, DOI 10.1038/s41588-019-0568-7; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Brittenham GM, 2011, NEW ENGL J MED, V364, P146, DOI 10.1056/NEJMct1004810; Calvaruso G, 2015, AM J HEMATOL, V90, P634, DOI 10.1002/ajh.24024; Cappellini MD, 2020, NEW ENGL J MED, V382, P1219, DOI 10.1056/NEJMoa1910182; Cappellini MD, 2011, BLOOD, V118, P884, DOI 10.1182/blood-2010-11-316646; Cappellini MD., 2014, GUIDELINES MANAGEMEN, V3; Carlberg KT, 2018, HEMATOL ONCOL CLIN N, V32, P297, DOI 10.1016/j.hoc.2017.11.004; Carpenter JP, 2013, HAEMATOLOGICA, V98, P1368, DOI 10.3324/haematol.2013.083634; Carpenter JP, 2011, CIRCULATION, V123, P1519, DOI 10.1161/CIRCULATIONAHA.110.007641; Efremov GD, 2007, HEMOGLOBIN, V31, P193, DOI 10.1080/03630260701290092; Eldor A, 2002, BLOOD, V99, P36, DOI 10.1182/blood.V99.1.36; Frangoul H, 2021, NEW ENGL J MED, V384, P252, DOI 10.1056/NEJMoa2031054; Frangoul H, 2020, BLOOD, V136, DOI 10.1182/blood-2020-139575; Fucharoen S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011734; Galanello R, 2009, BLOOD, V114, P3935, DOI 10.1182/blood-2009-04-217901; Garewal G, 2007, EUR J HAEMATOL, V79, P417, DOI 10.1111/j.1600-0609.2007.00958.x; Graffeo L, 2018, EUR J INTERN MED, V54, P76, DOI 10.1016/j.ejim.2018.06.009; Guerra A, 2019, BLOOD, V134, P568, DOI 10.1182/blood.2019001057; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Kattamis A, 2020, EUR J HAEMATOL, V105, P692, DOI 10.1111/ejh.13512; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kirk P, 2009, CIRCULATION, V120, P1961, DOI 10.1161/CIRCULATIONAHA.109.874487; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Kuo KHM, 2020, EHA25; Lal A, 2018, TRANSFUSION, V58, P2826, DOI 10.1111/trf.14875; Lechauve C, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav4881; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Maggio A, 2002, BLOOD CELL MOL DIS, V28, P196, DOI 10.1006/bcmd.2002.0510; Maggio A, 2020, LANCET HAEMATOL, V7, pE469, DOI 10.1016/S2352-3026(20)30100-9; Manfre L, 1999, AM J ROENTGENOL, V173, P1477, DOI 10.2214/ajr.173.6.10584785; Manolova V, 2020, J CLIN INVEST, V130, P491, DOI 10.1172/JCI129382; Marktel S, 2019, NAT MED, V25, P234, DOI 10.1038/s41591-018-0301-6; Matte A, 2016, 21 C EUR HEM ASS COP; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Mihailescu AM, 2020, ANN HEMATOL, V99, P903, DOI 10.1007/s00277-020-03958-y; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Mohamed Said Y, 2017, Hematol Oncol Stem Cell Ther, V10, P290, DOI 10.1016/j.hemonc.2017.05.022; Musallam KM, 2013, HAEMATOLOGICA, V98, P833, DOI 10.3324/haematol.2012.066845; Musallam KM, 2012, THROMB RES, V130, P695, DOI 10.1016/j.thromres.2012.07.013; Musallam KM, 2011, HAEMATOL-HEMATOL J, V96, P1605, DOI 10.3324/haematol.2011.047852; O'Donnell A, 2007, P NATL ACAD SCI USA, V104, P9440, DOI 10.1073/pnas.0703424104; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Patel K, 2019, ANN HEMATOL, V98, P851, DOI 10.1007/s00277-018-3557-5; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pennell DJ, 2014, BLOOD, V123, P1447, DOI 10.1182/blood-2013-04-497842; Pennell DJ, 2012, HAEMATOL-HEMATOL J, V97, P842, DOI 10.3324/haematol.2011.049957; Piel FB, 2014, NEW ENGL J MED, V371, P1908, DOI 10.1056/NEJMra1404415; Piga A, 2019, BLOOD, V133, P1279, DOI 10.1182/blood-2018-10-879247; Pinto VM, 2019, BLOOD REV, V38, DOI 10.1016/j.blre.2019.100594; Premawardhena A, 2005, BLOOD, V106, P3251, DOI 10.1182/blood-2005-02-0593; Psatha N, 2018, MOL THER-METH CLIN D, V10, P313, DOI 10.1016/j.omtm.2018.08.003; Rivella S, 2019, BLOOD, V133, P51, DOI 10.1182/blood-2018-07-815928; Rund D, 2005, NEW ENGL J MED, V353, P1135, DOI 10.1056/NEJMra050436; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sayani FA, 2015, ANN MED, V47, P592, DOI 10.3109/07853890.2015.1091942; Smith AR, 2019, BLOOD, V134, DOI 10.1182/blood-2019-125743; St Pierre TG, 2005, BLOOD, V105, P855, DOI 10.1182/blood-2004-01-0177; Steinberg MH, 2009, DISORDERS OF HEMOGLOBIN: GENETICS, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, 2ND EDITION, P1, DOI 10.1017/CBO9780511596582; Suragani RNVS, 2014, BLOOD, V123, P3864, DOI 10.1182/blood-2013-06-511238; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Taher A, 2017, GUIDELINES MANAGEMEN, V2nd; Taher AT, 2018, BLOOD, V132, P1781, DOI 10.1182/blood-2018-06-818187; Taher AT, 2018, LANCET, V391, P155, DOI 10.1016/S0140-6736(17)31822-6; Taher AT, 2017, AM J HEMATOL, V92, P420, DOI 10.1002/ajh.24668; Taher AT, 2015, BLOOD CELL MOL DIS, V55, P108, DOI 10.1016/j.bcmd.2015.05.011; Taher AT, 2013, ANN HEMATOL, V92, P1485, DOI 10.1007/s00277-013-1808-z; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vichinsky E, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27067; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982	79	77	78	6	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					727	743		10.1056/NEJMra2021838	http://dx.doi.org/10.1056/NEJMra2021838			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP4LK	33626255				2022-12-28	WOS:000623807600012
J	Woolston, C; Spinato, C				Woolston, Chris; Spinato, Cinzia			Taking graphene out of the laboratory and into the real world	NATURE			English	Editorial Material						Careers; Business; Physics		Business developer Cinzia Spinato helps nanoscientists to translate their inventions into marketable products. Business developer Cinzia Spinato helps nanoscientists to translate their inventions into marketable products.	[Woolston, Chris] Catalan Inst Nanosci & Nanotechnol, Barcelona, Spain; [Woolston, Chris] European Unions Graphene Flagship Consortium, Barcelona, Spain	Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2)	Woolston, C (corresponding author), Catalan Inst Nanosci & Nanotechnol, Barcelona, Spain.; Woolston, C (corresponding author), European Unions Graphene Flagship Consortium, Barcelona, Spain.								0	0	0	2	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847					684	684		10.1038/d41586-021-00463-8	http://dx.doi.org/10.1038/d41586-021-00463-8			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QK7TR	33619407	Bronze			2022-12-28	WOS:000620584900002
J	Kocher, RP; Shah, SL; Navathe, AS				Kocher, Robert P.; Shah, Soleil; Navathe, Amol S.			Overcoming the Market Dominance of Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint reviews the conditions which incentivize consolidation of health systems, hospitals, and physician practices into entities that decrease health care quality and increase prices, and in the context of financial pressures wrought by the COVID-19 pandemic proposes policy solutions that could protect patients against potential adverse effects of accelerating trends toward consolidation.	[Kocher, Robert P.; Shah, Soleil] Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA; [Navathe, Amol S.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Navathe, Amol S.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine	Kocher, RP (corresponding author), Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA.	bkocher@venrock.com		Navathe, Amol/0000-0001-7182-4988; Shah, Soleil/0000-0002-1967-8271				American Hospital Association, TRENDWATCH CHARTBOOK; Beaulieu ND, 2020, NEW ENGL J MED, V382, P51, DOI 10.1056/NEJMsa1901383; Capps C, 2018, J HEALTH ECON, V59, P139, DOI 10.1016/j.jhealeco.2018.04.001; Jia P, 2020, ANN GIS, V26, P251, DOI 10.1080/19475683.2020.1798509; Kocher B, 2012, JAMA-J AM MED ASSOC, V308, P1213, DOI 10.1001/2012.jama.11910; McKinsey and Company, 2020, PHYS EMPLOYMENT PATH; Merritt Hawkins, 2020, SURVEY AMERICAS PHYS; Neuman, 2020, KAISER FAMILY FDN WE; Physicians Advocacy Institute, 2019, UPDATED PHYS PRACTIC; PricewaterhouseCoopers Health Research Institute, MEDICAL COST TREND N	10	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					929	930		10.1001/jama.2021.0079	http://dx.doi.org/10.1001/jama.2021.0079		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33605976				2022-12-28	WOS:000619613100001
J	Nosil, P; Feder, JL; Gompert, Z				Nosil, Patrik; Feder, Jeffrey L.; Gompert, Zachariah			How many genetic changes create new species?	SCIENCE			English	Editorial Material							GENOMIC ARCHITECTURE; SPECIATION; DIVERGENCE		[Nosil, Patrik] Univ Paul Valery Montpellier, CNRS, Ctr Ecol Fonct & Evolut, EPHE,IRD, Montpellier, France; [Nosil, Patrik; Gompert, Zachariah] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Feder, Jeffrey L.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Utah System of Higher Education; Utah State University; University of Notre Dame	Nosil, P (corresponding author), Univ Paul Valery Montpellier, CNRS, Ctr Ecol Fonct & Evolut, EPHE,IRD, Montpellier, France.; Nosil, P (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	patrik.nosil@cefe.cnrs.fr			European Research Council [770826]; U.S. Department of Agriculture-National Institute of Food and Agriculture program [2015-67013-23289]; NSF [DEB-1638997, DEB 1844941]	European Research Council(European Research Council (ERC)European Commission); U.S. Department of Agriculture-National Institute of Food and Agriculture program; NSF(National Science Foundation (NSF))	The work was funded by a grant from the European Research Council (EE-Dynamics 770826, https://erc.europa.eu/) to P.N., from NSF (DEB-1638997) and the U.S. Department of Agriculture-National Institute of Food and Agriculture program (2015-67013-23289) toJ.L.F., and from the NSF (DEB 1844941) to Z.G. We thank D. Schluter for ongoing discussions concerning evolutionary genetics.	BARTON NH, 1983, EVOLUTION, V37, P454, DOI 10.1111/j.1558-5646.1983.tb05563.x; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Edelman NB, 2019, SCIENCE, V366, P594, DOI 10.1126/science.aaw2090; Flaxman SM, 2014, MOL ECOL, V23, P4074, DOI 10.1111/mec.12750; Gavrilets S, 2004, FITNESS LANDSCAPES O; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kautt AF, 2020, NATURE, V588, P106, DOI 10.1038/s41586-020-2845-0; Lamichhaney S, 2018, SCIENCE, V359, P224, DOI 10.1126/science.aao4593; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; McGee MD, 2020, NATURE, V586, P75, DOI 10.1038/s41586-020-2652-7; Michel AP, 2010, P NATL ACAD SCI USA, V107, P9724, DOI 10.1073/pnas.1000939107; Riesch R, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0082; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Todesco M, 2020, NATURE, V584, P602, DOI 10.1038/s41586-020-2467-6; Yeaman S, 2011, EVOLUTION, V65, P1897, DOI 10.1111/j.1558-5646.2011.01269.x	15	17	17	8	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					777	+		10.1126/science.abf6671	http://dx.doi.org/10.1126/science.abf6671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602840				2022-12-28	WOS:000619664700026
J	Xu, JY; Zhu, X; Tan, SJ; Zhang, Y; Li, B; Tian, YZ; Shan, H; Cui, XF; Zhao, AD; Dong, ZC; Yang, JL; Luo, Y; Wang, B; Hou, JG				Xu, Jiayu; Zhu, Xiang; Tan, Shijing; Zhang, Yao; Li, Bin; Tian, Yunzhe; Shan, Huan; Cui, Xuefeng; Zhao, Aidi; Dong, Zhenchao; Yang, Jinlong; Luo, Yi; Wang, Bing; Hou, J. G.			Determining structural and chemical heterogeneities of surface species at the single-bond limit	SCIENCE			English	Article								The structure determination of surface species has long been a challenge because of their rich chemical heterogeneities. Modern tip-based microscopic techniques can resolve heterogeneities from their distinct electronic, geometric, and vibrational properties at the single-molecule level but with limited interpretation from each. Here, we combined scanning tunneling microscopy (STM), noncontact atomic force microscopy (AFM), and tip-enhanced Raman scattering (TERS) to characterize an assumed inactive system, pentacene on the Ag(110) surface. This enabled us to unambiguously correlate the structural and chemical heterogeneities of three pentacene-derivative species through specific carbon-hydrogen bond breaking. The joint STM-AFM-TERS strategy provides a comprehensive solution for determining chemical structures that are widely present in surface catalysis, on-surface synthesis, and twodimensional materials.	[Xu, Jiayu; Zhu, Xiang; Tan, Shijing; Zhang, Yao; Li, Bin; Tian, Yunzhe; Shan, Huan; Cui, Xuefeng; Zhao, Aidi; Dong, Zhenchao; Yang, Jinlong; Luo, Yi; Wang, Bing; Hou, J. G.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Microscale & Synerget Innovat Ctr Quantum Informa, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tan, SJ; Wang, B; Hou, JG (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Microscale & Synerget Innovat Ctr Quantum Informa, Hefei 230026, Anhui, Peoples R China.	tansj@ustc.edu.cn; bwang@ustc.edu.cn; jghou@ustc.edu.cn	崔, 雪峰/AAZ-2509-2021; Wang, Bing/D-3535-2009; Luo, Yi/B-1449-2009; Dong, Z. C./HGD-0338-2022; Yang, Jinlong/D-3465-2009	崔, 雪峰/0000-0003-0350-1495; Wang, Bing/0000-0002-2953-2196; Luo, Yi/0000-0003-0007-0394; Dong, Zhen-Chao/0000-0002-4596-6269; Tian, Yunzhe/0000-0002-9494-5683; Xu, Jiayu/0000-0002-7160-1095; Zhu, Xiang/0000-0001-6216-1879; Tan, Shijing/0000-0002-8537-9528	Ministry of Science and Technology of China [2016YFA0200603]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB36020200]; National Natural Science Foundation of China [21972129]; Anhui Initiative in Quantum Information Technologies [AHY090000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Initiative in Quantum Information Technologies	This work was supported by the Ministry of Science and Technology of China (2016YFA0200603), the Strategic Priority Research Program of Chinese Academy of Sciences (XDB36020200), the National Natural Science Foundation of China (21972129), and the Anhui Initiative in Quantum Information Technologies (AHY090000).	Altman EI, 2015, ACCOUNTS CHEM RES, V48, P2640, DOI 10.1021/acs.accounts.5b00166; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Boneschanscher MP, 2014, ACS NANO, V8, P3006, DOI 10.1021/nn500317r; Chiang CL, 2014, SCIENCE, V344, P885, DOI 10.1126/science.1253405; Chiang NH, 2016, NANO LETT, V16, P7774, DOI 10.1021/acs.nanolett.6b03958; de Oteyza DG, 2013, SCIENCE, V340, P1434, DOI 10.1126/science.1238187; Domke KF, 2006, J AM CHEM SOC, V128, P14721, DOI 10.1021/ja065820b; Duan S, 2015, J AM CHEM SOC, V137, P9515, DOI 10.1021/jacs.5b03741; Fatayer S, 2019, SCIENCE, V365, P142, DOI 10.1126/science.aax5895; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Gross L, 2012, SCIENCE, V337, P1326, DOI 10.1126/science.1225621; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Han ZM, 2017, SCIENCE, V358, P206, DOI 10.1126/science.aai8625; Hapala P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.226101; Hapala P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085421; Hla SW, 2000, PHYS REV LETT, V85, P2777, DOI 10.1103/PhysRevLett.85.2777; Hla SW, 2003, ANNU REV PHYS CHEM, V54, P307, DOI 10.1146/annurev.physchem.54.011002.103852; Ho W, 1998, ACCOUNTS CHEM RES, V31, P567, DOI 10.1021/ar9501784; Hou JG, 2001, NATURE, V409, P304, DOI 10.1038/35053163; Hu W, 2017, PHYS CHEM CHEM PHYS, V19, P32389, DOI 10.1039/c7cp06329f; Jiang S, 2015, NAT NANOTECHNOL, V10, P865, DOI [10.1038/nnano.2015.170, 10.1038/NNANO.2015.170]; Kazuma E, 2020, ANGEW CHEM INT EDIT, V59, P7960, DOI 10.1002/anie.202001863; Kazuma E, 2018, SCIENCE, V360, P521, DOI 10.1126/science.aao0872; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Lee J, 2019, NATURE, V568, P78, DOI 10.1038/s41586-019-1059-9; Li SW, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.077401; Liu PC, 2019, ACS NANO, V13, P9342, DOI 10.1021/acsnano.9b03980; Ma RZ, 2020, NATURE, V577, P60, DOI 10.1038/s41586-019-1853-4; Moll N, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/125020; Patera LL, 2019, NATURE, V566, P245, DOI 10.1038/s41586-019-0910-3; Pavlicek N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086101; Peng JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02635-5; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Repp J, 2006, SCIENCE, V312, P1196, DOI 10.1126/science.1126073; Richard-Lacroix M, 2017, CHEM SOC REV, V46, P3922, DOI 10.1039/c7cs00203c; Riss A, 2016, NAT CHEM, V8, P678, DOI [10.1038/NCHEM.2506, 10.1038/nchem.2506]; Sharifzadeh S, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.125307; Soe WH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176102; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Somorjai GA, 2011, P NATL ACAD SCI USA, V108, P917, DOI 10.1073/pnas.1006669107; Sykes ECH, 2003, ACCOUNTS CHEM RES, V36, P945, DOI 10.1021/ar970286l; Tan SJ, 2018, J PHYS CHEM C, V122, P28805, DOI 10.1021/acs.jpcc.8b09784; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; TERSOFF J, 1983, PHYS REV LETT, V50, P1998, DOI 10.1103/PhysRevLett.50.1998; Titmuss S, 1996, CHEM REV, V96, P1291, DOI 10.1021/cr950214c; Xie Z, 2020, NANOSCALE, V12, P10474, DOI 10.1039/d0nr01629b; Xu J, 2021, **DATA OBJECT**, DOI [10.5061/dryad.d51c5b02c, DOI 10.5061/DRYAD.D51C5B02C]; Yang B, 2020, NAT PHOTONICS, V14, P693, DOI 10.1038/s41566-020-0677-y; Yu A, 2018, NANO LETT, V18, P3076, DOI 10.1021/acs.nanolett.8b00613; Zhang J, 2013, SCIENCE, V342, P611, DOI 10.1126/science.1242603; Zhang R, 2013, NATURE, V498, P82, DOI 10.1038/nature12151; Zhang Y, 2016, NATURE, V531, P623, DOI 10.1038/nature17428; Zhang Y, 2019, NATL SCI REV, V6, P1169, DOI 10.1093/nsr/nwz180; Zhang Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15225; Zhang YF, 2020, J AMB INTEL HUM COMP, V11, P4239, DOI 10.1007/s12652-020-01704-w; Zhang ZM, 2010, ANALYST, V135, P1138, DOI 10.1039/b922045c; Zhao AD, 2005, SCIENCE, V309, P1542, DOI 10.1126/science.1113449; Zhou Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05372-5; Zhu X., 2021, **DATA OBJECT**, DOI [10.5061/dryad.d51c5b02c, DOI 10.5061/DRYAD.D51C5B02C]	64	33	34	46	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					818	+		10.1126/science.abd1827	http://dx.doi.org/10.1126/science.abd1827			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602852				2022-12-28	WOS:000619664700051
J	Shuren, J; Stenzel, T				Shuren, Jeffrey; Stenzel, Timothy			The FDA's Experience with Covid-19 Antibody Tests	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shuren, Jeffrey; Stenzel, Timothy] US FDA, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Shuren, J (corresponding author), US FDA, Silver Spring, MD 20993 USA.							FDA, 2020, IMP INF US SER ANT T; Food and Drug Administration, 2020, POL DIAGN TESTS COR; Shah A., 2020, INSIGHT FDAS REVISED; Shuren J, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2023830	4	16	16	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2021	384	7					592	594		10.1056/NEJMp2033687	http://dx.doi.org/10.1056/NEJMp2033687			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL2HH	33605568	Bronze			2022-12-28	WOS:000620900000005
J	Mina, MJ; Peto, TE; Garcia-Finana, M; Semple, MG; Buchan, IE				Mina, Michael J.; Peto, Tim E.; Garcia-Finana, Marta; Semple, Malcolm G.; Buchan, Iain E.			Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19	LANCET			English	Editorial Material									[Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA USA; [Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Mina, Michael J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Peto, Tim E.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Semple, Malcolm G.] Univ Liverpool, Inst Infect Vet & Ecol Sci, Liverpool, Merseyside, England; [Garcia-Finana, Marta; Buchan, Iain E.] Univ Liverpool, Inst Populat Hlth, Liverpool L36 3GF, Merseyside, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oxford; University of Liverpool; University of Liverpool	Buchan, IE (corresponding author), Univ Liverpool, Inst Populat Hlth, Liverpool L36 3GF, Merseyside, England.	buchan@liverpool.ac.uk	Semple, Malcolm Gracie/A-8790-2008; Buchan, Iain/H-5767-2013	Semple, Malcolm Gracie/0000-0001-9700-0418; Garcia-Finana, Professor Marta/0000-0003-4939-0575; Buchan, Iain/0000-0003-3392-1650	EPSRC [EP/N014499/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Armstrong S, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4941; Ashton M, 2021, RESPONSE DEEKS BRIEF; Basile K, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1579, DOI 10.1093/CID/CIAA1579]; Buchan I., 2020, LIVERPOOL COVID 19 C; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Cevik M, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3862; Cevik M, 2021, CLIN INFECT DIS, V73, pS170, DOI 10.1093/cid/ciaa1442; Cleary B, 2021, SCI TRANSL MED, V13, DOI [10.1126/scitranslmed.abf1568, 10.1101/2020.05.01.20086801]; Crozier A, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n208; Deeks J., 2021, BMJ OPINION; Deeks JJ, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4787; Eyre DW, 2020, ELIFE, V9, DOI 10.7554/eLife.60675; Fearon E, 2021, BMJ, DOI [10.1136/bmj.n81, DOI 10.1136/BMJ.N81]; Hay James A, 2021, medRxiv, DOI 10.1101/2020.10.08.20204222; Huang CG, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01068-20; Jefferson T, 2021, CLIN INFECT DIS, V73, pe3884, DOI [10.1093/cid/ciaa1764, DOI 10.1093/CID/CIAA1764]; Kmietowicz Z, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n81; Lee L, OBSERVATIONAL STUDY, P2021; Marks M, 2021, LANCET INFECT DIS, V21, P629, DOI 10.1016/S1473-3099(20)30985-3; Mayhew M, 2020, 20202020120120237784, DOI [10.1101/ 2020.12.01.20237784, DOI 10.1101/2020.12.01.20237784, 10.1101/2020.12.01.20237784]; Pray IW, 2021, MMWR-MORBID MORTAL W, V69, P1642, DOI 10.15585/mmwr.mm695152a3; Sun JF, 2020, EMERG INFECT DIS, V26, P1834, DOI 10.3201/eid2608.201097; van Kampen JJA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20568-4; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; World Health Organization, 2020, CRIT REL COVID 19 PA	26	70	71	4	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1425	1427		10.1016/S0140-6736(21)00425-6	http://dx.doi.org/10.1016/S0140-6736(21)00425-6		APR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33609444	Bronze, Green Published			2022-12-28	WOS:000640378100005
J	Sanchez, MF; Els-Heindl, S; Beck-Sickinger, AG; Wieneke, R; Tampe, R				Sanchez, M. Florencia; Els-Heindl, Sylvia; Beck-Sickinger, Annette G.; Wieneke, Ralph; Tampe, Robert			Photoinduced receptor confinement drives ligand-independent GPCR signaling	SCIENCE			English	Article							PROTEIN INTERACTIONS; CELL-MIGRATION; Y2 RECEPTORS; PROLIFERATION; ORGANIZATION; SURFACES; INVESTIGATE; PLASTICITY; INDUCTION; AFFINITY	Cell-cell communication relies on the assembly of receptor-ligand complexes at the plasma membrane. The spatiotemporal receptor organization has a pivotal role in evoking cellular responses. We studied the clustering of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) and established a photoinstructive matrix with ultrasmall lock-and-key interaction pairs to control lateral membrane organization of hormone neuropeptide Y-2 receptors in living cells by light. Within seconds, receptor clustering was modulated in size, location, and density. After in situ confinement, changes in cellular morphology, motility, and calcium signaling revealed ligand-independent receptor activation. This approach may enhance the exploration of mechanisms in cell signaling and mechanotransduction.	[Sanchez, M. Florencia; Wieneke, Ralph; Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany; [Els-Heindl, Sylvia; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Life Sci, Inst Biochem, D-04109 Leipzig, Germany	Goethe University Frankfurt; Leipzig University	Tampe, R (corresponding author), Goethe Univ Frankfurt, Bioctr, Inst Biochem, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Sanchez, Maria Florencia/ABF-4838-2021; Tampe, Robert/H-2953-2015	Sanchez, Maria Florencia/0000-0003-1049-0368; Wieneke, Ralph/0000-0002-0767-4679; Tampe, Robert/0000-0002-0403-2160	German Research Foundation [GRK 1986, 237922874]; Volkswagen Foundation [Az. 91068, Az. 91067]; LOEWE DynaMem P3;  [CRC 1423];  [421152132 A4];  [CRC 807];  [57566863 P16]	German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); LOEWE DynaMem P3; ; ; ; 	1 1 This work was supported by the German Research Foundation (GRK 1986 no. 237922874 to R.W. and R.T.); CRC 1423 no. 421152132 A4 to A.G.B.-S.; CRC 807 no. 57566863 P16 to R.T.; LOEWE DynaMem P3 to R.W. and R.T.; and the Volkswagen Foundation (Az. 91068 to R.W. and Az. 91067 to R.T.).	[Anonymous], 2014, P NATL ACAD SCI US; Aydin C, 2014, PHARMACOL BIOCHEM BE, V125, P48, DOI 10.1016/j.pbb.2014.08.004; Bardhan A, 2019, CURR OPIN STRUC BIOL, V57, P164, DOI 10.1016/j.sbi.2019.03.028; Barry DJ, 2015, J CELL BIOL, V209, P163, DOI 10.1083/jcb.201501081; Bernard A, 2000, ADV MATER, V12, P1067, DOI 10.1002/1521-4095(200007)12:14<1067::AID-ADMA1067>3.3.CO;2-D; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; Care BR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-48; Chen G, 2000, MOL PHARMACOL, V57, P125; Chen YF, 2017, MOL BIOL CELL, V28, P3134, DOI 10.1091/mbc.E17-04-0228; Dijkman PM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03727-6; Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103; Dum E, 2017, NEUROPEPTIDES, V61, P49, DOI 10.1016/j.npep.2016.10.005; DUMONT Y, 1995, J PHARMACOL EXP THER, V272, P673; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Ekstrand AJ, 2003, P NATL ACAD SCI USA, V100, P6033, DOI 10.1073/pnas.1135965100; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Furtinger S, 2001, J NEUROSCI, V21, P5804, DOI 10.1523/JNEUROSCI.21-15-05804.2001; Gatterdam K, 2018, ANGEW CHEM INT EDIT, V57, P12395, DOI 10.1002/anie.201802746; Gatterdam V, 2014, ANGEW CHEM INT EDIT, V53, P5680, DOI 10.1002/anie.201309930; Grunwald C, 2010, P NATL ACAD SCI USA, V107, P6146, DOI 10.1073/pnas.0912617107; Hemphill J, 2015, J AM CHEM SOC, V137, P5642, DOI 10.1021/ja512664v; Kaiser A, 2018, MOL PHARMACOL, V93, P387, DOI 10.1124/mol.117.110544; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kostenis E, 2005, J PHARMACOL EXP THER, V313, P78, DOI 10.1124/jpet.104.080424; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Laboria N, 2013, ANGEW CHEM INT EDIT, V52, P848, DOI 10.1002/anie.201206698; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lindner D, 2009, CELL SIGNAL, V21, P61, DOI 10.1016/j.cellsig.2008.09.007; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Mackay JP, 2019, J NEUROSCI, V39, P4909, DOI 10.1523/JNEUROSCI.2226-18.2019; Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883; Medeiros PJ, 2012, INT J CANCER, V131, P276, DOI 10.1002/ijc.26350; Milligan G, 2019, CURR OPIN CELL BIOL, V57, P40, DOI 10.1016/j.ceb.2018.10.007; Moller J, 2020, NAT CHEM BIOL, V16, P946, DOI 10.1038/s41589-020-0566-1; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Nair PM, 2011, NAT PROTOC, V6, P523, DOI 10.1038/nprot.2011.302; Pediani JD, 2018, TRENDS PHARMACOL SCI, V39, P175, DOI 10.1016/j.tips.2017.09.001; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Sanchez M. F., 2020, ZENODO, DOI [10.5281/zenodo.4036276, DOI 10.5281/ZENODO.4036276]; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shelby SA, 2013, BIOPHYS J, V105, P2343, DOI 10.1016/j.bpj.2013.09.049; SMITH SJ, ELIFE; Smith SJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47889; Stanic D, 2008, P NATL ACAD SCI USA, V105, P3610, DOI 10.1073/pnas.0712303105; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Torres AJ, 2008, ANNU REV BIOPHYS, V37, P265, DOI 10.1146/annurev.biophys.36.040306.132651; Traub MC, 2016, ANNU REV CHEM BIOMOL, V7, P583, DOI 10.1146/annurev-chembioeng-080615-034635; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wacker D, 2017, CELL, V170, P414, DOI 10.1016/j.cell.2017.07.009; Walther C, 2011, J PEPT SCI, V17, P233, DOI 10.1002/psc.1357; Wu N, 2004, J AM CHEM SOC, V126, P14306, DOI 10.1021/ja040175z; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Zhou QT, 2019, ELIFE, V8, DOI 10.7554/eLife.50279; Ziemek R, 2006, EUR J PHARMACOL, V551, P10, DOI 10.1016/j.ejphar.2006.08.075; Ziffert I, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00537-6	60	6	6	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2021	371	6536					1334	+	eabb7657	10.1126/science.abb7657	http://dx.doi.org/10.1126/science.abb7657			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2GI	33632896				2022-12-28	WOS:000636043400030
J	Newby, G; Mpanju-Shumbusho, W; Feachem, RGA				Newby, Gretchen; Mpanju-Shumbusho, Winnie; Feachem, Richard G. A.			Global health security requires endemic disease eradication	LANCET			English	Editorial Material									[Newby, Gretchen; Feachem, Richard G. A.] Univ Calif San Francisco, Malaria Eliminat Initiat, Inst Global Hlth Sci, San Francisco, CA 94158 USA; [Mpanju-Shumbusho, Winnie] RBM Partnership End Malaria, Geneva, Switzerland	University of California System; University of California San Francisco	Newby, G (corresponding author), Univ Calif San Francisco, Malaria Eliminat Initiat, Inst Global Hlth Sci, San Francisco, CA 94158 USA.	gretchen.newby@ucsf.edu			Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	RGAF and WM-S are Co-Chairs of the Lancet Commission on malaria eradication. GN is a member of the UCSF Secretariat of the Commission. WM-S previously served as Assistant Director General at WHO and Board Chair for RBM Partnership to End Malaria; she is currently a Board Member of RBM Partnership to End Malaria. GN and RGAF are affiliated with the Malaria Elimination Initiative (MEI). The MEI collaborates with numerous governments and organisations around the world, and funding comes from multiple sources including the Bill & Melinda Gates Foundation. We declare no other competing interests.	Feachem RGA, 2019, LANCET, V394, P1056, DOI 10.1016/S0140-6736(19)31139-0; Global Fund, 2020, ACT 19 JUNE 2020 INT; Lal A, 2021, LANCET, V397, P61, DOI 10.1016/S0140-6736(20)32228-5; Ntoumi F, 2020, NATURE, V587, P331, DOI 10.1038/d41586-020-03220-5; RBM Partnership to End Malaria, 2020, RBM PARTN END MAL PO; RBM Partnership to End Malaria, 2021, COUNTR RESP DUAL CHA; Sands P., 2020, COVID 19 MUST TRANSF; Sherrard-Smith E, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1025-y; So AD, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4750; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2020, MAL ER BEN FUT SCEN; Worley W., 2020, BREAKING UK CUTS AID	13	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 27	2021	397	10280					1163	1165		10.1016/S0140-6736(21)00521-3	http://dx.doi.org/10.1016/S0140-6736(21)00521-3		MAR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RC7YE	33676598	Bronze			2022-12-28	WOS:000633010800005
J	Shahrizaila, N; Lehmann, HC; Kuwabara, S				Shahrizaila, Nortina; Lehmann, Helmar C.; Kuwabara, Satoshi			Guillain-Barre syndrome	LANCET			English	Review							CAMPYLOBACTER-JEJUNI INFECTION; EXPERIMENTAL ALLERGIC NEURITIS; BRAIN-STEM ENCEPHALITIS; INTRAVENOUS IMMUNOGLOBULIN; GANGLIOSIDE COMPLEXES; ANTI-GD1A ANTIBODY; CLINICAL-FEATURES; SYNDROME SUBTYPES; FISHER SYNDROME; IGG ANTIBODIES	Guillain-Barre syndrome is the most common cause of acute flaccid paralysis worldwide. Most patients present with an antecedent illness, most commonly upper respiratory tract infection, before the onset of progressive motor weakness. Several microorganisms have been associated with Guillain-Barre syndrome, most notably Campylobacter jejuni, Zika virus, and in 2020, the severe acute respiratory syndrome coronavirus 2. In C jejuni-related Guillain-Barre syndrome, there is good evidence to support an autoantibody-mediated immune process that is triggered by molecular mimicry between structural components of peripheral nerves and the microorganism. Making a diagnosis of so-called classical Guillain-Barre syndrome is straightforward; however, the existing diagnostic criteria have limitations and can result in some variants of the syndrome being missed. Most patients with Guillain-Barre syndrome do well with immunotherapy, but a substantial proportion are left with disability, and death can occur. Results from the International Guillain-Barre Syndrome Outcome Study suggest that geographical variations exist in Guillain-Barre syndrome, including insufficient access to immunotherapy in low-income countries. There is a need to provide improved access to treatment for all patients with Guillain-Barre syndrome, and to develop effective disease-modifying therapies that can limit the extent of nerve injury. Clinical trials are currently underway to investigate some of the potential therapeutic candidates, including complement inhibitors, which, together with emerging data from large international collaborative studies on the syndrome, will contribute substantially to understanding the many facets of this disease.	[Shahrizaila, Nortina] Univ Malaya, Fac Med, Dept Med, Neurol Unit, Kuala Lumpur 50603, Malaysia; [Lehmann, Helmar C.] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany; [Lehmann, Helmar C.] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan	Universiti Malaya; University of Cologne; University of Cologne; Chiba University	Shahrizaila, N (corresponding author), Univ Malaya, Fac Med, Dept Med, Neurol Unit, Kuala Lumpur 50603, Malaysia.	nortina@um.edu.my	Lehmann, Helmar C/G-4998-2016; SHAHRIZAILA, NORTINA/B-9402-2010	Lehmann, Helmar C/0000-0001-6205-2293; SHAHRIZAILA, NORTINA/0000-0003-0031-7692				Alberti P, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000741; ALDIN AN, 1982, BRAIN, V105, P481, DOI 10.1093/brain/105.3.481; Altmann P, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01737-0; Annane D, 1997, ANN NEUROL, V41, P298; [Anonymous], 1978, Ann Neurol, V3, P565; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Asbury AK, 1997, ANN NEUROL, V41, P287, DOI 10.1002/ana.410410302; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; Baker MG, 2012, EMERG INFECT DIS, V18, P226, DOI 10.3201/eid1802.111126; Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753; Benamer HTS, 2014, J NEUROL SCI, V343, P221, DOI 10.1016/j.jns.2014.05.065; Berciano J, 2017, J NEUROL, V264, P221, DOI 10.1007/s00415-016-8204-2; BICKERSTAFF ER, 1957, BRIT MED J, V1, P1384, DOI 10.1136/bmj.1.5032.1384; Brahmer JR, 2018, J ONCOL PRACT, V14, P247, DOI 10.1200/JOP.18.00005; BROSTOFF SW, 1977, NATURE, V268, P752, DOI 10.1038/268752a0; Buenz EJ, 2017, THER ADV NEUROL DISO, V10, P76, DOI 10.1177/1756285616659978; Camdessanche JP, 2020, REV NEUROL-FRANCE, V176, P516, DOI 10.1016/j.neurol.2020.04.003; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Capasso A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007622; Chen X, 2019, CLIN NEUROPHYSIOL, V130, P1440, DOI 10.1016/j.clinph.2019.03.035; Chen Y, 2020, EUR J EPIDEMIOL, V35, P363, DOI 10.1007/s10654-019-00596-1; Cheng Q, 2002, J NEUROL, V249, P25, DOI 10.1007/PL00007844; CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911; Doets AY, 2018, BRAIN, V141, P2866, DOI 10.1093/brain/awy232; FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115; Fokkink WJR, 2017, JAMA NEUROL, V74, P189, DOI 10.1001/jamaneurol.2016.4480; Gabriel CM, 1998, BRAIN, V121, P1895, DOI 10.1093/brain/121.10.1895; Gallardo E, 2015, CLIN NEUROPHYSIOL, V126, P810, DOI 10.1016/j.clinph.2014.06.051; Goodfellow JA, 2005, J NEUROSCI, V25, P1620, DOI 10.1523/JNEUROSCI.4279-04.2005; Gordon PH, 2001, ARCH NEUROL-CHICAGO, V58, P913, DOI 10.1001/archneur.58.6.913; Gorson KC, 1996, NEUROLOGY, V47, P813, DOI 10.1212/WNL.47.3.813; Grimm A, 2019, NEUROTHERAPEUTICS, V16, P838, DOI 10.1007/s13311-019-00716-5; Gutierrez-Ortiz C, 2020, NEUROLOGY, V95, pE601, DOI 10.1212/WNL.0000000000009619; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414; HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512; Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316; Hao YL, 2019, ANN CLIN TRANSL NEUR, V6, P2510, DOI 10.1002/acn3.50946; HEMACHUDHA T, 1987, NEUROLOGY, V37, P550, DOI 10.1212/WNL.37.4.550; HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597; Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6; Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6; Hughes RAC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001446.pub4; ILLA I, 1995, ANN NEUROL, V38, P218, DOI 10.1002/ana.410380214; Ishaque T, 2017, J PERIPHER NERV SYST, V22, P121, DOI 10.1111/jns.12215; Islam B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022862; Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735; Islam Z, 2019, ANN CLIN TRANSL NEUR, V6, P324, DOI 10.1002/acn3.706; Islam Z, 2011, EMERG INFECT DIS, V17, P1317, DOI [10.3201/eid1707.101999, 10.3201/eid1707.102031]; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kaida K, 2007, J NEUROIMMUNOL, V182, P212, DOI 10.1016/j.jneuroim.2006.09.013; Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222; Kao JC, 2017, JAMA NEUROL, V74, P1216, DOI 10.1001/jamaneurol.2017.1912; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Kokubun N, 2013, CLIN NEUROPHYSIOL, V124, P1671, DOI 10.1016/j.clinph.2013.02.010; Kokubun N, 2010, BRAIN, V133, P2897, DOI 10.1093/brain/awq260; Korinthenberg R, 2020, EUR J PAEDIATR NEURO, V25, P5, DOI 10.1016/j.ejpn.2020.01.003; Korinthenberg R, 2005, PEDIATRICS, V116, P8, DOI 10.1542/peds.2004-1324; Kuitwaard K, 2009, J PERIPHER NERV SYST, V14, P310, DOI 10.1111/j.1529-8027.2009.00243.x; Kuitwaard K, 2009, ANN NEUROL, V66, P597, DOI 10.1002/ana.21737; Kusunoki S, 2001, NEUROLOGY, V57, P736, DOI 10.1212/WNL.57.4.736; Kuwabara S, 2004, NEUROLOGY, V63, P529, DOI 10.1212/01.WNL.0000133205.05169.04; Kuwabara S, 1998, ANN NEUROL, V44, P202, DOI 10.1002/ana.410440210; Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1; Kuwahara M, 2017, J NEUROL, V264, P467, DOI 10.1007/s00415-016-8371-1; Kuwahara M, 2011, J NEUROIMMUNOL, V239, P87, DOI 10.1016/j.jneuroim.2011.08.016; Kwong JC, 2013, LANCET INFECT DIS, V13, P769, DOI 10.1016/S1473-3099(13)70104-X; Lehmann HC, 2007, J NEUROSCI, V27, P27, DOI 10.1523/JNEUROSCI.4017-06.2007; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Leonhard SE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008264; Leonhard SE, 2019, NAT REV NEUROL, V15, P671, DOI 10.1038/s41582-019-0250-9; Leung J, 2020, NEUROL SCI, V41, P885, DOI 10.1007/s10072-019-04156-z; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Lopez PH, 2010, J NEUROSCI, V30, P9533, DOI 10.1523/JNEUROSCI.2281-10.2010; Lopez PHH, 2008, BRAIN, V131, P1926, DOI 10.1093/brain/awn074; Matsui N, 2018, EUR J NEUROL, V25, P718, DOI 10.1111/ene.13569; Mausberg AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026280; McGonigal R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0291-x; McGonigal R, 2010, BRAIN, V133, P1944, DOI 10.1093/brain/awq119; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P; Misawa S, 2018, LANCET NEUROL, V17, P519, DOI 10.1016/S1474-4422(18)30114-5; Ng JKM, 2012, NEUROLOGY, V79, P2241, DOI 10.1212/WNL.0b013e31827689ad; Padroni M, 2020, J NEUROL, V267, P1877, DOI 10.1007/s00415-020-09849-6; Rajabally YA, 2015, J NEUROL NEUROSUR PS, V86, P115, DOI 10.1136/jnnp-2014-307815; Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2; Razali SNO, 2016, CLIN NEUROPHYSIOL, V127, P1652, DOI 10.1016/j.clinph.2015.06.030; REES JH, 1995, NEW ENGL J MED, V333, P1374, DOI 10.1056/NEJM199511233332102; Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62; Roodbol J, 2014, J PERIPHER NERV SYST, V19, P121, DOI 10.1111/jns5.12068; ROPPER AH, 1986, ARCH NEUROL-CHICAGO, V43, P1150, DOI 10.1001/archneur.1986.00520110044012; Rose NR, 2000, CELL MOL LIFE SCI, V57, P542, DOI 10.1007/PL00000716; Ruts L, 2010, NEUROLOGY, V74, P1680, DOI 10.1212/WNL.0b013e3181e07d14; Ryan MM, 2013, CURR OPIN PEDIATR, V25, P689, DOI 10.1097/MOP.0b013e328365ad3f; SAIDA T, 1979, SCIENCE, V204, P1103, DOI 10.1126/science.451555; Saito K, 2013, J NEUROL NEUROSUR PS, V84, P756, DOI 10.1136/jnnp-2012-304306; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; Samukawa M, 2014, J NEUROL SCI, V337, P55, DOI 10.1016/j.jns.2013.11.016; Sauteur PMM, 2016, ANN NEUROL, V80, P566, DOI 10.1002/ana.24755; Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sedaghat Z, 2020, J CLIN NEUROSCI, V76, P233, DOI 10.1016/j.jocn.2020.04.062; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Shahrizaila N, 2014, NEUROLOGY, V83, P118, DOI 10.1212/WNL.0000000000000577; Shahrizaila N, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/829129; Shang P, 2021, J NEUROL, V268, P2402, DOI 10.1007/s00415-020-09742-2; Spain L, 2017, ANN ONCOL, V28, P377, DOI 10.1093/annonc/mdw558; Susuki K, 2002, J NEUROL SCI, V195, P145, DOI 10.1016/S0022-510X(02)00005-9; Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007; Takahashi R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10809; Tan CY, 2020, CLIN NEUROPHYSIOL, V131, P63, DOI 10.1016/j.clinph.2019.09.025; Tan CY, 2019, J PERIPHER NERV SYST, V24, P168, DOI 10.1111/jns.12320; Tan CY, 2019, J NEUROL NEUROSUR PS, V90, P1298, DOI 10.1136/jnnp-2019-320756; Tharakan J, 1990, J Assoc Physicians India, V38, P550; Toscano G, 2020, NEW ENGL J MED, V382, P2574, DOI 10.1056/NEJMc2009191; Uncini A, 2018, CLIN NEUROPHYSIOL, V129, P2586, DOI 10.1016/j.clinph.2018.09.025; Uncini A, 2017, CLIN NEUROPHYSIOL, V128, P1176, DOI 10.1016/j.clinph.2017.03.048; Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310; van den Berg B, 2014, NEUROLOGY, V82, P491, DOI 10.1212/WNL.0000000000000111; van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc; van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X; Verboon C, 2020, J NEUROL NEUROSUR PS, V91, P113, DOI 10.1136/jnnp-2019-321496; Verboon C, 2019, NEUROLOGY, V93, pE59, DOI 10.1212/WNL.0000000000007719; Virani A., 2020, IDCASES, V20, DOI [10.1016/j.idcr.2020.e00771, DOI 10.1016/j.idcr.2020.e00771]; Vucic S, 2004, CLIN NEUROPHYSIOL, V115, P2329, DOI 10.1016/j.clinph.2004.05.009; Wachira VK, 2019, TROP MED INT HEALTH, V24, P132, DOI 10.1111/tmi.13181; Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138; WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213; Walgaard C, 2018, J PERIPHER NERV SYST, V23, P210, DOI 10.1111/jns.12286; Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976; Wang YZ, 2017, EXP NEUROL, V291, P134, DOI 10.1016/j.expneurol.2017.02.010; Wanschitz J, 2003, BRAIN, V126, P2034, DOI 10.1093/brain/awg207; Webb AJS, 2015, J NEUROL NEUROSUR PS, V86, P1196, DOI 10.1136/jnnp-2014-309056; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1; Wilson RAM, 2018, CLIN EXP IMMUNOL, V191, P133, DOI 10.1111/cei.13081; Yako K, 1999, J NEUROL SCI, V168, P85, DOI 10.1016/S0022-510X(99)00174-4; Yamagishi Y, 2017, J PERIPHER NERV SYST, V22, P433, DOI 10.1111/jns.12234; Yamana M, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000575; Yan WX, 2014, J NEUROIMMUNOL, V277, P13, DOI 10.1016/j.jneuroim.2014.09.012; Yuen Carlen, 2019, J Clin Neuromuscul Dis, V20, P194, DOI 10.1097/CND.0000000000000230; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101; YUKI N, 1991, LANCET, V337, P1109, DOI 10.1016/0140-6736(91)91767-O; Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; YUKI N, 1990, NEUROLOGY, V40, P1900, DOI 10.1212/WNL.40.12.1900; Zhang G, 2004, BRAIN, V127, P1085, DOI 10.1093/brain/awh127; Zhang G, 2017, ACTA NEUROPATHOL, V134, P321, DOI 10.1007/s00401-017-1730-x; Zhang G, 2016, EXP NEUROL, V282, P49, DOI 10.1016/j.expneurol.2016.05.020; Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067; Zhao H, 2020, LANCET NEUROL, V19, P383, DOI DOI 10.1016/S1474-4422(20)30109-5	152	98	97	16	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 27	2021	397	10280					1214	1228		10.1016/S0140-6736(21)00517-1	http://dx.doi.org/10.1016/S0140-6736(21)00517-1		MAR 2021	15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC7YE	33647239				2022-12-28	WOS:000633010800023
J	Wang, PF; Nair, MS; Liu, LH; Iketani, S; Luo, Y; Guo, YC; Wang, M; Yu, J; Zhang, BS; Kwong, PD; Graham, BS; Mascola, JR; Chang, JY; Yin, MT; Sobieszczyk, M; Kyratsous, CA; Shapiro, L; Sheng, ZZ; Huang, YX; Ho, DD				Wang, Pengfei; Nair, Manoj S.; Liu, Lihong; Iketani, Sho; Luo, Yang; Guo, Yicheng; Wang, Maple; Yu, Jian; Zhang, Baoshan; Kwong, Peter D.; Graham, Barney S.; Mascola, John R.; Chang, Jennifer Y.; Yin, Michael T.; Sobieszczyk, Magdalena; Kyratsous, Christos A.; Shapiro, Lawrence; Sheng, Zizhang; Huang, Yaoxing; Ho, David D.			Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7	NATURE			English	Article							RECEPTOR-BINDING DOMAIN; MUTATIONS	The COVID-19 pandemic has had widespread effects across the globe, and its causative agent, SARS-CoV-2, continues to spread. Effective interventions need to be developed to end this pandemic. Single and combination therapies with monoclonal antibodies have received emergency use authorization(1-3), and more treatments are under development(4-7). Furthermore, multiple vaccine constructs have shown promise(8), including two that have an approximately 95% protective efficacy against COVID-19(9,10). However, these interventions were directed against the initial SARS-CoV-2 virus that emerged in 2019. The recent detection of SARS-CoV-2 variants B.1.1.7 in the UK11 and B.1.351 in South Africa(12) is of concern because of their purported ease of transmission and extensive mutations in the spike protein. Here we show that B.1.1.7 is refractory to neutralization by most monoclonal antibodies against the N-terminal domain of the spike protein and is relatively resistant to a few monoclonal antibodies against the receptor-binding domain. It is not more resistant to plasma from individuals who have recovered from COVID-19 or sera from individuals who have been vaccinated against SARS-CoV-2. The B.1.351 variant is not only refractory to neutralization by most monoclonal antibodies against the N-terminal domain but also by multiple individual monoclonal antibodies against the receptor-binding motif of the receptor-binding domain, which is mostly due to a mutation causing an E484K substitution. Moreover, compared to wild-type SARS-CoV-2, B.1.351 is markedly more resistant to neutralization by convalescent plasma (9.4-fold) and sera from individuals who have been vaccinated (10.3-12.4-fold). B.1.351 and emergent variants(13,14) with similar mutations in the spike protein present new challenges for monoclonal antibody therapies and threaten the protective efficacy of current vaccines.	[Wang, Pengfei; Nair, Manoj S.; Liu, Lihong; Iketani, Sho; Luo, Yang; Guo, Yicheng; Wang, Maple; Yu, Jian; Chang, Jennifer Y.; Yin, Michael T.; Sobieszczyk, Magdalena; Shapiro, Lawrence; Sheng, Zizhang; Huang, Yaoxing; Ho, David D.] Columbia Univ, Vagelos Coll Phys & Surg, Aaron Diamond AIDS Res Ctr, New York, NY 10027 USA; [Iketani, Sho; Ho, David D.] Columbia Univ, Irving Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA; [Zhang, Baoshan; Kwong, Peter D.; Graham, Barney S.; Mascola, John R.] NIH, Vaccine Res Ctr, Bldg 10, Bethesda, MD 20892 USA; [Kwong, Peter D.; Shapiro, Lawrence] Columbia Univ, Dept Biochem, New York, NY USA; [Yin, Michael T.; Sobieszczyk, Magdalena; Ho, David D.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Internal Med, Div Infect Dis, New York, NY 10027 USA; [Kyratsous, Christos A.] Regeneron Pharmaceut, Tarrytown, NY USA; [Shapiro, Lawrence] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY USA	Columbia University; Columbia University; NewYork-Presbyterian Hospital; National Institutes of Health (NIH) - USA; Columbia University; Columbia University; Regeneron; Columbia University	Huang, YX; Ho, DD (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Aaron Diamond AIDS Res Ctr, New York, NY 10027 USA.; Ho, DD (corresponding author), Columbia Univ, Irving Med Ctr, Dept Microbiol & Immunol, New York, NY 10027 USA.; Ho, DD (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, Dept Internal Med, Div Infect Dis, New York, NY 10027 USA.	yh3253@cumc.columbia.edu; dh2994@cumc.columbia.edu	liu, li/HGC-0900-2022; Sheng, Zizhang/AFR-8049-2022; Nair, Manoj/B-4389-2009	Sheng, Zizhang/0000-0002-3253-3309; Nair, Manoj/0000-0002-5994-3957; Chang, Jennifer/0000-0002-2152-5071; Guo, Yicheng/0000-0001-5357-660X; Wang, Pengfei/0000-0003-2454-7652; Iketani, Sho/0000-0002-3733-9556; Yin, Michael T/0000-0002-9346-9056	JPB Foundation; Brii Biosciences; Bill and Melinda Gates Foundation	JPB Foundation; Brii Biosciences; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank S. Goff and B. DeKosky for helpful discussions. This study was supported by funding from Andrew and Peggy Cherng, Samuel Yin, Barbara Picower and the JPB Foundation, Brii Biosciences, Roger and David Wu, and the Bill and Melinda Gates Foundation.	Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Banach BB, 2021, CELL REP, V37, DOI [10.1016/j.celrep.2021.109771, 10.1101/2020.12.31.424987]; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Callaway E, 2021, NATURE, V590, P17, DOI 10.1038/d41586-021-00268-9; Cele S., 2021, MEDRXIV, DOI [10.1101/2021.01.26.21250224, DOI 10.1101/2021.01.26.21250224]; Cerutti g, CELL HOST MICROBE; Cerutti Gabriele, 2021, bioRxiv, DOI [10.1016/j.str.2021.05.014, 10.1101/2021.02.21.432168]; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Collier Dami A, 2021, medRxiv, DOI 10.1101/2021.01.19.21249840; Faria N., 2021, GENOMIC CHARACTERISA, DOI 10.1093/cid/ciaa1864; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Jarvis, 2020, MEDRXIV, DOI [10.1126/science.abg3055, 10.1101/2020.12.24.20248822]; Jones Bryan E, 2020, bioRxiv, DOI 10.1101/2020.09.30.318972; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Liu HJ, 2020, IMMUNITY, V53, P1272, DOI 10.1016/j.immuni.2020.10.023; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; McCallum M, 2021, CELL, V184, P2332, DOI [10.1016/j.cell.2021.03.028, 10.1101/2021.01.14.426475]; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Naveca F., 2021, VIROLOGICAL, DOI DOI 10.5281/ZENODO.4780600; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rambaut A., 2020, COVID 19 GENOMICS CO; Rees-Spear, 2021, BIORXIV, DOI 10.1101/2021.01.15.426849; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Tada Takuya, 2021, bioRxiv, DOI 10.1101/2021.02.05.430003; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Wadman M., 2021, SCIENCE, V12, P277, DOI [10.1126/science.abg8101, DOI 10.1126/SCIENCE.ABG8101]; Wang PF, 2020, EMERG MICROBES INFEC, V9, P2091, DOI 10.1080/22221751.2020.1823890; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wu K., 2021, MRNA 1273 VACCINE IN, V73, P1946, DOI [10.1101/2021.01.25.427948, DOI 10.1101/2021.01.25.427948]; Xie XP, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01270-4, 10.1101/2021.01.27.427998]; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	46	1024	1041	1	18	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					130	+		10.1038/s41586-021-03398-2	http://dx.doi.org/10.1038/s41586-021-03398-2		MAR 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33684923	Green Published, Bronze			2022-12-28	WOS:000635574800001
J	Guo, MF; Guo, CQ; Han, J; Chen, SL; He, S; Tang, TX; Li, Q; Strzalka, J; Ma, J; Yi, S; Wang, K; Xu, B; Gao, P; Huang, HB; Chen, LQ; Zhang, SJ; Lin, YH; Nan, CW; Shen, Y				Guo, Mengfan; Guo, Changqing; Han, Jian; Chen, Shulin; He, Shan; Tang, Tongxiang; Li, Qian; Strzalka, Joseph; Ma, Jing; Yi, Di; Wang, Ke; Xu, Ben; Gao, Peng; Huang, Houbing; Chen, Long-Qing; Zhang, Shujun; Lin, Yuan-Hua; Nan, Ce-Wen; Shen, Yang			Toroidal polar topology in strained ferroelectric polymer	SCIENCE			English	Article								Polar topological texture has become an emerging research field for exotic phenomena and potential applications in reconfigurable electronic devices. We report toroidal topological texture self-organized in a ferroelectric polymer, poly(vinylidene fluoride-ran-trifluoroethylene) [P(VDF-TrFE)], that exhibits concentric topology with anticoupled chiral domains. The interplay among the elastic, electric, and gradient energies results in continuous rotation and toroidal assembly of the polarization perpendicular to polymer chains, whereas relaxor behavior is induced along polymer chains. Such toroidal polar topology gives rise to periodic absorption of polarized far-infrared (FIR) waves, enabling the manipulation of the terahertz wave on a mesoscopic scale. Our observations should inform design principles for flexible ferroic materials toward complex topologies and provide opportunities for multistimuli conversions in flexible electronics.	[Guo, Mengfan; Han, Jian; He, Shan; Tang, Tongxiang; Li, Qian; Ma, Jing; Yi, Di; Wang, Ke; Xu, Ben; Lin, Yuan-Hua; Nan, Ce-Wen; Shen, Yang] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China; [Guo, Changqing] Beijing Inst Technol, Sch Aerosp Engn, Beijing 100081, Peoples R China; [Chen, Shulin; Gao, Peng] Peking Univ, Sch Phys, Electron Microscopy Lab, Beijing 100871, Peoples R China; [Chen, Shulin; Gao, Peng] Peking Univ, Sch Phys, Int Ctr Quantum Mat, Beijing 100871, Peoples R China; [Li, Qian; Strzalka, Joseph] Argonne Natl Lab, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA; [Huang, Houbing] Beijing Inst Technol, Adv Res Inst Multidisciplinary Sci, Beijing 100081, Peoples R China; [Chen, Long-Qing] Penn State Univ, Dept Mat Sci & Engn, State Coll, PA 16802 USA; [Zhang, Shujun] Univ Wollongong, Inst Superconducting & Elect Mat, Australian Inst Innovat Mat, Wollongong, NSW 2500, Australia; [Shen, Yang] Tsinghua Univ, Ctr Flexible Elect Technol, Beijing 100084, Peoples R China	Tsinghua University; Beijing Institute of Technology; Peking University; Peking University; United States Department of Energy (DOE); Argonne National Laboratory; Beijing Institute of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of Wollongong; Tsinghua University	Nan, CW; Shen, Y (corresponding author), Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.; Shen, Y (corresponding author), Tsinghua Univ, Ctr Flexible Elect Technol, Beijing 100084, Peoples R China.	cwnan@mail.tsinghua.edu.cn; shyang_mse@mails.tsinghua.edu.cn	Zhang, Shujun/A-5259-2008; Gao, Peng/AAC-8550-2019; Wang, Ke/J-8050-2012; Chen, Shulin/AAO-1212-2021	Zhang, Shujun/0000-0001-6139-6887; Wang, Ke/0000-0001-9840-2427; Chen, Shulin/0000-0003-4396-3213; Li, Qian/0000-0001-7922-598X; Tang, Tongxiang/0000-0003-2673-3467; Guo, Changqing/0000-0001-6570-0962; Yi, Di/0000-0002-7209-1947; Ma, Jing/0000-0003-0103-9858; Strzalka, Joseph/0000-0003-4619-8932; Guo, Mengfan/0000-0003-2735-4397	Basic Science Centre Program of NSFC [51788104]; NSF of China [51625202]; National Key Research & Development Program [2017YFB0701603]; Hamer Foundation for the Hamer Professorship	Basic Science Centre Program of NSFC; NSF of China(National Natural Science Foundation of China (NSFC)); National Key Research & Development Program; Hamer Foundation for the Hamer Professorship	This work was supported by the Basic Science Centre Program of NSFC (grant no. 51788104), the NSF of China (grant no. 51625202), and the National Key Research & Development Program (grant no. 2017YFB0701603). L.-Q.C. knowledges support from the Hamer Foundation for the Hamer Professorship. S.	Bangsund JS, 2019, NAT MATER, V18, P725, DOI 10.1038/s41563-019-0379-3; BAUER S, 1993, SENSOR ACTUAT A-PHYS, V37-8, P497, DOI 10.1016/0924-4247(93)80085-U; Bellet-Amalric E, 1998, EUR PHYS J B, V3, P225, DOI 10.1007/s100510050307; Binnie TD, 2000, IEEE T ULTRASON FERR, V47, P1413, DOI 10.1109/58.883530; BOERIO FJ, 1971, J POLYM SCI A2, V9, P1517, DOI 10.1002/pol.1971.160090811; Buhlmann S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214120; Chen LQ, 2008, J AM CERAM SOC, V91, P1835, DOI 10.1111/j.1551-2916.2008.02413.x; Crist B, 2016, PROG POLYM SCI, V56, P1, DOI 10.1016/j.progpolymsci.2015.11.006; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; Damodaran AR, 2017, NAT MATER, V16, P1003, DOI [10.1038/nmat4951, 10.1038/NMAT4951]; Damodaran AR, 2014, ADV MATER, V26, P6341, DOI 10.1002/adma.201400254; Das S, 2019, NATURE, V568, P368, DOI 10.1038/s41586-019-1092-8; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708; Fu DW, 2013, SCIENCE, V339, P425, DOI [10.1126/science.1230473, 10.1126/science.1229675]; FURUKAWA T, 1989, PHASE TRANSIT, V18, P143, DOI 10.1080/01411598908206863; Gee RH, 2003, J CHEM PHYS, V118, P3827, DOI 10.1063/1.1532346; Guo MF, 2019, ADV SCI, V6, DOI 10.1002/advs.201801931; Hassani A, 2008, OPT EXPRESS, V16, P20206, DOI 10.1364/OE.16.020206; Hattori T, 1996, J APPL PHYS, V79, P2016, DOI 10.1063/1.361055; Horiuchi S, 2008, NAT MATER, V7, P357, DOI 10.1038/nmat2137; Jiang Z, 2015, J APPL CRYSTALLOGR, V48, P917, DOI 10.1107/S1600576715004434; Jiang Z, 2012, J SYNCHROTRON RADIAT, V19, P627, DOI 10.1107/S0909049512022017; Jung HJ, 2009, MACROMOLECULES, V42, P4148, DOI 10.1021/ma900422n; KOBAYASHI M, 1975, MACROMOLECULES, V8, P158, DOI 10.1021/ma60044a013; Koenig S, 2013, NAT PHOTONICS, V7, P977, DOI [10.1038/NPHOTON.2013.275, 10.1038/nphoton.2013.275]; Lee JS, 2010, POLYMER, V51, P6319, DOI 10.1016/j.polymer.2010.10.053; Lee M, 2002, SCIENCE, V298, P1401, DOI 10.1126/science.1077446; Li SQ, 2019, SCIENCE, V364, P1087, DOI 10.1126/science.aaw6747; Liu Y, 2020, NAT MATER, V19, P1169, DOI 10.1038/s41563-020-0724-6; Liu Y, 2019, MACROMOLECULES, V52, P6741, DOI 10.1021/acs.macromol.9b01403; Liu Y, 2018, NATURE, V562, P96, DOI 10.1038/s41586-018-0550-z; LOVINGER AJ, 1983, POLYMER, V24, P1225, DOI 10.1016/0032-3861(83)90050-2; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; MEYER RB, 1975, J PHYS LETT-PARIS, V36, pL69, DOI 10.1051/jphyslet:0197500360306900; Millis AJ, 1998, NATURE, V392, P147, DOI 10.1038/32348; Mosk AP, 2012, NAT PHOTONICS, V6, P283, DOI [10.1038/NPHOTON.2012.88, 10.1038/nphoton.2012.88]; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Nan CW, 2008, J APPL PHYS, V103, DOI 10.1063/1.2836410; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Neese B, 2008, SCIENCE, V321, P821, DOI 10.1126/science.1159655; Nurkhamidah S, 2013, MACROMOL CHEM PHYS, V214, P673, DOI 10.1002/macp.201200673; Park YJ, 2008, MACROMOLECULES, V41, P8648, DOI 10.1021/ma801495k; Park YJ, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207831; Petzelt J, 2013, PHYS STATUS SOLIDI A, V210, P2259, DOI 10.1002/pssa.201329288; Poudel P, 2018, MACROMOLECULES, V51, P6119, DOI 10.1021/acs.macromol.8b01366; Prosandeev S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195111; Ramesh R, 2007, NAT MATER, V6, P21, DOI 10.1038/nmat1805; Schmid H, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434201; Serghei A, 2008, MACROMOLECULES, V41, P3636, DOI 10.1021/ma702381t; Serghei A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2839021; Shi PP, 2016, CHEM SOC REV, V45, P3811, DOI 10.1039/c5cs00308c; Shtukenberg AG, 2014, ANGEW CHEM INT EDIT, V53, P672, DOI 10.1002/anie.201301223; TAJITSU Y, 1987, JPN J APPL PHYS 1, V26, P1749, DOI 10.1143/JJAP.26.1749; Tang YL, 2015, SCIENCE, V348, P547, DOI 10.1126/science.1259869; TASHIRO K, 1984, FERROELECTRICS, V57, P297, DOI 10.1080/00150198408012770; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tokura Y, 1999, J MAGN MAGN MATER, V200, P1, DOI 10.1016/S0304-8853(99)00352-2; Wang ZB, 2007, MACROMOLECULES, V40, P4381, DOI 10.1021/ma070334+; Woo EM, 2015, EUR POLYM J, V71, P27, DOI 10.1016/j.eurpolymj.2015.07.045; Wu YJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.267601; Yadav AK, 2016, NATURE, V530, P198, DOI 10.1038/nature16463; YAGI T, 1980, POLYM J, V12, P209, DOI 10.1295/polymj.12.209; Ye HY, 2018, SCIENCE, V361, P151, DOI 10.1126/science.aas9330; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101; Zhang ZB, 2017, MACROMOLECULES, V50, P9360, DOI 10.1021/acs.macromol.7b02243	67	33	32	69	367	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1050	+		10.1126/science.abc4727	http://dx.doi.org/10.1126/science.abc4727			63	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674493	Green Submitted			2022-12-28	WOS:000625876100055
J	Martin, LW				Martin, Lane W.			Whirls and swirls of polarization Exotic toroidal polarization textures in a polymer ferroelectric interact with terahertz radiation	SCIENCE			English	Editorial Material									[Martin, Lane W.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Martin, Lane W.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Martin, LW (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Martin, LW (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.	lwmartin@berkeley.edu	Martin, Lane W./H-2409-2011	Martin, Lane W./0000-0003-1889-2513	National Science Foundation [DMR-1708615]	National Science Foundation(National Science Foundation (NSF))	L.W.M.acknowledges support from the National Science Foundation under grant DMR-1708615.	Cowley RA, 2011, ADV PHYS, V60, P229, DOI 10.1080/00018732.2011.555385; Damodaran AR, 2017, NAT MATER, V16, P1003, DOI [10.1038/nmat4951, 10.1038/NMAT4951]; Das S, 2021, NAT MATER, V20, P194, DOI 10.1038/s41563-020-00818-y; Das S, 2019, NATURE, V568, P368, DOI 10.1038/s41586-019-1092-8; Fert A, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.31; Guo MF, 2021, SCIENCE, V371, P1050, DOI 10.1126/science.abc4727; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Schmid H, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/43/434201; Shafer P, 2018, P NATL ACAD SCI USA, V115, P915, DOI 10.1073/pnas.1711652115; Yadav AK, 2016, NATURE, V530, P198, DOI 10.1038/nature16463; Yadav AK, 2019, NATURE, V565, P468, DOI 10.1038/s41586-018-0855-y	12	0	0	7	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					992	993		10.1126/science.abg4477	http://dx.doi.org/10.1126/science.abg4477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674480	Green Published			2022-12-28	WOS:000625876100033
J	Song, Y; Zhou, Q; Qiao, JJ; Chen, JH				Song, Yan; Zhou, Qin; Qiao, Jianjun; Chen, Jianghua			A boy with purpura on the legs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HENOCH-SCHONLEIN PURPURA		[Song, Yan; Zhou, Qin; Chen, Jianghua] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou, Peoples R China; [Qiao, Jianjun] Zhejiang Univ, Affiliated Hosp 1, Dept Dermatol, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Chen, JH (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou, Peoples R China.	azjukidney@zju.edu.cn	Qiao, Jianjun/AAE-7199-2022					Berden A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e26; Davin JC, 2014, NAT REV NEPHROL, V10, P563, DOI 10.1038/nrneph.2014.126; Gonzalez-Gay MA, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0735-3; Hetland LE, 2017, ACTA DERM-VENEREOL, V97, P1160, DOI 10.2340/00015555-2733; Kazandjieva J, 2017, CLIN DERMATOL, V35, P68, DOI 10.1016/j.clindermatol.2016.09.013; Marzano AV, 2013, AUTOIMMUN REV, V12, P467, DOI 10.1016/j.autrev.2012.08.005; Ozen S, 2019, RHEUMATOLOGY, V58, P1607, DOI 10.1093/rheumatology/kez041; Ramos-Casals M, 2012, LANCET, V379, P348, DOI 10.1016/S0140-6736(11)60242-0; Xie FY, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4109	9	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n329	10.1136/bmj.n329	http://dx.doi.org/10.1136/bmj.n329			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664120				2022-12-28	WOS:000632920100007
J	Graf, JS; Schorn, S; Kitzinger, K; Ahmerkamp, S; Woehle, C; Huettel, B; Schubert, CJ; Kuypers, MMM; Milucka, J				Graf, Jon S.; Schorn, Sina; Kitzinger, Katharina; Ahmerkamp, Soeren; Woehle, Christian; Huettel, Bruno; Schubert, Carsten J.; Kuypers, Marcel M. M.; Milucka, Jana			Anaerobic endosymbiont generates energy for ciliate host by denitrification	NATURE			English	Article								Mitochondria are specialized eukaryotic organelles that have a dedicated function in oxygen respiration and energy production. They evolved about 2 billion years ago from a free-living bacterial ancestor (probably an alphaproteobacterium), in a process known as endosymbiosis(1,2). Many unicellular eukaryotes have since adapted to life in anoxic habitats and their mitochondria have undergone further reductive evolution(3). As a result, obligate anaerobic eukaryotes with mitochondrial remnants derive their energy mostly from fermentation4. Here we describe 'Candidatus Azoamicus ciliaticola', which is an obligate endosymbiont of an anaerobic ciliate and has a dedicated role in respiration and providing energy for its eukaryotic host. 'Candidatus A. ciliaticola' contains a highly reduced 0.29-Mb genome that encodes core genes for central information processing, the electron transport chain, a truncated tricarboxylic acid cycle, ATP generation and iron-sulfur cluster biosynthesis. The genome encodes a respiratory denitrification pathway instead of aerobic terminal oxidases, which enables its host to breathe nitrate instead of oxygen. 'Candidatus A. ciliaticola' and its ciliate host represent an example of a symbiosis that is based on the transfer of energy in the form of ATP, rather than nutrition. This discovery raises the possibility that eukaryotes with mitochondrial remnants may secondarily acquire energy-providing endosymbionts to complement or replace functions of their mitochondria.	[Graf, Jon S.; Schorn, Sina; Kitzinger, Katharina; Ahmerkamp, Soeren; Kuypers, Marcel M. M.; Milucka, Jana] Max Planck Inst Marine Microbiol, Bremen, Germany; [Kitzinger, Katharina] Univ Vienna, Ctr Microbiol & Environm Syst Sci, Div Microbial Ecol, Vienna, Austria; [Woehle, Christian; Huettel, Bruno] Max Planck Genome Ctr Cologne, Max Planck Inst Plant Breeding Res, Cologne, Germany; [Schubert, Carsten J.] Eawag, Surface Waters Res & Management, Kastanienbaum, Switzerland	Max Planck Society; University of Vienna; Max Planck Society; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Graf, JS; Milucka, J (corresponding author), Max Planck Inst Marine Microbiol, Bremen, Germany.	jgraf@mpi-bremen.de; jmilucka@mpi-bremen.de	Kitzinger, Katharina/AAW-5533-2020; Schubert, Carsten/GQQ-1673-2022	Kitzinger, Katharina/0000-0001-7382-7103; Woehle, Christian/0000-0002-1394-1024	Max Planck Gesellschaft; Eawag	Max Planck Gesellschaft(Max Planck Society); Eawag	We thank the Swiss Federal Institute of Aquatic Science and Technology (Eawag) for the use of its boat, housing and research facilities; A. Zwyssig, C. Dinkel and K. Beck for their help during field trips; V. Hubner, D. Tienken, N. Rujanski and G. Lavik for technical support; N. Lehnen, A. Gruhl and S. Littmann for support with microscopy; H. Marchant, B. Kartal and B. Barker Jorgensen for helpful discussions and comments on the manuscript; K. Koren for providing oxygen-sensitive nanoparticles; and L. van Niftrik and R. Mesman for their effort in preparing samples for TEM. This study was financially supported by the Max Planck Gesellschaft and internal funds of Eawag.	[Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boscaro V, 2018, ENVIRON MICROBIOL, V20, P2218, DOI 10.1111/1462-2920.14264; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; CAVALIERSMITH T, 1987, NATURE, V326, P332, DOI 10.1038/326332a0; Chen JW, 2013, BBA-BIOENERGETICS, V1827, P136, DOI 10.1016/j.bbabio.2012.10.002; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Diepenbroek M, INFORM 2014 BIG DATA; Dopheide A, 2008, APPL ENVIRON MICROB, V74, P1740, DOI 10.1128/AEM.01438-07; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elbourne LDH, 2017, NUCLEIC ACIDS RES, V45, pD320, DOI 10.1093/nar/gkw1068; EMBLEY TM, 1995, P ROY SOC B-BIOL SCI, V262, P87, DOI 10.1098/rspb.1995.0180; Eme L, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016139; Fan L, 2020, NAT ECOL EVOL, V4, P1213, DOI 10.1038/s41559-020-1239-x; FINLAY BJ, 1983, NATURE, V303, P333, DOI 10.1038/303333a0; Foissner W, 2014, INT J SYST EVOL MICR, V64, P271, DOI 10.1099/ijs.0.057893-0; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gawryluk RMR, 2016, CURR BIOL, V26, P2729, DOI 10.1016/j.cub.2016.08.025; Glock N, 2019, P NATL ACAD SCI USA, V116, P2860, DOI 10.1073/pnas.1813887116; Glockner FO, 1996, SYST APPL MICROBIOL, V19, P403; Gong J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00498; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Graf JS, 2018, ENVIRON MICROBIOL, V20, P2598, DOI 10.1111/1462-2920.14285; Gray MW, 2015, P NATL ACAD SCI USA, V112, P10133, DOI 10.1073/pnas.1421379112; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Grosser K, 2018, GENOME BIOL EVOL, V10, P646, DOI 10.1093/gbe/evy024; Gruber-Vodicka HR, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00920-20; Hjort K, 2010, PHILOS T R SOC B, V365, P713, DOI 10.1098/rstb.2009.0224; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Karnkowska A, 2016, CURR BIOL, V26, P1274, DOI 10.1016/j.cub.2016.03.053; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kobayashi M, 1996, J BIOL CHEM, V271, P16263, DOI 10.1074/jbc.271.27.16263; Kuypers MMM, 2018, NAT REV MICROBIOL, V16, P263, DOI 10.1038/nrmicro.2018.9; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lewis WH, 2020, MOL BIOL EVOL, V37, P524, DOI 10.1093/molbev/msz239; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Magoc T, 2013, EVOL BIOINFORM, V9, DOI 10.4137/EBO.S11250; Major P, 2017, GENOME BIOL EVOL, V9, P480, DOI 10.1093/gbe/evx015; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Mendel RR, 2013, J BIOL CHEM, V288, P13165, DOI 10.1074/jbc.R113.455311; Moran NA, 2014, ANNU REV MICROBIOL, V68, P195, DOI 10.1146/annurev-micro-091213-112901; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02525-w; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; SAGAN L, 1967, J THEOR BIOL, V14, P225, DOI 10.1016/0022-5193(67)90079-3; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Salem H, 2017, CELL, V171, P1520, DOI 10.1016/j.cell.2017.10.029; SCHLIWA M, 1981, J CELL BIOL, V90, P222, DOI 10.1083/jcb.90.1.222; Schneider RE, 2011, INT J PARASITOL, V41, P1421, DOI 10.1016/j.ijpara.2011.10.001; Schramm A, 2002, ENVIRON MICROBIOL, V4, P713, DOI 10.1046/j.1462-2920.2002.00364.x; Schweikert M., PROKARYOTES PROKARYO; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; SHOUN H, 1991, J BIOL CHEM, V266, P11078; Stairs CW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0326; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Trentmann O, 2000, EUR J BIOCHEM, V267, P4098, DOI 10.1046/j.1432-1033.2000.01468.x; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wideman JG, 2020, NAT MICROBIOL, V5, P154, DOI 10.1038/s41564-019-0605-4; Woehle C, 2018, CURR BIOL, V28, P2536, DOI 10.1016/j.cub.2018.06.027; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	86	21	21	13	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					445	+		10.1038/s41586-021-03297-6	http://dx.doi.org/10.1038/s41586-021-03297-6		MAR 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33658719	Green Published, hybrid			2022-12-28	WOS:000625125200007
J	Moshe, M; Daunt, A; Flower, B; Simmons, B; Brown, JC; Frise, R; Penn, R; Kugathasan, R; Petersen, C; Stockmann, H; Ashby, D; Riley, S; Atchison, C; Taylor, GP; Satkunarajah, S; Naar, L; Klaber, R; Badhan, A; Rosadas, C; Marchesin, F; Fernandez, N; Sureda-Vives, M; Cheeseman, H; O'Hara, J; Shattock, R; Fontana, G; Pallett, SJC; Rayment, M; Jones, R; Moore, LSP; Ashrafian, H; Cherapanov, P; Tedder, R; McClure, M; Ward, H; Darzi, A; Elliott, P; Cooke, GS; Barclay, WS				Moshe, Maya; Daunt, Anna; Flower, Barnaby; Simmons, Bryony; Brown, Jonathan C.; Frise, Rebecca; Penn, Rebecca; Kugathasan, Ruthiran; Petersen, Claire; Stockmann, Helen; Ashby, Deborah; Riley, Steven; Atchison, Christina; Taylor, Graham P.; Satkunarajah, Sutha; Naar, Lenny; Klaber, Robert; Badhan, Anjna; Rosadas, Carolina; Marchesin, Federica; Fernandez, Natalia; Sureda-Vives, Macia; Cheeseman, Hannah; O'Hara, Jessica; Shattock, Robin; Fontana, Gianluca; Pallett, Scott J. C.; Rayment, Michael; Jones, Rachael; Moore, Luke S. P.; Ashrafian, Hutan; Cherapanov, Peter; Tedder, Richard; McClure, Myra; Ward, Helen; Darzi, Ara; Elliott, Paul; Cooke, Graham S.; Barclay, Wendy S.		React Study Team	SARS- CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To evaluate the performance of new lateral flow immunoassays (LFIAs) suitable for use in a national coronavirus disease 2019 (covid-19) seroprevalence programme (real time assessment of community transmission 2-React 2). DESIGN Diagnostic accuracy study. SETTING Laboratory analyses were performed in the United Kingdom at Imperial College, London and university facilities in London. Research clinics for finger prick sampling were run in two affiliated NHS trusts. PARTICIPANTS Sensitivity analyses were performed on sera stored from 320 previous participants in the React 2 programme with confirmed previous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specificity analyses were performed on 1000 prepandemic serum samples. 100 new participants with confirmed previous SARS-CoV-2 infection attended study clinics for finger prick testing. INTERVENTIONS Laboratory sensitivity and specificity analyses were performed for seven LFIAs on a minimum of 200 serum samples from participants with confirmed SARS-CoV-2 infection and 500 prepandemic serum samples, respectively. Three LFIAs were found to have a laboratory sensitivity superior to the finger prick sensitivity of the LFIA currently used in React 2 seroprevalence studies (84%). These LFIAs were then further evaluated through finger prick testing on participants with confirmed previous SARS-CoV-2 infection: two LFIAs (Surescreen, Panbio) were evaluated in clinics in June-July 2020 and the third LFIA (AbC-19) in September 2020. A spike protein enzyme linked immunoassay and hybrid double antigen binding assay were used as laboratory reference standards. MAIN OUTCOME MEASURES The accuracy of LFIAs in detecting immunoglobulin G (IgG) antibodies to SARS-CoV-2 compared with two reference standards. RESULTS The sensitivity and specificity of seven new LFIAs that were analysed using sera varied from 69% to 100%, and from 98.6% to 100%, respectively (compared with the two reference standards). Sensitivity on finger prick testing was 77% (95% confidence interval 61.4% to 88.2%) for Panbio, 86% (72.7% to 94.8%) for Surescreen, and 69% (53.8% to 81.3%) for AbC-19 compared with the reference standards. Sensitivity for sera from matched clinical samples performed on AbC-19 was significantly higher with serum than finger prick at 92% (80.0% to 97.7%, P=0.01). Antibody titres varied considerably among cohorts. The numbers of positive samples identified by finger prick in the lowest antibody titre quarter varied among LFIAs. CONCLUSIONS One new LFIA was identified with clinical performance suitable for potential inclusion in seroprevalence studies. However, none of the LFIAs tested had clearly superior performance to the LFIA currently used in React 2 seroprevalence surveys, and none showed sufficient sensitivity and specificity to be considered for routine clinical use.	[Moshe, Maya; Daunt, Anna; Flower, Barnaby; Simmons, Bryony; Brown, Jonathan C.; Frise, Rebecca; Penn, Rebecca; Kugathasan, Ruthiran; Taylor, Graham P.; Badhan, Anjna; Rosadas, Carolina; Marchesin, Federica; Fernandez, Natalia; Cheeseman, Hannah; O'Hara, Jessica; Shattock, Robin; Moore, Luke S. P.; Cherapanov, Peter; Tedder, Richard; McClure, Myra; Cooke, Graham S.; Barclay, Wendy S.] Imperial Coll London, Sch Med, St Marys Hosp, Dept Infect Dis, Praed St, London W2 1NY, England; [Daunt, Anna; Flower, Barnaby; Petersen, Claire; Stockmann, Helen; Klaber, Robert; Elliott, Paul; Barclay, Wendy S.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London, England; [Ashby, Deborah; Riley, Steven; Atchison, Christina; Ward, Helen; Elliott, Paul] Imperial Coll London, Sch Publ Hlth, St Marys Hosp, London, England; [Satkunarajah, Sutha; Naar, Lenny; Fontana, Gianluca; Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, London, England; [Sureda-Vives, Macia] Imperial Coll London, London Inst Med Sci, Synthet Biol Grp, London, England; [Pallett, Scott J. C.; Rayment, Michael; Jones, Rachael; Moore, Luke S. P.] Chelsea & Westminster NHS Fdn Trust, London, England; [Pallett, Scott J. C.] Queen Elizabeth Hosp, Ctr Def Pathol, Royal Ctr Def Med, Birmingham, W Midlands, England; [Ashrafian, Hutan] Imperial Coll London, Dept Surg & Canc, London, England; [Cherapanov, Peter] Francis Crick Inst, Chromatin Struct & Mobile DNA Lab, London, England; [Elliott, Paul] Imperial Coll London, Hlth Protect Res Unit HPRU Chem & Radiat Threats, Natl Inst Hlth Res NIHR, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Royal Centre for Defence Medicine; University of Birmingham; Imperial College London; Francis Crick Institute; Imperial College London	Moshe, M (corresponding author), Imperial Coll London, Sch Med, St Marys Hosp, Dept Infect Dis, Praed St, London W2 1NY, England.	maya.moshe18@imperial.ac.uk	Ward, Helen/A-1836-2009; Moore, Luke S P/Q-1012-2018; Pallett, Scott/AAQ-4060-2021	Ward, Helen/0000-0001-8238-5036; Moore, Luke S P/0000-0001-7095-7922; Moshe, Maya/0000-0003-3451-3579; Pallett, Scott/0000-0002-9465-5299; Barclay, Wendy/0000-0002-3948-0895; Brown, Jonathan/0000-0001-6849-3962; O'Hara, Jessica/0000-0002-2858-7996; Simmons, Bryony/0000-0002-3207-9935; TRANVAN, Luyen/0000-0002-9456-336X				ATCHINSON C, 2020, USABILITY ACCEPTABIL; Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516; Batra R, 2020, J CLIN VIROL, V132, DOI 10.1016/j.jcv.2020.104645; Conklin ES, 2020, MEDRXIV; Cooke, MEDRXIV, DOI 10.26.20219725v1; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Elliott P, 2014, ENVIRON RES, V134, P280, DOI 10.1016/j.envres.2014.07.025; FIND, 2020, SARS COV 2 DIAGNOSTI; Jennings F, 2020, MEDRXIV; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MHRA, 2020, TARG PROD PROF ANT; Pickering S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008817; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Riley Steven, 2020, Wellcome Open Res, V5, P200, DOI 10.12688/wellcomeopenres.16228.1; Silveira MF, 2020, NAT MED, V26, P1196, DOI 10.1038/s41591-020-0992-3; Simmons B, 2020, CLIN LAB EVALUATION, DOI [10.1136/thoraxjnl-2020-215732, DOI 10.1136/THORAXJNL-2020-215732]; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Ward H, 2020, MEDRXIV, DOI [10.1101/2020.08.12.20173690v210.1101/2020.08.12, DOI 10.1101/2020.08.12.20173690V210.1101/2020.08.12]	18	25	25	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n423	10.1136/bmj.n423	http://dx.doi.org/10.1136/bmj.n423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653694	hybrid, Green Published			2022-12-28	WOS:000625340300004
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: UK officials try to trace unidentified case of Brazil variant	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n592	10.1136/bmj.n592	http://dx.doi.org/10.1136/bmj.n592			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33648934	Bronze			2022-12-28	WOS:000625342000004
J	Pagel, C; Palmer, E				Pagel, Christina; Palmer, Edward			"We are setting ourselves on fire to keep everyone else warm"-what does the recovery look like for NHS staff?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pagel, Christina] UCL, Clin Operat Res Unit, London, England; [Palmer, Edward] UCL, Bloomsbury Inst Intens Care Med, London, England	University of London; University College London; University of London; University College London	Pagel, C (corresponding author), UCL, Clin Operat Res Unit, London, England.	c.pagel@ucl.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n569	10.1136/bmj.n569	http://dx.doi.org/10.1136/bmj.n569			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33648948	Bronze, Green Submitted			2022-12-28	WOS:000625342000009
J	Angus, DC; Gordon, AC; Bauchner, H				Angus, Derek C.; Gordon, Anthony C.; Bauchner, Howard			Emerging Lessons From COVID-19 for the US Clinical Research Enterprise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Angus, Derek C.] UPMC, 3550 Terrace St,614 Scaife Hall, Pittsburgh, PA 15261 USA; [Angus, Derek C.] Univ Pittsburgh, Sch Hlth Sci, 3550 Terrace St,614 Scaife Hall, Pittsburgh, PA 15261 USA; [Gordon, Anthony C.] Imperial Coll London, Div Anaesthet Pain Med & Intens, London, England; [Gordon, Anthony C.] St Marys Hosp, Intens Care Unit, London, England; [Bauchner, Howard] JAMA, Chicago, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Imperial College London; Imperial College London	Angus, DC (corresponding author), UPMC, 3550 Terrace St,614 Scaife Hall, Pittsburgh, PA 15261 USA.; Angus, DC (corresponding author), Univ Pittsburgh, Sch Hlth Sci, 3550 Terrace St,614 Scaife Hall, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Gordon, Anthony/A-3472-2012	Gordon, Anthony/0000-0002-0419-547X	Department of Health [RP-2015-06-018] Funding Source: Medline	Department of Health		Angus DC, 2020, JAMA-J AM MED ASSOC, V323, P1895, DOI 10.1001/jama.2020.4984; Collins FS, 2020, JAMA-J AM MED ASSOC, V323, P2455, DOI 10.1001/jama.2020.8920; Janiaud P, 2021, JAMA-J AM MED ASSOC, V325, P1185, DOI 10.1001/jama.2021.2747; National Health Service, NOV COR CLIN TRIALS; Sharfstein JM, 2021, JAMA-J AM MED ASSOC, V325, P1153, DOI 10.1001/jama.2021.1961; Worldometer, REP CAS DEATHS COUNT	6	32	30	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2021	325	12					1159	1161		10.1001/jama.2021.3284	http://dx.doi.org/10.1001/jama.2021.3284		FEB 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7PB	33635309	Bronze			2022-12-28	WOS:000621913000001
J	Mali, GR; Ali, FA; Lau, CK; Begum, F; Boulanger, J; Howe, JD; Chen, ZA; Rappsilber, J; Skehel, M; Carter, AP				Mali, Girish R.; Ali, Ferdos Abid; Lau, Clinton K.; Begum, Farida; Boulanger, Jerome; Howe, Jonathan D.; Chen, Zhuo A.; Rappsilber, Juri; Skehel, Mark; Carter, Andrew P.			Shulin packages axonemal outer dynein arms for ciliary targeting	SCIENCE			English	Article								The main force generators in eukaryotic cilia and flagella are axonemal outer dynein arms (ODAs). During ciliogenesis, these similar to 1.8-megadalton complexes are assembled in the cytoplasm and targeted to cilia by an unknown mechanism. Here, we used the ciliate Tetrahymena to identify two factors (Q22YU3 and Q22MS1) that bind ODAs in the cytoplasm and are required for ODA delivery to cilia. Q22YU3, which we named Shulin, locked the ODA motor domains into a closed conformation and inhibited motor activity. Cryo-electron microscopy revealed how Shulin stabilized this compact form of ODAs by binding to the dynein tails. Our findings provide a molecular explanation for how newly assembled dyneins are packaged for delivery to the cilia.	[Mali, Girish R.; Ali, Ferdos Abid; Lau, Clinton K.; Begum, Farida; Boulanger, Jerome; Howe, Jonathan D.; Skehel, Mark; Carter, Andrew P.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Chen, Zhuo A.; Rappsilber, Juri] Tech Univ Berlin, Inst Biotechnol, Bioanalyt, D-13355 Berlin, Germany; [Rappsilber, Juri] Univ Edinburgh, Wellcome Ctr Cell Biol, Edinburgh EH9 3BF, Midlothian, Scotland	MRC Laboratory Molecular Biology; Technical University of Berlin; University of Edinburgh	Carter, AP (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	cartera@mrc-lmb.cam.ac.uk	Rappsilber, Juri/B-7265-2015	Rappsilber, Juri/0000-0001-5999-1310; Boulanger, Jerome/0000-0003-0237-3743; Skehel, Mark/0000-0002-2432-0901; Howe, Jonathan/0000-0001-7941-2486; Lau, Clinton/0000-0003-1083-2989; Mali, Girish Ram/0000-0002-5551-7555	Medical Research Council, UK [MRC_UP_A025_1011]; Wellcome Trust [WT210711, 218653/Z/19/Z, 103139]; Deutsche Forschungsgemeinschaft [EXC 2008/1-390540038, 426290502]	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Medical Research Council, UK (MRC_UP_A025_1011) and Wellcome Trust (WT210711) to A.P.C., Wellcome Trust (218653/Z/19/Z) to F.A.A. and by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy-EXC 2008/1-390540038, project no. 426290502 and Wellcome Trust (103139) to J.R.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Alkanderi S, 2018, AM J HUM GENET, V103, P612, DOI 10.1016/j.ajhg.2018.08.015; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; ATTWELL GJ, 1992, J PROTOZOOL, V39, P261, DOI 10.1111/j.1550-7408.1992.tb01312.x; Chalker DL, 2012, METHOD CELL BIOL, V109, P327, DOI 10.1016/B978-0-12-385967-9.00011-6; Cuvillier A, 2000, J CELL SCI, V113, P2065; Dai J, 2018, MOL BIOL CELL, V29, P2553, DOI 10.1091/mbc.E18-05-0291; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer L, 2017, ANAL CHEM, V89, P3829, DOI 10.1021/acs.analchem.6b03745; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; GOODENOUGH U, 1984, J MOL BIOL, V180, P1083, DOI 10.1016/0022-2836(84)90272-9; GOODENOUGH UW, 1985, CELL, V41, P341, DOI 10.1016/S0092-8674(85)80003-9; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; King SM, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028100; Kubo S, 2020, REMODELING ACTIVATIO, DOI [10.1101/2020.11.30.404319, DOI 10.1101/2020.11.30.404319]; Lee C., 2020, CELL BIOL HENDERSON, DOI [10.1101/2020.04.21.052837, DOI 10.1101/2020.04.21.052837]; Lee C., 2020, CELL BIOL HENDERSON; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Leitner A, 2013, CELL, V154, P252, DOI 10.1016/j.cell.2013.06.025; Lin JF, 2018, SCIENCE, V360, DOI 10.1126/science.aar1968; Liu Y, 2020, NATURE, V577, P426, DOI 10.1038/s41586-019-1820-0; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mendes ML, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20198994; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pantelic RS, 2010, J STRUCT BIOL, V170, P152, DOI 10.1016/j.jsb.2009.12.020; PENQUE D, 1991, EUR J BIOCHEM, V195, P487, DOI 10.1111/j.1432-1033.1991.tb15729.x; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PORTER ME, 1983, J BIOL CHEM, V258, P6575; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; ROSENBAUM JL, 1969, J CELL BIOL, V40, P415, DOI 10.1083/jcb.40.2.415; SAKAKIBARA H, 1991, J CELL BIOL, V113, P615, DOI 10.1083/jcb.113.3.615; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Schmidt H, 2015, NATURE, V518, P435, DOI 10.1038/nature14023; Smith Claire M, 2012, Cilia, V1, P14, DOI 10.1186/2046-2530-1-14; Sydor AM, 2013, BIOCHEMISTRY-US, V52, P1788, DOI 10.1021/bi301600z; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Toropova K, 2019, NAT STRUCT MOL BIOL, V26, P823, DOI 10.1038/s41594-019-0286-y; VALE RD, 1988, CELL, V52, P459, DOI 10.1016/S0092-8674(88)80038-2; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x; Wilkes DE, 2007, CELL MOTIL CYTOSKEL, V64, P82, DOI 10.1002/cm.20165; Williams NE, 2006, EUKARYOT CELL, V5, P555, DOI 10.1128/EC.5.3.555-567.2006; Wood CR, 2007, J CELL SCI, V120, P3075, DOI 10.1242/jcs.007369; Wright KJ, 2011, GENE DEV, V25, P2347, DOI 10.1101/gad.173443.111; Zhang K, 2017, CELL, V169, P1303, DOI 10.1016/j.cell.2017.05.025; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X	58	12	12	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					910	+		10.1126/science.abe0526	http://dx.doi.org/10.1126/science.abe0526			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632841	Green Submitted, Green Accepted			2022-12-28	WOS:000621813400052
J	Solomon, S				Solomon, Susan			Paul J. Crutzen (1933-2021) Father of modern atmospheric chemistry	SCIENCE			English	Biographical-Item									[Solomon, Susan] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Solomon, S (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	solos@mit.edu						CRUTZEN PJ, PUBLICATION LIST	1	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					892	892		10.1126/science.abh0217	http://dx.doi.org/10.1126/science.abh0217			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632836				2022-12-28	WOS:000621813400027
J	Dove, J; Kerns, B; McClellan, RE; Miyasaka, S; Morton, DH; Nagai, K; Prasad, S; Sanftl, F; Scott, MBC; Tadepalli, AS; Aidala, CA; Arrington, J; Ayuso, C; Barker, CL; Brown, CN; Chang, WC; Chen, A; Christian, DC; Dannowitz, BP; Daugherity, M; Diefenthaler, M; El Fassi, L; Geesaman, DF; Gilman, R; Goto, Y; Guo, L; Guo, R; Hague, TJ; Holt, RJ; Isenhower, D; Kinney, ER; Kitts, N; Klein, A; Kleinjan, DW; Kudo, Y; Leung, C; Lin, PJ; Liu, K; Liu, MX; Lorenzon, W; Makins, NCR; de Medeiros, MM; McGaughey, PL; Miyachi, Y; Mooney, I; Nakahara, K; Nakano, K; Nara, S; Peng, JC; Puckett, AJ; Ramson, BJ; Reimer, PE; Rubin, JG; Sawada, S; Sawada, T; Shibata, TA; Su, D; Teo, M; Tice, BG; Towell, RS; Uemura, S; Watson, S; Wang, SG; Wickes, AB; Wu, J; Xi, Z; Ye, Z				Dove, J.; Kerns, B.; McClellan, R. E.; Miyasaka, S.; Morton, D. H.; Nagai, K.; Prasad, S.; Sanftl, F.; Scott, M. B. C.; Tadepalli, A. S.; Aidala, C. A.; Arrington, J.; Ayuso, C.; Barker, C. L.; Brown, C. N.; Chang, W. C.; Chen, A.; Christian, D. C.; Dannowitz, B. P.; Daugherity, M.; Diefenthaler, M.; El Fassi, L.; Geesaman, D. F.; Gilman, R.; Goto, Y.; Guo, L.; Guo, R.; Hague, T. J.; Holt, R. J.; Isenhower, D.; Kinney, E. R.; Kitts, N.; Klein, A.; Kleinjan, D. W.; Kudo, Y.; Leung, C.; Lin, P-J; Liu, K.; Liu, M. X.; Lorenzon, W.; Makins, N. C. R.; de Medeiros, M. Mesquita; McGaughey, P. L.; Miyachi, Y.; Mooney, I; Nakahara, K.; Nakano, K.; Nara, S.; Peng, J-C; Puckett, A. J.; Ramson, B. J.; Reimer, P. E.; Rubin, J. G.; Sawada, S.; Sawada, T.; Shibata, T-A; Su, D.; Teo, M.; Tice, B. G.; Towell, R. S.; Uemura, S.; Watson, S.; Wang, S. G.; Wickes, A. B.; Wu, J.; Xi, Z.; Ye, Z.			The asymmetry of antimatter in the proton	NATURE			English	Article							LIGHT-QUARK SEA; PARTON DISTRIBUTIONS; SYMMETRY-BREAKING; FLAVOR ASYMMETRY; NUCLEON; COLLISIONS; LEPTON	Quark-antiquark annihilation measurements provide a precise determination of the ratio of down and up antiquarks within protons as a function of momentum, which confirms the asymmetry between the abundance of down and up antiquarks. The fundamental building blocks of the proton-quarks and gluons-have been known for decades. However, we still have an incomplete theoretical and experimental understanding of how these particles and their dynamics give rise to the quantum bound state of the proton and its physical properties, such as its spin(1). The two up quarks and the single down quark that comprise the proton in the simplest picture account only for a few per cent of the proton mass, the bulk of which is in the form of quark kinetic and potential energy and gluon energy from the strong force(2). An essential feature of this force, as described by quantum chromodynamics, is its ability to create matter-antimatter quark pairs inside the proton that exist only for a very short time. Their fleeting existence makes the antimatter quarks within protons difficult to study, but their existence is discernible in reactions in which a matter-antimatter quark pair annihilates. In this picture of quark-antiquark creation by the strong force, the probability distributions as a function of momentum for the presence of up and down antimatter quarks should be nearly identical, given that their masses are very similar and small compared to the mass of the proton(3). Here we provide evidence from muon pair production measurements that these distributions are considerably different, with more abundant down antimatter quarks than up antimatter quarks over a wide range of momenta. These results are expected to revive interest in several proposed mechanisms for the origin of this antimatter asymmetry in the proton that had been disfavoured by previous results(4), and point to future measurements that can distinguish between these mechanisms.	[Dove, J.; Kerns, B.; McClellan, R. E.; Prasad, S.; Chen, A.; Dannowitz, B. P.; Diefenthaler, M.; Leung, C.; Makins, N. C. R.; Peng, J-C; Teo, M.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Miyasaka, S.; Nagai, K.; Sanftl, F.; Nakano, K.; Shibata, T-A] Tokyo Inst Technol, Sch Sci, Dept Phys, Tokyo, Japan; [Morton, D. H.; Scott, M. B. C.; Aidala, C. A.; Ayuso, C.; Chen, A.; Lorenzon, W.; Mooney, I; Ramson, B. J.; Rubin, J. G.; Sawada, T.] Univ Michigan, Randall Lab Phys, Ann Arbor, MI 48109 USA; [Nagai, K.; Chang, W. C.; Chen, A.; Su, D.; Wang, S. G.] Acad Sinica, Inst Phys, Taipei, Taiwan; [Tadepalli, A. S.; El Fassi, L.; Gilman, R.] State Univ New Jersey, Dept Phys & Astron, Rutgers, Piscataway, NJ USA; [Aidala, C. A.; Guo, L.; Klein, A.; Kleinjan, D. W.; Liu, K.; Liu, M. X.; McGaughey, P. L.; Puckett, A. J.; Uemura, S.; Wickes, A. B.] Los Alamos Natl Lab, Phys Div, Los Alamos, NM USA; [Arrington, J.; Geesaman, D. F.; Holt, R. J.; de Medeiros, M. Mesquita; Reimer, P. E.; Rubin, J. G.; Tice, B. G.; Ye, Z.] Argonne Natl Lab, Phys Div, Lemont, IL 60439 USA; [Barker, C. L.; Daugherity, M.; Hague, T. J.; Isenhower, D.; Kitts, N.; Towell, R. S.; Watson, S.; Xi, Z.] Abilene Christian Univ, Dept Engn & Phys, Abilene, TX USA; [Brown, C. N.] Fermilab Natl Accelerator Lab, Accelerator Div, Batavia, IL USA; [Christian, D. C.; Wu, J.] Fermilab Natl Accelerator Lab, Particle Phys Div, Batavia, IL USA; [El Fassi, L.] Mississippi State Univ, Dept Phys & Astron, Mississippi State, MS USA; [Goto, Y.; Nakano, K.] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama, Japan; [Guo, R.; Wang, S. G.] Natl Kaohsiung Normal Univ, Dept Phys, Kaohsiung, Taiwan; [Kinney, E. R.; Lin, P-J] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Kudo, Y.; Miyachi, Y.; Nara, S.] Yamagata Univ, Dept Phys, Yamagata, Japan; [Nakahara, K.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Sawada, S.] High Energy Accelerator Res Org, Inst Particle & Nucl Studies, KEK, Tsukuba, Ibaraki, Japan; [McClellan, R. E.; Tadepalli, A. S.; Diefenthaler, M.] Thomas Jefferson Natl Accelerator Facil, Expt Nucl Phys Div, Newport News, VA USA; [Arrington, J.] Lawrence Berkeley Natl Lab, Phys Div, Berkeley, CA USA; [Ayuso, C.] Mississippi State Univ, Dept Phys, Mississippi State, MS 39762 USA; [Geesaman, D. F.] GLobal Empire LLC, Lemont, IL USA; [Guo, L.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Holt, R. J.] CALTECH, Kellogg Radiat Lab, Pasadena, CA 91125 USA; [Mooney, I] Wayne State Univ, Dept Phys, Detroit, MI 48202 USA; [Nakahara, K.] Stanford Linear Accelerator Ctr, Menlo Pk, CA USA; [Puckett, A. J.] Univ Connecticut, Dept Phys, Storrs, CT USA; [Ramson, B. J.] Fermilab Natl Accelerator Lab, Neutrino Div, Batavia, IL USA; [Sawada, T.] Osaka City Univ, Dept Phys, Osaka, Japan; [Shibata, T-A] Nihon Univ, Coll Sci & Technol, Dept Phys, Tokyo, Japan; [Teo, M.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Uemura, S.] Tel Aviv Univ, Dept Phys, Tel Aviv, Israel; [Wang, S. G.] Argonne Natl Lab, Accelerator Syst Div, Lemont, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Tokyo Institute of Technology; University of Michigan System; University of Michigan; Academia Sinica - Taiwan; Rutgers State University New Brunswick; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Abilene Christian University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; Mississippi State University; RIKEN; National Kaohsiung Normal University; University of Colorado System; University of Colorado Boulder; Yamagata University; University System of Maryland; University of Maryland College Park; High Energy Accelerator Research Organization (KEK); United States Department of Energy (DOE); Jefferson National Accelerator; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Mississippi State University; State University System of Florida; Florida International University; California Institute of Technology; Wayne State University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Connecticut; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; Osaka Metropolitan University; Nihon University; Stanford University; Tel Aviv University; United States Department of Energy (DOE); Argonne National Laboratory	Reimer, PE (corresponding author), Argonne Natl Lab, Phys Div, Lemont, IL 60439 USA.	reimer@anl.gov	Chang, Wen-Chen/AAP-3897-2021; Ye, Zhihong/E-6651-2017; Reimer, Paul/E-2223-2013	Chang, Wen-Chen/0000-0002-1695-7830; Ye, Zhihong/0000-0002-1873-2344; Prasad, Shivangi/0000-0003-3404-0062; Sawada, Shinya/0000-0002-7122-1690; Lin, Po-Ju/0000-0001-7073-6839; Reimer, Paul/0000-0002-0301-2176; Hague, Tyler/0000-0003-1288-4045; Goto, Yuji/0000-0002-2973-7458; Leung, Ching Him/0000-0001-7907-3728				Ackerstaff K, 1998, PHYS REV LETT, V81, P5519, DOI 10.1103/PhysRevLett.81.5519; Agashe K, 2007, PHYS REV D, V76, DOI 10.1103/PhysRevD.76.115015; Aidala CA, 2019, NUCL INSTRUM METH A, V930, P49, DOI 10.1016/j.nima.2019.03.039; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberg M, 2019, PHYS REV C, V100, DOI 10.1103/PhysRevC.100.035205; Alberg M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.172001; AMAUDRUZ P, 1991, PHYS REV LETT, V66, P2712, DOI 10.1103/PhysRevLett.66.2712; ARNEODO M, 1994, PHYS REV D, V50, pR1, DOI 10.1103/PhysRevD.50.R1; BALDIT A, 1994, PHYS LETT B, V332, P244, DOI 10.1016/0370-2693(94)90884-2; Basso E, 2016, NUCL PHYS A, V948, P63, DOI 10.1016/j.nuclphysa.2016.02.001; Bourrely C, 2015, NUCL PHYS A, V941, P307, DOI 10.1016/j.nuclphysa.2015.06.018; Chang WC, 2014, PROG PART NUCL PHYS, V79, P95, DOI 10.1016/j.ppnp.2014.08.002; DRELL SD, 1970, PHYS REV LETT, V25, P316, DOI 10.1103/PhysRevLett.25.316; Dulat S, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.033006; Ehlers PJ, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.014010; FERMI E, 1947, PHYS REV, V72, P1139, DOI 10.1103/PhysRev.72.1139; FIELD RD, 1977, PHYS REV D, V15, P2590, DOI 10.1103/PhysRevD.15.2590; Geesaman DF, 2019, REP PROG PHYS, V82, DOI 10.1088/1361-6633/ab05a7; GLUCK M, 1977, NUCL PHYS B, V130, P76, DOI 10.1016/0550-3213(77)90393-5; Harland-Lang LA, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3397-6; Hou TJ, 2021, PHYS REV D, V103, DOI 10.1103/PhysRevD.103.014013; Ji XD, 2021, NAT REV PHYS, V3, P27, DOI 10.1038/s42254-020-00248-4; Kamano H, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.094037; Lai HL, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074024; Lin HW, 2018, PROG PART NUCL PHYS, V100, P107, DOI 10.1016/j.ppnp.2018.01.007; Londergan JT, 1998, PROG PART NUCL PHYS, V41, P49, DOI 10.1016/S0146-6410(98)00055-6; PARISI G, 1976, PHYS LETT B, V62, P331, DOI 10.1016/0370-2693(76)90088-5; Pobylitsa PV, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.034024; Pumplin J, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/07/012; ROSS DA, 1979, NUCL PHYS B, V149, P497, DOI 10.1016/0550-3213(79)90004-X; Sirunyan AM, 2019, PHYS LETT B, V792, P107, DOI 10.1016/j.physletb.2019.01.069; Steffens FM, 1997, PHYS REV C, V55, P900, DOI 10.1103/PhysRevC.55.900; THOMAS AW, 1983, PHYS LETT B, V126, P97, DOI 10.1016/0370-2693(83)90026-6; Towell RS, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.052002; Yang YB, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.212001	35	29	29	2	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03282-z	http://dx.doi.org/10.1038/s41586-021-03282-z			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627814	Green Submitted			2022-12-28	WOS:000621583600005
J	Cooper, A; Turney, CSM; Palmer, J; Hogg, A; McGlone, M; Wilmshurst, J; Lorrey, AM; Heaton, TJ; Russell, JM; McCracken, K; Anet, JG; Rozanov, E; Friedel, M; Suter, I; Peter, T; Muscheler, R; Adolphi, F; Dosseto, A; Faith, JT; Fenwick, P; Fogwill, CJ; Hughen, K; Lipson, M; Liu, JB; Nowaczyk, N; Rainsley, E; Ramsey, CB; Sebastianelli, P; Souilmi, Y; Stevenson, J; Thomas, Z; Tobler, R; Zech, R				Cooper, Alan; Turney, Chris S. M.; Palmer, Jonathan; Hogg, Alan; McGlone, Matt; Wilmshurst, Janet; Lorrey, Andrew M.; Heaton, Timothy J.; Russell, James M.; McCracken, Ken; Anet, Julien G.; Rozanov, Eugene; Friedel, Marina; Suter, Ivo; Peter, Thomas; Muscheler, Raimund; Adolphi, Florian; Dosseto, Anthony; Faith, J. Tyler; Fenwick, Pavla; Fogwill, Christopher J.; Hughen, Konrad; Lipson, Mathew; Liu, Jiabo; Nowaczyk, Norbert; Rainsley, Eleanor; Bronk Ramsey, Christopher; Sebastianelli, Paolo; Souilmi, Yassine; Stevenson, Janelle; Thomas, Zoe; Tobler, Raymond; Zech, Roland			A global environmental crisis 42,000 years ago	SCIENCE			English	Article								Geological archives record multiple reversals of Earth's magnetic poles, but the global impacts of these events, if any, remain unclear. Uncertain radiocarbon calibration has limited investigation of the potential effects of the last major magnetic inversion, known as the Laschamps Excursion [41 to 42 thousand years ago (ka)]. We use ancient New Zealand kauri trees (Agathis australis) to develop a detailed record of atmospheric radiocarbon levels across the Laschamps Excursion. We precisely characterize the geomagnetic reversal and perform global chemistry-climate modeling and detailed radiocarbon dating of paleoenvironmental records to investigate impacts. We find that geomagnetic field minima similar to 42 ka, in combination with Grand Solar Minima, caused substantial changes in atmospheric ozone concentration and circulation, driving synchronous global climate shifts that caused major environmental changes, extinction events, and transformations in the archaeological record.	[Cooper, Alan] South Australian Museum, Adelaide, SA 5000, Australia; [Cooper, Alan] BlueSky Genet, POB 287, Adelaide, SA 5137, Australia; [Turney, Chris S. M.; Palmer, Jonathan; Thomas, Zoe] Univ New South Wales, Chronos, Sydney, NSW 2052, Australia; [Rozanov, Eugene] Univ New South Wales, Carbon Cycle Facil, Sydney, NSW 2052, Australia; [Rozanov, Eugene] Univ New South Wales, Earth & Sustainabil Sci Res Ctr, Sydney, NSW 2052, Australia; [Hogg, Alan] Univ Waikato, Radiocarbon Dating Lab, Hamilton 3240, New Zealand; [McGlone, Matt; Wilmshurst, Janet] Landcare Res, POB 69040, Lincoln, New Zealand; [Wilmshurst, Janet] Univ Auckland, Sch Environm, Private Bag 92019, Auckland 1142, New Zealand; [Lorrey, Andrew M.] Natl Inst Water & Atmospher Res Ltd, Auckland 1010, New Zealand; [Heaton, Timothy J.] Univ Sheffield, Sch Math & Stat, Sheffield S3 7RH, S Yorkshire, England; [Russell, James M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [McCracken, Ken] Univ New South Wales, Sydney, NSW 2052, Australia; [Anet, Julien G.] Zurich Univ Appl Sci, Ctr Aviat, CH-8401 Winterthur, Switzerland; [Rozanov, Eugene; Friedel, Marina; Peter, Thomas] Swiss Fed Inst Technol, Inst Atmospher & Climat Sci, CH-8006 Zurich, Switzerland; [Rozanov, Eugene] Phys Meteorol Observat Davos & World Radiat Ctr, CH-7260 Davos, Switzerland; [Rozanov, Eugene] St Petersburg State Univ, Dept Phys Earth, Fac Phys, St Petersburg 198504, Russia; [Suter, Ivo] Swiss Fed Labs Mat Sci & Technol Empa, CH-8600 Dubendorf, Switzerland; [Muscheler, Raimund] Lund Univ, Dept Geol, Quaternary Sci, S-22362 Lund, Sweden; [Adolphi, Florian] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Dosseto, Anthony] Univ Wollongong, Sch Earth Atmospher & Life Sci, Wollongong Isotope Geochronol Lab, Wollongong, NSW 2522, Australia; [Faith, J. Tyler] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT 84108 USA; [Faith, J. Tyler] Univ Utah, Dept Anthropol, Salt Lake City, UT 84108 USA; [Fenwick, Pavla] Gondwana Tree Ring Lab, POB 14, Canterbury 7546, New Zealand; [Fogwill, Christopher J.; Rainsley, Eleanor] Univ Keele, Sch Geog Geol & Environm, Keele ST5 5BG, Staffs, England; [Hughen, Konrad] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Lipson, Mathew] Univ New South Wales, Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Liu, Jiabo] Southern Univ Sci & Technol, Dept Ocean Sci & Engn, Shenzhen 518055, Peoples R China; [Nowaczyk, Norbert] Helmholtz Ctr Potsdam, GFZ German Res Ctr Geosci, Sect 4-3, D-14473 Potsdam, Germany; [Bronk Ramsey, Christopher] Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, Oxford OX1 3TG, England; [Sebastianelli, Paolo] Natl Univ Cordoba, Fac Math Astron & Phys FAMAF, X5000HUA, Cordoba, Argentina; [Souilmi, Yassine; Tobler, Raymond] Univ Adelaide, Australian Ctr Ancient DNA, Adelaide, SA 5000, Australia; [Stevenson, Janelle] ANU Coll Asia & Pacific, Sch Culture Hist & Language, Archaeol & Nat Hist, Canberra, ACT 2601, Australia; [Stevenson, Janelle] Australian Natl Univ, Australia ARC Ctr Excellence Australian Biodivers, Canberra, ACT 2601, Australia; [Zech, Roland] Friedrich Schiller Univ Jena, Inst Geog, D-07743 Jena, Germany	South Australian Museum; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Waikato; Landcare Research - New Zealand; University of Auckland; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Sheffield; Brown University; University of New South Wales Sydney; Zurich University of Applied Sciences; Swiss Federal Institutes of Technology Domain; ETH Zurich; Saint Petersburg State University; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Lund University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Wollongong; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Keele University; Woods Hole Oceanographic Institution; University of New South Wales Sydney; Southern University of Science & Technology; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Oxford; National University of Cordoba; University of Adelaide; Australian National University; Australian National University; Friedrich Schiller University of Jena	Cooper, A (corresponding author), South Australian Museum, Adelaide, SA 5000, Australia.; Cooper, A (corresponding author), BlueSky Genet, POB 287, Adelaide, SA 5137, Australia.; Turney, CSM (corresponding author), Univ New South Wales, Chronos, Sydney, NSW 2052, Australia.	alan.cooper@blueskygenetics.com; c.turney@unsw.edu.au	Lipson, Mathew/AAP-6977-2021; Heaton, Timothy J/AFJ-8295-2022; Peter, Thomas/B-2529-2018; Ramsey, Christopher Bronk/AAQ-2227-2021; Thomas, Zoë A/D-1656-2016; Heaton, Tim/AAF-5132-2022; Palmer, Jonathan/J-7834-2012; Turney, Chris/P-8701-2018; Wilmshurst, Janet/C-2209-2009; Hogg, Alan/M-8427-2014	Heaton, Timothy J/0000-0002-9994-142X; Peter, Thomas/0000-0002-7218-7156; Ramsey, Christopher Bronk/0000-0002-8641-9309; Thomas, Zoë A/0000-0002-2323-4366; Palmer, Jonathan/0000-0002-6665-4483; Cooper, Alan/0000-0002-7738-7851; Anet, Julien/0000-0002-2949-1363; McGlone, Matt/0000-0002-8130-5724; Lorrey, Andrew/0000-0002-3923-3181; Turney, Chris/0000-0001-6733-0993; Souilmi, Yassine/0000-0001-7543-4864; Tobler, Raymond/0000-0002-4603-1473; Wilmshurst, Janet/0000-0002-4474-8569; Fogwill, Christopher/0000-0002-6471-1106; Faith, J. Tyler/0000-0002-1101-7161; Stevenson, Janelle/0000-0001-9640-7275; Sebastianelli, Paolo/0000-0002-5729-7509; Suter, Ivo/0000-0002-8612-4033; Hogg, Alan/0000-0002-4001-9027	Australian Research Council for Discovery Grant; University of Adelaide Environment Institute; Royal Society of New Zealand Marsden Fund [MFP-NIW1803]; NIWA; Leverhulme Trust [RF-2019-140\9]; Russian Science Foundation [20-67-46016]; Swiss National Science Foundation Ambizione grant [PZ00P2_180043]; Laureate Fellowship support [DP170104665, FL140100260, FL100100195]; University of Waikato; Australasian Antarctic Expedition; Tiama	Australian Research Council for Discovery Grant(Australian Research Council); University of Adelaide Environment Institute; Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); NIWA; Leverhulme Trust(Leverhulme Trust); Russian Science Foundation(Russian Science Foundation (RSF)); Swiss National Science Foundation Ambizione grant; Laureate Fellowship support; University of Waikato; Australasian Antarctic Expedition; Tiama	We thank the Australian Research Council for Discovery Grant and Laureate Fellowship support [DP170104665 and FL140100260 (A.C.) and FL100100195 (C.S.M.T.)], the University of Adelaide Environment Institute, the Australasian Antarctic Expedition 2013-2014 and The Tiama, the Royal Society of New Zealand Marsden Fund (contract MFP-NIW1803), NIWA, the University of Waikato, the Leverhulme Trust (RF-2019-140\9), the Russian Science Foundation (20-67-46016), and a Swiss National Science Foundation Ambizione grant (PZ00P2_180043).	Adolphi F, 2018, CLIM PAST, V14, P1755, DOI 10.5194/cp-14-1755-2018; Ahmed M, 2013, NAT GEOSCI, V6, P339, DOI [10.1038/NGEO1797, 10.1038/ngeo1797]; Aldrian E, 2003, INT J CLIMATOL, V23, P1435, DOI 10.1002/joc.950; Arsenovic P, 2018, ATMOS CHEM PHYS, V18, P3469, DOI 10.5194/acp-18-3469-2018; Aubert M, 2018, NATURE, V564, P254, DOI 10.1038/s41586-018-0679-9; Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Aubert M, 2019, NATURE, V576, P442, DOI 10.1038/s41586-019-1806-y; Becerra-Valdivia L, 2020, NATURE, V584, P93, DOI 10.1038/s41586-020-2491-6; Bednarik RG, 2002, ANTHROPOS, V97, P201; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brown M, 2018, P NATL ACAD SCI USA, V115, P5111, DOI 10.1073/pnas.1722110115; Budikova D, 2012, GEOGR COMPASS, V6, P401, DOI 10.1111/j.1749-8198.2012.00498.x; Buizert C, 2015, NATURE, V520, P661, DOI 10.1038/nature14401; Butchart N, 2014, REV GEOPHYS, V52, P157, DOI 10.1002/2013RG000448; Calisto M, 2011, ATMOS CHEM PHYS, V11, P4547, DOI 10.5194/acp-11-4547-2011; Carlson AE, 2018, QUATERNARY SCI REV, V196, P118, DOI 10.1016/j.quascirev.2018.07.039; Carwardine M., 2009, LAST CHANCE TO SEE; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; Channell JET, 2019, REV GEOPHYS, V57, P709, DOI 10.1029/2018RG000629; Chase BM, 2017, QUATERNARY SCI REV, V174, P54, DOI 10.1016/j.quascirev.2017.08.011; Chase BM, 2013, QUATERNARY SCI REV, V82, P199, DOI 10.1016/j.quascirev.2013.10.018; Checa-Garcia R, 2018, GEOPHYS RES LETT, V45, P3264, DOI 10.1002/2017GL076770; Cheng H, 2018, SCIENCE, V362, P1293, DOI 10.1126/science.aau0747; Clottes J., 2011, INT NEWSLETTER ROCK, V61, P1; Cole N, 2005, ANTIQUITY, V79, P661, DOI 10.1017/S0003598X00114590; Conard NJ, 2009, NATURE, V459, P248, DOI 10.1038/nature07995; Cooper A, 2015, SCIENCE, V349, P602, DOI 10.1126/science.aac4315; Cortes-Sanchez M, 2019, NAT ECOL EVOL, V3, P207, DOI 10.1038/s41559-018-0753-6; Cummings AC, 2016, ASTROPHYS J, V831, DOI [10.3847/0004-637x/831/1/18, 10.3847/0004-637X/831/1/18]; d'Errico F, 2012, P NATL ACAD SCI USA, V109, P13214, DOI 10.1073/pnas.1204213109; Dalton AS, 2019, GEOLOGY, V47, P111, DOI 10.1130/G45335.1; Dalton AS, 2016, QUATERNARY SCI REV, V146, P288, DOI 10.1016/j.quascirev.2016.06.015; David B, 2013, J ARCHAEOL SCI, V40, P2493, DOI 10.1016/j.jas.2012.08.015; Dawson ML, 2012, P NATL ACAD SCI USA, V109, P18719, DOI 10.1073/pnas.1211878109; DEACON HJ, 1979, WORLD ARCHAEOL, V10, P241, DOI 10.1080/00438243.1979.9979735; Deplazes G, 2013, NAT GEOSCI, V6, P213, DOI 10.1038/ngeo1712; di Lernia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056879; Diefendorf AF, 2010, P NATL ACAD SCI USA, V107, P5738, DOI 10.1073/pnas.0910513107; Dietzel M, 2008, CHEM ERDE-GEOCHEM, V68, P31, DOI 10.1016/j.chemer.2007.03.001; Duncan RP, 2010, CLIM DYNAM, V35, P1429, DOI 10.1007/s00382-010-0794-2; Egorova T, 2005, ATMOS CHEM PHYS, V5, P1557, DOI 10.5194/acp-5-1557-2005; Egorova TA, 2003, IZV ATMOS OCEAN PHY+, V39, P277; Emile-Geay J, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.88; FAIRBRIDGE RW, 1977, NATURE, V265, P430, DOI 10.1038/265430a0; Faith JT, 2013, J HUM EVOL, V65, P715, DOI 10.1016/j.jhevol.2013.09.001; Faith JT, 2019, PALEOZOOLOGY AND PALEOENVIRONMENTS: FUNDAMENTALS, ASSUMPTIONS, TECHNIQUES, P1, DOI 10.1017/9781108648608; Fankhauser B. L., 2001, HIST OLD AGES ESSAYS; Floss H., 2007, EDITIONS MUSEE FORUM; Gogorza CSG, 2004, PHYS EARTH PLANET IN, V145, P219, DOI 10.1016/j.pepi.2004.03.010; Hansford J, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat6925; HARRISON CG, 1974, NATURE, V250, P563, DOI 10.1038/250563a0; Harrison RG, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0164; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Haws JA, 2020, P NATL ACAD SCI USA, V117, P25414, DOI 10.1073/pnas.2016062117; Heaton TJ, 2020, RADIOCARBON, V62, P821, DOI 10.1017/RDC.2020.46; Higham T, 2014, NATURE, V512, P306, DOI 10.1038/nature13621; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hill HW, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001186; Hoffmann DL, 2018, SCIENCE, V359, P912, DOI 10.1126/science.aap7778; Hogg A., 1993, LIQUID SCINTILLATION, P135; Hogg A, 2013, RADIOCARBON, V55, P2035, DOI 10.2458/azu_js_rc.v55i2.16217; Hogg AG, 2006, QUAT GEOCHRONOL, V1, P241, DOI 10.1016/j.quageo.2006.11.001; Hogg AG, 2020, RADIOCARBON, V62, P759, DOI 10.1017/RDC.2020.59; Hope G, 2001, PALAEOGEOGR PALAEOCL, V171, P129, DOI 10.1016/S0031-0182(01)00243-7; Horton TW, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00414; Hoyle C. R., 2005, THESIS ETH ZURICH; Hublin JJ, 2020, NATURE, V581, P299, DOI 10.1038/s41586-020-2259-z; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Huyge D, 2011, ANTIQUITY, V85, P1184, DOI 10.1017/S0003598X00061998; IACETH, 2009, DOC SOCOL MOD; Jones T, 2017, J ARCHAEOL SCI-REP, V11, P80, DOI 10.1016/j.jasrep.2016.11.016; Kidston J, 2015, NAT GEOSCI, V8, P433, DOI [10.1038/ngeo2424, 10.1038/NGEO2424]; Kirana KH, 2018, PHYS EARTH PLANET IN, V275, P9, DOI 10.1016/j.pepi.2017.12.007; Kirkby J, 2007, SURV GEOPHYS, V28, P333, DOI 10.1007/s10712-008-9030-6; Kirkby J, 2016, NATURE, V533, P521, DOI 10.1038/nature17953; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kodera K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014557; Kodera K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002224; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kuroda Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009336; Laj C, 2014, EARTH PLANET SC LETT, V387, P184, DOI 10.1016/j.epsl.2013.11.031; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Langley MC, 2018, ARCHAEOLOGY OF PORTABLE ART: SOUTHEAST ASIAN, PACIFIC, AND AUSTRALIAN PERSPECTIVES, P25; Liu JB, 2020, J GEOPHYS RES-SOL EA, V125, DOI 10.1029/2019JB019225; Lorrey AM, 2018, QUATERNARY SCI REV, V183, P124, DOI 10.1016/j.quascirev.2017.12.019; Malotki E, 2011, ROCK ART RES, V28, P143; Manzini E, 2006, J CLIMATE, V19, P3863, DOI 10.1175/JCLI3826.1; Marsland SJ, 2003, OCEAN MODEL, V5, P91, DOI 10.1016/S1463-5003(02)00015-X; Masarik J, 1999, J GEOPHYS RES-ATMOS, V104, P12099, DOI 10.1029/1998JD200091; Masson-Delmotte V, 2005, SCIENCE, V309, P118, DOI 10.1126/science.1108575; McCracken KG, 2015, SOL PHYS, V290, P3051, DOI 10.1007/s11207-015-0777-x; McCracken KG, 2013, SOL PHYS, V286, P609, DOI 10.1007/s11207-013-0265-0; McCracken KG, 2012, ASTROPHYS J, V761, DOI 10.1088/0004-637X/761/2/101; McCracken KG, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010685; McGlone MS, 2002, QUATERNARY SCI REV, V21, P683, DOI 10.1016/S0277-3791(01)00044-0; Meehl GA, 2009, SCIENCE, V325, P1114, DOI 10.1126/science.1172872; Mekhaldi F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9611; Mishev Alexander, 2013, International Journal of Atmospheric Sciences, DOI 10.1155/2013/184508; Miyake F, 2017, P NATL ACAD SCI USA, V114, P881, DOI 10.1073/pnas.1613144114; Mooney SD, 2011, QUATERNARY SCI REV, V30, P28, DOI 10.1016/j.quascirev.2010.10.010; Moore P.D., 1991, BLACKWELL SCI PUBLI; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; Muthers S, 2014, GEOSCI MODEL DEV, V7, P2157, DOI 10.5194/gmd-7-2157-2014; NELSON CS, 1993, PALEOCEANOGRAPHY, V8, P435, DOI 10.1029/93PA01162; Nelson D. E., 1995, Archaeometry, V37, P151, DOI 10.1111/j.1475-4754.1995.tb00733.x; Neves WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032228; Nowaczyk NR, 2012, EARTH PLANET SC LETT, V351, P54, DOI 10.1016/j.epsl.2012.06.050; O'Connell JF, 2018, P NATL ACAD SCI USA, V115, P8482, DOI 10.1073/pnas.1808385115; O'Connor S, 2011, SCIENCE, V334, P1117, DOI 10.1126/science.1207703; O'Connor S, 2010, ANTIQUITY, V84, P649, DOI 10.1017/S0003598X00100146; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; OLSON RH, 1975, NATURE, V257, P113, DOI 10.1038/257113a0; Oughton EJ, 2017, SPACE WEATHER, V15, P65, DOI 10.1002/2016SW001491; Palmer JG, 2015, QUAT GEOCHRONOL, V27, P158, DOI 10.1016/j.quageo.2015.02.028; Palmer J, 2006, J QUATERNARY SCI, V21, P779, DOI 10.1002/jqs.1075; Pargeter J, 2018, AZANIA, V53, P156, DOI 10.1080/0067270X.2018.1436740; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Pike AWG, 2005, J ARCHAEOL SCI, V32, P1649, DOI 10.1016/j.jas.2005.05.002; Plagnes V, 2003, QUATERNARY RES, V60, P172, DOI 10.1016/S0033-5894(03)00064-4; PORTER HS, 1976, J CHEM PHYS, V65, P154, DOI 10.1063/1.432812; Quilty Patrick G., 2007, Papers and Proceedings of the Royal Society of Tasmania, V141, P35; Rainsley E, 2019, CLIM PAST, V15, P423, DOI 10.5194/cp-15-423-2019; Raisbeck GM, 2017, CLIM PAST, V13, P217, DOI 10.5194/cp-13-217-2017; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Rifkin RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136090; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Ross J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161726; Rozanov EV, 2001, J GEOPHYS RES-ATMOS, V106, P27233, DOI 10.1029/2000JD000058; Rule S, 2012, SCIENCE, V335, P1483, DOI 10.1126/science.1214261; Russell JM, 2014, P NATL ACAD SCI USA, V111, P5100, DOI 10.1073/pnas.1402373111; Saltre F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13277-0; Saltre F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10511; Schraner M, 2008, ATMOS CHEM PHYS, V8, P5957, DOI 10.5194/acp-8-5957-2008; Sealy J, 2016, J QUATERNARY SCI, V31, P919, DOI 10.1002/jqs.2916; SIEGENTHALER U, 1980, RADIOCARBON, V22, P177, DOI 10.1017/S0033822200009449; Singer BS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4621; Sinnhuber M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017265; Smith MA, 2009, GEOARCHAEOLOGY, V24, P191, DOI 10.1002/gea.20262; SOLOMON S, 1981, PLANET SPACE SCI, V29, P885, DOI 10.1016/0032-0633(81)90078-7; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Staff RA, 2019, EARTH PLANET SC LETT, V520, P1, DOI 10.1016/j.epsl.2019.05.021; Staubwasser M, 2018, P NATL ACAD SCI USA, V115, P9116, DOI 10.1073/pnas.1808647115; Steelman KL, 2002, ANTIQUITY, V76, P341, DOI 10.1017/S0003598X00090426; Stevenson J, 2005, QUATERNARY RES, V64, P372, DOI 10.1016/j.yqres.2005.08.011; Strand PD, 2019, QUATERNARY SCI REV, V220, P165, DOI 10.1016/j.quascirev.2019.07.022; Straus LG, 2012, QUATERN INT, V272, P111, DOI 10.1016/j.quaint.2012.03.053; Sukhodolov T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45257; Suter I, 2014, CLIM PAST, V10, P1183, DOI 10.5194/cp-10-1183-2014; Svendsen JI, 2010, QUATERNARY SCI REV, V29, P3138, DOI 10.1016/j.quascirev.2010.06.043; Svensson A, 2008, CLIM PAST, V4, P47, DOI 10.5194/cp-4-47-2008; Tacon PSC, 2016, ROCK ART RES, V33, P19; TALMA AS, 1992, QUATERNARY RES, V37, P203, DOI 10.1016/0033-5894(92)90082-T; Tamuntuan G, 2015, PALAEOGEOGR PALAEOCL, V420, P163, DOI 10.1016/j.palaeo.2014.12.008; Thompson D. W., 2003, N ATLANTIC OSCILLATI, V134, P81, DOI DOI 10.1029/134GM05; Tobler R, 2017, NATURE, V544, P180, DOI 10.1038/nature21416; Tokarska KB, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz9549; Turney CSM, 2008, P NATL ACAD SCI USA, V105, P12150, DOI 10.1073/pnas.0801360105; Turney CSM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20970-5; Turney CSM, 2017, CLIM PAST, V13, P231, DOI 10.5194/cp-13-231-2017; Turney CSM, 2016, J QUATERNARY SCI, V31, P12, DOI 10.1002/jqs.2828; Turney CSM, 2010, QUATERNARY SCI REV, V29, P3677, DOI 10.1016/j.quascirev.2010.08.017; Usoskin IG, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007150; Usoskin IG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013142; Valladas H, 2003, MEAS SCI TECHNOL, V14, P1487, DOI 10.1088/0957-0233/14/9/301; Vogelsang R., 1998, MIDDLE STONE AGE FUN, V11; Wagner G, 2001, GEOPHYS RES LETT, V28, P303, DOI 10.1029/2000GL006116; Wagner G, 2001, J GEOPHYS RES-ATMOS, V106, P3381, DOI 10.1029/2000JD900589; White LC, 2018, J BIOGEOGR, V45, P1, DOI 10.1111/jbi.13101; WHITLEY DS, 1987, WORLD ARCHAEOL, V19, P150, DOI 10.1080/00438243.1987.9980031; Zech R, 2011, CLIM PAST, V7, P41, DOI 10.5194/cp-7-41-2011; Zhang L, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2020GL087024	176	30	30	14	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					811	+		10.1126/science.abb8677	http://dx.doi.org/10.1126/science.abb8677			103	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602851	Green Accepted, Green Published			2022-12-28	WOS:000619664700050
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: No evidence that vaccines can affect fertility, says new guidance	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Association of Reproductive and Clinical Scientists British Fertility Society, 2021, COV 19 VACC FERT; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n460	2	19	18	2	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n509	10.1136/bmj.n509	http://dx.doi.org/10.1136/bmj.n509			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608302	Bronze			2022-12-28	WOS:000621237300002
J	Van Rijn, R; Schurink, IJ; de Vries, Y; van den Berg, AP; Cerisuelo, MC; Murad, SD; Erdmann, JI; Gilbo, N; de Haas, RJ; Heaton, N; van Hoek, B; Huurman, VAL; Jochmans, I; van Leeuwen, OB; de Meijer, VE; Monbaliu, D; Polak, WG; Slangen, JJG; Troisi, RI; Vanlander, A; de Jonge, J; Porte, RJ				Van Rijn, R.; Schurink, I. J.; de Vries, Y.; van den Berg, A. P.; Cerisuelo, M. Cortes; Murad, S. Darwish; Erdmann, J. I.; Gilbo, N.; de Haas, R. J.; Heaton, N.; van Hoek, B.; Huurman, V. A. L.; Jochmans, I.; van Leeuwen, O. B.; de Meijer, V. E.; Monbaliu, D.; Polak, W. G.; Slangen, J. J. G.; Troisi, R. I.; Vanlander, A.; de Jonge, J.; Porte, R. J.		DHOPE DCD Trial Investigators	Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND Transplantation of livers obtained from donors after circulatory death is associated with an increased risk of nonanastomotic biliary strictures. Hypothermic oxygenated machine perfusion of livers may reduce the incidence of biliary complications, but data from prospective, controlled studies are limited. METHODS In this multicenter, controlled trial, we randomly assigned patients who were undergoing transplantation of a liver obtained from a donor after circulatory death to receive that liver either after hypothermic oxygenated machine perfusion (machine-perfusion group) or after conventional static cold storage alone (control group). The primary end point was the incidence of nonanastomotic biliary strictures within 6 months after transplantation. Secondary end points included other graft-related and general complications. RESULTS A total of 160 patients were enrolled, of whom 78 received a machine-perfused liver and 78 received a liver after static cold storage only (4 patients did not receive a liver in this trial). Nonanastomotic biliary strictures occurred in 6% of the patients in the machine-perfusion group and in 18% of those in the control group (risk ratio, 0.36; 95% confidence interval [CI], 0.14 to 0.94; P=0.03). Postreperfusion syndrome occurred in 12% of the recipients of a machine-perfused liver and in 27% of those in the control group (risk ratio, 0.43; 95% CI, 0.20 to 0.91). Early allograft dysfunction occurred in 26% of the machine-perfused livers, as compared with 40% of control livers (risk ratio, 0.61; 95% CI, 0.39 to 0.96). The cumulative number of treatments for nonanastomotic biliary strictures was lower by a factor of almost 4 after machine perfusion, as compared with control. The incidence of adverse events was similar in the two groups. CONCLUSIONS Hypothermic oxygenated machine perfusion led to a lower risk of nonanastomotic biliary strictures following the transplantation of livers obtained from donors after circulatory death than conventional static cold storage.	[Van Rijn, R.; de Vries, Y.; van Leeuwen, O. B.; de Meijer, V. E.; Porte, R. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands; [van den Berg, A. P.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [de Haas, R. J.; Slangen, J. J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Schurink, I. J.; Polak, W. G.; de Jonge, J.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Murad, S. Darwish] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Erdmann, J. I.; Huurman, V. A. L.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [van Hoek, B.] Leiden Univ Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Cerisuelo, M. Cortes; Heaton, N.] Kings Coll Hosp NHS Fdn Trust, Inst Liver Studies, London, England; [Gilbo, N.; Jochmans, I.; Monbaliu, D.] Katholieke Univ Leuven, Transplantat Res Grp, Dept Microbiol Immunol & Transplantat, Leuven, Belgium; [Gilbo, N.; Jochmans, I.; Monbaliu, D.] Univ Hosp Leuven, Dept Abdominal Transplantat Surg & Coordinat, Leuven, Belgium; [Troisi, R. I.; Vanlander, A.] Ghent Univ Hosp, Dept Transplant Surg, Ghent, Belgium	University of Groningen; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); King's College Hospital NHS Foundation Trust; University of London; King's College London; KU Leuven; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital	Porte, RJ (corresponding author), Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, POB 30-001, NL-9700 RB Groningen, Netherlands.	r.j.porte@umcg.nl	de Meijer, Vincent Erwin/H-6610-2019; Gilbo, Nicholas/T-6487-2017; van Leeuwen, Otto B./AAF-1953-2019; Jochmans, Ina/R-2471-2017	de Meijer, Vincent Erwin/0000-0002-7900-5917; Gilbo, Nicholas/0000-0001-6456-7071; Jochmans, Ina/0000-0003-4592-2810; van Hoek, Bart/0000-0001-6527-764X; Eryigit, Ozgur/0000-0002-3837-9832; van Leeuwen, Otto/0000-0002-8600-0479; Polak, Wojciech/0000-0002-3096-4893	Fonds NutsOhra [1404-012]	Fonds NutsOhra	Supported by a grant for applied medical research (1404-012) from Fonds NutsOhra.	Abt P, 2003, TRANSPLANTATION, V75, P1659, DOI 10.1097/01.TP.0000062574.18648.7C; AGGARWAL S, 1987, TRANSPLANT P, V19, P54; Boteon YL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224066; Bral M, 2017, AM J TRANSPLANT, V17, P1071, DOI 10.1111/ajt.14049; Buis CI, 2007, LIVER TRANSPLANT, V13, P708, DOI 10.1002/lt.21166; Burlage LC, 2019, AM J TRANSPLANT, V19, P1061, DOI 10.1111/ajt.15173; Croome KP, 2012, CAN J GASTROENTEROL, V26, P607, DOI 10.1155/2012/346286; de Rougemont O, 2009, ANN SURG, V250, P674, DOI 10.1097/SLA.0b013e3181bcb1ee; de Vries Y, 2019, AM J TRANSPLANT, V19, P1202, DOI 10.1111/ajt.15228; de Vries Y, 2018, BBA-MOL BASIS DIS, V1864, P1507, DOI 10.1016/j.bbadis.2017.06.013; Dubbeld J, 2010, BRIT J SURG, V97, P744, DOI 10.1002/bjs.7043; Dutkowski P, 2006, ANN SURG, V244, P968, DOI 10.1097/01.sla.0000247056.85590.6b; Dutkowski P, 2014, J HEPATOL, V60, P765, DOI 10.1016/j.jhep.2013.11.023; Dutkowski P, 2019, GASTROENTEROLOGY, V156, P1542, DOI 10.1053/j.gastro.2018.12.037; Feng S, 2006, AM J TRANSPLANT, V6, P783, DOI 10.1111/j.1600-6143.2006.01242.x; Foley DP, 2011, ANN SURG, V253, P817, DOI 10.1097/SLA.0b013e3182104784; Guarrera JV, 2010, AM J TRANSPLANT, V10, P372, DOI 10.1111/j.1600-6143.2009.02932.x; Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381; Jay CL, 2010, ANN SURG, V251, P743, DOI 10.1097/SLA.0b013e3181d3d3da; Luer B, 2010, TRANSPL INT, V23, P944, DOI 10.1111/j.1432-2277.2010.01067.x; Meurisse N, 2012, TRANSPL P, V44, P2868, DOI 10.1016/j.transproceed.2012.09.077; Monbaliu D, 2010, CURR OPIN ORGAN TRAN, V15, P160, DOI 10.1097/MOT.0b013e328337342b; Muller X, 2019, ANN SURG, V270, P783, DOI 10.1097/SLA.0000000000003513; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; O'Neill S, 2014, TRANSPL INT, V27, P1159, DOI 10.1111/tri.12403; Olthoff KM, 2010, LIVER TRANSPLANT, V16, P943, DOI 10.1002/lt.22091; Patrono D, 2019, TRANSL GASTROENT HEP, V4, DOI 10.21037/tgh.2019.08.12; Schlegel A, 2014, ANN SURG, V260, P931, DOI 10.1097/SLA.0000000000000941; Selzner M, 2016, LIVER TRANSPLANT, V22, P1501, DOI 10.1002/lt.24499; Summers DM, 2010, TRANSPLANTATION, V90, P1506, DOI 10.1097/TP.0b013e3182007b33; Taner CB, 2012, TRANSPL INT, V25, P838, DOI 10.1111/j.1432-2277.2012.01508.x; Tullius SG, 2018, NEW ENGL J MED, V378, P1920, DOI 10.1056/NEJMra1507080; van der Hilst CS, 2013, TRANSPL INT, V26, P411, DOI 10.1111/tri.12059; van Leeuwen OB, 2019, ANN SURG, V270, P906, DOI 10.1097/SLA.0000000000003540; van Rijn R, 2017, BRIT J SURG, V104, P907, DOI 10.1002/bjs.10515; van Rijn R, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0956-6; van Rijn R, 2018, LIVER TRANSPLANT, V24, P655, DOI 10.1002/lt.25023; Xu J, 2020, TRANSPLANTATION, V104, P1792, DOI 10.1097/TP.0000000000003295	38	134	135	4	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2021	384	15					1391	1401		10.1056/NEJMoa2031532	http://dx.doi.org/10.1056/NEJMoa2031532			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN7TA	33626248	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000640554500006
J	Ebert, P; Audano, PA; Zhu, QH; Rodriguez-Martin, B; Porubsky, D; Bonder, MJ; Sulovari, A; Ebler, J; Zhou, WC; Mari, RS; Yilmaz, F; Zhao, XF; Hsieh, P; Lee, J; Kumar, S; Lin, JD; Rausch, T; Chen, Y; Ren, JW; Santamarina, M; Hops, W; Ashraf, H; Chuang, NT; Yang, XF; Munson, KM; Lewis, AP; Fairley, S; Tallon, LJ; Clarke, WE; Basile, AO; Byrska-Bishop, M; Corvelo, A; Evani, US; Lu, TY; Chaisson, MJP; Chen, JJ; Li, C; Brand, H; Wenger, AM; Ghareghani, M; Harvey, WT; Raeder, B; Hasenfeld, P; Regier, AA; Abel, HJ; Hall, IM; Flicek, P; Stegle, O; Gerstein, MB; Tubio, JMC; Mu, ZP; Li, YI; Shi, XH; Hastie, AR; Ye, K; Chong, ZC; Sanders, AD; Zody, MC; Talkowski, ME; Mills, RE; Devine, SE; Lee, C; Korbel, JO; Marschall, T; Eichler, EE				Ebert, Peter; Audano, Peter A.; Zhu, Qihui; Rodriguez-Martin, Bernardo; Porubsky, David; Bonder, Marc Jan; Sulovari, Arvis; Ebler, Jana; Zhou, Weichen; Mari, Rebecca Serra; Yilmaz, Feyza; Zhao, Xuefang; Hsieh, PingHsun; Lee, Joyce; Kumar, Sushant; Lin, Jiadong; Rausch, Tobias; Chen, Yu; Ren, Jingwen; Santamarina, Martin; Hops, Wolfram; Ashraf, Hufsah; Chuang, Nelson T.; Yang, Xiaofei; Munson, Katherine M.; Lewis, Alexandra P.; Fairley, Susan; Tallon, Luke J.; Clarke, Wayne E.; Basile, Anna O.; Byrska-Bishop, Marta; Corvelo, Andre; Evani, Uday S.; Lu, Tsung-Yu; Chaisson, Mark J. P.; Chen, Junjie; Li, Chong; Brand, Harrison; Wenger, Aaron M.; Ghareghani, Maryam; Harvey, William T.; Raeder, Benjamin; Hasenfeld, Patrick; Regier, Allison A.; Abel, Haley J.; Hall, Ira M.; Flicek, Paul; Stegle, Oliver; Gerstein, Mark B.; Tubio, Jose M. C.; Mu, Zepeng; Li, Yang, I; Shi, Xinghua; Hastie, Alex R.; Ye, Kai; Chong, Zechen; Sanders, Ashley D.; Zody, Michael C.; Talkowski, Michael E.; Mills, Ryan E.; Devine, Scott E.; Lee, Charles; Korbel, Jan O.; Marschall, Tobias; Eichler, Evan E.			Haplotype-resolved diverse human genomes and integrated analysis of structural variation	SCIENCE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENE-EXPRESSION; TRANSPOSABLE ELEMENTS; TANDEM REPEATS; SVA ELEMENTS; DISCOVERY; RETROTRANSPOSONS; EVOLUTION; ANCESTRY; VARIANTS	Long-read and strand-specific sequencing technologies together facilitate the de novo assembly of high-quality haplotype-resolved human genomes without parent-child trio data. We present 64 assembled haplotypes from 32 diverse human genomes. These highly contiguous haplotype assemblies (average minimum contig length needed to cover 50% of the genome: 26 million base pairs) integrate all forms of genetic variation, even across complex loci. We identified 107,590 structural variants (SVs), of which 68% were not discovered with short-read sequencing, and 278 SV hotspots (spanning megabases of gene-rich sequence). We characterized 130 of the most active mobile element source elements and found that 63% of all SVs arise through homology-mediated mechanisms. This resource enables reliable graph-based genotyping from short reads of up to 50,340 SVs, resulting in the identification of 1526 expression quantitative trait loci as well as SV candidates for adaptive selection within the human population.	[Ebert, Peter; Ebler, Jana; Mari, Rebecca Serra; Ashraf, Hufsah; Ghareghani, Maryam; Marschall, Tobias] Heinrich Heine Univ, Med Fac, Inst Med Biometry & Bioinformat, Moorenstr 20, D-40225 Dusseldorf, Germany; [Audano, Peter A.; Porubsky, David; Sulovari, Arvis; Hsieh, PingHsun; Munson, Katherine M.; Lewis, Alexandra P.; Harvey, William T.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Sch Med, 3720 15th Ave NE, Seattle, WA 98195 USA; [Zhu, Qihui; Yilmaz, Feyza; Lee, Charles] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA; [Rodriguez-Martin, Bernardo; Bonder, Marc Jan; Rausch, Tobias; Hops, Wolfram; Raeder, Benjamin; Hasenfeld, Patrick; Stegle, Oliver; Sanders, Ashley D.; Korbel, Jan O.] European Mol Biol Lab EMBL, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Bonder, Marc Jan; Stegle, Oliver] German Canc Res Ctr, Div Computat Genom & Syst Genet, D-69120 Heidelberg, Germany; [Zhou, Weichen; Mills, Ryan E.] Univ Michigan, Med Sch, Dept Computat Med & Bioinformat, 100 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Zhao, Xuefang; Brand, Harrison; Talkowski, Michael E.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Genom Med, Dept Neurol, Boston, MA 02114 USA; [Zhao, Xuefang; Brand, Harrison; Talkowski, Michael E.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Zhao, Xuefang; Brand, Harrison; Talkowski, Michael E.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Lee, Joyce; Hastie, Alex R.] Bionano Genom, San Diego, CA 92121 USA; [Kumar, Sushant; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, BASS 432 & 437,266 Whitney Ave, New Haven, CT 06520 USA; [Lin, Jiadong; Ye, Kai] Xi An Jiao Tong Univ, Fac Elect & Informat Engn, Sch Automat Sci & Engn, Xian 710049, Shaanxi, Peoples R China; [Chen, Yu; Chong, Zechen] Univ Alabama Birmingham, Sch Med, Dept Genet, Birmingham, AL 35294 USA; [Chen, Yu; Chong, Zechen] Univ Alabama Birmingham, Sch Med, Informat Inst, Birmingham, AL 35294 USA; [Ren, Jingwen; Lu, Tsung-Yu; Chaisson, Mark J. P.] Univ Southern Calif, Dept Quantitat & Computat Biol, Los Angeles, CA 90089 USA; [Santamarina, Martin; Tubio, Jose M. C.] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Genomes & Dis, Santiago De Compostela, Spain; [Santamarina, Martin; Tubio, Jose M. C.] Univ Santiago de Compostela, Dept Zool Genet & Phys Anthropol, Santiago De Compostela, Spain; [Chuang, Nelson T.; Tallon, Luke J.; Devine, Scott E.] Univ Maryland, Sch Med, Inst Genome Sci, 670 W Baltimore St, Baltimore, MD 21201 USA; [Yang, Xiaofei] Xi An Jiao Tong Univ, Fac Elect & Informat Engn, Sch Comp Sci & Technol, Xian 710049, Shaanxi, Peoples R China; [Fairley, Susan; Flicek, Paul; Korbel, Jan O.] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England; [Clarke, Wayne E.; Basile, Anna O.; Byrska-Bishop, Marta; Corvelo, Andre; Evani, Uday S.; Zody, Michael C.] New York Genome Ctr, New York, NY 10013 USA; [Chen, Junjie; Li, Chong; Shi, Xinghua] Temple Univ, Dept Comp & Informat Sci, Philadelphia, PA 19122 USA; [Wenger, Aaron M.] Pacific Biosci Calif, Menlo Pk, CA 94025 USA; [Ghareghani, Maryam] Max Planck Inst Informat, Saarland Informat Campus E1-4, D-66123 Saarbrucken, Germany; [Ghareghani, Maryam] Saarland Univ, Saarbrucken Grad Sch Comp Sci, Saarland Informat Campus E1-3, D-66123 Saarbrucken, Germany; [Regier, Allison A.; Abel, Haley J.] Washington Univ, Dept Med, St Louis, MO 63108 USA; [Hall, Ira M.] Yale Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA; [Mu, Zepeng] Univ Chicago, Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Li, Yang, I] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Ye, Kai; Mills, Ryan E.] Univ Michigan, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48109 USA; [Lee, Charles] Xi An Jiao Tong Univ, Affiliated Hosp 1, Precis Med Ctr, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Lee, Charles] Ewha Womans Univ, Dept Grad Studies Life Sci, Seoul 120750, South Korea; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	Heinrich Heine University Dusseldorf; University of Washington; University of Washington Seattle; Jackson Laboratory; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Xi'an Jiaotong University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Southern California; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University System of Maryland; University of Maryland Baltimore; Xi'an Jiaotong University; European Molecular Biology Laboratory (EMBL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Max Planck Society; Saarland University; Washington University (WUSTL); Yale University; University of Chicago; University of Chicago; University of Michigan System; University of Michigan; Xi'an Jiaotong University; Ewha Womans University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Marschall, T (corresponding author), Heinrich Heine Univ, Med Fac, Inst Med Biometry & Bioinformat, Moorenstr 20, D-40225 Dusseldorf, Germany.; Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Sch Med, 3720 15th Ave NE, Seattle, WA 98195 USA.; Lee, C (corresponding author), Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA.; Korbel, JO (corresponding author), European Mol Biol Lab EMBL, Genome Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.; Korbel, JO (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge CB10 1SD, England.; Lee, C (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Precis Med Ctr, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.; Lee, C (corresponding author), Ewha Womans Univ, Dept Grad Studies Life Sci, Seoul 120750, South Korea.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	charles.lee@jax.org; jan.korbel@embl.org; tobias.marschall@hhu.de; eee@gs.washington.edu	Li, Chong/AAU-7098-2021; Chen, Junjie/HHM-8839-2022; Evani, Uday/AAA-8112-2022; Rausch, Tobias/H-6511-2019; Mu, Zepeng/ABG-2060-2021; Hoeps, Wolfram/GXG-3884-2022; Ye, Kai/GSD-9856-2022; Mills, Ryan/F-4225-2010; Zhou, Weichen/AAA-3207-2020	Chen, Junjie/0000-0002-0483-303X; Rausch, Tobias/0000-0001-5773-5620; Ye, Kai/0000-0002-2851-6741; Mills, Ryan/0000-0003-3425-6998; Zhou, Weichen/0000-0003-4755-1072; Yang, Xiaofei/0000-0002-5118-7755; Flicek, Paul/0000-0002-3897-7955; Munson, Katherine/0000-0001-8413-6498; Stegle, Oliver/0000-0002-8818-7193; Sanders, Ashley/0000-0003-3945-0677; SANTAMARINA GARCIA, MARTIN/0000-0001-5914-0540; Chen, Yu/0000-0002-2037-7337; Fairley, Susan/0000-0001-9425-0788; Sulovari, Arvis/0000-0003-4354-9020; Ebert, Peter/0000-0001-7441-532X; Mu, Zepeng/0000-0002-7717-3247; Bonder, Marc Jan/0000-0002-8431-3180; Porubsky, David/0000-0001-8414-8966; ZHU, QIHUI/0000-0003-2401-8443; Raeder, Benjamin/0000-0002-9494-8884	Human Genome Structural Variation Consortium (HGSVC) from National Institutes of Health (NIH) [U24HG007497]; Human Genome Structural Variation Consortium (HGSVC) [NIH R01HG002898, NIH R01HD081256, NIH 1R01HG007068-01A1, NIH R01HG002385, HG010169, R01MH115957, NIH R15HG009565, NIH 1U01HG010973, NIH 1R35GM138212, 1OT3HL147154]; NIH/NHGRI [K99HG011041]; German Research Foundation [391137747, 395192176]; European Research Council [773026, 716290]; German Federal Ministry for Research and Education [BMBF 031L0184, BMBF 031L0181A]; Spanish Ministry of Economy, Industry and Competitiveness [SAF2015-66368-P]; Wellcome Trust [WT104947/Z/14/Z]; European Molecular Biology Laboratory; National Science Foundation of China [32070663, 61702406]; National Key RAMP;D Program of China [2017YFC0907500, 2018YFC0910400, 2018ZX10302205]; BMBF [031A537B, 031A533A, 031A538A, 031A533B, 031A535A, 031A537C, 031A534A, 031A532B]; Ewha Womans University; First Affiliated Hospital of Xi'an Jiaotong University; Centers for Common Disease Genomics (CCDG) grant from the National Human Genome Research Institute [UM1HG008901]; Xunta de Galicia (Spain); Alexander von Humboldt Foundation; NHGRI [3UM1HG008901-03S1, 3UM1HG008901-04S2]	Human Genome Structural Variation Consortium (HGSVC) from National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Genome Structural Variation Consortium (HGSVC); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry for Research and Education(Federal Ministry of Education & Research (BMBF)); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Laboratory; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RAMP;D Program of China; BMBF(Federal Ministry of Education & Research (BMBF)); Ewha Womans University; First Affiliated Hospital of Xi'an Jiaotong University(Xi'an Jiaotong University); Centers for Common Disease Genomics (CCDG) grant from the National Human Genome Research Institute; Xunta de Galicia (Spain)(Xunta de Galicia); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funding for this research project by the Human Genome Structural Variation Consortium (HGSVC) came from the following grants: National Institutes of Health (NIH) U24HG007497 (to C.L., E.E.E., J.O.K., T.M., M.E.T., M.B.G., S.E.D., I.M.H., R.E.M., and M.J.P.C.), NIH R01HG002898 (to S.E.D.), NIH R01HD081256 (to M.E.T.), NIH 1R01HG007068-01A1 (to R.E.M.), NIH R01HG002385 and HG010169 (to E.E.E.), R01MH115957 (to M.E.T.), NIH R15HG009565 (to X.S.), NIH 1U01HG010973 (to M.J.P.C., T.M., E.E.E., and J.O.K.), NIH 1R35GM138212 and a subaward from 1OT3HL147154 (to Z.C.), NIH/NHGRI Pathway to Independence Award K99HG011041 (to PH.H.), the German Research Foundation (391137747 and 395192176 to T.M.), the European Research Council (Consolidator grant 773026 to J.O.K. and Starting Grant 716290 to J.M.C.T.), the German Federal Ministry for Research and Education (BMBF 031L0184 to J.O.K. and T.M. and BMBF 031L0181A to J.O.K), the Spanish Ministry of Economy, Industry and Competitiveness (SAF2015-66368-P to J.M.C.T.), the Wellcome Trust grant WT104947/Z/14/Z and the European Molecular Biology Laboratory core funding (to B.R.-M., M.J.B., T.R., W.H., S.F., B.R., P.H., P.F., O.S., A.D.S., J.O.K.), National Science Foundation of China (32070663 to K.Y., 61702406 to X.Y.), and National Key R&D Program of China (2017YFC0907500 to K.Y., 2018YFC0910400 to K.Y., and 2018ZX10302205 to X.Y.). This work was supported by the BMBF-funded de.NBI Cloud within the German Network for Bioinformatics Infrastructure (de.NBI) (031A537B, 031A533A, 031A538A, 031A533B, 031A535A, 031A537C, 031A534A, and 031A532B). E.E.E. is an investigator of the Howard Hughes Medical Institute. J.O.K. and J.M.C.T. are European Research Council (ERC) investigators. C.L. was a distinguished Ewha Womans University Professor supported, in part, by an Ewha Womans University research grant for 2019-2020. Also, this study was supported, in part, by funds from The First Affiliated Hospital of Xi'an Jiaotong University (to C.L.). A.C., W.E.C., and M.C.Z. were supported in part by a Centers for Common Disease Genomics (CCDG) grant from the National Human Genome Research Institute (UM1HG008901). M.S. is supported by a PhD fellowship from Xunta de Galicia (Spain). A.D.S. received postdoctoral research funding through the Alexander von Humboldt Foundation. Illumina sequencing data from the 1000GP samples were generated at the New York Genome Center with funds provided by NHGRI Grants 3UM1HG008901-03S1 and 3UM1HG008901-04S2.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Abel HJ, 2020, NATURE, V583, P83, DOI 10.1038/s41586-020-2371-0; Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anantharaman TS, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P385; Andrews S., 2010, FASTQC QUALITY CONTR; Audano P. A., 2020, HGSVC KEY CALLSET RE; Audano P. A., 2020, HGSVC KEY CALLSET RE, DOI [10.5281/zenodo.4268828, DOI 10.5281/ZENODO.4268828]; Audano PA, 2019, CELL, V176, P663, DOI 10.1016/j.cell.2018.12.019; Babadi M, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-2287; Bakker B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0971-7; Ballif BC, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-8; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Becker T, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1404-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Bonder M. J., 2019, BIORXIV, DOI [10.1101/784967, DOI 10.1101/784967]; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Byrska-Bishop M., 2021, COLD SPRING HARBOR L; Byrska-Bishop M., HIGH COVERAGE WHOLE; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Carvalho CMB, 2016, NAT REV GENET, V17, P224, DOI 10.1038/nrg.2015.25; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Chaisson MJP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08148-z; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Chen S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1909-7; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Cheng H., 2020, ARXIV Q BIO GN; Chiang C, 2017, NAT GENET, V49, P692, DOI 10.1038/ng.3834; Chikhi R, 2016, BIOINFORMATICS, V32, P201, DOI 10.1093/bioinformatics/btw279; Chin C.-S., 2019, COLD SPRING HARBOR L, P705616; Chin C.-S., 2019, HUMAN GENOME ASSEMBL, P705616, DOI [10.1101/705616, DOI 10.1101/705616]; Collins RL, 2020, NATURE, V581, P444, DOI 10.1038/s41586-020-2287-8; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cotto K. C., 2021, COLD SPRING HARBOR L, P436634; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eberle MA, 2000, GENET EPIDEMIOL, V19, pS29, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI5>3.0.CO;2-P; Ebler J., 2020, COLD SPRING HARBOR L; Ebler J, 2020, PREPRINT BIORXIV, DOI [10.1101/2020.11.11.378133, DOI 10.1101/2020.11.11.378133]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edge P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12493-y; Eizenga JM, 2020, ANNU REV GENOM HUM G, V21, P139, DOI 10.1146/annurev-genom-120219-080406; Evans KL, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0206-6; Fairley S, 2020, NUCLEIC ACIDS RES, V48, pD941, DOI 10.1093/nar/gkz836; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Flasch DA, 2019, CELL, V177, P837, DOI 10.1016/j.cell.2019.02.050; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Gardner EJ, 2017, GENOME RES, V27, P1916, DOI 10.1101/gr.218032.116; Garg S, 2021, NAT BIOTECHNOL, V39, P309, DOI 10.1038/s41587-020-0711-0; Ghareghani M, 2018, BIOINFORMATICS, V34, P115, DOI 10.1093/bioinformatics/bty290; Gong L, 2019, JOVE-J VIS EXP, DOI 10.3791/58954; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Hancks DC, 2016, MOBILE DNA-UK, V7, DOI 10.1186/s13100-016-0065-9; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Heller D., 2020, BIOINFORMATICS; Hiatt S. M., 2020, COLD SPRING HARBOR L; Holley G., 2019, COLD SPRING HARBOR L, P695338; Hsieh P, 2019, SCIENCE, V366, P324, DOI 10.1126/science.aax2083; Huddleston J, 2017, GENOME RES, V27, P677, DOI 10.1101/gr.214007.116; JUKES TH, 1993, COMP BIOCHEM PHYS B, V106, P489, DOI 10.1016/0305-0491(93)90122-L; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Jung H, 2018, GENOME RES, V28, P1136, DOI 10.1101/gr.231837.117; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kamat MA, 2019, BIOINFORMATICS, V35, P4851, DOI 10.1093/bioinformatics/btz469; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Ke Guolin, 2017, ADV NEURAL INFORM PR, P3146; Kearse MG, 2017, GENE DEV, V31, P1717, DOI 10.1101/gad.305250.117; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khelik K, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1748-z; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Kolmogorov M, 2019, NAT BIOTECHNOL, V37, P540, DOI 10.1038/s41587-019-0072-8; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Kronenberg ZN, 2018, SCIENCE, V360, P1085, DOI 10.1126/science.aar6343; Kronenberg ZN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004572; Krueger F., 2012, TRIM GALORE; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Larson DE, 2019, BIOINFORMATICS, V35, P4782, DOI 10.1093/bioinformatics/btz492; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H, 2018, NAT METHODS, V15, P595, DOI 10.1038/s41592-018-0054-7; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li YI, 2018, NAT GENET, V50, P151, DOI 10.1038/s41588-017-0004-9; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; Logsdon G. A., 2020, COLD SPRING HARBOR L; Logsdon G. A., STRUCTURE FUNCTION E; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Lu T.-Y., 2020, HUMAN GENOME STRUCTU, DOI [10.1101/2020.08.13.249839, DOI 10.1101/2020.08.13.249839]; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Marcais G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005944; Marchani EE, 2009, GENOMICS, V94, P78, DOI 10.1016/j.ygeno.2009.04.002; Marschall T, 2018, BRIEF BIOINFORM, V19, P118, DOI 10.1093/bib/bbw089; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin M., 2016, WHATSHAP FAST ACCURA, DOI [10.1101/085050, DOI 10.1101/085050]; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Mikheenko A, 2018, BIOINFORMATICS, V34, P142, DOI 10.1093/bioinformatics/bty266; Miller D. E., 2020, COLD SPRING HARBOR L; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mirauta BA, 2020, ELIFE, V9, DOI 10.7554/eLife.57390; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Seclen SN, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2017-000401; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Nurk S, 2020, GENOME RES, V30, P1291, DOI 10.1101/gr.263566.120; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paten B, 2017, GENOME RES, V27, P665, DOI 10.1101/gr.214155.116; Patterson M, 2015, J COMPUT BIOL, V22, P498, DOI 10.1089/cmb.2014.0157; Poplin R., 2017, SCALING ACCURATE GEN, DOI [10.1101/201178, DOI 10.1101/201178]; Poplin R, 2018, NAT BIOTECHNOL, V36, P983, DOI 10.1038/nbt.4235; Porubsky D, 2021, NAT BIOTECHNOL, V39, P302, DOI 10.1038/s41587-020-0719-5; Porubsky D, 2020, NAT GENET, V52, P849, DOI 10.1038/s41588-020-0646-x; Porubsky D, 2020, BIOINFORMATICS, V36, P1260, DOI 10.1093/bioinformatics/btz681; Porubsky D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01389-4; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Rausch T, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6635-8; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Regier AA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06159-4; Ren J., 2020, COLD SPRING HARBOR L; Ren J., 2020, IRA LONG READ ALIGNE, DOI [10.1101/2020.11.15.383273, DOI 10.1101/2020.11.15.383273]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Martin B, 2020, NAT GENET, V52, P306, DOI 10.1038/s41588-019-0562-0; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Ruan J, 2020, NAT METHODS, V17, P155, DOI 10.1038/s41592-019-0669-3; Salem AH, 2003, J MOL BIOL, V326, P1127, DOI 10.1016/S0022-2836(03)00032-9; Sanders AD, 2020, NAT BIOTECHNOL, V38, P343, DOI 10.1038/s41587-019-0366-x; Sanders AD, 2017, NAT PROTOC, V12, P1151, DOI 10.1038/nprot.2017.029; Sanders AD, 2016, GENOME RES, V26, P1575, DOI 10.1101/gr.201160.115; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116; Scott EC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060131; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Seppey M, 2019, METHODS MOL BIOL, V1962, P227, DOI 10.1007/978-1-4939-9173-0_14; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Shi LL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12065; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Soleimanpour SA, 2014, CELL, V157, P1577, DOI 10.1016/j.cell.2014.05.016; Song L, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0509-9; Speidel Leo, 2019, Nat Genet, V51, P1321, DOI 10.1038/s41588-019-0484-x; Staley JR, 2016, BIOINFORMATICS, V32, P3207, DOI 10.1093/bioinformatics/btw373; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sulovari A, 2019, P NATL ACAD SCI USA, V116, P23243, DOI 10.1073/pnas.1912175116; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tubio JMC, 2014, SCIENCE, V345, P531, DOI 10.1126/science.1251343; Vollger MR, 2020, ANN HUM GENET, V84, P125, DOI 10.1111/ahg.12364; Vollger MR, 2019, NAT METHODS, V16, P88, DOI 10.1038/s41592-018-0236-3; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Wenger AM, 2019, NAT BIOTECHNOL, V37, P1155, DOI 10.1038/s41587-019-0217-9; Xing J, 2006, P NATL ACAD SCI USA, V103, P17608, DOI 10.1073/pnas.0603224103; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zerbino DR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0621-5; Zhao X., 2020, EXPECTATIONS BLIND S, DOI [10.1101/2020.07.03.168831, DOI 10.1101/2020.07.03.168831]; Zhao X., 2020, COLD SPRING HARBOR L; Zhao Xuefang, 2017, GigaScience, V6, P1, DOI 10.1093/gigascience/gix061; Zhou WC, 2020, NUCLEIC ACIDS RES, V48, P1146, DOI 10.1093/nar/gkz1173; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538; Zody MC, 2008, NAT GENET, V40, P1076, DOI 10.1038/ng.193; Zook JM, 2020, NAT BIOTECHNOL, V38, P1347, DOI 10.1038/s41587-020-0538-8; Zook JM, 2019, NAT BIOTECHNOL, V37, P561, DOI 10.1038/s41587-019-0074-6; Zook JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.25	199	124	124	11	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2021	372	6537					48	+	eabf7117	10.1126/science.abf7117	http://dx.doi.org/10.1126/science.abf7117			220	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2IP	33632895	Green Accepted			2022-12-28	WOS:000636049300048
J	Dyer, C				Dyer, Clare			Private provider was wrong to dismiss psychiatrist and refer her to the GMC, tribunal rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2021	372								n655	10.1136/bmj.n655	http://dx.doi.org/10.1136/bmj.n655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UD4OK	33685947				2022-12-28	WOS:000687187000001
J	Sabroe, I; Mather, S; Wilson, A; Hall-Flavin, DK; Fricker, M; Barron, LA; Millard, C				Sabroe, Ian; Mather, Sally; Wilson, Amy; Hall-Flavin, Daniel K.; Fricker, Miranda; Barron, Lauren A.; Millard, Chris			The art of medicine Error, injustice, and physician wellbeing	LANCET			English	Editorial Material									[Sabroe, Ian] SheffieldTeaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Sabroe, Ian] Univ Sheffield, Sch Hlth & Related Res, Fac Med, Sheffield, S Yorkshire, England; [Mather, Sally] Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England; [Millard, Chris] Univ Sheffield, Dept Hist, Sheffield, S Yorkshire, England; [Wilson, Amy] Univ Manchester, Ctr Hist Sci Technol & Med, Manchester, Lancs, England; [Hall-Flavin, Daniel K.] Mayo Clin, Dept Psychiat & Psychol, Rochester, MN USA; [Hall-Flavin, Daniel K.] Mayo Clin, Dolores Jean Lavins Ctr Humanities Med, Rochester, MN USA; [Fricker, Miranda] CUNY, Grad Ctr, Dept Philosophy, New York, NY USA; [Barron, Lauren A.] Baylor Univ, Coll Arts & Sci, Med Humanities Program, Waco, TX 76798 USA	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield; University of Manchester; Mayo Clinic; Mayo Clinic; City University of New York (CUNY) System; Baylor University	Sabroe, I (corresponding author), SheffieldTeaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England.; Sabroe, I (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Fac Med, Sheffield, S Yorkshire, England.	i.sabroe@nhs.net			Churchill Memorial Trust; Dutch Research Council	Churchill Memorial Trust; Dutch Research Council	Ian Sabroe was funded by a Churchill Memorial Trust Fellowship.The authors thank Dr Elianna Fetterolf for many helpful discussions inthe context of her postdoctoral work, funded by the Dutch Research Council,Towards Professional Epistemic Justice: Finance and Medicine.		0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					872	873						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676623	Green Accepted			2022-12-28	WOS:000626603400014
J	McRose, DL; Newman, DK				McRose, Darcy L.; Newman, Dianne K.			Redox-active antibiotics enhance phosphorus bioavailability	SCIENCE			English	Article								Microbial production of antibiotics is common, but our understanding of their roles in the environment is limited. In this study, we explore long-standing observations that microbes increase the production of redox-active antibiotics under phosphorus limitation. The availability of phosphorus, a nutrient required by all life on Earth and essential for agriculture, can be controlled by adsorption to and release from iron minerals by means of redox cycling. Using phenazine antibiotic production by pseudomonads as a case study, we show that phenazines are regulated by phosphorus, solubilize phosphorus through reductive dissolution of iron oxides in the lab and field, and increase phosphorus-limited microbial growth. Phenazines are just one of many examples of phosphorus-regulated antibiotics. Our work suggests a widespread but previously unappreciated role for redox-active antibiotics in phosphorus acquisition and cycling.	[McRose, Darcy L.; Newman, Dianne K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [McRose, Darcy L.; Newman, Dianne K.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Newman, DK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.; Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dkn@caltech.edu		McRose, Darcy/0000-0001-9637-7176	ARO [W911NF-17-1-0024]; NIH [1R01AI127850-01A1]; Biology and Biological Engineering at Caltech; Simons Foundation postdoctoral fellowship in Marine Microbial Ecology	ARO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biology and Biological Engineering at Caltech; Simons Foundation postdoctoral fellowship in Marine Microbial Ecology	This work was supported by grants from the ARO (W911NF-17-1-0024) and NIH (1R01AI127850-01A1) to D.K.N.; D. L.M. was supported by a division postdoctoral fellowship from Biology and Biological Engineering at Caltech, as well as the Simons Foundation postdoctoral fellowship in Marine Microbial Ecology.	Abou-Zeid A A, 1971, Zentralbl Bakteriol Parasitenkd Infektionskr Hyg, V126, P371; ABOUZEID AZ, 1972, ACTA MICROBIOL POL, V4, P83; ASTURIAS JA, 1994, J IND MICROBIOL, V13, P183, DOI 10.1007/BF01584005; BASAK K, 1975, ANTIMICROB AGENTS CH, V8, P391, DOI 10.1128/AAC.8.4.391; BOECK LD, 1973, ANTIMICROB AGENTS CH, V3, P49, DOI 10.1128/AAC.3.1.49; Borch T, 2008, DEV EARTH ENV SCI, V7, P321, DOI 10.1016/S1571-9197(07)07012-7; Brutinel ED, 2012, APPL MICROBIOL BIOT, V93, P41, DOI 10.1007/s00253-011-3653-0; BURTON MO, 1948, CAN J RES C, V26, P15, DOI 10.1139/cjr48c-002; Canarini A, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00157; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chowdhury G, 2012, CHEM RES TOXICOL, V25, P197, DOI 10.1021/tx2004213; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; CROSBY SA, 1984, ESTUAR COAST SHELF S, V19, P257, DOI 10.1016/0272-7714(84)90069-6; Dahlstrom KM, 2020, CURR BIOL, V30, pR1131, DOI 10.1016/j.cub.2020.08.005; Dar D, 2020, ELIFE, V9, DOI 10.7554/eLife.59726; Davies J, 2012, ACS CHEM BIOL, V7, P252, DOI 10.1021/cb200337h; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; DOULL JL, 1990, APPL MICROBIOL BIOT, V32, P449, DOI 10.1007/BF00903781; Du EZ, 2020, NAT GEOSCI, V13, P221, DOI 10.1038/s41561-019-0530-4; FROELICH PN, 1982, AM J SCI, V282, P474, DOI 10.2475/ajs.282.4.474; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glasser NR, 2017, ANNU REV MICROBIOL, V71, P731, DOI 10.1146/annurev-micro-090816-093913; Glockner FO, 2017, J BIOTECHNOL, V261, P169, DOI 10.1016/j.jbiotec.2017.06.1198; Gristwood T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-112; HAAVIK HI, 1974, J GEN MICROBIOL, V84, P226, DOI 10.1099/00221287-84-1-226; HALL MJ, 1970, APPL MICROBIOL, V19, P109, DOI 10.1128/AEM.19.1.109-112.1970; HEGETRESKATIS D, 1992, APPL MICROBIOL BIOT, V36, P440; HOBBS G, 1990, J GEN MICROBIOL, V136, P2291, DOI 10.1099/00221287-136-11-2291; HOEKSEMA H, 1961, Prog Ind Microbiol, V3, P91; Im J, 2013, J MICROBIOL METH, V95, P366, DOI 10.1016/j.mimet.2013.10.005; Jakeman DL, 2006, J IND MICROBIOL BIOT, V33, P767, DOI 10.1007/s10295-006-0113-4; Jensen V, 2006, J BACTERIOL, V188, P8601, DOI 10.1128/JB.01378-06; Jin XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep27393; KIRPEKAR AC, 1991, BIOTECHNOL BIOENG, V38, P1100, DOI 10.1002/bit.260380919; Kishimoto K, 1996, J ANTIBIOT, V49, P775, DOI 10.7164/antibiotics.49.775; KURATSU Y, 1983, J FERMENT TECHNOL, V61, P365; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; LEBRIHI A, 1987, APPL MICROBIOL BIOT, V26, P130, DOI 10.1007/BF00253896; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Levy A, 2018, NAT GENET, V50, P138, DOI 10.1038/s41588-017-0012-9; LILLEY G, 1981, J CHEM TECHNOL BIOT, V31, P127, DOI 10.1002/jctb.280310118; LIRAS P, 1990, TRENDS BIOTECHNOL, V8, P184, DOI 10.1016/0167-7799(90)90170-3; LIRAS P, 1977, J GEN MICROBIOL, V102, P269, DOI 10.1099/00221287-102-2-269; Mallet M, 2013, J COLLOID INTERF SCI, V407, P95, DOI 10.1016/j.jcis.2013.06.049; Martin J. F., 1977, ADV BIOCHEM ENG, V6, P105; Martin JF, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8030087; Martinez-Castro M, 2013, APPL MICROBIOL BIOT, V97, P2139, DOI 10.1007/s00253-012-4364-x; MASUMA R, 1986, J ANTIBIOT, V39, P1557, DOI 10.7164/antibiotics.39.1557; Mavrodi DV, 2012, APPL ENVIRON MICROB, V78, P804, DOI 10.1128/AEM.06784-11; McAlpine K. E., 2020, INT J MOL SCI, V101; McDowall KJ, 1999, J BACTERIOL, V181, P3025, DOI 10.1128/JB.181.10.3025-3032.1999; Mellbye B, 2014, J BACTERIOL, V196, P1155, DOI 10.1128/JB.01223-13; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; MERTZ FP, 1973, CAN J MICROBIOL, V19, P263, DOI 10.1139/m73-040; MULLER PJ, 1984, Z ALLG MIKROBIOL, V24, P555, DOI 10.1002/jobm.3630240812; NAKANO H, 1977, BIOTECHNOL BIOENG, V19, P1009, DOI 10.1002/bit.260190705; Obersteiner M, 2013, NAT GEOSCI, V6, P897, DOI 10.1038/ngeo1990; Ohnishi Y, 2004, J ANTIBIOT, V57, P218, DOI 10.7164/antibiotics.57.218; Peretyazhko T, 2005, GEOCHIM COSMOCHIM AC, V69, P3643, DOI 10.1016/j.gca.2005.03.045; PERLMAN D, 1952, J BACTERIOL, V63, P253, DOI 10.1128/JB.63.2.253-262.1952; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; PROKOFIEVABELGOVSKAYA A, 1959, J GEN MICROBIOL, V20, P462, DOI 10.1099/00221287-20-3-462; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; RAMANKUTTY M, 1969, INDIAN J BIOCHEM, V6, P230; RCoreTeam, 2020, R PROJECT STAT COMPU; REBOLLO A, 1989, GENE, V79, P47, DOI 10.1016/0378-1119(89)90091-7; Recinos DA, 2012, P NATL ACAD SCI USA, V109, P19420, DOI 10.1073/pnas.1213901109; Redfield A. C., 1934, P176; Rodriguez H, 1999, BIOTECHNOL ADV, V17, P319, DOI 10.1016/S0734-9750(99)00014-2; Romano S, 2015, APPL ENVIRON MICROB, V81, P3518, DOI 10.1128/AEM.04167-14; Rowe AR, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00784; Santos-Beneit F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00402; Santos-Beneit F, 2009, MOL MICROBIOL, V72, P53, DOI 10.1111/j.1365-2958.2009.06624.x; Schwertmann U., 2000, IRON OXIDES LAB PREP, DOI DOI 10.1002/9783527613229; Seyedsayamdost MR, 2010, ORG LETT, V12, P716, DOI 10.1021/ol902751x; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; STUMM W, 1992, GEOCHIM COSMOCHIM AC, V56, P3233, DOI 10.1016/0016-7037(92)90301-X; Sullivan NL, 2011, ACS CHEM BIOL, V6, P893, DOI 10.1021/cb200094w; Sunda W.G., 2005, ALGAE CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; van Rij ET, 2004, MOL PLANT MICROBE IN, V17, P557, DOI 10.1094/MPMI.2004.17.5.557; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; VANDAMME EJ, 1976, ANTIMICROB AGENTS CH, V10, P265, DOI 10.1128/AAC.10.2.265; VUTRONG K, 1981, ANTIMICROB AGENTS CH, V19, P209, DOI 10.1128/AAC.19.2.209; Wang XM, 2013, ENVIRON SCI TECHNOL, V47, P10322, DOI 10.1021/es401301z; Wang Y, 2008, ENVIRON SCI TECHNOL, V42, P2380, DOI 10.1021/es702290a; WHOOLEY MA, 1982, EUR J APPL MICROBIOL, V15, P161, DOI 10.1007/BF00511241; WITNEY FR, 1977, APPL ENVIRON MICROB, V33, P1042, DOI 10.1128/AEM.33.5.1042-1046.1977; Wu TW, 2019, CHEM ENG J, V366, P577, DOI 10.1016/j.cej.2019.02.128; Yang RJ, 2015, APPL MICROBIOL BIOT, V99, P10547, DOI 10.1007/s00253-015-6921-6; Zhang LL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00289; ZYGMUNT WA, 1964, APPL MICROBIOL, V12, P195, DOI 10.1128/AEM.12.3.195-196.1964; ZYUZINA ML, 1979, ANTIBIOT MED BIOTEK, V24, P656	97	25	27	59	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1033	+		10.1126/science.abd1515	http://dx.doi.org/10.1126/science.abd1515			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674490	Green Accepted			2022-12-28	WOS:000625876100051
J	Stockmaier, S; Stroeymeyt, N; Shattuck, EC; Hawley, DM; Meyers, LA; Bolnick, DI				Stockmaier, Sebastian; Stroeymeyt, Nathalie; Shattuck, Eric C.; Hawley, Dana M.; Meyers, Lauren Ancel; Bolnick, Daniel I.			Infectious diseases and social distancing in nature	SCIENCE			English	Review							ANIMAL BEHAVIOR; IMMUNE-SYSTEM; NO EVIDENCE; TRANSMISSION; EVOLUTION; AVOIDANCE; COMMUNICATION; CONSEQUENCES; MECHANISMS; NETWORKS	Spread of contagious pathogens critically depends on the number and types of contacts between infectious and susceptible hosts. Changes in social behavior by susceptible, exposed, or sick individuals thus have far-reaching downstream consequences for infectious disease spread. Although "social distancing" is now an all too familiar strategy for managing COVID-19, nonhuman animals also exhibit pathogen-induced changes in social interactions. Here, we synthesize the effects of infectious pathogens on social interactions in animals (including humans), review what is known about underlying mechanisms, and consider implications for evolution and epidemiology.	[Stockmaier, Sebastian; Meyers, Lauren Ancel] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Stroeymeyt, Nathalie] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Shattuck, Eric C.] Univ Texas San Antonio, Inst Hlth Dispar Res, San Antonio, TX USA; [Hawley, Dana M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Bolnick, Daniel I.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA	University of Texas System; University of Texas Austin; University of Bristol; University of Texas System; University of Texas at San Antonio (UTSA); Virginia Polytechnic Institute & State University; University of Connecticut	Stockmaier, S (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	sebastian.stockmaier@utexas.edu	; Stroeymeyt, Nathalie/H-2371-2013; Bolnick, Daniel/G-4440-2015	Hawley, Dana/0000-0001-9573-2914; Meyers, Lauren/0000-0002-5828-8874; Shattuck, Eric/0000-0002-3615-5931; Stroeymeyt, Nathalie/0000-0001-8047-449X; Stockmaier, Sebastian/0000-0001-8280-8086; Bolnick, Daniel/0000-0003-3148-6296	European Research Council (ERC) [802628]	European Research Council (ERC)(European Research Council (ERC)European Commission)	N.S. was supported by a European Research Council (ERC Starting Grant DISEASE no. 802628).	Adelman JS, 2017, HORM BEHAV, V88, P79, DOI 10.1016/j.yhbeh.2016.10.013; Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Almberg ES, 2015, ECOL LETT, V18, P660, DOI 10.1111/ele.12444; ANDERSON R M, 1991; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Aronsson G, 2005, J OCCUP ENVIRON MED, V47, P958, DOI 10.1097/01.jom.0000177219.75677.17; Axelsson J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2430; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bansal Shweta, 2010, Journal of Biological Dynamics, V4, P478, DOI 10.1080/17513758.2010.503376; Baracchi D, 2012, J INSECT PHYSIOL, V58, P1589, DOI 10.1016/j.jinsphys.2012.09.014; Barrett ES, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05587-2; Behringer DC, 2006, NATURE, V441, P421, DOI 10.1038/441421a; Boillat M, 2015, CURR BIOL, V25, P251, DOI 10.1016/j.cub.2014.11.061; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Bulmer MS, 2019, INSECTS, V10, DOI 10.3390/insects10080240; CHEESEMAN CL, 1981, J ZOOL, V194, P284, DOI 10.1111/j.1469-7998.1981.tb05780.x; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cremer S, 2018, ANNU REV ENTOMOL, V63, P105, DOI 10.1146/annurev-ento-020117-043110; Curtis V, 2011, PHILOS T R SOC B, V366, P3478, DOI 10.1098/rstb.2011.0165; Curtis VA, 2014, TRENDS IMMUNOL, V35, P457, DOI 10.1016/j.it.2014.08.006; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; Ewald P W, 1991, Hum Nat, V2, P1, DOI 10.1007/BF02692179; Ezenwa VO, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3078; Fairbanks BM, 2015, BEHAV ECOL SOCIOBIOL, V69, P371, DOI 10.1007/s00265-014-1849-x; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Geffre AC, 2020, P NATL ACAD SCI USA, V117, P10406, DOI 10.1073/pnas.2002268117; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hammerstein P, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0101; Hart BL, 2011, PHILOS T R SOC B, V366, P3406, DOI 10.1098/rstb.2011.0092; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Hawley DM, 2021, PARASITOLOGY, V148, P274, DOI 10.1017/S0031182020002048; Hawley DM, 2011, INTEGR COMP BIOL, V51, P528, DOI 10.1093/icb/icr062; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; Kazlauskas N, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00261; Kelley KW, 2003, BRAIN BEHAV IMMUN, V17, pS112; Kessler SE, 2017, J HUM EVOL, V108, P92, DOI 10.1016/j.jhevol.2017.02.009; Klein SL, 2003, PHYSIOL BEHAV, V79, P441, DOI 10.1016/S0031-9384(03)00163-X; Konrad M, 2018, P NATL ACAD SCI USA, V115, P2782, DOI 10.1073/pnas.1713501115; Konrad M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001300; Kurzban R, 2015, ANNU REV PSYCHOL, V66, P575, DOI 10.1146/annurev-psych-010814-015355; Lasselin J, 2018, PSYCHONEUROENDOCRINO, V87, P188, DOI 10.1016/j.psyneuen.2017.10.024; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Lopes PC, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.00172; Lopes PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35174-0; Lopes PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31790; Lopes PC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0218; Lopes PC, 2012, BEHAV ECOL SOCIOBIOL, V66, P1421, DOI 10.1007/s00265-012-1397-1; Martin LB, 2008, FUNCT ECOL, V22, P68, DOI 10.1111/j.1365-2435.2007.01347.x; McGrail DJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236619; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Mossad SB, 2017, INFECT CONT HOSP EP, V38, P966, DOI 10.1017/ice.2017.91; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Olsson MJ, 2014, PSYCHOL SCI, V25, P817, DOI 10.1177/0956797613515681; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033; Poirotte C, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2019.0869; Poirotte C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601721; Poulin R, 1995, INT J PARASITOL, V25, P1371, DOI 10.1016/0020-7519(95)00100-X; Pull CD, 2018, ELIFE, V7, DOI 10.7554/eLife.32073; Renault J, 2008, BRAIN BEHAV IMMUN, V22, P1201, DOI 10.1016/j.bbi.2008.05.008; Ripperger SP, 2020, BEHAV ECOL, V31, P1296, DOI 10.1093/beheco/araa111; Rizzo A, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042801; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P544, DOI 10.1007/s001140050672; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; Schaller M, 2011, PHILOS T R SOC B, V366, P3418, DOI 10.1098/rstb.2011.0029; Schaller M, 2010, PSYCHOL SCI, V21, P649, DOI 10.1177/0956797610368064; Scott S., 2001, BIOL PLAGUES EVIDENC; Shakhar K, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002276; Shattuck EC, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00004; Shattuck EC, 2015, AM J PHYS ANTHROPOL, V157, P1, DOI 10.1002/ajpa.22698; Skolnick AJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00091; Smith JE, 2021, J ANIM ECOL, V90, P62, DOI 10.1111/1365-2656.13362; Stephenson JF, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0557; Stephenson JF, 2018, J ANIM ECOL, V87, P1525, DOI 10.1111/1365-2656.12885; Stockmaier S, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0272; Stockmaier S, 2020, J ANIM ECOL, V89, P1387, DOI 10.1111/1365-2656.13193; Stroeymeyt N, 2018, SCIENCE, V362, P941, DOI 10.1126/science.aat4793; Stroeymeyt N, 2014, CURR OPIN INSECT SCI, V5, P1, DOI 10.1016/j.cois.2014.09.001; Townsend AK, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1039; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Tybur JM, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0204; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196; Watts DP, 2020, PRIMATES, V61, P55, DOI 10.1007/s10329-019-00735-y; Weinstein SB, 2018, SCIENCE, V359, P1213, DOI 10.1126/science.aas8694	92	45	45	24	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1007	+	eabc8881	10.1126/science.abc8881	http://dx.doi.org/10.1126/science.abc8881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674468	Green Submitted			2022-12-28	WOS:000625876100041
J	Arrazola, JM; Bergholm, V; Bradler, K; Bromley, TR; Collins, MJ; Dhand, I; Fumagalli, A; Gerrits, T; Goussev, A; Helt, LG; Hundal, J; Isacsson, T; Israel, RB; Izaac, J; Jahangiri, S; Janik, R; Killoran, N; Kumar, SP; Lavoie, J; Lita, AE; Mahler, DH; Menotti, M; Morrison, B; Nam, SW; Neuhaus, L; Qi, HY; Quesada, N; Repingon, A; Sabapathy, KK; Schuld, M; Su, D; Swinarton, J; Szava, A; Tan, K; Tan, P; Vaidya, VD; Vernon, Z; Zabaneh, Z; Zhang, Y				Arrazola, J. M.; Bergholm, V; Bradler, K.; Bromley, T. R.; Collins, M. J.; Dhand, I; Fumagalli, A.; Gerrits, T.; Goussev, A.; Helt, L. G.; Hundal, J.; Isacsson, T.; Israel, R. B.; Izaac, J.; Jahangiri, S.; Janik, R.; Killoran, N.; Kumar, S. P.; Lavoie, J.; Lita, A. E.; Mahler, D. H.; Menotti, M.; Morrison, B.; Nam, S. W.; Neuhaus, L.; Qi, H. Y.; Quesada, N.; Repingon, A.; Sabapathy, K. K.; Schuld, M.; Su, D.; Swinarton, J.; Szava, A.; Tan, K.; Tan, P.; Vaidya, V. D.; Vernon, Z.; Zabaneh, Z.; Zhang, Y.			Quantum circuits with many photons on a programmable nanophotonic chip	NATURE			English	Article							GENERATION; STATES; LIGHT	Growing interest in quantum computing for practical applications has led to a surge in the availability of programmable machines for executing quantum algorithms(1,2). Present-day photonic quantum computers(3-7) have been limited either to non-deterministic operation, low photon numbers and rates, or fixed random gate sequences. Here we introduce a full-stack hardware-software system for executing many-photon quantum circuit operations using integrated nanophotonics: a programmable chip, operating at room temperature and interfaced with a fully automated control system. The system enables remote users to execute quantum algorithms that require up to eight modes of strongly squeezed vacuum initialized as two-mode squeezed states in single temporal modes, a fully general and programmable four-mode interferometer, and photon number-resolving readout on all outputs. Detection of multi-photon events with photon numbers and rates exceeding any previous programmable quantum optical demonstration is made possible by strong squeezing and high sampling rates. We verify the non-classicality of the device output, and use the platform to carry out proof-of-principle demonstrations of three quantum algorithms: Gaussian boson sampling, molecular vibronic spectra and graph similarity(8). These demonstrations validate the platform as a launchpad for scaling photonic technologies for quantum information processing.	[Arrazola, J. M.; Bergholm, V; Bradler, K.; Bromley, T. R.; Collins, M. J.; Dhand, I; Fumagalli, A.; Gerrits, T.; Goussev, A.; Helt, L. G.; Hundal, J.; Isacsson, T.; Israel, R. B.; Izaac, J.; Jahangiri, S.; Janik, R.; Killoran, N.; Kumar, S. P.; Lavoie, J.; Mahler, D. H.; Menotti, M.; Morrison, B.; Neuhaus, L.; Qi, H. Y.; Quesada, N.; Repingon, A.; Sabapathy, K. K.; Schuld, M.; Su, D.; Swinarton, J.; Szava, A.; Tan, K.; Tan, P.; Vaidya, V. D.; Vernon, Z.; Zabaneh, Z.; Zhang, Y.] Xanadu, Toronto, ON, Canada; [Lita, A. E.; Nam, S. W.] NIST, Boulder, CO USA	National Institute of Standards & Technology (NIST) - USA	Arrazola, JM; Vernon, Z (corresponding author), Xanadu, Toronto, ON, Canada.	juanmiguel@xanadu.ai; zach@xanadu.ai	Helt, Luke/E-9545-2013	Helt, Luke/0000-0003-0346-2342; Arrazola, Juan Miguel/0000-0002-0619-9650; Sabapathy, Krishnakumar/0000-0003-3107-6844; Izaac, Joshua/0000-0003-2640-0734; Zabaneh, Zeid/0000-0003-2212-2968				Aaronson S, 2011, ACM S THEORY COMPUT, P333; Anschuetz E, 2019, LECT NOTES COMPUT SC, V11413, P74, DOI 10.1007/978-3-030-14082-3_7; Arrazola JM, 2019, PHYS REV A, V100, DOI 10.1103/PhysRevA.100.032306; Arrazola JM, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.030503; Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Asavanant W, 2019, SCIENCE, V366, P373, DOI 10.1126/science.aay2645; AYTUR O, 1990, PHYS REV LETT, V65, P1551, DOI 10.1103/PhysRevLett.65.1551; Banchi L, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax1950; Bradler K., 2018, GRAPH ISOMORPHISM GA; Bradler K., 2019, DUALITY HEART GAUSSI; Bradler K, 2018, PHYS REV A, V98, DOI 10.1103/PhysRevA.98.032310; Brod DJ, 2020, QUANTUM-AUSTRIA, V4, DOI 10.22331/q-2020-05-14-267; Bromley TR, 2020, QUANTUM SCI TECHNOL, V5, DOI 10.1088/2058-9565/ab8504; Burenkov IA, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.053806; CAIANIELLO ER, 1953, NUOVO CIMENTO, V10, P1634, DOI 10.1007/BF02781659; Christ A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033027; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Clements WR, 2016, OPTICA, V3, P1460, DOI 10.1364/OPTICA.3.001460; Dumitrescu EF, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.210501; Fluhmann C, 2019, NATURE, V566, P513, DOI 10.1038/s41586-019-0960-6; GLAUBER RJ, 1963, PHYS REV, V131, P2766, DOI 10.1103/PhysRev.131.2766; Hamilton CS, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.170501; Huh J, 2015, NAT PHOTONICS, V9, P615, DOI [10.1038/nphoton.2015.153, 10.1038/NPHOTON.2015.153]; Humphreys PC, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/10/103044; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Killoran N, 2019, PHYS REV RES, V1, DOI 10.1103/PhysRevResearch.1.033063; Larsen MV, 2019, SCIENCE, V366, P369, DOI 10.1126/science.aay4354; Levine ZH, 2012, J OPT SOC AM B, V29, P2066, DOI 10.1364/JOSAB.29.002066; Lund AP, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.100502; Lvovsky A.I., 2015, PHOTONICS-BASEL, P121, DOI DOI 10.1002/9781119009719.CH5; Mebel AM, 1999, J PHYS CHEM A, V103, P10674, DOI 10.1021/jp992429m; Muller CW, 2010, PHYS CHEM CHEM PHYS, V12, P2331, DOI 10.1039/b919912h; Nielsen, 2010, QUANTUM COMPUTATION; Paesani S, 2019, NAT PHYS, V15, P925, DOI 10.1038/s41567-019-0567-8; Pfeiffer MHP, 2018, IEEE J SEL TOP QUANT, V24, DOI 10.1109/JSTQE.2018.2808258; Preskill J, 2018, QUANTUM-AUSTRIA, V2, DOI 10.22331/q-2018-08-06-79; Qiang XG, 2018, NAT PHOTONICS, V12, P534, DOI 10.1038/s41566-018-0236-y; Quesada N, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5086387; Rahimi-Keshari S, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021039; Rosenberg D, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.061803; Rudolph T, 2017, APL PHOTONICS, V2, DOI 10.1063/1.4976737; Sawaya N. P., 2020, NEAR LONG TERM QUANT NEAR LONG TERM QUANT; Schuld M, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.032314; SHARP TE, 1964, J CHEM PHYS, V41, P3453, DOI 10.1063/1.1725748; Sudarshan E. C. G., 1963, PHYS REV LETT, V10, P277, DOI 10.1103/PhysRevLett.10.277; Vaidya VD, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba9186; Vignat C, 2012, STAT PROBABIL LETT, V82, P67, DOI 10.1016/j.spl.2011.09.008; Wang JW, 2020, NAT PHOTONICS, V14, P273, DOI 10.1038/s41566-019-0532-1; Wootton JR, 2018, PHYS REV A, V97, DOI 10.1103/PhysRevA.97.052313; Wright K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13534-2; Zhong HS, 2019, SCI BULL, V64, P511, DOI 10.1016/j.scib.2019.04.007	56	135	135	47	154	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					54	+		10.1038/s41586-021-03202-1	http://dx.doi.org/10.1038/s41586-021-03202-1			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TY4DI	33658692	Green Submitted			2022-12-28	WOS:000683733800001
J	del Rio, C; Malani, P				del Rio, Carlos; Malani, Preeti			COVID-19 in 2021-Continuing Uncertainty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint summarizes the current best evidence about COVID-19 vaccines, immunity, and whether SARS-CoV-2 will become an endemic or seasonal virus.	[del Rio, Carlos] Emory Univ, Sch Med, Dept Internal Med, Div Infect Dis, Atlanta, GA USA; [Malani, Preeti] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA	Emory University; University of Michigan System; University of Michigan	del Rio, C (corresponding author), Emory Univ, Sch Med, 49 Jesse Hill Jr Dr,FOB,Room 201, Atlanta, GA 30303 USA.	cdelrio@emory.edu	del Rio, Carlos/B-3763-2012	del Rio, Carlos/0000-0002-0153-3517				CDC, INT CLIN CONS US MRN; Creech CB., JAMA-J AM MED ASSOC; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Hamel L, 2020, KFF COVID 19 VACCINE; Iacobucci Gareth, 2021, BMJ, V372, pn18, DOI 10.1136/bmj.n18; Krammer F, MEDRXIV, DOI [10.1101/2021.01.29.21250653, DOI 10.1101/2021.01.29.21250653]; Moore JP, 2021, JAMA-J AM MED ASSOC, V325, P821, DOI 10.1001/jama.2021.1114; Salmon DA, 2015, AM J PREV MED, V49, pS391, DOI 10.1016/j.amepre.2015.06.009; US FDA Vaccines and Related Biological Products Advisory Committee, 2021, VACC REL BIOL PROD A	9	21	21	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2021	325	14					1389	1390		10.1001/jama.2021.3760	http://dx.doi.org/10.1001/jama.2021.3760		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9GZ	33662092	Bronze			2022-12-28	WOS:000625440200003
J	Liu, SJ; Hua, Y; Wang, JN; Li, LY; Yuan, JJ; Zhang, B; Wang, ZY; Ji, JG; Kong, DC				Liu, Sijie; Hua, Yu; Wang, Jingna; Li, Lingyan; Yuan, Junjie; Zhang, Bo; Wang, Ziyang; Ji, Jianguo; Kong, Daochun			RNA polymerase III is required for the repair of DNA double-strand breaks by homologous recombination	CELL			English	Article								End resection in homologous recombination (HR) and HR-mediated repair of DNA double-strand breaks (DSBs) removes several kilobases from 50 strands of DSBs, but 30 strands are exempted from degradation. The mechanism by which the 30 overhangs are protected has not been determined. Here, we established that the protection of 30 overhangs is achieved through the transient formation of RNA-DNA hybrids. The DNA strand in the hybrids is the 30 ssDNA overhang, while the RNA strand is newly synthesized. RNA polymerase III (RNAPIII) is responsible for synthesizing the RNA strand. Furthermore, RNAPIII is actively recruited to DSBs by the MRN complex. CtIP and MRN nuclease activity is required for initiating the RNAPIII-mediated RNA synthesis at DSBs. A reduced level of RNAPIII suppressed HR, and genetic loss > 30 bp increased at DSBs. Thus, RNAPIII is an essential HR factor, and the RNA-DNA hybrid is an essential repair intermediate for protecting the 30 overhangs in DSB repair.	[Liu, Sijie; Hua, Yu; Wang, Jingna; Li, Lingyan; Yuan, Junjie; Zhang, Bo; Wang, Ziyang; Ji, Jianguo; Kong, Daochun] Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Kong, DC (corresponding author), Peking Univ, Coll Life Sci, Peking Tsinghua Ctr Life Sci, Natl Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	kongdc@pku.edu.cn		Yuan, Junjie/0000-0001-5529-9677	Ministry of Science and Technology of China [2016YFA0500301, 2013CB911000]; National Natural Science Foundation of China [31230021]; Peking-Tsinghua Center for Life Sciences; National Key Laboratory of Protein and Plant Gene Research	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking-Tsinghua Center for Life Sciences; National Key Laboratory of Protein and Plant Gene Research	We thank all members of the Kong Laboratory for discussion and support, X. Xu (Capital Normal University) for help in laser micropoint microscopic analysis, Jun Huang (Zhejiang University) for providing DR-GFP cells that were originally from Dr. M. Jasin's lab, and X. Zhou for mass spectroscopy. This work was supported by grants from the Ministry of Science and Technology of China (2016YFA0500301 and 2013CB911000), the National Natural Science Foundation of China (no. 31230021), the Peking-Tsinghua Center for Life Sciences, and the National Key Laboratory of Protein and Plant Gene Research. We thank National Center for Protein Sciences (Beijing) at Peking University for assistance with FACS and laser micropoint irradiation assays.	Aguilera A, 2017, NAT STRUCT MOL BIOL, V24, P439, DOI 10.1038/nsmb.3395; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Beck C, 2014, EXP CELL RES, V329, P18, DOI 10.1016/j.yexcr.2014.07.003; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Daley JM, 2015, DNA REPAIR, V32, P66, DOI 10.1016/j.dnarep.2015.04.015; Deshpande RA, 2016, MOL CELL, V64, P593, DOI 10.1016/j.molcel.2016.10.010; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Haber JE, 2004, PHILOS T ROY SOC B, V359, P79, DOI 10.1098/rstb.2003.1367; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hu JZ, 2012, CELL, V149, P1221, DOI 10.1016/j.cell.2012.04.030; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Leland BA, 2018, ELIFE, V7, DOI 10.7554/eLife.33402; Li L, 2016, MOL CELL BIOL, V36, P2794, DOI 10.1128/MCB.00415-16; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Marcon E, 2005, BIOESSAYS, V27, P795, DOI 10.1002/bies.20264; Mehta A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016428; Michalik KM, 2012, NUCLEIC ACIDS RES, V40, P9596, DOI 10.1093/nar/gks711; Michelini F, 2017, NAT CELL BIOL, V19, P1400, DOI 10.1038/ncb3643; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2017, SCIENCE, V355, P40, DOI 10.1126/science.aak9704; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Ohle C, 2016, CELL, V167, P1001, DOI 10.1016/j.cell.2016.10.001; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Persky NS, 2008, CRIT REV BIOCHEM MOL, V43, P347, DOI [10.1080/10409230802485358, 10.1080/10409230802485358 ]; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Plosky BS, 2016, MOL CELL, V64, P643, DOI 10.1016/j.molcel.2016.11.010; Przetocka S, 2018, MOL CELL, V72, P568, DOI 10.1016/j.molcel.2018.09.014; Roeder R G, 1976, Symp Soc Dev Biol, P29; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroder O, 2003, P NATL ACAD SCI USA, V100, P934, DOI 10.1073/pnas.242735699; Seidl CI, 2013, NUCLEIC ACIDS RES, V41, P2552, DOI 10.1093/nar/gks1334; Sturzenegger A, 2014, J BIOL CHEM, V289, P27314, DOI 10.1074/jbc.M114.578823; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Wei HT, 2016, GENOM PROTEOM BIOINF, V14, P131, DOI 10.1016/j.gpb.2016.05.001; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Yan H, 2005, J CELL BIOL, V171, P217, DOI 10.1083/jcb.200502077; Zhang HM, 2016, J BIOL CHEM, V291, P24961, DOI 10.1074/jbc.M116.755991; Zhao WX, 2017, NATURE, V550, P360, DOI 10.1038/nature24060; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	55	50	51	14	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1314	+		10.1016/j.cell.2021.01.048	http://dx.doi.org/10.1016/j.cell.2021.01.048		MAR 2021	26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33626331	Bronze			2022-12-28	WOS:000629635700018
J	Zhang, JY				Zhang, Joy Y.			To keep nationalism in check, nurture science solidarity	NATURE			English	Editorial Material									[Zhang, Joy Y.] Univ Kent, Canterbury, Kent, England	University of Kent	Zhang, JY (corresponding author), Univ Kent, Canterbury, Kent, England.	yz203@kent.ac.uk	Zhang, Joy/HGB-8816-2022						0	0	0	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					9	9						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QQ5WB	33654299	Bronze			2022-12-28	WOS:000624594200002
J	Chernew, ME; Pany, MJ				Chernew, Michael E.; Pany, Maximilian J.			Regulation of Health Care Prices The Case for Backstop Price Caps in Commercial Health Care Markets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint reviews evidence that higher hospital prices reflect greater market power more than higher-quality services and proposes that backstop price caps can mitigate harms from the most excessive prices without constraining or distorting competitive health care markets.	[Chernew, Michael E.; Pany, Maximilian J.] Harvard Med Sch, Boston, MA 02115 USA; [Pany, Maximilian J.] Harvard Sch Business, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University	Chernew, ME (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	chernew@hcp.med.harvard.edu						Baum A, 2019, HEALTH AFFAIR, V38, P237, DOI 10.1377/hlthaff.2018.05164; Beaulieu ND, 2020, NEW ENGL J MED, V382, P51, DOI 10.1056/NEJMsa1901383; Bhargava S, 2017, Q J ECON, V132, P1319, DOI 10.1093/qje/qjx011; Chernew ME, 2020, HEALTH AFFAIR, V39, P791, DOI 10.1377/hlthaff.2019.01377; White C, 2019, PRICES PAID HOSPITAL, DOI 10.7249/RR3033	5	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					817	818		10.1001/jama.2020.26821	http://dx.doi.org/10.1001/jama.2020.26821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS4AP	33651096				2022-12-28	WOS:000625843100004
J	Stead, W				Stead, Wendy			It's Not Your Fault	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay an infectious diseases physician shares the sense of forgiveness she brings to anyone possibly involved in COVID-19 transmission, having learned as a child the healing power of family absolution after she witnessed the death of a cousin.	[Stead, Wendy] Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St,Lowry Med Off Bldg,Suite GB, Boston, MA 02215 USA; [Stead, Wendy] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Stead, W (corresponding author), Beth Israel Deaconess Med Ctr, Div Infect Dis, 110 Francis St,Lowry Med Off Bldg,Suite GB, Boston, MA 02215 USA.	wstead@bidmc.harvard.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					827	828		10.1001/jama.2021.0255	http://dx.doi.org/10.1001/jama.2021.0255			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651093				2022-12-28	WOS:000625843100009
J	Owens, DC				Owens, Deirdre Cooper			Listening to Black women saves Black lives	LANCET			English	Editorial Material									[Owens, Deirdre Cooper] Univ Nebraska, Dept Hist, Lincoln, NE 68588 USA; [Owens, Deirdre Cooper] Univ Nebraska, Humanities Med Program, Lincoln, NE 68588 USA; [Owens, Deirdre Cooper] Lib Co Philadelphia, Program African Amer Hist, Philadelphia, PA 19107 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Owens, DC (corresponding author), Univ Nebraska, Dept Hist, Lincoln, NE 68588 USA.; Owens, DC (corresponding author), Univ Nebraska, Humanities Med Program, Lincoln, NE 68588 USA.; Owens, DC (corresponding author), Lib Co Philadelphia, Program African Amer Hist, Philadelphia, PA 19107 USA.	dcooperowens2@unl.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					788	789						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640056				2022-12-28	WOS:000623925500017
J	Olsen, Y; Fitzgerald, RM; Wakeman, SE				Olsen, Yngvild; Fitzgerald, Ruchi M.; Wakeman, Sarah E.			Overcoming Barriers to Treatment of Opioid Use Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Olsen, Yngvild] Inst Behav Resources Inc, 2104 Maryland Ave, Baltimore, MD 21218 USA; [Fitzgerald, Ruchi M.] Rush Univ, Chicago, IL 60612 USA; [Wakeman, Sarah E.] Massachusetts Gen Hosp, Med, Charlestown, MA USA	Rush University; Harvard University; Massachusetts General Hospital	Olsen, Y (corresponding author), Inst Behav Resources Inc, 2104 Maryland Ave, Baltimore, MD 21218 USA.	yngvild.olsen@gmail.com						Department of Health and Human Services, HHS EXP ACC TREATM O; Duncan A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14045; Ghertner R, 2020, PSYCHIAT SERV, V71, P971, DOI 10.1176/appi.ps.201900635; Huhn AS, 2017, J SUBST ABUSE TREAT, V78, P1, DOI 10.1016/j.jsat.2017.04.005; Sordo L, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1550; Substance Abuse and Mental Health Services Administration, STAT REG X WAIV	6	10	10	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2021	325	12					1149	1150		10.1001/jama.2021.1741	http://dx.doi.org/10.1001/jama.2021.1741		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7PB	33630021				2022-12-28	WOS:000621911900001
J	Chokshi, DA				Chokshi, Dave A.			From Economic Recovery to Health Resilience	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Chokshi, Dave A.] New York City Dept Hlth & Hyg, 42-09 28th St, New York, NY 11101 USA		Chokshi, DA (corresponding author), New York City Dept Hlth & Hyg, 42-09 28th St, New York, NY 11101 USA.	dave.chokshi@alumni.duke.edu							0	2	2	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					710	711		10.1001/jama.2020.24936	http://dx.doi.org/10.1001/jama.2020.24936			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620391	Bronze			2022-12-28	WOS:000621957400002
J	Colla, C				Colla, Carrie			Surprise Billing-A Flashpoint for Major Policy Issues in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Colla, Carrie] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03755 USA	Dartmouth College	Colla, C (corresponding author), Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03755 USA.	carrie.h.colla@dartmouth.edu						Adler L, 2019, EXPERIENCE NEW YORKS; Cooper Z, 2020, J POLIT ECON, V128, P3626, DOI 10.1086/708819; Cooper Z, 2020, HEALTH AFFAIR, V39, P24, DOI 10.1377/hlthaff.2019.00507; Duffy EL, 2020, AM J MANAG CARE, V26, P401, DOI 10.37765/ajmc.2020.88491; Fisher R., 1991, GETTING YES NEGOTIAT; House Committee on Energy and Commerce, 2020, NO SURPR ACT; Pollitz Karen, 2020, JAMA, V323, P498, DOI 10.1001/jama.2020.0065; United States Government Accountability Office, 2019, AIR AMBULANCE AVAILA; Whaley CM., 2020, NATIONWIDE EVALUATIO; Zhu JNM, 2020, JAMA-J AM MED ASSOC, V323, P663, DOI 10.1001/jama.2019.21844	10	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					715	716		10.1001/jama.2020.26779	http://dx.doi.org/10.1001/jama.2020.26779			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620413				2022-12-28	WOS:000621957400013
J	Sevransky, JE; Rothman, RE; Hager, DN; Bernard, GR; Brown, SM; Buchman, TG; Busse, LW; Coopersmith, CM; DeWilde, C; Ely, W; Eyzaguirre, LM; Fowler, AA; Gaieski, DF; Gong, MN; Hall, A; Hinson, JS; Hooper, MH; Kelen, GD; Khan, A; Levine, MA; Lewis, RJ; Lindsell, CJ; Marlin, JS; McGlothlin, A; Moore, BL; Nugent, KL; Nwosu, S; Polito, CC; Rice, TW; Ricketts, EP; Rudolph, CC; Sanfilippo, F; Viele, K; Martin, GS; Wright, DW				Sevransky, Jonathan E.; Rothman, Richard E.; Hager, David N.; Bernard, Gordon R.; Brown, Samuel M.; Buchman, Timothy G.; Busse, Laurence W.; Coopersmith, Craig M.; DeWilde, Christine; Ely, Wesley; Eyzaguirre, Lindsay M.; Fowler, Alpha A.; Gaieski, David F.; Gong, Michelle N.; Hall, Alex; Hinson, Jeremiah S.; Hooper, Michael H.; Kelen, Gabor D.; Khan, Akram; Levine, Mark A.; Lewis, Roger J.; Lindsell, Chris J.; Marlin, Jessica S.; McGlothlin, Anna; Moore, Brooks L.; Nugent, Katherine L.; Nwosu, Samuel; Polito, Carmen C.; Rice, Todd W.; Ricketts, Erin P.; Rudolph, Caroline C.; Sanfilippo, Fred; Viele, Kert; Martin, Greg S.; Wright, David W.		VICTAS Investigators	Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis The VICTAS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-FAILURE; SEPTIC SHOCK; ASCORBIC-ACID; ORGAN FAILURE; INJURY	IMPORTANCE Sepsis is a common syndrome with substantial morbidity and mortality. A combination of vitamin C, thiamine, and corticosteroids has been proposed as a potential treatment for patients with sepsis. OBJECTIVE To determine whether a combination of vitamin C, thiamine, and hydrocortisone every 6 hours increases ventilator- and vasopressor-free days compared with placebo in patients with sepsis. DESIGN, SETTING, AND PARTICIPANTS Multicenter, randomized, double-blind, adaptive-sample-size, placebo-controlled trial conducted in adult patients with sepsis-induced respiratory and/or cardiovascular dysfunction. Participants were enrolled in the emergency departments or intensive care units at 43 hospitals in the United States between August 2018 and July 2019. After enrollment of 501 participants, funding was withheld, leading to an administrative termination of the trial. All study-related follow-up was completed by January 2020. INTERVENTIONS Participants were randomized to receive intravenous vitamin C (1.5 g), thiamine (100 mg), and hydrocortisone (50 mg) every 6 hours (n = 252) or matching placebo (n = 249) for 96 hours or until discharge from the intensive care unit or death. Participants could be treated with open-label corticosteroids by the clinical team, with study hydrocortisone or matching placebo withheld if the total daily dose was greater or equal to the equivalent of 200 mg of hydrocortisone. MAIN OUTCOMES AND MEASURES The primary outcome was the number of consecutive ventilator- and vasopressor-free days in the first 30 days following the day of randomization. The key secondary outcome was 30-day mortality. RESULTS Among 501 participants randomized (median age, 62 [interquartile range {IQR}, 50-70] years; 46% female; 30% Black; median Acute Physiology and Chronic Health Evaluation II score, 27 [IQR, 20.8-33.0]; median Sequential Organ Failure Assessment score, 9 [IQR, 7-12]), all completed the trial. Open-label corticosteroids were prescribed to 33% and 32% of the intervention and control groups, respectively. Ventilator- and vasopressor-free days were a median of 25 days (IQR, 0-29 days) in the intervention group and 26 days (IQR, 0-28 days) in the placebo group, with a median difference of -1 day (95% CI, -4 to 2 days; P =.85). Thirty-day mortality was 22% in the intervention group and 24% in the placebo group. CONCLUSIONS AND RELEVANCE Among critically ill patients with sepsis, treatment with vitamin C, thiamine, and hydrocortisone, compared with placebo, did not significantly increase ventilator- and vasopressor-free days within 30 days. However, the trial was terminated early for administrative reasons and may have been underpowered to detect a clinically important difference.	[Sevransky, Jonathan E.; Busse, Laurence W.; Polito, Carmen C.; Martin, Greg S.] Emory Univ, Sch Med, Div Pulm Allergy Crit Care & Sleep, Atlanta, GA USA; [Sevransky, Jonathan E.; Buchman, Timothy G.; Busse, Laurence W.; Coopersmith, Craig M.; Polito, Carmen C.; Martin, Greg S.] Emory Healthcare, Emory Crit Care Ctr, Atlanta, GA USA; [Rothman, Richard E.; Hinson, Jeremiah S.; Kelen, Gabor D.; Ricketts, Erin P.] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD USA; [Hager, David N.] Johns Hopkins Univ, Div Pulm Crit Care, Baltimore, MD 21205 USA; [Bernard, Gordon R.; Ely, Wesley; Rice, Todd W.] Vanderbilt Univ, Med Ctr, Div Pulm Crit Care, Nashville, TN 37235 USA; [Brown, Samuel M.] Intermt Med Ctr, Div Pulm Crit Care, Salt Lake City, UT USA; [Brown, Samuel M.] Univ Utah, Salt Lake City, UT USA; [Buchman, Timothy G.; Coopersmith, Craig M.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [DeWilde, Christine; Fowler, Alpha A.] Virginia Commonwealth Univ, Div Pulm Crit Care, Med Coll Virginia Campus, Richmond, VA USA; [Ely, Wesley] Johns Hopkins Crit Illness, Brain Dysfunct & Survivorship CIBS Ctr, Baltimore, MD USA; [Ely, Wesley] Vet Affairs Tennessee Valley Geriatr Res Educ Cli, Nashville, TN USA; [Eyzaguirre, Lindsay M.] Johns Hopkins Univ, Div Brain Injury Outcomes, Baltimore, MD USA; [Gaieski, David F.] Thomas Jefferson Univ Hosp, Dept Emergency Med, Philadelphia, PA 19107 USA; [Gong, Michelle N.] Montefiore Med Ctr, Dept Crit Care, 111 E 210th St, Bronx, NY 10467 USA; [Hall, Alex; Moore, Brooks L.; Nugent, Katherine L.; Rudolph, Caroline C.; Wright, David W.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [Hooper, Michael H.] Sentara Healthcare, Div Pulm Crit Care, Norfolk, VA USA; [Khan, Akram] Oregon Hlth & Sci Univ, Div Pulm Crit Care, Portland, OR 97201 USA; [Levine, Mark A.] NIH, Mol & Clin Nutr Sect, Bldg 10, Bethesda, MD 20892 USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Lewis, Roger J.; McGlothlin, Anna; Viele, Kert] Berry Consultants LLC, Austin, TX USA; [Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Emergency Med, Los Angeles, CA 90095 USA; [Lewis, Roger J.] Lundquist Inst Biomed Innovat, Torrance, CA USA; [Lindsell, Chris J.; Nwosu, Samuel] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Marlin, Jessica S.] Vanderbilt Univ, Med Ctr, Vanderbilt Coordinating Ctr, Nashville, TN USA; [Sanfilippo, Fred] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Viele, Kert] Univ Kentucky, Dept Biostat, Lexington, KY USA	Emory University; Emory University; Johns Hopkins University; Johns Hopkins University; Vanderbilt University; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Emory University; Virginia Commonwealth University; Geriatric Research Education & Clinical Center; Johns Hopkins University; Jefferson University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Emory University; Sentara Healthcare; Oregon Health & Science University; National Institutes of Health (NIH) - USA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Vanderbilt University; Vanderbilt University; Emory University; University of Kentucky	Sevransky, JE (corresponding author), Emory Univ Hosp, Room D226, Atlanta, GA 30322 USA.	jsevran@emory.edu	Martin, Greg/B-4085-2009; Hall, Alex/AAR-9495-2021; Khan, Akram/AAB-6446-2022; Gill, Jasreen/AAU-8351-2021; Moore, Brooks/GRJ-5636-2022; Brown, Samuel/E-6846-2015; Puskarich, Michael/N-7849-2014	Martin, Greg/0000-0002-9684-7593; Hall, Alex/0000-0001-8532-524X; Khan, Akram/0000-0003-3091-632X; Gill, Jasreen/0000-0002-1703-5379; Moore, Brooks/0000-0002-8835-0296; Files, Daniel Clark/0000-0002-1595-4080; McGlothlin, Anna/0000-0002-9079-6166; Brown, Samuel/0000-0003-1206-6261; Gibbs, Kevin/0000-0002-5272-2289; Greenwood, John/0000-0003-2337-557X; Belsky, Justin/0000-0002-3711-0954; Douglas, Ivor/0000-0002-4541-1431; Puskarich, Michael/0000-0001-6358-4670; Quinn, James/0000-0002-3694-2118	Marcus Foundation; Nova Biomedical Inc	Marcus Foundation; Nova Biomedical Inc	Funding for the trial was provided by the Marcus Foundation to Emory University, which supervised the distribution of resources to clinical sites. Johns Hopkins served as the clinical coordinating center and Vanderbilt University as the data coordinating center. Nova Biomedical Inc provided support to 6 sites with point-of-care glucometers. Vitamin C, thiamine, and hydrocortisone were purchased from McGuff Pharmaceuticals Inc. SCCM Discovery, a critical care research infrastructure program, facilitated the design and conduct of the study, provided administrative support to conducting the study, and was involved in critical manuscript revision. SCCM Discovery reviewed and critiqued the study, which met criteria for SCCM Discovery endorsement.	Barabutis N, 2017, CHEST, V152, P954, DOI 10.1016/j.chest.2017.07.014; Buchman TG, 2020, CRIT CARE MED, V48, P276, DOI 10.1097/CCM.0000000000004224; de Grooth HJ, 2020, JAMA-J AM MED ASSOC, V323, P792, DOI 10.1001/jama.2019.21981; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Fowler AA, 2020, JAMA-J AM MED ASSOC, V323, P792, DOI 10.1001/jama.2019.21987; Fowler AA, 2019, JAMA-J AM MED ASSOC, V322, P1261, DOI 10.1001/jama.2019.11825; Fujii T, 2020, JAMA-J AM MED ASSOC, V323, P423, DOI 10.1001/jama.2019.22176; Hager DN, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3254-2; Hager DN, 2018, CHEST, V154, P228, DOI 10.1016/j.chest.2018.03.018; Lindsell CJ, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3775-8; Marik PE, 2017, CHEST, V151, P1229, DOI 10.1016/j.chest.2016.11.036; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Moskowitz A, 2020, JAMA-J AM MED ASSOC, V324, P642, DOI 10.1001/jama.2020.11946; Putzu A, 2019, CRIT CARE MED, V47, P774, DOI 10.1097/CCM.0000000000003700; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Spoelstra-de Man AME, 2018, CURR OPIN CRIT CARE, V24, P248, DOI 10.1097/MCC.0000000000000510; Torio CM., 2016, HEALTHCARE COST UTIL; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wilson JX, 2013, ANTIOXID REDOX SIGN, V19, P2129, DOI 10.1089/ars.2013.5401; Yende S, 2016, CRIT CARE MED, V44, P1461, DOI 10.1097/CCM.0000000000001658	22	79	80	8	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					742	751		10.1001/jama.2020.24505	http://dx.doi.org/10.1001/jama.2020.24505			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620405	Green Published, Bronze			2022-12-28	WOS:000621957400022
J	Silberner, J				Silberner, Joanne			Behind the scenes of the Pfizer BioNTech covid-19 vaccine trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jsilberner@bmj.com							0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2021	372								n271	10.1136/bmj.n271	http://dx.doi.org/10.1136/bmj.n271			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8SP	33622695	Bronze			2022-12-28	WOS:000623407800014
J	Schwab, T				Schwab, Tim			Covid-19, trust, and Wellcome: how charity's pharma investments overlap with its research efforts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												timschwab2020@gmail.com						Abbott Laboratories, US SEC EXCH COMM 10Q; [Anonymous], 2020, REUTERS 1004; Benner Katie, 2020, NEW YORK TIMES; Chung J., 2020, WALL STREET J; Coombes R, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4911; Dyer O, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4809; Fandos N., 2021, NEW YORK TIMES; Farrar J., 2015, GUARDIAN 0417; Farrar J., 2020, GUARDIAN 1012; Guarascio F, 2020, REUTERS 1105; Honarvar Afshin Jon, 2011, GUARDIAN        0325; Looi MK, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n459; Malpani R, 2020, HLTH POLICY WATCH; McKie R., 2019, GUARDIAN 1222; Piller C, 2018, SCIENCE; Rosenthal, 2006, NEW YORK TIMES; Schreier P, 2020, LOOK INSIDE GLOBAL P; Schwab T, 2020, NATION; Thacker PD, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4716; UK Government Office of Science, LIST PART SAGE REL S; Wellcome Trust, ANN REP FIN STAT 202; Wellcome Trust, INV COMM LIST; Wellcome Trust, LIST DIR HELD EQ HOL; Wellcome Trust, US SEC EXCH COMM 13F	24	0	0	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2021	372								n556	10.1136/bmj.n556	http://dx.doi.org/10.1136/bmj.n556			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC5ZQ	33658184	Bronze			2022-12-28	WOS:000686604500001
J	Mirmirani, P; Fu, J				Mirmirani, Paradi; Fu, Jennifer			Diagnosis and Treatment of Nonscarring Hair Loss in Primary Care in 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALOPECIA	This JAMA Insights Clinical Update reviews the differential diagnosis, patterns, evaluation, and management of the most common causes of nonscarring hair loss, including male pattern balding, telogen effluvium, and alopecia areata.	[Mirmirani, Paradi; Fu, Jennifer] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA; [Mirmirani, Paradi] Permanente Med Grp Inc, Dept Dermatol, 975 Sereno Dr, Vallejo, CA 94589 USA; [Mirmirani, Paradi] Case Western Reserve Univ, Dept Dermatol, Cleveland, OH 44106 USA	University of California System; University of California San Francisco; Permanente Medical Groups; Case Western Reserve University	Mirmirani, P (corresponding author), Permanente Med Grp Inc, Dept Dermatol, 975 Sereno Dr, Vallejo, CA 94589 USA.	paradi.mirmirani@kp.org						Adil A, 2017, J AM ACAD DERMATOL, V77, P136, DOI 10.1016/j.jaad.2017.02.054; Gilhar A, 2012, NEW ENGL J MED, V366, P1515, DOI 10.1056/NEJMra1103442; HEADINGTON JT, 1993, ARCH DERMATOL, V129, P356, DOI 10.1001/archderm.129.3.356; Jackson AJ, 2013, DERMATOL CLIN, V31, P21, DOI 10.1016/j.det.2012.08.007; Mirzoyev SA, 2014, J INVEST DERMATOL, V134, P1141, DOI 10.1038/jid.2013.464; Mubki T, 2014, J AM ACAD DERMATOL, V71, DOI 10.1016/j.jaad.2014.05.008; Olsen EA, 2011, DERMATOL THER, V24, P311, DOI 10.1111/j.1529-8019.2011.01415.x; Schmidt TH, 2016, JAMA DERMATOL, V152, P391, DOI 10.1001/jamadermatol.2015.4498; Wang EHC, 2018, J INVEST DERMATOL, V138, P1911, DOI 10.1016/j.jid.2018.05.027	9	1	1	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					878	879		10.1001/jama.2020.19313	http://dx.doi.org/10.1001/jama.2020.19313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651080				2022-12-28	WOS:000625843100016
J	Shepherd, JP; Moore, SC; Long, A; Kollar, LMM; Sumner, SA				Shepherd, Jonathan P.; Moore, Simon C.; Long, Abigail; Mercer Kollar, Laura M.; Sumner, Steven A.			Association Between COVID-19 Lockdown Measures and Emergency Department Visits for Violence-Related Injuries in Cardiff, Wales	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study investigates emergency department visits for violence-related injuries occurring at home and outside the home in Cardiff, Wales, before and after COVID-19 lockdown measures were instituted in March 2020.	[Shepherd, Jonathan P.; Moore, Simon C.] Cardiff Univ, Crime & Secur Res Inst, Friary House,Greyfriars Rd, Cardiff CF10 3AE, Wales; [Long, Abigail] Informat & Reporting Team, Cardiff, Wales; [Long, Abigail] Vale Univ Hlth Board, Cardiff, Wales; [Mercer Kollar, Laura M.] US Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA USA; [Sumner, Steven A.] US Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA	Cardiff University; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Shepherd, JP (corresponding author), Cardiff Univ, Crime & Secur Res Inst, Friary House,Greyfriars Rd, Cardiff CF10 3AE, Wales.	shepherdjp@cardiff.ac.uk						Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Florence C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3313; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Shepherd JP, 2017, JAMA-J AM MED ASSOC, V317, P1525, DOI 10.1001/jama.2017.1854; 2014, GLOB STAT REP VIOL, P1	5	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					885	887		10.1001/jama.2020.25511	http://dx.doi.org/10.1001/jama.2020.25511			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651083	Bronze, Green Published			2022-12-28	WOS:000625843100019
J	Dyer, C				Dyer, Clare			Government faces legal action over 23m pound deal involving patient data	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Amnesty International, 2020, FAIL DO RIGHT URG NE; Dyer C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n511; Fitzgerald M, 2021, OPENDEMOCRACY	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n587	10.1136/bmj.n587	http://dx.doi.org/10.1136/bmj.n587			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33648951				2022-12-28	WOS:000625342000002
J	Watt, G				Watt, Graham			Julian Tudor Hart: medical pioneer and social advocate	LANCET			English	Editorial Material									[Watt, Graham] Univ Glasgow, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland	University of Glasgow	Watt, G (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Glasgow G12 9LX, Lanark, Scotland.	graham.watt@glasgow.ac.uk							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					786	787						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640055				2022-12-28	WOS:000623925500016
J	Ackley, SF; Elahi, F; Glymour, MM				Ackley, Sarah F.; Elahi, Fanny; Glymour, M. Maria			Instrumental variable meta-analysis of aggregated randomized drug trial data for evaluating proposed target mechanisms	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Clinical trials provide an opportunity to understand not only drug efficacy but also disease biology. Instrumental variable meta-analysis provides an approach to combining results from multiple trials into a single estimate of the effect of modifying a biological target on an outcome of interest.	[Ackley, Sarah F.; Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94143 USA; [Elahi, Fanny] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Glymour, MM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94143 USA.	maria.glymour@ucsf.edu		Elahi, Fanny/0000-0003-4663-4992	National Institutes of Health National Institute on Aging	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: support from the National Institutes of Health National Institute on Aging for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Ackley SF, 2021, BMJ-BRIT MED J, V372	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n346	10.1136/bmj.n346	http://dx.doi.org/10.1136/bmj.n346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632740	Bronze			2022-12-28	WOS:000624298000010
J	Rubin, R				Rubin, Rita			Locating COVID-19 Monoclonal Antibody Therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					712	712		10.1001/jama.2021.1230	http://dx.doi.org/10.1001/jama.2021.1230			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620389	Bronze			2022-12-28	WOS:000621957400005
J	Slomski, A				Slomski, Anita			Navigators Improve Autism Evaluations but Not Referrals to Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					713	713		10.1001/jama.2021.1259	http://dx.doi.org/10.1001/jama.2021.1259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QM7LT	33620403				2022-12-28	WOS:000621957400009
J	Forister, ML; Halsch, CA; Nice, CC; Fordyce, JA; Dilts, TE; Oliver, JC; Prudic, KL; Shapiro, AM; Wilson, JK; Glassberg, J				Forister, M. L.; Halsch, C. A.; Nice, C. C.; Fordyce, J. A.; Dilts, T. E.; Oliver, J. C.; Prudic, K. L.; Shapiro, A. M.; Wilson, J. K.; Glassberg, J.			Fewer butterflies seen by community scientists across the warming and drying landscapes of the American West	SCIENCE			English	Article								Uncertainty remains regarding the role of anthropogenic climate change in declining insect populations, partly because our understanding of biotic response to climate is often complicated by habitat loss and degradation among other compounding stressors. We addressed this challenge by integrating expert and community scientist datasets that include decades of monitoring across more than 70 locations spanning the western United States. We found a 1.6% annual reduction in the number of individual butterflies observed over the past four decades, associated in particular with warming during fall months. The pervasive declines that we report advance our understanding of climate change impacts and suggest that a new approach is needed for butterfly conservation in the region, focused on suites of species with shared habitat or host associations.	[Forister, M. L.; Halsch, C. A.] Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA; [Nice, C. C.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Fordyce, J. A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Dilts, T. E.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Oliver, J. C.] Univ Arizona, Off Digital Innovat & Stewardship, Univ Lib, Tucson, AZ 85721 USA; [Prudic, K. L.; Wilson, J. K.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Shapiro, A. M.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Glassberg, J.] North Amer Butterfly Assoc, Morristown, NJ 07960 USA; [Glassberg, J.] Rice Univ, Dept BioSci, Houston, TX 77251 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Texas State University System; Texas State University San Marcos; University of Tennessee System; University of Tennessee Knoxville; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Arizona; University of Arizona; University of California System; University of California Davis; Rice University	Forister, ML (corresponding author), Univ Nevada, Dept Biol, Program Ecol Evolut & Conservat Biol, Reno, NV 89557 USA.	forister@gmail.com		Fordyce, James/0000-0002-2731-0418; Prudic, Kathleen/0000-0001-8242-7769; Halsch, Christopher/0000-0003-1381-1905; Dilts, Thomas/0000-0003-4234-0698; Wilson, Jerome/0000-0002-0528-2137; Oliver, Jeffrey/0000-0003-2160-1086	Trevor James McMinn professorship; College of Agriculture and Life Science, Research Innovation and Impact; University of Arizona Libraries	Trevor James McMinn professorship; College of Agriculture and Life Science, Research Innovation and Impact; University of Arizona Libraries	M. L.F. was supported by a Trevor James McMinn professorship. K. L.P. and J.K.W. were supported by the College of Agriculture and Life Science, Research Innovation and Impact, and the University of Arizona Libraries.	Aizen M. A., 2021, **DROPPED REF**, V4, P114; [Anonymous], WATER USGS; [Anonymous], PACKAGES; Bowler DE, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0067; Cardoso P, 2020, BIOL CONSERV, V242, DOI 10.1016/j.biocon.2020.108426; Casner KL, 2014, J INSECT CONSERV, V18, P13, DOI 10.1007/s10841-013-9610-8; Chaplin-Kramer R, 2019, SCIENCE, V366, P255, DOI 10.1126/science.aaw3372; Conrad KF, 2006, BIOL CONSERV, V132, P279, DOI 10.1016/j.biocon.2006.04.020; Crossley MS, 2020, NAT ECOL EVOL, V4, P1368, DOI 10.1038/s41559-020-1269-4; Dray S, 2018, PACKAGE ADESPATIAL; Duong T., 2020, KS KERNEL SMOOTHING; Eskildsen A, 2015, DIVERS DISTRIB, V21, P792, DOI 10.1111/ddi.12340; Forister M.L., 2018, CLIMATE CHANGE RESPO, V5, P3, DOI [10.1186/s40665-018-0039-x, DOI 10.1186/S40665-018-0039-X]; Forister ML, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0475; Gallinat AS, 2015, TRENDS ECOL EVOL, V30, P169, DOI 10.1016/j.tree.2015.01.004; Gelman A, 1996, STAT SINICA, V6, P733; Glassberg J, 2017, SWIFT GUIDE BUTTERFL; Gonzalez P, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aade09; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Hall DM, 2019, ENVIRON SCI POLICY, V93, P118, DOI 10.1016/j.envsci.2018.12.026; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hart E. M., 2015, PRISM DOWNLOAD DATA; Homer C, 2020, ISPRS J PHOTOGRAMM, V162, P184, DOI 10.1016/j.isprsjprs.2020.02.019; Hunter MR, 2008, INSECT CONSERV DIVER, V1, P189, DOI 10.1111/j.1752-4598.2008.00024.x; iNaturalist, 2020, INATURALIST OBSERVAT; James G, 2013, SPRINGER TEXTS STAT, V103, P303, DOI 10.1007/978-1-4614-7138-7_8; Johnson DM, 2019, REMOTE SENS ENVIRON, V232, DOI 10.1016/j.rse.2019.111286; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kim Albert Y, 2018, CRAN; McAlpine K. E., 2020, INT J MOL SCI, V101; McElreath R, 2016, TEXT STAT SCI, pXI; Montgomery GA, 2020, BIOL CONSERV, V241, DOI 10.1016/j.biocon.2019.108327; NABA, 2020, N AM BUTTERFLY ASS C; Nakagaki N., 2007, ENHANCED NATL LAND C; Nice CC, 2019, GLOBAL CHANGE BIOL, V25, P2127, DOI 10.1111/gcb.14593; Oliver J., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4460647, DOI 10.5281/ZENODO.4460647]; Oliver J, 2021, REV RELEASE 3 VERSIO, DOI zenodo.4460647; Parmesan C, 2015, ANN BOT-LONDON, V116, P849, DOI 10.1093/aob/mcv169; Piano E, 2020, GLOBAL CHANGE BIOL, V26, P1196, DOI 10.1111/gcb.14934; Plummer M., 2015, RJAGS BAYESIAN GRAPH; R Core Team, 2016, R LANG ENV STAT COMP; Rhodes CJ, 2018, SCI PROGRESS-UK, V101, P121, DOI 10.3184/003685018X15202512854527; Scott J. A., 1986, BUTTERFLIES N AM NAT; Shapiro A. M, 2020, ART SHAPIROS BUTTERF; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Simmons BI, 2019, ECOL EVOL, V9, P3678, DOI 10.1002/ece3.5153; Thomas CD, 2019, GLOBAL CHANGE BIOL, V25, P1891, DOI 10.1111/gcb.14608; Ueda K., 2020, INATURALIST BLOG; van Klink R, 2020, SCIENCE, V368, P417, DOI 10.1126/science.aax9931; Wagner DL, 2020, ANNU REV ENTOMOL, V65, P457, DOI 10.1146/annurev-ento-011019-025151; Welti E. A. R, 2020, ECOEVORXIV V3SR2 PRE; Welti E. A. R., ECOEVORXIV; Wepprich T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216270; Zattara EE, 2021, ONE EARTH, V4, P114, DOI 10.1016/j.oneear.2020.12.005	54	38	38	16	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1042	+		10.1126/science.abe5585	http://dx.doi.org/10.1126/science.abe5585			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674492				2022-12-28	WOS:000625876100053
J	Fu, LW; Liu, YL; Qin, GC; Wu, P; Zi, HL; Xu, ZT; Zhao, XD; Wang, Y; Li, YX; Yang, SH; Peng, C; Wong, CCL; Yoo, SD; Zuo, ZC; Liu, RY; Cho, YH; Xiong, Y				Fu, Liwen; Liu, Yanlin; Qin, Guochen; Wu, Ping; Zi, Hailing; Xu, Zhongtian; Zhao, Xiaodi; Wang, Yue; Li, Yaxing; Yang, Shuhui; Peng, Chao; Wong, Catherine C. L.; Yoo, Sang-Dong; Zuo, Zecheng; Liu, Renyi; Cho, Young-Hee; Xiong, Yan			The TOR-EIN2 axis mediates nuclear signalling to modulate plant growth	NATURE			English	Article							CELL-PROLIFERATION; ARABIDOPSIS ROOT; ETHYLENE; EIN2; RAPAMYCIN; TARGET; ACTIVATION; RESPONSES; SEEDLINGS; PIF4	The evolutionarily conserved target of rapamycin (TOR) kinase acts as a master regulator that coordinates cell proliferation and growth by integrating nutrient, energy, hormone and stress signals in all eukaryotes(1,2). Research has focused mainly on TOR-regulated translation, but how TOR orchestrates the global transcriptional network remains unclear. Here we identify ethylene-insensitive protein 2 (EIN2), a central integrator(3-5) that shuttles between the cytoplasm and the nucleus, as a direct substrate of TOR in Arabidopsis thaliana. Glucose-activated TOR kinase directly phosphorylates EIN2 to prevent its nuclear localization. Notably, the rapid global transcriptional reprogramming that is directed by glucose-TOR signalling is largely compromised in the ein2-5 mutant, and EIN2 negatively regulates the expression of a wide range of target genes of glucose-activated TOR that are involved in DNA replication, cell wall and lipid synthesis and various secondary metabolic pathways. Chemical, cellular and genetic analyses reveal that cell elongation and proliferation processes that are controlled by the glucose-TOR-EIN2 axis are decoupled from canonical ethylene-CTR1-EIN2 signalling, and mediated by different phosphorylation sites. Our findings reveal a molecular mechanism by which a central signalling hub is shared but differentially modulated by diverse signalling pathways using distinct phosphorylation codes that can be specified by upstream protein kinases.	[Fu, Liwen; Qin, Guochen; Zi, Hailing; Xu, Zhongtian; Yang, Shuhui] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol, Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China; [Fu, Liwen; Liu, Yanlin; Zhao, Xiaodi; Wang, Yue; Li, Yaxing; Zuo, Zecheng; Xiong, Yan] Fujian Agr & Forestry Univ, Basic Forestry & Prote Res Ctr, Haixia Inst Sci & Technol, Fuzhou, Peoples R China; [Wu, Ping; Peng, Chao] Chinese Acad Sci, Natl Facil Prot Sci Shanghai, Zhangjiang Lab, Shanghai Adv Res Inst, Shanghai, Peoples R China; [Wong, Catherine C. L.] Peking Univ, Sch Pharmaceut Sci, Ctr Precis Med Multi Res, Hlth Sci Ctr, Beijing, Peoples R China; [Yoo, Sang-Dong; Cho, Young-Hee] Korea Univ, Div Life Sci, Coll Life Sci & Biotechnol, Seoul, South Korea; [Liu, Renyi] Fujian Agr & Forestry Univ, Ctr Agroforestry Mega Data Sci, Haixia Inst Sci & Technol, Fuzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; Peking University; Korea University; Fujian Agriculture & Forestry University	Xiong, Y (corresponding author), Fujian Agr & Forestry Univ, Basic Forestry & Prote Res Ctr, Haixia Inst Sci & Technol, Fuzhou, Peoples R China.	yanxiong@fafu.edu.cn	Liu, Yanlin/ABG-3719-2021	Qin, Guochen/0000-0002-2048-8571; Xiong, Yan/0000-0003-0676-8267; Fu, Liwen/0000-0002-7941-0728	National Natural Science Foundation of China [31870269, 31800199]; Chinese Academy of Sciences; Basic Forestry and Proteomics Research Centre, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Basic Forestry and Proteomics Research Centre, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University	We thank J. Sheen, T. D. Xu and X. Y. Zhu for critical reading of the manuscript, all members of the Xiong laboratory for discussion, C. B. Xiang for ERF1-OX seeds, W. F. Wang for the BZR1 antibody, R. X. Li for the CFP-HDEL plasmid and ABRC for the T-DNA insertional and point mutation mutants. This research was supported by funding from the National Natural Science Foundation of China (grant 31870269 to Y.X. and 31800199 to Yanlin Liu; the Chinese Academy of Sciences; and the Basic Forestry and Proteomics Research Centre, Haixia Institute of Science and Technology, Fujian Agriculture and Forestry University.	Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Brand L, 2006, PLANT PHYSIOL, V141, P1194, DOI 10.1104/pp.106.081299; Brunkard JO, 2020, DEV CELL, V54, P142, DOI 10.1016/j.devcel.2020.06.022; Chang KN, 2013, ELIFE, V2, DOI 10.7554/eLife.00675; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dobrenel T, 2016, ANNU REV PLANT BIOL, V67, P261, DOI 10.1146/annurev-arplant-043014-114648; Fu LW, 2020, PLANT PHYSIOL, V182, P1613, DOI 10.1104/pp.19.01214; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kotogany E, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-5; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Li XJ, 2017, P NATL ACAD SCI USA, V114, P2765, DOI 10.1073/pnas.1618782114; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Ma DB, 2016, P NATL ACAD SCI USA, V113, P224, DOI 10.1073/pnas.1511437113; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mao JL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005760; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Peng JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004664; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shi L, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160887; Street IH, 2015, PLANT PHYSIOL, V169, P338, DOI 10.1104/pp.15.00415; Tsai CF, 2014, ANAL CHEM, V86, P685, DOI 10.1021/ac4031175; Wang Jiajun, 2020, Abiotech, V1, P6, DOI 10.1007/s42994-019-00011-z; Wang PC, 2018, MOL CELL, V69, P100, DOI 10.1016/j.molcel.2017.12.002; Wen X, 2012, CELL RES, V22, P1613, DOI 10.1038/cr.2012.145; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xiong Y, 2013, NATURE, V496, P181, DOI 10.1038/nature12030; Xiong Y, 2012, J BIOL CHEM, V287, P2836, DOI 10.1074/jbc.M111.300749; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang JY, 2020, PLANT COMMUN, V1, DOI 10.1016/j.xplc.2020.100046; Zhang ZZ, 2016, CURR BIOL, V26, P1854, DOI 10.1016/j.cub.2016.05.005; Zhong SW, 2014, P NATL ACAD SCI USA, V111, P3913, DOI 10.1073/pnas.1402491111; Zhuo FP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082680	48	31	34	43	86	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					288	+		10.1038/s41586-021-03310-y	http://dx.doi.org/10.1038/s41586-021-03310-y		MAR 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8UA	33658715				2022-12-28	WOS:000625125200006
J	Hou, HT; Kyriacou, E; Thadani, R; Klutstein, M; Chapman, JH; Cooper, JP				Hou, Haitong; Kyriacou, Eftychia; Thadani, Rahul; Klutstein, Michael; Chapman, Joseph H.; Cooper, Julia Promisel			Centromeres are dismantled by foundational meiotic proteins Spo11 and Rec8	NATURE			English	Article								Meiotic processes are potentially dangerous to genome stability and could be disastrous if activated in proliferative cells. Here we show that two key meiosis-defining proteins, the topoisomerase Spo11 (which forms double-strand breaks) and the meiotic cohesin Rec8, can dismantle centromeres. This dismantlement is normally observable only in mutant cells that lack the telomere bouquet, which provides a nuclear microdomain conducive to centromere reassembly(1); however, overexpression of Spo11 or Rec8 leads to levels of centromere dismantlement that cannot be countered by the bouquet. Specific nucleosome remodelling factors mediate centromere dismantlement by Spo11 and Rec8. Ectopic expression of either protein in proliferating cells leads to the loss of mitotic kinetochores in both fission yeast and human cells. Hence, while centromeric chromatin has been characterized as extraordinarily stable, Spo11 and Rec8 challenge this stability and may jeopardize kinetochores in cancers that express meiotic proteins.	[Hou, Haitong; Thadani, Rahul; Cooper, Julia Promisel] Univ Colorado Anschutz Med Campus, Dept Biochem & Mol Genet, Aurora, CO USA; [Hou, Haitong; Kyriacou, Eftychia; Thadani, Rahul; Chapman, Joseph H.; Cooper, Julia Promisel] NCI, Telomere Biol Lab, Lab Biochem & Mol Biol, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Klutstein, Michael] Hebrew Univ Jerusalem, Inst Dent Sci, Chromatin & Aging Res Lab, Jerusalem, Israel; [Kyriacou, Eftychia] Ecole Polytech Federale Lausanne EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, Lausanne, Switzerland; [Chapman, Joseph H.] NHLBI, Single Mol Biophys Lab, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Hou, HT; Cooper, JP (corresponding author), Univ Colorado Anschutz Med Campus, Dept Biochem & Mol Genet, Aurora, CO USA.; Hou, HT; Cooper, JP (corresponding author), NCI, Telomere Biol Lab, Lab Biochem & Mol Biol, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	Haitong.hou@cuanschutz.edu; Julia.p.cooper@cuanschutz.edu		Kyriacou, Eftychia/0000-0003-3358-4850; Thadani, Rahul/0000-0002-9838-0683; cooper, julia promisel/0000-0003-2171-2587	National Cancer Institute; University of Colorado School of Medicine	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Colorado School of Medicine	We thank E. L. Denchi for reagents, equipment and advice for human cell experiments; I. Cheeseman for discussion and reagents for the piggyBac transposase system; our laboratory members and M. Lichten for discussions; D. Camerini-Otero, F. Pratto and K. Brick for discussions and the Spo11 antibody; A. Nussenzweig's laboratory for sharing equipment; and M. Diaz de la Loza for help with illustrations. This work was supported by the National Cancer Institute and the University of Colorado School of Medicine.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Barchi M, 2016, CHROMOSOMA, V125, P173, DOI 10.1007/s00412-016-0586-5; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; COOKE CA, 1990, J CELL BIOL, V110, P1475, DOI 10.1083/jcb.110.5.1475; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921; DeWall KM, 2005, GENE, V356, P77, DOI 10.1016/j.gene.2005.04.039; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Duro E, 2015, GENE DEV, V29, P109, DOI 10.1101/gad.255554.114; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Fennell A, 2015, J CELL BIOL, V208, P415, DOI 10.1083/jcb.201409058; Fernandez-Alvarez A, 2016, DEV CELL, V39, P544, DOI 10.1016/j.devcel.2016.10.021; Folco HD, 2017, NATURE, V543, P126, DOI 10.1038/nature21372; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Fowler KR, 2013, MOL CELL, V49, P983, DOI 10.1016/j.molcel.2013.01.008; Gruhn JR, 2019, SCIENCE, V365, P1466, DOI 10.1126/science.aav7321; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hennig BP, 2012, EMBO REP, V13, P997, DOI 10.1038/embor.2012.146; Hoffmann S, 2016, CELL REP, V17, P2394, DOI 10.1016/j.celrep.2016.10.084; Hou HT, 2018, DIFFERENTIATION, V100, P12, DOI 10.1016/j.diff.2018.01.002; Hou HT, 2010, J BIOL CHEM, V285, P1909, DOI 10.1074/jbc.M109.058487; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klutstein M, 2015, NAT CELL BIOL, V17, P458, DOI 10.1038/ncb3132; Klutstein M, 2014, CURR OPIN CELL BIOL, V26, P123, DOI 10.1016/j.ceb.2013.12.004; Koslowski M, 2002, CANCER RES, V62, P6750; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Kyriacou E, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0237-6; Liebelt F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11773-x; Lindsey SF, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/190109; Lopez-Serra L, 2014, NAT GENET, V46, P1147, DOI 10.1038/ng.3080; Lu M, 2019, CURR GENET, V65, P381, DOI 10.1007/s00294-018-0886-9; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Miller MP, 2012, ELIFE, V1, DOI 10.7554/eLife.00117; Mitra S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14276-x; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Munoz S, 2019, MOL CELL, V74, P664, DOI 10.1016/j.molcel.2019.02.027; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Pointner J, 2012, EMBO J, V31, P4388, DOI 10.1038/emboj.2012.289; Robert T, 2016, SCIENCE, V351, P943, DOI 10.1126/science.aad5309; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Sharif Wallace D, 2002, Cell Chromosome, V1, P1, DOI 10.1186/1475-9268-1-1; Shim YS, 2012, EMBO J, V31, P4375, DOI 10.1038/emboj.2012.267; Smoak EM, 2016, CURR BIOL, V26, P1110, DOI 10.1016/j.cub.2016.02.061; Sugiyama T, 2011, EMBO J, V30, P1027, DOI 10.1038/emboj.2011.32; Swartz SZ, 2019, DEV CELL, V51, P35, DOI 10.1016/j.devcel.2019.07.016; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; Vrielynck N, 2016, SCIENCE, V351, P939, DOI 10.1126/science.aad5196; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619; Zielinska AP, 2019, CURR BIOL, V29, P3749, DOI 10.1016/j.cub.2019.09.006	64	4	5	1	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					671	+		10.1038/s41586-021-03279-8	http://dx.doi.org/10.1038/s41586-021-03279-8		MAR 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33658710	Green Accepted			2022-12-28	WOS:000625125200002
J	Donato, AA; Lloyd, BJ				Donato, Anthony A.; Lloyd, Benjamin J.			In hyponatremia, rapid intermittent bolus vs. slow continuous infusion of hypertonic saline did not differ for overcorrection of serum sodium	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Donato, Anthony A.; Lloyd, Benjamin J.] Tower Hlth Reading Hosp, Reading, PA 19611 USA		Donato, AA (corresponding author), Tower Hlth Reading Hosp, Reading, PA 19611 USA.							Spasovski G, 2014, INTENS CARE MED, V40, P320, DOI 10.1007/s00134-014-3210-2	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC33	JC33		10.7326/ACPJ202103160-033	http://dx.doi.org/10.7326/ACPJ202103160-033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646842				2022-12-28	WOS:000669667000008
J	Wise, J				Wise, Jacqui			Covid-19: One in seven people in England have antibodies from infection or vaccination, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIFM (Research Institute for Fragrance Materials Inc), 2021, EXP SURV 30	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n561	10.1136/bmj.n561	http://dx.doi.org/10.1136/bmj.n561			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632718	Bronze			2022-12-28	WOS:000624298000001
J	Gharpure, R; Patel, A; Link-Gelles, R				Gharpure, Radhika; Patel, Anita; Link-Gelles, Ruth			First-Dose COVID-19 Vaccination Coverage Among Skilled Nursing Facility Residents and Staff	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES	This JAMA Insights review from CDC COVID-19 Response team members presents data on the number of long-term care facilities and the numbers of residents and staff of those facilities who received first-dose vaccination through mid-January 2021 under the agency's public-private partnership with CVS, Walgreens, and Managed Health Care Associates.	[Gharpure, Radhika; Patel, Anita; Link-Gelles, Ruth] Ctr Dis Control & Prevent, COVID 19 Response, 1600 Clifton Rd, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Gharpure, R (corresponding author), Ctr Dis Control & Prevent, COVID 19 Response, 1600 Clifton Rd, Atlanta, GA 30329 USA.	rgharpure@cdc.gov		Gharpure, Radhika/0000-0002-0702-5628				Black CL, 2018, MMWR-MORBID MORTAL W, V67, P1050, DOI 10.15585/mmwr.mm6738a2; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Centers for Disease Control and Prevention, UND PHARM PARTN LONG; Centers for Disease Control and Prevention, 2020, LONG TERM CAR FAC TO; Centers for Medicare and Medicaid Services, 2021, COVID 19 NURS HOM DA; Daugherty JD, 2015, AM J INFECT CONTROL, V43, P100, DOI 10.1016/j.ajic.2014.08.021; Dooling K, 2020, MMWR-MORBID MORTAL W, V69, P1857, DOI [10.15585/mmwr.mm6949e1, 10.15585/mmwr.mm695152e2]; Gharpure R, 2021, MMWR-MORBID MORTAL W, V70, P178, DOI 10.15585/mmwr.mm7005e2; Jaklevic MC, 2020, JAMA-J AM MED ASSOC, V324, P1928, DOI 10.1001/jama.2020.21354; Unroe KT, 2020, J AM GERIATR SOC	10	21	21	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1670	1671		10.1001/jama.2021.2352	http://dx.doi.org/10.1001/jama.2021.2352		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33625464	Green Accepted, Bronze			2022-12-28	WOS:000621915300004
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: GPs could get extra funding to boost vaccine uptake in hard-to-reach groups	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		HM Government, 2021, COV 19 RESP SPRING 2; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n460; NHS England, 2021, COV 19 VACC PROGR 20; O'Dowd A, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n357; Parveen N, 2021, GUARDIAN	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n548	10.1136/bmj.n548	http://dx.doi.org/10.1136/bmj.n548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627340	Bronze			2022-12-28	WOS:000623404800011
J	Mahase, E				Mahase, Elisabeth			Covid-19: All adults on learning disability register should be prioritised for vaccination, says advisory committee	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n510; Office for National Statistics, 2021, UPD EST COR COVID 19	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n547	10.1136/bmj.n547	http://dx.doi.org/10.1136/bmj.n547			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627352	Bronze			2022-12-28	WOS:000623404800010
J	Iacobucci, G; Mahase, E				Iacobucci, Gareth; Mahase, Elisabeth			Covid-19: Vaccine success drives England's lockdown exit	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cabinet Office, 2021, COVID 19 RESP	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2021	372								n528	10.1136/bmj.n528	http://dx.doi.org/10.1136/bmj.n528			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8SP	33622684	Bronze			2022-12-28	WOS:000623407800005
J	Jones, H				Jones, Helen			Why I . . . horse ride	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2021	372								n468	10.1136/bmj.n468	http://dx.doi.org/10.1136/bmj.n468			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7AW	33619065	Bronze			2022-12-28	WOS:000621236700008
J	Wise, J				Wise, Jacqui			Covid-19: Is vaccination roll out reducing cases and deaths in the UK?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Records of Scotland, DEATHS INV COVID 19; Office for National Statistics, 2021, COR COV 19 INF SURV; Public Health England, 2021, WEEKL NAT INFL COV 1; Public Health England, MOR 3 80S VACC COV 1; Wise J, 2021, BMJ, V372	5	7	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n506	10.1136/bmj.n506	http://dx.doi.org/10.1136/bmj.n506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608315	hybrid			2022-12-28	WOS:000621237300010
J	Lythgoe, KA; Hall, M; Ferretti, L; de Cesare, M; MacIntyre-Cockett, G; Trebes, A; Andersson, M; Otecko, N; Wise, EL; Moore, N; Lynch, J; Kidd, S; Cortes, N; Mori, M; Williams, R; Vernet, G; Justice, A; Green, A; Nicholls, SM; Ansari, MA; Abeler-Dorner, L; Moore, CE; Peto, TEA; Eyre, DW; Shaw, R; Simmonds, P; Buck, D; Todd, JA; Connor, TR; Ashraf, S; Filipe, AD; Shepherd, J; Thomson, EC; Bonsall, D; Fraser, C; Golubchik, T				Lythgoe, Katrina A.; Hall, Matthew; Ferretti, Luca; de Cesare, Mariateresa; MacIntyre-Cockett, George; Trebes, Amy; Andersson, Monique; Otecko, Newton; Wise, Emma L.; Moore, Nathan; Lynch, Jessica; Kidd, Stephen; Cortes, Nicholas; Mori, Matilde; Williams, Rebecca; Vernet, Gabrielle; Justice, Anita; Green, Angie; Nicholls, Samuel M.; Ansari, M. Azim; Abeler-Dorner, Lucie; Moore, Catrin E.; Peto, Timothy E. A.; Eyre, David W.; Shaw, Robert; Simmonds, Peter; Buck, David; Todd, John A.; Connor, Thomas R.; Ashraf, Shirin; Filipe, Ana da Silva; Shepherd, James; Thomson, Emma C.; Bonsall, David; Fraser, Christophe; Golubchik, Tanya		Oxford Virus Sequencing Anal Grp O; COVID-19 Genomics UK COG-UK Consor	SARS-CoV-2 within-host diversity and transmission	SCIENCE			English	Article							VIRUS; BOTTLENECKS; INFECTION; MUTATIONS; ALIGNMENT; IMPACT	Extensive global sampling and sequencing of the pandemic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have enabled researchers to monitor its spread and to identify concerning new variants. Two important determinants of variant spread are how frequently they arise within individuals and how likely they are to be transmitted. To characterize within-host diversity and transmission, we deep-sequenced 1313 clinical samples from the United Kingdom. SARS-CoV-2 infections are characterized by low levels of within-host diversity when viral loads are high and by a narrow bottleneck at transmission. Most variants are either lost or occasionally fixed at the point of transmission, with minimal persistence of shared diversity, patterns that are readily observable on the phylogenetic tree. Our results suggest that transmission-enhancing and/or immune-escape SARS-CoV-2 variants are likely to arise infrequently but could spread rapidly if successfully transmitted.	[Lythgoe, Katrina A.; Hall, Matthew; Ferretti, Luca; de Cesare, Mariateresa; MacIntyre-Cockett, George; Otecko, Newton; Abeler-Dorner, Lucie; Moore, Catrin E.; Bonsall, David; Fraser, Christophe; Golubchik, Tanya] Univ Oxford, Big Data Inst, Nuffield Dept Med, Old Rd Campus, Oxford OX3 7LF, England; [Lythgoe, Katrina A.; Golubchik, Tanya] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England; [de Cesare, Mariateresa; MacIntyre-Cockett, George; Trebes, Amy; Green, Angie; Buck, David; Todd, John A.; Bonsall, David; Fraser, Christophe] Univ Oxford, Wellcome Ctr Human Genet, NIHR Biomed Res Ctr, Nuffield Dept Med, Old Rd Campus, Oxford OX3 7BN, England; [Andersson, Monique; Justice, Anita; Peto, Timothy E. A.; Eyre, David W.; Shaw, Robert; Bonsall, David] Oxford Univ Hosp NHS Fdn Trust, John Radcliffe Hosp, Oxford OX3 9DU, England; [Andersson, Monique] Stellenbosch Univ, Div Med Virol, Stellenbosch, South Africa; [Wise, Emma L.; Moore, Nathan; Lynch, Jessica; Kidd, Stephen; Cortes, Nicholas; Williams, Rebecca; Vernet, Gabrielle] Hampshire Hosp NHS Fdn Trust, Basingstoke & North Hampshire Hosp, Basingstoke RG24 9NA, Hants, England; [Wise, Emma L.] Univ Surrey, Sch Biosci & Med, Guildford GU2 7XH, Surrey, England; [Cortes, Nicholas] Gibraltar Hlth Author, Gibraltar, Gibraltar; [Mori, Matilde] Univ Southampton, Sch Med, Southampton SO17 1BJ, Hants, England; [Nicholls, Samuel M.] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Ansari, M. Azim; Simmonds, Peter] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford OX1 3SY, England; [Peto, Timothy E. A.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Eyre, David W.] Univ Oxford, Big Data Inst, Nuffield Dept Publ Hlth, Old Rd Campus, Oxford OX3 7FL, England; [Connor, Thomas R.] Publ Hlth Wales Microbiol, Pathogen Genom Unit, Cardiff CF10 4BZ, Wales; [Connor, Thomas R.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Ashraf, Shirin; Filipe, Ana da Silva; Shepherd, James; Thomson, Emma C.] MRC Univ Glasgow Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland; [Fraser, Christophe] Wellcome Sanger Inst, Cambridge CB10 1SA, England	University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Stellenbosch University; University of Surrey; University of Southampton; University of Birmingham; University of Oxford; University of Oxford; University of Oxford; Cardiff University; University of Glasgow; Wellcome Trust Sanger Institute	Lythgoe, KA; Hall, M; Golubchik, T (corresponding author), Univ Oxford, Big Data Inst, Nuffield Dept Med, Old Rd Campus, Oxford OX3 7LF, England.; Lythgoe, KA; Golubchik, T (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.	Katrina.Lythgoe@bdi.ox.ac.uk; Matthew.Hall@bdi.ox.ac.uk; Tanya.Golubchik@bdi.ox.ac.uk	Connor, Thomas/ABD-6533-2021; Thomson, Emma C/M-8690-2017; de Cesare, Mariateresa/AAB-3089-2022; Beggs, Andrew D/A-6912-2013; Fraser, Christophe/A-8109-2008; Eyre, David/P-6887-2016; Golubchik, Tanya/B-4226-2018; Todd, John/A-3542-2010; Castellano, Sergi/A-7437-2016	Thomson, Emma C/0000-0003-1482-0889; de Cesare, Mariateresa/0000-0002-9847-1526; Beggs, Andrew D/0000-0003-0784-2967; Fraser, Christophe/0000-0003-2399-9657; Shepherd, James/0000-0003-3915-048X; Shaw, Robert/0000-0003-3449-5876; Hall, Matthew/0000-0002-2671-3864; Eyre, David/0000-0001-5095-6367; Ansari, M. Azim/0000-0003-2790-8353; Wise, Emma/0000-0002-0279-3900; Lythgoe, Katrina/0000-0002-7089-7680; Nicholls, Samuel/0000-0003-4081-065X; Golubchik, Tanya/0000-0003-2765-9828; Smith, Darren/0000-0003-4925-467X; Nelson, Andrew/0000-0001-6665-4929; Todd, John/0000-0003-2740-8148; Lynch, Jessica/0000-0003-2015-9986; Andersson, Monique/0000-0003-0619-1074; Ferretti, Luca/0000-0001-7578-7301; Bashton, Matthew/0000-0002-6847-1525; Castellano, Sergi/0000-0002-5819-4210; Young, Gregory/0000-0001-5342-1421	UK COVID-19 Genomics Consortium (COG UK); Medical Research Council (MRC) part of UK Research & Innovation (UKRI); National Institute of Health Research (NIHR); Genome Research Limited; Wellcome Core Award [203141/Z/16/Z]; NIHR Oxford Biomedical Research Centre; Wellcome Trust [209142/Z/17/Z]; Royal Society [107652/Z/15/Z, 220171/Z/20/Z]; Li Ka Shing Foundation; Wellcome Investigator Award [WT103767MA]; Fleming Fund at the Department of Health and Social Care, UK; Bill and Melinda Gates Foundation [OPP1176062]; Wellcome Trust	UK COVID-19 Genomics Consortium (COG UK); Medical Research Council (MRC) part of UK Research & Innovation (UKRI)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Genome Research Limited; Wellcome Core Award; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Li Ka Shing Foundation; Wellcome Investigator Award; Fleming Fund at the Department of Health and Social Care, UK; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome Trust)	We gratefully acknowledge the UK COVID-19 Genomics Consortium (COG UK) for funding. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR), and Genome Research Limited, operating as the Wellcome Sanger Institute. The research was also supported by a Wellcome Core Award (203141/Z/16/Z) with additional funding from the NIHR Oxford Biomedical Research Centre. The views exSHIOpressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. K.A.L. and M.A.A. were supported by The Wellcome Trust and The Royal Society (107652/Z/15/Z to K.A.L. and 220171/Z/20/Z to M.A.A.). M.H., L.F., M.d.C., G.M.C., N.O., L.A.D., D.B., C.F., and T.G. were supported by Li Ka Shing Foundation funding awarded to C.F. P.S. was supported by a Wellcome Investigator Award (WT103767MA). J.A.T. was supported by a Wellcome Core Award (203141/Z/16/Z). C.E.M. was supported by the Fleming Fund at the Department of Health and Social Care, UK; the Wellcome Trust (209142/Z/17/Z) and the Bill and Melinda Gates Foundation (OPP1176062). DWE is a Robertson Fellow and an NIHR Oxford BRC Senior Fellow.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonsall D, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00382-20; Bonsall David, 2015, F1000Res, V4, P1062, DOI 10.12688/f1000research.7111.1; Cele S., 2021, MEDRXIV, DOI [10.1101/2021.01.26.21250224, DOI 10.1101/2021.01.26.21250224]; Cortes N., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4570598, DOI 10.5281/ZENODO.4570598]; COVID-19 Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk, 2020, Lancet Microbe, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Dearlove B, 2020, P NATL ACAD SCI USA, V117, P23652, DOI 10.1073/pnas.2008281117; Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; du Plessis L, 2021, SCIENCE, V371, P708, DOI 10.1126/science.abf2946; Faria N., 2021, GENOMIC CHARACTERISA, DOI 10.1093/cid/ciaa1864; Ferretti L., 2020, TIMING COVID 19 TRAN, DOI [DOI 10.1101/2020.09.04.20188516, 10.1101/2020.09.04.20188516, 10.2139/ssrn.3716879, DOI 10.1101/2020.09.04.20188516V2]; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Gelbart M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009029; Ghafari M, 2020, J VIROL, V94, DOI 10.1128/JVI.00014-20; Goh C., 2019, BIORXIV716902, DOI [10.1101/716902, DOI 10.1101/716902]; Golubch T., 2020, CASTANET; Greaney AJ, 2020, COMPREHENSIVE MAPPIN, DOI [10.1101/2020.12.31.425021, DOI 10.1101/2020.12.31.425021]; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Harvey, 2020, SSRN ELECT J, DOI [DOI 10.2139/SSRN.3780277, 10.1101/2020.12.14.422555]; Herbeck JT, 2006, J VIROL, V80, P1637, DOI 10.1128/JVI.80.4.1637-1644.2006; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; James San Emmanuel, 2020, medRxiv, DOI 10.1101/2020.11.15.20231993; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim D, 2020, JAMA-J AM MED ASSOC, V323, P2085, DOI 10.1001/jama.2020.6266; Kissler SM., 2020, MEDRXIV, DOI [10.1101/2020.10.21.20217042, DOI 10.1101/2020.10.21.20217042]; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leonard AS, 2019, J VIROL, V93, DOI 10.1128/JVI.00936-19; Leonard AS, 2017, J VIROL, V91, DOI 10.1128/JVI.00171-17; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Lin GL, 2020, J INFECT DIS, V222, pS666, DOI 10.1093/infdis/jiaa448; Lu J, 2020, CELL, V181, P997, DOI 10.1016/j.cell.2020.04.023; Marks M, 2021, LANCET INFECT DIS, V21, P629, DOI 10.1016/S1473-3099(20)30985-3; Martin MA., 2021, REANALYSIS DEEP SEQU, DOI [10.1101/2021.02.22.432096, DOI 10.1101/2021.02.22.432096]; Mavian C, 2020, JMIR PUBLIC HLTH SUR, V6, P180, DOI [10.2196/19170, 10.2196/22853]; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; McCrone JT, 2018, ELIFE, V7, DOI 10.7554/eLife.35962; Morel B, 2021, MOL BIOL EVOL, V38, P1777, DOI 10.1093/molbev/msaa314; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nowak MD, 2020, J MED VIROL, V92, P1699, DOI 10.1002/jmv.25953; OToole A., 2021, PANGOLIN COVID19 LIN; Pond S., 2021, DATAMONKEY; Popa A, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abe2555; Raghwani J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007167; Rambaut A., 2020, COVID 19 GENOMICS CO; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Shen ZJ, 2020, CLIN INFECT DIS, V71, P713, DOI 10.1093/cid/ciaa203; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Thomson EC, 2021, CELL, V184, P1171, DOI 10.1016/j.cell.2021.01.037; Tonkin-Hill G, 2020, BIORXIV, DOI DOI 10.1101/2020.12.23.424229; Valesano AL, 2021, PLOS PATHOG, V17, DOI [10.1371/journal.ppat.1009499, 10.1101/2021.01.19.427330]; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Volz Erik, 2021, Cell, V184, P64, DOI 10.1016/j.cell.2020.11.020; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Wu Kai, 2021, bioRxiv, DOI 10.1101/2021.01.25.427948; Zambenedetti MR, 2017, MEM I OSWALDO CRUZ, V112, P339, DOI 10.1590/0074-02760160380; Zwart MP, 2015, ANNU REV VIROL, V2, P161, DOI 10.1146/annurev-virology-100114-055135	68	144	146	5	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2021	372	6539					256	+	eabg0821	10.1126/science.abg0821	http://dx.doi.org/10.1126/science.abg0821			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RO8JH	33688063	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000641286700031
J	Bluvstein, D; Omran, A; Levine, H; Keesling, A; Semeghini, G; Ebadi, S; Wang, TT; Michailidis, AA; Maskara, N; Ho, WW; Choi, S; Serbyn, M; Greiner, M; Vuletic, V; Lukin, MD				Bluvstein, D.; Omran, A.; Levine, H.; Keesling, A.; Semeghini, G.; Ebadi, S.; Wang, T. T.; Michailidis, A. A.; Maskara, N.; Ho, W. W.; Choi, S.; Serbyn, M.; Greiner, M.; Vuletic, V.; Lukin, M. D.			Controlling quantum many-body dynamics in driven Rydberg atom arrays	SCIENCE			English	Article								The control of nonequilibrium quantum dynamics in many-body systems is challenging because interactions typically lead to thermalization and a chaotic spreading throughout Hilbert space. We investigate nonequilibrium dynamics after rapid quenches in a many-body system composed of 3 to 200 strongly interacting qubits in one and two spatial dimensions. Using a programmable quantum simulator based on Rydberg atom arrays, we show that coherent revivals associated with so-called quantum many-body scars can be stabilized by periodic driving, which generates a robust subharmonic response akin to discrete timecrystalline order. We map Hilbert space dynamics, geometry dependence, phase diagrams, and system-size dependence of this emergent phenomenon, demonstrating new ways to steer complex dynamics in many-body systems and enabling potential applications in quantum information science.	[Bluvstein, D.; Omran, A.; Levine, H.; Keesling, A.; Semeghini, G.; Ebadi, S.; Wang, T. T.; Maskara, N.; Ho, W. W.; Greiner, M.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Omran, A.] QuEra Comp Inc, Boston, MA 02135 USA; [Michailidis, A. A.; Serbyn, M.] IST Austria, Campus 1, A-3400 Klosterneuburg, Austria; [Ho, W. W.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Choi, S.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Vuletic, V.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Vuletic, V.] MIT, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Institute of Science & Technology - Austria; Stanford University; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Omran, Ahmed/AHH-4541-2022; Semeghini, Giulia/H-6683-2018	Omran, Ahmed/0000-0002-2253-0278; Bluvstein, Dolev/0000-0002-9934-9530; Michailidis, Alexios/0000-0002-8443-1064; Ebadi, Sepehr/0000-0003-4146-3637; Ho, Wen Wei/0000-0001-7702-2900; Semeghini, Giulia/0000-0001-9071-2279	Center for Ultracold Atoms; National Science Foundation; Vannevar Bush Faculty Fellowship; U.S. Department of Energy [DE-SC0021013]; Office of Naval Research; Army Research Office MURI; DARPA DRINQS program [D18AC00033]; DARPA ONISQ program [W911NF2010021]; NSF [DGE1745303]; Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate (NDSEG) fellowship; Max Planck/Harvard Research Center for Quantum Optics; Gordon College; European Research Council (ERC) under the European Union [850899]; Department of Energy Computational Science Graduate Fellowship [DE-SC0021110]; Moore Foundation's EPiQS Initiative [GBMF4306]; NUS Development [AY2019/2020]; Stanford Institute of Theoretical Physics; Miller Institute for Basic Research in Science	Center for Ultracold Atoms; National Science Foundation(National Science Foundation (NSF)); Vannevar Bush Faculty Fellowship; U.S. Department of Energy(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research); Army Research Office MURI(MURI); DARPA DRINQS program; DARPA ONISQ program; NSF(National Science Foundation (NSF)); Fannie and John Hertz Foundation; National Defense Science and Engineering Graduate (NDSEG) fellowship; Max Planck/Harvard Research Center for Quantum Optics; Gordon College; European Research Council (ERC) under the European Union(European Research Council (ERC)); Department of Energy Computational Science Graduate Fellowship(United States Department of Energy (DOE)); Moore Foundation's EPiQS Initiative; NUS Development; Stanford Institute of Theoretical Physics; Miller Institute for Basic Research in Science	We acknowledge financial support from the Center for Ultracold Atoms, the National Science Foundation, the Vannevar Bush Faculty Fellowship, the U.S. Department of Energy (LBNL QSA Center and grant no. DE-SC0021013), the Office of Naval Research, the Army Research Office MURI, the DARPA DRINQS program (grant no. D18AC00033), and the DARPA ONISQ program (grant no. W911NF2010021). The authors acknowledge support from the NSF Graduate Research Fellowship Program (grant DGE1745303) and The Fannie and John Hertz Foundation (D.B.); a National Defense Science and Engineering Graduate (NDSEG) fellowship (H.L.); a fellowship from the Max Planck/Harvard Research Center for Quantum Optics (G.S.); Gordon College (T.T.W.); the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no. 850899) (A.A.M. and M.S.); a Department of Energy Computational Science Graduate Fellowship under award number DE-SC0021110 (N.M.); the Moore Foundation's EPiQS Initiative grant no. GBMF4306, the NUS Development grant AY2019/2020, and the Stanford Institute of Theoretical Physics (W.W.H.); and the Miller Institute for Basic Research in Science (S.C.).	Abanin DA, 2019, REV MOD PHYS, V91, DOI 10.1103/RevModPhys.91.021001; Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Ates C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.110603; Bernien H, 2017, NATURE, V551, P579, DOI 10.1038/nature24622; Choi S, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.220603; Ebadi S., 2020, ARXIV201212281QUANTP; Else DV, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.021032; Else DV, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011026; Else DV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.090402; Fan CH, 2020, PHYS REV A, V101, DOI 10.1103/PhysRevA.101.013417; Fendley P, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.075106; Guardado-Sanchez E, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021069; HELLER EJ, 1984, PHYS REV LETT, V53, P1515, DOI 10.1103/PhysRevLett.53.1515; Ho WW, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.040603; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Kaufman AM, 2016, SCIENCE, V353, P794, DOI 10.1126/science.aaf6725; Khemani V, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.161101; Khemani V, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.250401; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Langen T, 2015, SCIENCE, V348, P207, DOI 10.1126/science.1257026; Lesanovsky I, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.041601; Lienhard V, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021070; Lin CJ, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.173401; Maskara N., 2021, ARXIV210213160QUANTP; Michailidis AA, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.022065; Michailidis AA, 2020, PHYS REV X, V10, DOI 10.1103/PhysRevX.10.011055; Mizuta K, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.033284; Mukherjee B, 2020, PHYS REV B, V101, DOI 10.1103/PhysRevB.101.245107; Nandkishore R, 2015, ANNU REV CONDEN MA P, V6, P15, DOI 10.1146/annurev-conmatphys-031214-014726; Pohl T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.043002; Ponte P, 2015, ANN PHYS-NEW YORK, V353, P196, DOI 10.1016/j.aop.2014.11.008; Rigol M, 2008, NATURE, V452, P854, DOI 10.1038/nature06838; Schauss P, 2015, SCIENCE, V347, P1455, DOI 10.1126/science.1258351; Schreiber M, 2015, SCIENCE, V349, P842, DOI 10.1126/science.aaa7432; SREDNICKI M, 1994, PHYS REV E, V50, P888, DOI 10.1103/PhysRevE.50.888; Turner CJ, 2018, NAT PHYS, V14, P745, DOI 10.1038/s41567-018-0137-5; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; von Keyserlingk CW, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.085112; Yao NY, 2020, NAT PHYS, V16, P438, DOI 10.1038/s41567-019-0782-3	45	77	77	11	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2021	371	6536					1355	+		10.1126/science.abg2530	http://dx.doi.org/10.1126/science.abg2530			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RH2GI	33632894	Green Submitted			2022-12-28	WOS:000636043400048
J	Maust, DT; Strominger, J; Kim, HM; Langa, KM; Bynum, JPW; Chang, CH; Kales, HC; Zivin, K; Solway, E; Marcus, SC				Maust, Donovan T.; Strominger, Julie; Kim, H. Myra; Langa, Kenneth M.; Bynum, Julie P. W.; Chang, Chiang-Hua; Kales, Helen C.; Zivin, Kara; Solway, Erica; Marcus, Steven C.			Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; MEDICARE CLAIMS; MEDICATIONS; HEALTH; TRENDS; IMPACT; FALLS; CARE	Question What is the prevalence of polypharmacy with central nervous system (CNS)-active medications among community-dwelling older adults with dementia in the US? Findings In this cross-sectional analysis of 1 159 968 older adults with dementia, traditional Medicare, and prescription coverage in 2018, 13.9% were prescribed CNS-active polypharmacy, defined as overlapping prescription fills for 3 or more medications from the following drug classes: antidepressants, antipsychotics, antiepileptics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, and opioids. Meaning In 2018, 13.9% of older adults with dementia in the US had filled prescriptions consistent with CNS-active polypharmacy. Importance Community-dwelling older adults with dementia have a high prevalence of psychotropic and opioid use. In these patients, central nervous system (CNS)-active polypharmacy may increase the risk for impaired cognition, fall-related injury, and death. Objective To determine the extent of CNS-active polypharmacy among community-dwelling older adults with dementia in the US. Design, Setting, and Participants Cross-sectional analysis of all community-dwelling older adults with dementia (identified by International Classification of Diseases, Ninth Revision, Clinical Modification or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision diagnosis codes; N = 1 159 968) and traditional Medicare coverage from 2015 to 2017. Medication exposure was estimated using prescription fills between October 1, 2017, and December 31, 2018. Exposures Part D coverage during the observation year (January 1-December 31, 2018). Main Outcomes and Measures The primary outcome was the prevalence of CNS-active polypharmacy in 2018, defined as exposure to 3 or more medications for longer than 30 days consecutively from the following classes: antidepressants, antipsychotics, antiepileptics, benzodiazepines, nonbenzodiazepine benzodiazepine receptor agonist hypnotics, and opioids. Among those who met the criterion for polypharmacy, duration of exposure, number of distinct medications and classes prescribed, common class combinations, and the most commonly used CNS-active medications also were determined. Results The study included 1 159 968 older adults with dementia (median age, 83.0 years [interquartile range {IQR}, 77.0-88.6 years]; 65.2% were female), of whom 13.9% (n = 161 412) met the criterion for CNS-active polypharmacy (32 139 610 polypharmacy-days of exposure). Those with CNS-active polypharmacy had a median age of 79.4 years (IQR, 74.0-85.5 years) and 71.2% were female. Among those who met the criterion for CNS-active polypharmacy, the median number of polypharmacy-days was 193 (IQR, 88-315 polypharmacy-days). Of those with CNS-active polypharmacy, 57.8% were exposed for longer than 180 days and 6.8% for 365 days; 29.4% were exposed to 5 or more medications and 5.2% were exposed to 5 or more medication classes. Ninety-two percent of polypharmacy-days included an antidepressant, 47.1% included an antipsychotic, and 40.7% included a benzodiazepine. The most common medication class combination included an antidepressant, an antiepileptic, and an antipsychotic (12.9% of polypharmacy-days). Gabapentin was the most common medication and was associated with 33.0% of polypharmacy-days. Conclusions and Relevance In this cross-sectional analysis of Medicare claims data, 13.9% of older adults with dementia in 2018 filled prescriptions consistent with CNS-active polypharmacy. The lack of information on prescribing indications limits judgments about clinical appropriateness of medication combinations for individual patients. This pharmacoepidemiology study uses Medicare claims data to describe the prevalence of central nervous system-active polypharmacy among community-dwelling older adults with dementia in the US, including durations of exposure and number of drugs and drug classes.	[Maust, Donovan T.; Zivin, Kara] Univ Michigan, Dept Psychiat, 2800 Plymouth Rd,NCRC 016-226W, Ann Arbor, MI 48109 USA; [Maust, Donovan T.; Strominger, Julie; Kim, H. Myra; Langa, Kenneth M.; Zivin, Kara] VA Ann Arbor Healthcare Syst, Ctr Clin Management Res, Ann Arbor, MI USA; [Maust, Donovan T.; Kim, H. Myra; Langa, Kenneth M.; Bynum, Julie P. W.; Chang, Chiang-Hua; Zivin, Kara; Solway, Erica] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.; Bynum, Julie P. W.; Chang, Chiang-Hua] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Kales, Helen C.] Univ Calif Davis, Dept Psychiat, Sacramento, CA 95817 USA; [Marcus, Steven C.] Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Davis; University of Pennsylvania	Maust, DT (corresponding author), Univ Michigan, Dept Psychiat, 2800 Plymouth Rd,NCRC 016-226W, Ann Arbor, MI 48109 USA.	maustd@umich.edu		Zivin, Kara/0000-0001-8246-6864; Langa, Kenneth/0000-0002-2798-1836				2019 American Geriatrics Society, 2019, BEERS CRIT UPD EXP P; Abrahamson K, 2021, J APPL GERONTOL, V40, P1071, DOI 10.1177/0733464820948328; Bain Kevin T, 2006, Am J Geriatr Pharmacother, V4, P168, DOI 10.1016/j.amjopharm.2006.06.006; Breining A, 2017, INT J GERIATR PSYCH, V32, P750, DOI 10.1002/gps.4517; Bynum JPW, 2014, HEALTH AFFAIR, V33, P534, DOI 10.1377/hlthaff.2013.1247; Deshpande LS, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00011; Dudas R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003944.pub2; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767; Gray SL, 2020, J GERONTOL A-BIOL, V75, P1003, DOI 10.1093/gerona/glz270; Gustafsson M, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-56; Hanlon JT, 2009, J GERONTOL A-BIOL, V64, P492, DOI 10.1093/gerona/gln043; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Iaboni A, 2016, DRUG AGING, V33, P523, DOI 10.1007/s40266-016-0380-3; KALES HC, 2015, BMJ-BRIT MED J, V5, P350, DOI DOI 10.1136/BMJJ369; Kaufer DI, 1998, J AM GERIATR SOC, V46, P210, DOI 10.1111/j.1532-5415.1998.tb02542.x; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2318, DOI 10.1377/hlthaff.2011.0370; Lambiase PD, 2019, ARRHYTH ELECTROPHYSI, V8, P161, DOI 10.15420/aer.2019.8.3.G1; Landes AM, 2001, J AM GERIATR SOC, V49, P1700, DOI 10.1046/j.1532-5415.2001.49282.x; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Maust DT, 2020, JAMA-J AM MED ASSOC, V324, P706, DOI 10.1001/jama.2020.8519; Maust DT, 2017, JAMA INTERN MED, V177, P583, DOI 10.1001/jamainternmed.2016.9225; Maust DT, 2017, INT J GERIATR PSYCH, V32, P164, DOI 10.1002/gps.4452; McKean A, 2012, CNS DRUGS, V26, P383, DOI 10.2165/11632030-000000000-00000; Moore TJ, 2017, JAMA INTERN MED, V177, P274, DOI 10.1001/jamainternmed.2016.7507; Norgaard A, 2017, J ALZHEIMERS DIS, V56, P707, DOI 10.3233/JAD-160828; Orsel K, 2018, EUR NEUROPSYCHOPHARM, V28, P1260, DOI 10.1016/j.euroneuro.2018.04.005; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Porsteinsson AP, 2014, JAMA-J AM MED ASSOC, V311, P682, DOI 10.1001/jama.2014.93; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; US Food Drug Administration, 2016, FDA WARNS SER RISKS; Vasudev A, 2015, AM J GERIAT PSYCHIAT, V23, P1259, DOI 10.1016/j.jagp.2015.07.001; Vigen CLP, 2011, AM J PSYCHIAT, V168, P831, DOI 10.1176/appi.ajp.2011.08121844; Walsh KA, 2016, INT PSYCHOGERIATR, V28, P1807, DOI 10.1017/S1041610216001307; Wei YJ, 2016, MED CARE, V54, pE73; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Wright RM, 2009, J AM GERIATR SOC, V57, P243, DOI 10.1111/j.1532-5415.2008.02127.x	39	21	21	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					952	961		10.1001/jama.2021.1195	http://dx.doi.org/10.1001/jama.2021.1195			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV3UE	33687462	Green Published, Bronze			2022-12-28	WOS:000627899400017
J	Hung, IFN; Poland, GA				Hung, Ivan F. N.; Poland, Gregory A.			Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster	LANCET			English	Editorial Material									[Hung, Ivan F. N.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China; [Poland, Gregory A.] Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA	University of Hong Kong; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu	Hung, Ivan FN/ABD-5916-2021	Hung, Ivan FN/0000-0002-1556-2538				[Anonymous], 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMclde2101987; Fontanet A, 2021, LANCET, V397, P952, DOI 10.1016/S0140-6736(21)00370-6; Lipsitch M, 2020, SCIENCE, V370, P763, DOI 10.1126/science.abe5938; Medicines and Healthcare products Regulatory Agency, 2021, REG APPR COVID 19 VA; Moghadas Seyed M, 2021, medRxiv, DOI [10.1371/journal.pbio.3001211, 10.1101/2021.01.27.21250619]; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines, 2020, MRNA VACC COVID 19 P; UK Department of Health and Social Care, 2020, OXF U ASTRAZENECA VA; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; Won JH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249775	10	36	37	10	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					854	855						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QT5BR	33676614	Green Published, Bronze			2022-12-28	WOS:000626603400002
J	Casarotto, PC; Girych, M; Fred, SM; Kovaleva, V; Moliner, R; Enkavi, G; Biojone, C; Cannarozzo, C; Sahu, MP; Kaurinkoski, K; Brunello, CA; Steinzeig, A; Winkel, F; Patil, S; Vestring, S; Serchov, T; Diniz, CRAF; Laukkanen, L; Cardon, I; Antila, H; Rog, T; Piepponen, TP; Bramham, CR; Normann, C; Lauri, SE; Saarma, M; Vattulainen, I; Castren, E				Casarotto, Plinio C.; Girych, Mykhailo; Fred, Senem M.; Kovaleva, Vera; Moliner, Rafael; Enkavi, Giray; Biojone, Caroline; Cannarozzo, Cecilia; Sahu, Madhusmita Pryiadrashini; Kaurinkoski, Katja; Brunello, Cecilia A.; Steinzeig, Anna; Winkel, Frederike; Patil, Sudarshan; Vestring, Stefan; Serchov, Tsvetan; Diniz, Cassiano R. A. F.; Laukkanen, Liina; Cardon, Iseline; Antila, Hanna; Rog, Tomasz; Piepponen, Timo Petteri; Bramham, Clive R.; Normann, Claus; Lauri, Sari E.; Saarma, Mart; Vattulainen, Ilpo; Castren, Eero			Antidepressant drugs act by directly binding to TRKB neurotrophin receptors	CELL			English	Article								It is unclear how binding of antidepressant drugs to their targets gives rise to the clinical antidepressant effect. We discovered that the transmembrane domain of tyrosine kinase receptor 2 (TRKB), the brain-derived neurotrophic factor (BDNF) receptor that promotes neuronal plasticity and antidepressant responses, has a cholesterol-sensing function that mediates synaptic effects of cholesterol. We then found that both typical and fast-acting antidepressants directly bind to TRKB, thereby facilitating synaptic localization of TRKB and its activation by BDNF. Extensive computational approaches including atomistic molecular dynamics simulations revealed a binding site at the transmembrane region of TRKB dimers. Mutation of the TRKB antidepressant-binding motif impaired cellular, behavioral, and plasticity-promoting responses to antidepressants in vitro and in vivo. We suggest that binding to TRKB and allosteric facilitation of BDNF signaling is the common mechanism for antidepressant action, which may explain why typical antidepressants act slowly and how molecular effects of antidepressants are translated into clinical mood recovery.	[Casarotto, Plinio C.; Fred, Senem M.; Moliner, Rafael; Biojone, Caroline; Cannarozzo, Cecilia; Sahu, Madhusmita Pryiadrashini; Kaurinkoski, Katja; Brunello, Cecilia A.; Steinzeig, Anna; Winkel, Frederike; Diniz, Cassiano R. A. F.; Laukkanen, Liina; Cardon, Iseline; Antila, Hanna; Lauri, Sari E.; Castren, Eero] Univ Helsinki, Neurosci Ctr, HILIFE, Helsinki, Finland; [Girych, Mykhailo; Enkavi, Giray; Rog, Tomasz; Vattulainen, Ilpo] Univ Helsinki, Dept Phys, Helsinki, Finland; [Kovaleva, Vera; Saarma, Mart] Univ Helsinki, Inst Biotechnol, HILIFE, Helsinki, Finland; [Patil, Sudarshan; Bramham, Clive R.] Univ Bergen, Dept Biomed, Bergen, Norway; [Patil, Sudarshan; Bramham, Clive R.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway; [Vestring, Stefan; Serchov, Tsvetan; Normann, Claus] Univ Freiburg, Med Ctr Univ Freiburg, Fac Med, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Vestring, Stefan] Univ Freiburg, Fac Med, Berta Ottenstein Programme Clinician Scientists, Freiburg, Germany; [Diniz, Cassiano R. A. F.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, Sao Paulo, Brazil; [Cardon, Iseline] Aix Marseille Univ, Fac Sci, Brain Master Program, Marseille, France; [Cardon, Iseline] Univ Regensburg, Dept Psychiat, Regenburg, Germany; [Antila, Hanna] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Piepponen, Timo Petteri] Univ Helsinki, Fac Pharm, Div Pharmacol & Pharmacotherapy, Helsinki, Finland; [Normann, Claus] Univ Freiburg, Ctr Basics Neuromodulat NeuroModul Basics, Freiburg, Germany; [Lauri, Sari E.] Univ Helsinki, Mol & Integrat Biosci Res Program, Helsinki, Finland; [Vattulainen, Ilpo] Tampere Univ, Computat Phys Lab, Tampere, Finland; [Serchov, Tsvetan] Univ Strasbourg, Ctr Natl Rech Sci CNRS, Inst Neurosci Cellulaires & Integrat, F-67000 Strasbourg, France	University of Helsinki; University of Helsinki; University of Helsinki; University of Bergen; University of Bergen; University of Freiburg; University of Freiburg; Universidade de Sao Paulo; UDICE-French Research Universities; Aix-Marseille Universite; University of Regensburg; University of Pennsylvania; Pennsylvania Medicine; University of Helsinki; University of Freiburg; University of Helsinki; Tampere University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Castren, E (corresponding author), Univ Helsinki, Neurosci Ctr, HILIFE, Helsinki, Finland.	eero.castren@helsinki.fi	Lauri, Sari/AAD-6417-2021	Lauri, Sari/0000-0002-5895-1357; Sahu, Madhusmita Priyadarshini/0000-0003-1318-5799; Casarotto, Plinio/0000-0002-1090-4631; Moliner, Rafael/0000-0002-7392-0460; Rog, Tomasz/0000-0001-6765-7013; Cannarozzo, Cecilia/0000-0002-5676-3619; Vattulainen, Ilpo/0000-0001-7408-3214; Cardon, Iseline/0000-0001-5533-4727; Fred, Senem Merve/0000-0003-1992-5014; Antila, Hanna/0000-0001-8317-4564; Piepponen, Petteri/0000-0002-2318-1612; Castren, Eero/0000-0002-1402-2791; Kaurinkoski, Katja/0000-0002-3897-8448; Biojone, Caroline/0000-0002-9674-4930	ERC [322742]; JPND CircProt [301225, 643417, 30122]; Sigrid Juselius Foundation; Jane and Aatos Erkko Foundation; Academy of Finland [294710, 307416, 297211]; FAPESP [2018/18500-3, 2018/04250-5]; Academy of Finland (Center of Excellence) [307415]; Helsinki Institute of Life Science; Human Frontier Science Program [RGP0059/2019]; CSC-IT Center for Science; German Research Council [SE 2666/2-1]; Forschungskommission of the Medical Faculty of the University of Freiburg [SER1149/17]	ERC(European Research Council (ERC)European Commission); JPND CircProt; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Academy of Finland (Center of Excellence)(Academy of Finland); Helsinki Institute of Life Science; Human Frontier Science Program(Human Frontier Science Program); CSC-IT Center for Science; German Research Council(German Research Foundation (DFG)); Forschungskommission of the Medical Faculty of the University of Freiburg	The authors thank Sulo Kolehmainen and Seija Lagas (Neuroscience CenterUH), Marc Baumann and Rabah Soliymani (Department of Biochemistry and Developmental Biology-UH), and the Biomedicum Imaging Unit (BIU) at the University of Helsinki for technical help. We also thank Drs. Todd Gould (U. of Maryland) and Craig Thomas (NIH) for kindly supplying the R,R-HNK, Henri Huttunen (UH) for supplying GLuc-coupled raft-restricted FYN construct, and Yves-Alain Barde, Maija Castren, Juan Lima-Ojeda, and Heikki Ruskoaho for their insightful comments to the manuscript. The E.C. lab was supported by the ERC (322742-iPLASTICITY), JPND CircProt (project 301225 and project 643417), the Sigrid Juselius Foundation, the Jane and Aatos Erkko Foundation, and the Academy of Finland (294710 and 307416). C.R.A.F.D. received grants from FAPESP (project 2018/18500-3 and project 2018/04250-5). The C.R.B. lab was supported by the JPND CircProt (project 30122). The S.E.L. lab was funded by the Academy of Finland (297211). The I.V. lab was supported by the Academy of Finland (Center of Excellence) (307415), the Sigrid Juselius Foundation, the Helsinki Institute of Life Science, Human Frontier Science Program (project RGP0059/2019), and CSC-IT Center for Science. T.S. was funded by the German Research Council (SE 2666/2-1) and the Forschungskommission of the Medical Faculty of the University of Freiburg (SER1149/17). The M.S. lab was funded by the Jane and Aatos Erkko Foundation. None of the funders had a role in the data acquisition and analysis or manuscript preparation.	Abdallah CG, 2015, ANNU REV MED, V66, P509, DOI 10.1146/annurev-med-053013-062946; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Ampuero E, 2013, BEHAV BRAIN RES, V247, P92, DOI 10.1016/j.bbr.2013.03.011; Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Antila H, 2014, J NEUROSCI METH, V222, P142, DOI 10.1016/j.jneumeth.2013.11.001; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Baeza-Raja B, 2016, CELL REP, V14, P255, DOI 10.1016/j.celrep.2015.12.028; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI 10.1038/nrdp.2016.65; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Casarotto P.C., 2020, J NEUROSCI; Castren E, 2017, MOL PSYCHIATR, V22, P1085, DOI 10.1038/mp.2017.61; Castren E, 2013, JAMA PSYCHIAT, V70, P983, DOI 10.1001/jamapsychiatry.2013.1; Chen JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034024; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Dekkers MPJ, 2013, J CELL BIOL, V203, P385, DOI 10.1083/jcb.201306136; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Deschaux O, 2011, PSYCHOPHARMACOLOGY, V215, P231, DOI 10.1007/s00213-010-2134-y; Di Lieto A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032869; Diniz CRAF, 2018, NEUROPHARMACOLOGY, V135, P163, DOI 10.1016/j.neuropharm.2018.03.011; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Erb SJ, 2016, J BIOL CHEM, V291, P19725, DOI 10.1074/jbc.M116.727263; Ernfors P, 2003, TRENDS NEUROSCI, V26, P171, DOI 10.1016/S0166-2236(03)00064-X; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fantini J, 2019, ADV EXP MED BIOL, V1135, P3, DOI 10.1007/978-3-030-14265-0_1; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fred SM, 2019, J BIOL CHEM, V294, P18150, DOI 10.1074/jbc.RA119.008837; Gonzalez-Gonzalez IM, 2012, METHOD ENZYMOL, V504, P127, DOI 10.1016/B978-0-12-391857-4.00006-9; Greifzu F, 2014, P NATL ACAD SCI USA, V111, P1150, DOI 10.1073/pnas.1313385111; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; Haapasalo A, 2002, J BIOL CHEM, V277, P43160, DOI 10.1074/jbc.M205202200; Harmer CJ, 2017, LANCET PSYCHIAT, V4, P409, DOI 10.1016/S2215-0366(17)30015-9; Henry ME, 2000, AM J PSYCHIAT, V157, P1506, DOI 10.1176/appi.ajp.157.9.1506; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Jang SW, 2009, CHEM BIOL, V16, P644, DOI 10.1016/j.chembiol.2009.05.010; Jerabek-Willemsen M, 2014, J MOL STRUCT, V1077, P101, DOI 10.1016/j.molstruc.2014.03.009; Jiang W, 2010, J CHEM THEORY COMPUT, V6, P2559, DOI 10.1021/ct1001768; Jo S, 2017, J COMPUT CHEM, V38, P1114, DOI 10.1002/jcc.24660; Johnson RD, 2007, J ANAL TOXICOL, V31, P409, DOI 10.1093/jat/31.7.409; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kim YK, 2004, J AFFECT DISORDERS, V81, P161, DOI 10.1016/S0165-0327(03)00166-6; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klimovich PV, 2015, J COMPUT AID MOL DES, V29, P397, DOI 10.1007/s10822-015-9840-9; Kohler-Forsberg O, 2019, J AFFECT DISORDERS, V246, P706, DOI 10.1016/j.jad.2018.12.110; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Kornhuber J, 1995, J NEURAL TRANSM-SUPP, P315; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; Koskinen M, 2012, METHOD ENZYMOL, V505, P47, DOI 10.1016/B978-0-12-388448-0.00011-5; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Li SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-25; Lomize AL, 2018, BIOINFORMATICS, V34, P1061, DOI 10.1093/bioinformatics/btx720; Lomize AL, 2017, NUCLEIC ACIDS RES, V45, pD250, DOI 10.1093/nar/gkw712; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Longo FM, 2013, NAT REV DRUG DISCOV, V12, P507, DOI 10.1038/nrd4024; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Malhi GS, 2018, LANCET, V392, P2299, DOI 10.1016/S0140-6736(18)31948-2; Martin MG, 2014, EMBO MOL MED, V6, P902, DOI 10.15252/emmm.201303711; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McGuinn KP, 2014, METHODS MOL BIOL, V1195, P133, DOI 10.1007/7651_2014_71; Merezhko M, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20191290; Messaoudi E, 1998, J NEUROPHYSIOL, V79, P496, DOI 10.1152/jn.1998.79.1.496; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nackenoff AG, 2016, NEUROPSYCHOPHARMACOL, V41, P1733, DOI 10.1038/npp.2015.335; Nikoletopoulou V, 2010, NATURE, V467, P59, DOI 10.1038/nature09336; Normann C, 2018, BIOL PSYCHIAT, V84, P55, DOI 10.1016/j.biopsych.2017.10.008; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Panja D, 2014, NEUROPHARMACOLOGY, V76, P664, DOI 10.1016/j.neuropharm.2013.06.024; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Popova D, 2017, NEUROPHARMACOLOGY, V126, P250, DOI 10.1016/j.neuropharm.2017.09.003; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Raggi MA, 1998, J PHARMACEUT BIOMED, V18, P193, DOI 10.1016/S0731-7085(98)00170-8; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rantamaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020567; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sahu Madhusmita Priyadarshini, 2019, Neuronal Signal, V3, pNS20180207, DOI 10.1042/NS20180207; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saragovi HU, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00231; Schneider J, 2019, CLEV CLIN J MED, V86, P807, DOI 10.3949/ccjm.86a.19005; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shirts MR, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2978177; Sinclair JKL, 2018, CELL CHEM BIOL, V25, P857, DOI 10.1016/j.chembiol.2018.04.005; Steinzeig A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181788; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Tikka S, 2016, NEUROMOL MED, V18, P109, DOI 10.1007/s12017-015-8382-6; Tulodziecka K, 2016, MOL BIOL CELL, V27, P3480, DOI 10.1091/mbc.E16-06-0420; Ulmschneider JP, 2011, J AM CHEM SOC, V133, P15487, DOI 10.1021/ja204042f; Ulmschneider MB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5863; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3155, DOI 10.1021/ci3003649; Wang JY, 2006, BIOPHYS J, V91, P2798, DOI 10.1529/biophysj.106.084301; Wang YK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13535; Welsch ME, 2017, CELL, V168, P878, DOI 10.1016/j.cell.2017.02.006; Wray NH, 2019, MOL PSYCHIATR, V24, P1833, DOI 10.1038/s41380-018-0083-8; Wu XF, 2009, BIOL PSYCHIAT, V66, P5, DOI 10.1016/j.biopsych.2009.01.023; Yatham MS, 2019, J AFFECT DISORDERS, V257, P55, DOI 10.1016/j.jad.2019.07.002; Zanos P, 2018, PHARMACOL REV, V70, P621, DOI 10.1124/pr.117.015198; Zanos P, 2016, NATURE, V533, P481, DOI 10.1038/nature17998; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zheng CY, 2011, JOVE-J VIS EXP, DOI 10.3791/2568; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200; Zonta Barbara, 2013, Front Synaptic Neurosci, V5, P9, DOI 10.3389/fnsyn.2013.00009	130	146	148	30	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1299	+		10.1016/j.cell.2021.01.034	http://dx.doi.org/10.1016/j.cell.2021.01.034		MAR 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33606976	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000629635700017
J	Voysey, M; Clemens, SAC; Madhi, SA; Weckx, LY; Folegatti, PM; Aley, PK; Angus, B; Baillie, VL; Barnabas, SL; Bhorat, QE; Bibi, S; Briner, C; Cicconi, P; Clutterbuck, EA; Collins, AM; Cutland, CL; Darton, TC; Dheda, K; Dold, C; Duncan, CJA; Emary, KRW; Ewer, KJ; Flaxman, A; Fairlie, L; Faust, SN; Feng, S; Ferreira, DM; Finn, A; Galiza, E; Goodman, AL; Green, CM; Green, CA; Greenland, M; Hill, C; Hill, HC; Hirsch, I; Izu, A; Jenkin, D; Joe, CCD; Kerridge, S; Koen, A; Kwatra, G; Lazarus, R; Libri, V; Lillie, PJ; Marchevsky, NG; Marshall, RP; Mendes, AVA; Milan, EP; Minassian, AM; McGregor, A; Mujadidi, YF; Nana, A; Padayachee, SD; Phillips, DJ; Pittella, A; Plested, E; Pollock, KM; Ramasamy, MN; Ritchie, AJ; Robinson, H; Schwarzbold, AV; Smith, A; Song, R; Snape, MD; Sprinz, E; Sutherland, RK; Thomson, EC; Torok, ME; Toshner, M; Turner, DPJ; Vekemans, J; Villafana, TL; White, T; Williams, CJ; Douglas, AD; Hill, AVS; Lambe, T; Gilbert, SC; Pollard, AJ				Voysey, Merryn; Clemens, Sue Ann Costa; Madhi, Shabir A.; Weckx, Lily Y.; Folegatti, Pedro M.; Aley, Parvinder K.; Angus, Brian; Baillie, Vicky L.; Barnabas, Shaun L.; Bhorat, Qasim E.; Bibi, Sagida; Briner, Carmen; Cicconi, Paola; Clutterbuck, Elizabeth A.; Collins, Andrea M.; Cutland, Clare L.; Darton, Thomas C.; Dheda, Keertan; Dold, Christina; Duncan, Christopher J. A.; Emary, Katherine R. W.; Ewer, Katie J.; Flaxman, Amy; Fairlie, Lee; Faust, Saul N.; Feng, Shuo; Ferreira, Daniela M.; Finn, Adam; Galiza, Eva; Goodman, Anna L.; Green, Catherine M.; Green, Christopher A.; Greenland, Melanie; Hill, Catherine; Hill, Helen C.; Hirsch, Ian; Izu, Alane; Jenkin, Daniel; Joe, Carina C. D.; Kerridge, Simon; Koen, Anthonet; Kwatra, Gaurav; Lazarus, Rajeka; Libri, Vincenzo; Lillie, Patrick J.; Marchevsky, Natalie G.; Marshall, Richard P.; Mendes, Ana V. A.; Milan, Eveline P.; Minassian, Angela M.; McGregor, Alastair; Mujadidi, Yama F.; Nana, Anusha; Padayachee, Sherman D.; Phillips, Daniel J.; Pittella, Ana; Plested, Emma; Pollock, Katrina M.; Ramasamy, Maheshi N.; Ritchie, Adam J.; Robinson, Hannah; Schwarzbold, Alexandre V.; Smith, Andrew; Song, Rinn; Snape, Matthew D.; Sprinz, Eduardo; Sutherland, Rebecca K.; Thomson, Emma C.; Torok, M. Estee; Toshner, Mark; Turner, David P. J.; Vekemans, Johan; Villafana, Tonya L.; White, Thomas; Williams, Christopher J.; Douglas, Alexander D.; Hill, Adrian V. S.; Lambe, Teresa; Gilbert, Sarah C.; Pollard, Andrew J.		Oxford COVID Vaccine Trial Grp	Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials	LANCET			English	Article								Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, with a regimen of two standard doses given with an interval of 4-12 weeks. The planned roll-out in the UK will involve vaccinating people in high-risk categories with their first dose immediately, and delivering the second dose 12 weeks later. Here, we provide both a further prespecified pooled analysis of trials of ChAdOx1 nCoV-19 and exploratory analyses of the impact on immunogenicity and efficacy of extending the interval between priming and booster doses. In addition, we show the immunogenicity and protection afforded by the first dose, before a booster dose has been offered. Methods We present data from three single-blind randomised controlled trials-one phase 1/2 study in the UK (COV001), one phase 2/3 study in the UK (COV002), and a phase 3 study in Brazil (COV003)-and one double-blind phase 1/2 study in South Africa (COV005). As previously described, individuals 18 years and older were randomly assigned 1:1 to receive two standard doses of ChAdOx1 nCoV-19 (5 x 10(10) viral particles) or a control vaccine or saline placebo. In the UK trial, a subset of participants received a lower dose (2.2 x 10(10) viral particles) of the ChAdOx1 nCoV-19 for the first dose. The primary outcome was virologically confirmed symptomatic COVID-19 disease, defined as a nucleic acid amplification test (NAAT)-positive swab combined with at least one qualifying symptom (fever >= 37.8 degrees C, cough, shortness of breath, or anosmia or ageusia) more than 14 days after the second dose. Secondary efficacy analyses included cases occuring at least 22 days after the first dose. Antibody responses measured by immunoassay and by pseudovirus neutralisation were exploratory outcomes. All cases of COVID-19 with a NAAT-positive swab were adjudicated for inclusion in the analysis by a masked independent endpoint review committee. The primary analysis included all participants who were SARS-CoV-2 N protein seronegative at baseline, had had at least 14 days of follow-up after the second dose, and had no evidence of previous SARS-CoV-2 infection from NAAT swabs. Safety was assessed in all participants who received at least one dose. The four trials are registered at ISRCTN89951424 (COV003) and ClinicalTrials.gov, NCT04324606 (COV001), NCT04400838 (COV002), and NCT04444674 (COV005). Findings Between April 23 and Dec 6, 2020, 24 422 participants were recruited and vaccinated across the four studies, of whom 17 178 were included in the primary analysis (8597 receiving ChAdOx1 nCoV-19 and 8581 receiving control vaccine). The data cutoff for these analyses was Dec 7, 2020. 332 NAAT-positive infections met the primary endpoint of symptomatic infection more than 14 days after the second dose. Overall vaccine efficacy more than 14 days after the second dose was 66.7% (95% CI 57.4-74.0), with 84 (1.0%) cases in the 8597 participants in the ChAdOx1 nCoV-19 group and 248 (2.9%) in the 8581 participants in the control group. There were no hospital admissions for COVID-19 in the ChAdOx1 nCoV-19 group after the initial 21-day exclusion period, and 15 in the control group. 108 (0.9%) of 12 282 participants in the ChAdOx1 nCoV-19 group and 127 (1.1%) of 11 962 participants in the control group had serious adverse events. There were seven deaths considered unrelated to vaccination (two in the ChAdOx1 nCov-19 group and five in the control group), including one COVID-19-related death in one participant in the control group. Exploratory analyses showed that vaccine efficacy after a single standard dose of vaccine from day 22 to day 90 after vaccination was 76.0% (59.3-85.9). Our modelling analysis indicated that protection did not wane during this initial 3-month period. Similarly, antibody levels were maintained during this period with minimal waning by day 90 (geometric mean ratio [GMR] 0.66 [95% CI 0.59-0.74]). In the participants who received two standard doses, after the second dose, efficacy was higher in those with a longer prime-boost interval (vaccine efficacy 81.3% [95% CI 60.3-91.2] at >= 12 weeks) than in those with a short interval (vaccine efficacy 55.1% [33.0-69.9] at <6 weeks). These observations are supported by immunogenicity data that showed binding antibody responses more than two-fold higher after an interval of 12 or more weeks compared with an interval of less than 6 weeks in those who were aged 18-55 years (GMR 2.32 [2.01-2.68]). Interpretation The results of this primary analysis of two doses of ChAdOx1 nCoV-19 were consistent with those seen in the interim analysis of the trials and confirm that the vaccine is efficacious, with results varying by dose interval in exploratory analyses. A 3-month dose interval might have advantages over a programme with a short dose interval for roll-out of a pandemic vaccine to protect the largest number of individuals in the population as early as possible when supplies are scarce, while also improving protection after receiving a second dose. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Voysey, Merryn; Aley, Parvinder K.; Clutterbuck, Elizabeth A.; Dold, Christina; Emary, Katherine R. W.; Feng, Shuo; Greenland, Melanie; Kerridge, Simon; Marchevsky, Natalie G.; Mujadidi, Yama F.; Phillips, Daniel J.; Plested, Emma; Ramasamy, Maheshi N.; Robinson, Hannah; Song, Rinn; Snape, Matthew D.; Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Folegatti, Pedro M.; Ewer, Katie J.; Flaxman, Amy; Jenkin, Daniel; Joe, Carina C. D.; Minassian, Angela M.; Ritchie, Adam J.; Douglas, Alexander D.; Hill, Adrian V. S.; Lambe, Teresa; Gilbert, Sarah C.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Clemens, Sue Ann Costa] Univ Siena, Inst Global Hlth, Siena, Italy; [Clemens, Sue Ann Costa] Univ Oxford, Dept Paediat, Oxford, England; [Green, Catherine M.] Univ Oxford, Clin BioMfg Facil, Oxford, England; [Madhi, Shabir A.; Baillie, Vicky L.; Cutland, Clare L.; Hill, Catherine; Izu, Alane; Koen, Anthonet; Kwatra, Gaurav] Univ Witwatersrand, South African Med Res Council Vaccines & Infect D, Fac Hlth Sci, Johannesburg, South Africa; [Madhi, Shabir A.; Baillie, Vicky L.; Cutland, Clare L.; Hill, Catherine; Izu, Alane; Koen, Anthonet; Kwatra, Gaurav] Univ Witwatersrand, Dept Sci & Innovat, Natl Res Fdn, South African Res Chair Initiat Vaccine Preventab, Johannesburg, South Africa; [Fairlie, Lee] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Briner, Carmen; Nana, Anusha] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Weckx, Lily Y.] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, Brazil; [Hirsch, Ian; Marshall, Richard P.; Vekemans, Johan; Villafana, Tonya L.; White, Thomas] AstraZeneca BioPharmaceut, Cambridge, England; [Barnabas, Shaun L.] Univ Stellenbosch, Dept Paediat, Family Ctr Res Ubuntu, Cape Town, South Africa; [Bhorat, Qasim E.] Soweto Clin Trials Ctr, Soweto, South Africa; [Collins, Andrea M.; Ferreira, Daniela M.; Hill, Helen C.] Liverpool Sch ofTrop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Collins, Andrea M.; Ferreira, Daniela M.; Hill, Helen C.] Liverpool Univ Hosp NHS FoundationTrust, Liverpool, Merseyside, England; [Darton, Thomas C.] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England; [Darton, Thomas C.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Infect & Trop Med, Sheffield, S Yorkshire, England; [Mendes, Ana V. A.] Braziland Hosp Sao Rafael, Escola Bahiana Med Saude Publ, Salvador, BA, Brazil; [Mendes, Ana V. A.] Inst Or, Salvador, BA, Brazil; [Dheda, Keertan] Groote Schuur Hosp, Div Pulmonol, Cape Town, South Africa; [Dheda, Keertan] Univ CapeTown, Cape Town, South Africa	University of Oxford; University of Oxford; Jenner Institute; University of Siena; University of Oxford; University of Oxford; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Universidade Federal de Sao Paulo (UNIFESP); Stellenbosch University; University of Sheffield; University of Sheffield; Escola Bahiana de Medicina e Saude Publica; University of Cape Town; University of Cape Town	Voysey, M (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.		Tarr, Alexander W/B-7953-2008; Tomic, Adriana/AAX-7203-2021; Baker, Philip/ABI-2575-2020; Macdonald, Jonathan/AAU-7355-2021; Lambe, Teresa/E-5733-2016; Ferreira, Daniela M/AFF-4763-2022; Cardoso Mourão, João Renato/HHN-7944-2022; Souza, Bruno/AAO-4601-2021; Neto, José Cerbino/P-3713-2018; Cutland, Clare L./GXE-9967-2022; Darton, Thomas/H-2816-2017; Ferreira, Daniela M/AAE-9881-2022; Folegatti, Pedro/AAD-5238-2019; Jenkin, Daniel/AAB-7042-2022; Ewer, Katie J/B-4328-2011; Oldfield, Neil J/C-2599-2009; Dold, Christina/ABA-4237-2021; Chelysheva, Irina/AAQ-5231-2021; Thomson, Emma C/M-8690-2017; Duncan, Christopher/A-2018-2012; Faust, Saul/J-9779-2014; Knight, Julian/W-2399-2019	Tarr, Alexander W/0000-0003-1009-0823; Tomic, Adriana/0000-0001-9885-3535; Baker, Philip/0000-0002-4519-1563; Macdonald, Jonathan/0000-0003-0249-107X; Lambe, Teresa/0000-0001-7711-897X; Ferreira, Daniela M/0000-0002-0594-0902; Souza, Bruno/0000-0003-3771-0439; Neto, José Cerbino/0000-0001-9254-917X; Cutland, Clare L./0000-0001-8250-8307; Darton, Thomas/0000-0003-2209-9956; Folegatti, Pedro/0000-0001-5330-0240; Ewer, Katie J/0000-0001-9827-9836; Oldfield, Neil J/0000-0001-7423-8378; Chelysheva, Irina/0000-0001-7802-7025; Thomson, Emma C/0000-0003-1482-0889; Barnes, Eleanor/0000-0002-0860-0831; Thomas, Tonia/0000-0003-3091-5917; Salman, Ahmed/0000-0002-9259-7339; Birch, Sarah/0000-0002-0711-3740; Frater, John/0000-0001-7163-7277; Lias, Amelia/0000-0003-2939-7761; Liatsikos, Konstantinos/0000-0003-2061-8329; Moore, Maria/0000-0001-6456-927X; Marshall, Julia/0000-0002-9692-6769; McCaughan, Hugh/0000-0002-4090-9054; Pittella, Ana/0000-0002-8761-179X; EBERLLINE, ERIKA/0000-0002-2130-4228; Screaton, Gavin/0000-0002-3549-4309; Dong, Tao/0000-0003-3545-3758; Dunachie, Susanna/0000-0001-5665-6293; Robbins, Alexander/0000-0001-6929-5802; collins, andrea/0000-0002-4094-1572; Strickland, Louise/0000-0003-4486-1868; Farooq Mujadidi, Yama/0000-0002-2342-8531; Madhi, Shabir/0000-0002-7629-0636; Bhorat, Qasim Ebrahim/0000-0002-4102-8750; Hamaluba, Mainga/0000-0002-0266-1414; Ramasamy, Maheshi Nirmala/0000-0002-2119-951X; Mendes Lages, Pedro/0000-0002-2349-693X; Baillie, Vicky Lynne/0000-0003-1327-9090; Chadwick, Jim/0000-0001-9935-4762; Sanders, Katherine/0000-0002-4090-3277; Spencer, Alexandra/0000-0001-7958-6961; Costa Clemens, Sue Ann/0000-0001-9576-0878; Colton, Hayley/0000-0002-3287-4103; Khozoee, Baktash/0000-0002-2470-3283; Green, Catherine/0000-0002-7068-7106; Garlant, Harriet/0000-0001-7612-6441; Finn, Adam/0000-0003-1756-5668; Zuidewind, Peter/0000-0003-3235-7445; Aley, Parvinder/0000-0002-0749-8329; Williams, Rachel/0000-0003-4953-3556; Feng, Elaine Shuo/0000-0001-7855-0991; Bhorat, Asad/0000-0002-8764-7020; Duncan, Christopher/0000-0003-4181-2315; Faust, Saul/0000-0003-3410-7642; Marinou, Spyridoula/0000-0002-0764-5966; Goodman, Anna/0000-0003-0643-9017; Blacow, Rachel/0000-0002-0946-5539; Richards, Alexander James/0000-0003-0817-8631; WECKX, LILY/0000-0003-4949-3582; Tomasicchio, Michele/0000-0003-2421-7215; Leung, Stephanie/0000-0002-8880-2977; Knight, Julian/0000-0002-0377-5536; Harris, Clair/0000-0002-1575-8768; dold, christina/0000-0003-2314-507X; Dheda, Keertan/0000-0001-7709-5341; Jackson, Frederic/0000-0001-8230-083X; Savage, Helen/0000-0003-2592-9257; Phillips, Dan/0000-0003-0686-5091; Hyams, Catherine/0000-0003-3923-1773; Henry, Aaron/0000-0002-7650-0963; Cheliotis, Katerina/0000-0002-5992-4596; Morter, Richard/0000-0002-7005-1546; Duncan, Andrew/0000-0002-7767-472X; Sanders, Helen/0000-0002-9657-5524; Wright, Daniel/0000-0002-8114-1838; Cathie, Katrina/0000-0001-5074-0769; klenerman, paul/0000-0003-4307-9161; Marchevsky, Natalie/0000-0003-1055-0033; Patrick-Smith, Maia/0000-0001-7679-3754; Hou, Mimi/0000-0002-8517-9147; Budd, William/0000-0002-7475-0141; Bewley, Kevin/0000-0002-9078-6734; Mazzella, Andrea/0000-0003-1560-7465; Ireland, Aidan Taeke/0000-0001-9513-2302; Green, Christopher/0000-0002-1984-4014; Minassian, Angela/0000-0001-7832-9824; Moultrie, Andrew/0000-0002-8222-4168; Andritsou, Foteini/0000-0002-4408-167X; Owen, David/0000-0002-1198-7563; Mallett, Garry/0000-0001-5475-9061; Ramos Lopez, Fernando/0000-0002-9997-7879; Allen, Elizabeth/0000-0002-6406-4834; Anslow, Rachel/0000-0002-9111-2897; Gokani, Karishma/0000-0002-4144-3321; Nikolaou, Elissavet/0000-0003-4797-4710; Felle, Sally/0000-0001-7855-4482; Skelly, Donal/0000-0002-2426-3097; Ariaans, Markus/0000-0002-7392-8278; Torok, Mili Estee/0000-0001-9098-8590; Themistocleous, Andreas/0000-0002-1089-1543; Lillie, Patrick/0000-0002-4811-4774; Allen, Lauren/0000-0003-1846-8181; Williams, Christopher/0000-0002-5092-4987; Mentzer, Alexander/0000-0002-4502-2209; Snape, Matthew/0000-0003-0531-5426; Bibi, Sagida/0000-0002-0855-2737; Abeysekera, Kushala/0000-0001-7301-8250; Mukhopadhyay, Ekta/0000-0002-6045-2522; Naker, Kush/0000-0003-1853-9330; Moghaddas, Fiona/0000-0002-0406-6408; Toshner, Mark/0000-0002-3969-6143; Jenkin, Daniel/0000-0003-3088-310X	UK Research and Innovation; National Institutes of Health Research (NIHR); The Coalition for Epidemic Preparedness Innovations; Bill & Melinda Gates Foundation; Lemann Foundation; Rede D'Or; Brava and Telles Foundation; NIHR Oxford Biomedical Research Centre; Thames Valley and South Midland's NIHR Clinical Research Network; AstraZeneca; EPSRC [EP/R013756/1] Funding Source: UKRI; MRC [MC_PC_19055] Funding Source: UKRI	UK Research and Innovation(UK Research & Innovation (UKRI)); National Institutes of Health Research (NIHR)(National Institute for Health Research (NIHR)); The Coalition for Epidemic Preparedness Innovations; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Lemann Foundation; Rede D'Or; Brava and Telles Foundation; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Thames Valley and South Midland's NIHR Clinical Research Network; AstraZeneca(AstraZeneca); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Research and Innovation, National Institutes of Health Research (NIHR), The Coalition for Epidemic Preparedness Innovations, the Bill & Melinda Gates Foundation, the Lemann Foundation, Rede D'Or, the Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca.	Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barrett JR, 2021, NAT MED, V27, P279, DOI 10.1038/s41591-020-01179-4; Clover Biopharmaceuticals, 2021, COVID 19 VACCINE PLA; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Ewer KJ, 2021, NAT MED, V27, P270, DOI 10.1038/s41591-020-01194-5; Fernandez-Arias C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190940; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Jurgens G, 2021, MODELLING POPULATION, DOI [10.1101/2021.01.05.21249293, DOI 10.1101/2021.01.05.21249293]; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Medicines and Healthcare products Regulatory Agency, 2021, REGULATORY APPROVAL; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Rinke A, 2021, DENMARK APPROVES DEL; Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 vaccines, 2020, MRNA VACCINES COVID; UK Department of Health and Social Care, 2020, **NON-TRADITIONAL**; UK Department of Health and Social Care, 2020, OXFORD U ASTRAZENECA; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wu KJ, 2021, ROLLOUT FALTERS SCIE	18	566	575	4	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					881	891		10.1016/S0140-6736(21)00432-3	http://dx.doi.org/10.1016/S0140-6736(21)00432-3		MAR 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33617777	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000626603400026
J	Paterlini, M				Paterlini, Marta			Maurizio Cecconi: one year since Italy's darkest moment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												martapaterlini@gmail.com						[Anonymous], 2020, COVID 19 UPDATE OUR	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n525	10.1136/bmj.n525	http://dx.doi.org/10.1136/bmj.n525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653709	Bronze			2022-12-28	WOS:000625340300015
J	Mahase, E				Mahase, Elisabeth			Covid-19: School staff testing positive for antibodies rose to around 15% in December	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Torjesen I, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n287	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n598	10.1136/bmj.n598	http://dx.doi.org/10.1136/bmj.n598			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QW	33648952	Bronze			2022-12-28	WOS:000625342000001
J	Ravishankar, S; Unold, T; Kirchartz, T				Ravishankar, Sandheep; Unold, Thomas; Kirchartz, Thomas			Comment on "Resolving spatial and energetic distributions of trap states in metal halide perovskite solar cells"	SCIENCE			English	Editorial Material							SPECTROSCOPY; DEFECTS; BULK	Ni et al. (Research Articles, 20 March 2020, p. 1352) report bulk trap densities of 1011 cm(-3) and an increase in interfacial trap densities by one to four orders of magnitude from drive-level capacitance profiling of lead halide perovskites. From electrostatic arguments, we show that the results are not trap densities but are a consequence of the geometrical capacitance and charge injection into the perovskite layer.	[Ravishankar, Sandheep; Kirchartz, Thomas] Forschungszentrum Julich, IEK 5 Photovolta, D-52425 Julich, Germany; [Unold, Thomas] Helmholtz Zentrum Berlin, Dept Struct & Dynam Energy Mat, D-14109 Berlin, Germany; [Kirchartz, Thomas] Univ Duisburg Essen, Fac Engn, D-47057 Duisburg, Germany; [Kirchartz, Thomas] Univ Duisburg Essen, CENIDE, D-47057 Duisburg, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Duisburg Essen; University of Duisburg Essen	Kirchartz, T (corresponding author), Forschungszentrum Julich, IEK 5 Photovolta, D-52425 Julich, Germany.; Kirchartz, T (corresponding author), Univ Duisburg Essen, Fac Engn, D-47057 Duisburg, Germany.; Kirchartz, T (corresponding author), Univ Duisburg Essen, CENIDE, D-47057 Duisburg, Germany.	t.kirchartz@fz-juelich.de	Kirchartz, Thomas/G-7687-2014; Ravishankar, Sandheep/L-9360-2019	Kirchartz, Thomas/0000-0002-6954-8213; Ravishankar, Sandheep/0000-0002-8118-0159	Helmholtz Association via the project PEROSEED [DFG-SPP-2169]	Helmholtz Association via the project PEROSEED(Helmholtz Association)	Supported by the Helmholtz Association via the project PEROSEED (S.R. and T.K.) and by the DFG-SPP-2169 Peroint project (T.U.). Author contributions: S.R. performed the SCAPS simulations, made the figures, and wrote the major part of the text. T.U. and T.K. contributed to writing the text and deriving Eq. 1. All authors discussed the text and the data. Competing interests: The authors have no competing interests to declare. Data and materials availability: All data are available in the manuscript or in the supplementary materials. SCAPS definition files of all simulations in this Comment are archived in Zenodo (9).	Burgelman M, 2000, THIN SOLID FILMS, V361, P527, DOI 10.1016/S0040-6090(99)00825-1; Crandall R. S., 2001, MATER RES SOC S P, V664, pA192; Eisenbarth T, 2010, J APPL PHYS, V107, DOI 10.1063/1.3277043; Heath JT, 2004, J APPL PHYS, V95, P1000, DOI 10.1063/1.1633982; Herz LM, 2017, ACS ENERGY LETT, V2, P1539, DOI 10.1021/acsenergylett.7b00276; Kirchartz T, 2012, J PHYS CHEM C, V116, P7672, DOI 10.1021/jp300397f; Liu ZG, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4436; Maibach J, 2013, J MATER CHEM C, V1, P7635, DOI 10.1039/c3tc31745e; Mansfield LM, 2017, IEEE J PHOTOVOLT, V7, P286, DOI 10.1109/JPHOTOV.2016.2616188; Menossi D, 2017, THIN SOLID FILMS, V633, P97, DOI 10.1016/j.tsf.2016.10.008; Ni ZY, 2020, SCIENCE, V367, P1352, DOI 10.1126/science.aba0893; SCAPS, SCAPS DEFINITION FIL, DOI [10.5281/zenodo.4116604.1, DOI 10.5281/ZENODO.4116604.1]; Staub F, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.044017; Sze S. M., 2006, PHYS SEMICONDUCTOR D, P100	14	11	11	7	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532							eabd8014	10.1126/science.abd8014	http://dx.doi.org/10.1126/science.abd8014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632819	Green Submitted			2022-12-28	WOS:000621813400001
J	Schroeder, K; Lyons, SK; Smith, FA				Schroeder, Katlin; Lyons, S. Kathleen; Smith, Felisa A.			The influence of juvenile dinosaurs on community structure and diversity	SCIENCE			English	Article							BASAL SAUROPODOMORPH DINOSAUR; CEDAR-MOUNTAIN FORMATION; 2 MEDICINE FORMATION; CAMPANIAN KAIPAROWITS FORMATION; CRETACEOUS CLOVERLY FORMATION; PRINCE CREEK FORMATION; LA CARPA FORMATION; NEW-SOUTH-WALES; SP NOV.; ORNITHISCHIAN DINOSAURS	Despite dominating biodiversity in the Mesozoic, dinosaurs were not speciose. Oviparity constrained even gigantic dinosaurs to less than 15 kg at birth; growth through multiple morphologies led to the consumption of different resources at each stage. Such disparity between neonates and adults could have influenced the structure and diversity of dinosaur communities. Here, we quantified this effect for 43 communities across 136 million years and seven continents. We found that megatheropods (more than 1000 kg) such as tyrannosaurs had specific effects on dinosaur community structure. Although herbivores spanned the body size range, communities with megatheropods lacked carnivores weighing 100 to 1000 kg. We demonstrate that juvenile megatheropods likely filled the mesocarnivore niche, resulting in reduced overall taxonomic diversity. The consistency of this pattern suggests that ontogenetic niche shift was an important factor in generating dinosaur community structure and diversity.	[Schroeder, Katlin; Smith, Felisa A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Lyons, S. Kathleen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA	University of New Mexico; University of Nebraska System; University of Nebraska Lincoln	Schroeder, K (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	maguire@unm.edu	Smith, Felisa/ABE-6160-2021	Smith, Felisa/0000-0001-6262-436X; Schroeder, Katlin/0000-0001-7993-150X; Lyons, S. Kathleen/0000-0001-5112-2508				Agnolin FL, 2012, CRETACEOUS RES, V35, P33, DOI 10.1016/j.cretres.2011.11.014; Agnolin FL, 2010, J SYST PALAEONTOL, V8, P257, DOI 10.1080/14772011003594870; Alifanov V, 2009, PALEONTOL J+, V43, P94, DOI 10.1134/S0031030109010109; Allain R, 2000, J VERTEBR PALEONTOL, V20, P404, DOI 10.1671/0272-4634(2000)020[0404:ANGODD]2.0.CO;2; Allain R, 2014, GEOL ACTA, V12, P128, DOI 10.1344/105.000002083; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Antunes MT, 2003, CR PALEVOL, V2, P77, DOI 10.1016/S1631-0683(03)00003-4; Arbour V. M, 2014, SYSTEMATICS EVOLUTIO; Arbour VM, 2014, ZOOL J LINN SOC-LOND, V172, P631, DOI 10.1111/zoj12185; Arbour VM, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161086; Arbour VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108804; Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Averianov A, 2000, LETHAIA, V33, P330, DOI 10.1080/002411600750053899; Averianov A. O, 2002, B I R SCI NAT BELQIQ; Averianov A, 2019, J VERTEBR PALEONTOL, V39, DOI 10.1080/02724634.2019.1614941; Averianov A, 2017, CRETACEOUS RES, V69, P184, DOI 10.1016/j.cretres.2016.09.006; Averianov AO, 2007, J VERTEBR PALEONTOL, V27, P87, DOI 10.1671/0272-4634(2007)27[87:ANTDTF]2.0.CO;2; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Bandopadhyay S, 2010, NEW ASPECTS MESOZOIC, P45; Bannikov A. F, 1983, PALEONTOL J+, V17, P91; Barrett Paul M., 2011, Palaeontological Association Field Guides to Fossils, V14, P391; Barrett PM, 2009, J VERTEBR PALEONTOL, V29, P1032, DOI 10.1671/039.029.0401; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P823, DOI 10.1671/0272-4634(2005)025[0823:SODFTM]2.0.CO;2; Barrick RE, 1996, PALAIOS, V11, P295, DOI 10.2307/3515240; Bates KT, 2012, PALEOBIOLOGY, V38, P486, DOI 10.1666/10004.1; Bell PR, 2019, J VERTEBR PALEONTOL, V39, DOI 10.1080/02724634.2019.1564757; Bell PR, 2019, PALAEOGEOGR PALAEOCL, V514, P655, DOI 10.1016/j.palaeo.2018.11.020; Bell PR, 2018, PEERJ, V6, DOI 10.7717/peerj.6008; Benson Roger B J, 2014, PLoS Biol, V12, pe1001853, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2018, PALAEONTOLOGY, V61, P13, DOI 10.1111/pala.12329; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benton M. J, 2012, PREHISTORIC LIFE; Blows William T., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P29; Boyd CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057605; Boyd CA, 2009, J VERTEBR PALEONTOL, V29, P758, DOI 10.1671/039.029.0328; Boyle A., 2015, NBC NEWS; Brockhurst D., 2010, WEALDEN NEWS, V8, P13; Brooks K, 2011, HAST 501 GEOL SOC J, V17, P7; Brougham T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57667-7; Brougham T, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.180826; Brown B, 1944, B AM MUS NAT HIST, V82, P116; Brown CM, 2013, PALAEOGEOGR PALAEOCL, V372, P108, DOI 10.1016/j.palaeo.2012.06.027; Brown CM, 2011, CAN J EARTH SCI, V48, P1342, DOI 10.1139/E11-017; BROWN JH, 1991, AM NAT, V138, P1478, DOI 10.1086/285297; Brusatte SL, 2010, J IBER GEOL, V36, P275, DOI 10.5209/rev_JIGE.2010.v36.n2.12; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2016, CRETACEOUS RES, V65, P232, DOI 10.1016/j.cretres.2016.02.007; Brusatte SL, 2016, P NATL ACAD SCI USA, V113, P3447, DOI 10.1073/pnas.1600140113; Buffetaut E, 2012, ORYCTOS, V10, P1; Burnham D. A., 2000, PALEONTOLOGICAL CONT; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Camp C. L, 1936, U CALIF PUBL GEOL SC; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; CARPENTER K, 1982, CAN J EARTH SCI, V19, P689, DOI 10.1139/e82-058; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K, 2010, J IBER GEOL, V36, P145, DOI 10.5209/rev_JIGE.2010.v36.n2.3; Carpenter K., 2018, GEOLOGY INTERMOUNTAI, V5, P167, DOI DOI 10.31711/giw.v5.pp167-207; Carpenter Kenneth, 2002, Rocky Mountain Geology, V37, P237, DOI 10.2113/gsrocky.37.2.237; Carpenter K, 2008, J VERTEBR PALEONTOL, V28, P1089, DOI 10.1671/0272-4634-28.4.1089; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carr TD, 2020, PEERJ, V8, DOI 10.7717/peerj.9192; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, J VERTEBR PALEONTOL, V30, P1, DOI 10.1080/02724630903413032; Casanovas ML, 1999, GEOL MIJNBOUW-N J G, V78, P345, DOI 10.1023/A:1003859501941; Cau A, 2017, NATURE, V552, P395, DOI 10.1038/nature24679; Chadwick A.V., 2018, SOC AM SE SECT 67 AN; Charig A. J., 1980, ASPECTS VERTEBRATE H, P19; Chen W, 1996, T CONTINENTAL JURASS, P97; Chiappe Luis M., 2002, P87; Chiba K, 2015, PALAIOS, V30, P655, DOI 10.2110/palo.2014.084; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; Chung E., 2016, CBC NEWS; Chure DJ, 2020, PEERJ, V8, DOI 10.7717/peerj.7803; Clark J.M., 1986, P285; Clark JM, 2001, J VERTEBR PALEONTOL, V21, P209, DOI 10.1671/0272-4634(2001)021[0209:TNOTOU]2.0.CO;2; Clauss M., 2016, FRONT ECOL EVOL, V4; Codron D, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00015; Codron D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077110; Codron D, 2012, BIOL LETTERS, V8, P620, DOI 10.1098/rsbl.2012.0240; Conkwright R. D, 1998, MARYLANDS STATE DINO; Coombs W, 1971, THESIS COLUMBIA U NE; Coria RA, 2012, AMEGHINIANA, V49, P552, DOI 10.5710/AMGH.9.4.2012.487; Coria RA, 2013, ZOOTAXA, V3683, P357, DOI 10.11646/zootaxa.3683.4.2; Coria Rodolfo A., 2001, P3; Cruzado-Caballero P., 2016, 7 JORN INT PAL ENT B; Cruzado-Caballero P, 2018, CRETACEOUS RES, V83, P182, DOI 10.1016/j.cretres.2017.07.022; Cruzado-Caballero P, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1289381; Cruzado-Caballero P, 2016, AMEGHINIANA, V53, P231, DOI 10.5710/AMGH.25.09.2015.2943; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2005, LIFE O PAST, P313; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2255, DOI 10.1139/e93-196; Czepinski L, 2020, HIST BIOL, V32, P1394, DOI 10.1080/08912963.2019.1593404; Dalman SG, 2013, B PEABODY MUS NAT HI, V54, P241; Ezcurra MD, 2009, B GEOSCI, V84, P547, DOI 10.3140/bull.geosci.1106; de Fabregues CP, 2016, PEERJ, V4, DOI 10.7717/peerj.1639; Delair J.B., 1973, Wiltshire Archaeol Nat Hist Mag (Nat Hist), V68, P1; Delcourt R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28154-x; DePalma Robert A., 2015, Paleontological Contributions, P1; Derstler K, 1995, J VERTEBR PALEONTOL, V15, p26A; Dong Zhiming, 1989, Vertebrata Palasiatica, V27, P140; Eaton J.G., 1999, UTAH GEOLOGICAL SURV, V99-1, P345; Eberth DA, 2020, CAN J EARTH SCI, V57, P1220, DOI 10.1139/cjes-2019-0019; Eberth DA, 2013, CAN J EARTH SCI, V50, P701, DOI 10.1139/cjes-2012-0185; ERBEN HK, 1979, PALEOBIOLOGY, V5, P380, DOI 10.1017/S0094837300016900; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2006, SCIENCE, V313, P213, DOI 10.1126/science.1125721; Erickson GM, 2010, CAN J EARTH SCI, V47, P1269, DOI 10.1139/E10-051; Estep J.W., 1998, NEW MEXICO MUSEUM NA, V14, P297; Evans D.C., 2014, HADROSAURS LIFE, P361; Evans DC, 2017, CAN J EARTH SCI, V54, P813, DOI 10.1139/cjes-2017-0034; Evans DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130007; Evans DC, 2014, CAN J EARTH SCI, V51, P730, DOI 10.1139/cjes-2014-0073; Evans DC, 2013, NATURWISSENSCHAFTEN, V100, P1041, DOI 10.1007/s00114-013-1107-5; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Farke AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112055; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; Farlow James O., 2002, Paleontological Society Papers, V8, P251; Filippi LS, 2008, AMEGHINIANA, V45, P575; Filippi LS, 2011, ACTA PALAEONTOL POL, V56, P505, DOI 10.4202/app.2010.0019; Fiorillo AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091287; Fiorillo AR, 2011, PALAEONTOL ELECTRON, V14; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Foster J., 2007, JURASSIC W DINOSAURS; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Foth C, 2016, PEERJ, V4, DOI 10.7717/peerj.1589; Fowler DW, 2011, ACTA PALAEONTOL POL, V56, P685, DOI 10.4202/app.2010.0105; Frederickson JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35689-6; Funston G., 2020, VERTEBR ANAT MORPHOL, V8, P105, DOI [10.18435/vamp29362, DOI 10.18435/VAMP29362]; Funston GF, 2021, HIST BIOL, V33, P1671, DOI 10.1080/08912963.2020.1726908; Funston GF, 2015, CRETACEOUS RES, V54, P179, DOI 10.1016/j.cretres.2014.12.002; Funston GF, 2016, ACTA PALAEONTOL POL, V61, P159, DOI 10.4202/app.00129.2014; Galton PM, 2019, NEUES JAHRB GEOL P-A, V291, P205, DOI 10.1127/njgpa/2019/0800; Galton Peter M., 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V198, P297; Gangloff RA, 2005, J PALEONTOL, V79, P997, DOI 10.1666/0022-3360(2005)079[0997:TFPDFT]2.0.CO;2; Gao Yuhui, 1993, Vertebrata Palasiatica, V31, P308; Garcia RA, 2013, ACTA PALAEONTOL POL, V58, P269, DOI 10.4202/app.2011.0055; Garcia RA, 2013, CRETACEOUS RES, V41, P82, DOI 10.1016/j.cretres.2012.10.004; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, 2007, ZOOL J LINN SOC-LOND, V151, P351, DOI 10.1111/j.1096-3642.2007.00349.x; Gates TA, 2018, PEERJ, V6, DOI 10.7717/peerj.5300; Gates TA, 2015, ACTA PALAEONTOL POL, V60, P131, DOI 10.4202/app.2012.0145; Gates TA, 2011, J VERTEBR PALEONTOL, V31, P798, DOI 10.1080/02724634.2011.577854; Gay R, 2005, LIFE O PAST, P277; Gay R, 2010, NOTES EARLY MESOZOIC, P1; Gignac P, 2016, INTEGR COMP BIOL, V56, P449, DOI 10.1093/icb/icw041; Gillette D.D., 1991, Journal of Vertebrate Paleontology, V11, P417; Glut D. F., 1997, DINOSAURS ENCY; Goodwin M. B, 1989, J VERTEBR PALEONTOL, V3, p23A; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; Greenwald M, 1971, THESIS S DAKOTA SCH; Grellet-Tinner G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032051; Hammer William R., 1994, Antarctic Journal of the United States, V29, P31; Han G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5382; Hartman J.H., 2002, GEOLOGICAL SOC AM SP, DOI [10.1130/SPE361, DOI 10.1130/SPE361]; Hatcher J. B., 1907, CERATOPSIA, V49; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; Holtz Jr T. R, 2007, DINOSAURS MOST COMPL; HOPSON JA, 1975, S AFR J SCI, V71, P302; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Hulke J. W, 1879, OWEN Q J GEOL SOC LO, V35, P752, DOI [10.1144/GSL.JGS.1879.035.01-04.55, DOI 10.1144/GSL.JGS.1879.035.01-04.55]; Hulke J. W., 1887, Q J GEOL SOC LOND, V43, P695, DOI [10.1144/GSL.JGS.1887.043.01-04.52, DOI 10.1144/GSL.JGS.1887.043.01-04.52]; JAIN SL, 1975, PROC R SOC SER B-BIO, V188, P221, DOI 10.1098/rspb.1975.0014; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; [Ji Qiang 季强], 2012, [地质通报, Geological Bulletin of China], V31, P2102; Juárez Valieri Rubén D., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P217; Jun C., 2012, BERNISSART DINOSAURS, P467; Kelt DA, 1996, ECOLOGY, V77, P746, DOI 10.2307/2265499; Khishigjav T, 2015, 12 S EC SHEN CHIN 16; Kirkland J. I., 1999, VERTEBRATE PALEONTOL, V99, P243; Kirkland J.I., 2016, GEOLOGY INTERMOUNTAI, V3, P101, DOI [10.31711/GIW.V3.PP101-228, DOI 10.31711/GIW.V3.PP101-228, 10.31711/giw.v3.pp101-228]; Kirkland James I., 2010, P117; Krause DW, 2007, J VERTEBR PALEONTOL, V27, P1, DOI 10.1671/0272-4634(2007)27[1:OOTHOD]2.0.CO;2; Ksepka DT, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3508[1:EEALSF]2.0.CO;2; Kurzanov S.M., 1976, Paleontological J, V10, P361; Lamanna MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092022; Lambert D, 1998, WORDSWORTH BOOK DINO; Larramendi A, 2020, DINOSAUR FACTS FIGUR; Larson D. W, 2010, THESIS U ALBERTA EDM; Larson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054329; Lavigne J. M, 2000, **DROPPED REF**, V15, P123, DOI DOI 10.7939/R32B8VS51; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Li Kui, 2011, Volumina Jurassica, V9, P21; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Longrich NR, 2013, B PEABODY MUS NAT HI, V54, P23, DOI 10.3374/014.054.0102; Longrich NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032623; Longrich NR, 2011, CRETACEOUS RES, V32, P264, DOI 10.1016/j.cretres.2010.12.007; Longrich NR, 2010, PALAEONTOLOGY, V53, P945, DOI 10.1111/j.1475-4983.2010.00968.x; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; Loyal Raminder S., 2000, Gaia (Lisboa), V15, P379; Lu JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep11775; Lu JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4788; Lucas R. M., 2015, B NEW MEXICO MUSEUM, V68; Lund EK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154403; Lydekker R., 1893, Quarterly Journal of the Geological Society, Vxlix, P284; Madsen S.K., 1999, VERTEBRATE PALEONTOL, V99, P201; Maidment SCR, 2006, GEOL MAG, V143, P621, DOI 10.1017/S0016756806002500; Maiorino L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081608; Maisch MW, 2016, NEUES JAHRB GEOL P-A, V280, P215, DOI 10.1127/njgpa/2016/0576; Makovicky PJ, 2003, AM MUS NOVIT, P1; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Mallon JC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51709-5; Mallon JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154218; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Mannion PD, 2019, ZOOL J LINN SOC-LOND, V185, P784, DOI 10.1093/zoolinnean/zly068; Mannion PD, 2010, PALAEONTOLOGY, V53, P277, DOI 10.1111/j.1475-4983.2009.00919.x; Mao L, 2020, HIST BIOL, V32, P1062, DOI 10.1080/08912963.2018.1563784; Marsh O. C., 1892, American Journal of Science, V(3), P449; Martill D.M., 1988, Mercian Geologist, V11, P171; Martinelli AG, 2007, ZOOTAXA, P1; Martinelli Agustin G., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P257; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; Mateus O., 2006, N MEX MUS NAT HIST S, V36, P223; Mateus O, 2009, P ROY SOC B-BIOL SCI, V276, P1815, DOI 10.1098/rspb.2008.1909; Mazzetta Gerardo V., 2004, Historical Biology, V16, P71, DOI 10.1080/08912960410001715132; McClelland L, 1998, NPSNRGRDGRDTR9801, P36; McDonald AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151453; McDonald AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022710; McDonald Andrew T., 2010, P156; McPhee BW, 2017, ACTA PALAEONTOL POL, V62, P441, DOI 10.4202/app.00377.2017; McPhee BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13224; Mohabey Dhananjay M., 2019, Open Journal of Geology, V9, P639; Molnar Ralph E., 1991, P605; Molnar RE, 2005, LIFE O PAST, P454; Munyikwa Darlington, 1999, Palaeontologia Africana, V35, P55; Naish D, 2011, CRETACEOUS RES, V32, P464, DOI 10.1016/j.cretres.2011.03.001; Nakajima J, 2018, PALAEOGEOGR PALAEOCL, V494, P147, DOI 10.1016/j.palaeo.2017.10.026; Natural History Museum of Los Angeles County, 2019, ANT DIN MAK W COAST; NICHOLLS EL, 1981, CAN J EARTH SCI, V18, P518, DOI 10.1139/e81-045; Norell MA, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3545[1:ANDTFU]2.0.CO;2; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; Novas FE, 2009, P ROY SOC B-BIOL SCI, V276, P1101, DOI 10.1098/rspb.2008.1554; Novas Fernando E., 2004, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V6, P67; O'connor PM, 2010, J VERTEBR PALEONTOL, V30, P1178, DOI 10.1080/02724634.2010.483544; O'Gorman EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051925; Oreska MPJ, 2013, J VERTEBR PALEONTOL, V33, P264, DOI 10.1080/02724634.2012.717567; Osmolska H., 1982, NEUES JB GEOLOGIE PA, V7, P440; Osmolska H., 2007, DINOSAURIA, V2; OSTROM JH, 1978, J PALEONTOL, V52, P697; Ott C. J., 2006, HORNS BEAKS CERATOPS, P213, DOI [10.2307/j.ctt1zxz1md, DOI 10.2307/J.CTT1ZXZ1MD]; PADIAN K, 1989, GEOLOGY, V17, P438, DOI 10.1130/0091-7613(1989)017<0438:POTDSI>2.3.CO;2; Parish JC, 2004, CAN J EARTH SCI, V41, P299, DOI 10.1139/E03-101; PARRISH J M, 1987, Palaios, V2, P377, DOI 10.2307/3514763; Parsons WL, 2009, CAN J EARTH SCI, V46, P721, DOI 10.1139/E09-045; Paul G. S, 1989, PREDATORY DINOSAURS; Paul G.S., 2016, PRINCETON FIELD GUID; Pearson D. A., 2002, SPECIAL PAPERS GEOLO, V361, DOI [10.1130/SPE361, DOI 10.1130/SPE361]; Peng G. Z., 1999, P 7 ANN M CHIN VERT, P27; Peng GZ, 2005, JURASSIC DINOSAUR FA, P81; Peng J., 2001, 25 PROV MUS ALB; Penkalski P, 2014, ACTA PALAEONTOL POL, V59, P617, DOI 10.4202/app.2012.0125; Perle A., 1999, NATL U MONGOLIA GEOL, P1; Porfiri J., 2010, BRAZILIAN GEOGRAPHIC, V1, P100; Porfiri JD, 2018, CRETACEOUS RES, V89, P302, DOI 10.1016/j.cretres.2018.03.014; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Pu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063423; Purwandana D, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1351-6; Ratsimbaholison N. O., 2016, ACTA PALAEONTOL POL; Rauhut OWM, 2011, SPEC PAP PALAEONTOL, P195, DOI 10.1111/j.1475-4983.2011.01084.x; Rauhut OWM, 2005, GEOL MAG, V142, P97, DOI 10.1017/S0016756804000330; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Raymond C.R., 2007, 20071047 USGS, V003, DOI [10.3133/of2007-1047.srp003, DOI 10.3133/OF2007-1047.SRP003]; Remes K, 2009, FOSS REC, V12, P23, DOI 10.1002/mmng.200800008; Riera V, 2009, PALAEOGEOGR PALAEOCL, V283, P160, DOI 10.1016/j.palaeo.2009.09.018; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2014, J VERTEBR PALEONTOL, V34, P606, DOI 10.1080/02724634.2013.822874; Rowe T., 1989, Journal of Vertebrate Paleontology, V9, P125; Rowe TB, 2011, P ROY SOC B-BIOL SCI, V278, P1044, DOI 10.1098/rspb.2010.1867; Ruiz-Omenaca J., 2005, GEOGACETA; Ryan M. J, 2006, GEOLOGICAL SOC AM AB, P62; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Ryan MJ, 2014, NATURWISSENSCHAFTEN, V101, P505, DOI 10.1007/s00114-014-1183-1; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Sahni A, 1972, B AM MUS NAT HIST, V147, P6; Sahni A., 2003, NEW ABELISAURID DINO; Salgado L, 2000, AMEGHINIANA, V37, P259; Salgado L, 2007, CRETACEOUS RES, V28, P392, DOI 10.1016/j.cretres.2006.06.007; Salgado L, 2009, ZOOTAXA, P1; Salgado Leonardo, 1993, Ameghiniana, V30, P119; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sankey Julia T., 2008, P117; Scannella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028705; Scannella JB, 2010, J VERTEBR PALEONTOL, V30, P1157, DOI 10.1080/02724634.2010.483632; Schwarz D, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1008134; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sekiya T, 2014, HIST BIOL, V26, P252, DOI 10.1080/08912963.2013.821702; Sereno PC, 2012, ZOOKEYS, P1, DOI [10.3897/zookeys.226.2840, 10.3897/zookeys.223.2840]; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sertich JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009789; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Shen Cai-zhi, 2017, Acta Geoscientica Sinica, V38, P359; Shen CZ, 2019, HIST BIOL, V31, P253, DOI 10.1080/08912963.2017.1360296; Shen CZ, 2017, ACTA GEOL SIN-ENGL, V91, P763, DOI 10.1111/1755-6724.13307; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; Stanton T. W, 1909, WASH ACAD SCI, V11, P239; Stiles D, 2004, ENVIRON CONSERV, V31, P309, DOI 10.1017/S0376892904001614; Sues HD, 2016, CRETACEOUS RES, V57, P90, DOI 10.1016/j.cretres.2015.07.012; Sues HD, 2013, CAN J EARTH SCI, V50, P306, DOI 10.1139/e2012-033; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Sullivan R. M., 1997, NEW MEX GEOL SOC 48, P249; Sullivan R. M., 2005, NEW MEX GEOL SOC 56, P395; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; Takasaki R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41325-8; Tan C, 2021, HIST BIOL, V33, P1817, DOI 10.1080/08912963.2020.1743286; Tanke Darren H., 2001, P206; Tatarinov L. P., 1996, DINOSAURS NO EURASIA; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Taylor MP, 2018, PEERJ, V6, DOI 10.7717/peerj.5212; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Titus A.L., 2016, GEOLOGY INTERMOUNTAI, V3, P229, DOI [10.31711/giw.v3.pp229-291, DOI 10.31711/GIW.V3.PP229-291]; Torices A, 2015, ACTA PALAEONTOL POL, V60, P611, DOI 10.4202/app.2012.0121; Tschopp E, 2015, PEERJ, V3, DOI 10.7717/peerj.857; Tsogtbaatar C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05272-6; Tsogtbaatar K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208480; Tsuihiji T, 2015, CRETACEOUS RES, V56, P60, DOI 10.1016/j.cretres.2015.03.007; Tumanova TA, 2018, PALEONTOL J+, V52, P1771, DOI 10.1134/S0031030118140186; Turner AH, 2011, AM MUS NOVIT, P1, DOI 10.1206/3722.2; Turner AH, 2009, AM MUS NOVIT, P1; Turner C. E., 1999, VERTEBRATE PALAEONTO; Tykoski R. S., 2005, MESA SOUTHWEST MUS B, V11, P72; Tykoski RS, 2019, J SYST PALAEONTOL, V17, P1177, DOI 10.1080/14772019.2018.1532464; Ulanksy R. E, 2014, DINOLOGIA, P1; Upchurch P, 2003, J VERTEBR PALEONTOL, V23, P208, DOI 10.1671/0272-4634(2003)23[208:TAATOC]2.0.CO;2; Upchurch P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125819; Van Itterbeeck J, 2005, CRETACEOUS RES, V26, P699, DOI 10.1016/j.cretres.2005.03.004; Varricchio David J., 2001, P42; Varricchio DJ, 2011, HIST BIOL, V23, P91, DOI 10.1080/08912963.2010.500379; VARRICCHIO DJ, 1995, PALAEOGEOGR PALAEOCL, V114, P297, DOI 10.1016/0031-0182(94)00084-L; von Huene F, 1923, BULL GEOL SOC AM, V34, P449; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Wang S, 2017, CURR BIOL, V27, P144, DOI 10.1016/j.cub.2016.10.043; Wang SC, 2006, P NATL ACAD SCI USA, V103, P13601, DOI 10.1073/pnas.0606028103; Wang XR, 2007, ACTA GEOL SIN-ENGL, V81, P911; Watabe M., 2011, NEW MEXICO MUSEUM NA, V53, P489; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wiersma JP, 2018, PEERJ, V6, DOI 10.7717/peerj.5016; Williamson T. E., 1997, UTAH J VERTEBR PALEO, V17, p84A; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; Williamson TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093190; Wilson J.A., 2009, REASSESSMENT SAUROPO; Wilson JA, 2003, J SYST PALAEONTOL, V1, P125, DOI 10.1017/S1477201903001044; Wilson JP, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200284; Wilson LE, 2008, PALAIOS, V23, P289, DOI 10.2110/palo.2007.p07-006r; Woodruff DC, 2012, CRETACEOUS RES, V36, P58, DOI 10.1016/j.cretres.2012.02.003; Woodward HN, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6250; Wosik M, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1398168; Xing H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175253; Xing LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044012; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Yadagiri P., 1988, Records of the Geological Survey of India, V116, P102; Yates Adam M., 2005, Palaeontologia Africana, V41, P105; Yates AM, 2011, J VERTEBR PALEONTOL, V31, P610, DOI 10.1080/02724634.2011.560626; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; You HL, 2014, ZOOTAXA, V3873, P233, DOI 10.11646/zootaxa.3873.3.3; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zanno Lindsay E., 2013, P504; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1; Zhou Chang-Fu, 2006, Palaeoworld, V15, P100, DOI 10.1016/j.palwor.2005.11.001	377	23	23	7	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					941	+		10.1126/science.abd9220	http://dx.doi.org/10.1126/science.abd9220			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632845	Green Published			2022-12-28	WOS:000621813400042
J	Feldstein, LR; Tenforde, MW; Friedman, KG; Newhams, M; Rose, EB; Dapul, H; Soma, VL; Maddux, AB; Mourani, PM; Bowens, C; Maamari, M; Hall, MW; Riggs, BJ; Giuliano, JS; Singh, AR; Li, S; Kong, M; Schuster, JE; McLaughlin, GE; Schwartz, SP; Walker, TC; Loftis, LL; Hobbs, CV; Halasa, NB; Doymaz, S; Babbitt, CJ; Hume, JR; Gertz, SJ; Irby, K; Clouser, KN; Cvijanovich, NZ; Bradford, TT; Smith, LS; Heidemann, SM; Zackai, SP; Wellnitz, K; Nofziger, RA; Horwitz, SM; Carroll, RW; Rowan, CM; Tarquinio, KM; Mack, EH; Fitzgerald, JC; Coates, BM; Jackson, AM; Young, CC; Son, MBF; Patel, MM; Newburger, JW; Randolph, AG				Feldstein, Leora R.; Tenforde, Mark W.; Friedman, Kevin G.; Newhams, Margaret; Rose, Erica Billig; Dapul, Heda; Soma, Vijaya L.; Maddux, Aline B.; Mourani, Peter M.; Bowens, Cindy; Maamari, Mia; Hall, Mark W.; Riggs, Becky J.; Giuliano, John S., Jr.; Singh, Aalok R.; Li, Simon; Kong, Michele; Schuster, Jennifer E.; McLaughlin, Gwenn E.; Schwartz, Stephanie P.; Walker, Tracie C.; Loftis, Laura L.; Hobbs, Charlotte V.; Halasa, Natasha B.; Doymaz, Sule; Babbitt, Christopher J.; Hume, Janet R.; Gertz, Shira J.; Irby, Katherine; Clouser, Katharine N.; Cvijanovich, Natalie Z.; Bradford, Tamara T.; Smith, Lincoln S.; Heidemann, Sabrina M.; Zackai, Sheemon P.; Wellnitz, Kari; Nofziger, Ryan A.; Horwitz, Steven M.; Carroll, Ryan W.; Rowan, Courtney M.; Tarquinio, Keiko M.; Mack, Elizabeth H.; Fitzgerald, Julie C.; Coates, Bria M.; Jackson, Ashley M.; Young, Cameron C.; Son, Mary Beth F.; Patel, Manish M.; Newburger, Jane W.; Randolph, Adrienne G.		Overcoming Covid-19 Investigators	Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KAWASAKI-DISEASE; RATIOS; RISK	IMPORTANCE Refinement of criteria for multisystem inflammatory syndrome in children (MIS-C) may inform efforts to improve health outcomes. OBJECTIVE To compare clinical characteristics and outcomes of children and adolescents with MIS-C vs those with severe corona virus disease 2019 (COVID-19). SETTING, DESIGN, AND PARTICIPANTS Case series of 1116 patients aged younger than 21 years hospitalized between March 15 and October 31, 2020, at 66 US hospitals in 31 states. Final date of follow-up was January 5, 2021. Patients with MIS-C had fever, inflammation, multisystem involvement, and positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reverse transcriptase-polymerase chain reaction (RT-PCR) or antibody test results or recent exposure with no alternate diagnosis. Patients with COVID-19 had positive RT-PCR test results and severe organ system involvement. EXPOSURE SARS-CoV-2. MAIN OUTCOMES AND MEASURES Presenting symptoms, organ system complications, laboratory biomarkers, interventions, and clinical outcomes. Multivariable regression was used to compute adjusted risk ratios (aRRs) of factors associated with MIS-C vs COVID-19. RESULTS Of 1116 patients (median age, 9.7 years; 4.5% female), 539 (48%) were diagnosed with MIS-C and 577 (52%) with COVID-19. Compared with patients with COVID-19, patients with MIS-C were more likely to be 6 to 12 years old (40.8% vs 19.4%; absolute risk difference [RD], 21.4% [95% CI, 16.1%-26.7%); aRR, 1.51[95% Cl, 133-1.72] vs 0-5 years) and non-Hispanic Black (32.3% vs 21.5%; RD, 10.8% [95% CI, 5.6%16.0%]; aRR, 1.43 [95% CI, 1.17-1.76] vs White). Compared with patients with COVID-19. patients with MIS-C were more likely to have cardiorespiratory involvement (56.0% vs 8.8%; RD, 47.2% [95% CI, 42.4%-52.0%); aRR, 2.99 [95% CI, 235-3.50] vs respiratory involvement), cardiovascular without respiratory involvement (10.6% vs 2.9%; RD, 7.7% [95% CI. 4.7%-10.6%); aRR, 2.49 [95% CI, 2.05-3.02] vs respiratory involvement), and mucocutaneous without cardiorespiratory involvement (7.1% vs 2.3%; RD, 4.8% [95% CI, 23%-73%); aRR, 2.29 [95% CI, 1.84-2.85] vs respiratory involvement). Patients with MIS-C had higher neutrophil to lymphocyte ratio (median, 6.4 vs 2.7, P < .001), higher C-reactive protein level (median, 152 mg/L vs 33 mg/L; P < .001), and lower platelet count (<150 x10(3) cells/mu L [212/523 {41%) vs 84/486 {17%}, P < .001]). A total of 398 patients (73.8%) with MIS-C and 253 (43.8%) with COVID-19 were admitted to the intensive care unit, and 10 (1.9%) with MIS-C and 8 (1.4%) with COVID-19 died during hospitalization. Among patients with MIS-C with reduced left ventricular systolic function (172/503, 34.2%) and coronary artery aneurysm (57/424, 13.4%), an estimated 91.0% (95% CI, 86.0%-94.7%) and 79.1% (95% CI, 67.1%-89.1%). respectively, normalized within 30 days. CONCLUSIONS AND RELEVANCE This case series of patients with MIS-C and with COVID-19 identified patterns of clinical presentation and organ system involvement. These patterns may help differentiate between MIS-C and COVID-19.	[Feldstein, Leora R.; Tenforde, Mark W.; Rose, Erica Billig; Jackson, Ashley M.; Patel, Manish M.] Ctr Dis Control & Prevent, COVID 19 Response Team, Atlanta, GA USA; [Feldstein, Leora R.; Rose, Erica Billig; Patel, Manish M.] Publ Hlth Serv Commissioned Corps, Rockville, MD USA; [Friedman, Kevin G.; Newburger, Jane W.] Harvard Med Sch, Dept Pediat, Dept Cardiol, Boston Childrens Hosp, Boston, MA 02115 USA; [Newhams, Margaret; Young, Cameron C.; Randolph, Adrienne G.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [Dapul, Heda] NYU, Dept Pediat, Grossman Sch Med, Div Pediat Crit Care Med, New York, NY 10016 USA; [Soma, Vijaya L.] NYU, Dept Pediat, Grossman Sch Med, Div Pediat Infect Dis, New York, NY 10016 USA; [Maddux, Aline B.; Mourani, Peter M.] Univ Colorado, Sch Med, Dept Pediat, Sect Crit Care Med, Aurora, CO USA; [Maddux, Aline B.; Mourani, Peter M.] Childrens Hosp Colorado, Aurora, CO USA; [Bowens, Cindy; Maamari, Mia] Univ Texas Southwestern, Dept Pediat, Div Crit Care Med, Childrens Med Ctr Dallas, Dallas, TX USA; [Hall, Mark W.] Nationwide Childrens Hosp, Div Crit Care Med, Dept Pediat, Columbus, OH USA; [Riggs, Becky J.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care Med, Div Pediat Anesthesiol & Crit Care Med, Baltimore, MD USA; [Giuliano, John S., Jr.] Yale Univ, Sch Med, Dept Pediat, Div Crit Care, New Haven, CT 06510 USA; [Singh, Aalok R.] Maria Fareri Childrens Hosp, Westchester Med Ctr, Pediat Crit Care Div, Valhalla, NY USA; [Singh, Aalok R.] New York Med Coll, Valhalla, NY 10595 USA; [Li, Simon] Rutgers State Univ, Robert Wood Johnson Med Sch, Bristol Myers Squibb Childrens Hosp, Div Pediat Crit Care,Dept Pediat, New Brunswick, NJ USA; [Kong, Michele] Univ Alabama Birmingham, Dept Pediat, Div Pediat Crit Care Med, Birmingham, AL USA; [Schuster, Jennifer E.] Childrens Mercy Kansas City, Div Pediat Infect Dis, Dept Pediat, Kansas City, MO USA; [McLaughlin, Gwenn E.] Univ Miami, Miller Sch Med, Dept Pediat, Div Pediat Crit Care Med, Miami, FL 33136 USA; [Schwartz, Stephanie P.; Walker, Tracie C.] Univ N Carolina, Dept Pediat, Chapel Hill Childrens Hosp, Chapel Hill, NC 27515 USA; [Loftis, Laura L.] Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA; [Hobbs, Charlotte V.] Univ Mississippi, Med Ctr, Dept Microbiol, Div Infect Dis,Dept Pediat, Jackson, MS 39216 USA; [Halasa, Natasha B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Nashville, TN 37232 USA; [Doymaz, Sule] SUNY Downstate Hlth Sci Univ, Dept Pediat, Div Pediat Crit Care, Brooklyn, NY USA; [Babbitt, Christopher J.] Miller Childrens & Womens Hosp Long Beach, Div Pediat Crit Care, Long Beach, CA USA; [Hume, Janet R.] Univ Minnesota, Mason Childrens Hosp, Div Pediat Crit Care, Minneapolis, MN USA; [Gertz, Shira J.] St Barnabas Hosp, Dept Pediat, Div Pediat Crit Care, Livingston, NJ USA; [Irby, Katherine] Arkansas Childrens Hosp, Dept Pediat, Pediat Crit Care Sect, Little Rock, AR 72202 USA; [Clouser, Katharine N.] Hackensack Univ, Med Ctr, Dept Pediat, Div Hosp Med, Hackensack, NJ USA; [Cvijanovich, Natalie Z.] UCSF Benioff Childrens Hosp Oakland, Div Crit Care Med, Oakland, CA USA; [Bradford, Tamara T.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, Div Cardiol, New Orleans, LA USA; [Bradford, Tamara T.] Childrens Hosp New Orleans, New Orleans, LA USA; [Smith, Lincoln S.] Univ Washington, Dept Pediat, Div Pediat Crit Care Med, Seattle, WA 98195 USA; [Heidemann, Sabrina M.] Cent Michigan Univ, Dept Pediat, Div Pediat Crit Care Med, Detroit, MI USA; [Zackai, Sheemon P.] Icahn Sch Med Mt Sinai, Dept Pediat, Pediat Crit Care Med, Kravis Childrens Hosp, New York, NY 10029 USA; [Wellnitz, Kari] Univ Iowa, Carver Coll Med, Stead Family Dept Pediat, Div Pediat Crit Care, Iowa City, IA USA; [Nofziger, Ryan A.] Akron Childrens Hosp, Dept Pediat, Div Crit Care Med, Akron, OH 44308 USA; [Horwitz, Steven M.] Rutgers Robert Wood Johnson Med Sch, Div Crit Care, Dept Pediat, New Brunswick, NJ USA; [Carroll, Ryan W.] Harvard Med Sch, MassGen Hosp Children, Div Pediat Crit Care Med, Boston, MA 02115 USA; [Rowan, Courtney M.] Indiana Univ Sch Med, Dept Pediat, Riley Hosp Children, Div Pediat Crit Care Med, Indianapolis, IN 46202 USA; [Tarquinio, Keiko M.] Emory Univ, Sch Med, Dept Pediat, Div Crit Care Med,Childrens Healthcare Atlanta, Atlanta, GA USA; [Mack, Elizabeth H.] Med Univ South Carolina, Div Pediat Crit Care Med, Charleston, SC 29425 USA; [Fitzgerald, Julie C.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Div Crit Care, Philadelphia, PA 19104 USA; [Coates, Bria M.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Crit Care Med,Feinberg Sch Med, Chicago, IL 60611 USA; [Son, Mary Beth F.] Harvard Med Sch, Dept Pediat, Div Immunol, Boston Childrens Hosp, Boston, MA 02115 USA; [Randolph, Adrienne G.] Harvard Med Sch, Dept Anesthesia, Boston, MA 02115 USA; [Randolph, Adrienne G.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; New York University; New York University; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Johns Hopkins University; Johns Hopkins Medicine; Yale University; Westchester Medical Center; New York Medical College; Bristol-Myers Squibb; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Alabama System; University of Alabama Birmingham; Children's Mercy Hospital; University of Miami; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; University of Mississippi; University of Mississippi Medical Center; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; Arkansas Children's Hospital; Hackensack University Medical Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Washington; University of Washington Seattle; Central Michigan University; Icahn School of Medicine at Mount Sinai; University of Iowa; Akron Children's Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children; Children's Healthcare of Atlanta (CHOA); Emory University; Medical University of South Carolina; University of Pennsylvania; Pennsylvania Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Randolph, AG (corresponding author), Boston Childrens Hosp, 300 Longwood Ave,Bader 634, Boston, MA 02115 USA.	adrienne.randolph@childrens.harvard.edu	Fernandes, Neil Dominic/AAF-5852-2019; Young, Cameron/AAK-6772-2021	Fernandes, Neil Dominic/0000-0002-3024-1994; Young, Cameron/0000-0001-7323-4834; Li, Simon/0000-0002-5371-1995; Schwartz, Stephanie/0000-0003-4314-6117; Maddux, Aline/0000-0002-0949-4284; Hume, Janet/0000-0002-8891-6800; Hobbs, Charlotte/0000-0003-4829-0791; Wellnitz, Kari/0000-0001-9451-8879; Dapul, Heda/0000-0002-7209-1285; Randolph, Adrienne/0000-0002-3084-3071	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control and Prevention (CDC) under a contract to Boston Children's Hospital.	Abdelaziz B, 2017, HEALTH PROMOT INT, V32, P7, DOI 10.1093/heapro/daw103; Alsaied T, 2021, CIRCULATION, V143, P78, DOI 10.1161/CIRCULATIONAHA.120.049836; Belhadjer Z, 2020, CIRCULATION, V142, P2282, DOI 10.1161/CIRCULATIONAHA.120.050147; Belhadjer Z, 2020, CIRCULATION, V142, P429, DOI 10.1161/CIRCULATIONAHA.120.048360; Castagnoli R, 2020, JAMA PEDIATR, V174, P882, DOI 10.1001/jamapediatrics.2020.1467; Centers for Disease Control and Prevention, 2021, INT CLIN CONS US COV; Chan WM, 2004, BRIT J OPHTHALMOL, V88, P968, DOI 10.1136/bjo.2003.039461; Clark DE, 2018, PEDIATR INFECT DIS J, V37, P1227, DOI 10.1097/INF.0000000000002019; Dufort EM, 2020, NEW ENGL J MED, V383, P347, DOI 10.1056/NEJMoa2021756; Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680; Fernandes DM, 2021, J PEDIATR-US, V230, P23, DOI 10.1016/j.jpeds.2020.11.016; Freaney PM, 2020, JAMA-J AM MED ASSOC, V324, P1499, DOI 10.1001/jama.2020.17445; Godfred-Cato S, 2020, MMWR-MORBID MORTAL W, V69, P1074, DOI 10.15585/mmwr.mm6932e2; Gotzinger F, 2020, LANCET CHILD ADOLESC, V4, P653, DOI 10.1016/S2352-4642(20)30177-2; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Henderson LA., 2020, ARTHRITIS RHEUMATOL; Lee ELH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30280; Lee PY, 2020, J CLIN INVEST, V130, P5942, DOI 10.1172/JCI141113; Leteurtre S, 2010, CAN MED ASSOC J, V182, P1181, DOI 10.1503/cmaj.081715; Linkins LA, 2012, CHEST, V141, pE495S, DOI 10.1378/chest.11-2303; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Lu XX, 2020, NEW ENGL J MED, V382, P1663, DOI 10.1056/NEJMc2005073; Matics TJ, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2352; Matsubara D, 2020, J AM COLL CARDIOL, V76, P1947, DOI 10.1016/j.jacc.2020.08.056; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Muniz JCG, 2013, CIRC-CARDIOVASC IMAG, V6, P239, DOI 10.1161/CIRCIMAGING.112.000159; Norton EC, 2013, STATA J, V13, P492, DOI 10.1177/1536867X1301300304; NYC Health, 2020, COVID 19 DAT; Office of the Federal Register Government Publishing Office, ELECT CODE FEDERAL R; Portman MA, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3675; Riphagen Shelley, 2020, Lancet, V395, P1607, DOI 10.1016/S0140-6736(20)31094-1; Rowley AH, 2020, NAT REV IMMUNOL, V20, P453, DOI 10.1038/s41577-020-0367-5; Shulman ST, 2015, NAT REV RHEUMATOL, V11, P475, DOI 10.1038/nrrheum.2015.54; Sperotto F, 2021, EUR J PEDIATR, V180, P307, DOI 10.1007/s00431-020-03766-6; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Swann OV, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3249; Theocharis P, 2021, EUR HEART J-CARD IMG, V22, P896, DOI 10.1093/ehjci/jeaa212; Valverde I, 2021, CIRCULATION, V143, P21, DOI 10.1161/CIRCULATIONAHA.120.050065; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X	39	332	337	10	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1074	1087		10.1001/jama.2021.2091	http://dx.doi.org/10.1001/jama.2021.2091		FEB 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33625505	Green Published, Bronze			2022-12-28	WOS:000621915300002
J	Adler-Milstein, J				Adler-Milstein, Julia			From Digitization to Digital Transformation Policy Priorities for Closing the Gap	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adler-Milstein, Julia] Univ Calif San Francisco, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA	University of California System; University of California San Francisco	Adler-Milstein, J (corresponding author), Univ Calif San Francisco, 3333 Calif St,Ste 265, San Francisco, CA 94118 USA.	julia.adler-milstein@ucsf.edu						Adler-Milstein J, 2017, HEALTH AFFAIR, V36, P1416, DOI 10.1377/hlthaff.2016.1651; American Medical Association, 2021, CPT EV MAN E M OFF O; D'Amore JD, 2014, J AM MED INFORM ASSN, V21, P1060, DOI 10.1136/amiajnl-2014-002883; Office of the Inspector General, OIG PROP RUL CIV MON; Office of the National Coordinator for Health Information Technology, 2020, EHR REP PROGR; Office of the National Coordinator for Health Information Technology, C CDA SCOR 2 0; U.S. Food and Drug Administration, 2020, WHAT IS DIG HLTH	7	7	7	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					717	718		10.1001/jama.2020.27014	http://dx.doi.org/10.1001/jama.2020.27014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QM7LT	33620414				2022-12-28	WOS:000621957400014
J	Meeks, LM				Meeks, Lisa M.			COVID-19 Communication-The Need for Humanity, Empathy, and Grace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Meeks, Lisa M.] Univ Michigan, Sch Med, Dept Family Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Meeks, LM (corresponding author), Univ Michigan, Dept Family Med, 1018 Fuller St, Ann Arbor, MI 48104 USA.	meeksli@med.umich.edu	Meeks, Lisa/AAJ-9958-2021	Meeks, Lisa M./0000-0002-3647-3657					0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					725	726		10.1001/jama.2021.0119	http://dx.doi.org/10.1001/jama.2021.0119			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620410	Bronze			2022-12-28	WOS:000621957400018
J	Nelson, EJ; McKune, SL; Ryan, KA; Lednicky, JA; Crowe, SR; Myers, PD; Morris, JG				Nelson, Eric J.; McKune, Sarah L.; Ryan, Kathleen A.; Lednicky, John A.; Crowe, Susanne R.; Myers, Paul D.; Morris, J. Glenn, Jr.			SARS-CoV-2 Positivity on or After 9 Days Among Quarantined Student Contacts of Confirmed Cases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study describes coronavirus test positivity rates among elementary, middle, and high school student contacts of confirmed COVID-19 cases in a Florida county where schools required a negative test on day 9 before return to school on day 10.	[Nelson, Eric J.; Ryan, Kathleen A.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [McKune, Sarah L.; Lednicky, John A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Crowe, Susanne R.] Florida Dept Hlth, Jacksonville, FL USA; [Myers, Paul D.] Florida Dept Hlth, Gainesville, FL USA; [Morris, J. Glenn, Jr.] Univ Florida, Emerging Pathogens Inst, 2055 Mowry Rd, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Florida Department of Health; Florida Department of Health; State University System of Florida; University of Florida	Nelson, EJ (corresponding author), Univ Florida, Emerging Pathogens Inst, 2055 Mowry Rd, Gainesville, FL 32611 USA.	eric.nelson@ufl.edu						Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Lednickya JA, 2020, INT J INFECT DIS, V100, P476, DOI [10.1016/j.ijid.2020.09.025, 10.1101/2020.08.03.20167395]; Macartney K, 2020, LANCET CHILD ADOLESC, V4, P807, DOI 10.1016/S2352-4642(20)30251-0; US Centers for Disease Control and Prevention, OPT RED QUAR CONT PE	5	6	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1561	1562		10.1001/jama.2021.2392	http://dx.doi.org/10.1001/jama.2021.2392		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33605978	Bronze, Green Published			2022-12-28	WOS:000619613100002
J	Sampaziotis, F; Muraro, D; Tysoe, OC; Sawiak, S; Beach, TE; Godfrey, EM; Upponi, SS; Brevini, T; Wesley, BT; Garcia-Bernardo, J; Mahbubani, K; Canu, G; Gieseck, R; Berntsen, NL; Mulcahy, VL; Crick, K; Fear, C; Robinson, S; Swift, L; Gambardella, L; Bargehr, J; Ortmann, D; Brown, SE; Osnato, A; Murphy, MP; Corbett, G; Gelson, WTH; Mells, GF; Humphreys, P; Davies, SE; Amin, I; Gibbs, P; Sinha, S; Teichmann, SA; Butler, AJ; See, TC; Melum, E; Watson, CJE; Saeb-Parsy, K; Vallier, L				Sampaziotis, Fotios; Muraro, Daniele; Tysoe, Olivia C.; Sawiak, Stephen; Beach, Timothy E.; Godfrey, Edmund M.; Upponi, Sara S.; Brevini, Teresa; Wesley, Brandon T.; Garcia-Bernardo, Jose; Mahbubani, Krishnaa; Canu, Giovanni; Gieseck, Richard, III; Berntsen, Natalie L.; Mulcahy, Victoria L.; Crick, Keziah; Fear, Corrina; Robinson, Sharayne; Swift, Lisa; Gambardella, Laure; Bargehr, Johannes; Ortmann, Daniel; Brown, Stephanie E.; Osnato, Anna; Murphy, Michael P.; Corbett, Gareth; Gelson, William T. H.; Mells, George F.; Humphreys, Peter; Davies, Susan E.; Amin, Irum; Gibbs, Paul; Sinha, Sanjay; Teichmann, Sarah A.; Butler, Andrew J.; See, Teik Choon; Melum, Espen; Watson, Christopher J. E.; Saeb-Parsy, Kourosh; Vallier, Ludovic			Cholangiocyte organoids can repair bile ducts after transplantation in the human liver	SCIENCE			English	Article								Organoid technology holds great promise for regenerative medicine but has not yet been applied to humans. We address this challenge using cholangiocyte organoids in the context of cholangiopathies, which represent a key reason for liver transplantation. Using single-cell RNA sequencing, we show that primary human cholangiocytes display transcriptional diversity that is lost in organoid culture. However, cholangiocyte organoids remain plastic and resume their in vivo signatures when transplanted back in the biliary tree. We then utilize a model of cell engraftment in human livers undergoing ex vivo normothermic perfusion to demonstrate that this property allows extrahepatic organoids to repair human intrahepatic ducts after transplantation. Our results provide proof of principle that cholangiocyte organoids can be used to repair human biliary epithelium.	[Sampaziotis, Fotios; Muraro, Daniele; Tysoe, Olivia C.; Brevini, Teresa; Wesley, Brandon T.; Canu, Giovanni; Gambardella, Laure; Bargehr, Johannes; Ortmann, Daniel; Brown, Stephanie E.; Osnato, Anna; Humphreys, Peter; Sinha, Sanjay; Vallier, Ludovic] Wellcome MRC Cambridge Stem Cell Inst, Cambridge, Cambs, England; [Sampaziotis, Fotios; Mulcahy, Victoria L.; Gambardella, Laure; Bargehr, Johannes; Gelson, William T. H.; Mells, George F.; Sinha, Sanjay] Univ Cambridge, Dept Med, Cambridge, Cambs, England; [Sampaziotis, Fotios; Gelson, William T. H.; Mells, George F.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Liver Unit, Cambridge, Cambs, England; [Tysoe, Olivia C.; Beach, Timothy E.; Mahbubani, Krishnaa; Amin, Irum; Gibbs, Paul; Butler, Andrew J.; Watson, Christopher J. E.; Saeb-Parsy, Kourosh; Vallier, Ludovic] Univ Cambridge, Dept Surg, Cambridge, Cambs, England; [Tysoe, Olivia C.; Beach, Timothy E.; Mahbubani, Krishnaa; Amin, Irum; Gibbs, Paul; Butler, Andrew J.; Watson, Christopher J. E.; Saeb-Parsy, Kourosh; Vallier, Ludovic] NIHR Cambridge Biomed Res Ctr, Cambridge, Cambs, England; [Sawiak, Stephen] Univ Cambridge, Dept Clin Neurosci, Cambridge, Cambs, England; [Godfrey, Edmund M.; Upponi, Sara S.; See, Teik Choon] Cambridge Univ Hosp NHS Fdn Trust, Dept Radiol, Cambridge, Cambs, England; [Garcia-Bernardo, Jose; Teichmann, Sarah A.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, Cambs, England; [Gieseck, Richard, III] NIAID, Immunopathogenesis Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Berntsen, Natalie L.; Melum, Espen] Oslo Univ Hosp, Rikshosp, Norwegian PSC Res Ctr, Dept Transplantat Med,Div Surg Inflammatory Dis &, Oslo, Norway; [Berntsen, Natalie L.; Melum, Espen] Oslo Univ Hosp, Res Inst Internal Med, Div Surg Inflammatory Dis & Transplantat, Oslo, Norway; [Berntsen, Natalie L.; Melum, Espen] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Mulcahy, Victoria L.; Mells, George F.] Univ Cambridge, Acad Dept Med Genet, Cambridge, Cambs, England; [Crick, Keziah; Fear, Corrina; Robinson, Sharayne; Swift, Lisa; Amin, Irum; Gibbs, Paul; Butler, Andrew J.; Watson, Christopher J. E.; Saeb-Parsy, Kourosh] Cambridge Univ Hosp NHS Fdn Trust, Dept Surg, Cambridge, Cambs, England; [Bargehr, Johannes] Univ Cambridge, Div Cardiovasc Med, Cambridge, Cambs, England; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, Cambs, England; [Corbett, Gareth] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, Cambs, England; [Davies, Susan E.] Cambridge Univ Hosp NHS Fdn Trust, Dept Histopathol, Cambridge, Cambs, England; [Teichmann, Sarah A.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, Cambs, England; [Melum, Espen] Oslo Univ Hosp, Rikshosp, Div Surg Inflammatory Dis & Transplantat, Sect Gastroenterol,Dept Transplantat Med, Oslo, Norway; [Melum, Espen] Univ Oslo, Fac Med, Hybrid Technol Hub Ctr Excellence, Inst Basic Med Sci, Oslo, Norway; [Watson, Christopher J. E.] Natl Inst Hlth Res NIHR, Cambridge Biomed Res Ctr, Cambridge, Cambs, England; [Watson, Christopher J. E.] NIHR Blood & Transplant Res Unit BTRU, Cambridge, Cambs, England; [Watson, Christopher J. E.] Univ Cambridge Collaborat Newcastle Univ & Partne, Cambridge, Cambs, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Oslo; National Hospital Norway; University of Oslo; University of Cambridge	Sampaziotis, F; Vallier, L (corresponding author), Wellcome MRC Cambridge Stem Cell Inst, Cambridge, Cambs, England.; Sampaziotis, F (corresponding author), Univ Cambridge, Dept Med, Cambridge, Cambs, England.; Sampaziotis, F (corresponding author), Cambridge Univ Hosp NHS Fdn Trust, Cambridge Liver Unit, Cambridge, Cambs, England.	fs347@cam.ac.uk; lv225@cam.ac.uk	Canu, Giovanni/AAN-8515-2021; Corbett, Gareth/GOK-1289-2022; Sawiak, Stephen/I-8944-2012	Canu, Giovanni/0000-0002-3349-4479; Garcia-Bernardo, Jose/0000-0003-3626-5433; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Sawiak, Stephen/0000-0003-4210-9816; Vallier, Ludovic/0000-0002-3848-2602; Wesley, Brandon/0000-0003-0530-329X; Bargehr, Johannes/0000-0002-9304-3573	NIHR Clinical Lectureship; Academy of Medical Sciences Starter Grant for Clinical Lecturers; Addenbrooke's Charitable Trust; Rosetrees Trust; EASL Juan Rodes fellowship; Cambridge University Hospitals NIHR Biomedical Research Centre; Medical Research Council of the Wellcome-MRC Cambridge Stem Cell Institute; BHF Senior Research Fellowship [FS/18/46/33663]; NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]; ERC advanced grant New-Chol; Wellcome Trust; EPSRC [TS/H001220/1] Funding Source: UKRI; MRC [G0701448] Funding Source: UKRI	NIHR Clinical Lectureship; Academy of Medical Sciences Starter Grant for Clinical Lecturers; Addenbrooke's Charitable Trust; Rosetrees Trust(Rosetrees Trust); EASL Juan Rodes fellowship; Cambridge University Hospitals NIHR Biomedical Research Centre; Medical Research Council of the Wellcome-MRC Cambridge Stem Cell Institute; BHF Senior Research Fellowship; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); ERC advanced grant New-Chol; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	F.S. was supported by an NIHR Clinical Lectureship, the Academy of Medical Sciences Starter Grant for Clinical Lecturers, the Addenbrooke's Charitable Trust, and the Rosetrees Trust. T.B. was supported an EASL Juan Rodes fellowship. The L.V. laboratory is funded by the ERC advanced grant New-Chol, the Cambridge University Hospitals NIHR Biomedical Research Centre, and the core support grant from the Wellcome Trust and Medical Research Council of the Wellcome-MRC Cambridge Stem Cell Institute. L.G. and S.Si. were supported by a BHF Senior Research Fellowship (FS/18/46/33663). This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Arber C, 2013, SEMIN HEMATOL, V50, P131, DOI 10.1053/j.seminhematol.2013.03.026; Berntsen NL, 2018, AM J PHYSIOL-GASTR L, V314, pG349, DOI 10.1152/ajpgi.00124.2017; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Caballero B., 2003, **DROPPED REF**, V2, P471; Drost J, 2017, DEVELOPMENT, V144, P968, DOI 10.1242/dev.140566; Enestvedt CK, 2013, LIVER TRANSPLANT, V19, P965, DOI 10.1002/lt.23696; FARMER RG, 1975, GASTROENTEROLOGY, V68, P627; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kwon SB, 2008, TOXICOL PATHOL, V36, P660, DOI 10.1177/0192623308320272; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Masyuk AI, 2006, HEPATOLOGY, V43, pS75, DOI 10.1002/hep.20996; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; Parikh K, 2019, NATURE, V567, P49, DOI 10.1038/s41586-019-0992-y; Pepe-Mooney B. J., CELL STEM CELL, V25; Pepe-Mooney BJ, 2019, CELL STEM CELL, V25, P23, DOI 10.1016/j.stem.2019.04.004; Planas-Paz L, 2019, CELL STEM CELL, V25, P39, DOI 10.1016/j.stem.2019.04.005; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ravikumar R, 2016, AM J TRANSPLANT, V16, P1779, DOI 10.1111/ajt.13708; Rimland CA, 2021, HEPATOLOGY, V73, P247, DOI 10.1002/hep.31252; Sampaziotis F, 2017, NAT MED, V23, P954, DOI 10.1038/nm.4360; Sampaziotis F, 2017, NAT PROTOC, V12, P814, DOI 10.1038/nprot.2017.011; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Skaro AI, 2009, SURGERY, V146, P543, DOI 10.1016/j.surg.2009.06.052; Squires RH, 2014, HEPATOLOGY, V60, P362, DOI 10.1002/hep.27191; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019; Tysoe OC, 2019, NAT PROTOC, V14, P1884, DOI 10.1038/s41596-019-0168-0; Watson CJE, 2018, AM J TRANSPLANT, V18, P2005, DOI 10.1111/ajt.14687; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yoo KS, 2016, GUT LIVER, V10, P851, DOI 10.5009/gnl15600; Zappia L, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy083; Zong YW, 2011, INT J BIOCHEM CELL B, V43, P257, DOI 10.1016/j.biocel.2010.06.020; Zweers SJLB, 2012, HEPATOLOGY, V55, P575, DOI 10.1002/hep.24702	39	70	76	32	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					839	+		10.1126/science.aaz6964	http://dx.doi.org/10.1126/science.aaz6964			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602855	Green Accepted, Green Submitted			2022-12-28	WOS:000619664700055
J	Hanchard, NA; Wonkam, A				Hanchard, Neil A.; Wonkam, Ambroise			"Iron''ing out hemophagocytosis through PIEZO1	CELL			English	Editorial Material							ASSOCIATION	In this issue of Cell, Ma et al. reveal a mechanistic role for PIEZO1 in iron homeostasis through molecular genetic mouse studies. They also demonstrate implications for human iron overload and deficiency syndromes, susceptibility to malarial infection, and red blood cell turnover in persons of African ancestries.	[Hanchard, Neil A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wonkam, Ambroise] Univ Cape Town, Div Human Genet, Dept Med, Fac Hlth Sci, Cape Town, South Africa; [Hanchard, Neil A.] NHGRI, Childhood Complex Dis Genom Sect, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA	Baylor College of Medicine; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Hanchard, NA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Hanchard, NA (corresponding author), NHGRI, Childhood Complex Dis Genom Sect, Med Genom & Metab Genet Branch, NIH, Bethesda, MD 20892 USA.	hanchard@bcm.edu	Hanchard, Neil/AAY-9075-2021; Wonkam, Ambroise/AFU-6901-2022	Hanchard, Neil/0000-0003-1925-2665; 	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH, USA) [5U24HL135600-02]	National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH, USA)	Illustration developed in part with help from Adam Gillum, ARS, Children's Nutrition Research Center, Baylor College of Medicine, Houston, TX. A.W. is funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH, USA), grant number 5U24HL135600-02. The views expressed are solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Benyamin B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5926; Choudhury A, 2020, NATURE, V586, P741, DOI 10.1038/s41586-020-2859-7; Ekrikpo UE, 2020, AM J KIDNEY DIS, V76, P100, DOI 10.1053/j.ajkd.2020.01.006; Fan SH, 2016, SCIENCE, V354, P54, DOI 10.1126/science.aaf5098; Gurdasani D, 2019, CELL, V179, P984, DOI 10.1016/j.cell.2019.10.004; Kefauver JM, 2020, NATURE, V587, P567, DOI 10.1038/s41586-020-2933-1; Li J, 2015, HUM MOL GENET, V24, P572, DOI 10.1093/hmg/ddu454; Ma S, 2021, CELL, V184, P969, DOI 10.1016/j.cell.2021.01.024; Nguetse CN, 2020, P NATL ACAD SCI USA, V117, P9074, DOI 10.1073/pnas.1919843117; Winn NC, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132964	11	1	1	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					856	858		10.1016/j.cell.2021.01.038	http://dx.doi.org/10.1016/j.cell.2021.01.038		FEB 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606984				2022-12-28	WOS:000629633400004
J	Jenkins, DJA; Dehghan, M; Mente, A; Bangdiwala, SI; Rangarajan, S; Srichaikul, K; Mohan, V; Avezum, A; Diaz, R; Rosengren, A; Lanas, F; Lopez-Jaramillo, P; Li, W; Oguz, A; Khatib, R; Poirier, P; Mohammadifard, N; Pepe, A; Alhabib, KF; Chifamba, J; Yusufali, AH; Iqbal, R; Yeates, K; Yusoff, K; Ismail, N; Teo, K; Swaminathan, S; Liu, XY; Zatonska, K; Yusuf, R; Yusuf, S				Jenkins, David J. A.; Dehghan, Mahshid; Mente, Andrew; Bangdiwala, Shrikant I.; Rangarajan, Sumathy; Srichaikul, Kristie; Mohan, Viswanathan; Avezum, Alvaro; Diaz, Rafael; Rosengren, Annika; Lanas, Fernando; Lopez-Jaramillo, Patricio; Li, Wei; Oguz, Aytekin; Khatib, Rasha; Poirier, Paul; Mohammadifard, Noushin; Pepe, Andrea; Alhabib, Khalid F.; Chifamba, Jephat; Yusufali, Afzal Hussein; Iqbal, Romaina; Yeates, Karen; Yusoff, Khalid; Ismail, Noorhassim; Teo, Koon; Swaminathan, Sumathi; Liu, Xiaoyun; Zatonska, Katarzyna; Yusuf, Rita; Yusuf, Salim		PURE Study Investigators	Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Most data regarding the association between the glycemic index and cardiovascular disease come from high-income Western populations, with little information from non-Western countries with low or middle incomes. To fill this gap, data are needed from a large, geographically diverse population. Methods This analysis includes 137,851 participants between the ages of 35 and 70 years living on five continents, with a median follow-up of 9.5 years. We used country-specific food-frequency questionnaires to determine dietary intake and estimated the glycemic index and glycemic load on the basis of the consumption of seven categories of carbohydrate foods. We calculated hazard ratios using multivariable Cox frailty models. The primary outcome was a composite of a major cardiovascular event (cardiovascular death, nonfatal myocardial infarction, stroke, and heart failure) or death from any cause. Results In the study population, 8780 deaths and 8252 major cardiovascular events occurred during the follow-up period. After performing extensive adjustments comparing the lowest and highest glycemic-index quintiles, we found that a diet with a high glycemic index was associated with an increased risk of a major cardiovascular event or death, both among participants with preexisting cardiovascular disease (hazard ratio, 1.51; 95% confidence interval [CI], 1.25 to 1.82) and among those without such disease (hazard ratio, 1.21; 95% CI, 1.11 to 1.34). Among the components of the primary outcome, a high glycemic index was also associated with an increased risk of death from cardiovascular causes. The results with respect to glycemic load were similar to the findings regarding the glycemic index among the participants with cardiovascular disease at baseline, but the association was not significant among those without preexisting cardiovascular disease. Conclusions In this study, a diet with a high glycemic index was associated with an increased risk of cardiovascular disease and death. (Funded by the Population Health Research Institute and others.) In this large, international study, investigators found that participants with a broad range of carbohydrate intakes and diverse dietary patterns who consumed a diet with a high glycemic index had an increased risk of cardiovascular disease and death.	[Jenkins, David J. A.] Univ Toronto, Temerty Fac Med, Dept Nutr Sci, Toronto, ON, Canada; [Jenkins, David J. A.] Univ Toronto, Temerty Fac Med, Dept Med, Toronto, ON, Canada; [Jenkins, David J. A.; Srichaikul, Kristie] St Michaels Hosp Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Dehghan, Mahshid; Bangdiwala, Shrikant I.; Teo, Koon; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Mente, Andrew; Bangdiwala, Shrikant I.] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Rangarajan, Sumathy] McMaster Univ, Hamilton, ON, Canada; [Rangarajan, Sumathy] Hamilton Hlth Sci, Hamilton, ON, Canada; [Poirier, Paul] Univ Laval, Fac Pharm, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Pepe, Andrea] Univ Ottawa, Inst Heart, Div Cardiac Prevent & Rehabil, Ottawa, ON, Canada; [Yeates, Karen] Queens Univ, Dept Med, Kingston, ON, Canada; [Mohan, Viswanathan] Madras Diabet Res Fdn, Chennai, Tamil Nadu, India; [Swaminathan, Sumathi] St Johns Natl Acad Hlth Sci, St Johns Res Inst, Bangalore, Karnataka, India; [Avezum, Alvaro] Hosp Alemao Oswaldo Cruz, Int Res Ctr, Sao Paulo, Brazil; [Diaz, Rafael] Estudios Clin Latino Amer, Rosario, Santa Fe, Argentina; [Rosengren, Annika] Sahlgrens Acad, Dept Mol & Clin Med, Inst Med, Gothenburg, Sweden; [Rosengren, Annika] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Lopez-Jaramillo, Patricio] Univ Santander, Masira Res Inst, Sch Med, Bucaramanga, Colombia; [Li, Wei; Liu, Xiaoyun] Chinese Acad Med Sci, Med Res & Biometr Ctr, Fuwai Hosp, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Li, Wei; Liu, Xiaoyun] Peking Union Med Coll, Beijing, Peoples R China; [Oguz, Aytekin] Istanbul Medeniyet Univ, Dept Internal Med, Fac Med, Istanbul, Turkey; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Palestine; [Khatib, Rasha] Advocate Hlth Care, Advocate Res Inst, Downers Grove, IL USA; [Mohammadifard, Noushin] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Cardiovasc Res Inst, Esfahan, Iran; [Alhabib, Khalid F.] King Saud Univ, Coll Med, King Fahad Cardiac Ctr, Dept Cardiac Sci, Riyadh, Saudi Arabia; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Phys, Harare, Zimbabwe; [Yusufali, Afzal Hussein] Dubai Hlth Author, Hatta Hosp, Dubai Med Coll, Dubai, U Arab Emirates; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Yusoff, Khalid] Univ Teknol MARA, Sungai Buloh, Malaysia; [Yusoff, Khalid] UCSI Univ, Selangor, Malaysia; [Ismail, Noorhassim] Univ Kebangsaan Malaysia, Med Ctr, Dept Community Hlth, Kuala Lumpur, Malaysia; [Zatonska, Katarzyna] Wroclaw Med Univ, Dept Social Med, Wroclaw, Poland; [Yusuf, Rita] Independent Univ, Sch Life Sci, Dhaka, Bangladesh	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Laval University; University of Ottawa; University of Ottawa Heart Institute; Queens University - Canada; Madras Diabetes Research Foundation; St. John's National Academy of Health Sciences; St. John's Research Institute; University of Gothenburg; Sahlgrenska University Hospital; Universidad de La Frontera; Universidad Industrial de Santander; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Istanbul Medeniyet University; Birzeit University; Isfahan University Medical Science; King Saud University; University of Zimbabwe; Aga Khan University; Universiti Teknologi MARA; UCSI University; Universiti Kebangsaan Malaysia; Wroclaw Medical University; Independent University Bangladesh (IUB)	Jenkins, DJA (corresponding author), Dept Nutr Sci, Med Sci Bldg,5th Fl,Rm 5336B,1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	david.jenkins@utoronto.ca	Lanas, Fernando/AAE-8842-2022; Zatońska, Katarzyna/ABD-4236-2021; Swaminathan, Sumathi/AGI-7678-2022; Chifamba, Jephat/AHE-4535-2022; Zakirov, Umid/AHB-3654-2022; Khatib, Rasha/GXV-8883-2022; Mirrakhimov, Erkin/E-6900-2017; Abilova, Saamay/E-4227-2017; Rozanska, Dorota/S-5239-2018; Heidari, Hadi/K-5853-2015; Igumbor, Ehimario/B-2652-2012	Chifamba, Jephat/0000-0001-8166-1182; Zakirov, Umid/0000-0003-0283-6402; Mirrakhimov, Erkin/0000-0003-2982-6108; Abilova, Saamay/0000-0002-0482-3915; Szuba, Andrzej/0000-0002-7555-6201; Gulec, Sadi/0000-0002-2685-2522; Camacho, Paul Anthony/0000-0002-6233-9582; Rozanska, Dorota/0000-0002-0561-2749; Regulska-Ilow, Bozena/0000-0002-5941-1715; Lanas, Fernando/0000-0003-3595-9759; Zatonska, Katarzyna/0000-0002-3772-5588; Heidari, Hadi/0000-0001-8412-8164; Wolyniec, Maria/0000-0003-2054-1691; Yusuf, Salim/0000-0003-4776-5601; Igumbor, Ehimario/0000-0002-6313-6031	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Strategy for Patient Oriented Research of the Canadian Institutes of Health Research through the Ontario Strategy for Patient-Oriented Research Support Unit; Ontario Ministry of Health and Long-Term Care; AstraZeneca (Canada); Sanofi-Aventis (France); Sanofi-Aventis (Canada); Boehringer Ingelheim (Germany); Boehringer Ingelheim (Canada); Servier; GlaxoSmithKline; Novartis; King Pharma; Argentina: Fundacion Estudios Clinicos Latino America; Bangladesh: Independent University, Bangladesh; Bangladesh: Mitra and Associates; Brazil: Unilever Health Institute; Canada: Dairy Farmers of Canada; Canada: National Dairy Council of the United States; Canada: Public Health Agency of Canada; Canada: Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera; China: National Center for Cardiovascular Diseases; China: ThinkTank Research Center for Health Development; Colombia: Colciencias; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology, and Innovation of Malaysia; Malaysia: Ministry of Higher Education of Malaysia; Malaysia: Universiti Teknologi MARA; Malaysia: Universiti Kebangsaan Malaysia; Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education; Poland: Wroclaw Medical University; Saudi Arabia: Saudi Heart Association; Saudi Arabia: Dr. Mohammad Alfagih Hospital; Saudi Arabia: Deanship of Scientific Research at King Saud University; Saudi Arabia: Saleh Hamza Serafi Chair for Research of Coronary Heart Disease; Saudi Arabia: Umm al-Qura University; South Africa: North-West University; South Africa: Netherlands Programme for Alternative Development; South Africa: National Research Foundation; South Africa: Medical Research Council of South Africa; South Africa: South Africa Sugar Association; South Africa: Faculty of Community and Health Sciences; Sweden: Swedish government; Sweden: Swedish Heart and Lung Foundation; Sweden: Swedish Research Council; Sweden: Swedish Council for Health, Working Life, and Welfare; Sweden: King Gustaf V and Queen Victoria's Foundation of Freemasons; Sweden: AFA Insurance; Turkey: Metabolic Syndrome Society; Turkey: AstraZeneca; Turkey: SanofiAventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; United Arab Emirates: Dubai Health Authority; Canada Research Chair endowment of the federal government of Canada; Marion W. Burke Chair in Cardiovascular Disease of the Heart and Stroke Foundation of Ontario; Palestinian territory: International Development Research Centre, Canada	Population Health Research Institute; Hamilton Health Sciences Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Strategy for Patient Oriented Research of the Canadian Institutes of Health Research through the Ontario Strategy for Patient-Oriented Research Support Unit(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); AstraZeneca (Canada)(AstraZeneca); Sanofi-Aventis (France)(Sanofi-Aventis); Sanofi-Aventis (Canada)(Sanofi-Aventis); Boehringer Ingelheim (Germany)(Boehringer Ingelheim); Boehringer Ingelheim (Canada)(Boehringer Ingelheim); Servier(Servier); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); King Pharma; Argentina: Fundacion Estudios Clinicos Latino America; Bangladesh: Independent University, Bangladesh; Bangladesh: Mitra and Associates; Brazil: Unilever Health Institute; Canada: Dairy Farmers of Canada; Canada: National Dairy Council of the United States; Canada: Public Health Agency of Canada; Canada: Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera; China: National Center for Cardiovascular Diseases; China: ThinkTank Research Center for Health Development; Colombia: Colciencias; India: Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Malaysia: Ministry of Science, Technology, and Innovation of Malaysia; Malaysia: Ministry of Higher Education of Malaysia; Malaysia: Universiti Teknologi MARA; Malaysia: Universiti Kebangsaan Malaysia; Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education; Poland: Wroclaw Medical University; Saudi Arabia: Saudi Heart Association; Saudi Arabia: Dr. Mohammad Alfagih Hospital; Saudi Arabia: Deanship of Scientific Research at King Saud University; Saudi Arabia: Saleh Hamza Serafi Chair for Research of Coronary Heart Disease; Saudi Arabia: Umm al-Qura University; South Africa: North-West University; South Africa: Netherlands Programme for Alternative Development; South Africa: National Research Foundation(National Research Foundation - South Africa); South Africa: Medical Research Council of South Africa(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South Africa: South Africa Sugar Association; South Africa: Faculty of Community and Health Sciences; Sweden: Swedish government; Sweden: Swedish Heart and Lung Foundation; Sweden: Swedish Research Council; Sweden: Swedish Council for Health, Working Life, and Welfare; Sweden: King Gustaf V and Queen Victoria's Foundation of Freemasons; Sweden: AFA Insurance; Turkey: Metabolic Syndrome Society; Turkey: AstraZeneca; Turkey: SanofiAventis; United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences; United Arab Emirates: Dubai Health Authority; Canada Research Chair endowment of the federal government of Canada(Canada Research Chairs); Marion W. Burke Chair in Cardiovascular Disease of the Heart and Stroke Foundation of Ontario; Palestinian territory: International Development Research Centre, Canada	Supported by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Strategy for Patient Oriented Research of the Canadian Institutes of Health Research through the Ontario Strategy for Patient-Oriented Research Support Unit, and the Ontario Ministry of Health and Long-Term Care; by unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline; and by additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries as follows: Argentina: Fundacion Estudios Clinicos Latino America; Bangladesh: Independent University, Bangladesh, and Mitra and Associates; Brazil: Unilever Health Institute; Canada: Dairy Farmers of Canada, National Dairy Council of the United States, Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network; Chile: Universidad de La Frontera; China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development; Colombia: Colciencias; India: Indian Council of Medical Research; Malaysia: Ministry of Science, Technology, and Innovation of Malaysia, Ministry of Higher Education of Malaysia, Universiti Teknologi MARA, and Universiti Kebangsaan Malaysia; Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East and International Development Research Centre, Canada; Philippines: Philippine Council for Health Research and Development; Poland: Polish Ministry of Science and Higher Education and Wroclaw Medical University; Saudi Arabia: Saudi Heart Association, Dr. Mohammad Alfagih Hospital, Deanship of Scientific Research at King Saud University, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, and Umm al-Qura University; South Africa: North-West University, Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, and Faculty of Community and Health Sciences; Sweden: Swedish government, Swedish Heart and Lung Foundation, Swedish Research Council, Swedish Council for Health, Working Life, and Welfare, King Gustaf V and Queen Victoria's Foundation of Freemasons, and AFA Insurance; Turkey: Metabolic Syndrome Society, AstraZeneca, and SanofiAventis; and the United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and Dubai Health Authority. Dr. Jenkins receives salary support and discretionary funding from the Canada Research Chair endowment of the federal government of Canada. Dr. S. Yusuf is supported by the Marion W. Burke Chair in Cardiovascular Disease of the Heart and Stroke Foundation of Ontario.	[Anonymous], DIET REV KETOGENIC D; [Anonymous], 2020, PALEO DIET WHAT IS I; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Augustin LSA, 2015, NUTR METAB CARDIOVAS, V25, P795, DOI 10.1016/j.numecd.2015.05.005; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Carroll JF, 2007, OBESITY, V15, P2974, DOI 10.1038/oby.2007.355; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Jenkins DJA, 2008, JAMA-J AM MED ASSOC, V300, P2742, DOI 10.1001/jama.2008.808; Levitan EB, 2007, AM J CLIN NUTR, V85, P1521, DOI 10.1093/ajcn/85.6.1521; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Livesey Geoffrey, 2019, Mayo Clin Proc Innov Qual Outcomes, V3, P52, DOI 10.1016/j.mayocpiqo.2018.12.007; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Miller V, 2017, LANCET, V390, P2037, DOI [10.1016/S0140-6736(17)32253-5, 10.1016/s0140-6736(17)32253-5]; Mirrahimi A, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000752; Nagata C, 2014, BRIT J NUTR, V112, P2010, DOI 10.1017/S0007114514003109; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Shahdadian F, 2019, AM J CLIN NUTR, V110, P921, DOI 10.1093/ajcn/nqz061; Su C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030227; WOLEVER TMS, 1991, AM J CLIN NUTR, V54, P846, DOI 10.1093/ajcn/54.5.846; Yusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	28	65	66	10	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2021	384	14					1312	1322		10.1056/NEJMoa2007123	http://dx.doi.org/10.1056/NEJMoa2007123			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7RN	33626252	Bronze			2022-12-28	WOS:000637799800009
J	Yu, YJ; Zhang, FL; Peng, TY; Wang, CL; Cheng, J; Chen, C; Houk, KN; Wang, YF				Yu, You-Jie; Zhang, Feng-Lian; Peng, Tian-Yu; Wang, Chang-Ling; Cheng, Jie; Chen, Chen; Houk, Kendall N.; Wang, Yi-Feng			Sequential C-F bond functionalizations of trifluoroacetamides and acetates via spin-center shifts	SCIENCE			English	Article								Defluorinative functionalization of readily accessible trifluoromethyl groups constitutes an economical route to partially fluorinated molecules. However, the controllable replacement of one or two fluorine atoms while maintaining high chemoselectivity remains a formidable challenge. Here we describe a general strategy for sequential carbon-fluorine (C-F) bond functionalizations of trifluoroacetamides and trifluoroacetates. The reaction begins with the activation of a carbonyl oxygen atom by a 4-dimethylaminopyridine-boryl radical, followed by a spin-center shift to trigger the C-F bond scission. A chemoselectivity-controllable two-stage process enables sequential generation of difluoro- and monofluoroalkyl radicals, which are selectively functionalized with different radical traps to afford diverse fluorinated products. The reaction mechanism and the origin of chemoselectivity were established by experimental and computational approaches.	[Yu, You-Jie; Zhang, Feng-Lian; Peng, Tian-Yu; Wang, Chang-Ling; Cheng, Jie; Chen, Chen; Wang, Yi-Feng] Univ Sci & Technol China, Dept Chem, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Wang, Yi-Feng] Chinese Acad Sci, Ctr Excellence Mol Synth, Hefei 230026, Anhui, Peoples R China; [Wang, Yi-Feng] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Nankai University	Wang, YF (corresponding author), Univ Sci & Technol China, Dept Chem, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China.; Houk, KN (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Wang, YF (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Synth, Hefei 230026, Anhui, Peoples R China.; Wang, YF (corresponding author), Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.	houk@chem.ucla.edu; yfwangzj@ustc.edu.cn	Wang, Yi-Feng/B-8096-2014	Wang, Yi-Feng/0000-0003-1360-8931	National Natural Science Foundation of China [21672195, 21702201, 21971226]; Fundamental Research Funds for the Central Universities [WK2060000017]; U.S. National Science Foundation [CHE-1764328]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); U.S. National Science Foundation(National Science Foundation (NSF))	We thank the National Natural Science Foundation of China (21672195, 21702201, and 21971226) and the Fundamental Research Funds for the Central Universities (WK2060000017) for financial support. K.N.H. was supported by the U.S. National Science Foundation (CHE-1764328). The numerical calculations in this study have been done on the supercomputing system in the Super-computing Center of the University of Science and Technology of China.	Adler P, 2019, NAT CHEM, V11, P329, DOI 10.1038/s41557-019-0215-z; Ahrens T, 2015, CHEM REV, V115, P931, DOI 10.1021/cr500257c; Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Ashida K, 2020, J AM CHEM SOC, V142, P1594, DOI 10.1021/jacs.9b12493; Ashley MA, 2020, J AM CHEM SOC, V142, P18310, DOI 10.1021/jacs.0c08595; Beckwith ALJ, 1997, CHEM REV, V97, P3273, DOI 10.1021/cr950207o; Berger R, 2011, CHEM SOC REV, V40, P3496, DOI 10.1039/c0cs00221f; Biahmi MM, 2010, J ORG CHEM, V75, P6983, DOI 10.1021/jo101301d; Bianchini G, 2005, BIOORGAN MED CHEM, V13, P4740, DOI 10.1016/j.bmc.2005.04.079; Bieszczad B, 2019, ANGEW CHEM INT EDIT, V58, P16878, DOI 10.1002/anie.201910641; Blond G, 2002, CHEM-EUR J, V8, P2917, DOI 10.1002/1521-3765(20020703)8:13<2917::AID-CHEM2917>3.0.CO;2-M; Briard E, 2004, J LABELLED COMPD RAD, V47, P217, DOI 10.1002/jlcr.816; Butcher TW, 2020, NATURE, V583, P548, DOI 10.1038/s41586-020-2399-1; Byun E, 2007, J ORG CHEM, V72, P9815, DOI 10.1021/jo701503q; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; Chen K, 2017, J AM CHEM SOC, V139, P18444, DOI 10.1021/jacs.7b10755; Dai W, 2018, J AM CHEM SOC, V140, P15868, DOI 10.1021/jacs.8b09288; Denes F, 2014, CHEM REV, V114, P2587, DOI 10.1021/cr400441m; Ding WB, 2012, PHYTOCHEMISTRY, V81, P165, DOI 10.1016/j.phytochem.2012.05.010; Dong JY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9955; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; EMRI J, 1983, J CHEM SOC CHEM COMM, P1303, DOI 10.1039/c39830001303; Feng Z, 2018, ACCOUNTS CHEM RES, V51, P2264, DOI 10.1021/acs.accounts.8b00230; Feng Z, 2017, NAT CHEM, V9, P918, DOI [10.1038/NCHEM.2746, 10.1038/nchem.2746]; Frisch M.J., 2019, GAUSSIAN 09; FUCHIGAMI T, 1994, J ORG CHEM, V59, P607, DOI 10.1021/jo00082a018; Fujita T, 2019, ANGEW CHEM INT EDIT, V58, P390, DOI 10.1002/anie.201805292; Fujiwara T, 2014, J FLUORINE CHEM, V167, P16, DOI 10.1016/j.jfluchem.2014.06.014; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Fuse H, 2020, CHEM SCI, V11, P12206, DOI 10.1039/d0sc04114a; Fuse H, 2020, J AM CHEM SOC, V142, P4493, DOI 10.1021/jacs.0c00123; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Gillis EP, 2015, J MED CHEM, V58, P8315, DOI 10.1021/acs.jmedchem.5b00258; GRILLER D, 1980, ACCOUNTS CHEM RES, V13, P317, DOI 10.1021/ar50153a004; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Halliwell B., 2015, FREE RADICALS BIOL M; Hehre W. J., 1986, AB INITIO MOL ORBITA; Horner JH, 2004, J AM CHEM SOC, V126, P14979, DOI 10.1021/ja046089g; Huang WH, 2016, ACS CATAL, V6, P7471, DOI 10.1021/acscatal.6b02420; Iwamoto H, 2020, J AM CHEM SOC, V142, P19360, DOI 10.1021/jacs.0c09639; Jaroschik F, 2018, CHEM-EUR J, V24, P14572, DOI 10.1002/chem.201801702; Jin J, 2015, NATURE, V525, P87, DOI 10.1038/nature14885; Kalia D, 2017, ANGEW CHEM INT EDIT, V56, P1885, DOI 10.1002/anie.201609733; Ke ML, 2017, CHEM COMMUN, V53, P2222, DOI 10.1039/c6cc09643c; Koeller S, 2014, CHEM-EUR J, V20, P2849, DOI 10.1002/chem.201303662; Lalevee J, 2010, CHEM-EUR J, V16, P12920, DOI 10.1002/chem.201001440; Lalevee J, 2009, J PHYS ORG CHEM, V22, P986, DOI 10.1002/poc.1549; Laot Y, 2010, ORG LETT, V12, P3426, DOI 10.1021/ol101240f; Legault C., 2009, CYLVIEW 1 0 B; Levin MD, 2017, SCIENCE, V356, P1272, DOI 10.1126/science.aan1411; Li JS, 2018, NAT CHEM BIOL, V14, P853, DOI 10.1038/s41589-018-0085-5; Liang QM, 2020, CHEM SOC REV, V49, P1209, DOI 10.1039/c9cs00508k; Liu CF, 2005, CLIN EXP ALLERGY, V35, P515, DOI 10.1111/j.1365-2222.2005.02205.x; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Luo CS, 2019, J AM CHEM SOC, V141, P14120, DOI 10.1021/jacs.9b07766; Ma XX, 2020, CHEM SOC REV, V49, P9197, DOI 10.1039/d0cs00604a; Mandal D, 2020, J AM CHEM SOC, V142, P2572, DOI 10.1021/jacs.9b12167; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Merchant RR, 2018, SCIENCE, V360, P75, DOI 10.1126/science.aar7335; Montgomery JA, 2000, J CHEM PHYS, V112, P6532, DOI 10.1063/1.481224; Montgomery JA, 1999, J CHEM PHYS, V110, P2822, DOI 10.1063/1.477924; Nacsa ED, 2018, J AM CHEM SOC, V140, P3322, DOI 10.1021/jacs.7b12768; Newcomb M, 1999, J AM CHEM SOC, V121, P10685, DOI 10.1021/ja991012r; Ni CF, 2015, CHEM REV, V115, P765, DOI 10.1021/cr5002386; Nishikata T, 2016, ANGEW CHEM INT EDIT, V55, P10008, DOI 10.1002/anie.201603426; Noshita M, 2016, ORG LETT, V18, P6062, DOI 10.1021/acs.orglett.6b03016; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Pan XC, 2012, J AM CHEM SOC, V134, P5669, DOI 10.1021/ja300416f; Prakash GKS, 2001, J FLUORINE CHEM, V112, P357; Ramachandran PV, 2016, CHEM COMMUN, V52, P11885, DOI 10.1039/c6cc06031e; Rauniyar V, 2011, SCIENCE, V334, P1681, DOI 10.1126/science.1213918; Ren SC, 2017, J AM CHEM SOC, V139, P6050, DOI 10.1021/jacs.7b01889; Roberts BP, 1999, CHEM SOC REV, V28, P25, DOI 10.1039/a804291h; Saadi J, 2016, NAT CHEM, V8, P276, DOI [10.1038/nchem.2437, 10.1038/NCHEM.2437]; Sap JBI, 2020, J AM CHEM SOC, V142, P9181, DOI 10.1021/jacs.0c03881; Schoepfer J, 1998, BIOORG MED CHEM LETT, V8, P2865, DOI 10.1016/S0960-894X(98)00513-7; Shen Q, 2015, J FLUORINE CHEM, V179, P14, DOI 10.1016/j.jfluchem.2015.07.007; Shi YH, 2002, J AM CHEM SOC, V124, P6921, DOI 10.1021/ja016897x; Taniguchi T, 2019, EUR J ORG CHEM, V2019, P6308, DOI 10.1002/ejoc.201901010; Uehling DE, 2002, J MED CHEM, V45, P567, DOI 10.1021/jm0101500; Ueng SH, 2008, J AM CHEM SOC, V130, P10082, DOI 10.1021/ja804150k; Ueng SH, 2009, J AM CHEM SOC, V131, P11256, DOI 10.1021/ja904103x; Uneyama K, 2002, J FLUORINE CHEM, V114, P127, DOI 10.1016/S0022-1139(02)00039-8; Uneyama K, 1999, J ORG CHEM, V64, P6717, DOI 10.1021/jo990571d; Van Hoomissen DJ, 2017, J PHYS CHEM A, V121, P8675, DOI 10.1021/acs.jpca.7b08895; Vogt DB, 2019, J AM CHEM SOC, V141, P13203, DOI 10.1021/jacs.9b06004; Wang HB, 2018, J AM CHEM SOC, V140, P163, DOI 10.1021/jacs.7b12590; Wessig P, 2001, ANGEW CHEM INT EDIT, V40, P1064, DOI 10.1002/1521-3773(20010316)40:6<1064::AID-ANIE10640>3.0.CO;2-5; Wessig P, 2007, EUR J ORG CHEM, V2007, P2219, DOI 10.1002/ejoc.200600915; Wettergren J, 2010, CHEM COMMUN, V46, P7596, DOI 10.1039/c0cc02009e; White NA, 2014, J AM CHEM SOC, V136, P14674, DOI 10.1021/ja5080739; Wolfe MMW, 2020, J AM CHEM SOC, V142, P18698, DOI 10.1021/jacs.0c09505; Wu C, 2017, J ORG CHEM, V82, P2898, DOI 10.1021/acs.joc.6b02849; Yang XY, 2015, CHEM REV, V115, P826, DOI 10.1021/cr500277b; Yoshida S, 2016, ANGEW CHEM INT EDIT, V55, P10406, DOI 10.1002/anie.201604776; Yu Y.-J., 2021, SEQUENTIAL C F BOND, DOI [10.5281/zenodo.4510886, DOI 10.5281/ZENODO.4510886]; Yu YJ, 2018, ORG LETT, V20, P24, DOI 10.1021/acs.orglett.7b03201; Zhang F.-L., 2019, SCI SYNTHESIS ADV OR, P355; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Zhou Y, 2016, CHEM REV, V116, P422, DOI 10.1021/acs.chemrev.5b00392; Zhu Y, 2018, CHEM REV, V118, P3887, DOI 10.1021/acs.chemrev.7b00778; Zipse H, 1999, ACCOUNTS CHEM RES, V32, P571, DOI 10.1021/ar980035s	105	74	73	25	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2021	371	6535					1232	+		10.1126/science.abg0781	http://dx.doi.org/10.1126/science.abg0781			595	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RE3JJ	33674411				2022-12-28	WOS:000634054600037
J	Pillon, NJ; Loos, RJF; Marshall, SM; Zierath, JR				Pillon, Nicolas J.; Loos, Ruth J. F.; Marshall, Sally M.; Zierath, Juleen R.			Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care	CELL			English	Review							CIRCADIAN CLOCK; SKELETAL-MUSCLE; INSULIN-RESISTANCE; BODY-WEIGHT; SHIFT-WORK; EXERCISE; TIME; ASSOCIATION; COVID-19; EXPOSURE	The prevalence of type 2 diabetes and obesity has risen dramatically for decades and is expected to rise further, secondary to the growing aging, sedentary population. The strain on global health care is projected to be colossal. This review explores the latest work and emerging ideas related to genetic and environmental factors influencing metabolism. Translational research and clinical applications, including the impact of the COVID-19 pandemic, are highlighted. Looking forward, strategies to personalize all aspects of prevention, management and care are necessary to improve health outcomes and reduce the impact of these metabolic diseases.	[Pillon, Nicolas J.; Zierath, Juleen R.] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY USA; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY USA; [Marshall, Sally M.] Newcastle Univ, Fac Clin Med Sci, Translat & Clin Res Inst, Diabet Res Grp, 4th Floor William Leech Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Zierath, Juleen R.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark	Karolinska Institutet; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Newcastle University - UK; Karolinska Institutet; Novo Nordisk Foundation; University of Copenhagen	Zierath, JR (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.; Zierath, JR (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	juleen.zierath@ki.se	Pillon, Nicolas J/M-4170-2019; Loos, Ruth/GON-5877-2022; Loos, Ruth/Q-2862-2016	Pillon, Nicolas J/0000-0003-1107-9490; Marshall, Sally/0000-0001-5735-713X; Loos, Ruth/0000-0002-8532-5087	Marie Sklodowska-Curie Actions (European Commission) [704978]; Swedish Research Council (Vetenskapsradet) [2015-00165]; Novo Nordisk Foundation Challenge Grant [NNF14OC0011493]; Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen [NNF18CC0034900, 190503]; National Institutes of Health [R01DK110113, R01DK107786, R01HL142302, R01 DK124097]	Marie Sklodowska-Curie Actions (European Commission); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Novo Nordisk Foundation Challenge Grant; Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	N.J.P. was supported by an Individual Fellowship from the Marie Sklodowska-Curie Actions (European Commission, 704978). J.R.Z. was supported from the Swedish Research Council (Vetenskapsradet) (2015-00165), a Novo Nordisk Foundation Challenge Grant (NNF14OC0011493), and the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen (NNF18CC0034900). R.J.F.L. was supported by the National Institutes of Health (R01DK110113; R01DK107786; R01HL142302; R01 DK124097) and the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen (Alliance 190503).	Achebak H, 2019, LANCET PLANET HEALTH, V3, pE297, DOI 10.1016/S2542-5196(19)30090-7; Ahlqvist E, 2018, LANCET DIABETES ENDO, V6, P361, DOI 10.1016/S2213-8587(18)30051-2; Al-Mrabeh A, 2020, CELL METAB, V31, P233, DOI 10.1016/j.cmet.2019.11.018; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; American Diabetes Association, 2020, Diabetes Care, V43, pS14, DOI 10.2337/dc20-S002; Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2; Archer AE, 2018, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0529; Areta JL, 2013, J PHYSIOL-LONDON, V591, P2319, DOI 10.1113/jphysiol.2012.244897; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Barbosa TD, 2016, MOL METAB, V5, P184, DOI 10.1016/j.molmet.2015.12.002; Barres R, 2016, NAT REV ENDOCRINOL, V12, P441, DOI 10.1038/nrendo.2016.87; Barres R, 2013, CELL REP, V3, P1020, DOI 10.1016/j.celrep.2013.03.018; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2; Barroso I, 2019, CELL, V177, P146, DOI 10.1016/j.cell.2019.02.024; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Boskovic A, 2018, ANNU REV GENET, V52, P21, DOI 10.1146/annurev-genet-120417-031404; Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Catalano PM, 2017, BMJ-BRIT MED J, V356, DOI [10.1136/bmj.j1, 10.1136/bmj.j1631]; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chan JCN, 2020, LANCET, V396, P2019, DOI 10.1016/S0140-6736(20)32374-6; Charlot K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060592; Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Chung WK, 2020, DIABETOLOGIA, V63, P1671, DOI [10.1007/s00125-020-05181-w, 10.2337/dci20-0022]; Cienfuegos S, 2020, CELL METAB, V32, P366, DOI 10.1016/j.cmet.2020.06.018; Crameri Giovanni Andrea Gerardo, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.36.2001542; Crosby P, 2019, CELL, V177, P896, DOI 10.1016/j.cell.2019.02.017; da Silveira MP, 2021, CLIN EXP MED, V21, P15, DOI 10.1007/s10238-020-00650-3; Dennis JM, 2018, CLIN EPIDEMIOL, V10, P1869, DOI 10.2147/CLEP.S179555; Elks Cathy E, 2012, Front Endocrinol (Lausanne), V3, P29, DOI 10.3389/fendo.2012.00029; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Feehan KT, 2019, TRENDS MOL MED, V25, P198, DOI 10.1016/j.molmed.2019.01.006; Forouhi NG, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2234; Freese Jens, 2017, F1000Res, V6, P1787, DOI 10.12688/f1000research.12724.2; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Gabriel BM, 2019, NAT REV ENDOCRINOL, V15, P197, DOI 10.1038/s41574-018-0150-x; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gasparrini A, 2015, LANCET, V386, P369, DOI 10.1016/S0140-6736(14)62114-0; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Guisado-Vasco P, 2020, TRENDS ENDOCRIN MET, V31, P802, DOI 10.1016/j.tem.2020.08.004; Hajat S, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0284-7; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hattersley AT, 2017, DIABETOLOGIA, V60, P769, DOI 10.1007/s00125-017-4226-2; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Holman N, 2020, LANCET DIABETES ENDO, V8, P823, DOI 10.1016/S2213-8587(20)30271-0; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Huang CR, 2012, CIRC-CARDIOVASC QUAL, V5, P609, DOI 10.1161/CIRCOUTCOMES.112.965707; Ji YJ, 2019, DIABETES, V68, P207, DOI 10.2337/db18-0708; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kassir R, 2020, OBES REV, V21, DOI 10.1111/obr.13034; KELLEY DE, 1992, DIABETES, V41, P698, DOI 10.2337/diabetes.41.6.698; Kenny Glen P, 2016, Temperature (Austin), V3, P119, DOI 10.1080/23328940.2015.1131506; Kettner NM, 2015, CELL METAB, V22, P448, DOI 10.1016/j.cmet.2015.06.005; Khera AV, 2019, CELL, V177, P587, DOI 10.1016/j.cell.2019.03.028; Kim YH, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa014; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; Kondo T, 2014, EBIOMEDICINE, V1, P80, DOI 10.1016/j.ebiom.2014.11.001; Koopman ADM, 2017, J BIOL RHYTHM, V32, P359, DOI 10.1177/0748730417713572; Krause M, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00572-w; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lancaster GI, 2014, TRENDS IMMUNOL, V35, P262, DOI 10.1016/j.it.2014.02.008; Larder R, 2017, P NATL ACAD SCI USA, V114, P9421, DOI 10.1073/pnas.1707310114; Lee YS, 2018, CELL, V172, P22, DOI 10.1016/j.cell.2017.12.025; Li YP, 2010, DIABETES, V59, P2400, DOI 10.2337/db10-0385; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lin YC, 2009, CHRONOBIOL INT, V26, P740, DOI 10.1080/07420520902929029; Lo KB, 2020, CARDIORENAL MED, V10, P1, DOI 10.1159/000503919; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lowe DA, 2020, JAMA INTERN MED, V180, P1491, DOI 10.1001/jamainternmed.2020.4153; Lundell LS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18412-w; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Meade RD, 2020, ENVIRON INT, V144, DOI 10.1016/j.envint.2020.105909; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Morley JE, 2020, J CACHEXIA SARCOPENI, V11, P863, DOI 10.1002/jcsm.12589; Multhaup ML, 2015, CELL METAB, V21, P138, DOI 10.1016/j.cmet.2014.12.014; Murashov AK, 2016, FASEB J, V30, P775, DOI 10.1096/fj.15-274274; Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2; Nanayakkara N, 2021, DIABETOLOGIA, V64, P275, DOI 10.1007/s00125-020-05319-w; Newman AC, 2017, BRIT J CANCER, V116, P1499, DOI 10.1038/bjc.2017.118; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; Palsson-McDermott EM, 2020, CELL RES, V30, P300, DOI 10.1038/s41422-020-0291-z; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Peek CB, 2017, CELL METAB, V25, P86, DOI 10.1016/j.cmet.2016.09.010; Periard JD, 2015, SCAND J MED SCI SPOR, V25, P20, DOI 10.1111/sms.12408; Pillon NJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE825, DOI 10.1152/ajpendo.00296.2016; Ranheim T, 1997, ARTERIOSCL THROM VAS, V17, P3286, DOI 10.1161/01.ATV.17.11.3286; Rathjen T, 2017, NAT NEUROSCI, V20, P1096, DOI 10.1038/nn.4590; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Reidy PT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041514; Rubino F, 2020, NEW ENGL J MED, V383, P789, DOI [10.1056/NEJMc2018688, 10.1056/NEJMc2021832]; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Ryder JW, 2000, DIABETES, V49, P647, DOI 10.2337/diabetes.49.4.647; Rynders CA, 2018, J PHYSIOL-LONDON, V596, P1319, DOI 10.1113/JP273282; Sanchez-Sanchez E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092826; Sato S, 2019, CELL METAB, V30, P92, DOI 10.1016/j.cmet.2019.03.013; Savikj M, 2020, DIABETOLOGIA, V63, P1491, DOI 10.1007/s00125-020-05166-9; Savikj M, 2019, DIABETOLOGIA, V62, P233, DOI 10.1007/s00125-018-4767-z; Song JD, 2020, CELL METAB, V32, P726, DOI 10.1016/j.cmet.2020.09.008; Stanford KI, 2015, DIABETES, V64, P427, DOI 10.2337/db13-1848; Taylor R, 2015, CLIN SCI, V128, P405, DOI 10.1042/CS20140553; Tiffon C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113425; Timpel P, 2019, DIABETOLOGIA, V62, P1842, DOI 10.1007/s00125-019-4941-y; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Udler MS, 2019, ENDOCR REV, V40, P1500, DOI 10.1210/er.2019-00088; Udler MS, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002654; van der Klaauw AA, 2015, CELL, V161, P119, DOI 10.1016/j.cell.2015.03.008; Vimalananda VG, 2015, DIABETOLOGIA, V58, P699, DOI 10.1007/s00125-014-3480-9; VROMAN NB, 1983, J APPL PHYSIOL, V55, P69, DOI 10.1152/jappl.1983.55.1.69; Wang SF, 2020, DIABETOLOGIA, V63, P2102, DOI 10.1007/s00125-020-05209-1; Wang X, 2020, TRENDS ENDOCRIN MET, V31, P712, DOI 10.1016/j.tem.2020.07.001; West MA, 2016, BRIT J SURG, V103, P744, DOI 10.1002/bjs.10112; Wilkinson MJ, 2020, CELL METAB, V31, P92, DOI 10.1016/j.cmet.2019.11.004; Willemsen G, 2015, TWIN RES HUM GENET, V18, P762, DOI 10.1017/thg.2015.83; Xin YQ, 2020, DIABETOLOGIA, V63, P2112, DOI 10.1007/s00125-020-05224-2; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Young MW, 2018, ANGEW CHEM INT EDIT, V57, P11532, DOI 10.1002/anie.201803337; Yuan S, 2020, DIABETOLOGIA, V63, P2359, DOI 10.1007/s00125-020-05253-x	123	53	53	12	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2021	184	6					1530	1544		10.1016/j.cell.2021.02.012	http://dx.doi.org/10.1016/j.cell.2021.02.012		MAR 2021	15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QY9LN	33675692	Green Published, hybrid			2022-12-28	WOS:000630357400017
J	Oldfield, BJ; Tetrault, JM; Berland, G				Oldfield, Benjamin J.; Tetrault, Jeanette M.; Berland, Gretchen			Addiction Screening-The A Star Is Born Movie Series and Destigmatization of Substance Use Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Arts and Medicine feature uses the A Star is Born movie series to chart trends in popular cultural representations of addiction and to argue for more authentic Hollywood depictions of substance use disorder.	[Oldfield, Benjamin J.] Fair Haven Community Hlth Care, 374 Grand Ave, New Haven, CT 06513 USA; [Oldfield, Benjamin J.; Tetrault, Jeanette M.; Berland, Gretchen] Yale Sch Med, Dept Med, New Haven, CT USA	Yale University	Oldfield, BJ (corresponding author), Fair Haven Community Hlth Care, 374 Grand Ave, New Haven, CT 06513 USA.; Oldfield, BJ (corresponding author), Yale Sch Med, 374 Grand Ave, New Haven, CT 06513 USA.	benjamin.oldfield@yale.edu		Oldfield, Benjamin/0000-0003-1708-803X				Denzin N., 1991, HOLLYWOOD SHOT SHOT; Dixit A, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113089; Edelman EJ, 2018, MED CLIN N AM, V102, P635, DOI 10.1016/j.mcna.2018.02.007; Haley DF, 2020, JAMA-J AM MED ASSOC, V324, P1615, DOI 10.1001/jama.2020.18543; HASIN DS, 1990, AM J PSYCHIAT, V147, P1537; National Academies of Sciences Engineering and Medicine, 2016, END DISCR PEOPL MENT; Slat S, 2020, CORONAVIRUS DIS 2019; Volkow ND, 2020, ANN INTERN MED, V173, P61, DOI 10.7326/M20-1212; Volkow ND, 2017, NEW ENGL J MED, V377, P391, DOI 10.1056/NEJMsr1706626; Zuger A, 2019, JAMA-J AM MED ASSOC, V321, P228, DOI 10.1001/jama.2018.19480	10	0	0	2	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					915	917		10.1001/jama.2020.25256	http://dx.doi.org/10.1001/jama.2020.25256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687448				2022-12-28	WOS:000627899400001
J	Darouich, S; Masmoudi, A				Darouich, Sihem; Masmoudi, Aida			Tracheal Agenesis with Bronchoesophageal Fistula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Darouich, Sihem; Masmoudi, Aida] Univ Tunis El Manar, Tunis, Tunisia	Universite de Tunis-El-Manar	Darouich, S (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.	sihem.darouich@free.fr	Darouich, Sihem/GQZ-2265-2022						0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					E27	E27		10.1056/NEJMicm2027782	http://dx.doi.org/10.1056/NEJMicm2027782			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33657297				2022-12-28	WOS:000626124800001
J	Gibbons, GH; Seidman, CE; Topol, EJ				Gibbons, Gary H.; Seidman, Christine E.; Topol, Eric J.			Conquering Atherosclerotic Cardiovascular Disease-50 Years of Progress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gibbons, Gary H.] NHLBI, Bldg 10, Bethesda, MD 20892 USA; [Seidman, Christine E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Seidman, Christine E.] Harvard Med Sch, Boston, MA 02115 USA; [Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Topol, Eric J.] Scripps Res Translat Inst, La Jolla, CA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Gibbons, GH (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.			Topol, Eric/0000-0002-1478-4729				Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Havranek EP, 2015, CIRCULATION, V132, P873, DOI 10.1161/CIR.0000000000000228; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]	4	12	12	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					785	788		10.1056/NEJMp2033115	http://dx.doi.org/10.1056/NEJMp2033115			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33657686				2022-12-28	WOS:000626124800012
J	McDonald, MM; Khoo, WH; Ng, PY; Xiao, Y; Zamerli, J; Thatcher, P; Kyaw, W; Pathmanandavel, K; Grootveld, AK; Moran, I; Butt, D; Nguyen, A; Corr, A; Warren, S; Biro, M; Butterfield, NC; Guilfoyle, SE; Komla-Ebri, D; Dack, MRG; Dewhurst, HF; Logan, JG; Li, YX; Mohanty, ST; Byrne, N; Terry, RL; Simic, MK; Chai, RY; Quinn, JMW; Youlten, SE; Pettitt, JA; Abi-Hanna, D; Jain, R; Weninger, W; Lundberg, M; Sun, ST; Ebetino, FH; Timpson, P; Lee, WM; Baldock, PA; Rogers, MJ; Brink, R; Williams, GR; Bassett, JHD; Kemp, JP; Pavlos, NJ; Croucher, PI; Phan, TG				McDonald, Michelle M.; Khoo, Weng Hua; Ng, Pei Ying; Xiao, Ya; Zamerli, Jad; Thatcher, Peter; Kyaw, Wunna; Pathmanandavel, Karrnan; Grootveld, Abigail K.; Moran, Imogen; Butt, Danyal; Nguyen, Akira; Corr, Alexander; Warren, Sean; Biro, Mate; Butterfield, Natalie C.; Guilfoyle, Siobhan E.; Komla-Ebri, Davide; Dack, Michael R. G.; Dewhurst, Hannah F.; Logan, John G.; Li, Yongxiao; Mohanty, Sindhu T.; Byrne, Niall; Terry, Rachael L.; Simic, Marija K.; Chai, Ryan; Quinn, Julian M. W.; Youlten, Scott E.; Pettitt, Jessica A.; Abi-Hanna, David; Jain, Rohit; Weninger, Wolfgang; Lundberg, Mischa; Sun, Shuting; Ebetino, Frank H.; Timpson, Paul; Lee, Woei Ming; Baldock, Paul A.; Rogers, Michael J.; Brink, Robert; Williams, Graham R.; Bassett, J. H. Duncan; Kemp, John P.; Pavlos, Nathan J.; Croucher, Peter, I; Phan, Tri Giang			Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption	CELL			English	Article								Osteoclasts are large multinucleated bone-resorbing cells formed by the fusion of monocyte/macrophagederived precursors that are thought to undergo apoptosis once resorption is complete. Here, by intravital imaging, we reveal that RANKL-stimulated osteoclasts have an alternative cell fate in which they fission into daughter cells called osteomorphs. Inhibiting RANKL blocked this cellular recycling and resulted in osteomorph accumulation. Single-cell RNA sequencing showed that osteomorphs are transcriptionally distinct from osteoclasts and macrophages and express a number of non-canonical osteoclast genes that are associated with structural and functional bone phenotypes when deleted in mice. Furthermore, genetic variation in human orthologs of osteomorph genes causes monogenic skeletal disorders and associates with bone mineral density, a polygenetic skeletal trait. Thus, osteoclasts recycle via osteomorphs, a cell type involved in the regulation of bone resorption that may be targeted for the treatment of skeletal diseases.	[McDonald, Michelle M.; Khoo, Weng Hua; Xiao, Ya; Zamerli, Jad; Thatcher, Peter; Corr, Alexander; Mohanty, Sindhu T.; Byrne, Niall; Terry, Rachael L.; Simic, Marija K.; Chai, Ryan; Quinn, Julian M. W.; Youlten, Scott E.; Pettitt, Jessica A.; Abi-Hanna, David; Baldock, Paul A.; Rogers, Michael J.; Croucher, Peter, I] Garvan Inst Med Res, Hlth Ageing Theme, Sydney, NSW, Australia; [McDonald, Michelle M.; Khoo, Weng Hua; Corr, Alexander; Mohanty, Sindhu T.; Byrne, Niall; Terry, Rachael L.; Simic, Marija K.; Quinn, Julian M. W.; Baldock, Paul A.; Rogers, Michael J.; Brink, Robert; Croucher, Peter, I; Phan, Tri Giang] UNSW Sydney, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Ng, Pei Ying; Pavlos, Nathan J.] Univ Western Australia, Sch Biomed Sci, Bone Biol & Dis Lab, Nedlands, WA, Australia; [Kyaw, Wunna; Pathmanandavel, Karrnan; Grootveld, Abigail K.; Moran, Imogen; Butt, Danyal; Nguyen, Akira; Brink, Robert; Phan, Tri Giang] Garvan Inst Med Res, Immunol Theme, Sydney, NSW, Australia; [Warren, Sean; Timpson, Paul] Garvan Inst Med Res, Canc, Sydney, NSW, Australia; [Biro, Mate] Univ New South Wales, Sch Med Sci, Single Mol Sci Node, EMBL Australia, Sydney, NSW, Australia; [Butterfield, Natalie C.; Guilfoyle, Siobhan E.; Komla-Ebri, Davide; Dack, Michael R. G.; Dewhurst, Hannah F.; Logan, John G.; Williams, Graham R.; Bassett, J. H. Duncan] Imperial Coll London, Dept Metab Digest & Reprod, Mol Endocrinol Lab, London, England; [Li, Yongxiao; Lee, Woei Ming] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Jain, Rohit; Weninger, Wolfgang] Centenary Inst, Immune Imaging Program, Sydney, NSW, Australia; [Jain, Rohit; Weninger, Wolfgang] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Weninger, Wolfgang] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Lundberg, Mischa; Kemp, John P.] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia; [Lundberg, Mischa] Transformat Bioinformat Commonwealth Sci & Ind Re, Sydney, NSW, Australia; [Sun, Shuting; Ebetino, Frank H.] Biovinc, Pasadena, CA USA; [Kemp, John P.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England	Garvan Institute of Medical Research; University of New South Wales Sydney; University of Western Australia; Garvan Institute of Medical Research; Garvan Institute of Medical Research; European Molecular Biology Laboratory (EMBL); University of New South Wales Sydney; Imperial College London; University of London; Queen Mary University London; Australian National University; John Curtin School of Medical Research; University of Sydney; Centenary Institute; University of Sydney; Medical University of Vienna; University of Queensland; University of Bristol	Croucher, PI (corresponding author), Garvan Inst Med Res, Hlth Ageing Theme, Sydney, NSW, Australia.; Croucher, PI; Phan, TG (corresponding author), UNSW Sydney, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia.; Phan, TG (corresponding author), Garvan Inst Med Res, Immunol Theme, Sydney, NSW, Australia.	p.croucher@garvan.org.au; t.phan@garvan.org.au	Lee, W M Steve/AAQ-4478-2021; Byrne, Niall M/AAH-6643-2021; Jain, Rohit/O-2015-2019; Komla-Ebri, Davide/ABE-6209-2021; Biro, Mate/H-6292-2014; Phan, Tri/G-3937-2012	Lee, W M Steve/0000-0002-3912-6095; Jain, Rohit/0000-0002-4905-462X; Rogers, Michael/0000-0002-1818-9249; Timpson, Paul/0000-0002-5514-7080; Byrne, Niall/0000-0002-3429-6685; Croucher, Peter/0000-0002-7102-2413; Pavlos, Nathan/0000-0001-7003-188X; Biro, Mate/0000-0001-5852-3726; Phan, Tri/0000-0002-4909-2984; Komla-Ebri, Davide/0000-0002-8381-5381; Butterfield, Natalie/0000-0002-5209-7508; Khoo, Weng Hua/0000-0001-9985-7415; Lundberg, Mischa/0000-0002-4816-785X	Ernest Heine Family Foundation; CINSW Career Development Fellowship; UNSW Cellular Genomics Futures Institute; Future Fellowship from the Australian Research Council; National Health and Medical Research Council of Australia (NHMRC) [GNT1105877, GNT1155678]; Australian Government Research Training Scholarships; Wellcome Trust Strategic Award [101123]; University of Queensland Development Fellowship [UQFEL1718945]; NHMRC [GNT1177938, GNT1158758, GNT1143921]	Ernest Heine Family Foundation; CINSW Career Development Fellowship; UNSW Cellular Genomics Futures Institute; Future Fellowship from the Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Scholarships(Australian Government); Wellcome Trust Strategic Award(Wellcome Trust); University of Queensland Development Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	P.I.C., T.G.P., and this work are supported by Mrs. Janice Gibson and the Ernest Heine Family Foundation. M.M.M. is supported by a CINSW Career Development Fellowship, W.H.K. is supported by the UNSW Cellular Genomics Futures Institute, P.A.B. is supported by a Future Fellowship from the Australian Research Council, and R.B. (GNT1105877) and T.G.P. (GNT1155678) are supported by Fellowships from the National Health and Medical Research Council of Australia (NHMRC). I.M., S.E.Y., M.K.S., and W.H.K. are supported by Australian Government Research Training Scholarships. G.R.W., J.H.D.B., and P.I.C. received funding from a Wellcome Trust Strategic Award (101123) for this work. J.P.K. was funded by a University of Queensland Development Fellowship (UQFEL1718945), NHMRC Investigator grant (GNT1177938), and project grant (GNT1158758). N.J.P. is supported by an NHMRC project grant (GNT1143921). We thank Peter and Val Duncan and the Australian Cancer Research Foundation INCITe Centre, the UNSW Cellular Genomics Futures Institute, and the Garvan-Weizmann Centre for Cellular Genomics. This research has been conducted using the UK Biobank Resource (accession ID: 53641).	Akiyama T, 2005, BIOL PROCED ONLINE, V7, P48, DOI 10.1251/bpo105; Anastasilakis AD, 2017, J BONE MINER RES, V32, P1291, DOI 10.1002/jbmr.3110; Anastasilakis AD, 2017, EUR J ENDOCRINOL, V176, P677, DOI 10.1530/EJE-16-1027; Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; ARNETT TR, 1986, ENDOCRINOLOGY, V119, P119, DOI 10.1210/endo-119-1-119; Baker S, 2004, INT J COMPUT VISION, V56, P221, DOI 10.1023/B:VISI.0000011205.11775.fd; Bassett JHD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002858; Boissy P, 2002, ENDOCRINOLOGY, V143, P1913, DOI 10.1210/en.143.5.1913; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Boyce BF, 2013, J BONE MINER RES, V28, P711, DOI 10.1002/jbmr.1885; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Chtanova T, 2014, J BIOPHOTONICS, V7, P425, DOI 10.1002/jbio.201200175; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cook D., 2020, BIOVIZBASE BASIC GRA; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; de Leeuw CA, 2016, NAT REV GENET, V17, P353, DOI 10.1038/nrg.2016.29; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Freudenthal B, 2016, J ENDOCRINOL, V231, pR31, DOI 10.1530/JOE-16-0258; Furuya M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02541-w; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Han YJ, 2019, J CLIN INVEST, V129, P1895, DOI 10.1172/JCI124590; HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0; HUGHES DE, 1995, J BONE MINER RES, V10, P1478; Hughes DE, 1996, NAT MED, V2, P1132, DOI 10.1038/nm1096-1132; Ikeda K, 2016, J BIOCHEM, V159, P1, DOI 10.1093/jb/mvv112; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jacome-Galarza CE, 2019, NATURE, V568, P541, DOI 10.1038/s41586-019-1105-7; Jansen IDC, 2012, CALCIFIED TISSUE INT, V90, P515, DOI 10.1007/s00223-012-9600-y; JONES SJ, 1977, CELL TISSUE RES, V185, P387; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; KANEHISA J, 1988, BONE, V9, P73, DOI 10.1016/8756-3282(88)90106-8; Kang J, 2015, CELL MOL LIFE SCI, V72, P181, DOI 10.1007/s00018-014-1665-5; Kannan M, 2017, P NATL ACAD SCI USA, V114, pE9308, DOI 10.1073/pnas.1713625114; Kemp JP, 2017, NAT GENET, V49, P1468, DOI 10.1038/ng.3949; Khoo WH, 2019, BLOOD, V134, P30, DOI 10.1182/blood.2018880930; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kobayashi Y, 2000, J BONE MINER RES, V15, P1924, DOI 10.1359/jbmr.2000.15.10.1924; Lassen NE, 2017, J BONE MINER RES, V32, P1395, DOI 10.1002/jbmr.3091; Lawson MA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9983; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Limaye A, 2012, PROC SPIE, V8506, DOI 10.1117/12.935640; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda H, 2016, NAT CHEM BIOL, V12, P579, DOI [10.1038/NCHEMBIO.2096, 10.1038/nchembio.2096]; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McClung MR, 2017, OSTEOPOROSIS INT, V28, P1723, DOI 10.1007/s00198-017-3919-1; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moran I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05772-7; Morris JA, 2019, NAT GENET, V51, P258, DOI 10.1038/s41588-018-0302-x; Mortier GR, 2019, AM J MED GENET A, V179, P2393, DOI 10.1002/ajmg.a.61366; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Pereira M, 2018, J CELL SCI, V131, DOI 10.1242/jcs.216267; Popp AW, 2016, OSTEOPOROSIS INT, V27, P1917, DOI 10.1007/s00198-015-3458-6; Quinn JMW, 1999, BONE, V25, P1, DOI 10.1016/S8756-3282(99)00094-0; ROSA R, 1978, J CLIN INVEST, V62, P907, DOI 10.1172/JCI109218; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Selander KS, 1996, MOL PHARMACOL, V50, P1127; Soe K, 2017, J CELL SCI, V130, P2026, DOI 10.1242/jcs.202036; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373, DOI 10.1210/endo-122-4-1373; Tang Y, 2016, R J, V8, P474, DOI 10.32614/rj-2016-060; Tsourdi E, 2017, BONE, V105, P11, DOI 10.1016/j.bone.2017.08.003; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; Vallejos CA, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0930-3; Vallejos CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004333; Venables W.N., 2013, MODERN APPL STAT P; VESELY P, 1992, J ANAT, V181, P277; Warren SC, 2018, ELIFE, V7, DOI 10.7554/eLife.35800; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Youlten S.E., 2020, OSTEOCYTE TRANSCRIPT, DOI [10.1101/2020.04.20.051409., DOI 10.1101/2020.04.20.051409]; Zanchetta MB, 2018, OSTEOPOROSIS INT, V29, P41, DOI 10.1007/s00198-017-4242-6	84	87	93	21	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1330	+		10.1016/j.cell.2021.02.002	http://dx.doi.org/10.1016/j.cell.2021.02.002		MAR 2021	31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33636130	Green Published, hybrid			2022-12-28	WOS:000629635700019
J	Appleby, J				Appleby, John			NHS sickness absence during the covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, London, England		Appleby, J (corresponding author), Nuffield Trust, London, England.	john.appleby@nuffieldtrust.org.uk						NHS Digital, 2021, NHS SICKN ABS RAT JU; NHS Digital, 2019, NHS SICKN AB RAT APR; NHS England, 2021, COVID 19 HOSP ACT; Office for National Statistics, 2021, DEATHS INVOLVING COV	4	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2021	372								n471	10.1136/bmj.n471	http://dx.doi.org/10.1136/bmj.n471			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6OT	33658183	Bronze			2022-12-28	WOS:000632918700002
J	Barsky, BA; Reinhart, E; Farmer, P; Keshavjee, S				Barsky, Benjamin A.; Reinhart, Eric; Farmer, Paul; Keshavjee, Salmaan			Vaccination plus Decarceration - Stopping Covid-19 in Jails and Prisons	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Vaccination plus Decarceration With the rollout of Covid vaccines, public debate regarding health in jails and prisons has increasingly shifted from decarceration toward vaccination of incarcerated people. But several factors suggest that vaccination alone won't be enough to stop carceral outbreaks.	[Barsky, Benjamin A.] Univ Penn, Scattergood Program Appl Eth Behav Hlth Care, Philadelphia, PA 19104 USA; [Barsky, Benjamin A.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Reinhart, Eric] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Reinhart, Eric] World Bank, Data & Evidence Justice Reform DE JURE, 1818 H St NW, Washington, DC 20433 USA; [Reinhart, Eric] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Reinhart, Eric] Chicago Ctr Psychoanal, Chicago, IL USA; [Farmer, Paul; Keshavjee, Salmaan] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Farmer, Paul; Keshavjee, Salmaan] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	University of Pennsylvania; Harvard University; Harvard University; The World Bank; University of Chicago; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Barsky, BA (corresponding author), Univ Penn, Scattergood Program Appl Eth Behav Hlth Care, Philadelphia, PA 19104 USA.; Barsky, BA (corresponding author), Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA.			Keshavjee, Salmaan/0000-0002-6967-3305; Reinhart, Eric/0000-0003-0246-5197				Harvey A., 2020, COVID 19 JAILS PUBLI; Malloy GSP, 2020, EFFECTIVENESS INTERV, DOI [10.1101/2020.06.16.20133280, DOI 10.1101/2020.06.16.20133280]; Paltiel AD, 2021, HEALTH AFFAIR, V40, P42, DOI 10.1377/hlthaff.2020.02054; Puglisi LB, 2021, ANN EPIDEMIOL, V53, P103, DOI 10.1016/j.annepidem.2020.09.002; Wang E., 2020, DECARCERATING CORREC	5	26	26	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1583	1585		10.1056/NEJMp2100609	http://dx.doi.org/10.1056/NEJMp2100609		MAR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV1ND	33657290	Bronze			2022-12-28	WOS:000640362100001
J	Chagla, Z				Chagla, Zain			In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 > 14 d after the 2nd dose	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chagla, Zain] McMaster Univ, Hamilton, ON, Canada	McMaster University	Chagla, Z (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Food and Drug Administration, FACT SHEET HEALTHC P; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; UK Department of Health and Social Care and the Medicines & Healthcare products Regulatory Agency, REG 174 INF UK HEALT	3	3	3	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC29	JC29		10.7326/ACPJ202103160-029	http://dx.doi.org/10.7326/ACPJ202103160-029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646835				2022-12-28	WOS:000669667000004
J	Bakhai, M; Atherton, H				Bakhai, Minal; Atherton, Helen			How to conduct written online consultations with patients in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH LITERACY; COMMUNICATION; EXPERIENCES; CLINICIAN; INTERNET		[Bakhai, Minal] NHS England & NHS Improvement London, Skipton House, London SE1 6LH, England; [Atherton, Helen] Warwick Med Sch, Warwick, England	University of Warwick	Bakhai, M (corresponding author), NHS England & NHS Improvement London, Skipton House, London SE1 6LH, England.	minal.bakhai1@nhs.net	Atherton, Helen/AFK-5296-2022	Atherton, Helen/0000-0002-7072-1925				Atherton H, 2018, HEALTH SERV DELIVERY, V6, P1, DOI [10.3310/hsdr06200, DOI 10.3310/HSDR06200]; Atherton H, 2018, GUIDANCE ALTERNATIVE; Atherton H, 2020, J MED INTERNET RES, V22, DOI 10.2196/18218; Atherton H, 2016, DIGIT HEALTH, V2, DOI 10.1177/2055207616675559; Atherton H, 2018, BRIT J GEN PRACT, V68, pE293, DOI 10.3399/bjgp18X694853; Atherton H, 2013, BRIT J GEN PRACT, V63, pE760, DOI 10.3399/bjgp13X674440; Atherton H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007978.pub2; Bakhai M., 2020, KEY PRINCIPLES INTIM; Bakhai M., 2020, ADVICE ESTABLISH REM; Bakhai M., 2019, USING ONLINE CONSULT; Bakhai M., 2020, USE ONLINE VIDEO CON; Bertelsen P, 2015, STUD HEALTH TECHNOL, V216, P376, DOI 10.3233/978-1-61499-564-7-376; Borg K, 2019, HEALTH COMMUN, V34, P1320, DOI 10.1080/10410236.2018.1485077; Chambers D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027743; Chen C, 2009, HEALTH AFFAIR, V28, P323, DOI 10.1377/hlthaff.28.2.323; Clarke G, 2020, ARE TOTAL TRIAGE REM; Colligan L, 2015, INT J MED INFORM, V84, P469, DOI 10.1016/j.ijmedinf.2015.03.003; Eccles A, 2019, BRIT J GEN PRACT, V69, pE336, DOI 10.3399/bjgp19X702197; Edwards HB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016901; Farr M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019966; Goldzweig CL, 2013, ANN INTERN MED, V159, P677, DOI 10.7326/0003-4819-159-10-201311190-00006; Gronning A, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039442; Hansen CS, 2014, DAN MED J, V61; Huxley CJ, 2015, BRIT J GEN PRACT, V65, pE813, DOI 10.3399/bjgp15X687853; Huygens MWJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019233; Jones D, 2019, BRIT J GEN PRACT, V69, pE70, DOI 10.3399/bjgp18X700193; Kings Fund, 2020, LEAD TEAMS VIRT; Koh HK, 2013, HEALTH AFFAIR, V32, P357, DOI 10.1377/hlthaff.2012.1205; Mirsky JB, 2016, J HEALTH COMMUN, V21, P85, DOI 10.1080/10810730.2015.1033118; Mold F, 2019, JMIR MED INF, V7, P4, DOI 10.2196/13042; NHS Digital, CLIN RISK MAN ITS AP; NHS England, 2018, EMP PERS ROADM DIG H; Palen TE, 2012, JAMA-J AM MED ASSOC, V308, P2012, DOI 10.1001/jama.2012.14126; Pearl R, 2014, HEALTH AFFAIR, V33, P251, DOI 10.1377/hlthaff.2013.1005; Rodgers M., 2019, HEALTH SERV DELIVERY, V7, DOI [10.3310/hsdr07200, DOI 10.3310/HSDR07410]; Sarkar U, 2010, J HEALTH COMMUN, V15, P183, DOI 10.1080/10810730.2010.499988; Sheridan SL, 2011, J HEALTH COMMUN, V16, P30, DOI 10.1080/10810730.2011.604391; Shimada SL, 2017, J AM MED INFORM ASSN, V24, P942, DOI 10.1093/jamia/ocx021; Stuart B, 2019, PATIENT EDUC COUNS, V102, P687, DOI 10.1016/j.pec.2018.11.009; Turner A, 2020, S W SOC AC PRIM CAR; Weiss D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195447	41	4	4	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n264	10.1136/bmj.n264	http://dx.doi.org/10.1136/bmj.n264			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QO8RL	33627324	Green Accepted			2022-12-28	WOS:000623404800012
J	Eldin, C; Gautret, P				Eldin, Carole; Gautret, Philippe			Multiple itchy lesions after recent travel	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CUTANEOUS LARVA MIGRANS		[Eldin, Carole; Gautret, Philippe] Aix Marseille Univ, Fac Med, Marseille, France; [Eldin, Carole; Gautret, Philippe] IHU Mediterranee Infect, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Eldin, C (corresponding author), Aix Marseille Univ, Fac Med, Marseille, France.; Eldin, C (corresponding author), IHU Mediterranee Infect, Marseille, France.	carole.eldin@gmail.com	Gautret, Philippe/AAY-5126-2021	Gautret, Philippe/0000-0002-1664-958X				Eksomtramage T, 2018, IDCases, V12, P130, DOI 10.1016/j.idcr.2018.05.003; Heukelbach J, 2008, LANCET INFECT DIS, V8, P302, DOI 10.1016/S1473-3099(08)70098-7; Paul S, 2016, INT J DERMATOL, V55, pE79, DOI 10.1111/ijd.12927; Sow D, 2017, TRAVEL MED INFECT DI, V20, P61, DOI 10.1016/j.tmaid.2017.06.003	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n231	10.1136/bmj.n231	http://dx.doi.org/10.1136/bmj.n231			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627341				2022-12-28	WOS:000623404800018
J	Rao, CT; Coyte, KZ; Bainter, W; Geha, RS; Martin, CR; Rakoff-Nahoum, S				Rao, Chitong; Coyte, Katharine Z.; Bainter, Wayne; Geha, Raif S.; Martin, Camilia R.; Rakoff-Nahoum, Seth			Multi-kingdom ecological drivers of microbiota assembly in preterm infants	NATURE			English	Article								The gut microbiota of preterm infants develops predictably(1-7), with pioneer species colonizing the gut after birth, followed by an ordered succession of microorganisms. The gut microbiota is vital to the health of preterm infants(8,9), but the forces that shape these predictable dynamics of microbiome assembly are unknown. The environment, the host and interactions between microorganisms all potentially shape the dynamics of the microbiota, but in such a complex ecosystem, identifying the specific role of any individual factor is challenging(10-14). Here we use multi-kingdom absolute abundance quantification, ecological modelling and experimental validation to address this challenge. We quantify the absolute dynamics of bacteria, fungi and archaea in a longitudinal cohort of 178 preterm infants. We uncover microbial blooms and extinctions, and show that there is an inverse correlation between bacterial and fungal loads in the infant gut. We infer computationally and demonstrate experimentally in vitro and in vivo that predictable assembly dynamics may be driven by directed, context-dependent interactions between specific microorganisms. Mirroring the dynamics of macroscopic ecosystems(15-17), a late-arriving member of the microbiome, Klebsiella, exploits the pioneer microorganism, Staphylococcus, to gain a foothold within the gut. Notably, we find that interactions between different kingdoms can influence assembly, with a single fungal species-Candida albicans-inhibiting multiple dominant genera of gut bacteria. Our work reveals the centrality of simple microbe-microbe interactions in shaping host-associated microbiota, which is critical both for our understanding of microbiota ecology and for targeted microbiota interventions.	[Rao, Chitong; Coyte, Katharine Z.; Rakoff-Nahoum, Seth] Boston Childrens Hosp, Div Infect Dis, Dept Pediat, Boston, MA USA; [Coyte, Katharine Z.] Univ Manchester, Sch Biol Sci, Div Evolut & Genom Sci, Manchester, Lancs, England; [Bainter, Wayne; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Dept Pediat, Boston, MA USA; [Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; [Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Div Translat Res, Boston, MA 02215 USA; [Rakoff-Nahoum, Seth] Boston Childrens Hosp, Div Gastroenterol, Dept Pediat, Boston, MA USA; [Rakoff-Nahoum, Seth] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Rakoff-Nahoum, Seth] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; University of Manchester; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Coyte, KZ; Rakoff-Nahoum, S (corresponding author), Boston Childrens Hosp, Div Infect Dis, Dept Pediat, Boston, MA USA.; Coyte, KZ (corresponding author), Univ Manchester, Sch Biol Sci, Div Evolut & Genom Sci, Manchester, Lancs, England.; Rakoff-Nahoum, S (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Dept Pediat, Boston, MA USA.; Rakoff-Nahoum, S (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.; Rakoff-Nahoum, S (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	katharine.coyte@manchester.ac.uk; seth.rakoff-nahoum@childrens.harvard.edu		Coyte, Katharine/0000-0002-5231-9350; Rao, Chitong/0000-0003-1162-7530	Sir Henry Wellcome Postdoctoral Research Fellowship [201341/A/16/Z]; University of Manchester Presidential Fellowship; Career Award for Medical Scientists from the Burroughs Wellcome Fund; Pew Biomedical Scholarship; Basil O'Connor Starter Scholar Award from the March of Dimes [P30DK040561, K08AI130392-01]; NIH Director's New Innovator Award [DP2GM136652];  [1R01AI153257-01];  [5R01AI139633-03]	Sir Henry Wellcome Postdoctoral Research Fellowship; University of Manchester Presidential Fellowship; Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Pew Biomedical Scholarship; Basil O'Connor Starter Scholar Award from the March of Dimes; NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	We thank all of the infants and their families who participated in the study; J. Xavier, J. Ordovas-Montanes, O. Cunrath and members of the Rakoff-Nahoum laboratory for discussions; and L. Martin for assistance with sample collection. K.Z.C. is funded by a Sir Henry Wellcome Postdoctoral Research Fellowship (grant 201341/A/16/Z) and a University of Manchester Presidential Fellowship; R.S.G. is supported by grants 1R01AI153257-01 and 5R01AI139633-03; and S.R-N. is supported by a Career Award for Medical Scientists from the Burroughs Wellcome Fund, a Pew Biomedical Scholarship, a Basil O'Connor Starter Scholar Award from the March of Dimes, P30DK040561, K08AI130392-01 and a NIH Director's New Innovator Award DP2GM136652.	Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Bucci V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0980-6; Carr A, 2019, ISME J, V13, P2647, DOI 10.1038/s41396-019-0459-z; Charbonneau MR, 2016, NATURE, V535, P48, DOI 10.1038/nature18845; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Contijoch EJ, 2019, ELIFE, V8, DOI 10.7554/eLife.40553; Costello EK, 2013, MBIO, V4, DOI 10.1128/mBio.00782-13; Derrien M, 2019, TRENDS MICROBIOL, V27, P997, DOI 10.1016/j.tim.2019.08.001; DiBartolomeo ME, 2016, CLIN THER, V38, P733, DOI 10.1016/j.clinthera.2016.02.003; Duran P, 2018, CELL, V175, P973, DOI 10.1016/j.cell.2018.10.020; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fischbach MA, 2018, CELL, V174, P785, DOI 10.1016/j.cell.2018.07.038; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Freilich MA, 2018, ECOLOGY, V99, P690, DOI 10.1002/ecy.2142; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Gasparrini AJ, 2019, NAT MICROBIOL, V4, P2285, DOI 10.1038/s41564-019-0550-2; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Gonze D, 2018, CURR OPIN MICROBIOL, V44, P41, DOI 10.1016/j.mib.2018.07.004; Gregory KE, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0214-x; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Ishwaran H, 2005, ANN STAT, V33, P730, DOI 10.1214/009053604000001147; Koskinen K, 2017, MBIO, V8, DOI 10.1128/mBio.00824-17; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lim ES, 2015, NAT MED, V21, P1228, DOI 10.1038/nm.3950; Limon JJ, 2017, CELL HOST MICROBE, V22, P156, DOI 10.1016/j.chom.2017.07.002; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Nash AK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0373-4; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pammi M, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0248-8; Pammi M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-257; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8; Reynolds LA, 2017, NAT REV IMMUNOL, V17, P518, DOI 10.1038/nri.2017.39; Shade A, 2018, TRENDS ECOL EVOL, V33, P731, DOI 10.1016/j.tree.2018.08.005; Shao Y, 2019, NATURE, V574, P117, DOI 10.1038/s41586-019-1560-1; Stammler F, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0175-0; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Stewart CJ, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0216-8; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Vrancken G, 2019, NAT REV MICROBIOL, V17, P754, DOI 10.1038/s41579-019-0264-8; Walter J, 2020, CELL, V180, P221, DOI 10.1016/j.cell.2019.12.025; Watts SC, 2019, BIOINFORMATICS, V35, P1064, DOI 10.1093/bioinformatics/bty734; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45; Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	49	61	63	22	106	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 25	2021	591	7851					633	+		10.1038/s41586-021-03241-8	http://dx.doi.org/10.1038/s41586-021-03241-8		FEB 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RB5UT	33627867	Green Submitted, Green Accepted			2022-12-28	WOS:000621335600005
J	Slomski, A				Slomski, Anita			Finerenone for Patients With CKD and Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					713	713		10.1001/jama.2021.1255	http://dx.doi.org/10.1001/jama.2021.1255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620401				2022-12-28	WOS:000621957400007
J	Vourc'h, M; Garret, C; Gacouin, A; Lacherade, JC; Jonas, M; Klouche, K; Ferrandiere, M; Jaber, S; Flet, L; Dailly, E; Pouplet, C; Maamar, A; Reignier, J; Roquilly, A; Feuillet, F; Mahe, PJ; Asehnoune, K				Vourc'h, Mickael; Garret, Charlotte; Gacouin, Arnaud; Lacherade, Jean-Claude; Jonas, Maud; Klouche, Kada; Ferrandiere, Martine; Jaber, Samir; Flet, Laurent; Dailly, Eric; Pouplet, Caroline; Maamar, Adel; Reignier, Jean; Roquilly, Antoine; Feuillet, Fanny; Mahe, Pierre-Joachim; Asehnoune, Karim		BACLOREA Study Grp	Effect of High-Dose Baclofen on Agitation-Related Events Among Patients With Unhealthy Alcohol Use Receiving Mechanical Ventilation A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SAMPLE-SIZE RECALCULATION; CRITICALLY-ILL; PRACTICE GUIDELINES; DELIRIUM; MANAGEMENT; ICU; PREVENTION; WITHDRAWAL; SCORE; MODEL	IMPORTANCE Unhealthy alcohol use can lead to agitation in the intensive care unit (ICU). OBJECTIVE To assess whether high-dose baclofen reduces agitation-related events compared with placebo in patients with unhealthy alcohol use receiving mechanical ventilation. DESIGN, SETTINGS, AND PARTICIPANTS This phase 3, double-blind, placebo-controlled, randomized clinical trial conducted in 18 ICUs in France recruited adults receiving mechanical ventilation who met criteria for unhealthy alcohol use. Patients were enrolled from June 2016 to February 2018; the last follow-up was in May 2019. INTERVENTIONS Baclofen (n = 159), adjusted from 50 to 150 mg per day based on estimated glomerular filtration rate, or placebo (n = 155) during mechanical ventilation up to a maximum of 15 days before gradual dose reduction over 3 to 6 days. MAIN OUTCOMES AND MEASURES The primary end point was the percentage of patients with at least 1 agitation-related event over the treatment period. Secondary outcomes included duration of mechanical ventilation, length of ICU stay, and 28-day mortality. RESULTS Among 314 patients who were randomized (mean age, 57 years; 60 [17.2%] women), 313 (99.7%) completed the trial. There was a statistically significant decrease in the percentage of patients who experienced at least 1 agitation-related event in the baclofen group vs the placebo group (31 [19.7%] vs 46 [29.7%]; difference, -9.93%[95% CI, -19.45% to -0.42%]; adjusted odds ratio, 0.59 [95% CI, 0.35-0.99]). Of 18 prespecified secondary end points, 14 were not significantly different. Compared with the placebo group, the baclofen group had a significantly longer median length of mechanical ventilation (9 vs 8 days; difference, 2.00 [95% CI, 0.00-3.00]; hazard ratio [HR] for extubation, 0.76 [95% CI, 0.60-0.97]) and stay in the ICU (14 vs 11 days; difference, 2.00 [95% CI, 0.00-4.00]; HR for discharge, 0.70 [95% CI, 0.54-0.90]). At 28 days, there was no significant difference in mortality in the baclofen vs placebo group (25.3% vs 21.6%; adjusted odds ratio, 1.24 [95% CI, 0.72-2.13]). Delayed awakening (no eye opening at 72 hours after cessation of sedatives and analgesics) occurred in 14 patients (8.9%) in the baclofen group vs 3 (1.9%) in the placebo group. CONCLUSIONS AND RELEVANCE Among patients with unhealthy alcohol use receiving mechanical ventilation, treatment with high-dose baclofen, compared with placebo, resulted in a statistically significant reduction in agitation-related events. However, considering the modest effect and the totality of findings for the secondary end points and adverse events, further research is needed to determine the possible role of baclofen in this setting and to potentially optimize dosing.	[Vourc'h, Mickael; Roquilly, Antoine; Mahe, Pierre-Joachim; Asehnoune, Karim] Ctr Hosp Univ Nantes, Serv Anesthesie Reanimat Chirurg, Nantes, France; [Garret, Charlotte; Gacouin, Arnaud; Maamar, Adel; Reignier, Jean] Ctr Hosp Univ Nantes, Serv Med Intens Reanimat, Nantes, France; [Lacherade, Jean-Claude; Pouplet, Caroline] Ctr Hosp Dept Vendee, Serv Med Intens Reanimat, La Roche Sur Yon, France; [Jonas, Maud] Ctr Hosp Gen St Nazaire, Serv Med Intens Reanimat, St Nazaire, France; [Klouche, Kada] Ctr Hosp Univ Montpellier, Serv Med Intens Reanimat, Montpellier, France; [Ferrandiere, Martine] Ctr Hosp Univ Tours, Serv Anesthesie Reanimat, Tours, France; [Jaber, Samir] Ctr Hosp Univ Montpellier, Serv Anesthesie Reanimat, Montpellier, France; [Flet, Laurent] Ctr Hosp Univ Nantes, Serv Pharm, Nantes, France; [Dailly, Eric] Ctr Hosp Univ Nantes, Serv Pharmacol Clin, Nantes, France; [Feuillet, Fanny] Ctr Hosp Univ Nantes, Plateforme Methodol & Biostat, Nantes, France; [Feuillet, Fanny] Univ Nantes, INSERM, SPHERE U1246, Nantes, France	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; CHD Vendee; Universite de Montpellier; CHU de Montpellier; CHU Tours; Universite de Montpellier; CHU de Montpellier; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Asehnoune, K (corresponding author), CHU Nantes, Serv Anesthesie Reanimat, 1 Pl Alexis Ricordeau, F-44093 Nantes 1, France.	karim.asehnoune@chu-nantes.fr	FLET, Laurent/X-1192-2019	FLET, Laurent/0000-0001-8305-7085; Maamar, Adel/0000-0001-8352-3613; Roquilly, Antoine/0000-0002-1029-6242	French Ministry of Health (Interregion French Clinical Hospital Research Program) [PHRCI 2014-API14/N/096]; Nantes University Hospital	French Ministry of Health (Interregion French Clinical Hospital Research Program); Nantes University Hospital	The BACLOREA study was supported by the French Ministry of Health (Interregion French Clinical Hospital Research Program, PHRCI 2014-API14/N/096). Nantes University Hospital sponsored the study.	[Anonymous], 2020, NAT SURV DRUG US HLT; [Anonymous], 2014, TEMP REC US BACL ALC; Awissi DK, 2013, INTENS CARE MED, V39, P16, DOI 10.1007/s00134-012-2758-y; Boulain T, 1998, AM J RESP CRIT CARE, V157, P1131, DOI 10.1164/ajrccm.157.4.9702083; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1899, DOI 10.1001/jama.2018.16789; de Beaurepaire Renaud, 2012, Front Psychiatry, V3, P103, DOI 10.3389/fpsyt.2012.00103; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Friede T, 2004, PHARM STAT, V3, P269, DOI 10.1002/pst.140; Friede T, 2006, BIOMETRICAL J, V48, P537, DOI 10.1002/bimj.200510238; Gacouin A, 2014, CRIT CARE MED, V42, P860, DOI 10.1097/CCM.0000000000000041; Girard TD, 2018, NEW ENGL J MED, V379, P2506, DOI 10.1056/NEJMoa1808217; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Griswold MG, 2018, LANCET, V392, P1015, DOI [10.1016/S0140-6736(18)31310-2, 10.1016/s0140-6736(18)31310-2, 10.1136/bmj.l94]; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kuan Y, 2005, NEPHROL DIAL TRANSPL, V20, P2394, DOI 10.1093/ndt/gfi076; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Long AC, 2014, INTENS CARE MED, V40, P820, DOI 10.1007/s00134-014-3306-8; Mackenbach JP, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001909; Naudet F, 2018, LANCET PSYCHIAT, V5, P961, DOI 10.1016/S2215-0366(18)30419-X; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Riker RR, 2013, AM J CRIT CARE, V22, P153, DOI 10.4037/ajcc2013480; Saitz R, 2005, NEW ENGL J MED, V352, P596, DOI 10.1056/NEJMcp042262; Schuckit MA, 2014, NEW ENGL J MED, V371, P2109, DOI 10.1056/NEJMra1407298; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; Siegel MD, 2003, CLIN CHEST MED, V24, P713, DOI 10.1016/S0272-5231(03)00104-7; Spillane S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.21451; Stewart Donald, 2019, J Intensive Care Soc, V20, P208, DOI 10.1177/1751143718787748; Thibault, 2020, ANAESTH CRIT CARE ME, V5, DOI [10.23880/accmj-16000170, DOI 10.23880/ACCMJ-16000170]; van den Boogaard M, 2018, JAMA-J AM MED ASSOC, V319, P680, DOI 10.1001/jama.2018.0160; Vourc'h M, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104231; Vourc'h M, 2019, PROG NEURO-PSYCHOPH, V92, P450, DOI 10.1016/j.pnpbp.2019.02.016; Vourc'h M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1539-2; Wan SZ, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/5193028; Wassenaar A, 2015, INTENS CARE MED, V41, P1048, DOI 10.1007/s00134-015-3777-2	35	2	2	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					732	741		10.1001/jama.2021.0658	http://dx.doi.org/10.1001/jama.2021.0658			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620407	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000621957400021
J	Dyer, C				Dyer, Clare			Covid-19: Hancock's failure to publish contracts was unlawful	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, R APPL GOOD LAW PROJ	1	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n511	10.1136/bmj.n511	http://dx.doi.org/10.1136/bmj.n511			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608255	Bronze			2022-12-28	WOS:000621237300007
J	Hanna, RE; Hegde, M; Fagre, CR; DeWeirdt, PC; Sangree, AK; Szegletes, Z; Griffith, A; Feeley, MN; Sanson, KR; Baidi, Y; Koblan, LW; Liu, DR; Neal, JT; Doench, JG				Hanna, Ruth E.; Hegde, Mudra; Fagre, Christian R.; DeWeirdt, Peter C.; Sangree, Annabel K.; Szegletes, Zsofia; Griffith, Audrey; Feeley, Marissa N.; Sanson, Kendall R.; Baidi, Yossef; Koblan, Luke W.; Liu, David R.; Neal, James T.; Doench, John G.			Massively parallel assessment of human variants with base editor screens	CELL			English	Article							GENOMIC DNA; INHIBITOR; MUTATIONS; DISCOVERY; ENZYMES; DOMAIN; MCL-1	Understanding the functional consequences of single-nucleotide variants is critical to uncovering the genetic underpinnings of diseases, but technologies to characterize variants are limiting. Here, we leverage CRISPR-Cas9 cytosine base editors in pooled screens to scalably assay variants at endogenous loci in mammalian cells. We benchmark the performance of base editors in positive and negative selection screens, identifying known loss-of-function mutations in BRCA1 and BRCA2 with high precision. To demonstrate the utility of base editor screens to probe small molecule-protein interactions, we screen against BH3 mimetics and PARP inhibitors, identifying point mutations that confer drug sensitivity or resistance. We also create a library of single guide RNAs (sgRNAs) predicted to generate 52,034 ClinVar variants in 3,584 genes and conduct screens in the presence of cellular stressors, identifying loss-of-function variants in numerous DNA damage repair genes. We anticipate that this screening approach will be broadly useful to readily and scalably functionalize genetic variants.	[Hanna, Ruth E.; Hegde, Mudra; DeWeirdt, Peter C.; Sangree, Annabel K.; Szegletes, Zsofia; Griffith, Audrey; Feeley, Marissa N.; Sanson, Kendall R.; Doench, John G.] Broad Inst, Genet Perturbat Platform, Cambridge, MA 02142 USA; [Fagre, Christian R.; Baidi, Yossef; Neal, James T.] Broad Inst, Canc Program, Cambridge, MA 02142 USA; [Koblan, Luke W.; Liu, David R.] Broad Inst, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA; [Koblan, Luke W.; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Howard Hughes Medical Institute	Doench, JG (corresponding author), Broad Inst, Genet Perturbat Platform, Cambridge, MA 02142 USA.	jdoench@broadinstitute.org	Doench, John G/HCI-9570-2022; Liu, David R./HCH-3132-2022	Doench, John G/0000-0002-3707-9889; Baidi, Yossef/0000-0002-9289-5213; Hanna, Ruth/0000-0001-5586-2300; Feeley, Marissa/0000-0002-2869-2315	Functional Genomics Consortium; NSF GRFP fellowship [DGE1144152]; NIH [U01AI142756]; Broad V2F Initiative	Functional Genomics Consortium; NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad V2F Initiative	We thank Amy Goodale, Edith Sawyer, Jonah O'Mara Schwartz, Hinako Kawabe, Briana Fritchman, and Xiaoping Yang for producing guide libraries and lentivirus; Olivia Bare, Max Macaluso, and Yenarae Lee for operations support; Matthew Greene, Adam Brown, Doug Alan, Mark Tomko, and Tom Green for software engineering support; David Root for senior leadership of the Genetic Perturbation Platform; and the Broad Institute Genomics Platform Walk-up Sequencing group for Illumina sequencing. We thank Greg Findlay (University of Washington), Sarah Weiss (Harvard Medical School), Nicky Persky (Broad Institute), and Kendell Clement and Luca Pinello (Massachusetts General Hospital) for helpful conversations. Schematics were created with BioRender.com. Funding support was provided in part by the Broad V2F Initiative and the Functional Genomics Consortium. L.W.K. and D.R.L. recognize support from the NSF GRFP fellowship (DGE1144152) and NIH (U01AI142756).	Arbab M, 2020, CELL, V182, P463, DOI 10.1016/j.cell.2020.05.037; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Chang WC, 2020, ENDOCR-RELAT CANCER, V27, P81, DOI 10.1530/ERC-19-0095; Chen HQ, 2020, NAT BIOTECHNOL, V38, P165, DOI 10.1038/s41587-019-0331-8; Chen HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41053-z; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Clohessy JG, 2004, BRIT J HAEMATOL, V125, P655, DOI 10.1111/j.1365-2141.2004.04949.x; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Dawicki-McKenna JM, 2015, MOL CELL, V60, P755, DOI 10.1016/j.molcel.2015.10.013; Despres PC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15796-7; DeWeirdt PC, 2021, NAT BIOTECHNOL, V39, P94, DOI 10.1038/s41587-020-0600-6; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Donovan KF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170445; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gelman H, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0698-7; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Hamilton EM, 2014, BRAIN, V137, P1921, DOI 10.1093/brain/awu110; Han K, 2017, NAT BIOTECHNOL, V35, P463, DOI 10.1038/nbt.3834; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Herrant M, 2004, ONCOGENE, V23, P7863, DOI 10.1038/sj.onc.1208069; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Horlbeck MA, 2018, CELL, V174, P953, DOI 10.1016/j.cell.2018.06.010; Jun S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0888-2; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Kluesner M. G., 2020, CRISPR CAS9 CYTIDINE, DOI [10.1101/2020.04.16.045336, DOI 10.1101/2020.04.16.045336, DOI 10.1074/jbc.M410077200]; Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; Kweon J, 2020, ONCOGENE, V39, P30, DOI 10.1038/s41388-019-0968-2; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642; Ma YQ, 2016, NAT METHODS, V13, P1029, DOI [10.1038/NMETH.4027, 10.1038/nmeth.4027]; Marquart K. F., 2020, PREDICTING BASE EDIT, DOI [DOI 10.1038/s41467-018-04580-3, 10.1101/2020.07.05.186544, DOI 10.1101/2020.07.05.186544]; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mehta IS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r135; Melnikov A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku511; Miller SM, 2020, NAT BIOTECHNOL, V38, P471, DOI 10.1038/s41587-020-0412-8; Najm FJ, 2018, NAT BIOTECHNOL, V36, P179, DOI 10.1038/nbt.4048; Neggers JE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02349-8; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Patel MR, 2014, J MED CHEM, V57, P5579, DOI 10.1021/jm5002502; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pettitt SJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03917-2; Replogle JM, 2020, NAT BIOTECHNOL, V38, P954, DOI 10.1038/s41587-020-0470-y; Ruffner H, 2001, P NATL ACAD SCI USA, V98, P5134, DOI 10.1073/pnas.081068398; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharon E, 2018, CELL, V175, P544, DOI 10.1016/j.cell.2018.08.057; Song M, 2020, NAT BIOTECHNOL, V38, P1037, DOI 10.1038/s41587-020-0573-5; Starita LM, 2017, AM J HUM GENET, V101, P315, DOI 10.1016/j.ajhg.2017.07.014; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Walton RT, 2020, SCIENCE, V368, P290, DOI 10.1126/science.aba8853; Yao JA, 2010, BRIT J PHARMACOL, V160, P2055, DOI 10.1111/j.1476-5381.2010.00860.x; Zandarashvili L, 2020, SCIENCE, V368, P46, DOI 10.1126/science.aax6367; Zhang SD, 2018, GENOME RES, V28, P968, DOI 10.1101/gr.231902.117; Zimmermann M, 2018, NATURE, V559, P285, DOI 10.1038/s41586-018-0291-z	68	58	60	6	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					1064	+		10.1016/j.cell.2021.01.012	http://dx.doi.org/10.1016/j.cell.2021.01.012		FEB 2021	37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606977	Bronze, Green Submitted			2022-12-28	WOS:000629633400019
J	Olusanya, O				Olusanya, Olufolakemi			Still we rise	CELL			English	Editorial Material								Olufolakemi "Fola'' Olusanya is the winner of the first Rising Black Scientist Award for an undergraduate scholar. For this award, we asked emerging Black scientists to tell us about the experiences that sparked their journey in the life sciences. This is her story.	[Olusanya, Olufolakemi] Howard Univ, Washington, DC 20059 USA	Howard University	Olusanya, O (corresponding author), Howard Univ, Washington, DC 20059 USA.	olufolakemi.olusany@bison.howard.edu							0	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					849	850		10.1016/j.cell.2021.01.031	http://dx.doi.org/10.1016/j.cell.2021.01.031		FEB 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606981	Bronze			2022-12-28	WOS:000629633400001
J	Dean, N				Dean, Natalie			Coordinate vaccine studies to stem confusion	NATURE			English	Editorial Material						Vaccines; Research management		Incompatible research designs will obscure essential answers about vaccine effectiveness. It's time to plan together.	[Dean, Natalie] Univ Florida, Infect Dis Epidemiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Dean, N (corresponding author), Univ Florida, Infect Dis Epidemiol, Gainesville, FL 32611 USA.	nataliedean@ufl.edu							0	1	1	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					179	179		10.1038/d41586-021-00563-5	http://dx.doi.org/10.1038/d41586-021-00563-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QX8UA	33658668				2022-12-28	WOS:000629617300003
J	Samarasekera, U				Samarasekera, Udani			Robin Shattock: novel vaccine developer	LANCET			English	Biographical-Item															Medical Research Council [MC_PC_19076] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					870	870						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676622	Bronze			2022-12-28	WOS:000626603400012
J	Normile, D				Normile, Dennis			Endless cleanup	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					983	983		10.1126/science.371.6533.983	http://dx.doi.org/10.1126/science.371.6533.983			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674478				2022-12-28	WOS:000625876100021
J	Liu, Y; Duan, XD; Shin, HJ; Park, S; Huang, Y; Duan, XF				Liu, Yuan; Duan, Xidong; Shin, Hyeon-Jin; Park, Seongjun; Huang, Yu; Duan, Xiangfeng			Promises and prospects of two-dimensional transistors	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; WAFER-SCALE GROWTH; HIGH-MOBILITY; MONOLAYER MOS2; GRAPHENE TRANSISTORS; VELOCITY SATURATION; METAL CONTACTS; PERFORMANCE; SEMICONDUCTOR; INTEGRATION	Two-dimensional (2D) semiconductors have attracted tremendous interest as atomically thin channels that could facilitate continued transistor scaling. However, despite many proof-of-concept demonstrations, the full potential of 2D transistors has yet to be determined. To this end, the fundamental merits and technological limits of 2D transistors need a critical assessment and objective projection. Here we review the promise and current status of 2D transistors, and emphasize that widely used device parameters (such as carrier mobility and contact resistance) could be frequently misestimated or misinterpreted, and may not be the most reliable performance metrics for benchmarking 2D transistors. We suggest that the saturation or on-state current density, especially in the short-channel limit, could provide a more reliable measure for assessing the potential of diverse 2D semiconductors, and should be applied for cross-checking different studies, especially when milestone performance metrics are claimed. We also summarize the key technical challenges in optimizing the channels, contacts, dielectrics and substrates and outline potential pathways to push the performance limit of 2D transistors. We conclude with an overview of the critical technical targets, the key technological obstacles to the 'lab-to-fab' transition and the potential opportunities arising from the use of these atomically thin semiconductors.	[Liu, Yuan] Hunan Univ, Sch Phys & Elect, Changsha, Hunan, Peoples R China; [Duan, Xidong] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemobiosensing & Chemometr, Changsha, Hunan, Peoples R China; [Shin, Hyeon-Jin; Park, Seongjun] Samsung Adv Inst Technol, Inorgan Mat Lab, Suwon, South Korea; [Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA; [Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Huang, Yu; Duan, Xiangfeng] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90024 USA	Hunan University; Hunan University; Samsung; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Duan, XF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.; Duan, XF (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90024 USA.	xduan@chem.ucla.edu	Shin, Hyeon-Jin/AAK-2278-2021; Liu, Yuan/G-4834-2016	Shin, Hyeon-Jin/0000-0002-6992-6341; Liu, Yuan/0000-0002-0024-9290				Akinwande D, 2019, NATURE, V573, P507, DOI 10.1038/s41586-019-1573-9; Allain A, 2015, NAT MATER, V14, P1195, DOI 10.1038/nmat4452; [Anonymous], 2020, INT ROADMAP DEVICES; Auth C, 2017, INT EL DEVICES MEET; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bandurin DA, 2017, NAT NANOTECHNOL, V12, P223, DOI [10.1038/nnano.2016.242, 10.1038/NNANO.2016.242]; Barraud S, 2017, INT EL DEVICES MEET; Bernard E, 2009, IEEE T ELECTRON DEV, V56, P1243, DOI 10.1109/TED.2009.2019700; Bittle EG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10908; Boyd DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7620; Cao W, 2014, IEEE T ELECTRON DEV, V61, P4282, DOI 10.1109/TED.2014.2365028; Chen ML, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15096-0; Chen TA, 2020, NATURE, V579, P219, DOI 10.1038/s41586-020-2009-2; Chen XL, 2018, ACS NANO, V12, P5003, DOI 10.1021/acsnano.8b02295; Chen XL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8315; Cheng L, 2018, J AM CHEM SOC, V140, P17895, DOI 10.1021/jacs.8b07871; Cheng R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6143; Cheng R, 2012, P NATL ACAD SCI USA, V109, P11588, DOI 10.1073/pnas.1205696109; Chhowalla M, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats2016.52; Cho S, 2015, SCIENCE, V349, P625, DOI 10.1126/science.aab3175; Choi HH, 2018, NAT MATER, V17, P2, DOI 10.1038/nmat5035; Chuang HJ, 2016, NANO LETT, V16, P1896, DOI 10.1021/acs.nanolett.5b05066; Collaert N, SEMICON TAIWAN; Cui X, 2017, NANO LETT, V17, P4781, DOI 10.1021/acs.nanolett.7b01536; Cui X, 2015, NAT NANOTECHNOL, V10, P534, DOI [10.1038/nnano.2015.70, 10.1038/NNANO.2015.70]; Desai SB, 2016, SCIENCE, V354, P99, DOI 10.1126/science.aah4698; Duan XD, 2016, NANO LETT, V16, P264, DOI 10.1021/acs.nanolett.5b03662; English CD, 2016, NANO LETT, V16, P3824, DOI 10.1021/acs.nanolett.6b01309; Farmer DB, 2009, NANO LETT, V9, P4474, DOI 10.1021/nl902788u; Ferain I, 2011, NATURE, V479, P310, DOI 10.1038/nature10676; Ferry DK, 2017, SEMICOND SCI TECH, V32, DOI 10.1088/1361-6641/aa7472; Frank DJ, 1998, IEEE ELECTR DEVICE L, V19, P385, DOI 10.1109/55.720194; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gonzalez JM, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.125443; Grundmann M, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-13884-3_1; Guo J, 2018, ADV MATER, V30, DOI 10.1002/adma.201705934; Hu CM, 2012, ECS TRANSACTIONS, V50, P17, DOI 10.1149/05009.0017ecst; Huang YT, 2018, ACS APPL MATER INTER, V10, P33450, DOI 10.1021/acsami.8b10576; Huyghebaert C, 2018, INT EL DEVICES MEET, DOI 10.1109/iedm.2018.8614679; International Roadmap Committee, 2015, INT TECHNOLOGY ROADM; Ionescu AM, 2011, NATURE, V479, P329, DOI 10.1038/nature10679; Iqbal MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep10699; Jariwala B, 2016, CHEM MATER, V28, P3352, DOI 10.1021/acs.chemmater.6b00364; Jena D, 2013, P IEEE, V101, P1585, DOI 10.1109/JPROC.2013.2253435; Jiang JK, 2018, IEEE SOI3DSUB MICRO; Jin ZH, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.045422; Jo I, 2013, NANO LETT, V13, P550, DOI 10.1021/nl304060g; Jung CS, 2015, ACS NANO, V9, P9585, DOI 10.1021/acsnano.5b04876; Jung Y, 2019, NAT ELECTRON, V2, P187, DOI 10.1038/s41928-019-0245-y; Kang K, 2017, NATURE, V550, P229, DOI 10.1038/nature23905; Kang K, 2015, NATURE, V520, P656, DOI 10.1038/nature14417; Kang P, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/aa8763; Kappera R, 2014, NAT MATER, V13, P1128, DOI [10.1038/nmat4080, 10.1038/NMAT4080]; Kasap S., 2017, SPRINGER HDB ELECT P; Kaushik N, 2017, NPJ 2D MATER APPL, V1, DOI 10.1038/s41699-017-0038-y; Kim HG, 2017, CHEM MATER, V29, P3809, DOI 10.1021/acs.chemmater.6b05103; Kim S, 2020, NAT NANOTECHNOL, V15, P203, DOI 10.1038/s41565-019-0623-7; Kiriya D, 2014, J AM CHEM SOC, V136, P7853, DOI 10.1021/ja5033327; Kong LG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15776-x; Kum HS, 2020, NATURE, V578, P75, DOI 10.1038/s41586-020-1939-z; Late DJ, 2012, ACS NANO, V6, P5635, DOI 10.1021/nn301572c; Lee JH, 2014, SCIENCE, V344, P286, DOI 10.1126/science.1252268; Lee JS, 2018, SCIENCE, V362, P817, DOI 10.1126/science.aau2132; Leong WS, 2015, ACS NANO, V9, P869, DOI 10.1021/nn506567r; Li HL, 2015, J AM CHEM SOC, V137, P5284, DOI 10.1021/jacs.5b01594; Li J, 2020, NATURE, V579, P368, DOI 10.1038/s41586-020-2098-y; Li JZ, 2019, ADV MATER, V31, DOI 10.1002/adma.201902431; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/NNANO.2014.35, 10.1038/nnano.2014.35]; Li W, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.23; Li WS, 2019, NAT ELECTRON, V2, P563, DOI 10.1038/s41928-019-0334-y; Li XF, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3194; Li XF, 2015, ADV MATER, V27, P1547, DOI 10.1002/adma.201405068; Liao L, 2010, NANO LETT, V10, P3952, DOI 10.1021/nl101724k; Liao L, 2010, NATURE, V467, P305, DOI 10.1038/nature09405; Liao L, 2010, P NATL ACAD SCI USA, V107, P6711, DOI 10.1073/pnas.0914117107; Lin YC, 2014, NAT NANOTECHNOL, V9, P391, DOI [10.1038/nnano.2014.64, 10.1038/NNANO.2014.64]; Liu C, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.034020; Liu H, 2012, ACS NANO, V6, P8563, DOI 10.1021/nn303513c; Liu W, 2013, NANO LETT, V13, P1983, DOI 10.1021/nl304777e; Liu Y, 2019, NATURE, V567, P323, DOI 10.1038/s41586-019-1013-x; Liu Y, 2018, CHEM SOC REV, V47, P6388, DOI 10.1039/c8cs00318a; Liu Y, 2018, NATURE, V557, P696, DOI 10.1038/s41586-018-0129-8; Liu Y, 2017, NANO LETT, V17, P5495, DOI 10.1021/acs.nanolett.7b02161; Liu Y, 2016, NANO LETT, V16, P6337, DOI 10.1021/acs.nanolett.6b02713; Liu Y, 2015, NANO LETT, V15, P3030, DOI 10.1021/nl504957p; Liu YY, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600069; Luisier M, 2019, 2019 IEEE INT EL DEV, P586; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; McClellan CJ, 2017, IEEE DEVICE RES CONF, DOI 10.1109/DRC.2017.7999392; Mleczko MJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700481; Nasr JR, 2019, ADV MATER, V31, DOI 10.1002/adma.201806020; Nathawat J, 2020, PHYS REV MATER, V4, DOI 10.1103/PhysRevMaterials.4.014002; Neumaier D, 2019, NAT MATER, V18, P525, DOI 10.1038/s41563-019-0359-7; Patel KA, 2020, 2D MATER, V7, DOI 10.1088/2053-1583/ab4ef0; Poljak M, 2012, IEEE T ELECTRON DEV, V59, P1636, DOI 10.1109/TED.2012.2189217; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Rhodes D, 2019, NAT MATER, V18, P541, DOI 10.1038/s41563-019-0366-8; Roy T, 2015, ACS NANO, V9, P2071, DOI 10.1021/nn507278b; Sachid AB, 2016, ADV MATER, V28, P2547, DOI 10.1002/adma.201505113; SAKAKI H, 1987, APPL PHYS LETT, V51, P1934, DOI 10.1063/1.98305; Sarkar D, 2015, NATURE, V526, P91, DOI 10.1038/nature15387; Schmidt M, 2009, SOLID STATE ELECTRON, V53, P1246, DOI 10.1016/j.sse.2009.09.017; Schram T, 2017, PROC EUR S-STATE DEV, P212, DOI 10.1109/ESSDERC.2017.8066629; Shim J, 2016, ADV MATER, V28, P6985, DOI 10.1002/adma.201601002; Shu JP, 2016, NANOSCALE, V8, P3049, DOI 10.1039/c5nr07336g; Singh J, 2018, IEEE T ELECTRON DEV, V65, P31, DOI 10.1109/TED.2017.2776838; Smets Q, 2019, INT EL DEVICES MEET, DOI 10.1109/IEDM19573.2019.8993650; Smithe KKH, 2018, NANO LETT, V18, P4516, DOI 10.1021/acs.nanolett.8b01692; Smithe KKH, 2017, ACS NANO, V11, P8456, DOI 10.1021/acsnano.7b04100; Smithe KKH, 2017, 2D MATER, V4, DOI 10.1088/2053-1583/4/1/011009; Sze S. M., 2006, PHYS SEMICONDUCTOR D; Tao L, 2015, NAT NANOTECHNOL, V10, P227, DOI [10.1038/nnano.2014.325, 10.1038/NNANO.2014.325]; Telford EJ, 2018, NANO LETT, V18, P1416, DOI 10.1021/acs.nanolett.7b05161; Uchida K, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P47, DOI 10.1109/IEDM.2002.1175776; Utama MIB, 2019, NAT ELECTRON, V2, P60, DOI 10.1038/s41928-019-0207-4; Tran V, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.235319; Waldrop MM, 2016, NATURE, V530, P144, DOI 10.1038/530144a; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang L, 2019, NATURE, V570, P91, DOI 10.1038/s41586-019-1226-z; Wang Y, 2019, NATURE, V568, P70, DOI 10.1038/s41586-019-1052-3; Wang YX, 2018, NAT ELECTRON, V1, P228, DOI 10.1038/s41928-018-0058-4; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307; Wu RX, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201806611; Xie LM, 2015, NANOSCALE, V7, P18392, DOI 10.1039/c5nr05712d; Yalon E, 2017, NANO LETT, V17, P3429, DOI 10.1021/acs.nanolett.7b00252; Yamoah MK, 2017, ACS NANO, V11, P9914, DOI 10.1021/acsnano.7b03878; Yan RS, 2015, NANO LETT, V15, P5791, DOI 10.1021/acs.nanolett.5b01792; Yang LM, 2014, NANO LETT, V14, P6275, DOI 10.1021/nl502603d; Yang SX, 2018, NANO RES, V11, P554, DOI 10.1007/s12274-017-1712-2; Yang SX, 2014, NANOSCALE, V6, P7226, DOI 10.1039/c4nr01741b; Yang Z, 2019, ADV MATER, V31, DOI 10.1002/adma.201808231; Yu H, 2017, ACS NANO, V11, P12001, DOI 10.1021/acsnano.7b03819; Yuan SF, 2018, NANO LETT, V18, P3172, DOI 10.1021/acs.nanolett.8b00835; Yun WS, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.033305; Zhang Q, 2019, NAT ELECTRON, V2, P164, DOI 10.1038/s41928-019-0233-2; Zhang XW, 2018, MATER HORIZ, V5, P1058, DOI 10.1039/c8mh01001c; Zhang ZP, 2019, ACS NANO, V13, P885, DOI 10.1021/acsnano.8b08677; Zhao QY, 2017, PHYS STATUS SOLIDI B, V254, DOI 10.1002/pssb.201700033; Zhao YD, 2017, ADV MATER, V29, DOI 10.1002/adma.201604230; Zhao YD, 2016, ADV MATER, V28, P2399, DOI 10.1002/adma.201504572; Zhong MZ, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201802581	141	194	195	186	608	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					43	53		10.1038/s41586-021-03339-z	http://dx.doi.org/10.1038/s41586-021-03339-z			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33658691				2022-12-28	WOS:000626921700010
J	Samae, V; Cordier, P; Demouchy, S; Bollinger, C; Gasc, J; Koizumi, S; Mussi, A; Schryvers, D; Idrissi, H				Samae, Vahid; Cordier, Patrick; Demouchy, Sylvie; Bollinger, Caroline; Gasc, Julien; Koizumi, Sanae; Mussi, Alexandre; Schryvers, Dominique; Idrissi, Hosni			Stress-induced amorphization triggers deformation in the lithospheric mantle	NATURE			English	Article								The mechanical properties of olivine-rich rocks are key to determining the mechanical coupling between Earth's lithosphere and asthenosphere. In crystalline materials, the motion of crystal defects is fundamental to plastic flow(1-4.) However, because the main constituent of olivine-rich rocks does not have enough slip systems, additional deformation mechanisms are needed to satisfy strain conditions. Experimental studies have suggested a non-Newtonian, grain-size-sensitive mechanism in olivine involving grain-boundary sliding(5,6). However, very few microstructural investigations have been conducted on grain-boundary sliding, and there is no consensus on whether a single or multiple physical mechanisms are at play. Most importantly, there are no theoretical frameworks for incorporating the mechanics of grain boundaries in polycrystalline plasticity models. Here we identify a mechanism for deformation at grain boundaries in olivine-rich rocks. We show that, in forsterite, amorphization takes place at grain boundaries under stress and that the onset of ductility of olivine-rich rocks is due to the activation of grain-boundary mobility in these amorphous layers. This mechanism could trigger plastic processes in the deep Earth, where high-stress conditions are encountered (for example, at the brittle-plastic transition). Our proposed mechanism is especially relevant at the lithosphere-asthenosphere boundary, where olivine reaches the glass transition temperature, triggering a decrease in its viscosity and thus promoting grain-boundary sliding.	[Samae, Vahid; Schryvers, Dominique; Idrissi, Hosni] Univ Antwerp, Elect Microscopy Mat Sci, Antwerp, Belgium; [Cordier, Patrick; Mussi, Alexandre] Univ Lille, Unite Mat & Transformat, Centrale Lille, CNRS,INRAE,UMR 8207,UMET, Lille, France; [Cordier, Patrick] Inst Univ France, Paris, France; [Demouchy, Sylvie; Gasc, Julien] Univ Montpellier, CNRS, Geosci Montpellier, UMR, Montpellier, France; [Bollinger, Caroline] Univ Bayreuth, Bayer Geoinst, Bayreuth, Germany; [Koizumi, Sanae] Univ Tokyo, Earthquake Res Inst, Tokyo, Japan; [Idrissi, Hosni] Catholic Univ Louvain, Inst Mech Mat & Civil Engn, Louvain La Neuve, Belgium; [Bollinger, Caroline] Univ Toulouse, CNRS, CNES, UPS,IRAP, Toulouse, France; [Gasc, Julien] Ecole Normale Super, CNRS, Lab Geol, UMR8538, Paris, France	University of Antwerp; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); INRAE; Universite de Lille - ISITE; Centrale Lille; Universite de Lille; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Bayreuth; University of Tokyo; Universite Catholique Louvain; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Cordier, P (corresponding author), Univ Lille, Unite Mat & Transformat, Centrale Lille, CNRS,INRAE,UMR 8207,UMET, Lille, France.; Cordier, P (corresponding author), Inst Univ France, Paris, France.	patrick.cordier@univ-lille.fr	Schryvers, Nick/ABA-9708-2021; DEMOUCHY, sylvie/A-2502-2009; Cordier, Patrick/D-2357-2012; MUSSI, Alexandre/N-9476-2013; Gasc, Julien/Q-2688-2018	DEMOUCHY, sylvie/0000-0001-5023-4655; Cordier, Patrick/0000-0002-1883-2994; MUSSI, Alexandre/0000-0003-2093-0144; Koizumi, Sanae/0000-0003-4680-2482; Gasc, Julien/0000-0003-4914-5289; Schryvers, Dominique/0000-0001-9242-7375; Samaee, Vahid/0000-0003-1351-2147	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [787198]; Conseil Regional du Nord-Pas de Calais; European Regional Development Fund (ERDF); Agence Nationale de la Recherche through the ANR INDIGO grant [ANR-14-CE33-0011]; JSPS KAKENHI grant [JP18K03799]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Conseil Regional du Nord-Pas de Calais(Region Hauts-de-FranceRegion Ile-de-France); European Regional Development Fund (ERDF)(European Commission); Agence Nationale de la Recherche through the ANR INDIGO grant(French National Research Agency (ANR)); JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We acknowledge funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement number 787198 -TimeMan. The TEM facility in Lille is supported by the Conseil Regional du Nord-Pas de Calais and the European Regional Development Fund (ERDF). H.I. is mandated by the Belgian National Fund for Scientific Research (FSR-FNRS). This study was partially supported by the Agence Nationale de la Recherche through the ANR INDIGO grant (ANR-14-CE33-0011) for the low-pressure experiments, by the German Alexander von Humboldt Foundation and the Free State of Bavaria for the high-pressure experiments, and by the JSPS KAKENHI grant (number JP18K03799) to S.K. and cooperative research program of the Earthquake Research Institute, Tokyo.	ANDRAULT D, 1995, PHYS CHEM MINER, V22, P99, DOI 10.1007/BF00202469; ASHBY MF, 1972, SURF SCI, V31, P498, DOI 10.1016/0039-6028(72)90273-7; ASHBY MF, 1978, PHILOS T R SOC A, V288, P59, DOI 10.1098/rsta.1978.0006; Barrell J, 1914, J GEOL, V22, P28, DOI 10.1086/622131; Ben Ismail W, 1998, TECTONOPHYSICS, V296, P145; Boioli F, 2015, EARTH PLANET SC LETT, V432, P232, DOI 10.1016/j.epsl.2015.10.012; Bollinger C, 2019, AM MINERAL, V104, P220, DOI 10.2138/am-2019-6629; BOLLMANN W., 1970, CRYSTAL DEFECTS CRYS; Burnley PC, 2019, AM MINERAL, V104, P276, DOI 10.2138/am-2019-6666; CARTER NL, 1970, GEOL SOC AM BULL, V81, P2181, DOI 10.1130/0016-7606(1970)81[2181:HTFODA]2.0.CO;2; CHEN CH, 1975, AM MINERAL, V60, P398; CLIFF G, 1975, J MICROSC-OXFORD, V103, P203, DOI 10.1111/j.1365-2818.1975.tb03895.x; Cooper RF, 2002, REV MINERAL GEOCHEM, V51, P253, DOI 10.2138/gsrmg.51.1.253; Cordier P, 2014, NATURE, V507, P51, DOI 10.1038/nature13043; Couvy H, 2004, EUR J MINERAL, V16, P877, DOI 10.1127/0935-1221/2004/0016-0877; Dupas-Bruzek C, 1998, PHYS CHEM MINER, V25, P501, DOI 10.1007/s002690050142; Eaton DW, 2009, LITHOS, V109, P1, DOI 10.1016/j.lithos.2008.05.009; Fei HZ, 2012, EARTH PLANET SC LETT, V345, P95, DOI 10.1016/j.epsl.2012.06.044; Fischer KM, 2010, ANNU REV EARTH PL SC, V38, P551, DOI 10.1146/annurev-earth-040809-152438; Fryer DS, 2000, MACROMOLECULES, V33, P6439, DOI 10.1021/ma0003349; Gaillard F, 2008, SCIENCE, V322, P1363, DOI 10.1126/science.1164446; Gasc J, 2019, TECTONOPHYSICS, V761, P16, DOI 10.1016/j.tecto.2019.04.009; Gasparik T., 2003, PHASE DIAGRAMS GEOLO, V462; Gouriet K, 2019, MINERALS-BASEL, V9, DOI 10.3390/min9120787; Green DH, 2010, NATURE, V467, P448, DOI 10.1038/nature09369; Guignard J, 2011, EUR J MINERAL, V23, P323, DOI 10.1127/0935-1221/2011/0023-2099; Guo DZ, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.145504; Hiraga T, 2010, NATURE, V468, P1091, DOI 10.1038/nature09685; HIRTH G, 1995, J GEOPHYS RES-SOL EA, V100, P15441, DOI 10.1029/95JB01292; Hirth JP, 2020, P NATL ACAD SCI USA, V117, P196, DOI 10.1073/pnas.1915140117; Jackson I, 2014, PHYS EARTH PLANET IN, V228, P203, DOI 10.1016/j.pepi.2013.11.014; JEANLOZ R, 1977, SCIENCE, V197, P457, DOI 10.1126/science.197.4302.457; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; KE TS, 1947, PHYS REV, V71, P533, DOI 10.1103/PhysRev.71.533; Keblinski P, 1996, PHYS REV LETT, V77, P2965, DOI 10.1103/PhysRevLett.77.2965; Kneller EA, 2005, EARTH PLANET SC LETT, V237, P781, DOI 10.1016/j.epsl.2005.06.049; KOCKS UF, 1975, PROG MATER SCI, V19, P1; Koizumi S, 2010, PHYS CHEM MINER, V37, P505, DOI 10.1007/s00269-009-0350-y; Kranjc K, 2020, J GEOPHYS RES-SOL EA, V125, DOI 10.1029/2019JB019242; LACAM A, 1980, NATURE, V288, P155, DOI 10.1038/288155a0; LANGDON TG, 1972, METALL TRANS, V3, P797, DOI 10.1007/BF02647651; Mainprice D, 2005, NATURE, V433, P731, DOI 10.1038/nature03266; Manthilake MAGM, 2012, HIGH PRESSURE RES, V32, P195, DOI 10.1080/08957959.2012.680450; Marquardt K, 2018, PHYS CHEM MINER, V45, P139, DOI 10.1007/s00269-017-0935-9; Maruyama G, 2017, J GEOPHYS RES-SOL EA, V122, P5890, DOI 10.1002/2017JB014254; Masuda H, 2016, ACTA MATER, V120, P205, DOI 10.1016/j.actamat.2016.08.034; McKenzie D, 2005, EARTH PLANET SC LETT, V233, P337, DOI 10.1016/j.epsl.2005.02.005; Mei S, 2000, J GEOPHYS RES-SOL EA, V105, P21457, DOI 10.1029/2000JB900179; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; Nakamura K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.059903; Nakamura K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184109; O'Reilly SY, 2010, LITHOS, V120, P1, DOI 10.1016/j.lithos.2010.03.016; Ohuchi T, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500360; Paterson M. S., 1990, GEOPHYS MONOGR SER, P187, DOI DOI 10.1029/GM056P0187; POLLACK HN, 1977, TECTONOPHYSICS, V38, P279, DOI 10.1016/0040-1951(77)90215-3; Pollitz FF, 2019, PHYS EARTH PLANET IN, V293, DOI 10.1016/j.pepi.2019.106271; RAJ R, 1971, METALL TRANS, V2, P1113, DOI 10.1007/BF02664244; RALEIGH CB, 1968, J GEOPHYS RES, V73, P5391, DOI 10.1029/JB073i016p05391; READ WT, 1950, PHYS REV, V78, P275, DOI 10.1103/PhysRev.78.275; RICHET P, 1993, GEOPHYS RES LETT, V20, P1675, DOI 10.1029/93GL01836; Rosner H, 2014, ULTRAMICROSCOPY, V142, P1, DOI 10.1016/j.ultramic.2014.03.006; Rosenhain W, 1912, J I MET, V8, P149; Sakamaki T, 2013, NAT GEOSCI, V6, P1041, DOI [10.1038/NGEO1982, 10.1038/ngeo1982]; Schneibel J.H., 1982, STRENGTH METALS ALLO, P649; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; Tasaka M, 2013, J GEOPHYS RES-SOL EA, V118, P3991, DOI 10.1002/jgrb.50284; Taupin V, 2013, J MECH PHYS SOLIDS, V61, P370, DOI 10.1016/j.jmps.2012.10.001; Thieme M, 2018, PHYS EARTH PLANET IN, V278, P34, DOI 10.1016/j.pepi.2018.03.002; VANCAPPELLEN E, 1994, ULTRAMICROSCOPY, V53, P343, DOI 10.1016/0304-3991(94)90047-7; VASTAVA RB, 1979, ACTA METALL MATER, V27, P251, DOI 10.1016/0001-6160(79)90103-2; Volterra V., 1907, ANNLS SCIENT EC NORM, V24, P401; Wallis D, 2019, J GEOPHYS RES-SOL EA, V124, P6337, DOI 10.1029/2019JB017867; Wang Q, 2016, SCI CHINA EARTH SCI, V59, P1138, DOI 10.1007/s11430-016-5310-z; Warren JM, 2006, EARTH PLANET SC LETT, V248, P438, DOI 10.1016/j.epsl.2006.06.006; Watanabe T., 1982, P 6 INT C STRENGTH M, P671; Watts AB, 2000, GEOPHYS J INT, V142, P855, DOI 10.1046/j.1365-246x.2000.00189.x; Zhang Z, 2016, RSC ADV, V6, P12885, DOI 10.1039/c5ra25796d; Zoback M. L., 2007, TREATISE GEOPHYS, V6, P253	78	12	12	10	62	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					82	+		10.1038/s41586-021-03238-3	http://dx.doi.org/10.1038/s41586-021-03238-3			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QT9QO	33658696	Green Submitted			2022-12-28	WOS:000626921700014
J	Senthilingam, M				Senthilingam, Meera			Covid-19 has made the obesity epidemic worse, but failed to ignite enough action	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												meera.senthi@gmail.com						Department of Health and Social Care, 2020, POL PAP TACKL OB EMP; Department of Health and Social Care, 2020, RESTR PROM PROD HIGH; Food Safety and Standards Authority of India, 2020, FSSAI PROP 10 POINT; Sanchez-Romero LM, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1311; NCD Alliance, 2020, NEW REP DET 100S EX; Pellini R, 2021, INCREASED C REACTIVE, DOI [10.1101/2021.02.24.21251664, DOI 10.1101/2021.02.24.21251664]; Public Health England, 2020, EXC WEIGHT CAN INCR; Taylor L, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4952; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n623; World Obesity Federation, OB COVID 19 POL STAT	10	21	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n411	10.1136/bmj.n411	http://dx.doi.org/10.1136/bmj.n411			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664084	Bronze			2022-12-28	WOS:000632920100004
J	Wong, F; Pappas, SC; Curry, MP; Reddy, KR; Rubin, RA; Porayko, MK; Gonzalez, SA; Mumtaz, K; Lim, N; Simonetto, DA; Sharma, P; Sanyal, AJ; Mayo, MJ; Frederick, RT; Escalante, S; Jamil, K				Wong, F.; Pappas, S. C.; Curry, M. P.; Reddy, K. R.; Rubin, R. A.; Porayko, M. K.; Gonzalez, S. A.; Mumtaz, K.; Lim, N.; Simonetto, D. A.; Sharma, P.; Sanyal, A. J.; Mayo, M. J.; Frederick, R. T.; Escalante, S.; Jamil, K.		CONFIRM Study Investigators	Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE KIDNEY INJURY; COMPARATIVE EFFICACY; CIRRHOSIS; MANAGEMENT; DYSFUNCTION; DIAGNOSIS; REVERSAL; TRIAL	BACKGROUND The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1) in many parts of the world and is part of the clinical practice guidelines in Europe. METHODS We conducted a phase 3 trial to confirm the efficacy and safety of terlipressin plus albumin in adults with HRS-1. The patients were randomly assigned in a 2:1 ratio to receive terlipressin or placebo for up to 14 days; in both groups, concomitant use of albumin was strongly recommended. The primary end point was verified reversal of HRS, defined as two consecutive serum creatinine measurements of 1.5 mg per deciliter or less at least 2 hours apart and survival without renal-replacement therapy for at least 10 days after the completion of treatment. Four prespecified secondary end points were analyzed with the Hochberg procedure to account for multiple comparisons. RESULTS A total of 300 patients underwent randomization - 199 were assigned to the terlipressin group and 101 to the placebo group. Verified reversal of HRS was reported in 63 patients (32%) in the terlipressin group and 17 patients (17%) in the placebo group (P = 0.006). With respect to the prespecified secondary end points, HRS reversal, defined as any serum creatinine level of 1.5 mg per deciliter or less during the first 14 days, was reported in 78 patients (39%) in the terlipressin group and 18 (18%) in the placebo group (P<0.001); HRS reversal without renal-replacement therapy by day 30, in 68 (34%) and 17 (17%), respectively (P = 0.001); HRS reversal among patients with systemic inflammatory response syndrome (84 patients in the terlipressin group and 48 patients in the placebo group), in 31 (37%) and 3 (6%), respectively (P<0.001); and verified reversal of HRS without recurrence by day 30, in 52 (26%) and 17 (17%), respectively (P = 0.08). At day 90, liver transplantations had been performed in 46 patients (23%) in the terlipressin group and 29 patients (29%) in the placebo group, and death occurred in 101 (51%) and 45 (45%), respectively. More adverse events, including abdominal pain, nausea, diarrhea, and respiratory failure, occurred with terlipressin than with placebo. Death within 90 days due to respiratory disorders occurred in 22 patients (11%) in the terlipressin group and 2 patients (2%) in the placebo group. CONCLUSIONS In this trial involving adults with cirrhosis and HRS-1, terlipressin was more effective than placebo in improving renal function but was associated with serious adverse events, including respiratory failure. (Funded by Mallinckrodt Pharmaceuticals; CONFIRM ClinicalTrials.gov number, NCT02770716.)	[Wong, F.] Univ Toronto, Dept Med, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada; [Pappas, S. C.; Escalante, S.; Jamil, K.] Orphan Therapeut, Annandale, NJ USA; [Pappas, S. C.; Escalante, S.; Jamil, K.] Mallinckrodt Pharmaceut, Bedminster, NJ USA; [Curry, M. P.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Reddy, K. R.] Univ Penn, Philadelphia, PA 19104 USA; [Rubin, R. A.] Piedmont Healthcare, Piedmont Transplant Inst, Atlanta, GA USA; [Porayko, M. K.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Gonzalez, S. A.] Baylor Scott & White All Saints Med Ctr, Dept Med, Ft Worth, TX USA; [Mayo, M. J.] Univ Texas Southwestern Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Mumtaz, K.] Ohio State Univ, Columbus, OH 43210 USA; [Lim, N.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Simonetto, D. A.] Mayo Clin, Dept Med, Rochester, MN USA; [Sharma, P.] Univ Michigan, Med Ctr, Dept Med, Ann Arbor, MI 48109 USA; [Sanyal, A. J.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Frederick, R. T.] Calif Pacific Med Ctr, Hepatol & Liver Transplantat, San Francisco, CA USA	University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; University of Pennsylvania; Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; University of Michigan System; University of Michigan; Virginia Commonwealth University; California Pacific Medical Center	Wong, F (corresponding author), Univ Toronto, Dept Med, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	florence.wong@utoronto.ca		Lim, Nicholas/0000-0001-9740-8923	Mallinckrodt Pharmaceuticals	Mallinckrodt Pharmaceuticals	Supported by Mallinckrodt Pharmaceuticals.	Adebayo D, 2015, KIDNEY INT, V87, P509, DOI 10.1038/ki.2014.338; Allegretti AS, 2018, CLIN J AM SOC NEPHRO, V13, P16, DOI 10.2215/CJN.03610417; Angeli P, 2015, J HEPATOL, V62, P968, DOI 10.1016/j.jhep.2014.12.029; Boyer TD, 2016, GASTROENTEROLOGY, V150, P1579, DOI 10.1053/j.gastro.2016.02.026; Cavallin M, 2015, HEPATOLOGY, V62, P567, DOI 10.1002/hep.27709; Devarakonda, 2017, J EXP PHARM, V1, P2; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Facciorusso A, 2017, LANCET GASTROENTEROL, V2, P94, DOI 10.1016/S2468-1253(16)30157-1; Food and Drug Administration, 2018, SPEC PROT ASS GUID I; Gines P, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0022-7; Gluud LL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005162.pub3; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Hiremath SB, 2013, INDIAN J PHARMACOL, V45, P54, DOI 10.4103/0253-7613.106436; Israelsen M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011532.pub2; Jamil K, 2019, OPEN ACCESS J CLIN T, V11, P67, DOI 10.2147/OAJCT.S224974; Kalambokis GN, 2012, HEPATOB PANCREAT DIS, V11, P434, DOI 10.1016/S1499-3872(12)60204-5; Kiszka-Kanowitz M, 2004, SCAND J GASTROENTERO, V39, P486, DOI 10.1080/00365520310008728; Krag A, 2010, EUR J GASTROEN HEPAT, V22, P1085, DOI 10.1097/MEG.0b013e32833a4822; Martin-Llahi M, 2008, GASTROENTEROLOGY, V134, P1352, DOI 10.1053/j.gastro.2008.02.024; Mindikoglu AL, 2018, CLIN GASTROENTEROL H, V16, P162, DOI 10.1016/j.cgh.2017.05.041; Mukhtar A, 2011, CRIT CARE MED, V39, P1329, DOI 10.1097/CCM.0b013e3182120842; Narahara Y, 2012, J GASTROENTEROL, V47, P313, DOI 10.1007/s00535-011-0485-8; Narahara Y, 2009, J GASTROEN HEPATOL, V24, P1791, DOI 10.1111/j.1440-1746.2009.05873.x; Papaluca T, 2018, J GASTROEN HEPATOL, V33, P591, DOI 10.1111/jgh.14009; Piano S, 2018, SEMIN LIVER DIS, V38, P230, DOI 10.1055/s-0038-1661372; Reiberger T, 2018, CLIN GASTROENTEROL H, V16, P1710, DOI 10.1016/j.cgh.2018.04.020; Rodriguez E, 2014, J HEPATOL, V60, P955, DOI 10.1016/j.jhep.2013.12.032; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Sanyal AJ, 2017, ALIMENT PHARM THER, V45, P1390, DOI 10.1111/apt.14052; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1360, DOI 10.1053/j.gastro.2008.02.014; Wang HQ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010431; Wong F, 2017, CLIN GASTROENTEROL H, V15, P266, DOI 10.1016/j.cgh.2016.07.016; Zheng JN, 2017, EXPERT REV GASTROENT, V11, P1009, DOI 10.1080/17474124.2017.1356223	34	75	76	3	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					818	828		10.1056/NEJMoa2008290	http://dx.doi.org/10.1056/NEJMoa2008290			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS8DS	33657294	Bronze			2022-12-28	WOS:000626124800017
J	Chen, WT; Wang, RS; Yuan, DF; Zhao, HL; Luo, C; Tan, YX; Li, SH; Zhang, DH; Wang, XG; Sun, ZG; Yang, XM				Chen, Wentao; Wang, Ransheng; Yuan, Daofu; Zhao, Hailin; Luo, Chang; Tan, Yuxin; Li, Shihao; Zhang, Dong H.; Wang, Xingan; Sun, Zhigang; Yang, Xueming			Quantum interference between spin-orbit split partial waves in the F plus HD -> HF plus D reaction	SCIENCE			English	Article								The effect of electron spin-orbit interactions on chemical reaction dynamics has been a topic of much research interest. Here we report a combined experimental and theoretical study on the effect of electron spin and orbital angular momentum in the F + HD -> HF + D reaction. Using a high-resolution imaging technique, we observed a peculiar horseshoe-shaped pattern in the product rotational-state-resolved differential cross sections around the forward-scattering direction. The unusual dynamics pattern could only be explained properly by highly accurate quantum dynamics theory when full spin-orbit characteristics were considered. Theoretical analysis revealed that the horseshoe pattern was largely the result of quantum interference between spin-orbit split-partial-wave resonances with positive and negative parities, providing a distinctive example of how spin-orbit interaction can effectively influence reaction dynamics.	[Chen, Wentao; Yuan, Daofu; Luo, Chang; Tan, Yuxin; Li, Shihao; Wang, Xingan] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Chen, Wentao; Yuan, Daofu; Luo, Chang; Tan, Yuxin; Li, Shihao; Wang, Xingan] Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Peoples R China; [Wang, Ransheng; Zhao, Hailin; Zhang, Dong H.; Sun, Zhigang; Yang, Xueming] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China; [Yang, Xueming] Southern Univ Sci & Technol, Coll Sci, Dept Chem, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Southern University of Science & Technology	Wang, XG (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China.; Wang, XG (corresponding author), Univ Sci & Technol China, Dept Chem Phys, Hefei 230026, Peoples R China.; Sun, ZG; Yang, XM (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Mol React Dynam, Dalian 116023, Peoples R China.; Yang, XM (corresponding author), Southern Univ Sci & Technol, Coll Sci, Dept Chem, Shenzhen 518055, Peoples R China.	xawang@ustc.edu.cn; zsun@dicp.ac.cn; xmyang@dicp.ac.cn	Yang, Xueming/C-8764-2013; Yuan, Daofu/ABB-9092-2020	Yuan, Daofu/0000-0001-8461-6889; Zhang, DongHui/0000-0001-9426-8822; Luo, Chang/0000-0001-9118-5618; Wang, Ransheng/0000-0003-1571-1166; Sun, Zhigang/0000-0002-6600-4923; Li, Shihao/0000-0002-4427-843X; Zhao, Hailin/0000-0002-6636-3432	National Key R&D Program of China [2016YFF0200500]; National Natural Science Foundation of China [21688102, 21590800, 21733006, 21825303, 21327901]; Chinese Academy of Sciences [XDB 17010000]; Ministry of Science and Technology	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Key R&D Program of China (no. 2016YFF0200500), National Natural Science Foundation of China (nos. 21688102, 21590800, 21733006, 21825303, and 21327901), Chinese Academy of Sciences (grant no. XDB 17010000), and Ministry of Science and Technology.	Alexander MH, 2004, J CHEM PHYS, V121, P5221, DOI 10.1063/1.1779574; Alexander MH, 2002, SCIENCE, V296, P715, DOI 10.1126/science.1070472; Alexander MH, 2000, J CHEM PHYS, V113, P11084, DOI 10.1063/1.1326850; Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; AOIZ FJ, 1994, CHEM PHYS LETT, V223, P215, DOI 10.1016/0009-2614(94)00435-8; Castillo JF, 1996, J CHEM PHYS, V104, P6531, DOI 10.1063/1.471373; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; Chen J, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4904546; Chen W., 2021, **DROPPED REF**, DOI [10.5061/dryad.2547d7wpr, DOI 10.5061/DRYAD.2547D7WPR]; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Durr HA, 1997, SCIENCE, V277, P213, DOI 10.1126/science.277.5323.213; Eyles CJ, 2011, NAT CHEM, V3, P597, DOI [10.1038/nchem.1071, 10.1038/NCHEM.1071]; HILBIG R, 1982, APPL OPTICS, V21, P913, DOI 10.1364/AO.21.000913; Jambrina PG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13439; Kakkar, 2015, ATOMIC MOL SPECTROSC, DOI 10.1017/CBO9781107479999; Kim JB, 2015, SCIENCE, V349, P510, DOI 10.1126/science.aac6939; Lefebvre-Brion H., 2004, SPECTRA DYNAMICS DIA; Lin JJ, 2003, REV SCI INSTRUM, V74, P2495, DOI 10.1063/1.1561604; Lique F, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3603453; MANOLOPOULOS DE, 1993, SCIENCE, V262, P1852, DOI 10.1126/science.262.5141.1852; Mellnik AR, 2014, NATURE, V511, P449, DOI 10.1038/nature13534; NEUMARK DM, 1984, PHYS REV LETT, V53, P226, DOI 10.1103/PhysRevLett.53.226; Peng T, 1996, J CHEM PHYS, V105, P6072, DOI 10.1063/1.472444; Qiu MH, 2006, SCIENCE, V311, P1440, DOI 10.1126/science.1123452; Ren ZF, 2008, P NATL ACAD SCI USA, V105, P12662, DOI 10.1073/pnas.0709974105; SCHATZ GC, 1973, J CHEM PHYS, V58, P4023, DOI 10.1063/1.1679760; Skodje RT, 2000, PHYS REV LETT, V85, P1206, DOI 10.1103/PhysRevLett.85.1206; Sun ZG, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3290946; TULLY JC, 1974, J CHEM PHYS, V60, P3042, DOI 10.1063/1.1681488; Uhlenbeck G. E., 1925, NATURWISSENSCHAFTEN, V13, P953, DOI [DOI 10.1007/BF01558878, 10.1007/BF01558878]; Wang T, 2018, CHEM SOC REV, V47, P6744, DOI 10.1039/c8cs00041g; Wang XG, 2008, SCIENCE, V322, P573, DOI 10.1126/science.1163195; Wang XG, 2008, P NATL ACAD SCI USA, V105, P6227, DOI 10.1073/pnas.0710840105; WU SF, 1973, MOL PHYS, V25, P839, DOI 10.1080/00268977300100731; Wunderlich J, 2010, SCIENCE, V330, P1801, DOI 10.1126/science.1195816; Xu CX, 2006, CHINESE J CHEM PHYS, V19, P96, DOI 10.1360/cjcp2006.19(2).96.3; Yang TG, 2019, NAT CHEM, V11, P744, DOI 10.1038/s41557-019-0280-3; Yu DQ, 2015, J PHYS CHEM A, V119, P12193, DOI 10.1021/acs.jpca.5b06153; Yu SR, 2015, J PHYS CHEM A, V119, P8090, DOI 10.1021/acs.jpca.5b04438; Yuan DF, 2018, SCIENCE, V362, P1289, DOI 10.1126/science.aav1356; Yuan DF, 2018, NAT CHEM, V10, P653, DOI 10.1038/s41557-018-0032-9; ZARE RN, 1973, J MOL SPECTROSC, V46, P37, DOI 10.1016/0022-2852(73)90025-8; Zhang D., 2021, **DATA OBJECT**, DOI [10.5061/dryad.2547d7wpr, DOI 10.5061/DRYAD.2547D7WPR]; Zhao HL, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5085651	44	8	8	22	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					936	+		10.1126/science.abf4205	http://dx.doi.org/10.1126/science.abf4205			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632844	Green Submitted			2022-12-28	WOS:000621813400041
J	Janiaud, P; Axfors, C; Schmitt, AM; Gloy, V; Ebrahimi, F; Hepprich, M; Smith, ER; Haber, NA; Khanna, N; Moher, D; Goodman, SN; Ioannidis, JPA; Hemkens, LG				Janiaud, Perrine; Axfors, Cathrine; Schmitt, Andreas M.; Gloy, Viktoria; Ebrahimi, Fahim; Hepprich, Matthias; Smith, Emily R.; Haber, Noah A.; Khanna, Nina; Moher, David; Goodman, Steven N.; Ioannidis, John P. A.; Hemkens, Lars G.			Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19 A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HETEROGENEITY	IMPORTANCE Convalescent plasma is a proposed treatment for COVID-19. OBJECTIVE To assess clinical outcomes with convalescent plasma treatment vs placebo or standard of care in peer-reviewed and preprint publications or press releases of randomized clinical trials (RCTs). DATA SOURCES PubMed, the Cochrane COVID-19 trial registry, and the Living Overview of Evidence platform were searched until January 29, 2021. STUDY SELECTION The RCTs selected compared any type of convalescent plasma vs placebo or standard of care for patients with confirmed or suspected COVID-19 in any treatment setting. DATA EXTRACTION AND SYNTHESIS Two reviewers independently extracted data on relevant clinical outcomes, trial characteristics, and patient characteristics and used the Cochrane Risk of Bias Assessment Tool. The primary analysis included peer-reviewed publications of RCTs only, whereas the secondary analysis included all publicly available RCT data (peer-reviewed publications, preprints, and press releases). Inverse variance-weighted meta-analyses were conducted to summarize the treatment effects. The certainty of the evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation. MAIN OUTCOMES AND MEASURES All-cause mortality, length of hospital stay, clinical improvement, clinical deterioration, mechanical ventilation use, and serious adverse events. RESULTS A total of 1060 patients from 4 peer-reviewed RCTs and 10 722 patients from 6 other publicly available RCTs were included. The summary risk ratio (RR) for all-cause mortality with convalescent plasma in the 4 peer-reviewed RCTs was 0.93 (95% CI, 0.63 to 1.38), the absolute risk difference was -1.21% (95% CI, -5.29% to 2.88%), and there was low certainty of the evidence due to imprecision. Across all 10 RCTs, the summary RR was 1.02 (95% CI, 0.92 to 1.12) and there was moderate certainty of the evidence due to inclusion of unpublished data. Among the peer-reviewed RCTs, the summary hazard ratio was 1.17 (95% CI, 0.07 to 20.34) for length of hospital stay, the summary RR was 0.76 (95% CI, 0.20 to 2.87) for mechanical ventilation use (the absolute risk difference for mechanical ventilation use was -2.56%[95% CI, -13.16% to 8.05%]), and there was low certainty of the evidence due to imprecision for both outcomes. Limited data on clinical improvement, clinical deterioration, and serious adverse events showed no significant differences. CONCLUSIONS AND RELEVANCE Treatment with convalescent plasma compared with placebo or standard of care was not significantly associated with a decrease in all-cause mortality or with any benefit for other clinical outcomes. The certainty of the evidence was low to moderate for all-cause mortality and low for other outcomes.	[Janiaud, Perrine; Schmitt, Andreas M.; Gloy, Viktoria; Hemkens, Lars G.] Univ Basel, Univ Hosp Basel, Dept Clin Res, Basel, Switzerland; [Axfors, Cathrine; Haber, Noah A.; Goodman, Steven N.; Ioannidis, John P. A.; Hemkens, Lars G.] Stanford Univ, Meta Res Innovat Ctr Stanford, Stanford, CA 94305 USA; [Axfors, Cathrine] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Schmitt, Andreas M.] Univ Basel, Dept Med Oncol, Basel, Switzerland; [Ebrahimi, Fahim] Univ Ctr Gastrointestinal & Liver Dis, Dept Gastroenterol & Hepatol, Basel, Switzerland; [Hepprich, Matthias] Univ Hosp Basel, Clin Endocrinol Diabet & Metab, Basel, Switzerland; [Hepprich, Matthias] Cantonal Hosp Olten, Clin Endocrine & Metab Disorders, Olten, Switzerland; [Smith, Emily R.] George Washington Univ, Dept Global Hlth, Milken Inst, Sch Publ Hlth, Washington, DC USA; [Khanna, Nina] Univ Basel, Univ Hosp Basel, Div Infect Dis, Basel, Switzerland; [Khanna, Nina] Univ Basel, Univ Hosp Basel, Hosp Hyg & Infect Biol Lab, Basel, Switzerland; [Moher, David] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada; [Goodman, Steven N.; Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Goodman, Steven N.; Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.; Hemkens, Lars G.] Berlin Inst Hlth, Meta Res Innovat Ctr Berlin, Berlin, Germany	University of Basel; Stanford University; Uppsala University; University of Basel; University of Basel; Kantonsspital Olten; George Washington University; University of Basel; University of Basel; University of Ottawa; Ottawa Hospital Research Institute; Stanford University; Stanford University; Stanford University; Stanford University; Berlin Institute of Health	Hemkens, LG (corresponding author), Univ Hosp Basel, Dept Clin Res, Spitalstr 12, CH-4031 Basel, Switzerland.	lars.hemkens@usb.ch	Khanna, Nina/AAL-7648-2021; Schmitt, Andreas M/AAB-3328-2020; Ioannidis, John P. A./G-9836-2011	Schmitt, Andreas M/0000-0002-9568-8164; Hepprich, Matthias/0000-0002-6905-6235; Haber, Noah/0000-0002-5672-1769; Goodman, Steven/0000-0002-3872-5723	Laura and John Arnold Foundation; Knut and Alice Wallenberg Foundation; Swedish Society of Medicine; Blanceflor Foundation; Sweden-America Foundation; Swiss National Science Foundation; National Center of Competence in Research; Uppsala University	Laura and John Arnold Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Society of Medicine; Blanceflor Foundation; Sweden-America Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research(Swiss National Science Foundation (SNSF)); Uppsala University	TheMeta-Research Innovation Center at Stanford (Stanford University) is supported by a grant from the Laura and John Arnold Foundation. Dr Axfors is supported by postdoctoral grants from the Knut and Alice Wallenberg Foundation, Uppsala University, the Swedish Society of Medicine, the Blanceflor Foundation, and the Sweden-America Foundation. Dr Khanna is supported by the Swiss National Science Foundation and the National Center of Competence in Research. Drs Janiaud and Hemkens are supported by grants from Swiss National Science Foundation.	Agarwal A, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3939; AlQahtani M., MEDRXIV, DOI 10.1101/2020.11.02.20224303; Avendano-Sola C., 2020, CONVALESCENT PLASMA, DOI [https://doi.org/10.1101/2020.08.26.20182444, 10.1101/2020.08.26.20182444, DOI 10.1101/2020.08.26.20182444]; Bajpai M., 2020, PREPRINT, DOI [10.25.20219337, 10.1101/2020.10.25.20219337, DOI 10.1101/2020.10.25.20219337]; Gharbharan A., CNVALESCENT PLASMA C, DOI 10.1101/2020.07.01.20139857; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horby P, 2020, NEW ENGL J MED, DOI [10.1101/2020.06.22.20137273:24, DOI 10.1056/NEJMOA2021436, 10.1101/2020.06.22.20137273, 10.1101/2020.06.22.20137273v1, DOI 10.1101/2020.07.15.20151852]; Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4; Horby PW., MEDRXIV, DOI 10.1101/2020.12.10.20245944; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Joyner MJ, 2020, MAYO CLIN PROC, V95, P1888, DOI 10.1016/j.mayocp.2020.06.028; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Langan D, 2017, RES SYNTH METHODS, V8, P181, DOI 10.1002/jrsm.1198; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; LIBSTER R, N ENGL J MED; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; PAGE M, PRISMA 2020 STATEMEN; Petkova E, 2020, JAMA-J AM MED ASSOC, V324, P543, DOI 10.1001/jama.2020.13042; Ray Y., 2020, INFECT DIS EXCEPT HI, V2020, p11.25.20237883, DOI 10.1101/2020.11.25.20237883; *RECOVERY COLL GRO, NEW ENGL J MED; RECOVERY Trial, RAND EV COVID 19 THE; Schmitt, 2020, COVID EVIDENCE LIVIN; SIMONOVICH V, N ENGL J MED; US Food and Drug Administration, 2020, FDA ISS EM US AUTH C; Zarin DA, 2021, CLIN TRIALS, V18, P263, DOI 10.1177/1740774520972082	28	136	138	5	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2021	325	12					1185	1195		10.1001/jama.2021.2747	http://dx.doi.org/10.1001/jama.2021.2747		FEB 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7PB	33635310	Green Published, Bronze			2022-12-28	WOS:000621913000003
J	Wong, JP; Damania, B				Wong, Jason P.; Damania, Blossom			SARS-CoV-2 dependence on host pathways	SCIENCE			English	Editorial Material							TRANSLATION		[Wong, Jason P.; Damania, Blossom] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Wong, Jason P.; Damania, Blossom] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Damania, B (corresponding author), Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Damania, B (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	damania@med.unc.edu		Wong, Jason/0000-0002-0710-3112	National Institutes of Health [CA096500, CA254564, CA019014, CA163217, DE028211]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.P.W. and B.D. are supported by National Institutes of Health grants CA096500, CA254564,CA019014, CA163217, and DE028211.	Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Basta N., MCGILL COVID19 VACCI, V2021; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Jaafar ZA, 2019, NAT REV MICROBIOL, V17, P110, DOI 10.1038/s41579-018-0117-x; Laham-Karam N, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00276; Nakagawa K, 2016, ADV VIRUS RES, V96, P165, DOI 10.1016/bs.aivir.2016.08.001; Pruijssers Andrea J, 2020, bioRxiv, DOI 10.1101/2020.04.27.064279; Reuschl A-K., 2021, BIORXIV; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; White KM, 2021, SCIENCE, V371, P926, DOI 10.1126/science.abf4058	13	16	16	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					884	885		10.1126/science.abg6837	http://dx.doi.org/10.1126/science.abg6837			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632832				2022-12-28	WOS:000621813400022
J	Bouffard, MA; Chwalisz, BK; Romero, JM; Arrillaga-Romany, IC; Massoth, LR				Bouffard, Marc A.; Chwalisz, Bart K.; Romero, Javier M.; Arrillaga-Romany, Isabel C.; Massoth, Lucas R.			Case 6-2021: A 65-Year-Old Man with Eye Pain and Decreased Vision	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Bouffard, Marc A.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Chwalisz, Bart K.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Romero, Javier M.] Massachusetts Gen Hosp, Dept Radiol, 32 Fruit St, Boston, MA 02114 USA; [Arrillaga-Romany, Isabel C.] Massachusetts Gen Hosp, Dept Neurooncol, Boston, MA 02114 USA; [Massoth, Lucas R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Chwalisz, Bart K.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Romero, Javier M.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Arrillaga-Romany, Isabel C.] Harvard Med Sch, Dept Neurooncol, Boston, MA 02115 USA; [Massoth, Lucas R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bouffard, MA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.			Romero, Javier/0000-0001-5749-3000				Abeykoon JP, 2018, AM J HEMATOL, V93, P1384, DOI 10.1002/ajh.25254; Alexander P, 2008, EYE, V22, P1089, DOI 10.1038/eye.2008.193; ARNOLD AC, 1994, J NEURO-OPHTHALMOL, V14, P66; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; Cabannes-Hamy A, 2016, AM J HEMATOL, V91, pE17, DOI 10.1002/ajh.24279; Cacoub P, 2015, AM J MED, V128, P950, DOI 10.1016/j.amjmed.2015.02.017; Castillo JJ, 2019, BRIT J HAEMATOL, V187, P277, DOI 10.1111/bjh.16167; Castillo JJ, 2019, BLOOD, V133, P299, DOI 10.1182/blood-2018-10-879593; Castillo JJ, 2016, BRIT J HAEMATOL, V172, P709, DOI 10.1111/bjh.13883; Chen JJ, 2018, J NEURO-OPHTHALMOL, V38, P276, DOI 10.1097/WNO.0000000000000593; Chen JJ, 2018, AM J OPHTHALMOL, V195, P8, DOI 10.1016/j.ajo.2018.07.020; Cohen DA, 2020, OPHTHALMOLOGY, V127, P221, DOI 10.1016/j.ophtha.2019.09.012; Cross SA, 2003, ANN NEUROL, V54, P38, DOI 10.1002/ana.10587; Davis EJ, 2012, J OPHTHALMIC INFLAMM, V2, P183, DOI 10.1007/s12348-012-0079-5; Dinkin M, 2019, J NEURO-OPHTHALMOL, V39, P313, DOI 10.1097/WNO.0000000000000722; Doshi RR, 2011, J NEURO-OPHTHALMOL, V31, P94, DOI 10.1097/WNO.0b013e31820ecbc1; Ghinai RAM, 2017, J NEURO-OPHTHALMOL, V37, P34, DOI 10.1097/WNO.0000000000000447; Hayreh SS, 1998, AM J OPHTHALMOL, V125, P509, DOI 10.1016/S0002-9394(99)80192-5; Hughes MS, 2014, J NEURO-OPHTHALMOL, V34, P340, DOI 10.1097/WNO.0000000000000138; Jarius S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0718-0; KELTNER JL, 1993, ARCH OPHTHALMOL-CHIC, V111, P231, DOI 10.1001/archopht.1993.01090020085029; Keltner JL, 2014, INVEST OPHTH VIS SCI, V55, P3200, DOI 10.1167/iovs.14-14243; Kleiter I, 2016, ANN NEUROL, V79, P206, DOI 10.1002/ana.24554; Kunchok A, 2019, CURR OPIN NEUROL, V32, P452, DOI 10.1097/WCO.0000000000000676; Leleu X, 2009, J CLIN ONCOL, V27, P250, DOI 10.1200/JCO.2007.15.1530; Levin LA, 1996, SURV OPHTHALMOL, V41, P142, DOI 10.1016/S0039-6257(96)80004-X; Lin P, 2003, AM J SURG PATHOL, V27, P1104, DOI 10.1097/00000478-200308000-00007; Lin P, 2003, AM J CLIN PATHOL, V120, P246, DOI 10.1039/R01VXG46MFCDVNHL; Ly KI, 2011, CL LYMPH MYELOM LEUK, V11, P180, DOI 10.3816/CLML.2011.n.043; Mason C, 2017, BRIT J HAEMATOL, V179, P339, DOI 10.1111/bjh.14218; Merle H, 2012, ARCH OPHTHALMOL-CHIC, V130, P858, DOI 10.1001/archophthalmol.2012.1126; Minnema MC, 2017, HAEMATOLOGICA, V102, P43, DOI 10.3324/haematol.2016.147728; Myers KA, 2017, NEURO-ONCOL PRACT, V4, P60, DOI 10.1093/nop/npw006; O'Neil DS, 2018, CASE REP HEMATOL, V2018, DOI 10.1155/2018/8573105; Owen RG, 2003, SEMIN ONCOL, V30, P110, DOI 10.1053/sonc.2003.50082; Papais-Alvarenga RM, 2008, ARCH OPHTHALMOL-CHIC, V126, P12, DOI 10.1001/archophthalmol.2007.26; Rizzo JF, 2002, OPHTHALMOLOGY, V109, P1679, DOI 10.1016/S0161-6420(02)01148-X; Schlegel Uwe, 2009, Ther Adv Neurol Disord, V2, P93, DOI 10.1177/1756285608101222; Sepulveda M, 2018, MULT SCLER J, V24, P1753, DOI 10.1177/1352458517731914; Sivak-Callcott JA, 2004, BRIT J OPHTHALMOL, V88, P681, DOI 10.1136/bjo.2003.021725; Stacy RC, 2010, J NEURO-OPHTHALMOL, V30, P255, DOI 10.1097/WNO.0b013e3181dee96c; Storoni M, 2013, J NEURO-OPHTHALMOL, V33, P123, DOI 10.1097/WNO.0b013e318283c3ed; Swerdlow SH, 2017, WHO CLASSIFICATION T; Talmi YP, 2002, OTOLARYNG HEAD NECK, V127, P22, DOI 10.1067/mhn.2002.126587; Terrier B, 2013, MEDICINE, V92, P61, DOI 10.1097/MD.0b013e318288925c; THOMAS EL, 1983, BRIT J OPHTHALMOL, V67, P102, DOI 10.1136/bjo.67.2.102; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Treon SP, 2009, BLOOD, V114, P2375, DOI 10.1182/blood-2009-05-174359; Wall M, 1998, INVEST OPHTH VIS SCI, V39, P134; Wall M, 2019, INVEST OPHTH VIS SCI, V60, P1898, DOI 10.1167/iovs.18-26252; White D, 2019, J NEURO-OPHTHALMOL, V39, P411, DOI 10.1097/WNO.0000000000000842; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107	53	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					745	753		10.1056/NEJMcpc2027089	http://dx.doi.org/10.1056/NEJMcpc2027089			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP4LK	33626257				2022-12-28	WOS:000623807600014
J	Kuehn, BM				Kuehn, Bridget M.			COVID-19 Rates Increased Where In-Person College Classes Were Held	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					714	714		10.1001/jama.2021.0621	http://dx.doi.org/10.1001/jama.2021.0621			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620415	Bronze			2022-12-28	WOS:000621957400011
J	Tenforde, MW; Fisher, KA; Patel, MM				Tenforde, Mark W.; Fisher, Kiva A.; Patel, Manish M.			Identifying COVID-19 Risk Through Observational Studies to Inform Control Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FACILITIES; SARS-COV-2; EXPOSURES; COMMUNITY		[Tenforde, Mark W.; Fisher, Kiva A.; Patel, Manish M.] Ctr Dis Control & Prevent, COVID 19 Response Team, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Tenforde, MW (corresponding author), Ctr Dis Control & Prevent, Influenza Div, 1600 Clifton Rd NE,H24-7, Atlanta, GA 30329 USA.	pij6@cdc.gov						Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Fisher KA, 2020, MMWR-MORBID MORTAL W, V69, P1258, DOI 10.15585/mmwr.mm6936a5; Grantz KH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18190-5; Hobbs CV, 2020, MMWR-MORBID MORTAL W, V69, P1925, DOI 10.15585/mmwr.mm6950e3; Honein MA, 2020, MMWR-MORBID MORTAL W, V69, P1860, DOI 10.15585/mmwr.mm6949e2; Mahale P, 2020, MMWR-MORBID MORTAL W, V69, P1686, DOI 10.15585/mmwr.mm6945a5; Pringle JC, 2020, MMWR-MORBID MORTAL W, V69, P1569, DOI 10.15585/mmwr.mm6943e1	8	11	11	2	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2021	325	14					1464	1465		10.1001/jama.2021.1995	http://dx.doi.org/10.1001/jama.2021.1995		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9GZ	33616617	Bronze			2022-12-28	WOS:000621912400001
J	Blum, TR; Liu, H; Packer, MS; Xiong, XZ; Lee, PG; Zhang, SC; Richter, M; Minasov, G; Satchell, KJF; Dong, M; Liu, DR				Blum, Travis R.; Liu, Hao; Packer, Michael S.; Xiong, Xiaozhe; Lee, Pyung-Gang; Zhang, Sicai; Richter, Michelle; Minasov, George; Satchell, Karla J. F.; Dong, Min; Liu, David R.			Phage-assisted evolution of botulinum neurotoxin proteases with reprogrammed specificity	SCIENCE			English	Article							CONTINUOUS DIRECTED EVOLUTION; SUBSTRATE RECOGNITION; SUBTILISIN E; LIGHT-CHAIN; SELECTION; VARIANTS; SYSTEM; MODEL; MUTATIONS; MECHANISM	Although bespoke, sequence-specific proteases have the potential to advance biotechnology and medicine, generation of proteases with tailor-made cleavage specificities remains a major challenge. We developed a phage-assisted protease evolution system with simultaneous positive and negative selection and applied it to three botulinum neurotoxin (BoNT) light-chain proteases. We evolved BoNT/X protease into separate variants that preferentially cleave vesicle-associated membrane protein 4 (VAMP4) and Ykt6, evolved BoNT/F protease to selectively cleave the non-native substrate VAMP7, and evolved BoNT/E protease to cleave phosphatase and tensin homolog (PTEN) but not any natural BoNT protease substrate in neurons. The evolved proteases display large changes in specificity (218- to >11,000,000-fold) and can retain their ability to form holotoxins that self-deliver into primary neurons. These findings establish a versatile platform for reprogramming proteases to selectively cleave new targets of therapeutic interest.	[Blum, Travis R.; Packer, Michael S.; Richter, Michelle; Liu, David R.] Broad Inst Harvard & MIT, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA; [Blum, Travis R.; Packer, Michael S.; Richter, Michelle; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Blum, Travis R.; Packer, Michael S.; Richter, Michelle; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Liu, Hao; Xiong, Xiaozhe; Lee, Pyung-Gang; Zhang, Sicai; Dong, Min] Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA; [Liu, Hao; Xiong, Xiaozhe; Lee, Pyung-Gang; Zhang, Sicai; Dong, Min] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Liu, Hao; Xiong, Xiaozhe; Lee, Pyung-Gang; Zhang, Sicai; Dong, Min] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Minasov, George; Satchell, Karla J. F.] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Liu, DR (corresponding author), Broad Inst Harvard & MIT, Merkin Inst Transformat Technol Healthcare, Cambridge, MA 02142 USA.; Liu, DR (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.; Liu, DR (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Dong, M (corresponding author), Boston Childrens Hosp, Dept Urol, Boston, MA 02115 USA.; Dong, M (corresponding author), Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA.; Dong, M (corresponding author), Harvard Med Sch, Dept Surg, Boston, MA 02115 USA.	min.dong@childrens.harvard.edu; liu@chemistry.harvard.edu	Satchell, Karla/GSN-3100-2022; Liu, David R./HCH-3132-2022	Satchell, Karla/0000-0003-3274-7611; Zhang, Sicai/0000-0002-8894-5476; Minasov, George/0000-0001-5460-3462; xiong, xiaozhe/0000-0001-9493-707X; Lee, Pyung-Gang/0000-0001-9895-1098	U.S. NIH [R01EB027793, R01EB022376, R35GM118062, R01NS080833, R01AI132387, R01AI139087, R21NS106159, HHSN272201700060C]; Burroughs Wellcome Fund; Howard Hughes Medical Institute; DOE Office of Science [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Ipsen Bioinnovation; Ruth L. Kirchstein National Research Service [F32 GM122261-03]; LS-CAT Sector 21	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); DOE Office of Science(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Ipsen Bioinnovation(Ipsen); Ruth L. Kirchstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LS-CAT Sector 21	This work was supported by U.S. NIH grants R01EB027793, R01EB022376, R35GM118062, R01NS080833, R01AI132387, R01AI139087, R21NS106159, and HHSN272201700060C, the Burroughs Wellcome Fund, the Howard Hughes Medical Institute, and Ipsen Bioinnovation. T.R.B. is a Ruth L. Kirchstein National Research Service Award Postdoctoral Fellow (F32 GM122261-03). This research used the Advanced Photon Source, operated for the DOE Office of Science by Argonne National Laboratory (DE-AC02-06CH11357) and LS-CAT Sector 21, supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (085P1000817).	Agarwal R, 2009, NAT STRUCT MOL BIOL, V16, P789, DOI 10.1038/nsmb.1626; Allen GA, 2007, ARTERIOSCL THROM VAS, V27, P683, DOI 10.1161/01.ATV.0000257204.82396.2b; Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938; Badran AH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9425; Binz T, 2018, TOXICON, V156, pS10, DOI 10.1016/j.toxicon.2018.11.030; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Bryson DI, 2017, NAT CHEM BIOL, V13, P1253, DOI [10.1038/NCHEMBIO.2474, 10.1038/nchembio.2474]; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/NCHEMBIO.1453, 10.1038/nchembio.1453]; Carrico ZM, 2016, BIOTECHNOL BIOENG, V113, P1187, DOI 10.1002/bit.25904; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2009, P NATL ACAD SCI USA, V106, P9180, DOI 10.1073/pnas.0903111106; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daste F, 2015, J CELL SCI, V128, P4263, DOI 10.1242/jcs.178574; Dickinson BC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6352; Dickinson BC, 2013, P NATL ACAD SCI USA, V110, P9007, DOI 10.1073/pnas.1220670110; Dong M, 2019, ANNU REV BIOCHEM, V88, P811, DOI 10.1146/annurev-biochem-013118-111654; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Guerrero JL, 2017, BIOTECHNOL BIOENG, V114, P33, DOI 10.1002/bit.26066; Guerrero JL, 2016, ACS CHEM BIOL, V11, P961, DOI 10.1021/acschembio.5b01051; Hill ME, 2016, ACS CHEM BIOL, V11, P1603, DOI 10.1021/acschembio.5b00971; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Hubbard BP, 2015, NAT METHODS, V12, P939, DOI [10.1038/NMETH.3515, 10.1038/nmeth.3515]; Keith F, 2010, TOXINS, V2, P2795, DOI 10.3390/toxins2122795; Lee YR, 2018, NAT REV MOL CELL BIO, V19, P547, DOI 10.1038/s41580-018-0015-0; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; Li Q, 2013, FEBS LETT, V587, P1155, DOI 10.1016/j.febslet.2012.12.019; Lin YC, 2000, J VIROL, V74, P4710, DOI 10.1128/JVI.74.10.4710-4720.2000; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Masuyer G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22842-4; Masuyer G, 2014, ANNU REV PHARMACOL, V54, P27, DOI 10.1146/annurev-pharmtox-011613-135935; Meister SW, 2019, BIOL CHEM, V400, P405, DOI 10.1515/hsz-2018-0362; Miller SM, 2020, NAT BIOTECHNOL, V38, P471, DOI 10.1038/s41587-020-0412-8; Min D, 2004, P NATL ACAD SCI USA, V101, P14701, DOI 10.1073/pnas.0404107101; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Packer MS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01055-9; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pickett A, 2011, TOXINS, V3, P63, DOI 10.3390/toxins3010063; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; Ramesh B, 2019, ACS CHEM BIOL, V14, P2616, DOI 10.1021/acschembio.9b00506; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Renicke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067915; Richter MF, 2020, NAT BIOTECHNOL, V38, P883, DOI 10.1038/s41587-020-0453-z; Ridky TW, 1996, J BIOL CHEM, V271, P10538, DOI 10.1074/jbc.271.18.10538; Roth TB, 2019, ACS SYNTH BIOL, V8, P796, DOI 10.1021/acssynbio.8b00481; Ruge DR, 2011, ANAL BIOCHEM, V411, P200, DOI 10.1016/j.ab.2011.01.002; Sanchez MI, 2020, NAT METHODS, V17, P167, DOI 10.1038/s41592-019-0665-7; Santoro SW, 2002, NAT BIOTECHNOL, V20, P1044, DOI 10.1038/nbt742; Sellamuthu S, 2008, BIOCHEM BIOPH RES CO, V371, P122, DOI 10.1016/j.bbrc.2008.04.026; Sellamuthu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022554; Sidhu SS, 1996, J MOL BIOL, V257, P233, DOI 10.1006/jmbi.1996.0159; Sikorra S, 2008, J BIOL CHEM, V283, P21145, DOI 10.1074/jbc.M800610200; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thuronyi BW, 2019, NAT BIOTECHNOL, V37, P1070, DOI 10.1038/s41587-019-0193-0; Tran DT, 2016, P NATL ACAD SCI USA, V113, P14686, DOI 10.1073/pnas.1609925113; Varadarajan N, 2005, P NATL ACAD SCI USA, V102, P6855, DOI 10.1073/pnas.0500063102; Varadarajan N, 2008, ANGEW CHEM INT EDIT, V47, P7861, DOI 10.1002/anie.200800736; Varadarajan N, 2008, NAT CHEM BIOL, V4, P290, DOI 10.1038/nchembio.80; Verhoeven KD, 2012, APPL BIOCHEM BIOTECH, V166, P1340, DOI 10.1007/s12010-011-9522-6; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yi L, 2013, P NATL ACAD SCI USA, V110, P7229, DOI 10.1073/pnas.1215994110; You L, 1996, PROTEIN ENG, V9, P77, DOI 10.1093/protein/9.1.77; Zhang SC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14130; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	72	16	18	35	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					803	+		10.1126/science.abf5972	http://dx.doi.org/10.1126/science.abf5972			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602850	Green Accepted			2022-12-28	WOS:000619664700049
J	Shivdasani, RA; Clevers, H; de Sauvage, FJ				Shivdasani, Ramesh A.; Clevers, Hans; de Sauvage, Frederic J.			Tissue regeneration: Reserve or reverse?	SCIENCE			English	Editorial Material							STEM-CELLS; SMALL-INTESTINE; IN-VIVO; DEDIFFERENTIATION		[Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shivdasani, Ramesh A.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Shivdasani, Ramesh A.] Harvard Med Sch, Boston, MA 02115 USA; [Shivdasani, Ramesh A.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Clevers, Hans] Hubrecht Inst, Utrecht, Netherlands; [Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [de Sauvage, Frederic J.] Genentech Inc, Dept Mol Oncol, San Francisco, CA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Roche Holding; Genentech	Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Shivdasani, RA (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.; Shivdasani, RA (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Shivdasani, RA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Shivdasani, RA (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	ramesh_shivdasani@dfci.harvard.edu						Ayyaz A, 2019, NATURE, V569, P121, DOI 10.1038/s41586-019-1154-y; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Karthaus WR, 2020, SCIENCE, V368, P497, DOI 10.1126/science.aay0267; Lynch TJ, 2018, CELL STEM CELL, V22, P653, DOI 10.1016/j.stem.2018.03.017; Murata K, 2020, CELL STEM CELL, V26, P377, DOI 10.1016/j.stem.2019.12.011; Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Yan KS, 2017, CELL STEM CELL, V21, P78, DOI 10.1016/j.stem.2017.06.014	15	14	14	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					784	786		10.1126/science.abb6848	http://dx.doi.org/10.1126/science.abb6848			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602845				2022-12-28	WOS:000619664700032
J	Cuella-Martin, R; Hayward, SB; Fan, X; Chen, X; Huang, JW; Taglialatela, A; Leuzzi, G; Zhao, JF; Rabadan, R; Lu, C; Shen, YF; Ciccia, A				Cuella-Martin, Raquel; Hayward, Samuel B.; Fan, Xiao; Chen, Xiao; Huang, Jen-Wei; Taglialatela, Angelo; Leuzzi, Giuseppe; Zhao, Junfei; Rabadan, Raul; Lu, Chao; Shen, Yufeng; Ciccia, Alberto			Functional interrogation of DNA damage response variants with base editing screens	CELL			English	Article							CANCER SUSCEPTIBILITY; GENOMIC DNA; 53BP1; REPLICATION; REPAIR; ACTIVATION; KINASE; BRCA1; TRAIP; CLASSIFICATION	Mutations in DNA damage response (DDR) genes endanger genome integrity and predispose to cancer and genetic disorders. Here, using CRISPR-dependent cytosine base editing screens, we identify > 2,000 sgRNAs that generate nucleotide variants in 86 DDR genes, resulting in altered cellular fitness upon DNA damage. Among those variants, we discover loss- and gain-of-function mutants in the Tudor domain of the DDR regulator 53BP1 that define a non-canonical surface required for binding the deubiquitinase USP28. Moreover, we characterize variants of the TRAIP ubiquitin ligase that define a domain, whose loss renders cells resistant to topoisomerase I inhibition. Finally, we identify mutations in the ATM kinase with opposing genome stability phenotypes and loss-of-function mutations in the CHK2 kinase previously categorized as variants of uncertain significance for breast cancer. We anticipate that this resource will enable the discovery of additional DDR gene functions and expedite studies of DDR variants in human disease.	[Cuella-Martin, Raquel; Hayward, Samuel B.; Chen, Xiao; Huang, Jen-Wei; Taglialatela, Angelo; Leuzzi, Giuseppe; Lu, Chao; Ciccia, Alberto] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Fan, Xiao; Zhao, Junfei; Rabadan, Raul; Shen, Yufeng] Columbia Univ, Irving Med Ctr, Dept Syst Biol, New York, NY 10032 USA; [Fan, Xiao; Zhao, Junfei; Rabadan, Raul; Shen, Yufeng] Columbia Univ, Irving Med Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Zhao, Junfei; Rabadan, Raul] Columbia Univ, Irving Med Ctr, Program Math Genom, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Ciccia, A (corresponding author), Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, Dept Genet & Dev, New York, NY 10032 USA.	ac3685@cumc.columbia.edu	Chen, Xiao/ABG-4082-2021; Cuella Martin, Raquel/AAV-9649-2021	Chen, Xiao/0000-0001-5059-8846; Hayward, Samuel/0000-0002-8818-2886; Lu, Chao/0000-0003-0982-8122; Huang, Jen-Wei/0000-0001-8345-1656	NIH [R01CA197774, R01CA227450, P01CA174653]; EMBO Long-Term Fellowship [ALTF 366-2019]; Damon Runyon Cancer Research Foundation [DFS-28-18]; Pew-Stewart Scholar for Cancer Research program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Damon Runyon Cancer Research Foundation; Pew-Stewart Scholar for Cancer Research program	We thank Richard Baer and Alex Chavez for comments on the manuscript, Han S. Ryu for technical support, Eric Bryant and Juan Patino Galindo for bioinformatic Ysupport, Enrique Vazquez de Luis for NGS advice, and Aaron and Sarah Meltzer for the online database. LentiGuide fluorescent constructs and TRAIP antibodies were kindly provided by Daniel Durocher, Niels Mailand, and Andrew Jackson. Graphical abstract was created using BioRender. This work was supported by the NIH grants R01CA197774 and R01CA227450 to A.C., P01CA174653 to A.C. and R.R., the EMBO Long-Term Fellowship (ALTF 366-2019) to R.C.-M., and the Damon Runyon Cancer Research Foundation (DFS-28-18) and Pew-Stewart Scholar for Cancer Research program to C.L.	Adamovich AI, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008049; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Apostolou P, 2017, BREAST CANCER-TARGET, V9, P331, DOI 10.2147/BCTT.S111394; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Baretic D, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700933; Becker J.R., 2020, BIORXIV 202006011279; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Billing D, 2018, MOL CELL, V72, P127, DOI 10.1016/j.molcel.2018.08.016; Billon P, 2017, MOL CELL, V67, P1068, DOI 10.1016/j.molcel.2017.08.008; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Boonen RACM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13194-2; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2013, CANCER DISCOV, V3, P1142, DOI 10.1158/2159-8290.CD-13-0094; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Colic M, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0665-3; Cuella-Martin R, 2016, MOL CELL, V64, P51, DOI 10.1016/j.molcel.2016.08.002; Despres PC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15796-7; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Farrugia DJ, 2008, CANCER RES, V68, P3523, DOI 10.1158/0008-5472.CAN-07-1587; Feng WJ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.16; Feng WR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00634-0; Findlay GM, 2018, NATURE, V562, P217, DOI 10.1038/s41586-018-0461-z; Gapinske M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1482-5; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Ghezraoui H, 2018, NATURE, V560, P122, DOI 10.1038/s41586-018-0362-1; Guidugli L, 2014, HUM MUTAT, V35, P151, DOI 10.1002/humu.22478; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Hanna RE, 2021, CELL, V184, P1064, DOI 10.1016/j.cell.2021.01.012; Harley ME, 2016, NAT GENET, V48, P36, DOI 10.1038/ng.3451; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hoffmann S, 2016, J CELL BIOL, V212, P63, DOI 10.1083/jcb.201506071; Hsiau T, 2018, BIORXIV, DOI [10.1101/251082, DOI 10.1101/251082]; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Huang SS, 2019, ISCIENCE, V15, P640, DOI 10.1016/j.isci.2019.05.008; Hustedt N, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190156; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Jun S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0888-2; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Knobel PA, 2014, MOL CELL BIOL, V34, P2062, DOI 10.1128/MCB.00197-14; Koblan LW, 2021, NATURE, V589, P608, DOI 10.1038/s41586-020-03086-7; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kuscu C, 2017, NAT METHODS, V14, P710, DOI 10.1038/nmeth.4327; Kweon J, 2020, ONCOGENE, V39, P30, DOI 10.1038/s41388-019-0968-2; Lee C, 2015, HUM MUTAT, V36, P1205, DOI 10.1002/humu.22902; Lee NS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10463; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; McKinnon PJ, 2009, NAT REV NEUROSCI, V10, P100, DOI 10.1038/nrn2559; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Noordermeer SM, 2018, NATURE, V560, P117, DOI 10.1038/s41586-018-0340-7; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Park ES, 2007, BIOCHEM BIOPH RES CO, V363, P971, DOI 10.1016/j.bbrc.2007.09.103; Rao QH, 2018, CELL RES, V28, P143, DOI 10.1038/cr.2017.158; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Setiaputra D, 2019, EMBO REP, V20, DOI 10.15252/embr.201847560; Sonneville R, 2019, ELIFE, V8, DOI 10.7554/eLife.48686; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Tan JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08034-8; Walton RT, 2020, SCIENCE, V368, P290, DOI 10.1126/science.aba8853; Wang HB, 2017, ONCOTARGET, V8, P48671, DOI 10.18632/oncotarget.16225; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang N, 2015, ONCOGENE, V34, P5198, DOI 10.1038/onc.2014.443; Wiltshire T, 2020, GENET MED, V22, P622, DOI 10.1038/s41436-019-0682-z; Wu RA, 2019, NATURE, V567, P267, DOI 10.1038/s41586-019-1002-0; Yeh WH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04580-3; Zafra MP, 2018, NAT BIOTECHNOL, V36, P888, DOI 10.1038/nbt.4194; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	87	51	53	3	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					1081	+		10.1016/j.cell.2021.01.041	http://dx.doi.org/10.1016/j.cell.2021.01.041		FEB 2021	36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606978	Green Accepted			2022-12-28	WOS:000629633400020
J	Motzer, R; Alekseev, B; Rha, SY; Porta, C; Eto, M; Powles, T; Grunwald, V; Hutson, TE; Kopyltsov, E; Mendez-Vidal, MJ; Kozlov, V; Alyasova, A; Hong, SH; Kapoor, A; Gordoa, TA; Merchan, JR; Winquist, E; Maroto, P; Goh, JC; Kim, M; Gurney, H; Patel, V; Peer, A; Procopio, G; Takagi, T; Melichar, B; Rolland, F; De Giorgi, U; Wong, S; Bedke, J; Schmidinger, M; Dutcus, CE; Smith, AD; Dutta, L; Mody, K; Perini, RF; Xing, DY; Choueiri, TK				Motzer, Robert; Alekseev, Boris; Rha, Sun-Young; Porta, Camillo; Eto, Masatoshi; Powles, Thomas; Gruenwald, Viktor; Hutson, Thomas E.; Kopyltsov, Evgeny; Mendez-Vidal, Maria J.; Kozlov, Vadim; Alyasova, Anna; Hong, Sung-Hoo; Kapoor, Anil; Alonso Gordoa, Teresa; Merchan, Jaime R.; Winquist, Eric; Maroto, Pablo; Goh, Jeffrey C.; Kim, Miso; Gurney, Howard; Patel, Vijay; Peer, Avivit; Procopio, Giuseppe; Takagi, Toshio; Melichar, Bohuslav; Rolland, Frederic; De Giorgi, Ugo; Wong, Shirley; Bedke, Jens; Schmidinger, Manuela; Dutcus, Corina E.; Smith, Alan D.; Dutta, Lea; Mody, Kalgi; Perini, Rodolfo F.; Xing, Dongyuan; Choueiri, Toni K.		CLEAR Trial Investigators	Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1ST-LINE TREATMENT; FOLLOW-UP; SUNITINIB; CABOZANTINIB; MONOTHERAPY; THERAPY; CANCER; TRIAL	BACKGROUND Lenvatinib in combination with pembrolizumab or everolimus has activity against advanced renal cell carcinoma. The efficacy of these regimens as compared with that of sunitinib is unclear. METHODS In this phase 3 trial, we randomly assigned (in a 1:1:1 ratio) patients with advanced renal cell carcinoma and no previous systemic therapy to receive lenvatinib (20 mg orally once daily) plus pembrolizumab (200 mg intravenously once every 3 weeks), lenvatinib (18 mg orally once daily) plus everolimus (5 mg orally once daily), or sunitinib (50 mg orally once daily, alternating 4 weeks receiving treatment and 2 weeks without treatment). The primary end point was progression-free survival, as assessed by an independent review committee in accordance with Response Evaluation Criteria in Solid Tumors, version 1.1. Overall survival and safety were also evaluated. RESULTS A total of 1069 patients were randomly assigned to receive lenvatinib plus pembrolizumab (355 patients), lenvatinib plus everolimus (357), or sunitinib (357). Progression-free survival was longer with lenvatinib plus pembrolizumab than with sunitinib (median, 23.9 vs. 9.2 months; hazard ratio for disease progression or death, 0.39; 95% confidence interval [CI], 0.32 to 0.49; P<0.001) and was longer with lenvatinib plus everolimus than with sunitinib (median, 14.7 vs. 9.2 months; hazard ratio, 0.65; 95% CI, 0.53 to 0.80; P<0.001). Overall survival was longer with lenvatinib plus pembrolizumab than with sunitinib (hazard ratio for death, 0.66; 95% CI, 0.49 to 0.88; P=0.005) but was not longer with lenvatinib plus everolimus than with sunitinib (hazard ratio, 1.15; 95% CI, 0.88 to 1.50; P = 0.30). Grade 3 or higher adverse events emerged or worsened during treatment in 82.4% of the patients who received lenvatinib plus pembrolizumab, 83.1% of those who received lenvatinib plus everolimus, and 71.8% of those who received sunitinib. Grade 3 or higher adverse events occurring in at least 10% of the patients in any group included hypertension, diarrhea, and elevated lipase levels. CONCLUSIONS Lenvatinib plus pembrolizumab was associated with significantly longer progression-free survival and overall survival than sunitinib.	[Motzer, Robert] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA; [Alekseev, Boris] P Hertsen Moscow Oncol Res Inst, Moscow, Russia; [Kopyltsov, Evgeny] State Inst Hlth Care Reg Clin Oncol Dispensary, Omsk, Russia; [Kozlov, Vadim] State Budgetary Hlth Care Inst Novosibirsk Reg Cl, Novosibirsk, Russia; [Alyasova, Anna] Prevoljskiy Reg Med Ctr, Novgorod, Russia; [Rha, Sun-Young] Yonsei Univ Hlth Syst, Yonsei Canc Ctr, Seoul, South Korea; [Hong, Sung-Hoo] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea; [Kim, Miso] Seoul Natl Univ Hosp, Seoul, South Korea; [Porta, Camillo] San Matteo Univ Hosp Fdn, Pavia, Italy; [Procopio, Giuseppe] Ist Nazl Tumori IRCCS, Milan, Italy; [De Giorgi, Ugo] Ist Sci Romagnolo Studio & Cura Tumori IRCCS, Meldola, Italy; [Eto, Masatoshi] Kyushu Univ, Fukuoka, Japan; [Takagi, Toshio] Tokyo Womens Med Univ, Tokyo, Japan; [Powles, Thomas] Royal Free NHS Trust, London, England; [Smith, Alan D.] Eisai, Hatfield, Herts, England; [Gruenwald, Viktor] Univ Hosp Essen, Essen, Germany; [Bedke, Jens] Univ Tubingen, Tubingen, Germany; [Hutson, Thomas E.] Texas Oncol, Dallas, TX USA; [Mendez-Vidal, Maria J.] Univ Reina Sofia, Cordoba Hosp, Maimonides Inst Biomed Res, Dept Med Oncol, Cordoba, Spain; [Alonso Gordoa, Teresa] Hosp Univ Ramon y Cajal, Madrid, Spain; [Maroto, Pablo] Hosp Santa Creu & Sant Pau, Barcelona, Spain; [Kapoor, Anil] McMaster Univ, Hamilton, ON, Canada; [Winquist, Eric] Western Univ, London, ON, Canada; [Merchan, Jaime R.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Patel, Vijay] Florida Canc Specialists, Gainesville, FL USA; [Goh, Jeffrey C.] ICON Res, South Brisbane, Qld, Australia; [Goh, Jeffrey C.] Univ Queensland, St Lucia, Qld, Australia; [Gurney, Howard] Macquarie Univ, Sydney, NSW, Australia; [Wong, Shirley] Western Hlth, Melbourne, Vic, Australia; [Peer, Avivit] Rambam Hlth Care Campus, Haifa, Israel; [Melichar, Bohuslav] Palacky Univ, Olomouc, Czech Republic; [Melichar, Bohuslav] Univ Hosp Olomouc, Olomouc, Czech Republic; [Rolland, Frederic] Ctr Rene Gauducheau, St Herblain, France; [Schmidinger, Manuela] Med Univ Vienna, Dept Urol, Vienna, Austria; [Dutcus, Corina E.; Dutta, Lea; Mody, Kalgi; Xing, Dongyuan] Eisai, Woodcliff Lake, NJ USA; [Perini, Rodolfo F.] Merck, Kenilworth, NJ USA; [Choueiri, Toni K.] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA	Memorial Sloan Kettering Cancer Center; Yonsei University; Yonsei University Health System; Catholic University of Korea; Seoul St. Mary's Hospital; Seoul National University (SNU); Seoul National University Hospital; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Meldola (IRST); Kyushu University; Tokyo Women's Medical University; University of London; University College London; Eisai Co Ltd; University of Duisburg Essen; Eberhard Karls University of Tubingen; Texas Oncology; Hospital Universitario Ramon y Cajal; Hospital of Santa Creu i Sant Pau; McMaster University; Western University (University of Western Ontario); University of Miami; Florida Cancer Specialists; ICON plc; University of Queensland; Macquarie University; Rambam Health Care Campus; Palacky University Olomouc; University Hospital Olomouc; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Medical University of Vienna; Eisai Co Ltd; Merck & Company; Harvard University; Dana-Farber Cancer Institute	Motzer, R (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.; Choueiri, TK (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	motzerr@mskcc.org; toni_choueiri@dfci.harvard.edu	Kapoor, Anil/AAQ-7184-2021; Choueiri, Toni/K-5238-2019; Massari, Francesco/K-7239-2016; Bedke, Jens/AAS-2837-2020; riccardi, ferdinando/K-7370-2016; KIMURA, GO/Y-7843-2018; Alekseev, Boris/O-1008-2017	Kapoor, Anil/0000-0001-9180-8029; Choueiri, Toni/0000-0002-9201-3217; Massari, Francesco/0000-0001-6476-6871; Bedke, Jens/0000-0003-2778-3108; riccardi, ferdinando/0000-0002-2852-2770; Rha, Sun Young/0000-0002-2512-4531; KIMURA, GO/0000-0003-0088-9324; Bambury, Richard/0000-0002-2189-6972; OUDARD, Stephane/0000-0003-0893-285X; Powles, Thomas/0000-0001-7760-4724; Calabro', Fabio/0000-0002-7863-3540; Gurney, Howard/0000-0003-0217-5261; Alekseev, Boris/0000-0002-3398-4128	Eisai; Merck Sharp and Dohme; Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA008748]	Eisai(Eisai Co Ltd); Merck Sharp and Dohme(Merck & Company); Memorial Sloan Kettering Cancer Center Support Grant/Core Grant	Supported by Eisai and Merck Sharp and Dohme. The conduct of the trial at the Memorial Sloan Kettering Cancer Center was supported in part by a Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA008748).	[Anonymous], 2020, AFINITOR EVEROLIMUS; [Anonymous], 2020, LENVIMA LENVATINIB; Bedke J., 2020, EUR UROL; Choueiri TK, 2020, ANN ONCOL, V31, pS1159, DOI 10.1016/j.annonc.2020.08.2257; Choueiri TK., 2018, J CLIN ONCOL; Choueiri TK, 2020, NAT MED, V26, P1519, DOI 10.1038/s41591-020-1093-z; Choueiri TK, 2017, J CLIN ONCOL, V35, P591, DOI 10.1200/JCO.2016.70.7398; Choueiri TK, 2017, NEW ENGL J MED, V376, P354, DOI 10.1056/NEJMra1601333; Lee JL, 2020, J CLIN ONCOL, V38; Makker V, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.02627; Maurer W, 2013, STAT BIOPHARM RES, V5, P311, DOI 10.1080/19466315.2013.807748; Molina AM, 2014, CANCER CHEMOTH PHARM, V73, P181, DOI 10.1007/s00280-013-2339-y; Motzer RJ, 2018, NEW ENGL J MED, V378, P1277, DOI 10.1056/NEJMoa1712126; Motzer RJ, 2002, J CLIN ONCOL, V20, P289, DOI 10.1200/JCO.20.1.289; Motzer RJ, 2020, J NATL COMPR CANC NE, V18, P1161, DOI 10.6004/jnccn.2020.0043; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; Powles T, 2020, LANCET ONCOL, V21, P1563, DOI 10.1016/S1470-2045(20)30436-8; Rassy E, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920907504; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; RxList, 2020, KEYTRUDA PEMBROLIZUM; SCHAG CC, 1984, J CLIN ONCOL, V2, P187, DOI 10.1200/JCO.1984.2.3.187; Taylor MH, 2020, J CLIN ONCOL, V38, P1154, DOI 10.1200/JCO.19.01598	22	425	428	13	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 8	2021	384	14					1289	1300		10.1056/NEJMoa2035716	http://dx.doi.org/10.1056/NEJMoa2035716			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RJ7RN	33616314	Bronze			2022-12-28	WOS:000637799800007
J	Andreano, E; Nicastri, E; Paciello, I; Pileri, P; Manganaro, N; Piccini, G; Manenti, A; Pantano, E; Kabanova, A; Troisi, M; Vacca, F; Cardamone, D; De Santi, C; Torres, JL; Ozorowski, G; Benincasa, L; Jang, H; Di Genova, C; Depau, L; Brunetti, J; Agrati, C; Capobianchi, MR; Castilletti, C; Emiliozzi, A; Fabbiani, M; Montagnani, F; Bracci, L; Sautto, G; Ross, TM; Montomoli, E; Temperton, N; Ward, AB; Sala, C; Ippolito, G; Rappuoli, R				Andreano, Emanuele; Nicastri, Emanuele; Paciello, Ida; Pileri, Piero; Manganaro, Noemi; Piccini, Giulia; Manenti, Alessandro; Pantano, Elisa; Kabanova, Anna; Troisi, Marco; Vacca, Fabiola; Cardamone, Dario; De Santi, Concetta; Torres, Jonathan L.; Ozorowski, Gabriel; Benincasa, Linda; Jang, Hyesun; Di Genova, Cecilia; Depau, Lorenzo; Brunetti, Jlenia; Agrati, Chiara; Capobianchi, Maria Rosaria; Castilletti, Concetta; Emiliozzi, Arianna; Fabbiani, Massimiliano; Montagnani, Francesca; Bracci, Luisa; Sautto, Giuseppe; Ross, Ted M.; Montomoli, Emanuele; Temperton, Nigel; Ward, Andrew B.; Sala, Claudia; Ippolito, Giuseppe; Rappuoli, Rino			Extremely potent human monoclonal antibodies from COVID-19 convalescent patients	CELL			English	Article							CRYO-EM STRUCTURE; CELLS; SPIKE	Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly developed to help restore the massive health and economic disruption caused by the coronavirus disease 2019 (COVID-19) pandemic. By single-cell sorting 4,277 SARS-CoV-2 spike protein-specific memory B cells from 14 COVID-19 survivors, 453 neutralizing antibodies were identified. The most potent neutralizing antibodies recognized the spike protein receptor-binding domain, followed in potency by antibodies that recognize the S1 domain, the spike protein trimer, and the S2 subunit. Only 1.4% of them neutralized the authentic virus with a potency of 1-10 ng/mL. The most potent monoclonal antibody, engineered to reduce the risk of antibody-dependent enhancement and prolong half-life, neutralized the authentic wild-type virus and emerging variants containing D614G, E484K, and N501Y substitutions. Prophylactic and therapeutic efficacy in the hamster model was observed at 0.25 and 4 mg/kg respectively in absence of Fc functions.	[Andreano, Emanuele; Paciello, Ida; Pileri, Piero; Manganaro, Noemi; Pantano, Elisa; Kabanova, Anna; Troisi, Marco; Vacca, Fabiola; Cardamone, Dario; De Santi, Concetta; Sala, Claudia; Rappuoli, Rino] Fdn Toscana Life Sci, Monoclonal Antibody Discovery MAD Lab, Siena, Italy; [Piccini, Giulia; Manenti, Alessandro; Montomoli, Emanuele] VisMederi Srl, Siena, Italy; [Manenti, Alessandro; Benincasa, Linda; Montomoli, Emanuele] VisMederi Res Srl, Siena, Italy; [Nicastri, Emanuele; Agrati, Chiara; Capobianchi, Maria Rosaria; Castilletti, Concetta; Ippolito, Giuseppe] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Emiliozzi, Arianna; Montagnani, Francesca] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Emiliozzi, Arianna; Fabbiani, Massimiliano; Montagnani, Francesca] Univ Hosp Siena, Dept Med Sci, Infect & Trop Dis Unit, Siena, Italy; [Montomoli, Emanuele] Univ Siena, Dept Mol & Dev Med, Siena, Italy; [Rappuoli, Rino] Imperial Coll, Fac Med, London, England; [Troisi, Marco; Vacca, Fabiola] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy; [Cardamone, Dario] Univ Turin, Turin, Italy; [Kabanova, Anna] Fdn Toscana Life Sci, Tumour Immunol Unit, Siena, Italy; [Depau, Lorenzo; Brunetti, Jlenia; Bracci, Luisa] Univ Siena, MedBiotech Hub, Dept Med Biotechnol, Siena, Italy; [Depau, Lorenzo; Brunetti, Jlenia; Bracci, Luisa] Univ Siena, Competence Ctr, Dept Med Biotechnol, Siena, Italy; [Jang, Hyesun; Sautto, Giuseppe; Ross, Ted M.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Ross, Ted M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Di Genova, Cecilia; Temperton, Nigel] Univ Kent, Medway Sch Pharm, Viral Pseudotype Unit, Chatham, Kent, England; [Torres, Jonathan L.; Ozorowski, Gabriel; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	IRCCS Lazzaro Spallanzani; University of Siena; University of Siena; University Hospital of Siena; University of Siena; Imperial College London; University of Siena; University of Turin; University of Siena; University of Siena; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Greenwich; University of Kent; Scripps Research Institute	Rappuoli, R (corresponding author), Fdn Toscana Life Sci, Monoclonal Antibody Discovery MAD Lab, Siena, Italy.; Rappuoli, R (corresponding author), Imperial Coll, Fac Med, London, England.	rino.r.rappuoli@gsk.com	Montagnani, Francesca/R-3334-2016; Ozorowski, Gabriel/HCH-0634-2022; Temperton, Nigel James/K-5158-2013; Temperton, Nigel James/M-1164-2019; Ward, Andrew/ABD-7728-2021; Brunetti, Jlenia/E-6464-2019; BRACCI, LUISA/V-9913-2018; /N-6227-2016	Montagnani, Francesca/0000-0002-2267-1337; Temperton, Nigel James/0000-0002-7978-3815; Temperton, Nigel James/0000-0002-7978-3815; Ward, Andrew/0000-0001-7153-3769; Brunetti, Jlenia/0000-0001-8144-7186; MANGANARO, NOEMI/0000-0001-8512-4704; Torres, Jonathan/0000-0003-0137-8497; BRACCI, LUISA/0000-0002-0738-5746; Di Genova, Cecilia/0000-0002-2121-0715; Piccini, Giulia/0000-0001-8090-7910; Kabanova, Anna/0000-0002-2077-472X; /0000-0002-2888-8748	European Research Council (ERC) [787552]; Wellcome Trust; Centro Regionale Medicina di Precisione; European Virus Archive goes Global (EVAg) project from the European Union's Horizon 2020 research and innovation program [653316]; Italian Ministry of Health [COVID-2020-12371817]; University of Georgia (UGA) [UGA-001]; Georgia Research Alliance; AchilleS Vaccines; EU Malaria Fund; Fondazione Toscana Life Sciences	European Research Council (ERC)(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome Trust); Centro Regionale Medicina di Precisione; European Virus Archive goes Global (EVAg) project from the European Union's Horizon 2020 research and innovation program; Italian Ministry of Health(Ministry of Health, Italy); University of Georgia (UGA); Georgia Research Alliance; AchilleS Vaccines; EU Malaria Fund; Fondazione Toscana Life Sciences	We wish to thank Fondazione Toscana Life Sciences in the persons of Dr. Fabrizio Landi and Dr. Andrea Paolini and the whole Administration for their help and support. In particular, we would like to thank Mr. Francesco Senatore, Mrs. Laura Canavacci, and Mrs. Cinzia Giordano for their support in preparing all the documents needed for the ethical approval of the clinical studies carried out within this project. Wewish to thank the National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani Rome (IT), and the Azienda Ospedaliera Universitaria Senese, Siena (IT) for providing blood samples from COVID-19 convalescent donors under studies approved by local ethic committees. We also wish to thank all the nursing staff who chose to cooperate for blood withdrawal and all the donors who decided to participate in this study. We would like to thank the whole GSK Vaccines Pre-clinical Evidence Generation and Assay -Immunolgy function led by Dr. Oretta Finco for their availability and support as well as Mrs. Simona Tavarini, Mrs. Chiara Sammicheli, Dr. Monia Bardelli, Dr. Michela Brazzoli, Dr. Elisabetta Frigimelica, Dr. Erica Borgogni, and Dr. Elisa Faenzi for sharing their expertise, extreme availability, and technical support. We would also like to thank Dr. Mariagrazia Pizza and Dr. Simone Pecetta for initial insightful advice and discussions on this project. We would like to thank Dr. Jason McLellan and his team for generously providing the SARS-CoV-2 S protein stabilized in its prefusion conformation used in this study. Furthermore, we would like to thank Dr. Daniel Wrapp and Dr. Nianshuang Wang for the precious information and suggestions. The authors wish to thank Seromyx for their support in assessing the functionality of the antibodies Fc portion. The authors would like to thank the University of Georgia Animal Resource staff, technicians, and veterinarians for animal care as well as the staff of the University of Georgia AHRC BSL-3 facility for providing biosafety and animal care. The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2 Isolate USA-WA1/2020, NR52281. This work was funded by the European Research Council (ERC) advanced grant agreement no. 787552 (vAMRes). The Laboratory is also supported by the Wellcome Trust. This publication was supported by funds from the "Centro Regionale Medicina di Precisione'' and by all the people who answered the call to fight with us the battle against SARS-CoV-2 with their kind donations on the platform ForFunding (https://www.forfunding.intesasanpaolo.com/DonationPlatform-ISP/nav/progetto/id/3380).This publication was supported by the European Virus Archive goes Global (EVAg) project, which has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 653316. This publication was supported by the COVID-2020-12371817 project, which has received funding from the Italian Ministry of Health. This work was funded, in part, by the University of Georgia (UGA) (UGA-001) and a contract by Fondazione Toscana Life Sciences. In addition, T.M.R. is supported by the Georgia Research Alliance as an Eminent Scholar. We wish to thank AchilleS Vaccines and the EU Malaria Fund for funding and managing the development of the human monoclonal antibody for clinical studies.	Ackerman ME, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005315; Ackerman ME, 2013, J VIROL, V87, P5468, DOI 10.1128/JVI.03403-12; Alsoussi WB, 2020, J IMMUNOL, V205, P915, DOI 10.4049/jimmunol.2000583; Andreano E., 2020, SARS COV 2 ESCAPE IN, DOI [10.1101/2020.12.28.424451.Aratani,L.(2020).Jobless, DOI 10.1101/2020.12.28.424451.ARATANI,L.(2020).JOBLESS]; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Booth BJ, 2018, MABS-AUSTIN, V10, P1098, DOI 10.1080/19420862.2018.1490119; Carnell G, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2514; Carnell GW, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00161; CDC, 2021, EM SARS COV 2 VAR; Chakraborty S, 2021, NAT IMMUNOL, V22, P67, DOI [10.1038/s41590-020-00828-7, 10.1101/2020.05.15.20103341]; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Cutler DM, 2020, JAMA-J AM MED ASSOC, V324, P1495, DOI 10.1001/jama.2020.19759; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; FDA, 2021, COVID 19 VACC; Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493; Grehan K, 2015, METHODSX, V2, P379, DOI 10.1016/j.mex.2015.09.003; Griffin MP, 2020, NEW ENGL J MED, V383, P415, DOI 10.1056/NEJMoa1913556; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Jang H, 2020, VET MICROBIOL, V251, DOI 10.1016/j.vetmic.2020.108907; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Karsten CB, 2019, J IMMUNOL METHODS, V471, P46, DOI 10.1016/j.jim.2019.05.006; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Kelley B, 2020, NAT BIOTECHNOL, V38, P540, DOI 10.1038/s41587-020-0512-5; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kreer C, 2020, CELL, V182, P843, DOI 10.1016/j.cell.2020.06.044; Kreye J, 2020, CELL, V183, P1058, DOI 10.1016/j.cell.2020.09.049; Kundi M, 1999, ANTIVIR RES, V41, P145, DOI 10.1016/S0166-3542(99)00008-X; Kupferschmidt K, 2019, SCIENCE, V365, P628, DOI 10.1126/science.365.6454.628; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Lilly, 2020, LILL NEUTR ANT BAML; Mackness BC, 2019, MABS-AUSTIN, V11, P1276, DOI 10.1080/19420862.2019.1633883; Manenti A, 2020, J MED VIROL, V92, P2096, DOI 10.1002/jmv.25986; Mullard A, 2020, NAT REV DRUG DISCOV, V19, P827, DOI 10.1038/d41573-020-00197-8; Pegu A, 2017, IMMUNOL REV, V275, P296, DOI 10.1111/imr.12511; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Regeneron, 2020, REG CAS IMB ANT COCK; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Romano M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051267; Schafer A, 2021, J EXP MED, V218, DOI 10.1084/jem.20201993; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schlothauer T, 2016, PROTEIN ENG DES SEL, V29, P457, DOI 10.1093/protein/gzw040; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Sparrow E, 2017, B WORLD HEALTH ORGAN, V95, P235, DOI [10.2471/BLT.16.178061, 10.2471/blt.16.178061]; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; United States Food & Drug Administration, 2020, COR COVID 19 UPD FDA; van Huijsduijnen RH, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007860; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wardemann H, 2019, METHODS MOL BIOL, V1956, P105, DOI 10.1007/978-1-4939-9151-8_5; Wellcome and IAVI, 2020, EXP ACC MON ANT BAS; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0; Zuo Y, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abd3876	70	91	93	6	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2021	184	7					1821	+		10.1016/j.cell.2021.02.035	http://dx.doi.org/10.1016/j.cell.2021.02.035		APR 2021	31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RI2IU	33667349	Green Submitted, Bronze, Green Published, Green Accepted			2022-12-28	WOS:000636734000016
J	Chou, R; Dana, T; Jungbauer, R; Weeks, C				Chou, Roger; Dana, Tracy; Jungbauer, Rebecca; Weeks, Chandler			Update Alert 5: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings	ANNALS OF INTERNAL MEDICINE			English	Letter							WORKERS; SEROPREVALENCE		[Chou, Roger; Dana, Tracy; Jungbauer, Rebecca; Weeks, Chandler] Pacific Northwest Evidence Based Practice Ctr, Portland, OR USA; [Chou, Roger; Dana, Tracy; Jungbauer, Rebecca; Weeks, Chandler] Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, 3181 SW Sam Jackson Pk Rd,Mail Code BICC, Portland, OR 97239 USA.	chour@ohsu.edu						Akinbami LJ, 2020, EMERG INFECT DIS, V26, P2863, DOI 10.3201/eid2612.203764; Bundgaard H, 2021, ANN INTERN MED, V174, P335, DOI 10.7326/M20-6817; Chatterjee P, 2020, INDIAN J MED RES, V151, P459, DOI 10.4103/ijmr.IJMR_2234_20; Chou R, 2020, ANN INTERN MED, V173, P542, DOI 10.7326/M20-3213; Doung-ngern P, 2020, EMERG INFECT DIS, V26, P2607, DOI 10.3201/eid2611.203003; Khalil Md Musab, 2020, SN Compr Clin Med, V2, P1733, DOI 10.1007/s42399-020-00471-1; Piapan L, 2020, J HOSP INFECT, V106, P626, DOI 10.1016/j.jhin.2020.08.012; Sims MD, 2021, CLIN INFECT DIS, V73, pS154, DOI 10.1093/cid/ciaa1684; van den Broek-Altenburg EM, 2021, JMIR PUBLIC HLTH SUR, V7, P151, DOI 10.2196/24320; Venugopal U, 2021, INT J INFECT DIS, V102, P63, DOI 10.1016/j.ijid.2020.10.036; Wang Y, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002794	11	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					W47	W47		10.7326/L21-0116	http://dx.doi.org/10.7326/L21-0116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RU1WZ	33683928	Green Published			2022-12-28	WOS:000644942400002
J	Adimora, AA; Ramirez, C; Poteat, T; Archin, NM; Averitt, D; Auerbach, JD; Agwu, AL; Currier, J; Gandhi, M				Adimora, Adaora A.; Ramirez, Catalina; Poteat, Tonia; Archin, Nancie M.; Averitt, Dawn; Auerbach, Judith D.; Agwu, Allison L.; Currier, Judith; Gandhi, Monica			HIV and women in the USA: what we know and where to go from here	LANCET			English	Review							UNITED-STATES; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; TRANSGENDER WOMEN; FELON DISFRANCHISEMENT; SEX-DIFFERENCES; INFECTED WOMEN; BLACK-WOMEN; DISPARITIES; PREVALENCE	New diagnoses of HIV infection have decreased among women in the USA overall, but marked racial and geographical disparities persist. The federal government has announced an initiative that aims to decrease the number of new infections in the nation by 90% within the next 10 years. With this in mind, we highlight important recent developments concerning HIV epidemiology, comorbidities, treatment, and prevention among women in the USA. We conclude that, to end the US HIV epidemic, substantially greater inclusion of US women in clinical research will be required, as will better prevention and treatment efforts, with universal access to health care and other supportive services that enable women to exercise agency in their own HIV prevention and care. Ending the epidemic will also require eliminating the race, class, and gender inequities, as well as the discrimination and structural violence, that have promoted and maintained the distribution of HIV in the USA, and that will, if unchecked, continue to fuel the epidemic in the future.	[Adimora, Adaora A.; Ramirez, Catalina; Archin, Nancie M.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA; [Poteat, Tonia] Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27515 USA; [Adimora, Adaora A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Adimora, Adaora A.; Averitt, Dawn; Auerbach, Judith D.] Well Project, Res Initiat HIV AIDS, New York, NY USA; [Auerbach, Judith D.; Gandhi, Monica] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA; [Agwu, Allison L.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Agwu, Allison L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Currier, Judith] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Adimora, AA (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA.	adimora@med.unc.edu						Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; Adimora AA, 2017, CLIN INFECT DIS, V65, P324, DOI 10.1093/cid/cix313; Adimora AA, 2014, AIDS, V28, P1393, DOI 10.1097/QAD.0000000000000225; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bavinton BR, 2018, LANCET HIV, V5, pE438, DOI 10.1016/S2352-3018(18)30132-2; Becasen JS, 2019, AM J PUBLIC HEALTH, V109, pE1, DOI 10.2105/AJPH.2018.304727; Bourgi K, 2020, CLIN INFECT DIS, V70, P1267, DOI 10.1093/cid/ciz407; Bradley E, 2019, J WOMENS HEALTH, V28, P1272, DOI 10.1089/jwh.2018.7353; Bradley ELP, 2019, MMWR-MORBID MORTAL W, V68, P416, DOI 10.15585/mmwr.mm6818a3; Braun HM, 2017, LGBT HEALTH, V4, P371, DOI 10.1089/lgbt.2017.0057; Bukowski LA, 2018, JAIDS-J ACQ IMM DEF, V79, P413, DOI 10.1097/QAI.0000000000001831; Calabrese SK, 2019, LANCET HIV, V6, pE211, DOI 10.1016/S2352-3018(19)30030-X; Chappell CA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.03.045; Chen JS, 2019, AIDS, V33, P637, DOI 10.1097/QAD.0000000000002094; Chow FC, 2018, AIDS, V32, P59, DOI [10.1097/QAD.0000000000001650, 10.1097/qad.0000000000001650]; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohn SE, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy232; Cook JA, 2018, AIDS BEHAV, V22, P3141, DOI 10.1007/s10461-018-2051-3; Cottrell ML, 2019, CLIN INFECT DIS, V69, P2201, DOI 10.1093/cid/ciz290; Cottrell ML, 2016, J INFECT DIS, V214, P55, DOI 10.1093/infdis/jiw077; Coy KC, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25252; Crepaz N, 2017, AIDS, V31, P1641, DOI 10.1097/QAD.0000000000001526; Crepaz N, 2016, CLIN INFECT DIS, V63, P976, DOI 10.1093/cid/ciw418; Crissman HP, 2017, AM J PUBLIC HEALTH, V107, P213, DOI 10.2105/AJPH.2016.303571; Curno MJ, 2016, JAIDS-J ACQ IMM DEF, V71, P181, DOI 10.1097/QAI.0000000000000842; Das B, 2018, P NATL ACAD SCI USA, V115, pE7795, DOI 10.1073/pnas.1803468115; Delaporte, 2019, 10 IAS C HIV SCI MEX; Demeke HB, 2018, AM J PUBLIC HEALTH, V108, pS299, DOI [10.2105/AJPH.2018.304641, 10.2105/ajph.2018.304641]; Denning P., 2010, 18 INT AIDS C; Dunn David T, 2019, Stat Commun Infect Dis, V11, P20190006, DOI 10.1515/scid-2019-0006; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Feinstein MJ, 2019, CIRCULATION, V140, pE98, DOI 10.1161/CIR.0000000000000695; Frederiksen B, 2019, NEW TITLE 10 REGULAT; Gianella S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20706; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Hatleberg CI, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25083; Hill A, 2019, J VIRUS ERAD, V5, P41; Hodder SL, 2013, ANN INTERN MED, V158, P10, DOI 10.7326/0003-4819-158-1-201301010-00004; Hoffman RM, 2019, CLIN INFECT DIS, V68, P273, DOI 10.1093/cid/ciy471; Huang YLA, 2018, MMWR-MORBID MORTAL W, V67, P1147, DOI 10.15585/mmwr.mm6741a3; Hynes JS, 2019, J WOMENS HEALTH, V28, P665, DOI 10.1089/jwh.2018.7001; Janjua SA, 2017, J AM COLL CARDIOL, V69, P107, DOI 10.1016/j.jacc.2016.11.013; Kaiser Family Foundation, 2020, STAT STAT ACT MED EX; Kaiser Family Foundation, 2018, KEY FACTS UN POP; Kates, 2014, HIV INTIMATE PARTNER; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Koethe JR, 2016, AIDS RES HUM RETROV, V32, P50, DOI 10.1089/aid.2015.0147; Maki PM, 2018, JAIDS-J ACQ IMM DEF, V79, P101, DOI 10.1097/QAI.0000000000001764; Maki PM, 2015, NEUROLOGY, V84, P231, DOI 10.1212/WNL.0000000000001151; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mendoza MCB, 2018, AIDS, V32, P2033, DOI [10.1097/QAD.0000000000001921, 10.1097/qad.0000000000001921]; Mills JC, 2019, JAIDS-J ACQ IMM DEF, V82, P225, DOI 10.1097/QAI.0000000000002140; Mills JC, 2018, CLIN INFECT DIS, V67, P1575, DOI 10.1093/cid/ciy264; Mizuno Y, 2015, LGBT HEALTH, V2, P228, DOI 10.1089/lgbt.2014.0099; Mofenson LM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25352; Mofenson LM, 2016, J INFECT DIS, V213, P1051, DOI 10.1093/infdis/jiv390; NORWOOD J, 2017, ACQUIR IMMUNE DEFIC, V76, P527; Nwangwu-Ike N, 2020, J RURAL HEALTH, V36, P217, DOI 10.1111/jrh.12384; O'Leary A, 2017, AIDS BEHAV, V21, P2895, DOI 10.1007/s10461-016-1635-z; Perez-Brumer A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202389; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Poteat T, 2020, CLIN INFECT DIS, V70, P1131, DOI 10.1093/cid/ciz322; Poteat T, 2019, JAIDS-J ACQ IMM DEF, V82, P131, DOI 10.1097/QAI.0000000000002112; Prevention Access Campaign, 2019, UND UNTR; Purtle J, 2013, AM J PUBLIC HEALTH, V103, P632, DOI 10.2105/AJPH.2012.300933; Radix A, 2016, J INT AIDS SOC, V19, P44, DOI 10.7448/IAS.19.3.20810; Raifman JR, 2019, JAIDS-J ACQ IMM DEF, V80, P36, DOI 10.1097/QAI.0000000000001879; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; Rodger Alison J, 2016, JAMA, V316, P171, DOI 10.1001/jama.2016.5148; Rosen JG, 2019, AIDS BEHAV, V23, P2588, DOI 10.1007/s10461-019-02581-x; Rubin LH, 2019, JAIDS-J ACQ IMM DEF, V81, P274, DOI 10.1097/QAI.0000000000002029; Rubin LH, 2018, JAIDS-J ACQ IMM DEF, V79, P83, DOI [10.1097/qai.0000000000001755, 10.1097/QAI.0000000000001755]; Rubin LH, 2017, NEUROLOGY, V89, P1594, DOI 10.1212/WNL.0000000000004491; Rudolph JE, 2019, EPIDEMIOLOGY, V30, P358, DOI 10.1097/EDE.0000000000000966; Sales JM, 2019, CONTRACEPTION, V99, P233, DOI 10.1016/j.contraception.2018.12.008; Scully EP, 2019, J INFECT DIS, V219, P1084, DOI 10.1093/infdis/jiy617; Smith DK, 2018, ANN EPIDEMIOL, V28, P850, DOI 10.1016/j.annepidem.2018.05.003; Spudich S, 2019, J CLIN INVEST, V129, P3339, DOI 10.1172/JCI127413; Sullivan PS, 2018, ANN EPIDEMIOL, V28, P833, DOI 10.1016/j.annepidem.2018.06.009; Sundermann EE, 2018, AIDS, V32, P2719, DOI 10.1097/QAD.0000000000002012; Tanner AE, 2018, MATERN CHILD HLTH J, V22, P1233, DOI 10.1007/s10995-018-2603-1; Thurman AR, 2017, AIDS RES HUM RETROV, V33, P807, DOI [10.1089/AID.2016.0320, 10.1089/aid.2016.0320]; Tomko C, 2019, AIDS PATIENT CARE ST, V33, P49, DOI 10.1089/apc.2018.0182; Tuthill EL, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25224; Uggen C, 2002, AM SOCIOL REV, V67, P777, DOI 10.2307/3088970; US Census Bureau, 2019, US WORLD POP CLOCK; US Centers for Disease Control and Prevention, 2018, HIV PEOPL AG 50 OLD; US Centers for Disease Control and Prevention, 2019, HIV PREGN WOM INF CH; US Centers for Disease Control and Prevention, 2019, NCHHSTP ATLASPLUS; US Centers for Disease Control and Prevention, 20 HIV US CDCP; US Centers for Disease Control and Prevention, 2018, PREEXP PROPH PREV HI; US Centers for Disease Control and Prevention, 2019, HIV WOM; US Centers for Disease Control and Prevention, 2018, HIV SURVEILLANCE REP; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Womack JA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001035; Xilong, 2018, ID WEEK; Zanni MV, 2020, J INFECT DIS, V221, P1315, DOI 10.1093/infdis/jiz184; Zash R, 2019, NEW ENGL J MED, V381, P827, DOI 10.1056/NEJMoa1905230	99	15	15	2	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1107	1115		10.1016/S0140-6736(21)00396-2	http://dx.doi.org/10.1016/S0140-6736(21)00396-2		MAR 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617768				2022-12-28	WOS:000630397800028
J	Dougan, M; Luoma, AM; Dougan, SK; Wucherpfennig, KW				Dougan, Michael; Luoma, Adrienne M.; Dougan, Stephanie K.; Wucherpfennig, Kai W.			Understanding and treating the inflammatory adverse events of cancer immunotherapy	CELL			English	Review								During the past decade, immunotherapies have made a major impact on the treatment of diverse types of cancer. Inflammatory toxicities are not only a major concern for Food and Drug Administration (FDA)-approved checkpoint blockade and chimeric antigen receptor (CAR) T cell therapies, but also limit the development and use of combination therapies. Fundamentally, these adverse events highlight the intricate balance of pro- and anti-inflammatory pathways that regulate protective immune responses. Here, we discuss the cellular and molecular mechanisms of inflammatory adverse events, current approaches to treatment, as well as opportunities for the design of immunotherapies that limit such inflammatory toxicities while preserving anti-tumor efficacy.	[Dougan, Michael] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Dougan, Michael] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Dougan, Michael] Harvard Med Sch, Boston, MA 02114 USA; [Luoma, Adrienne M.; Dougan, Stephanie K.; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, 450 Brookline Ave, Boston, MA 02215 USA; [Luoma, Adrienne M.; Dougan, Stephanie K.; Wucherpfennig, Kai W.] Harvard Med Sch, Dept Immunol, 25 Shattuck St, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Brigham & Womens Hosp, Dept Neurol, 25 Shattuck St, Boston, MA 02115 USA; [Wucherpfennig, Kai W.] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Dougan, M (corresponding author), Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.; Dougan, M (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Dougan, M (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & Virol, 450 Brookline Ave, Boston, MA 02215 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, Dept Immunol, 25 Shattuck St, Boston, MA 02115 USA.; Wucherpfennig, KW (corresponding author), Brigham & Womens Hosp, Dept Neurol, 25 Shattuck St, Boston, MA 02115 USA.; Wucherpfennig, KW (corresponding author), Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA.	mldougan@partners.org; kai_wucherpfennig@dfci.harvard.edu			American Cancer Society [MRAT-18-113-01]; Melanoma Research Alliance [597698]; NIH [R01 CA238039, R01CA251599, P01 CA163222, T32CA207021]; NIH Mentored Clinical Scientist Development Award [1K08DK114563-01]; American Gastroenterological Association Research Scholars Award	American Cancer Society(American Cancer Society); Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Mentored Clinical Scientist Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association Research Scholars Award	This work was supported by a Team Award from the American Cancer Society (MRAT-18-113-01), the Melanoma Research Alliance (597698 to K.W.W., S.K.D., and M.D.), NIH (R01 CA238039, R01CA251599, and P01 CA163222 to K.W.W. and T32CA207021 to A.M.L. and K.W.W.), a NIH Mentored Clinical Scientist Development Award (1K08DK114563-01 to M.D.), and the American Gastroenterological Association Research Scholars Award (to M.D.).	Abu-Sbeih H, 2020, J CLIN ONCOL, V38, P576, DOI 10.1200/JCO.19.01674; Abu-Sbeih H, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0461-4; Acharya N, 2020, IMMUNITY, V53, P658, DOI 10.1016/j.immuni.2020.08.005; Alspach E, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a028480; Arbour KC, 2018, J CLIN ONCOL, V36, P2872, DOI 10.1200/JCO.2018.79.0006; Badran YR, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0711-0; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bertrand F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02358-7; Brudno JN, 2019, BLOOD REV, V34, P45, DOI 10.1016/j.blre.2018.11.002; Cappelli LC, 2017, ARTHRIT CARE RES, V69, P1751, DOI 10.1002/acr.23177; Cavalli G, 2015, RHEUMATOLOGY, V54, P2134, DOI 10.1093/rheumatology/kev269; Charych DH, 2016, CLIN CANCER RES, V22, P680, DOI 10.1158/1078-0432.CCR-15-1631; Cohen JV, 2021, MODERN PATHOL, V34, P426, DOI 10.1038/s41379-020-00653-1; Crayne CB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00119; de Filette J, 2019, HORM METAB RES, V51, P145, DOI 10.1055/a-0843-3366; Deya-Martinez A, 2021, BONE MARROW TRANSPL, V56, P376, DOI 10.1038/s41409-020-01027-6; Dolladille C, 2020, JAMA ONCOL, V6, P865, DOI 10.1001/jamaoncol.2020.0726; Dougan M, 2021, GASTROENTEROLOGY, V160, P1384, DOI 10.1053/j.gastro.2020.08.063; Dougan M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01547; Dougan M, 2017, J CELL BIOCHEM, V118, P3049, DOI 10.1002/jcb.26005; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Esfahani K, 2020, NAT REV CLIN ONCOL, V17, P504, DOI 10.1038/s41571-020-0352-8; Eshhar Z, 2014, CANCER J, V20, P123, DOI 10.1097/PPO.0000000000000027; Faje AT, 2018, CANCER-AM CANCER SOC, V124, P3706, DOI 10.1002/cncr.31629; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Gust J, 2018, CNS DRUGS, V32, P1091, DOI 10.1007/s40263-018-0582-9; Horvat TZ, 2015, J CLIN ONCOL, V33, P3193, DOI 10.1200/JCO.2015.60.8448; Hughes MS, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0756-0; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Kalos M, 2013, IMMUNITY, V39, P49, DOI 10.1016/j.immuni.2013.07.002; Keegan A, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000678; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Leonardi GC, 2018, J CLIN ONCOL, V36, P1905, DOI 10.1200/JCO.2017.77.0305; Letourneau S, 2010, P NATL ACAD SCI USA, V107, P2171, DOI 10.1073/pnas.0909384107; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Luoma AM, 2020, CELL, V182, P655, DOI 10.1016/j.cell.2020.06.001; Marthey L, 2016, J CROHNS COLITIS, V10, P395, DOI 10.1093/ecco-jcc/jjv227; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Maude SL, 2014, CANCER J, V20, P119, DOI 10.1097/PPO.0000000000000035; Menzies AM, 2017, ANN ONCOL, V28, P368, DOI 10.1093/annonc/mdw443; Mooradian MJ, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000451; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Morsut L, 2016, CELL, V164, P780, DOI 10.1016/j.cell.2016.01.012; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Neurath MF, 2019, CYTOKINE GROWTH F R, V45, P1, DOI 10.1016/j.cytogfr.2018.12.002; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Parker KR, 2020, CELL, V183, P126, DOI 10.1016/j.cell.2020.08.022; Pauken KE, 2019, TRENDS IMMUNOL, V40, P511, DOI 10.1016/j.it.2019.04.002; Phillips GS, 2019, J CLIN ONCOL, V37, P2746, DOI 10.1200/JCO.18.02141; Pollack MH, 2018, ANN ONCOL, V29, P250, DOI 10.1093/annonc/mdx642; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Raje N, 2019, NEW ENGL J MED, V380, P1726, DOI 10.1056/NEJMoa1817226; Reynolds K, 2018, ONCOLOGIST, V23, P991, DOI 10.1634/theoncologist.2018-0174; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Rosato PC, 2020, CURR OPIN IMMUNOL, V63, P35, DOI 10.1016/j.coi.2020.01.001; Roybal KT, 2016, CELL, V167, P419, DOI 10.1016/j.cell.2016.09.011; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Safa H, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0774-y; Salem JE, 2019, NEW ENGL J MED, V380, P2377, DOI 10.1056/NEJMc1901677; Shiuan E, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0210-0; Silva DA, 2019, NATURE, V565, P186, DOI 10.1038/s41586-018-0830-7; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Srivastava S, 2019, CANCER CELL, V35, P489, DOI 10.1016/j.ccell.2019.02.003; Stamatouli A, 2018, DIABETES, V67, P1471, DOI 10.2337/dbi18-0002; Tahir SA, 2019, P NATL ACAD SCI USA, V116, P22246, DOI 10.1073/pnas.1908079116; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Tsang VHM, 2019, J CLIN ENDOCR METAB, V104, P5499, DOI 10.1210/jc.2019-00423; U.S. Food and Drug Administration, 2017, YESCARTA PACKAGE INS; U.S. Food and Drug Administration, 2017, KYMRIAH PRODUCT INFO; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Verheijden RJ, 2020, CLIN CANCER RES, V26, P2268, DOI 10.1158/1078-0432.CCR-19-3322; Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923; Wucherpfennig KW, 2011, SEMIN IMMUNOL, V23, P84, DOI 10.1016/j.smim.2011.01.007; Zhao YL, 2019, IMMUNITY, V51, P1059, DOI 10.1016/j.immuni.2019.11.003; Zhu EF, 2015, CANCER CELL, V27, P489, DOI 10.1016/j.ccell.2015.03.004	86	28	30	23	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2021	184	6					1575	1588		10.1016/j.cell.2021.02.011	http://dx.doi.org/10.1016/j.cell.2021.02.011		MAR 2021	14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QY9LN	33675691	Bronze, Green Accepted			2022-12-28	WOS:000630357400020
J	Verma, A; Ahmad, A; Giovannini, F				Verma, Aditi; Ahmad, Ali; Giovannini, Francesca			Nuclear energy, ten years after Fukushima	NATURE			English	Editorial Material						Energy; Policy		Amid the urgent need to decarbonize, the industry that delivers one-tenth of global electricity must consult the public on reactor research, design, regulation, location and waste. Amid the urgent need to decarbonize, the industry that delivers one-tenth of global electricity must consult the public on reactor research, design, regulation, location and waste.	[Verma, Aditi; Ahmad, Ali; Giovannini, Francesca] Harvard Univ, John F Kennedy Sch Govt, Project Managing Atom, Cambridge, MA 02138 USA	Harvard University	Giovannini, F (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Project Managing Atom, Cambridge, MA 02138 USA.	francesca_giovannini@hks.harvard.edu						CostanzaChock S, 2020, INFORM POL, P1; Goldstein J., 2019, NY TIMES; International Atomic Energy Agency, 1981, ANN REPORT; Kurokawa K., 2018, EXAMINING REGULATORY; Morgan MG, 2018, P NATL ACAD SCI USA, V115, P7184, DOI 10.1073/pnas.1804655115; Nuclear Energy Agency, NUCL ENERGY DATA 200; SCHNEIDER M., 2020, WORLD NUCL IND STATU; Sovacool BK, 2015, SCI TECHNOL HUM VAL, V40, P96, DOI 10.1177/0162243914542350; STARR C, 1969, SCIENCE, V165, P1232, DOI 10.1126/science.165.3899.1232; Takamura N., 2019, EIGHT YEARS FUKUSHIM; Turner K. M., 2020, ATOMIC SCIENTISTS; Verma A., 2019, THESIS	12	6	6	6	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					199	201		10.1038/d41586-021-00580-4	http://dx.doi.org/10.1038/d41586-021-00580-4			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS6DD	33674786				2022-12-28	WOS:000625987600001
J	Mahase, E				Mahase, Elisabeth			A vaccine against malaria: five minutes with ... Richard Bucala	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2021	372								n651	10.1136/bmj.n651	http://dx.doi.org/10.1136/bmj.n651			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6RV	33685925				2022-12-28	WOS:000632926700001
J	Abu Srour, S				Abu Srour, Shatha			Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory	LANCET			English	Editorial Material												shatha857@gmail.com						Anabtawi S, 2019, WASHINGTON POST; Hammad S., 2020, MIDDLE E EYE    1120; UNICEF, 2020, COV 19 PROT NEEDS ID; WHO, 2020, HLTH COND OCC PAL TE	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					861	862						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676617				2022-12-28	WOS:000626603400006
J	Vimalesvaran, S; Ireland, J; Khashu, M				Vimalesvaran, Sunitha; Ireland, Jillian; Khashu, Minesh			Mind your language: respectful language within maternity services	LANCET			English	Editorial Material							CHILDBIRTH; BIRTH; CARE		[Vimalesvaran, Sunitha] Luton & Dunstable Hosp, Luton, Beds, England; [Ireland, Jillian; Khashu, Minesh] Univ Hosp Dorset, Poole BH15 2JB, Dorset, England; [Ireland, Jillian; Khashu, Minesh] Bournemouth Univ, Poole, Dorset, England	Bournemouth University	Khashu, M (corresponding author), Univ Hosp Dorset, Poole BH15 2JB, Dorset, England.; Khashu, M (corresponding author), Bournemouth Univ, Poole, Dorset, England.	minesh.khashu@nhs.net	van Teijlingen, Edwin R/A-3727-2010; Khashu, Minesh/GLT-6749-2022; Khashu, Minesh/GRF-0302-2022	van Teijlingen, Edwin R/0000-0001-5523-8583; Khashu, Minesh/0000-0003-2673-5948; Vimalesvaran, Sunitha/0000-0002-5289-6537				Afulani PA, 2019, LANCET GLOB HEALTH, V7, pE96, DOI 10.1016/S2214-109X(18)30403-0; [Anonymous], 2018, RECOMMENDATIONS INTR; Bohren MA, 2019, LANCET, V394, P1750, DOI 10.1016/S0140-6736(19)31992-0; Briscoe L, 2016, J ADV NURS, V72, P2330, DOI 10.1111/jan.13017; Carboon F., 1999, AUST COLL MIDWIVES I; Chadwick RJ, 2014, MIDWIFERY, V30, P862, DOI 10.1016/j.midw.2013.12.014; Hunter LP, 2006, J MIDWIFERY WOM HEAL, V51, P119, DOI 10.1016/j.jmwh.2005.11.009; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; NICE, 2017, INTR CAR HLTH WOM BA; Oakley A, 2016, SOCIOL HEALTH ILL, V38, P689, DOI 10.1111/1467-9566.12400; Spratt V., 2020, REFINERY29 0217, V29; Vedam S, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0729-2; Warren CE, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-21, 10.1186/1471-2393-13-150]	14	2	2	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					859	861						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QT5BR	33676616				2022-12-28	WOS:000626603400005
J	Blendon, RJ; Benson, JM; Schneider, EC				Blendon, Robert J.; Benson, John M.; Schneider, Eric C.			The Future of Health Policy in a Partisan United States Insights From Public Opinion Polls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint summarizes views measured in national opinion polls about COVID-19 response, national health insurance reform, reforming the US health care system in general, and race and race disparities in health, with a focus on differences between Democrat and Republican respondents and implications of those differences for enacting meaningful legislation.	[Blendon, Robert J.; Benson, John M.] Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA; [Schneider, Eric C.] Commonwealth Fund, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Commonwealth Fund	Blendon, RJ (corresponding author), Harvard TH Chan Sch Publ Hlth, 677 Huntington Ave, Boston, MA 02115 USA.	rblendon@hsph.harvard.edu			Commonwealth Fund	Commonwealth Fund	This research was supported by a grant from The Commonwealth Fund.		0	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2021	325	13					1253	1254		10.1001/jama.2021.1147	http://dx.doi.org/10.1001/jama.2021.1147		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK4TM	33666642				2022-12-28	WOS:000625804000001
J	Lamontagne, F; Agoritsas, T; Siemieniuk, R; Rochwerg, B; Bartoszko, J; Askie, L; Macdonald, H; Amin, W; Bausch, FJ; Burhan, E; Cecconi, M; Chanda, D; Dat, VQ; Du, B; Geduld, H; Gee, P; Nerina, H; Hashimi, M; Hunt, BJ; Kabra, S; Kanda, S; Kawano-Dourado, L; Kim, YJ; Kissoon, N; Kwizera, A; Leo, YS; Mahaka, I; Manai, H; Mino, G; Nsutebu, E; Pshenichnaya, N; Qadir, N; Ranganathan, SS; Sabzwari, S; Sarin, R; Sharland, M; Shen, YZ; Souza, JP; Stegemann, M; Ugarte, S; Venkatapuram, S; Vuyiseka, D; Preller, J; Brignardello-Petersen, R; Kum, E; Qasim, A; Zeraatkar, D; Owen, A; Guyatt, G; Lytvyn, L; Diaz, J; Vandvik, PO; Jacobs, M				Lamontagne, Francois; Agoritsas, Thomas; Siemieniuk, Reed; Rochwerg, Bram; Bartoszko, Jessica; Askie, Lisa; Macdonald, Helen; Amin, Wagdy; Bausch, Frederique Jacquerioz; Burhan, Erlina; Cecconi, Maurizio; Chanda, Duncan; Vu Quoc Dat; Du, Bin; Geduld, Heike; Gee, Patrick; Nerina, Harley; Hashimi, Madiha; Hunt, Beverley J.; Kabra, Sushil; Kanda, Seema; Kawano-Dourado, Leticia; Kim, Yae-Jean; Kissoon, Niranjan; Kwizera, Arthur; Leo, Yee-Sin; Mahaka, Imelda; Manai, Hela; Mino, Greta; Nsutebu, Emmanuel; Pshenichnaya, Natalia; Qadir, Nida; Ranganathan, Shalini Sri; Sabzwari, Saniya; Sarin, Rohit; Sharland, Michael; Shen, Yinzhong; Souza, Joao Paulo; Stegemann, Miriam; Ugarte, Sebastian; Venkatapuram, Sridhar; Vuyiseka, Dubula; Preller, Jacobus; Brignardello-Petersen, Romina; Kum, Elena; Qasim, Anila; Zeraatkar, Dena; Owen, Andrew; Guyatt, Gordon; Lytvyn, Lyubov; Diaz, Janet; Vandvik, Per Olav; Jacobs, Michael			A living WHO guideline on drugs to prevent covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								CLINICAL QUESTION What is the role of drugs in preventing covid-19? WHY DOES THIS MATTER? There is widespread interest in whether drug interventions can be used for the prevention of covid-19, but there is uncertainty about which drugs, if any, are effective. The first version of this living guideline focuses on the evidence for hydroxychloroquine. Subsequent updates will cover other drugs being investigated for their role in the prevention of covid-19. RECOMMENDATION The guideline development panel made a strong recommendation against the use of hydroxychloroquine for individuals who do not have covid-19 (high certainty). HOW THIS GUIDELINE WAS CREATED This living guideline is from the World Health Organization (WHO) and provides up to date covid-19 guidance to inform policy and practice worldwide. Magic Evidence Ecosystem Foundation (MAGIC) provided methodological support. A living systematic review with network analysis informed the recommendations. An international guideline development panel of content experts, clinicians, patients, an ethicist and methodologists produced recommendations following standards for trustworthy guideline development using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. UNDERSTANDING THE NEW RECOMMENDATION The linked systematic review and network meta-analysis (6 trials and 6059 participants) found that hydroxychloroquine had a small or no effect on mortality and admission to hospital (high certainty evidence). There was a small or no effect on laboratory confirmed SARS-CoV-2 infection (moderate certainty evidence) but probably increased adverse events leading to discontinuation (moderate certainty evidence). The panel judged that almost all people would not consider this drug worthwhile. In addition, the panel decided that contextual factors such as resources, feasibility, acceptability, and equity for countries and healthcare systems were unlikely to alter the recommendation. The panel considers that this drug is no longer a research priority and that resources should rather be oriented to evaluate other more promising drugs to prevent covid-19. UPDATES This is a living guideline. New recommendations will be published in this article and signposted by update notices to this guideline. READERS NOTE This is the first version of the living guideline for drugs to prevent covid-19. It complements the WHO living guideline on drugs to treat covid-19. When citing this article, please consider adding the update number and date of access for clarity. Drugs could be used as prophylaxis to prevent covid-19 developing in those who are free from disease. Such drugs complement vaccines that, through developing immune responses to SARS-Cov-2, reduce the risk of developing covid-19 and its consequences. Drugs to prevent covid-19 could target whole populations, those at higher risk of becoming infected with SARS-CoV-2 (due to their work, social circumstances, or a particular exposure), or those at higher risk of death and poor outcomes if infected. There are 2610 trials investigating various drug interventions for covid-19 (see section on emerging evidence).1 This rapidly evolving evidence landscape requires trustworthy interpretation and expeditious clinical practice guidelines to inform clinicians, patients, governments, ministries and health administrators. This living guideline uses emerging evidence from RCTs on drugs to prevent covid-19 and complements the livingWHOguideline on drugs to treat covid-19.(2) The living network meta-analysis associated with this guideline will incorporate new trial data and allow for analysis of comparative effectiveness.3 Details of the network meta-analysis and other related publications are listed in box 1. We will also use additional relevant evidence on long term safety, prognosis, and patient values and preferences related to covid-19 treatments to inform the living guidance.	[Lamontagne, Francois] Univ Sherbrooke, Ctr Rech CHU Sherbrooke, Sherbrooke, PQ, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Agoritsas, Thomas; Siemieniuk, Reed; Rochwerg, Bram; Bartoszko, Jessica; Brignardello-Petersen, Romina; Kum, Elena; Qasim, Anila; Zeraatkar, Dena; Guyatt, Gordon; Lytvyn, Lyubov] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Agoritsas, Thomas; Diaz, Janet; Vandvik, Per Olav] MAGIC Evidence Ecosyst Fdn, Oslo, Norway; [Siemieniuk, Reed; Rochwerg, Bram; Guyatt, Gordon] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Askie, Lisa; Preller, Jacobus] WHO, Geneva, Switzerland; [Amin, Wagdy] Minist Hlth & Populat, Cairo, Egypt; [Bausch, Frederique Jacquerioz] Geneva Univ Hosp, Geneva, Switzerland; [Burhan, Erlina] Univ Indonesia, Infect Div, Dept Pulmonol & Resp Med, Fac Med, Depok, Indonesia; [Cecconi, Maurizio] IRCCS, Dept Anesthesia & Intens Care Med, Humanitas Clin & Res Ctr, Rozzano, Italy; [Chanda, Duncan] Univ Teaching Hosp, Adult Infect Dis Ctr, Lusaka, Zambia; [Vu Quoc Dat] Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam; [Du, Bin] Peking Union Med Coll Hosp, Beijing, Peoples R China; [Geduld, Heike] Stellenbosch Univ, Div Emergency Med, Fac Med & Hlth Sci, Cape Town, South Africa; [Nerina, Harley] Royal Melbourne Hosp, Melbourne, Australia; [Hashimi, Madiha] Ziauddin Univ, Karachi, Pakistan; [Hunt, Beverley J.] Guys & St Thomas NHS Fdn Trust, London, England; [Kabra, Sushil] All India Inst Med Sci, New Delhi, India; [Kanda, Seema] McMaster Univ, Hamilton, ON, Canada; [Kawano-Dourado, Leticia] Univ Sao Paulo, Heart Inst InCor HCFMUSP, Med Sch, Pulm Div, Sao Paulo, Brazil; [Kawano-Dourado, Leticia] Hosp Coracao HCor, Res Inst, Sao Paulo, Brazil; [Kim, Yae-Jean] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Kissoon, Niranjan] Univ British Columbia, Dept Paediat & Emergency Med, Vancouver, BC, Canada; [Kwizera, Arthur] Makerere Univ, Dept Anaesthesia & Crit Care, Coll Hlth Sci, Kampala, Uganda; [Leo, Yee-Sin] Natl Ctr Infect Dis, Singapore, Singapore; [Mahaka, Imelda] Pangaea Harare, Harare, Zimbabwe; [Manai, Hela] Emergency Med Serv, Fac Med, Tunis, Tunisia; [Mino, Greta] Alcivar Hosp, Guayaquil, Ecuador; [Nsutebu, Emmanuel] Sheikh Shakhbout Med City, Abu Dhabi, U Arab Emirates; [Pshenichnaya, Natalia] Cent Res Inst Epidemiol Rospotrebnadzor, Moscow, Russia; [Qadir, Nida] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Ranganathan, Shalini Sri] Univ Colombo, Colombo, Sri Lanka; [Sabzwari, Saniya] Aga Khan Univ, Karachi, Pakistan; [Sarin, Rohit] Natl Inst TB & Resp Dis, New Delhi, India; [Sharland, Michael] St Georges Univ Hosp, London, England; [Shen, Yinzhong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Souza, Joao Paulo] Univ Sao Paulo, Sao Paulo, Brazil; [Stegemann, Miriam] Charite Univ Med Berlin, Berlin, Germany; [Stegemann, Miriam] Free Univ Berlin, Berlin, Germany; [Stegemann, Miriam] Humboldt Univ, Dept Infect Dis & Resp Med, Berlin, Germany; [Ugarte, Sebastian] Andres Bello Univ, Indisa Clin, Fac Med, Santiago, Chile; [Venkatapuram, Sridhar] Kings Coll London, London, England; [Vuyiseka, Dubula] Univ Stellenbosch, Stellenbosch, South Africa; [Owen, Andrew] Univ Liverpool, Liverpool, Merseyside, England; [Vandvik, Per Olav] Univ Oslo, Dept Hlth Econ & Hlth Management, Inst Hlth & Soc, Oslo, Norway; [Jacobs, Michael] Royal Free London NHS Fdn Trust, London, England	University of Sherbrooke; University of Geneva; University of Geneva; McMaster University; McMaster University; World Health Organization; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; University of Geneva; University of Indonesia; IRCCS Humanitas Research Hospital; University of Zambia; Hanoi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Stellenbosch University; Royal Melbourne Hospital; Ziauddin University; Guy's & St Thomas' NHS Foundation Trust; All India Institute of Medical Sciences (AIIMS) New Delhi; McMaster University; Universidade de Sao Paulo; Hospital do Coracao - HCor; Sungkyunkwan University (SKKU); Samsung Medical Center; University of British Columbia; Makerere University; National Centre for Infectious Diseases Singapore; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Colombo; Aga Khan University; St Georges University London; Fudan University; Universidade de Sao Paulo; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Clinica Indisa; Universidad Andres Bello; University of London; King's College London; Stellenbosch University; University of Liverpool; University of Oslo; University of London; University College London; Royal Free London NHS Foundation Trust	Lamontagne, F (corresponding author), Univ Sherbrooke, Ctr Rech CHU Sherbrooke, Sherbrooke, PQ, Canada.; Jacobs, M (corresponding author), Royal Free London NHS Fdn Trust, London, England.	francois.lamontagne@usherbrooke.ca; michael.jacobs@ucl.ac.uk	Preller, Jacobus/AAD-4334-2022; Cecconi, Maurizio/HDN-8785-2022; Pshenichcnaya, Natalia Y/Q-2352-2016; Burhan, Erlina/AAR-6425-2021; Zeraatkar, Dena/GNM-9600-2022; Chanda, Duncan/N-1045-2019; Souza, João Paulo/G-1982-2010; Cecconi, Maurizio/A-6241-2012; Venkatapuram, Sridhar/B-4846-2017	Preller, Jacobus/0000-0001-5706-816X; Cecconi, Maurizio/0000-0002-4376-6538; Pshenichcnaya, Natalia Y/0000-0003-2570-711X; Burhan, Erlina/0000-0002-6617-499X; Souza, João Paulo/0000-0002-2288-4244; Cecconi, Maurizio/0000-0002-4376-6538; Kissoon, Niranjan/0000-0001-8847-9973; Venkatapuram, Sridhar/0000-0003-3076-0783; Lamontagne, Francois/0000-0002-0360-3427; Stegemann, Miriam Songa/0000-0002-7968-0429; Kum, Elena/0000-0002-6548-2632; Qasim, Anila/0000-0001-9658-0078; Hunt, Beverley Jane/0000-0002-4709-0774				Abella BS, 2021, JAMA INTERN MED, V181, P195, DOI 10.1001/jamainternmed.2020.6319; Barnabas RV, 2021, ANN INTERN MED, V174, P344, DOI 10.7326/M20-6519; Bartoszko JJ, 2021, PROPHYLAXIS COVID 19, DOI [10.1101/2021.02.24.21250469v1, DOI 10.1101/2021.02.24.21250469V1]; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379; Maguire Brittany J, 2020, Wellcome Open Res, V5, P60, DOI 10.12688/wellcomeopenres.15821.1; Marti-Soler H, 2020, BMC INFECT DIS, DOI [10.21203/rs.3.rs-72132/v1, DOI 10.21203/RS.3.RS-72132/V1]; Mitja O, 2021, NEW ENGL J MED, V384, P417, DOI 10.1056/NEJMoa2021801; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Rajasingham Radha, 2021, Clin Infect Dis, V72, pe835, DOI [10.1101/2020.09.18.20197327, 10.1093/cid/ciaa1571]; Schreiber K, 2020, LANCET RHEUMATOL, V2, pE735, DOI 10.1016/S2665-9913(20)30382-9; World Health Organization, 2008, HDB GUID DEV	12	46	46	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n526	10.1136/bmj.n526	http://dx.doi.org/10.1136/bmj.n526			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33649077	Green Published, Bronze			2022-12-28	WOS:000625340300003
J	Sutton, EL				Sutton, Eliza L.			In the clinic Insomnia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							COGNITIVE-BEHAVIORAL THERAPY; OBSTRUCTIVE SLEEP-APNEA; RESTLESS LEGS SYNDROME; AMERICAN-ACADEMY; PRACTICE GUIDELINE; PRACTICE PARAMETERS; MEDICINE; DISORDER; HEALTH; ADULTS		[Sutton, Eliza L.] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Sutton, EL (corresponding author), Univ Washington, Seattle, WA 98195 USA.				American College of Physicians	American College of Physicians	American College of Physicians.	Abraham O, 2017, SLEEP HEALTH, V3, P43, DOI 10.1016/j.sleh.2016.11.004; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, DOI DOI 10.1176/APPI.BOOKS.9780890425596.893619; Amra B, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_653_18; [Anonymous], 2018, MED LETT DRUGS THER, V60, P201; Appleton SL, 2018, SLEEP HEALTH, V4, P13, DOI 10.1016/j.sleh.2017.10.006; Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988; Beaulieu-Bonneau S, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx002; Brasure M, 2016, ANN INTERN MED, V165, P113, DOI 10.7326/M15-1782; Broomfield NM, 2005, J SLEEP RES, V14, P401, DOI 10.1111/j.1365-2869.2005.00481.x; Capezuti E, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0794-3; Chung F, 2009, CURR OPIN ANESTHESIO, V22, P405, DOI 10.1097/ACO.0b013e32832a96e2; Chung KF, 2018, FAM PRACT, V35, P365, DOI 10.1093/fampra/cmx122; Edinger JD, 2021, J CLIN SLEEP MED, V17, P255, DOI 10.5664/jcsm.8986; Erland LAE, 2017, J CLIN SLEEP MED, V13, P275, DOI 10.5664/jcsm.6462; Espie CA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004183; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Gunn HE, 2019, SLEEP MED CLIN, V14, P235, DOI 10.1016/j.jsmc.2019.02.003; Haghayegh S, 2019, J MED INTERNET RES, V21, DOI 10.2196/16273; Herbert V, 2018, SLEEP MED REV, V39, P37, DOI 10.1016/j.smrv.2017.07.001; Hom MA, 2017, PSYCHIAT RES, V253, P116, DOI 10.1016/j.psychres.2017.03.046; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Kishi T, 2020, J PSYCHIATR RES, V128, P68, DOI 10.1016/j.jpsychires.2020.05.025; Kolla BP, 2018, SLEEP MED REV, V38, P131, DOI 10.1016/j.smrv.2017.06.002; Koopman ADM, 2020, J CLIN ENDOCR METAB, V105, P614, DOI 10.1210/clinem/dgz065; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Liu J, 2019, TELEMED E-HEALTH, V25, P1189, DOI 10.1089/tmj.2018.0202; Luik AI, 2019, BRIT J GEN PRACT, V69, P79, DOI 10.3399/bjgp19X701045; Maust DT, 2019, AM J GERIAT PSYCHIAT, V27, P32, DOI 10.1016/j.jagp.2018.09.004; Morgenthaler T, 2006, SLEEP, V29, P1415; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 2009, ARCH INTERN MED, V169, P447, DOI 10.1001/archinternmed.2008.610; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Mukherjee S, 2015, AM J RESP CRIT CARE, V191, P1450, DOI 10.1164/rccm.201504-0767ST; National Sleep Foundation, SLEEP DIAR; Nesbitt AD, 2018, J THORAC DIS, V10, pS103, DOI 10.21037/jtd.2018.01.11; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Rezaie L, 2018, SLEEP MED REV, V40, P196, DOI 10.1016/j.smrv.2018.01.002; Riemann D, 2017, J SLEEP RES, V26, P675, DOI 10.1111/jsr.12594; Rios P, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-1163-9; Ryden AM, 2019, J CLIN SLEEP MED, V15, P543, DOI 10.5664/jcsm.7710; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Schroeck JL, 2016, CLIN THER, V37, P2340, DOI 10.1016/j.clinthera.2016.09.010; Schutte-Rodin S, 2008, J CLIN SLEEP MED, V4, P487; Smith MT, 2018, J CLIN SLEEP MED, V14, P1209, DOI 10.5664/jcsm.7228; Soh HL, 2020, SLEEP MED, V75, P315, DOI 10.1016/j.sleep.2020.08.020; Stewart NH, 2018, SLEEP MED CLIN, V13, P127, DOI 10.1016/j.jsmc.2017.09.012; Suh S, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0940-9; Sutton EL, 2014, MED CLIN N AM, V98, P1123, DOI 10.1016/j.mcna.2014.06.009; U.S. Food and Drug Administration, 2019, SLEEP DIS SED HYPN D; University of Pittsburgh Center for Sleep and Circadian Science, MEAS STUD INSTR; van Straten A, 2018, SLEEP MED REV, V38, P3, DOI 10.1016/j.smrv.2017.02.001; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Zhu LR, 2012, NEUROL CLIN, V30, P1167, DOI 10.1016/j.ncl.2012.08.011	54	15	16	5	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					ITC33	ITC48		10.7326/AITC202103160	http://dx.doi.org/10.7326/AITC202103160			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UU3YH	33683929				2022-12-28	WOS:000698735100001
J	Galib, M; Limmer, DT				Galib, Mirza; Limmer, David T.			Reactive uptake of N2O5 by atmospheric aerosol is dominated by interfacial processes	SCIENCE			English	Article								Nitrogen oxides are removed from the troposphere through the reactive uptake of N2O5 into aqueous aerosol. This process is thought to occur within the bulk of an aerosol, through solvation and subsequent hydrolysis. However, this perspective is difficult to reconcile with field measurements and cannot be verified directly because of the fast reaction kinetics of N2O5. Here, we use molecular simulations, including reactive potentials and importance sampling, to study the uptake of N2O5 into an aqueous aerosol. Rather than being mediated by the bulk, uptake is dominated by interfacial processes due to facile hydrolysis at the liquid-vapor interface and competitive reevaporation. With this molecular information, we propose an alternative interfacial reactive uptake model consistent with existing experimental observations.	[Galib, Mirza; Limmer, David T.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Limmer, David T.] Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Limmer, David T.] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Limmer, David T.] Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Limmer, DT (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Limmer, DT (corresponding author), Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA.; Limmer, DT (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Limmer, DT (corresponding author), Lawrence Berkeley Natl Lab, Chem Sci Div, Berkeley, CA 94720 USA.	dlimmer@berkeley.edu		Galib, Mirza/0000-0001-9186-3220; Limmer, David/0000-0002-2766-0688	National Science Foundation through the National Science Foundation Center for Aerosol Impacts on Chemistry of the Environment (NSF-CAICE) [CHE 1801971]; National Energy Research Scientific Computing Center (NERSC), a U.S. Department of Energy Office of Science User Facility [DE-AC02-05CH1123]	National Science Foundation through the National Science Foundation Center for Aerosol Impacts on Chemistry of the Environment (NSF-CAICE); National Energy Research Scientific Computing Center (NERSC), a U.S. Department of Energy Office of Science User Facility	This work was funded by the National Science Foundation through the National Science Foundation Center for Aerosol Impacts on Chemistry of the Environment (NSF-CAICE) under grant no. CHE 1801971. This research used resources of the National Energy Research Scientific Computing Center (NERSC), a U.S. Department of Energy Office of Science User Facility operated under contract no. DE-AC02-05CH1123.		0	34	34	15	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					921	+		10.1126/science.abd7716	http://dx.doi.org/10.1126/science.abd7716			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632842				2022-12-28	WOS:000621813400038
J	Mehrotra, A; Nimgaonkar, A; Richman, B				Mehrotra, Ateev; Nimgaonkar, Alok; Richman, Barak			Telemedicine and Medical Licensure - Potential Paths for Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mehrotra, Ateev] Harvard Med Sch, Boston, MA 02115 USA; [Mehrotra, Ateev] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Nimgaonkar, Alok] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Richman, Barak] Duke Univ, Sch Law, Durham, NC 27706 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Tufts University; Duke University	Mehrotra, A (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Mehrotra, A (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.		Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582				Federation of State Medical Boards, 2018, US MED REG TRENDS AC; Federation of State Medical Boards, 2021, US STAT TERR MOD LIC; Norman J., 2012, TELEMEDICINE SUPPORT; Norwood Candice, 2020, PBS NEWSHOUR	4	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					687	690		10.1056/NEJMp2031608	http://dx.doi.org/10.1056/NEJMp2031608			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP4LK	33626604	Bronze			2022-12-28	WOS:000623807600007
J	Flanagin, A; Frey, T; Christiansen, SL; Bauchner, H				Flanagin, Annette; Frey, Tracy; Christiansen, Stacy L.; Bauchner, Howard			The Reporting of Race and Ethnicity in Medical and Science Journals Comments Invited	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Flanagin, Annette; Christiansen, Stacy L.; Bauchner, Howard] JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA; [Flanagin, Annette; Frey, Tracy] JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA		Flanagin, A (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.; Flanagin, A (corresponding author), JAMA Network, 330 N Wabash Ave, Chicago, IL 60611 USA.	annette.flanagin@jamanetwork.org	Christiansen, Stacy/AAM-1170-2021					American Sociological Association, RACE AND ETHNICITY; [Anonymous], 2020, AMA MANUAL STYLE GUI, V11th ed; Bauchner H, 2015, JAMA-J AM MED ASSOC, V313, P1423, DOI 10.1001/jama.2015.2262; Campbell KM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.15220; Carnethon MR, 2020, JAMA-J AM MED ASSOC, V323, P211, DOI 10.1001/jama.2019.19329; Cooper LA, 2019, JAMA INTERN MED, V179, P1686, DOI 10.1001/jamainternmed.2019.4100; Doubeni CA, 2021, JAMA-J AM MED ASSOC, V325, P627, DOI 10.1001/jama.2020.26188; Eneanya ND, 2019, JAMA-J AM MED ASSOC, V322, P113, DOI 10.1001/jama.2019.5774; Flores G, 2020, JAMA PEDIATR, V174, DOI 10.1001/jamapediatrics.2020.3238; Fontanarosa PB, 2018, JAMA-J AM MED ASSOC, V320, P1539, DOI 10.1001/jama.2018.14438; Gianfrancesco MA, 2018, JAMA INTERN MED, V178, P1544, DOI 10.1001/jamainternmed.2018.3763; Ioannidis JPA, 2021, JAMA-J AM MED ASSOC, V325, P623, DOI 10.1001/jama.2021.0003; JAMA, INSTR AUTH REP DEM I; Malina D, 2021, NEW ENGL J MED, V384, P474, DOI 10.1056/NEJMms2029562; National Cancer Institute, CANC DISP; Ogedegbe G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16531; OSBORNE NG, 1992, JAMA-J AM MED ASSOC, V267, P275, DOI 10.1001/jama.267.2.275; Parikh RB, 2019, JAMA-J AM MED ASSOC, V322, P2377, DOI 10.1001/jama.2019.18058; Pew research center, WHO IS HISP; Polite BN, 2019, JAMA-J AM MED ASSOC, V321, P1663, DOI 10.1001/jama.2019.4266; Powe NR, 2020, JAMA-J AM MED ASSOC, V324, P737, DOI 10.1001/jama.2020.13378; Rivara FP, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16825; Satcher D, 1973, JAMA, V223, P1498; US Department of Health and Human Services, HHS IMPL GUID DAT CO; Weinberger DR, 2020, NEURON, V107, P407, DOI 10.1016/j.neuron.2020.07.008; Yancy CW, 2020, JAMA-J AM MED ASSOC, V324, P435, DOI 10.1001/jama.2020.12532	26	118	117	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2021	325	11					1049	1052		10.1001/jama.2021.2104	http://dx.doi.org/10.1001/jama.2021.2104		FEB 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QZ1BV	33616604	Bronze			2022-12-28	WOS:000621912400003
J	Siva, N				Siva, Nayanah			Severe mental illness: reassessing COVID-19 vaccine priorities	LANCET			English	Editorial Material																			0	11	11	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					657	657						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33610199	Green Published, Bronze			2022-12-28	WOS:000620991800011
J	Jiang, BB; Yu, Y; Cui, J; Liu, XX; Xie, L; Liao, JC; Zhang, QH; Huang, Y; Ning, SC; Jia, BH; Zhu, B; Bai, SQ; Chen, LD; Pennycook, SJ; He, JQ				Jiang, Binbin; Yu, Yong; Cui, Juan; Liu, Xixi; Xie, Lin; Liao, Jincheng; Zhang, Qihao; Huang, Yi; Ning, Shoucong; Jia, Baohai; Zhu, Bin; Bai, Shengqiang; Chen, Lidong; Pennycook, Stephen J.; He, Jiaqing			High-entropy-stabilized chalcogenides with high thermoelectric performance	SCIENCE			English	Article							LATTICE THERMAL-CONDUCTIVITY; TRANSPORT-PROPERTIES; POWER-GENERATION; POINT-DEFECTS; EFFICIENCY; ELECTRON; ALLOYS; PBSE; LEAD; PBTE	Thermoelectric technology generates electricity from waste heat, but one bottleneck for wider use is the performance of thermoelectric materials. Manipulating the configurational entropy of a material by introducing different atomic species can tune phase composition and extend the performance optimization space. We enhanced the figure of merit (zT) value to 1.8 at 900 kelvin in an n-type PbSe-based high-entropy material formed by entropy-driven structural stabilization. The largely distorted lattices in this high-entropy system caused unusual shear strains, which provided strong phonon scattering to largely lower lattice thermal conductivity. The thermoelectric conversion efficiency was 12.3% at temperature difference Delta T = 507 kelvin, for the fabricated segmented module based on this n-type high-entropy material. Our demonstration provides a paradigm to improve thermoelectric performance for high-entropy thermoelectric materials through entropy engineering.	[Jiang, Binbin; Yu, Yong; Cui, Juan; Liu, Xixi; Xie, Lin; Huang, Yi; Jia, Baohai; Zhu, Bin; He, Jiaqing] Southern Univ Sci & Technol, Dept Phys, Shenzhen Key Lab Thermoelect Mat, Shenzhen 518055, Peoples R China; [Yu, Yong; Ning, Shoucong; Pennycook, Stephen J.] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117575, Singapore; [Liao, Jincheng; Zhang, Qihao; Bai, Shengqiang; Chen, Lidong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China; [He, Jiaqing] Southern Univ Sci & Technol, Guangdong Hong Kong Macao Joint Lab Photon Therma, Shenzhen 518055, Peoples R China	Southern University of Science & Technology; National University of Singapore; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Southern University of Science & Technology	He, JQ (corresponding author), Southern Univ Sci & Technol, Dept Phys, Shenzhen Key Lab Thermoelect Mat, Shenzhen 518055, Peoples R China.; He, JQ (corresponding author), Southern Univ Sci & Technol, Guangdong Hong Kong Macao Joint Lab Photon Therma, Shenzhen 518055, Peoples R China.	hejq@sustech.edu.cn	Zhang, Qihao/AAN-6011-2021; Jiang, Binbin/AAJ-5292-2021; Bai, Shengqiang/E-9284-2014; Chen, Lidong/F-2705-2010; He, Jiaqing/A-2245-2010	Jiang, Binbin/0000-0001-5337-8945; Bai, Shengqiang/0000-0002-6985-2960; He, Jiaqing/0000-0003-3954-6003; Zhang, Qihao/0000-0001-7168-7864; YU, Yong/0000-0003-4035-6557	leading talents of the Guangdong Province Program [00201517]; Guangdong-Hong Kong-Macao Joint Laboratory [2019B121205001]; National Natural Science Foundation of China [51632010, 52002167, 11874194, 11934007, 51632005]; Science and Technology Innovation Committee Foundation of Shenzhen [KQTD2016022619565991, ZDSYS20141118160434515]; high level of special funds [G02206302]	leading talents of the Guangdong Province Program; Guangdong-Hong Kong-Macao Joint Laboratory; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Committee Foundation of Shenzhen; high level of special funds	We acknowledge support from the leading talents of the Guangdong Province Program (grant no. 00201517), the Guangdong-Hong Kong-Macao Joint Laboratory (grant no. 2019B121205001), the National Natural Science Foundation of China (grant nos. 52002167, 11874194, 11934007, and 51632005), the Science and Technology Innovation Committee Foundation of Shenzhen (grant nos. KQTD2016022619565991 and ZDSYS20141118160434515), and a high level of special funds (G02206302). L.C. is grateful for support from the National Natural Science Foundation of China (grant no. 51632010).	ABELES B, 1963, PHYS REV, V131, P1906, DOI 10.1103/PhysRev.131.1906; Androulakis J, 2011, J AM CHEM SOC, V133, P10920, DOI 10.1021/ja203022c; Beche A, 2013, ULTRAMICROSCOPY, V131, P10, DOI 10.1016/j.ultramic.2013.03.014; Berardan D, 2017, J ALLOY COMPD, V704, P693, DOI 10.1016/j.jallcom.2017.02.070; Bouchbinder E, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aacef4; Boukhris N, 2014, B MATER SCI, V37, P1159, DOI 10.1007/s12034-014-0057-7; Braun JL, 2018, ADV MATER, V30, DOI 10.1002/adma.201805004; CAHILL DG, 1992, PHYS REV B, V46, P6131, DOI 10.1103/PhysRevB.46.6131; CALLAWAY J, 1960, PHYS REV, V120, P1149, DOI 10.1103/PhysRev.120.1149; Cardona M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075211; Chang C, 2018, SCIENCE, V360, P778, DOI 10.1126/science.aaq1479; Chen ZW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13828; Cui L, 2016, J PHYS CHEM C, V120, P23807, DOI 10.1021/acs.jpcc.6b07162; D'Angelo J, 2011, J ELECTRON MATER, V40, P2051, DOI 10.1007/s11664-011-1717-7; Dragoe N, 2019, SCIENCE, V366, P573, DOI 10.1126/science.aaz1598; FAHEY PM, 1989, REV MOD PHYS, V61, P289, DOI 10.1103/RevModPhys.61.289; Fu CG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9144; Greer AL, 2013, MAT SCI ENG R, V74, P71, DOI 10.1016/j.mser.2013.04.001; He J, 2017, SCIENCE, V357, DOI 10.1126/science.aak9997; Heremans JP, 2012, ENERG ENVIRON SCI, V5, P5510, DOI 10.1039/c1ee02612g; Hu LP, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201802116; Hu XK, 2016, ENERG ENVIRON SCI, V9, P517, DOI 10.1039/c5ee02979a; Hue F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.156602; Jia TT, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.155206; Jiang B, 2018, MATER TODAY PHYS, V5, P20, DOI 10.1016/j.mtphys.2018.05.001; Jiang BB, 2020, ENERG ENVIRON SCI, V13, P579, DOI 10.1039/c9ee03410b; Jiang BB, 2017, J MATER CHEM C, V5, P943, DOI 10.1039/c6tc05068a; Jood P, 2018, JOULE, V2, P1339, DOI 10.1016/j.joule.2018.04.025; Kamila H, 2019, J MATER CHEM A, V7, P1045, DOI 10.1039/c8ta08920e; Korkosz RJ, 2014, J AM CHEM SOC, V136, P3225, DOI 10.1021/ja4121583; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kurosaki K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2009828; Liu HL, 2012, NAT MATER, V11, P422, DOI [10.1038/NMAT3273, 10.1038/nmat3273]; Liu RH, 2017, ADV MATER, V29, DOI 10.1002/adma.201702712; Luo ZZ, 2018, ENERG ENVIRON SCI, V11, P3220, DOI 10.1039/c8ee01755g; Mao J, 2019, SCIENCE, V365, P495, DOI 10.1126/science.aax7792; Miracle DB, 2017, ACTA MATER, V122, P448, DOI 10.1016/j.actamat.2016.08.081; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Pei YZ, 2011, NATURE, V473, P66, DOI 10.1038/nature09996; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Rost CM, 2020, ACTA MATER, V196, P231, DOI 10.1016/j.actamat.2020.06.005; Rost CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9485; Sarkar A, 2019, ADV MATER, V31, DOI 10.1002/adma.201806236; Singh A, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/1/015502; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Song HQ, 2017, PHYS REV MATER, V1, DOI 10.1103/PhysRevMaterials.1.023404; Su WY, 2017, NANO ENERGY, V38, P510, DOI 10.1016/j.nanoen.2017.05.060; Tan GJ, 2016, CHEM REV, V116, P12123, DOI 10.1021/acs.chemrev.6b00255; Togo A, 2015, SCRIPTA MATER, V108, P1, DOI 10.1016/j.scriptamat.2015.07.021; Venkatasubramanian R, 2000, PHYS REV B, V61, P3091, DOI 10.1103/PhysRevB.61.3091; Wan CL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.144109; Wang H, 2012, P NATL ACAD SCI USA, V109, P9705, DOI 10.1073/pnas.1111419109; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Wu YX, 2019, JOULE, V3, P1276, DOI 10.1016/j.joule.2019.02.008; Xiao Y, 2017, J AM CHEM SOC, V139, P18732, DOI 10.1021/jacs.7b11662; Xing YF, 2019, ENERG ENVIRON SCI, V12, P3390, DOI 10.1039/c9ee02228g; Yang J, 2004, APPL PHYS LETT, V85, P1140, DOI 10.1063/1.1783022; Ye YF, 2018, ACTA MATER, V150, P182, DOI 10.1016/j.actamat.2018.03.008; YEH JW, 2004, ADV ENG MATER, V6, P299; Zhang QH, 2017, ENERG ENVIRON SCI, V10, P956, DOI 10.1039/c7ee00447h; Zhang QY, 2012, ENERG ENVIRON SCI, V5, P5246, DOI 10.1039/c1ee02465e; Zhao DG, 2010, MAT SCI SEMICON PROC, V13, P221, DOI 10.1016/j.mssp.2010.10.016; Zhao LD, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3485050; Zong PA, 2017, ENERG ENVIRON SCI, V10, P183, DOI 10.1039/c6ee02467j; ZUNGER A, 1990, PHYS REV LETT, V65, P353, DOI 10.1103/PhysRevLett.65.353	66	218	219	255	973	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					830	+		10.1126/science.abe1292	http://dx.doi.org/10.1126/science.abe1292			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602853				2022-12-28	WOS:000619664700053
J	Roe, N				Roe, Nicholas			The art of medicine John Keats, medicine, and poetry	LANCET			English	Editorial Material									[Roe, Nicholas] Univ St Andrews, Sch English, St Andrews KY16 9AL, Fife, Scotland	University of St Andrews	Roe, N (corresponding author), Univ St Andrews, Sch English, St Andrews KY16 9AL, Fife, Scotland.	nhr@st-andrews.ac.uk							0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2021	397	10278					962	963		10.1016/S0140-6736(21)00450-5	http://dx.doi.org/10.1016/S0140-6736(21)00450-5		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QV2NT	33631129				2022-12-28	WOS:000627814200014
J	Li, L; Neuroth, LM; Valachovic, E; Schwebel, DC; Zhu, MT				Li, Li; Neuroth, Lucas M.; Valachovic, Edward; Schwebel, David C.; Zhu, Motao			Association Between Changes in Social Distancing Policies in Ohio and Traffic Volume and Injuries, January Through July 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study compares traffic volume and motor vehicle crash injuries before, during, and after state-of-emergency and stay-at-home orders in the state of Ohio from January to July 2020 vs the same period in 2019.	[Li, Li] Ohio State Univ, Coll Publ Hlth, Columbus, OH USA; [Neuroth, Lucas M.; Zhu, Motao] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH USA; [Valachovic, Edward] SUNY Rensselaer, Dept Epidemiol & Biostat, Rensselaer, NY USA; [Schwebel, David C.] Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; State University of New York (SUNY) System; University of Alabama System; University of Alabama Birmingham	Zhu, MT (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.	motao.zhu@nationwidechildrens.org	Schwebel, David/GXH-9944-2022	Neuroth, Lucas/0000-0002-0097-6631	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01HD074594]; National Institute on Aging (NIA) [R01AG050581]	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; R01HD074594 [2013-2022]) and the National Institute on Aging (NIA; R01AG050581 [2016-2021]).	Katrakazas Christos, 2020, Transp Res Interdiscip Perspect, V7, P100186, DOI 10.1016/j.trip.2020.100186; Mervosh S, 2020, NEW YORK TIMES; Thomas FD, 2020, 813018 DOT HS	3	7	7	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					1003	1006		10.1001/jama.2020.25770	http://dx.doi.org/10.1001/jama.2020.25770			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687457	Green Published, Bronze			2022-12-28	WOS:000627899400023
J	China, L; Freemantle, N; Forrest, E; Kallis, Y; Ryder, SD; Wright, G; Portal, AJ; Salles, NB; Gilroy, DW; O'Brien, A				China, Louise; Freemantle, Nick; Forrest, Ewan; Kallis, Yiannis; Ryder, Stephen D.; Wright, Gavin; Portal, Andrew J.; Salles, Natalia Becares; Gilroy, Derek W.; O'Brien, Alastair		ATTIRE Trial Investigators	A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTELY DECOMPENSATED CIRRHOSIS; CHRONIC LIVER-FAILURE; BACTERIAL-INFECTIONS; INTRAVENOUS ALBUMIN; MORTALITY; SURVIVAL	BACKGROUND Infection and increased systemic inflammation cause organ dysfunction and death in patients with decompensated cirrhosis. Preclinical studies provide support for an antiinflammatory role of albumin, but confirmatory large-scale clinical trials are lacking. Whether targeting a serum albumin level of 30 g per liter or greater in these patients with repeated daily infusions of 20% human albumin solution, as compared with standard care, would reduce the incidences of infection, kidney dysfunction, and death is unknown. METHODS We conducted a randomized, multicenter, open-label, parallel-group trial involving hospitalized patients with decompensated cirrhosis who had a serum albumin level of less than 30 g per liter at enrollment. Patients were randomly assigned to receive either targeted 20% human albumin solution for up to 14 days or until discharge, whichever came first, or standard care. Treatment commenced within 3 days after admission. The composite primary end point was new infection, kidney dysfunction, or death between days 3 and 15 after the initiation of treatment. RESULTS A total of 777 patients underwent randomization, and alcohol was reported to be a cause of cirrhosis in most of these patients. A median total infusion of albumin of 200 g (interquartile range, 140 to 280) per patient was administered to the targeted albumin group (increasing the albumin level to =30 g per liter), as compared with a median of 20 g (interquartile range, 0 to 120) per patient administered to the standard-care group (adjusted mean difference, 143 g; 95% confidence interval [CI], 127 to 158.2). The percentage of patients with a primary end-point event did not differ significantly between the targeted albumin group (113 of 380 patients [29.7%]) and the standard-care group (120 of 397 patients [30.2%]) (adjusted odds ratio, 0.98; 95% CI, 0.71 to 1.33; P = 0.87). A time-to-event analysis in which data were censored at the time of discharge or at day 15 also showed no significant between-group difference (hazard ratio, 1.04; 95% CI, 0.81 to 1.35). More severe or life-threatening serious adverse events occurred in the albumin group than in the standard-care group. CONCLUSIONS In patients hospitalized with decompensated cirrhosis, albumin infusions to increase the albumin level to a target of 30 g per liter or more was not more beneficial than the current standard care in the United Kingdom. (Funded by the Health Innovation Challenge Fund; ATTIRE EudraCT number, 2014-002300-24; ISRCT number, N14174793.)	[China, Louise; Salles, Natalia Becares; O'Brien, Alastair] UCL, Inst Liver & Digest Hlth, London, England; [Freemantle, Nick] UCL, Comprehens Clin Trials Unit, London, England; [Gilroy, Derek W.] UCL, Div Med, London, England; [Kallis, Yiannis] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England; [Forrest, Ewan] Glasgow Royal Infirm, Glasgow, Lanark, Scotland; [Forrest, Ewan] Univ Glasgow, Glasgow, Lanark, Scotland; [Ryder, Stephen D.] Nottingham Univ Hosp NHS Trust, Natl Inst Hlth Res, Nottingham Biomed Res Ctr, Nottingham, England; [Ryder, Stephen D.] Univ Nottingham, Queens Med Ctr, Nottingham, England; [Wright, Gavin] Mid & South Essex NHS Fdn Trust, Basildon, England; [Wright, Gavin] Basildon & Thurrock Univ Hosp NHS Fdn Trust, Basildon, England; [Portal, Andrew J.] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; Queen Mary University London; University of Glasgow; University of Glasgow; Nottingham University Hospital NHS Trust; University of Nottingham; University of Nottingham; Bristol Royal Infirmary	O'Brien, A (corresponding author), UCL, Inst Liver & Digest Hlth, Div Med, Upper 3rd Fl,Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	a.o'brien@ucl.ac.uk	Skene, Simon S/L-6239-2015; China, Louise/O-9540-2018	Skene, Simon S/0000-0002-7828-3122; ramage, john/0000-0003-4824-6600; China, Louise/0000-0001-5870-2310; Elsharkawy, Ahmed Mohamed/0000-0001-5369-3734; McPherson, Stuart/0000-0002-5638-2453; Aspinall, Richard/0000-0002-5208-8185; Ryder, Stephen David/0000-0001-9649-4444; corless, lynsey/0000-0001-9720-8729; Forrest, Ewan/0000-0002-7293-2574; O'Brien, Alastair/0000-0002-9168-7009; Blackstone, James/0000-0003-4335-5269	Wellcome Trust [HICF-R8-439, WT102568]; Department of Health and Social Care [HICF-R8-439, WT102568]	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health and Social Care	Supported by a grant (HICF reference HICF-R8-439, WT grant number WT102568, to Dr. O'Brien) from the Health Innovation Challenge Fund (a partnership between the Wellcome Trust and the Department of Health and Social Care).	Alcaraz-Quiles J, 2018, HEPATOLOGY, V68, P1937, DOI 10.1002/hep.30135; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Bajaj JS, 2018, AM J GASTROENTEROL, V113, P1339, DOI 10.1038/s41395-018-0119-3; Bajaj JS, 2014, HEPATOLOGY, V60, P250, DOI 10.1002/hep.27077; Bajaj JS, 2012, HEPATOLOGY, V56, P2328, DOI 10.1002/hep.25947; Best LMJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013103.pub2; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Caraceni P, 2018, LANCET, V391, P2417, DOI 10.1016/S0140-6736(18)30840-7; China L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023754; China L, 2018, CLIN GASTROENTEROL H, V16, P748, DOI 10.1016/j.cgh.2017.09.012; China L, 2018, CLIN GASTROENTEROL H, V16, P738, DOI 10.1016/j.cgh.2017.08.027; Dionigi E, 2017, AM J GASTROENTEROL, V112, P588, DOI 10.1038/ajg.2017.19; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Fernandez Javier, 2020, Clin Gastroenterol Hepatol, V18, P963, DOI 10.1016/j.cgh.2019.07.055; Fernandez J, 2019, GASTROENTEROLOGY, V157, P149, DOI 10.1053/j.gastro.2019.03.021; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Garcia-Martinez R, 2015, J HEPATOL, V62, P799, DOI 10.1016/j.jhep.2014.10.031; Garioud A, 2017, J CLIN GASTROENTEROL, V51, P831, DOI [10.1097/MCG.0000000000000735, 10.1097/mcg.0000000000000735]; Guevara M, 2012, J HEPATOL, V57, P759, DOI 10.1016/j.jhep.2012.06.013; KUNKEL HG, 1948, J CLIN INVEST, V27, P305, DOI 10.1172/JCI101959; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; O'Brien AJ, 2014, NAT MED, V20, P522, DOI 10.1038/nm.3516; Piano S, 2016, HEPATOLOGY, V63, P1299, DOI 10.1002/hep.27941; Poca M, 2012, CLIN GASTROENTEROL H, V10, P309, DOI 10.1016/j.cgh.2011.11.012; Public Health England, 2020, LIV DIS APPL ALL OUR; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Salerno F, 2013, CLIN GASTROENTEROL H, V11, P123, DOI 10.1016/j.cgh.2012.11.007; Schmidt ML, 2015, GASTROENTEROLOGY, V148, P967, DOI 10.1053/j.gastro.2015.01.032; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; Simon-Talero M, 2013, J HEPATOL, V59, P1184, DOI 10.1016/j.jhep.2013.07.020; Simonetti RG, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004039.pub2; Sola E, 2018, J HEPATOL, V69, P1250, DOI 10.1016/j.jhep.2018.08.006; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Thevenot T, 2015, J HEPATOL, V62, P822, DOI 10.1016/j.jhep.2014.11.017; Thursz MR, 2015, NEW ENGL J MED, V372, P1619, DOI 10.1056/NEJMoa1412278; Trebicka J, 2020, J HEPATOL, V73, P842, DOI 10.1016/j.jhep.2020.06.013	37	76	75	5	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					808	817		10.1056/NEJMoa2022166	http://dx.doi.org/10.1056/NEJMoa2022166			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS8DS	33657293	Green Published, Bronze			2022-12-28	WOS:000626124800016
J	Ogunwole, SM				Ogunwole, S. Michelle			Without Sanctuary	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ogunwole, S. Michelle] Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA	Johns Hopkins University	Ogunwole, SM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gen Internal Med, Baltimore, MD 21205 USA.			Ogunwole, Serena Michelle/0000-0001-9479-7695				Brandeis University, 2020, AM RAC RECK BLACK LI; Essien U, 2020, CLIN PROBLEM SOLVERS; Garrison V, 2020, GIRLTREK BLACK HIST; Kendi IX, 2019, BE ANTIRACIST, DOI [10.1056/NEJMp2030623, DOI 10.1056/NEJMP2030623]; Skrine Jeffers K, 2020, INT J NURS STUD	5	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					791	793		10.1056/NEJMp2030623	http://dx.doi.org/10.1056/NEJMp2030623			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QS8DS	33657685	Bronze			2022-12-28	WOS:000626124800014
J	Sehn, LH; Salles, G				Sehn, Laurie H.; Salles, Gilles			Diffuse Large B-Cell Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; NON-HODGKIN-LYMPHOMA; PHASE-III TRIAL; ELDERLY-PATIENTS; RESPONSE ASSESSMENT; SINGLE-ARM; OPEN-LABEL; R-CHOP; 6 CYCLES; MULTICENTER		[Sehn, Laurie H.] BC Canc Ctr Lymphoid Canc, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada; [Sehn, Laurie H.] Univ British Columbia, Vancouver, BC, Canada; [Salles, Gilles] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA	University of British Columbia; Memorial Sloan Kettering Cancer Center	Sehn, LH (corresponding author), BC Canc Ctr Lymphoid Canc, 600 W 10th Ave, Vancouver, BC V5Z 4E6, Canada.	lsehn@bccancer.bc.ca	Salles, Gilles/Z-2336-2019	Salles, Gilles/0000-0002-9541-8666				Abramson JS, 2020, LANCET, V396, P839, DOI 10.1016/S0140-6736(20)31366-0; Advani R, 2018, NEW ENGL J MED, V379, P1711, DOI 10.1056/NEJMoa1807315; Ansell SM, 2019, J CLIN ONCOL, V37, P481, DOI 10.1200/JCO.18.00766; Arnason JE, 2020, 62 AM SOC HEM VIRT A; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Bartlett NL, 2019, J CLIN ONCOL, V37, P1790, DOI 10.1200/JCO.18.01994; Casasnovas RO, 2011, BLOOD, V118, P37, DOI 10.1182/blood-2010-12-327767; Cerhan JR, 2014, NAT GENET, V46, P1233, DOI 10.1038/ng.3105; Cerhan James R., 2014, Journal of the National Cancer Institute Monographs, P15, DOI 10.1093/jncimonographs/lgu010; Chapuy B, 2018, NAT MED, V24, P679, DOI 10.1038/s41591-018-0016-8; Cheah CY, 2014, BRIT J CANCER, V111, P1072, DOI 10.1038/bjc.2014.405; Cheson BD, 2016, BLOOD, V128, P2489, DOI 10.1182/blood-2016-05-718528; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Crump M, 2017, BLOOD, V130, P1800, DOI 10.1182/blood-2017-03-769620; Crump M, 2016, J CLIN ONCOL, V34, P2484, DOI 10.1200/JCO.2015.65.7171; Crump M, 2014, J CLIN ONCOL, V32, P3490, DOI 10.1200/JCO.2013.53.9593; Czuczman MS, 2017, CLIN CANCER RES, V23, P4127, DOI 10.1158/1078-0432.CCR-16-2818; Davids MS, 2017, J CLIN ONCOL, V35, P826, DOI 10.1200/JCO.2016.70.4320; Davies A, 2019, LANCET ONCOL, V20, P649, DOI 10.1016/S1470-2045(18)30935-5; Dierickx D, 2018, NEW ENGL J MED, V378, P549, DOI 10.1056/NEJMra1702693; Ennishi D, 2019, J CLIN ONCOL, V37, P190, DOI 10.1200/JCO.18.01583; Eyre TA, 2020, HAEMATOLOGICA, V105, P1914, DOI 10.3324/haematol.2019.229948; Fields PA, 2014, J CLIN ONCOL, V32, P282, DOI 10.1200/JCO.2013.49.7586; Freeman CL, 2020, BLOOD; Gisselbrecht C, 2010, J CLIN ONCOL, V28, P4184, DOI 10.1200/JCO.2010.28.1618; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hamadani M, 2020, BLOOD; Hutchings M, J CLIN ONCOL; Hutchings M, 2020, BLOOD, V136, DOI 10.1182/blood-2020-133820; Jacobsen ED, 2015, BLOOD, V125, P1394, DOI 10.1182/blood-2014-09-598763; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Jurczak W, 2018, ANN ONCOL, V29, P1266, DOI 10.1093/annonc/mdy056; Kalakonda N, 2020, LANCET HAEMATOL, V7, pE509; Klanova M, 2019, BLOOD, V133, P919, DOI 10.1182/blood-2018-07-862862; Kurtz DM, 2018, J CLIN ONCOL, V36, P2845, DOI 10.1200/JCO.2018.78.5246; Lamy T, 2018, BLOOD, V131, P174, DOI 10.1182/blood-2017-07-793984; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Leonard JP, 2017, J CLIN ONCOL, V35, P3538, DOI 10.1200/JCO.2017.73.2784; Lin JK, 2019, J CLIN ONCOL, V37, P2105, DOI 10.1200/JCO.18.02079; Locke FL, 2019, LANCET ONCOL, V20, P31, DOI 10.1016/S1470-2045(18)30864-7; Maurer MJ, 2018, J CLIN ONCOL, V36, P1603, DOI 10.1200/JCO.2017.76.5198; Maurer MJ, 2014, J CLIN ONCOL, V32, P1066, DOI 10.1200/JCO.2013.51.5866; McKay P, 2018, BLOOD, V132, P4196, DOI DOI 10.1182/BLOOD-2018-99-113411; Meyer PN, 2011, J CLIN ONCOL, V29, P200, DOI 10.1200/JCO.2010.30.0368; Miller TP, 1998, NEW ENGL J MED, V339, P21, DOI 10.1056/NEJM199807023390104; Moccia AA, BLOOD ADV; Mounier N, 2013, HAEMATOLOGICA, V98, P1726, DOI 10.3324/haematol.2013.090597; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Nowakowski GS, J CLIN ONCOL; Nowakowski GS, 2021, J CLIN ONCOL; Orellana-Noia VM, 2020, BLOOD, V136, DOI 10.1182/blood-2020-134798; Palanca-Wessels MCA, 2015, LANCET ONCOL, V16, P704, DOI 10.1016/S1470-2045(15)70128-2; Persky DO, 2020, J CLIN ONCOL, V38, P3003, DOI 10.1200/JCO.20.00999; Petrich AM, 2014, BLOOD, V124, P2354, DOI 10.1182/blood-2014-05-578963; Peyrade F, 2017, LANCET HAEMATOL, V4, pE46, DOI 10.1016/S2352-3026(16)30171-5; Peyrade F, 2011, LANCET ONCOL, V12, P460, DOI 10.1016/S1470-2045(11)70069-9; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Poeschel V, 2019, LANCET, V394, P2271, DOI 10.1016/S0140-6736(19)33008-9; Recher C, 2011, LANCET, V378, P1858, DOI 10.1016/S0140-6736(11)61040-4; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2019, J CLIN ONCOL, V37, P3359, DOI 10.1200/JCO.19.00743; Ruppert AS, 2020, BLOOD, V135, P2041, DOI 10.1182/blood.2019002729; Rutherford SC, 2020, BLOOD ADV, V4, P1589, DOI 10.1182/bloodadvances.2019001261; Salles G, 2020, LANCET ONCOL, V21, P978, DOI 10.1016/S1470-2045(20)30225-4; Savage KJ, 2016, BLOOD, V127, P2182, DOI 10.1182/blood-2015-10-676700; Schmitz N, 2016, J CLIN ONCOL, V34, P3150, DOI 10.1200/JCO.2015.65.6520; Schuster SJ, 2019, BLOOD, V134, DOI 10.1182/blood-2019-123742; Schuster SJ, 2019, NEW ENGL J MED, V380, P45, DOI 10.1056/NEJMoa1804980; Scott DW, 2018, BLOOD, V131, P2060, DOI 10.1182/blood-2017-12-820605; Scott DW, 2015, J CLIN ONCOL, V33, P2848, DOI 10.1200/JCO.2014.60.2383; Sehn LH, 2007, BLOOD, V109, P1857, DOI 10.1182/blood-2006-08-038257; Sehn LH, 2019, BLOOD, V134, DOI 10.1182/blood-2019-128722; Sehn LH, 2020, J CLIN ONCOL, V38, P155, DOI 10.1200/JCO.19.00172; Sehn LH, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-116845; Sehn LH, 2011, J CLIN ONCOL, V29, P1452, DOI 10.1200/JCO.2010.33.3419; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Stephens DM, 2016, J CLIN ONCOL, V34, P2997, DOI 10.1200/JCO.2015.65.4582; Swerdlow SH., 2017, WHO CLASSIFICATION T, V2, P453; Thieblemont C, 2017, J CLIN ONCOL, V35, P2473, DOI 10.1200/JCO.2017.72.6984; Vercellino L, 2020, BLOOD, V135, P1396, DOI 10.1182/blood.2019003526; Viardot A, 2016, BLOOD, V127, P1410, DOI [10.1182/blood-2015-06-651380, 10.1182/blood-2015-06651380]; Vitolo U, 2017, J CLIN ONCOL, V35, P3529, DOI 10.1200/JCO.2017.73.3402; Wang YC, 2019, J CLIN ONCOL, V37, P1819, DOI 10.1200/JCO.19.00014; Wilson WH, 2015, NAT MED, V21, P922, DOI 10.1038/nm.3884; Witzig TE, 2018, ANN ONCOL, V29, P707, DOI 10.1093/annonc/mdx764; Wright GW, 2020, CANCER CELL, V37, P551, DOI 10.1016/j.ccell.2020.03.015; Younes A, 2019, J CLIN ONCOL, V37, P1285, DOI 10.1200/JCO.18.02403; Zhou Z, 2014, BLOOD, V123, P837, DOI 10.1182/blood-2013-09-524108	89	116	119	24	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2021	384	9					842	858		10.1056/NEJMra2027612	http://dx.doi.org/10.1056/NEJMra2027612			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS8DS	33657296	Green Accepted			2022-12-28	WOS:000626124800019
J	Gu, ZR; Pan, SK; Lin, ZZ; Hu, L; Dai, XY; Chang, J; Xue, YC; Su, H; Long, J; Sun, MR; Ganusevich, S; Sokolov, V; Sokolov, A; Pokrovsky, I; Ji, F; Bruford, MW; Dixon, A; Zhan, XJ				Gu, Zhongru; Pan, Shengkai; Lin, Zhenzhen; Hu, Li; Dai, Xiaoyang; Chang, Jiang; Xue, Yuanchao; Su, Han; Long, Juan; Sun, Mengru; Ganusevich, Sergey; Sokolov, Vasiliy; Sokolov, Aleksandr; Pokrovsky, Ivan; Ji, Fen; Bruford, Michael W.; Dixon, Andrew; Zhan, Xiangjiang			Climate-driven flyway changes and memory-based long-distance migration	NATURE			English	Article							WHOLE-GENOME ASSOCIATION; PEREGRINE FALCONS; GENETIC-STRUCTURE; BREEDING HABITAT; FACTOR-BINDING; SELECTION; TRANSCRIPTION; INFERENCE; EVOLUTION; DATABASE	Millions of migratory birds occupy seasonally favourable breeding grounds in the Arctic(1), but we know little about the formation, maintenance and future of the migration routes of Arctic birds and the genetic determinants of migratory distance. Here we established a continental-scale migration system that used satellite tracking to follow 56 peregrine falcons (Falco peregrinus) from 6 populations that breed in the Eurasian Arctic, and resequenced 35 genomes from 4 of these populations. The breeding populations used five migration routes across Eurasia, which were probably formed by longitudinal and latitudinal shifts in their breeding grounds during the transition from the Last Glacial Maximum to the Holocene epoch. Contemporary environmental divergence between the routes appears to maintain their distinctiveness. We found that the gene ADCY8 is associated with population-level differences in migratory distance. We investigated the regulatory mechanism of this gene, and found that long-term memory was the most likely selective agent for divergence in ADCY8 among the peregrine populations. Global warming is predicted to influence migration strategies and diminish the breeding ranges of peregrine populations of the Eurasian Arctic. Harnessing ecological interactions and evolutionary processes to study climate-driven changes in migration can facilitate the conservation of migratory birds.	[Gu, Zhongru; Pan, Shengkai; Lin, Zhenzhen; Hu, Li; Su, Han; Long, Juan; Zhan, Xiangjiang] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Gu, Zhongru; Pan, Shengkai; Lin, Zhenzhen; Hu, Li; Su, Han; Long, Juan; Bruford, Michael W.; Dixon, Andrew; Zhan, Xiangjiang] Chinese Acad Sci, Cardiff Univ Inst Zool Joint Lab Biocomplex Res, Beijing, Peoples R China; [Gu, Zhongru; Hu, Li; Su, Han; Long, Juan; Sun, Mengru; Zhan, Xiangjiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Dai, Xiaoyang] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Chang, Jiang] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China; [Xue, Yuanchao; Sun, Mengru] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China; [Ganusevich, Sergey] Wild Anim Rescue Ctr, Moscow, Russia; [Sokolov, Vasiliy] Russian Acad Sci, Inst Plant & Anim Ecol, Ural Div, Ekaterinburg, Russia; [Sokolov, Aleksandr; Pokrovsky, Ivan] Russian Acad Sci, Ural Div, Arctic Res Stn, Inst Plant & Anim Ecol, Labytnangi, Russia; [Pokrovsky, Ivan] Max Planck Inst Anim Behav, Dept Migrat, Radolfzell am Bodensee, Germany; [Pokrovsky, Ivan] North FEB RAS, Inst Biol Problems, Lab Ornithol, Magadan, Russia; [Ji, Fen] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Bruford, Michael W.] Cardiff Univ, Sch Biosci, Cardiff, Wales; [Bruford, Michael W.] Cardiff Univ, Sustainable Pl Inst, Cardiff, Wales; [Dixon, Andrew] Emirates Falconers Club, Abu Dhabi, U Arab Emirates; [Dixon, Andrew] Reneco Int Wildlife Consultants, Abu Dhabi, U Arab Emirates; [Dixon, Andrew] Int Wildlife Consultants, Carmarthen, Dyfed, Wales; [Zhan, Xiangjiang] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Bristol; Chinese Research Academy of Environmental Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; Max Planck Society; Institute of Biological Problems of the North; Chinese Academy of Sciences; Institute of Zoology, CAS; Cardiff University; Cardiff University; Chinese Academy of Sciences	Zhan, XJ (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.; Zhan, XJ (corresponding author), Chinese Acad Sci, Cardiff Univ Inst Zool Joint Lab Biocomplex Res, Beijing, Peoples R China.; Zhan, XJ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhan, XJ (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.	zhanxj@ioz.ac.cn	Sokolov, Aleksandr/P-3421-2017; Pokrovsky, Ivan/B-5144-2010; Sokolov, Vasiliy/B-3657-2013	Sokolov, Aleksandr/0000-0002-1521-3856; Pokrovsky, Ivan/0000-0002-6533-674X; Sokolov, Vasiliy/0000-0002-0115-3151; XUE, YUANCHAO/0000-0002-8113-2333; Dai, Xiaoyang/0000-0002-3613-1219; Chang, Jiang/0000-0001-7064-9321	National Natural Science Foundation of China [31821001, 31930013, 31911530186, 91740201]; Strategic Priority Program of Chinese Academy of Sciences [XDB31000000]; National Key Program of Research and Development, Ministry of Science and Technology [2016YFC0503200]; Youth Innovation Promotion Association of Chinese Academy of Sciences [2020086]; Second Tibetan Plateau Scientific Expedition and Research Program (STEP) [2019QZKK0501]; Water Ecological Security Assessment; Major Research Strategy for Middle and Lower Yangtze River [ZDRW-ZS-2017-3]; Biodiversity Survey, Monitoring and Assessment Project (2019-2023) of Ministry of Ecology and Environment, China; CAS President's International Fellowship Initiative for Visiting Scientists; Environment Agency-Abu Dhabi; Max Planck Institute of Animal Behavior; Earthspan; Royal Society	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Program of Chinese Academy of Sciences; National Key Program of Research and Development, Ministry of Science and Technology; Youth Innovation Promotion Association of Chinese Academy of Sciences; Second Tibetan Plateau Scientific Expedition and Research Program (STEP); Water Ecological Security Assessment; Major Research Strategy for Middle and Lower Yangtze River; Biodiversity Survey, Monitoring and Assessment Project (2019-2023) of Ministry of Ecology and Environment, China; CAS President's International Fellowship Initiative for Visiting Scientists; Environment Agency-Abu Dhabi; Max Planck Institute of Animal Behavior; Earthspan; Royal Society(Royal Society of London)	This study was supported by National Natural Science Foundation of China (31821001, 31930013, 31911530186 and 91740201), Strategic Priority Program of Chinese Academy of Sciences (XDB31000000), the National Key Program of Research and Development, Ministry of Science and Technology (2016YFC0503200), Youth Innovation Promotion Association of Chinese Academy of Sciences (2020086) to S.P., Second Tibetan Plateau Scientific Expedition and Research Program (STEP) (2019QZKK0501), Water Ecological Security Assessment, the Major Research Strategy for Middle and Lower Yangtze River (ZDRW-ZS-2017-3), Biodiversity Survey, Monitoring and Assessment Project (2019-2023) of Ministry of Ecology and Environment, China, the Royal Society to X.Z. and M.W.B., and the CAS President's International Fellowship Initiative for Visiting Scientists to M.W.B. Funding for satellite tracking, sampling and partial genome resequencing was provided by the Environment Agency-Abu Dhabi. Additional tracking and sampling from Kolguev and Kola was funded by the Max Planck Institute of Animal Behavior to I.P. and Earthspan (www.earthspan.foundation).We thank J. M. Graves for her suggestions; M. Al Bowardi and M. Al Mansouri for their support; X. Li, Q. Dai, X. Liu, Y. Chen, Y. Lin, J. Jiao, G. Wang, X. Guang, W. He and M. Barbato for their help with data analysis; W. Wu, X. Hou, Y. Wang and Y. Zhan for their advice on figure drawing; and O. Kulikova, V. Pozdnyakov, S. Troyev, L. Zhou, Y. Shang, C. Dai, Y. Yin, C. Li and N. C. Fox for assistance during fieldwork.	Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Bay RA, 2018, SCIENCE, V359, P83, DOI 10.1126/science.aan4380; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Beissinger TM, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0105-9; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Beyer RM, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0552-1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brambilla M, 2006, J ORNITHOL, V147, P428, DOI 10.1007/s10336-005-0028-2; Brown JW, 2007, MOL ECOL, V16, P327, DOI 10.1111/j.1365-294X.2007.03151.x; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cao XY, 2019, QUATERNARY SCI REV, V220, P291, DOI 10.1016/j.quascirev.2019.07.034; Carlzon Linnea, 2018, Ornis Hungarica, V26, P38; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Csillery K, 2012, METHODS ECOL EVOL, V3, P475, DOI 10.1111/j.2041-210X.2011.00179.x; Damas J, 2017, GENOME RES, V27, P875, DOI 10.1101/gr.213660.116; Delmore KE, 2016, CURR BIOL, V26, P2167, DOI 10.1016/j.cub.2016.06.015; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Enderson, 2013, PEREGRINE FALCONS WO; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Francois O, 2016, MOL ECOL, V25, P454, DOI 10.1111/mec.13513; Franke A, 2020, AMBIO, V49, P762, DOI 10.1007/s13280-019-01300-z; Frichot E, 2015, METHODS ECOL EVOL, V6, P925, DOI 10.1111/2041-210X.12382; Ganusevich SA, 2004, IBIS, V146, P291, DOI 10.1046/j.1474-919X.2004.00253.x; Hausdorff F, 1914, MATH ANN, V75, P428, DOI 10.1007/BF01563735; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Lameris TK, 2017, GLOBAL CHANGE BIOL, V23, P4058, DOI 10.1111/gcb.13684; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lok T, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0944; Lopez-Lopez P, 2014, CURR ZOOL, V60, P642, DOI 10.1093/czoolo/60.5.642; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McRae, 2010, ARCTIC SPECIES TREND; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pan SK, 2017, MOL ECOL, V26, P2993, DOI 10.1111/mec.14090; Perdeck A. C., 1964, Ardea, V52, P133; Peterson Mark P, 2013, F1000Res, V2, P115, DOI 10.12688/f1000research.2-115.v1; Pitt D, 2019, EVOL APPL, V12, P105, DOI 10.1111/eva.12641; Pudlo P, 2016, BIOINFORMATICS, V32, P859, DOI 10.1093/bioinformatics/btv684; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Ramilo ST, 2012, MOL ECOL RESOUR, V12, P873, DOI 10.1111/j.1755-0998.2012.03156.x; Rosenegger D, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-9; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Staab PR, 2015, BIOINFORMATICS, V31, P1680, DOI 10.1093/bioinformatics/btu861; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Szpiech ZA, 2014, MOL BIOL EVOL, V31, P2824, DOI 10.1093/molbev/msu211; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; TERHORST J, 2017, NAT GENET, V49, P303, DOI [10.1038/ng.3748, DOI 10.1038/NG.3748]; Trautmann S, 2018, FASCINAT LIFE SCI, P217, DOI 10.1007/978-3-319-91689-7_12; Trierweiler C, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2897; Wauchope HS, 2017, GLOBAL CHANGE BIOL, V23, P1085, DOI 10.1111/gcb.13404; Wieczorek L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.50; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao SC, 2013, NAT GENET, V45, P67, DOI 10.1038/ng.2494; Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432; Zurell D, 2018, NAT CLIM CHANGE, V8, P992, DOI 10.1038/s41558-018-0312-9	77	21	22	24	154	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					259	+		10.1038/s41586-021-03265-0	http://dx.doi.org/10.1038/s41586-021-03265-0		MAR 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QU6WY	33658718	Green Accepted			2022-12-28	WOS:000625125200008
J	Chagla, Z				Chagla, Zain			In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 >= 14 d after the 2nd dose	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chagla, Zain] McMaster Univ, Hamilton, ON, Canada	McMaster University	Chagla, Z (corresponding author), McMaster Univ, Hamilton, ON, Canada.								0	18	19	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC28	JC28		10.7326/ACPJ202103160-028	http://dx.doi.org/10.7326/ACPJ202103160-028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646836				2022-12-28	WOS:000669667000003
J	Cookson, R; Doran, T; Asaria, M; Gupta, I; Mujica, FP				Cookson, Richard; Doran, Tim; Asaria, Miqdad; Gupta, Indrani; Mujica, Fiorella Parra			The inverse care law re-examined: a global perspective	LANCET			English	Article								An inverse care law persists in almost all low-income and middle-income countries, whereby socially disadvantaged people receive less, and lower-quality, health care despite having greater need. By contrast, a disproportionate care law persists in high-income countries, whereby socially disadvantaged people receive more health care, but of worse quality and insufficient quantity to meet their additional needs. Both laws are caused not only by financial barriers and fragmented health insurance systems but also by social inequalities in care seeking and co-investment as well as the costs and benefits of health care. Investing in more integrated universal health coverage and stronger primary care, delivered in proportion to need, can improve population health and reduce health inequality. However, trade-offs sometimes exist between health policy objectives. Health-care technologies, policies, and resourcing should be subjected to distributional analysis of their equity impacts, to ensure the objective of reducing health inequalities is kept in sight.	[Cookson, Richard] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Doran, Tim; Mujica, Fiorella Parra] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Asaria, Miqdad] London Sch Econ, Dept Hlth Policy, London, England; [Gupta, Indrani] Inst Econ Growth, Hlth Policy Res Unit, Delhi, India	University of York - UK; University of York - UK; University of London; London School Economics & Political Science	Cookson, R (corresponding author), Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England.	richard.cookson@york.ac.uk	Cookson, Richard/AAO-3225-2021; Asaria, Miqdad/T-9980-2019	Asaria, Miqdad/0000-0002-3538-4417; Parra-Mujica, Claudia Fiorella/0000-0002-0974-7528	Wellcome Trust [205427/Z/16/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	RC, TD, and FPM are supported by the Wellcome Trust (grant number 205427/Z/16/Z). For helpful comments we would like to thank Mark Ashworth, Rama Baru, Chris Bentley, Callum Brindley, Kevin Fiscella, Robert Fleetcroft, John Ford, Peter Goldblatt, Hugh Gravelle, Davidson Gwatkin, Elaine Kelly, Julian Le Grand, Ajay Mahal, Owen O'Donnell, Trevor Sheldon, Peter Smith, Cesar Victora, Elizabeth Walton, and Margaret Whitehead. Any errors or opinions expressed in this publication are those of the authors and not those of the NHS, Wellcome Trust, or any individuals who provided comment.	Adeyanju O, 2017, HEALTH POLICY PLANN, V32, P1111, DOI 10.1093/heapol/czx049; Adler NE, 2010, ANN NY ACAD SCI, V1186, P1, DOI 10.1111/j.1749-6632.2009.05385.x; Agency for Healthcare Research and Quality, 2018, NATL HEALTHCARE QUAL; Almond D, 2018, J ECON LIT, V56, P1360, DOI 10.1257/jel.20171164; [Anonymous], 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3544; Arsenault C, 2018, LANCET GLOB HEALTH, V6, pE1186, DOI 10.1016/S2214-109X(18)30389-9; Asante A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152866; Asaria M, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001445; Asaria M, 2016, J EPIDEMIOL COMMUN H, V70, P990, DOI 10.1136/jech-2016-207447; Asthana S, 2013, HEALTH ECON POLICY L, V8, P167, DOI 10.1017/S1744133112000126; Atun R, 2015, LANCET, V385, P1230, DOI 10.1016/S0140-6736(14)61646-9; Balsa AI, 2005, HEALTH SERV RES, V40, P227, DOI 10.1111/j.1475-6773.2005.00351.x; Banerjee S, INEQUITIES CURATIVE; Barbosa EC, 2019, SOC SCI MED, V228, P1, DOI 10.1016/j.socscimed.2019.02.034; Barr B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3231; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Ben J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189900; Berkman Nancy D, 2011, Evid Rep Technol Assess (Full Rep), P1; Bertolini P., 2008, POVERTY SOCIAL EXCLU; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Boerma T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001731; Bowser D, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0921-6; Bradshaw JR, 1972, PROBLEMS PROGR MED C, P71; Braveman Paula, 2009, Pediatrics, V124 Suppl 3, pS163, DOI 10.1542/peds.2009-1100D; Carrieri V, 2013, HEALTH POLICY, V113, P247, DOI 10.1016/j.healthpol.2013.09.014; Cash-Gibson L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191901; Collyer TA, 2020, SOC SCI MED, V264, DOI 10.1016/j.socscimed.2020.113330; Cookson R, 2018, SOC SCI MED, V198, P148, DOI 10.1016/j.socscimed.2018.01.004; Cookson R, J HEALTH ORGAN MANAG; Cookson R., 2020, DISTRIBUTIONAL COST, DOI DOI 10.1093/MED/9780198838197.001.0001; Cookson R, 2020, VALUE HEALTH, V24, P118; Cookson R, 2016, FISC STUD, V37, P371, DOI 10.1111/j.1475-5890.2016.12109; Cooper K., 2010, REV LIT DOES INVERSE; Culyer AJ, 2012, HUMBLE ECONOMIST TON, P133; d'Uva TB, 2009, J HEALTH ECON, V28, P280, DOI 10.1016/j.jhealeco.2008.09.008; Delgadillo J, 2016, BRIT J PSYCHIAT, V209, P431, DOI 10.1192/bjp.bp.115.171017; Dixon J., 2015, EQUITY PROVISION PAL; Dobler CC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4065; Dolea C, 2010, B WORLD HEALTH ORGAN, V88, P379, DOI 10.2471/BLT.09.070607; Doran T, 2019, DATA SOC CHALLENGING; Doran T, 2017, ANNU REV PUBL HEALTH, V38, P449, DOI 10.1146/annurev-publhealth-032315-021457; Doty MM, 2021, HEALTH AFFAIR, V40, P113, DOI 10.1377/hlthaff.2020.01566; Dowell J, 2015, BMC MED ED, V15, P1; Durand MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094670; Dwivedi R, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0517-y; Faye CM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002232; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Fiscella K, 2016, ANNU REV PUBL HEALTH, V37, P375, DOI 10.1146/annurev-publhealth-032315-021439; Fisher R, LEVEL NOT 2020; French E, 2016, FISC STUD, V37, P327, DOI 10.1111/j.1475-5890.2016.12127; Fryatt RB, 2006, INT J EPIDEMIOL, V35, P1109; Galea S, 2020, JAMA-J AM MED ASSOC, V324, P227, DOI 10.1001/jama.2020.11132; Government of India Ministry of Statistics & Programme Implementation National Statistical Office, 2019, KEY INDICATORS SOCIA; Gupta S., 2019, ECOL ECON SOC, V2, P93, DOI [10.37773/ees.v2i1.57, DOI 10.37773/EES.V2I1.57]; Gwatkin DR, 2017, LANCET GLOB HEALTH, V5, pE371, DOI 10.1016/S2214-109X(17)30080-3; Gwatkin DR, 2011, LANCET, V377, P2160, DOI 10.1016/S0140-6736(10)62058-2; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Himanshu, 2018, WIDENING GAPS INDIA; Horton R, 2013, LANCET, V382, P1318, DOI 10.1016/S0140-6736(13)62103-0; Huot S, 2019, INT J CIRCUMPOL HEAL, V78, DOI 10.1080/22423982.2019.1571385; Joseph G, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000898; Krieger N, 2008, SOC SCI MED, V67, P1970, DOI 10.1016/j.socscimed.2008.09.039; Le Grand J., 1982, STRATEGY EQUALITY; Leech AA, 2018, VALUE HEALTH, V21, P759, DOI 10.1016/j.jval.2017.12.016; Lewis TT, 2015, ANNU REV CLIN PSYCHO, V11, P407, DOI 10.1146/annurev-clinpsy-032814-112728; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Love-Koh J, 2015, VALUE HEALTH, V18, P655, DOI 10.1016/j.jval.2015.03.1784; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marmot M, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3216; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Mathers CD, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00458-3; McGuire F, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002763; McIntyre D, 2011, HEALTH POLICY PLANN, V26, P174, DOI 10.1093/heapol/czq031; McKinnon B, 2011, INT J PUBLIC HEALTH, V56, P139, DOI 10.1007/s00038-010-0224-6; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; Mullan F, 2006, HEALTH AFFAIR, V25, P380, DOI 10.1377/hlthaff.25.2.380; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Nelson CA, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3048; Nwosu CO, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7840-8; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; ODonnell O., 2015, HDB INCOME DISTRIBUT, V2, P1419; OECD, 2019, HLTH EVERYONE; Pan American Health Organization WHO, 2019, REPORT COMMISSION PA; Pfeiffer J, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0520-8; Poupakis S, 2019, DEVELOPMENTAL ORIGIN; Reinhardt UE, 2004, JAMA-J AM MED ASSOC, V292, P1227, DOI 10.1001/jama.292.10.1227; Rivenbark JG, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-019-8124-z; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Sengupta A., UNIVERSAL HLTH COVER; Sheldon T, 2011, J HEALTH SERV RES PO, V16, P118, DOI 10.1258/jhsrp.2010.010155; Sherr K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035840; Shroff ZC, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003801; Singh N, 2008, HEALTH AFFAIR, V27, P991, DOI 10.1377/hlthaff.27.4.991; Smith PC, 2003, OXFORD REV ECON POL, V19, P301, DOI 10.1093/oxrep/19.2.301; Smith PC, 2008, B WORLD HEALTH ORGAN, V86, P884, DOI 10.2471/BLT.07.049528; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steven K, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0536-1; Stoye G, 2020, MILBANK Q, V98, P1134, DOI 10.1111/1468-0009.12479; Sturgiss E, 2019, AUST J GEN PRACT, V48, P811, DOI 10.31128/AJGP-06-19-4960; Sum G, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000505; Tangcharoensathie V, 2019, HEALTH SYST REFORM, V5, P195, DOI 10.1080/23288604.2019.1630595; Tikkanen R, 2020, US; Tikkanen R, 2020, SWITZERLAND; Tobasia-Hege C, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.36; United Nations, 2020, LANCET; University of Essex, WAVES 1 9 2009 2018; Verma P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1370-1; Victora CG, 2017, LANCET GLOB HEALTH, V5, pE402, DOI [10.1016/s2214-109x(17)30077-3, 10.1016/S2214-109X(17)30077-3]; Victora CG, 2018, AM J PUBLIC HEALTH, V108, P464, DOI [10.2105/AJPH.2017.304277, 10.2105/ajph.2017.304277]; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Wagstaff A, 2014, WHO BENEFITS GOVT HL; Wagstaff A, 2014, WORLD BANK RES OBSER, V29, P137, DOI 10.1093/wbro/lku008; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7; Watt G, 2018, BRIT J GEN PRACT, V68, P562, DOI 10.3399/bjgp18X699893; Watt G, 2011, BRIT J GEN PRACT, V61, P66, DOI 10.3399/bjgp11X549090; Wehrmeister FC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232350; Wehrmeister FC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000437; WHO, BUILT IN DATABASE ED; Williams AH, 2006, INT J TECHNOL ASSESS, V22, P1; Wilson NW, 2009, RURAL REMOTE HEALTH, V9; Woods B, 2016, VALUE HEALTH, V19, P929, DOI 10.1016/j.jval.2016.02.017; World Bank, 2019, WORLDWIDE GOVERNANCE; World Health Organization, 2014, MAKING FAIR CHOICES; World Health Organization, 2017, TRACKING UNIVERSAL H; World Health Organization, 2021, GLOB TUB REP 2021	129	21	21	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					828	838						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640069	Green Accepted			2022-12-28	WOS:000623925500033
J	Haines, A; Floss, M				Haines, Andy; Floss, Mayara			The inverse care law in the Anthropocene epoch	LANCET			English	Editorial Material									[Haines, Andy] London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London WC1H 9SH, England; [Floss, Mayara] Grp Hosp Conceicao, Porto Alegre, RS, Brazil	University of London; London School of Hygiene & Tropical Medicine	Haines, A (corresponding author), London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London WC1H 9SH, England.	andy.haines@lshtm.ac.uk		Floss, Mayara/0000-0003-0926-1306; Haines, Andy/0000-0002-8053-4605				Barros EF, 2020, QUE MINA GUAIBA MAIO; Cookson R, 2021, LANCET, V397, P828, DOI 10.1016/S0140-6736(21)00243-9; Garrett-Peltier H, 2017, ECON MODEL, V61, P439, DOI 10.1016/j.econmod.2016.11.012; HART JT, 1991, BMJ-BRIT MED J, V302, P1509, DOI 10.1136/bmj.302.6791.1509; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; McGlade C, 2015, NATURE, V517, P187, DOI 10.1038/nature14016; Medina MG, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00149720, 10.1590/0102-311X00149720]; NHS England and NHS Improvement, 2020, 2020 DEL NET ZER NAT; Park S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3691; Pettigrew LM, 2015, LANCET, V386, P2119, DOI 10.1016/S0140-6736(15)00949-6; The Health Foundation, 2020, BUILD BACK FAIR COVI; United Nations, 2015, 2030 AG SUST DEV SUS; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1; WHO, PRIM HLTH CAR ROAD U, V2019, P162; Zarebski A.E., 2020, SOCIAL RACIAL INEQUA, DOI [10.1101/2020.12.09.20246207, DOI 10.1101/2020.12.09.20246207]	15	1	1	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					773	774						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640046				2022-12-28	WOS:000623925500006
J	Taylor, HS; Kotlyar, AM; Flores, VA				Taylor, Hugh S.; Kotlyar, Alexander M.; Flores, Valerie A.			Endometriosis is a chronic systemic disease: clinical challenge and novel innovations	LANCET			English	Review								Endometriosis is a common disease affecting 5-10% of women of reproductive age globally. However, despite its prevalence, diagnosis is typically delayed by years, misdiagnosis is common, and delivery of effective therapy is prolonged. Identification and prompt treatment of endometriosis are essential and facilitated by accurate clinical diagnosis. Endometriosis is classically defined as a chronic, gynaecological disease characterised by endometrial-like tissue present outside of the uterus and is thought to arise by retrograde menstruation. However, this description is outdated and no longer reflects the true scope and manifestations of the disease. The clinical presentation is varied, the presence of pelvic lesions is heterogeneous, and the manifestations of the disease outside of the female reproductive tract remain poorly understood. Endometriosis is now considered a systemic disease rather than a disease predominantly affecting the pelvis. Endometriosis affects metabolism in liver and adipose tissue, leads to systemic inflammation, and alters gene expression in the brain that causes pain sensitisation and mood disorders. The full effect of the disease is not fully recognised and goes far beyond the pelvis. Recognition of the full scope of the disease will facilitate clinical diagnosis and allow for more comprehensive treatment than currently available. Progestins and low-dose oral contraceptives are unsuccessful in a third of symptomatic women globally, probably as a result of progesterone resistance. Oral gonadotropin-releasing hormone (GnRH) antagonists constitute an effective and tolerable therapeutic alternative when first-line medications do not work. The development of GnRH antagonists has resulted in oral drugs that have fewer side-effects than other therapies and has allowed for rapid movement between treatments to optimise and personalise endometriosis care. In this Review, we discuss the latest understanding of endometriosis as a systemic disease with multiple manifestations outside the parameters of classic gynaecological disease.	[Taylor, Hugh S.; Kotlyar, Alexander M.; Flores, Valerie A.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Yale University	Taylor, HS (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	hugh.taylor@yale.edu						Abe W, 2013, HUM REPROD, V28, P750, DOI 10.1093/humrep/des446; Adamson GD, 2010, FERTIL STERIL, V94, P1609, DOI 10.1016/j.fertnstert.2009.09.035; ADAMSON GD, 1994, AM J OBSTET GYNECOL, V171, P1488, DOI 10.1016/0002-9378(94)90392-1; Agarwal SK, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.12.039; Agarwal SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/878517; Ailawadi RK, 2004, FERTIL STERIL, V81, P290, DOI 10.1016/j.fertnstert.2003.09.029; Akoum A, 2000, J CLIN ENDOCR METAB, V85, P896, DOI 10.1210/jc.85.2.896; Albee RB, 2008, J MINIM INVAS GYN, V15, P32, DOI 10.1016/j.jmig.2007.08.619; Alderman MH, 2017, SEMIN REPROD MED, V35, P263, DOI 10.1055/s-0037-1603582; Amsterdam LL, 2005, FERTIL STERIL, V84, P300, DOI 10.1016/j.fertnstert.2005.02.018; Andres MD, 2015, ARCH GYNECOL OBSTET, V292, P523, DOI 10.1007/s00404-015-3681-6; Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; Apostolopoulos NV, 2016, ARCH GYNECOL OBSTET, V293, P439, DOI 10.1007/s00404-015-3855-2; Arici A, 1997, FERTIL STERIL, V67, P1065, DOI 10.1016/S0015-0282(97)81440-9; Arici A, 1998, J CLIN ENDOCR METAB, V83, P1201, DOI 10.1210/jc.83.4.1201; As-Sanie S, 2013, OBSTET GYNECOL, V122, P1047, DOI 10.1097/AOG.0b013e3182a7e1f5; As-Sanie S, 2012, PAIN, V153, P1006, DOI 10.1016/j.pain.2012.01.032; Ashrafi M, 2016, INT J FERTIL STERIL, V10, P11; Attar E, 2006, HUM REPROD UPDATE, V12, P49, DOI 10.1093/humupd/dmi034; Bajaj P, 2003, J PAIN, V4, P372, DOI 10.1016/S1526-5900(03)00720-X; Balasch J, 1996, HUM REPROD, V11, P387, DOI 10.1093/HUMREP/11.2.387; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; BARBIERI RL, 1992, AM J OBSTET GYNECOL, V166, P740, DOI 10.1016/0002-9378(92)91706-G; Bau DT, 2007, CHINESE J PHYSIOL, V50, P326; Bazot M, 2017, FERTIL STERIL, V108, P886, DOI 10.1016/j.fertnstert.2017.10.026; Bellelis P, 2010, REV ASSOC MED BRAS, V56, P467, DOI 10.1590/S0104-42302010000400022; Berlac JF, 2017, ACTA OBSTET GYN SCAN, V96, P751, DOI 10.1111/aogs.13111; Bouchard P, 2011, FERTIL STERIL, V96, P1175, DOI 10.1016/j.fertnstert.2011.08.021; BRAUN DP, 1994, FERTIL STERIL, V61, P78; Brawn J, 2014, HUM REPROD UPDATE, V20, P737, DOI 10.1093/humupd/dmu025; Bressler LH, 2017, HSOA J REPROD MED GY, V2, P2; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Brown J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002122.pub2; Brown J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008475.pub2; BRUHAT MA, 1991, EUR J OBSTET GYN R B, V41, P4, DOI 10.1016/0028-2243(91)90308-8; Buggio L, 2017, EXPERT OPIN PHARMACO, V18, P1569, DOI 10.1080/14656566.2017.1381086; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2005, J STEROID BIOCHEM, V95, P57, DOI 10.1016/j.jsbmb.2005.04.012; Bulun SE, 2000, J MOL ENDOCRINOL, V25, P35, DOI 10.1677/jme.0.0250035; Bulun SE, 2019, ENDOCR REV, V40, P1048, DOI 10.1210/er.2018-00242; Bulun SE, 2015, SEMIN REPROD MED, V33, P220, DOI 10.1055/s-0035-1554053; Bulun SE, 2010, SEMIN REPROD MED, V28, P36, DOI 10.1055/s-0029-1242991; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Camargo-Kosugi CM, 2009, EUR J OBSTET GYN R B, V145, P180, DOI 10.1016/j.ejogrb.2009.04.027; Canis M, 1997, FERTIL STERIL, V67, P817; Chapron C, 2002, J AM ASSOC GYN LAP, V9, P115, DOI 10.1016/S1074-3804(05)60117-X; Chapron C, 2002, HUM REPROD, V17, P1334, DOI 10.1093/humrep/17.5.1334; Chapron C, 2019, NAT REV ENDOCRINOL, V15, P666, DOI 10.1038/s41574-019-0245-z; Chapron C, 2017, HUM REPROD, V32, P1393, DOI 10.1093/humrep/dex088; Chen LC, 2016, J AFFECT DISORDERS, V190, P282, DOI 10.1016/j.jad.2015.10.030; Cheng YH, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.014; Cho S, 2016, FERTIL STERIL, V106, P673, DOI 10.1016/j.fertnstert.2016.05.020; Clement PB, 2007, ADV ANAT PATHOL, V14, P241, DOI 10.1097/PAP.0b013e3180ca7d7b; Cobo A, 2020, FERTIL STERIL, V113, P836, DOI 10.1016/j.fertnstert.2019.11.017; Cosar E, 2016, FERTIL STERIL, V106, P402, DOI 10.1016/j.fertnstert.2016.04.013; Cosson M, 2002, FERTIL STERIL, V77, P684, DOI 10.1016/S0015-0282(01)03270-8; Dalsgaard T, 2013, HUM REPROD, V28, P2284, DOI [10.1093/humrep/det231, 10.10]; de Ziegler D, 2010, FERTIL STERIL, V94, P2796, DOI 10.1016/j.fertnstert.2010.05.056; Donnez J, 2020, FERTIL STERIL, V114, P44, DOI 10.1016/j.fertnstert.2020.02.114; Donnez J, 2018, EXPERT OPIN DRUG SAF, V17, P1225, DOI 10.1080/14740338.2018.1550070; Dorien FO, 2018, BEST PRACT RES CL OB, V50, P72, DOI 10.1016/j.bpobgyn.2018.04.001; Du HL, 2007, STEM CELLS, V25, P2082, DOI 10.1634/stemcells.2006-0828; Du YB, 2017, HUM REPROD, V32, P794, DOI 10.1093/humrep/dex014; Duffy JMN, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011031.pub2; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Eskenazi B, 2001, FERTIL STERIL, V76, P929, DOI 10.1016/S0015-0282(01)02736-4; Exacoustos C, 2014, FERTIL STERIL, V102, P143, DOI 10.1016/j.fertnstert.2014.03.043; Farland LV, 2019, OBSTET GYNECOL, V134, P527, DOI 10.1097/AOG.0000000000003410; Fatemi HM, 2005, REPROD BIOMED ONLINE, V11, P455, DOI 10.1016/S1472-6483(10)61140-6; Fauconnier A, 2009, GYNECOL OBSTET FERTI, V37, P57, DOI 10.1016/j.gyobfe.2008.08.016; Ferrero S, 2005, EUR J OBSTET GYN R B, V121, P94, DOI 10.1016/j.ejogrb.2004.11.019; Ferrero S, 2010, EUR J OBSTET GYN R B, V150, P199, DOI 10.1016/j.ejogrb.2010.02.023; Ferrero S, 2009, DRUGS, V69, P943, DOI 10.2165/00003495-200969080-00001; Flores I, 2008, INT J GYNECOL OBSTET, V100, P257, DOI 10.1016/j.ijgo.2007.08.010; Flores VA, 2019, GYNECOL ENDOCRINOL, V35, P390, DOI 10.1080/09513590.2018.1559288; Flores VA, 2018, J CLIN ENDOCR METAB, V103, P4561, DOI 10.1210/jc.2018-01227; Flores VA, 2018, OBSTET GYNECOL, V132, P475, DOI 10.1097/AOG.0000000000002739; Forster R, 2019, FASEB J, V33, P11210, DOI 10.1096/fj.201900797R; FOSTER DC, 1981, OBSTET GYNECOL, V58, P552; Fu J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009881.pub2; Gargett CE, 2014, MOL HUM REPROD, V20, P591, DOI 10.1093/molehr/gau025; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Ghazal S, 2015, EMBO MOL MED, V7, P996, DOI 10.15252/emmm.201505245; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Goetz LG, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.142877; Gonzalez-Ramos R, 2010, FERTIL STERIL, V94, P1985, DOI 10.1016/j.fertnstert.2010.01.013; Goodman LR, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.029; Greene R, 2009, FERTIL STERIL, V91, P32, DOI 10.1016/j.fertnstert.2007.11.020; Guerriero S, 2018, ULTRASOUND OBST GYN, V51, P586, DOI 10.1002/uog.18961; Guo SW, 2009, MOL HUM REPROD, V15, P587, DOI 10.1093/molehr/gap064; Gurates B, 2003, SEMIN REPROD MED, V21, P125; Guzick DS, 1997, FERTIL STERIL, V67, P822, DOI 10.1016/S0015-0282(97)81392-1; Haas D, 2013, ACTA OBSTET GYN SCAN, V92, P562, DOI 10.1111/aogs.12118; Haas D, 2011, FERTIL STERIL, V95, P1574, DOI 10.1016/j.fertnstert.2011.01.135; HANEY AF, 1981, FERTIL STERIL, V35, P696; Hapangama DK, 2019, HUM REPROD, V34, P56, DOI 10.1093/humrep/dey336; Harada T, 2009, FERTIL STERIL, V91, P675, DOI 10.1016/j.fertnstert.2007.12.080; Hart RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004992.pub3; Hayashi A, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-31; Hefler LA, 2005, FERTIL STERIL, V84, P1033, DOI 10.1016/j.fertnstert.2005.04.059; Hill AM, 2018, CLIN CASE REP, V6, P990, DOI 10.1002/ccr3.1501; HO HN, 1995, HUM REPROD, V10, P2671, DOI 10.1093/oxfordjournals.humrep.a135765; HORNSTEIN MD, 1995, HUM REPROD, V10, P932, DOI 10.1093/oxfordjournals.humrep.a136064; Hudelist G, 2011, ULTRASOUND OBST GYN, V37, P257, DOI 10.1002/uog.8858; Hufnagel D, 2015, SEMIN REPROD MED, V33, P333, DOI 10.1055/s-0035-1564609; Hull DB, 2002, FERTIL STERIL, V77, pS21, DOI 10.1016/S0015-0282(01)03076-X; Husby GK, 2003, ACTA OBSTET GYN SCAN, V82, P649, DOI 10.1034/j.1600-0412.2003.00168.x; Ichimiya Makoto, 1998, Journal of Dermatology (Tokyo), V25, P333; Janssens R, 2018, CELL MOL IMMUNOL, V15, P299, DOI 10.1038/cmi.2017.107; JAVERT CT, 1949, CANCER, V2, P399, DOI 10.1002/1097-0142(194905)2:3<399::AID-CNCR2820020304>3.0.CO;2-L; Jeng CJ, 2014, EXPERT OPIN PHARMACO, V15, P767, DOI 10.1517/14656566.2014.888414; Jensen JT, 2018, FERTIL STERIL, V110, P137, DOI 10.1016/j.fertnstert.2018.03.012; Johnson NP, 2017, HUM REPROD, V32, P315, DOI 10.1093/humrep/dew293; Joshi NR, 2017, J CLIN ENDOCR METAB, V102, P141, DOI 10.1210/jc.2016-2076; Kao LC, 2003, ENDOCRINOLOGY, V144, P2870, DOI 10.1210/en.2003-0043; Kao LC, 2002, ENDOCRINOLOGY, V143, P2119, DOI 10.1210/en.143.6.2119; Kazanegra R, 2008, J MINIM INVAS GYN, V15, P176, DOI 10.1016/j.jmig.2007.10.005; Khine Yin Mon, 2016, Reproductive Medicine and Biology, V15, P217, DOI 10.1007/s12522-016-0237-9; KHORRAM O, 1993, AM J OBSTET GYNECOL, V169, P1545, DOI 10.1016/0002-9378(93)90433-J; Kim JJ, 2007, MOL HUM REPROD, V13, P323, DOI 10.1093/molehr/gam005; Kodaman PH, 2015, OBSTET GYN CLIN N AM, V42, P87, DOI 10.1016/j.ogc.2014.10.005; Kulak J, 2011, ENDOCRINOLOGY, V152, P3226, DOI 10.1210/en.2010-1010; Lagana AS, 2015, EUR J OBSTET GYN R B, V194, P30, DOI 10.1016/j.ejogrb.2015.08.015; Lalani S, 2018, HUM REPROD, V33, P1854, DOI 10.1093/humrep/dey269; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Lee B, 2009, BIOL REPROD, V80, P79, DOI 10.1095/biolreprod.108.070391; Lemaire GS, 2004, JOGNN-J OBST GYN NEO, V33, P71, DOI 10.1177/0884217503261085; Lessey BA, 1996, FERTIL STERIL, V65, P477, DOI 10.1016/S0015-0282(16)58140-0; Lessey BA, 2017, FERTIL STERIL, V108, P19, DOI 10.1016/j.fertnstert.2017.05.031; Li F, 2018, STEM CELLS, V36, P881, DOI 10.1002/stem.2804; Li MH, 2019, REPROD SCI, V26, P1506, DOI 10.1177/1933719119862050; Li T, 2018, BIOL REPROD, V99, P349, DOI 10.1093/biolre/ioy035; Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002; MALINAK LR, 1980, AM J OBSTET GYNECOL, V137, P332, DOI 10.1016/0002-9378(80)90918-7; Mamillapalli R, 2017, ONCOTARGET, V10, P2282, DOI 10.18632/oncotarget.16889.eCollection2019Mar19; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MATHUR S, 1982, CLIN EXP IMMUNOL, V50, P259; Matsuura K, 1999, GYNECOL OBSTET INVES, V47, P18, DOI 10.1159/000052855; May KE, 2010, HUM REPROD UPDATE, V16, P651, DOI 10.1093/humupd/dmq009; Mol BWJ, 1998, FERTIL STERIL, V70, P1101, DOI 10.1016/S0015-0282(98)00355-0; Monsivais D, 2014, MOL ENDOCRINOL, V28, P1304, DOI 10.1210/me.2013-1421; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; MORI H, 1991, AM J REPROD IMMUNOL, V26, P62, DOI 10.1111/j.1600-0897.1991.tb00972.x; Moridi I, 2017, REPROD SCI, V24, P526, DOI 10.1177/1933719116672587; Moustafa S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.02.050; Mu F, 2016, CIRC-CARDIOVASC QUAL, V9, P257, DOI 10.1161/CIRCOUTCOMES.115.002224; Naqvi H, 2014, REPROD SCI, V21, P1237, DOI 10.1177/1933719114532841; Naqvi H, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114165; Nasu K, 2011, J OBSTET GYNAECOL RE, V37, P683, DOI 10.1111/j.1447-0756.2011.01663.x; Nematian SE, 2018, J CLIN ENDOCR METAB, V103, P64, DOI 10.1210/jc.2017-01199; Nezhat C, 2016, JSLS-J SOC LAPAROEND, V20, DOI 10.4293/JSLS.2016.00053; Ng J, 2017, J CLIN ENDOCR METAB, V102, P1683, DOI 10.1210/jc.2016-3845; NICE, 2017, END DIAGN MAN; Nisenblat V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012179; Nisenblat V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009591.pub2; NISOLLE M, 1990, FERTIL STERIL, V53, P984; Nothnick WB, 2017, REPROD SCI, V24, P1195, DOI 10.1177/1933719116681519; ODUKOYA OA, 1995, HUM REPROD, V10, P1214, DOI 10.1093/oxfordjournals.humrep.a136121; OLIVE DL, 1985, FERTIL STERIL, V44, P772; Osuga Y, 2021, FERTIL STERIL, V115, P397, DOI 10.1016/j.fertnstert.2020.07.055; Othman EEDR, 2008, EUR J OBSTET GYN R B, V137, P240, DOI 10.1016/j.ejogrb.2007.05.001; Parazzini F, 2001, HUM REPROD, V16, P2668; Patel BG, 2017, ACTA OBSTET GYN SCAN, V96, P623, DOI 10.1111/aogs.13156; Pavone ME, 2012, FERTIL STERIL, V98, P1370, DOI 10.1016/j.fertnstert.2012.08.053; Pavone ME, 2010, J CLIN ENDOCR METAB, V95, pE300, DOI 10.1210/jc.2010-0459; Pfeifer S, 2014, FERTIL STERIL, V101, P927, DOI 10.1016/j.fertnstert.2014.02.012; Pluchino N, 2020, J CELL MOL MED, V24, P2464, DOI 10.1111/jcmm.14933; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Raffi F, 2012, J CLIN ENDOCR METAB, V97, P3146, DOI 10.1210/jc.2012-1558; Ramin-Wright A, 2018, HUM REPROD, V33, P1459, DOI 10.1093/humrep/dey115; Razzi S, 2004, BJOG-INT J OBSTET GY, V111, P182, DOI 10.1046/j.1471-0528.2003.00038.x; Reis FM, 2013, HUM REPROD UPDATE, V19, P406, DOI 10.1093/humupd/dmt010; Rousset P, 2014, CLIN RADIOL, V69, P323, DOI 10.1016/j.crad.2013.10.014; Saha R, 2015, FERTIL STERIL, V104, P947, DOI 10.1016/j.fertnstert.2015.06.035; Sahin C, 2018, J CELL MOL MED, V22, P5346, DOI 10.1111/jcmm.13807; Sakr S, 2014, ENDOCRINOLOGY, V155, P1489, DOI 10.1210/en.2013-1977; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; SANFILIPPO JS, 1986, AM J OBSTET GYNECOL, V154, P39, DOI 10.1016/0002-9378(86)90389-3; Santulli P, 2015, J MINIM INVAS GYN, V22, P275, DOI 10.1016/j.jmig.2014.10.013; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Schliep KC, 2015, HUM REPROD, V30, P2427, DOI 10.1093/humrep/dev147; Senapati S, 2016, FERTIL STERIL, V106, P164, DOI 10.1016/j.fertnstert.2016.03.037; Shigesi N, 2019, HUM REPROD UPDATE, V25, P486, DOI 10.1093/humupd/dmz014; Shippen ER, 2004, FERTIL STERIL, V81, P1395, DOI 10.1016/j.fertnstert.2003.11.027; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Slabe N, 2013, GEBURTSH FRAUENHEILK, V73, P1042, DOI 10.1055/s-0033-1350702; Somigliana E, 2020, FERTIL STERIL, V113, P765, DOI 10.1016/j.fertnstert.2019.12.020; Somigliana E, 2015, HUM REPROD, V30, P1280, DOI 10.1093/humrep/dev078; Soto E, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2016.12.033; STEELE RW, 1984, AM J REPROD IMMUNOL, V6, P33, DOI 10.1111/j.1600-0897.1984.tb00106.x; Stegmann BJ, 2008, FERTIL STERIL, V89, P1632, DOI 10.1016/j.fertnstert.2007.05.042; Stratton P, 2008, OBSTET GYNECOL, V111, P88, DOI 10.1097/01.AOG.0000297307.35024.b5; Strowitzki T, 2010, HUM REPROD, V25, P633, DOI 10.1093/humrep/dep469; Strowitzki T, 2012, INT J GYNECOL OBSTET, V117, P228, DOI 10.1016/j.ijgo.2012.01.009; Strowitzki T, 2010, EUR J OBSTET GYN R B, V151, P193, DOI 10.1016/j.ejogrb.2010.04.002; SUGINAMI H, 1991, AM J OBSTET GYNECOL, V165, P214, DOI 10.1016/0002-9378(91)90254-O; Surrey E, 2018, OBSTET GYNECOL, V132, P147, DOI 10.1097/AOG.0000000000002675; Surrey ES, 2019, FERTIL STERIL, V112, P298, DOI 10.1016/j.fertnstert.2019.02.031; Surrey ES, 2002, FERTIL STERIL, V78, P699, DOI 10.1016/S0015-0282(02)03373-3; Takayama K, 1998, FERTIL STERIL, V69, P709, DOI 10.1016/S0015-0282(98)00022-3; Taylor HS, 2017, NEW ENGL J MED, V377, P28, DOI 10.1056/NEJMoa1700089; Taylor HS, 2018, INT J GYNECOL OBSTET, V142, P131, DOI 10.1002/ijgo.12521; Treloar SA, 1999, FERTIL STERIL, V71, P701, DOI 10.1016/S0015-0282(98)00540-8; Tseng JF, 1996, J CLIN ENDOCR METAB, V81, P1118, DOI 10.1210/jc.81.3.1118; Vercellini P, 2007, HUM REPROD, V22, P266, DOI 10.1093/humrep/del339; Vercellini P, 1996, FERTIL STERIL, V65, P299, DOI 10.1016/S0015-0282(16)58089-3; Vercellini P, 2009, EUR J OBSTET GYN R B, V146, P15, DOI 10.1016/j.ejogrb.2009.05.007; Vercellini P, 2009, HUM REPROD, V24, P254, DOI 10.1093/humrep/den379; Vodolazkaia A, 2012, HUM REPROD, V27, P2698, DOI 10.1093/humrep/des234; Wall DJ, 2015, ULTRASOUND Q, V31, P37, DOI 10.1097/RUQ.0000000000000132; Wang XL, 2015, STEM CELL RES, V15, P14, DOI 10.1016/j.scr.2015.04.004; Whitehouse H B, 1926, Proc R Soc Med, V19, P15; Williams CE, 2014, BJOG-INT J OBSTET GY, V121, P1653, DOI 10.1111/1471-0528.12899; WILSON TJ, 1994, FERTIL STERIL, V62, P1086; Wu Y, 2006, EPIGENETICS-US, V1, P106, DOI 10.4161/epi.1.2.2766; Wykes CB, 2004, BJOG-INT J OBSTET GY, V111, P1204, DOI 10.1111/j.1471-0528.2004.00433.x; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Yao Z, 2005, J INVEST SURG, V18, P177, DOI 10.1080/08941930591004412; Yoo JY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04577-w; Yu JJ, 2016, REPRODUCTION, V152, P151, DOI 10.1530/REP-16-0089; Zanatta A, 2010, J ASSIST REPROD GEN, V27, P701, DOI 10.1007/s10815-010-9471-y; Zeitoun KM, 1999, FERTIL STERIL, V72, P961, DOI 10.1016/S0015-0282(99)00393-3; Zolbin MM, 2019, REPROD BIOL ENDOCRIN, V17, DOI 10.1186/s12958-019-0480-0; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5; Zullo F, 2017, FERTIL STERIL, V108, P667, DOI 10.1016/j.fertnstert.2017.07.019	229	99	105	19	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					839	852						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP6DN	33640070				2022-12-28	WOS:000623925500034
J	Basnyat, B; Qamar, FN; Rupali, P; Ahmed, T; Parry, CM				Basnyat, Buddha; Qamar, Farah Naz; Rupali, Priscilla; Ahmed, Tahmeed; Parry, Christopher M.			Enteric fever	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TYPHOID CONJUGATE VACCINE; SALMONELLA-TYPHI; CLINICAL-FEATURES; WIDAL TEST; METAANALYSIS; BLOOD		[Basnyat, Buddha] Univ Oxford, Clin Res Unit, Patan Acad Hlth Sci Kathmandu, Kathmandu, Nepal; [Basnyat, Buddha; Parry, Christopher M.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Qamar, Farah Naz] Aga Khan Univ, Karachi, Pakistan; [Rupali, Priscilla] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Ahmed, Tahmeed] Icddr B, Dhaka, Bangladesh; [Parry, Christopher M.] Alder Hey Children Hosp, Liverpool, Merseyside, England; [Parry, Christopher M.] Liverpool Univ Hosp, Liverpool, Merseyside, England	University of Oxford; University of Oxford; Aga Khan University; Christian Medical College & Hospital (CMCH) Vellore; International Centre for Diarrhoeal Disease Research (ICDDR); Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Basnyat, B (corresponding author), Univ Oxford, Clin Res Unit, Patan Acad Hlth Sci Kathmandu, Kathmandu, Nepal.; Basnyat, B (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England.	Buddha.Basnyat@ndm.ox.ac.uk						Andrews JR, 2019, CLIN INFECT DIS, V68, P949, DOI 10.1093/cid/ciy578; Antillon M, 2018, J INFECT DIS, V218, pS255, DOI 10.1093/infdis/jiy471; Azmatullah A, 2015, J GLOB HEALTH, V5, P107, DOI 10.7189/jogh.05.020407; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Bhargava A, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4766; Britto C, 2017, CLIN INFECT DIS, V64, P1604, DOI 10.1093/cid/cix229; Browne AJ, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1443-1; Contini S, 2017, WORLD J GASTROENTERO, V23, P1925, DOI 10.3748/wjg.v23.i11.1925; Crump JA, 2019, CLIN INFECT DIS, V68, pS4, DOI 10.1093/cid/ciy846; De Mel S, 2015, IDCases, V2, P83, DOI 10.1016/j.idcr.2015.08.003; Dolecek C, 2019, WHO TECHN REP SER, V1021, P19; Effa EE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004530.pub4; Effa EE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006083.pub2; Espinoza LMC, 2019, CLIN INFECT DIS, V69, pS435, DOI 10.1093/cid/ciz477; Gal-Mor O, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00088-18; HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203; Hooda Y, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007868; Hsiao A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005928; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Karkey A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002391; Keddy KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164939; Kim JH, 2019, CLIN INFECT DIS, V69, pS492, DOI 10.1093/cid/ciz525; Klemm EJ, 2018, MBIO, V9, DOI 10.1128/mBio.00105-18; LEVINE MM, 1978, AM J TROP MED HYG, V27, P795, DOI 10.4269/ajtmh.1978.27.795; Luby SP, 2018, J INFECT DIS, V218, pS250, DOI 10.1093/infdis/jiy324; Mashe T, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4114-0; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Mather RG, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001831; Milligan R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub4; Mogasale V, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0147-z; Mohanty S, 2009, J INFECT DEV COUNTR, V3, P633, DOI 10.3855/jidc.557; Nagaraja V, 2014, ALIMENT PHARM THER, V39, P745, DOI 10.1111/apt.12655; Parry C, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5322; Parry CM, 1999, J CLIN MICROBIOL, V37, P2882, DOI 10.1128/JCM.37.9.2882-2886.1999; Parry CM, 2020, OXFORD TXB MED, V6th, DOI [10.1093/MED/9780198746690.001.0001/MED-9780198746690-CHAPTER-113, DOI 10.1093/MED/9780198746690.001.0001/MED-9780198746690-CHAPTER-113]; PHE, 2017, INT PUBL HLTH OP GUI; Pieters Z, 2018, CLIN INFECT DIS, V67, P628, DOI 10.1093/cid/ciy190; Qamar FN, 2020, VACCINE, V38, P3518, DOI 10.1016/j.vaccine.2020.03.028; Qureshi S, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008682; Shakya M, 2019, NEW ENGL J MED, V381, P2209, DOI 10.1056/NEJMoa1905047; Stanaway JD, 2019, LANCET INFECT DIS, V19, P369, DOI 10.1016/S1473-3099(18)30685-6; Thwaites GE, 2017, NEW ENGL J MED, V376, P548, DOI 10.1056/NEJMra1508435; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Watkins LKF, 2020, MMWR-MORBID MORTAL W, V69, P618, DOI 10.15585/mmwr.mm6920a2; WHO, 2005, HDB IMCI INT MAN CHI; Wijedoru L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008892.pub2; World Hlth Org, 2019, VACCINE, V37, P214, DOI 10.1016/j.vaccine.2018.04.022	47	9	9	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2021	372								n437	10.1136/bmj.n437	http://dx.doi.org/10.1136/bmj.n437			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1OX	33637488	Green Published, hybrid			2022-12-28	WOS:000624297200002
J	Skegg, D; Gluckman, P; Boulton, G; Hackmann, H; Karim, SSA; Piot, P; Woopen, C				Skegg, David; Gluckman, Peter; Boulton, Geoffrey; Hackmann, Heide; Karim, Salim S. Abdool; Piot, Peter; Woopen, Christiane			Future scenarios for the COVID-19 pandemic	LANCET			English	Editorial Material									[Skegg, David] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Gluckman, Peter; Boulton, Geoffrey; Hackmann, Heide] Int Sci Council, Paris, France; [Gluckman, Peter] Univ Auckland, Koi Tu Ctr Informed Futures, Auckland 1142, New Zealand; [Boulton, Geoffrey] Univ Edinburgh, Grant Inst, Edinburgh, Midlothian, Scotland; [Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa, Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Piot, Peter] London Sch Hyg & Trop Med, London, England; [Woopen, Christiane] Univ Cologne, Cologne Ctr Eth Rights Econ & Social Sci Hlth, Cologne, Germany	University of Otago; University of Auckland; University of Edinburgh; University of Kwazulu Natal; Columbia University; University of London; London School of Hygiene & Tropical Medicine; University of Cologne	Gluckman, P (corresponding author), Int Sci Council, Paris, France.; Gluckman, P (corresponding author), Univ Auckland, Koi Tu Ctr Informed Futures, Auckland 1142, New Zealand.	pd.gluckman@auckland.ac.nz	Abdool Karim, Salim/N-5947-2013	Abdool Karim, Salim/0000-0002-4986-2133				Brauner JM, 2021, SCIENCE, V371, P802, DOI 10.1126/science.abd9338; Chand M., 2020, INVESTIGATION NOVEL; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Fontanet A, 2021, LANCET, V397, P952, DOI 10.1016/S0140-6736(21)00370-6; Gluckman P., 2020, TRACKING GLOBAL EVID; Haug N., 2020, NAT HUM BEHAV, V4, P1303, DOI DOI 10.1038/s41562-020-01009-0; Jain S, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040649; Mahdy MAA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.596391; Roser M., 2020, DAILY NEW CONFIRMED; Sachs JD, 2021, LANCET, V397, P947, DOI 10.1016/S0140-6736(21)00388-3; Sridhar D, 2021, SCIENCE, V371, P230, DOI 10.1126/science.abf7921; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]	12	74	77	2	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					777	778		10.1016/S0140-6736(21)00424-4	http://dx.doi.org/10.1016/S0140-6736(21)00424-4		FEB 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33607000	Green Published, Bronze			2022-12-28	WOS:000623925500008
J	Brett, L				Brett, Luce			Incontinence is lonely and hard to talk about	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												lucebrettauthor@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n207	10.1136/bmj.n207	http://dx.doi.org/10.1136/bmj.n207			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627339	Bronze			2022-12-28	WOS:000623404800006
J	Mahase, E				Mahase, Elisabeth			Statins have no overall effect on frequency or severity of muscle symptoms, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															National Institute for Health Research	National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the National Institute for Health Research.	Herrett E, 2021, BMJ, V372	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n553	10.1136/bmj.n553	http://dx.doi.org/10.1136/bmj.n553			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627332				2022-12-28	WOS:000623404800003
J	Camarillo-Guerrero, LF; Almeida, A; Rangel-Pineros, G; Finn, RD; Lawley, TD				Camarillo-Guerrero, Luis F.; Almeida, Alexandre; Rangel-Pineros, Guillermo; Finn, Robert D.; Lawley, Trevor D.			Massive expansion of human gut bacteriophage diversity	CELL			English	Article							READ ALIGNMENT; GENOME; VIRUS; MICROBIOME; TAXONOMY; ELEMENTS	Bacteriophages drive evolutionary change in bacterial communities by creating gene flow networks that fuel ecological adaptions. However, the extent of viral diversity and its prevalence in the human gut remains largely unknown. Here, we introduce the Gut Phage Database, a collection of similar to 142,000 non-redundant viral genomes (>10 kb) obtained by mining a dataset of 28,060 globally distributed human gut metagenomes and 2,898 reference genomes of cultured gut bacteria. Host assignment revealed that viral diversity is highest in the Firmicutes phyla and that similar to 36% of viral clusters (VCs) are not restricted to a single species, creating gene flow networks across phylogenetically distinct bacterial species. Epidemiological analysis uncovered 280 globally distributed VCs found in at least 5 continents and a highly prevalent phage clade with features reminiscent of p-crAssphage. This high-quality, large-scale catalog of phage genomes will improve future virome studies and enable ecological and evolutionary analysis of human gut bacteriophages.	[Camarillo-Guerrero, Luis F.; Lawley, Trevor D.] Wellcome Sanger Inst, Host Microbiota Interact Lab, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Almeida, Alexandre; Rangel-Pineros, Guillermo; Finn, Robert D.] European Bioinformat Inst EMBL EBI, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Almeida, Alexandre] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Rangel-Pineros, Guillermo] Univ los Andes, Dept Biol Sci, Max Planck Tandem Grp Computat Biol, Bogota 111711, Colombia	Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Universidad de los Andes (Colombia)	Camarillo-Guerrero, LF; Lawley, TD (corresponding author), Wellcome Sanger Inst, Host Microbiota Interact Lab, Wellcome Genome Campus, Hinxton CB10 1SA, England.	lg15@sanger.ac.uk; tl2@sanger.ac.uk	Almeida, Alexandre/J-3294-2019	Almeida, Alexandre/0000-0001-8803-0893; Finn, Robert/0000-0001-8626-2148; Rangel-Pineros, Guillermo/0000-0003-3848-4330	Wellcome Trust [098051]; Wellcome Sanger Institute PhD Studentship; EMBL; Biotechnology and Biological Sciences Research Council [BB/P027849/1]; BBSRC [BB/P027849/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Sanger Institute PhD Studentship; EMBL; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (098051). L.F.C. is supported by a Wellcome Sanger Institute PhD Studentship. A.A. and R.D.F are funded by EMBL core funds. G.R.P. was supported by the Biotechnology and Biological Sciences Research Council (BB/P027849/1). We would like to thank Y. Shao and H. Browne for fruitful discussions and feedback about the manuscript.	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Ackermann HW, 1999, ADV VIRUS RES, V51, P135; Al-Shayeb B, 2020, NATURE, V578, P425, DOI 10.1038/s41586-020-2007-4; Almeida A, 2021, NAT BIOTECHNOL, V39, P105, DOI 10.1038/s41587-020-0603-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Betts A, 2014, P NATL ACAD SCI USA, V111, P11109, DOI 10.1073/pnas.1406763111; Bi DX, 2012, NUCLEIC ACIDS RES, V40, pD621, DOI 10.1093/nar/gkr846; Breitbart M, 2018, NAT MICROBIOL, V3, P754, DOI 10.1038/s41564-018-0166-y; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Brussow H, 2002, CELL, V108, P13, DOI 10.1016/S0092-8674(01)00637-7; Chan CX, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-120; Chaumeil PA, 2020, BIOINFORMATICS, V36, P1925, DOI 10.1093/bioinformatics/btz848; Chen J, 2018, SCIENCE, V362, P207, DOI 10.1126/science.aat5867; Chen MM, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01576-17; Clooney AG, 2019, CELL HOST MICROBE, V26, P764, DOI 10.1016/j.chom.2019.10.009; Couvin D, 2018, NUCLEIC ACIDS RES, V46, pW246, DOI 10.1093/nar/gky425; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Gregory A.C., 2019, HUMAN GUT VIROME DAT, P655910, DOI [10.1101/655910, DOI 10.1101/655910]; Gregory AC, 2020, CELL HOST MICROBE, V28, P724, DOI 10.1016/j.chom.2020.08.003; Guerin E, 2018, CELL HOST MICROBE, V24, P653, DOI 10.1016/j.chom.2018.10.002; Harrison E, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700112; Hoyles L, 2014, RES MICROBIOL, V165, P803, DOI 10.1016/j.resmic.2014.10.006; Huerta-Cepas J, 2019, NUCLEIC ACIDS RES, V47, pD309, DOI 10.1093/nar/gky1085; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jahn MT, 2019, CELL HOST MICROBE, V26, P542, DOI 10.1016/j.chom.2019.08.019; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jang HB, 2019, NAT BIOTECHNOL, V37, P632, DOI 10.1038/s41587-019-0100-8; Jiang XF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223680; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kho ZY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01835; Koonin EV, 2020, TRENDS MICROBIOL, V28, P349, DOI 10.1016/j.tim.2020.01.010; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manrique P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/pnas.1601060113; Marbouty M, 2020, BIORXIV, DOI 13.093716; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Nayfach S, 2020, BIORXIV, DOI [10.1101/2020.05.06.081778, DOI 10.1101/2020.05.06.081778]; Paez-Espino D, 2019, NUCLEIC ACIDS RES, V47, pD678, DOI 10.1093/nar/gky1127; Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ren J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0283-5; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Roux S, 2019, NAT BIOTECHNOL, V37, P29, DOI 10.1038/nbt.4306; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040418; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Simmonds P, 2017, NAT REV MICROBIOL, V15, P161, DOI 10.1038/nrmicro.2016.177; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Suzuki Y, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0737-z; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yehl K, 2019, CELL, V179, P459, DOI 10.1016/j.cell.2019.09.015; Zou YQ, 2019, NAT BIOTECHNOL, V37, P179, DOI 10.1038/s41587-018-0008-8	63	121	125	17	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					1098	+		10.1016/j.cell.2021.01.029	http://dx.doi.org/10.1016/j.cell.2021.01.029		FEB 2021	21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606979	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000629633400021
J	Rosenbaum, L				Rosenbaum, Lisa			No Cure without Care - Soothing Science Skepticism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								No Cure without Care - Soothing Science Skepticism To the extent that Covid vaccine hesitancy reflects deeper, longer-standing fractures in medicine's relationship with the public, its exploration provides an opportunity to improve patient care in ways that go far beyond the pandemic.										Blendon RJ, 2014, NEW ENGL J MED, V371, P1570, DOI 10.1056/NEJMp1407373; Center for Strategic and International Studies, 2020, CSIS BOOK LAUNCH HEI; Centers for Medicare and Medicaid Services, 2019, PREV CAR SCREEN INFL; Larson H.J., 2020, STUCK VACCINE RUMORS; Levinovitz, 2020, NATURAL FAITH NATURE; Lu Yunfei, 2020, CONVERSATION FOUNDER; Shapin Steven, 2019, ANGELES REV BOOKS; Villegas P., 2020, WASH POST	8	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2021	384	15					1462	1465		10.1056/NEJMms2101989	http://dx.doi.org/10.1056/NEJMms2101989			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN7TA	33606366	Bronze			2022-12-28	WOS:000640554500015
J	Liu, YZ; Cruz-Morales, P; Zargar, A; Belcher, MS; Pang, B; Englund, E; Dan, QY; Yin, K; Keasling, JD				Liu, Yuzhong; Cruz-Morales, Pablo; Zargar, Amin; Belcher, Michael S.; Pang, Bo; Englund, Elias; Dan, Qingyun; Yin, Kevin; Keasling, Jay D.			Biofuels for a sustainable future	CELL			English	Review							MICROBIAL BIOSYNTHESIS; POLYKETIDE SYNTHASE; ESCHERICHIA-COLI; CARBON-DIOXIDE; MARGINAL LAND; FATTY-ACIDS; BIOMASS; FUELS; EFFICIENCIES; CONVERSION	Rapid increases of energy consumption and human dependency on fossil fuels have led to the accumulation of greenhouse gases and consequently, climate change. As such, major efforts have been taken to develop, test, and adopt clean renewable fuel alternatives. Production of bioethanol and biodiesel from crops is well developed, while other feedstock resources and processes have also shown high potential to provide efficient and cost-effective alternatives, such as landfill and plastic waste conversion, algal photosynthesis, as well as electrochemical carbon fixation. In addition, the downstream microbial fermentation can be further engineered to not only increase the product yield but also expand the chemical space of biofuels through the rational design and fine-tuning of biosynthetic pathways toward the realization of "designer fuels" and diverse future applications.	[Liu, Yuzhong; Cruz-Morales, Pablo; Zargar, Amin; Belcher, Michael S.; Pang, Bo; Englund, Elias; Dan, Qingyun; Yin, Kevin; Keasling, Jay D.] Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Liu, Yuzhong; Cruz-Morales, Pablo; Zargar, Amin; Belcher, Michael S.; Pang, Bo; Englund, Elias; Dan, Qingyun; Yin, Kevin; Keasling, Jay D.] Lawrence Berkeley Natl Lab, Div Biol Syst & Engn, Berkeley, CA 94720 USA; [Liu, Yuzhong; Cruz-Morales, Pablo; Zargar, Amin; Pang, Bo; Englund, Elias; Dan, Qingyun; Keasling, Jay D.] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Belcher, Michael S.; Yin, Kevin] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark; [Keasling, Jay D.] Shenzhen Inst Adv Technol, Ctr Synthet Biochem, Shenzhen, Peoples R China	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Technical University of Denmark; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Keasling, JD (corresponding author), Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Emeryville, CA 94608 USA.; Keasling, JD (corresponding author), Lawrence Berkeley Natl Lab, Div Biol Syst & Engn, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.; Keasling, JD (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.; Keasling, JD (corresponding author), Shenzhen Inst Adv Technol, Ctr Synthet Biochem, Shenzhen, Peoples R China.	Keasling@berkeley.edu	Pang, Bo/AAS-7249-2020; Liu, Yuzhong/P-7198-2017	Pang, Bo/0000-0001-7110-6732; Cruz-Morales, Pablo/0000-0002-6751-8897; Dan, Qingyun/0000-0002-3110-9450; Yin, Kevin/0000-0002-3639-1125; Belcher, Michael/0000-0003-2352-6817; Liu, Yuzhong/0000-0001-5614-1951	DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research; DOE [DEAC02-05CH11231]; Lawrence Berkeley National Laboratory [DEAC02-05CH11231]	DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	This work was funded by the DOE Joint BioEnergy Institute (https://www.jbei.org/), supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, and by the Co-Optimization of Fuels & Engines project sponsored by the U.S. DOE Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies and Vehicle Technologies Offices, under contract DEAC02-05CH11231 between DOE and Lawrence Berkeley National Laboratory.	Abdullah B, 2019, RENEW SUST ENERG REV, V107, P37, DOI 10.1016/j.rser.2019.02.018; Akhtar MK, 2013, P NATL ACAD SCI USA, V110, P87, DOI 10.1073/pnas.1216516110; Alalwan Hayder A., 2019, Renewable Energy Focus, V28, P127, DOI 10.1016/j.ref.2018.12.006; Aleku GA, 2018, CHEMCATCHEM, V10, P3736, DOI 10.1002/cctc.201800643; [Anonymous], 2005, EN POL ACT 2005; Atelge MR, 2020, WASTE BIOMASS VALORI, V11, P1019, DOI 10.1007/s12649-018-00546-0; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Aznar A, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-017-1007-6; Baral NR, 2019, ACS SUSTAIN CHEM ENG, V7, P9062, DOI 10.1021/acssuschemeng.9b01229; Belcher MS, 2020, NAT CHEM BIOL, V16, P857, DOI 10.1038/s41589-020-0547-4; Biotechnology Innovation Organization (BIO), 2014, RENEWABLE FUEL STAND; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Brennan TCR, 2015, APPL ENVIRON MICROB, V81, P3316, DOI 10.1128/AEM.04144-14; Buyel JF, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01893; Capell T, 2020, TRENDS PLANT SCI, V25, P635, DOI 10.1016/j.tplants.2020.04.009; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Chuck CJ, 2014, APPL ENERG, V118, P83, DOI 10.1016/j.apenergy.2013.12.019; Claassens NJ, 2016, NAT REV MICROBIOL, V14, P692, DOI 10.1038/nrmicro.2016.130; Clark M, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00210; Cooney MJ, 2008, ENERG ENVIRON SCI, V1, P320, DOI 10.1039/b809009b; Curran SC, 2018, ACS CHEM BIOL, V13, P2261, DOI 10.1021/acschembio.8b00422; Danso D, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01095-19; De Bhowmick G, 2015, RENEW SUST ENERG REV, V50, P1239, DOI 10.1016/j.rser.2015.04.131; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dent M, 2020, CURR OPIN BIOTECH, V61, P82, DOI 10.1016/j.copbio.2019.11.004; Diallo B, 2019, IND CROP PROD, V137, P221, DOI 10.1016/j.indcrop.2019.05.030; Donini M, 2019, BIOTECHNOL LETT, V41, P335, DOI 10.1007/s10529-019-02651-z; dos Santos AC, 2019, TRENDS BIOTECHNOL, V37, P518, DOI 10.1016/j.tibtech.2018.10.010; Eng CH, 2018, NUCLEIC ACIDS RES, V46, pD509, DOI 10.1093/nar/gkx893; Eudes A, 2015, PLANT BIOTECHNOL J, V13, P1241, DOI 10.1111/pbi.12310; Fang Z, 2020, ACS APPL BIO MATER, V3, P881, DOI 10.1021/acsabm.9b00954; Field JL, 2020, P NATL ACAD SCI USA, V117, P21968, DOI 10.1073/pnas.1920877117; Food & Agriculture Organization, 2015, GLOBAL FOOD LOSSES F; Gao ZX, 2012, ENERG ENVIRON SCI, V5, P9857, DOI 10.1039/c2ee22675h; Han W, 2016, SCI REP-UK, V6, DOI 10.1038/srep38395; Holladay JA, 2020, SUSTAINABLE AVIATION; Incha M.R., 2019, METABOLIC ENG COMMUN, V10; Isikgor FH, 2015, POLYM CHEM-UK, V6, P4497, DOI 10.1039/c5py00263j; Jiang D, 2019, J CLEAN PROD, V220, P225, DOI 10.1016/j.jclepro.2019.01.294; Kalkreuter E, 2019, J AM CHEM SOC, V141, P1961, DOI 10.1021/jacs.8b10521; Kings AJ, 2017, ENERG CONVERS MANAGE, V141, P224, DOI 10.1016/j.enconman.2016.08.018; Kirst H, 2017, PLANTA, V245, P1009, DOI 10.1007/s00425-017-2659-y; Knoot CJ, 2018, J BIOL CHEM, V293, P5044, DOI 10.1074/jbc.R117.815886; Kopf M, 2014, DNA RES, V21, P527, DOI 10.1093/dnares/dsu018; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Liang FY, 2018, METAB ENG, V46, P51, DOI 10.1016/j.ymben.2018.02.006; Liao JC, 2016, NAT REV MICROBIOL, V14, P288, DOI 10.1038/nrmicro.2016.32; Liu C, 2016, SCIENCE, V352, P1210, DOI 10.1126/science.aaf5039; Liu TG, 2010, ANNU REV GENET, V44, P53, DOI 10.1146/annurev-genet-102209-163440; Liu XF, 2019, ENERG ENVIRON SCI, V12, P2765, DOI [10.1039/c9ee01214a, 10.1039/C9EE01214A]; Logan BE, 2019, NAT REV MICROBIOL, V17, P307, DOI 10.1038/s41579-019-0173-x; Lu JN, 2012, APPL MICROBIOL BIOT, V96, P283, DOI 10.1007/s00253-012-4320-9; Melis A, 1998, J APPL PHYCOL, V10, P515, DOI 10.1023/A:1008076231267; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Mihreteab M, 2019, APPL MICROBIOL BIOT, V103, P7729, DOI 10.1007/s00253-019-09999-2; Misi SN, 2001, BIORESOURCE TECHNOL, V80, P19, DOI 10.1016/S0960-8524(01)00078-5; Mortimer JC, 2019, EXP BIOL MED, V244, P323, DOI 10.1177/1535370218793890; Nevin KP, 2011, APPL ENVIRON MICROB, V77, P2882, DOI 10.1128/AEM.02642-10; Nevin KP, 2010, MBIO, V1, DOI 10.1128/mBio.00103-10; Nichols EM, 2015, P NATL ACAD SCI USA, V112, P11461, DOI 10.1073/pnas.1508075112; Oliver JWK, 2015, METAB ENG, V29, P106, DOI 10.1016/j.ymben.2015.03.006; Pang B, 2019, BIOTECHNOL BIOPROC E, V24, P413, DOI 10.1007/s12257-019-0083-9; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Pimienta JAP, 2019, GREEN CHEM, V21, P3152, DOI [10.1039/c9gc00323a, 10.1039/C9GC00323A]; Rashid N, 2013, BIOCHEM ENG J, V75, P101, DOI 10.1016/j.bej.2013.04.001; Rodrigues RM, 2019, NAT CATAL, V2, P407, DOI 10.1038/s41929-019-0264-0; Rui Z, 2014, P NATL ACAD SCI USA, V111, P18237, DOI 10.1073/pnas.1419701112; Saerens SMG, 2006, J BIOL CHEM, V281, P4446, DOI 10.1074/jbc.M512028200; Sarria S, 2014, ACS SYNTH BIOL, V3, P466, DOI 10.1021/sb4001382; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Schwander T, 2016, SCIENCE, V354, P900, DOI 10.1126/science.aah5237; Shabestary Kiyan, 2016, Metab Eng Commun, V3, P216, DOI 10.1016/j.meteno.2016.07.003; Shih PM, 2014, J BIOL CHEM, V289, P9493, DOI 10.1074/jbc.C113.543132; Slorach PC, 2019, J ENVIRON MANAGE, V236, P798, DOI 10.1016/j.jenvman.2019.02.001; Smith A, 2001, WASTE MANAGEMENT OPT, P224; Sorigue D, 2017, SCIENCE, V357, P903, DOI 10.1126/science.aan6349; South PF, 2019, SCIENCE, V363, P45, DOI 10.1126/science.aat9077; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tatsumi H, 1999, ANAL CHEM, V71, P1753, DOI 10.1021/ac981003l; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tros M, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148206; US Department of agriculture. National cooperative extension, 2019, BIOD CLOUD POINT COL; US Department of Energy; Alternative fuel data center, 2014, FUEL PROP COMP; US Department of Energy; Alternative fuels data center, 2020, GLOB ETH PROD STAT S; US Department of Energy; Energy Information Administration (U.S.E.I.A), 2020, MONTHL EN REV; US Environmental Protection Agency, 2020, GREENH GAS EN CONS R; Wang CL, 2016, BIOTECHNOL J, V11, P1291, DOI 10.1002/biot.201600250; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Yan JW, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1196-7; Yang ML, 2020, P NATL ACAD SCI USA, V117, P8639, DOI 10.1073/pnas.2000053117; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Yuzawa S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07040-0; Zargar A, 2020, METAB ENG, V61, P389, DOI 10.1016/j.ymben.2020.07.001; Zargar A, 2020, J AM CHEM SOC, V142, P9896, DOI 10.1021/jacs.0c02549; Zhang ZY, 2016, CURR OPIN BIOTECH, V38, P97, DOI 10.1016/j.copbio.2016.01.010; Zheng YN, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-57; Zhu Y., 2018, ALGAE FARM COST MODE	99	46	48	17	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2021	184	6					1636	1647		10.1016/j.cell.2021.01.052	http://dx.doi.org/10.1016/j.cell.2021.01.052		MAR 2021	12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QY9LN	33639085	Bronze, Green Submitted			2022-12-28	WOS:000630357400024
J	Jonas, DE; Reuland, DS; Reddy, SM; Nagle, M; Clark, SD; Weber, RP; Enyioha, C; Malo, TL; Brenner, AT; Armstrong, C; Coker-Schwimmer, M; Middleton, JC; Voisin, C; Harris, RP				Jonas, Daniel E.; Reuland, Daniel S.; Reddy, Shivani M.; Nagle, Max; Clark, Stephen D.; Weber, Rachel Palmieri; Enyioha, Chineme; Malo, Teri L.; Brenner, Alison T.; Armstrong, Charli; Coker-Schwimmer, Manny; Middleton, Jennifer Cook; Voisin, Christiane; Harris, Russell P.			Screening for Lung Cancer With Low-Dose Computed Tomography Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review								Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To review the evidence on screening for lung cancer with low-dose computed tomography (LDCT) to inform the US Preventive Services Task Force (USPSTF). Data Sources MEDLINE, Cochrane Library, and trial registries through May 2019; references; experts; and literature surveillance through November 20, 2020. Study Selection English-language studies of screening with LDCT, accuracy of LDCT, risk prediction models, or treatment for early-stage lung cancer. Data Extraction and Synthesis Dual review of abstracts, full-text articles, and study quality; qualitative synthesis of findings. Data were not pooled because of heterogeneity of populations and screening protocols. Main Outcomes and Measures Lung cancer incidence, lung cancer mortality, all-cause mortality, test accuracy, and harms. Results This review included 223 publications. Seven randomized clinical trials (RCTs) (N = 86 486) evaluated lung cancer screening with LDCT; the National Lung Screening Trial (NLST, N = 53 454) and Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON, N = 15 792) were the largest RCTs. Participants were more likely to benefit than the US screening-eligible population (eg, based on life expectancy). The NLST found a reduction in lung cancer mortality (incidence rate ratio [IRR], 0.85 [95% CI, 0.75-0.96]; number needed to screen [NNS] to prevent 1 lung cancer death, 323 over 6.5 years of follow-up) with 3 rounds of annual LDCT screening compared with chest radiograph for high-risk current and former smokers aged 55 to 74 years. NELSON found a reduction in lung cancer mortality (IRR, 0.75 [95% CI, 0.61-0.90]; NNS to prevent 1 lung cancer death of 130 over 10 years of follow-up) with 4 rounds of LDCT screening with increasing intervals compared with no screening for high-risk current and former smokers aged 50 to 74 years. Harms of screening included radiation-induced cancer, false-positive results leading to unnecessary tests and invasive procedures, overdiagnosis, incidental findings, and increases in distress. For every 1000 persons screened in the NLST, false-positive results led to 17 invasive procedures (number needed to harm, 59) and fewer than 1 person having a major complication. Overdiagnosis estimates varied greatly (0%-67% chance that a lung cancer was overdiagnosed). Incidental findings were common, and estimates varied widely (4.4%-40.7% of persons screened). Conclusions and Relevance Screening high-risk persons with LDCT can reduce lung cancer mortality but also causes false-positive results leading to unnecessary tests and invasive procedures, overdiagnosis, incidental findings, increases in distress, and, rarely, radiation-induced cancers. Most studies reviewed did not use current nodule evaluation protocols, which might reduce false-positive results and invasive procedures for false-positive results. This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening for lung cancer summarizes published evidence about the relative benefits and harms of low-dose computed tomography to identify lung cancer in persons at high risk.	[Jonas, Daniel E.; Reddy, Shivani M.; Weber, Rachel Palmieri; Armstrong, Charli; Coker-Schwimmer, Manny; Middleton, Jennifer Cook; Voisin, Christiane] Univ N Carolina, RTI Int, Evidence Based Practice Ctr, Chapel Hill, NC 27515 USA; [Jonas, Daniel E.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Reuland, Daniel S.; Harris, Russell P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; [Reuland, Daniel S.; Weber, Rachel Palmieri; Armstrong, Charli; Coker-Schwimmer, Manny; Middleton, Jennifer Cook; Voisin, Christiane; Harris, Russell P.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27515 USA; [Reuland, Daniel S.; Malo, Teri L.; Brenner, Alison T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Reddy, Shivani M.] RTI Int, Res Triangle Pk, NC USA; [Nagle, Max] Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA; [Clark, Stephen D.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA; [Enyioha, Chineme] Univ N Carolina, Dept Family Med, Chapel Hill, NC 27515 USA	Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; University of Michigan System; University of Michigan; Virginia Commonwealth University; University of North Carolina; University of North Carolina Chapel Hill	Jonas, DE (corresponding author), Ohio State Univ, Dept Internal Med, Div Gen Internal Med, 2050 Kenny Rd, Columbus, OH 43221 USA.	Daniel.Jonas@osumc.edu		Reddy, Shivani/0000-0003-2803-6155; Weber, Rachel/0000-0001-7119-7734; Malo, Teri/0000-0002-5620-4841				Aberle DR, 2019, J THORAC ONCOL, V14, P1732, DOI 10.1016/j.jtho.2019.05.044; Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Aggestrup LM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000663; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; American Cancer Society , 2017, KEY STAT LUNG CANC; American Cancer Society, 2019, WHAT LUNG CANC; American College of Radiology, LUNG CT SCREENING RE; Anderson CM, 2009, CANCER EPIDEM BIOMAR, V18, P3476, DOI 10.1158/1055-9965.EPI-09-0176; Ashraf H, 2009, THORAX, V64, P388, DOI 10.1136/thx.2008.102475; Ashraf H, 2014, THORAX, V69, P574, DOI 10.1136/thoraxjnl-2013-203849; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Becker N, 2015, J THORAC ONCOL, V10, P890, DOI 10.1097/JTO.0000000000000530; Becker N, 2012, J CANCER RES CLIN, V138, P1475, DOI 10.1007/s00432-012-1228-9; Becker N, 2020, INT J CANCER, V146, P1503, DOI 10.1002/ijc.32486; Brenner AT, 2018, JAMA INTERN MED, V178, P1311, DOI 10.1001/jamainternmed.2018.3054; Byrne MM, 2008, MED DECIS MAKING, V28, P917, DOI 10.1177/0272989X08322013; Chung K, 2017, RADIOLOGY, V284, P264, DOI 10.1148/radiol.2017161624; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Clark MA, 2016, NICOTINE TOB RES, V18, P17, DOI 10.1093/ntr/ntv037; Cox LS, 2003, CANCER, V98, P2495, DOI 10.1002/cncr.11813; Croswell JM, 2010, ANN INTERN MED, V152, P505, DOI 10.7326/0003-4819-152-8-201004200-00007; Crucitti P, 2015, MINERVA CHIR, V70, P393; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Doroudi M, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky042; Dunn CE, 2017, PATIENT EDUC COUNS, V100, P1572, DOI 10.1016/j.pec.2017.02.024; Field JK, 2016, THORAX, V71, P161, DOI 10.1136/thoraxjnl-2015-207140; Field JK, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20400; Gareen IF, 2014, CANCER-AM CANCER SOC, V120, P3401, DOI 10.1002/cncr.28833; Gierada DS, 2017, EUR RADIOL, V27, P3249, DOI 10.1007/s00330-016-4705-8; Gohagan J, 2004, CHEST, V126, P114, DOI 10.1378/chest.126.1.114; Gohagan JK, 2005, LUNG CANCER, V47, P9, DOI 10.1016/j.lungcan.2004.06.007; Heleno B, 2018, JAMA INTERN MED, V178, P1420, DOI 10.1001/jamainternmed.2018.3056; Henschke CI, 2004, CLIN IMAG, V28, P317, DOI 10.1016/j.clinimag.2004.05.001; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Henschke CI, 2016, AM J ROENTGENOL, V207, P1176, DOI 10.2214/AJR.16.16043; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Heuvelmans MA, 2013, EUR RADIOL, V23, P1836, DOI 10.1007/s00330-013-2799-9; Horeweg N, 2014, LANCET ONCOL, V15, P1342, DOI 10.1016/S1470-2045(14)70387-0; Horeweg N, 2013, EUR RESPIR J, V42, P1659, DOI 10.1183/09031936.00197712; Howard DH, 2015, CANCER-AM CANCER SOC, V121, P4341, DOI 10.1002/cncr.29677; Humphrey L, 2013, SCREENING LUNG CANC; Humphrey LL, 2013, ANN INTERN MED, V159, P411, DOI 10.7326/0003-4819-159-6-201309170-00690; Infante M, 2008, LUNG CANCER, V59, P355, DOI 10.1016/j.lungcan.2007.08.040; Infante M, 2015, AM J RESP CRIT CARE, V191, P1166, DOI 10.1164/rccm.201408-1475OC; Infante M, 2011, J THORAC ONCOL, V6, P327, DOI 10.1097/JTO.0b013e318200f523; Infante M, 2009, AM J RESP CRIT CARE, V180, P445, DOI 10.1164/rccm.200901-0076OC; Jahan S, 2016, HUMAN DEV REPORT 201; Jonas D., 2021, AHRQ PUBLICATION; Kaerlev L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-188; Kinsinger LS, 2017, JAMA INTERN MED, V177, P399, DOI 10.1001/jamainternmed.2016.9022; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Mascalchi M, 2006, AM J ROENTGENOL, V187, P421, DOI 10.2214/AJR.05.0088; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Menezes RJ, 2010, LUNG CANCER, V67, P177, DOI 10.1016/j.lungcan.2009.03.030; Morgan L, 2017, ANN AM THORAC SOC, V14, P1450, DOI [10.1513/AnnalsATS.201612-1023OC, 10.1513/annalsats.201612-1023oc]; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; National Cancer Institute, SURV EP END RES PROG; Nguyen XV, 2017, J AM COLL RADIOL, V14, P324, DOI 10.1016/j.jacr.2016.09.044; O'Grady TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106880; Paci E, 2017, THORAX, V72, P825, DOI 10.1136/thoraxjnl-2016-209825; Pastorino U, 2012, EUR J CANCER PREV, V21, P308, DOI 10.1097/CEJ.0b013e328351e1b6; Patz EF, 2014, JAMA INTERN MED, V174, P269, DOI 10.1001/jamainternmed.2013.12738; Pedersen JH, 2009, J THORAC ONCOL, V4, P608, DOI 10.1097/JTO.0b013e3181a0d98f; Pegna AL, 2013, J THORAC ONCOL, V8, P866, DOI 10.1097/JTO.0b013e31828f68d6; Pegna AL, 2009, LUNG CANCER, V64, P34, DOI 10.1016/j.lungcan.2008.07.003; Pinsky PF, 2018, J MED SCREEN, V25, P110, DOI 10.1177/0969141317727771; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Pinsky PF, 2014, ANN INTERN MED, V161, P627, DOI 10.7326/M14-1484; Pinsky PF, 2013, J MED SCREEN, V20, P165, DOI 10.1177/0969141313500666; Pinsky PF, 2013, RADIOLOGY, V268, P865, DOI 10.1148/radiol.13121530; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Rampinelli C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j347; Rasmussen JF, 2015, LUNG CANCER, V87, P65, DOI 10.1016/j.lungcan.2014.11.003; Reuland DS, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0582-1; Ru Zhao Ying, 2011, Cancer Imaging, V11 Spec No A, pS79, DOI 10.1102/1470-7330.2011.9020; Saghir Z, 2012, THORAX, V67, P296, DOI 10.1136/thoraxjnl-2011-200736; Schabath MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159880; Scholten ET, 2015, EUR RADIOL, V25, P81, DOI 10.1007/s00330-014-3394-4; Siegel R., 2015, CA-CANCER J CLIN, V65, P29, DOI [10.3322/caac.21254, DOI 10.3322/CAAC.21254, DOI 10.3322/caac.21208]; Styn MA, 2009, CANCER EPIDEM BIOMAR, V18, P3484, DOI 10.1158/1055-9965.EPI-09-0895; Sverzellati N, 2016, EUR RADIOL, V26, P3821, DOI 10.1007/s00330-016-4228-3; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662; Tammemagi MC, 2017, LANCET ONCOL, V18, P1523, DOI [10.1016/S1470-2045(17)30597-1, 10.1016/s1470-2045(17)30597-1]; Tanner NT, 2015, AM J RESP CRIT CARE, V192, P200, DOI 10.1164/rccm.201502-0259OC; Taylor KL, 2007, LUNG CANCER, V56, P125, DOI 10.1016/j.lungcan.2006.11.015; Thalanayar PM, 2015, ANN AM THORAC SOC, V12, P1193, DOI 10.1513/AnnalsATS.201412-577OC; Toumazis, 2020, AHRQ PUBLICATION; Townsend CO, 2005, CANCER-AM CANCER SOC, V103, P2154, DOI 10.1002/cncr.21045; Toyoda Y, 2008, BRIT J CANCER, V98, P1602, DOI 10.1038/sj.bjc.6604351; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Tsushima K, 2008, RESPIROLOGY, V13, P817, DOI 10.1111/j.1440-1843.2008.01379.x; US Preventive Services Task Force , 2015, PROC MAN APP 6 CRIT; van den Bergh KAM, 2011, EUR RESPIR J, V38, P154, DOI 10.1183/09031936.00123410; van den Bergh KAM, 2010, BRIT J CANCER, V102, P27, DOI 10.1038/sj.bjc.6605459; van den Bergh KAM, 2008, CANCER, V113, P396, DOI 10.1002/cncr.23590; van der Aalst CM, 2011, EUR RESPIR J, V37, P1466, DOI 10.1183/09031936.00035410; van der Aalst CM, 2010, THORAX, V65, P600, DOI 10.1136/thx.2009.133751; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; van Riel SJ, 2015, RADIOLOGY, V277, P863, DOI 10.1148/radiol.2015142700; van't Westeinde SC, 2012, CHEST, V142, P377, DOI 10.1378/chest.11-2030; Veronesi G, 2008, LUNG CANCER, V61, P340, DOI 10.1016/j.lungcan.2008.01.001; Veronesi G, 2008, J THORAC CARDIOV SUR, V136, P611, DOI 10.1016/j.jtcvs.2008.02.082; Veronesi G, 2012, ANN INTERN MED, V157, P776, DOI 10.7326/0003-4819-157-11-201212040-00005; Wagnetz U, 2012, AM J ROENTGENOL, V198, P351, DOI 10.2214/AJR.11.6726; Walker BL, 2015, ANN THORAC SURG, V100, P1218, DOI 10.1016/j.athoracsur.2015.04.112; Walter JE, 2016, LANCET ONCOL, V17, P907, DOI 10.1016/S1470-2045(16)30069-9; Wang Y, 2012, RADIOLOGY, V262, P320, DOI 10.1148/radiol.11102289; West SL., 2010, AHRQ PUBLICATION; Wille MMW, 2016, AM J RESP CRIT CARE, V193, P542, DOI 10.1164/rccm.201505-1040OC; Wille MMW, 2014, EUR RADIOL, V24, P2692, DOI 10.1007/s00330-014-3294-7; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P956, DOI 10.1164/rccm.200802-336OC; Xu DM, 2006, LUNG CANCER, V54, P177, DOI 10.1016/j.lungcan.2006.08.006; Yankelevitz DF, 2015, RADIOLOGY, V277, P555, DOI 10.1148/radiol.2015142554; Yip R, 2014, RADIOLOGY, V273, P591, DOI 10.1148/radiol.14132950; Young RP, 2015, AM J RESP CRIT CARE, V192, P1060, DOI 10.1164/rccm.201505-0894OC; Zeliadt SB, 2018, AM J PREV MED, V54, P568, DOI 10.1016/j.amepre.2018.01.001; Zhao YR, 2014, RADIOLOGY, V270, P872, DOI 10.1148/radiol.13130332	120	92	94	12	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					971	987		10.1001/jama.2021.0377	http://dx.doi.org/10.1001/jama.2021.0377			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687468	Bronze			2022-12-28	WOS:000627899400019
J	Ghosh, DD; Lee, D; Jin, X; Horvitz, HR; Nitabach, MN				Ghosh, D. Dipon; Lee, Dongyeop; Jin, Xin; Horvitz, H. Robert; Nitabach, Michael N.			C. elegans discriminates colors to guide foraging	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; PATHOGENIC BACTERIA; PATHWAY; JNK; ACTIVATION; LIGHT; AVOIDANCE; NEURONS; MKK7	Color detection is used by animals of diverse phyla to navigate colorful natural environments and is thought to require evolutionarily conserved opsin photoreceptor genes. We report that Caenorhabditis elegans roundworms can discriminate between colors despite the fact that they lack eyes and opsins. Specifically, we found that white light guides C. elegans foraging decisions away from a blue-pigment toxin secreted by harmful bacteria. These foraging decisions are guided by specific blue-to-amber ratios of light. The color specificity of color-dependent foraging varies notably among wild C. elegans strains, which indicates that color discrimination is ecologically important. We identified two evolutionarily conserved cellular stress response genes required for opsin-independent, color-dependent foraging by C. elegans, and we speculate that cellular stress response pathways can mediate spectral discrimination by photosensitive cells and organisms-even by those lacking opsins.	[Ghosh, D. Dipon; Jin, Xin; Nitabach, Michael N.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Ghosh, D. Dipon; Lee, Dongyeop; Horvitz, H. Robert] MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Nitabach, Michael N.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Nitabach, Michael N.] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Yale University; Yale University	Ghosh, DD; Nitabach, MN (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.; Ghosh, DD (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Nitabach, MN (corresponding author), Yale Univ, Dept Genet, New Haven, CT 06520 USA.; Nitabach, MN (corresponding author), Yale Univ, Dept Neurosci, New Haven, CT 06520 USA.	dipon@mit.edu; michael.nitabach@yale.edu		Horvitz, Howard/0000-0002-9964-9613; Ghosh, D. Dipon/0000-0001-6391-5767; JIN, XIN/0000-0002-7271-7655	National Institute of General Medical Sciences (NIGMS), NIH [R01GM024663]; NIGMS, NIH [R01GM098931]	National Institute of General Medical Sciences (NIGMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.D.G. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. Work in the laboratory of H.R.H. was supported by the National Institute of General Medical Sciences (NIGMS), NIH (R01GM024663). H.R.H. is an investigator of the Howard Hughes Medical Institute. Work in the laboratory of M.N.N. is supported in part by NIGMS, NIH (R01GM098931).	ASTM, 2006, G17303 ASTM, DOI [10.1520/G0173-03R20, DOI 10.1520/G0173-03R20]; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Barriere Antoine, 2005, P1; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Bhatla N, 2015, CURR BIOL, V25, P2075, DOI 10.1016/j.cub.2015.06.052; Bhatla N, 2015, NEURON, V85, P804, DOI 10.1016/j.neuron.2014.12.061; Brandt B, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.1; Burlinson P, 2013, ISME J, V7, P1126, DOI 10.1038/ismej.2013.9; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Cook DE, 2017, NUCLEIC ACIDS RES, V45, pD650, DOI 10.1093/nar/gkw893; Cuthill IC, 2017, SCIENCE, V357, DOI 10.1126/science.aan0221; De Magalhaes CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02934-5; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Evans KS, 2017, G3-GENES GENOM GENET, V7, P289, DOI 10.1534/g3.116.035162; Foltz IN, 1998, J BIOL CHEM, V273, P9344, DOI 10.1074/jbc.273.15.9344; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; Gong JK, 2016, CELL, V167, P1252, DOI 10.1016/j.cell.2016.10.053; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kuwabara I, 2002, J BIOL CHEM, V277, P3487, DOI 10.1074/jbc.M109360200; Liu GY, 2009, TRENDS MICROBIOL, V17, P406, DOI 10.1016/j.tim.2009.06.006; Liu J, 2010, NAT NEUROSCI, V13, P715, DOI 10.1038/nn.2540; Longden KD, 2016, CURR BIOL, V26, pR981, DOI 10.1016/j.cub.2016.07.071; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Meisel JD, 2014, TRENDS IMMUNOL, V35, P465, DOI 10.1016/j.it.2014.08.008; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Nemoto-Sasaki Y, 2008, BBA-GEN SUBJECTS, V1780, P1131, DOI 10.1016/j.bbagen.2008.07.003; Page AP, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0632-x; Pichaud F, 1999, CURR OPIN NEUROBIOL, V9, P622, DOI 10.1016/S0959-4388(99)00014-8; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; Samuel BS, 2016, P NATL ACAD SCI USA, V113, pE3941, DOI 10.1073/pnas.1607183113; Singh J, 2019, ELIFE, V8, DOI 10.7554/eLife.50033; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	40	7	7	7	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1059	+		10.1126/science.abd3010	http://dx.doi.org/10.1126/science.abd3010			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674494	Green Published, Green Accepted			2022-12-28	WOS:000625876100057
J	Gleeson, SE; Zhang, XC; Azar, MM				Gleeson, Shana E.; Zhang, Xuchen; Azar, Marwan M.			Recurrent Hematochezia in a Returning Traveler	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								A 28-year-old man who while traveling swam in the upper Nile River in Uganda developed intermittent diarrhea and hematochezia but no vomiting, fever, or weight loss; physical examination and laboratory findings were unremarkable, and colonoscopy with biopsy showed rectal granulomas containing oval-shaped features with lateral spines. What is the diagnosis and what would you do next?	[Gleeson, Shana E.; Azar, Marwan M.] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, POB 208022, New Haven, CT 06510 USA; [Zhang, Xuchen] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University; Yale University	Gleeson, SE (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, POB 208022, New Haven, CT 06510 USA.	Shana.gleeson@yale.edu	zhang, xu/GYE-3558-2022	Zhang, Xuchen/0000-0002-1484-4672				Botes SN, 2015, WORLD J SURG, V39, P1080, DOI 10.1007/s00268-015-2954-3; Branda JA, 2006, CLIN INFECT DIS, V42, P972, DOI 10.1086/500937; Clerinx J, 2011, TRAVEL MED INFECT DI, V9, P6, DOI 10.1016/j.tmaid.2010.11.002; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Helleberg M, 2010, J TRAVEL MED, V17, P94, DOI 10.1111/j.1708-8305.2009.00387.x; Morgan OW, 2010, EMERG INFECT DIS, V16, P866, DOI 10.3201/eid1605.091740; Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4	8	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1558	1559		10.1001/jama.2021.0368	http://dx.doi.org/10.1001/jama.2021.0368		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33666646				2022-12-28	WOS:000625804000002
J	Huang, HL; Zhou, PP; Wei, J; Long, LY; Shi, H; Dhungana, Y; Chapman, NM; Fu, GT; Saravia, J; Raynor, JL; Liu, SF; Palacios, G; Wang, YD; Qian, CX; Yu, JY; Chi, HB				Huang, Hongling; Zhou, Peipei; Wei, Jun; Long, Lingyun; Shi, Hao; Dhungana, Yogesh; Chapman, Nicole M.; Fu, Guotong; Saravia, Jordy; Raynor, Jana L.; Liu, Shaofeng; Palacios, Gustavo; Wang, Yong-Dong; Qian, Chenxi; Yu, Jiyang; Chi, Hongbo			In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8(+) T cell fate decisions	CELL			English	Article							PROTEIN O-FUCOSYL-TRANSFERASE-1; TRANSCRIPTION FACTORS; LINEAGE RELATIONSHIP; READ ALIGNMENT; MEMORY; EFFECTOR; NOTCH; PROLIFERATION; EXPRESSION; DIFFERENTIATION	How early events in effector T cell (T-EFF) subsets tune memory T cell (T-MEM) responses remains incompletely understood. Here, we systematically investigated metabolic factors in fate determination of T-EFF and T-MEM cells using in vivo pooled CRISPR screening, focusing on negative regulators of T-MEM responses. We found that amino acid transporters Slc7a1 and Slc38a2 dampened the magnitude of T-MEM differentiation, in part through modulating mTORC1 signaling. By integrating genetic and systems approaches, we identified cellular and metabolic heterogeneity among T-EFF cells, with terminal effector differentiation associated with establishment of metabolic quiescence and exit from the cell cycle. Importantly, Pofut1 (protein-O-fucosyltransferase-1) linked GDP-fucose availability to downstream Notch-Rbpj signaling, and perturbation of this nutrient signaling axis blocked terminal effector differentiation but drove context-dependent T-EFF proliferation and T-MEM development. Our study establishes that nutrient uptake and signaling are key determinants of T cell fate and shape the quantity and quality of T-MEM responses.	[Huang, Hongling; Zhou, Peipei; Wei, Jun; Long, Lingyun; Shi, Hao; Dhungana, Yogesh; Chapman, Nicole M.; Fu, Guotong; Saravia, Jordy; Raynor, Jana L.; Liu, Shaofeng; Palacios, Gustavo; Qian, Chenxi; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Wang, Yong-Dong] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, Memphis, TN 38105 USA; [Qian, Chenxi; Yu, Jiyang] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Fu, Guotong/ABG-3381-2021; Chi, Hongbo/M-9397-2018; SHI, HAO/ABE-4662-2020	Chi, Hongbo/0000-0002-9997-2496; SHI, HAO/0000-0002-2796-629X; Wei, Jun/0000-0002-6769-847X; Fu, Guotong/0000-0002-2673-9378; Dhungana, Yogesh/0000-0002-4021-0075	National Institutes of Health [NIH AI105887, AI131703, AI140761, AI150241, AI150514, CA250533, CA221290]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge B.A. Youngblood for P14 mice; D.A. Vignali for B16-OVA cell line; Y.C. Liu for Plat-E cells; E.J. Wherry and Z. Chen for scientific discussions; Y. Wang for editing the manuscript; M. Hendren, A. KC, and S. Rankin for animal management; St. Jude Immunology flow cytometry core facility for cell sorting; The Hartwell Center for microarray, ATAC-seq, and scRNA-seq analyses; Center for Advanced Genome Engineering for targeted sequencing; and Veterinary Pathology Core for histology examination. This work was supported by the National Institutes of Health (NIH AI105887, AI131703, AI140761, AI150241, AI150514, CA250533, and CA221290 to H.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Amsen D, 2015, TRENDS IMMUNOL, V36, P802, DOI 10.1016/j.it.2015.10.007; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carty SA, 2018, J IMMUNOL, V200, P82, DOI 10.4049/jimmunol.1700559; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Chen ZY, 2021, CELL, V184, P1262, DOI 10.1016/j.cell.2021.02.019; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Crompton JG, 2014, IMMUNOL REV, V257, P264, DOI 10.1111/imr.12135; Endo Y, 2019, NAT METAB, V1, P261, DOI 10.1038/s42255-018-0025-4; Fraietta JA, 2018, NATURE, V558, P307, DOI 10.1038/s41586-018-0178-z; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Haines Ricci J, 2011, Int J Biochem Mol Biol, V2, P8; Hamilton SE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00353; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hsiao HW, 2009, IMMUNITY, V31, P72, DOI 10.1016/j.immuni.2009.04.017; Huang HL, 2020, IMMUNOL REV, V295, P15, DOI 10.1111/imr.12845; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kim Myoungjoo V, 2014, Bio Protoc, V4, DOI 10.21769/BioProtoc.1172; Korotkevich G., 2016, BIORXIV, DOI [10.1101/060012v3, DOI 10.1101/060012, 10.1101/060012]; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McInnes L., 2018, ARXIV ARXIV180203426; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Omilusik KD, 2019, CURR OPIN IMMUNOL, V58, P89, DOI 10.1016/j.coi.2019.04.009; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pollizzi KN, 2016, NAT IMMUNOL, V17, P704, DOI 10.1038/ni.3438; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanson KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07901-8; Saravia J, 2020, CELL RES, V30, P328, DOI 10.1038/s41422-020-0301-1; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Sentmanat MF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19441-8; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Verbist KC, 2016, NATURE, V532, P389, DOI 10.1038/nature17442; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yamada T, 2009, NAT IMMUNOL, V10, P618, DOI 10.1038/ni.1730; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	82	32	32	13	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1245	+		10.1016/j.cell.2021.02.021	http://dx.doi.org/10.1016/j.cell.2021.02.021		MAR 2021	38	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33636132	Bronze, Green Accepted			2022-12-28	WOS:000629635700014
J	SteelFisher, GK; Blendon, RJ; Caporello, H				SteelFisher, Gillian K.; Blendon, Robert J.; Caporello, Hannah			An Uncertain Public - Encouraging Acceptance of Covid-19 Vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An Uncertain Public An analysis of multiple polls suggests that much of the U.S. public is currently undecided about whether to take a Covid-19 vaccine. These findings can inform outreach efforts to encourage vaccine uptake - efforts in which physicians can play an important role.	[SteelFisher, Gillian K.; Blendon, Robert J.; Caporello, Hannah] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	SteelFisher, GK (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Dimock Michael., 2020, AM IS EXCEPTIONAL NA; Hoffman J, 2020, NEW YORK TIMES; Jamison AM, 2019, SOC SCI MED, V221, P87, DOI 10.1016/j.socscimed.2018.12.020; Keeter S., 2020, PEW RES CTR; Paek H.J., 2017, RISK PERCEPTIONS RIS, DOI [10.1093/acrefore/9780190228613.013.283, DOI 10.1093/ACREFORE/9780190228613.013.283]	5	46	46	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1483	1487		10.1056/NEJMp2100351	http://dx.doi.org/10.1056/NEJMp2100351		MAR 2021	5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RQ6OT	33657291	Bronze			2022-12-28	WOS:000640362400001
J	Ni, ZY; Xu, S; Huang, JS				Ni, Zhenyi; Xu, Shuang; Huang, Jinsong			Response to Comment on "Resolving spatial and energetic distributions of trap states in metal halide perovskite solar cells"	SCIENCE			English	Editorial Material							DIFFUSION; FILMS	Ravishankar et al. claimed that drive-level capacitance profiling (DLCP) cannot resolve trap density in perovskites of given thickness. We point out that the trap densities derived by DLCP are from the differential capacitance at different frequencies; thus, the background charges caused by diffusion and geometry capacitance have been subtracted. Even for the nondifferential doping analysis, the contribution from diffusion capacitance is negligible and that from geometry capacitance is excluded.	[Ni, Zhenyi; Xu, Shuang; Huang, Jinsong] Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Huang, JS (corresponding author), Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC 27599 USA.	jhuang@unc.edu		Ni, Zhenyi/0000-0002-8379-9182	Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center - Office of Basic Energy Sciences, Office of Science within the U.S. Department of Energy	Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center - Office of Basic Energy Sciences, Office of Science within the U.S. Department of Energy(United States Department of Energy (DOE))	Supported by Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center funded by the Office of Basic Energy Sciences, Office of Science within the U.S. Department of Energy. Author contributions: Z.N. and S.X. carried out the capacitance measurements, Z.N. performed the SCAPS simulations, J.H. and Z.N. wrote the paper, and all authors reviewed the paper. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and in the references cited. Additional data related to this paper may be requested from the authors.	Burgelman M, 2000, THIN SOLID FILMS, V361, P527, DOI 10.1016/S0040-6090(99)00825-1; Chen Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12253; Chen ZL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02039-5; Deng YH, 2020, JOULE, V4, P1949, DOI 10.1016/j.joule.2020.07.003; Heath JT, 2004, J APPL PHYS, V95, P1000, DOI 10.1063/1.1633982; Li JV, 2018, CAPACITANCE SPECTROSCOPY OF SEMICONDUCTORS, P1; Ni ZY, 2020, SCIENCE, V367, P1352, DOI 10.1126/science.aba0893; Peng JJ, 2017, CHEM SOC REV, V46, P5714, DOI 10.1039/c6cs00942e; Ravishankar S, 2021, SCIENCE, V371, DOI 10.1126/science.abd8014; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Sze S. M., 2006, PHYS SEMICONDUCTOR D, P100; TYAGI MS, 1983, SOLID STATE ELECTRON, V26, P577, DOI 10.1016/0038-1101(83)90174-0; Wang Q, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4899051; Wu WQ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8925	15	3	3	13	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532								10.1126/science.abd8598	http://dx.doi.org/10.1126/science.abd8598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QM5IR	33632821	Green Submitted			2022-12-28	WOS:000621813400002
J	Zhou, B; Thao, TTN; Hoffmann, D; Taddeo, A; Ebert, N; Labroussaa, F; Pohlmann, A; King, J; Steiner, S; Kelly, JN; Portmann, J; Halwe, NJ; Ulrich, L; Trueb, BS; Fan, XY; Hoffmann, B; Wang, L; Thomann, L; Lin, XD; Stalder, H; Pozzi, B; de Brot, S; Jiang, NN; Cui, D; Hossain, J; Wilson, MM; Keller, MW; Stark, TJ; Barnes, JR; Dijkman, R; Jores, J; Benarafa, C; Wentworth, DE; Thiel, V; Beer, M				Zhou, Bin; Tran Thi Nhu Thao; Hoffmann, Donata; Taddeo, Adriano; Ebert, Nadine; Labroussaa, Fabien; Pohlmann, Anne; King, Jacqueline; Steiner, Silvio; Kelly, Jenna N.; Portmann, Jasmine; Halwe, Nico Joel; Ulrich, Lorenz; Trueb, Bettina Salome; Fan, Xiaoyu; Hoffmann, Bernd; Wang, Li; Thomann, Lisa; Lin, Xudong; Stalder, Hanspeter; Pozzi, Berta; de Brot, Simone; Jiang, Nannan; Cui, Dan; Hossain, Jaber; Wilson, Malania M.; Keller, Matthew W.; Stark, Thomas J.; Barnes, John R.; Dijkman, Ronald; Jores, Joerg; Benarafa, Charaf; Wentworth, David E.; Thiel, Volker; Beer, Martin			SARS-CoV-2 spike D614G change enhances replication and transmission	NATURE			English	Article							CORONAVIRUS; INFECTION	During the evolution of SARS-CoV-2 in humans, a D614G substitution in the spike glycoprotein (S) has emerged; virus containing this substitution has become the predominant circulating variant in the COVID-19 pandemic(1). However, whether the increasing prevalence of this variant reflects a fitness advantage that improves replication and/or transmission in humans or is merely due to founder effects remains unknown. Here we use isogenic SARS-CoV-2 variants to demonstrate that the variant that contains S(D614G) has enhanced binding to the human cell-surface receptor angiotensin-converting enzyme 2 (ACE2), increased replication in primary human bronchial and nasal airway epithelial cultures as well as in a human ACE2 knock-in mouse model, and markedly increased replication and transmissibility in hamster and ferret models of SARS-CoV-2 infection. Our data show that the D614G substitution in S results in subtle increases in binding and replication in vitro, and provides a real competitive advantage in vivo-particularly during the transmission bottleneck. Our data therefore provide an explanation for the global predominance of the variant that contains S(D614G) among the SARS-CoV-2 viruses that are currently circulating.	[Zhou, Bin; Fan, Xiaoyu; Wang, Li; Hossain, Jaber; Wilson, Malania M.; Keller, Matthew W.; Stark, Thomas J.; Barnes, John R.; Wentworth, David E.] Ctr Dis Control & Prevent, CDC COVID 19 Response, Atlanta, GA 30333 USA; [Tran Thi Nhu Thao; Taddeo, Adriano; Ebert, Nadine; Steiner, Silvio; Kelly, Jenna N.; Portmann, Jasmine; Thomann, Lisa; Stalder, Hanspeter; Dijkman, Ronald; Benarafa, Charaf; Thiel, Volker] Inst Virol & Immunol IVI, Mittelausern, Switzerland; [Tran Thi Nhu Thao; Taddeo, Adriano; Ebert, Nadine; Labroussaa, Fabien; Steiner, Silvio; Kelly, Jenna N.; Portmann, Jasmine; Trueb, Bettina Salome; Thomann, Lisa; Stalder, Hanspeter; Dijkman, Ronald; Jores, Joerg; Benarafa, Charaf; Thiel, Volker] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland; [Tran Thi Nhu Thao; Steiner, Silvio] Univ Bern, Grad Sch Biomed Sci, Bern, Switzerland; [Hoffmann, Donata; Pohlmann, Anne; King, Jacqueline; Halwe, Nico Joel; Ulrich, Lorenz; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Labroussaa, Fabien; Trueb, Bettina Salome; Jores, Joerg] Univ Bern, Vetsuisse Fac, Inst Vet Bacteriol, Bern, Switzerland; [Lin, Xudong; Cui, Dan] Battelle Mem Inst, Atlanta, GA USA; [Pozzi, Berta] Univ Bern, Inst Cell Biol, Bern, Switzerland; [de Brot, Simone] Univ Bern, Inst Anim Pathol, COMPATH, Bern, Switzerland; [Jiang, Nannan] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Dijkman, Ronald] Univ Bern, Inst Infect Dis, Bern, Switzerland	Centers for Disease Control & Prevention - USA; University of Bern; University of Bern; Friedrich Loeffler Institute; University of Bern; University of Bern; University of Bern; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; University of Bern	Wentworth, DE (corresponding author), Ctr Dis Control & Prevent, CDC COVID 19 Response, Atlanta, GA 30333 USA.; Benarafa, C; Thiel, V (corresponding author), Inst Virol & Immunol IVI, Mittelausern, Switzerland.; Benarafa, C; Thiel, V (corresponding author), Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.; Beer, M (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany.	charaf.benarafa@vetsuisse.unibe.ch; dwentworth@cdc.gov; volker.thiel@vetsuisse.unibe.ch; martin.beer@fli.de	Taddeo, Adriano/AAW-3861-2021; Labroussaa, Fabien/AAN-2833-2021; Zhou, Bin/H-8688-2014	Taddeo, Adriano/0000-0003-3281-1548; Labroussaa, Fabien/0000-0002-8712-3024; Pozzi, Berta/0000-0002-4744-9337; Steiner, Silvio/0000-0003-1999-1425; Trueb, Bettina Salome/0000-0001-7256-9245; Kelly, Jenna/0000-0001-7265-2233; Keller, Matthew/0000-0002-5850-1698; Zhou, Bin/0000-0002-1535-6283; Thiel, Volker/0000-0002-5783-0887; de Brot, Simone/0000-0003-3049-0103; Hoffmann, Donata/0000-0003-4552-031X; THAO, Tran Thi Nhu/0000-0003-3906-4629; Jores, Joerg/0000-0003-3790-5746; Thomann, Lisa/0000-0003-3530-0524; Benarafa, Charaf/0000-0002-2049-7769	Swiss National Science Foundation (SNF) [31CA30_196644, 31CA30_196062, 310030_173085]; European Commission (Marie Sklodowska-Curie Innovative Training Network 'HONOURS') [721367]; Federal Ministry of Education and Research (BMBF) (grant RAPID) [01KI1723A]; University of Bern; German Federal Ministry of Food and Agriculture; NIH/NIAID [P01AI059576, U54-AI-057158]; US Centers for Disease Control and Prevention COVID-19 Task Force; COVID-19 special funds from the Swiss Federal Office of Public Health; Swiss Federal Office of Food Safety and Veterinary Affairs; European Commission (Horizon 2020 project 'VEO') [874735]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Commission (Marie Sklodowska-Curie Innovative Training Network 'HONOURS'); Federal Ministry of Education and Research (BMBF) (grant RAPID)(Federal Ministry of Education & Research (BMBF)); University of Bern; German Federal Ministry of Food and Agriculture; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Centers for Disease Control and Prevention COVID-19 Task Force; COVID-19 special funds from the Swiss Federal Office of Public Health; Swiss Federal Office of Food Safety and Veterinary Affairs; European Commission (Horizon 2020 project 'VEO')(European Commission)	This work was supported by the Swiss National Science Foundation (SNF) (grants 31CA30_196644, 31CA30_196062 and 310030_173085), the European Commission (Marie Sklodowska-Curie Innovative Training Network `HONOURS'; grant agreement no. 721367, and the Horizon 2020 project `VEO' grant agreement no. 874735), the Federal Ministry of Education and Research (BMBF) (grant RAPID, no. 01KI1723A) and by core funds of the University of Bern and the German Federal Ministry of Food and Agriculture. The hACE2 knock-in (B6) mice were generated with support from NIH/NIAID P01AI059576 (subproject 5) and partial support from NIH/NIAID U54-AI-057158. Partial support was provided by the US Centers for Disease Control and Prevention COVID-19 Task Force. This work was supported by COVID-19 special funds from the Swiss Federal Office of Public Health and, from the Swiss Federal Office of Food Safety and Veterinary Affairs, and we thank A. Summerfield for help in securing Swiss government funds. We thank the NGS platform of the University of Bern; M. Lange, C. Korthase, M. Currie, G. Larson and S. Renzullo for their excellent technical assistance; and F. Klipp, D. Fiedler, H. Manthei, C. Lipinski, J. Tang and A. Godel for their invaluable support in the animal experiments. This activity was reviewed by the CDC and was conducted in a manner consistent with applicable federal laws and CDC policies: 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 U.S.C. Sect. 552a; 44 U.S.C. Sect. 3501 et seq. The findings and conclusions in this Article are those of the authors and do not necessarily represent the official position of the US Centers for Disease Control and Prevention.	Alouane T, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9100829; Anderson C., 2019, **DATA OBJECT**; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; ECDC, 2020, COMM DIS THREATS REP; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Kim YI, 2020, CELL HOST MICROBE, V27, P704, DOI 10.1016/j.chom.2020.03.023; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1101/2020.01.22.915660, 10.1038/s41564-020-0688-y]; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Osterrieder N., 2020, VIRUSES-BASEL, V12, P779, DOI [DOI 10.3390/v12070779, 10.3390/v12070779]; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Richard M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17367-2; Shepard SS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3030-6; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Thiel V, 2001, J GEN VIROL, V82, P1273, DOI 10.1099/0022-1317-82-6-1273; Thao TTN, 2020, NATURE, V582, P561, DOI 10.1038/s41586-020-2294-9; van den Worm SHE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032857; WHO, PROT REAL TIM RT PRC, DOI [10.1038/s41586-021-03361-1, DOI 10.1038/S41586-021-03361-1]; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	27	190	200	6	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 1	2021	592	7852					122	+		10.1038/s41586-021-03361-1	http://dx.doi.org/10.1038/s41586-021-03361-1		FEB 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT1AI	33636719	Green Published, Bronze			2022-12-28	WOS:000632421600001
J	Gerada, C				Gerada, Clare			Clare Gerada: Loss has become a daily experience in the covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2021	372								n496	10.1136/bmj.n496	http://dx.doi.org/10.1136/bmj.n496			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8SP	33622767	Bronze			2022-12-28	WOS:000623407800011
J	Christidis, G; Lammert, F; Krawczyk, M				Christidis, Grigorios; Lammert, Frank; Krawczyk, Marcin			Amiodarone and hypothyroidism	LANCET			English	Editorial Material									[Christidis, Grigorios; Lammert, Frank; Krawczyk, Marcin] Saarland Univ, Med Ctr, Dept Med 2, D-66421 Homburg, Germany; [Krawczyk, Marcin] Med Univ Warsaw, Lab Metab Liver Dis, Ctr Preclin Res, Dept Gen Transplant & Liver Surg, Warsaw, Poland	Universitatsklinikum des Saarlandes; Medical University of Warsaw	Krawczyk, M (corresponding author), Saarland Univ, Med Ctr, Dept Med 2, D-66421 Homburg, Germany.	marcin.krawczyk@uks.eu	Krawczyk, Marcin/AAG-4356-2020	Krawczyk, Marcin/0000-0002-0113-0777					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					704	704						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33610214				2022-12-28	WOS:000620991800032
J	Horton, R				Horton, Richard			Offline: It's time to ask questions and learn lessons	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					865	865						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676619	Bronze, Green Published			2022-12-28	WOS:000626603400009
J	Mann, ME; Steinman, BA; Brouillette, DJ; Miller, SK				Mann, Michael E.; Steinman, Byron A.; Brouillette, Daniel J.; Miller, Sonya K.			Multidecadal climate oscillations during the past millennium driven by volcanic forcing	SCIENCE			English	Article							LEVEL PRESSURE VARIABILITY; ANTARCTIC CIRCUMPOLAR WAVE; SURFACE-TEMPERATURE; SEA-ICE; INTERNAL VARIABILITY; NORTHERN-HEMISPHERE; SOUTHERN-HEMISPHERE; SIGNAL-DETECTION; ATLANTIC; PACIFIC	Past research argues for an internal multidecadal (40- to 60-year) oscillation distinct from climate noise. Recent studies have claimed that this so-termed Atlantic Multidecadal Oscillation is instead a manifestation of competing time-varying effects of anthropogenic greenhouse gases and sulfate aerosols. That conclusion is bolstered by the absence of robust multidecadal climate oscillations in control simulations of current-generation models. Paleoclimate data, however, do demonstrate multidecadal oscillatory behavior during the preindustrial era. By comparing control and forced "Last Millennium" simulations, we show that these apparent multidecadal oscillations are an artifact of pulses of volcanic activity during the preindustrial era that project markedly onto the multidecadal (50- to 70-year) frequency band. We conclude that there is no compelling evidence for internal multidecadal oscillations in the climate system.	[Mann, Michael E.; Brouillette, Daniel J.; Miller, Sonya K.] Penn State Univ, Dept Meteorol & Atmospher Sci, 514 Walker Bldg, University Pk, PA 16802 USA; [Steinman, Byron A.] Univ Minnesota Duluth, Dept Earth & Environm Sci, 2205 East 5th St, Duluth, MN 55812 USA; [Steinman, Byron A.] Univ Minnesota Duluth, Large Lakes Observ, 2205 East 5th St, Duluth, MN 55812 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Minnesota System; University of Minnesota Duluth; University of Minnesota Twin Cities; University of Minnesota Hospital; University of Minnesota System; University of Minnesota Duluth; University of Minnesota Twin Cities; University of Minnesota Hospital	Mann, ME (corresponding author), Penn State Univ, Dept Meteorol & Atmospher Sci, 514 Walker Bldg, University Pk, PA 16802 USA.	mann@psu.edu	Mann, Michael E/B-8472-2017	Mann, Michael E/0000-0003-3067-296X; Brouillette, Daniel/0000-0003-0445-132X	NSF Paleoclimate Program [1748097, 1748115]	NSF Paleoclimate Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M.E.M., B.A.S., D.J.B., and S.K.M. were supported by grants 1748097 and 1748115 from the NSF Paleoclimate Program.	Alghamdi O. A, 2009, CROWNCOM 09 4 INT C; Allan R, 2000, NINO SO OSCILLATION, P3, DOI DOI 10.1017/CB09780511573125.002; Ammann CM, 2007, P NATL ACAD SCI USA, V104, P3713, DOI 10.1073/pnas.0605064103; Ammann CM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016388; Apipattanavis S, 2009, J CLIMATE, V22, P6251, DOI 10.1175/2009JCLI2791.1; Bellomo K, 2018, CLIM DYNAM, V50, P3687, DOI 10.1007/s00382-017-3834-3; Bellucci A, 2017, J CLIMATE, V30, P7317, DOI 10.1175/JCLI-D-16-0301.1; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Cane MA, 2017, J CLIMATE, V30, P7529, DOI 10.1175/JCLI-D-16-0810.1; Cioffi F, 2015, INT J CLIMATOL, V35, P1749, DOI 10.1002/joc.4116; Clement A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2575; Clement A, 2015, SCIENCE, V350, P320, DOI 10.1126/science.aab3980; Cook ER, 2002, J CLIMATE, V15, P1754, DOI 10.1175/1520-0442(2002)015<1754:AWVMRO>2.0.CO;2; Crowley T.J., 2008, PAGES NEWS, V16, P22, DOI [DOI 10.1029/2002GL0166335, 10.22498/pages.16.2.22, DOI 10.22498/PAGES.16.2.22]; D'Arrigo RD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017250; DelSole T, 2011, J CLIMATE, V24, P909, DOI 10.1175/2010JCLI3659.1; Delworth TL, 2000, CLIM DYNAM, V16, P661, DOI 10.1007/s003820000075; Fischer H, 2005, CLIM DYNAM, V25, P65, DOI 10.1007/s00382-005-0011-x; FOLLAND CK, 1986, NATURE, V320, P602, DOI 10.1038/320602a0; FOLLAND CK, 1984, NATURE, V310, P670, DOI 10.1038/310670a0; Frankcombe LM, 2018, J CLIMATE, V31, P5681, DOI 10.1175/JCLI-D-17-0662.1; Frankcombe LM, 2015, J CLIMATE, V28, P8184, DOI 10.1175/JCLI-D-15-0069.1; Gao RS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009358; Goosse H, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012737; Goosse H, 2012, CLIM DYNAM, V39, P2847, DOI 10.1007/s00382-012-1297-0; Gray ST, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019932; Guo Z, 2013, ADV ATMOS SCI, V30, P1758, DOI 10.1007/s00376-013-2227-8; Han X, 2008, ADV ATMOS SCI, V25, P458, DOI 10.1007/s00376-008-0458-x; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Haustein K, 2019, J CLIMATE, V32, P4893, DOI 10.1175/JCLI-D-18-0555.1; Haykin S, 2005, IEEE J SEL AREA COMM, V23, P201, DOI 10.1109/JSAC.2004.839380; Henley BJ, 2017, GLOBAL PLANET CHANGE, V155, P42, DOI 10.1016/j.gloplacha.2017.06.004; Hughes M. K., 2003, AGU FALL M SAN FRANC; Jolliffe I, 2011, PRINCIPAL COMPONENT; Kerr RA, 2000, SCIENCE, V288, P1984, DOI 10.1126/science.288.5473.1984; Knight JR, 2009, J CLIMATE, V22, P1610, DOI 10.1175/2008JCLI2628.1; Knight JR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024233; Knudsen MF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4323; LATIF M, 1994, SCIENCE, V266, P634, DOI 10.1126/science.266.5185.634; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Mann M. E, 2004, GEOPHYS RES LETT, V35; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; MANN ME, 1995, NATURE, V378, P266, DOI 10.1038/378266a0; Mann ME, 1999, ADV GEOPHYS, V41, P1, DOI 10.1016/S0065-2687(08)60026-6; Mann ME, 1996, J CLIMATE, V9, P2137, DOI 10.1175/1520-0442(1996)009<2137:JSMOST>2.0.CO;2; MANN ME, 1994, J GEOPHYS RES-ATMOS, V99, P25819, DOI 10.1029/94JD02396; MANN ME, 1995, GEOPHYS RES LETT, V22, P937, DOI 10.1029/95GL00704; Mann ME, 2000, EL NINO SO OSCILLATI, P357, DOI 10.1017/CBO9780511573125.011; Mann ME, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13823-w; Mann ME, 2014, GEOPHYS RES LETT, V41, P3211, DOI 10.1002/2014GL059233; Mann ME, 2012, NAT GEOSCI, V5, P202, DOI [10.1038/ngeo1394, 10.1038/NGEO1394]; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McCabe GJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012866; Meehl GA, 2014, NAT CLIM CHANGE, V4, P898, DOI [10.1038/NCLIMATE2357, 10.1038/nclimate2357]; Meehl GA, 2014, B AM METEOROL SOC, V95, P243, DOI 10.1175/BAMS-D-12-00241.1; Minobe S, 2000, PROG OCEANOGR, V47, P381, DOI 10.1016/S0079-6611(00)00042-2; Minobe S, 1997, GEOPHYS RES LETT, V24, P683, DOI 10.1029/97GL00504; Muller-Plath G, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.559337; Murphy LN, 2017, GEOPHYS RES LETT, V44, P2472, DOI 10.1002/2016GL071337; Newman M, 2016, J CLIMATE, V29, P4399, DOI 10.1175/JCLI-D-15-0508.1; Park J., **DROPPED REF**; Plattner GK., 2013, CLIM CHANG 2013 PHYS; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; Ribera P, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013905; Ribera P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015818; SCHLESINGER ME, 1994, NATURE, V367, P723, DOI 10.1038/367723a0; Schmidt GA, 2011, GEOSCI MODEL DEV, V4, P33, DOI 10.5194/gmd-4-33-2011; Shindell DT, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004151; Singh HKA, 2018, CLIM PAST, V14, P157, DOI 10.5194/cp-14-157-2018; Small D, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005623; Steinhilber F, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040142; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Stocker T F, 2013, CLIM CHANG 2013 PHYS; STOCKER TF, 1992, CLIMATIC CHANGE, V20, P227, DOI 10.1007/BF00139840; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Ting MF, 2009, J CLIMATE, V22, P1469, DOI 10.1175/2008JCLI2561.1; Tourre YM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025176; Tourre YM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018476; Tourre YM, 1999, J CLIMATE, V12, P2285, DOI 10.1175/1520-0442(1999)012<2285:DPOCVI>2.0.CO;2; Tourre YM, 2001, GEOPHYS RES LETT, V28, P2069, DOI 10.1029/2000GL012780; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Venegas SA, 2000, J CLIMATE, V13, P3412, DOI 10.1175/1520-0442(2000)013<3412:ITADTO>2.0.CO;2; Venegas SA, 2003, J CLIMATE, V16, P2509, DOI 10.1175/1520-0442(2003)016<2509:TACWAC>2.0.CO;2; Venegas SA, 2001, GEOPHYS RES LETT, V28, P3301, DOI 10.1029/2001GL012991; Vieira LEA, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200913276; Wang JL, 2017, NAT GEOSCI, V10, P512, DOI [10.1038/NGEO2962, 10.1038/ngeo2962]; Waple AM, 2002, CLIM DYNAM, V18, P563, DOI 10.1007/s00382-001-0199-3; White WB, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002395; White WB, 2007, J OCEANOGR, V63, P223, DOI 10.1007/s10872-007-0024-7; White WB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017055; White WB, 2004, J CLIMATE, V17, P2765, DOI 10.1175/1520-0442(2004)017<2765:TRITAC>2.0.CO;2; White WB, 2004, J CLIMATE, V17, P2249, DOI 10.1175/1520-0442(2004)017<2249:COSVIT>2.0.CO;2; Wu S, 2011, J OCEANOGR, V67, P27, DOI 10.1007/s10872-011-0003-x; Yang J, 2018, INT J CLIMATOL, V38, P1706, DOI 10.1002/joc.5290; Zanchettin D, 2014, CLIM DYNAM, V42, P381, DOI 10.1007/s00382-013-1669-0; Zhang R, 2017, GEOPHYS RES LETT, V44, P7865, DOI 10.1002/2017GL074342; Zhang ZH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004896; Zhao L, 2011, 25 C ADV INF NETW AP	99	70	70	11	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1014	+		10.1126/science.abc5810	http://dx.doi.org/10.1126/science.abc5810			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33674487				2022-12-28	WOS:000625876100048
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Universities may need to test students every three days to prevent major outbreaks, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2021	372								n618	10.1136/bmj.n618	http://dx.doi.org/10.1136/bmj.n618			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4NT	33658248	Bronze			2022-12-28	WOS:000687185300001
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Stepping back from vaccination priorities and focusing on minimising the risk of exposure	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Clift AK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3731; Independent SAGE, 2021, RET SCH CONS DOC; Lawrie E., 2021, BBC	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n591	10.1136/bmj.n591	http://dx.doi.org/10.1136/bmj.n591			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653701	Bronze			2022-12-28	WOS:000625340300001
J	Bates, ER				Bates, Eric R.			In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC30	JC30		10.7326/ACPJ202103160-030	http://dx.doi.org/10.7326/ACPJ202103160-030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646848				2022-12-28	WOS:000669667000005
J	Herrett, E; Williamson, E; Brack, K; Beaumont, D; Perkins, A; Thayne, A; Shakur-Still, H; Roberts, I; Prowse, D; Goldacre, B; van Staa, T; MacDonald, TM; Armitage, J; Wimborne, J; Melrose, P; Singh, J; Brooks, L; Moore, M; Hoffman, M; Smeeth, L				Herrett, Emily; Williamson, Elizabeth; Brack, Kieran; Beaumont, Danielle; Perkins, Alexander; Thayne, Andrew; Shakur-Still, Haleema; Roberts, Ian; Prowse, Danielle; Goldacre, Ben; van Staa, Tjeerd; MacDonald, Thomas M.; Armitage, Jane; Wimborne, Jon; Melrose, Paula; Singh, Jayshireen; Brooks, Lucy; Moore, Michael; Hoffman, Maurice; Smeeth, Liam		StatinWISE Trial Grp	Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To establish the effect of statins on muscle symptoms in people who had previously reported muscle symptoms when taking statins. DESIGN Series of randomised, placebo controlled n-of-1 trials. SETTING Primary care across 50 sites in the United Kingdom, December 2016 to April 2018. PARTICIPANTS 200 participants who had recently stopped or were considering stopping treatment with statins because of muscle symptoms. INTERVENTIONS Participants were randomised to a sequence of six double blinded treatment periods (two months each) of atorvastatin 20 mg daily or placebo. MAIN OUTCOME MEASURES At the end of each treatment period, participants rated their muscle symptoms on a visual analogue scale (0-10). The primary analysis compared symptom scores in the statin and placebo periods. RESULTS 151 participants provided symptoms scores for at least one statin period and one placebo period and were included in the primary analysis. Overall, no difference in muscle symptom scores was found between the statin and placebo periods (mean difference statin minus placebo -0.11, 95% confidence interval -0.36 to 0.14; P=0.40)). Withdrawals because of intolerable muscle symptoms were 18 participants (9%) during a statin period and 13 (7%) during a placebo period. Two thirds of those completing the trial reported restarting long term treatment with statins. CONCLUSIONS No overall effect of atorvastatin 20 mg on muscle symptoms compared with placebo was found in participants who had previously reported severe muscle symptoms when taking statins. Most people completing the trial intended to restart treatment with statins. N-of-1 trials can assess drug effects at the group level and guide individual treatment.	[Herrett, Emily; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Williamson, Elizabeth; Perkins, Alexander] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Brack, Kieran; Beaumont, Danielle; Thayne, Andrew; Shakur-Still, Haleema; Roberts, Ian; Prowse, Danielle] London Sch Hyg & Trop Med, Dept Populat Hlth, Clin Trials Unit, London, England; [Goldacre, Ben] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [van Staa, Tjeerd] Univ Manchester, Div Informat Imaging & Data Sci, Manchester, Lancs, England; [MacDonald, Thomas M.] Univ Dundee, MEMO Res, Dundee, Scotland; [Armitage, Jane] Univ Oxford, Nuffield Dept Populat Hlth, Med Res Council Populat Hlth Res Unit, Oxford, England; [Wimborne, Jon; Melrose, Paula] York Bridge Surg, Bay Med Practice, Morecambe, England; [Singh, Jayshireen] Guys Hosp, NIHR Clin Res Network, London, England; [Brooks, Lucy] Keats & Hampstead Grp Practice, London, England; [Moore, Michael] Univ Southampton, Sch Primary Care & Populat Sci, Southampton, Hants, England; [Hoffman, Maurice] NIHR, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Manchester; University of Dundee; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of Southampton; University of London; King's College London	Smeeth, L (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	statinwise@lshtm.ac	; Smeeth, Liam/X-5862-2018	Goldacre, Ben/0000-0002-5127-4728; Herrett, Emily/0000-0002-9425-644X; MacDonald, Thomas/0000-0001-5189-6669; Prowse, Danielle/0000-0002-7470-4823; Smeeth, Liam/0000-0002-9168-6022; Perkins, Alexander/0000-0002-9817-2390; Roberts, Ian/0000-0003-1596-6054; Shakur-Still, Haleema/0000-0002-6511-109X; Williamson, Elizabeth/0000-0001-6905-876X	National Institute for Health Research-Health Technology Programme [14/49/159]; London School of Hygiene and Tropical Medicine, Keppel Street, London	National Institute for Health Research-Health Technology Programme; London School of Hygiene and Tropical Medicine, Keppel Street, London	The StatinWISE trial was funded by the National Institute for Health Research-Health Technology Programme (reference 14/49/159). The study was sponsored by the London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; American College of Cardiology, 2019, STAT INT TOOL; Bae SS, 2020, CLIN CARDIOL, V43, P732, DOI 10.1002/clc.23375; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; De Vera MA, 2014, BRIT J CLIN PHARMACO, V78, P684, DOI 10.1111/bcp.12339; Fulcher J, 2019, LANCET, V393, P407, DOI 10.1016/S0140-6736(18)31942-1; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Garavalia L, 2009, J CARDIOVASC NURS, V24, P371, DOI 10.1097/JCN.0b013e3181ae7b2a; Gupta A, 2017, LANCET, V389, P2473, DOI 10.1016/S0140-6736(17)31075-9; GUYATT G, 1986, NEW ENGL J MED, V314, P889, DOI 10.1056/NEJM198604033141406; Joy TR, 2014, ANN INTERN MED, V160, P301, DOI 10.7326/M13-1921; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Laufs U, 2017, ATHEROSCLEROSIS SUPP, V26, P45, DOI 10.1016/S1567-5688(17)30024-7; Macedo AF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-51; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Mampuya WM, 2013, AM HEART J, V166, P597, DOI 10.1016/j.ahj.2013.06.004; Matthews A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3283; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; Moriarty PM, 2014, J CLIN LIPIDOL, V8, P554, DOI 10.1016/j.jacl.2014.09.007; Newman CB, 2019, ARTERIOSCL THROM VAS, V39, pE38, DOI 10.1161/ATV.0000000000000073; Nielsen SF, 2016, EUR HEART J, V37, P908, DOI 10.1093/eurheartj/ehv641; Nissen SE, 2016, JAMA-J AM MED ASSOC, V315, P1580, DOI 10.1001/jama.2016.3608; Reith C, 2016, AM HEART J, V176, P63, DOI 10.1016/j.ahj.2016.01.016; Schaffer AL, 2015, MED J AUSTRALIA, V202, P591, DOI 10.5694/mja15.00103; Stroes ES, 2015, EUR HEART J, V36, P1012, DOI 10.1093/eurheartj/ehv043; Vinogradova Y, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3305; Wood FA, 2020, NEW ENGL J MED, V383, P2182, DOI 10.1056/NEJMc2031173; Zhang HB, 2017, ANN INTERN MED, V167, P221, DOI 10.7326/M16-0838; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	30	44	44	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n135	10.1136/bmj.n135	http://dx.doi.org/10.1136/bmj.n135			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627334	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000623404800014
J	Oliver, D				Oliver, David			David Oliver: We can support primary care without blaming hospital doctors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Campbell D., 2019, GUARDIAN; King's Fund, 2016, UND QUAL DISTR NURS; Lind S., 2021, PULSE; NHS England, 2016, DEM MAN GOOD PRACT G; Nuffield Trust, 2020, NUFFIELD TRUST  0618; Oliver D., 2020, INDEPENDENT; Oliver D, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3747; Papanicolas I, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6326; Rolewicz L., 2021, NUFFIELD TRUST  0212; Sheather J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n28; Vindrola-Padros C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040503	11	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n502	10.1136/bmj.n502	http://dx.doi.org/10.1136/bmj.n502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627310	Bronze			2022-12-28	WOS:000623404800009
J	Limb, M				Limb, Matthew			Covid-19: Recognise long covid as occupational disease and compensate frontline workers, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	4	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n503	10.1136/bmj.n503	http://dx.doi.org/10.1136/bmj.n503			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608317	Bronze			2022-12-28	WOS:000621237300011
J	Krist, AH; Davidson, KW; Mangione, CM; Barry, MJ; Cabana, M; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Kubik, M; Landefeld, CS; Li, L; Ogedegbe, G; Owens, DK; Pbert, L; Silverstein, M; Stevermer, J; Tseng, CW; Wong, JB				Krist, Alex H.; Davidson, Karina W.; Mangione, Carol M.; Barry, Michael J.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Kubik, Martha; Landefeld, C. Seth; Li, Li; Ogedegbe, Gbenga; Owens, Douglas K.; Pbert, Lori; Silverstein, Michael; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		US Preventive Serv Task Force	Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DOSE COMPUTED-TOMOGRAPHY; POSITIVE TEST RESULT; SMOKING; CT; RISK; TRIAL; MORTALITY; EXPOSURE; ADULTS	ImportanceLung cancer is the second most common cancer and the leading cause of cancer death in the US. In 2020, an estimated 228820 persons were diagnosed with lung cancer, and 135720 persons died of the disease. The most important risk factor for lung cancer is smoking. Increasing age is also a risk factor for lung cancer. Lung cancer has a generally poor prognosis, with an overall 5-year survival rate of 20.5%. However, early-stage lung cancer has a better prognosis and is more amenable to treatment. ObjectiveTo update its 2013 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on the accuracy of screening for lung cancer with low-dose computed tomography (LDCT) and on the benefits and harms of screening for lung cancer and commissioned a collaborative modeling study to provide information about the optimum age at which to begin and end screening, the optimal screening interval, and the relative benefits and harms of different screening strategies compared with modified versions of multivariate risk prediction models. PopulationThis recommendation statement applies to adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Evidence AssessmentThe USPSTF concludes with moderate certainty that annual screening for lung cancer with LDCT has a moderate net benefit in persons at high risk of lung cancer based on age, total cumulative exposure to tobacco smoke, and years since quitting smoking. RecommendationThe USPSTF recommends annual screening for lung cancer with LDCT in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Screening should be discontinued once a person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery. (B recommendation) This recommendation replaces the 2013 USPSTF statement that recommended annual screening for lung cancer with LDCT in adults aged 55 to 80 years who have a 30 pack-year smoking history and currently smoke or have quit within the past 15 years. This US Preventive Services Task Force Recommendation Statement concludes with moderate certainty that annual screening for lung cancer with low-dose computed tomography has a moderate benefit in persons at high risk of lung cancer based on age, total cumulative exposure to tobacco smoke, and years since quitting smoking (Grade B).	[Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, 830 E Main St,One Capitol Sq,Sixth Floor, Richmond, VA 23219 USA; [Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA 02115 USA; [Cabana, Michael] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Pbert, Lori] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Stevermer, James] Univ Missouri, Columbia, MO USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Virginia Commonwealth University; Northwell Health; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; George Mason University; University of Alabama System; University of Alabama Birmingham; University of Virginia; New York University; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Krist, AH (corresponding author), Virginia Commonwealth Univ, 830 E Main St,One Capitol Sq,Sixth Floor, Richmond, VA 23219 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				Aberle DR, 2019, J THORAC ONCOL, V14, P1732, DOI 10.1016/j.jtho.2019.05.044; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Aldrich MC, 2019, JAMA ONCOL, V5, P1318, DOI 10.1001/jamaoncol.2019.1402; [Anonymous], 2013, CLIN PREVENTIVE SERV; [Anonymous], 2020, NCCN GUIDELINES PATI; [Anonymous], KEY STAT LUNG CANC; [Anonymous], LUNG CANC SCREENING; [Anonymous], 2015, PROCEDURE MANUAL; [Anonymous], NONSMALL CELL LUNG C; [Anonymous], CANC STAT FACTS LUNG; Bach PB, 2003, JNCI-J NATL CANCER I, V95, P470, DOI 10.1093/jnci/95.6.470; BIERA F, 2016, TOB INDUC DIS, V14, P23, DOI DOI 10.1186/S12971-016-0090-Y; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; Henschke CI, 2013, ANN INTERN MED, V158, P246, DOI 10.7326/0003-4819-158-4-201302190-00004; Casillas CEH, 2014, FUTURE ONCOL, V10, P1501, DOI [10.2217/FON.14.21, 10.2217/fon.14.21]; Jaklitsch MT, 2012, J THORAC CARDIOV SUR, V144, P33, DOI 10.1016/j.jtcvs.2012.05.060; Jonas D., 2021, AHRQ PUBLICATION; Jonas DE, 2021, JAMA-J AM MED ASSOC, V325, P971, DOI 10.1001/jama.2021.0377; Kaplan RC, 2014, AM J PREV MED, V46, P496, DOI 10.1016/j.amepre.2014.01.014; Katki HA, 2018, ANN INTERN MED, V169, P10, DOI [10.7326/M17-2701, 10.7326/m17-2701]; Kinsinger LS, 2017, JAMA INTERN MED, V177, P399, DOI 10.1001/jamainternmed.2016.9022; Lim KP, 2020, ANN AM THORAC SOC, V17, P503, DOI 10.1513/AnnalsATS.201902-102OC; Mascalchi M, 2006, AM J ROENTGENOL, V187, P421, DOI 10.2214/AJR.05.0088; Mazzone PJ, 2018, CHEST, V153, P954, DOI 10.1016/j.chest.2018.01.016; Meza R., 2021, AHRQ PUBLICATION; Meza R, 2021, JAMA-J AM MED ASSOC, V325, P988, DOI 10.1001/jama.2021.1077; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Nguyen XV, 2017, J AM COLL RADIOL, V14, P324, DOI 10.1016/j.jacr.2016.09.044; Oken MM, 2011, JAMA-J AM MED ASSOC, V306, P1865, DOI 10.1001/jama.2011.1591; Pinsky PF, 2006, CANCER CAUSE CONTROL, V17, P1017, DOI 10.1007/s10552-006-0038-2; Pinsky PF, 2015, ANN INTERN MED, V162, P485, DOI 10.7326/M14-2086; Pinsky PF, 2013, J MED SCREEN, V20, P165, DOI 10.1177/0969141313500666; Pinsky PF, 2013, CANCER-AM CANCER SOC, V119, P593, DOI 10.1002/cncr.27774; Rampinelli C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j347; SAMET JM, 1991, CLIN CHEST MED, V12, P669; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; Stram DO, 2019, JNCI-J NATL CANCER I, V111, P811, DOI 10.1093/jnci/djy206; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; US Preventive Ser Task, 2020, JAMA-J AM MED ASSOC, V323, P1590, DOI 10.1001/jama.2020.4679; van Klaveren RJ, 2009, NEW ENGL J MED, V361, P2221, DOI 10.1056/NEJMoa0906085; Yan TD, 2009, J CLIN ONCOL, V27, P2553, DOI 10.1200/JCO.2008.18.2733; Yip R, 2014, RADIOLOGY, V273, P591, DOI 10.1148/radiol.14132950; Zahnd WE, 2019, AM J PREV MED, V57, P250, DOI 10.1016/j.amepre.2019.03.015	46	206	209	33	93	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					962	970		10.1001/jama.2021.1117	http://dx.doi.org/10.1001/jama.2021.1117			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687470	Bronze			2022-12-28	WOS:000627899400018
J	Mathew, R				Mathew, Rammya, I			Rammya Mathew: Workforce must be at the centre of covid-19 recovery plans	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rammya.mathew@nhs.net						Diver T., 2020, TELEGRAPH	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2021	372								n635	10.1136/bmj.n635	http://dx.doi.org/10.1136/bmj.n635			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6QO	33687989	Bronze			2022-12-28	WOS:000632923400010
J	Tuna, MA; Rothwell, PM				Tuna, Maria A.; Rothwell, Peter M.		Oxford Vasc Study	Diagnosis of non-consensus transient ischaemic attacks with focal, negative, and non-progressive symptoms: population-based validation by investigation and prognosis	LANCET			English	Article								Background Diagnosis of transient ischaemic attacks (TIAs) can be difficult. There is consensus on classic symptoms (eg, motor weakness, dysphasia, hemianopia, monocular visual loss) but no consensus on several monosymptomatic events with sudden-onset, non-progressive, focal negative symptoms (eg, isolated diplopia, dysarthria, vertigo, ataxia, sensory loss, and bilateral visual disturbance), with much variation in investigation and treatment. Methods We prospectively ascertained and investigated all strokes and sudden onset transient neurological symptoms in a population of 92728 people (no age restrictions) from Oxfordshire, UK, who sought medical attention at nine primary care practices or at the John Radcliffe Hospital, Oxford, UK (Oxford Vascular Study). Patients classified at baseline with minor ischaemic stroke (National Institutes of Health Stroke Score <5), classic TIA, or non-consensus TIA were treated according to secondary prevention guidelines. Risks of stroke (7-day, 90-day, and 10-year risks) and risks of all major vascular events (from the time of first event, and from the time of seeking medical attention) were established by face-to-face follow-up visits and were compared with the risk expected from age and sex-specific stroke incidence in the underlying study population. Findings Between April 1, 2002, and March 31, 2018, 2878 patients were identified with minor ischaemic stroke (n=1287), classic TIA (n=1021), or non-consensus TIA (n=570). Follow-up was to Oct 1, 2018 (median 5.2 [IQR 2.6-9.2] years). 577 first recurrent strokes after the index event occurred during 17 009 person-years of follow-up. 90-day stroke risk from time of the index event after a non-consensus TIA was similar to that after classic TIA (10.6% [95% CI 7.8-12.9] vs 11.6% [95% CI 9.6-13.6]; hazard ratio 0.87, 95% CI 0.64-1.19; p=0.43), and higher than after amaurosis fugax (4.3% [95% CI 0.6-8.0]; p=0.042). However, patients with non-consensus TIA were less likely to seek medical attention on the day of the event than were those with classic TIA (336 of 570 [59%] vs 768 of 1021 [75%]; odds ratio [OR] 0.47, 95% CI 0.38-0.59; p<0.0001) and were more likely to have recurrent strokes before seeking attention (45 of 570 [8%] vs 47 of 1021 [5%]; OR 1.77, 95% CI 1.16-2.71; p=0.007). After excluding such recurrent strokes, 7-day stroke risk after seeking attention for non-consensus TIA (2.9% [95% CI 1.5-4.3]) was still considerably higher than the expected background risk (relative risk [RR] 203, 95% CI 113-334), particularly if the patient sought attention on the day of the index event (5.0% [2.1-7.9]; RR 300, 137-569). 10-year risk of all major vascular events was similar for non-consensus and classic TIAs (27.1% [95% CI 22.8-31.4] vs 30.9% [27.2-33.7]; p=0.12). Baseline prevalence of atrial fibrillation, patent foramen ovale, and arterial stenoses were also similar for non-consensus TIA and classic TIA, although stenoses in the posterior circulation were more frequent with non-consensus TIA (OR 2.21, 95% CI 1.59-3.08; p<0.0001). Interpretation Patients with non-consensus TIA are at high early and long-term risk of stroke and have cardiovascular pathological findings on investigation similar to those of classic TIA. Designation of non-consensus TIAs as definite cerebrovascular events will increase overall TIA diagnoses by about 50%. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Tuna, Maria A.; Rothwell, Peter M.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Wolfson Ctr Prevent Stroke & Dementia, Oxford OX3 9DU, England	University of Oxford	Rothwell, PM (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Wolfson Ctr Prevent Stroke & Dementia, Oxford OX3 9DU, England.	peter.rothwell@ndcn.ox.ac.uk			Wellcome Trust; National Institute for Health Research Oxford Biomedical Research Centre; Wolfson Foundation; Masonic Charitable Foundation; British Heart Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Wolfson Foundation; Masonic Charitable Foundation; British Heart Foundation(British Heart Foundation)	Wellcome Trust, National Institute for Health Research Oxford Biomedical Research Centre, Wolfson Foundation, Masonic Charitable Foundation, and British Heart Foundation.	Amarenco P, 2018, NEW ENGL J MED, V378, P2182, DOI 10.1056/NEJMoa1802712; Amarenco P, 2016, NEW ENGL J MED, V374, P1533, DOI 10.1056/NEJMoa1412981; [Anonymous], 1975, Stroke, V6, P564; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Bos MJ, 2007, JAMA-J AM MED ASSOC, V298, P2877, DOI 10.1001/jama.298.24.2877; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Castle J, 2010, STROKE, V41, P1367, DOI 10.1161/STROKEAHA.109.577650; Degan D, 2017, STROKE, V48, P530, DOI [10.1161/STROKEAHA.116.015417, 10.1161/strokeaha.116.015417]; DENNIS MS, 1989, LANCET, V1, P185; Diener HC, 2005, EXPERT OPIN PHARMACO, V6, P755, DOI 10.1517/14656566.6.5.755; Dutta D, 2015, STROKE, V46, P1227, DOI 10.1161/STROKEAHA.114.008632; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; FEINBERG WM, 1994, CIRCULATION, V89, P2950, DOI 10.1161/01.CIR.89.6.2950; Ferro JM, 1996, STROKE, V27, P2225, DOI 10.1161/01.STR.27.12.2225; Fonseca AC, 2011, EUR J NEUROL, V18, P644, DOI 10.1111/j.1468-1331.2010.03241.x; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2006, STROKE, V37, P1254, DOI 10.1161/01.STR.0000217388.57851.62; Hankey GJ, 1994, TRANSIENT ISCHAEMIC; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kidwell CS, 1999, STROKE, V30, P1174, DOI 10.1161/01.STR.30.6.1174; KOUDSTAAL PJ, 1992, LANCET, V340, P630, DOI 10.1016/0140-6736(92)92170-K; KOUDSTAAL PJ, 1986, STROKE, V17, P723, DOI 10.1161/01.STR.17.4.723; KOUDSTAAL PJ, 1989, STROKE, V20, P300, DOI 10.1161/01.STR.20.2.300; KRAAIJEVELD CL, 1984, STROKE, V15, P723, DOI 10.1161/01.STR.15.4.723; LANDI G, 1992, LANCET, V339, P402, DOI 10.1016/0140-6736(92)90086-I; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Lavallee PC, 2017, STROKE, V48, P1495, DOI 10.1161/STROKEAHA.117.016743; Li LX, 2015, LANCET NEUROL, V14, P903, DOI 10.1016/S1474-4422(15)00132-5; Luengo-Fernandez R, 2009, LANCET NEUROL, V8, P235, DOI 10.1016/S1474-4422(09)70019-5; Mazzucco S, 2018, LANCET NEUROL, V17, P609, DOI 10.1016/S1474-4422(18)30167-4; Paul NLM, 2013, LANCET NEUROL, V12, P65, DOI 10.1016/S1474-4422(12)70299-5; Prabhakaran S, 2008, CEREBROVASC DIS, V26, P630, DOI 10.1159/000166839; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schrock JW, 2012, ANN EMERG MED, V59, P19, DOI 10.1016/j.annemergmed.2011.03.009; Sherman DG, 2004, NEUROLOGY, V62, pS20, DOI 10.1212/WNL.62.8_suppl_6.S20; Sylaja PN, 2008, STROKE, V39, P1898, DOI 10.1161/STROKEAHA.107.497453; Tarnutzer AA, 2017, NEUROLOGY, V88, P1468, DOI 10.1212/WNL.0000000000003814; Wardlaw J, 2014, HEALTH TECHNOL ASSES, V18, P1; Warlow C, 2008, STROKE PRACTICAL MAN; Wolters FJ, 2018, JAMA NEUROL, V75, P1225, DOI 10.1001/jamaneurol.2018.1603	47	11	12	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					902	912						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676629	Green Published, hybrid			2022-12-28	WOS:000626603400028
J	Bao, ZR; Baylies, MK; Hadjantonakis, AK; Huangfu, DW; Jasin, M; Joyner, AL; Lacy, E; Lai, EC; Studer, L; Vierbuchen, T; Zallen, JA				Bao, Zhirong; Baylies, Mary K.; Hadjantonakis, Anna-Katerina; Huangfu, Danwei; Jasin, Maria; Joyner, Alexandra L.; Lacy, Elizabeth; Lai, Eric C.; Studer, Lorenz; Vierbuchen, Thomas; Zallen, Jennifer A.			Kathryn Anderson (1952-2020) Obituary	CELL			English	Biographical-Item							DORSAL-VENTRAL PATTERN; DROSOPHILA EMBRYO; TOLL GENE; POLARITY; RATES; RNA		[Bao, Zhirong; Baylies, Mary K.; Hadjantonakis, Anna-Katerina; Huangfu, Danwei; Jasin, Maria; Joyner, Alexandra L.; Lacy, Elizabeth; Lai, Eric C.; Studer, Lorenz; Vierbuchen, Thomas; Zallen, Jennifer A.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Lacy, E; Zallen, JA (corresponding author), Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA.	lacye@mskcc.org; zallenj@mskcc.org	Lai, Eric C/A-3412-2008; Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987; Lacy, Elizabeth/0000-0001-5457-0728; Huangfu, Danwei/0000-0002-1145-6199				ANDERSON KV, 1979, DEV BIOL, V70, P217, DOI 10.1016/0012-1606(79)90018-6; ANDERSON KV, 1987, TRENDS GENET, V3, P91, DOI 10.1016/0168-9525(87)90191-0; ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; ANDERSON KV, 1984, NATURE, V311, P223, DOI 10.1038/311223a0; ANDERSON KV, 1980, CELL, V21, P717, DOI 10.1016/0092-8674(80)90435-3; ANDERSON KV, PUBLICATION LIST; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243	14	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1123	1126		10.1016/j.cell.2021.01.054	http://dx.doi.org/10.1016/j.cell.2021.01.054		MAR 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33667364	Bronze			2022-12-28	WOS:000629635700001
J	Moore, JP				Moore, John P.			Approaches for Optimal Use of Different COVID-19 Vaccines Issues of Viral Variants and Vaccine Efficacy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint proposes ways to maximize vaccine efficacy and allocation given the rise of coronavirus variants and authorization of a Johnson & Johnson vaccine, including reserving the latter for younger healthier populations, boosting it with a single-dose messenger RNA (mRNA) vaccination, and single mRNA immunization of people with prior documented SARS-CoV-2 infection.	[Moore, John P.] Cornell Univ, Weill Cornell Med, 1300 York Ave, New York, NY 10065 USA	Cornell University	Moore, JP (corresponding author), Cornell Univ, Weill Cornell Med, 1300 York Ave, New York, NY 10065 USA.	jpm2003@med.cornell.edu						Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Creech CB, 2021, JAMA-J AM MED ASSOC, V325, P1318, DOI 10.1001/jama.2021.3199; Garcia-Beltran W.F., 2021, CIRCULATING SARS COV, DOI [10.1101/2021.02.14.21251704, 10.1101/2021.02. 14.21251704, DOI 10.1101/2021.02.14.21251704]; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Madhi SA., 2021, SAFETY EFFICACY CHAD, DOI [10.1101/2021.02.10.21251247, DOI 10.1101/2021.02.10.21251247]; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Saad-Roy Chadi M, 2021, medRxiv, DOI 10.1101/2021.02.01.21250944; Shen Xiaoying, 2021, Cell Host Microbe, V29, P529, DOI [10.1101/2021.01.27.428516, 10.1016/j.chom.2021.03.002]; Stamatatos Leonidas, 2021, medRxiv, DOI 10.1101/2021.02.05.21251182	10	34	36	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2021	325	13					1251	1252		10.1001/jama.2021.3465	http://dx.doi.org/10.1001/jama.2021.3465		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK4TM	33662101	Bronze			2022-12-28	WOS:000625440200002
J	Thomson, EC; Rosen, LE; Shepherd, JG; Spreafico, R; Filipe, AD; Wojcechowskyj, JA; Davis, C; Piccoli, L; Pascall, DJ; Dillen, J; Lytras, S; Czudnochowski, N; Shah, R; Meury, M; Jesudason, N; De Marco, A; Li, K; Bassi, J; O'Toole, A; Pinto, D; Colquhoun, RM; Culap, K; Jackson, B; Zatta, F; Rambaut, A; Jaconi, S; Sreenu, VB; Nix, J; Zhang, I; Jarrett, RF; Glass, WG; Beltramello, M; Nomikou, K; Pizzuto, M; Tong, L; Cameroni, E; Croll, TI; Johnson, N; Di Iulio, J; Wickenhagen, A; Ceschi, A; Harbison, AM; Mair, D; Ferrari, P; Smollett, K; Sallusto, F; Carmichael, S; Garzoni, C; Nichols, J; Galli, M; Hughes, J; Riva, A; Ho, A; Schiuma, M; Semple, MG; Openshaw, PJM; Fadda, E; Baillie, JK; Chodera, JD; Rihn, SJ; Lycett, SJ; Virgin, HW; Telenti, A; Corti, D; Robertson, DL; Snell, G				Thomson, Emma C.; Rosen, Laura E.; Shepherd, James G.; Spreafico, Roberto; Filipe, Ana da Silva; Wojcechowskyj, Jason A.; Davis, Chris; Piccoli, Luca; Pascall, David J.; Dillen, Josh; Lytras, Spyros; Czudnochowski, Nadine; Shah, Rajiv; Meury, Marcel; Jesudason, Natasha; De Marco, Anna; Li, Kathy; Bassi, Jessica; O'Toole, Aine; Pinto, Dora; Colquhoun, Rachel M.; Culap, Katja; Jackson, Ben; Zatta, Fabrizia; Rambaut, Andrew; Jaconi, Stefano; Sreenu, Vattipally B.; Nix, Jay; Zhang, Ivy; Jarrett, Ruth F.; Glass, William G.; Beltramello, Martina; Nomikou, Kyriaki; Pizzuto, Matteo; Tong, Lily; Cameroni, Elisabetta; Croll, Tristan, I; Johnson, Natasha; Di Iulio, Julia; Wickenhagen, Arthur; Ceschi, Alessandro; Harbison, Aoife M.; Mair, Daniel; Ferrari, Paolo; Smollett, Katherine; Sallusto, Federica; Carmichael, Stephen; Garzoni, Christian; Nichols, Jenna; Galli, Massimo; Hughes, Joseph; Riva, Agostino; Ho, Antonia; Schiuma, Marco; Semple, Malcolm G.; Openshaw, Peter J. M.; Fadda, Elisa; Baillie, J. Kenneth; Chodera, John D.; Rihn, Suzannah J.; Lycett, Samantha J.; Virgin, Herbert W.; Telenti, Amalio; Corti, Davide; Robertson, David L.; Snell, Gyorgy		ISARIC4C Investigators; COVID-19 Genomics Uk COG-UK Consor	Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity	CELL			English	Article							RECEPTOR-BINDING DOMAIN; MUTATIONS; SYSTEM	SARS-CoV-2 canmutate and evade immunity, with consequences for efficacy of emerging vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-CoV-2 spike (S) receptor binding motif (RBM) is a highly variable region of S and provide epidemiological, clinical, and molecular characterization of a prevalent, sentinel RBM mutation, N439K. We demonstrate N439K S protein has enhanced binding affinity to the hACE2 receptor, and N439K viruses have similar in vitro replication fitness and cause infections with similar clinical outcomes as compared to wild type. We show the N439K mutation confers resistance against several neutralizing monoclonal antibodies, including one authorized for emergency use by the US Food and Drug Administration (FDA), and reduces the activity of some polyclonal sera from persons recovered from infection. Immune evasion mutations that maintain virulence and fitness such as N439K can emerge within SARS-CoV-2 S, highlighting the need for ongoing molecular surveillance to guide development and usage of vaccines and therapeutics.	[Thomson, Emma C.; Shepherd, James G.; Filipe, Ana da Silva; Davis, Chris; Lytras, Spyros; Shah, Rajiv; Jesudason, Natasha; Li, Kathy; Sreenu, Vattipally B.; Jarrett, Ruth F.; Nomikou, Kyriaki; Tong, Lily; Johnson, Natasha; Wickenhagen, Arthur; Mair, Daniel; Smollett, Katherine; Carmichael, Stephen; Nichols, Jenna; Hughes, Joseph; Ho, Antonia; Rihn, Suzannah J.; Robertson, David L.] Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland; [Thomson, Emma C.; ISARIC4C Investigators] London Sch Hyg & Trop Med, Dept Clin Res, London WC1 7HT, England; [Rosen, Laura E.; Spreafico, Roberto; Wojcechowskyj, Jason A.; Dillen, Josh; Czudnochowski, Nadine; Meury, Marcel; Di Iulio, Julia; Virgin, Herbert W.; Telenti, Amalio; Snell, Gyorgy] Vir Biotechnol, San Francisco, CA 94158 USA; [Piccoli, Luca; De Marco, Anna; Bassi, Jessica; Pinto, Dora; Culap, Katja; Zatta, Fabrizia; Jaconi, Stefano; Beltramello, Martina; Pizzuto, Matteo; Cameroni, Elisabetta; Corti, Davide] Humabs Biomed SA, CH-6500 Bellinzona, Switzerland; [Pascall, David J.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G61 1QN, Lanark, Scotland; [O'Toole, Aine; Colquhoun, Rachel M.; Jackson, Ben; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Nix, Jay] Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA; [Zhang, Ivy; Glass, William G.; Chodera, John D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Computat & Syst Biol Program, New York, NY 10065 USA; [Zhang, Ivy] Weill Cornell Grad Sch Med Sci, Triinst PhD Program Computat Biol & Med, New York, NY 10065 USA; [Croll, Tristan, I] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Ceschi, Alessandro] Univ Svizzera Italiana, Fac Biomed Sci, CH-6900 Lugano, Switzerland; [Ceschi, Alessandro] Ente Osped Cantonale, Div Clin Pharmacol & Toxicol, Inst Pharmacol Sci Southern Switzerland, CH-6900 Lugano, Switzerland; [Ceschi, Alessandro] Univ Hosp Zurich, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Harbison, Aoife M.; Fadda, Elisa] Maynooth Univ, Dept Chem & Hamilton Inst, Maynooth, Kildare, Ireland; [Ferrari, Paolo] Ente Osped Cantonale, Osped Civ Lugano, Dept Nephrol, CH-6900 Lugano, Switzerland; [Ferrari, Paolo] Univ New South Wales, Prince Wales Hosp, Clin Sch, Sydney, NSW 2052, Australia; [Sallusto, Federica] Univ Svizzera Italiana, Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Sallusto, Federica] Swiss Fed Inst Technol, ETH Inst Microbiol, CH-8093 Zurich, Switzerland; [Garzoni, Christian] Clin Luganese Moncucco, Clin Internal Med & Infect Dis, CH-6900 Lugano, Switzerland; [Galli, Massimo; Riva, Agostino; Schiuma, Marco] Luigi Sacco Hosp, Div Infect Dis 3, ASST Fatebenefratelli Sacco, I-20157 Milan, Italy; [Semple, Malcolm G.] Univ Liverpool, Fac Hlth & Life Sci, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Inst Infect Vet & Ecol Sci, Liverpool L69 7BE, Merseyside, England; [Semple, Malcolm G.] Alder Hey Childrens Hosp, Resp Med, Liverpool L12 2AP, Merseyside, England; [Openshaw, Peter J. M.] Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England; [Baillie, J. Kenneth; Lycett, Samantha J.] Univ Edinburgh, Roslin Inst, Edinburgh EH25 9RG, Midlothian, Scotland; [Baillie, J. Kenneth] Royal Infirm Edinburgh NHS Trust, Intens Care Unit, Edinburgh EH16 4SA, Midlothian, Scotland; [Virgin, Herbert W.] Washington Univ, Sch Med, St Louis, MO 63110 USA	University of Glasgow; University of London; London School of Hygiene & Tropical Medicine; University of Glasgow; University of Edinburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Cambridge; Universita della Svizzera Italiana; University of Zurich; University Zurich Hospital; Maynooth University; University of New South Wales Sydney; Universita della Svizzera Italiana; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Milan; Luigi Sacco Hospital; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Washington University (WUSTL)	Robertson, DL (corresponding author), Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.; Snell, G (corresponding author), Vir Biotechnol, San Francisco, CA 94158 USA.	david.l.robertson@glasgow.ac.uk; gsnell@vir.bio	Zhang, Ivy/GRX-9322-2022; Beggs, Andrew D/A-6912-2013; Semple, Malcolm Gracie/A-8790-2008; Telenti, Amalio/AAY-1674-2021; Resende, Paola Cristina/P-5002-2015; Baillie, John Kenneth/F-3124-2011; Nomikou, Kyriaki/P-1840-2018; Baillie, Kenneth/AEK-6650-2022; Spreafico, Roberto/AAY-7867-2021; Lytras, Spyros/GPT-0655-2022; Lytras, Spyros/ABF-4438-2020; Dorman, Matthew J/M-6603-2013; Thomson, Emma C/M-8690-2017; Smollett, Katherine/E-3650-2012; Castellano, Sergi/A-7437-2016	Beggs, Andrew D/0000-0003-0784-2967; Semple, Malcolm Gracie/0000-0001-9700-0418; Resende, Paola Cristina/0000-0002-2884-3662; Baillie, John Kenneth/0000-0001-5258-793X; Nomikou, Kyriaki/0000-0002-7013-1853; Baillie, Kenneth/0000-0001-5258-793X; Spreafico, Roberto/0000-0001-8282-7658; Lytras, Spyros/0000-0003-4202-6682; Dorman, Matthew J/0000-0001-7064-6163; Thomson, Emma C/0000-0003-1482-0889; Finch, Lorna/0000-0002-8167-8766; Rosen, Laura/0000-0002-8030-0219; Moore, Shona/0000-0001-8610-2806; Bewshea, Claire/0000-0002-0965-9587; Green, Christopher/0000-0002-1984-4014; Bashton, Matthew/0000-0002-6847-1525; Mair, Daniel/0000-0001-7169-9080; Nichols, Jenna/0000-0003-0093-7170; Piccoli, Luca/0000-0002-1085-6502; Jarrett, Ruth/0000-0003-0390-3478; Shepherd, James/0000-0003-3915-048X; Harbison, Aoife/0000-0001-7471-8064; Asiimwe, Innocent Gerald/0000-0002-1196-1822; da Silva Filipe, Ana Cristina/0000-0002-9442-2903; Smith, Darren/0000-0003-4925-467X; davis, chris/0000-0002-7317-3266; Schiuma, Marco/0000-0001-6539-1039; Ho, Antonia/0000-0003-1465-3785; Croll, Tristan/0000-0002-3514-8377; Ferrari, Paolo/0000-0002-9619-3104; Young, Gregory/0000-0001-5342-1421; Zhang, Ivy/0000-0003-0628-6276; Palmalux, Natasha/0000-0002-4246-6082; Wickenhagen, Arthur/0000-0001-5470-1505; Nelson, Andrew/0000-0001-6665-4929; Ceschi, Alessandro/0000-0002-4308-0405; Colquhoun, Rachel/0000-0002-5577-9897; Smollett, Katherine/0000-0001-7961-7377; Pascall, David/0000-0002-7543-0860; Hughes, Joseph/0000-0003-2556-2563; Rihn, Suzannah/0000-0001-9495-4056; Shah, Rajiv/0000-0002-2827-5108; Castellano, Sergi/0000-0002-5819-4210	DOE Office of Science User Facility [DE-AC02-05CH11231]; ALS-ENABLE program - NIH, National Institute of General Medical Sciences [P30 GM124169-01]; NHS; FAH Project [17311]; Medical Research Council (MRC) [MC UU 1201412]; Wellcome Trust [206298/Z/17/Z]; Chief Scientist Office [COV/EDI/20/11]; MRC part of UK Research & Innovation (UKRI); NIH Research (NIHR); Genome Research Limited; NIHR [CO-CIN-01, 201385]; MRC [MC_PC_ 19059]; NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool; Public Health England (PHE); Liverpool School of Tropical Medicine; University of Oxford [200907]; NIHR HPRU in Respiratory Infections at Imperial College London with PHE [200927]; Wellcome Trust and Department for International Development (DID) [215091/Z/18/Z]; Bill and Melinda Gates Foundation [OPP1209135]; Liverpool Experimental Cancer Medicine Centre [C18616/A25153]; NIHR Biomedical Research Centre at Imperial College London [IS-BRC-1215-20013]; EU Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) [602525]; NIH [P30 CA008748, R01 GM121505, R01 GM132386]; NSF [CHI-1904822]; Sloan Kettering Institute; Henry Krenter Foundation; Helmut Horten Foundation; Tri-Institutional PhD Program in Computational Biology and Medicine; Vir Biotechnology; Molecular Sciences Software Institute; Bayer; Randy Read's Wellcome Trust [209407/Z/17/Z]; MRC [MC_UU_12014/10, MC_PC_19027] Funding Source: UKRI; UKRI [MR/S032304/1] Funding Source: UKRI	DOE Office of Science User Facility(United States Department of Energy (DOE)); ALS-ENABLE program - NIH, National Institute of General Medical Sciences; NHS; FAH Project; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC part of UK Research & Innovation (UKRI); NIH Research (NIHR); Genome Research Limited; NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool; Public Health England (PHE); Liverpool School of Tropical Medicine; University of Oxford; NIHR HPRU in Respiratory Infections at Imperial College London with PHE; Wellcome Trust and Department for International Development (DID)(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Liverpool Experimental Cancer Medicine Centre; NIHR Biomedical Research Centre at Imperial College London; EU Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Sloan Kettering Institute; Henry Krenter Foundation; Helmut Horten Foundation; Tri-Institutional PhD Program in Computational Biology and Medicine; Vir Biotechnology; Molecular Sciences Software Institute; Bayer(Bayer AG); Randy Read's Wellcome Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKRI	We thank all Scottish NHS virology laboratories who provided samples for sequencing and Scott Arkison for HPC maintenance. We thank Chiara Silacci-Fregni from Humabs BioMed, Sandra Jovic, Blanca Fernandez Rodriguez, and Federico Mele, from the Institute for Research in Biomedicine in Bellinzona, and Tatiana Terrot from Ente Ospedaliero Cantonale in Lugano for the help in collecting serum samples. We thank Cindy Ng for help with protein production, Jesse Bloom for helpful comments, and Siro Bianchi for help with the graphical abstract. We gratefully acknowledge the authors originating and submitting laboratories of the sequences from GISAID (https://www.gisaid.org).Our genome sequence acknowledgments can be found in Data S2. Molecular Biology Consortium beamline 4.2.2 of the Advanced Light Source, a DOE Office of Science User Facility under Contract DE-AC02-05CH11231, is supported in part by the ALS-ENABLE program funded by the NIH, National Institute of General Medical Sciences (P30 GM124169-01). The ISARIC WHO CCP-UK study protocol is available at http://isaric4c.net/protocols; study registry https://www.isrctn.com/ISRCTN66726260.This work uses data provided by patients and collected by the NHS as part of their care and support #DataSavesLives. We are grateful to the 2,648 frontline NHS clinical and research staff and volunteer medical students who collected the data in challenging circumstances and the generosity of the participants and their families for their individual contributions in these difficult times. We also acknowledge the support of Jeremy J. Farrar and Nahoko Shindo. We are grateful to Gregory R. Bowman at Washington University in St. Louis, Joseph Coffland at Cauldron Development, Peter K. Eastman at Stanford University for developing and maintaining the Folding@home infrastructure, Amazon Web Services for critical Folding@home infrastructure support, and the many Folding@ home volunteers who contributed their computational resources to this project (FAH Project 17311). We are also grateful to Rafal P. Wiewiora at Memorial Sloan Kettering Cancer Center and Redesign Science and Sukrit Singh at Washington University in St. Louis for their guidance on setting up and managing simulations on Folding@home.For funding, we thank the Medical Research Council (MRC) (MC UU 1201412), Wellcome Trust (Collaborators Award 206298/Z/17/Z-ARTIC Network), and Chief Scientist Office (Project COV/EDI/20/11). COG-UK is supported by funding from the MRC part of UK Research & Innovation (UKRI), the NIH Research (NIHR) and Genome Research Limited, operating as the Wellcome Sanger Institute. We also thank NIHR (CO-CIN-01), MRC (MC_PC_ 19059), the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE) and in collaboration with Liverpool School of Tropical Medicine and the University of Oxford (200907), NIHR HPRU in Respiratory Infections at Imperial College London with PHE (200927), Wellcome Trust and Department for International Development (DID; 215091/Z/18/Z), the Bill and Melinda Gates Foundation (OPP1209135), Liverpool Experimental Cancer Medicine Centre (C18616/A25153), NIHR Biomedical Research Centre at Imperial College London (IS-BRC-1215-20013), EU Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE; FP7 project 602525), and NIHR Clinical Research Network for providing infrastructure support for this research. P.J.M.O. is supported by an NIHR senior investigator award (201385).; The views expressed are those of the authors and not necessarily those of the Department of Health and Social Care, DID, NIHR, MRC, Wellcome Trust, or PHE. J.D.C. acknowledges support from NIH (P30 CA008748, R01 GM121505, and R01 GM132386), NSF (CHI-1904822), and the Sloan Kettering Institute. F.S. is supported by the Henry Krenter Foundation. F.S. and the Institute for Research in Biomedicine are supported by the Helmut Horten Foundation. I.Z. acknowledges support from the Tri-Institutional PhD Program in Computational Biology and Medicine, Vir Biotechnology, the Molecular Sciences Software Institute, and the Sloan Kettering Institute. W.G.G. acknowledges support from Bayer and the Sloan Kettering Institute. T.I.C acknowledges support from Randy Read's Wellcome Trust (209407/Z/17/Z).	Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Burkner PC, 2018, R J, V10, P395; Casalino Lorenzo, 2020, bioRxiv, DOI 10.1101/2020.06.11.146522; Case D. A., 2017, AMBER 2017; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; COVID-19 Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk, 2020, Lancet Microbe, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Filipe AD, 2021, NAT MICROBIOL, V6, P112, DOI 10.1038/s41564-020-00838-z; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Maio N., 2020, NCOV 2019 GENOMIC EP; Dearlove B, 2020, P NATL ACAD SCI USA, V117, P23652, DOI 10.1073/pnas.2008281117; Doud MB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03665-3; Eastman P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005659; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Forleo-Neto E., 2020, CLIN INFECT DIS; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Giroglou T, 2004, J VIROL, V78, P9007, DOI 10.1128/JVI.78.17.9007-9015.2004; Gowers R. J., 2016, 15 PYTH SCI C SCIPY, P98, DOI [10.25080/majora-629-541a-00e, DOI 10.25080/MAJORA-629-541A-00E, DOI 10.25080/MAJORA-629E541A-00E]; Greaney AJ, 2020, COMPREHENSIVE MAPPIN, DOI [10.1101/2020.12.31.425021, DOI 10.1101/2020.12.31.425021]; Greaney Allison J, 2021, Cell Host Microbe, V29, P44, DOI [10.1101/2020.09.10.292078, 10.1016/j.chom.2020.11.007]; Grolemond G, 2011, J STAT SOFTW, V40, P1; Grubaugh ND, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1618-7; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Harbison AM, 2019, GLYCOBIOLOGY, V29, P94, DOI 10.1093/glycob/cwy097; Hou Yixuan J, 2020, bioRxiv, DOI 10.1101/2020.09.28.317685; Hu J, 2020, D614G MUTATION SARS, DOI DOI 10.1101/2020.06.20.161323; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Jones Bryan E, 2020, bioRxiv, DOI 10.1101/2020.09.30.318972; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Kirkpatrick E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28706-1; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kluyver T, 2016, POSITIONING AND POWER IN ACADEMIC PUBLISHING: PLAYERS, AGENTS AND AGENDAS, P87, DOI 10.3233/978-1-61499-649-1-87; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Leimkuhler B, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4802990; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li PF, 2015, J CHEM THEORY COMPUT, V11, P1645, DOI 10.1021/ct500918t; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Li X, 2020, LECT NOTES ELECTR EN, V574, P1, DOI [10.1101/2020.03.20.000885, 10.1007/978-981-13-9718-9_1, 10.1126/sciadv.abb9153]; Li XG, 2020, J MED VIROL, V92, P501, DOI 10.1002/jmv.25701; Liu Y, 2015, STAT COMPUT, V25, P809, DOI 10.1007/s11222-015-9563-8; Lorenzo-Redondo R, 2020, EBIOMEDICINE, V62, DOI 10.1016/j.ebiom.2020.103112; Lycett S.J., 2021, EPIDEMIC WAVES COVID, DOI [10.1101/2021.01.08.20248677, DOI 10.1101/2021.01.08.20248677]; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Meredith LW, 2020, LANCET INFECT DIS, V20, P1263, DOI 10.1016/S1473-3099(20)30562-4; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Muller Nicola F, 2020, medRxiv, DOI 10.1101/2020.09.30.20204230; Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Pohlmann S., CELL, V181; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Robson F, 2020, MOL CELL, V79, P710, DOI 10.1016/j.molcel.2020.07.027; Rodrigues Joao P G L M, 2018, F1000Res, V7, P1961, DOI 10.12688/f1000research.17456.1; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Shajahan Asif, 2020, Glycobiology, V30, P981, DOI 10.1093/glycob/cwaa042; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Starr Tyler N, 2020, bioRxiv, DOI [10.1126/science.abf9302, 10.1101/2020.11.30.405472]; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Tortorici MA, 2020, SCIENCE, V370, P950, DOI 10.1126/science.abe3354; Volz E., 2021, MEDRXIV, DOI [10.1101/2020.12.30.20249034, DOI 10.1101/2020.12.30.20249034]; Volz EM, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex025; Volz Erik, 2021, Cell, V184, P64, DOI 10.1016/j.cell.2020.11.020; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Watanabe Y, 2020, SCIENCE, V369, P330, DOI 10.1126/science.abb9983; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu SP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17972-1; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zhao P, 2020, CELL HOST MICROBE, V28, P586, DOI [10.1101/2020.06.25.172403, 10.1016/j.chom.2020.08.004]; Zimmerman Maxwell I, 2020, bioRxiv, DOI 10.1101/2020.06.27.175430	100	304	309	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1171	+		10.1016/j.cell.2021.01.037	http://dx.doi.org/10.1016/j.cell.2021.01.037		MAR 2021	37	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33621484	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000629635700009
J	Chanda, E				Chanda, Emmanuel			Averting malaria transmission with lethal house lure intervention	LANCET			English	Editorial Material									[Chanda, Emmanuel] World Hlth Org Reg Off Africa, Communicable & Noncommunicable Dis Cluster, Trop & Vectorborne Dis, Cite Du Djoue, DEM REP CONGO	World Health Organization	Chanda, E (corresponding author), World Hlth Org Reg Off Africa, Communicable & Noncommunicable Dis Cluster, Trop & Vectorborne Dis, Cite Du Djoue, DEM REP CONGO.	chandae@who.int						Alonso P, 2017, LANCET, V389, P2270, DOI 10.1016/S0140-6736(17)31376-4; BEACH RF, 1993, AM J TROP MED HYG, V49, P290, DOI 10.4269/ajtmh.1993.49.290; Chanda E, 2017, TRENDS PARASITOL, V33, P30, DOI 10.1016/j.pt.2016.09.006; Getawen SK, 2018, ACTA TROP, V181, P84, DOI 10.1016/j.actatropica.2018.02.009; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Manrique-Saide P, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009005; Sternberg ED, 2021, LANCET, V397, P805, DOI 10.1016/S0140-6736(21)00250-6; Sternberg ED, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5746-5; WHO, 2020, WORLD MAL REP 2020; WHO, 2020, 12 M WHO VECT CONTR; WHO Regional Office for Africa, 2019, FRAM IMPL GLOB VECT	12	0	0	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					769	771						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640044				2022-12-28	WOS:000623925500004
J	He, LJ; Pu, WJ; Liu, XX; Zhang, ZQ; Han, MY; Li, Y; Huang, XZ; Han, XM; Li, Y; Liu, K; Shi, MY; Lai, L; Sun, RL; Wang, QD; Ji, Y; Tchorz, JS; Zhou, B				He, Lingjuan; Pu, Wenjuan; Liu, Xiuxiu; Zhang, Zhenqian; Han, Maoying; Li, Yi; Huang, Xiuzhen; Han, Ximeng; Li, Yan; Liu, Kuo; Shi, Mengyang; Lai, Liang; Sun, Ruilin; Wang, Qing-Dong; Ji, Yong; Tchorz, Jan S.; Zhou, Bin			Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair	SCIENCE			English	Article							STEM-CELLS; RAT-LIVER; REGENERATION; LINEAGE; ZONATION; CONTRIBUTES; INITIATION; TAMOXIFEN; DIVISION; RENEWAL	Organ homeostasis is orchestrated by time- and spatially restricted cell proliferation. Studies identifying cells with superior proliferative capacities often rely on the lineage tracing of a subset of cell populations, which introduces a potential selective bias. In this work, we developed a genetic system [proliferation tracer (ProTracer)] by incorporating dual recombinases to seamlessly record the proliferation events of entire cell populations over time in multiple organs. In the mouse liver, ProTracer revealed more hepatocyte proliferation in distinct zones during liver homeostasis, injury repair, and regrowth. Clonal analysis showed that most of the hepatocytes labeled by ProTracer had undergone cell division. By genetically recording proliferation events of entire cell populations, ProTracer enables the unbiased detection of specific cellular compartments with enhanced regenerative capacities.	[He, Lingjuan; Pu, Wenjuan; Liu, Xiuxiu; Zhang, Zhenqian; Han, Maoying; Li, Yi; Huang, Xiuzhen; Han, Ximeng; Li, Yan; Liu, Kuo; Shi, Mengyang; Zhou, Bin] Univ Chinese Acad Sci, Chinese Acad Sci,State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Han, Maoying; Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Lai, Liang; Sun, Ruilin] Shanghai Model Organisms Ctr Inc, Shanghai, Peoples R China; [Wang, Qing-Dong] AstraZeneca, Cardiovasc Renal & Metab CVRM, BioPharmaceut R&D, Biosci Cardiovasc Res & Early Dev, Gothenburg, Sweden; [Ji, Yong] Nanjing Med Univ, Collaborat Innovat Ctr Cardiovasc Dis Translat Me, Nanjing, Peoples R China; [Tchorz, Jan S.] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland; [Zhou, Bin] Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou, Peoples R China; [Zhou, Bin] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; AstraZeneca; Nanjing Medical University; Novartis; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Zhou, B (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci,State Key Lab Cell Biol, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China.; Zhou, B (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Zhou, B (corresponding author), Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou, Peoples R China.; Zhou, B (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.	zhoubin@sibs.ac.cn		maoying, han/0000-0003-3532-4921	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDB19000000, XDA16010507]; National Key Research AMP; Development Program of China [2019YFA0110403, 2018YFA0107900, 2019YFA0110400, 2018YFA0108100, 2017YFC1001303]; National Science Foundation of China [82088101, 31730112, 31625019, 91849202, 32050087, 91639302, 81872241, 31922032]; Key Project of Frontier Sciences of CAS [QYZDB-SSW-SMC003]; Shanghai Science and Technology Commission [19JC1415700, 19ZR1479800]; Program for Guangdong Introduction Innovative and Entrepreneurial Teams [2017ZT07S347]; Shanghai Rising-Star Project; China Postdoctoral Science Foundation; China Postdoctoral Innovative Talent Support Program; SIBS President Fund; Royal Society-Newton Advanced Fellowship; AstraZeneca; Youth Innovation Promotion Association of CAS; innovative research teams of highlevel local universities in Shanghai	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); National Key Research AMP; Development Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Frontier Sciences of CAS; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Program for Guangdong Introduction Innovative and Entrepreneurial Teams; Shanghai Rising-Star Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Postdoctoral Innovative Talent Support Program; SIBS President Fund; Royal Society-Newton Advanced Fellowship; AstraZeneca(AstraZeneca); Youth Innovation Promotion Association of CAS; innovative research teams of highlevel local universities in Shanghai	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS; XDB19000000 and XDA16010507), the National Key Research & Development Program of China (2019YFA0110403, 2018YFA0107900, 2019YFA0110400, 2018YFA0108100, and 2017YFC1001303), the National Science Foundation of China (82088101, 31730112, 31625019, 91849202, 32050087, 91639302, 81872241, and 31922032), the Youth Innovation Promotion Association of CAS, the Key Project of Frontier Sciences of CAS (QYZDB-SSW-SMC003), the innovative research teams of highlevel local universities in Shanghai, the Shanghai Science and Technology Commission (19JC1415700 and 19ZR1479800), the Program for Guangdong Introduction Innovative and Entrepreneurial Teams (2017ZT07S347), the Shanghai Rising-Star Project, the China Postdoctoral Science Foundation, the China Postdoctoral Innovative Talent Support Program, the SIBS President Fund, the Royal Society-Newton Advanced Fellowship, AstraZeneca, and the support from the XPLORER PRIZE.	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Ang CH, 2019, P NATL ACAD SCI USA, V116, P19530, DOI 10.1073/pnas.1908099116; Basak O, 2018, P NATL ACAD SCI USA, V115, pE610, DOI 10.1073/pnas.1715911114; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; BRALET MP, 1994, AM J PATHOL, V144, P896; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen F, 2020, CELL STEM CELL, V26, P27, DOI 10.1016/j.stem.2019.11.001; Colnot S, 2011, MOL PATHOL LIB, V5, P7, DOI 10.1007/978-1-4419-7107-4_2; Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97; GRISHAM JW, 1962, CANCER RES, V22, P842; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; Hirai M, 2016, CIRC RES, V118, P20, DOI 10.1161/CIRCRESAHA.115.307697; JIRTLE RL, 1991, J BIOL CHEM, V266, P22444; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Katsuda T, 2020, CELL MOL GASTROENTER, V9, P161, DOI 10.1016/j.jcmgh.2019.08.011; Kim TH, 2000, HEPATOLOGY, V31, P75, DOI 10.1002/hep.510310114; Kretzschmar K, 2018, P NATL ACAD SCI USA, V115, pE12245, DOI 10.1073/pnas.1805829115; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Lehner B, 2011, CELL TISSUE RES, V345, P313, DOI 10.1007/s00441-011-1213-7; Levkoff LH, 2008, NEOPLASIA, V10, P804, DOI 10.1593/neo.08382; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Li Y, 2018, CIRCULATION, V138, P793, DOI 10.1161/CIRCULATIONAHA.118.034250; Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Manco R, 2019, J HEPATOL, V70, P1180, DOI 10.1016/j.jhep.2019.02.003; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Matsumoto T, 2020, CELL STEM CELL, V26, DOI 10.1016/j.stem.2019.11.014; Merrell AJ, 2016, NAT REV MOL CELL BIO, V17, P413, DOI 10.1038/nrm.2016.24; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Park YG, 2019, NAT BIOTECHNOL, V37, P73, DOI 10.1038/nbt.4281; Planas-Paz L, 2016, NAT CELL BIOL, V18, P467, DOI 10.1038/ncb3337; Preziosi M, 2018, HEPATOL COMMUN, V2, P845, DOI 10.1002/hep4.1196; Pu WJ, 2018, CIRC RES, V123, P86, DOI 10.1161/CIRCRESAHA.118.312981; Pu WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13369; Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Russell JO, 2019, HEPATOLOGY, V69, P742, DOI 10.1002/hep.30270; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Shin S, 2015, GASTROENTEROLOGY, V148, P192, DOI 10.1053/j.gastro.2014.09.039; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Sun TL, 2020, CELL STEM CELL, V26, P97, DOI 10.1016/j.stem.2019.10.011; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang Y, 2017, J BIOL CHEM, V292, P8594, DOI 10.1074/jbc.M117.782029; Whelan J., 1978, CIBA F S, P31; Yang G, 2013, PHARMACOL THERAPEUT, V139, P392, DOI 10.1016/j.pharmthera.2013.05.005; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; ZAJICEK G, 1985, LIVER, V5, P293; ZAJICEK G, 1995, AM J PATHOL, V146, P772; Zhang H, 2016, CIRC RES, V118, P1880, DOI 10.1161/CIRCRESAHA.116.308749; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202	64	56	60	37	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2021	371	6532					905	+	eabc4346	10.1126/science.abc4346	http://dx.doi.org/10.1126/science.abc4346			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM5IR	33632818				2022-12-28	WOS:000621813400047
J	Ecoffet, A; Huizinga, J; Lehman, J; Stanley, KO; Clune, J				Ecoffet, Adrien; Huizinga, Joost; Lehman, Joel; Stanley, Kenneth O.; Clune, Jeff			First return, then explore	NATURE			English	Article							ARCADE LEARNING-ENVIRONMENT; LEVEL	A reinforcement learning algorithm that explicitly remembers promising states and returns to them as a basis for further exploration solves all as-yet-unsolved Atari games and out-performs previous algorithms on Montezuma's Revenge and Pitfall. Reinforcement learning promises to solve complex sequential-decision problems autonomously by specifying a high-level reward function only. However, reinforcement learning algorithms struggle when, as is often the case, simple and intuitive rewards provide sparse(1) and deceptive(2) feedback. Avoiding these pitfalls requires a thorough exploration of the environment, but creating algorithms that can do so remains one of the central challenges of the field. Here we hypothesize that the main impediment to effective exploration originates from algorithms forgetting how to reach previously visited states (detachment) and failing to first return to a state before exploring from it (derailment). We introduce Go-Explore, a family of algorithms that addresses these two challenges directly through the simple principles of explicitly 'remembering' promising states and returning to such states before intentionally exploring. Go-Explore solves all previously unsolved Atari games and surpasses the state of the art on all hard-exploration games(1), with orders-of-magnitude improvements on the grand challenges of Montezuma's Revenge and Pitfall. We also demonstrate the practical potential of Go-Explore on a sparse-reward pick-and-place robotics task. Additionally, we show that adding a goal-conditioned policy can further improve Go-Explore's exploration efficiency and enable it to handle stochasticity throughout training. The substantial performance gains from Go-Explore suggest that the simple principles of remembering states, returning to them, and exploring from them are a powerful and general approach to exploration-an insight that may prove critical to the creation of truly intelligent learning agents.	[Ecoffet, Adrien; Huizinga, Joost; Lehman, Joel; Stanley, Kenneth O.; Clune, Jeff] Uber AI Labs, San Francisco, CA 94107 USA; [Ecoffet, Adrien; Huizinga, Joost; Lehman, Joel; Stanley, Kenneth O.; Clune, Jeff] OpenAI, San Francisco, CA 94110 USA		Ecoffet, A; Huizinga, J; Clune, J (corresponding author), Uber AI Labs, San Francisco, CA 94107 USA.; Ecoffet, A; Huizinga, J; Clune, J (corresponding author), OpenAI, San Francisco, CA 94110 USA.	adrienecoffet@gmail.com; joost.hui@gmail.com; jclune@gmail.com		Huizinga, Joost/0000-0003-0877-3051; Ecoffet, Adrien/0000-0001-9985-365X				Alvernaz Samuel, 2017, 2017 IEEE Conference on Computational Intelligence and Games (CIG), P1, DOI 10.1109/CIG.2017.8080408; Amodei D., 2016, CONCRETE PROBLEMS AI; Andrychowicz M, 2020, INT J ROBOT RES, V39, P3, DOI 10.1177/0278364919887447; [Anonymous], 2019, OPEN AI DOTA 2 LARGE; [Anonymous], ATARI VCS 2600 SCORE; Aytar Y., 2018, P ADV NEUR INF PROC, P2930; Badia AP, 2020, P MACHINE LEARNING R; Bellemare M, 2016, ADV NEURAL INFORM PR, P1471, DOI DOI 10.3390/BS3030459; Bellemare M.G., 2020, INT C LEARN REPRESEN; Bellemare MG, 2013, J ARTIF INTELL RES, V47, P253, DOI 10.1613/jair.3912; Brockman G., 2016, ARXIV160601540; Chaslot G., 2008, AIIDE, P216; Cho K., 2014, P SSST 8 EIGHTHWORKS, P103, DOI 10.1038/s41586-020-03157-9; Choi J., 2019, INT C LEARN REPRESEN; Conti E., 2018, ADV NEURAL INFORM PR, V31, P5027; Cuccu G, 2019, AAMAS '19: PROCEEDINGS OF THE 18TH INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS AND MULTIAGENT SYSTEMS, P998; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; Dymesich D, 2016, WORKSHOP AUTONOMOUS; Espeholt L, 2018, PR MACH LEARN RES, V80; Fedus W., 2019, HYPERBOLIC DISCOUNTI; Goldenberg A. A., 1985, IEEE Journal of Robotics and Automation, VRA-1, P14; Guo X., 2014, ADV NEURAL INFORM PR, V27, P3338; Guo Y., 2019, EFFICIENT EXPLORATIO; HART PE, 1968, IEEE T SYST SCI CYB, VSSC4, P100, DOI 10.1109/TSSC.1968.300136; Hester T, 2018, AAAI CONF ARTIF INTE, P3223; Horgan D, 2018, INT C LEARN REP; Hussein A, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3054912; Jaderberg M., 2017, INT C LEAR REPRESENT; Klimov O., 2019, INT C LEARN REPRESEN; Klimov O., 2017, PROXIMAL POLICY OPTI; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Kumar Saurabh, 2018, DOPAMINE RES FRAMEWO; Lavalle S. M., 1998, TECHNICAL REPORT NO; Lehman J, 2020, ARTIF LIFE, V26, P274, DOI 10.1162/artl_a_00319; Lehman J, 2011, GENET EVOL COMPUT, P37; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Li Y., 2018, REPRESENTATION LEARN; Lipovetzky N, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P1610; Madotto A., 2020, EXPLORATION BASED LA; Martin J., 2017, P 26 INT JOINT C ART, P2471; Merel J., 2019, INT C LEARN REP; Mnih V., 2016, INT C MACH LEARN, P1928; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moutarde F., 2019, 39 C NEUR INF PROC S; Ng AY, 1999, MACHINE LEARNING, PROCEEDINGS, P278; ODonoghue B., 2018, P ICML, P3839; Oh J, 2018, P 35 INT C MACH LEAR, P3878; Ostrovski G, 2017, PR MACH LEARN RES, V70; Peng XB, 2018, IEEE INT CONF ROBOT, P3803, DOI 10.1109/ICCABS.2018.8541936; Plappert M., 2018, MULTIGOAL REINFORCEM; Popova M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap7885; PuigdomenechBadia A, 2020, INT C LEARN REPR; Salakhutdinov Ruslan, 2019, P C NEUR INF PROC SY; Salimans T, 2018, LEARNING MONTEZUMAS; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Smart WD, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P3404, DOI 10.1109/ROBOT.2002.1014237; Smith DE, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P889; Spong M.W., 2006, ROBOT MODELING CONTR, VVolume 3; Strehl AL, 2008, J COMPUT SYST SCI, V74, P1309, DOI 10.1016/j.jcss.2007.08.009; Tang H., 2017, NEURAL INFORM PROCES, V30, P2750; Todorov E, 2012, IEEE INT C INT ROBOT, P5026, DOI 10.1109/IROS.2012.6386109; Valko M., 2020, P INT C MACH LEARN I, P9397; van Hasselt H, 2016, ADV NEUR IN, V29; Vinyals O, 2019, NATURE, V575, P350, DOI 10.1038/s41586-019-1724-z; Zhao ZQ, 2019, IEEE T NEUR NET LEAR, V30, P3212, DOI 10.1109/TNNLS.2018.2876865	68	31	31	12	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-020-03157-9	http://dx.doi.org/10.1038/s41586-020-03157-9			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627813	Green Submitted			2022-12-28	WOS:000621583600009
J	Van Damme, P; Robberecht, W				Van Damme, Philip; Robberecht, Wim			STING-Induced Inflammation - A Novel Therapeutic Target in ALS?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Van Damme, Philip] VIB, Ctr Brain & Dis Res, Neurobiol Lab, Leuven, Belgium; [Van Damme, Philip; Robberecht, Wim] Univ Leuven, KU Leuven, Dept Neurosci, Expt Neurol, Leuven, Belgium; [Van Damme, Philip; Robberecht, Wim] Univ Leuven, KU Leuven, Leuven Brain Inst, Leuven, Belgium; [Van Damme, Philip; Robberecht, Wim] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven	Van Damme, P (corresponding author), VIB, Ctr Brain & Dis Res, Neurobiol Lab, Leuven, Belgium.; Van Damme, P (corresponding author), Univ Leuven, KU Leuven, Dept Neurosci, Expt Neurol, Leuven, Belgium.; Van Damme, P (corresponding author), Univ Leuven, KU Leuven, Leuven Brain Inst, Leuven, Belgium.; Van Damme, P (corresponding author), Univ Hosp Leuven, Dept Neurol, Leuven, Belgium.		Van Damme, Philip/A-6464-2009	Van Damme, Philip/0000-0002-4010-2357				Hu Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09097-1; McCauley ME, 2020, NATURE, V585, P96, DOI 10.1038/s41586-020-2625-x; Miller T, 2020, NEW ENGL J MED, V383, P109, DOI 10.1056/NEJMoa2003715; Wang WZ, 2016, NAT MED, V22, P869, DOI 10.1038/nm.4130; Yu CH, 2020, CELL, V183, P636, DOI 10.1016/j.cell.2020.09.020	5	2	2	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					765	767		10.1056/NEJMcibr2031048	http://dx.doi.org/10.1056/NEJMcibr2031048			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP4LK	33626258	Green Published			2022-12-28	WOS:000623807600018
J	Zhong, YP; Chang, HS; Bienfait, A; Dumur, E; Chou, MH; Conner, CR; Grebel, J; Povey, RG; Yan, HX; Schuster, DI; Cleland, AN				Zhong, Youpeng; Chang, Hung-Shen; Bienfait, Audrey; Dumur, Etienne; Chou, Ming-Han; Conner, Christopher R.; Grebel, Joel; Povey, Rhys G.; Yan, Haoxiong; Schuster, David, I; Cleland, Andrew N.			Deterministic multi-qubit entanglement in a quantum network	NATURE			English	Article							STATE TRANSFER; REMOTE ENTANGLEMENT; SUPERCONDUCTING QUBITS; MICROWAVE; COMMUNICATION; INEQUALITY; MEMORY	High-fidelity deterministic quantum state transfer and multi-qubit entanglement are demonstrated in a quantum network comprising two superconducting quantum nodes one metre apart, with each node including three interconnected qubits. The generation of high-fidelity distributed multi-qubit entanglement is a challenging task for large-scale quantum communication and computational networks(1-4). The deterministic entanglement of two remote qubits has recently been demonstrated with both photons(5-10) and phonons(11). However, the deterministic generation and transmission of multi-qubit entanglement has not been demonstrated, primarily owing to limited state-transfer fidelities. Here we report a quantum network comprising two superconducting quantum nodes connected by a one-metre-long superconducting coaxial cable, where each node includes three interconnected qubits. By directly connecting the cable to one qubit in each node, we transfer quantum states between the nodes with a process fidelity of 0.911 +/- 0.008. We also prepare a three-qubit Greenberger-Horne-Zeilinger (GHZ) state(12-14) in one node and deterministically transfer this state to the other node, with a transferred-state fidelity of 0.656 +/- 0.014. We further use this system to deterministically generate a globally distributed two-node, six-qubit GHZ state with a state fidelity of 0.722 +/- 0.021. The GHZ state fidelities are clearly above the threshold of 1/2 for genuine multipartite entanglement(15), showing that this architecture can be used to coherently link together multiple superconducting quantum processors, providing a modular approach for building large-scale quantum computers(16,17).	[Zhong, Youpeng; Chang, Hung-Shen; Bienfait, Audrey; Dumur, Etienne; Chou, Ming-Han; Conner, Christopher R.; Grebel, Joel; Povey, Rhys G.; Yan, Haoxiong; Schuster, David, I; Cleland, Andrew N.] Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA; [Dumur, Etienne; Cleland, Andrew N.] Argonne Natl Lab, Inst Mol Engn, Argonne, IL 60439 USA; [Dumur, Etienne; Cleland, Andrew N.] Argonne Natl Lab, Mat Sci Div, Argonne, IL 60439 USA; [Chou, Ming-Han; Povey, Rhys G.; Schuster, David, I] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Zhong, Youpeng] Southern Univ Sci & Technol, Shenzhen Inst Quantum Sci & Engn, Shenzhen, Peoples R China; [Bienfait, Audrey] Univ Lyon, Univ Claude Bernard, ENS Lyon, CNRS,Lab Phys, Lyon, France; [Dumur, Etienne] Univ Grenoble Alpes, CEA, INAC PheLiqs, Grenoble, France	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Southern University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Cleland, AN (corresponding author), Univ Chicago, Pritzker Sch Mol Engn, Chicago, IL 60637 USA.; Cleland, AN (corresponding author), Argonne Natl Lab, Inst Mol Engn, Argonne, IL 60439 USA.; Cleland, AN (corresponding author), Argonne Natl Lab, Mat Sci Div, Argonne, IL 60439 USA.	anc@uchicago.edu	Chang, Hung-Shen/AGZ-8235-2022	Chang, Hung-Shen/0000-0001-9681-6108; Conner, Christopher/0000-0002-6875-2298; Chou, Ming-Han/0000-0002-5646-4272; Dumur, Etienne/0000-0001-8010-9580; Povey, Rhys/0000-0002-3382-3287; Zhong, Youpeng/0000-0002-8120-6259				Arute F, 2019, NATURE, V574, P505, DOI 10.1038/s41586-019-1666-5; Axline CJ, 2018, NAT PHYS, V14, P705, DOI 10.1038/s41567-018-0115-y; Baksic A, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.230503; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Bienfait A, 2019, SCIENCE, V364, P368, DOI 10.1126/science.aaw8415; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Burkhart L.D, 2020, ERROR DETECTED STATE; Campagne-Ibarcq P, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.200501; Chang HS, 2020, PHYS REV LETT, V124, DOI 10.1103/PhysRevLett.124.240502; Chen Y, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.220502; Chou KS, 2018, NATURE, V561, P368, DOI 10.1038/s41586-018-0470-y; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; DiCarlo L, 2010, NATURE, V467, P574, DOI 10.1038/nature09416; Dickel C, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.064508; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Guhne O, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/5/053002; Hensen B, 2015, NATURE, V526, P682, DOI 10.1038/nature15759; Humphreys PC, 2018, NATURE, V558, P268, DOI 10.1038/s41586-018-0200-5; Jiang L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062323; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; Korotkov AN, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.014510; Kurpiers P, 2019, PHYS REV APPL, V12, DOI 10.1103/PhysRevApplied.12.044067; Kurpiers P, 2018, NATURE, V558, P264, DOI 10.1038/s41586-018-0195-y; Lee KC, 2011, SCIENCE, V334, P1253, DOI 10.1126/science.1211914; Leung N, 2019, NPJ QUANTUM INFORM, V5, DOI 10.1038/s41534-019-0128-0; Liao SK, 2017, NATURE, V549, P43, DOI 10.1038/nature23655; Magnard P, 2020, PHYS REV LETT, V125, DOI 10.1103/PhysRevLett.125.260502; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Mirhosseini M, 2020, NATURE, V588, P599, DOI 10.1038/s41586-020-3038-6; Moehring DL, 2007, NATURE, V449, P68, DOI 10.1038/nature06118; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Narla A, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031036; Neeley M, 2008, NAT PHYS, V4, P523, DOI 10.1038/nphys972; Neeley M, 2010, NATURE, V467, P570, DOI 10.1038/nature09418; Nielsen, 2010, QUANTUM COMPUTATION; Pechal M, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041010; Ritter S, 2012, NATURE, V484, P195, DOI 10.1038/nature11023; Roch N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.170501; Rosenberg D, 2020, IEEE MICROW MAG, V21, P72, DOI 10.1109/MMM.2020.2993478; Sete EA, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.144509; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Srinivasan SJ, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.033857; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Strauch FW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.167005; Vermersch B, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.133601; Wang YD, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105010; Wenner J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.210501; Xiang ZL, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011035; Yin Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.107001; Zeytinoglu S, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.043846; Zhong YP, 2019, NAT PHYS, V15, P741, DOI 10.1038/s41567-019-0507-7; Zhou BB, 2017, NAT PHYS, V13, P330, DOI [10.1038/nphys3967, 10.1038/NPHYS3967]	55	31	32	5	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 25	2021	590	7847								10.1038/s41586-021-03288-7	http://dx.doi.org/10.1038/s41586-021-03288-7			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QM2BL	33627810	Green Submitted			2022-12-28	WOS:000621583600007
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Debts of gratitude	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						BBC, 2021, BBC; Woodcock A., 2021, INDEPENDENT	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2021	372								n514	10.1136/bmj.n514	http://dx.doi.org/10.1136/bmj.n514			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8SP	33622674	Bronze			2022-12-28	WOS:000623407800006
J	Horton, R				Horton, Richard			Offline: What is the UK for? Comment	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2021	397	10275					654	654						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QL3PK	33610197	Green Published, Bronze			2022-12-28	WOS:000620991800009
J	Griffin, S				Griffin, Shaun			Covid-19: Ethnicity vaccination gap narrows in England, but concerns remain	BMJ-BRITISH MEDICAL JOURNAL			English	News Item													Griffin, Shaun/GLT-2847-2022					[Anonymous], 2021, NHS COV 19 VACC COV; O'Dowd A, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n357; Randhawa G, 2021, COVID 19 MUST BE TIP	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2021	372								n505	10.1136/bmj.n505	http://dx.doi.org/10.1136/bmj.n505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7BC	33608261	Bronze			2022-12-28	WOS:000621237300008
J	Itoh, Y; Andrell, J; Choi, A; Richter, U; Maiti, P; Best, RB; Barrientos, A; Battersby, BJ; Amunts, A				Itoh, Yuzuru; Andrell, Juni; Choi, Austin; Richter, Uwe; Maiti, Priyanka; Best, Robert B.; Barrientos, Antoni; Battersby, Brendan J.; Amunts, Alexey			Mechanism of membrane-tethered mitochondrial protein synthesis	SCIENCE			English	Article								Mitochondrial ribosomes (mitoribosomes) are tethered to the mitochondrial inner membrane to facilitate the cotranslational membrane insertion of the synthesized proteins. We report cryo-electron microscopy structures of human mitoribosomes with nascent polypeptide, bound to the insertase oxidase assembly 1-like (OXA1L) through three distinct contact sites. OXA1L binding is correlated with a series of conformational changes in the mitoribosomal large subunit that catalyze the delivery of newly synthesized polypeptides. The mechanism relies on the folding of mL45 inside the exit tunnel, forming two specific constriction sites that would limit helix formation of the nascent chain. A gap is formed between the exit and the membrane, making the newly synthesized proteins accessible. Our data elucidate the basis by which mitoribosomes interact with the OXA1L insertase to couple protein synthesis and membrane delivery.	[Itoh, Yuzuru; Andrell, Juni; Amunts, Alexey] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-17165 Solna, Sweden; [Itoh, Yuzuru; Andrell, Juni; Amunts, Alexey] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Choi, Austin; Maiti, Priyanka; Barrientos, Antoni] Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA; [Richter, Uwe; Battersby, Brendan J.] Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland; [Richter, Uwe] Univ Helsinki, Fac Biol & Environm Sci, Helsinki 00790, Finland; [Richter, Uwe] Newcastle Univ, Wellcome Ctr Mitochondrial Res, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Best, Robert B.] NIDDKD, Lab Chem Phys, NIH, Bethesda, MD 20892 USA	Stockholm University; Karolinska Institutet; University of Miami; University of Helsinki; University of Helsinki; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Amunts, A (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-17165 Solna, Sweden.; Amunts, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.; Barrientos, A (corresponding author), Univ Miami, Dept Neurol, Miller Sch Med, Miami, FL 33136 USA.; Battersby, BJ (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki 00790, Finland.	abarrientos@med.miami.edu; brendan.battersby@helsinki.fi; amunts@scilifelab.se	Richter, Uwe/Y-3643-2019; Maiti, Priyanka/AAA-6903-2020	Richter, Uwe/0000-0002-0724-6957; Maiti, Priyanka/0000-0003-4207-0341; Amunts, A./0000-0002-5302-1740; Andrell, Juni/0000-0003-2313-9155; Itoh, Yuzuru/0000-0001-7802-5572	Swedish Foundation for Strategic Research [FFL15: 0325]; Ragnar Soderberg Foundation [M44/16]; Cancerfonden [2017/1041]; European Research Council [ERC-2018-StG-805230]; Knut and Alice Wallenberg Foundation [2018.0080]; Academy of Finland [307431, 314706]; Sigrid Juselius Foundation; NIH-R35 grant [GM118141]; MDA Research Grant [MDA-381828]; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH; American Heart Association [19POST34450174];  [H2020-MSCA-IF-2017 (799399-Itohribo)]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Ragnar Soderberg Foundation; Cancerfonden(Swedish Cancer Society); European Research Council(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NIH-R35 grant; MDA Research Grant; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH; American Heart Association(American Heart Association); 	Swedish Foundation for Strategic Research (FFL15: 0325), Ragnar Soderberg Foundation (M44/16), Cancerfonden (2017/1041), European Research Council (ERC-2018-StG-805230), Knut and Alice Wallenberg Foundation (2018.0080), The Academy of Finland (307431 and 314706 to B. J.B.), Sigrid Juselius Foundation (to B.J. B), NIH-R35 grant (GM118141 to A.B.), and MDA Research Grant (MDA-381828 to A.B.) supported this work. R.B.B. was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH. This work used the computational resources of the NIH HPC Biowulf cluster (https://hpc.nih.gov).Y.I.was supported by H2020-MSCA-IF-2017 (799399-Itohribo). P.M. is the recipient of a postdoctoral fellowship from the American Heart Association (19POST34450174).	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Aibara S, 2020, ELIFE, V9, DOI 10.7554/eLife.58362; Aibara S, 2018, JOVE-J VIS EXP, DOI 10.3791/57877; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Ban N, 2014, CURR OPIN STRUC BIOL, V24, P165, DOI 10.1016/j.sbi.2014.01.002; Bano-Polo M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07554-7; Bauerschmitt H, 2010, MOL BIOL CELL, V21, P1937, DOI 10.1091/mbc.E10-02-0101; Brown A, 2017, NAT STRUCT MOL BIOL, V24, P866, DOI 10.1038/nsmb.3464; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YY, 2017, STRUCTURE, V25, P1403, DOI 10.1016/j.str.2017.07.008; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; De Silva D, 2015, CELL CYCLE, V14, P2226, DOI 10.1080/15384101.2015.1053672; DeLano W. L, 2014, HYPERTENS RES, V37, P362; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Englmeier R, 2017, STRUCTURE, V25, P1574, DOI 10.1016/j.str.2017.07.011; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Greber BJ, 2014, NATURE, V515, P283, DOI 10.1038/nature13895; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; Hildenbeutel M, 2012, J MOL BIOL, V423, P590, DOI 10.1016/j.jmb.2012.07.018; Holmstrom ED, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10356-0; Itoh Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18830-w; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kedrov A, 2016, CELL REP, V17, P2943, DOI 10.1016/j.celrep.2016.11.059; Khawaja A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16503-2; Kim HJ, 2018, NUCLEIC ACIDS RES, V46, P8435, DOI 10.1093/nar/gky672; Kudva R, 2018, ELIFE, V7, DOI 10.7554/eLife.36326; Kumazaki K, 2014, NATURE, V509, P516, DOI 10.1038/nature13167; Kummer E, 2018, NATURE, V560, P263, DOI 10.1038/s41586-018-0373-y; Kutzner C, 2019, J COMPUT CHEM, V40, P2418, DOI 10.1002/jcc.26011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee RG, 2020, J CELL SCI, V133, DOI 10.1242/jcs.240374; Liutkute M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010097; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mercier E, 2018, BIOCHEMISTRY-US, V57, P3460, DOI 10.1021/acs.biochem.8b00293; Moggridge S, 2018, J PROTEOME RES, V17, P1730, DOI 10.1021/acs.jproteome.7b00913; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; Petrov AS, 2019, MOL BIOL EVOL, V36, P207, DOI 10.1093/molbev/msy221; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Suomalainen A, 2018, NAT REV MOL CELL BIO, V19, P77, DOI 10.1038/nrm.2017.66; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Thompson K, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809060; Tobiasson V, 2020, ELIFE, V9, DOI 10.7554/eLife.59264; Troshin PV, 2018, BIOINFORMATICS, V34, P1939, DOI 10.1093/bioinformatics/bty045; Tu YT, 2015, CELL REP, V10, P854, DOI 10.1016/j.celrep.2015.01.033; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Wickles S, 2014, ELIFE, V3, DOI 10.7554/eLife.03035; Zhang J, 2015, ELIFE, V4, DOI 10.7554/eLife.09684; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	61	33	33	12	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					846	+		10.1126/science.abe0763	http://dx.doi.org/10.1126/science.abe0763			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QJ4MB	33602856	Green Accepted, Green Submitted			2022-12-28	WOS:000619664700056
J	Dyer, C				Dyer, Clare			Surgeon who lied about his experience to get consultant post is struck off	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		DYER C, 2018, BMJ-BRIT MED J, V360, DOI DOI 10.1136/BMJ.K574	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 9	2021	372								n670	10.1136/bmj.n670	http://dx.doi.org/10.1136/bmj.n670			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6QO	33687924				2022-12-28	WOS:000632923400005
J	Kuehn, BM				Kuehn, Bridget M.			More Resources, Community Outreach Needed to Boost Contact Tracing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					925	925		10.1001/jama.2021.1575	http://dx.doi.org/10.1001/jama.2021.1575			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687472	Bronze			2022-12-28	WOS:000627899400008
J	McKee, M				McKee, Martin			The UK's PPE procurement scandal reminds us why we need ways to hold ministers to account	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	Martin.McKee@lshtm.ac.uk							0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 8	2021	372								n639	10.1136/bmj.n639	http://dx.doi.org/10.1136/bmj.n639			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6RV	33685915	Green Published, Bronze			2022-12-28	WOS:000632926700006
J	Wallauer, R; Raths, M; Stallberg, K; Munster, L; Brandstetter, D; Yang, X; Gudde, J; Puschnig, P; Soubatch, S; Kumpf, C; Bocquet, FC; Tautz, FS; Hofer, U				Wallauer, R.; Raths, M.; Stallberg, K.; Muenster, L.; Brandstetter, D.; Yang, X.; Guedde, J.; Puschnig, P.; Soubatch, S.; Kumpf, C.; Bocquet, F. C.; Tautz, F. S.; Hoefer, U.			Tracing orbital images on ultrafast time scales	SCIENCE			English	Article								Frontier orbitals determine fundamental molecular properties such as chemical reactivities. Although electron distributions of occupied orbitals can be imaged in momentum space by photoemission tomography, it has so far been impossible to follow the momentum-space dynamics of a molecular orbital in time, for example, through an excitation or a chemical reaction. Here, we combined time-resolved photoemission using high laser harmonics and a momentum microscope to establish a tomographic, femtosecond pump-probe experiment of unoccupied molecular orbitals. We measured the full momentum-space distribution of transiently excited electrons, connecting their excited-state dynamics to real-space excitation pathways. Because in molecules this distribution is closely linked to orbital shapes, our experiment may, in the future, offer the possibility of observing ultrafast electron motion in time and space.	[Wallauer, R.; Stallberg, K.; Muenster, L.; Guedde, J.; Hoefer, U.] Philipps Univ Marburg, Fachbereich Phys, Renthof 5, D-35032 Marburg, Germany; [Wallauer, R.; Stallberg, K.; Muenster, L.; Guedde, J.; Hoefer, U.] Philipps Univ Marburg, Zentrum Mat Wissensch, Renthof 5, D-35032 Marburg, Germany; [Raths, M.; Yang, X.; Soubatch, S.; Kumpf, C.; Bocquet, F. C.; Tautz, F. S.] Forschungszentrum Julich, Peter Grunberg Inst PGI 3, D-52425 Julich, Germany; [Raths, M.; Yang, X.; Soubatch, S.; Kumpf, C.; Bocquet, F. C.; Tautz, F. S.] Julich Aachen Res Alliance JARA, Fundamentals Future Informat Technol, D-52425 Julich, Germany; [Raths, M.; Yang, X.; Kumpf, C.; Tautz, F. S.] Rhein Westfal TH Aachen, Expt Phys 4, Otto Blumenthal Str, D-52074 Aachen, Germany; [Brandstetter, D.; Puschnig, P.] Karl Franzens Univ Graz, Inst Phys, NAWI Graz, A-8010 Graz, Austria	Philipps University Marburg; Philipps University Marburg; Helmholtz Association; Research Center Julich; RWTH Aachen University; University of Graz	Hofer, U (corresponding author), Philipps Univ Marburg, Fachbereich Phys, Renthof 5, D-35032 Marburg, Germany.; Hofer, U (corresponding author), Philipps Univ Marburg, Zentrum Mat Wissensch, Renthof 5, D-35032 Marburg, Germany.; Tautz, FS (corresponding author), Forschungszentrum Julich, Peter Grunberg Inst PGI 3, D-52425 Julich, Germany.; Tautz, FS (corresponding author), Julich Aachen Res Alliance JARA, Fundamentals Future Informat Technol, D-52425 Julich, Germany.; Tautz, FS (corresponding author), Rhein Westfal TH Aachen, Expt Phys 4, Otto Blumenthal Str, D-52074 Aachen, Germany.	s.tautz@fz-juelich.de; hoefer@physik.uni-marburg.de	Tautz, Frank Stefan/L-4500-2016; Yang, Xiaosheng/AAH-5604-2021; Bocquet, François C/B-7845-2010; Münster, Lasse/GYU-7296-2022; Puschnig, Peter/C-9203-2011; Kumpf, Christian/K-3624-2013; Wallauer, Robert/K-6610-2018	Tautz, Frank Stefan/0000-0003-3583-2379; Yang, Xiaosheng/0000-0002-7632-0401; Bocquet, François C/0000-0002-9471-4439; Münster, Lasse/0000-0003-1933-4767; Puschnig, Peter/0000-0002-8057-7795; Kumpf, Christian/0000-0003-3567-5377; Stallberg, Klaus/0000-0002-7253-156X; Wallauer, Robert/0000-0002-0359-0814; Gudde, Jens/0000-0002-0243-7877; Subach, Sergey/0000-0002-1455-0260; Brandstetter, Dominik/0000-0002-0434-1289; Raths, Miriam/0000-0002-1965-6064	Deutsche Forschungsgemeinschaft (DFG) [223848855SFB 1083]; Austrian Science Fund (FWF) [I3731]; DFG [396769409]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG))	R.W., U.H., F.C.B., C.K., and F.S.T. acknowledge financial support from the Deutsche Forschungsgemeinschaft (DFG), project-ID 223848855SFB 1083. D.B. and P.P. acknowledge financial support from the Austrian Science Fund (FWF), project I3731. S.S., F.C.B., and F.S.T. acknowledge financial support from the DFG, project-ID 396769409.	Bisgaard CZ, 2009, SCIENCE, V323, P1464, DOI 10.1126/science.1169183; Cocker TL, 2016, NATURE, V539, P263, DOI 10.1038/nature19816; Cui XF, 2014, NAT PHYS, V10, P505, DOI [10.1038/nphys2981, 10.1038/NPHYS2981]; Dauth M, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/10/103005; Duan X, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.075430; Echenique PM, 2004, SURF SCI REP, V52, P219, DOI 10.1016/j.surfrep.2004.02.002; Eich S, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602094; FUKUI K, 1982, SCIENCE, V218, P747, DOI 10.1126/science.218.4574.747; Gartner S, 2014, BEILSTEIN J ORG CHEM, V10, P2055, DOI 10.3762/bjoc.10.213; Heyl CM, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/7/074020; Holmegaard L, 2010, NAT PHYS, V6, P428, DOI [10.1038/nphys1666, 10.1038/NPHYS1666]; Iddir H, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.241404; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; JANAK JF, 1978, PHYS REV B, V18, P7165, DOI 10.1103/PhysRevB.18.7165; Klamroth T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.035420; Kliuiev P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13254-7; Koopmans T, 1934, PHYSICA, V1, P104, DOI 10.1016/S0031-8914(34)90011-2; Krylov AI, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0018597; Luftner D, 2014, P NATL ACAD SCI USA, V111, P605, DOI 10.1073/pnas.1315716110; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Na MX, 2019, SCIENCE, V366, P1231, DOI 10.1126/science.aaw1662; Nicholson CW, 2018, SCIENCE, V362, P821, DOI 10.1126/science.aar4183; Ortiz JV, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0016472; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Puschnig P, 2017, J PHYS CHEM LETT, V8, P208, DOI 10.1021/acs.jpclett.6b02517; Puschnig P, 2009, SCIENCE, V326, P702, DOI 10.1126/science.1176105; Refaely-Abramson S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.226405; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Rohwer T, 2011, NATURE, V471, P490, DOI 10.1038/nature09829; Sekiba D, 2000, SURF SCI, V470, P43, DOI 10.1016/S0039-6028(00)00836-0; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; Trabattoni A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16270-0; Truhlar DG, 2019, ANGEW CHEM INT EDIT, V58, P12332, DOI 10.1002/anie.201904609; Tusche C, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4955015; Ueba H, 2000, APPL PHYS A-MATER, V71, P537, DOI 10.1007/s003390000711; Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; von Conta A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05292-4; Wallauer R, 2020, **DROPPED REF**, DOI [10.26165/JUELICH-DATA/9U1IPE, DOI 10.26165/JUELICH-DATA/9U1IPE]; Wang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8459; Weiss S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9287; Wiessner M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5156; WOODWARD RB, 1965, J AM CHEM SOC, V87, P395, DOI 10.1021/ja01080a054; WUTTIG M, 1989, SURF SCI, V213, P103, DOI 10.1016/0039-6028(89)90254-9; Yang XS, 2018, CHEM COMMUN, V54, P9039, DOI 10.1039/c8cc03334j; Zeng H.C., 1989, SURF SCI, V208, pL7, DOI [10.1016/0039-6028(89)90023-X, DOI 10.1016/0039-6028(89)90023-X]; Zhu XY, 2004, SURF SCI REP, V56, P1, DOI 10.1016/j.surfrep.2004.09.002; Ziroff J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233004	47	23	23	7	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					1056	+		10.1126/science.abf3286	http://dx.doi.org/10.1126/science.abf3286			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QS4MM	33602865	Green Submitted			2022-12-28	WOS:000625876100056
J	Zhang, MF; Wei, XH				Zhang, Mingfang; Wei, Xiaohua			Deforestation, forestation, and water supply A systematic approach helps to illuminate the complex forest-water nexus	SCIENCE			English	Editorial Material							RESOURCES		[Zhang, Mingfang] Univ Elect Sci & Technol China, Sch Resources & Environm, Chengdu 611731, Peoples R China; [Wei, Xiaohua] Univ British Columbia Okanagan, Dept Earth Environm & Geog Sci, Kelowna, BC V1V 1V7, Canada	University of Electronic Science & Technology of China; University of British Columbia; University of British Columbia Okanagan	Zhang, MF (corresponding author), Univ Elect Sci & Technol China, Sch Resources & Environm, Chengdu 611731, Peoples R China.	mingfangzhang@uestc.edu.cn			China National Science Foundation [31770759]	China National Science Foundation(National Natural Science Foundation of China (NSFC))	This paper was supported by China National Science Foundation (no.31770759).	[Anonymous], 2018, WORLED SERIES VOL, DOI DOI 10.5751/ES-08748-210341; Coble AA, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138926; Feng XM, 2016, NAT CLIM CHANGE, V6, P1019, DOI [10.1038/nclimate3092, 10.1038/NCLIMATE3092]; Filoso S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183210; Grant GE, 2017, WATER RESOUR RES, V53, P2605, DOI 10.1002/2017WR020835; Hallema DW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03735-6; Holl KD, 2020, SCIENCE, V368, P580, DOI 10.1126/science.aba8232; Keenan RJ, 2015, FOREST ECOL MANAG, V352, P9, DOI 10.1016/j.foreco.2015.06.014; Lawrence D, 2015, NAT CLIM CHANGE, V5, P27, DOI [10.1038/nclimate2430, 10.1038/NCLIMATE2430]; McDonnell JJ, 2018, NAT SUSTAIN, V1, P378, DOI 10.1038/s41893-018-0099-8; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Slinski KM, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074010; Wei XH, 2018, GLOBAL CHANGE BIOL, V24, P786, DOI 10.1111/gcb.13983; Zhang MF, 2017, J HYDROL, V546, P44, DOI 10.1016/j.jhydrol.2016.12.040; Zhou GY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6918	15	31	33	22	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2021	371	6533					990	991		10.1126/science.abe7821	http://dx.doi.org/10.1126/science.abe7821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QS4MM	33674479				2022-12-28	WOS:000625876100032
J	Murray, CJL; Piot, P				Murray, Christopher J. L.; Piot, Peter			The Potential Future of the COVID-19 Pandemic Will SARS-CoV-2 Become a Recurrent Seasonal Infection?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the prospect that COVID-19 could become a recurrent seasonal disease like influenza and proposes strategies to mitigate the consequences for communities and health systems, including changes in surveillance, medical and public health response, and socioeconomic programs.	[Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, 3980 15th Ave NE, Seattle, WA 98195 USA; [Piot, Peter] London Sch Hyg & Trop Med, London, England	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 3980 15th Ave NE, Seattle, WA 98195 USA.	cjlm@uw.edu						[Anonymous], 2021, JOHNSON JOHNSON ANNO; CMU Delphi Research Group, COVID SYMPT SURV; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; Saad-Roy CM, 2020, SCIENCE, V370, P811, DOI 10.1126/science.abd7343; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	6	73	74	3	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2021	325	13					1249	1250		10.1001/jama.2021.2828	http://dx.doi.org/10.1001/jama.2021.2828		MAR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RK4TM	33656519	Bronze			2022-12-28	WOS:000625441500002
J	[Anonymous]				[Anonymous]			Rules Finalized for New Tobacco Product Approvals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2021	325	9					816	816		10.1001/jama.2021.1478	http://dx.doi.org/10.1001/jama.2021.1478			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QS4AP	33651076				2022-12-28	WOS:000625843100023
J	Griffin, TP; Dinneen, SF				Griffin, Tomas P.; Dinneen, Sean F.			In T2DM, weekly insulin icodec did not differ from daily glargine for reducing HbA(1c) or significant/severe hypoglycemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Griffin, Tomas P.; Dinneen, Sean F.] Galway Univ Hosp, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Griffin, TP (corresponding author), Galway Univ Hosp, Galway, Ireland.							Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS66, DOI 10.2337/dc20-S006; Qiao Q, 2016, DIABET METAB SYND OB, V9, P201, DOI 10.2147/DMSO.S99732; Zinman B, 2012, DIABETES CARE, V35, P2464, DOI 10.2337/dc12-1205	3	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR	2021	174	3					JC34	JC34		10.7326/ACPJ202103160-034	http://dx.doi.org/10.7326/ACPJ202103160-034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD9VR	33646841				2022-12-28	WOS:000669667000009
J	Saadat, S; Tehrani, ZR; Logue, J; Newman, M; Frieman, MB; Harris, AD; Sajadi, MM				Saadat, Saman; Tehrani, Zahra Rikhtegaran; Logue, James; Newman, Michelle; Frieman, Matthew B.; Harris, Anthony D.; Sajadi, Mohammad M.			Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study compares titers of binding and neutralizing antibodies after a single mRNA coronavirus vaccine dose in health care workers previously infected with SARS-CoV-2.	[Saadat, Saman; Tehrani, Zahra Rikhtegaran; Sajadi, Mohammad M.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Logue, James; Frieman, Matthew B.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Newman, Michelle; Harris, Anthony D.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Sajadi, MM (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Global Virus Network Ctr Excellence, 725 W Lombard St,N548, Baltimore, MD 21201 USA.	msajadi@ihv.umaryland.edu	Logue, James/AAD-1040-2021	Logue, James/0000-0002-7410-9741; , Mohammad/0000-0001-7798-3605; Saadat, Saman/0000-0001-9851-7638				Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Haute Autorit? de Sant? (HAS), 2021, STRAT GIE VACCINATIO; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Tehrani ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237828; Ward M., 2021, CLIN BIOCHEM; Winter, 2021, SCIENTIST	6	217	219	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2021	325	14					1467	1469		10.1001/jama.2021.3341	http://dx.doi.org/10.1001/jama.2021.3341		MAR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN9GZ	33646292	Green Published			2022-12-28	WOS:000625438800001
J	Ackley, SF; Zimmerman, SC; Brenowitz, WD; Tchetgen, EJT; Gold, AL; Manly, JJ; Mayeda, ER; Filshtein, TJ; Power, MC; Elahi, FM; Brickman, AM; Glymour, MM				Ackley, Sarah F.; Zimmerman, Scott C.; Brenowitz, Willa D.; Tchetgen, Eric J. Tchetgen; Gold, Audra L.; Manly, Jennifer J.; Mayeda, Elizabeth Rose; Filshtein, Teresa J.; Power, Melinda C.; Elahi, Fanny M.; Brickman, Adam M.; Glymour, M. Maria			Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article								OBJECTIVE To evaluate trials of drugs that target amyloid to determine whether reductions in amyloid levels are likely to improve cognition. DESIGN Instrumental variable meta-analysis. SETTING 14 randomized controlled trials of drugs for the prevention or treatment of Alzheimer's disease that targeted an amyloid mechanism, identified from ClinicalTrials.gov. POPULATION Adults enrolled in randomized controlled trials of amyloid targeting drugs. Inclusion criteria for trials vary, but typically include adults aged 50 years or older with a diagnosis of mild cognitive impairment or Alzheimer's disease, and amyloid positivity at baseline. MAIN OUTCOME MEASURES Analyses included trials for which information could be obtained on both change in brain amyloid levels measured with amyloid positron emission tomography and change in at least one cognitive test score reported for each randomization arm. RESULTS Pooled results from the 14 randomized controlled trials were more precise than estimates from any single trial. The pooled estimate for the effect of reducing amyloid levels by 0.1 standardized uptake value ratio units was an improvement in the mini-mental state examination score of 0.03 (95% confidence interval -0.06 to 0.1) points. This study provides a web application that allows for the re-estimation of the results when new data become available and illustrates the magnitude of the new evidence that would be necessary to achieve a pooled estimate supporting the benefit of reducing amyloid levels. CONCLUSIONS Pooled evidence from available trials reporting both reduction in amyloid levels and change in cognition suggests that amyloid reduction strategies do not substantially improve cognition.	[Ackley, Sarah F.; Zimmerman, Scott C.; Brenowitz, Willa D.; Gold, Audra L.; Glymour, M. Maria] Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94143 USA; [Brenowitz, Willa D.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Tchetgen, Eric J. Tchetgen] Univ Penn, Dept Stat, Philadelphia, PA 19104 USA; [Manly, Jennifer J.; Brickman, Adam M.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, GH Sergievsky Ctr, Dept Neurol, New York, NY USA; [Mayeda, Elizabeth Rose] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA USA; [Filshtein, Teresa J.] 23&Me, Sunnyvale, CA USA; [Power, Melinda C.] George Washington Univ, Dept Epidemiol, Milken Inst Sch Publ Hlth, Washington, DC USA; [Elahi, Fanny M.] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; Columbia University; University of California System; University of California Los Angeles; George Washington University; University of California System; University of California San Francisco	Glymour, MM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 550 16th St, San Francisco, CA 94143 USA.	sarah.ackley@ucsf.edu; maria.glymour@ucsf.edu		Elahi, Fanny/0000-0003-4663-4992	National Institutes of Health (NIH) National Institute on Aging (NIA); NIH NIA [R01AG057869, R01AG065276, T32AG049663, K01AG062722, 5R00AG053410]	National Institutes of Health (NIH) National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) National Institute on Aging (NIA). SFA, SCZ, MCP, ERM, and MMG were supported by NIH NIA grant R01AG057869. EJTT was supported by NIH NIA grant R01AG065276. WDB was supported by NIH NIA grants T32AG049663 and K01AG062722. ERM was supported by NIH NIA grant 5R00AG053410. The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Abushouk AI, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0850-1; Baiocchi M, 2014, STAT MED, V33, P2297, DOI 10.1002/sim.6128; Balsis S, 2015, CLIN NEUROPSYCHOL, V29, P1002, DOI 10.1080/13854046.2015.1119312; Bourgeat P, 2018, NEUROIMAGE, V183, P387, DOI 10.1016/j.neuroimage.2018.08.044; Clarke JR, 2018, J ALZHEIMERS DIS, V64, pS405, DOI 10.3233/JAD-179911; Cummings J, 2018, J ALZHEIMERS DIS, V64, pS3, DOI 10.3233/JAD-179901; FDA, PER CENTR NERV SYST; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2006, J ALZHEIMERS DIS, V9, P151; Howard J, 2019, CNN CABLENEWS NETWOR; Imbimbo BP, 2012, EXPERT REV CLIN IMMU, V8, P135, DOI [10.1586/eci.11.93, 10.1586/ECI.11.93]; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Lannfelt L, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt246; Logovinsky V, 2016, ALZHEIMERS RES THER, V8, DOI [10.1016/j.trci.2016.01.001, 10.1186/s13195-016-0181-2]; Mullane K, 2013, BIOCHEM PHARMACOL, V85, P289, DOI 10.1016/j.bcp.2012.11.014; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2011, NAT MED, V17, P1060, DOI 10.1038/nm.2460; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323	24	60	60	3	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2021	372								n156	10.1136/bmj.n156	http://dx.doi.org/10.1136/bmj.n156			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1PF	33632704	hybrid, Green Published			2022-12-28	WOS:000624298000004
J	Dyer, C				Dyer, Clare			England's clinical negligence system needs urgent reform, say medical organisations	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V364, P10905, DOI DOI 10.1136/BMJ.L1362; HM Treasury, 2020, BAL SHEET REV REP IM	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2021	372								n551	10.1136/bmj.n551	http://dx.doi.org/10.1136/bmj.n551			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QO8RL	33627358				2022-12-28	WOS:000623404800005
J	Kelly, B; Carrizo, GE; Edwards-Hicks, J; Sanin, DE; Stanczak, MA; Priesnitz, C; Flachsmann, LJ; Curtis, JD; Mittler, G; Musa, Y; Becker, T; Buescher, JM; Pearce, EL				Kelly, Beth; Carrizo, Gustavo E.; Edwards-Hicks, Joy; Sanin, David E.; Stanczak, Michal A.; Priesnitz, Chantal; Flachsmann, Lea J.; Curtis, Jonathan D.; Mittler, Gerhard; Musa, Yaarub; Becker, Thomas; Buescher, Joerg M.; Pearce, Erika L.			Sulfur sequestration promotes multicellularity during nutrient limitation	NATURE			English	Article							DICTYOSTELIUM-DISCOIDEUM; AMINO-ACID; MITOCHONDRIAL; PROTEIN; REDOX; NFS1; DIFFERENTIATION; OSCILLATIONS; DEGRADATION; BIOGENESIS	The behaviour of Dictyostelium discoideum depends on nutrients(1). When sufficient food is present these amoebae exist in a unicellular state, but upon starvation they aggregate into a multicellular organism(2,3). This biology makes D. discoideum an ideal model for investigating how fundamental metabolism commands cell differentiation and function. Here we show that reactive oxygen species-generated as a consequence of nutrient limitation-lead to the sequestration of cysteine in the antioxidant glutathione. This sequestration limits the use of the sulfur atom of cysteine in processes that contribute to mitochondrial metabolism and cellular proliferation, such as protein translation and the activity of enzymes that contain an iron-sulfur cluster. The regulated sequestration of sulfur maintains D. discoideum in a nonproliferating state that paves the way for multicellular development. This mechanism of signalling through reactive oxygen species highlights oxygen and sulfur as simple signalling molecules that dictate cell fate in an early eukaryote, with implications for responses to nutrient fluctuations in multicellular eukaryotes.	[Kelly, Beth; Carrizo, Gustavo E.; Edwards-Hicks, Joy; Sanin, David E.; Stanczak, Michal A.; Flachsmann, Lea J.; Curtis, Jonathan D.; Mittler, Gerhard; Musa, Yaarub; Buescher, Joerg M.; Pearce, Erika L.] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany; [Priesnitz, Chantal] Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, ZMBZ, Freiburg, Germany; [Priesnitz, Chantal] Univ Freiburg, Fac Biol, Freiburg, Germany; [Becker, Thomas] Univ Bonn, Fac Med, Inst Biochem & Mol Biol, Bonn, Germany; [Pearce, Erika L.] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD 21218 USA	Max Planck Society; University of Freiburg; University of Freiburg; University of Bonn; Johns Hopkins University	Pearce, EL (corresponding author), Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.; Pearce, EL (corresponding author), Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD 21218 USA.	epearce6@jhmi.edu	Sanin, David E/CAA-0373-2022; Sanin, David E/CAA-0391-2022	Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267; Edwards-Hicks, Joy/0000-0002-9313-5718; Stanczak, Michal/0000-0003-2563-7254; Buescher, Joerg/0000-0002-6547-0076; Kelly, Beth/0000-0002-3195-6860; Carrizo, Gustavo/0000-0002-9263-2085	Max Planck Society; Deutsche Forschungsgemeinschaft, Research Training Group [BE4679/2-2, 278002225/RTG2202, SFB1218, 269925409]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft, Research Training Group(German Research Foundation (DFG))	We thank E. J. Pearce for critical input to this study. E.L.P. is funded by the Max Planck Society. T.B. is funded by grants of the Deutsche Forschungsgemeinschaft (BE4679/2-2), Research Training Group 278002225/RTG2202 and SFB1218 project identifier 269925409.	Alvarez SW, 2017, NATURE, V551, P639, DOI 10.1038/nature24637; Azzu V, 2010, J CELL SCI, V123, P578, DOI 10.1242/jcs.060004; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bloomfield G, 2003, J CELL SCI, V116, P3387, DOI 10.1242/jcs.00649; BONNER JT, 1947, J EXP ZOOL, V106, P1, DOI 10.1002/jez.1401060102; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Carretero J, 1999, CLIN EXP METASTAS, V17, P567, DOI 10.1023/A:1006725226078; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Combs JA, 2019, CANCERS, V11, DOI 10.3390/cancers11050678; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crooks DR, 2018, J BIOL CHEM, V293, P8297, DOI 10.1074/jbc.RA118.001885; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009; Gonzalez-Velasco O, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101187; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; Hamanaka RB, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003638; Huang XJ, 2014, ANAL CHEM, V86, P1632, DOI 10.1021/ac403384n; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; Iuso A, 2017, METHODS MOL BIOL, V1567, P217, DOI 10.1007/978-1-4939-6824-4_13; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Katoh M, 2007, EUKARYOT CELL, V6, P2038, DOI 10.1128/EC.00223-07; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Laxman S, 2013, CELL, V154, P416, DOI 10.1016/j.cell.2013.06.043; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Maeda Y, 2013, BIOMOLECULES, V3, P943, DOI 10.3390/biom3040943; MARIN FT, 1976, DEV BIOL, V48, P110, DOI 10.1016/0012-1606(76)90050-6; Mesquita A, 2017, AUTOPHAGY, V13, P24, DOI 10.1080/15548627.2016.1226737; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Musa YR, 2018, J PROTEOME RES, V17, P76, DOI 10.1021/acs.jproteome.7b00369; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Papagiannakis A, 2017, MOL CELL, V65, P285, DOI 10.1016/j.molcel.2016.11.018; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; POHLANDT F, 1974, ACTA PAEDIATR SCAND, V63, P801, DOI 10.1111/j.1651-2227.1974.tb04866.x; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Raper KB, 1935, J AGRIC RES, V50, P0135; Reid GK, 2017, PEDIATR RES, V82, P362, DOI 10.1038/pr.2017.49; Rosengarten RD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1491-7; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Stehling O, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011312; STIPANUK MH, 1986, ANNU REV NUTR, V6, P179, DOI 10.1146/annurev.nu.06.070186.001143; TORNHEIM K, 1991, J BIOL CHEM, V266, P15675; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Venkatachalam KV, 1998, J BIOL CHEM, V273, P19311, DOI 10.1074/jbc.273.30.19311; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wills J, 2017, ANAL CHEM, V89, P9616, DOI 10.1021/acs.analchem.7b02401; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhu JJ, 2019, CELL METAB, V30, P865, DOI 10.1016/j.cmet.2019.09.009	61	12	12	4	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					471	+		10.1038/s41586-021-03270-3	http://dx.doi.org/10.1038/s41586-021-03270-3		FEB 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33627869	Green Published, hybrid			2022-12-28	WOS:000621335600007
J	Tigano, M; Vargas, DC; Tremblay-Belzile, S; Fu, Y; Sfeir, A				Tigano, Marco; Vargas, Danielle C.; Tremblay-Belzile, Samuel; Fu, Yi; Sfeir, Agnel			Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance	NATURE			English	Article								Mitochondrial DNA double-strand breaks (mtDSBs) are toxic lesions that compromise the integrity of mitochondrial DNA (mtDNA) and alter mitochondrial function(1). Communication between mitochondria and the nucleus is essential to maintain cellular homeostasis; however, the nuclear response to mtDSBs remains unknown(2). Here, using mitochondrial-targeted transcription activator-like effector nucleases (TALENs)(1,3,4), we show that mtDSBs activate a type-I interferon response that involves the phosphorylation of STAT1 and activation of interferon-stimulated genes. After the formation of breaks in the mtDNA, herniation5 mediated by BAX and BAK releases mitochondrial RNA into the cytoplasm and triggers a RIG-I-MAVS-dependent immune response. We further investigated the effect of mtDSBs on interferon signalling after treatment with ionizing radiation and found a reduction in the activation of interferon-stimulated genes when cells that lack mtDNA are exposed to gamma irradiation. We also show that mtDNA breaks synergize with nuclear DNA damage to mount a robust cellular immune response. Taken together, we conclude that cytoplasmic accumulation of mitochondrial RNA is an intrinsic immune surveillance mechanism for cells to cope with mtDSBs, including breaks produced by genotoxic agents.	[Tigano, Marco; Vargas, Danielle C.; Tremblay-Belzile, Samuel; Fu, Yi; Sfeir, Agnel] NYU, Sch Med, Dept Cell Biol, Skirball Inst BiomoL Med, New York, NY 10016 USA; [Tigano, Marco; Tremblay-Belzile, Samuel; Fu, Yi; Sfeir, Agnel] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA	New York University; Memorial Sloan Kettering Cancer Center	Sfeir, A (corresponding author), NYU, Sch Med, Dept Cell Biol, Skirball Inst BiomoL Med, New York, NY 10016 USA.; Sfeir, A (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA.	SfeirA@mskcc.org		Tigano, Marco/0000-0002-4353-9220	David and Lucile Packard Foundation; Mallinckrodt Scholars Program; Pew-Innovator fund; Pershing Square award	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Mallinckrodt Scholars Program; Pew-Innovator fund; Pershing Square award(Pershing Square Foundation)	We thank R. Greenberg, E. Brunet and D. E. Levy for providing reagents; S. Zaganelli, J.-C. Martinou (Universite de Geneve) and D. Moreau (ACCESS Geneva) for help with assessing the effect of irradiation on mtRNA granules; the Genome Technology Center (GTC) and the Microscopy Laboratory at NYU School of Medicine; and E. Lazzerini-Denchi, L. Walton Masters, A. Barrientos, F. Fontanesi and members of the Sfeir laboratory for reading the manuscript. This work was supported by the David and Lucile Packard Foundation (A.S.), Mallinckrodt Scholars Program (A.S.), Pew-Innovator fund (A.S.) and Pershing Square award (A.S.).	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Bernardini JP, 2019, EMBO J, V38, DOI 10.15252/embj.201899916; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Faccenda D, 2013, CELL DEATH DIFFER, V20, P686, DOI 10.1038/cdd.2012.163; Fazal FM, 2019, CELL, V178, P473, DOI 10.1016/j.cell.2019.05.027; Fu Y, 2020, NAT STRUCT MOL BIOL, V27, P687, DOI 10.1038/s41594-020-0474-9; Guo XY, 2020, NATURE, V579, P427, DOI 10.1038/s41586-020-2078-2; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Jourdain AA, 2016, J CELL BIOL, V212, P611, DOI 10.1083/jcb.201507125; Jourdain AA, 2015, CELL REP, V10, P1110, DOI 10.1016/j.celrep.2015.01.063; Kim E, 2012, GENOME RES, V22, P1327, DOI 10.1101/gr.138792.112; Kitay BM, 2013, HUM MOL GENET, V22, P1601, DOI 10.1093/hmg/ddt009; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Liu GQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05745-w; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; McArthur K, 2018, SCIENCE, V359, P883, DOI 10.1126/science.aao6047; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Moretton A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176795; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nelson I, 1997, SOMAT CELL MOLEC GEN, V23, P287, DOI 10.1007/BF02674419; Nissanka N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04895-1; Niu X, 2017, CELL CHEM BIOL, V24, P493, DOI 10.1016/j.chembiol.2017.03.011; Peeva V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04131-w; Phillips AF, 2017, MOL CELL, V65, P527, DOI 10.1016/j.molcel.2016.12.014; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Renaud JB, 2016, CELL REP, V14, P2263, DOI 10.1016/j.celrep.2016.02.018; Reynders K, 2015, CANCER TREAT REV, V41, P503, DOI 10.1016/j.ctrv.2015.03.011; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; Schuster S, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00333-17; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shokolenko IN, 2013, DNA REPAIR, V12, P488, DOI 10.1016/j.dnarep.2013.04.023; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; WAUGH DS, 1993, P NATL ACAD SCI USA, V90, P9596, DOI 10.1073/pnas.90.20.9596; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156	43	79	80	21	94	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 18	2021	591	7850					477	+		10.1038/s41586-021-03269-w	http://dx.doi.org/10.1038/s41586-021-03269-w		FEB 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QY6JL	33627873	Green Submitted			2022-12-28	WOS:000621335600002
J	Slomski, A				Slomski, Anita			Physician Videos Improve COVID-19 Knowledge Among Minorities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					713	713		10.1001/jama.2021.1261	http://dx.doi.org/10.1001/jama.2021.1261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620404	Bronze			2022-12-28	WOS:000621957400010
J	Dagan, N; Barda, N; Kepten, E; Miron, O; Perchik, S; Katz, MA; Hernan, MA; Lipsitch, M; Reis, B; Balicer, RD				Dagan, Noa; Barda, Noam; Kepten, Eldad; Miron, Oren; Perchik, Shay; Katz, Mark A.; Hernan, Miguel A.; Lipsitch, Marc; Reis, Ben; Balicer, Ran D.			BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19) commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes across diverse populations in a noncontrolled setting. In this study, data from Israel's largest health care organization were used to evaluate the effectiveness of the BNT162b2 mRNA vaccine. Methods All persons who were newly vaccinated during the period from December 20, 2020, to February 1, 2021, were matched to unvaccinated controls in a 1:1 ratio according to demographic and clinical characteristics. Study outcomes included documented infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), symptomatic Covid-19, Covid-19-related hospitalization, severe illness, and death. We estimated vaccine effectiveness for each outcome as one minus the risk ratio, using the Kaplan-Meier estimator. Results Each study group included 596,618 persons. Estimated vaccine effectiveness for the study outcomes at days 14 through 20 after the first dose and at 7 or more days after the second dose was as follows: for documented infection, 46% (95% confidence interval [CI], 40 to 51) and 92% (95% CI, 88 to 95); for symptomatic Covid-19, 57% (95% CI, 50 to 63) and 94% (95% CI, 87 to 98); for hospitalization, 74% (95% CI, 56 to 86) and 87% (95% CI, 55 to 100); and for severe disease, 62% (95% CI, 39 to 80) and 92% (95% CI, 75 to 100), respectively. Estimated effectiveness in preventing death from Covid-19 was 72% (95% CI, 19 to 100) for days 14 through 20 after the first dose. Estimated effectiveness in specific subpopulations assessed for documented infection and symptomatic Covid-19 was consistent across age groups, with potentially slightly lower effectiveness in persons with multiple coexisting conditions. Conclusions This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial. Effectiveness of the BNT162b2 mRNA Vaccine in Israel Nearly 600,000 people in a large health care organization were followed after vaccination for infection, hospitalization, and severe Covid-19. Estimated vaccine effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and for the period 7 or more days after the second dose, hospitalization was reduced by 87%. These results were similar to those reported in a randomized trial.	[Dagan, Noa; Barda, Noam; Kepten, Eldad; Miron, Oren; Perchik, Shay; Katz, Mark A.; Balicer, Ran D.] Clalit Hlth Serv, Clalit Res Inst, Innovat Div, Tel Aviv, Israel; [Miron, Oren; Katz, Mark A.; Balicer, Ran D.] Ben Gurion Univ Negev, Sch Publ Hlth, Beer Sheva, Israel; [Katz, Mark A.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Dagan, Noa; Barda, Noam] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hernan, Miguel A.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA USA; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Immunol & Infect Dis, Boston, MA USA; [Hernan, Miguel A.] Harvard MIT Div Hlth Sci & Technol, Boston, MA USA; [Reis, Ben] Boston Childrens Hosp, Predict Med Grp, Computat Hlth Informat Program, Boston, MA USA	Clalit Health Services; Ben Gurion University; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Boston Children's Hospital	Balicer, RD (corresponding author), Clalit Hlth Serv, Clalit Res Inst, Innovat Div, Tel Aviv, Israel.	Rbalicer@clalit.org.il	Dagan, Noa/ABC-3018-2021; Barda, Noam/AAC-9434-2020	Dagan, Noa/0000-0001-8811-7825; Barda, Noam/0000-0002-3400-235X; Lipsitch, Marc/0000-0003-1504-9213; Hernan, Miguel/0000-0003-1619-8456	Morris-Singer Fund	Morris-Singer Fund	Dr. Lipsitch receives support from the Morris-Singer Fund.	[Anonymous], 2021, JOHNSON JOHNSON ANNO; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Centers for Disease Control and Prevention, 2021, PEOPLE CERTAIN MEDIC; Centers for Disease Control and Prevention , 2020, OLDER ADULTS GREATER; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chodick G., 2021, EFFECTIVENESS 1 DOSE, DOI [10.1101/2021.01.27.21250612, DOI 10.1101/2021.01.27.21250612, 10.1101/2021.01.27.21250612v1]; Efrati I., 2021, HAARETZ; Gallagher T, 2019, EPIDEMIOL REV, V41, P13, DOI 10.1093/epirev/mxz014; Graham B.S., 2021, NATURE, DOI [10.1101/2021.01.25.428137, DOI 10.1038/S41586-021-03398-2]; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Hernan MA, 2016, AM J EPIDEMIOL, V183, P758, DOI 10.1093/aje/kwv254; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Hoffman M., 2021, JERUSALEM POST 0202; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaslow DC., 2021, FORCE INFECT DETERMI, DOI [10.1101/2021.01.21.21250235v1.full, DOI 10.1101/2021.01.21.21250235V1.FULL]; Lipsitch M, 2019, Epidemiol Infect, V147, pe306, DOI 10.1017/S0950268819001961; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n296; National Institutes of Health, 2021, CORONAVIRUS DIS 2019; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sanger B., 2021, SCIENCE; Xie X., 2021, 33442691 BIORXIV	23	1248	1263	14	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 15	2021	384	15					1412	1423		10.1056/NEJMoa2101765	http://dx.doi.org/10.1056/NEJMoa2101765			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN7TA	33626250	Bronze, Green Published			2022-12-28	WOS:000640554500008
J	Challen, R; Brooks-Pollock, E; Read, JM; Dyson, L; Tsaneva-Atanasova, K; Danon, L				Challen, Robert; Brooks-Pollock, Ellen; Read, Jonathan M.; Dyson, Louise; Tsaneva-Atanasova, Krasimira; Danon, Leon			Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COVID-19	OBJECTIVE To establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2, designated a variant of concern (VOC-202012/1) in December 2020, compared with circulating SARS-CoV-2 variants. DESIGN Matched cohort study. SETTING Community based (pillar 2) covid-19 testing centres in the UK using the TaqPath assay (a proxy measure of VOC-202012/1 infection). PARTICIPANTS 54 906 matched pairs of participants who tested positive for SARS-CoV-2 in pillar 2 between 1 October 2020 and 29 January 2021, followed-up until 12 February 2021. Participants were matched on age, sex, ethnicity, index of multiple deprivation, lower tier local authority region, and sample date of positive specimens, and differed only by detectability of the spike protein gene using the TaqPath assay. MAIN OUTCOME MEASURE Death within 28 days of the first positive SARS-CoV-2 test result. RESULTS The mortality hazard ratio associated with infection with VOC-202012/1 compared with infection with previously circulating variants was 1.64 (95% confidence interval 1.32 to 2.04) in patients who tested positive for covid-19 in the community. In this comparatively low risk group, this represents an increase in deaths from 2.5 to 4.1 per 1000 detected cases. CONCLUSIONS The probability that the risk of mortality is increased by infection with VOC-202012/01 is high. If this finding is generalisable to other populations, infection with VOC-202012/1 has the potential to cause substantial additional mortality compared with previously circulating variants. Healthcare capacity planning and national and international control policies are all impacted by this finding, with increased mortality lending weight to the argument that further coordinated and stringent measures are justified to reduce deaths from SARS-CoV-2.	[Challen, Robert; Tsaneva-Atanasova, Krasimira] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Challen, Robert] Somerset NHS Fdn Trust, Taunton, Somerset, England; [Challen, Robert; Brooks-Pollock, Ellen; Read, Jonathan M.; Dyson, Louise; Danon, Leon] Joint Univ Pandem & Epidemiol Res JUNIPER Consort, Taunton, Somerset, England; [Brooks-Pollock, Ellen] Univ Bristol, Bristol Vet Sch, Bristol, Avon, England; [Brooks-Pollock, Ellen; Danon, Leon] Univ Bristol, Populat Hlth Sci, Bristol Med Sch, Bristol, Avon, England; [Read, Jonathan M.] Univ Lancaster, Lancaster Med Sch, Lancaster, England; [Tsaneva-Atanasova, Krasimira] Univ Warwick, Sch Life Sci, Zeeman Inst Syst Biol & Infect Dis Epidemiol Res, Coventry, W Midlands, England; [Tsaneva-Atanasova, Krasimira] Univ Warwick, Math Inst, Coventry, W Midlands, England; [Danon, Leon] British Lib, Alan Turing Inst, London, England; [Danon, Leon] Univ Bristol, Dept Engn Math, Bristol, Avon, England	University of Exeter; University of Bristol; University of Bristol; Lancaster University; University of Warwick; University of Warwick; University of Bristol	Challen, R (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England.; Challen, R (corresponding author), Somerset NHS Fdn Trust, Taunton, Somerset, England.; Challen, R (corresponding author), Joint Univ Pandem & Epidemiol Res JUNIPER Consort, Taunton, Somerset, England.	rc538@exeter.ac.uk	Danon, Leon/AFV-8758-2022	Danon, Leon/0000-0002-7076-1871; Tsaneva-Atanasova, Krasimira/0000-0002-6294-7051; Read, Jonathan/0000-0002-9697-0962; Brooks-Pollock, Ellen/0000-0002-5984-4932; Challen, Robert/0000-0002-5504-7768; Dyson, Louise/0000-0001-9788-4858	Engineering and Physical Sciences Research Council (EPSRC) [EP/N014391/1, EP/T017856/1]; NHS England, Global Digital Exemplar programme; Alan Turing Institute (EPSRC) [EP/N510129/1]; Medical Research Council (MRC) [MC/PC/19067]; EPSRC [EP/V051555/1, EP/N014499/1]; MRC [MR/S004793/1, MR/V028456/1, MR/V038613/1, MR/V009761/1]; National Institute for Health Research Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol; Public Health England; MRC [MC_PC_19067] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NHS England, Global Digital Exemplar programme; Alan Turing Institute (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol; Public Health England; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	RC and KTA were supported by the Engineering and Physical Sciences Research Council (EPSRC; grants EP/N014391/1, EP/T017856/1) and NHS England, Global Digital Exemplar programme. LDanon and KTA were supported by The Alan Turing Institute (EPSRC grant EP/N510129/1). LDanon, RC, and EBP are supported by the Medical Research Council (MRC; MC/PC/19067). JMR is supported by EPSRC (EP/N014499/1) and MRC (MR/S004793/1, MR/V028456/1). EBP was partly supported by the National Institute for Health Research Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, in partnership with Public Health England. LDanon, EBP, JMR, and LDyson are further supported by MRC (MR/V038613/1), and LDanon by EPSRC EP/V051555/1. LDyson also received support through the MRC through the covid-19 rapid response rolling call (grant No MR/V009761/1).	[Anonymous], HELIX COVID 19 SURVE; Brazauskas R, 2016, BIOL BLOOD MARROW TR, V22, P557, DOI 10.1016/j.bbmt.2015.12.005; CDC, 2020, US COVID 19 CAS CAUS; Cox D. R., 1984, ANAL SURVIVAL DATA; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Davies B, 2021, CORONAVIRUS COVID 19; Davies Nicholas G, 2021, Science, V372, DOI 10.1126/science.abg3055; du Plessis L, 2021, SCIENCE, V371, P708, DOI 10.1126/science.abf2946; ECDC, 2021, RISK REL SPREAD NEW; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n230; Lacasa L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241027; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n158; NERVTAG, 2021, UPD NOT B 1 1 7 SEV; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A., 2020, COVID 19 GENOMICS CO; Seaman S, 2020, NOWCASTING COVID 19, DOI [10.1101/2020.09.15.20194209, DOI 10.1101/2020.09.15.20194209V1]; Semple C., NERVTAG NOTE B 1 1 7; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Therneau TM, 2020, **DATA OBJECT**; Therneau TM, 2000, MODELING SURVIVAL DA; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wilde H, 2021, MEDRXIV, DOI [10.1101/2021.01.11.21249461, DOI 10.1101/2021.01.11.21249461]; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Winfield M, DETECTING SARS COV 2, DOI [10.1101/2020.11.18.388140, DOI 10.1101/2020.11.18.388140]; Wise J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4857	25	398	404	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2021	372								n579	10.1136/bmj.n579	http://dx.doi.org/10.1136/bmj.n579			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6SN	33687922	Green Published, hybrid			2022-12-28	WOS:000632928500001
J	Bourgeois, G; Richard, M; Danset, M; Perard, L; Breton, AL; Berthoux, E				Bourgeois, Gaelle; Richard, Mael; Danset, Marie; Perard, Laurent; Breton, Anne-Laure; Berthoux, Emilie			Deficiency of adenosine deaminase 2 diagnosed at 65 years of age	LANCET			English	Editorial Material									[Bourgeois, Gaelle; Richard, Mael; Danset, Marie; Perard, Laurent; Breton, Anne-Laure; Berthoux, Emilie] Ctr Hosp St Joseph St Luc, Serv Med Interne, Dermatol, Malad Infect, F-69365 Lyon, France		Bourgeois, G (corresponding author), Ctr Hosp St Joseph St Luc, Serv Med Interne, Dermatol, Malad Infect, F-69365 Lyon, France.	gaelle.bourgeois@live.fr		Richard, Mael/0000-0001-6474-5181					0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 6	2021	397	10277					913	913						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QT5BR	33676630				2022-12-28	WOS:000626603400029
J	Matthews, D				Matthews, David			HOW TO GET STARTED IN QUANTUM COMPUTING	NATURE			English	Editorial Material								Tempted to try your hand at a new technique? These tools will help you on your way.											0	6	6	1	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 4	2021	591	7848					166	167		10.1038/d41586-021-00533-x	http://dx.doi.org/10.1038/d41586-021-00533-x			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QP8JF	33649510				2022-12-28	WOS:000624076300003
J	Villa, M; Stanczak, MA; Pearce, EL				Villa, Matteo; Stanczak, Michal A.; Pearce, Erika L.			How to make a better T cell: in vivo CRISPR screens have some answers	CELL			English	Editorial Material								Understanding what regulates CD8(+) T cell responses is key to effectively harnessing these cells in human disease. In this issue of Cell, Huang et al. and Chen et al. use in vivo CRISPR screens to discover novel regulators of CD8(+) T cell immunity to engineer a more efficacious response against cancer and infections.	[Villa, Matteo; Stanczak, Michal A.; Pearce, Erika L.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany; [Pearce, Erika L.] Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD 21287 USA	Max Planck Society	Pearce, EL (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany.; Pearce, EL (corresponding author), Bloomberg Kimmel Inst Canc Immunotherapy Johns Ho, Baltimore, MD 21287 USA.	epearce6@jhmi.edu		Villa, Matteo/0000-0003-2684-0596				Alatrash G, 2019, CLIN CANCER RES, V25, P2610, DOI 10.1158/1078-0432.CCR-18-1527; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Chen ZY, 2021, CELL, V184, P1262, DOI 10.1016/j.cell.2021.02.019; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Huang HL, 2021, CELL, V184, P1245, DOI 10.1016/j.cell.2021.02.021; Liang W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00078; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Okada M, 2017, CELL REP, V20, P1017, DOI 10.1016/j.celrep.2017.07.027; Schneider M, 2018, NAT CHEM BIOL, V14, P65, DOI [10.1038/NCHEMBIO.2520, 10.1038/nchembio.2520]; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074	12	0	0	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 4	2021	184	5					1135	1136		10.1016/j.cell.2021.02.003	http://dx.doi.org/10.1016/j.cell.2021.02.003		MAR 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AZ	33667366	Green Published, Bronze			2022-12-28	WOS:000629635700004
J	Mahase, E				Mahase, Elisabeth			Fabricated illness: guidance is updated as survey shows nearly all paediatricians see potential cases	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n610	10.1136/bmj.n610	http://dx.doi.org/10.1136/bmj.n610			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653699				2022-12-28	WOS:000625340300009
J	Haines, A; Clark, H; Phumaphi, J; Whitmee, S; Green, R				Haines, Andy; Clark, Helen; Phumaphi, Joy; Whitmee, Sarah; Green, Rosemary			The Lancet Pathfinder Commission: pathways to a healthy, zero-carbon future-a call for evidence	LANCET			English	Editorial Material									[Haines, Andy; Whitmee, Sarah; Green, Rosemary] London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London WC1H 9SH, England; [Clark, Helen] Helen Clark Fdn, Auckland, New Zealand; [Phumaphi, Joy] African Leaders Malaria Alliance, Dar Es Salaam, Tanzania	University of London; London School of Hygiene & Tropical Medicine	Whitmee, S (corresponding author), London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London WC1H 9SH, England.	sarah.whitmee@lshtm.ac.uk		Haines, Andy/0000-0002-8053-4605; Whitmee, Sarah/0000-0001-9161-868X	Wellcome [221284/Z/20/Z]; Oak Foundation [OFIL-20-093]	Wellcome; Oak Foundation	We declare no competing interests. The Pathfinder Initiative is funded by Wellcome (grant number 221284/Z/20/Z) with support from the Oak Foundation (grant number OFIL-20-093). The Lancet Pathfinder Commission is co-chaired by Helen Clark, Joy Phumaphi, and Andy Haines.	Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Seddon N, 2019, NAT CLIM CHANGE, V9, P84, DOI 10.1038/s41558-019-0405-0; Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709; Whitmee S, 2015, LANCET, V386, P1973, DOI 10.1016/S0140-6736(15)60901-1	4	4	4	2	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					779	779						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QP6DN	33640048	Green Submitted			2022-12-28	WOS:000623925500009
J	Munshi, NC; Anderson, LD; Shah, N; Madduri, D; Berdeja, J; Lonial, S; Raje, N; Lin, Y; Siegel, D; Oriol, A; Moreau, P; Yakoub-Agha, I; Delforge, M; Cavo, M; Einsele, H; Goldschmidt, H; Weisel, K; Rambaldi, A; Reece, D; Petrocca, F; Massaro, M; Connarn, JN; Kaiser, S; Patel, P; Huang, LP; Campbell, TB; Hege, K; San-Miguel, J				Munshi, Nikhil C.; Anderson, Larry D., Jr.; Shah, Nina; Madduri, Deepu; Berdeja, Jesus; Lonial, Sagar; Raje, Noopur; Lin, Yi; Siegel, David; Oriol, Albert; Moreau, Philippe; Yakoub-Agha, Ibrahim; Delforge, Michel; Cavo, Michele; Einsele, Hermann; Goldschmidt, Hartmut; Weisel, Katja; Rambaldi, Alessandro; Reece, Donna; Petrocca, Fabio; Massaro, Monica; Connarn, Jamie N.; Kaiser, Shari; Patel, Payal; Huang, Liping; Campbell, Timothy B.; Hege, Kristen; San-Miguel, Jesus			Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND Idecabtagene vicleucel (ide-cel, also called bb2121), a B-cell maturation antigendirected chimeric antigen receptor (CAR) T-cell therapy, has shown clinical activity with expected CAR T-cell toxic effects in patients with relapsed and refractory multiple myeloma. METHODS In this phase 2 study, we sought to confirm the efficacy and safety of ide-cel in patients with relapsed and refractory myeloma. Patients with disease after at least three previous regimens including a proteasome inhibitor, an immunomodulating agent, and an anti-CD38 antibody were enrolled. Patients received ide-cel target doses of 150 x 10(6) to 450 x 10(6) CAR-positive (CAR+) T cells. The primary end point was an overall response (partial response or better); a key secondary end point was a complete response or better (comprising complete and stringent complete responses). RESULTS Of 140 patients enrolled, 128 received ide-cel. At a median follow-up of 13.3 months, 94 of 128 patients (73%) had a response, and 42 of 128 (33%) had a complete response or better. Minimal residual disease (MRD)-negative status (<10(-5) nucleated cells) was confirmed in 33 patients, representing 26% of all 128 patients who were treated and 79% of the 42 patients who had a complete response or better. The median progression-free survival was 8.8 months (95% confidence interval, 5.6 to 11.6). Common toxic effects among the 128 treated patients included neutropenia in 117 patients (91%), anemia in 89 (70%), and thrombocytopenia in 81 (63%). Cytokine release syndrome was reported in 107 patients (84%), including 7 (5%) who had events of grade 3 or higher. Neurotoxic effects developed in 23 patients (18%) and were of grade 3 in 4 patients (3%); no neurotoxic effects higher than grade 3 occurred. Cellular kinetic analysis confirmed CAR+ T cells in 29 of 49 patients (59%) at 6 months and 4 of 11 patients (36%) at 12 months after infusion. CONCLUSIONS Ide-cel induced responses in a majority of heavily pretreated patients with refractory and relapsed myeloma; MRD-negative status was achieved in 26% of treated patients. Almost all patients had grade 3 or 4 toxic effects, most commonly hematologic toxic effects and cytokine release syndrome.	[Munshi, Nikhil C.] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA; [Munshi, Nikhil C.] Harvard Med Sch, Vet Affairs Boston Healthcare Syst, Boston, MA 02215 USA; [Raje, Noopur] Massachusetts Gen Hosp, Boston, MA USA; [Petrocca, Fabio; Massaro, Monica] Bluebird Bio, Cambridge, MA USA; [Anderson, Larry D., Jr.] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Shah, Nina] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Madduri, Deepu] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Berdeja, Jesus] Sarah Cannon Res Inst, Nashville, TN USA; [Berdeja, Jesus] Tennessee Oncol, Nashville, TN USA; [Lonial, Sagar] Emory Sch Med, Atlanta, GA USA; [Lin, Yi] Mayo Clin, Rochester, MN USA; [Siegel, David] Hackensack Univ, Med Ctr, Hackensack, NJ USA; [Connarn, Jamie N.; Kaiser, Shari; Patel, Payal; Huang, Liping; Campbell, Timothy B.; Hege, Kristen] Bristol Myers Squibb, Princeton, NJ USA; [Oriol, Albert] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Badalona, Spain; [Oriol, Albert] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain; [San-Miguel, Jesus] Ctr Invest Biomed Red Canc, Inst Invest Sanitaria Navarra, Ctr Invest Med Aplicada, Clin Univ Navarra, Pamplona, Spain; [Moreau, Philippe] Ctr Hosp Univ CHU Nantes, Nantes, France; [Yakoub-Agha, Ibrahim] Univ Lille, Inst Translat Res Inflammat, INSERM Unite 1286, CHU Lille, Lille, France; [Delforge, Michel] Univ Hosp Leuven, Leuven, Belgium; [Cavo, Michele] Bologna Univ, Seragnoli Inst Hematol, Sch Med, Bologna, Italy; [Rambaldi, Alessandro] Univ Milan, Dept Oncol & Hematol, Milan, Italy; [Rambaldi, Alessandro] Azienda Socio Sanitaria Terr Papa Giovanni XXIII, Bergamo, Italy; [Einsele, Hermann] Univ Hosp Wurzburg, Wurzburg, Germany; [Goldschmidt, Hartmut] Univ Hosp Heidelberg, Heidelberg, Germany; [Goldschmidt, Hartmut] Natl Ctr Tumor Dis, Heidelberg, Germany; [Weisel, Katja] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Weisel, Katja] Univ Klinikum Tubingen, Tubingen, Germany; [Reece, Donna] Princess Margaret Canc Ctr, Toronto, ON, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Sarah Cannon Research Institute; Tennessee Oncology; Emory University; Mayo Clinic; Hackensack University Medical Center; Bristol-Myers Squibb; Hospital Germans Trias i Pujol; Institut de Recerca Contra la Leucemia Josep Carreras (IJC); Catalan Institute of Oncology; Hospital Germans Trias i Pujol; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Navarra; Nantes Universite; CHU de Nantes; Universite de Lille - ISITE; CHU Lille; Universite de Lille; KU Leuven; University Hospital Leuven; University of Bologna; University of Milan; ASST Papa Giovanni XXIII; University of Wurzburg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Munshi, NC (corresponding author), Harvard Med Sch, Myeloma Ctr, Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.	nikhil_munshi@dfci.harvard.edu	Goldschmidt, Hartmut/AAL-8069-2021; Anderson, Jr, Larry D./H-8363-2019; Munshi, Nikhil/ABE-2338-2021; San-Miguel, Jesús F./V-8977-2018	Anderson, Jr, Larry D./0000-0002-6531-9595; San-Miguel, Jesús F./0000-0002-9183-4857; moreau, philippe/0000-0003-1780-8746; Patel, Payal/0000-0003-2918-8724; CAVO, MICHELE/0000-0003-4514-3227; Siegel, David/0000-0002-3604-2574; Lin, Yi/0000-0002-1556-6416	bluebird bio; Celgene, a Bristol-Myers Squibb company	bluebird bio; Celgene, a Bristol-Myers Squibb company	Supported by bluebird bio and Celgene, a Bristol-Myers Squibb company.; We thank all the study participants and their families. Medical writing assistance was provided by Johna Van Stelten, Ph.D., of Bio Connections and was funded by Celgene, a Bristol-Myers Squibb company.	Badar T, 2020, CURR TREAT OPTION ON, V21, DOI 10.1007/s11864-020-0706-6; Braggio Esteban, 2015, Cancer Cell, V28, P678, DOI 10.1016/j.ccell.2015.10.014; Chari A, 2019, NEW ENGL J MED, V381, P727, DOI 10.1056/NEJMoa1903455; Cheng JL, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01237; DaVia M, 2020, 25 EUR HEM ASS EHA C; Friedman KM, 2018, HUM GENE THER, V29, P585, DOI 10.1089/hum.2018.001; Fulciniti M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/832049; Gandhi UH, 2019, LEUKEMIA, V33, P2266, DOI 10.1038/s41375-019-0435-7; Holstein SA, 2020, CLIN PHARMACOL THER, V107, P112, DOI 10.1002/cpt.1674; Kumar S, 2016, LANCET ONCOL, V17, pE328, DOI 10.1016/S1470-2045(16)30206-6; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Lonial S, 2020, LANCET ONCOL, V21, P207, DOI 10.1016/S1470-2045(19)30788-0; Mikhael J, 2020, CL LYMPH MYELOM LEUK, V20, P1, DOI 10.1016/j.clml.2019.09.621; Nijhof IS, 2018, DRUGS, V78, P19, DOI 10.1007/s40265-017-0841-y; Raje N, 2019, NEW ENGL J MED, V380, P1726, DOI 10.1056/NEJMoa1817226; Rasche L, 2017, CANCER TREAT REV, V55, P190, DOI 10.1016/j.ctrv.2017.03.010; Sidana S, 2019, BLOOD ADV, V3, P3473, DOI 10.1182/bloodadvances.2019000370; Sonneveld P, 2016, HAEMATOLOGICA, V101, P396, DOI 10.3324/haematol.2015.129189; US Food and Drug Administration (FDA), 2007, GUID IND CLIN TRIAL	19	446	456	19	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2021	384	8					705	716		10.1056/NEJMoa2024850	http://dx.doi.org/10.1056/NEJMoa2024850			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP4LK	33626253	Bronze			2022-12-28	WOS:000623807600010
J	Slomski, A				Slomski, Anita			Common Weight Loss Surgeries' Benefits Sustained at Year 7	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2021	325	8					713	713		10.1001/jama.2021.1257	http://dx.doi.org/10.1001/jama.2021.1257			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QM7LT	33620402				2022-12-28	WOS:000621957400008
J	Cunningham, AL; McIntyre, P; Subbarao, K; Booy, R; Levin, MJ				Cunningham, Anthony L.; McIntyre, Peter; Subbarao, Kanta; Booy, Robert; Levin, Myron J.			Vaccines for older adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PNEUMOCOCCAL CONJUGATE VACCINE; VARICELLA-ZOSTER-VIRUS; DOSE INFLUENZA VACCINATION; SUBUNIT CANDIDATE VACCINE; HERPES-ZOSTER; POLYSACCHARIDE VACCINE; SEASONAL INFLUENZA; IMMUNE-RESPONSES; COST-EFFECTIVENESS; ADVISORY-COMMITTEE	The proportion of the global population aged 65 and older is rapidly increasing. Infections in this age group, most recently with SARS-CoV-2, cause substantial morbidity and mortality. Major improvements have been made in vaccines for older people, either through the addition of novel adjuvants-as in the new recombinant zoster vaccine and an adjuvanted influenza vaccine-or by increasing antigen concentration, as in influenza vaccines. In this article we review improvements in immunization for the three most important vaccine preventable diseases of aging. The recombinant zoster vaccine has an efficacy of 90% that is minimally affected by the age of the person being vaccinated and persists for more than four years. Increasing antigen dose or inclusion of adjuvant has improved the immunogenicity of influenza vaccines in older adults, although the relative effectiveness of the enhanced influenza vaccines and the durability of the immune response are the focus of ongoing clinical trials. Conjugate and polysaccharide pneumococcal vaccines have similar efficacy against invasive pneumococcal disease and pneumococcal pneumonia caused by vaccine serotypes in older adults. Their relative value varies by setting, depending on the prevalence of vaccine serotypes, largely related to conjugate vaccine coverage in children. Improved efficacy will increase public confidence and uptake of these vaccines. Co-administration of these vaccines is feasible and important for maximal uptake in older people. Development of new vaccine platforms has accelerated following the arrival of SARS-CoV-2, and will likely result in new vaccines against other pathogens in the future.	[Cunningham, Anthony L.] Univ Sydney, Westmead Inst Med Res, Fac Med & Hlth, Ctr Virus Res, Sydney, NSW, Australia; [McIntyre, Peter] Univ Otago, Dunedin Sch Med, Womens & Childrens Hlth, Dunedin, New Zealand; [Subbarao, Kanta] Univ Melbourne, Peter Doherty Inst Infect & Immun, WHO Collaborating Ctr Reference & Res Influenz, Melbourne, Vic, Australia; [Subbarao, Kanta] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Booy, Robert] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia; [Booy, Robert] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sch Biol Sci, Sydney, NSW, Australia; [Booy, Robert] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Levin, Myron J.] Univ Colorado, Dept Pediat & Med, Sch Med, Anschutz Med Campus, Aurora, CO USA	University of Sydney; Westmead Institute for Medical Research; University of Otago; University of Melbourne; University of Melbourne; University of Sydney; University of Sydney; University of Sydney; University of Colorado System; University of Colorado Anschutz Medical Campus	Cunningham, AL (corresponding author), Univ Sydney, Westmead Inst Med Res, Fac Med & Hlth, Ctr Virus Res, Sydney, NSW, Australia.	tony.cunningham@sydney.edu.au	McIntyre, Peter/GNM-5277-2022	McIntyre, Peter/0000-0001-5808-7450; Cunningham, Anthony/0000-0002-6744-5667				Ahmed SS, 2020, CLIN INFECT DIS, V70, P2484, DOI 10.1093/cid/ciz739; Alexander KE, 2018, VACCINE, V36, P3890, DOI 10.1016/j.vaccine.2018.05.078; Amirthalingam G, 2018, LANCET PUBLIC HEALTH, V3, pE82, DOI 10.1016/S2468-2667(17)30234-7; ARVIN AM, 1980, J CLIN INVEST, V65, P869, DOI 10.1172/JCI109739; Arvin AM, 2008, J INFECT DIS, V197, pS58, DOI 10.1086/522123; Asada H, 2013, J DERMATOL SCI, V69, P243, DOI 10.1016/j.jdermsci.2012.10.015; Australian Government Department of Health, 2020, PHARM BEN SCHEM COST; Australian Institute of Health and Welfare, BURD VACC PREV DIS A; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; Bastidas A, 2019, JAMA-J AM MED ASSOC, V322, P123, DOI 10.1001/jama.2019.9053; Baxter R, 2018, AM J EPIDEMIOL, V187, P161, DOI 10.1093/aje/kwx245; Berkowitz EM, 2015, J INFECT DIS, V211, P1279, DOI 10.1093/infdis/jiu606; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Camilloni B, 2015, HUM VACC IMMUNOTHER, V11, P553, DOI 10.1080/21645515.2015.1011562; Cassini A., 2018, Eurosurveillance, V23, P00454; Centers for Disease Control and Prevention, 2019, ADV COMM IMM PRACT E; Chen C, 2018, VACCINE, V36, P6307, DOI 10.1016/j.vaccine.2018.08.084; Chen SY, 2014, INFECTION, V42, P325, DOI 10.1007/s15010-013-0550-8; Chit A, 2015, LANCET INFECT DIS, V15, P1459, DOI 10.1016/S1473-3099(15)00249-2; Chit A, 2015, VACCINE, V33, P734, DOI 10.1016/j.vaccine.2014.10.079; Chlibek R, 2016, VACCINE, V34, P863, DOI 10.1016/j.vaccine.2015.09.073; Chlibek R, 2014, VACCINE, V32, P1745, DOI 10.1016/j.vaccine.2014.01.019; Chlibek R, 2013, J INFECT DIS, V208, P1953, DOI 10.1093/infdis/jit365; Clark TG, 2005, DEV BIOLOGICALS, V121, P153; Coccia M, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0027-3; Colindres R, 2020, HUM VACC IMMUNOTHER, V16, P2628, DOI 10.1080/21645515.2020.1741312; Cowling BJ, 2020, J INFECT DIS, V222, P1383, DOI 10.1093/infdis/jiaa255; Cowling BJ, 2020, CLIN INFECT DIS, V71, P1704, DOI 10.1093/cid/ciz1034; Crooke SN, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0164-9; Cunningham AL, 2016, NEW ENGL J MED, V375, P1019, DOI 10.1056/NEJMoa1603800; Cunningham AL, 2018, J INFECT DIS, V217, P1750, DOI 10.1093/infdis/jiy095; Curran D, 2021, J AM GERIATR SOC, V69, P744, DOI 10.1111/jgs.16917; Da Silva FT, 2013, VACCINE, V31, P1870, DOI 10.1016/j.vaccine.2013.01.042; Dagnew AF, 2019, LANCET INFECT DIS, V19, P988, DOI 10.1016/S1473-3099(19)30163-X; Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001; Del Giudice G, 2015, CURR TOP MICROBIOL, V386, P151, DOI 10.1007/82_2014_406; Dendouga N, 2012, VACCINE, V30, P3126, DOI 10.1016/j.vaccine.2012.01.088; DiazGranados CA, 2015, VACCINE, V33, P4565, DOI 10.1016/j.vaccine.2015.07.003; DiazGranados CA, 2014, NEW ENGL J MED, V371, P635, DOI 10.1056/NEJMoa1315727; Didierlaurent AM, 2017, EXPERT REV VACCINES, V16, P55, DOI 10.1080/14760584.2016.1213632; Didierlaurent AM, 2014, J IMMUNOL, V193, P1920, DOI 10.4049/jimmunol.1400948; Djennad A, 2018, ECLINICALMEDICINE, V6, P42, DOI 10.1016/j.eclinm.2018.12.007; Domnich A, 2017, VACCINE, V35, P513, DOI 10.1016/j.vaccine.2016.12.011; Dooling KL, 2018, MMWR-MORBID MORTAL W, V67, P103, DOI 10.15585/mmwr.mm6703a5; Dorrington MG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00171; Drolet M, 2010, CLIN J PAIN, V26, P656, DOI 10.1097/AJP.0b013e3181eef686; Dunkle LM, 2017, NEW ENGL J MED, V376, P2427, DOI [10.1056/NEJMoa1608862, 10.1056/nejmoa1608862]; Dunning AJ, 2016, CLIN VACCINE IMMUNOL, V23, P228, DOI 10.1128/CVI.00604-15; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Flannery B, 2020, J INFECT DIS, V221, P8, DOI 10.1093/infdis/jiz543; Flannery B, 2019, CLIN INFECT DIS, V68, P1798, DOI 10.1093/cid/ciy775; Frenck RW, 2012, CLIN VACCINE IMMUNOL, V19, P1296, DOI 10.1128/CVI.00176-12; Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960; Garcon N, 2011, EXPERT REV VACCINES, V10, P471, DOI [10.1586/erv.11.29, 10.1586/ERV.11.29]; Gasparini R, 2001, EUR J EPIDEMIOL, V17, P135, DOI 10.1023/A:1017919305501; Gessner BD, 2019, VACCINE, V37, P4147, DOI 10.1016/j.vaccine.2019.05.065; Gilbert PB, 2014, J INFECT DIS, V210, P1573, DOI 10.1093/infdis/jiu279; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; Godeaux O, 2017, HUM VACC IMMUNOTHER, V13, P1051, DOI 10.1080/21645515.2016.1265715; Grabenstein JD, 2012, CLIN MICROBIOL INFEC, V18, P15, DOI 10.1111/j.1469-0691.2012.03943.x; Gravenstein S, 2017, LANCET RESP MED, V5, P738, DOI 10.1016/S2213-2600(17)30235-7; Grupping K, 2017, J INFECT DIS, V216, P1343, DOI 10.1093/infdis/jix482; Haq K, 2014, CURR OPIN IMMUNOL, V29, P38, DOI 10.1016/j.coi.2014.03.008; Harpaz R, MMWR RECOMM REP; Haumont M, 1996, VIRUS RES, V40, P199, DOI 10.1016/0168-1702(95)01270-2; Huijts SM, 2017, VACCINE, V35, P4444, DOI 10.1016/j.vaccine.2017.01.071; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Izurieta HS, 2015, LANCET INFECT DIS, V15, P293, DOI 10.1016/S1473-3099(14)71087-4; Jackson LA, 2018, VACCINE, V36, P606, DOI 10.1016/j.vaccine.2017.12.061; Jackson ML, 2017, NEW ENGL J MED, V377, P534, DOI [10.1056/NEJMoa1700153, 10.1056/nejmoa1700153]; Jiang Y, 2014, EXPERT REV PHARM OUT, V14, P913, DOI 10.1586/14737167.2014.950232; Kawai K, 2017, MAYO CLIN PROC, V92, P1806, DOI 10.1016/j.mayocp.2017.10.009; Keitel WA, 2009, VACCINE, V28, P379, DOI 10.1016/j.vaccine.2009.10.037; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Kim JH, 2019, VACCINE, V37, P2797, DOI 10.1016/j.vaccine.2019.04.017; Kolditz M, 2018, CLIN MICROBIOL INFEC, V24, P500, DOI 10.1016/j.cmi.2017.08.010; Kolditz M, 2019, CLIN INFECT DIS, V68, P2117, DOI 10.1093/cid/ciy993; Kovac M, 2018, VACCINE, V36, P1537, DOI 10.1016/j.vaccine.2018.02.029; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; LaFon DC, 2018, J IMMUNOL METHODS, V461, P37, DOI 10.1016/j.jim.2018.08.002; Lal H, 2015, NEW ENGL J MED, V372, P2087, DOI 10.1056/NEJMoa1501184; Lee JKH, 2018, EXPERT REV VACCINES, V17, P435, DOI 10.1080/14760584.2018.1471989; Lee LH, 2003, VACCINE, V21, P2190, DOI 10.1016/S0264-410X(03)00025-2; Leroux-Roels I, 2012, J INFECT DIS, V206, P1280, DOI 10.1093/infdis/jis497; Levin MJ, 2008, J INFECT DIS, V197, P825, DOI 10.1086/528696; Levin MJ, 2017, VACCINES-BASEL, P1145; Levin MJ, 2019, HUM VACC IMMUNOTHER, V15, P772, DOI 10.1080/21645515.2018.1560918; Levin MJ, 2018, J CLIN INVEST, V128, P4429, DOI [10.1172/JCI121484, 10.1172/jci121484]; Levin MJ, 2017, EXPERT REV VACCINES, V16, P1217, DOI 10.1080/14760584.2017.1395703; Levin MJ, 2016, J INFECT DIS, V213, P14, DOI 10.1093/infdis/jiv480; Lewnard JA, 2019, LANCET INFECT DIS, V19, pE213, DOI 10.1016/S1473-3099(18)30660-1; Lindert K, 2019, INT J INFECT DIS, V85, pS10, DOI 10.1016/j.ijid.2019.03.020; Masomian M, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8010132; Matanock A, 2019, MMWR-MORBID MORTAL W, V68, P1069, DOI 10.15585/mmwr.mm6846a5; McLaughlin JM, 2018, CLIN INFECT DIS, V67, P1498, DOI 10.1093/cid/ciy312; Meder KN, 2020, CLIN INFECT DIS, V70, P2607, DOI 10.1093/cid/ciz731; Monto AS, 2017, J INFECT DIS, V215, P1782, DOI 10.1093/infdis/jix173; Morrison VA, 2015, CLIN INFECT DIS, V60, P900, DOI 10.1093/cid/ciu918; Ng TWY, 2019, J INFECT DIS, V219, P1525, DOI 10.1093/infdis/jiy720; O'Hagan DT, 2013, EXPERT REV VACCINES, V12, P13, DOI [10.1586/ERV.12.140, 10.1586/erv.12.140]; Oostvogels L, 2019, HUM VACC IMMUNOTHER, V15, P2865, DOI 10.1080/21645515.2019.1627818; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Oxman MN, 2019, VARICELLA HERPES ZOS; Patterson S., 2016, Trials in Vaccinology, V5, P92, DOI 10.1016/j.trivac.2016.04.004; Paules C, 2017, LANCET, V390, P697, DOI 10.1016/S0140-6736(17)30129-0; Paules CI, 2018, NEW ENGL J MED, V378, P7, DOI 10.1056/NEJMp1714916; Remschmidt C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2040-y; Richardson DM, 2015, CLIN INFECT DIS, V61, P171, DOI 10.1093/cid/civ261; Robertson CA, 2016, EXPERT REV VACCINES, V15, P1495, DOI 10.1080/14760584.2016.1254044; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Rolfes MA, 2019, CLIN INFECT DIS, V69, P1845, DOI 10.1093/cid/ciz075; Schmader KE, 2012, CLIN INFECT DIS, V55, P1320, DOI 10.1093/cid/cis638; Schwarz TF, 2018, HUM VACC IMMUNOTHER, V14, P1370, DOI 10.1080/21645515.2018.1442162; Schwarz TF, 2017, J INFECT DIS, V216, P1352, DOI 10.1093/infdis/jix481; Shi M, 2020, OPEN FORUM INFECT DI, V7, pS4, DOI [10.1093/ofid/ofaa417.007, DOI 10.1093/OFID/OFAA417.007]; Shiri T, 2017, LANCET GLOB HEALTH, V5, pE51, DOI 10.1016/S2214-109X(16)30306-0; Squarcione S, 2003, VACCINE, V21, P1268, DOI 10.1016/S0264-410X(02)00401-2; Stadtmauer EA, 2014, BLOOD, V124, P2921, DOI 10.1182/blood-2014-04-573048; Stoecker C, 2020, VACCINE, V38, P1770, DOI 10.1016/j.vaccine.2019.12.029; Sullivan S, 2018, LANCET, V391, P1242, DOI 10.1016/S0140-6736(17)33292-0; Suzuki M, 2017, LANCET INFECT DIS, V17, P803, DOI 10.1016/S1473-3099(17)30411-5; Talbot HKB, 2012, HUM VACC IMMUNOTHER, V8, P96, DOI 10.4161/hv.8.1.18129; Thompson A, 2019, VACCINE, V37, P6201, DOI 10.1016/j.vaccine.2019.08.048; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Thorrington D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192640; Tseng HF, 2016, J INFECT DIS, V213, P1872, DOI 10.1093/infdis/jiw047; TUOMANEN EI, 1995, NEW ENGL J MED, V332, P1280, DOI 10.1056/NEJM199505113321907; Vadlamudi NK, 2019, VACCINE, V37, P1021, DOI 10.1016/j.vaccine.2019.01.014; VAFAI A, 1995, VACCINE, V13, P1336, DOI 10.1016/0264-410X(94)00073-V; van Hoek AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039150; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Vermeulen JN, 2012, VACCINE, V30, P904, DOI 10.1016/j.vaccine.2011.11.096; Vesikari T, 2013, HUM VACC IMMUNOTHER, V9, P858, DOI 10.4161/hv.23412; Vestjens SMT, 2019, VACCINE, V37, P6558, DOI 10.1016/j.vaccine.2019.08.025; Vestrheim DF, PATHOGENS, V2020, P2; Vink P, 2020, CLIN INFECT DIS, V70, P181, DOI 10.1093/cid/ciz177; Vink P, 2019, CANCER-AM CANCER SOC, V125, P1301, DOI 10.1002/cncr.31909; Vono M, 2013, P NATL ACAD SCI USA, V110, P21095, DOI 10.1073/pnas.1319784110; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Walker JL, 2018, VACCINE, V36, P2371, DOI 10.1016/j.vaccine.2018.02.021; Warrington R, 2018, Can Commun Dis Rep, V44, P220, DOI 10.14745/ccdr.v44i09a06; Weinberg A, 2018, J INFECT DIS, V218, pS81, DOI 10.1093/infdis/jiy383; Weinberg A, 2019, J INFECT DIS, V219, P335, DOI 10.1093/infdis/jiy514; Weinberg A, 2010, J INFECT DIS, V201, P1024, DOI 10.1086/651199; Weinberg A, 2009, J INFECT DIS, V200, P1068, DOI 10.1086/605611; Wiemken TL, 2014, VACCINE, V32, P2198, DOI 10.1016/j.vaccine.2014.02.048; Willer DO, 2019, VACCINE, V37, P6262, DOI 10.1016/j.vaccine.2019.09.028; Willis ED, 2017, VACCINE, V35, P7231, DOI 10.1016/j.vaccine.2017.11.013; Yanni EA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020528; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	156	17	17	2	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2021	372								n188	10.1136/bmj.n188	http://dx.doi.org/10.1136/bmj.n188			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QL7AW	33619170				2022-12-28	WOS:000621236700010
J	Wang, ZY; Altenburger, R; Backhaus, T; Covaci, A; Diamond, ML; Grimalt, JO; Lohmann, R; Schaffer, A; Scheringer, M; Selin, H; Soehl, A; Suzuki, N				Wang, Zhanyun; Altenburger, Rolf; Backhaus, Thomas; Covaci, Adrian; Diamond, Miriam L.; Grimalt, Joan O.; Lohmann, Rainer; Schaffer, Andreas; Scheringer, Martin; Selin, Henrik; Soehl, Anna; Suzuki, Noriyuki			We need a global science-policy body on chemicals and waste	SCIENCE			English	Editorial Material							IPBES		[Wang, Zhanyun] Swiss Fed Inst Technol, Inst Environm Engn, Chair Ecol Syst Design, CH-8093 Zurich, Switzerland; [Altenburger, Rolf] UFZ Helmholtz Ctr Environm Res, Permoserstr 15, D-04318 Leipzig, Germany; [Altenburger, Rolf; Schaffer, Andreas] Rhein Westfal TH Aachen, Inst Environm Res, Worringerweg 1, D-52074 Aachen, Germany; [Backhaus, Thomas] Univ Gothenburg, Dept Biol & Environm Sci, Carl Skottsbergs Gata 22B, S-40530 Gothenburg, Sweden; [Covaci, Adrian] Univ Antwerp, Toxicol Ctr, Univ Pl 1, B-2610 Antwerp, Belgium; [Diamond, Miriam L.] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Diamond, Miriam L.] Univ Toronto, Sch Environm, Toronto, ON M5S 3E8, Canada; [Grimalt, Joan O.] CSIC, Dept Environm Chem, IDAEA, ES-08034 Barcelona, Spain; [Lohmann, Rainer] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Scheringer, Martin] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland; [Scheringer, Martin] Masaryk Univ, RECETOX, Brno 62500, Czech Republic; [Selin, Henrik] Boston Univ, Frederick S Pardee Sch Global Studies, Boston, MA 02215 USA; [Soehl, Anna] Int Panel Chem Pollut, CH-8092 Zurich, Switzerland; [Suzuki, Noriyuki] Natl Inst Environm Studies, Ctr Hlth & Environm Risk Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); RWTH Aachen University; University of Gothenburg; University of Antwerp; University of Toronto; University of Toronto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); University of Rhode Island; Swiss Federal Institutes of Technology Domain; ETH Zurich; Masaryk University Brno; Boston University; National Institute for Environmental Studies - Japan	Wang, ZY (corresponding author), Swiss Fed Inst Technol, Inst Environm Engn, Chair Ecol Syst Design, CH-8093 Zurich, Switzerland.	Zhanyun.wang@ifu.baug.ethz.ch	Schaeffer, Andreas/AAK-1332-2021; Grimalt, Joan/E-2073-2011	Schaeffer, Andreas/0000-0002-4110-2631; Grimalt, Joan/0000-0002-7391-5768; Altenburger, Rolf/0000-0003-2929-2978	CETOCOEN PLUS project of the Ministry of Education,Youth and Sports of the Czech Republic [CZ.02.1.01/0.0/0.0/15_003/0000469]	CETOCOEN PLUS project of the Ministry of Education,Youth and Sports of the Czech Republic	The authors gratefully acknowledge G.White (Health Canada), M.Tschirren (Swiss Federal Office for the Environment), S. Sakai (Kyoto University), and S.T.Jahre (Norwegian Ministry of Climate and Environment) for helpful comments. The authors declare no competing interests. M.S. acknowledges financial support by the CETOCOEN PLUS project (CZ.02.1.01/0.0/0.0/15_003/0000469) of the Ministry of Education,Youth and Sports of the Czech Republic.	Beck S., 2016, HDB SCI TECHNOLOGY S; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; Grennfelt P, 2020, AMBIO, V49, P849, DOI 10.1007/s13280-019-01244-4; KARLSSON M, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/SU11174785; Kohler PiaM., 2020, SCI ADVICE GLOBAL EN; Lawrence F, 2020, NATURE, V578, P28, DOI 10.1038/d41586-020-00273-4; Lofmarck E, 2017, ENVIRON SCI POLICY, V69, P22, DOI 10.1016/j.envsci.2016.12.008; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Ruckelshaus MH, 2020, TRENDS ECOL EVOL, V35, P407, DOI 10.1016/j.tree.2020.01.009; Scheringer M, 2006, ENVIRON SCI POLLUT R, V13, P432, DOI 10.1065/espr2006.09.347; Selin H., 2010, GLOBAL GOVERNANCE HA; Singh GG, 2019, FRONT ECOL ENVIRON, V17, P375, DOI 10.1002/fee.2084; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; United Nations Environment Programme, 2020, ASS OPT STRENGTH SCI; United Nations Environment Programme, 2019, GLOB CHEM OUTL 2 LEG; Wang Z., 2019, ZENODO; Wang ZX, 2021, IEEE T SYST MAN CY-S, V51, P1267, DOI 10.1109/TSMC.2019.2896022; Wexler P, 2012, CHEMICALS, ENVIRONMENT, HEALTH: A GLOBAL MANAGEMENT PERSPECTIVE, P1; 2012, CHEM ENV HLTH GLOB, P1	19	31	32	20	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2021	371	6531					774	+		10.1126/science.abe9090	http://dx.doi.org/10.1126/science.abe9090			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QJ4MB	33602839	Green Submitted			2022-12-28	WOS:000619664700025
J	Josephs, TM; Belousoff, MJ; Liang, YL; Piper, SJ; Cao, JJ; Garama, DJ; Leach, K; Gregory, KJ; Christopoulos, A; Hay, DL; Danev, R; Wootten, D; Sexton, PM				Josephs, Tracy M.; Belousoff, Matthew J.; Liang, Yi-Lynn; Piper, Sarah J.; Cao, Jianjun; Garama, Daniel J.; Leach, Katie; Gregory, Karen J.; Christopoulos, Arthur; Hay, Debbie L.; Danev, Radostin; Wootten, Denise; Sexton, Patrick M.			Structure and dynamics of the CGRP receptor in apo and peptide-bound forms	SCIENCE			English	Article							CRYO-EM STRUCTURE; MOLECULAR-BASIS; PROTEIN; GPCR; ACTIVATION; BINDING; PHARMACOLOGY; SPECIFICITY; REFINEMENT; FEATURES	G protein-coupled receptors (GPCRs) are key regulators of information transmission between cells and organs. Despite this, we have only a limited understanding of the behavior of GPCRs in the apo state and the conformational changes upon agonist binding that lead to G protein recruitment and activation. We expressed and purified unmodified apo and peptide-bound calcitonin gene-related peptide (CGRP) receptors from insect cells to determine their cryo-electron microscopy (cryo-EM) structures, and we complemented these with analysis of protein conformational dynamics using hydrogen-deuterium exchange mass spectrometry and three-dimensional variance analysis of the cryo-EM data. Together with our previously published structure of the active, Gs-bound CGRP receptor complex, our work provides insight into the mechanisms of class B1 GPCR activation.	[Josephs, Tracy M.; Belousoff, Matthew J.; Liang, Yi-Lynn; Piper, Sarah J.; Cao, Jianjun; Leach, Katie; Gregory, Karen J.; Christopoulos, Arthur; Wootten, Denise; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic 3052, Australia; [Garama, Daniel J.] Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Garama, Daniel J.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia; [Hay, Debbie L.] Univ Otago, Dept Pharmacol & Toxicol, Dunedin 9054, New Zealand; [Danev, Radostin] Univ Tokyo, Grad Sch Med, Bunkyo Ku, N415,7-3-1 Hongo, Tokyo 1130033, Japan; [Liang, Yi-Lynn] Confo Therapeut, Technol Pk 94, B-9052 Ghent, Zwijnaarde, Belgium	Monash University; Hudson Institute of Medical Research; Monash University; University of Otago; University of Tokyo	Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic 3052, Australia.; Danev, R (corresponding author), Univ Tokyo, Grad Sch Med, Bunkyo Ku, N415,7-3-1 Hongo, Tokyo 1130033, Japan.	rado@m.u.tokyo.ac.jp; denise.wootten@monash.edu; patrick.sexton@monash.edu	Christopoulos, Arthur/B-6207-2013; Wootten, Denise/ABD-5703-2021; Piper, Sarah/GLV-2174-2022; Belousoff, Matthew/N-4066-2017	Christopoulos, Arthur/0000-0003-4442-3294; Wootten, Denise/0000-0003-4563-1642; Piper, Sarah/0000-0001-5337-5197; Belousoff, Matthew/0000-0002-3229-474X; Garama, Daniel/0000-0002-4484-3603; Liang, Yi-Lynn/0000-0001-6948-5550; Cao, Jianjun/0000-0001-9160-0228; Hay, Debbie/0000-0002-9558-5122; Josephs, Tracy/0000-0002-7799-3683	Monash University Ramaciotti Centre for Cryo-Electron Microscopy; Monash MASSIVE high-performance computing facility; MIPS seed funding; Australian Research Council (ARC) Centre grant [IC200100052]; ARC Discovery Project [DP210101504]; National Health and Medical Research Council of Australia (NHMRC) [1120919, 1159006]; NHMRC program grant [1150083]; Takeda Science Foundation 2019 Medical Research Grant; Japan Science and Technology Agency PRESTO [18069571]; Australian Research Council Future Fellowship [FT160100075]	Monash University Ramaciotti Centre for Cryo-Electron Microscopy; Monash MASSIVE high-performance computing facility; MIPS seed funding; Australian Research Council (ARC) Centre grant(Australian Research Council); ARC Discovery Project(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC program grant(National Health and Medical Research Council (NHMRC) of Australia); Takeda Science Foundation 2019 Medical Research Grant; Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Australian Research Council Future Fellowship(Australian Research Council)	The work was supported by the Monash University Ramaciotti Centre for Cryo-Electron Microscopy, the Monash MASSIVE high-performance computing facility, MIPS seed funding to T.M.J., the Australian Research Council (ARC) Centre grant (IC200100052) and ARC Discovery Project (DP210101504), the National Health and Medical Research Council of Australia (NHMRC) project grants (1120919 and 1159006), and NHMRC program grant (1150083). P.M.S. is an NHMRC Senior Principal Research Fellow and D.W. is an NHMRC Senior Research Fellow. T.M.J. is a Victoria Endowment for Science Knowledge and Innovation Fellow. R.D. was supported by the Takeda Science Foundation 2019 Medical Research Grant and the Japan Science and Technology Agency PRESTO (18069571), and K.L. was supported by an Australian Research Council Future Fellowship (FT160100075).	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS21, DOI 10.1111/bph.14748; [Anonymous], 2010, PYMOL MOL GRAPHICS S; Ayoub Mohammed Akli, 2012, Front Endocrinol (Lausanne), V3, P82, DOI 10.3389/fendo.2012.00082; Barwell J, 2011, BBA-MOL CELL RES, V1813, P1906, DOI 10.1016/j.bbamcr.2011.06.005; Casiraghi M, 2019, MOL CELL ENDOCRINOL, V484, P69, DOI 10.1016/j.mce.2018.12.019; Cevheroglu O, 2017, BBA-BIOMEMBRANES, V1859, P2435, DOI 10.1016/j.bbamem.2017.09.022; Charles A, 2019, LANCET, V394, P1765, DOI 10.1016/S0140-6736(19)32504-8; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; de Graaf C, 2017, TRENDS BIOCHEM SCI, V42, P946, DOI 10.1016/j.tibs.2017.10.003; Du Y, 2019, CELL, V177, P1232, DOI 10.1016/j.cell.2019.04.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Li YZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18607-1; Liang YL, 2020, ACS PHARMACOL TRANSL, V3, P263, DOI 10.1021/acsptsci.9b00080; Liang YL, 2020, MOL CELL, V77, P656, DOI 10.1016/j.molcel.2020.01.012; Liang YL, 2018, ACS PHARMACOL TRANSL, V1, P12, DOI 10.1021/acsptsci.8b00017; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Ma SS, 2020, MOL CELL, V77, P669, DOI 10.1016/j.molcel.2020.01.013; Masson GR, 2019, NAT METHODS, V16, P595, DOI 10.1038/s41592-019-0459-y; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Munk C, 2019, NAT METHODS, V16, P151, DOI 10.1038/s41592-018-0302-x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pioszak Augen A, 2020, Adv Pharmacol, V88, P115, DOI 10.1016/bs.apha.2020.01.001; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Schipani E, 1996, NEW ENGL J MED, V335, P708, DOI 10.1056/NEJM199609053351004; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shukla A. K., 2016, METHODS CELL BIOL, V132; Simms J, 2009, BIOCHEMISTRY-US, V48, P198, DOI 10.1021/bi801869n; Sutkeviciute I, 2020, J BIOL CHEM, V295, P11626, DOI 10.1074/jbc.REV120.009348; Thal DM, 2018, CURR OPIN STRUC BIOL, V51, P28, DOI 10.1016/j.sbi.2018.03.002; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Wang JJ, 2020, CURR OPIN STRUC BIOL, V63, P82, DOI 10.1016/j.sbi.2020.04.008; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; Wingler LM, 2020, TRENDS CELL BIOL, V30, P736, DOI 10.1016/j.tcb.2020.06.002; Woolley MJ, 2017, MOL CELL ENDOCRINOL, V454, P39, DOI 10.1016/j.mce.2017.05.034; Woolley MJ, 2013, CURR PROTEIN PEPT SC, V14, P358, DOI 10.2174/13892037113149990053; Wootten D, 2016, BIOCHEM PHARMACOL, V118, P68, DOI 10.1016/j.bcp.2016.08.015; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Wu F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14934-5; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yano A, 2017, BBA-MOL CELL BIOL L, V1862, P615, DOI 10.1016/j.bbalip.2017.03.006; Zhang X, 2020, MOL CELL, V80, P485, DOI 10.1016/j.molcel.2020.09.020; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	55	24	25	6	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2021	372	6538					147	+	eabf7258	10.1126/science.abf7258	http://dx.doi.org/10.1126/science.abf7258			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RL8LG	33602864	Bronze			2022-12-28	WOS:000639216800035
J	Hendelman, A; Zebell, S; Rodriguez-Leal, D; Dukler, N; Robitaille, G; Wu, XL; Kostyun, J; Tal, L; Wang, PP; Bartlett, ME; Eshed, Y; Efroni, I; Lippman, ZB				Hendelman, Anat; Zebell, Sophia; Rodriguez-Leal, Daniel; Dukler, Noah; Robitaille, Gina; Wu, Xuelin; Kostyun, Jamie; Tal, Lior; Wang, Peipei; Bartlett, Madelaine E.; Eshed, Yuval; Efroni, Idan; Lippman, Zachary B.			Conserved pleiotropy of an ancient plant homeobox gene uncovered by cis-regulatory dissection	CELL			English	Article							WOX GENES; INFLORESCENCE ARCHITECTURE; TARGETED MUTAGENESIS; MERISTEM MATURATION; ORGAN DEVELOPMENT; EVOLUTION; EXPRESSION; ALIGNMENT; CROP; DOMESTICATION	Divergence of gene function is a hallmark of evolution, but assessing functional divergence over deep time is not trivial. The few alleles available for cross-species studies often fail to expose the entire functional spectrum of genes, potentially obscuring deeply conserved pleiotropic roles. Here, we explore the functional divergence of WUSCHEL HOMEOBOX9 (WOX9), suggested to have species-specific roles in embryo and inflorescence development. Using a cis-regulatory editing drive system, we generate a comprehensive allelic series in tomato, which revealed hidden pleiotropic roles for WOX9. Analysis of accessible chromatin and conserved cis-regulatory sequences identifies the regions responsible for this pleiotropic activity, the functions of which are conserved in groundcherry, a tomato relative. Mimicking these alleles in Arabidopsis, distantly related to tomato and groundcherry, reveals new inflorescence phenotypes, exposing a deeply conserved pleiotropy. We suggest that targeted cis-regulatory mutations can uncover conserved gene functions and reduce undesirable effects in crop improvement.	[Hendelman, Anat; Zebell, Sophia; Rodriguez-Leal, Daniel; Dukler, Noah; Robitaille, Gina; Lippman, Zachary B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Zebell, Sophia; Robitaille, Gina; Lippman, Zachary B.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Wu, Xuelin] Salk Inst Biol Res, San Diego, CA USA; [Kostyun, Jamie; Bartlett, Madelaine E.] Univ Massachusetts, Biol Dept, Amherst, MA USA; [Tal, Lior; Eshed, Yuval] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel; [Wang, Peipei; Efroni, Idan] Hebrew Univ Jerusalem, Robert H Smith Fac Agr, Inst Plant Sci & Genet Agr, Rehovot, Israel; [Rodriguez-Leal, Daniel] Inari Agr, Cambridge, MA USA; [Tal, Lior] Univ Calif Davis, Plant Biol Dept, Davis, CA USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Amherst; Weizmann Institute of Science; Hebrew University of Jerusalem; University of California System; University of California Davis	Lippman, ZB (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.; Lippman, ZB (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.; Efroni, I (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr, Inst Plant Sci & Genet Agr, Rehovot, Israel.	idan.efroni@mail.huji.ac.il; lippman@cshl.edu	Leal, Daniel Rodriguez/AAI-8049-2021	Leal, Daniel Rodriguez/0000-0003-1871-7432; Tal, Lior/0000-0002-1119-3392; Zebell, Sophia/0000-0003-1854-6389; Hendelman, Anat/0000-0002-6089-710X	Howard Hughes Medical Institute; BARD (United States-Israel Binational Agricultural Research and Development Fund) [IS-5120-18C]; Vaadia-BARD Postdoctoral Fellowship [FL-542-16]; Howard Hughes Medical Institute International Scholar Grant [55008730]; Israel Science Foundation [ISF966/17]; National Science Foundation Plant Genome Research Program [IOS-1546837]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); BARD (United States-Israel Binational Agricultural Research and Development Fund); Vaadia-BARD Postdoctoral Fellowship; Howard Hughes Medical Institute International Scholar Grant; Israel Science Foundation(Israel Science Foundation); National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank members of the Lippman laboratory for valuable comments and discussions. We thank J. Kim and A. Krainer for technical support. We thank L. Randall, A. Horowitz Doyle, P. Keen, K. Swartwood, M. Tjahjadi, and J. Van Eck for performing tomato and groundcherry transformations. We thank T. Mulligan, K. Schlecht, A. Krainer, and S. Qiao for assistance with plant care. We thank M. Karaca from Inari Agriculture for assistance with ATAC-seq (prior to September 2018). We thank B. Usadel, S. Strickler, and L. Mueller for sharing the S. lycopersicoides genome assembly and annotation sequences. We thank D. Jackson for comments on the manuscript. This research was supported by the Howard Hughes Medical Institute and grant support from the BARD (United States-Israel Binational Agricultural Research and Development Fund, IS-5120-18C) to Y.E. and Z.B.L. and the Vaadia-BARD Postdoctoral Fellowship (award no. FL-542-16) to A.H., the Howard Hughes Medical Institute International Scholar Grant (55008730) and Israel Science Foundation (ISF966/17) to I.E., and the National Science Foundation Plant Genome Research Program (grant no. IOS-1546837) to M.E.B. and Z.B.L.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barton MK, 2010, DEV BIOL, V341, P95, DOI 10.1016/j.ydbio.2009.11.029; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803; Breuninger H, 2008, DEV CELL, V14, P867, DOI 10.1016/j.devcel.2008.03.008; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cameron RA, 2009, DEV BIOL, V336, P122, DOI 10.1016/j.ydbio.2009.09.018; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Chow CN, 2019, NUCLEIC ACIDS RES, V47, pD1155, DOI 10.1093/nar/gky1081; Cohen O, 2014, NEW PHYTOL, V202, P1014, DOI 10.1111/nph.12711; Costanzo E, 2014, ANN BOT-LONDON, V114, P1545, DOI 10.1093/aob/mcu123; Deveaux Y, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-291; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolzblasz A, 2016, MOL PLANT, V9, P1028, DOI 10.1016/j.molp.2016.04.007; Dutheil JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-53; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eshed Y, 2019, SCIENCE, V366, P705, DOI 10.1126/science.aax0025; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Fuqua T, 2020, NATURE, V587, P235, DOI 10.1038/s41586-020-2816-5; Galli M, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.591194; Gilchrist CLM, 2021, BIOINFORMATICS, V37, P2473, DOI 10.1093/bioinformatics/btab007; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo DS, 2015, PLANT CELL, V27, P3112, DOI 10.1105/tpc.15.00829; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Holland PWH, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2015.0480; Honda E, 2018, PLANT CELL PHYSIOL, V59, P376, DOI 10.1093/pcp/pcx196; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kyozuka J, 2014, CURR OPIN PLANT BIOL, V17, P110, DOI 10.1016/j.pbi.2013.11.010; Lanfear R, 2016, GENOME BIOL EVOL, V8, P2319, DOI 10.1093/gbe/evw171; LeBlanc C, 2018, PLANT J, V93, P377, DOI [10.1111/tpj.13782, 10.1111/tpj.13828]; Leisner CP, 2018, PLANT J, V94, P562, DOI 10.1111/tpj.13857; Lemmon ZH, 2018, NAT PLANTS, V4, P766, DOI 10.1038/s41477-018-0259-x; Lemmon ZH, 2016, GENOME RES, V26, P1676, DOI 10.1101/gr.207837.116; Lemoine F, 2018, NATURE, V556, P452, DOI 10.1038/s41586-018-0043-0; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MD, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5684-3; Lian GB, 2014, SCI WORLD J, DOI 10.1155/2014/534140; Lin H, 2013, P NATL ACAD SCI USA, V110, P366, DOI 10.1073/pnas.1215376110; Lippman ZB, 2008, PLOS BIOL, V6, P2424, DOI 10.1371/journal.pbio.0060288; Lu ZF, 2019, NAT PLANTS, V5, P1250, DOI 10.1038/s41477-019-0548-z; Maumus F., 2019, 767764 BIORXIV; Meng YY, 2019, J EXP BOT, V70, P149, DOI 10.1093/jxb/ery346; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Miller Mark A., 2010, 2010 Gateway Computing Environments Workshop (GCE 2010), DOI 10.1109/GCE.2010.5676129; Mishra R, 2020, PLANT BIOTECHNOL J, V18, P20, DOI 10.1111/pbi.13225; Nelson AC, 2013, DEVELOPMENT, V140, P1385, DOI 10.1242/dev.084459; Paaby AB, 2013, TRENDS GENET, V29, P66, DOI 10.1016/j.tig.2012.10.010; Panchy N, 2016, PLANT PHYSIOL, V171, P2294, DOI 10.1104/pp.16.00523; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Park SJ, 2014, CURR OPIN PLANT BIOL, V17, P70, DOI 10.1016/j.pbi.2013.11.006; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Potok ME, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11291-w; Powell A.F., 2020, SOLANUM LYCOPERSICOI, DOI [10.1101/2020.04.16.039636, DOI 10.1101/2020.04.16.039636]; Priest HD, 2009, CURR OPIN PLANT BIOL, V12, P643, DOI 10.1016/j.pbi.2009.07.016; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2009, R LANG ENV STAT COMP; Radoeva T, 2019, DEV CELL, V50, P533, DOI 10.1016/j.devcel.2019.07.011; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rebeiz M, 2017, CURR OPIN GENET DEV, V45, P115, DOI 10.1016/j.gde.2017.04.006; Rebocho AB, 2008, DEV CELL, V15, P437, DOI 10.1016/j.devcel.2008.08.007; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rodriguez-Leal D, 2017, CELL, V171, P470, DOI 10.1016/j.cell.2017.08.030; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Scheben A, 2018, CURR OPIN PLANT BIOL, V45, P218, DOI 10.1016/j.pbi.2018.04.013; Schorderet M, 2018, PLANT SIGNAL BEHAV, V13, DOI 10.1080/15592324.2018.1471299; Schwarzer W, 2014, CURR OPIN GENET DEV, V27, P74, DOI 10.1016/j.gde.2014.03.014; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Soyk S, 2017, CELL, V169, P1142, DOI 10.1016/j.cell.2017.04.032; Springer N, 2019, TRENDS PLANT SCI, V24, P1075, DOI 10.1016/j.tplants.2019.07.004; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stearns FW, 2010, GENETICS, V186, P767, DOI 10.1534/genetics.110.122549; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Stuurman J, 2002, GENE DEV, V16, P2213, DOI 10.1101/gad.230702; Swartwood K, 2019, PLANT CELL TISS ORG, V137, P465, DOI 10.1007/s11240-019-01582-x; Swinnen G, 2016, TRENDS PLANT SCI, V21, P506, DOI 10.1016/j.tplants.2016.01.014; Tanaka W, 2015, PLANT CELL, V27, P1173, DOI 10.1105/tpc.15.00074; Tyler AL, 2016, BRIEF BIOINFORM, V17, P13, DOI 10.1093/bib/bbv050; Van de Velde J, 2016, PLANT PHYSIOL, V171, P2586, DOI 10.1104/pp.16.00821; VanEck J., 2019, TRANSGENIC PLANTS ME, P171; Visscher PM, 2016, NAT GENET, V48, P707, DOI 10.1038/ng.3604; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang WF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004154; Wang Z, 2010, P NATL ACAD SCI USA, V107, P18034, DOI 10.1073/pnas.1004666107; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016765; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wong ES, 2020, SCIENCE, V370, P681, DOI 10.1126/science.aax8137; Wu CC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223521; Wu XL, 2005, CURR BIOL, V15, P436, DOI 10.1016/j.cub.2004.12.079; Wu X, 2007, DEV BIOL, V309, P306, DOI 10.1016/j.ydbio.2007.07.019; Zhang ZJ, 2020, CURR BIOL, V30, P4857, DOI 10.1016/j.cub.2020.09.037; Zhu TQ, 2014, J EXP BOT, V65, P6543, DOI 10.1093/jxb/eru371	105	39	42	21	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2021	184	7					1724	+		10.1016/j.cell.2021.02.001	http://dx.doi.org/10.1016/j.cell.2021.02.001		APR 2021	32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RI2IU	33667348	Bronze			2022-12-28	WOS:000636734000010
J	Beyrer, C; Adimora, AA; Hodder, SL; Hopkins, E; Millett, G; Mon, SHH; Sullivan, PS; Walensky, RP; Pozniak, A; Warren, M; Richman, B; Copeland, R; Mayer, KH				Beyrer, Chris; Adimora, Adaora A.; Hodder, Sally L.; Hopkins, Ernest; Millett, Greg; Mon, Sandra Hsu Hnin; Sullivan, Patrick S.; Walensky, Rochelle P.; Pozniak, Anton; Warren, Mitchell; Richman, Bruce; Copeland, Raniyah; Mayer, Kenneth H.			Call to action: how can the US Ending the HIV Epidemic initiative succeed?	LANCET			English	Review								With more than 1.2 million people living with HIV in the USA, a complex epidemic across the large and diverse country, and a fragmented health-care system marked by widening health disparities, the US HIV epidemic requires sustained scientific and public health attention. The epidemic has been stubbornly persistent; high incidence densities have been sustained over decades and the epidemic is increasingly concentrated among racial, ethnic, and sexual and gender minority communities. This fact remains true despite extraordinary scientific advances in prevention, treatment, and care-advances that have been led, to a substantial degree, by US-supported science and researchers. In this watershed year of 2021 and in the face of the COVID-19 pandemic, it is clear that the USA will not meet the stated goals of the National HIV/AIDS Strategy, particularly those goals relating to reductions in new infections, decreases in morbidity, and reductions in HIV stigma. The six papers in the Lancet Series on HIV in the USA have each examined the underlying causes of these challenges and laid out paths forward for an invigorated, sustained, and more equitable response to the US HIV epidemic than has been seen to date. The sciences of HIV surveillance, prevention, treatment, and implementation all suggest that the visionary goals of the Ending the HIV Epidemic initiative in the USA might be achievable. However, fundamental barriers and challenges need to be addressed and the research effort sustained if we are to succeed.	[Beyrer, Chris; Mon, Sandra Hsu Hnin] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Adimora, Adaora A.] Univ N Carolina, Gillings Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Hodder, Sally L.] West Virginia Univ, Sch Med, Infect Dis Sect, Morgantown, WV 26506 USA; [Hopkins, Ernest] San Francisco AIDS Fdn, San Francisco, CA USA; [Millett, Greg] Fdn AIDS Res amfAR, Washington, DC USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Pozniak, Anton] Chelsea & Westminster Hosp NHS Trust, Dept HIV, London, England; [Warren, Mitchell] AIDS Vaccine Advocacy Coalit AVAC, New York, NY USA; [Richman, Bruce] Prevent Access Campaign, New York, NY USA; [Copeland, Raniyah] Black AIDS Inst, Los Angeles, CA USA; [Mayer, Kenneth H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Fenway Hlth, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; West Virginia University; Emory University; Rollins School Public Health; Harvard University; Massachusetts General Hospital; Imperial College London; Fenway Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Beyrer, C (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhu.edu		Mon, Sandra Hsu Hnin/0000-0001-5421-9401; Sullivan, Patrick Sean/0000-0002-7728-0587	Foundation for AIDS Research; National Institute on Drug Abuse; Center for AIDS Research at Johns Hopkins University [P30AI094189]; Emory University; Harvard University; University of North Carolina; Desmond M Tutu Professorship in Public Health and Human Rights at Johns Hopkins University	Foundation for AIDS Research; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Center for AIDS Research at Johns Hopkins University; Emory University; Harvard University; University of North Carolina; Desmond M Tutu Professorship in Public Health and Human Rights at Johns Hopkins University	The work in this Series paper occurred before Rochelle Walensky joined the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR). The findings and conclusions are those of the authors and do not necessarily represent the official position of the CDC or the ATSDR. Support for this paper and the Lancet Series on HIV in the USA was provided in part by the Foundation for AIDS Research, the National Institute on Drug Abuse, the Center for AIDS Research (P30AI094189) at Johns Hopkins University, Emory University, Harvard University, and the University of North Carolina, and the Desmond M Tutu Professorship in Public Health and Human Rights at Johns Hopkins University.	Abelson R, 2020, TRUMP DECIDES 0401; Adimora AA, 2021, LANCET, V397, P1107, DOI 10.1016/S0140-6736(21)00396-2; Arscott J, 2020, AIDS BEHAV, V24, P173, DOI 10.1007/s10461-019-02607-4; Avert, 2019, HIV AIDS US US; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; Barre-Sinoussi F, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25161; Bekker LG, 2018, LANCET, V392, P312, DOI [10.1016/S0140-6736(18)31070-5, 10.1016/s0140-6736(18)31070-5]; Beyrer C, 2018, LANCET HIV, V5, pE541, DOI 10.1016/S2352-3018(18)30212-1; Brincks AM, 2019, AIDS BEHAV, V23, P2859, DOI 10.1007/s10461-019-02464-1; Buchbinder SP, 2019, JAIDS-J ACQ IMM DEF, V82, pS176, DOI 10.1097/QAI.0000000000002200; Burns PA, 2020, J RACIAL ETHN HEALTH, V7, P193, DOI 10.1007/s40615-019-00691-9; Central Intelligence Agency, 2016, WORLD FACTB HIV AIDS; Csete J, 2016, LANCET, V387, P1427, DOI 10.1016/S0140-6736(16)00619-X; del Rio C, 2019, CLIN INFECT DIS, V69, P1434, DOI 10.1093/cid/ciz155; Desir FA, 2019, CLIN INFECT DIS, V68, P795, DOI 10.1093/cid/ciy556; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Goldstein RH, 2019, NEW ENGL J MED, V381, P2491, DOI 10.1056/NEJMp1913547; Gonsalves GS, 2018, LANCET HIV, V5, pE569, DOI 10.1016/S2352-3018(18)30176-0; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hodder SL, 2021, LANCET, V397, P1139, DOI 10.1016/S0140-6736(21)00391-3; Karasz HN, 2017, HIV AIDS; Kates J, 2021, LANCET, V397, P1127, DOI 10.1016/S0140-6736(21)00397-4; Mandsager P, 2018, AM J PUBLIC HEALTH, V108, pS246, DOI [10.2105/AJPH.2018.304689, 10.2105/ajph.2018.304689]; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; Mayer KH, 2021, LANCET, V397, P1116, DOI 10.1016/S0140-6736(21)00321-4; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Millett GA, 2012, LANCET, V380, P341, DOI 10.1016/S0140-6736(12)60899-X; Mofenson LM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25352; Office of the Governor of New York State, 2019, GOV CUOM ANN NEW DAT; Page KR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005953; Poteat T, 2020, ANN EPIDEMIOL, V47, P1, DOI 10.1016/j.annepidem.2020.05.004; Siegler AJ, 2018, ANN EPIDEMIOL, V28, P841, DOI 10.1016/j.annepidem.2018.06.005; Sofer D, 2019, AM J NURS, V119, P15, DOI 10.1097/01.NAJ.0000554536.64901.d4; Sullivan PS, 2021, LANCET, V397, P1095, DOI 10.1016/S0140-6736(21)00395-0; Sullivan PS, 2014, CURR OPIN HIV AIDS, V9, P199, DOI 10.1097/COH.0000000000000039; Suttle R, 2019, WHY IS US TREAT IT O; Tolbert Jennifer, 2020, KEY FACTS UN POP; UNAIDS, 2020, WORLD AIDS DAY 2020; United States Leadership Against HIV/AIDS Tuberculosis and Malaria Act of 2003, 2003, TUB MAL ACT 2003 HR; US Centers for Disease Control and Prevention, 2018, HIV SURVEILLANCE SUP; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; White House Office of National AIDS Policy, 2015, NAT HIV AIDS STRAT U	43	13	13	2	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 20	2021	397	10279					1151	1156		10.1016/S0140-6736(21)00390-1	http://dx.doi.org/10.1016/S0140-6736(21)00390-1		MAR 2021	6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QZ0AN	33617770	Green Accepted			2022-12-28	WOS:000630397800032
J	Shepherd, A				Shepherd, Alison			Portraits of the people who made vaccines possible	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2021	372								n595	10.1136/bmj.n595	http://dx.doi.org/10.1136/bmj.n595			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RC6PH	33664050	Bronze			2022-12-28	WOS:000632920100011
J	Boytchev, H				Boytchev, Hristio			Covid-19: Germany struggles with slow uptake of Oxford AstraZeneca vaccine	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		AstraZeneca, 2021, KOMMT BALD NEUE EMPF; Boytchev H, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n414; Robert Kock Institut,, DIG IMPFQ ZUR COV 19	3	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2021	372								n619	10.1136/bmj.n619	http://dx.doi.org/10.1136/bmj.n619			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UD4NT	33658177	Bronze			2022-12-28	WOS:000687185300002
J	Mahase, E				Mahase, Elisabeth			Covid-19: Where are we on vaccines and variants?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, BLOOMBERG NEWS; [Anonymous], 2021, JOHNSON JOHNSON COVI; [Anonymous], 2021, S AFR UN RAT HITS NE; [Anonymous], 2021, NOVAVAX COVID 19 VAC; Beusekom MV, 2021, PFIZER MODERNA VACCI; Boytchev H, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n414; Garde D, 2021, STAT; Glenza Jessica., 2021, GUARDIAN; Golubchik Emary T., 2021, EFFICACY CHADOX1 NCO; Howard Jonathan C., 2009, Journal of Biology (London), V8, P15, DOI 10.1186/jbiol123; Logunov DY, 2021, LANCET; LOOI MK, 2021, BMJ-BRIT MED J, V372, DOI DOI 10.1136/BMJ.N459; MAHASE E, 2021, BMJ BRIT MED J, V372; MAHASE E, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4826; MAHASE E, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4471; MAHASE E, 2020, BMJ-BRIT MED J, V371, P61120, DOI DOI 10.1136/BMJ.M4944; Mallapaty S., 2021, NATURE; Rawlinson K., 2021, GUARDIAN; TORJESEN I, 2021, BMJ-BRIT MED J, V372, P19037, DOI DOI 10.1136/BMJ.N523; Wee, 2020, NEW YORK TIMES; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n567; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n326	22	59	59	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 2	2021	372								n597	10.1136/bmj.n597	http://dx.doi.org/10.1136/bmj.n597			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QR6QF	33653708	Bronze			2022-12-28	WOS:000625340300012
J	Robinson, F				Robinson, Francesca			Valuing staff in a pandemic: emergency medicine consultant Stevan Bruijns	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 1	2021	372								n539	10.1136/bmj.n539	http://dx.doi.org/10.1136/bmj.n539			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UC5ZB	33648955	Bronze			2022-12-28	WOS:000686602900001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: NHS England pledges extra funding to local areas to reduce vaccine inequalities	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cabinet Office, RAC DISP UN 2 Q REP; Iacobucci G., 2021, BMJ-BRIT MED J, P372, DOI DOI 10.1136/BMJ.N18.HTTPS://WWW.BMJ.C0M/C0NTENT/372/BMJ.N18.PMID:33408068; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n548; NHS England, 2021, FURTH OPP PCN COMM P; NHS England, 2021, SUPP CCGS ADDR VACC	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2021	372								n580	10.1136/bmj.n580	http://dx.doi.org/10.1136/bmj.n580			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QQ1OX	33637487	Bronze			2022-12-28	WOS:000624297200003
J	Sternberg, ED; Cook, J; Alou, LPA; Assi, SB; Koffi, AA; Doudou, DT; Aoura, CJ; Wolie, RZ; Oumbouke, WA; Worrall, E; Kleinschmidt, I; N'Guessan, R; Thomas, MB				Sternberg, Eleanore D.; Cook, Jackie; Alou, Ludovic P. Ahoua; Assi, Serge Brice; Koffi, Alphonsine A.; Doudou, Dimi T.; Aoura, Carine J.; Wolie, Rosine Z.; Oumbouke, Welbeck A.; Worrall, Eve; Kleinschmidt, Immo; N'Guessan, Raphael; Thomas, Matthew B.			Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Cote d'Ivoire: a two-arm, cluster-randomised controlled trial	LANCET			English	Article							EAVE TUBES; AFRICA; INSECTICIDES; PERMETHRIN; SEMIFIELD	Background New vector control tools are required to sustain the fight against malaria. Lethal house lures, which target mosquitoes as they attempt to enter houses to blood feed, are one approach. Here we evaluated lethal house lures consisting of In2Care (Wageningen, Netherlands) Eave Tubes, which provide point-source insecticide treatments against host-seeking mosquitoes, in combination with house screening, which aims to reduce mosquito entry. Methods We did a two-arm, cluster-randomised controlled trial with 40 village-level clusters in central Cote d'Ivoire between Sept 26, 2016, and April 10, 2019. All households received new insecticide-treated nets at universal coverage (one bednet per two people). Suitable households within the clusters assigned to the treatment group were offered screening plus Eave Tubes, with Eave Tubes treated using a 10% wettable powder formulation of the pyrethroid beta-cyfluthrin. Because of the nature of the intervention, treatment could not be masked for households and field teams, but all analyses were blinded. The primary endpoint was clinical malaria incidence recorded by active case detection over 2 years in cohorts of children aged 6 months to 10 years. This trial is registered with ISRCTN, ISRCTN18145556. Findings 3022 houses received screening plus Eave Tubes, with an average coverage of 70% across the intervention clusters. 1300 eligible children were recruited for active case detection in the control group and 1260 in the intervention group. During the 2-year follow-up period, malaria case incidence was 2.29 per child-year (95% CI 1.97-2.61) in the control group and 1.43 per child-year (1.21-1.65) in the intervention group (hazard ratio 0.62, 95% CI 0.51-0.76; p<0.0001). Cost-effectiveness simulations suggested that screening plus Eave Tubes has a 74.0% chance of representing a cost-effective intervention, compared with existing healthcare activities in Cote d'Ivoire, and is similarly cost-effective to other core vector control interventions across sub-Saharan Africa. No serious adverse events associated with the intervention were reported during follow-up. Interpretation Screening plus Eave Tubes can provide protection against malaria in addition to the effects of insecticide-treated nets, offering potential for a new, cost-effective strategy to supplement existing vector control tools. Additional trials are needed to confirm these initial results and further optimise Eave Tubes and the lethal house lure concept to facilitate adoption. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Sternberg, Eleanore D.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Sternberg, Eleanore D.; Worrall, Eve] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Oumbouke, Welbeck A.] Univ Liverpool Liverpool Sch Trop Med, Innovat Vector Control Consortium, Liverpool, Merseyside, England; [Cook, Jackie; Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Oumbouke, Welbeck A.; N'Guessan, Raphael] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Alou, Ludovic P. Ahoua; Assi, Serge Brice; Koffi, Alphonsine A.; Aoura, Carine J.; Wolie, Rosine Z.; Oumbouke, Welbeck A.; N'Guessan, Raphael] Inst Natl Sante Publ, Inst Pierre Richet, Bouake, Cote Ivoire; [Doudou, Dimi T.] Univ Alassane Ouattara, Ctr Rech Dev, Lab Sante Nutr & Hyg, Bouake, Cote Ivoire; [Wolie, Rosine Z.] Univ Felix Houphouet Boigny, Lab Genet, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Kleinschmidt, Immo] Univ Witwatersrand, Wits Res Inst Malaria, Sch Pathol, Johannesburg, South Africa; [Kleinschmidt, Immo] Southern African Dev Community Malaria Eliminat E, Windhoek, Namibia; [Thomas, Matthew B.] Univ York, York Environm Sustainabil Inst, York, N Yorkshire, England; [Thomas, Matthew B.] Univ York, Dept Biol, York, N Yorkshire, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Liverpool School of Tropical Medicine; Liverpool School of Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; University of York - UK; University of York - UK	Sternberg, ED (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England.	eleanore.sternberg@lstmed.ac.uk	Worrall, Eve/J-2564-2015; Worrall, Eve/O-4845-2019	Worrall, Eve/0000-0001-9147-3388; Worrall, Eve/0000-0001-9147-3388; Oumbouke, Welbeck/0000-0002-7254-7860; NGuessan, Raphael/0000-0003-4930-4534	Bill AMP; Melinda Gates Foundation	Bill AMP; Melinda Gates Foundation(CGIAR)	The Bill & Melinda Gates Foundation.	Andriessen R, 2015, P NATL ACAD SCI USA, V112, P12081, DOI 10.1073/pnas.1510801112; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; Barreaux AMG, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2457-4; BEACH RF, 1993, AM J TROP MED HYG, V49, P290, DOI 10.4269/ajtmh.1993.49.290; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Dalrymple U, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2371-9; Feachem RGA, 2019, LANCET, V394, P1056, DOI 10.1016/S0140-6736(19)31139-0; Garner, 2019, COCHRANE DB SYST REV, V8; Getawen SK, 2018, ACTA TROP, V181, P84, DOI 10.1016/j.actatropica.2018.02.009; Jatta E, 2018, LANCET PLANET HEALTH, V2, pE498, DOI [10.1016/S2542-5196(18)30234-1, 10.1016/s2542-5196(18)30234-1]; Killeen GF, 2017, EMERG INFECT DIS, V23, P782, DOI 10.3201/eid2305.160662; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Knols BGJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1452-x; Koffi AA, 2015, PARASITE, V22, DOI 10.1051/parasite/2015028; Koffi AA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-151; Mmbando AS, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2520-1; Ondiba IM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198970; Oumbouke WA, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2517-9; Pinder M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1400-7; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Shenton FC, 2019, CITIES HLTH, DOI [10.1080/23748834.2019.1684771, DOI 10.1080/23748834.2019.1684771]; Snetselaar J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1926-5; Sternberg ED, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5746-5; Sternberg ED, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1499-8; Tusting LS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003055; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; von Seidlein L, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002909; Waite JL, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1505-1; WHO, 2020, OV INT CLASS PROT PR; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2019, MAL ER BEN FUT SCEN	31	10	10	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2021	397	10276					805	815		10.1016/S0140-6736(21)00250-6	http://dx.doi.org/10.1016/S0140-6736(21)00250-6		FEB 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QP6DN	33640067	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000623925500031
J	Mundt, S; Keller, A; Greter, M				Mundt, Sarah; Keller, Annika; Greter, Melanie			The dural sinus hub: more than just a brain drain	CELL			English	Editorial Material								Recent findings of an active neuroimmune exchange at brain border regions have challenged the concept of the immune-privileged central nervous system. The study by Rustenhoven et al. in this issue of Cell shows that dural sinuses serve as a conduit for brain- derived antigens to interact with the immune system, allowing in situ immune surveillance.	[Mundt, Sarah; Greter, Melanie] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Keller, Annika] Univ Zurich, Univ Zurich Hosp, Dept Neurosurg, Clin Neurosci Ctr, CH-8952 Schlieren, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital	Greter, M (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	greter@immunology.uzh.ch		Mundt, Sarah/0000-0003-2169-2109; Greter, Melanie/0000-0002-7220-5369				[Anonymous], TITLE ERROR; Engelhardt B, 2016, ACTA NEUROPATHOL, V132, P317, DOI 10.1007/s00401-016-1606-5; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Mastorakos P, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav0492; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Mrdjen D., 2018, IMMUNITY, V48; Mundt S, 2019, TRENDS NEUROSCI, V42, P667, DOI 10.1016/j.tins.2019.07.008; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2021	184	4					858	860		10.1016/j.cell.2021.01.040	http://dx.doi.org/10.1016/j.cell.2021.01.040		FEB 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	QX9AD	33606985				2022-12-28	WOS:000629633400005
J	Cai, WJ; Ng, B; Geng, T; Wu, LX; Santoso, A; McPhaden, MJ				Cai, Wenju; Ng, Benjamin; Geng, Tao; Wu, Lixin; Santoso, Agus; McPhaden, Michael J.			Butterfly effect and a self-modulating El Nino response to global warming (vol 585, pg 68, 2020)	NATURE			English	Correction												Wenju.cai@csiro.au; lxwu@ouc.edu.cn	Ng, Benjamin/AAG-1306-2020; Santoso, Agus/P-1918-2019	Ng, Benjamin/0000-0002-4458-4592; Santoso, Agus/0000-0001-7749-8124; geng, tao/0000-0002-3385-7110				Cai WJ, 2020, NATURE, V585, P68, DOI 10.1038/s41586-020-2641-x	1	1	1	7	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2021	591	7849					E14	E15		10.1038/s41586-021-03261-4	http://dx.doi.org/10.1038/s41586-021-03261-4		FEB 2021	2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QX8UA	33199920	Bronze			2022-12-28	WOS:000619509600001
J	Cai, WJ; Ng, B; Geng, T; Wu, LX; Santoso, A; McPhaden, MJ				Cai, Wenju; Ng, Benjamin; Geng, Tao; Wu, Lixin; Santoso, Agus; McPhaden, Michael J.			Butterfly effect and a self-modulating El Nino response to global warming (vol 585, pg 68, 2020)	NATURE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				Wenju.cai@csiro.au	Ng, Benjamin/AAG-1306-2020; Santoso, Agus/P-1918-2019	Ng, Benjamin/0000-0002-4458-4592; Santoso, Agus/0000-0001-7749-8124; geng, tao/0000-0002-3385-7110				Cai WJ, 2020, NATURE, V585, P68, DOI 10.1038/s41586-020-2641-x	1	1	1	7	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 3	2021	588	7836					E3	E3		10.1038/s41586-020-2958-5	http://dx.doi.org/10.1038/s41586-020-2958-5			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ZL2KB	33199920	Bronze			2022-12-28	WOS:000763507800004
J	Cutler, D				Cutler, David			Building Health Care Better Means Reining In Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Cutler, David] Harvard Univ, Dept Econ, 1805 Cambridge St, Cambridge, MA 02138 USA; [Cutler, David] Harvard Univ, Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard University	Cutler, D (corresponding author), Harvard Univ, Dept Econ, 1805 Cambridge St, Cambridge, MA 02138 USA.	dcutler@harvard.edu		Cutler, David/0000-0002-4949-8917					0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 9	2021	325	10					922	923		10.1001/jama.2021.1578	http://dx.doi.org/10.1001/jama.2021.1578			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QV3UE	33687455	Bronze			2022-12-28	WOS:000627899400003
